PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Benito, J; Shi, YX; Szymanska, B; Carol, H; Boehm, I; Lu, HB; Konoplev, S; Fang, WD; Zweidler-McKay, PA; Campana, D; Borthakur, G; Bueso-Ramos, C; Shpall, E; Thomas, DA; Jordan, CT; Kantarjian, H; Wilson, WR; Lock, R; Andreeff, M; Konopleva, M				Benito, Juliana; Shi, Yuexi; Szymanska, Barbara; Carol, Hernan; Boehm, Ingrid; Lu, Hongbo; Konoplev, Sergej; Fang, Wendy; Zweidler-McKay, Patrick A.; Campana, Dario; Borthakur, Gautam; Bueso-Ramos, Carlos; Shpall, Elizabeth; Thomas, Deborah A.; Jordan, Craig T.; Kantarjian, Hagop; Wilson, William R.; Lock, Richard; Andreeff, Michael; Konopleva, Marina			Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; NF-KAPPA-B; ACUTE MYELOID-LEUKEMIA; BONE-MARROW MICROENVIRONMENT; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; KETO REDUCTASE 1C3; INDUCIBLE FACTOR-1-ALPHA; CANCER-TREATMENT; GENE-EXPRESSION	Recent studies indicate that interactions between leukemia cells and the bone marrow (BM) microenvironment promote leukemia cell survival and confer resistance to anti-leukemic drugs. There is evidence that BM microenvironment contains hypoxic areas that confer survival advantage to hematopoietic cells. In the present study we investigated whether hypoxia in leukemic BM contributes to the protective role of the BM microenvironment. We observed a marked expansion of hypoxic BM areas in immunodeficient mice engrafted with acute lymphoblastic leukemia (ALL) cells. Consistent with this finding, we found that hypoxia promotes chemoresistance in various ALL derived cell lines. These findings suggest to employ hypoxia-activated prodrugs to eliminate leukemia cells within hypoxic niches. Using several xenograft models, we demonstrated that administration of the hypoxia-activated dinitrobenzamide mustard, PR-104 prolonged survival and decreased leukemia burden of immune-deficient mice injected with primary acute lymphoblastic leukemia cells. Together, these findings strongly suggest that targeting hypoxia in leukemic BM is feasible and may significantly improve leukemia therapy.	[Benito, Juliana; Shi, Yuexi; Lu, Hongbo; Borthakur, Gautam; Thomas, Deborah A.; Kantarjian, Hagop; Andreeff, Michael; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA; [Shpall, Elizabeth; Andreeff, Michael; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Konoplev, Sergej; Bueso-Ramos, Carlos] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Fang, Wendy; Zweidler-McKay, Patrick A.] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Szymanska, Barbara; Carol, Hernan; Boehm, Ingrid] Univ New S Wales, Lowy Canc Res Ctr C25, Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia; [Campana, Dario] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Jordan, Craig T.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Wilson, William R.; Lock, Richard] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Children's Cancer Institute; University of New South Wales Sydney; St Jude Children's Research Hospital; University of Rochester; University of Auckland	Benito, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA.	mkonople@mdanderson.org	Carol, Hernan/F-5750-2013; Borthakur, Gautam/AAQ-4490-2021; jordan, craig/D-7666-2014	Carol, Hernan/0000-0002-9443-8032; Stacey, Ingrid/0000-0002-3032-6031; Zweidler-McKay, Patrick/0000-0001-6621-523X; jordan, craig/0000-0003-0869-3465; Lock, Richard/0000-0002-3436-9071	National Cancer Institute [NOI-CM-42216, NOI-CM-91001-03, P01 CA55164, 1R21CA153019-01, 1R01CA155056-01]; UTMDACC; Paul and Mary Haas Chair in Genetics; National Institutes of Health Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, R21CA153019, R01CA042216, R01CA155056, P01CA055164] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UTMDACC; Paul and Mary Haas Chair in Genetics; National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, NOI-CM-42216 and NOI-CM-91001-03, P01 CA55164 (to MA), 1R21CA153019-01 and 1R01CA155056-01 (MK), UTMDACC Institutional Research Grant (to MK), the Paul and Mary Haas Chair in Genetics (to MA) and National Institutes of Health Cancer Center Support Grant CA016672 (to Flow Cytometry and Cellular Imaging Facility and Research Animal Support Facility at UT MD Anderson Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ADV EXP MED BIOL, V602, P61; Birtwistle L, 2009, MUTAT RES-FUND MOL M, V662, P67, DOI 10.1016/j.mrfmmm.2008.12.010; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cairns R, 2006, MOL CANCER RES, V4, P61, DOI 10.1158/1541-7786.MCR-06-0002; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Colla S, 2010, LEUKEMIA, V24, P1967, DOI 10.1038/leu.2010.193; Fiegl M, 2009, BLOOD, V113, P1504, DOI 10.1182/blood-2008-06-161539; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Greenberger LM, 2008, MOL CANCER THER, V7, P3598, DOI 10.1158/1535-7163.MCT-08-0510; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Hicks KO, 2007, INT J RADIAT ONCOL, V69, P560, DOI 10.1016/j.ijrobp.2007.05.049; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Houghton PJ, 2011, PEDIATR BLOOD CANCER, V57, P443, DOI 10.1002/pbc.22921; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Iwasaki H, 2009, CANCER SCI, V100, P1166, DOI 10.1111/j.1349-7006.2009.01177.x; Jameson MB, 2010, CANCER CHEMOTH PHARM, V65, P791, DOI 10.1007/s00280-009-1188-1; Jensen PO, 2000, CELL PROLIFERAT, V33, P381, DOI 10.1046/j.1365-2184.2000.00183.x; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mortensen BT, 1998, BRIT J HAEMATOL, V102, P458; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Patterson AV, 2007, CLIN CANCER RES, V13, P3922, DOI 10.1158/1078-0432.CCR-07-0478; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Reikvam Hakon, 2009, Critical Reviews in Oncogenesis, V15, P1; Schaefer C, 2008, LEUKEMIA, V22, P59, DOI 10.1038/sj.leu.2404947; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Singleton RS, 2009, CANCER RES, V69, P3884, DOI 10.1158/0008-5472.CAN-08-4023; Stratford IJ, 2003, SEMIN RADIAT ONCOL, V13, P42, DOI 10.1053/srao.2003.50008; Sung B, 2010, CANCER RES, V70, P3259, DOI 10.1158/0008-5472.CAN-09-4230; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Taylor CT, 2009, ANN NY ACAD SCI, V1177, P178, DOI 10.1111/j.1749-6632.2009.05024.x; Thompson JE, 2007, EXP HEMATOL, V35, P21, DOI 10.1016/j.exphem.2006.08.017; Tracey L, 2010, LEUKEMIA, V24, P806, DOI 10.1038/leu.2010.2; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wellmann S, 2004, LEUKEMIA, V18, P926, DOI 10.1038/sj.leu.2403332; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhong H, 1999, CANCER RES, V59, P5830	53	89	94	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23108	10.1371/journal.pone.0023108	http://dx.doi.org/10.1371/journal.pone.0023108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853076	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953400027
J	Wang, XQ; Zhang, SG				Wang, Xiaoqiang; Zhang, Shuguang			Production of a Bioengineered G-Protein Coupled Receptor of Human Formyl Peptide Receptor 3	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DRUG DISCOVERY; RHODOPSIN; EXPRESSION; PURIFICATION; ANTAGONIST; ACTIVATION; MUTANTS; CXCR4; OPSIN	G-protein coupled receptors (GPCRs) participate in a wide range of vital regulations of our physiological actions. They are also of pharmaceutical importance and have become many therapeutic targets for a number of disorders and diseases. Purified GPCR-based approaches including structural study and novel biophysical and biochemical function analyses are increasingly being used in GPCR-directed drug discovery. Before these approaches become routine, however, several hurdles need to be overcome; they include overexpression, solubilization, and purification of large quantities of functional and stable receptors on a regular basis. Here we report milligram production of a human formyl peptide receptor 3 (FPR3). FPR3 comprises a functionally distinct GPCR subfamily that is involved in leukocyte chemotaxis and activation. The bioengineered FPR3 was overexpressed in stable tetracycline-inducible mammalian cell lines (HEK293S). After a systematic detergent screening, fos-choline-14 (FC-14) was selected for subsequent solubilization and purification processes. A two-step purification method, immunoaffinity using anti-rho-tag monoclonal antibody 1D4 and gel filtration, was used to purify the receptors to near homogeneity. Immunofluorescence analysis showed that expressed FPR3 was predominantly displayed on cellular membrane. Secondary structural analysis using circular dichroism showed that the purified FPR3 receptor was correctly folded with >50% alpha-helix, which is similar to other known GPCR secondary structures. Our method can readily produce milligram quantities of human FPR3, which would facilitate in developing human FPR as therapeutic drug targets.	[Wang, Xiaoqiang] China Univ Petr E China, Ctr Bioengn Biotechnol, Qingdao, Shandong, Peoples R China; [Zhang, Shuguang] MIT, Lab Mol Fabricat, Ctr Bits & Atoms, Cambridge, MA 02139 USA	China University of Petroleum; Massachusetts Institute of Technology (MIT)	Wang, XQ (corresponding author), China Univ Petr E China, Ctr Bioengn Biotechnol, Qingdao, Shandong, Peoples R China.	shuguang@mit.edu		Zhang, Shuguang/0000-0002-3856-3752	China University of Petroleum (East China);  [DARPA-HR0011-09-C-0012]	China University of Petroleum (East China); 	This work is supported in part from DARPA-HR0011-09-C-0012. XW is also supported from a fellowship from China University of Petroleum (East China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalfioui F, 2009, CURR OPIN PHARMACOL, V9, P629, DOI 10.1016/j.coph.2009.04.002; BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; Braun MC, 2001, BLOOD, V97, P3531, DOI 10.1182/blood.V97.11.3531; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; DURSTIN M, 1994, BIOCHEM BIOPH RES CO, V201, P174, DOI 10.1006/bbrc.1994.1685; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Gupta R, 2004, PREDICTION N GLYCOSY; Heilker R, 2009, DRUG DISCOV TODAY, V14, P231, DOI 10.1016/j.drudis.2008.11.011; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Leck KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015027; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Lundstrom K, 2005, TRENDS BIOTECHNOL, V23, P103, DOI 10.1016/j.tibtech.2004.12.006; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Panaro MA, 2006, IMMUNOPHARM IMMUNOT, V28, P103, DOI 10.1080/08923970600625975; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Su SB, 1999, BLOOD, V93, P3885, DOI 10.1182/blood.V93.11.3885.411k19_3885_3892; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23076	10.1371/journal.pone.0023076	http://dx.doi.org/10.1371/journal.pone.0023076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853070	Green Published, gold			2022-12-27	WOS:000293953400024
J	Zhou, YE; O'Rourke, JP; Edwards, JS; Ness, SA				Zhou, Ye E.; O'Rourke, John P.; Edwards, Jeremy S.; Ness, Scott A.			Single Molecule Analysis of c-myb Alternative Splicing Reveals Novel Classifiers for Precursor B-ALL	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TERMINAL TRUNCATION; GENE; CELLS; PROTEINS; DIFFERENTIATION; TRANSFORMATION; ACTIVATION; ONCOGENE; SF2/ASF	The c-Myb transcription factor, a key regulator of proliferation and differentiation in hematopoietic and other cell types, has an N-terminal DNA binding domain and a large C-terminal domain responsible for transcriptional activation, negative regulation and determining target gene specificity. Overexpression and rearrangement of the c-myb gene (MYB) has been reported in some patients with leukemias and other types of cancers, implicating activated alleles of c-myb in the development of human tumors. Alternative RNA splicing can produce variants of c-myb with qualitatively distinct transcriptional activities that may be involved in transformation and leukemogenesis. Here, by performing a detailed, single molecule assay we found that c-myb alternative RNA splicing was elevated and much more complex in leukemia samples than in cell lines or CD34+ hematopoietic progenitor cells from normal donors. The results revealed that leukemia samples express more than 60 different c-myb splice variants, most of which have multiple alternative splicing events and were not detectable by conventional microarray or PCR approaches. For example, the single molecule assay detected 21 and 22 splice variants containing the 9B and 9S exons, respectively, most of which encoded unexpected variant forms of c-Myb protein. Furthermore, the detailed analysis identified some splice variants whose expression correlated with poor survival in a small cohort of precursor B-ALL samples. Our findings indicate that single molecule assays can reveal complexities in c-myb alternative splicing that have potential as novel biomarkers and could help explain the role of c-Myb variants in the development of human leukemia.	[Zhou, Ye E.; O'Rourke, John P.; Edwards, Jeremy S.; Ness, Scott A.] Univ New Mexico, Dept Mol Genet & Microbiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Zhou, YE (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	ness@unm.edu	Ness, Scott/AAV-4009-2020	Ness, Scott/0000-0001-6965-8909	National Institutes of Health (NIH) [5R01CA058443, 5R01CA105257]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Core Center of Excellence in Hematology [DK56465]; UNM Cancer Center [2P30CA118100]; UNM Clinical Translational Science Center [1UL1RR031977]; NATIONAL CANCER INSTITUTE [P30CA118100, R01CA058443, R01CA105257] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Core Center of Excellence in Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UNM Cancer Center; UNM Clinical Translational Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants 5R01CA058443 and 5R01CA105257 (to SAN). Purified CD34+ cells were provided by the Fred Hutchinson Cancer Research Center Large-Scale Cell Processing Core, supported by the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Core Center of Excellence in Hematology grant DK56465. Some experiments used the Keck-University of New Mexico (UNM) Genomics Resource, the microarray and gene expression shared resource supported by the UNM Cancer Center (2P30CA118100) and the UNM Clinical Translational Science Center (1UL1RR031977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bies J, 1997, ONCOGENE, V14, P203, DOI 10.1038/sj.onc.1200828; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; Fahl SP, 2009, J IMMUNOL, V183, P5582, DOI 10.4049/jimmunol.0901187; GONDA TJ, 1989, EMBO J, V8, P1777, DOI 10.1002/j.1460-2075.1989.tb03571.x; Hu TS, 2010, NAT IMMUNOL, V11, P435, DOI 10.1038/ni.1865; HU YL, 1991, ONCOGENE, V6, P1549; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Kang HN, 2010, BLOOD, V115, P1394, DOI 10.1182/blood-2009-05-218560; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kumar A, 2003, MOL CELL BIOL, V23, P6631, DOI 10.1128/MCB.23.18.6631-6645.2003; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lei WL, 2004, J BIOL CHEM, V279, P29519, DOI 10.1074/jbc.M403133200; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Mullighan CG, 2011, CLIN CANCER RES, V17, P396, DOI 10.1158/1078-0432.CCR-10-1203; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; O'Rourke JP, 2008, MOL CELL BIOL, V28, P2091, DOI 10.1128/MCB.01870-07; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Quintana AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017362; RAMSAY RG, 1989, ONCOGENE RES, V4, P259; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; SCHUUR ER, 1994, ONCOGENE, V9, P3363; SHENONG GLC, 1987, EMBO J, V6, P4035, DOI 10.1002/j.1460-2075.1987.tb02748.x; Somervaille TCP, 2010, INT J HEMATOL, V91, P735, DOI 10.1007/s12185-010-0579-8; Sun SY, 2010, NAT STRUCT MOL BIOL, V17, P306, DOI 10.1038/nsmb.1750; WESTIN EH, 1990, ONCOGENE, V5, P1117; Woo CH, 1998, J VIROL, V72, P6813, DOI 10.1128/JVI.72.8.6813-6821.1998; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792	36	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22880	10.1371/journal.pone.0022880	http://dx.doi.org/10.1371/journal.pone.0022880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853052	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953400016
J	Figueiredo, J; Simoes-Correia, J; Soderberg, O; Suriano, G; Seruca, R				Figueiredo, Joana; Simoes-Correia, Joana; Soderberg, Ola; Suriano, Gianpaolo; Seruca, Raquel			ADP-Ribosylation Factor 6 Mediates E-Cadherin Recovery by Chemical Chaperones	PLOS ONE			English	Article							CELL-CELL ADHESION; DIFFUSE GASTRIC-CANCER; GERMLINE MUTATIONS; ADHERENS JUNCTIONS; PLASMA-MEMBRANE; BETA-CATENIN; I-GAMMA; ENDOCYTOSIS; PROTEIN; ARF6	E-cadherin plays a powerful tumor suppressor role. Germline E-cadherin mutations justify 30% of Hereditary Diffuse Gastric Cancer (HDGC) and missense mutations are found in 30% of these families. We found possible to restore in vitro mutant E-cadherin associated to HDGC syndrome by using Chemical Chaperones (CCs). Herein, our aim was to disclose the molecular mechanisms underlying the CCs effects in E-cadherin regulation. Using cells stably expressing WT E-cadherin or two HDGC-associated missense mutations, we show that upon DMSO treatment, not only mutant E-cadherin is restored and stabilized at the plasma membrane (PM), but also Arf6 and PIPKI gamma expressions are altered. We show that modulation of Arf6 expression partially mimics the effect of CCs, suggesting that the cellular effects observed upon CCs treatment are mediated by Arf6. Further, we show that E-cadherin expression recovery is specifically linked to Arf6 due to its role on endocytosis and recycling pathways. Finally, we demonstrated that, as DMSO, several others CCs are able to modulate the trafficking machinery through an Arf6 dependent mechanism. Interestingly, the more effective compounds in E-cadherin recovery to PM are those that simultaneously inhibit Arf6 and stimulate PIPKI gamma expression and binding to E-cadherin. Here, we present the first evidence of a direct influence of CCs in cellular trafficking machinery and we show that this effect is of crucial importance in the context of juxtamembrane E-cadherin missense mutations associated to HDGC. We propose that this influence should be taken into account when exploring the therapeutic potential of this type of chemicals in genetic diseases associated to protein-misfolding.	[Figueiredo, Joana; Simoes-Correia, Joana; Suriano, Gianpaolo; Seruca, Raquel] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Figueiredo, Joana; Seruca, Raquel] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Simoes-Correia, Joana] Ctr Ophthalmol & Vis Sci, Inst Biomed Res Light & Image, Coimbra, Portugal; [Soderberg, Ola] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Uppsala University	Figueiredo, J (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.		seruca, raquel/F-8187-2011; Söderberg, Ola/O-5130-2017; Simões Correia, Joana/C-8755-2012; Figueiredo, Joana/J-7305-2013	Söderberg, Ola/0000-0003-2883-1925; Simões Correia, Joana/0000-0003-2623-5628; Figueiredo, Joana/0000-0002-1590-1974; Seruca, Raquel/0000-0002-8851-4166	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAUOBD/64319/2006, PTDC/SAUOBD/104017/2008, SFRH/BD/43763/2008, PTDC/SAU-ONC/110294/2009]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grants from the Fundacao para a Ciencia e Tecnologia, Portugal: PTDC/SAUOBD/64319/2006, PTDC/SAUOBD/104017/2008, SFRH/BD/43763/2008, and PTDC/SAU-ONC/110294/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Angst BD, 2001, J CELL SCI, V114, P625; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; CARNEIRO F, INT J SURG PATHOL, V18, pS33; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Gabbert HE, 1996, INT J CANCER, V69, P184, DOI 10.1002/(SICI)1097-0215(19960621)69:3<184::AID-IJC6>3.0.CO;2-W; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jovanovic OA, 2006, MOL BIOL CELL, V17, P327, DOI 10.1091/mbc.E05-06-0523; Karam R, 2008, ONCOGENE, V27, P4255, DOI 10.1038/onc.2008.62; Kaurah P, 2007, JAMA-J AM MED ASSOC, V297, P2360, DOI 10.1001/jama.297.21.2360; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; KUMARI S, CELL RES, V20, P256; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; More H, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9473; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Okamoto R, 2005, GENES CELLS, V10, P435, DOI 10.1111/j.1365-2443.2005.00846.x; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peters PJ, 2002, NAT CELL BIOL, V4, P240, DOI 10.1038/ncb761; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Popov Z, 2000, BRIT J CANCER, V83, P209; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Saitoh M, 2009, BIOCHEM BIOPH RES CO, V381, P560, DOI 10.1016/j.bbrc.2009.02.098; Schweitzer JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005193; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Simoes-Correia J, 2008, HUM MOL GENET, V17, P3566, DOI 10.1093/hmg/ddn249; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Suriano G, 2005, CLIN CANCER RES, V11, P5401, DOI 10.1158/1078-0432.CCR-05-0247; Suriano G, 2003, ONCOGENE, V22, P5716, DOI 10.1038/sj.onc.1206672; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008	63	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23188	10.1371/journal.pone.0023188	http://dx.doi.org/10.1371/journal.pone.0023188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853084	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200050
J	Guo, K; Zhou, WX; Cheng, SW; Sornette, D				Guo, Kun; Zhou, Wei-Xing; Cheng, Si-Wei; Sornette, Didier			The US Stock Market Leads the Federal Funds Rate and Treasury Bond Yields	PLOS ONE			English	Article							TIME LAG STRUCTURE; ECONOMIC-GROWTH; NONPARAMETRIC DETERMINATION; FINANCIAL VARIABLES; MONETARY-POLICY; REAL ACTIVITY; UNIT-ROOT; SERIES; STATISTICS; INFLATION	Using a recently introduced method to quantify the time-varying lead-lag dependencies between pairs of economic time series (the thermal optimal path method), we test two fundamental tenets of the theory of fixed income: (i) the stock market variations and the yield changes should be anti-correlated; (ii) the change in central bank rates, as a proxy of the monetary policy of the central bank, should be a predictor of the future stock market direction. Using both monthly and weekly data, we found very similar lead-lag dependence between the S&P 500 stock market index and the yields of bonds inside two groups: bond yields of short-term maturities (Federal funds rate (FFR), 3M, 6M, 1Y, 2Y, and 3Y) and bond yields of long-term maturities (5Y, 7Y, 10Y, and 20Y). In all cases, we observe the opposite of (i) and (ii). First, the stock market and yields move in the same direction. Second, the stock market leads the yields, including especially the FFR. Moreover, we find that the short-term yields in the first group lead the long-term yields in the second group before the financial crisis that started in mid-2007 and the inverse relationship holds afterwards. These results suggest that the Federal Reserve is increasingly mindful of the stock market behavior, seen as key to the recovery and health of the economy. Long-term investors seem also to have been more reactive and mindful of the signals provided by the financial stock markets than the Federal Reserve itself after the start of the financial crisis. The lead of the S&P 500 stock market index over the bond yields of all maturities is confirmed by the traditional lagged cross-correlation analysis.	[Guo, Kun; Zhou, Wei-Xing; Cheng, Si-Wei] Chinese Acad Sci, Res Ctr Fictitious Econ & Data Sci, Beijing, Peoples R China; [Zhou, Wei-Xing] E China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China; [Zhou, Wei-Xing] E China Univ Sci & Technol, Sch Sci, Shanghai 200237, Peoples R China; [Zhou, Wei-Xing] E China Univ Sci & Technol, Res Ctr Econophys, Shanghai 200237, Peoples R China; [Sornette, Didier] ETH, Dept Management Technol & Econ, Zurich, Switzerland; [Sornette, Didier] Univ Geneva, Swiss Finance Inst, Geneva, Switzerland	Chinese Academy of Sciences; East China University of Science & Technology; East China University of Science & Technology; East China University of Science & Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Guo, K (corresponding author), Chinese Acad Sci, Res Ctr Fictitious Econ & Data Sci, Beijing, Peoples R China.	wxzhou@ecust.edu.cn; dsornette@ethz.ch	Zhou, Wei-Xing/B-1250-2008	Zhou, Wei-Xing/0000-0002-8952-8228; Guo, Kun/0000-0002-4787-8406	Chinese Academy of Sciences Foundation for Planning and Strategy Research [0929015ED2]; Shanghai Municipal Education Commission [2008SG29]; Shanghai Education Development Foundation; National Natural Science Foundation of China [11075054]; Fundamental Research Funds for the Central Universities; ETH Competence Center [CH1-01-08-2]; ETH Zurich Foundation; ETH [ETH-31 10-3]	Chinese Academy of Sciences Foundation for Planning and Strategy Research; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); ETH Competence Center; ETH Zurich Foundation(ETH Zurich); ETH(ETH Zurich)	KG and SWC acknowledge financial support from the Chinese Academy of Sciences Foundation for Planning and Strategy Research (Grant No. 0929015ED2). WXZ acknowledges financial support from the "Shu Guang" project (Grant No. 2008SG29) sponsored by Shanghai Municipal Education Commission and Shanghai Education Development Foundation, the National Natural Science Foundation of China (Grant No. 11075054), and the Fundamental Research Funds for the Central Universities. DS acknowledges financial support from the ETH Competence Center "Coping with crises in complex socio-economic systems" (CCSS) through ETH Research Grant CH1-01-08-2 and ETH Zurich Foundation and ETH Research Grant ETH-31 10-3 "Testing the predictability of financial bubbles and of systemic instabilities." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro L, 2004, J INT ECON, V64, P89, DOI 10.1016/S0022-1996(03)00081-3; Arestis P, 2001, J MONEY CREDIT BANK, V33, P16, DOI 10.2307/2673870; Baeriswyl R, 2010, J MONETARY ECON, V57, P682, DOI 10.1016/j.jmoneco.2010.06.001; BERAN R, 1988, J AM STAT ASSOC, V83, P687, DOI 10.2307/2289292; Bernanke BS, 2005, J FINANC, V60, P1221, DOI 10.1111/j.1540-6261.2005.00760.x; Bjornland HC, 2009, J MONETARY ECON, V56, P275, DOI 10.1016/j.jmoneco.2008.12.001; Brissimis SN, 2006, J MONETARY ECON, V53, P1225, DOI 10.1016/j.jmoneco.2005.05.014; DICKEY DA, 1981, ECONOMETRICA, V49, P1057, DOI 10.2307/1912517; Dooley M, 2009, J INT MONEY FINANC, V28, P1331, DOI 10.1016/j.jimonfin.2009.08.004; FAMA EF, 1981, AM ECON REV, V71, P545; Fatum R, 1999, J MONEY CREDIT BANK, V31, P54, DOI 10.2307/2601139; Forni M, 2003, J MONETARY ECON, V50, P1243, DOI 10.1016/S0304-3932(03)00079-5; Gilchrist S, 2009, J MONETARY ECON, V56, P471, DOI 10.1016/j.jmoneco.2009.03.017; HAUGH LD, 1976, J AM STAT ASSOC, V71, P378, DOI 10.2307/2285318; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Pan X, 2007, INT J THEOR APPL FIN, V10, P437, DOI 10.1142/S0219024907004305; PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335, DOI 10.1093/biomet/75.2.335; Reinhart CM, 2009, AM ECON REV, V99, P466, DOI 10.1257/aer.99.2.466; Rigobon R, 2004, J MONETARY ECON, V51, P1553, DOI 10.1016/j.jmoneco.2004.02.004; SCHWERT GW, 1990, J FINANC, V45, P1237, DOI 10.2307/2328722; Sornette D, 2005, QUANT FINANC, V5, P577, DOI 10.1080/14697680500383763; Tobin J., 1969, J MONEY CREDIT BANK, V1, P15, DOI DOI 10.2307/1991374; Wang XH, 2000, J PHYS CHEM B, V104, P3875, DOI 10.1021/jp993504w; Warnock FE, 2009, J INT MONEY FINANC, V28, P903, DOI 10.1016/j.jimonfin.2009.03.002; Werner RA, 2005, NEW PARADIGM IN MACROECONOMICS: SOLVING THE RIDDLE OF JAPANESE MACROECONOMIC PERFORMANCE, P1, DOI 10.1057/9780230506077; Zhou WX, 2007, PHYSICA A, V380, P287, DOI 10.1016/j.physa.2007.02.114; Zhou WX, 2006, J MACROECON, V28, P195, DOI 10.1016/j.jmacro.2005.10.015; Zhou WX, 2004, PHYSICA A, V337, P586, DOI 10.1016/j.physa.2004.02.009	29	34	34	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22794	10.1371/journal.pone.0022794	http://dx.doi.org/10.1371/journal.pone.0022794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	827UM	21857954	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200021
J	Petersen, AM; Schjorring, S; Gerstrom, SC; Krogfelt, KA				Petersen, Andreas Munk; Schjorring, Susanne; Gerstrom, Sarah Choi; Krogfelt, Karen Angeliki			Treatment of Inflammatory Bowel Disease Associated E. coli with Ciprofloxacin and E. coli Nissle in the Streptomycin-Treated Mouse Intestine	PLOS ONE			English	Article							ESCHERICHIA-COLI; CROHNS-DISEASE; ULCERATIVE-COLITIS; STRAIN NISSLE-1917; PHYLOGENETIC GROUP; EPITHELIAL-CELLS; HIGH PREVALENCE; ILEAL MUCOSA; METAANALYSIS; MESALAZINE	Background: E. coli belonging to the phylogenetic group B2 are linked to Inflammatory Bowel Disease (IBD). Studies have shown that antimicrobials have some effect in the treatment of IBD, and it has been demonstrated that E. coli Nissle has prophylactic abilities comparable to 5-aminosalicylic acid (5-ASA) therapy in ulcerative colitis. The objective of this study was to test if ciprofloxacin and/or E. coli Nissle could eradicate IBD associated E. coli in the streptomycin-treated mouse intestine. Results: After successful colonization with the IBD associated E. coli strains in mice the introduction of E. coli Nissle did not result in eradication of either IBD associated strains or an E. coli from a healthy control, instead, co-colonization at high levels were obtained. Treatment of mice, precolonized with IBD associated E. coli, with ciprofloxacin for three days alone apparently resulted in effective eradication of tested E. coli. However, treatment of precolonized mice with a combination of ciprofloxacin for 3 days followed by E. coli Nissle surprisingly allowed one IBD associated E. coli to re-colonize the mouse intestine, but at a level 3 logs under E. coli Nissle. A prolonged treatment with ciprofloxacin for 7 days did not change this outcome. Conclusions: In the mouse model E. coli Nissle can not be used alone to eradicate IBD associated E. coli; rather, 3 days of ciprofloxacin are apparently efficient in eradicating these strains, but surprisingly, after ciprofloxacin treatment (3 or 7 days), the introduction of E. coli Nissle may support re-colonization with IBD associated E. coli.	[Petersen, Andreas Munk; Schjorring, Susanne; Gerstrom, Sarah Choi; Krogfelt, Karen Angeliki] Statens Serum Inst, Dept Microbiol Surveillance & Res, Unit Gastrointestinal & Serol Res, DK-2300 Copenhagen, Denmark; [Petersen, Andreas Munk] Hvidovre Univ Hosp, Dept Gastroenterol, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen	Petersen, AM (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, Unit Gastrointestinal & Serol Res, DK-2300 Copenhagen, Denmark.	munk@dadlnet.dk	Krogfelt, Karen Angeliki/P-2430-2018; Krogfelt, Karen Angeliki A/O-8145-2016	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Petersen, Andreas Munk/0000-0003-0531-0553; Schjorring, Susanne/0000-0001-5575-7252				Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; COOKE EM, 1974, GUT, V15, P143, DOI 10.1136/gut.15.2.143; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Feller M, 2010, CLIN INFECT DIS, V50, P473, DOI 10.1086/649923; Fellermann K, 2003, EUR J GASTROEN HEPAT, V15, P627, DOI 10.1097/00042737-200306000-00008; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Janowitz HD, 1998, INFLAMM BOWEL DIS, V4, P29, DOI 10.1097/00054725-199802000-00006; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Kuzela L, 2001, AM J GASTROENTEROL, V96, P3216; Leatham MP, 2009, INFECT IMMUN, V77, P2876, DOI 10.1128/IAI.00059-09; Madsen KL, 2001, CLIN INVEST MED, V24, P250; Malchow HA, 1997, J CLIN GASTROENTEROL, V25, P653, DOI 10.1097/00004836-199712000-00021; Marks DJB, 2006, GUT, V55, P1662, DOI 10.1136/gut.2006.104943; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Patzer SI, 2003, MICROBIOL-SGM, V149, P2557, DOI 10.1099/mic.0.26396-0; Petersen AM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-171; POULSEN LK, 1994, INFECT IMMUN, V62, P5191, DOI 10.1128/IAI.62.11.5191-5194.1994; Rahimi R, 2007, DIGEST DIS SCI, V52, P2920, DOI 10.1007/s10620-007-9760-1; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Schjorring S, 2008, J ANTIMICROB CHEMOTH, V62, P1086, DOI 10.1093/jac/dkn323; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9	29	5	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22823	10.1371/journal.pone.0022823	http://dx.doi.org/10.1371/journal.pone.0022823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853049	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200022
J	Stabler, S; Koyama, T; Zhao, ZG; Martinez-Ferrer, M; Allen, RH; Luka, Z; Loukachevitch, LV; Clark, PE; Wagner, C; Bhowmick, NA				Stabler, Sally; Koyama, Tatsuki; Zhao, Zhiguo; Martinez-Ferrer, Magaly; Allen, Robert H.; Luka, Zigmund; Loukachevitch, Lioudmila V.; Clark, Peter E.; Wagner, Conrad; Bhowmick, Neil A.			Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression	PLOS ONE			English	Article							GLYCINE N-METHYLTRANSFERASE; RADICAL PROSTATECTOMY; FOLATE-DEFICIENCY; SARCOSINE; MEN; COBALAMIN; ANTIGEN; MARKER; URINE; ACID	Background: Clinical decision for primary treatment for prostate cancer is dictated by variables with insufficient specificity. Early detection of prostate cancer likely to develop rapid recurrence could support neo-adjuvant therapeutics and adjuvant options prior to frank biochemical recurrence. This study compared markers in serum and urine of patients with rapidly recurrent prostate cancer to recurrence-free patients after radical prostatectomy. Based on previous identification of urinary sarcosine as a metastatic marker, we tested whether methionine metabolites in urine and serum could serve as pre-surgical markers for aggressive disease. Methodology/Principal Findings: Urine and serum samples (n = 54 and 58, respectively), collected at the time of prostatectomy were divided into subjects who developed biochemical recurrence within 2 years and those who remained recurrence-free after 5 years. Multiple methionine metabolites were measured in urine and serum by GC-MS. The role of serum metabolites and clinical variables (biopsy Gleason grade, clinical stage, serum prostate specific antigen [PSA]) on biochemical recurrence prediction were evaluated. Urinary sarcosine and cysteine levels were significantly higher (p = 0.03 and p = 0.007 respectively) in the recurrent group. However, in serum, concentrations of homocysteine (p = 0.003), cystathionine (p = 0.007) and cysteine (p<0.001) were more abundant in the recurrent population. The inclusion of serum cysteine to a model with PSA and biopsy Gleason grade improved prediction over the clinical variables alone (p<0.001). Conclusions: Higher serum homocysteine, cystathionine, and cysteine concentrations independently predicted risk of early biochemical recurrence and aggressiveness of disease in a nested case control study. The methionine metabolites further supplemented known clinical variables to provide superior sensitivity and specificity in multivariable prediction models for rapid biochemical recurrence following prostatectomy.	[Stabler, Sally; Allen, Robert H.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Koyama, Tatsuki; Zhao, Zhiguo] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Martinez-Ferrer, Magaly] Univ Puerto Rico, Dept Surg, San Juan, PR 00936 USA; [Luka, Zigmund; Loukachevitch, Lioudmila V.; Wagner, Conrad] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Clark, Peter E.; Bhowmick, Neil A.] Vanderbilt Univ, Dept Urol Surg, Nashville, TN USA; [Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Vanderbilt University; Vanderbilt University; Cedars Sinai Medical Center	Stabler, S (corresponding author), Univ Colorado, Dept Med, Aurora, CO 80045 USA.	bhowmickn@cshs.org	Clark, Peter/E-1423-2011; Bhowmick, Neil/AAA-7302-2019	Clark, Peter/0000-0002-8006-7015; Bhowmick, Neil/0000-0001-8747-5989	NCI NIH HHS [R01 CA108646] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108646] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; ALLEN RH, 1993, METABOLISM, V42, P978, DOI 10.1016/0026-0495(93)90010-L; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Baik HW, 1999, ANNU REV NUTR, V19, P357, DOI 10.1146/annurev.nutr.19.1.357; Beam CA, 2009, J CLIN ONCOL, V27, P1087, DOI 10.1200/JCO.2008.18.3061; Blum DL, 2008, CLIN CANCER RES, V14, P7790, DOI 10.1158/1078-0432.CCR-08-1716; Cao DL, 2011, PROSTATE CANCER P D, V14, P166, DOI 10.1038/pcan.2011.2; Capitanio U, 2009, INT J UROL, V16, P526, DOI 10.1111/j.1442-2042.2009.02270.x; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Etzioni R, 2002, J NATL CANCER I, V94, P981; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HEADY JE, 1975, CANCER RES, V35, P640; Hewavitharana AK, 2010, EUR UROL, V58, pE39, DOI 10.1016/j.eururo.2010.07.031; HORNE DW, 1988, CLIN CHEM, V34, P2357; Huang YC, 2007, CLIN CANCER RES, V13, P1412, DOI 10.1158/1078-0432.CCR-06-1551; Jentzmik F, 2011, J UROLOGY, V185, P706, DOI 10.1016/j.juro.2010.09.077; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; Kane CJ, 2010, UROLOGY, V76, P695, DOI 10.1016/j.urology.2009.12.073; Khan N, 2010, CANCER LETT, V293, P133, DOI 10.1016/j.canlet.2009.12.013; LEVY HL, 1984, PEDIATRICS, V74, P509; Lin J, 2010, CANCER RES, V70, P2397, DOI 10.1158/0008-5472.CAN-09-3648; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Roehl KA, 2002, J UROLOGY, V167, P2435, DOI 10.1016/S0022-5347(05)64999-3; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STABLER SP, 1988, J CLIN INVEST, V81, P466, DOI 10.1172/JCI113343; Struys EA, 2010, ANN CLIN BIOCHEM, V47, P282, DOI 10.1258/acb.2010.009270; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Thompson KE, 2005, J UROLOGY, V174, P553, DOI 10.1097/01.ju.0000165184.72337.9d	33	65	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22486	10.1371/journal.pone.0022486	http://dx.doi.org/10.1371/journal.pone.0022486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853037	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200014
J	Strickland, IT; Richards, L; Holmes, FE; Wynick, D; Uney, JB; Wong, LF				Strickland, Iain T.; Richards, Louise; Holmes, Fiona E.; Wynick, David; Uney, James B.; Wong, Liang-Fong			Axotomy-Induced miR-21 Promotes Axon Growth in Adult Dorsal Root Ganglion Neurons	PLOS ONE			English	Article							NERVE INJURY; GENE-EXPRESSION; SCIATIC-NERVE; SPINAL-CORD; TRANSCRIPTION FACTOR; PERIPHERAL AXOTOMY; LENTIVIRAL VECTOR; NEUROPATHIC PAIN; SENSORY AXONS; C-JUN	Following injury, dorsal root ganglion (DRG) neurons undergo transcriptional changes so as to adopt phenotypic changes that promote cell survival and axonal regeneration. Here we used a microarray approach to profile changes in a population of small noncoding RNAs known as microRNAs ( miRNAs) in the L4 and L5 DRG following sciatic nerve transection. Results showed that 20 miRNA transcripts displayed a significant change in expression levels, with 8 miRNAs transcripts being altered by more than 1.5-fold. Using quantitative reverse transcription PCR, we demonstrated that one of these miRNAs, miR-21, was upregulated by 7-fold in the DRG at 7 days post-axotomy. In dissociated adult rat DRG neurons lentiviral vector-mediated overexpression of miR-21 promoted neurite outgrowth on a reduced laminin substrate. miR-21 directly downregulated expression of Sprouty2 protein, as confirmed by Western blot analysis and 39 untranslated region (UTR) luciferase assays. Our data show that miR-21 is an axotomy-induced miRNA that enhances axon growth, and suggest that miRNAs are important players in regulating growth pathways following peripheral nerve injury.	[Strickland, Iain T.; Richards, Louise; Holmes, Fiona E.; Wynick, David; Uney, James B.; Wong, Liang-Fong] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Holmes, Fiona E.; Wynick, David] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol; University of Bristol	Strickland, IT (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	L.Wong@bristol.ac.uk			Medical Research Council [G0700986]; Research Councils UK; Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish; Medical Research Council [G0300028, G1000863] Funding Source: researchfish; MRC [G0700986, G1000863, G0300028] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK(UK Research & Innovation (UKRI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (grant code G0700986) and Research Councils UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Alexander M, 2003, ACTA NEUROPATHOL, V105, P420, DOI 10.1007/s00401-002-0658-x; Araki T, 2001, J BIOL CHEM, V276, P34131, DOI 10.1074/jbc.M104271200; BOLIN LM, 1995, J NEUROCHEM, V64, P850; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hausott B, 2009, MOL CELL NEUROSCI, V42, P328, DOI 10.1016/j.mcn.2009.08.005; Izumi B, 2011, NEUROSCI LETT, V492, P114, DOI 10.1016/j.neulet.2011.01.068; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Jimenez CR, 2005, MOL CELL PROTEOMICS, V4, P120, DOI 10.1074/mcp.M400076-MCP200; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Komori N, 2007, PHYSIOL GENOMICS, V29, P215, DOI 10.1152/physiolgenomics.00255.2006; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lee N, 2004, J COMP NEUROL, V474, P535, DOI 10.1002/cne.20140; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Paschen W, 1998, NEUROREPORT, V9, P3147, DOI 10.1097/00001756-199810050-00005; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Rau CS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-181; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Stam FJ, 2007, EUR J NEUROSCI, V25, P3629, DOI 10.1111/j.1460-9568.2007.05597.x; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wong LF, 2006, NAT NEUROSCI, V9, P243, DOI 10.1038/nn1622; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yip PK, 2006, HUM MOL GENET, V15, P3107, DOI 10.1093/hmg/ddl251; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010	46	127	133	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23423	10.1371/journal.pone.0023423	http://dx.doi.org/10.1371/journal.pone.0023423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853131	gold, Green Submitted, Green Published			2022-12-27	WOS:000295454200084
J	Yu, R; Dhall, D; Nissen, NN; Zhou, CQ; Ren, SG				Yu, Run; Dhall, Deepti; Nissen, Nicholas N.; Zhou, Cuiqi; Ren, Song-Guang			Pancreatic Neuroendocrine Tumors in Glucagon Receptor-Deficient Mice	PLOS ONE			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; ALPHA-CELL HYPERPLASIA; KNOCKOUT MICE; GLUCOSE-HOMEOSTASIS; PRECURSOR LESIONS; GLYCEMIC CONTROL; TRANSGENIC MICE; T-ANTIGEN; MEN1; GENE	Inhibition of glucagon signaling causes hyperglucagonemia and pancreatic alpha cell hyperplasia in mice. We have recently demonstrated that a patient with an inactivating glucagon receptor mutation (P86S) also exhibits hyperglucagonemia and pancreatic alpha cell hyperplasia but further develops pancreatic neuroendocrine tumors (PNETs). To test the hypothesis that defective glucagon signaling causes PNETs, we studied the pancreata of mice deficient in glucagon receptor (Gcgr(-/-)) from 2 to 12 months, using WT and heterozygous mice as controls. At 2-3 months, Gcgr(-/-) mice exhibited normal islet morphology but the islets were mostly composed of alpha cells. At 5-7 months, dysplastic islets were evident in Gcgr(-/-) mice but absent in WT or heterozygous controls. At 10-12 months, gross PNETs (>= 1 mm) were detected in most Gcgr(-/-) pancreata and micro-PNETs (<1 mm) were found in all (n = 14), whereas the islet morphology remained normal and no PNETs were found in any WT (n = 10) or heterozygous (n = 25) pancreata. Most PNETs in Gcgr(-/-) mice were glucagonomas, but some were non-functioning. No tumors predominantly expressed insulin, pancreatic polypeptide, or somatostatin, although some harbored focal aggregates of tumor cells expressing one of those hormones. The PNETs in Gcgr(-/-) mice were well differentiated and occasionally metastasized to the liver. Menin expression was aberrant in most dysplatic islets and PNETs. Vascular endothelial growth factor (VEGF) was overexpressed in PNET cells and its receptor Flk-1 was found in the abundant blood vessels or blood islands inside the tumors. We conclude that defective glucagon signaling causes PNETs in the Gcgr(-/-) mice, which may be used as a model of human PNETs. Our results further suggest that completely inhibiting glucagon signaling may not be a safe approach to treat diabetes.	[Yu, Run] Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med, Div Endocrinol, Los Angeles, CA 90048 USA; [Yu, Run] Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med, Carcinoid & Neuroendocrine Tumor Ctr, Los Angeles, CA 90048 USA; [Dhall, Deepti] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Nissen, Nicholas N.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Nissen, Nicholas N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Zhou, Cuiqi; Ren, Song-Guang] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Yu, R (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med, Div Endocrinol, Los Angeles, CA 90048 USA.	run.yu@cshs.org			National Institutes of Health [DK071870]; Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK071870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: Supported by National Institutes of Health grant DK071870 (R.Y.) and Cedars-Sinai Medical Center. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Anlauf M, 2007, PATHOBIOLOGY, V74, P279, DOI 10.1159/000105810; Antonello D, 2009, PANCREATOLOGY, V9, P25, DOI 10.1159/000178872; Asa SL, 1996, VIRCHOWS ARCH, V427, P595; Authier F, 2008, CELL MOL LIFE SCI, V65, P1880, DOI 10.1007/s00018-008-7479-6; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chesnokova V, 2009, ENDOCRINOLOGY, V150, P2603, DOI 10.1210/en.2008-0972; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Corbo V, 2010, ENDOCR-RELAT CANCER, V17, P771, DOI 10.1677/ERC-10-0028; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gu W, 2009, J PHARMACOL EXP THER, V331, P871, DOI 10.1124/jpet.109.157685; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kedees MH, 2007, DEV DYNAM, V236, P1126, DOI 10.1002/dvdy.21112; KIMURA W, 1991, DIGEST DIS SCI, V36, P933, DOI 10.1007/BF01297144; Kloppel G, 2007, ENDOCR PATHOL, V18, P150, DOI 10.1007/s12022-007-0025-5; LEE YC, 1992, J BIOL CHEM, V267, P10705; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Mang Y, 2004, DIABETES, V53, P410; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Oberg K, 2009, CURR OPIN ENDOCRINOL, V16, P72, DOI 10.1097/MED.0b013e328320d845; Parker JC, 2002, BIOCHEM BIOPH RES CO, V290, P839, DOI 10.1006/bbrc.2001.6265; Perren A, 2007, J CLIN ENDOCR METAB, V92, P1118, DOI 10.1210/jc.2006-1944; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; RINDI G, 1991, VIRCHOWS ARCH A, V419, P115, DOI 10.1007/BF01600225; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Sloop KW, 2005, EXPERT OPIN THER TAR, V9, P593, DOI 10.1517/14728222.9.3.593; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sorensen H, 2006, DIABETES, V55, P2843, DOI 10.2337/db06-0222; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Vuguin PM, 2006, ENDOCRINOLOGY, V147, P3995, DOI 10.1210/en.2005-1410; Webb GC, 2002, DIABETES, V51, P398, DOI 10.2337/diabetes.51.2.398; Winzell MS, 2007, DIABETOLOGIA, V50, P1453, DOI 10.1007/s00125-007-0675-3; Wu Xinjiang, 2008, Curr Mol Med, V8, P805, DOI 10.2174/156652408786733702; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009; Yu R, 2008, PANCREAS, V36, P428, DOI 10.1097/MPA.0b013e31815ceb23; Yu Run, 2011, Endocrinol Nutr, V58, P258, DOI 10.1016/j.endonu.2011.04.002; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	49	13	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23397	10.1371/journal.pone.0023397	http://dx.doi.org/10.1371/journal.pone.0023397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853126	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200080
J	Ung, D; Amy, M; Leboucher, G				Ung, Davy; Amy, Mathieu; Leboucher, Gerard			Heaven It's My Wife! Male Canaries Conceal Extra-Pair Courtships but Increase Aggressions When Their Mate Watches	PLOS ONE			English	Article							SIAMESE FIGHTING FISH; SERINUS-CANARIA; JAPANESE-QUAIL; MALE DISPLAYS; AUDIENCE; PREFERENCES; EAVESDROP; CHOICE; BIRDS; INFORMATION	Many animals live in a communication network, an environment where individuals can obtain information about competitors or potential mates by observing interactions between conspecifics. In such an environment, interactants might benefit by changing their signalling behaviour in the presence of an audience. This audience effect seems widespread among species, has been observed during various types of interaction (e. g. intra-sexual vs. inter-sexual interaction) and varies according to the social context (e. g. gender, hierarchical or mating status of the audience). However, the way individuals might adapt their signalling behaviour to a combination of these factors remains poorly understood. To address this question, we studied how the presence of an audience affects the behaviour of male domestic canaries Serinus canaria during two types of interactions: (i) an extra-pair interaction and (ii) a male-male competition for food. Males were observed under three conditions: (a) in the absence of audience, (b) in the presence of their mate or (c) of a familiar female. Our results show that male domestic canaries minutely adapt their courting and agonistic behaviours to a combination of: (i) the type of interaction (extra-pair interaction/male-male competition), (ii) the social context (mate, familiar female or nobody in audience) and (iii) the behaviours of both the audience and the interactant. These results highlight the ability of animals to subtly adapt their behaviour to the social environment. This also raises questions about the cognitive foundations and evolution of these processes especially considering that canaries are known neither for having high cognitive abilities nor for being a typical example for the social intelligence hypothesis.	[Ung, Davy; Amy, Mathieu; Leboucher, Gerard] Univ Paris Ouest Nanterre Def, Lab Ethol & Cognit Comparees, EA 3456, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Universite Paris Nanterre	Ung, D (corresponding author), Univ Paris Ouest Nanterre Def, Lab Ethol & Cognit Comparees, EA 3456, Paris, France.	davyu@free.fr			French Ministry of National Education [20028-2010]	French Ministry of National Education	Dr. Ung is supported by the French Ministry of National Education (no 20028-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy M, 2008, ANIM BEHAV, V76, P971, DOI 10.1016/j.anbehav.2008.03.023; Amy M, 2007, ANIM BEHAV, V74, P57, DOI 10.1016/j.anbehav.2006.07.019; Amy M, 2009, ETHOLOGY, V115, P239, DOI 10.1111/j.1439-0310.2008.01579.x; Baltz AP, 1997, ANIM BEHAV, V53, P1017, DOI 10.1006/anbe.1996.0354; Beguin N, 2006, ACTA ETHOL, V9, P65, DOI 10.1007/s10211-006-0017-3; BIRKHEAD TR, 1981, ANIM BEHAV, V29, P304, DOI 10.1016/S0003-3472(81)80183-2; Brockway B. F., 1964, Behaviour, V23, P294, DOI 10.1163/156853964X00193; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; Daumas F, 1982, REV STAT APPL, V30, P23; Di Bitetti MS, 2005, ANIM BEHAV, V69, P911, DOI 10.1016/j.anbehav.2004.05.021; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; Dugatkin LA, 1996, P NATL ACAD SCI USA, V93, P2770, DOI 10.1073/pnas.93.7.2770; FOLLETT BK, 1973, J ENDOCRINOL, V59, P151, DOI 10.1677/joe.0.0590151; HECTOR ACK, 1989, ANIM BEHAV, V38, P262, DOI 10.1016/S0003-3472(89)80088-0; HOVI M, 1995, BEHAV ECOL SOCIOBIOL, V37, P283; Leboucher G, 2004, ANIM BEHAV, V68, P957, DOI 10.1016/j.anbehav.2003.12.011; LINDSAY DR, 1976, ANIM BEHAV, V24, P818, DOI 10.1016/S0003-3472(76)80012-7; Matessi G, 2005, BEHAVIOUR, V142, P507, DOI 10.1163/1568539054012010; Matos Ricardo J., 2005, P63, DOI 10.1017/CBO9780511610363.006; Matos RJ, 2003, BEHAV PROCESS, V63, P53, DOI 10.1016/S0376-6357(03)00029-9; Matos RJ, 2002, BEHAVIOUR, V139, P1211, DOI 10.1163/15685390260437344; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; McGregor Peter K., 1996, P409; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mulligan J. A., 1969, P165; Naguib M, 1997, ANIM BEHAV, V54, P1535, DOI 10.1006/anbe.1997.9997; Naguib M, 1999, P ROY SOC B-BIOL SCI, V266, P537, DOI 10.1098/rspb.1999.0669; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Ophir AG, 2005, J COMP PSYCHOL, V119, P3, DOI 10.1037/0735-7036.119.1.3; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Peake TM, 2001, P ROY SOC B-BIOL SCI, V268, P1183, DOI 10.1098/rspb.2001.1648; Plath M, 2008, ANIM BEHAV, V75, P21, DOI 10.1016/j.anbehav.2007.05.013; Price AC, 2006, ETHOLOGY, V112, P22, DOI 10.1111/j.1439-0310.2006.01142.x; Ratikainen II, 2010, BEHAV ECOL, V21, P195, DOI 10.1093/beheco/arp168; Tachon G, 1999, J INSECT BEHAV, V12, P533, DOI 10.1023/A:1020970908541; Townsend Simon, 2009, Communicative & Integrative Biology, V2, P282; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Voigt C., 1998, Boletim do Museu Municipal do Funchal, P117; Voigt C, 2003, J ORNITHOL, V144, P86, DOI 10.1007/BF02465520; WETTON JH, 1991, P ROY SOC B-BIOL SCI, V245, P227, DOI 10.1098/rspb.1991.0114; Zuberbuhler K, 2008, CURR BIOL, V18, pR189, DOI 10.1016/j.cub.2007.12.041	44	19	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22686	10.1371/journal.pone.0022686	http://dx.doi.org/10.1371/journal.pone.0022686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857945	Green Submitted, Green Published, gold			2022-12-27	WOS:000293774300006
J	Bregeon, F; Xeridat, F; Andreotti, N; Lepidi, H; Delpierre, S; Roch, A; Ravailhe, S; Jammes, Y; Steinberg, JG				Bregeon, Fabienne; Xeridat, Francois; Andreotti, Nicolas; Lepidi, Hubert; Delpierre, Stephane; Roch, Antoine; Ravailhe, Sylvie; Jammes, Yves; Steinberg, Jean-Guillaume			Activation of Nicotinic Cholinergic Receptors Prevents Ventilator-Induced Lung Injury in Rats	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; ACETYLCHOLINE-RECEPTORS; ANTIINFLAMMATORY PATHWAY; HUMAN-MONOCYTES; STIMULATION; ALPHA-7; CYTOKINES; METHYLLYCACONITINE; DISCOVERY; AGONISTS	Respiratory distress syndrome is responsible for 40 to 60 percent mortality. An over mortality of about 10 percent could result from additional lung injury and inflammation due to the life-support mechanical ventilation, which stretches the lung. It has been recently demonstrated, in vitro, that pharmacological activation of the alpha 7 nicotinic receptors (alpha 7-nAChR) could down regulate intracellular mediators involved in lung cell inflammatory response to stretch. Our aim was to test in vivo the protective effect of the pharmacological activation of the alpha 7-nAChR against ventilator-induced lung injury (VILI). Anesthetized rats were ventilated for two hours with a high stretch ventilation mode delivering a stroke volume large enough to generate 25-cmH(2)O airway pressure, and randomly assigned to four groups: pretreated with parenteral injection of saline or specific agonist of the alpha 7-nAChR (PNU-282987), or submitted to bilateral vagus nerve electrostimulation while pre-treated or not with the alpha 7-nAChR antagonist methyllycaconitine (MLA). Controls ventilated with a conventional stroke volume of 10 mL/kg gave reference data. Physiological indices (compliance of the respiratory system, lung weight, blood oxygenation, arterial blood pressure) and lung contents of inflammatory mediators (IL-6 measured by ELISA, substance P assessed using HPLC) were severely impaired after two hours of high stretch ventilation (sham group). Vagal stimulation was able to maintain the respiratory parameters close to those obtained in Controls and reduced lung inflammation except when associated to nicotinic receptor blockade (MLA), suggesting the involvement of alpha 7-nAChR in vagally-mediated protection against VILI. Pharmacological pre-treatment with PNU-282987 strongly decreased lung injury and lung IL-6 and substance P contents, and nearly abolished the increase in plasmatic IL-6 levels. Pathological examination of the lungs confirmed the physiological differences observed between the groups. In conclusion, these data suggest that the stimulation of alpha 7-nAChR is able to attenuate VILI in rats.	[Bregeon, Fabienne; Delpierre, Stephane; Ravailhe, Sylvie; Jammes, Yves; Steinberg, Jean-Guillaume] Univ Aix Marseille 2, Fac Med, Inst Federatif Rech Jean Roche, UMR MD2 P2COE, F-13284 Marseille 07, France; [Xeridat, Francois; Roch, Antoine] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Detresses Resp & Infect Severes, Marseille, France; [Xeridat, Francois; Roch, Antoine] Univ Mediterrane & Reanimat Med, Fac Med, Unite Rech Malad Infect & Trop URMITE, Marseille, France; [Andreotti, Nicolas] Univ Aix Marseille 2, ERT 62, Inst Federatif Rech Jean Roche, F-13284 Marseille 07, France; [Lepidi, Hubert] Hop La Timone, Assistance Publ Hop Marseille, Serv Anat Pathol & Neuropathol, Marseille, France; [Lepidi, Hubert] URMITE, CNRS, IRD 198, Unite Rickettsies,UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Bregeon, F (corresponding author), Univ Aix Marseille 2, Fac Med, Inst Federatif Rech Jean Roche, UMR MD2 P2COE, F-13284 Marseille 07, France.	fabienne.bregeon@ap-hm.fr			Universite de la Mediterranee Aix Marseille II institute	Universite de la Mediterranee Aix Marseille II institute	This study was supported by the Universite de la Mediterranee Aix Marseille II institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALELBERMANI WI, 1973, AM J ANAT, V137, P19; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; BARNES PJ, 1986, LANCET, V1, P242; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Bodnar AL, 2005, J MED CHEM, V48, P905, DOI 10.1021/jm049363q; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bregeon F, 2010, J PHYSIOL-LONDON, V588, P1309, DOI 10.1113/jphysiol.2010.187658; Bregeon F, 2008, CRIT CARE MED, V36, P3205, DOI 10.1097/CCM.0b013e31818f0e20; CAMPOS HA, 1969, J PHYSIOL-LONDON, V200, P311, DOI 10.1113/jphysiol.1969.sp008695; Davies ARL, 1999, NEUROPHARMACOLOGY, V38, P679, DOI 10.1016/S0028-3908(98)00221-4; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; DeKoninck P, 1995, J NEUROSCI, V15, P7966; dos Santos CC, 2011, AM J RESP CRIT CARE, V183, P471, DOI 10.1164/rccm.201002-0314OC; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Grando SA, 2003, LIFE SCI, V72, P2009, DOI 10.1016/S0024-3205(03)00063-8; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Killingsworth CR, 1997, AM J PHYSIOL-LUNG C, V273, pL1073, DOI 10.1152/ajplung.1997.273.5.L1073; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Laffey JG, 2003, CRIT CARE MED, V31, P2634, DOI 10.1097/01.CCM.0000089646.52395.BA; Li HF, 2009, ADV EXP MED BIOL, V648, P421, DOI 10.1007/978-90-481-2259-2_48; Li YF, 2009, NEUROSCI LETT, V462, P20, DOI 10.1016/j.neulet.2009.06.081; LOTVALL J, 1992, ACTA PHYSIOL SCAND, V144, P101, DOI 10.1111/j.1748-1716.1992.tb09272.x; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; LUNDBERG JM, 1987, ANNU REV PHYSIOL, V49, P557; Mioni C, 2005, CRIT CARE MED, V33, P2621, DOI 10.1097/01.CCM.0000186762.05301.13; Oke SL, 2008, J LEUKOCYTE BIOL, V83, P512, DOI 10.1189/jlb.0607363; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Si ML, 2002, CIRC RES, V91, P62, DOI 10.1161/01.RES.0000024417.79275.23; Stegelmeier BL, 2003, J ANIM SCI, V81, P1237; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Sykes AP, 2000, INFLAMM RES, V49, P311, DOI 10.1007/s000110050597; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; TUREK JW, 1995, J NEUROSCI METH, V61, P113, DOI 10.1016/0165-0270(95)00032-P; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Wong SS, 2004, AM J PHYSIOL-LUNG C, V287, pL859, DOI 10.1152/ajplung.00388.2003; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Yu J, 2007, RESP PHYSIOL NEUROBI, V156, P116, DOI 10.1016/j.resp.2006.11.005	42	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22386	10.1371/journal.pone.0022386	http://dx.doi.org/10.1371/journal.pone.0022386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857926	Green Published, gold, Green Submitted			2022-12-27	WOS:000293773300004
J	Vilboux, T; Ciccone, C; Blancato, JK; Cox, GF; Deshpande, C; Introne, WJ; Gahl, WA; Smith, ACM; Huizing, M				Vilboux, Thierry; Ciccone, Carla; Blancato, Jan K.; Cox, Gerald F.; Deshpande, Charu; Introne, Wendy J.; Gahl, William A.; Smith, Ann C. M.; Huizing, Marjan			Molecular Analysis of the Retinoic Acid Induced 1 Gene (RAI1) in Patients with Suspected Smith-Magenis Syndrome without the 17p11.2 Deletion	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; SYNDROME DEL 17P11.2; REAL-TIME PCR; INTERSTITIAL DELETION; ALAGILLE-SYNDROME; HUMAN JAGGED1; MUTATIONS; EXPRESSION; PHENOTYPE; DISEASE	Smith-Magenis syndrome (SMS) is a complex neurobehavioral disorder characterized by multiple congenital anomalies. The syndrome is primarily ascribed to a similar to 3.7 Mb de novo deletion on chromosome 17p11.2. Haploinsufficiency of multiple genes likely underlies the complex clinical phenotype. RAI1 (Retinoic Acid Induced 1) is recognized as a major gene involved in the SMS phenotype. Extensive genetic and clinical analyses of 36 patients with SMS-like features, but without the 17p11.2 microdeletion, yielded 10 patients with RAI1 variants, including 4 with de novo deleterious mutations, and 6 with novel missense variants, 5 of which were familial. Haplotype analysis showed two major RAI1 haplotypes in our primarily Caucasian cohort; the novel RAI1 variants did not occur in a preferred haplotype. RNA analysis revealed that RAI1 mRNA expression was significantly decreased in cells of patients with the common 17p11.2 deletion, as well as in those with de novo RAI1 variants. Expression levels varied in patients with familial RAI1 variants and in non-17p11.2 deleted patients without identified RAI1 defects. No correlation between SNP haplotype and RAI1 expression was found. Two clinical features, ocular abnormalities and polyembolokoilomania (object insertion), were significantly correlated with decreased RAI1 expression. While not significantly correlated, the presence of hearing loss, seizures, hoarse voice, childhood onset of obesity and specific behavioral aspects and the absence of immunologic abnormalities and cardiovascular or renal structural anomalies, appeared to be specific for the de novo RAI1 subgroup. Recognition of the combination of these features will assist in referral for RAI1 analysis of patients with SMS-like features without detectable microdeletion of 17p11.2. Moreover, RAI1 expression emerged as a genetic target for development of therapeutic interventions for SMS.	[Vilboux, Thierry; Ciccone, Carla; Gahl, William A.; Huizing, Marjan] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Blancato, Jan K.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Cox, Gerald F.] Harvard Univ, Sch Med, Dept Pediat, Div Genet,Childrens Hosp Boston, Boston, MA 02115 USA; [Deshpande, Charu] Guys Hosp, Dept Genet, London SE1 9RT, England; [Introne, Wendy J.; Gahl, William A.; Smith, Ann C. M.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Cox, Gerald F.] Genzyme Corp, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Georgetown University; Harvard University; Boston Children's Hospital; Harvard Medical School; Guy's & St Thomas' NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Sanofi-Aventis; Genzyme Corporation	Vilboux, T (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	mhuizing@mail.nih.gov	Huizing, Marjan/AAR-8860-2020		National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200322, ZIAHG000215] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Bi W, 2006, AM J MED GENET A, V140A, P2454, DOI 10.1002/ajmg.a.31510; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Burns B, 2010, HUM MOL GENET, V19, P4026, DOI 10.1093/hmg/ddq317; Carmona-Mora P, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-63; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Devriendt Koen, 2004, Human Genomics, V1, P126; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girirajan S, 2009, MAMM GENOME, V20, P247, DOI 10.1007/s00335-009-9180-y; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Griffin AE, 2005, CLIN GENET, V68, P23, DOI 10.1111/j.1399-0004.2005.00461.x; Gropman AL, 2007, CURR OPIN NEUROL, V20, P125, DOI 10.1097/WCO.0b013e3280895dba; Gropman AL, 2006, PEDIATR NEUROL, V34, P337, DOI 10.1016/j.pediatrneurol.2005.08.018; Gualandi G, 2001, MUTAGENESIS, V16, P203, DOI 10.1093/mutage/16.3.203; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Huizing M, 2001, AM J HUM GENET, V69, P1022, DOI 10.1086/324168; IMAI Y, 1995, MOL BRAIN RES, V31, P1, DOI 10.1016/0169-328X(95)00020-S; INTRONE W, 2005, IMMUNOLOGIC ABNORMAL; Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010; Juyal RC, 1996, AM J HUM GENET, V58, P998; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; Livak K., 1997, COMP CT METHOD ABI P; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Rachid R, 2006, CURR ALLERGY ASTHM R, V6, P357, DOI 10.1007/s11882-996-0004-9; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; Seranski P, 2001, GENE, V270, P69, DOI 10.1016/S0378-1119(01)00415-2; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; SMITH ACM, 2005, CLIN MANAGEMENT GENE; SMITH ACM, 2004, GROWTH ASSESSMENT SM; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Truong HT, 2008, GENET TEST, V12, P67, DOI 10.1089/gte.2007.0058; Truong HT, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-142; Vlangos CN, 2005, AM J MED GENET A, V132A, P278, DOI 10.1002/ajmg.a.30461; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; Williams SR, 2010, J MED GENET, V47, P223, DOI 10.1136/jmg.2009.068072; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	59	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22861	10.1371/journal.pone.0022861	http://dx.doi.org/10.1371/journal.pone.0022861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857958	gold, Green Submitted, Green Published			2022-12-27	WOS:000293773300010
J	Cameron, PU; Jones, P; Gorniak, M; Dunster, K; Paul, E; Lewin, S; Woolley, I; Spelman, D				Cameron, Paul U.; Jones, Penelope; Gorniak, Malgorzata; Dunster, Kate; Paul, Eldho; Lewin, Sharon; Woolley, Ian; Spelman, Denis			Splenectomy Associated Changes in IgM Memory B Cells in an Adult Spleen Registry Cohort	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; OVERWHELMING POSTSPLENECTOMY INFECTION; SPLENIC MARGINAL ZONE; IMMUNOGLOBULIN-M; PNEUMOCOCCAL DISEASE; HIV-1 INFECTION; CHILDREN; PROPHYLAXIS; PREVENTION; RESPONSES	Asplenic patients have a lifelong risk of overwhelming post-splenectomy infection and have been reported to have low numbers of peripheral blood IgM memory B cells. The clinical value of quantitation of memory B cells as an indicator of splenic abnormality or risk of infection has been unclear. To assess changes in B cell sub-populations after splenectomy we studied patients recruited to a spleen registry (n = 591). A subset of 209 adult asplenic or hyposplenic subjects, and normal controls (n = 140) were tested for IgM memory B cells. We also determined a) changes in IgM memory B cells with time after splenectomy using the cross-sectional data from patients on the registry and b) the kinetics of changes in haematological markers associated with splenectomy(n = 45). Total B cells in splenectomy patients did not differ from controls, but memory B cells, IgM memory B cells and switched B cells were significantly (p < 0.001) reduced. The reduction was similar for different indications for splenectomy. Changes of asplenia in routine blood films including presence of Howell-Jolly bodies (HJB), occurred early (median 25 days) and splenectomy associated thrombocytosis and lymphocytosis peaked by 50 days. There was a more gradual decrease in IgM memory B cells reaching a stable level within 6 months after splenectomy. IgM memory B cells as proportion of B cells was the best discriminator between splenectomized patients and normal controls and at the optimal cut-off of 4.53, showed a true positive rate of 95% and false positive rate of 20%. In a survey of 152 registry patients stratified by IgM memory B cells around this cut-off there was no association with minor infections and no registry patients experienced OPSI during the study. Despite significant changes after splenectomy, conventional measures of IgM memory cells have limited clinical utility in this population.	[Cameron, Paul U.; Gorniak, Malgorzata; Dunster, Kate; Spelman, Denis] Alfred Hosp, Pathol Serv, Melbourne, Vic, Australia; [Cameron, Paul U.; Jones, Penelope; Lewin, Sharon; Woolley, Ian; Spelman, Denis] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Cameron, Paul U.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Lewin, Sharon; Woolley, Ian] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Woolley, Ian] Monash Med Ctr, Dept Infect Dis, Clayton, Vic 3168, Australia; [Lewin, Sharon] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Paul, Eldho] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Monash University; Burnet Institute; Monash University	Cameron, PU (corresponding author), Alfred Hosp, Pathol Serv, Melbourne, Vic, Australia.	Paul.U.Cameron@monash.edu	Lewin, Sharon/Z-3297-2019	Paul, Eldho/0000-0003-1263-7255; Lewin, Sharon Ruth/0000-0002-0330-8241; Cameron, Paul Urquhart/0000-0002-1906-6945; Woolley, Ian John/0000-0003-2928-1291	Flack foundation	Flack foundation	This work was supported by a grant from the Flack foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2002, CLIN IMMUNOL, V103, P34, DOI 10.1006/clim.2001.5197; BABIKER MA, 1986, TROP GEOGR MED, V38, P119; Baxendale HE, 2008, CLIN EXP IMMUNOL, V151, P51, DOI 10.1111/j.1365-2249.2007.03535.x; Berglund LJ, 2008, PATHOLOGY, V40, P288, DOI 10.1080/00313020801911470; Bitaraes EL, 2008, J PEDIAT, V84, P316, DOI 10.1590/S0021-75572008000400006; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Bouts AHM, 2004, CLIN EXP IMMUNOL, V137, P589, DOI 10.1111/j.1365-2249.2004.02571.x; Carsetti R, 2006, J INFECT DIS, V193, P1189, DOI 10.1086/501375; Carsetti R, 2005, J ALLERGY CLIN IMMUN, V115, P412, DOI 10.1016/j.jaci.2004.10.048; Castagnola E, 2003, EUR J HAEMATOL, V71, P319, DOI 10.1034/j.1600-0609.2003.00158.x; CULLINGFORD GL, 1991, BRIT J SURG, V78, P716, DOI 10.1002/bjs.1800780626; D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7; de Porto APNA, 2010, EUR J CLIN MICROBIOL, V29, P1465, DOI 10.1007/s10096-010-1049-1; Denholm JT, 2010, MED J AUSTRALIA, V192, P49, DOI 10.5694/j.1326-5377.2010.tb03404.x; Di Sabatino A, 2004, Eur Rev Med Pharmacol Sci, V8, P199; Di Sabatino A, 2005, AM J GASTROENTEROL, V100, P1788, DOI 10.1111/j.1572-0241.2005.41939.x; Di Sabatino A, 2007, J ALLERGY CLIN IMMUN, V120, P1461, DOI 10.1016/j.jaci.2007.07.054; El-Alfy MS, 2004, HEMATOL J, V5, P77, DOI 10.1038/sj.thj.6200328; Ferry BL, 2005, CLIN EXP IMMUNOL, V140, P532, DOI 10.1111/j.1365-2249.2005.02793.x; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Macallan DC, 2005, BLOOD, V105, P3633, DOI 10.1182/blood-2004-09-3740; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martinez-Gamboa L, 2009, CLIN IMMUNOL, V130, P199, DOI 10.1016/j.clim.2008.09.009; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; Okabayashi T, 2008, WORLD J GASTROENTERO, V14, P176, DOI 10.3748/wjg.14.176; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Price VE, 2006, PEDIATR BLOOD CANCER, V46, P597, DOI 10.1002/pbc.20477; Ramachandra J, 2003, ANN ROY COLL SURG, V85, P252, DOI 10.1308/003588403766274962; Sanchez-Ramon S, 2008, CLIN IMMUNOL, V128, P314, DOI 10.1016/j.clim.2008.02.013; Seifert M, 2009, J EXP MED, V206, P2659, DOI 10.1084/jem.20091087; Shi YH, 2005, J IMMUNOL, V175, P3262, DOI 10.4049/jimmunol.175.5.3262; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Spelman D, 2008, INTERN MED J, V38, P349, DOI 10.1111/j.1445-5994.2007.01579.x; Subramaniam K, 2009, J INFECT DIS, V200, P244, DOI 10.1086/599318; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Vodjgani M, 2007, J INVEST ALLERG CLIN, V17, P321; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214; Waghorn DJ, 1997, J INFECTION, V35, P289, DOI 10.1016/S0163-4453(97)93232-1; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wasserstrom H, 2008, J IMMUNOL, V181, P3684, DOI 10.4049/jimmunol.181.5.3684; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Zandvoort A, 2002, CLIN EXP IMMUNOL, V130, P4, DOI 10.1046/j.1365-2249.2002.01953.x	52	70	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23164	10.1371/journal.pone.0023164	http://dx.doi.org/10.1371/journal.pone.0023164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829713	Green Published, gold			2022-12-27	WOS:000293561200053
J	Park, J; Lee, J; Choi, C				Park, Junseong; Lee, Jungsul; Choi, Chulhee			Mitochondrial Network Determines Intracellular ROS Dynamics and Sensitivity to Oxidative Stress through Switching Inter-Mitochondrial Messengers	PLOS ONE			English	Article							PERINATAL HYPOXIA-ISCHEMIA; CARDIAC MYOCYTES; SUPEROXIDE DISMUTASES; HYDROGEN-PEROXIDE; RAT-HEART; CELL; CRITICALITY; RELEASE; DEATH; MICE	Oxidative stresses caused by reactive oxygen species (ROS) can induce rapid depolarization of inner mitochondrial membrane potential and subsequent impairment of oxidative phosphorylation. Damaged mitochondria produce more ROS, especially the superoxide anion (O-2(-)) and hydrogen peroxide (H2O2), which potentiate mitochondria-driven ROS propagation, so-called ROS-induced ROS release (RIRR), via activation of an inter-mitochondria signaling network. Therefore, loss of function in only a fraction of mitochondria might eventually affect cell viability through this positive feedback loop. Since ROS are very short-lived molecules in the biological milieu, mitochondrial network dynamics, such as density, number, and spatial distribution, can affect mitochondria-driven ROS propagation. To address this issue, we developed a mathematical model using an agent-based modeling approach, and tested the effect of mitochondrial network dynamics on RIRR for mitochondria under various conditions. Simulation results show that the intracellular ROS signaling pattern, such as ROS propagation speed and oxidative stress vulnerability, are critically affected by mitochondrial network dynamics. Mitochondrial network dynamics of mitochondrial distribution, density, activity, and size can mediate inter-mitochondrial signaling under certain conditions and determine the identity of the ROS signaling pattern. We further elucidated the potential mechanism of these actions, i.e., conversion of major messenger molecules involved in ROS signaling. If the average distance between neighboring mitochondria is large or mitochondrial distribution becomes randomized, messenger molecule of the ROS signaling network can be switched from O-2(-) to H2O2. In this case, mitochondria-driven ROS propagation is efficiently blocked by introduction of excess cytosolic glutathione peroxidase 1, while introduction of cytosolic superoxide dismutase has no effect. Together, these results suggest that mitochondrial network dynamics is a major determinant for cellular responses to RIRR through changing the key messenger molecules.	[Park, Junseong; Lee, Jungsul; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Choi, Chulhee] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Park, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	cchoi@kaist.ac.kr	Lee, Jungsul/A-7851-2013; Park, Junseong/C-1973-2012; Choi, Chulhee/C-1642-2011	Lee, Jungsul/0000-0002-8600-5851; Choi, Chulhee/0000-0001-5542-9136; Park, Junseong/0000-0003-0436-8614	Korea government (MEST) [2009-0080280]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study is supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST 2009-0080280) (to C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2006, BBA-MOL BASIS DIS, V1762, P232, DOI 10.1016/j.bbadis.2005.06.008; Aon MA, 2004, P NATL ACAD SCI USA, V101, P4447, DOI 10.1073/pnas.0307156101; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Ardanaz N, 2006, EXP BIOL MED, V231, P237; Bankes SC, 2002, P NATL ACAD SCI USA, V99, P7199, DOI 10.1073/pnas.072081299; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cortassa S, 2004, BIOPHYS J, V87, P2060, DOI 10.1529/biophysj.104.041749; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; Dzeja PP, 2002, P NATL ACAD SCI USA, V99, P10156, DOI 10.1073/pnas.152259999; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Kuznetsov AV, 2009, INT J BIOCHEM CELL B, V41, P1928, DOI 10.1016/j.biocel.2009.03.007; Li XM, 2007, J PHARMACEUT BIOMED, V43, P364, DOI 10.1016/j.jpba.2006.06.041; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; RIBIERE C, 1992, BIOCHEM PHARMACOL, V44, P1495, DOI 10.1016/0006-2952(92)90463-S; SADOSHIMA J, 1992, P NATL ACAD SCI USA, V89, P9905, DOI 10.1073/pnas.89.20.9905; Sharma A, 2000, PHARMACOL RES, V41, P635, DOI 10.1006/phrs.1999.0631; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Zaheer A, 2004, NEUROCHEM RES, V29, P1473, DOI 10.1023/B:NERE.0000029558.82943.00; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; ZHOU L, 1957, PLOS COMPUT BIOL, V6; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	30	137	141	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23211	10.1371/journal.pone.0023211	http://dx.doi.org/10.1371/journal.pone.0023211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829717	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200055
J	Showell, C; Carruthers, S; Hall, A; de Villena, FPM; Stemple, D; Conlon, FL				Showell, Chris; Carruthers, Samantha; Hall, Amanda; de Villena, Fernando Pardo-Manuel; Stemple, Derek; Conlon, Frank L.			A Comparative Survey of the Frequency and Distribution of Polymorphism in the Genome of Xenopus tropicalis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOTYPING ERRORS; DNA POLYMORPHISMS; HIGH-RESOLUTION; ZEBRAFISH; DISCOVERY; STRAINS; GENES; IDENTIFICATION; POPULATIONS	Naturally occurring DNA sequence variation within a species underlies evolutionary adaptation and can give rise to phenotypic changes that provide novel insight into biological questions. This variation exists in laboratory populations just as in wild populations and, in addition to being a source of useful alleles for genetic studies, can impact efforts to identify induced mutations in sequence-based genetic screens. The Western clawed frog Xenopus tropicalis ( X. tropicalis) has been adopted as a model system for studying the genetic control of embryonic development and a variety of other areas of research. Its diploid genome has been extensively sequenced and efforts are underway to isolate mutants by phenotype- and genotype-based approaches. Here, we describe a study of genetic polymorphism in laboratory strains of X. tropicalis. Polymorphism was detected in the coding and non-coding regions of developmental genes distributed widely across the genome. Laboratory strains exhibit unexpectedly high frequencies of genetic polymorphism, with alleles carrying a variety of synonymous and non-synonymous codon substitutions and nucleotide insertions/deletions. Inter-strain comparisons of polymorphism uncover a high proportion of shared alleles between Nigerian and Ivory Coast strains, in spite of their distinct geographical origins. These observations will likely influence the design of future sequence-based mutation screens, particularly those using DNA mismatch-based detection methods which can be disrupted by the presence of naturally occurring sequence variants. The existence of a significant reservoir of alleles also suggests that existing laboratory stocks may be a useful source of novel alleles for mapping and functional studies.	[Showell, Chris; Conlon, Frank L.] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27515 USA; [Showell, Chris; de Villena, Fernando Pardo-Manuel; Conlon, Frank L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [de Villena, Fernando Pardo-Manuel] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Conlon, Frank L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Carruthers, Samantha; Hall, Amanda; Stemple, Derek] Wellcome Trust Sanger Inst, Cambridge, England	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wellcome Trust Sanger Institute	Showell, C (corresponding author), Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27515 USA.	chris_showell@med.unc.edu	Pillay, Nischalan/F-9536-2012		National Institutes of Health (NHLBI) [HL089641]; National Institutes of Health (NIDCR) [DEO18825]; American Heart Association; National Institutes of Health (NICHD) [HD054354]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054354] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011901] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Heart Association(American Heart Association); National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by grants to F.L.C. from the National Institutes of Health (NHLBI grant HL089641, www.nhlbi.nih.gov; NIDCR grant DEO18825, www.nidcr.nih.gov), an award to F.L.C. from the American Heart Association (www.heart.org), and a grant to D.S. from the National Institutes of Health (NICHD grant HD054354, www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkley NA, 2008, CURR GENOMICS, V9, P212, DOI 10.2174/138920208784533656; Ben-Ari G, 2005, HEREDITY, V95, P493, DOI 10.1038/sj.hdy.6800759; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRZUSTOWSKI J, INDIVIDUAL INDIVIDUA; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; FELSENSTEIN J, 1989, PHYLIP PHYLOGENY INF, P164, DOI DOI 10.1101/GR.1725103; Gilchrist EJ, 2006, MOL ECOL, V15, P1367, DOI 10.1111/j.1365-294X.2006.02885.x; Goda T, 2006, PLOS GENET, V2, P811, DOI 10.1371/journal.pgen.0020091; Goldstein DR, 1997, HUM HERED, V47, P86, DOI 10.1159/000154396; Grammer TC, 2005, MECH DEVELOP, V122, P263, DOI 10.1016/j.mod.2004.11.003; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; JOHNSON SL, 1994, GENOMICS, V19, P152, DOI 10.1006/geno.1994.1026; KUROSAWA T, 2001, INBRED ANIMAL STRAIN; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Postlethwait JH, 1997, TRENDS GENET, V13, P183, DOI 10.1016/S0168-9525(97)01129-3; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SHOWELL C, 2009, COLD SPRING HARB PRO; Showell C, 2007, GENESIS, V45, P418, DOI 10.1002/dvg.20286; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Till BJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl479; WELLS DE, DEV BIOL, V354, P1; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wright S, 1921, GENETICS, V6, P124; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Xu ZK, 2008, BIOINFORM BIOL INSIG, V2, P157	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22392	10.1371/journal.pone.0022392	http://dx.doi.org/10.1371/journal.pone.0022392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829622	Green Submitted, Green Published, gold			2022-12-27	WOS:000293561200018
J	Landgraf, T; Rojas, R; Nguyen, H; Kriegel, F; Stettin, K				Landgraf, Tim; Rojas, Raul; Hai Nguyen; Kriegel, Fabian; Stettin, Katja			Analysis of the Waggle Dance Motion of Honeybees for the Design of a Biomimetic Honeybee Robot	PLOS ONE			English	Article							COMMUNICATION; BEES; INFORMATION; COMMON	The honeybee dance "language" is one of the most popular examples of information transfer in the animal world. Today, more than 60 years after its discovery it still remains unknown how follower bees decode the information contained in the dance. In order to build a robotic honeybee that allows a deeper investigation of the communication process we have recorded hundreds of videos of waggle dances. In this paper we analyze the statistics of visually captured high-precision dance trajectories of European honeybees (Apis mellifera carnica). The trajectories were produced using a novel automatic tracking system and represent the most detailed honeybee dance motion information available. Although honeybee dances seem very variable, some properties turned out to be invariant. We use these properties as a minimal set of parameters that enables us to model the honeybee dance motion. We provide a detailed statistical description of various dance properties that have not been characterized before and discuss the role of particular dance components in the commmunication process.	[Landgraf, Tim; Rojas, Raul; Hai Nguyen; Kriegel, Fabian] Free Univ Berlin, Dept Math & Comp Sci, D-1000 Berlin, Germany; [Stettin, Katja] Univ Cambridge, Dept Zool, Cambridge, England	Free University of Berlin; University of Cambridge	Landgraf, T (corresponding author), Free Univ Berlin, Dept Math & Comp Sci, D-1000 Berlin, Germany.	tim.landgraf@fu-berlin.de	Rojas-Gonzalez, Raul/AAF-1871-2020	Rojas-Gonzalez, Raul/0000-0003-1596-7030; Kriegel, Fabian/0000-0003-1536-2840; Landgraf, Tim/0000-0003-4951-5235	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozic J., 1991, J APIC RES; De Marco RJ, 2008, J EXP BIOL, V211, P1635, DOI 10.1242/jeb.013425; DEMARCO R, 2008, LEARNING MEMORY COMM, P1; ESCH H, 1965, SCIENCE, V149, P320, DOI 10.1126/science.149.3681.320; Gil M, 2010, ANIM BEHAV, V80, P887, DOI 10.1016/j.anbehav.2010.08.012; Griffin D., 1994, ANIMAL MINDS; KIRCHNER WH, 1994, SCI AM; LANDGRAF T, 2007, B0177 FB MATH INF; Landgraf T, 2010, IEEE INT C INT ROBOT, P3097, DOI 10.1109/IROS.2010.5650930; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Michelsen A, 2003, J COMP PHYSIOL A, V189, P165, DOI 10.1007/s00359-003-0398-y; Peirce C., 1965, COLLECTED PAPERS CHA, V5; Rohrseitz K, 1999, J COMP PHYSIOL A, V184, P463, DOI 10.1007/s003590050346; SCHWAIER T, 2010, THESIS FREIE U BERLI; Seeley T., 1995, WISDOM HIVE SOCIAL P; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; STABENTHEINER A, 1991, NATURWISSENSCHAFTEN, V78, P471, DOI 10.1007/BF01134389; Tautz J, 1996, J EXP BIOL, V199, P1375; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; TOWNE W F, 1988, Journal of Insect Behavior, V1, P129, DOI 10.1007/BF01052234; von Frisch Karl, 1965, TANZSPRACHE ORIENTIE; Weidenmuller A, 1999, BEHAV ECOL SOCIOBIOL, V46, P190, DOI 10.1007/s002650050609	23	26	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e21354	10.1371/journal.pone.0021354	http://dx.doi.org/10.1371/journal.pone.0021354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857906	Green Submitted, Green Published, gold			2022-12-27	WOS:000293558900007
J	Soowannayan, C; Cowley, JA; Michalski, WP; Walker, PJ				Soowannayan, Chumporn; Cowley, Jeff A.; Michalski, Wojtek P.; Walker, Peter J.			RNA-Binding Domain in the Nucleocapsid Protein of Gill-Associated Nidovirus of Penaeid Shrimp	PLOS ONE			English	Article							YELLOW-HEAD-VIRUS; INFECTIOUS-BRONCHITIS VIRUS; MONOCLONAL-ANTIBODIES; PACKAGING SIGNAL; CORONAVIRUS; IDENTIFICATION; MONODON; GENES; DIFFERENTIATION; PHOSPHOPROTEIN	Gill-associated virus (GAV) infects Penaeus monodon shrimp and is the type species okavirus in the Roniviridae, the only invertebrate nidoviruses known currently. Electrophoretic mobility shift assays (EMSAs) using His(6)-tagged full-length and truncated proteins were employed to examine the nucleic acid binding properties of the GAV nucleocapsid (N) protein in vitro. The EMSAs showed full-length N protein to bind to all synthetic single-stranded (ss) RNAs tested independent of their sequence. The ssRNAs included (+) and (-) sense regions of the GAV genome as well as a (+) sense region of the M RNA segment of Mourilyan virus, a crustacean bunya-like virus. GAV N protein also bound to double-stranded (ds) RNAs prepared to GAV ORF1b gene regions and to bacteriophage M13 genomic ssDNA. EMSAs using the five N protein constructs with variable-length N-terminal and/or C-terminal truncations localized the RNA binding domain to a 50 amino acid (aa) N-terminal sequence spanning Met(11) to Arg(60). Similarly to other RNA binding proteins, the first 16 aa portion of this sequence was proline/arginine rich. To examine this domain in more detail, the 18 aa peptide (M(11) PVRRPLPPQPPRNARLI(29)) encompassing this sequence was synthesized and found to bind nucleic acids similarly to the full-length N protein in EMSAs. The data indicate a fundamental role for the GAV N protein proline/arginine-rich domain in nucleating genomic ssRNA to form nucleocapsids. Moreover, as the synthetic peptide formed higher-order complexes in the presence of RNA, the domain might also play some role in protein/protein interactions stabilizing the helical structure of GAV nucleocapsids.	[Soowannayan, Chumporn; Cowley, Jeff A.; Walker, Peter J.] Queensland Biosci Precinct, CSIRO Livestock Ind, St Lucia, Qld, Australia; [Michalski, Wojtek P.; Walker, Peter J.] Australian Anim Hlth Lab, CSIRO Livestock Ind, Geelong, Vic, Australia; [Soowannayan, Chumporn] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Patumthani, Thailand; [Soowannayan, Chumporn] Mahidol Univ, Fac Sci, CENTEX SHRIMP, Bangkok 10400, Thailand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Soowannayan, C (corresponding author), Queensland Biosci Precinct, CSIRO Livestock Ind, St Lucia, Qld, Australia.	chumporn@biotec.or.th	Walker, Peter J/H-6059-2013; Cowley, Jeff A/H-7553-2013; Michalski, Wojtek/H-3544-2013	Walker, Peter J/0000-0003-1851-642X; Cowley, Jeff/0000-0003-0454-4825	CSIRO Livestock Industries; Australian Government Department of Education, Employment and Workplace Relations (DEEWR); Thai National Center for Genetic Engineering and Biotechnology	CSIRO Livestock Industries; Australian Government Department of Education, Employment and Workplace Relations (DEEWR)(Australian GovernmentDepartment of Industry, Innovation and Science); Thai National Center for Genetic Engineering and Biotechnology	Research contributing to the PhD degree of CS was supported financially by CSIRO Livestock Industries (JAC and PJW) and by an Australia-Asia Award from the Australian Government Department of Education, Employment and Workplace Relations (DEEWR), formerly the Department of Education Science and Training (DEST) and by the split mode scholarship from the Thai National Center for Genetic Engineering and Biotechnology. The funders had no role in study design, data collection and analysis, or the decision prepare this manuscript for publication.	BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CAREY J, 1991, METHOD ENZYMOL, V208, P103; Cowley JA, 2005, DIS AQUAT ORGAN, V66, P91, DOI 10.3354/dao066091; Cowley JA, 2004, J VIROL, V78, P8935, DOI 10.1128/JVI.78.16.8935-8941.2004; Cowley JA, 2004, J VIROL METHODS, V117, P49, DOI 10.1016/j.jviromet.2003.11.018; COWLEY JA, 2001, GILL ASS VIRUS PENAE, P43; Duckmanton LM, 1998, VIRUS RES, V58, P83, DOI 10.1016/S0168-1702(98)00104-X; FOSMIRE JA, 1992, J VIROL, V66, P3522, DOI 10.1128/JVI.66.6.3522-3530.1992; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Herranz MC, 2004, J GEN VIROL, V85, P761, DOI 10.1099/vir.0.19534-0; Kroneman A, 1998, J VIROL, V72, P3507, DOI 10.1128/JVI.72.5.3507-3511.1998; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; Lesley SA, 2002, PROTEIN ENG, V15, P153, DOI 10.1093/protein/15.2.153; Liu PH, 2004, J GEN VIROL, V85, P3725, DOI 10.1099/vir.0.80325-0; MAKINO S, 1990, J VIROL, V64, P6045, DOI 10.1128/JVI.64.12.6045-6053.1990; MASTERS PS, 1990, ADV EXP MED BIOL, V276, P235; MASTERS PS, 1992, ARCH VIROL, V125, P141, DOI 10.1007/BF01309634; Mavrakis M, 2006, VIROLOGY, V349, P422, DOI 10.1016/j.virol.2006.01.030; Nadala ECB, 1997, DIS AQUAT ORGAN, V31, P141, DOI 10.3354/dao031141; Narayanan K, 2001, J VIROL, V75, P9059, DOI 10.1128/JVI.75.19.9059-9067.2001; Rajendran KS, 2003, J VIROL, V77, P9244, DOI 10.1128/JVI.77.17.9244-9258.2003; Sithigorngul P, 2002, DIS AQUAT ORGAN, V49, P71, DOI 10.3354/dao049071; Sittidilokratna N, 2006, VIRUS RES, V116, P21, DOI 10.1016/j.virusres.2005.08.009; SNIJDER EJ, 1989, J GEN VIROL, V70, P3363, DOI 10.1099/0022-1317-70-12-3363; Soowannayan C, 2003, DIS AQUAT ORGAN, V57, P193, DOI 10.3354/dao057193; STOHLMAN SA, 1988, J VIROL, V62, P4288, DOI 10.1128/JVI.62.11.4288-4295.1988; TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282; Wijegoonawardane PKM, 2008, VIROLOGY, V380, P213, DOI 10.1016/j.virol.2008.07.005; WILLIAMS AK, 1992, VIRUS RES, V25, P213, DOI 10.1016/0168-1702(92)90135-V; Wootton SK, 1998, CLIN DIAGN LAB IMMUN, V5, P773, DOI 10.1128/CDLI.5.6.773-779.1998; YOUN S, 2003, IN VITRO ASSEMBLY IN; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou ML, 1996, VIROLOGY, V217, P191, DOI 10.1006/viro.1996.0106; Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22156	10.1371/journal.pone.0022156	http://dx.doi.org/10.1371/journal.pone.0022156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857914	gold, Green Published, Green Submitted			2022-12-27	WOS:000293558900011
J	Finkelstein, A; Kunis, G; Seksenyan, A; Ronen, A; Berkutzki, T; Azoulay, D; Koronyo-Hamaoui, M; Schwartz, M				Finkelstein, Arseny; Kunis, Gilad; Seksenyan, Akop; Ronen, Ayal; Berkutzki, Tamara; Azoulay, David; Koronyo-Hamaoui, Maya; Schwartz, Michal			Abnormal Changes in NKT Cells, the IGF-1 Axis, and Liver Pathology in an Animal Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; KILLER T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MOTOR-NEURON DEGENERATION; WILD-TYPE MICROGLIA; GROWTH-FACTOR-I; GLATIRAMER ACETATE; ALZHEIMERS-DISEASE; MOUSE MODEL	Amyotrophic lateral sclerosis (ALS) is a rapidly progressing fatal neurodegenerative disorder characterized by the selective death of motor neurons (MN) in the spinal cord, and is associated with local neuroinflammation. Circulating CD4(+) T cells are required for controlling the local detrimental inflammation in neurodegenerative diseases, and for supporting neuronal survival, including that of MN. T-cell deficiency increases neuronal loss, while boosting T cell levels reduces it. Here, we show that in the mutant superoxide dismutase 1 G93A (mSOD1) mouse model of ALS, the levels of natural killer T (NKT) cells increased dramatically, and T-cell distribution was altered both in lymphoid organs and in the spinal cord relative to wildtype mice. The most significant elevation of NKT cells was observed in the liver, concomitant with organ atrophy. Hepatic expression levels of insulin-like growth factor (IGF)-1 decreased, while the expression of IGF binding protein (IGFBP)-1 was augmented by more than 20-fold in mSOD1 mice relative to wild-type animals. Moreover, hepatic lymphocytes of pre-symptomatic mSOD1 mice were found to secrete significantly higher levels of cytokines when stimulated with an NKT ligand, ex-vivo. Immunomodulation of NKT cells using an analogue of alpha-galactosyl ceramide (alpha-GalCer), in a specific regimen, diminished the number of these cells in the periphery, and induced recruitment of T cells into the affected spinal cord, leading to a modest but significant prolongation of life span of mSOD1 mice. These results identify NKT cells as potential players in ALS, and the liver as an additional site of major pathology in this disease, thereby emphasizing that ALS is not only a non-cell autonomous, but a non-tissue autonomous disease, as well. Moreover, the results suggest potential new therapeutic targets such as the liver for immunomodulatory intervention for modifying the disease, in addition to MN-based neuroprotection and systemic treatments aimed at reducing oxidative stress.	[Finkelstein, Arseny; Kunis, Gilad; Ronen, Ayal; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Seksenyan, Akop; Azoulay, David; Koronyo-Hamaoui, Maya] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Berkutzki, Tamara] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Cedars Sinai Medical Center; Weizmann Institute of Science	Finkelstein, A (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	michal.schwartz@weizmann.ac.il	Azoulay, David/AAC-2495-2020; Finkelstein, Arseny/AAH-9250-2021; Koronyo-Hamaoui, Maya/AAG-2040-2021	Azoulay, David/0000-0002-3451-5737; Finkelstein, Arseny/0000-0003-1480-5670; Koronyo-Hamaoui, Maya/0000-0003-2864-8442	IsrA.L.S.; Israel Science Foundation (ISF)	IsrA.L.S.; Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by IsrA.L.S. Research Fund and Israel Science Foundation (ISF) Legacy BioMed Program. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Bakalash S, 2003, INVEST OPHTH VIS SCI, V44, P3374, DOI 10.1167/iovs.03-0080; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Beaudoin L, 2002, IMMUNITY, V17, P725, DOI 10.1016/S1074-7613(02)00473-9; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Butovsky O, 2007, EUR J NEUROSCI, V26, P413, DOI 10.1111/j.1460-9568.2007.05652.x; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; DAWSON G, 1984, J NEUROSCI RES, V12, P213, DOI 10.1002/jnr.490120209; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Desbois-Mouthon C, 2006, FASEB J, V20, P773, DOI 10.1096/fj.05-4704fje; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dolcetti L, 2008, CANCER LETT, V267, P216, DOI 10.1016/j.canlet.2008.03.012; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Frenkel D, 2005, J NEUROL SCI, V233, P125, DOI 10.1016/j.jns.2005.03.022; Frenkel D, 2005, J CLIN INVEST, V115, P2423, DOI 10.1172/JCI23241; Gowing G, 2008, J NEUROSCI, V28, P10234, DOI 10.1523/JNEUROSCI.3494-08.2008; Grajewski RS, 2008, J IMMUNOL, V181, P4791, DOI 10.4049/jimmunol.181.7.4791; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Habisch HJ, 2007, EXP NEUROL, V206, P288, DOI 10.1016/j.expneurol.2007.05.007; Haenggeli C, 2007, NEUROBIOL DIS, V26, P146, DOI 10.1016/j.nbd.2006.12.013; Halder RC, 2007, NEUROCHEM RES, V32, P257, DOI 10.1007/s11064-006-9145-4; Hammond KJL, 2003, CURR OPIN IMMUNOL, V15, P683, DOI 10.1016/j.coi.2003.09.014; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Ito H, 2003, HEPATOLOGY, V38, P1116, DOI 10.1053/jhep.2003.50471; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kang J, 2007, J CELL BIOL, V179, P1219, DOI 10.1083/jcb.200705046; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kawamura T, 2009, J IMMUNOL, V182, P250, DOI 10.4049/jimmunol.182.1.250; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kong JM, 1998, J NEUROSCI, V18, P3241; KUNDU SK, 1984, BIOCHEM BIOPH RES CO, V118, P82; La Cava A, 2006, TRENDS IMMUNOL, V27, P322, DOI 10.1016/j.it.2006.05.003; Leu JI, 2003, J CLIN INVEST, V111, P129, DOI 10.1172/JCI200316712; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; Mars LT, 2008, J IMMUNOL, V181, P2321, DOI 10.4049/jimmunol.181.4.2321; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; MASUI Y, 1985, J NEUROL, V232, P15, DOI 10.1007/BF00314034; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Pomie C, 2008, HUM IMMUNOL, V69, P708, DOI 10.1016/j.humimm.2008.08.288; RAPPORT MM, 1985, ANN NEUROL, V18, P60, DOI 10.1002/ana.410180111; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Ricort JM, 2004, GROWTH HORM IGF RES, V14, P277, DOI 10.1016/j.ghir.2004.02.002; Roelofs-Haarhuis K, 2004, J IMMUNOL, V173, P1043, DOI 10.4049/jimmunol.173.2.1043; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SANTODOMINGOGAR.T, 2008, HEPATOLOGY; SCHWARTZ M, NAT REV NEUROL; Schwartz M, 2008, BIODRUGS, V22, P293, DOI 10.2165/00063030-200822050-00002; Schwartz M, 2008, TRENDS PHARMACOL SCI, V29, P287, DOI 10.1016/j.tips.2008.03.006; SEKSENYAN A, J CELL MOL MED, V4, P2470; Serizawa I, 2000, EXP ANIM TOKYO, V49, P171, DOI 10.1538/expanim.49.171; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Uldrich AP, 2005, J IMMUNOL, V175, P3092, DOI 10.4049/jimmunol.175.5.3092; van der Vliet HJJ, 2001, CLIN IMMUNOL, V100, P144, DOI 10.1006/clim.2001.5060; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Zimmermann EM, 2000, AM J PHYSIOL-GASTR L, V278, pG447, DOI 10.1152/ajpgi.2000.278.3.G447	75	54	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22374	10.1371/journal.pone.0022374	http://dx.doi.org/10.1371/journal.pone.0022374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829620	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511900006
J	Li, T; Yu, SY; Du, J; Chen, HH; Jiang, HF; Xu, K; Fu, YM; Wang, DX; Zhao, M				Li, Ting; Yu, Shunying; Du, Jiang; Chen, Hanhui; Jiang, Haifeng; Xu, Ke; Fu, Yingmei; Wang, Dongxiang; Zhao, Min			Role of Novelty Seeking Personality Traits as Mediator of the Association between COMT and Onset Age of Drug Use in Chinese Heroin Dependent Patients	PLOS ONE			English	Article							EXON-III POLYMORPHISM; ENVIRONMENTAL RISK-FACTORS; DOPAMINE TRANSPORTER GENE; SUBSTANCE USE; TRIDIMENSIONAL PERSONALITY; VAL158MET POLYMORPHISM; CHARACTER INVENTORY; PROMOTER REGION; ENZYME-ACTIVITY; ALCOHOL-USE	Background: Personality traits such as novelty seeking (NS) are associated with substance dependence but the mechanism underlying this association remains uncertain. Previous studies have focused on the role of the dopamine pathway. Objective: Examine the relationships between allelic variants of the catechol-O-methlytransferase (COMT) gene, NS personality traits, and age of onset of drug use in heroin-dependent subjects in China. Methods: The 478 heroin dependent subjects from four drug rehabilitation centers in Shanghai who were genotyped for eight tagging single nucleotide polymorphisms (SNP) on the COMT gene completed the NS subscale from the Temperament and Character Inventory. Multivaritate analyses were used to assess the potential mediating role of NS personality traits in the association between COMT gene variants and the age of onset of heroin use. Principal Findings and Conclusions: In the univariate analysis the COMT rs737866 gene variants were independently associated with both NS and age of onset of drug use: those with the TT genotype had higher NS subscale scores and an earlier onset age of heroin use than individuals with CT or CC genotypes. In the multivariate analysis the inclusion of the NS subscore variable weakened the relationship between the COMT rs737866 TT genotype and an earlier age of onset of drug use. Our findings that COMT is associated with both NS personality traits and with the age of onset of heroin use helps to clarify the complex relationship between genetic and psychological factors in the development of substance abuse.	[Li, Ting; Yu, Shunying; Du, Jiang; Chen, Hanhui; Jiang, Haifeng; Fu, Yingmei; Wang, Dongxiang; Zhao, Min] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Xu, Ke] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	Shanghai Jiao Tong University; Yale University	Li, T (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	drminzhao@gmail.com	Xu, Ke/V-5941-2019; Fu, Yingmei/AAN-1675-2021	Xu, Ke/0000-0002-6472-7052; Li, Ting/0000-0002-8408-2482	National Nature Science Foundation [30971048]; National Institutes of Health/Fogarty International Center [R01TW007279]; Science and Technology Commission of Shanghai Municipality [09410707000]; FOGARTY INTERNATIONAL CENTER [R01TW007279] Funding Source: NIH RePORTER	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Institutes of Health/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant from the National Nature Science Foundation (30971048), National Institutes of Health/Fogarty International Center (R01TW007279) and Science and Technology Commission of Shanghai Municipality (09410707000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3; Barnow S, 2005, NERVENARZT, V76, P839, DOI 10.1007/s00115-004-1810-8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basiaux P, 2001, ALCOHOL ALCOHOLISM, V36, P584, DOI 10.1093/alcalc/36.6.584; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Cao Liping, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P127; CASTROMAN JL, 2009, DRUG ALCOHOL DEPEN, V101, P210; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; CHUAN YC, 2009, ADDICITIVE BEHAV, V34, P319; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cloninger CR, 1998, J AFFECT DISORDERS, V51, P21, DOI 10.1016/S0165-0327(98)00153-0; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Conner BT, 2010, J SUBST ABUSE TREAT, V38, P178, DOI 10.1016/j.jsat.2009.07.004; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Golimbet V E, 2007, Neurosci Behav Physiol, V37, P601, DOI 10.1007/s11055-007-0058-8; Gordon HW, 2002, PSYCHONEUROENDOCRINO, V27, P115, DOI 10.1016/S0306-4530(01)00039-7; Gruber SA, 2007, NEUROPSYCHOL REV, V17, P299, DOI 10.1007/s11065-007-9041-y; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Gunnarsdottir ED, 2000, ADDICT BEHAV, V25, P641, DOI 10.1016/S0306-4603(99)00043-X; Han DH, 2008, COMPR PSYCHIAT, V49, P387, DOI 10.1016/j.comppsych.2008.01.008; Hashimoto R, 2007, NEUROSCI LETT, V428, P17, DOI 10.1016/j.neulet.2007.09.036; Heck A, 2009, GENES BRAIN BEHAV, V8, P464, DOI 10.1111/j.1601-183X.2009.00494.x; Hien D, 2010, CHILD ABUSE NEGLECT, V34, P105, DOI 10.1016/j.chiabu.2009.05.006; Hill SY, 2008, AM J MED GENET B, V147B, P517, DOI 10.1002/ajmg.b.30630; Horowitz R, 2000, AM J MED GENET, V96, P599, DOI 10.1002/1096-8628(20001009)96:5<599::AID-AJMG4>3.3.CO;2-F; Hosak L, 2006, NEUROENDOCRINOL LETT, V27, P799; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Ko CH, 2006, CAN J PSYCHIAT, V51, P887, DOI 10.1177/070674370605101404; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Laucht M, 2005, J AM ACAD CHILD PSY, V44, P477, DOI 10.1097/01.chi.0000155980.01792.7f; Laucht M, 2007, BIOL PSYCHIAT, V61, P87, DOI 10.1016/j.biopsych.2006.05.025; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Najafabadi MS, 2005, AM J MED GENET B, V134B, P39, DOI 10.1002/ajmg.b.30117; Parker G, 2003, ACTA PSYCHIAT SCAND, V108, P367, DOI 10.1034/j.1600-0447.2003.00192.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; Ronai Z, 2001, MOL PSYCHIATR, V6, P35, DOI 10.1038/sj.mp.4000832; Saxon AJ, 2005, HARVARD REV PSYCHIAT, V13, P218, DOI 10.1080/10673220500243364; Schmid B, 2009, ADDICT BIOL, V14, P489, DOI 10.1111/j.1369-1600.2009.00171.x; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Silberg J, 2003, J CHILD PSYCHOL PSYC, V44, P664, DOI 10.1111/1469-7610.00153; Suzuki G, 2009, HUM MOL GENET, V18, P3914, DOI 10.1093/hmg/ddp334; Tarter RE, 2007, PSYCHOL ADDICT BEHAV, V21, P266, DOI 10.1037/0893-164X.21.2.266; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V50, P153, DOI 10.1159/000079107; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; Whitty M, 2007, PSYCHIATR BULL, V31, P450, DOI 10.1192/pb.bp.106.011585; Wills T A, 1994, J Subst Abuse, V6, P1, DOI 10.1016/S0899-3289(94)90039-6	51	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22923	10.1371/journal.pone.0022923	http://dx.doi.org/10.1371/journal.pone.0022923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810JJ	21857968	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300009
J	Peterson, SE; Westra, JW; Rehen, SK; Young, H; Bushman, DM; Paczkowski, CM; Yung, YC; Lynch, CL; Tran, HT; Nickey, KS; Wang, YC; Laurent, LC; Loring, JF; Carpenter, MK; Chun, J				Peterson, Suzanne E.; Westra, Jurjen W.; Rehen, Stevens K.; Young, Holly; Bushman, Diane M.; Paczkowski, Christine M.; Yung, Yun C.; Lynch, Candace L.; Tran, Ha T.; Nickey, Kyle S.; Wang, Yu-Chieh; Laurent, Louise C.; Loring, Jeanne F.; Carpenter, Melissa K.; Chun, Jerold			Normal Human Pluripotent Stem Cell Lines Exhibit Pervasive Mosaic Aneuploidy	PLOS ONE			English	Article							CHROMOSOMAL-ABNORMALITIES; SEGREGATION DEFECTS; GENE-EXPRESSION; CULTURE; BRAIN; DIFFERENTIATION; HETEROGENEITY; FIBROBLASTS; DERIVATION; SELECTION	Human pluripotent stem cell (hPSC) lines have been considered to be homogeneously euploid. Here we report that normal hPSC - including induced pluripotent - lines are karyotypic mosaics of euploid cells intermixed with many cells showing non-clonal aneuploidies as identified by chromosome counting, spectral karyotyping (SKY) and fluorescent in situ hybridization (FISH) of interphase/non-mitotic cells. This mosaic aneuploidy resembles that observed in progenitor cells of the developing brain and preimplantation embryos, suggesting that it is a normal, rather than pathological, feature of stem cell lines. The karyotypic heterogeneity generated by mosaic aneuploidy may contribute to the reported functional and phenotypic heterogeneity of hPSCs lines, as well as their therapeutic efficacy and safety following transplantation.	[Peterson, Suzanne E.; Westra, Jurjen W.; Bushman, Diane M.; Paczkowski, Christine M.; Yung, Yun C.; Chun, Jerold] Scripps Res Inst, Dept Mol Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Peterson, Suzanne E.; Lynch, Candace L.; Tran, Ha T.; Nickey, Kyle S.; Wang, Yu-Chieh; Laurent, Louise C.; Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Westra, Jurjen W.; Bushman, Diane M.; Yung, Yun C.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, San Diego, CA 92103 USA; [Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Young, Holly; Carpenter, Melissa K.] Robarts Res Inst, London, ON N6A 5C1, Canada; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92103 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; Universidade Federal do Rio de Janeiro; Western University (University of Western Ontario); University of California System; University of California San Diego	Peterson, SE (corresponding author), Scripps Res Inst, Dept Mol Biol, Dorris Neurosci Ctr, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@scripps.edu	Rehen, Stevens/J-5874-2012; Chun, Jerold/Y-4670-2019; Loring, Jeanne F/A-1620-2011	Rehen, Stevens/0000-0003-4216-9501; Loring, Jeanne F/0000-0001-6226-9767; Yung, Yun/0000-0001-8973-7612; Laurent, Louise/0000-0002-2095-7534	NIMH [R21 MH076145, K02 MH01723]; NIH [T32 AG00216-13]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001723, R21MH076145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIMH R21 MH076145, K02 MH01723 (JC), NIH Training Grant T32 AG00216-13 (SP), and NSF Predoctoral Fellowship (YY). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ambartsumyan G, 2008, HUM MOL GENET, V17, pR10, DOI 10.1093/hmg/ddn170; Barch MJ, 1997, AGT CYTOGENETICS LAB; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Dupont C, 2010, FERTIL STERIL, V93, P2545, DOI 10.1016/j.fertnstert.2009.06.040; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Frumkin T, 2008, MOL CELL ENDOCRINOL, V282, P112, DOI 10.1016/j.mce.2007.11.009; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hough SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007708; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Kaushal D, 2003, J NEUROSCI, V23, P5599; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; Mack GS, 2011, NAT BIOTECHNOL, V29, P95, DOI 10.1038/nbt0211-95; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Meisner LF, 2008, METHODS, V45, P133, DOI 10.1016/j.ymeth.2008.03.005; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; MUNNE S, 1994, BIOL REPROD, V51, P373, DOI 10.1095/biolreprod51.3.373; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Pera MF, 2004, NAT BIOTECHNOL, V22, P42, DOI 10.1038/nbt0104-42; Peterson S, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P71, DOI 10.1016/B978-012370465-8/50011-9; Rajendran RS, 2007, DEV NEUROBIOL, V67, P1334, DOI 10.1002/dneu.20365; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanasijevic B, 2009, EPIGENETICS-US, V4, P330, DOI 10.4161/epi.4.5.9275; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilton L, 2002, PRENATAL DIAG, V22, P512, DOI 10.1002/pd.388; Wisconsin Alumni Research Foundation, 2001, [No title captured], Patent No. [US6200806, 6200806]; Yang AH, 2003, J NEUROSCI, V23, P10454; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	60	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23018	10.1371/journal.pone.0023018	http://dx.doi.org/10.1371/journal.pone.0023018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857983	gold, Green Published, Green Submitted			2022-12-27	WOS:000294125500013
J	Sale, MM; Chen, WM; Weeks, DE; Mychaleckyj, JC; Hou, XL; Marion, M; Segade, F; Casselbrant, ML; Mandel, EM; Ferrell, RE; Rich, SS; Daly, KA				Sale, Michele M.; Chen, Wei-Min; Weeks, Daniel E.; Mychaleckyj, Josyf C.; Hou, Xuanlin; Marion, Miranda; Segade, Fernando; Casselbrant, Margaretha L.; Mandel, Ellen M.; Ferrell, Robert E.; Rich, Stephen S.; Daly, Kathleen A.			Evaluation of 15 Functional Candidate Genes for Association with Chronic Otitis Media with Effusion and/or Recurrent Otitis Media (COME/ROM)	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; SURFACTANT PROTEIN-A; SYNCYTIAL VIRUS-INFECTION; HUMAN MIDDLE-EAR; UP-REGULATION; MUCIN GENE; INFLAMMATORY CYTOKINES; SUSCEPTIBILITY LOCI; UNITED-STATES; EXPRESSION	DNA sequence variants in genes involved in the innate immune response and secondary response to infection may confer susceptibility to chronic otitis media with effusion and/or recurrent otitis media (COME/ROM). We evaluated single nucleotide polymorphisms (SNPs) in 15 functional candidate genes. A total of 99 SNPs were successfully genotyped on the Sequenom platform in 142 families (618 subjects) from the Minnesota COME/ROM Family Study. Data were analyzed for association with COME/ROM using the Generalized Disequilibrium Test (GDT). Sex and age at exam were adjusted as covariates, relatedness was accounted for, and genotype differences from all phenotypically discordant relative pairs were utilized to measure the evidence of association between COME/ROM and each SNP. SNP rs2735733 in the region of the mucin 5, subtypes A/C gene (MUC5AC) exhibited nominal evidence for association with COME/ROM (P = 0.002). Two additional SNPs from this region had P values < 0.05. Other variants exhibiting associations with COME/ROM at P < 0.05 included the SCN1B SNP rs8100085 (P = 0.013), SFTPD SNP rs1051246 (P = 0.039) and TLR4 SNP rs2770146 (P = 0.038). However, none of these associations replicated in an independent sample of COME/ROM families. The candidate gene variants examined do not appear to make a major contribution to COME/ROM susceptibility, despite a priori evidence from functional or animal model studies for a role in COME/ROM pathology.	[Sale, Michele M.; Chen, Wei-Min; Mychaleckyj, Josyf C.; Hou, Xuanlin; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Sale, Michele M.; Rich, Stephen S.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Sale, Michele M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Chen, Wei-Min; Mychaleckyj, Josyf C.; Hou, Xuanlin; Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Weeks, Daniel E.; Casselbrant, Margaretha L.; Ferrell, Robert E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Marion, Miranda] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Segade, Fernando] Univ Penn, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Casselbrant, Margaretha L.; Mandel, Ellen M.] UPMC, Childrens Hosp Pittsburgh, Dept Otolaryngol, Pittsburgh, PA USA; [Daly, Kathleen A.] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Wake Forest Baptist Medical Center; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities	Sale, MM (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.	msale@virginia.edu	Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Rich, Stephen/0000-0003-3872-7793	National Institutes of Health [DC003166, DC003166-S1, R01DC005630, UL1RR024153]; National Institutes of Health General Clinical Research Center [M01RR000084]; Children's Hospital of Pittsburgh of UPMC; University of Pittsburgh; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000084, UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005630, R01DC003166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Children's Hospital of Pittsburgh of UPMC; University of Pittsburgh(University of Pittsburgh); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants DC003166 and DC003166-S1 (KAD). The replication work was supported primarily by the National Institutes of Health grant R01DC005630 (to MLC), as well as by the National Institutes of Health General Clinical Research Center grant M01RR000084, National Institutes of Health Clinical and Translational Science Award UL1RR024153, Children's Hospital of Pittsburgh of UPMC, and the University of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; Daly K A, 1999, Pediatr Rev, V20, P85, DOI 10.1542/pir.20-3-85; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Daly KA, 1996, GENET EPIDEMIOL, V13, P451, DOI 10.1002/(SICI)1098-2272(1996)13:5<451::AID-GEPI2>3.0.CO;2-5; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Elsheikh MN, 2006, LARYNGOSCOPE, V116, P365, DOI 10.1097/01.MLG.0000195290.71090.A1; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Heikkinen T, 2000, VACCINE, V19, pS51, DOI 10.1016/S0264-410X(00)00278-4; Ho V, 2002, LARYNGOSCOPE, V112, P513, DOI 10.1097/00005537-200203000-00020; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; HOTOMI M, 1994, ACTA OTO-LARYNGOL, V114, P406, DOI 10.3109/00016489409126078; Hunter LL, 2007, INT J PEDIATR OTORHI, V71, P1429, DOI 10.1016/j.ijporl.2007.05.020; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kawano H, 2000, LARYNGOSCOPE, V110, P668, DOI 10.1097/00005537-200004000-00024; Kerschner JE, 2004, ARCH OTOLARYNGOL, V130, P1163, DOI 10.1001/archotol.130.10.1163; Kim YT, 2001, ACTA OTO-LARYNGOL, V121, P364; Klein JO, 1997, PEDIATR INFECT DIS J, V16, pS5, DOI 10.1097/00006454-199702001-00002; Kubba H, 2000, CLIN OTOLARYNGOL, V25, P181, DOI 10.1046/j.1365-2273.2000.00350.x; Kvaerner KJ, 1997, ANN OTO RHINOL LARYN, V106, P624, DOI 10.1177/000348949710600802; KVAERNER KJ, 2004, ADV THERAPY OTITIS M, P106; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lin JZ, 2002, INT J PEDIATR OTORHI, V65, P203, DOI 10.1016/S0165-5876(02)00130-1; Lofgren J, 2002, J INFECT DIS, V185, P283, DOI 10.1086/338473; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Mason KM, 2006, MOL MICROBIOL, V62, P1357, DOI 10.1111/j.1365-2958.2006.05460.x; Moon SK, 2007, INFECT IMMUN, V75, P3361, DOI 10.1128/IAI.01886-06; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramet M, 2001, J PEDIATR-US, V138, P266, DOI 10.1067/mpd.2001.110133; RASMUSSEN F, 1993, INT J PEDIATR OTORHI, V26, P29, DOI 10.1016/0165-5876(93)90193-7; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Schousboe LP, 2001, ACTA OTO-LARYNGOL, V121, P596, DOI 10.1080/000164801316878881; Segade F, 2006, ARCH OTOLARYNGOL, V132, P729, DOI 10.1001/archotol.132.7.729; Smirnova MG, 2002, EUR CYTOKINE NETW, V13, P161; SPRAY BJ, 2002, P 7 INT S REC ADV OT, P225; Takeuchi K, 2003, INT J PEDIATR OTORHI, V67, P53, DOI 10.1016/S0165-5876(02)00361-0; TAKEUCHI K, 1994, ANN OTO RHINOL LARYN, V103, P404, DOI 10.1177/000348949410300511; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; UBELL ML, 2009, MUCIN GENE POLYMORPH; *US DEP HHS, 2006, VIS HEAR HLTH PEOPL, P28; Wiertsema SP, 2006, CLIN VACCINE IMMUNOL, V13, P892, DOI 10.1128/CVI.00100-06; Wiertsema SP, 2006, J ALLERGY CLIN IMMUN, V117, P1344, DOI 10.1016/j.jaci.2006.01.031; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619	58	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22297	10.1371/journal.pone.0022297	http://dx.doi.org/10.1371/journal.pone.0022297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857919	Green Accepted, Green Published, gold			2022-12-27	WOS:000294125500007
J	Chow, EPF; Wilson, DP; Zhang, L				Chow, Eric P. F.; Wilson, David P.; Zhang, Lei			HIV and Syphilis Co-Infection Increasing among Men Who Have Sex with Men in China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SEXUALLY-TRANSMITTED-DISEASES; RISK-FACTORS; PREVALENCE; INFECTIONS; EPIDEMIC; MUNICIPALITY; SHENZHEN; PROVINCE; JIANGSU; WORKERS	Background: This study aims to estimate the magnitude and changing trends of HIV, syphilis and HIV-syphilis co-infections among men who have sex with men (MSM) in China during 2003-2008 through a systematic review of published literature. Methodology/Principal Findings: Chinese and English literatures were searched for studies reporting HIV and syphilis prevalence among MSM from 2003 to 2008. The prevalence estimates were summarized and analysed by meta-analyses. Meta-regression was used to identify the potential factors that are associated with high heterogeneities in meta-analysis. Seventy-one eligible articles were selected in this review (17 in English and 54 in Chinese). Nationally, HIV prevalence among MSM increased from 1.3% during 2003-2004 to 2.4% during 2005-2006 and to 4.7% during 2007-2008. Syphilis prevalence increased from 6.8% during 2003-2004 to 10.4% during 2005-2006 and to 13.5% during 2007-2008. HIV-syphilis co-infection increased from 1.4% during 2005-2006 to 2.7% during 2007-2008. Study locations and study period are the two major contributors of heterogeneities of both HIV and syphilis prevalence among Chinese MSM. Conclusions/Significance: There have been significant increases in HIV and syphilis prevalence among MSM in China. Scale-up of HIV and syphilis screening and implementation of effective public health intervention programs should target MSM to prevent further spread of HIV and syphilis infection.	[Chow, Eric P. F.; Wilson, David P.; Zhang, Lei] Univ New S Wales, Fac Med, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Chow, EPF (corresponding author), Univ New S Wales, Fac Med, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.	dwilson@nchecr.unsw.edu.au	Zhang, Lei/D-4039-2011; Chow, Eric P.F./W-6684-2019; Wilson, David P/G-4614-2013; Chow, Eric Pui Fung/H-3196-2013	Zhang, Lei/0000-0003-2343-084X; Chow, Eric P.F./0000-0003-1766-0657; Chow, Eric Pui Fung/0000-0003-1766-0657	Australian Government Department of Health and Ageing; Australian Research Council [FT0991990]; University of New South Wales	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Research Council(Australian Research Council); University of New South Wales	This study was funded by the Australian Government Department of Health and Ageing; Australian Research Council (FT0991990); the University of New South Wales. The views expressed in this publication do not necessarily represent the position of the Australian Government. The National Centre in HIV Epidemiology and Clinical Research (NCHECR) is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELL M, 1989, NEW ENGL J MED, V321, P464, DOI 10.1056/NEJM198908173210708; Bao Yu-gang, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P981; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bozicevic I, 2009, AIDS BEHAV, V13, P303, DOI 10.1007/s10461-008-9436-7; CAI GF, 2008, CHINA PREVENTIVE MED, V9, P482; CAI WD, 2005, MOD PREV MED, V32, P328; CAI X, 2007, PREV MED TRIB, V13, P888; CAI YM, 2008, MOD PREV MED, V35, P2203; CHEN S, 2007, PREV MED TRIB, V13, P772; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; *CHIN MIN HLTH, 2006, NOT DIS CHIN 2005; *CHIN MIN HLTH, 2005, NOT DIS CHIN 2004 NO; *CHIN MIN HLTH, 2010, NOT DIS CHIN 2010; *CHIN MIN HLTH, 2007, NOT DIS CHIN 2006; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Cohen MS, 1996, J INFECT DIS, V174, pS223, DOI 10.1093/infdis/174.Supplement_2.S223; Ding Xianbin F., 2010, CHIN J DIS CONTROL P, V14, P227; DUAN YW, 2010, CHINESE J DIS CONTRO, V14, P1189; Feng F, 2009, MODERN PREVENTIVE ME, V36, P2902; FENG F, 2009, MODERN PREVENTIVE ME, V36, P2909; FENG JF, 2008, SHANGHAI J PREVENTIV, V20, P531; FENG JF, 2008, SHANGHAI J PREVENTIV, V20, P541; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng TJ, 2008, SEX TRANSM DIS, V35, P1022, DOI 10.1097/OLQ.0b013e31818600f4; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Fu LingJun, 2007, Disease Surveillance, V22, P818; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; GU Y, 2004, CHINESE J PUBLIC HLT, V20, P573; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; GUO Y, 2009, CHINESE J AIDS STD, V15, P71; GUO Y, 2009, CHIN J AIDS STD, V15, P50; HAN XY, 2007, PREV MED TRIB, V13, P1091; HE Q, 2005, CHINESE J DIS CONTRO, V9, P106; He Q, 2008, AIDS BEHAV, V12, pS93, DOI 10.1007/s10461-008-9388-y; Hong FC, 2009, SEX TRANSM INFECT, V85, P42, DOI 10.1136/sti.2008.031682; HU J, 2008, J PUBLIC HLTH PREV M, V19, P44; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; JIANG SM, 2006, PREV MED TRIB, V12, P763; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Karp G, 2009, EUR J INTERN MED, V20, P9, DOI 10.1016/j.ejim.2008.04.002; Kassutto Sigall, 2003, AIDS Clin Care, V15, P9; LAI WH, 2009, J PREVENTIVE MED INF, V25, P496; LAN GH, 2009, APPL PREV MED, V15, P168; LI Y, 2007, CHINESE MED SCI HLTH, V8, P1; LIANG L, 2009, HEBEI MED J, V31, P1991; LIAO MZ, 2006, CHIN J AIDS STD, V12, P530; Lin CC, 2006, SEX TRANSM DIS, V33, P726, DOI 10.1097/01.olq.0000222703.12018.58; LIU H, 2007, CHINESE J AIDS STD, V13, P234; LIU H, 2007, CHIN J AIDS STD, V13, P230; LU CG, 2006, GUIZHOU MED J, V30, P202; LU CG, 2006, CHIN J PUBLIC HLTH, V2, P1320; LU HY, 2008, CHINESE J AIDS STD, V14, P467; LU ZX, 2009, PREV MED TRIB, V15, P702; MA J, 2007, MODERN PREVENTIVE ME, V34, P3928; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Marcus U, 2005, SEX TRANSM INFECT, V81, P456, DOI 10.1136/sti.2005.014555; Mi GD, 2007, AIDS, V21, pS67, DOI 10.1097/01.aids.0000304699.85379.32; MIAO ZF, 2009, J NINGXIA MED U, V31, P761; Ministry of Health of the People's Republic of China, 2010, CHIN 2010 UNGASS COU; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nasio JM, 1996, INT J STD AIDS, V7, P410, DOI 10.1258/0956462961918374; Pisani E, 2004, SEX TRANSM INFECT, V80, P536, DOI 10.1136/sti.2003.007500; QIAO XW, 2009, HLTH VOCATIONAL ED, V27, P104; QU L, 2009, CHIN J EPIDEMIOL, V30; [曲琳 QU Lin], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P1089; RAZAK MH, 2002, SITUATION ASSESSMENT; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; SHI WD, 2009, MED SOC, V22, P42; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; *STAT COUNC AIDS W, 2007, JOING ASS HIV AIDS P; Sun JP, 2010, INT J EPIDEMIOL, V39, pII14, DOI 10.1093/ije/dyq208; SUN ML, 2009, PREVENTIVE MED TRIBU, V15, P1074; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; TANG WM, 2008, CHIN J AIDS STD, V14, P471; TANG WM, 2008, CHIN J AIDS STD, V14, P488; TAO X, 2004, MODERN PREVENTIVE ME, V31, P247; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; *UNAIDS WHO, 2009, AIDS EP UPD 2009 JOI; *UNGASS, 2010, CHIN 2010 UNGASS COU; WANG CH, 2007, CHINESE J HLTH LAB T, V17, P883; WANG J, 2008, CHIN J AIDS STD, V14, P75; WANG J, 2004, CHIN J PUBLIC HLTH, V20, P1377; WANG X, 2009, J PUBLIC HLTH, V25, P787; WANG Y, 2008, MODERN PREVENTIVE ME, V35, P3780; WANG Y, 2009, PRACTICAL PREVENTIVE, V16, P375; WANG Y, 2008, MODERN PREVENTIVE ME, V35, P3789; Wen F., 2010, S CHINA J PREV MED, V36, P19; WENG YQ, 2009, J APPL PREV MED, V15, P152; *WHO, 2010, 2009 EST HIV AIDS EP; WU J, 2008, J DIAGN CONCEPTS PRA, V7, P296; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; XU H, 2009, CHIN J HLTH LAB TECH, V19, P658; XU H, 2009, CHINESE J HLTH LAB T, V19, P713; XU J, 2007, MOD PREV MED, V34, P3014; XU J, 2007, MOD PREV MED, V34, P3009; XU JJ, 2010, SEX TRANSM DIS; [许娟 XU Juan], 2007, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V16, P205; XU ZH, 2009, CHIN J PUBLIC HLTH, V25, P226; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; YANG SP, 2008, ENDEMIC DIS B, V23, P49; Zeng Gang, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P977; ZHANG B, 2008, CHINESE J AIDS STD, V14, P541; Zhang HB., 2007, CHIN J AIDS STD, V13, P350; ZHANG JD, 2008, CHIN J AIDS STD, V14, P69; ZHANG M, 2009, CHIN J PUBLIC HLTH, V25, P1075; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c; Zhang Yi, 2008, Endemic Diseases Bulletin / Di Fang Bing Tong Bao, V23, P26; ZHAO H, 2009, GUIDE CHINA MED, V7, P181; ZHONG F, 2009, AIDS BEHAV; ZHOU J, 2008, CHINESE J AIDS STD, V14, P47; ZHU YW, 2007, PREVENTIVE MED TRIBU, V13, P490	118	78	85	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e22768	10.1371/journal.pone.0022768	http://dx.doi.org/10.1371/journal.pone.0022768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21857952	Green Published, gold			2022-12-27	WOS:000293953700002
J	Ugolin, N; Ory, C; Lefevre, E; Benhabiles, N; Hofman, P; Schlumberger, M; Chevillard, S				Ugolin, Nicolas; Ory, Catherine; Lefevre, Emilie; Benhabiles, Nora; Hofman, Paul; Schlumberger, Martin; Chevillard, Sylvie			Strategy to Find Molecular Signatures in a Small Series of Rare Cancers: Validation for Radiation-Induced Breast and Thyroid Tumors	PLOS ONE			English	Article							GENE-EXPRESSION DATA; MICROARRAY DATA; CLASSIFICATION; TRANSCRIPTOMES; PREDICTION; NEOPLASMS; CARCINOMA; PROFILE	Methods of classification using transcriptome analysis for case-by-case tumor diagnosis could be limited by tumor heterogeneity and masked information in the gene expression profiles, especially as the number of tumors is small. We propose a new strategy, EMts_2PCA, based on: 1) The identification of a gene expression signature with a great potential for discriminating subgroups of tumors (EMts stage), which includes: a) a learning step, based on an expectation-maximization (EM) algorithm, to select sets of candidate genes whose expressions discriminate two subgroups, b) a training step to select from the sets of candidate genes those with the highest potential to classify training tumors, c) the compilation of genes selected during the training step, and standardization of their levels of expression to finalize the signature. 2) The predictive classification of independent prospective tumors, according to the two subgroups of interest, by the definition of a validation space based on a two-step principal component analysis (2PCA). The present method was evaluated by classifying three series of tumors and its robustness, in terms of tumor clustering and prediction, was further compared with that of three classification methods (Gene expression bar code, Top-scoring pair(s) and a PCA-based method). Results showed that EMts_2PCA was very efficient in tumor classification and prediction, with scores always better that those obtained by the most common methods of tumor clustering. Specifically, EMts_2PCA permitted identification of highly discriminating molecular signatures to differentiate post-Chernobyl thyroid or post-radiotherapy breast tumors from their sporadic counterparts that were previously unsuccessfully classified or classified with errors.	[Ugolin, Nicolas; Ory, Catherine; Lefevre, Emilie; Benhabiles, Nora; Chevillard, Sylvie] CEA, DSV, IRCM, SREIT,Lab Cancerol Expt, Fontenay Aux Roses, France; [Hofman, Paul] INSERM ERI 21, Nice, France; [Hofman, Paul] Louis Pasteur Hosp, Lab Clin & Expt Pathol, Nice, France; [Hofman, Paul] Louis Pasteur Hosp, CHU CRLCC UNSA Tumour Tissue Bank Nice Area, Nice, France; [Hofman, Paul] Univ Nice Sophia Antipolis, IFR 50, Nice, France; [Schlumberger, Martin] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Villejuif, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Nice; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Gustave Roussy	Ugolin, N (corresponding author), CEA, DSV, IRCM, SREIT,Lab Cancerol Expt, BP6, Fontenay Aux Roses, France.	catherine.ory@cea.fr	Hofman, Paul/P-7654-2018	Hofman, Paul/0000-0003-0431-9353; Chevillard, Sylvie/0000-0001-5889-4041	Electricite de France; European DoReMi framework; European Union	Electricite de France; European DoReMi framework; European Union(European Commission)	This work was supported by Electricite de France, the European DoReMi framework and the European Union 6th Framework GenRiskT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, GENOME INFORM SER, V18, P130; Amundson SA, 2005, ONCOGENE, V24, P4572, DOI 10.1038/sj.onc.1208653; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Chevillard S, 2004, CLIN CANCER RES, V10, P6586, DOI 10.1158/1078-0432.CCR-04-0053; Chiappetta P, 2004, J COMPUT BIOL, V11, P1090, DOI 10.1089/cmb.2004.11.1090; Cuperlovic-Culf M, 2005, DRUG DISCOV TODAY, V10, P429, DOI 10.1016/S1359-6446(05)03393-3; Daino K, 2009, INT J CANC; Detours V, 2007, BRIT J CANCER, V97, P818, DOI 10.1038/sj.bjc.6603938; Detours V, 2005, BRIT J CANCER, V92, P1545, DOI 10.1038/sj.bjc.6602521; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron B., 1993, MONOGRAPHS STAT APPL; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Fujarewicz K, 2007, ENDOCR-RELAT CANCER, V14, P809, DOI 10.1677/ERC-06-0048; Geman Donald, 2004, Stat Appl Genet Mol Biol, V3, pArticle19; Ghosh Debashis, 2002, Pac Symp Biocomput, P18; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Hastie T, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-2-RESEARCH0003; Hofman P, 2006, M S-MED SCI, V22, P21; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Kong W, 2008, BIOTECHNIQUES, V45, P501, DOI 10.2144/000112950; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Ory C, 2011, ENDOCR-RELAT CANCER, V18, P193, DOI 10.1677/ERC-10-0205; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ressom HW, 2008, FRONT BIOSCI-LANDMRK, V13, P691, DOI 10.2741/2712; Tothill RW, 2005, CANCER RES, V65, P4031, DOI 10.1158/0008-5472.CAN-04-3617; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Vegt B, 2009, CRIT REV ONCOL HEMAT, V70, P1, DOI 10.1016/j.critrevonc.2008.09.001; Yang XMJ, 2006, J UROLOGY, V175, P2302, DOI 10.1016/S0022-5347(06)00255-2; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	36	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23581	10.1371/journal.pone.0023581	http://dx.doi.org/10.1371/journal.pone.0023581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853153	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400053
J	Ahmed, F; Raghava, GPS				Ahmed, Firoz; Raghava, Gajendra P. S.			Designing of Highly Effective Complementary and Mismatch siRNAs for Silencing a Gene	PLOS ONE			English	Article							TARGET RNA; SEQUENCE; PREDICTION; EFFICIENT; DISCRIMINATION; ACCESSIBILITY; SPECIFICITY; TOLERANCE; SELECTION; STRAND	In past, numerous methods have been developed for predicting efficacy of short interfering RNA (siRNA). However these methods have been developed for predicting efficacy of fully complementary siRNA against a gene. Best of author's knowledge no method has been developed for predicting efficacy of mismatch siRNA against a gene. In this study, a systematic attempt has been made to identify highly effective complementary as well as mismatch siRNAs for silencing a gene. Support vector machine (SVM) based models have been developed for predicting efficacy of siRNAs using composition, binary and hybrid pattern siRNAs. We achieved maximum correlation 0.67 between predicted and actual efficacy of siRNAs using hybrid model. All models were trained and tested on a dataset of 2182 siRNAs and performance was evaluated using five-fold cross validation techniques. The performance of our method desiRm is comparable to other well-known methods. In this study, first time attempt has been made to design mutant siRNAs (mismatch siRNAs). In this approach we mutated a given siRNA on all possible sites/positions with all possible nucleotides. Efficacy of each mutated siRNA is predicted using our method desiRm. It is well known from literature that mismatches between siRNA and target affects the silencing efficacy. Thus we have incorporated the rules derived from base mismatches experimental data to find out over all efficacy of mutated or mismatch siRNAs. Finally we developed a webserver, desiRm (http://www.imtech.res.in/raghava/desirm/) for designing highly effective siRNA for silencing a gene. This tool will be helpful to design siRNA to degrade disease isoform of heterozygous single nucleotide polymorphism gene without depleting the wild type protein.	[Ahmed, Firoz; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ahmed, F (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Ahmed, Firoz/AAR-6971-2021; Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009	Ahmed, Firoz/0000-0003-4702-5144; Raghava, Gajendra P.S./0000-0002-8902-2876; 	Open Source for Drug Discovery, Council of Scientific and Industrial Research, and Department of Biotechnology, Government of India	Open Source for Drug Discovery, Council of Scientific and Industrial Research, and Department of Biotechnology, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaDepartment of Biotechnology (DBT) India)	This study was supported by Open Source for Drug Discovery, Council of Scientific and Industrial Research, and Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Firoz, 2009, In Silico Biology, V9, P135, DOI 10.3233/ISB-2009-0395; Ahmed F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-105; Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Burchard J, 2009, RNA, V15, P308, DOI 10.1261/rna.1326809; Chalk AM, 2008, BIOINFORMATICS, V24, P1316, DOI 10.1093/bioinformatics/btn121; Chu CY, 2008, RNA, V14, P1714, DOI 10.1261/rna.1161908; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Far RKK, 2003, NUCLEIC ACIDS RES, V31, P4417, DOI 10.1093/nar/gkg649; Geng CM, 2008, ACTA PHARMACOL SIN, V29, P211, DOI 10.1111/j.1745-7254.2008.00740.x; Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jia PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-271; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Qiu SB, 2009, IEEE ACM T COMPUT BI, V6, P190, DOI 10.1109/TCBB.2008.139; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Zhou H, 2006, INFORM-J COMPUT INFO, V30, P357	41	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23443	10.1371/journal.pone.0023443	http://dx.doi.org/10.1371/journal.pone.0023443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853133	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200086
J	Alexandrov, AA; Boricheva, DO; Pulvermuller, F; Shtyrov, Y				Alexandrov, Alexander A.; Boricheva, Daria O.; Pulvermueller, Friedemann; Shtyrov, Yury			Strength of Word-Specific Neural Memory Traces Assessed Electrophysiologically	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; HUMAN BRAIN; SPEECH-PERCEPTION; SPOKEN WORDS; LANGUAGE; RECOGNITION; FAMILIARITY; MODEL; REPRESENTATIONS; COMPETITION	Memory traces for words are frequently conceptualized neurobiologically as networks of neurons interconnected via reciprocal links developed through associative learning in the process of language acquisition. Neurophysiological reflection of activation of such memory traces has been reported using the mismatch negativity brain potential (MMN), which demonstrates an enhanced response to meaningful words over meaningless items. This enhancement is believed to be generated by the activation of strongly intraconnected long-term memory circuits for words that can be automatically triggered by spoken linguistic input and that are absent for unfamiliar phonological stimuli. This conceptual framework critically predicts different amounts of activation depending on the strength of the word's lexical representation in the brain. The frequent use of words should lead to more strongly connected representations, whereas less frequent items would be associated with more weakly linked circuits. A word with higher frequency of occurrence in the subject's language should therefore lead to a more pronounced lexical MMN response than its low-frequency counterpart. We tested this prediction by comparing the event-related potentials elicited by low- and high-frequency words in a passive oddball paradigm; physical stimulus contrasts were kept identical. We found that, consistent with our prediction, presenting the high-frequency stimulus led to a significantly more pronounced MMN response relative to the low-frequency one, a finding that is highly similar to previously reported MMN enhancement to words over meaningless pseudowords. Furthermore, activation elicited by the higher-frequency word peaked earlier relative to low-frequency one, suggesting more rapid access to frequently used lexical entries. These results lend further support to the above view on word memory traces as strongly connected assemblies of neurons. The speed and magnitude of their activation appears to be linked to the strength of internal connections in a memory circuit, which is in turn determined by the everyday use of language elements.	[Alexandrov, Alexander A.; Boricheva, Daria O.] St Petersburg State Univ, St Petersburg, Russia; [Pulvermueller, Friedemann; Shtyrov, Yury] MRC, Cognit & Brain Sci Unit, Cambridge, England	Saint Petersburg State University	Alexandrov, AA (corresponding author), St Petersburg State Univ, St Petersburg, Russia.	yury.shtyrov@mrc-cbu.cam.ac.uk	Aleksandrov, Aleksander/M-8465-2019; Boricheva, Daria/G-6075-2015; Shtyrov, Yury/I-3421-2013; Shtyrov, Yury/ABI-2266-2020; Aleksandrov, Aleksandr/D-5820-2013	Aleksandrov, Aleksander/0000-0002-0129-9038; Boricheva, Daria/0000-0002-3946-6647; Shtyrov, Yury/0000-0001-7203-4902; Aleksandrov, Aleksandr/0000-0002-0129-9038; pulvermuller, friedemann/0000-0003-3210-7112	University of St. Petersburg, Russia; Medical Research Council, UK [U.1055.04.014.00001.01, MC_US_A060_0043]; Russian Ministry of Education and Science [02.740.11.5148]; MRC [MC_U105597122, MC_U105580445] Funding Source: UKRI; Medical Research Council [MC_U105580445, MC_U105597122] Funding Source: researchfish	University of St. Petersburg, Russia; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the University of St. Petersburg, Russia, Medical Research Council, UK (U.1055.04.014.00001.01, MC_US_A060_0043), and Russian Ministry of Education and Science (state contract 02.740.11.5148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 2002, WORDS MIND INTRO MEN; Assadollahi R, 2001, NEUROREPORT, V12, P207, DOI 10.1097/00001756-200102120-00007; Bilenko NY, 2009, J COGNITIVE NEUROSCI, V21, P960, DOI 10.1162/jocn.2009.21073; Boudelaa S, 2010, J COGNITIVE NEUROSCI, V22, P998, DOI 10.1162/jocn.2009.21273; Braitenberg V., 1992, LANGUAGE ORIGIN MULT, P89; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; CONNINE CM, 1990, J EXP PSYCHOL LEARN, V16, P1084, DOI 10.1037/0278-7393.16.6.1084; Endrass T, 2004, EUR J NEUROSCI, V19, P1653, DOI 10.1111/j.1460-9568.2004.03247.x; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Garagnani M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.010.2009; Gaskell MG, 1997, LANG COGNITIVE PROC, V12, P613, DOI 10.1080/016909697386646; GERNSBACHER MA, 1984, J EXP PSYCHOL GEN, V113, P256, DOI 10.1037/0096-3445.113.2.256; Harley T, 2008, PSYCHOL LANGUAGE DAT; Hasting AS, 2008, EUR J NEUROSCI, V27, P1561, DOI 10.1111/j.1460-9568.2008.06103.x; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Jacobsen T, 2005, J COGNITIVE NEUROSCI, V17, P1704, DOI 10.1162/089892905774589262; Jacobsen T, 2004, BRAIN LANG, V88, P54, DOI 10.1016/S0093-934X(03)00156-1; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; Kujala A, 2002, NEUROSCI LETT, V331, P91, DOI 10.1016/S0304-3940(02)00843-1; MARSLENWILSON W, 1994, PSYCHOL REV, V101, P3, DOI 10.1037/0033-295X.101.1.3; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 1997, AUDIOL NEURO-OTOL, V2, P341; Naatanen R, 1995, Int J Neurosci, V80, P317, DOI 10.3109/00207459508986107; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; Pettigrew C, 2004, APHASIOLOGY, V18, P3, DOI 10.1080/02687030344000463; Pettigrew CM, 2004, EAR HEARING, V25, P284, DOI 10.1097/01.AUD.0000130800.88987.03; Pulvermuller F, 2009, CEREB CORTEX, V19, P79, DOI 10.1093/cercor/bhn060; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Pulvermuller F, 2004, PSYCHOPHYSIOLOGY, V41, P106, DOI 10.1111/j.1469-8986.2003.00135.x; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Pulvermuller F, 2009, BRAIN LANG, V110, P81, DOI 10.1016/j.bandl.2008.12.001; Revill KP, 2008, P NATL ACAD SCI USA, V105, P13111, DOI 10.1073/pnas.0807054105; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; SHAROFF S, 2001, WORD FREQUENCY DICT; Shtyrov Y, 2000, NEUROIMAGE, V12, P657, DOI 10.1006/nimg.2000.0646; Shtyrov Y, 1998, NEUROSCI LETT, V251, P141, DOI 10.1016/S0304-3940(98)00529-1; Shtyrov Y, 2005, NEUROIMAGE, V27, P37, DOI 10.1016/j.neuroimage.2005.02.003; Shtyrov Y, 2002, NEUROREPORT, V13, P521, DOI 10.1097/00001756-200203250-00033; SHTYROV Y, 2010, J COGNITIVE NEUROSCI, P22; Shtyrov Y, 2007, J PSYCHOPHYSIOL, V21, P176, DOI 10.1027/0269-8803.21.34.176; Shtyrov Y, 2008, CEREB CORTEX, V18, P29, DOI 10.1093/cercor/bhm028; Shtyrov Y, 2011, NEUROIMAGE, V55, P658, DOI 10.1016/j.neuroimage.2010.12.002; Sittiprapaporn W, 2003, ANN NY ACAD SCI, V999, P199, DOI 10.1196/annals.1284.029; Tamminen J, 2008, Q J EXP PSYCHOL, V61, P361, DOI 10.1080/17470210701634545; Wennekers T, 2006, J PHYSIOL-PARIS, V100, P16, DOI 10.1016/j.jphysparis.2006.09.007	53	41	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22999	10.1371/journal.pone.0022999	http://dx.doi.org/10.1371/journal.pone.0022999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	827UM	21853063	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200033
J	Gorden, DL; Ivanova, PT; Myers, DS; McIntyre, JO; VanSaun, MN; Wright, JK; Matrisian, LM; Brown, HA				Gorden, D. Lee; Ivanova, Pavlina T.; Myers, David S.; McIntyre, J. Oliver; VanSaun, Michael N.; Wright, J. Kelly; Matrisian, Lynn M.; Brown, H. Alex			Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; PROTEIN-KINASE-C; STEATOSIS; METABOLISM; STEATOHEPATITIS; QUANTITATION; ACTIVATION; EXTRACTS; PROMOTES; OBESITY	Background and Aims: The spectrum of nonalcoholic fatty liver disease (NAFLD) includes steatosis, nonalcoholic steatohepatitis (NASH), and progression to cirrhosis. While differences in liver lipids between disease states have been reported, precise composition of phospholipids and diacylglycerols (DAG) at a lipid species level has not been previously described. The goal of this study was to characterize changes in lipid species through progression of human NAFLD using advanced lipidomic technology and compare this with a murine model of early and advanced NAFLD. Methods: Utilizing mass spectrometry lipidomics, over 250 phospholipid and diacylglycerol species (DAGs) were identified in normal and diseased human and murine liver extracts. Results: Significant differences between phospholipid composition of normal and diseased livers were demonstrated, notably among DAG species, consistent with previous reports that DAG transferases are involved in the progression of NAFLD and liver fibrosis. In addition, a novel phospholipid species (ether linked phosphatidylinositol) was identified in human cirrhotic liver extracts. Conclusions: Using parallel lipidomics analysis of murine and human liver tissues it was determined that mice maintained on a high-fat diet provide a reproducible model of NAFLD in regards to specificity of lipid species in the liver. These studies demonstrated that novel lipid species may serve as markers of advanced liver disease and importantly, marked increases in DAG species are a hallmark of NAFLD. Elevated DAGs may contribute to altered triglyceride, phosphatidylcholine (PC), and phosphatidylethanolamine (PE) levels characteristic of the disease and specific DAG species might be important lipid signaling molecules in the progression of NAFLD.	[Gorden, D. Lee; McIntyre, J. Oliver; VanSaun, Michael N.; Matrisian, Lynn M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA; [Gorden, D. Lee; McIntyre, J. Oliver; VanSaun, Michael N.; Matrisian, Lynn M.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Ivanova, Pavlina T.; Myers, David S.; Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Gorden, D. Lee; VanSaun, Michael N.; Wright, J. Kelly] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Brown, H. Alex] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Gorden, DL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA.	lee.gorden@vanderbilt.edu	Ivanova, Pavlina/K-8307-2012		National Institutes of Health [U54 GM069338, 5K08DK0707, 5P30DK58404]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a large scale consortium grant from the National Institutes of Health U54 GM069338 (to HAB), and 5K08DK0707, nd DDRC award 5P30DK58404 (to DLG). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; BISHOP WR, 1988, ONCOGENE RES, V2, P205; Callender HL, 2007, ANAL CHEM, V79, P263, DOI 10.1021/ac061083q; CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Deacon EM, 2002, J CELL SCI, V115, P983; Dobrzyn P, 2008, EUR J LIPID SCI TECH, V110, P93, DOI 10.1002/ejlt.200700249; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; HARMEET M, 2008, SEMINARS LIVER DIS, V28, P360; Hjartaker A, 2008, ADV EXP MED BIOL, V630, P72; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Ivanova PT, 2010, J LIPID RES, V51, P1581, DOI 10.1194/jlr.D003715; Koteish A, 2002, BEST PRACT RES CL GA, V16, P679, DOI 10.1053/bega.2002.0332; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Larter CZ, 2008, J HEPATOL, V48, P638, DOI 10.1016/j.jhep.2007.12.011; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Mattila Ismo, 2008, V456, P123, DOI 10.1007/978-1-59745-245-8_9; Milne S, 2006, METHODS, V39, P92, DOI 10.1016/j.ymeth.2006.05.014; Milne SB, 2008, BIOCHEMISTRY-US, V47, P9372, DOI 10.1021/bi800492c; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; Rouzer CA, 2006, BIOCHEMISTRY-US, V45, P14795, DOI 10.1021/bi061723j; VANGINNEKEN V, 2007, BIOCHIM BIOPHYS ACTA, V177, P1263; VanSaun MN, 2009, AM J PATHOL, V175, P355, DOI 10.2353/ajpath.2009.080703; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Woods AS, 2006, AAPS J, V8, pE391, DOI 10.1007/BF02854910; Yamaguchi K, 2008, HEPATOLOGY, V47, P625, DOI 10.1002/hep.21988; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12	35	99	103	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22775	10.1371/journal.pone.0022775	http://dx.doi.org/10.1371/journal.pone.0022775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857953	Green Submitted, Green Published, gold			2022-12-27	WOS:000293774300007
J	Hallschmid, M; Wilhelm, I; Michel, C; Perras, B; Born, J				Hallschmid, Manfred; Wilhelm, Ines; Michel, Christian; Perras, Boris; Born, Jan			A Role for Central Nervous Growth Hormone-Releasing Hormone Signaling in the Consolidation of Declarative Memories	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SPATIAL MEMORY; SYNAPTIC PLASTICITY; GH DEFICIENCY; ADULT MEN; SLEEP; RECEPTOR; GHRELIN; EXPRESSION; RAT	Contributions of somatotropic hormonal activity to memory functions in humans, which are suggested by clinical observations, have not been systematically examined. With previous experiments precluding a direct effect of systemic growth hormone (GH) on acute memory formation, we assessed the role of central nervous somatotropic signaling in declarative memory consolidation. We examined the effect of intranasally administered growth hormone releasing-hormone (GHRH; 600 mu g) that has direct access to the brain and suppresses endogenous GHRH via an ultra-short negative feedback loop. Twelve healthy young men learned word-pair associates at 2030 h and were administered GHRH and placebo, respectively, at 2100 h. Retrieval was tested after 11 hours of wakefulness. Compared to placebo, intranasal GHRH blunted GH release within 3 hours after substance administration and reduced the number of correctly recalled word-pairs by similar to 12% (both P < 0.05). The impairment of declarative memory consolidation was directly correlated to diminished GH concentrations (P < 0.05). Procedural memory consolidation as examined by the parallel assessment of finger sequence tapping performance was not affected by GHRH administration. Our findings indicate that intranasal GHRH, by counteracting endogenous GHRH release, impairs hippocampal memory processing. They provide first evidence for a critical contribution of central nervous somatotropic activity to hippocampus-dependent memory consolidation.	[Hallschmid, Manfred; Wilhelm, Ines; Perras, Boris] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Michel, Christian; Perras, Boris] Med Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany; [Born, Jan] Univ Tubingen, Dept Med Psychol & Behav Neurobiol, Tubingen, Germany	University of Lubeck; University of Lubeck; Eberhard Karls University of Tubingen	Hallschmid, M (corresponding author), Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany.	hallschmid@kfg.uni-luebeck.de	Born, Jan/K-2596-2016	Born, Jan/0000-0002-1847-6248	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 654; http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILA MC, 1985, ENDOCRINOLOGY, V117, P762, DOI 10.1210/endo-117-2-762; Arwert LI, 2005, HORM BEHAV, V47, P343, DOI 10.1016/j.yhbeh.2004.11.015; BANKS WA, 1990, P NATL ACAD SCI USA, V87, P6762, DOI 10.1073/pnas.87.17.6762; Benedict C, 2009, FASEB J, V23, P3629, DOI 10.1096/fj.08-122853; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Born J, 2009, OBSTET GYN CLIN N AM, V36, P809, DOI 10.1016/j.ogc.2009.10.001; Brandenberger G, 2000, LANCET, V356, P1408, DOI 10.1016/S0140-6736(00)02847-6; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Casanueva FF, 2008, P NATL ACAD SCI USA, V105, P20452, DOI 10.1073/pnas.0811680106; Chen LA, 2011, EUR J NEUROSCI, V33, P266, DOI 10.1111/j.1460-9568.2010.07491.x; CHRISTOFIDES ND, 1984, J CLIN ENDOCR METAB, V59, P747, DOI 10.1210/jcem-59-4-747; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donahue CP, 2006, P NATL ACAD SCI USA, V103, P6031, DOI 10.1073/pnas.0507776103; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2006, PSYCHONEUROENDOCRINO, V31, P786, DOI 10.1016/j.psyneuen.2006.02.009; KERKHOFS M, 1993, AM J PHYSIOL, V264, pE594, DOI 10.1152/ajpendo.1993.264.4.E594; Kim E, 2010, AM J PHYSIOL-REG I, V298, pR1588, DOI 10.1152/ajpregu.00580.2009; KRUEGER JM, 1993, FASEB J, V7, P645, DOI 10.1096/fasebj.7.8.8500689; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Le Greves M, 2002, P NATL ACAD SCI USA, V99, P7119, DOI 10.1073/pnas.092135399; LUMPKIN MD, 1985, ENDOCRINOLOGY, V116, P2070, DOI 10.1210/endo-116-5-2070; Marshall L, 1999, PSYCHONEUROENDOCRINO, V24, P363, DOI 10.1016/S0306-4530(98)00085-7; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; MATSUBARA S, 1995, ENDOCRINOLOGY, V136, P4147, DOI 10.1210/en.136.9.4147; MEISENBERG G, 1983, LIFE SCI, V32, P2611, DOI 10.1016/0024-3205(83)90352-1; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nieves-Martinez E, 2010, J ENDOCRINOL, V204, P31, DOI 10.1677/JOE-09-0323; Nyberg F, 2000, FRONT NEUROENDOCRIN, V21, P330, DOI 10.1006/frne.2000.0200; Obal F, 2004, SLEEP MED REV, V8, P367, DOI 10.1016/j.smrv.2004.03.005; Park SW, 2010, ENDOCRINOLOGY, V151, P4418, DOI 10.1210/en.2010-0152; Payne JD, 2005, BEHAV BRAIN SCI, V28, P77, DOI 10.1017/S0140525X05340027; Perras B, 1999, PSYCHONEUROENDOCRINO, V24, P743, DOI 10.1016/S0306-4530(99)00027-X; Perras B, 2004, J CLIN ENDOCR METAB, V89, P4642, DOI 10.1210/jc.2004-0089; Perras B, 2002, REGUL PEPTIDES, V110, P85, DOI 10.1016/S0167-0115(02)00163-5; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; RISOLD PY, 1994, J COMP NEUROL, V348, P1, DOI 10.1002/cne.903480102; SADOW TF, 1992, PSYCHONEUROENDOCRINO, V17, P293, DOI 10.1016/0306-4530(92)90036-7; SAWCHENKO PE, 1990, HDB CHEM NEUROANAT 2, V9, P131; Spiegel K, 2000, AM J PHYSIOL-REG I, V279, pR874, DOI 10.1152/ajpregu.2000.279.3.R874; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Steyer, 1997, MEHRDIMENSIONALE BEF; Tannenbaum GS, 2003, ENDOCRINOLOGY, V144, P967, DOI 10.1210/en.2002-220852; TWERY MJ, 1985, PEPTIDES, V6, P609, DOI 10.1016/0196-9781(85)90161-5; Vitiello MV, 2006, NEUROBIOL AGING, V27, P318, DOI 10.1016/j.neurobiolaging.2005.01.010; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wass JAH, 2010, J ENDOCRINOL, V207, P125, DOI 10.1677/JOE-10-0126; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	55	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23435	10.1371/journal.pone.0023435	http://dx.doi.org/10.1371/journal.pone.0023435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803EC	21850272	Green Submitted, gold, Green Published			2022-12-27	WOS:000293563300057
J	Kumar, A; Bhandari, A; Sinha, R; Goyal, P; Grapputo, A				Kumar, Abhishek; Bhandari, Anita; Sinha, Rahul; Goyal, Pankaj; Grapputo, Alessandro			Spliceosomal Intron Insertions in Genome Compacted Ray-Finned Fishes as Evident from Phylogeny of MC Receptors, Also Supported by a Few Other GPCRs	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MELANOCORTIN RECEPTORS; FUNCTIONAL-CHARACTERIZATION; GENE REPERTOIRE; TELEOST FISH; EVOLUTION; ORIGIN; GAIN; CONSERVATION; DATABASE	Background: Insertions of spliceosomal introns are very rare events during evolution of vertebrates and the mechanisms governing creation of novel intron(s) remain obscure. Largely, gene structures of melanocortin (MC) receptors are characterized by intron-less architecture. However, recently a few exceptions have been reported in some fishes. This warrants a systematic survey of MC receptors for understanding intron insertion events during vertebrate evolution. Methodology/Principal Findings: We have compiled an extended list of MC receptors from different vertebrate genomes with variations in fishes. Notably, the closely linked MC2Rs and MC5Rs from a group of ray-finned fishes have three and one intron insertion(s), respectively, with conserved positions and intron phase. In both genes, one novel insertion was in the highly conserved DRY motif at the end of helix TM3. Further, the proto-splice site MAG up arrow R is maintained at intron insertion sites in these two genes. However, the orthologs of these receptors from zebrafish and tetrapods are intron-less, suggesting these introns are simultaneously created in selected fishes. Surprisingly, these novel introns are traceable only in four fish genomes. We found that these fish genomes are severely compacted after the separation from zebrafish. Furthermore, we also report novel intron insertions in P2Y receptors and in CHRM3. Finally, we report ultrasmall introns in MC2R genes from selected fishes. Conclusions/Significance: The current repository of MC receptors illustrates that fishes have no MC3R ortholog. MC2R, MC5R, P2Y receptors and CHRM3 have novel intron insertions only in ray-finned fishes that underwent genome compaction. These receptors share one intron at an identical position suggestive of being inserted contemporaneously. In addition to repetitive elements, genome compaction is now believed to be a new hallmark that promotes intron insertions, as it requires rapid DNA breakage and subsequent repair processes to gain back normal functionality.	[Kumar, Abhishek; Grapputo, Alessandro] Univ Padua, Dept Biol, Padua, Italy; [Kumar, Abhishek] Univ Kiel, Inst Bot, Abt Bot Genet & Mol Biol, D-2300 Kiel, Germany; [Kumar, Abhishek] Univ Kiel, Bot Garten, Kiel, Germany; [Bhandari, Anita] Int Grad Sch IHI Zittau, Zittau, Germany; [Sinha, Rahul] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Goyal, Pankaj] Univ Greifswald, Univ Klinikum, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Greifswald, Germany	University of Padua; University of Kiel; University of Kiel; Technische Universitat Dresden; Cold Spring Harbor Laboratory; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kumar, A (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	abhishek.abhishekkumar@gmail.com	Grapputo, Alessandro/AAR-1252-2020; Kumar, Abhishek/A-8727-2012; Goyal, Pankaj/C-3567-2012	Grapputo, Alessandro/0000-0001-9255-4294; Kumar, Abhishek/0000-0003-4172-4059; 				Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P3724, DOI 10.1093/nar/gkh686; Baron A, 2009, GEN COMP ENDOCR, V161, P13, DOI 10.1016/j.ygcen.2008.11.026; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bjenning Christina, 2004, Curr Opin Investig Drugs, V5, P1051; Bryson-Richardson RJ, 2004, GENE, V338, P15, DOI 10.1016/j.gene.2004.05.001; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; Coulombe-Huntington J, 2007, GENOME RES, V17, P23, DOI 10.1101/gr.5703406; CRICK F, 1979, SCIENCE, V204, P264, DOI 10.1126/science.373120; CRICK FHC, 1978, EUR J BIOCHEM, V83, P1, DOI 10.1111/j.1432-1033.1978.tb12061.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; DIBB NJ, 1989, EMBO J, V8, P2015, DOI 10.1002/j.1460-2075.1989.tb03609.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Farlow A, 2011, TRENDS GENET, V27, P1, DOI 10.1016/j.tig.2010.10.004; FIGUEROA F, 1995, P ROY SOC B-BIOL SCI, V259, P325, DOI 10.1098/rspb.1995.0048; Flicek Paul, 2010, Nucleic Acids Res, V38, pD557, DOI 10.1093/nar/gkp972; Force A, 1999, GENETICS, V151, P1531; Fridmanis D, 2007, MOL PHYLOGENET EVOL, V43, P864, DOI 10.1016/j.ympev.2006.11.007; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Genome 10K Community of Scientists, 2009, J Hered, V100, P659, DOI 10.1093/jhered/esp086; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GIROUX MJ, 1994, P NATL ACAD SCI USA, V91, P12150, DOI 10.1073/pnas.91.25.12150; Gregory TR, 2008, ANIMAL GENOME SIZE D; Haitina T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-101; Hankeln T, 1997, GENE, V205, P151, DOI 10.1016/S0378-1119(97)00518-0; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HINEGARD.R, 1968, AM NAT, V102, P517, DOI 10.1086/282564; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; Iwamoto M, 1998, THEOR APPL GENET, V97, P9, DOI 10.1007/s001220050861; Iwamoto M, 1999, THEOR APPL GENET, V98, P853, DOI 10.1007/s001220051144; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kask A, 1998, BIOCHEM BIOPH RES CO, V248, P245, DOI 10.1006/bbrc.1998.8961; Klovins J, 2004, EUR J BIOCHEM, V271, P4320, DOI 10.1111/j.1432-1033.2004.04374.x; Klovins J, 2004, MOL BIOL EVOL, V21, P563, DOI 10.1093/molbev/msh050; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-250; Logan DW, 2003, GENOMICS, V81, P184, DOI 10.1016/S0888-7543(02)00037-x; Logsdon JM, 1998, CURR OPIN GENET DEV, V8, P637, DOI 10.1016/S0959-437X(98)80031-2; Loh YH, 2008, MOL BIOL EVOL, V25, P526, DOI 10.1093/molbev/msm278; Losos J, 2005, PROPOSAL SEQUENCE 1; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; MARKS D, 2004, RECENT PROG HORM RES, V56, P359; Metz JR, 2006, GEN COMP ENDOCR, V148, P150, DOI 10.1016/j.ygcen.2006.03.001; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Moriyama S, 2008, ZOOL SCI, V25, P604, DOI 10.2108/zsj.25.604; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ogino K, 2010, GENE, V449, P70, DOI 10.1016/j.gene.2009.09.002; Ohno S., 1970, P1; Omilian AR, 2008, MOL BIOL EVOL, V25, P2129, DOI 10.1093/molbev/msn164; Perusse L, 2005, OBES RES, V13, P381, DOI 10.1038/oby.2005.50; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; Ragg H, 2011, CELL MOL LIFE SCI, V68, P235, DOI 10.1007/s00018-010-0532-2; Ragg H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-208; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Rees JL, 1999, ANN NY ACAD SCI, V885, P134; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; Ringholm A, 2002, J NEUROCHEM, V82, P6, DOI 10.1046/j.1471-4159.2002.00934.x; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; ROGERS JH, 1989, TRENDS GENET, V5, P213, DOI 10.1016/0168-9525(89)90084-X; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Roy SW, 2007, MOL BIOL EVOL, V24, P1579, DOI 10.1093/molbev/msm082; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Roy SW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-251; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; Schioth HB, 2001, VITAM HORM, V63, P195, DOI 10.1016/S0083-6729(01)63007-3; Schioth HB, 2005, ANN NY ACAD SCI, V1040, P460, DOI 10.1196/annals.1327.090; Schioth HB, 2005, PEPTIDES, V26, P1886, DOI 10.1016/j.peptides.2004.11.034; Schioth HB, 2003, GENOMICS, V81, P504, DOI 10.1016/S0888-7543(03)00028-4; Schioth HB, 1996, LIFE SCI, V59, P797, DOI 10.1016/0024-3205(96)00370-0; Selz Y, 2007, GENE, V401, P114, DOI 10.1016/j.gene.2007.07.005; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Slamovits CH, 2009, MOL BIOL EVOL, V26, P1699, DOI 10.1093/molbev/msp081; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1308, P164, DOI 10.1016/0167-4781(96)00100-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tordai H, 2004, FEBS LETT, V575, P109, DOI 10.1016/j.febslet.2004.08.045; TSUJIMOTO Y, 1979, CELL, V18, P591, DOI 10.1016/0092-8674(79)90075-8; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; VASTERMARK A, 2011, EUR J PHARM; Venkatesh B, 1999, P NATL ACAD SCI USA, V96, P10267, DOI 10.1073/pnas.96.18.10267; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Volff JN, 2003, TRENDS GENET, V19, P674, DOI 10.1016/j.tig.2003.10.006; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Wolfsberg Tyra G, 2010, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0105s29; Zhuo DG, 2007, P NATL ACAD SCI USA, V104, P882, DOI 10.1073/pnas.0604777104	112	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22046	10.1371/journal.pone.0022046	http://dx.doi.org/10.1371/journal.pone.0022046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850219	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000293563300003
J	Martel, CJM; Agger, EM; Poulsen, JJ; Jensen, TH; Andresen, L; Christensen, D; Nielsen, LP; Blixenkrone-Moller, M; Andersen, P; Aasted, B				Martel, Cyril Jean-Marie; Agger, Else Marie; Poulsen, Julie Juul; Jensen, Trine Hammer; Andresen, Lars; Christensen, Dennis; Nielsen, Lars Peter; Blixenkrone-Moller, Merete; Andersen, Peter; Aasted, Bent			CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS-INFECTION; MONOCLONAL-ANTIBODIES; PROTECTION; LIPOSOMES; ADJUVANT; DIMETHYLDIOCTADECYLAMMONIUM; LYMPHOCYTES; ACTIVATION; CHALLENGE	Trivalent inactivated vaccines (TIV) against influenza are given to 350 million people every year. Most of these are non-adjuvanted vaccines whose immunogenicity and protective efficacy are considered suboptimal. Commercially available non-adjuvanted TIV are known to elicit mainly a humoral immune response, whereas the induction of cell-mediated immune responses is negligible. Recently, a cationic liposomal adjuvant (dimethyldioctadecylammonium/trehalose 6,6'-dibehenate, CAF01) was developed. CAF01 has proven to enhance both humoral and cell-mediated immune responses to a number of different experimental vaccine candidates. In this study, we compared the immune responses in ferrets to a commercially available TIV with the responses to the same vaccine mixed with the CAF01 adjuvant. Two recently circulating H1N1 viruses were used as challenge to test the vaccine efficacy. CAF01 improved the immunogenicity of the vaccine, with increased influenza-specific IgA and IgG levels. Additionally, CAF01 promoted cellular-mediated immunity as indicated by interferon-gamma expressing lymphocytes, measured by flow cytometry. CAF01 also enhanced the protection conferred by the vaccine by reducing the viral load measured in nasal washes by RT-PCR. Finally, CAF01 allowed for dose-reduction and led to higher levels of protection compared to TIV adjuvanted with a squalene emulsion. The data obtained in this human-relevant challenge model supports the potential of CAF01 in future influenza vaccines.	[Martel, Cyril Jean-Marie; Poulsen, Julie Juul; Jensen, Trine Hammer; Andresen, Lars; Blixenkrone-Moller, Merete; Aasted, Bent] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark; [Agger, Else Marie; Christensen, Dennis; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Nielsen, Lars Peter] Statens Serum Inst, Natl Influenza Lab, DK-2300 Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut; Statens Serum Institut	Martel, CJM (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Copenhagen, Denmark.	PA@ssi.dk; bas@life.ku.dk	Andresen, Lars/K-1287-2012; Christensen, Dennis/C-6378-2008; Andresen, Lars/O-2271-2019	Christensen, Dennis/0000-0003-2382-8639; Andresen, Lars/0000-0002-6362-7973; Andersen, Peter/0000-0002-5869-2551	Danish Graduate School of Immunology; Danish National Advanced Technology Foundation; FluSecure; European Commission DG SANCO [2005207]; Danish Fur Breeders' Association	Danish Graduate School of Immunology; Danish National Advanced Technology Foundation; FluSecure; European Commission DG SANCO(European CommissionEuropean Commission Joint Research Centre); Danish Fur Breeders' Association	This work has been financially supported by the Danish Graduate School of Immunology, the Danish National Advanced Technology Foundation and FluSecure. FluSecure has been made possible by contributions from the European Commission DG SANCO (Contract no. 2005207) and the 10 participating members. BA has been supported by a grant from the Danish Fur Breeders' Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasted B, 2007, VET IMMUNOL IMMUNOP, V119, P27, DOI 10.1016/j.vetimm.2007.06.025; Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; [Anonymous], 2005, HHS PAND INFL PLAN; Bodewes R, 2011, J VIROL, V85, P2695, DOI 10.1128/JVI.02371-10; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; COATES DM, 1986, J GEN VIROL, V67, P419, DOI 10.1099/0022-1317-67-3-419; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Ellebedy AH, 2010, CLIN VACCINE IMMUNOL, V17, P1998, DOI 10.1128/CVI.00247-10; *EUR MED AG, 2009, PREP EUR PUBL ASS RE, P11601; Fedson DS, 2008, BIOLOGICALS, V36, P346, DOI 10.1016/j.biologicals.2008.07.001; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Guo HL, 2011, J LEUKOCYTE BIOL, V89, P189, DOI 10.1189/jlb.0610319; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hehme N, 2004, VIRUS RES, V103, P163, DOI 10.1016/j.virusres.2004.02.029; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V142, P180, DOI 10.1016/j.jconrel.2009.10.022; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Jones T, 2009, CURR OPIN MOL THER, V11, P337; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Korsholm KS, 2007, IMMUNOLOGY, V121, P216, DOI 10.1111/j.1365-2567.2007.02560.x; KORSMAN S, 2006, VACCINES, P11601; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Launay O, 2008, VACCINE, V26, P4073, DOI 10.1016/j.vaccine.2008.05.035; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Long BR, 2008, CLIN VACCINE IMMUNOL, V15, P120, DOI 10.1128/CVI.00357-07; Mann JFS, 2009, EXPERT REV VACCINES, V8, P103, DOI 10.1586/14760584.8.1.103; Mann JFS, 2009, VACCINE, V27, P3643, DOI 10.1016/j.vaccine.2009.03.040; Martel CJM, 2009, VET IMMUNOL IMMUNOP, V132, P109, DOI 10.1016/j.vetimm.2009.05.011; Mukherjee S, 2002, J LEUKOCYTE BIOL, V72, P921; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Orenstein WA, 2008, AM J MED, V121, pS22, DOI 10.1016/j.amjmed.2008.05.004; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; PILLET S, 2011, VACCINE IN PRESS, P11601; Pinnamaneni S, 2003, PHARMAZIE, V58, P554; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Sant AJ, 2007, EXPERT REV VACCINES, V6, P357, DOI 10.1586/14760584.6.3.357; STEBBING N, 1982, J VIROL METHODS, V5, P343, DOI 10.1016/0166-0934(82)90026-X; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Tambyah PA, 2008, RESPIROLOGY, V13, pS41, DOI 10.1111/j.1440-1843.2008.01257.x; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; *WHO, 2002, RESP CDSA, P11601; Wood JM, 2002, VACCINE, V20, pB40, DOI 10.1016/S0264-410X(02)00509-1	51	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22891	10.1371/journal.pone.0022891	http://dx.doi.org/10.1371/journal.pone.0022891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850242	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300027
J	Ragsdale, G; Foley, RA				Ragsdale, Gillian; Foley, Robert A.			A Maternal Influence on Reading the Mind in the Eyes Mediated by Executive Function: Differential Parental Influences on Full and Half-Siblings	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; INDIVIDUAL-DIFFERENCES; ASPERGER-SYNDROME; FEAR RECOGNITION; NEURAL BASIS; EMPATHY QUOTIENT; NORMAL ADULTS; AUTISM; BRAIN; CHILDRENS	Background: Parent-of-origin effects have been found to influence the mammalian brain and cognition and have been specifically implicated in the development of human social cognition and theory of mind. The experimental design in this study was developed to detect parent-of-origin effects on theory of mind, as measured by the 'Reading the mind in the eyes' (Eyes) task. Eyes scores were also entered into a principal components analysis with measures of empathy, social skills and executive function, in order to determine what aspect of theory of mind Eyes is measuring. Methodology/Principal Findings: Maternal and paternal influences on Eyes scores were compared using correlations between pairs of full (70 pairs), maternal (25 pairs) and paternal siblings (15 pairs). Structural equation modelling supported a maternal influence on Eyes scores over the normal range but not low-scoring outliers, and also a sex-specific influence on males acting to decrease male Eyes scores. It was not possible to differentiate between genetic and environmental influences in this particular sample because maternal siblings tended to be raised together while paternal siblings were raised apart. The principal components analysis found Eyes was associated with measures of executive function, principally behavioural inhibition and attention, rather than empathy or social skills. Conclusions/Significance: In conclusion, the results suggest a maternal influence on Eye scores in the normal range and a sex-specific influence acting to reduce scores in males. This influence may act via aspects of executive function such as behavioural inhibition and attention. There may be different influences acting to produce the lowest Eyes scores which implies that the heratibility and/or maternal influence on poor theory of mind skills may be qualitatively different to the influence on the normal range.	[Ragsdale, Gillian; Foley, Robert A.] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England	University of Cambridge	Ragsdale, G (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England.	gill.ragsdale@btinternet.com		Lauwereyns, Jan/0000-0003-0551-2550				Aboulafia-Brakha T, 2011, J NEUROPSYCHOL, V5, P39, DOI 10.1348/174866410X533660; Ahmed FS, 2011, J AUTISM DEV DISORD, V41, P667, DOI 10.1007/s10803-010-1087-7; Anokhin AP, 2010, BEHAV GENET, V40, P178, DOI 10.1007/s10519-010-9337-1; Apperly IA, 2009, DEV PSYCHOL, V45, P190, DOI 10.1037/a0014098; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Blair RJR, 2008, Q J EXP PSYCHOL, V61, P157, DOI 10.1080/17470210701508855; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Brent E, 2004, AUTISM, V8, P283, DOI 10.1177/1362361304045217; Bull R, 2008, COGNITION, V107, P663, DOI 10.1016/j.cognition.2007.07.015; Campbell R, 2006, DEV PSYCHOPATHOL, V18, P99, DOI 10.1017/S0954579406060068; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Carroll JM, 2006, J AUTISM DEV DISORD, V36, P949, DOI 10.1007/s10803-006-0127-9; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cassidy KW, 2005, CHILD DEV, V76, P97, DOI 10.1111/j.1467-8624.2005.00832.x; Chakrabarti B, 2006, EUR J NEUROSCI, V23, P1944, DOI 10.1111/j.1460-9568.2006.04697.x; Cole K, 2000, BRIT J DEV PSYCHOL, V18, P279, DOI 10.1348/026151000165698; Crespi B, 2008, BEHAV BRAIN SCI, V31, P284, DOI 10.1017/S0140525X08004457; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Crews D, 2011, HORM BEHAV, V59, P393, DOI 10.1016/j.yhbeh.2010.07.001; Cutting AL, 1999, CHILD DEV, V70, P853, DOI 10.1111/1467-8624.00061; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; DENHAM SA, 1994, DEV PSYCHOL, V30, P928, DOI 10.1037/0012-1649.30.6.928; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Ekman P., 1997, NONVERBAL COMMUNICAT, P27; Elgar K, 2002, P ROY SOC B-BIOL SCI, V269, P2415, DOI 10.1098/rspb.2002.2173; Farhadian M, 2010, J SCI RES, V7, P25; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Garner PW, 1997, SOC DEV, V6, P37, DOI 10.1111/j.1467-9507.1997.tb00093.x; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Goos LM, 2006, J NEUROGENET, V20, P19, DOI 10.1080/01677060600685840; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Harkness KL, 2005, COGNITION EMOTION, V19, P999, DOI 10.1080/02699930541000110; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hughes C, 2005, CHILD DEV, V76, P356, DOI 10.1111/j.1467-8624.2005.00850_a.x; Hughes C, 1999, PSYCHOL SCI, V10, P429, DOI 10.1111/1467-9280.00181; Jenkins JM, 1996, DEV PSYCHOL, V32, P70, DOI 10.1037/0012-1649.32.1.70; Kesler SR, 2003, BIOL PSYCHIAT, V54, P636, DOI 10.1016/S0006-3223(03)00289-0; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Lawrence K, 2003, NEUROPSYCHOLOGIA, V41, P894, DOI 10.1016/S0028-3932(03)00002-2; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Lewis C, 1996, CHILD DEV, V67, P2930, DOI 10.2307/1131760; Mazzola F, 2006, SOC NEUROSCI-UK, V1, P259, DOI 10.1080/17470910600989912; Meins E, 1998, SOC DEV, V7, P1, DOI 10.1111/1467-9507.00047; Nelson ED, 2011, NEUROBIOL LEARN MEM, V96, P53, DOI 10.1016/j.nlm.2011.02.015; Nugent BM, 2011, NEUROENDOCRINOLOGY, V93, P150, DOI 10.1159/000325264; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; PERNER J, 1994, CHILD DEV, V65, P1228, DOI 10.1111/j.1467-8624.1994.tb00814.x; Plagge A, 2005, MOL CELL BIOL, V25, P3019, DOI 10.1128/MCB.25.8.3019-3026.2005; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Roth TL, 2011, J CHILD PSYCHOL PSYC, V52, P398, DOI 10.1111/j.1469-7610.2010.02282.x; Ruffman T, 1998, DEV PSYCHOL, V34, P161, DOI 10.1037/0012-1649.34.1.161; Ruffman T, 2002, CHILD DEV, V73, P734, DOI 10.1111/1467-8624.00435; Sabbagh MA, 2008, DEVELOPMENTAL SCI, V11, P354, DOI 10.1111/j.1467-7687.2008.00680.x; Skuse D, 2006, PHILOS T R SOC B, V361, P2129, DOI 10.1098/rstb.2006.1935; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Viding E, 2004, J CHILD PSYCHOL PSYC, V45, P1329, DOI 10.1111/j.1469-7610.2004.00323.x; Voracek M, 2006, PERS INDIV DIFFER, V41, P1481, DOI 10.1016/j.paid.2006.06.009; Weiss LA, 2007, HUM MOL GENET, V16, P107, DOI 10.1093/hmg/ddl445; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5	80	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23236	10.1371/journal.pone.0023236	http://dx.doi.org/10.1371/journal.pone.0023236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803EC	21850264	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300049
J	Zhang, JE; Luo, A; Xin, HP; Zhao, J; Li, SS; Qu, LH; Ma, LG; Scholten, S; Sun, MX				Zhang, Jun-E; Luo, An; Xin, Hai-Ping; Zhao, Jing; Li, Shi-Sheng; Qu, Liang-Huan; Ma, Li-Gang; Scholten, Stefan; Sun, Meng-Xiang			Genes of Both Parental Origins Are Differentially Involved in Early Embryogenesis of a Tobacco Interspecies Hybrid	PLOS ONE			English	Article							TO-ZYGOTIC TRANSITION; SEED DEVELOPMENT; ARABIDOPSIS; EMBRYO; CHROMATIN; MAIZE	Background: In animals, early embryonic development is largely dependent on maternal transcripts synthesized during gametogenesis. However, in higher plants, the extent of maternal control over zygote development and early embryogenesis is not fully understood yet. Nothing is known about the activity of the parental genomes during seed formation of interspecies hybrids. Methodology/Principal Findings: Here, we report that an interspecies hybridization system between SR1 (Nicotiana tabacum) and Hamayan (N. rustica) has been successfully established. Based on the system we selected 58 genes that have polymorphic sites between SR1 and Hamayan, and analyzed the allele-specific expression of 28 genes in their hybrid zygotes (Hamayan x SR1). Finally the allele-specific expressions of 8 genes in hybrid zygotes were repeatedly confirmed. Among them, 4 genes were of paternal origin, 1 gene was of maternal origin and 3 genes were of biparental origin. These results revealed obvious biparental involvement and differentially contribution of parental-origin genes to zygote development in the interspecies hybrid. We further detected the expression pattern of the genes at 8-celled embryo stage found that the involvement of the parental-origin genes may change at different stages of embryogenesis. Conclusions/Significance: We reveal that genes of both parental origins are differentially involved in early embryogenesis of a tobacco interspecies hybrid and functions in a developmental stage-dependent manner. This finding may open a window to seek for the possible molecular mechanism of hybrid vigor.	[Zhang, Jun-E; Luo, An; Xin, Hai-Ping; Zhao, Jing; Li, Shi-Sheng; Qu, Liang-Huan; Ma, Li-Gang; Sun, Meng-Xiang] Wuhan Univ, Key Lab, Minist Educ Plant Dev Biol, Coll Life Sci, Wuhan 430072, Peoples R China; [Zhang, Jun-E] Jiangxi Normal Univ, Coll Life Sci, Nanchang, Peoples R China; [Scholten, Stefan] Univ Hamburg, Bioctr Klein Flottbek Dev Biol & Biotechnol, Hamburg, Germany	Wuhan University; Jiangxi Normal University; University of Hamburg	Zhang, JE (corresponding author), Wuhan Univ, Key Lab, Minist Educ Plant Dev Biol, Coll Life Sci, Wuhan 430072, Peoples R China.	mxsun@whu.edu.cn	Ma, Ligang/O-9603-2014	Ma, Ligang/0000-0003-3451-5291	"973" project [2007CB108700]; National Natural Science Foundation of China [30821064, 31070284]; "111" project	"973" project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" project(Ministry of Education, China - 111 Project)	The work was financially supported by "973" project (2007CB108700), the National Natural Science Foundation of China (30821064; 31070284) and "111" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroux C, 2001, FEBS LETT, V509, P11, DOI 10.1016/S0014-5793(01)03097-6; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; DAPHNE A, 2011, CELL, V145, P707; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Fu ChunMei, 1996, Acta Botanica Sinica, V38, P262; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Grimanelli D, 2005, PLANT CELL, V17, P1061, DOI 10.1105/tpc.104.029819; He Yu-Chi, 2006, Wuhan Zhiwuxue Yanjiu, V24, P6; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Newman-Smith ED, 1998, CURR OPIN GENET DEV, V8, P472, DOI 10.1016/S0959-437X(98)80120-2; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Scholten S, 2002, PLANT J, V32, P221, DOI 10.1046/j.1365-313X.2002.01418.x; Sun Meng-Xiang, 1993, Acta Botanica Sinica, V35, P893; Sun MX, 2000, SEX PLANT REPROD, V12, P267; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; Xin HP, 2011, SEX PLANT REPROD, V24, P37, DOI 10.1007/s00497-010-0151-y; Zhao J, 2011, PLANT J, V65, P131, DOI 10.1111/j.1365-313X.2010.04403.x	20	6	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23153	10.1371/journal.pone.0023153	http://dx.doi.org/10.1371/journal.pone.0023153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829711	gold, Green Submitted, Green Published			2022-12-27	WOS:000293561200052
J	Pankratz, N; Dumitriu, A; Hetrick, KN; Sun, M; Latourelle, JC; Wilk, JB; Halter, C; Doheny, KF; Gusella, JF; Nichols, WC; Myers, RH; Foroud, T; DeStefano, AL				Pankratz, Nathan; Dumitriu, Alexandra; Hetrick, Kurt N.; Sun, Mei; Latourelle, Jeanne C.; Wilk, Jemma B.; Halter, Cheryl; Doheny, Kimberly F.; Gusella, James F.; Nichols, William C.; Myers, Richard H.; Foroud, Tatiana; DeStefano, Anita L.			Copy Number Variation in Familial Parkinson Disease	PLOS ONE			English	Article							HIDDEN-MARKOV MODEL; MUTATIONS; ASSOCIATION; VARIANTS; ONSET; GENES; RARE; HETEROZYGOSITY; LINKAGE; SAMPLE	Copy number variants (CNVs) are known to cause Mendelian forms of Parkinson disease (PD), most notably in SNCA and PARK2. PARK2 has a recessive mode of inheritance; however, recent evidence demonstrates that a single CNV in PARK2 (but not a single missense mutation) may increase risk for PD. We recently performed a genome-wide association study for PD that excluded individuals known to have either a LRRK2 mutation or two PARK2 mutations. Data from the Illumina370Duo arrays were re-clustered using only white individuals with high quality intensity data, and CNV calls were made using two algorithms, PennCNV and QuantiSNP. After quality assessment, the final sample included 816 cases and 856 controls. Results varied between the two CNV calling algorithms for many regions, including the PARK2 locus (genome-wide p = 0.04 for PennCNV and p = 0.13 for QuantiSNP). However, there was consistent evidence with both algorithms for two novel genes, USP32 and DOCK5 (empirical, genome-wide p-values<0.001). PARK2 CNVs tended to be larger, and all instances that were molecularly tested were validated. In contrast, the CNVs in both novel loci were smaller and failed to replicate using real-time PCR, MLPA, and gel electrophoresis. The DOCK5 variation is more akin to a VNTR than a typical CNV and the association is likely caused by artifact due to DNA source. DNA for all the cases was derived from whole blood, while the DNA for all controls was derived from lymphoblast cell lines. The USP32 locus contains many SNPs with low minor allele frequency leading to a loss of heterozygosity that may have been spuriously interpreted by the CNV calling algorithms as support for a deletion. Thus, only the CNVs within the PARK2 locus could be molecularly validated and associated with PD susceptibility.	[Pankratz, Nathan; Halter, Cheryl; Foroud, Tatiana] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Dumitriu, Alexandra; Latourelle, Jeanne C.; Wilk, Jemma B.; Myers, Richard H.; DeStefano, Anita L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hetrick, Kurt N.; Doheny, Kimberly F.] Johns Hopkins Univ, Sch Med, Inst Med Genet, CIDR, Baltimore, MD USA; [Sun, Mei; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Sun, Mei] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Nichols, William C.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH USA; [Nichols, William C.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [DeStefano, Anita L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Indiana University System; Indiana University Bloomington; Boston University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Boston University	Pankratz, N (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46204 USA.	npankrat@iupui.edu	Pillay, Nischalan/F-9536-2012; Sander-Effron, Samuel/AAX-2231-2020; Litvan, Irene/X-9319-2018; Resource Center, NINDS Human Genetics/AGF-2474-2022; Goldwurm, Stefano/Q-8978-2016	Litvan, Irene/0000-0002-3485-3445; Goldwurm, Stefano/0000-0002-1651-567X; Pankratz, Nathan/0000-0001-5958-693X; Dumitriu, Alexandra/0000-0002-4467-4803; Latourelle, Jeanne/0000-0002-4218-9572; Nagle, Michael/0000-0002-4677-7582; Myers, Richard/0000-0002-8365-2674; DeStefano, Anita/0000-0002-9335-2819; Walker, Francis/0000-0002-7817-9421; Chinnery, Patrick/0000-0002-7065-6617	Robert P. & Judith N. Goldberg Foundation; Bumpus Foundation; Harvard NeuroDiscovery Center; Italian Telethon [GTB07001]; Fondazione Grigioni per il Morbo di Parkinson; National Institutes of Health [HHSN268200782096C];  [R01 NS37167];  [R01 NS036711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037167, R01NS036711] Funding Source: NIH RePORTER	Robert P. & Judith N. Goldberg Foundation; Bumpus Foundation; Harvard NeuroDiscovery Center; Italian Telethon(Fondazione Telethon); Fondazione Grigioni per il Morbo di Parkinson; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by R01 NS37167, R01 NS036711, the Robert P. & Judith N. Goldberg Foundation, the Bumpus Foundation and the Harvard NeuroDiscovery Center. This study used samples from the NINDS Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds), as well as clinical data. DNA samples contributed by the Parkinson Institute - Istituti Clinici di Perfezionamento, Milan, Italy were from the "Human genetic bank of patients affected by PD and parkinsonisms", supported by Italian Telethon grant n. GTB07001 and by the "Fondazione Grigioni per il Morbo di Parkinson". Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Karamohamed S, 2005, MOVEMENT DISORD, V20, P1188, DOI 10.1002/mds.20515; Klein C, 2000, ANN NEUROL, V48, P65, DOI 10.1002/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO;2-L; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nichols WC, 2007, NEUROLOGY, V69, P1737, DOI 10.1212/01.wnl.0000278115.50741.4e; Nichols WC, 2004, MOVEMENT DISORD, V19, P649, DOI 10.1002/mds.20097; Pankratz N, 2009, NEUROLOGY, V73, P279, DOI 10.1212/WNL.0b013e3181af7a33; Pankratz N, 2007, GENET MED, V9, P801, DOI 10.1097/GIM.0b013e31815bf97c; Pankratz N, 2006, MOVEMENT DISORD, V21, P2257, DOI 10.1002/mds.21162; Pankratz N, 2006, NEUROSCI LETT, V408, P209, DOI 10.1016/j.neulet.2006.09.003; Pankratz N, 2009, MOVEMENT DISORD, V24, P1125, DOI 10.1002/mds.22524; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simon-Sanchez J, 2008, HUM MUTAT, V29, P315, DOI 10.1002/humu.20626; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sun M, 2006, ARCH NEUROL-CHICAGO, V63, P826, DOI 10.1001/archneur.63.6.826; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	25	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e20988	10.1371/journal.pone.0020988	http://dx.doi.org/10.1371/journal.pone.0020988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829596	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511900001
J	Frisvad, JC; Larsen, TO; Thrane, U; Meijer, M; Varga, J; Samson, RA; Nielsen, KF				Frisvad, Jens C.; Larsen, Thomas O.; Thrane, Ulf; Meijer, Martin; Varga, Janos; Samson, Robert A.; Nielsen, Kristian F.			Fumonisin and Ochratoxin Production in Industrial Aspergillus niger Strains	PLOS ONE			English	Article							CITRIC-ACID PRODUCTION; ORGANIC-ACIDS; B-2; METABOLITES; GENOMICS; GRAPES; SAFETY; WASTE; WINE; B2	Aspergillus niger is perhaps the most important fungus used in biotechnology, and is also one of the most commonly encountered fungi contaminating foods and feedstuffs, and occurring in soil and indoor environments. Many of its industrial applications have been given GRAS status (generally regarded as safe). However, A. niger has the potential to produce two groups of potentially carcinogenic mycotoxins: fumonisins and ochratoxins. In this study all available industrial and many non-industrial strains of A. niger (180 strains) as well as 228 strains from 17 related black Aspergillus species were examined for mycotoxin production. None of the related 17 species of black Aspergilli produced fumonisins. Fumonisins (B-2, B-4, and B-6) were detected in 81% of A. niger, and ochratoxin A in 17%, while 10% of the strains produced both mycotoxins. Among the industrial strains the same ratios were 83%, 33% and 26% respectively. Some of the most frequently used strains in industry NRRL 337, 3112 and 3122 produced both toxins and several strains used for citric acid production were among the best producers of fumonisins in pure agar culture. Most strains used for other biotechnological processes also produced fumonisins. Strains optimized through random mutagenesis usually maintained their mycotoxin production capability. Toxigenic strains were also able to produce the toxins on media suggested for citric acid production with most of the toxins found in the biomass, thereby questioning the use of the remaining biomass as animal feed. In conclusion it is recommended to use strains of A. niger with inactive or inactivated gene clusters for fumonisins and ochratoxins, or to choose isolates for biotechnological uses in related non-toxigenic species such as A. tubingensis, A. brasiliensis, A vadensis or A. acidus, which neither produce fumonisins nor ochratoxins.	[Frisvad, Jens C.; Larsen, Thomas O.; Thrane, Ulf; Nielsen, Kristian F.] Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Meijer, Martin; Varga, Janos; Samson, Robert A.] CBS Fungal Biodivers Ctr, Utrecht, Netherlands; [Varga, Janos] Univ Szeged, Dept Microbiol, Fac Sci & Informat, Szeged, Hungary	Technical University of Denmark; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Szeged University	Frisvad, JC (corresponding author), Tech Univ Denmark, Ctr Microbial Biotechnol, Dept Syst Biol, DK-2800 Lyngby, Denmark.	jcf@bio.dtu.dk	Thrane, Ulf/G-2978-2016; Samson, Robert/ABE-6704-2020; Frisvad, Jens C/K-2818-2017; Nielsen, Kristian Fog/C-7233-2011	Thrane, Ulf/0000-0002-6040-4141; Frisvad, Jens C/0000-0002-0573-4340; Nielsen, Kristian Fog/0000-0002-5848-0911; Larsen, Thomas Ostenfeld/0000-0002-3362-5707; Samson, Robert A./0000-0002-2979-3097	The Danish Research Council for Production and Technology Sciences [26-04-0050]; Danish Food Industry Agency [3304-FVFP-07-730-01]	The Danish Research Council for Production and Technology Sciences; Danish Food Industry Agency	The authors were supported by The Danish Research Council for Production and Technology Sciences (26-04-0050) and Danish Food Industry Agency for financial support (3304-FVFP-07-730-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca ML, 2004, ANTON LEEUW INT J G, V86, P33, DOI 10.1023/B:ANTO.0000024907.85688.05; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; ARCHER DB, 1990, BIO-TECHNOL, V8, P741, DOI 10.1038/nbt0890-741; Baker SE, 2006, MED MYCOL, V44, pS17, DOI 10.1080/13693780600921037; BLOCH F, 1973, AM POTATO J, V50, P357, DOI 10.1007/BF02851891; Blumenthal CZ, 2004, REGUL TOXICOL PHARM, V39, P214, DOI 10.1016/j.yrtph.2003.09.002; Brown DW, 2005, FUNGAL GENET BIOL, V42, P848, DOI 10.1016/j.fgb.2005.06.001; Butchko RAE, 2006, J AGR FOOD CHEM, V54, P9398, DOI 10.1021/jf0617869; CHRISTIAS C, 1975, APPL MICROBIOL, V29, P250, DOI 10.1111/1741-5705.00031; Coulibaly L, 2002, WATER RES, V36, P3941, DOI 10.1016/S0043-1354(02)00117-3; Frisvad JC, 2004, STUD MYCOL, P1; Frisvad JC, 2007, J AGR FOOD CHEM, V55, P9727, DOI 10.1021/jf0718906; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Goldberg I, 2006, J CHEM TECHNOL BIOT, V81, P1601, DOI 10.1002/jctb.1590; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; HANG YD, 1976, PROG WATER TECHNOL, V8, P325; Hofmann G, 2009, METAB ENG, V11, P8, DOI 10.1016/j.ymben.2008.07.002; JERNEJC K, 1982, EUR J APPL MICROBIOL, V14, P29, DOI 10.1007/BF00508000; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; Karaffa L, 2003, APPL MICROBIOL BIOT, V61, P189, DOI 10.1007/s00253-002-1201-7; Kirimura K, 1999, BIOSCI BIOTECH BIOCH, V63, P226, DOI 10.1271/bbb.63.226; Knudsen PB, 2011, J AGR FOOD CHEM, V59, P772, DOI 10.1021/jf103855x; Logrieco A, 2010, FOOD ADDIT CONTAM A, V27, P1136, DOI 10.1080/19440041003716547; Lubertozzi D, 2009, BIOTECHNOL ADV, V27, P53, DOI 10.1016/j.biotechadv.2008.09.001; Magnoli C, 2003, LETT APPL MICROBIOL, V37, P179, DOI 10.1046/j.1472-765X.2003.01376.x; Mansson M, 2010, J AGR FOOD CHEM, V58, P949, DOI 10.1021/jf902834g; Mogensen JM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-281; Mogensen JM, 2010, J AGR FOOD CHEM, V58, P954, DOI 10.1021/jf903116q; Mogensen JM, 2010, J AGR FOOD CHEM, V58, P4853, DOI 10.1021/jf904520t; MOYER AJ, 1953, APPL MICROBIOL, V1, P1; Myung K, 2008, APPL MICROBIOL BIOT, V78, P343, DOI 10.1007/s00253-007-1314-0; Navaratnam P, 1998, WORLD J MICROB BIOT, V14, P559, DOI 10.1023/A:1008856603769; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Noonim P, 2009, FOOD ADDIT CONTAM A, V26, P94, DOI 10.1080/02652030802366090; Oboh G, 2002, J FOOD COMPOS ANAL, V15, P617, DOI [10.1016/S0889-1575(02)91065-3, 10.1006/jfca.2002.1065]; Ousmanova D, 2007, WATER AIR SOIL POLL, V179, P365, DOI 10.1007/s11270-006-9241-8; Pariza MW, 2010, REGUL TOXICOL PHARM, V56, P332, DOI 10.1016/j.yrtph.2009.10.005; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Romero SM, 2005, INT J FOOD MICROBIOL, V104, P43, DOI 10.1016/j.ijfoodmicro.2005.04.001; Samson RA, 2007, STUD MYCOL, P129, DOI 10.3114/sim.2007.59.13; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Schuster E, 2002, APPL MICROBIOL BIOT, V59, P426, DOI 10.1007/s00253-002-1032-6; Soccol CR, 2006, FOOD TECHNOL BIOTECH, V44, P141; Sorensen LM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-255; Sun JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r182; Susca A, 2010, J AGR FOOD CHEM, V58, P9266, DOI 10.1021/jf101591x; Varga J, 2010, INT J FOOD MICROBIOL, V143, P143, DOI 10.1016/j.ijfoodmicro.2010.08.008; Wang JL, 1998, PROCESS BIOCHEM, V33, P313, DOI 10.1016/S0032-9592(97)87513-9	51	128	133	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23496	10.1371/journal.pone.0023496	http://dx.doi.org/10.1371/journal.pone.0023496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853139	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953400048
J	Huang, XM; Auinger, P; Eberly, S; Oakes, D; Schwarzschild, M; Ascherio, A; Mailman, R; Chen, HL				Huang, Xuemei; Auinger, Peggy; Eberly, Shirley; Oakes, David; Schwarzschild, Michael; Ascherio, Alberto; Mailman, Richard; Chen, Honglei		Parkinson Study Grp DATATOP	Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; INCREASES DOPAMINE RELEASE; RAT NUCLEUS-ACCUMBENS; IN-VITRO; RISK; STATINS; COHORT; DISABILITY; MORPHINE	Background: Recent studies have suggested that higher serum cholesterol may be associated with lower occurrence of Parkinson's disease (PD). This study is to test the hypothesis that higher serum cholesterol correlates with slower PD progression. Methods: Baseline non-fasting serum total cholesterol was measured in 774 of the 800 subjects with early PD enrolled between 1987 and 1988 in the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) trial. Participants were followed for up to two years, with clinical disability requiring levodopa therapy as the primary endpoint. Hazard ratios (HRs) and 95% confidence intervals (CI) were determined for increasing serum cholesterol concentration (in quintiles) for clinical disability requiring levodopa therapy, after adjusting for confounders. At baseline, only nine subjects reported use of cholesterol-lowering agents (two with statins). Results: The overall mean cholesterol level was 216 mg/dL (range 100-355). The HR of progressing to the primary endpoint decreased with increasing serum cholesterol concentrations. Compared to the lowest quintile, the HRs (95% CI), for each higher quintile (in ascending order) are 0.83 (0.59-1.16); 0.86 (0.61-1.20); 0.84 (0.60-1.18); and 0.75 (0.52-1.09). The HR for one standard deviation (SD) increase = 0.90 [(0.80-1.01), p for trend = 0.09]. This trend was found in males (HR per SD = 0.88 [(0.77-1.00), p for trend = 0.05], but not in females [ HR = 1.03 (0.81-1.32)]. Conclusions: This secondary analysis of the DATATOP trial provides preliminary evidence that higher total serum cholesterol concentrations may be associated with a modest slower clinical progression of PD, and this preliminary finding needs confirmation from larger prospective studies.	[Huang, Xuemei; Mailman, Richard] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Huang, Xuemei; Mailman, Richard] Penn State Univ, Milton S Hershey Med Ctr, Dept Pharmacol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Kinesiol, Hershey, PA 17033 USA; [Auinger, Peggy] Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Human Expt Therapeut, Rochester, NY 14642 USA; [Eberly, Shirley; Oakes, David] Univ Rochester, Sch Med & Dent, Dept Biostat, Rochester, NY USA; [Schwarzschild, Michael] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Ascherio, Alberto] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ascherio, Alberto] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chen, Honglei] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Rochester; University of Rochester; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Huang, XM (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA.	Xuemei@psu.edu	Mayeux, Richard/E-9788-2013	Mayeux, Richard/0000-0001-6519-9696; Mailman, Richard/0000-0003-1353-2738; Chen, Honglei/0000-0003-3446-7779	Parkinson's Disease Foundation; National Institutes of Health [NS060722]; Pennsylvania Tobacco Settlement Fund; National Institute of Environmental Health Sciences [Z01-ES-101986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060722] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Fund; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by Parkinson's Disease Foundation, National Institutes of Health (NS060722 to XH), the Pennsylvania Tobacco Settlement Fund, and the intramural research program of the National Institute of Environmental Health Sciences (Z01-ES-101986 to HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation.	Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; Barrot M, 1999, EUR J NEUROSCI, V11, P3757, DOI 10.1046/j.1460-9568.1999.00816.x; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; de Lau LML, 2006, AM J EPIDEMIOL, V164, P998, DOI 10.1093/aje/kwj283; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Frank C, 2000, PROG NEURO-PSYCHOPH, V24, P1117, DOI 10.1016/S0278-5846(00)00124-X; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hu G, 2008, NEUROLOGY, V70, P1972, DOI 10.1212/01.wnl.0000312511.62699.a8; Huang XM, 2008, MOVEMENT DISORD, V23, P1013, DOI 10.1002/mds.22013; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lee PH, 2009, MOVEMENT DISORD, V24, P752, DOI 10.1002/mds.22459; MAES M, 1994, ACTA PSYCHIAT SCAND, V90, P252, DOI 10.1111/j.1600-0447.1994.tb01589.x; Marras C, 2005, NEUROLOGY, V64, P87, DOI 10.1212/01.WNL.0000148603.44618.19; Miyake Y, 2010, J NEUROL SCI, V293, P82, DOI 10.1016/j.jns.2010.03.002; Rouge-Pont F, 2002, EUR J NEUROSCI, V16, P169, DOI 10.1046/j.1460-9568.2002.02084.x; SCHAEFER EJ, 1994, J LIPID RES, V35, P779; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; Shoulson I, 2007, NEUROLOGY, V69, P1480, DOI 10.1212/01.wnl.0000277648.63931.c0; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Simon KC, 2007, NEUROLOGY, V69, P1688, DOI 10.1212/01.wnl.0000271883.45010.8a; Stepien K, 2005, PHARMACOL REP, V57, P561; Stoffel-Wagner B, 2001, EUR J ENDOCRINOL, V145, P669, DOI 10.1530/eje.0.1450669; TANNER CM, 2002, PARKINSONS DIS MOVEM, P90; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; VASAN RS, 1992, ARCH INTERN MED, V152, P414, DOI 10.1001/archinte.152.2.414; Weiss R, 2003, CLIN THER, V25, P1490, DOI 10.1016/S0149-2918(03)80134-0; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	34	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22854	10.1371/journal.pone.0022854	http://dx.doi.org/10.1371/journal.pone.0022854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853051	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953400015
J	Roe, B; Kensicki, E; Mohney, R; Hall, WW				Roe, Barbara; Kensicki, Elizabeth; Mohney, Robert; Hall, William W.			Metabolomic Profile of Hepatitis C Virus-Infected Hepatocytes	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; OXIDATIVE STRESS; LIPID-METABOLISM; RNA REPLICATION; RAT HEPATOCYTES; IN-VITRO; CELLS; LIVER; METHYLTHIOADENOSINE; APOPTOSIS	Hepatitis C virus (HCV) is capable of disrupting different facets of lipid metabolism and lipids have been shown to play a crucial role in the viral life cycle. The aim of this study was to examine the effect HCV infection has on the hepatocyte metabolome. Huh-7.5 cells were infected using virus produced by the HCV J6/JFH1 cell culture system and cells were harvested 24, 48, and 72-hours following infection. Metabolic profiling was performed using a non-targeted multiple platform methodology combining ultrahigh performance liquid chromatography/tandem mass spectrometry (UHPLC/MS/MS(2)) and gas chromatography/mass spectrometry (GC/MS). There was a significant increase in a number of metabolites involved in nucleotide synthesis and RNA replication during early HCV infection. NAD levels were also significantly increased along with several amino acids. A number of lipid metabolic pathways were disrupted by HCV infection, resulting in an increase in cholesterol and sphingolipid levels, altered phospholipid metabolism and a possible disruption in mitochondrial fatty acid transport. Fluctuations in 5'-methylthioadenosine levels were also noted, along with alterations in the glutathione synthesis pathway. These results highlight a number of previously unreported metabolic interactions and give a more in depth insight into the effect HCV has on host cell biochemical processes.	[Roe, Barbara; Hall, William W.] Univ Coll Dublin, Ctr Res Infect Dis, Sch Med & Med Sci, Dublin 2, Ireland; [Kensicki, Elizabeth; Mohney, Robert] Metabolon Inc, Durham, NC USA	University College Dublin; Metabolon	Roe, B (corresponding author), Univ Coll Dublin, Ctr Res Infect Dis, Sch Med & Med Sci, Dublin 2, Ireland.	barbara.roe@ucd.ie			National Virus Reference Laboratory; Centre for Research in Infectious Diseases, University College Dublin, Ireland [8090]	National Virus Reference Laboratory; Centre for Research in Infectious Diseases, University College Dublin, Ireland	This study was funded by the National Virus Reference Laboratory and the Centre for Research in Infectious Diseases, University College Dublin, Ireland (Grant No. 8090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Ahn EH, 2010, ANTICANCER RES, V30, P2881; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; D'Arrigo P, 2010, MOLECULES, V15, P1354, DOI 10.3390/molecules15031354; Dabrowska MM, 2009, WORLD J GASTROENTERO, V15, P2184, DOI 10.3748/wjg.15.2184; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Hutin Y, 2004, J CLIN PHARMACOL, V44, P20, DOI 10.1177/0091270003258669; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kell DB, 2005, NAT REV MICROBIOL, V3, P557, DOI 10.1038/nrmicro1177; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; Nakano T, 2009, BBA-BIOMEMBRANES, V1788, P2222, DOI 10.1016/j.bbamem.2009.07.015; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schmeding M, 2007, LIVER TRANSPLANT, V13, P687, DOI 10.1002/lt.21138; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; SOGA T, 2011, J HEPATOL; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Stuyver LJ, 2003, J VIROL, V77, P10689, DOI 10.1128/JVI.77.19.10689-10694.2003; Tan KC, 2009, MOL PLANT PATHOL, V10, P703, DOI [10.1111/J.1364-3703.2009.00565.X, 10.1111/j.1364-3703.2009.00565.x]; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	48	71	76	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23641	10.1371/journal.pone.0023641	http://dx.doi.org/10.1371/journal.pone.0023641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853158	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400054
J	Ribeiro, AC; Ceccarini, G; Dupre, C; Friedman, JM; Pfaff, DW; Mark, AL				Ribeiro, Ana C.; Ceccarini, Giovanni; Dupre, Christophe; Friedman, Jeffrey M.; Pfaff, Donald W.; Mark, Allyn L.			Contrasting Effects of Leptin on Food Anticipatory and Total Locomotor Activity	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSE; GENE-EXPRESSION; BODY-WEIGHT; OBESE GENE; DEFICIENCY; REPLACEMENT; DYSFUNCTION; RESISTANCE; BEHAVIOR	Obese, leptin deficient obob mice have profoundly decreased activity and increased food seeking behavior. The decreased activity has been attributed to obesity. In mice, we tested the hypothesis that leptin increases total locomotor activity but inhibits food anticipatory activity. We also sought to determine if leptin induced increases in total locomotor activity are independent of changes in body weight and obesity. We studied obob mice and also created a novel transgenic mouse where leptin is over-expressed in a tetracycline-off system and can be abruptly and non-invasively suppressed by doxycycline within few hours. The studies were performed using two independent behavioral assays: home cage activity (HCA) and running wheel activity (RWA). Systemic administration of leptin (150 ng/hr) to obob mice produced a 122% +/- 30% (mean +/- SEM) increase (p <= 0.01) in locomotor activity within 2 days In addition, cerebroventricular administration of leptin (5 ng/hr) also produced an early and progressive increase in total locomotor activity beginning on the 1st day (+28 +/- 8%; p <= 0.05) and increasing to +69 +/- 23% on day 3 without a decrease in body weight during this time. The increase in activity was restricted to the dark phase. Conversely, in a tet-off transgenic obob mouse line, acute leptin suppression reduced spontaneous locomotor activity. To further define activities that are leptin regulated, we assayed food anticipatory activity (FAA) and found that it was markedly augmented in obob mice compared to wild type mice (+38 +/- 6.7 in obob vs +20 +/- 6.3% in wild type at peak; mean +/- SEM; p <= 0.001) and abolished by leptin. Although melanocortin-3 receptors (MC3R) reportedly mediate FAA, we found augmented FAA and preserved inhibitory effects of leptin on FAA in MC3R-/-obob mice. In summary, this study demonstrates that total activity and FAA are regulated independently by leptin. Leptin, acting in the central nervous system and at physiologic levels, produces early increases in locomotor activity before substantial weight loss. In contrast, leptin suppresses augmented food anticipatory activity in obob mice.	[Ribeiro, Ana C.; Dupre, Christophe; Pfaff, Donald W.] Rockefeller Univ, Neurobiol & Behav Lab, New York, NY 10021 USA; [Ribeiro, Ana C.] Coll Mt St Vincent, Div Nat Sci, New York, NY USA; [Ceccarini, Giovanni; Friedman, Jeffrey M.; Mark, Allyn L.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA; [Mark, Allyn L.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Ceccarini, Giovanni] Univ Hosp Pisa, Dept Endocrinol, Pisa, Italy	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Iowa; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Ribeiro, AC (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave, New York, NY 10021 USA.	friedj@rockefeller.edu; pfaff@rockefeller.edu; amark@rockefeller.edu	CECCARINI, GIOVANNI/S-3871-2019	CECCARINI, GIOVANNI/0000-0003-0701-642X; Dupre, Christophe/0000-0002-5929-8492	Howard Hughes Medical Institute; National Institutes of Health [NIH HD-05751, NIH HL-086018, NIH PO1-HL84207]; Roy J. Carver Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD005751] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207, F32HL086018] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. Carver Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds from the Howard Hughes Medical Institute (Jeffrey M. Friedman; www.hhmi.org); National Institutes of Health (www.nih.gov) NIH HD-05751 (Donald W. Pfaff), NIH HL-086018 (Ana C. Ribeiro); NIH PO1-HL84207 (Allyn L Mark) and the Roy J. Carver Trust (Allyn L. Mark; carvertrust.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gossen Manfred, 1994, Current Opinion in Biotechnology, V5, P516, DOI 10.1016/0958-1669(94)90067-1; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Ioffe E, 1998, P NATL ACAD SCI USA, V95, P11852, DOI 10.1073/pnas.95.20.11852; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Mesaros A, 2008, CELL METAB, V7, P236, DOI 10.1016/j.cmet.2008.01.007; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Montez JM, 2005, P NATL ACAD SCI USA, V102, P2537, DOI 10.1073/pnas.0409530102; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Qiu J, 2001, ENDOCRINOLOGY, V142, P348, DOI 10.1210/en.142.1.348; Rico L, 2005, ENDOCRINOLOGY, V146, P4167, DOI 10.1210/en.2005-0156; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; Surwit RS, 2000, DIABETES, V49, P1203, DOI 10.2337/diabetes.49.7.1203; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; VASSELLI JR, 1980, PHYSIOL BEHAV, V25, P565, DOI 10.1016/0031-9384(80)90123-7; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	34	67	67	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23364	10.1371/journal.pone.0023364	http://dx.doi.org/10.1371/journal.pone.0023364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853117	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200074
J	Hayes, S; Boote, C; Kamma-Lorger, CS; Rajan, MS; Harris, J; Dooley, E; Hawksworth, N; Hiller, J; Terill, NJ; Hafezi, F; Brahma, AK; Quantock, AJ; Meek, KM				Hayes, Sally; Boote, Craig; Kamma-Lorger, Christina S.; Rajan, Madhavan S.; Harris, Jonathan; Dooley, Erin; Hawksworth, Nicholas; Hiller, Jennifer; Terill, Nick J.; Hafezi, Farhad; Brahma, Arun K.; Quantock, Andrew J.; Meek, Keith M.			Riboflavin/UVA Collagen Cross-Linking-Induced Changes in Normal and Keratoconus Corneal Stroma	PLOS ONE			English	Article							X-RAY-DIFFRACTION; ULTRAVIOLET-A; RABBIT CORNEA; KERATECTASIA; FIBRILS; SCATTERING; HYDRATION; THERAPY; LASIK	Purpose: To determine the effect of Ultraviolet-A collagen cross-linking with hypo-osmolar and iso-osmolar riboflavin solutions on stromal collagen ultrastructure in normal and keratoconus ex vivo human corneas. Methods: Using small-angle X-ray scattering, measurements of collagen D-periodicity, fibril diameter and interfibrillar spacing were made at 1 mm intervals across six normal post-mortem corneas (two above physiological hydration (swollen) and four below (unswollen)) and two post-transplant keratoconus corneal buttons (one swollen; one unswollen), before and after hypo-osmolar cross-linking. The same parameters were measured in three other unswollen normal corneas before and after iso-osmolar cross-linking and in three pairs of swollen normal corneas, in which only the left was cross-linked (with iso-osmolar riboflavin). Results: Hypo-osmolar cross-linking resulted in an increase in corneal hydration in all corneas. In the keratoconus corneas and unswollen normal corneas, this was accompanied by an increase in collagen interfibrillar spacing (p<0.001); an increase in fibril diameter was also seen in two out of four unswollen normal corneas and one unswollen keratoconus cornea (p<0.001). Iso-osmolar cross-linking resulted in a decrease in tissue hydration in the swollen normal corneas only. Although there was no consistent treatment-induced change in hydration in the unswollen normal samples, iso-osmolar cross-linking of these corneas did result in a compaction of collagen fibrils and a reduced fibril diameter (p<0.001); these changes were not seen in the swollen normal corneas. Collagen D-periodicity was not affected by either treatment. Conclusion: The observed structural changes following Ultraviolet-A cross-linking with hypo-osmolar or iso-osmolar riboflavin solutions are more likely a consequence of treatment-induced changes in tissue hydration rather than cross-linking.	[Hayes, Sally; Boote, Craig; Kamma-Lorger, Christina S.; Harris, Jonathan; Dooley, Erin; Quantock, Andrew J.; Meek, Keith M.] Cardiff Univ, Struct Biophys Res Grp, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Rajan, Madhavan S.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Hawksworth, Nicholas] Royal Glamorgan Hosp, Llantrisant, Rhondda Cynon, England; [Hiller, Jennifer; Terill, Nick J.] Diamond Light Source, Didcot, Oxon, England; [Hafezi, Farhad] Univ Hosp Geneva, Div Ophthalmol, Geneva, Switzerland; [Brahma, Arun K.] Manchester Royal Eye Hosp, Manchester M13 9WH, Lancs, England	Cardiff University; Anglia Ruskin University; Diamond Light Source; University of Geneva; Manchester Royal Eye Hospital	Hayes, S (corresponding author), Cardiff Univ, Struct Biophys Res Grp, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.	meekkm@cf.ac.uk	Hafezi, Farhad/A-1446-2010	Hafezi, Farhad/0000-0001-8935-4558; Hayes, Sally/0000-0001-8550-0108; Bardsley, Jennifer/0000-0001-8714-942X; Boote, Craig/0000-0003-0348-6547; Rajan, Madhavan/0000-0003-2223-5364	Medical Research Council [G0600755]; Science and Technology Facilities Council [SM-194]; Royal Society; MRC [G0600755] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a 5-year Medical Research Council Grant number (G0600755) and Science and Technology Facilities Council (SM-194). Keith Meek is a Royal Society-Wolfson Research Merit Award Holder. These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Jennifer Hiller and Nick J. Terill are employees of Diamond Light Source Ltd, where the data for the study was collected. These authors were involved in data collection and provided expertise in the revision of the paper.	BLANCO T, 2008, ARVO M, V49, P3911; Boote C, 2003, INVEST OPHTH VIS SCI, V44, P2941, DOI 10.1167/iovs.03-0131; Caporossi A, 2006, J CATARACT REFR SURG, V32, P837, DOI 10.1016/j.jcrs.2006.01.091; CINTRON C, 1978, J ULTRA MOL STRUCT R, V65, P13, DOI 10.1016/S0022-5320(78)90017-5; Daxer A, 1998, INVEST OPHTH VIS SCI, V39, P644; FRATZL P, 1993, BIOPHYS J, V64, P1210, DOI 10.1016/S0006-3495(93)81487-5; FULLWOOD NJ, 1993, J MICROSC-OXFORD, V169, P53, DOI 10.1111/j.1365-2818.1993.tb03277.x; Hafezi F, 2007, J CATARACT REFR SURG, V33, P2035, DOI 10.1016/j.jcrs.2007.07.028; Hafezi F, 2009, J CATARACT REFR SURG, V35, P621, DOI 10.1016/j.jcrs.2008.10.060; Hayes S, 2008, J CATARACT REFR SURG, V34, P657, DOI 10.1016/j.jcrs.2008.02.002; HEDBYS BO, 1966, EXP EYE RES, V5, P221, DOI 10.1016/S0014-4835(66)80010-6; Huang YF, 1999, BIOPHYS J, V77, P1655, DOI 10.1016/S0006-3495(99)77013-X; KHOLHAAS M, 2006, J CATARACT REFR SURG, V32, P279; Kohlhaas M, 2005, KLIN MONATSBL AUGENH, V222, P430, DOI 10.1055/s-2005-857950; Malik NS, 1996, AGE AGEING, V25, P279, DOI 10.1093/ageing/25.4.279; MALIK NS, 1992, BIOCHIM BIOPHYS ACTA, V1138, P222, DOI 10.1016/0925-4439(92)90041-K; MALIK NS, 1992, INVEST OPHTH VIS SCI, V33, P895; MAROUDAS A, 1991, BIOCHIM BIOPHYS ACTA, V1073, P285, DOI 10.1016/0304-4165(91)90133-2; MEEK KM, 1991, BIOPHYS J, V60, P467, DOI 10.1016/S0006-3495(91)82073-2; Meek KM, 2001, PROG RETIN EYE RES, V20, P95, DOI 10.1016/S1350-9462(00)00016-1; MEEK KM, 2008, ARVO M, V49, P3913; Salgado JP, 2011, BRIT J OPHTHALMOL, V95, P493, DOI 10.1136/bjo.2010.179424; SAYERS Z, 1982, J MOL BIOL, V160, P593, DOI 10.1016/0022-2836(82)90317-5; Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2010, J CATARACT REFR SURG, V36, P114, DOI 10.1016/j.jcrs.2009.07.044; Wollensak G, 2009, ACTA OPHTHALMOL, V87, P48, DOI 10.1111/j.1755-3768.2008.01190.x; WORTHINGTON CR, 1985, INT J BIOL MACROMOL, V7, P2, DOI 10.1016/0141-8130(85)90057-1	32	39	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22405	10.1371/journal.pone.0022405	http://dx.doi.org/10.1371/journal.pone.0022405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850225	gold, Green Published			2022-12-27	WOS:000293563300009
J	Chen, JC; Dai, FP; Balakrishnan-Renuka, A; Leese, F; Schempp, W; Schaller, F; Hoffmann, MM; Morosan-Puopolo, G; Yusuf, F; Bisschoff, IJ; Chankiewitz, V; Xue, JL; Chen, JZ; Ying, K; Brand-Saberi, B				Chen, Jingchen; Dai, Fangping; Balakrishnan-Renuka, Ajeesh; Leese, Florian; Schempp, Werner; Schaller, Felix; Hoffmann, Michael M.; Morosan-Puopolo, Gabriela; Yusuf, Faisal; Bisschoff, Izak Johannes; Chankiewitz, Verena; Xue, Jinglun; Chen, Jingzhong; Ying, Kang; Brand-Saberi, Beate			Diversification and Molecular Evolution of ATOH8, a Gene Encoding a bHLH Transcription Factor	PLOS ONE			English	Article							PRONEURAL GENE; GENOME; EXPRESSION; PROMOTER; ORIGIN; FAMILY; MATH6; IDENTIFICATION; PHYLOGENIES; COMPONENT	ATOH8 is a bHLH domain transcription factor implicated in the development of the nervous system, kidney, pancreas, retina and muscle. In the present study, we collected sequence of ATOH8 orthologues from 18 vertebrate species and 24 invertebrate species. The reconstruction of ATOH8 phylogeny and sequence analysis showed that this gene underwent notable divergences during evolution. For those vertebrate species investigated, we analyzed the gene structure and regulatory elements of ATOH8. We found that the bHLH domain of vertebrate ATOH8 was highly conserved. Mammals retained some specific amino acids in contrast to the non-mammalian orthologues. Mammals also developed another potential isoform, verified by a human expressed sequence tag (EST). Comparative genomic analyses of the regulatory elements revealed a replacement of the ancestral TATA box by CpG-islands in the eutherian mammals and an evolutionary tendency for TATA box reduction in vertebrates in general. We furthermore identified the region of the effective promoter of human ATOH8 which could drive the expression of EGFP reporter in the chicken embryo. In the opossum, both the coding region and regulatory elements of ATOH8 have some special features, such as the unique extended C-terminus encoded by the third exon and absence of both CpG islands and TATA elements in the regulatory region. Our gene mapping data showed that in human, ATOH8 was hosted in one chromosome which is a fusion product of two orthologous chromosomes in non-human primates. This unique chromosomal environment of human ATOH8 probably subjects its expression to the regulation at chromosomal level. We deduce that the great interspecific differences found in both ATOH8 gene sequence and its regulatory elements might be significant for the fine regulation of its spatiotemporal expression and roles of ATOH8, thus orchestrating its function in different tissues and organisms.	[Chen, Jingchen; Balakrishnan-Renuka, Ajeesh; Morosan-Puopolo, Gabriela; Yusuf, Faisal; Chankiewitz, Verena; Brand-Saberi, Beate] Ruhr Univ Bochum, Dept Anat & Mol Embryol, Bochum, Germany; [Leese, Florian] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Hoffmann, Michael M.] Univ Freiburg, Dept Med, D-7800 Freiburg, Germany; [Balakrishnan-Renuka, Ajeesh] Univ Freiburg, Fac Biol, D-7800 Freiburg, Germany; [Dai, Fangping; Brand-Saberi, Beate] Univ Freiburg, Dept Mol Embryol, D-7800 Freiburg, Germany; [Schempp, Werner; Schaller, Felix; Bisschoff, Izak Johannes] Univ Freiburg, Inst Human Genet, D-7800 Freiburg, Germany; [Xue, Jinglun; Chen, Jingzhong; Ying, Kang] Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China	Ruhr University Bochum; Ruhr University Bochum; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Fudan University	Chen, JC (corresponding author), Ruhr Univ Bochum, Dept Anat & Mol Embryol, Bochum, Germany.	Beate.Brand-Saberi@rub.de	Hoffmann, Michael M/D-4074-2015; Brand-Saberi, Beate/GVT-9451-2022; Leese, Florian/D-4277-2012	Hoffmann, Michael M/0000-0001-8459-6080; Leese, Florian/0000-0002-5465-913X	EU [511978]; DFG [GRK 1104]; DAAD [D/08/01771]	EU(European Commission); DFG(German Research Foundation (DFG)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	The project was supported by an EU's Sixth Framework Program grant to Prof. Dr. B. Brand-Saberi (MYORES, 511978), by the DFG (GRK 1104) and the DAAD D/08/01771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Brentrup D, 2000, DEVELOPMENT, V127, P4729; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; DRUMMOND AJ, 2009, GENEIOUS V4 7; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Freire P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004076; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kubo F, 2010, DEV DYNAM, V239, P2492, DOI 10.1002/dvdy.22381; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; LEDENT V, 2002, GENOME BIOL, V3; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Nunez E, 2008, CELL, V132, P996, DOI 10.1016/j.cell.2008.01.051; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Sambrook J., 2001, MOL CLONING LAB MANU; Scaal M, 2004, DEV DYNAM, V229, P643, DOI 10.1002/dvdy.10433; Schmidt J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005288; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Spicuglia S, 2006, CURR OPIN IMMUNOL, V18, P158, DOI 10.1016/j.coi.2006.01.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Thomas N, 2005, CELL CYCLE, V4, P191, DOI 10.4161/cc.4.1.1405; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang Y, 2009, J MOL EVOL, V68, P629, DOI 10.1007/s00239-009-9232-7; Watanabe Hidemi, 2006, Tanpakushitsu Kakusan Koso, V51, P178; Yao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010945; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; 1991, P NATL ACAD SCI US, V88, P9051	48	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23005	10.1371/journal.pone.0023005	http://dx.doi.org/10.1371/journal.pone.0023005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21857980	gold, Green Submitted, Green Published			2022-12-27	WOS:000293561200041
J	Andrew, T; Calloway, CD; Stuart, S; Lee, SH; Gill, R; Clement, G; Chowienczyk, P; Spector, TD; Valdes, AM				Andrew, Toby; Calloway, Cassandra D.; Stuart, Sarah; Lee, Sang Hoon; Gill, Raj; Clement, Gail; Chowienczyk, Philip; Spector, Tim D.; Valdes, Ana M.			A Twin Study of Mitochondrial DNA Polymorphisms Shows that Heteroplasmy at Multiple Sites Is Associated with mtDNA Variant 16093 but Not with Zygosity	PLOS ONE			English	Article							CONTROL REGION; OXIDATIVE STRESS; HVII REGION; LIFE-SPAN; MUTATIONS; DISEASE; FREQUENCY; SEQUENCE; AGE; DEGENERATION	The mitochondrial theory of ageing proposes that damage to mitochondria and diminished mitochondrial DNA (mtDNA) repair are major contributors to cellular dysfunction and age-related diseases. We investigate the prevalence of heteroplasmy in the mtDNA control region in buccal swab and blood derived samples for 178 women from the TwinsUK cohort (41 DZ pair 39 MZ pairs, 18 singletons, mean age 57.5 range 28-82) and its relationship to age, BMI and fasting insulin and glucose serum levels. The overall estimated prevalence of heteroplasmy for both tissues in the control region measured for 37 sites was 17%. The prevalence of heteroplasmy was higher among the older half of the study subjects than in the younger half (23% vs 10% p<0.03), primarily reflecting the increase in the prevalence of a heteroplasmic dinucleotide CA repeat in variable region II (VRII) with age. The VRII 523-524 heteroplasmic site (heteroplasmic in 25 subjects) was also associated with a decrease in BMI. In addition, concordance rates for common heteroplasmy were observed to be near complete for both dizygotic (DZ = 94%) and monozygotic twin pairs (MZ = 100%), consistent with previous reports that suggest variation in heteroplasmy rates between generations are determined by bottlenecks in maternal transmission of mitochondria. Differences in the prevalence of heteroplasmy were observed overall between samples derived from buccal swabs (19%) and blood (15%, p<0.04). These were particularly marked at position 16093 of hypervariable region I (HVI, 7% vs 0%, respectively, p<4x10(-11)). The presence of the C allele at position 16093 in blood was associated with the presence of heteroplasmy in buccal swabs at this position (p = 3.5x10(-14)) and also at VRII (p = 2x10(-4)) suggesting a possible predisposing role for this site in the accumulation of heteroplasmy. Our data indicate that BMI is potentially associated with control region heteroplasmy.	[Andrew, Toby; Gill, Raj; Clement, Gail; Spector, Tim D.; Valdes, Ana M.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Chowienczyk, Philip] Kings Coll London, Dept Clin Pharmacol, London WC2R 2LS, England; [Calloway, Cassandra D.; Stuart, Sarah; Lee, Sang Hoon] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	University of London; King's College London; University of London; King's College London; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Andrew, T (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	ana.valdes@kcl.ac.uk	; Andrew, Toby/O-8868-2017	Chowienczyk, Phil/0000-0003-4507-038X; Valdes, Ana M./0000-0003-1141-4471; Andrew, Toby/0000-0001-8838-4384	Guy's and St Thomas' Charity [R070719]; Wellcome Trust; Medical Research Council UK [91993]; University of London (AR/CRF/B); EU [200800 TREAT-OA]; NIH NIDDK [DK61722]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061722, R01DK061722] Funding Source: NIH RePORTER	Guy's and St Thomas' Charity; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of London (AR/CRF/B); EU(European Commission); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Guy's and St Thomas' Charity project grant R070719. The TwinsUK resource is supported by the Wellcome Trust; T Andrew is supported by the Medical Research Council UK (New Investigator Award 91993) and the Central Research Fund, University of London (AR/CRF/B); AM Valdes is supported by the EU FP7 large collaborative project 200800 TREAT-OA and by NIH NIDDK R01 grant DK61722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; AQUADRO CF, 1983, GENETICS, V103, P287; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844; Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002; Falchi M, 2008, DIABETES, V57, P1120, DOI 10.2337/db07-0708; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Fukae J, 2007, MITOCHONDRION, V7, P58, DOI 10.1016/j.mito.2006.12.002; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hopper JL, 1998, ENCY BIOSTATISTICS, P4626; Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Maruszak A, 2006, ACTA NEUROBIOL EXP, V66, P153; Moosmann B, 2008, AGING CELL, V7, P32, DOI 10.1111/j.1474-9726.2007.00349.x; Reynolds R, 2000, J FORENSIC SCI, V45, P1210; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; StataCorp, 2021, STATA STAT SOFTWARE; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Theves C, 2006, J FORENSIC SCI, V51, P865, DOI 10.1111/j.1556-4029.2006.00163.x; Tully LA, 2000, AM J HUM GENET, V67, P432, DOI 10.1086/302996; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Witte JS, 1999, GENET EPIDEMIOL, V16, P290, DOI 10.1002/(SICI)1098-2272(1999)16:3<290::AID-GEPI5>3.0.CO;2-8; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514	28	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22332	10.1371/journal.pone.0022332	http://dx.doi.org/10.1371/journal.pone.0022332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857921	Green Published, gold, Green Submitted			2022-12-27	WOS:000293558900014
J	Courvoisier, DS; Agoritsas, T; Perneger, TV; Schmidt, RE; Cullati, S				Courvoisier, Delphine S.; Agoritsas, Thomas; Perneger, Thomas V.; Schmidt, Ralph E.; Cullati, Stephane			Regrets Associated with Providing Healthcare: Qualitative Study of Experiences of Hospital-Based Physicians and Nurses	PLOS ONE			English	Article							ANTICIPATED REGRET; MEDICAL MISTAKES; ERRORS; RESIDENTS; TRAINEES; TURNOVER; IMPACT	Background: Regret is an unavoidable corollary of clinical practice. Physicians and nurses perform countless clinical decisions and actions, in a context characterised by time pressure, information overload, complexity and uncertainty. Objective: To explore feelings associated with regretted clinical decisions or interventions of hospital-based physicians and nurses and to examine how these regrets are coped with. Method: Qualitative study of a volunteer sample of 12 physicians and 13 nurses from Swiss University Hospitals using semi-structured interviews and thematic analysis Results: All interviewees reported at least one intense regret, which sometimes led to sleep problems, or taking sickness leave. Respondents also reported an accumulation effect of small and large regrets, which sometimes led to quitting one's unit or choosing another specialty. Respondents used diverse ways of coping with regrets, including changing their practices and seeking support from peers and family but also suppression of thoughts related to the situation and ruminations on the situation. Another coping strategy was acceptance of one's limits and of medicine's limits. Physicians reported that they avoided sharing with close colleagues because they felt they could lose their credibility. Conclusions: Since regret seems related to both positive and negative consequences, it is important to learn more about regret coping among healthcare providers and to determine whether training in coping strategies could help reduce negative consequences such as sleep problems, absenteeism, or turnover.	[Courvoisier, Delphine S.; Agoritsas, Thomas; Perneger, Thomas V.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Courvoisier, Delphine S.; Perneger, Thomas V.] Univ Geneva, Fac Med, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Schmidt, Ralph E.] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Cullati, Stephane] Univ Hosp Geneva, Qual Care Serv, Geneva, Switzerland; [Cullati, Stephane] Univ Geneva, Inst Demog & Life Course Studies, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Courvoisier, DS (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland.	delphine.courvoisier@hcuge.ch	Agoritsas, Thomas/F-4321-2014; Cullati, Stephane/F-7991-2011; Courvoisier, Delphine/H-6054-2011	Agoritsas, Thomas/0000-0002-6182-9969; Cullati, Stephane/0000-0002-3881-446X; Courvoisier, Delphine/0000-0002-1956-2607	University Hospitals of Geneva [2009-02]	University Hospitals of Geneva	This study was supported by a grant from the University Hospitals of Geneva (Quality project 2009-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama A, 2010, ARCH GERONTOL GERIAT, V50, P175, DOI 10.1016/j.archger.2009.03.006; BOURGEOISGIROND.S, PHILOS T R SOC LON B, V365, P249; CHRISTENSEN JF, 1992, J GEN INTERN MED, V7, P424, DOI 10.1007/BF02599161; Croskerry P, 2008, LANCET, V372, P1205, DOI 10.1016/S0140-6736(08)61500-7; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Giver H, 2010, SCAND J PUBLIC HEALT, V38, P239, DOI 10.1177/1403494809348939; Goldberg RM, 2002, ANN EMERG MED, V39, P287, DOI 10.1067/mem.2002.121995; Groopman J, 2007, DOCTORS THINK; Hozo I, 2008, MED DECIS MAKING, V28, P540, DOI 10.1177/0272989X08315249; Kennedy TJT, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b128; Leiter MP, 2009, J NURS MANAGE, V17, P331, DOI 10.1111/j.1365-2834.2009.01004.x; Marchiori D, 2008, SCIENCE, V319, P1111, DOI 10.1126/science.1151185; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MIZRAHI T, 1984, SOC SCI MED, V19, P135, DOI 10.1016/0277-9536(84)90280-6; Montgomery K, 2006, DOCTORS THINK CLIN J; O'Brien-Pallas L, 2010, J NURS MANAGE, V18, P1073, DOI 10.1111/j.1365-2834.2010.01167.x; O'Connor E, 2010, INT J QUAL HEALTH C, V22, P371, DOI 10.1093/intqhc/mzq042; Schmidt RE, 2009, EMOTION, V9, P549, DOI 10.1037/a0015856; Scott IA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1860; Sorum PC, 2004, MED DECIS MAKING, V24, P149, DOI 10.1177/0272989X04263163; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; Treiber LA, 2010, QUAL HEALTH RES, V20, P1327, DOI 10.1177/1049732310372228; Varkevisser M, 2005, J SLEEP RES, V14, P49, DOI 10.1111/j.1365-2869.2004.00414.x; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; White AA, 2008, ACAD MED, V83, P250, DOI 10.1097/ACM.0b013e3181636e96; Wrosch C, 2005, PSYCHOL AGING, V20, P657, DOI 10.1037/0882-7974.20.4.657; Zeelenberg M, 2007, J CONSUM PSYCHOL, V17, P3, DOI 10.1207/s15327663jcp1701_3; Zeidner M., 1996, HDB COPING THEORY RE; Ziarnowski KL, 2009, PREV MED, V48, P411, DOI 10.1016/j.ypmed.2008.10.006; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	31	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23138	10.1371/journal.pone.0023138	http://dx.doi.org/10.1371/journal.pone.0023138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	802LF	21829706	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511900029
J	Scholten, A; Koch, KW				Scholten, Alexander; Koch, Karl-Wilhelm			Differential Calcium Signaling by Cone Specific Guanylate Cyclase-Activating Proteins from the Zebrafish Retina	PLOS ONE			English	Article							CA2+; BINDING; CALMODULIN; EXPRESSION; CLONING; DIMERIZATION; TRANSDUCIN; DIVERSITY; RETGC; GCAPS	Zebrafish express in their retina a higher number of guanylate cyclase-activating proteins (zGCAPs) than mammalians pointing to more complex guanylate cyclase signaling systems. All six zGCAP isoforms show distinct and partial overlapping expression profiles in rods and cones. We determined critical Ca2+-dependent parameters of their functional properties using purified zGCAPs after heterologous expression in E.coli. Isoforms 1-4 were strong, 5 and 7 were weak activators of membrane bound guanylate cyclase. They further displayed different Ca2+-sensitivities of guanylate cyclase activation, which is half maximal either at a free Ca2+ around 30 nM (zGCAP1, 2 and 3) or around 400 nM (zGCAP4, 5 and 7). Zebrafish GCAP isoforms showed also differences in their Ca2+/Mg2+-dependent conformational changes and in the Ca2+-dependent monomer-dimer equilibrium. Direct Ca2+-binding revealed that all zGCAPs bound at least three Ca2+. The corresponding apparent affinity constants reflect binding of Ca2+ with high (<= 100 nM), medium (0.1-5 mu M) and/or low (>= 5 mu M) affinity, but were unique for each zGCAP isoform. Our data indicate a Ca2+-sensor system in zebrafish rod and cone cells supporting a Ca2+-relay model of differential zGCAP operation in these cells.	[Scholten, Alexander; Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany; [Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-2900 Oldenburg, Germany; [Koch, Karl-Wilhelm] Carl von Ossietzky Univ Oldenburg, Ctr Interface Sci, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Scholten, A (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany.	karl.w.koch@uni-oldenburg.de	Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044	Deutsche Forschungsgemeinschaft [KO 948/7-1, KO948/7-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft to K-WK (KO 948/7-1, KO948/7-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Behnen P, 2009, J BIOL INORG CHEM, V14, P89, DOI 10.1007/s00775-008-0426-z; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; Brown SE, 1997, J BIOL CHEM, V272, P3389, DOI 10.1074/jbc.272.6.3389; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Cilluffo MC, 2004, VISUAL NEUROSCI, V21, P599, DOI 10.1017/S0952523804214092; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; GrayKeller MP, 1996, NEURON, V17, P323, DOI 10.1016/S0896-6273(00)80163-4; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Helten A, 2007, J NEUROCHEM, V103, P1439, DOI 10.1111/j.1471-4159.2007.04923.x; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BBA-PROTEINS PROTEOM, V1600, P111, DOI 10.1016/S1570-9639(02)00451-X; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Koch Karl-Wilhelm, 2008, P121; KOCH KW, 2006, CALCIUM BINDING PROT, V1, P3; Leung YT, 2007, J PHYSIOL-LONDON, V579, P15, DOI 10.1113/jphysiol.2006.120162; LINSE S, 1991, BIOCHEMISTRY-US, V30, P154, DOI 10.1021/bi00215a023; Linse Sara, 2002, Methods Mol Biol, V173, P15; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Mirzoeva S, 1999, BIOCHEMISTRY-US, V38, P3936, DOI 10.1021/bi9821263; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Peersen OB, 1997, PROTEIN SCI, V6, P794; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; PHILIPPOV PP, NEURONAL CALCIUM SEN; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Ratscho N, 2010, MOL CELL BIOCHEM, V334, P207, DOI 10.1007/s11010-009-0320-1; Ratscho N, 2009, BBA-MOL CELL RES, V1793, P1110, DOI 10.1016/j.bbamcr.2008.12.021; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106	47	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23117	10.1371/journal.pone.0023117	http://dx.doi.org/10.1371/journal.pone.0023117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829700	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511900026
J	Stevens, D; Gassmann, R; Oegema, K; Desai, A				Stevens, Deanna; Gassmann, Reto; Oegema, Karen; Desai, Arshad			Uncoordinated Loss of Chromatid Cohesion Is a Common Outcome of Extended Metaphase Arrest	PLOS ONE			English	Article							SPINDLE CHECKPOINT; CHROMOSOMAL STABILITY; CENTROSOME INTEGRITY; ANAPHASE; SEPARATION; PROTEIN; KINETOCHORES; MAINTENANCE; INHIBITION; CENTROMERE	Chromosome segregation requires coordinated separation of sister chromatids following biorientation of all chromosomes on the mitotic spindle. Chromatid separation at the metaphase-to-anaphase transition is accomplished by cleavage of the cohesin complex that holds chromatids together. Here we show using live-cell imaging that extending the metaphase bioriented state using five independent perturbations (expression of non-degradable Cyclin B, expression of a Spindly point mutant that prevents spindle checkpoint silencing, depletion of the anaphase inducer Cdc20, treatment with a proteasome inhibitor, or treatment with an inhibitor of the mitotic kinesin CENP-E) leads to eventual scattering of chromosomes on the spindle. This scattering phenotype is characterized by uncoordinated loss of cohesion between some, but not all sister chromatids and subsequent spindle defects that include centriole separation. Cells with scattered chromosomes persist long-term in a mitotic state and eventually die or exit. Partial cohesion loss-associated scattering is observed in both transformed cells and in karyotypically normal human cells, albeit at lower penetrance. Suppressing microtubule dynamics reduces scattering, suggesting that cohesion at centromeres is unable to resist dynamic microtubule-dependent pulling forces on the kinetochores. Consistent with this view, strengthening cohesion by inhibiting the two pathways responsible for its removal significantly inhibits scattering. These results establish that chromosome scattering due to uncoordinated partial loss of chromatid cohesion is a common outcome following extended arrest with bioriented chromosomes in human cells. These findings have important implications for analysis of mitotic phenotypes in human cells and for development of anti-mitotic chemotherapeutic approaches in the treatment of cancer.	[Stevens, Deanna] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Stevens, D (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Gassmann, Reto/M-6488-2013	Gassmann, Reto/0000-0002-0360-2977	National Institutes of Health [GM074215]; National Institute for General Medical Sciences [T32 GM008666]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health to A. D. (GM074215). D. S. was supported in part by an Institutional Ruth L. Kirschstein National Research Service Award from the National Institute for General Medical Sciences to the UCSD Genetics Training Program (T32 GM008666). K.O. and A. D. receive salary and additional support from the Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban KH, 2007, DEV CELL, V13, P29, DOI 10.1016/j.devcel.2007.04.017; Bloom K, 2010, CURR BIOL, V20, pR1040, DOI 10.1016/j.cub.2010.10.055; Cho JH, 2006, BIOCHEM BIOPH RES CO, V339, P742, DOI 10.1016/j.bbrc.2005.11.074; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; GALLANT P, 1992, J CELL BIOL, V117, P213, DOI 10.1083/jcb.117.1.213; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Hardwick Kevin G, 2010, F1000 Biol Rep, V2, P55, DOI 10.3410/B2-55; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Matos I, 2009, J CELL BIOL, V186, P11, DOI 10.1083/jcb.200904153; Mattiuzzo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016307; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Nakajima M, 2007, J CELL SCI, V120, P4188, DOI 10.1242/jcs.011528; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; QIAN X, 2008, Patent No. 0255182; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Yang S, 2008, FASEB J, V22, P1960, DOI 10.1096/fj.07-081463; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	41	64	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22969	10.1371/journal.pone.0022969	http://dx.doi.org/10.1371/journal.pone.0022969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829677	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511900020
J	Vierkotten, S; Muether, PS; Fauser, S				Vierkotten, Sarah; Muether, Philipp S.; Fauser, Sascha			Overexpression of HTRA1 Leads to Ultrastructural Changes in the Elastic Layer of Bruch's Membrane via Cleavage of Extracellular Matrix Components	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; IN-VIVO; METALLOPROTEINASES-3 TIMP-3; TISSUE INHIBITOR; SERINE-PROTEASE; GENE; BINDING; DISEASE; FIBULIN-5	Variants in the chromosomal region 10q26 are strongly associated with an increased risk for age-related macular degeneration (AMD). Two potential AMD genes are located in this region: ARMS2 and HTRA1 (high-temperature requirement A1). Previous studies have suggested that polymorphisms in the promotor region of HTRA1 result in overexpression of HTRA1 protein. This study investigated the role of HTRA1 overexpression in the pathogenesis of AMD. Transgenic Htra1 mice overexpressing the murine protein in the retinal pigment epithelium (RPE) layer of the retina were generated and characterized by transmission electron microscopy, immunofluorescence staining and Western Blot analysis. The elastic layer of Bruch's membrane (BM) in the Htra1 transgenic mice was fragmented and less continuous than in wild type (WT) controls. Recombinant HTRA1 lacking the N-terminal domain cleaved various extracellular matrix (ECM) proteins. Subsequent Western Blot analysis revealed an overexpression of fibronectin fragments and a reduction of fibulin 5 and tropoelastin in the RPE/choroid layer in transgenic mice compared to WT. Fibulin 5 is essential for elastogenesis by promoting elastic fiber assembly and maturation. Taken together, our data implicate that HTRA1 overexpression leads to an altered elastogenesis in BM through fibulin 5 cleavage. It highlights the importance of ECM related proteins in the development of AMD and links HTRA1 to other AMD risk genes such as fibulin 5, fibulin 6, ARMS2 and TIMP3.	[Vierkotten, Sarah; Muether, Philipp S.; Fauser, Sascha] Univ Cologne, Ctr Ophthalmol, Cologne, Germany	University of Cologne	Vierkotten, S (corresponding author), Univ Cologne, Ctr Ophthalmol, Cologne, Germany.	sfauser@gmx.net			Novartis; Retinovit Foundation	Novartis(Novartis); Retinovit Foundation	This work was supported by grants from Novartis and the Retinovit Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 1997, J MOL BIOL, V272, P226, DOI 10.1006/jmbi.1997.1244; An E, 2010, INVEST OPHTH VIS SCI, V51, P3379, DOI 10.1167/iovs.09-4853; Austin BA, 2009, INVEST OPHTH VIS SCI, V50, P2896, DOI 10.1167/iovs.08-2495; Boulanger A, 2000, J BIOL CHEM, V275, P31274, DOI 10.1074/jbc.M003441200; CARSONS S, 1981, ARTHRITIS RHEUM, V24, P1261; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Chowers I, 2008, MOL VIS, V14, P2263; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; DeAngelis MM, 2008, OPHTHALMOLOGY, V115, P1209, DOI 10.1016/j.ophtha.2007.10.032; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Gu YC, 2000, BRIT J HAEMATOL, V109, P305, DOI 10.1046/j.1365-2141.2000.02011.x; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jomaa A, 2009, J BACTERIOL, V191, P1924, DOI 10.1128/JB.01187-08; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Kortvely E, 2010, INVEST OPHTH VIS SCI, V51, P79, DOI 10.1167/iovs.09-3850; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Martin J, 2001, J AM SOC NEPHROL, V12, P88, DOI 10.1681/ASN.V12188; Mendioroz M, 2010, NEUROLOGY, V75, P2033, DOI 10.1212/WNL.0b013e3181ff96ac; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nonaka R, 2009, CLIN BIOCHEM, V42, P713, DOI 10.1016/j.clinbiochem.2008.12.020; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenthal AK, 2011, ARTHRITIS RHEUM-US, V63, P401, DOI 10.1002/art.30120; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; Sasaki T, 1999, FEBS LETT, V460, P280, DOI 10.1016/S0014-5793(99)01362-9; SHIGA A, 2011, HUM MOL GENET; Sivaprasad S, 2005, INVEST OPHTH VIS SCI, V46, P3046, DOI 10.1167/iovs.04-1277; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tong Y, 2010, MOL VIS, V16, P1958; van Soest SS, 2007, MOL VIS, V13, P1608; VIDMAR SL, 1991, EUR J BIOCHEM, V201, P79, DOI 10.1111/j.1432-1033.1991.tb16258.x; Wachi H, 2008, J BIOCHEM, V143, P633, DOI 10.1093/jb/mvn014; Weger M, 2007, MOL VIS, V13, P1274; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yeow KM, 2002, MATRIX BIOL, V21, P75, DOI 10.1016/S0945-053X(01)00180-9; Yu HG, 2008, INVEST OPHTH VIS SCI, V49, P2599, DOI 10.1167/iovs.07-1508; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004; Zheng Q, 2007, MOL CELL BIOL, V27, P1083, DOI 10.1128/MCB.01330-06	53	109	112	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22959	10.1371/journal.pone.0022959	http://dx.doi.org/10.1371/journal.pone.0022959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829675	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511900018
J	Winkler, J; Kao, KC				Winkler, James; Kao, Katy C.			Transcriptional Analysis of Lactobacillus brevis to N-Butanol and Ferulic Acid Stress Responses	PLOS ONE			English	Article							P-COUMARATE DECARBOXYLASE; PHENOLIC-COMPOUNDS; ESCHERICHIA-COLI; DEGRADATION-PRODUCTS; COMPARATIVE GENOMICS; OENOCOCCUS-OENI; TOLERANCE; MEMBRANE; GROWTH; MECHANISMS	Background: The presence of anti-microbial phenolic compounds, such as the model compound ferulic acid, in biomass hydrolysates pose significant challenges to the widespread use of biomass in conjunction with whole cell biocatalysis or fermentation. Currently, these inhibitory compounds must be removed through additional downstream processing or sufficiently diluted to create environments suitable for most industrially important microbial strains. Simultaneously, product toxicity must also be overcome to allow for efficient production of next generation biofuels such as n-butanol, isopropanol, and others from these low cost feedstocks. Methodology and Principal Findings: This study explores the high ferulic acid and n-butanol tolerance in Lactobacillus brevis, a lactic acid bacterium often found in fermentation processes, by global transcriptional response analysis. The transcriptional profile of L. brevis reveals that the presence of ferulic acid triggers the expression of currently uncharacterized membrane proteins, possibly in an effort to counteract ferulic acid induced changes in membrane fluidity and ion leakage. In contrast to the ferulic acid stress response, n-butanol challenges to growing cultures primarily induce genes within the fatty acid synthesis pathway and reduced the proportion of 19: 1 cyclopropane fatty acid within the L. brevis membrane. Both inhibitors also triggered generalized stress responses. Separate attempts to alter flux through the Escherichia coli fatty acid synthesis by overexpressing acetyl-CoA carboxylase subunits and deleting cyclopropane fatty acid synthase (cfa) both failed to improve n-butanol tolerance in E. coli, indicating that additional components of the stress response are required to confer n-butanol resistance. Conclusions: Several promising routes for understanding both ferulic acid and n-butanol tolerance have been identified from L. brevis gene expression data. These insights may be used to guide further engineering of model industrial organisms to better tolerate both classes of inhibitors to enable facile production of biofuels from lignocellulosic biomass.	[Winkler, James; Kao, Katy C.] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Winkler, J (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.	kao.katy@mail.che.tamu.edu		Kao, Katy/0000-0002-1184-276X	United States National Science Foundation [CBET-1032487]; National Science Foundation; Texas Engineering Experiment Station	United States National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Texas Engineering Experiment Station	The authors gratefully acknowledge the partial financial support of the United States National Science Foundation grant CBET-1032487, the National Science Foundation Graduate Research Fellowship Program, and the Texas Engineering Experiment Station for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson WF, 2008, J IND MICROBIOL BIOT, V35, P355, DOI 10.1007/s10295-007-0291-8; ARCHIBALD FS, 1981, J BACTERIOL, V146, P928, DOI 10.1128/JB.146.3.928-936.1981; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAER SH, 1987, APPL ENVIRON MICROB, V53, P2854, DOI 10.1128/AEM.53.12.2854-2861.1987; Berezina OV, 2010, APPL MICROBIOL BIOT, V87, P635, DOI 10.1007/s00253-010-2480-z; Borden JR, 2007, APPL ENVIRON MICROB, V73, P3061, DOI 10.1128/AEM.02296-06; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brown JL, 1997, INT J FOOD MICROBIOL, V37, P163, DOI 10.1016/S0168-1605(97)00068-8; Campos FM, 2009, INT J FOOD MICROBIOL, V135, P144, DOI 10.1016/j.ijfoodmicro.2009.07.031; Campos FM, 2003, J APPL MICROBIOL, V94, P167, DOI 10.1046/j.1365-2672.2003.01801.x; CARTWRIGHT CP, 1986, J GEN MICROBIOL, V132, P369; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Cho DH, 2009, APPL MICROBIOL BIOT, V83, P1035, DOI 10.1007/s00253-009-1925-8; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Clomburg JM, 2010, APPL MICROBIOL BIOT, V86, P419, DOI 10.1007/s00253-010-2446-1; Cueva C, 2010, RES MICROBIOL, V161, P372, DOI 10.1016/j.resmic.2010.04.006; Cullen JJ, 2003, CANCER RES, V63, P5513; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; De Angelis M, 2004, PROTEOMICS, V4, P106, DOI 10.1002/pmic.200300497; DEGRASSI G, 1995, APPL ENVIRON MICROB, V61, P326, DOI 10.1128/AEM.61.1.326-332.1995; *DEP EN JOINT GEN, 2010, 367 ATCC DEP EN JOIN; Diez-Gonzalez F, 2004, J APPL MICROBIOL, V96, P1237, DOI 10.1111/j.1365-2672.2004.02251.x; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Duerre Peter, 2007, Biotechnology Journal, V2, P1525, DOI 10.1002/biot.200700168; Ezeji T, 2007, BIOTECHNOL BIOENG, V97, P1460, DOI 10.1002/bit.21373; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Goh YJ, 2009, FRONT BIOSCI-LANDMRK, V14, P1362, DOI 10.2741/3313; GOLD RS, 1992, J IND MICROBIOL, V10, P45, DOI 10.1007/BF01583633; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Guo W, 2010, APPL BIOCHEM BIOTECH, V161, P124, DOI 10.1007/s12010-009-8857-8; HARADA T, 1976, CAN J MICROBIOL, V22, P1258, DOI 10.1139/m76-186; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; INGRAM LO, 1986, TRENDS BIOTECHNOL, V4, P40, DOI 10.1016/0167-7799(86)90152-6; INGRAM LO, 1976, J BACTERIOL, V125, P670, DOI 10.1128/JB.125.2.670-678.1976; Isken S, 1998, EXTREMOPHILES, V2, P229, DOI 10.1007/s007920050065; Kim JH, 2009, MICROBIOL-SGM, V155, P1351, DOI 10.1099/mic.0.024653-0; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KROON P, 2003, EUROPEAN J BIOCH, V267, P6740; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Liu M, 2008, APPL ENVIRON MICROB, V74, P4590, DOI 10.1128/AEM.00150-08; Liu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-36; Liu SQ, 2009, NEW BIOTECHNOL, V26, P117, DOI 10.1016/j.nbt.2009.06.984; Lopez MJ, 2004, APPL MICROBIOL BIOT, V64, P125, DOI 10.1007/s00253-003-1401-9; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2007, J BACTERIOL, V189, P1199, DOI 10.1128/JB.01351-06; Landete JM, 2010, J IND MICROBIOL BIOT, V37, P617, DOI 10.1007/s10295-010-0709-6; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Nichols NN, 2005, APPL BIOCHEM BIOTECH, V121, P379, DOI 10.1385/ABAB:121:1-3:0379; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Pienkos PT, 2009, CELLULOSE, V16, P743, DOI 10.1007/s10570-009-9309-x; Ramos JL, 1997, J BIOL CHEM, V272, P3887, DOI 10.1074/jbc.272.7.3887; Reguant C, 2000, J APPL MICROBIOL, V88, P1065, DOI 10.1046/j.1365-2672.2000.01075.x; Rodriguez H, 2008, J AGR FOOD CHEM, V56, P3068, DOI 10.1021/jf703779s; Rodriguez H, 2009, INT J FOOD MICROBIOL, V132, P79, DOI 10.1016/j.ijfoodmicro.2009.03.025; Vaquero MJR, 2007, FOOD CONTROL, V18, P93, DOI 10.1016/j.foodcont.2005.08.010; Rozes N, 1998, APPL MICROBIOL BIOT, V49, P108, DOI 10.1007/s002530051145; Rutherford BJ, 2010, APPL ENVIRON MICROB, V76, P1935, DOI 10.1128/AEM.02323-09; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakai S, 2007, APPL ENVIRON MICROB, V73, P2349, DOI 10.1128/AEM.02880-06; Sambrook J., 2001, MOL CLONING LAB MANU; Sami M, 1997, J FERMENT BIOENG, V84, P1, DOI 10.1016/S0922-338X(97)82778-X; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Sriprapundh D, 2003, PROTEIN ENG, V16, P683, DOI 10.1093/protein/gzg082; STEAD D, 2008, J APPL MICROBIOL, V75, P135; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Tomas CA, 2004, J BACTERIOL, V186, P2006, DOI 10.1128/JB.186.7.2006-2018.2004; Tomas CA, 2003, APPL ENVIRON MICROB, V69, P4951, DOI 10.1128/AEM.69.8.4951-4965.2003; VERMUE M, 1993, BIOTECHNOL BIOENG, V42, P747, DOI 10.1002/bit.260420610; Wackett LP, 2008, CURR OPIN CHEM BIOL, V12, P187, DOI 10.1016/j.cbpa.2008.01.025; WHITE S, 2005, ANN REV BIOCH; WINKLER J, 2010, BIOTECHNOL LETT, P1; WOOD B, 1998, MICROBIOLOGY FERMENT, P48; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	85	40	42	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e21438	10.1371/journal.pone.0021438	http://dx.doi.org/10.1371/journal.pone.0021438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829598	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511900002
J	Marathe, A; Lewis, B; Chen, JZ; Eubank, S				Marathe, Achla; Lewis, Bryan; Chen, Jiangzhuo; Eubank, Stephen			Sensitivity of Household Transmission to Household Contact Structure and Size	PLOS ONE			English	Article							PANDEMIC INFLUENZA	Objective: Study the influence of household contact structure on the spread of an influenza-like illness. Examine whether changes to in-home care giving arrangements can significantly affect the household transmission counts. Method: We simulate two different behaviors for the symptomatic person; either s/he remains at home in contact with everyone else in the household or s/he remains at home in contact with only the primary caregiver in the household. The two different cases are referred to as full mixing and single caregiver, respectively. Results: The results show that the household's cumulative transmission count is lower in case of a single caregiver configuration than in the full mixing case. The household transmissions vary almost linearly with the household size in both single caregiver and full mixing cases. However the difference in household transmissions due to the difference in household structure grows with the household size especially in case of moderate flu. Conclusions: These results suggest that details about human behavior and household structure do matter in epidemiological models. The policy of home isolation of the sick has significant effect on the household transmission count depending upon the household size.	[Marathe, Achla; Lewis, Bryan; Chen, Jiangzhuo; Eubank, Stephen] Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA; [Marathe, Achla] Virginia Tech, Dept Agr & Appl Econ, Blacksburg, VA USA; [Eubank, Stephen] Virginia Tech, Dept Phys, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Marathe, A (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Network Dynam & Simulat Sci Lab, Blacksburg, VA 24061 USA.	amarathe@vbi.vt.edu	Eubank, Stephen/AAD-5089-2021; Eubank, Stephen/D-7497-2011	Eubank, Stephen/0000-0002-7177-309X; Chen, Jiangzhuo/0000-0002-2729-3881	National Science Foundation (NSF) [CNS-0626964, SES-0729441, OCI-0904844, CNS-0831633, CNS-0845700, CNS-1011769, OCI-1032677]; National Institutes of Health [2U01GM070694-7]; Defense Threat Reduction Agency (DTRA) [HDTRA1-0901-0017, HDTRA1-07-C-0113]; Department of Homeland Security [4112-31805]; Department of Energy [DE-SC0003957]; US Naval Surface Warfare Center [N00178-09-D-3017 DEL ORDER 13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Department of Homeland Security(United States Department of Homeland Security (DHS)); Department of Energy(United States Department of Energy (DOE)); US Naval Surface Warfare Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been partially supported by National Science Foundation (NSF) NeTS Grant CNS-0626964, NSF HSD Grant SES-0729441, National Institutes of Health MIDAS project 2U01GM070694-7, NSF PetaApps Grant OCI-0904844, Defense Threat Reduction Agency (DTRA) R&D Grant HDTRA1-0901-0017, DTRA CNIMS Grant HDTRA1-07-C-0113, NSF NeTS CNS-0831633, Department of Homeland Security 4112-31805, Department of Energy DE-SC0003957, NSF REU Supplement CNS-0845700, US Naval Surface Warfare Center N00178-09-D-3017 DEL ORDER 13, NSF Netse CNS-1011769, and NSF SDCI OCI-1032677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barrett C, 2009, AI MAG, V31, P75; Barrett C.L., 2008, SC 2008 P 2008 ACMIE, P1, DOI DOI 10.1109/SC.2008.5214892; Bisset K., 2009, DOE SCIDAC MAG, V66, P36; Bisset K, 2009, P 23 ACM INT C SUP I, P230; Blendon RJ, 2008, EMERG INFECT DIS, V14, P778, DOI 10.3201/eid1405.071437; Carcione D, 2011, EUROSURVEILLANCE, V16, P32; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Halloran M, 2008, P NATL ACAD SCI USA, pPMC2290797; Odaira F, 2009, EUROSURVEILLANCE, V14, P2; Savage R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-234; Taylor C, 2010, INT J INFECT DIS, V14, pE792, DOI 10.1016/j.ijid.2010.02.2267	14	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22461	10.1371/journal.pone.0022461	http://dx.doi.org/10.1371/journal.pone.0022461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829625	Green Submitted, gold, Green Published			2022-12-27	WOS:000293511200010
J	Porto, G; Giordano, RJ; Marti, LC; Stolf, B; Pasqualini, R; Arap, W; Kalil, J; Coelho, V				Porto, Georgia; Giordano, Ricardo J.; Marti, Luciana C.; Stolf, Beatriz; Pasqualini, Renata; Arap, Wadih; Kalil, Jorge; Coelho, Veronica			Identification of Novel Immunoregulatory Molecules in Human Thymic Regulatory CD4(+)CD25(+) T Cells by Phage Display	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; IMMUNOLOGICAL SELF-TOLERANCE; AUTOIMMUNE-DISEASES; RETINOIC-ACID; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; INTERLEUKIN-11 RECEPTOR; MEDIATED TRANSCRIPTION; DENDRITIC CELLS; IMMUNE-SYSTEM	Thymic CD4(+)CD25(+) cells play an important role in immune regulation and are continuously developed in the thymus as an independent lineage. How these cells are generated, what are their multiple pathways of suppressive activity and which are their specific markers are questions that remain unanswered. To identify molecules involved in the function and development of human CD4(+)CD25(+) T regulatory cells we targeted thymic CD4(+)CD25(+) cells by peptide phage display. A phage library containing random peptides was screened ex vivo for binding to human thymic CD4(+)CD25(+) T cells. After four rounds of selection on CD4(+)CD25(+) enriched populations of thymocytes, we sequenced several phage displayed peptides and selected one with identity to the Vitamin D Receptor (VDR). We confirmed the binding of the VDR phage to active Vitamin D in vitro, as well as the higher expression of VDR in CD4(+)CD25(+) cells. We suggest that differential expression of VDR on natural Tregs may be related to the relevance of Vitamin D in function and ontogeny of these cells.	[Porto, Georgia; Stolf, Beatriz; Kalil, Jorge; Coelho, Veronica] Univ Sao Paulo, Sch Med, Inst Coracao InCor, Inst Heart, Sao Paulo, Brazil; [Porto, Georgia; Kalil, Jorge; Coelho, Veronica] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Kalil, Jorge; Coelho, Veronica] Natl Inst Sci & Technol Iii INCT, Inst Invest Immunol, Sao Paulo, Brazil; [Giordano, Ricardo J.; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA; [Marti, Luciana C.] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [Stolf, Beatriz] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Giordano, Ricardo J.] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Texas System; UTMD Anderson Cancer Center; Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Universidade de Sao Paulo	Porto, G (corresponding author), Univ Sao Paulo, Sch Med, Inst Coracao InCor, Inst Heart, Sao Paulo, Brazil.	vecoelho@usp.br	Stolf, Beatriz S/H-7943-2012; Marti, Luciana/E-8242-2010; KALIL, JORGE/C-8029-2012; Marti, Luciana Cavalheiro/Z-2555-2019; Giordano, Ricardo/A-2074-2010; COELHO, VERONICA/D-1433-2013	Stolf, Beatriz S/0000-0001-7661-3311; Marti, Luciana/0000-0002-3890-0827; KALIL, JORGE/0000-0001-8415-4274; Marti, Luciana Cavalheiro/0000-0002-3890-0827; Giordano, Ricardo/0000-0001-8116-6771; Coelho, Veronica/0000-0002-0989-2581	FAPESP [2003/04721-2]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP under grant number: 2003/04721-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2002, INT IMMUNOPHARMACOL, V2, P1017, DOI 10.1016/S1567-5769(02)00049-8; Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Adorini L, 2006, CURR TOP MED CHEM, V6, P1297, DOI 10.2174/156802606777864890; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Itoh M, 1999, J IMMUNOL, V162, P5317; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Kang I, 2010, J IMMUNOL, V184; Levings MK, 2000, J ALLERGY CLIN IMMUN, V106, pS109, DOI 10.1067/mai.2000.106635; Lewis VO, 2009, CANCER RES, V69, P1995, DOI 10.1158/0008-5472.CAN-08-4845; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; Mizwicki MT, 2004, P NATL ACAD SCI USA, V101, P12876, DOI 10.1073/pnas.0403606101; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2007, CELL ADHES MIGR, V1, P142, DOI 10.4161/cam.1.3.5062; NAKAJIMA S, 1994, MOL ENDOCRINOL, V8, P159, DOI 10.1210/me.8.2.159; Nezbedova P, 2004, Endocr Regul, V38, P29; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Penna G, 2007, J BONE MINER RES, V22, pV69, DOI 10.1359/JBMR.07S217; Powrie Fiona, 2003, Novartis Found Symp, V252, P92; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Tagami T, 1998, BIOCHEM BIOPH RES CO, V253, P358, DOI 10.1006/bbrc.1998.9799; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8; Velappan N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp809; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Yu Y, 2008, J BIOMOL SCREEN, V13, P968, DOI 10.1177/1087057108326537; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zhao GS, 2010, STEROIDS, V75, P555, DOI 10.1016/j.steroids.2009.12.001; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	47	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e21702	10.1371/journal.pone.0021702	http://dx.doi.org/10.1371/journal.pone.0021702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829599	gold, Green Submitted, Green Published			2022-12-27	WOS:000293511200003
J	Sovero, M; Garcia, J; Kochel, T; Laguna-Torres, VA; Gomez, J; Chicaiza, W; Barrantes, M; Sanchez, F; Jimenez, M; Comach, G; de Rivera, IL; Arango, AE; Agudo, R; Halsey, ES				Sovero, Merly; Garcia, Josefina; Kochel, Tadeusz; Alberto Laguna-Torres, V.; Gomez, Jorge; Chicaiza, Wilson; Barrantes, Melvin; Sanchez, Felix; Jimenez, Mirna; Comach, Guillermo; Lorenzana de Rivera, Ivette; Arango, Ana E.; Agudo, Roberto; Halsey, Eric S.			Circulating Strains of Human Respiratory Syncytial Virus in Central and South America	PLOS ONE			English	Article							GROUP-A; SUBGROUP-A; GENETIC-VARIABILITY; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; ANTIGENIC DIVERSITY; G-GLYCOPROTEIN; PCR ASSAY; G-PROTEIN; INFECTION	Human respiratory syncytial virus (HRSV) is a major cause of viral lower respiratory tract infections among infants and young children. HRSV strains vary genetically and antigenically and have been classified into two broad subgroups, A and B (HRSV-A and HRSV-B, respectively). To date, little is known about the circulating strains of HRSV in Latin America. We have evaluated the genetic diversity of 96 HRSV strains by sequencing a variable region of the G protein gene of isolates collected from 2007 to 2009 in Central and South America. Our results show the presence of the two antigenic subgroups of HRSV during this period with the majority belonging to the genotype HRSV-A2.	[Sovero, Merly; Garcia, Josefina; Kochel, Tadeusz; Alberto Laguna-Torres, V.; Halsey, Eric S.] USN, Med Res Unit 6, Lima, Peru; [Gomez, Jorge] Minist Salud, Direcc Gen Epidemiol, Lima, Peru; [Chicaiza, Wilson] Hosp Vozandes, Quito, Ecuador; [Barrantes, Melvin] Hosp Solano, Buenos Aires, DF, Argentina; [Sanchez, Felix] Hosp Infantil Manuel de Jesus Rivera, Managua, Nicaragua; [Jimenez, Mirna] Hosp Nacl Metapan, Metapan, El Salvador; [Comach, Guillermo] LARDIDEV Biomed UC, Maracay, Venezuela; [Lorenzana de Rivera, Ivette] Univ Nacl Autonoma Honduras, Tegucigalpa, Honduras; [Arango, Ana E.] Univ Antioquia, Medellin, Colombia; [Agudo, Roberto] Minist Salud, Direcc Gen Epidemiol, Cochabamba, Bolivia	Universidad Nacional Autonoma de Honduras; Universidad de Antioquia	Sovero, M (corresponding author), USN, Med Res Unit 6, Lima, Peru.	josefina.garcia@med.navy.mil	CANOS, AVELINO CORMA/A-3040-2013; Halsey, Eric/AAC-8110-2022; Gomez, Jorge/E-5258-2012	CANOS, AVELINO CORMA/0000-0002-2232-3527; Halsey, Eric/0000-0001-6291-8923; , Merly Sovero/0000-0002-4373-0295; Lorenzana, Ivette/0000-0002-8128-8602; Tripp, Ralph/0000-0002-2924-9956; Gomez, Jorge/0000-0003-1342-3507; Chicaiza-Ayala, Wilson/0000-0001-8639-698X; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301	US Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS); division of the Armed Forces Health Surveillance Center [847705.82000.25GB.B0016]	US Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS)(United States Department of Defense); division of the Armed Forces Health Surveillance Center	This study was funded by the US Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS), a division of the Armed Forces Health Surveillance Center, WORK UNIT NUMBER: 847705.82000.25GB.B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Baumeister EG, 2003, J CLIN VIROL, V27, P44, DOI 10.1016/S1386-6532(02)00125-7; Bedoya VI, 1996, PEDIATR INFECT DIS J, V15, P1123, DOI 10.1097/00006454-199612000-00014; Boonyasuppayakorn S, 2010, INFLUENZA OTHER RESP, V4, P313, DOI 10.1111/j.1750-2659.2010.00152.x; CANE PA, 1992, VIRUS RES, V25, P15, DOI 10.1016/0168-1702(92)90096-R; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; Carballal G, 2000, J MED VIROL, V61, P275, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;275::AID-JMV15&gt;3.0.CO;2-E; Casiano-Colon AE, 2003, J CLIN VIROL, V28, P169, DOI 10.1016/S1386-6532(03)00002-7; CHERRIE AH, 1992, J VIROL, V66, P2102, DOI 10.1128/JVI.66.4.2102-2110.1992; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; CRISTINA J, 1990, VIROLOGY, V174, P126, DOI 10.1016/0042-6822(90)90061-U; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Galiano MC, 2005, J MED VIROL, V77, P311, DOI 10.1002/jmv.20456; GARCIA O, 1994, J VIROL, V68, P5448; GLEZEN WP, 1990, PEDIATR ANN, V19, P535, DOI 10.3928/0090-4481-19900901-09; Goto-Sugai K, 2010, JPN J INFECT DIS, V63, P393; Gueudin M, 2003, J VIROL METHODS, V109, P39, DOI 10.1016/S0166-0934(03)00042-9; Jalal H, 2007, J CLIN MICROBIOL, V45, P1690, DOI 10.1128/JCM.01912-06; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; KAPIKIAN AZ, 1961, AM J HYG, V74, P234, DOI 10.1093/oxfordjournals.aje.a120216; Kuypers J, 2009, TRANSPL INFECT DIS, V11, P298, DOI 10.1111/j.1399-3062.2009.00400.x; Martinello RA, 2002, J INFECT DIS, V186, P839, DOI 10.1086/342414; MCCONNOCHIE KM, 1990, J PEDIATR-US, V117, P52, DOI 10.1016/S0022-3476(05)82443-6; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Oliveira TFM, 2008, MEM I OSWALDO CRUZ, V103, P417, DOI 10.1590/S0074-02762008000500002; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; SANZ MC, 1994, VIRUS RES, V33, P203; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; STORCH GA, 1991, J INFECT DIS, V163, P858, DOI 10.1093/infdis/163.4.858; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Teng MN, 2002, J VIROL, V76, P6164, DOI 10.1128/JVI.76.12.6164-6171.2002; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; Visser A, 2008, J MED VIROL, V80, P724, DOI 10.1002/jmv.21128; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; ZELAYA EAC, 1994, AM J TROP MED HYG, V51, P577, DOI 10.4269/ajtmh.1994.51.577; Zhang RF, 2010, J CLIN MICROBIOL, V48, P4193, DOI 10.1128/JCM.00179-10; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09	46	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22111	10.1371/journal.pone.0022111	http://dx.doi.org/10.1371/journal.pone.0022111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829605	Green Submitted, gold, Green Published			2022-12-27	WOS:000293511200005
J	Baugh, EH; Lyskov, S; Weitzner, BD; Gray, JJ				Baugh, Evan H.; Lyskov, Sergey; Weitzner, Brian D.; Gray, Jeffrey J.			Real-Time PyMOL Visualization for Rosetta and PyRosetta	PLOS ONE			English	Article							SWISS-MODEL; PROTEIN	Computational structure prediction and design of proteins and protein-protein complexes have long been inaccessible to those not directly involved in the field. A key missing component has been the ability to visualize the progress of calculations to better understand them. Rosetta is one simulation suite that would benefit from a robust real-time visualization solution. Several tools exist for the sole purpose of visualizing biomolecules; one of the most popular tools, PyMOL (Schrodinger), is a powerful, highly extensible, user friendly, and attractive package. Integrating Rosetta and PyMOL directly has many technical and logistical obstacles inhibiting usage. To circumvent these issues, we developed a novel solution based on transmitting biomolecular structure and energy information via UDP sockets. Rosetta and PyMOL run as separate processes, thereby avoiding many technical obstacles while visualizing information on-demand in real-time. When Rosetta detects changes in the structure of a protein, new coordinates are sent over a UDP network socket to a PyMOL instance running a UDP socket listener. PyMOL then interprets and displays the molecule. This implementation also allows remote execution of Rosetta. When combined with PyRosetta, this visualization solution provides an interactive environment for protein structure prediction and design.	[Baugh, Evan H.; Lyskov, Sergey; Weitzner, Brian D.; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Gray, Jeffrey J.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Baugh, EH (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	pyrosetta@graylab.jhu.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Weitzner, Brian/0000-0002-1909-0961	National Institutes of Health [R01-GM073151]; National Science Foundation [CBET 0846324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grant R01-GM073151 and a National Science Foundation CAREER grant to JJG (CBET 0846324). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; FRIGERIO F, 1992, J MOL BIOL, V225, P107, DOI 10.1016/0022-2836(92)91029-O; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson GT, 2011, STRUCTURE, V19, P293, DOI 10.1016/j.str.2010.12.023; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; O'Donoghue SI, 2010, NAT METHODS, V7, pS42, DOI [10.1038/NMETH.1427, 10.1038/nmeth.1427]; RICHARDSON DC, 1992, PROTEIN SCI, V1, P3; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Wang Yi, 2011, Comput Sci Discov, V4, DOI 10.1088/1749-4699/4/1/015002	17	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e21931	10.1371/journal.pone.0021931	http://dx.doi.org/10.1371/journal.pone.0021931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857909	gold, Green Published, Green Submitted			2022-12-27	WOS:000294125500005
J	Pahlevan, NM; Gharib, M				Pahlevan, Niema M.; Gharib, Morteza			Aortic Wave Dynamics and Its Influence on Left Ventricular Workload	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; FINITE-ELEMENT-ANALYSIS; FLUID-FLOWS; STRUCTURAL INTERACTIONS; ARTERIAL STIFFNESS; SMOKING; HYPERTENSION; REFLECTION; DISEASE	The pumping mechanism of the heart is pulsatile, so the heart generates pulsatile flow that enters into the compliant aorta in the form of pressure and flow waves. We hypothesized that there exists a specific heart rate at which the external left ventricular (LV) power is minimized. To test this hypothesis, we used a computational model to explore the effects of heart rate (HR) and aortic rigidity on left ventricular (LV) power requirement. While both mean and pulsatile parts of the pressure play an important role in LV power requirement elevation, at higher rigidities the effect of pulsatility becomes more dominant. For any given aortic rigidity, there exists an optimum HR that minimizes the LV power requirement at a given cardiac output. The optimum HR shifts to higher values as the aorta becomes more rigid. To conclude, there is an optimum condition for aortic waves that minimizes the LV pulsatile load and consequently the total LV workload.	[Pahlevan, Niema M.; Gharib, Morteza] CALTECH, Div Engn & Appl Sci, Grad Aerosp Labs, Pasadena, CA 91125 USA	California Institute of Technology	Pahlevan, NM (corresponding author), CALTECH, Div Engn & Appl Sci, Grad Aerosp Labs, Pasadena, CA 91125 USA.	mgharib@caltech.edu	Pahlevan, Niema M/ABF-7268-2021; Pahlevan, Niema/AAY-4299-2020; Stefanadis, Christodoulos/ABH-2232-2020	Pahlevan, Niema/0000-0001-7498-0396; Gharib, Mohammed/0000-0001-9611-1693; Stefanadis, Christodoulos/0000-0001-5974-6454	Fletcher Jones foundation; Medtronic Corp; Charyk Family foundation	Fletcher Jones foundation; Medtronic Corp; Charyk Family foundation	This research effort has been funded by unrestricted (research topic or publication approval) gift funds from Fletcher Jones foundation, Medtronic Corp, and Charyk Family foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADINA R& D I, 2009, THEOR MOD GUID, VIII; ADINA R& D I, 2009, THEOR MOD GUID, VI; Avrahami I, 2008, J FLUID MECH, V608, P139, DOI 10.1017/S0022112008002012; Bathe K.-J., 2006, FINITE ELEMENT PROCE; Bathe KJ, 1997, COMPUT STRUCT, V64, P909, DOI 10.1016/S0045-7949(97)00040-0; Bathe KJ, 1999, COMPUT STRUCT, V72, P1, DOI 10.1016/S0045-7949(99)00042-5; BATHE KJ, 1995, COMPUT STRUCT, V56, P193, DOI 10.1016/0045-7949(95)00015-9; Bathe M, 1999, J BIOMECH ENG-T ASME, V121, P361, DOI 10.1115/1.2798332; Caro C. G., 2012, MECH CIRCULATION, VSecond; Curtis SL, 2007, AM J PHYSIOL-HEART C, V293, pH557, DOI 10.1152/ajpheart.01095.2006; ELZINGA G, 1991, CIRC RES, V68, P1495, DOI 10.1161/01.RES.68.6.1495; Feldman MD, 1988, J CLIN INVESTIGATION, V82; Fung Y. C., 1997, BIOMECHANICS CIRCULA; GIANNATTASIO C, 1994, J HYPERTENS, V12, P691; Hickerson AI, 2005, EXP FLUIDS, V38, P534, DOI 10.1007/s00348-005-0946-z; KANNEL WB, 1994, BRIT HEART J, V72, P3; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; KOOL MJF, 1993, J AM COLL CARDIOL, V22, P1881, DOI 10.1016/0735-1097(93)90773-T; LANIADO S, 1982, CIRCULATION, V66, P226, DOI 10.1161/01.CIR.66.1.226; LASKEY WK, 1987, CIRCULATION, V75, P711, DOI 10.1161/01.CIR.75.4.711; LEVENSON J, 1987, ARTERIOSCLEROSIS, V7, P572, DOI 10.1161/01.ATV.7.6.572; Levent E, 2004, J ADOLESCENT HEALTH, V34, P339, DOI 10.1016/j.jadohealth.2003.07.012; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mahmud A, 2003, HYPERTENSION, V41, P183, DOI 10.1161/01.HYP.0000047464.66901.60; Matthys KS, 2007, J BIOMECH, V40, P11; Milnor W. R., 1989, HAEMODYNAMICS; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mitchell GF, 2001, HYPERTENSION, V38, P1433, DOI 10.1161/hy1201.098298; Moser M, 1996, J AM COLL CARDIOL, V27, P1214, DOI 10.1016/0735-1097(95)00606-0; Nichols W, 1998, MCDONALDS BLOOD FLOW; O'ROURKE MICHAEL F., 1967, CARDIOVASC RES, V1, P313, DOI 10.1093/cvr/1.4.313; Ohte N, 2003, HEART VESSELS, V18, P136, DOI 10.1007/s00380-003-0697-9; Ooi Henry, 2008, Congest Heart Fail, V14, P31, DOI 10.1111/j.1751-7133.2008.07210.x; ORourke MF, 1996, CLIN EXP PHARMACOL P, V23, pS11, DOI 10.1111/j.1440-1681.1996.tb03035.x; Pahlevan NM, 2011, ANN BIOMED ENG, V39, P1470, DOI 10.1007/s10439-011-0246-0; Safar ME, 2006, HDB HYPERTENSION, V23; Stefanadis C, 1997, CIRCULATION, V95, P31, DOI 10.1161/01.CIR.95.1.31; WESTERHOF N, 1995, J HYPERTENS, V13, P943, DOI 10.1097/00004872-199509000-00002	39	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23106	10.1371/journal.pone.0023106	http://dx.doi.org/10.1371/journal.pone.0023106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853075	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000293953400026
J	Li, H; Wang, HW; Wang, F; Gu, Q; Xu, X				Li, Hui; Wang, Hongwei; Wang, Fang; Gu, Qing; Xu, Xun			Snail Involves in the Transforming Growth Factor beta 1-Mediated Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; PROLIFERATIVE VITREORETINOPATHY; GENE-EXPRESSION; TUMOR-GROWTH; FIBROSIS; ACTIVATION; REPRESSOR	Background: The proliferation of retinal pigment epithelium (RPE) cells resulting from an epithelial-mesenchymal transition (EMT) plays a key role in proliferative vitreoretinopathy (PVR), which leads to complex retinal detachment and the loss of vision. Genes of Snail family encode the zinc finger transcription factors that have been reported to be essential in EMT during embryonic development and cancer metastasis. However, the function of Snail in RPE cells undergoing EMT is largely unknown. Principal Findings: Transforming growth factor beta(TGF-beta)-1 resulted in EMT in human RPE cells (ARPE-19), which was characterized by the expected decrease in E-cadherin and Zona occludin-1(ZO-1) expression, and the increase in fibronectin and a-smooth muscle actin (alpha-SMA) expression, as well as the associated increase of Snail expression at both mRNA and protein levels. Furthermore, TGF-beta 1 treatment caused a significant change in ARPE-19 cells morphology, with transition from a typical epithelial morphology to mesenchymal spindle-shaped. More interestingly, Snail silencing significantly attenuated TGF-beta 1-induced EMT in ARPE-19 cells by decreasing the mesenchymal markers fibronectin and a-SMA and increasing the epithelial marker E-cadherin and ZO-1. Snail knockdown could effectively suppress ARPE-19 cell migration. Finally, Snail was activated in epiretinal membranes from PVR patients. Taken together, Snail plays very important roles in TGF-beta-1-induced EMT in human RPE cells and may contribute to the development of PVR. Significance: Snail transcription factor plays a critical role in TGF-beta 1-induced EMT in human RPE cells, which provides deep insight into the pathogenesis of human PVR disease. The specific inhibition of Snail may provide a new approach to treat and prevent PVR.	[Li, Hui; Gu, Qing; Xu, Xun] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Wang, Hongwei] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Wang, Fang] Tongji Univ, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; University of Chicago; Tongji University	Li, H (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China.	milwang_122@msn.com			National Natural Science Funding of China [30870558]	National Natural Science Funding of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Funding of China (30870558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2008, BRIT J OPHTHALMOL, V92, P699, DOI 10.1136/bjo.2007.134346; Abu El-Asrar AM, 2011, ACTA OPHTHALMOL, V89, pE115, DOI 10.1111/j.1755-3768.2010.01916.x; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Ceglia L, 2010, J MOL HISTOL, V41, P137, DOI 10.1007/s10735-010-9270-x; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P2708, DOI 10.1167/iovs.06-0639; Franz M, 2009, HISTOCHEM CELL BIOL, V131, P651, DOI 10.1007/s00418-009-0559-3; Garcia S, 2008, J CELL BIOCHEM, V104, P377, DOI 10.1002/jcb.21633; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kokudo T, 2008, J CELL SCI, V121, P3317, DOI 10.1242/jcs.028282; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee J, 2008, J CELL PHYSIOL, V216, P520, DOI 10.1002/jcp.21424; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Olmeda D, 2007, CANCER RES, V67, P11721, DOI 10.1158/0008-5472.CAN-07-2318; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Palma-Nicolas JP, 2010, J CELL BIOCHEM, V110, P948, DOI 10.1002/jcb.22608; Saad S, 2010, INT J BIOCHEM CELL B, V42, P1115, DOI 10.1016/j.biocel.2010.03.016; Saika S, 2007, ARCH OPHTHALMOL-CHIC, V125, P647, DOI 10.1001/archopht.125.5.647; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Vandromme M, 1996, TRENDS BIOCHEM SCI, V21, P59, DOI 10.1016/S0968-0004(96)80182-4; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146; Yu J, 2008, PROTEOMICS, V8, P3667, DOI 10.1002/pmic.200700824; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	40	33	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23322	10.1371/journal.pone.0023322	http://dx.doi.org/10.1371/journal.pone.0023322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853110	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200069
J	Parhar, RK; Mooers, AO				Parhar, Rakesh K.; Mooers, Arne O.			Phylogenetically Clustered Extinction Risks Do Not Substantially Prune the Tree of Life	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; BIODIVERSITY CONSERVATION; MOLECULAR PHYLOGENIES; NONRANDOM EXTINCTION; MAMMALIAN DIVERSITY; PATTERNS; DIVERSIFICATION; SPECIATION; MODELS; SIGNAL	Anthropogenic activities have increased the rate of biological extinction many-fold. Recent empirical studies suggest that projected extinction may lead to extensive loss to the Tree of Life, much more than if extinction were random. One suggested cause is that extinction risk is heritable (phylogenetically patterned), such that entire higher groups will be lost. We show here with simulation that phylogenetically clustered extinction risks are necessary but not sufficient for the extensive loss of phylogenetic diversity (PD) compared to random extinction. We simulated Yule trees and evolved extinction risks at various levels of heritability (measured using Pagel's lambda). At most levels of heritability (l in range of 0 to 10), mean values of extinction risk (range 0.25 to 0.75), tree sizes (64 to 128 tips), tree balance and temporal heterogeneity of diversification rates (Yule and coalescent trees), extinction risks do not substantially increase the loss of PD in these trees when compared to random extinction. The maximum loss of PD (20% above random) was only associated with the combination of extremely excessive values of phylogenetic signal, high mean species' extinction probabilities, and extreme (coalescent) tree shapes. Interestingly, we also observed a decline in the rate of increase in the loss of PD at high phylogenetic clustering (l? 10) of extinction risks. Our results suggest that the interplay between various aspects of tree shape and a predisposition of higher extinction risks in species-poor clades is required to explain the substantial pruning of the Tree of Life.	[Parhar, Rakesh K.; Mooers, Arne O.] Simon Fraser Univ, IRMACS, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Parhar, RK (corresponding author), Simon Fraser Univ, IRMACS, Burnaby, BC V5A 1S6, Canada.	rakesh_parhar@yahoo.ca			NSERC Canada	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	RKP and AOM each acknowledge NSERC Canada for funding and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bininda-Emonds ORP, 2002, ANNU REV ECOL SYST, V33, P265, DOI 10.1146/annurev.ecolsys.33.010802.150511; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; BROWN JKM, 1994, SYST BIOL, V43, P78, DOI 10.2307/2413582; CEBALLOS G, 1995, CONSERV BIOL, V9, P559, DOI 10.1046/j.1523-1739.1995.09030559.x; Ceballos G, 1998, ECOL APPL, V8, P8, DOI 10.1890/1051-0761(1998)008[0008:ACPIMM]2.0.CO;2; Corey SJ, 2008, DIVERS DISTRIB, V14, P614, DOI 10.1111/j.1472-4642.2007.00448.x; Erwin DH, 2008, P NATL ACAD SCI USA, V105, P11520, DOI 10.1073/pnas.0801913105; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faller B, 2008, J THEOR BIOL, V251, P286, DOI 10.1016/j.jtbi.2007.11.034; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hartmann K, 2010, SYST BIOL IN PRESS; Hartmann K, 2006, SYST BIOL, V55, P644, DOI 10.1080/10635150600873876; HEARD SB, 1992, EVOLUTION, V46, P1818, DOI 10.1111/j.1558-5646.1992.tb01171.x; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; HEY J, 1992, EVOLUTION, V46, P627, DOI [10.2307/2409633, 10.1111/j.1558-5646.1992.tb02071.x]; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Mooers A.O., 2007, RECONSTRUCTING EVOLU, P149; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Mooers AO, 2003, ANIM CONSERV, V6, P183, DOI 10.1017/S1367943003003226; Mooers Arne O., 2009, P263; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; O'Meara BC, 2006, EVOLUTION, V60, P922; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2005, EVOLUTION, V59, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Revell LJ, 2005, SYST BIOL, V54, P973, DOI 10.1080/10635150500354647; Roy K, 2009, SCIENCE, V325, P733, DOI 10.1126/science.1173073; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Velasco JD, 2008, BIOL PHILOS, V23, P455, DOI 10.1007/s10539-007-9105-7; von Euler F, 2001, P ROY SOC B-BIOL SCI, V268, P127, DOI 10.1098/rspb.2000.1340; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	55	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23528	10.1371/journal.pone.0023528	http://dx.doi.org/10.1371/journal.pone.0023528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853147	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200095
J	Valdes, AM; Styrkarsdottir, U; Doherty, M; Morris, DL; Mangino, M; Tamm, A; Doherty, SA; Kisand, K; Kerna, I; Tamm, A; Wheeler, M; Maciewicz, RA; Zhang, WY; Muir, KR; Dennison, EM; Hart, DJ; Metrustry, S; Jonsdottir, I; Jonsson, GF; Jonsson, H; Ingvarsson, T; Cooper, C; Vyse, TJ; Spector, TD; Stefansson, K; Arden, NK				Valdes, Ana M.; Styrkarsdottir, Unnur; Doherty, Michael; Morris, David L.; Mangino, Massimo; Tamm, Agu; Doherty, Sally A.; Kisand, Kalle; Kerna, Irina; Tamm, Ann; Wheeler, Margaret; Maciewicz, Rose A.; Zhang, Weiya; Muir, Kenneth R.; Dennison, Elaine M.; Hart, Deborah J.; Metrustry, Sarah; Jonsdottir, Ingileif; Jonsson, Gudbjorn F.; Jonsson, Helgi; Ingvarsson, Thorvaldur; Cooper, Cyrus; Vyse, Timothy J.; Spector, Tim D.; Stefansson, Kari; Arden, Nigel K.			Large Scale Replication Study of the Association between HLA Class II/BTNL2 Variants and Osteoarthritis of the Knee in European-Descent Populations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CLASS II/III REGION; EXTENDED HUMAN MHC; RISK-FACTORS; T-CELLS; GENOTYPES; DISEASE; ATLAS; GENE; MAP	Osteoarthritis (OA) is the most common form of arthritis and a major cause of disability. This study evaluates the association in Caucasian populations of two single nucleotide polymorphisms (SNPs) mapping to the Human Leukocyte Antigen (HLA) region and deriving from a genome wide association scan (GWAS) of knee OA in Japanese populations. The frequencies for rs10947262 were compared in 36,408 controls and 5,749 knee OA cases from European-descent populations. rs7775228 was tested in 32,823 controls and 1,837 knee OA cases of European descent. The risk (major) allele at rs10947262 in Caucasian samples was not significantly associated with an odds ratio (OR) = 1.07 (95% CI 0.94 -1.21; p = 0.28). For rs7775228 the meta-analysis resulted in OR = 0.94 (95% CI 0.81-1.09; p = 0.42) for the allele associated with risk in the Japanese GWAS. In Japanese individuals these two SNPs are in strong linkage disequilibrium (LD) (r(2) = 0.86) with the HLA class II haplotype DRB1*1502 DQA1*0103 DQB1*0601 (frequency 8%). In Caucasian and Chinese samples, using imputed data, these SNPs appear not to be in LD with that haplotype (r(2)<0.07). The rs10947262 and rs7775228 variants are not associated with risk of knee OA in European descent populations and they do not appear tag the same HLA class II haplotype as they do in Japanese individuals.	[Valdes, Ana M.; Mangino, Massimo; Hart, Deborah J.; Metrustry, Sarah; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Styrkarsdottir, Unnur; Jonsdottir, Ingileif; Jonsson, Gudbjorn F.; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Doherty, Michael; Doherty, Sally A.; Wheeler, Margaret; Zhang, Weiya] Univ Nottingham, Nottingham NG7 2RD, England; [Morris, David L.; Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [Morris, David L.; Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Tamm, Agu; Kisand, Kalle; Kerna, Irina; Tamm, Ann] Univ Tartu, Dept Internal Med, EE-50090 Tartu, Estonia; [Tamm, Ann] Univ Tartu, Dept Sports Med & Rehabil, EE-50090 Tartu, Estonia; [Maciewicz, Rose A.] AstraZeneca, Resp & Inflammat Res Area, Loughborough, Leics, England; [Muir, Kenneth R.] Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Dennison, Elaine M.; Cooper, Cyrus; Arden, Nigel K.] Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton, Hants, England; [Jonsdottir, Ingileif; Jonsson, Helgi; Ingvarsson, Thorvaldur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonsson, Helgi] Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Univ Hosp, Inst Hlth Sci, Akureyri, Iceland; [Cooper, Cyrus; Arden, Nigel K.] Univ Oxford, Musculoskeletal Biomed Res Unit, Oxford, England	University of London; King's College London; University of Nottingham; University of London; King's College London; University of London; King's College London; University of Tartu; University of Tartu; AstraZeneca; University of Warwick; University of Southampton; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; University of Akureyri; University of Oxford	Valdes, AM (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	ana.valdes@kcl.ac.uk	Kisand, Kalle/S-5958-2016; Zhang, Weiya/X-9481-2019; Stefansson, Kari/AAE-7187-2019; Mangino, Massimo/F-5134-2011; Kisand, Kalle/AAZ-2563-2020	Kisand, Kalle/0000-0002-7789-5565; Zhang, Weiya/0000-0003-1142-1460; Mangino, Massimo/0000-0002-2167-7470; Kisand, Kalle/0000-0002-7789-5565; Doherty, Michael/0000-0002-5763-8326; Dennison, Elaine/0000-0002-3048-4961; Morris, David/0000-0002-1754-8932; Valdes, Ana M./0000-0003-1141-4471; Cooper, Cyrus/0000-0003-3510-0709; Styrkarsdottir, Unnur/0000-0001-8146-8278; Jonsson, Helgi/0000-0003-0187-8985	European Commission [200800]; Wellcome Trust UK; Medical Research Council (UK); Oxford NIHR Musculoskeletal Biomedical Research Unit; Estonian Science Foundation [5308]; Estonian Ministry of Social Affairs [9.6-4/2035, 12.1-5/597]; Arthritis Research Campaign UK; Medical Research Council [U1475000001, MC_UP_A620_1014] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust UK(Wellcome Trust); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford NIHR Musculoskeletal Biomedical Research Unit; Estonian Science Foundation; Estonian Ministry of Social Affairs; Arthritis Research Campaign UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This project was funded by European Commission Framework 7 programme grant 200800 TREAT-OA and the Wellcome Trust UK. Individual cohort data collection was funded by the Medical Research Council (UK), the Oxford NIHR Musculoskeletal Biomedical Research Unit, the Estonian Science Foundation grant No 5308, the Estonian Ministry of Social Affairs grants No 9.6-4/2035 and 12.1-5/597, the Arthritis Research Campaign UK, and the Wellcome Trust UK. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The GOAL study was funded by AstraZeneca, Macclesfield UK, and a BBSRC for CASE studentship funding. AstraZeneca had a role in the GOAL study design. deCODE genetics had a role in study design of the deCODE case controls, data collection of the same study and analysis, decision to publish, and preparation of the manuscript.	ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; HART DJ, 1993, ANN RHEUM DIS, V52, P93, DOI 10.1136/ard.52.2.93; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mack SJ, 2000, TISSUE ANTIGENS, V55, P383, DOI 10.1034/j.1399-0039.2000.550501.x; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nagaosa Y, 2000, ANN RHEUM DIS, V59, P587, DOI 10.1136/ard.59.8.587; Nakajima M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009723; Nakamura H, 2006, RHEUMATOL INT, V26, P984, DOI 10.1007/s00296-006-0116-5; Neame RL, 2004, ANN RHEUM DIS, V63, P1022, DOI 10.1136/ard.2003.014498; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Samuels J, 2008, BULL HOSP JT DIS, V66, P244; Shi D, 2010, OSTEOARTHR CARTILAGE, V18, P1454, DOI 10.1016/j.joca.2010.07.009; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Styrkarsdottir U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013217; Tamm A, 2008, J RHEUMATOL, V35, P543; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Valdes AM, 2011, ANN RHEUM DIS, V70, P873, DOI 10.1136/ard.2010.134155; Valdes AM, 2011, NAT REV RHEUMATOL, V7, P23, DOI 10.1038/nrrheum.2010.191; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2688, DOI 10.1002/art.27574; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; Zhang W, 2008, ARTHRITIS RHEUM, V58, P137, DOI 10.1002/art.23237	28	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23371	10.1371/journal.pone.0023371	http://dx.doi.org/10.1371/journal.pone.0023371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853121	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000295454200078
J	Serra, M; Correia, C; Malpique, R; Brito, C; Jensen, J; Bjorquist, P; Carrondo, MJT; Alves, PM				Serra, Margarida; Correia, Claudia; Malpique, Rita; Brito, Catarina; Jensen, Janne; Bjorquist, Petter; Carrondo, Manuel J. T.; Alves, Paula M.			Microencapsulation Technology: A Powerful Tool for Integrating Expansion and Cryopreservation of Human Embryonic Stem Cells	PLOS ONE			English	Article							ALGINATE-BASED MICROCAPSULES; SCALABLE CULTURE; ENCAPSULATION; DIFFERENTIATION; VIABILITY	The successful implementation of human embryonic stem cells (hESCs)-based technologies requires the production of relevant numbers of well-characterized cells and their efficient long-term storage. In this study, cells were microencapsulated in alginate to develop an integrated bioprocess for expansion and cryopreservation of pluripotent hESCs. Different three-dimensional (3D) culture strategies were evaluated and compared, specifically, microencapsulation of hESCs as: i) single cells, ii) aggregates and iii) immobilized on microcarriers. In order to establish a scalable bioprocess, hESC-microcapsules were cultured in stirred tank bioreactors. The combination of microencapsulation and microcarrier technology resulted in a highly efficient protocol for the production and storage of pluripotent hESCs. This strategy ensured high expansion ratios (an approximately twenty-fold increase in cell concentration) and high cell recovery yields (>70%) after cryopreservation. When compared with non-encapsulated cells, cell survival post-thawing demonstrated a three-fold improvement without compromising hESC characteristics. Microencapsulation also improved the culture of hESC aggregates by protecting cells from hydrodynamic shear stress, controlling aggregate size and maintaining cell pluripotency for two weeks. This work establishes that microencapsulation technology may prove a powerful tool for integrating the expansion and cryopreservation of pluripotent hESCs. The 3D culture strategy developed herein represents a significant breakthrough towards the implementation of hESCs in clinical and industrial applications.	[Serra, Margarida; Correia, Claudia; Malpique, Rita; Brito, Catarina; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Serra, Margarida; Correia, Claudia; Malpique, Rita; Brito, Catarina; Carrondo, Manuel J. T.; Alves, Paula M.] Inst Biol Expt & Tecnol, Oeiras, Portugal; [Jensen, Janne; Bjorquist, Petter] Cellartis AB, Gotemborg, Sweden; [Carrondo, Manuel J. T.] Univ Nova Lisboa, Fac Ciencias & Tecnol, P-2825 Monte De Caparica, Portugal	Universidade Nova de Lisboa; Takara Bio Inc.; Cellartis; Universidade Nova de Lisboa	Serra, M (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	marques@itqb.unl.pt	Brito, Catarina/A-2389-2009; Carrondo, Manuel JT/C-8155-2011; Serra, Margarida/N-1769-2013; Malpique, Rita/M-2404-2015; Alves, Paula M/C-1070-2008	Brito, Catarina/0000-0002-8926-279X; Serra, Margarida/0000-0001-5013-6625; Malpique, Rita/0000-0002-5282-6790; Alves, Paula M/0000-0003-1445-3556; Carrondo, Manuel/0000-0002-4550-4574	FCT Portugal [PTDC/BIO/72755/2006, SFRH/BD/42176/2007]; European Commission [Clinigene: LSHB-CT-2006-018933, HYPERLAB: 223011]	FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by FCT Portugal (PTDC/BIO/72755/2006, SFRH/BD/42176/2007) and European Commission (Clinigene: LSHB-CT-2006-018933, HYPERLAB: 223011). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Janne Jensen and Petter Bjorquist are employees of Cellartis AB and played a role in analysis and writing of the manuscript.	Azarin SM, 2010, BIOCHEM ENG J, V48, P378, DOI 10.1016/j.bej.2009.10.020; Chayosumrit M, 2010, BIOMATERIALS, V31, P505, DOI 10.1016/j.biomaterials.2009.09.071; Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; Fernandes AM, 2009, BRAZ J MED BIOL RES, V42, P515, DOI 10.1590/S0100-879X2009000600007; Freimark D, 2010, TRANSFUS MED HEMOTH, V37, P66, DOI 10.1159/000285777; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004; Hunt CJ, 2007, TRANSFUS MED HEMOTH, V34, P293, DOI 10.1159/000104458; Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028; Ji L, 2004, BIOTECHNOL BIOENG, V88, P299, DOI 10.1002/bit.20243; Jing D, 2010, CELL TRANSPLANT; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Kim SJ, 2004, STEM CELLS, V22, P950, DOI 10.1634/stemcells.22-6-950; KRAWETZ R, 2009, TISSUE ENG C; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Li ZS, 2010, BIOMATERIALS, V31, P404, DOI 10.1016/j.biomaterials.2009.09.070; Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]; Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748; Malpique R, 2010, TISSUE ENG PART C-ME, V16, P965, DOI 10.1089/ten.TEC.2009.0660; Malpique R, 2009, TISSUE ENG PART C-ME, V15, P373, DOI 10.1089/ten.tec.2008.0410; Miranda JP, 2010, TISSUE ENG PART C-ME, V16, P1223, DOI [10.1089/ten.tec.2009.0784, 10.1089/ten.TEC.2009.0784]; Murase N, 1997, CRYO-LETT, V18, P157; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI 10.1002/btpr.110; Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044; Nirmalanandhan VS, 2009, J BIOMOL SCREEN, V14, P755, DOI 10.1177/1087057109336591; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442; Sargent CY, 2010, BIOTECHNOL BIOENG, V105, P611, DOI 10.1002/bit.22578; Schwinger C, 2002, J MICROENCAPSUL, V19, P273, DOI 10.1080/02652040110105328; Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015; Siti-Ismail N, 2008, BIOMATERIALS, V29, P3946, DOI 10.1016/j.biomaterials.2008.04.027; Tostoes RM, 2010, BIOTECHNOL IN PRESS; Wang N, 2009, J BIOTECHNOL, V144, P304, DOI 10.1016/j.jbiotec.2009.08.008; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2; Zimmermann H, 2007, BIOMATERIALS, V28, P1327, DOI 10.1016/j.biomaterials.2006.11.032; Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x	42	115	120	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23212	10.1371/journal.pone.0023212	http://dx.doi.org/10.1371/journal.pone.0023212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850261	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300046
J	Tsubota, T; Ohashi, Y; Tamura, K; Sato, A; Miyashita, Y				Tsubota, Tadashi; Ohashi, Yohei; Tamura, Keita; Sato, Ayana; Miyashita, Yasushi			Optogenetic Manipulation of Cerebellar Purkinje Cell Activity In Vivo	PLOS ONE			English	Article							LENTIVIRAL VECTORS; CARDIOVASCULAR CONTROL; MILLISECOND-TIMESCALE; VESTIBULAR INFLUENCES; OPTICAL TECHNOLOGIES; COMPLEX SPIKE; MOTOR CORTEX; EXPRESSION; NEURONS; BRAIN	Purkinje cells (PCs) are the sole output neurons of the cerebellar cortex. Although their anatomical connections and physiological response properties have been extensively studied, the causal role of their activity in behavioral, cognitive and autonomic functions is still unclear because PC activity cannot be selectively controlled. Here we developed a novel technique using optogenetics for selective and rapidly reversible manipulation of PC activity in vivo. We injected into rat cerebellar cortex lentiviruses expressing either the light-activated cationic channel channelrhodopsin-2 (ChR2) or light-driven chloride pump halorhodopsin (eNpHR) under the control of the PC-specific L7 promoter. Transgene expression was observed in most PCs (ChR2, 92.6%; eNpHR, 95.3%), as determined by immunohistochemical analysis. In vivo electrophysiological recordings showed that all light-responsive PCs in ChR2-transduced rats increased frequency of simple spike in response to blue laser illumination. Similarly, most light-responsive PCs (93.8%) in eNpHR-transduced rats decreased frequency of simple spike in response to orange laser illumination. We then applied these techniques to characterize the roles of rat cerebellar uvula, one of the cardiovascular regulatory regions in the cerebellum, in resting blood pressure (BP) regulation in anesthetized rats. ChR2-mediated photostimulation and eNpHR-mediated photoinhibition of the uvula had opposite effects on resting BP, inducing depressor and pressor responses, respectively. In contrast, manipulation of PC activity within the neighboring lobule VIII had no effect on BP. Blue and orange laser illumination onto PBS-injected lobule IX didn't affect BP, indicating the observed effects on BP were actually due to PC activation and inhibition. These results clearly demonstrate that the optogenetic method we developed here will provide a powerful way to elucidate a causal relationship between local PC activity and functions of the cerebellum.	[Tsubota, Tadashi; Ohashi, Yohei; Tamura, Keita; Sato, Ayana; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan; [Sato, Ayana; Miyashita, Yasushi] Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Tsubota, T (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Tamura, Keita/I-2931-2012; Miyashita, Yasushi/B-7171-2019	Tamura, Keita/0000-0003-2697-1510; Miyashita, Yasushi/0000-0003-3496-8637	Ministry for Education, Culture, Sports, Science and Technology (MEXT) [19002010]; Japan Society for the Promotion of Science (JSPS) [235569, 195225, 211438]; Grants-in-Aid for Scientific Research [19002010] Funding Source: KAKEN	Ministry for Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for specially Promoted Research from Ministry for Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/) to Y.M. (19002010), Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT (http://www.mext.go.jp/english/) to Y.M., and Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/index.html) Research Fellowships for Young Scientists to T.T. (235569), Y.O. (195225) and K.T. (211438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; BALL GG, 1974, PHYSIOL BEHAV, V13, P123, DOI 10.1016/0031-9384(74)90313-8; Barman SM, 2009, AM J PHYSIOL-REG I, V297, pR210, DOI 10.1152/ajpregu.90989.2008; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRADLEY DJ, 1987, J PHYSIOL-LONDON, V393, P107, DOI 10.1113/jphysiol.1987.sp016813; BRADLEY DJ, 1987, J PHYSIOL-LONDON, V383, P537; BRADLEY DJ, 1991, NEUROSCI RES, V12, P45, DOI 10.1016/0168-0102(91)90099-K; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; EKEROT CF, 1981, J PHYSIOL-LONDON, V318, P207; Frecha C, 2008, CURR GENE THER, V8, P449, DOI 10.2174/156652308786848003; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Mandolesi G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005243; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Miall RC, 1998, NAT NEUROSCI, V1, P13, DOI 10.1038/212; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Neki A, 1996, NEUROSCI LETT, V202, P197, DOI 10.1016/0304-3940(95)12248-6; Nisimaru N, 2004, JPN J PHYSIOL, V54, P431, DOI 10.2170/jjphysiol.54.431; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Ohashi Y, 2011, MOL CELL NEUROSCI, V46, P136, DOI 10.1016/j.mcn.2010.08.013; Orduz D, 2007, P NATL ACAD SCI USA, V104, P17831, DOI 10.1073/pnas.0707489104; PATON JFR, 1990, J PHYSIOL-LONDON, V427, P533, DOI 10.1113/jphysiol.1990.sp018186; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; RUSSO AF, 1988, NEURON, V1, P311, DOI 10.1016/0896-6273(88)90079-7; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Sawada Y, 2010, CEREBELLUM, V9, P291, DOI 10.1007/s12311-010-0161-1; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; THACH WT, 1967, J NEUROPHYSIOL, V30, P675, DOI 10.1152/jn.1967.30.4.675; Yates BJ, 2000, BRAIN RES BULL, V53, P3, DOI 10.1016/S0361-9230(00)00302-6; Yates BJ, 1996, ANN NY ACAD SCI, V781, P458, DOI 10.1111/j.1749-6632.1996.tb15720.x; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	51	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22400	10.1371/journal.pone.0022400	http://dx.doi.org/10.1371/journal.pone.0022400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850224	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300008
J	Berentzen, TL; Jakobsen, MU; Halkjaer, J; Tjonneland, A; Sorensen, TIA; Overvad, K				Berentzen, Tina Landsvig; Jakobsen, Marianne Uhre; Halkjaer, Jytte; Tjonneland, Anne; Sorensen, Thorkild I. A.; Overvad, Kim			Changes in Waist Circumference and the Incidence of Diabetes in Middle-Aged Men and Women	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; FOOD FREQUENCY QUESTIONNAIRE; INSULIN-RESISTANCE; VISCERAL ADIPOSITY; PROSPECTIVE COHORT; HEALTH; RISK; POPULATION; DENMARK; OBESITY	Background: Waist circumference (WC) is positively associated with diabetes, but the association with changes in WC (DWC) is less clear. We investigated the association between DWC and the subsequent risk of diabetes in middle-aged men and women, and evaluated the influence from concurrent changes in body mass index (DBMI). Methodology/Principal Findings: Data on 15,577 men and 20,066 women from the Danish Diet, Cancer and Health study were analyzed. Anthropometry was assessed in 1993-97 and 1999-02. Information on diabetes was obtained from The Danish National Diabetes Register. Hazard ratios (HR) were calculated from Cox' proportional hazard models with individuals considered at risk from 1999-02 until December 31 2006. During 5.4 years of follow-up, 1,027 and 876 new cases of diabetes occurred among men and women, respectively. WC was positively associated with diabetes in both sexes also with adjustment for covariates and BMI. DWC was positively associated with diabetes in women, but not in men (HR per 5 cm change = 1.09 (1.04:1.15) in women, and 1.00 (0.94, 1.07) in men with adjustment for covariates, baseline WC, BMI and DBMI). Associations with DWC were not notably different in sub-groups stratified according to baseline WC or DBMI, or when individuals with diseases or diabetes occurring within the first years of follow-up were excluded. Conclusions/Significance: While this study confirmed that WC is positively associated with the risk of diabetes in middle-aged men and women, it surprisingly showed that changes in WC were not associated with the subsequent risk of diabetes in men, and only weakly positively associated with the risk of diabetes in women. Accordingly, these findings suggest that a reduction in WC may be a weak or insufficient or target for prevention of diabetes in middle-aged men and women.	[Berentzen, Tina Landsvig; Sorensen, Thorkild I. A.] Univ Copenhagen Hosp, Inst Prevent Med, DK-2100 Copenhagen, Denmark; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg, Denmark	University of Copenhagen; Aarhus University; Danish Cancer Society; Aalborg University; Aalborg University Hospital; Aarhus University	Berentzen, TL (corresponding author), Univ Copenhagen Hosp, Inst Prevent Med, DK-2100 Copenhagen, Denmark.	tb@ipm.regionh.dk	Jakobsen, Marianne Uhre/I-8550-2018	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Tjonneland, Anne/0000-0003-4385-2097; Overvad, Kim/0000-0001-6429-7921	European Commission [LSHM-CT-2005-018734]; Danish Obesity Research Centre; Danish Council for Strategic Research; Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Obesity Research Centre; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen	This work was supported by the project "Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome'' (HEPADIP; www.hepadip.org) supported by the European Commission as an Integrated Project under the 6th Framework Program (contract LSHM-CT-2005-018734), and the research program of the Danish Obesity Research Centre (DanORC; www.danorc.dk) supported by the Danish Council for Strategic Research (contract 2101-06-0005). Funding was also obtained from The Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Berentzen TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013097; Bigaard J, 2005, J NUTR, V135, P2263; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hanley AJG, 2009, DIABETOLOGIA, V52, P2079, DOI 10.1007/s00125-009-1464-y; Harrel jF, 2002, APPL LINEAR MODELS L; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Kristensen JK, 2001, DAN MED BULL, V48, P33; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Mikkelsen KL, 1999, EPIDEMIOLOGY, V10, P671, DOI 10.1097/00001648-199911000-00005; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Park K, 2010, OBESITY, V18, P370, DOI 10.1038/oby.2009.252; Schooling CM, 2010, DIABETOLOGIA, V53, P393, DOI 10.1007/s00125-009-1613-3; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Sorensen TIA, 2011, OBESITY FACTS, V4, P91, DOI 10.1159/000328198; Sorensen TIA, 2010, BBA-MOL CELL BIOL L, V1801, P400, DOI 10.1016/j.bbalip.2009.12.011; SWINBURN BA, 1991, J CLIN INVEST, V88, P168, DOI 10.1172/JCI115274; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2010, DIABETOLOGIA, V53, P890, DOI 10.1007/s00125-010-1670-7; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	33	6	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23104	10.1371/journal.pone.0023104	http://dx.doi.org/10.1371/journal.pone.0023104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829698	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200047
J	Morita, H; Toh, H; Oshima, K; Yoshizaki, M; Kawanishi, M; Nakaya, K; Suzuki, T; Miyauchi, E; Ishii, Y; Tanabe, S; Murakami, M; Hattori, M				Morita, Hidetoshi; Toh, Hidehiro; Oshima, Kenshiro; Yoshizaki, Mariko; Kawanishi, Michiko; Nakaya, Kohei; Suzuki, Takehito; Miyauchi, Eiji; Ishii, Yasuo; Tanabe, Soichi; Murakami, Masaru; Hattori, Masahira			Complete Genome Sequence and Comparative Analysis of the Fish Pathogen Lactococcus garvieae	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; LACTIC-ACID BACTERIUM; ENTEROCOCCUS-SERIOLICIDA; EXOPOLYSACCHARIDE BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; GENE-CLUSTER; VIRULENCE; IDENTIFICATION; ENDOCARDITIS; INFECTIONS	Lactococcus garvieae causes fatal haemorrhagic septicaemia in fish such as yellowtail. The comparative analysis of genomes of a virulent strain Lg2 and a non-virulent strain ATCC 49156 of L. garvieae revealed that the two strains shared a high degree of sequence identity, but Lg2 had a 16.5-kb capsule gene cluster that is absent in ATCC 49156. The capsule gene cluster was composed of 15 genes, of which eight genes are highly conserved with those in exopolysaccharide biosynthesis gene cluster often found in Lactococcus lactis strains. Sequence analysis of the capsule gene cluster in the less virulent strain L. garvieae Lg2-S, Lg2-derived strain, showed that two conserved genes were disrupted by a single base pair deletion, respectively. These results strongly suggest that the capsule is crucial for virulence of Lg2. The capsule gene cluster of Lg2 may be a genomic island from several features such as the presence of insertion sequences flanked on both ends, different GC content from the chromosomal average, integration into the locus syntenic to other lactococcal genome sequences, and distribution in human gut microbiomes. The analysis also predicted other potential virulence factors such as haemolysin. The present study provides new insights into understanding of the virulence mechanisms of L. garvieae in fish.	[Morita, Hidetoshi; Nakaya, Kohei; Suzuki, Takehito; Ishii, Yasuo; Murakami, Masaru] Azabu Univ, Sch Vet Med, Kanagawa, Japan; [Toh, Hidehiro] RIKEN, Planning Off, Ctr Computat & Quantitat Life Sci, Kanagawa, Japan; [Kawanishi, Michiko] Minist Agr Forestry & Fisheries, Natl Vet Assay Lab, Tokyo, Japan; [Miyauchi, Eiji; Tanabe, Soichi] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan; [Oshima, Kenshiro; Yoshizaki, Mariko; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan	Azabu University; RIKEN; Ministry of Agriculture Forestry & Fisheries - Japan; Hiroshima University; University of Tokyo	Morita, H (corresponding author), Azabu Univ, Sch Vet Med, Kanagawa, Japan.	hattori@k.u-tokyo.ac.jp	Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Tanabe, Soichi/R-6229-2019	Hattori, Masahira/0000-0001-9467-0344; 	The Promotion and Mutual Aid Corporation for Private Schools of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	The Promotion and Mutual Aid Corporation for Private Schools of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by The Promotion and Mutual Aid Corporation for Private Schools of Japan, Grant-in-Aid for Matching Fund Subsidy for Private Universities to H. M. and Grant-in-Aid for Scientific Research on Priority Areas 'Comprehensive Genomics' from the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes AC, 2002, FISH SHELLFISH IMMUN, V12, P155, DOI 10.1006/fsim.2001.0361; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Brinster S, 2007, J BACTERIOL, V189, P1244, DOI 10.1128/JB.00773-06; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Dabour N, 2005, APPL ENVIRON MICROB, V71, P7414, DOI 10.1128/AEM.71.11.7414-7425.2005; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Forde A, 2003, PLASMID, V49, P130, DOI 10.1016/S0147-619X(02)00156-7; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kang Sung Hyun, 2004, J Vet Sci, V5, P387; Kawanishi M, 2007, LETT APPL MICROBIOL, V44, P481, DOI 10.1111/j.1472-765X.2007.02114.x; Kawanishi M, 2006, J APPL MICROBIOL, V101, P496, DOI 10.1111/j.1365-2672.2006.02951.x; KUSUDA R, 1991, INT J SYST BACTERIOL, V41, P406, DOI 10.1099/00207713-41-3-406; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Morita H, 2007, MICROBES ENVIRON, V22, P214, DOI 10.1264/jsme2.22.214; Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Siezen R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-126; Siezen RJ, 2008, APPL ENVIRON MICROB, V74, P424, DOI 10.1128/AEM.01850-07; Siezen RJ, 2010, J BACTERIOL, V192, P2649, DOI 10.1128/JB.00276-10; Teixeira LM, 1996, INT J SYST BACTERIOL, V46, P664, DOI 10.1099/00207713-46-3-664; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003; Vinh DC, 2006, DIAGN MICR INFEC DIS, V56, P91, DOI 10.1016/j.diagmicrobio.2006.02.010; Wang CYC, 2007, INT J CLIN PRACT, V61, P68, DOI 10.1111/j.1742-1241.2006.00855.x; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Yiu KH, 2007, INT J CARDIOL, V114, P286, DOI 10.1016/j.ijcard.2005.11.092; Yoshida T, 1997, DIS AQUAT ORGAN, V29, P233, DOI 10.3354/dao029233	33	67	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23184	10.1371/journal.pone.0023184	http://dx.doi.org/10.1371/journal.pone.0023184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829716	gold, Green Published, Green Submitted			2022-12-27	WOS:000293561200054
J	Le, L; Leluk, J				Ly Le; Leluk, Jacek			Study on Phylogenetic Relationships, Variability, and Correlated Mutations in M2 Proteins of Influenza Virus A	PLOS ONE			English	Article							A VIRUS; PROTON CHANNEL; M-GENE; MECHANISM; INHIBITION; ALGORITHM; CONSURF; BLAST	M2 channel, an influenza virus transmembrane protein, serves as an important target for antiviral drug design. There are still discordances concerning the role of some residues involved in proton transfer as well as the mechanism of inhibition by commercial drugs. The viral M2 proteins show high conservativity; about 3/4 of the positions are occupied by one residue in over 95%. Nine M2 proteins from the H3N2 strain and possibly two proteins from H2N2 strains make a phylogenic cluster closely related to 2RLF. The variability range is limited to 4 residues/position with one exception. The 2RLF protein stands out by the presence of 2 serines at the positions 19 and 50, which are in most other M2 proteins occupied by cysteines. The study of correlated mutations shows that there are several positions with significant mutational correlation that have not been described so far as functionally important. That there are 5 more residues potentially involved in the M2 mechanism of action. The original software used in this work (Consensus Constructor, SSSSg, Corm, Talana) is freely accessible as stand-alone offline applications upon request to the authors. The other software used in this work is freely available online for noncommercial purposes at public services on bioinformatics such as ExPASy or NCBI. The study on mutational variability, evolutionary relationship, and correlated mutation presented in this paper is a potential way to explain more completely the role of significant factors in proton channel action and to clarify the inhibition mechanism by specific drugs.	[Ly Le] Ho Chi Minh Int Univ, Sch Biotechnol, Ho Chi Minh City, Vietnam; [Leluk, Jacek] Univ Zielona Gora, Dept Mol Biol, Fac Biol Sci, Zielona Gora, Poland	Vietnam National University Hochiminh City; University of Zielona Gora	Le, L (corresponding author), Ho Chi Minh Int Univ, Sch Biotechnol, Ho Chi Minh City, Vietnam.	J.Leluk@wnb.uz.zgora.pl	Leluk, Jacek/G-2839-2015	Leluk, Jacek/0000-0002-4410-4317	Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.99-2010.03]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED))	The authors wish to thank the Vietnam National Foundation for Science and Technology Development (NAFOSTED) for the funding under grant number 106.99-2010.03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D; Du QS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009388; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fogtman A, 2005, BIOALGORITHMS MED SY, V1, P117; Forrest LR, 2000, BIOPHYS J, V78, P55, DOI 10.1016/S0006-3495(00)76572-6; Furuse Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-67; Gajewska E, 2005, BIOALGORITHMS MED SY, V1, P121; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GORECKI A, 2005, IDENTIFICATION FREE; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Intharathep P, 2008, J MOL GRAPH MODEL, V27, P342, DOI 10.1016/j.jmgm.2008.06.002; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; KUSKA J, 2010, TALANA NOVEL APPL PR; Lamb R. A., 1994, RECEPTOR MEDIATED VI, P303; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laohpongspaisan C, 2009, J CHEM INF MODEL, V49, P847, DOI 10.1021/ci800267a; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000939; Leluk J, 2001, ACTA BIOCHIM POL, V48, P21; Leluk J, 2000, BIOSYSTEMS, V56, P83, DOI 10.1016/S0303-2647(00)00074-5; Leluk J, 1998, COMPUT CHEM, V22, P123, DOI 10.1016/S0097-8485(97)00035-1; Leluk J, 2000, COMPUT CHEM, V24, P659, DOI 10.1016/S0097-8485(00)00070-X; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Sansom MSP, 1997, VIROLOGY, V233, P163, DOI 10.1006/viro.1997.8578; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22970	10.1371/journal.pone.0022970	http://dx.doi.org/10.1371/journal.pone.0022970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829678	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511900021
J	Sofrata, A; Santangelo, EM; Azeem, M; Borg-Karlson, AK; Gustafsson, A; Putsep, K				Sofrata, Abier; Santangelo, Ellen M.; Azeem, Muhammad; Borg-Karlson, Anna-Karin; Gustafsson, Anders; Putsep, Katrin			Benzyl Isothiocyanate, a Major Component from the Roots of Salvadora Persica Is Highly Active against Gram-Negative Bacteria	PLOS ONE			English	Article							MISWAK; PERIODONTITIS; MICROORGANISMS; METABOLISM; MYROSINASE; PRODUCTS; EXTRACTS; DEFENSE	Plants produce a number of antimicrobial substances and the roots of the shrub Salvadora persica have been demonstrated to possess antimicrobial activity. Sticks from the roots of S. persica, Miswak sticks, have been used for centuries as a traditional method of cleaning teeth. Diverging reports on the chemical nature and antimicrobial repertoire of the chewing sticks from S. persica led us to explore its antibacterial properties against a panel of pathogenic or commensal bacteria and to identify the antibacterial component/s by methodical chemical characterization. S. persica root essential oil was prepared by steam distillation and solid-phase microextraction was used to sample volatiles released from fresh root. The active compound was identified by gas chromatography-mass spectrometry and antibacterial assays. The antibacterial compound was isolated using medium-pressure liquid chromatography. Transmission electron microscopy was used to visualize the effect on bacterial cells. The main antibacterial component of both S. persica root extracts and volatiles was benzyl isothiocyanate. Root extracts as well as commercial synthetic benzyl isothiocyanate exhibited rapid and strong bactericidal effect against oral pathogens involved in periodontal disease as well as against other Gram-negative bacteria, while Gram-positive bacteria mainly displayed growth inhibition or remained unaffected. The short exposure needed to obtain bactericidal effect implies that the chewing sticks and the essential oil may have a specific role in treatment of periodontal disease in reducing Gram-negative periodontal pathogens. Our results indicate the need for further investigation into the mechanism of the specific killing of Gram-negative bacteria by S. persica root stick extracts and its active component benzyl isothiocyanate.	[Sofrata, Abier; Gustafsson, Anders] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Santangelo, Ellen M.; Azeem, Muhammad; Borg-Karlson, Anna-Karin] Royal Inst Technol, Sch Chem Sci & Engn, Dept Chem, Stockholm, Sweden; [Putsep, Katrin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Karolinska Institutet	Sofrata, A (corresponding author), Karolinska Inst, Dept Dent Med, Stockholm, Sweden.	katrin.putsep@ki.se	Azeem, Muhammad/AAX-9422-2020	Azeem, Muhammad/0000-0003-3054-700X; Sofrata, Abier H./0000-0003-4761-3042	Swedish Research Council [06XD-14653]; Swedish Medical Society; Ake Wiberg foundation; Swedish Research Council Formas; Higher Education Commission Pakistan HEC; Ministry of Health, Riyadh, Saudi Arabia	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Society; Ake Wiberg foundation; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Higher Education Commission Pakistan HEC(Higher Education Commission of Pakistan); Ministry of Health, Riyadh, Saudi Arabia	This study was supported by the Swedish Research Council (06XD-14653 to KP), the Swedish Medical Society (to KP), the Ake Wiberg foundation (to KP), the Swedish Research Council Formas (to AKBK), Higher Education Commission Pakistan HEC (to MA), and the Ministry of Health, Riyadh, Saudi Arabia (to AS). These funding bodies had no role in study design, data collection, analysis of data, writing the manuscript or in the decision to submit this manuscript for publication.	Aires A, 2009, J APPL MICROBIOL, V106, P2086, DOI 10.1111/j.1365-2672.2009.04180.x; Al lafi T, 1995, Int Dent J, V45, P218; Al-Otaibi M, 2004, J CLIN PERIODONTOL, V31, P1048, DOI 10.1111/j.1600-051X.2004.00618.x; ALBAGIEH NH, 1994, MICROBIOS, V80, P107; ALBAGIEH NH, 1989, MICROBIOS LETT, V29, P143; Almas K, 2005, Int J Dent Hyg, V3, P18, DOI 10.1111/j.1601-5037.2004.00111.x; Almas K, 1997, BIOMED LETT, V56, P145; ALMAS K, 1999, INDIAN J DENT RES, P23; Amano A, 2010, PERIODONTOL 2000, V54, P9, DOI 10.1111/j.1600-0757.2010.00376.x; Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Beevi SS, 2009, FOODBORNE PATHOG DIS, V6, P129, DOI 10.1089/fpd.2008.0166; BOMAN HG, 1974, ANN NY ACAD SCI, V235, P569, DOI 10.1111/j.1749-6632.1974.tb43291.x; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; BRIENSIMPSON NM, 2003, CURR PROTEIN PEPT SC, V4, P409; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Darmani H, 2006, Int J Dent Hyg, V4, P62, DOI 10.1111/j.1601-5037.2006.00149.x; Darout IA, 2000, ACTA ODONTOL SCAND, V58, P25, DOI 10.1080/000163500429398; Darout Ismail A., 2000, Indian Journal of Pharmacology, V32, P11; DELOUVOIS J, 1982, J ANTIMICROB CHEMOTH, V9, P253, DOI 10.1093/jac/9.4.253; Dierickx K, 2002, J CLIN PERIODONTOL, V29, P987, DOI 10.1034/j.1600-051X.2002.291103.x; Ezmirly S., 1981, J SOC CHEMIS PAKISTA, V3, P9; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; FENWICK GR, 1983, CRC CR REV FOOD SCI, V18, P123, DOI 10.1080/10408398209527361; Fives-Taylor P, 1995, Adv Dent Res, V9, P55; Garboui SS, 2009, J MED ENTOMOL, V46, P1415, DOI 10.1603/033.046.0623; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Haraszthy VI, 2000, J PERIODONTOL, V71, P912, DOI 10.1902/jop.2000.71.6.912; Holst B, 2004, NAT PROD REP, V21, P425, DOI 10.1039/b204039p; Hyson John M Jr, 2003, J Hist Dent, V51, P73; Kassie F, 1999, MUTAGENESIS, V14, P595, DOI 10.1093/mutage/14.6.595; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Liblikas I, 2005, J NAT PROD, V68, P886, DOI 10.1021/np049647d; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Marsh P D, 1994, Adv Dent Res, V8, P263; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Miyoshi N, 2004, CARCINOGENESIS, V25, P567, DOI 10.1093/carcin/bgh051; Munday R, 2004, J AGR FOOD CHEM, V52, P1867, DOI 10.1021/jf030549s; Nakamura Y, 2002, J BIOL CHEM, V277, P8492, DOI 10.1074/jbc.M109760200; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Rescala B, 2010, J PERIODONTOL, V81, P1308, DOI 10.1902/jop.2010.090643; Shapiro TA, 1998, CANCER EPIDEM BIOMAR, V7, P1091; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sofrata A, 2007, CARIES RES, V41, P451, DOI 10.1159/000107931; Sofrata AH, 2008, J PERIODONTOL, V79, P1474, DOI [10.1902/jop.2008.070506, 10.1902/jop.2008.070506 ]; Warin R, 2009, CANCER RES, V69, P9473, DOI 10.1158/0008-5472.CAN-09-2960	45	123	124	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23045	10.1371/journal.pone.0023045	http://dx.doi.org/10.1371/journal.pone.0023045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829688	Green Submitted, gold, Green Published			2022-12-27	WOS:000293511200033
J	Clery-Melin, ML; Schmidt, L; Lafargue, G; Baup, N; Fossati, P; Pessiglione, M				Clery-Melin, Marie-Laure; Schmidt, Liane; Lafargue, Gilles; Baup, Nicolas; Fossati, Philippe; Pessiglione, Mathias			Why Don't You Try Harder? An Investigation of Effort Production in Major Depression	PLOS ONE			English	Article							AMYGDALA REACTIVITY; PARKINSONS-DISEASE; MOTIVATION; REWARD; BRAIN; DISORDER; STIMULI; FMRI; NEUROSCIENCE; INDIVIDUALS	Depression is mainly characterized as an emotional disorder, associated with reduced approach behavior. It remains unclear whether the difficulty in energising behavior relates to abnormal emotional states or to a flattened response to potential rewards, as suggested by several neuroimaging studies. Here, we aimed to demonstrate a specific incentive motivation deficit in major depression, independent of patients' emotional state. We employed a behavioral paradigm designed to measure physical effort in response to both emotional modulation and incentive motivation. Patients did exert more effort following emotionally arousing pictures (whether positive or negative) but not for higher monetary incentives, contrary to healthy controls. These results show that emotional and motivational sources of effort production are dissociable in pathological conditions. In addition, patients' ratings of perceived effort increased for high incentives, whereas controls' ratings were decreased. Thus, depressed patients objectively behave as if they do not want to gain larger rewards, but subjectively feel that they try harder. We suggest that incentive motivation impairment is a core deficit of major depression, which may render everyday tasks abnormally effortful for patients.	[Clery-Melin, Marie-Laure; Schmidt, Liane; Pessiglione, Mathias] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere ICM, Motivat Brain & Behav Lab MBB, Paris, France; [Clery-Melin, Marie-Laure; Schmidt, Liane; Fossati, Philippe; Pessiglione, Mathias] Univ Paris 06, CNRS, INSERM, UMRS 975,UMR 7225, Paris, France; [Lafargue, Gilles] Univ Lille 3, CNRS, UMR 8160, Villeneuve Dascq, France; [Baup, Nicolas] Hop Bicetre, AP HP, Serv Psychiat Adulte, Le Kremlin Bicetre, France; [Fossati, Philippe] Hop La Pitie Salpetriere, CNRS, Ctr Emot, USR 3246, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Clery-Melin, ML (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere ICM, Motivat Brain & Behav Lab MBB, Paris, France.	mathias.pessiglione@gmail.com	Pessiglione, Mathias/E-2141-2017	Pessiglione, Mathias/0000-0002-6992-3677; Schmidt, Liane/0000-0002-4159-9705	French Academie Nationale de Medecine; French Ministere de la Recherche et de l'Education Nationale	French Academie Nationale de Medecine; French Ministere de la Recherche et de l'Education Nationale	M-LC-M received a grant from the French Academie Nationale de Medecine. LS was supported by a fellowship from the French Ministere de la Recherche et de l'Education Nationale. There were no specific external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauregard M, 2006, NEUROREPORT, V17, P843, DOI 10.1097/01.wnr.0000220132.32091.9f; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; COHEN RM, 1982, ARCH GEN PSYCHIAT, V39, P593; Dannlowski U, 2007, PSYCHIAT RES-NEUROIM, V154, P13, DOI 10.1016/j.pscychresns.2006.05.005; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Gotlib IH, 2005, NEUROREPORT, V16, P1731, DOI 10.1097/01.wnr.0000183901.70030.82; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Kumar P, 2008, BRAIN, V131, P2084, DOI 10.1093/brain/awn136; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Naranjo CA, 2001, PROG NEURO-PSYCHOPH, V25, P781, DOI 10.1016/S0278-5846(01)00156-7; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Opmeer EM, 2010, PROG NEUROBIOL, V92, P112, DOI 10.1016/j.pneurobio.2010.06.003; Pessiglione M, 2004, EUR J NEUROSCI, V19, P437, DOI 10.1111/j.0953-816X.2003.03089.x; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Ramel W, 2007, BIOL PSYCHIAT, V61, P231, DOI 10.1016/j.biopsych.2006.05.004; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Schmidt L, 2008, BRAIN, V131, P1303, DOI 10.1093/brain/awn045; Schmidt L, 2010, PSYCHOL SCI, V21, P977, DOI 10.1177/0956797610372636; Schmidt L, 2009, J NEUROSCI, V29, P9450, DOI 10.1523/JNEUROSCI.1951-09.2009; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	96	97	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23178	10.1371/journal.pone.0023178	http://dx.doi.org/10.1371/journal.pone.0023178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853083	Green Submitted, gold, Green Published			2022-12-27	WOS:000295454200049
J	Cooper, MT; Kennison, JA				Cooper, Monica T.; Kennison, James A.			Molecular Genetic Analyses of Polytene Chromosome Region 72A-D in Drosophila melanogaster Reveal a Gene Desert in 72D	PLOS ONE			English	Article							INDUCED MUTATIONS; GENOME; IDENTIFICATION; SEQUENCE; EXPRESSION; PROJECT; PROTEIN; BRAHMA; SCREEN; BLAT	We have investigated a region of similar to 310 kb of genomic DNA within polytene chromosome subdivisions 72A to 72D of Drosophila melanogaster. This region includes 57 predicted protein-coding genes. Seventeen of these genes are in six clusters that appear to have arisen by tandem duplication. Within this region we found 23 complementation groups that are essential for zygotic viability, and we have identified the transcription units for 18 of the 23. We also found a 55 kb region in 72D that is nonessential. Flies deficient for this region are viable and fertile. Within this nonessential region are 48 DNA sequences of 12 to 33 base pairs that are completely conserved among 12 distantly related Drosophila species. These sequences do not have the evolutionary signature of conserved protein-coding DNA sequences, nor do they appear to encode microRNAs, however, the strong selection suggests functions in wild populations that are not apparent in laboratory cultures. This region resembles dispensable gene deserts previously characterized in the mouse genome.	[Cooper, Monica T.; Kennison, James A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Cooper, MT (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	Jim_Kennison@nih.gov			National Institutes of Health, NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001005] Funding Source: NIH RePORTER	National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the National Institutes of Health, NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 1999, GENETICS, V153, P179; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Blumenstiel JP, 2009, GENETICS, V182, P25, DOI 10.1534/genetics.109.101998; BRIZUELA BJ, 1994, GENETICS, V137, P803; Brumby A, 2004, GENETICS, V168, P227, DOI 10.1534/genetics.104.026617; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Collins RT, 2005, GENETICS, V170, P173, DOI 10.1534/genetics.104.039420; Cooper JL, 2008, GENETICS, V180, P661, DOI 10.1534/genetics.108.092437; Cooper MT, 2010, GENETICS, V185, P811, DOI 10.1534/genetics.110.115121; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Huang AM, 2000, DROSOPHILA PROTOCOLS, P429; KENNISON JA, 1983, GENETICS, V103, P219; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; LEFEVRE G, 1986, GENETICS, V113, P869; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MELENDEZ A, 1995, GENETICS, V141, P1507; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Mizuno T, 2002, DEVELOPMENT, V129, P1215; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; STOWERS RS, 2007, DROSOPHILA HUNTINGTI; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23509	10.1371/journal.pone.0023509	http://dx.doi.org/10.1371/journal.pone.0023509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853143	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200091
J	Dimasi, DP; Hewitt, AW; Kagame, K; Ruvama, S; Tindyebwa, L; Llamas, B; Kirk, KA; Mitchell, P; Burdon, KP; Craig, JE				Dimasi, David P.; Hewitt, Alex W.; Kagame, Kenneth; Ruvama, Sam; Tindyebwa, Ludovica; Llamas, Bastien; Kirk, Kirsty A.; Mitchell, Paul; Burdon, Kathryn P.; Craig, Jamie E.			Ethnic and Mouse Strain Differences in Central Corneal Thickness and Association with Pigmentation Phenotype	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; OSTEOGENESIS IMPERFECTA; IN-VITRO; TYROSINASE; ORBSCAN; ABNORMALITIES; HERITABILITY; MELANOCYTES; PREVALENCE	The cornea is a transparent structure that permits the refraction of light into the eye. Evidence from a range of studies indicates that central corneal thickness (CCT) is strongly genetically determined. Support for a genetic component comes from data showing significant variation in CCT between different human ethnic groups. Interestingly, these studies also appear to show that skin pigmentation may influence CCT. To validate these observations, we undertook the first analysis of CCT in an oculocutaneous albinism (OCA) and Ugandan cohort, populations with distinct skin pigmentation phenotypes. There was a significant difference in the mean CCT of the OCA, Ugandan and Australian-Caucasian cohorts (Ugandan: 517.3 +/- 37 mu m; Caucasian: 539.7 +/- 32.8 mu m, OCA: 563.3 +/- 37.2 mu m; p<0.001). A meta-analysis of 53 studies investigating the CCT of different ethnic groups was then performed and demonstrated that darker skin pigmentation is associated with a thinner CCT (p<0.001). To further verify these observations, we measured CCT in 13 different inbred mouse strains and found a significant difference between the albino and pigmented strains (p = 0.008). Specific mutations within the melanin synthesis pathway were then investigated in mice for an association with CCT. Significant differences between mutant and wild type strains were seen with the nonagouti (p<0.001), myosin VA (p<0.001), tyrosinase (p = 0.025) and tyrosinase related protein (p = 0.001) genes. These findings provide support for our hypothesis that pigmentation is associated with CCT and identifies pigment-related genes as candidates for developmental determination of a non-pigmented structure.	[Dimasi, David P.; Llamas, Bastien; Kirk, Kirsty A.; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia; [Hewitt, Alex W.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [Kagame, Kenneth; Ruvama, Sam; Tindyebwa, Ludovica] Mbarara Municipal, Ruharo Eye Ctr, Mbarara, Uganda; [Llamas, Bastien] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Mitchell, Paul] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Westmead, NSW 2145, Australia; [Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia	Flinders University South Australia; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Adelaide; University of Sydney; University of Sydney; Westmead Institute for Medical Research	Dimasi, DP (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia.	jamie.craig@flinders.edu.au	Llamas, Bastien/Y-2781-2018; Mitchell, Paul/P-1498-2014; Burdon, Kathryn/AAD-2334-2022; Llamas, Bastien/AAK-1693-2021; Hewitt, Alex W/D-1936-2013; Burdon, Kathryn/A-5026-2009	Llamas, Bastien/0000-0002-5550-9176; Burdon, Kathryn/0000-0001-8217-1249; Llamas, Bastien/0000-0002-5550-9176; Hewitt, Alex W/0000-0002-5123-5999; Burdon, Kathryn/0000-0001-8217-1249; Craig, Jamie/0000-0001-9955-9696	Ophthalmic Research Institute of Australia; Pfizer Australia; Glaucoma Australia; American Health Assistance Foundation; Australian National Health and Medical Research Council	Ophthalmic Research Institute of Australia; Pfizer Australia(PfizerPfizer Australia); Glaucoma Australia; American Health Assistance Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge that this study and preparation of the manuscript was made possible by funding from the following agencies: the Ophthalmic Research Institute of Australia; Pfizer Australia; Glaucoma Australia; American Health Assistance Foundation; the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaian E, 2004, OPHTHALMOLOGY, V111, P2211, DOI 10.1016/j.ophtha.2004.06.013; Biasutti Renato, 1941, RAZZE POPOLI TERRA; Brandt JD, 2004, AM J OPHTHALMOL, V137, P348, DOI 10.1016/j.ajo.2003.09.038; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; CAMERON JA, 1993, CORNEA, V12, P54, DOI 10.1097/00003226-199301000-00009; CAMPBELL S, 1989, DEVELOPMENT, V106, P717; Dimasi DP, 2010, MOL VIS, V16, P562; Dimasi DP, 2010, HUM GENET, V127, P33, DOI 10.1007/s00439-009-0729-3; Dimasi DP, 2009, BR J OPHTHALMOL; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Durkin SR, 2007, CLIN EXP OPHTHALMOL, V35, P728, DOI 10.1111/j.1442-9071.2007.01574.x; Evereklioglu C, 2002, OPHTHAL PHYSL OPT, V22, P511, DOI 10.1046/j.1475-1313.2002.00062.x; Francis BA, 2008, AM J OPHTHALMOL, V146, P741, DOI 10.1016/j.ajo.2008.05.048; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Hahn S, 2003, INVEST OPHTH VIS SCI, V44, P1508, DOI 10.1167/iovs.02-0641; Henriksson JT, 2009, INVEST OPHTH VIS SCI, V50, P3648, DOI 10.1167/iovs.08-2941; Heur M, 2008, AM J OPHTHALMOL, V145, P997, DOI 10.1016/j.ajo.2008.01.028; Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023; JACKSON IJ, 1990, P NATL ACAD SCI USA, V87, P7010, DOI 10.1073/pnas.87.18.7010; Jimenez-Cervantes C, 1998, BIOCHEM BIOPH RES CO, V253, P761, DOI 10.1006/bbrc.1998.9817; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lackner B, 2005, OPTOMETRY VISION SCI, V82, P892, DOI 10.1097/01.opx.0000180817.46312.0a; Landers JA, 2007, AM J OPHTHALMOL, V143, P360, DOI 10.1016/j.ajo.2006.09.047; Landers JA, 2009, INVEST OPHTH VIS SCI, V50, P4087, DOI 10.1167/iovs.08-3271; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; Lively GD, 2009, INVEST OPHTHALMOL VI; Lively GD, 2010, PHYSIOL GENOMICS, V42, P281, DOI 10.1152/physiolgenomics.00140.2009; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montoliu L, 2010, COLOUR GENES; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Nemesure B, 2003, ARCH OPHTHALMOL-CHIC, V121, P240; PEDERSEN U, 1984, ORL J OTO-RHINO-LARY, V46, P38, DOI 10.1159/000275682; Pesudovs K, 2004, J CATARACT REFR SURG, V30, P1795, DOI 10.1016/j.jcrs.2004.05.002; Schulz D, 2003, VISION RES, V43, P723, DOI 10.1016/S0042-6989(03)00005-1; Segev F, 2006, INVEST OPHTH VIS SCI, V47, P565, DOI 10.1167/iovs.05-0771; Sultan G, 2002, INVEST OPHTH VIS SCI, V43, P1757; Suzuki S, 2003, J CATARACT REFR SURG, V29, P1313, DOI 10.1016/S0886-3350(03)00123-8; Suzuki S, 2005, OPHTHALMOLOGY, V112, P1327, DOI 10.1016/j.ophtha.2005.03.022; Toh TY, 2005, INVEST OPHTH VIS SCI, V46, P3718, DOI 10.1167/iovs.04-1497; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; Vitart V, 2010, HUM MOL GENET; Vithana EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/hmg/ddq511; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x; Whitson Jess T, 2005, Eye Contact Lens, V31, P221, DOI 10.1097/01.ICL.0000152487.16012.40; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; ZDARSKY E, 1990, GENETICS, V126, P443; Zhao PS, 2007, AM J OPHTHALMOL, V143, P1047, DOI 10.1016/j.ajo.2007.01.050; Zheng YF, 2008, INVEST OPHTH VIS SCI, V49, P4303, DOI 10.1167/iovs.08-1934	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22103	10.1371/journal.pone.0022103	http://dx.doi.org/10.1371/journal.pone.0022103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853026	Green Published, gold			2022-12-27	WOS:000295454200007
J	Laczi, M; Torok, J; Rosivall, B; Hegyi, G				Laczi, Miklos; Toeroek, Janos; Rosivall, Balazs; Hegyi, Gergely			Integration of Spectral Reflectance across the Plumage: Implications for Mating Patterns	PLOS ONE			English	Article							BLACK-CAPPED CHICKADEES; MULTIPLE SEXUAL SIGNALS; FEMALE MATE CHOICE; CONDITION-DEPENDENCE; INFORMATION-CONTENT; COLOR VARIATION; ULTRAVIOLET COLORATION; REPRODUCTIVE SUCCESS; NORTHERN CARDINALS; PIED FLYCATCHERS	Background: In complex sexual signaling systems such as plumage color, developmental or genetic links may occur among seemingly distinct traits. However, the interrelations of such traits and the functional significance of their integration rarely have been examined. Methodology/Principal Findings: We investigated the parallel variation of two reflectance descriptors (brightness and UV chroma) across depigmented and melanized plumage areas of collared flycatchers (Ficedula albicollis), and the possible role of integrated color signals in mate acquisition. We found moderate integration in brightness and UV chroma across the plumage, with similar correlation structures in the two sexes despite the strong sexual dichromatism. Patterns of parallel color change across the plumage were largely unrelated to ornamental white patch sizes, but they all showed strong assortative mating between the sexes. Comparing different types of assortative mating patterns for individual spectral variables suggested a distinct role for plumage-level color axes in mate acquisition. Conclusions/Significance: Our results indicate that the plumage-level, parallel variation of coloration might play a role in mate acquisition. This study underlines the importance of considering potential developmental and functional integration among apparently different ornaments in studies of sexual selection.	[Laczi, Miklos; Toeroek, Janos; Rosivall, Balazs; Hegyi, Gergely] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary	Eotvos Lorand University	Laczi, M (corresponding author), Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary.	laczi.miklos@gmail.com	Torok, Janos/C-6144-2008; Rosivall, Balázs/T-1057-2017; Laczi, Miklós/AAE-5892-2020; Hegyi, Gergely/AAG-4988-2021	Torok, Janos/0000-0002-4799-5522; Rosivall, Balázs/0000-0002-0732-1160; Laczi, Miklós/0000-0001-9235-2553; Hegyi, Gergely/0000-0002-4906-3550	Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [PD72117, PD75481, K75618]; Bolyai Janos fellowship; Pilis Park Forestry; Erdok a Kozjoert Alapitvany	Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos fellowship(Hungarian Academy of Sciences); Pilis Park Forestry; Erdok a Kozjoert Alapitvany	The research was supported by Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA, http://www.otka.hu/) grants PD72117, PD75481 and K75618 to G. H., B. R. and J.T., respectively; a Bolyai Janos fellowship (www.mta.hu) to G. H.; the Pilis Park Forestry (http://www.parkerdo.hu/); and the Erdok a Kozjoert Alapitvany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; Badyaev Alexander V., 2006, P349; Badyaev AV, 2004, EVOL ECOL RES, V6, P975; Badyaev AV, 2001, AM NAT, V158, P221, DOI 10.1086/321325; Ballentine B, 2003, CONDOR, V105, P593, DOI 10.1650/7234; BALMFORD A, 1992, BEHAV ECOL SOCIOBIOL, V31, P107, DOI 10.1007/BF00166343; Bitton PP, 2008, BEHAV ECOL SOCIOBIOL, V62, P1543, DOI 10.1007/s00265-008-0583-7; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Bonato M, 2009, ANIM BEHAV, V77, P1033, DOI 10.1016/j.anbehav.2009.02.008; BONSER RHC, 1995, CONDOR, V97, P590, DOI 10.2307/1369048; Bridge ES, 2005, J AVIAN BIOL, V36, P18, DOI 10.1111/j.0908-8857.2005.03470.x; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Budden AE, 2009, J AVIAN BIOL, V40, P18, DOI 10.1111/j.1600-048X.2008.04344.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Cramp S, BIRDS W PALEARCTIC, VVII; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Delhey K, 2006, BEHAV ECOL, V17, P790, DOI 10.1093/beheco/arl012; Doucet SM, 2003, J AVIAN BIOL, V34, P237, DOI 10.1034/j.1600-048X.2003.03113.x; Doucet SM, 2005, BEHAV ECOL, V16, P218, DOI 10.1093/beheco/arh154; DZIUBAN CD, 1974, PSYCHOL BULL, V81, P358, DOI 10.1037/h0036316; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Fargallo JA, 2007, EVOL ECOL, V21, P157, DOI 10.1007/s10682-006-0020-1; Flury B, 1988, COMMON PRINCIPAL COM; Galvan I, 2010, IBIS, V152, P359; Galvan I, 2009, P ROY SOC B-BIOL SCI, V276, P3089, DOI 10.1098/rspb.2009.0774; Garamszegi LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002647; Garamszegi LZ, 2004, BIRD STUDY, V51, P270, DOI 10.1080/00063650409461363; Goldstein G, 2004, AUK, V121, P656, DOI 10.1642/0004-8038(2004)121[0656:BDOBAW]2.0.CO;2; Gotmark F, 1997, BEHAV ECOL SOCIOBIOL, V40, P41, DOI 10.1007/s002650050314; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Griffith SC, 2003, J EVOLUTION BIOL, V16, P1045, DOI 10.1046/j.1420-9101.2003.00550.x; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Griggio M, 2007, BEHAV ECOL SOCIOBIOL, V61, P423, DOI 10.1007/s00265-006-0270-5; Griggio M, 2011, BEHAV ECOL SOCIOBIOL, V65, P655, DOI 10.1007/s00265-010-1067-0; Griggio M, 2009, BEHAV ECOL, V20, P1072, DOI 10.1093/beheco/arp099; Hanssen SA, 2006, ANIM BEHAV, V71, P337, DOI 10.1016/j.anbehav.2005.04.021; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hegyi G, 2002, J EVOLUTION BIOL, V15, P710, DOI 10.1046/j.1420-9101.2002.00449.x; Hegyi G, 2008, NATURWISSENSCHAFTEN, V95, P993, DOI 10.1007/s00114-008-0408-6; Hegyi G, 2008, EVOL ECOL RES, V10, P559; Hegyi G, 2008, ANIM BEHAV, V75, P977, DOI 10.1016/j.anbehav.2007.08.009; Hegyi G, 2007, J AVIAN BIOL, V38, P698, DOI 10.1111/j.2007.0908-8857.04075.x; Hegyi G, 2007, BEHAV ECOL, V18, P1116, DOI 10.1093/beheco/arm085; Hegyi G, 2007, EVOL ECOL RES, V9, P905; Hegyi G, 2010, NATURWISSENSCHAFTEN, V97, P567, DOI 10.1007/s00114-010-0672-0; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Jawor JM, 2004, ETHOLOGY, V110, P113, DOI 10.1111/j.1439-0310.2003.00962.x; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; JOHNSTONE RA, 1995, J THEOR BIOL, V177, P87, DOI 10.1016/S0022-5193(05)80006-2; JONES IL, 1993, NATURE, V362, P238, DOI 10.1038/362238a0; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Kose M, 1999, BEHAV ECOL SOCIOBIOL, V45, P430, DOI 10.1007/s002650050581; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Lehtonen PK, 2009, ANIM BEHAV, V77, P1103, DOI 10.1016/j.anbehav.2009.01.014; Loyau A, 2005, BEHAV ECOL SOCIOBIOL, V58, P552, DOI 10.1007/s00265-005-0958-y; MacDougall AK, 2003, NATURWISSENSCHAFTEN, V90, P464, DOI 10.1007/s00114-003-0459-7; Macedonia JM, 2004, J HERPETOL, V38, P340, DOI 10.1670/183-03A; Martin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1743, DOI 10.1007/s00265-009-0794-6; McGlothlin JW, 2007, BEHAV ECOL SOCIOBIOL, V61, P1391, DOI 10.1007/s00265-007-0370-x; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Merila J, 1999, ECOSCIENCE, V6, P12, DOI 10.1080/11956860.1999.11952203; Moller AP, 2002, BEHAV ECOL, V13, P248, DOI 10.1093/beheco/13.2.248; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Perrier G, 2002, BEHAV ECOL, V13, P728, DOI 10.1093/beheco/13.6.728; Peters A, 2006, BEHAV ECOL SOCIOBIOL, V59, P666, DOI 10.1007/s00265-005-0095-7; Peters A, 2008, FUNCT ECOL, V22, P831, DOI 10.1111/j.1365-2435.2008.01437.x; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; Prum RO, 2009, J R SOC INTERFACE, V6, pS253, DOI 10.1098/rsif.2008.0466.focus; Prum RO, 2006, BIRD COLORATION, V1, P295; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; Reudink MW, 2009, ANIM BEHAV, V77, P495, DOI 10.1016/j.anbehav.2008.11.005; Riesz J., 2007, THESIS U QUEENSLAND; Rosivall B, 2009, ANIM BEHAV, V77, P611, DOI 10.1016/j.anbehav.2008.11.009; Roulin A, 1999, BEHAV ECOL, V10, P688, DOI 10.1093/beheco/10.6.688; Roulin A, 2003, HEREDITY, V90, P359, DOI 10.1038/sj.hdy.6800260; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Shawkey MD, 2005, BIOL J LINN SOC, V84, P259, DOI 10.1111/j.1095-8312.2005.00428.x; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Siefferman L, 2005, J AVIAN BIOL, V36, P428, DOI 10.1111/j.0908-8857.2005.03401.x; Siefferman L, 2005, EVOLUTION, V59, P1819, DOI 10.1111/j.0014-3820.2005.tb01828.x; Siefferman L, 2003, BEHAV ECOL, V14, P855, DOI 10.1093/beheco/arg063; Siitari H, 2002, BEHAV ECOL, V13, P737, DOI 10.1093/beheco/13.6.737; Siitari H, 2002, ANIM BEHAV, V63, P97, DOI 10.1006/anbe.2001.1870; Silva N, 2008, BEHAV ECOL SOCIOBIOL, V62, P1969, DOI 10.1007/s00265-008-0628-y; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; SLAGSVOLD T, 1995, ANIM BEHAV, V50, P1109, DOI 10.1016/0003-3472(95)80110-3; SORENSON LG, 1994, BEHAV ECOL SOCIOBIOL, V35, P389, DOI 10.1007/s002650050111; Stoddard MC, 2008, AM NAT, V171, P755, DOI 10.1086/587526; Svensson L., 1992, IDENTIFICATION GUIDE; Szigeti B, 2007, J AVIAN BIOL, V38, P105, DOI 10.1111/j.2007.0908-8857.03769.x; Torok J, 2003, BEHAV ECOL, V14, P382, DOI 10.1093/beheco/14.3.382; Vagasi CI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014215; Vincent S. E., 2008, Journal of Orthoptera Research, V17, P219, DOI 10.1665/1082-6467-17.2.219; Woodcock EA, 2005, ETHOLOGY, V111, P891, DOI 10.1111/j.1439-0310.2005.01120.x; Garamszegi LZ, 2006, BEHAV ECOL SOCIOBIOL, V60, P663, DOI 10.1007/s00265-006-0210-4	111	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23201	10.1371/journal.pone.0023201	http://dx.doi.org/10.1371/journal.pone.0023201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853088	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000295454200052
J	Pachikian, BD; Essaghir, A; Demoulin, JB; Neyrinck, AM; Catry, E; De Backer, FC; Dejeans, N; Dewulf, EM; Sohet, FM; Portois, L; Deldicque, L; Molendi-Coste, O; Leclercq, IA; Francaux, M; Carpentier, YA; Foufelle, F; Muccioli, GG; Cani, PD; Delzenne, NM				Pachikian, Barbara D.; Essaghir, Ahmed; Demoulin, Jean-Baptiste; Neyrinck, Audrey M.; Catry, Emilie; De Backer, Fabienne C.; Dejeans, Nicolas; Dewulf, Evelyne M.; Sohet, Florence M.; Portois, Laurence; Deldicque, Louise; Molendi-Coste, Olivier; Leclercq, Isabelle A.; Francaux, Marc; Carpentier, Yvon A.; Foufelle, Fabienne; Muccioli, Giulio G.; Cani, Patrice D.; Delzenne, Nathalie M.			Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets	PLOS ONE			English	Article							LIVER-X-RECEPTOR; LONG-CHAIN; FISH-OIL; SREBP-1C TRANSCRIPTION; CB1 RECEPTORS; GENE; ACTIVATION; BINDING; GLUCOSE; ALPHA	Patients with non-alcoholic fatty liver disease are characterised by a decreased n-3/n-6 polyunsaturated fatty acid (PUFA) ratio in hepatic phospholipids. The metabolic consequences of n-3 PUFA depletion in the liver are poorly understood. We have reproduced a drastic drop in n-3 PUFA among hepatic phospholipids by feeding C57Bl/6J mice for 3 months with an n-3 PUFA depleted diet (DEF) versus a control diet (CT), which only differed in the PUFA content. DEF mice exhibited hepatic insulin resistance (assessed by euglycemic-hyperinsulinemic clamp) and steatosis that was associated with a decrease in fatty acid oxidation and occurred despite a higher capacity for triglyceride secretion. Microarray and qPCR analysis of the liver tissue revealed higher expression of all the enzymes involved in lipogenesis in DEF mice compared to CT mice, as well as increased expression and activation of sterol regulatory element binding protein-1c (SREBP-1c). Our data suggest that the activation of the liver X receptor pathway is involved in the overexpression of SREBP-1c, and this phenomenon cannot be attributed to insulin or to endoplasmic reticulum stress responses. In conclusion, n-3 PUFA depletion in liver phospholipids leads to activation of SREBP-1c and lipogenesis, which contributes to hepatic steatosis.	[Pachikian, Barbara D.; Neyrinck, Audrey M.; Catry, Emilie; De Backer, Fabienne C.; Dewulf, Evelyne M.; Sohet, Florence M.; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Essaghir, Ahmed; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, B-1200 Brussels, Belgium; [Dejeans, Nicolas] Catholic Univ Louvain, Louvain Drug Res Inst, Toxicol & Canc Biol Res Grp, B-1200 Brussels, Belgium; [Portois, Laurence; Carpentier, Yvon A.] Univ Libre Bruxelles, Expt Surg Lab, Brussels, Belgium; [Deldicque, Louise] Katholieke Univ Leuven, Dept Biomed Kinesiol, Res Ctr Exercise & Hlth, Louvain, Belgium; [Molendi-Coste, Olivier; Leclercq, Isabelle A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Hepatogastroenterol, B-1200 Brussels, Belgium; [Francaux, Marc] Catholic Univ Louvain, Inst Neurosci, Res Grp Muscle & Exercise Physiol, B-1348 Louvain, Belgium; [Foufelle, Fabienne] Ctr Rech Cordeliers, INSERM, UMR S 872, Paris, France; [Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, CHAM7230, Bioanal & Pharmacol Bioact Lipids Lab, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Libre de Bruxelles; KU Leuven; Universite Catholique Louvain; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Catholique Louvain	Pachikian, BD (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016; Neyrinck, Audrey/AAE-7929-2019	Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Neyrinck, Audrey/0000-0002-9435-3338; Demoulin, Jean-Baptiste/0000-0002-8016-6689; Molendi-Coste, Olivier/0000-0002-0498-9456; FOUFELLE, Fabienne/0000-0002-0752-622X; Deldicque, Louise/0000-0003-3393-5278; Muccioli, Giulio/0000-0002-1600-9259; Francaux, Marc/0000-0001-8182-1588	FRS-FNRS (Fonds de la recherche scientifique) [FRSM 3.4574.07, FRFC 2.4555.08]; Region Wallonne [Walnut 20]	FRS-FNRS (Fonds de la recherche scientifique)(Fonds de la Recherche Scientifique - FNRS); Region Wallonne	This work was supported by the FRS-FNRS (Fonds de la recherche scientifique) (convention FRSM 3.4574.07 and FRFC 2.4555.08) and by the Region Wallonne (Walnut 20). P. D. C. and I. L. are research associates from the FRS-FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL LJ, 1993, ARCH INTERN MED, V153, P1429, DOI 10.1001/archinte.153.12.1429; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Clarke SD, 2001, AM J PHYSIOL-GASTR L, V281, pG865, DOI 10.1152/ajpgi.2001.281.4.G865; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; Delarue J, 2006, BRIT J NUTR, V95, P267, DOI 10.1079/BJN20051631; Dentin R, 2006, J NUTR, V136, P1145, DOI 10.1093/jn/136.5.1145; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Elizondo A, 2007, OBESITY, V15, P24, DOI 10.1038/oby.2007.518; Esfandiari F, 2005, AM J PHYSIOL-GASTR L, V289, pG54, DOI 10.1152/ajpgi.00542.2004; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Howell III G, 2009, BIOCH BIOPHYS ACTA; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kammoun HL, 2009, CURR OPIN CLIN NUTR, V12, P575, DOI 10.1097/MCO.0b013e32833189db; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Louchami K, 2006, INT J MOL MED, V18, P1047; Malaisse WJ, 2009, INT J MOL MED, V24, P111, DOI 10.3892/ijmm_00000214; Malhi H, 2010, J HEPATOL; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nakatani T, 2005, BBA-MOL CELL BIOL L, V1736, P77, DOI 10.1016/j.bbalip.2005.07.003; Neyrinck A, 1999, LIFE SCI, V65, P2851, DOI 10.1016/S0024-3205(99)00554-8; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pachikian B. D., 2008, BMC Physiology, V8, P21, DOI 10.1186/1472-6793-8-21; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; RICHELLE M, 1994, BIOCHEMISTRY-US, V33, P4872, DOI 10.1021/bi00182a015; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Shapiro H, 2011, CLIN NUTR, V30, P6, DOI 10.1016/j.clnu.2010.06.001; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wang J, 2009, PROSTAG OTH LIPID M, V89, P112, DOI 10.1016/j.prostaglandins.2008.12.002; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Xu J, 2002, J NUTR, V132, P3333, DOI 10.1093/jn/132.11.3333; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020	63	71	72	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23365	10.1371/journal.pone.0023365	http://dx.doi.org/10.1371/journal.pone.0023365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853118	gold, Green Published, Green Submitted			2022-12-27	WOS:000295454200075
J	Villegas-Amtmann, S; Simmons, SE; Kuhn, CE; Huckstadt, LA; Costa, DP				Villegas-Amtmann, Stella; Simmons, Samantha E.; Kuhn, Carey E.; Huckstadt, Luis A.; Costa, Daniel P.			Latitudinal Range Influences the Seasonal Variation in the Foraging Behavior of Marine Top Predators	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; DIVING BEHAVIOR; ZALOPHUS-CALIFORNIANUS; TEMPORAL VARIATION; STABLE-ISOTOPES; LIFE-HISTORY; LION; ECOLOGY; ENERGETICS; CARBON	Non-migratory resident species should be capable of modifying their foraging behavior to accommodate changes in prey abundance and availability associated with a changing environment. Populations that are better adapted to change will have higher foraging success and greater potential for survival in the face of climate change. We studied two species of resident central place foragers from temperate and equatorial regions with differing population trends and prey availability associated to season, the California sea lion (Zalophus californianus) (CSL) whose population is increasing and the endangered Galapagos sea lion (Zalophus wollebaeki) (GSL) whose population is declining. To determine their response to environmental change, we studied and compared their diving behavior using time-depth recorders and satellite location tags and their diet by measuring C and N isotope ratios during a warm and a cold season. Based on latitudinal differences in oceanographic productivity, we hypothesized that the seasonal variation in foraging behavior would differ for these two species. CSL exhibited greater seasonal variability in their foraging behavior as seen in changes to their diving behavior, foraging areas and diet between seasons. Conversely, GSL did not change their diving behavior between seasons, presenting three foraging strategies (shallow, deep and bottom divers) during both. GSL exhibited greater dive and foraging effort than CSL. We suggest that during the warm and less productive season a greater range of foraging behaviors in CSL was associated with greater competition for prey, which relaxed during the cold season when resource availability was greater. GSL foraging specialization suggests that resources are limited throughout the year due to lower primary production and lower seasonal variation in productivity compared to CSL. These latitudinal differences influence their foraging success, pup survival and population growth reflected in contrasting population trends in which CSL are more successful and potentially more resilient to climate change.	[Villegas-Amtmann, Stella; Simmons, Samantha E.; Kuhn, Carey E.; Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Huckstadt, Luis A.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Villegas-Amtmann, S (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	stella.villegas@gmail.com	Huckstadt, Luis/A-5838-2018; Huckstadt, Luis A./J-8532-2019; Costa, Daniel/E-2616-2013	Huckstadt, Luis/0000-0002-2453-7350; Huckstadt, Luis A./0000-0002-2453-7350; Simmons, Samantha/0000-0003-0326-6990; Kuhn, Carey/0000-0002-6835-9744; Costa, Daniel/0000-0002-0233-5782	Sloan Foundation; Packard Foundation; Moore Foundation; Office of Naval Research; UC MEXUS; CONACYT; NSF Office of Polar Programs; CRS (Center for Remote Sensing); Ecology and Evolutionary Biology Department at UCSC	Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation); Moore Foundation(Gordon and Betty Moore Foundation); Office of Naval Research(Office of Naval Research); UC MEXUS; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF Office of Polar Programs(National Science Foundation (NSF)); CRS (Center for Remote Sensing); Ecology and Evolutionary Biology Department at UCSC	This work was part of the TOPP (Tagging of Pacific Predators) Program supported by the Sloan, Packard and Moore Foundations, the Office of Naval Research, UC MEXUS, CONACYT, NSF Office of Polar Programs, CRS (Center for Remote Sensing) and the Ecology and Evolutionary Biology Department at UCSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alava JJ, 2006, LOW WAKE FI, P495; AURIOLES D, 2008, ZALOPHUS CALIFORNIAN; Aurioles D., 2008, ZALOPHUS WOLLEBAEKI; Beauplet G, 2004, MAR ECOL PROG SER, V273, P211, DOI 10.3354/meps273211; Campagna C, 2001, J ZOOL, V255, P205, DOI 10.1017/S0952836901001285; COSTA DP, 1991, AM ZOOL, V31, P111; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Costa DP, 2000, J EXP BIOL, V203, P3655; COSTA DP, 2006, POTENTIAL INFLUENCES, P344; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darwin C, 1859, ORIGIN SPECIES MEANS; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Farina JM, 2003, J ANIM ECOL, V72, P873, DOI 10.1046/j.1365-2656.2003.00760.x; FELDKAMP SD, 1989, CAN J ZOOL, V67, P872, DOI 10.1139/z89-129; FELDMAN GC, 1986, PATTERNS PHYTOPLANKT, P77; Ferguson SH, 2006, OECOLOGIA, V150, P318, DOI 10.1007/s00442-006-0489-x; Gales NJ, 1997, CAN J ZOOL, V75, P1695, DOI 10.1139/z97-796; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Garcia-Rodriguez FJ, 2004, FISH B-NOAA, V102, P47; Georges JY, 2000, POLAR BIOL, V23, P59, DOI 10.1007/s003000050008; Halsey LG, 2006, FUNCT ECOL, V20, P889, DOI 10.1111/j.1365-2435.2006.01170.x; Hernandez-Camacho CJ, 2008, J MAMMAL, V89, P1059, DOI 10.1644/07-MAMM-A-404.1; Hockey PAR, 2003, OSTRICH, V74, P110, DOI 10.2989/00306520309485376; Huckstadt LA, 2007, J EXP MAR BIOL ECOL, V347, P123, DOI 10.1016/j.jembe.2007.03.014; Johnson CN, 1998, J ANIM ECOL, V67, P689, DOI 10.1046/j.1365-2656.1998.00232.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KOOYMAN GL, 1986, DIVING BEHAV GALAPAG, P209; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; KUHN CE, 2006, MEASURING FEEDING RA; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Mate BR, 1999, MAR MAMMAL SCI, V15, P1246, DOI 10.1111/j.1748-7692.1999.tb00888.x; Mattlin RH, 1998, CAN J ZOOL, V76, P350, DOI 10.1139/cjz-76-2-350; McGarigal K., 2000, MULTIVARIATE STAT WI; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; Orians G.H., 1979, P155; PAK H, 1973, J GEOPHYS RES, V78, P7845, DOI 10.1029/JC078i033p07845; Sakamoto CM, 1998, DEEP-SEA RES PT II, V45, P1055, DOI 10.1016/S0967-0645(98)00013-7; Salazar S., 2002, RESERVA MARINA GALAP, P267; SALAZAR SK, 2005, VARIACION TEMPORAL E; SALAZARALDAS D, 2007, ECOLOGIA ALIMENTARIA; SCHOOLEY RL, 1994, J MAMMAL, V75, P466, DOI 10.2307/1382569; Szteren D, 2006, LOW WAKE FI, P369; Tanaka H, 2006, ZOOL SCI, V23, P991, DOI 10.2108/zsj.23.991; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Tracy CR, 2007, COPEIA, P901; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Tremblay Y, 2003, MAR ECOL PROG SER, V251, P279, DOI 10.3354/meps251279; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Villegas-Amtmann S, 2008, MAR ECOL PROG SER, V363, P299, DOI 10.3354/meps07457; Villegas-Amtmann S, 2010, FUNCT ECOL, V24, P785, DOI 10.1111/j.1365-2435.2009.01685.x; ZEITZSCHEL B, 1969, MAR BIOL, V3, P201, DOI 10.1007/BF00360952	53	29	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23166	10.1371/journal.pone.0023166	http://dx.doi.org/10.1371/journal.pone.0023166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853081	Green Published, gold			2022-12-27	WOS:000295454200048
J	German, CR; Ramirez-Llodra, E; Baker, MC; Tyler, PA				German, Christopher R.; Ramirez-Llodra, Eva; Baker, Maria C.; Tyler, Paul A.		ChEss Sci Steering Comm	Deep-Water Chemosynthetic Ecosystem Research during the Census of Marine Life Decade and Beyond: A Proposed Deep-Ocean Road Map	PLOS ONE			English	Article							SPREADING GAKKEL RIDGE; COLD SEEP COMMUNITIES; HYDROTHERMAL ACTIVITY; MUSSEL BEDS; PHYLOGENETIC-RELATIONSHIPS; BRANSFIELD STRAIT; CHILE RIDGE; SEA; VENT; DISCOVERY	The ChEss project of the Census of Marine Life (2002-2010) helped foster internationally-coordinated studies worldwide focusing on exploration for, and characterization of new deep-sea chemosynthetic ecosystem sites. This work has advanced our understanding of the nature and factors controlling the biogeography and biodiversity of these ecosystems in four geographic locations: the Atlantic Equatorial Belt (AEB), the New Zealand region, the Arctic and Antarctic and the SE Pacific off Chile. In the AEB, major discoveries include hydrothermal seeps on the Costa Rica margin, deepest vents found on the Mid-Cayman Rise and the hottest vents found on the Southern Mid-Atlantic Ridge. It was also shown that the major fracture zones on the MAR do not create barriers for the dispersal but may act as trans-Atlantic conduits for larvae. In New Zealand, investigations of a newly found large cold-seep area suggest that this region may be a new biogeographic province. In the Arctic, the newly discovered sites on the Mohns Ridge (71 degrees N) showed extensive mats of sulfur-oxidisng bacteria, but only one gastropod potentially bears chemosynthetic symbionts, while cold seeps on the Haakon Mossby Mud Volcano (72 degrees N) are dominated by siboglinid worms. In the Antarctic region, the first hydrothermal vents south of the Polar Front were located and biological results indicate that they may represent a new biogeographic province. The recent exploration of the South Pacific region has provided evidence for a sediment hosted hydrothermal source near a methane-rich cold-seep area. Based on our 8 years of investigations of deep-water chemosynthetic ecosystems worldwide, we suggest highest priorities for future research: (i) continued exploration of the deep-ocean ridge-crest; (ii) increased focus on anthropogenic impacts; (iii) concerted effort to coordinate a major investigation of the deep South Pacific Ocean - the largest contiguous habitat for life within Earth's biosphere, but also the world's least investigated deep-ocean basin.	[German, Christopher R.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Ramirez-Llodra, Eva] Inst Ciencias Mar, Consejo Super Invest Cient, E-08039 Barcelona, Spain; [Baker, Maria C.; Tyler, Paul A.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton, Hants, England	Woods Hole Oceanographic Institution; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); NERC National Oceanography Centre; University of Southampton	German, CR (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	ezr@icm.csic.es	Dubilier, Nicole/I-8203-2018; Santos, Ricardo/B-3960-2008; Bright, Monika/AAA-7015-2021; Cordes, Erik E/B-3293-2009; Boetius, Antje/D-5459-2013; Juniper, Kim/N-6769-2015	Dubilier, Nicole/0000-0002-9394-825X; Santos, Ricardo/0000-0002-2536-1369; Bright, Monika/0000-0001-7066-1363; Cordes, Erik E/0000-0002-6989-2348; Boetius, Antje/0000-0003-2117-4176; Ramirez-Llodra, Eva/0000-0003-0137-1906; Rowden, Ashley/0000-0003-2975-2524; Juniper, Kim/0000-0002-7608-260X; Levin, Lisa/0000-0002-2858-8622; Van Dover, Cindy/0000-0001-9845-8391	Alfred P. Sloan Foundation; SYNDEEP synthesis project; Fondation Total for the ChEss synthesis phase; Petersen Fellowship in IFM-GEOMAR	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); SYNDEEP synthesis project; Fondation Total for the ChEss synthesis phase; Petersen Fellowship in IFM-GEOMAR	Alfred P. Sloan Foundation for the ChEss-Census of Marine Life programme (2002-2010) and the SYNDEEP synthesis project (2009-2010) (www.coml.org). Fondation Total for the ChEss synthesis phase and SYNDEEP synthesis project (2007-2010) (http://fondation.total.com/). Petersen Fellowship in IFM-GEOMAR to CRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2005, PALAEOGEOGR PALAEOCL, V215, P345, DOI 10.1016/j.palaeo.2004.10.003; Bach W, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000279; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Baco AR, 1999, MAR ECOL PROG SER, V182, P137, DOI 10.3354/meps182137; Baker ET, 2004, GEOPHYS MONOGR SER, V148, P245, DOI 10.1029/148GM10; Baker M. C., 2010, CHESSBASE ONLINE INF; BAKER MC, 2009, OCEAN CHALLENGE J; Barker PF, 2001, EARTH-SCI REV, V55, P1, DOI 10.1016/S0012-8252(01)00055-1; Bergquist DC, 2003, J EXP MAR BIOL ECOL, V289, P197, DOI 10.1016/S0022-0981(03)00046-7; BLACK MB, 1997, MAR BIOL, P1; BOWEN AD, 2009, P IEEE MTS OCEANS C; CAMILLI R, 2010, TRACKING HYDROCARBON; CANDE SC, 1987, J GEOPHYS RES-SOLID, V92, P495, DOI 10.1029/JB092iB01p00495; CONNELLY DP, 2002, EOS T AM GEOPHYS UN, V83, pOS205; CONNELLY DP, HYDROTHERMAL F UNPUB; CONNELLY DP, 2007, KNIPOVICH RIDGE GEOC, V8; Cordes EE, 2006, J EXP MAR BIOL ECOL, V339, P159, DOI 10.1016/j.jembe.2006.07.017; Cordes EE, 2010, MAR ECOL-EVOL PERSP, V31, P51, DOI 10.1111/j.1439-0485.2009.00334.x; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Desbruyeres D, 2006, GEOPHYS MONOGR SER, V166, P215; DEVEY C, 2010, INTERRIDGE NEWS, V19, P44; Devey CW, 2007, OCEANOGRAPHY, V20, P162, DOI 10.5670/oceanog.2007.90; Distel DL, 2000, MOL PHYLOGENET EVOL, V15, P25, DOI 10.1006/mpev.1999.0733; Domack E., 2005, EOS, V86, P269, DOI DOI 10.1029/2005EO290001; DOMACK E, 2007, P AM GEOPH UN 2008 F; Dreyer JC, 2005, MAR ECOL PROG SER, V302, P121, DOI 10.3354/meps302121; DUBILIER N, 2010, INTERRIDGE NEWS, V19, P25; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Edmonds HN, 2003, NATURE, V421, P252, DOI 10.1038/nature01351; Erickson KL, 2009, DEEP-SEA RES PT II, V56, P1577, DOI 10.1016/j.dsr2.2009.05.002; FISHER C, 2007, OCEANOGRAPHY, V20, P68; Foucher JP, 2009, OCEANOGRAPHY, V22, P92, DOI 10.5670/oceanog.2009.11; Gage JD, 2003, ECOSY WORLD, V28, P313; GALLARDO VA, 1977, NATURE, V268, P331, DOI 10.1038/268331a0; German CR, 2008, EARTH PLANET SC LETT, V273, P332, DOI 10.1016/j.epsl.2008.06.048; German CR, 2010, P NATL ACAD SCI USA, V107, P14020, DOI 10.1073/pnas.1009205107; German CR, 2010, DEEP-SEA RES PT I, V57, P518, DOI 10.1016/j.dsr.2009.12.011; German CR, 2008, DEEP-SEA RES PT I, V55, P203, DOI 10.1016/j.dsr.2007.11.004; German CR, 2004, GEOPHYS MONOGR SER, V148, P1, DOI 10.1029/148GM01; German CR, 2000, EARTH PLANET SC LETT, V184, P241, DOI 10.1016/S0012-821X(00)00319-8; German CR, 1998, NATURE, V395, P490, DOI 10.1038/26730; GERMAN CR, 2010, AM GEOPH UN FALL M 2; Gollner S., 2010, PLOS ONE, V5; Haase KM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001509; HAASE KM, 2009, MARINE GEOLOGY, V266; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Hoagland P, 2010, MAR POLICY, V34, P728, DOI 10.1016/j.marpol.2009.12.001; Hucke-Gaete R, 2004, P ROY SOC B-BIOL SCI, V271, pS170, DOI 10.1098/rsbl.2003.0132; JAKUBA MV, 2008, UNDER ICE OPERATIONS; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; JOLLIVET D, 1990, PROG OCEANOGR, V24, P25, DOI 10.1016/0079-6611(90)90017-V; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; JOYE SB, 2011, NATURE GEOSCIENCES; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Kiel S, 2009, ACTA PALAEONTOL POL, V54, P443, DOI 10.4202/app.2009.0022; Klaucke I, 2010, MAR GEOL, V272, P49, DOI 10.1016/j.margeo.2009.02.009; Klinkhammer GP, 2001, EARTH PLANET SC LETT, V193, P395, DOI 10.1016/S0012-821X(01)00536-2; KOSCHINSKY A, 2006, INTERRIDGE NEWS, P9; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Levin LA, 2006, J EXP MAR BIOL ECOL, V330, P132, DOI 10.1016/j.jembe.2005.12.022; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; LEVIN LA, 2010, 12 INT DEEP SEA BIOL; Levin LA, 2009, MARINE ECOLOGY, V31, P94; Losekann T, 2008, ENVIRON MICROBIOL, V10, P3237, DOI 10.1111/j.1462-2920.2008.01712.x; MARIENFELD P, 1992, MAR GEOL, V105, P241, DOI 10.1016/0025-3227(92)90191-J; McMullin ER, 2003, SYMBIOSIS, V34, P1; METAXAS A, 2010, PLOS ONE, V5; Morales E, 2003, ELECTRON J BIOTECHN, V6, P80; Niemann H, 2009, BIOGEOSCIENCES, V6, P2383, DOI 10.5194/bg-6-2383-2009; Olu K, 1997, DEEP-SEA RES PT I, V44, P811, DOI 10.1016/S0967-0637(96)00123-9; Olu K, 1996, MAR ECOL PROG SER, V132, P109, DOI 10.3354/meps132109; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; *OSPAR, 2009, 0841ADD27E16 OSPAR M, V27, P16; OUDIN E, 1984, NATURE, V308, P349, DOI 10.1038/308349a0; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; PEDERSEN R, 1999, INTERRIDGE NEWS, V8, P32; Peek AS, 2000, J MOL EVOL, V50, P141, DOI 10.1007/s002399910016; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; RAMIREZLLODRA E, 2011, PLOS ONE IN PRESS; Roberts H., 2007, EOS T AM GEOPHYS UN, V88, P341, DOI DOI 10.1029/2007E; ROGERS AD, PLOS BIOL UNPUB; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Sahling H, 2005, LIMNOL OCEANOGR, V50, P598, DOI 10.4319/lo.2005.50.2.0598; Sahling H, 2008, MAR GEOL, V249, P206, DOI 10.1016/j.margeo.2007.11.010; Samadi S, 2007, CR BIOL, V330, P446, DOI 10.1016/j.crvi.2007.04.001; Schander C, 2010, MAR BIOL RES, V6, P155, DOI 10.1080/17451000903147450; Sellanes J, 2008, ICES J MAR SCI, V65, P1102, DOI 10.1093/icesjms/fsn099; Sellanes J, 2004, J MAR BIOL ASSOC UK, V84, P1065, DOI 10.1017/S0025315404010422h; SHANK T, 2007, EOS T AGU FALL M S; Shaw AM, 2010, EARTH PLANET SC LETT, V289, P311, DOI 10.1016/j.epsl.2009.11.018; Sibuet M, 2009, DEEP-SEA RES PT II, V56, P2156, DOI 10.1016/j.dsr2.2009.04.015; Sinha MC, 2004, GEOPHYS MONOGR SER, V148, P19, DOI 10.1029/148GM02; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 2008, TECHNICAL STUDY INT, V3; Sohn RA, 2008, NATURE, V453, P1236, DOI 10.1038/nature07075; Speer K.G., 2003, ENERGY MASS TRANSFER, P287; Stranne C, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005776; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; THURBER AR, PLOS ONE IN PRESS; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; TUNNICLIFFE V, 1997, TECTONIC MAGMATIC HY, P225; Turnipseed M, 2003, ECOL LETT, V6, P518, DOI 10.1046/j.1461-0248.2003.00465.x; Tyler PA, 2002, OCEANOL ACTA, V25, P227, DOI 10.1016/S0399-1784(02)01202-1; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2011, NATURE, V470, P31, DOI 10.1038/470031a; Van Dover CL, 2011, ICES J MAR SCI, V68, P341, DOI 10.1093/icesjms/fsq086; Van Dover CL, 2000, MAR ECOL PROG SER, V195, P169, DOI 10.3354/meps195169; Van Dover CL, 2003, MAR ECOL PROG SER, V253, P55, DOI 10.3354/meps253055; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDERHEIJDEN K, PLOS ONE UNPUB; VANDOVER CL, 2011, ISA TECHNICAL STUDY, V8; Vanreusel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012449; WELANDER P, 1969, DEEP-SEA RES, VS, P369; YOERGER DR, 2011, SYSTEMATIC EXPLORATI, pS9	116	83	86	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23259	10.1371/journal.pone.0023259	http://dx.doi.org/10.1371/journal.pone.0023259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829722	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000293561200060
J	Rimsza, LM; Unger, JM; Tome, ME; LeBlanc, ML				Rimsza, Lisa M.; Unger, Joseph M.; Tome, Margaret E.; LeBlanc, Michael L.			A Strategy for Full Interrogation of Prognostic Gene Expression Patterns: Exploring the Biology of Diffuse Large B Cell Lymphoma	PLOS ONE			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR; SURVIVAL; PREDICTION; BURKITTS; FAMILY; MODEL; BCL-6; TRANSCRIPTION; SEROTONIN	Background: Gene expression profiling yields quantitative data on gene expression used to create prognostic models that accurately predict patient outcome in diffuse large B cell lymphoma (DLBCL). Often, data are analyzed with genes classified by whether they fall above or below the median expression level. We sought to determine whether examining multiple cut-points might be a more powerful technique to investigate the association of gene expression with outcome. Methodology/Principal Findings: We explored gene expression profiling data using variable cut-point analysis for 36 genes with reported prognostic value in DLBCL. We plotted two-group survival logrank test statistics against corresponding cut-points of the gene expression levels and smooth estimates of the hazard ratio of death versus gene expression levels. To facilitate comparisons we also standardized the expression of each of the genes by the fraction of patients that would be identified by any cut-point. A multiple comparison adjusted permutation p-value identified 3 different patterns of significance: 1) genes with significant cut-point points below the median, whose loss is associated with poor outcome (e.g. HLA-DR); 2) genes with significant cut-points above the median, whose over-expression is associated with poor outcome (e.g. CCND2); and 3) genes with significant cut-points on either side of the median, (e.g. extracellular molecules such as FN1). Conclusions/Significance: Variable cut-point analysis with permutation p-value calculation can be used to identify significant genes that would not otherwise be identified with median cut-points and may suggest biological patterns of gene effects.	[Rimsza, Lisa M.; Tome, Margaret E.] Univ Arizona, Dept Pathol, Tucson, AZ 85721 USA; [Unger, Joseph M.; LeBlanc, Michael L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	University of Arizona; Fred Hutchinson Cancer Center	Rimsza, LM (corresponding author), Univ Arizona, Dept Pathol, Tucson, AZ 85721 USA.	lrimsza@email.arizona.edu	Unger, Joseph/O-7457-2019		NIH [R01 CA90998]; American Cancer Society [RSG0605501LIB]; NATIONAL CANCER INSTITUTE [R01CA090998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by NIH grant R01 CA90998 (PI LeBlanc) and American Cancer Society grant RSG0605501LIB (PI Rimsza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ST, 2010, BLOOD, V115, P4447, DOI 10.1182/blood-2009-06-229872; Akasaka T, 2000, J CLIN ONCOL, V18, P510, DOI 10.1200/JCO.2000.18.3.510; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Barnett ME, 2007, CELL SIGNAL, V19, P1820, DOI 10.1016/j.cellsig.2007.05.014; Becker KG, 1997, GENOMICS, V41, P502, DOI 10.1006/geno.1997.4678; Bialik S, 2010, CURR OPIN CELL BIOL, V22, P199, DOI 10.1016/j.ceb.2009.11.004; Bowman AW, 2000, BIOMETRICS, V56, P563, DOI 10.1111/j.0006-341X.2000.00563.x; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chang KC, 2007, CLIN CANCER RES, V13, P6666, DOI 10.1158/1078-0432.CCR-07-0504; Chiles TC, 2004, J IMMUNOL, V173, P2901, DOI 10.4049/jimmunol.173.5.2901; Cooper TK, 2010, VET PATHOL, V47, P1028, DOI 10.1177/0300985810374842; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; COX DR, 1972, J R STAT SOC B, V34, P187; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Desjobert C, 2009, BIOCHEM J, V417, P121, DOI 10.1042/BJ20080872; Gadad SS, 2010, BIOCHEMISTRY-US, V49, P1355, DOI 10.1021/bi9021632; GENTLEMAN R, 1991, BIOMETRICS, V47, P1283, DOI 10.2307/2532386; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hastie T., 2009, UNSUPERVISED LEARNIN; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Iqbal J, 2003, BLOOD, V102, p884A; KARTTUNEN T, 1989, J HISTOCHEM CYTOCHEM, V37, P279, DOI 10.1177/37.3.2918219; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; LEBLANC M, 1995, CAN J STAT, V23, P109, DOI 10.2307/3315439; LEBLANC M, 2005, HDB STAT CLIN ONCOLO, P365; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; LIST AF, 1993, LEUKEMIA, V7, P398; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Lu XQ, 2007, BLOOD, V110, P4268, DOI 10.1182/blood-2007-04-087775; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; MILLER TP, 1994, BLOOD, V83, P1460, DOI 10.1182/blood.V83.6.1460.1460; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pan ZG, 2007, BRIT J HAEMATOL, V137, P578, DOI 10.1111/j.1365-2141.2007.06597.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Paterson MA, 2007, BIOCHEM J, V405, P489, DOI 10.1042/BJ20070174; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pienkowska-Grela B, 2005, CANCER GENET CYTOGEN, V156, P114, DOI 10.1016/j.cancergencyto.2004.04.009; Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Roberts RG, 1998, HUM MOL GENET, V7, P589, DOI 10.1093/hmg/7.4.589; Roberts RA, 2007, LAB INVEST, V87, P979, DOI 10.1038/labinvest.3700665; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; RYBSKI JA, 1991, LEUKEMIA LYMPHOMA, V6, P31, DOI 10.3109/10428199109064876; Saheki T, 2007, J BIOL CHEM, V282, P25041, DOI 10.1074/jbc.M702031200; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; SLEEPER LA, 1990, J AM STAT ASSOC, V85, P941, DOI 10.2307/2289591; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sperandio M, 2009, IMMUNOL REV, V230, P97, DOI 10.1111/j.1600-065X.2009.00795.x; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Tome ME, 2005, BLOOD, V106, P3594, DOI 10.1182/blood-2005-02-0487; Vicaut E, 2000, ANN MED, V32, P187, DOI 10.3109/07853890008998826; Vitolo U, 1998, ANN ONCOL, V9, P55, DOI 10.1023/A:1008201729596; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zhang SH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-71	75	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22267	10.1371/journal.pone.0022267	http://dx.doi.org/10.1371/journal.pone.0022267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829609	gold, Green Published, Green Submitted			2022-12-27	WOS:000293561200010
J	Boteva, L; Wu, YL; Cortes-Hernandez, J; Martin, J; Vyse, TJ; Fernando, MMA				Boteva, Lora; Wu, Yee Ling; Cortes-Hernandez, Josefina; Martin, Javier; Vyse, Timothy J.; Fernando, Michelle M. A.		IMAGEN	Determination of the Loss of Function Complement C4 Exon 29 CT Insertion Using a Novel Paralog-Specific Assay in Healthy UK and Spanish Populations	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DETERMINING DISEASE SUSCEPTIBILITY; COPY-NUMBER; MOLECULAR-BASIS; GENE; DEFICIENCY; ASSOCIATION; RISK; NULL; SLE	Genetic variants resulting in non-expression of complement C4A and C4B genes are common in healthy European populations and have shown association with a number of diseases, most notably the autoimmune disease, systemic lupus erythematosus. The most frequent cause of a C4 "null" allele, following that of C4 gene copy number variation (CNV), is a non-sense mutation arising from a 2 bp CT insertion into codon 1232 of exon 29. Previous attempts to accurately genotype this polymorphism have not been amenable to high-throughput typing, and have been confounded by failure to account for CNV at this locus, as well as by inability to distinguish between paralogs. We have developed a novel, high-throughput, paralog-specific assay to detect the presence and copy number of this polymorphism. We have genotyped healthy cohorts from the United Kingdom (UK) and Spain. Overall, 30/719 (4.17%) individuals from the UK cohort and 8/449 (1.78%) individuals from the Spanish cohort harboured the CT insertion in a C4A gene. A single Spanish individual possessed a C4B CT insertion. There is weak correlation between the C4 CT insertion and flanking MHC polymorphism. Therefore it is important to note that, as with C4 gene CNV, disease-association due to this variant will be missed by current SNP-based genome-wide association strategies.	[Boteva, Lora; Vyse, Timothy J.; Fernando, Michelle M. A.] Kings Coll London, Guys Hosp, Div Mol Med & Genet, London WC2R 2LS, England; [Boteva, Lora; Vyse, Timothy J.; Fernando, Michelle M. A.] Kings Coll London, Guys Hosp, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Wu, Yee Ling] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Cortes-Hernandez, Josefina] Univ Autonoma Barcelona, Vall dHebron Univ Hosp Res Inst, Autoimmune Dis Res Unit, E-08193 Barcelona, Spain; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Boteva, L (corresponding author), Kings Coll London, Guys Hosp, Div Mol Med & Genet, London WC2R 2LS, England.	michelle.fernando@kcl.ac.uk	Centeno, Norberto Ortego/C-4793-2019; Fernando, Michelle/F-5554-2012; Martín, Javier/AAV-5209-2021; de Bakker, Paul IW/B-8730-2009; Martín, María/HDL-9512-2022; Martin, Javier/B-8141-2008	Centeno, Norberto Ortego/0000-0003-2325-0937; de Bakker, Paul IW/0000-0001-7735-7858; Martin, Javier/0000-0002-2202-0622; Lopez Nevot, Miguel Angel/0000-0002-3465-6062; Klareskog, Lars/0000-0001-9601-6186; Alfredsson, Lars/0000-0003-1688-6697	Arthritis Research UK [18239]; National Institutes of Allergy and Infectious Diseases [AI067152]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MF and LB are supported by a Clinician Scientist Fellowship from Arthritis Research UK (Grant 18239). The IMAGEN consortium is supported by Grant AI067152 from the National Institutes of Allergy and Infectious Diseases. We acknowledge the use of DNA from the 1958 British Birth Cohort (D. Strachan, S. Ring, W. McArdle and M. Pembrey) funded by the Medical Research Council Grant G0000934 and Wellcome Trust Grant 068545/Z/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBA G, 1993, J CLIN INVEST, V91, P1681, DOI 10.1172/JCI116377; CHRISTIANSEN FT, 1983, AUST NZ J MED, V13, P483, DOI 10.1111/j.1445-5994.1983.tb02699.x; Dragon-Durey MA, 2001, CLIN EXP IMMUNOL, V123, P133, DOI 10.1046/j.1365-2249.2001.01438.x; Fernando MMA, 2010, HUM MUTAT, V31, P866, DOI 10.1002/humu.21259; FIELDER AHL, 1983, BMJ-BRIT MED J, V286, P425, DOI 10.1136/bmj.286.6363.425; Fredrikson GN, 1998, HUM IMMUNOL, V59, P713, DOI 10.1016/S0198-8859(98)00068-8; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Ittiprasert W, 2005, J AUTOIMMUN, V25, P77, DOI 10.1016/j.jaut.2005.04.004; Lokki ML, 1999, J IMMUNOL, V162, P3687; Man XY, 2003, ANN RHEUM DIS, V62, P71, DOI 10.1136/ard.62.1.71; Naves M, 1998, EUR J IMMUNOGENET, V25, P317, DOI 10.1046/j.1365-2370.1998.00110.x; Pickering MC, 2000, RHEUMATOLOGY, V39, P133, DOI 10.1093/rheumatology/39.2.133; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Rupert KL, 2002, J IMMUNOL, V169, P1570, DOI 10.4049/jimmunol.169.3.1570; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wu YL, 2009, GENES IMMUN, V10, P433, DOI 10.1038/gene.2009.10; Wu YL, 2008, CYTOGENET GENOME RES, V123, P131, DOI 10.1159/000184700; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1991, J IMMUNOL, V146, P1057	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22128	10.1371/journal.pone.0022128	http://dx.doi.org/10.1371/journal.pone.0022128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857912	Green Published, gold, Green Submitted			2022-12-27	WOS:000293558900010
J	McCowan, B; Beisner, BA; Capitanio, JP; Jackson, ME; Cameron, AN; Seil, S; Atwill, ER; Fushing, H				McCowan, Brenda; Beisner, Brianne A.; Capitanio, John P.; Jackson, Megan E.; Cameron, Ashley N.; Seil, Shannon; Atwill, Edward R.; Fushing, Hsieh			Network Stability Is a Balancing Act of Personality, Power, and Conflict Dynamics in Rhesus Macaque Societies	PLOS ONE			English	Article							PRIMATES; BEHAVIOR	Stability in biological systems requires evolved mechanisms that promote robustness. Cohesive primate social groups represent one example of a stable biological system, which persist in spite of frequent conflict. Multiple sources of stability likely exist for any biological system and such robustness, or lack thereof, should be reflected and thus detectable in the group's network structure, and likely at multiple levels. Here we show how network structure and group stability are linked to the fundamental characteristics of the individual agents in groups and to the environmental and social contexts in which these individuals interact. Both internal factors (e.g., personality, sex) and external factors (e.g., rank dynamics, sex ratio) were considered from the level of the individual to that of the group to examine the effects of network structure on group stability in a nonhuman primate species. The results yielded three main findings. First, successful third-party intervention behavior is a mechanism of group stability in rhesus macaques in that successful interventions resulted in less wounding in social groups. Second, personality is the primary factor that determines which individuals perform the role of key intervener, via its effect on social power and dominance discrepancy. Finally, individuals with high social power are not only key interveners but also key players in grooming networks and receive reconciliations from a higher diversity of individuals. The results from this study provide sound evidence that individual and group characteristics such as personality and sex ratio influence network structures such as patterns of reconciliation, grooming and conflict intervention that are indicators of network robustness and consequent health and well-being in rhesus macaque societies. Utilizing this network approach has provided greater insight into how behavioral and social processes influence social stability in nonhuman primate groups.	[McCowan, Brenda; Beisner, Brianne A.; Capitanio, John P.; Jackson, Megan E.; Cameron, Ashley N.; Seil, Shannon] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [McCowan, Brenda; Atwill, Edward R.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Beisner, Brianne A.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Capitanio, John P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Fushing, Hsieh] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis; University of California System; University of California Davis	McCowan, B (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.	bjmccowan@ucdavis.edu			National Institutes of Health [R24 RR024396, PR51 RR000169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169, R24RR024396] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by National Institutes of Health grants #R24 RR024396 and #PR51 RR000169, and conducted under Institutional Animal Care and Use Committee protocol #11843. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Beisner BA, APPL ANIMAL IN PRESS; Beisner BA, 2010, AM J PRIMATOLOGY; Beisner BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016365; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; DAZEY J, 1977, AM J PHYS ANTHROPOL, V46, P73, DOI 10.1002/ajpa.1330460110; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Flack JC, 2006, AM NAT, V168, pE87, DOI 10.1086/506526; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Flack JC, 2005, AM NATURALIST, V165, pE000; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Hogg RV, 1995, MATH STAT, P251; *INS CORP, 2001, S PLUS; Isbell LA, 2002, BEHAVIOUR, V139, P177, DOI 10.1163/156853902760102645; Krakauer David C., 2006, P183; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Sprague DS, 1998, AM J PHYS ANTHROPOL, V105, P511, DOI 10.1002/(SICI)1096-8644(199804)105:4<511::AID-AJPA8>3.3.CO;2-Z; Stata, 2009, STAT STAT SOFTW REL, V2; STEVENSONHINDE, 1978, PRIMATES, V19, P473; Thierry B., 2007, PRIMATES PERSPECTIVE, P224; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; Wasserman S., 1995, SOCIAL NETWORK ANAL; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	28	49	49	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22350	10.1371/journal.pone.0022350	http://dx.doi.org/10.1371/journal.pone.0022350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857922	Green Published, gold, Green Submitted			2022-12-27	WOS:000293558900015
J	Balaguer, L; Arroyo-Garcia, R; Jimenez, P; Jimenez, MD; Villegas, L; Cordero, I; de Casas, RR; Fernandez-Delgado, R; Ron, ME; Manrique, E; Vargas, P; Cano, E; Pueyo, JJ; Aronson, J				Balaguer, Luis; Arroyo-Garcia, Rosa; Jimenez, Percy; Dolores Jimenez, Maria; Villegas, Luis; Cordero, Irene; de Casas, Rafael Rubio; Fernandez-Delgado, Raul; Eugenia Ron, Maria; Manrique, Esteban; Vargas, Pablo; Cano, Emilio; Pueyo, Jose J.; Aronson, James			Forest Restoration in a Fog Oasis: Evidence Indicates Need for Cultural Awareness in Constructing the Reference	PLOS ONE			English	Article							PERMUTATION TESTS; GENETIC DIVERSITY; WATER-USE; TREE; CONSERVATION; POLLINATION; POPULATIONS; ADAPTATION; FABACEAE; ECOLOGY	Background: In the Peruvian Coastal Desert, an archipelago of fog oases, locally called lomas, are centers of biodiversity and of past human activity. Fog interception by a tree canopy, dominated by the legume tree tara (Caesalpinia spinosa), enables the occurrence in the Atiquipa lomas (southern Peru) of an environmental island with a diverse flora and high productivity. Although this forest provides essential services to the local population, it has suffered 90% anthropogenic reduction in area. Restoration efforts are now getting under way, including discussion as to the most appropriate reference ecosystem to use. Methodology/Principal Findings: Genetic diversity of tara was studied in the Atiquipa population and over a wide geographical and ecological range. Neither exclusive plastid haplotypes to loma formations nor clear geographical structuring of the genetic diversity was found. Photosynthetic performance and growth of seedlings naturally recruited in remnant patches of loma forest were compared with those of seedlings recruited or planted in the adjacent deforested area. Despite the greater water and nitrogen availability under tree canopy, growth of forest seedlings did not differ from that of those recruited into the deforested area, and was lower than that of planted seedlings. Tara seedlings exhibited tight stomatal control of photosynthesis, and a structural photoprotection by leaflet closure. These drought-avoiding mechanisms did not optimize seedling performance under the conditions produced by forest interception of fog moisture. Conclusions/Significance: Both weak geographic partitioning of genetic variation and lack of physiological specialization of seedlings to the forest water regime strongly suggest that tara was introduced to lomas by humans. Therefore, the most diverse fragment of lomas is the result of landscape management and resource use by pre-Columbian cultures. We argue that an appropriate reference ecosystem for ecological restoration of lomas should include sustainable agroforestry practices that emulate the outcomes of ancient uses.	[Balaguer, Luis; Cordero, Irene; Eugenia Ron, Maria] Univ Complutense Madrid, Dept Biol Vegetal 1, Madrid, Spain; [Arroyo-Garcia, Rosa; Fernandez-Delgado, Raul] INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotecnol, Madrid, Spain; [Jimenez, Percy; Villegas, Luis] Univ Nacl San Agustin, IRECA, Arequipa, Peru; [Dolores Jimenez, Maria] Univ Complutense Madrid, Dept Interuniv Ecol, Madrid, Spain; [Cordero, Irene; Manrique, Esteban; Pueyo, Jose J.] CSIC, Inst Ciencias Agr, Madrid, Spain; [de Casas, Rafael Rubio] Natl Evolutionary Synth Ctr NESCent, Durham, NC USA; [Vargas, Pablo; Cano, Emilio] CSIC, Real Jardin Bot Madrid, Madrid, Spain; [Aronson, James] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Aronson, James] Missouri Bot Garden, St Louis, MO USA	Complutense University of Madrid; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Nacional de San Agustin de Arequipa; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA); The National Evolutionary Synthesis Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Missouri Botanical Gardens	Balaguer, L (corresponding author), Univ Complutense Madrid, Dept Biol Vegetal 1, Madrid, Spain.	balaguer@bio.ucm.es	Cordero, Irene/H-8171-2019; Jimenez, María Dolores/R-4762-2016; Manrique, Esteban/C-3163-2017; Arenas, Maria Dolores/AAB-7002-2020; Fernández-Delgado, Raúl/S-6617-2019; Pueyo, José J./D-8993-2016; de Casas, Rafael Rubio/AAA-6912-2019	Jimenez, María Dolores/0000-0002-2982-3743; Manrique, Esteban/0000-0002-6565-0704; Fernández-Delgado, Raúl/0000-0001-7411-9010; Pueyo, José J./0000-0003-0337-4078; de Casas, Rafael Rubio/0000-0003-4276-4968; Arroyo-Garcia, R/0000-0002-0597-1282; Cordero, Irene/0000-0002-6249-8348	Banco de Bilbao Vizcaya Argentaria Foundation (FBBVA) [BIOCON 05-102/06]; Comunidad de Madrid [REMEDINAL-2, S2009/AMB-1783]	Banco de Bilbao Vizcaya Argentaria Foundation (FBBVA); Comunidad de Madrid(Comunidad de Madrid)	This research was funded by the Biodiversity Conservation Programme of the Banco de Bilbao Vizcaya Argentaria Foundation (FBBVA, project BIOCON 05-102/06). The authors are also indebted to the Comunidad de Madrid (project REMEDINAL-2, S2009/AMB-1783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Aronson J., 1990, Desert Plants, V10, P65; ARONSON J, 1995, RESTOR ECOL, V3, P1, DOI 10.1111/j.1526-100X.1995.tb00069.x; Aronson J., 1990, DESERT PLANTS, V10, P79; BARREIRO RPA, 1931, RELACION VIAJE HECHO; Borges LA, 2009, FLORA, V204, P111, DOI 10.1016/j.flora.2008.01.003; CANZIANI J, 2007, CUAD ARQUITECT CIUD, V5, P1; Chepstow-Lusty A, 2000, AMBIO, V29, P322, DOI 10.1639/0044-7447(2000)029[0322:IALFTP]2.0.CO;2; Chung SM, 2003, THEOR APPL GENET, V107, P757, DOI 10.1007/s00122-003-1311-3; *CIZA, 1989, APR NIEBL COST ZON A; Cobo B., 1956, HIST NUEVO MUNDO; CONRAD GW, 1981, AM ANTIQUITY, V46, P3, DOI 10.2307/279981; D'Orangeville L, 2008, FOREST ECOL MANAG, V255, P1637, DOI 10.1016/j.foreco.2007.11.023; De la Cruz Lapa P, 2004, REV I INVEST FIGMMG, V7, P64; DEESPINOSA AV, 1992, CRONICAS AM, V68, P695; Dillon M. O., 2005, MONOGRAPHS SYSTEMATI, V104, P131; Dillon M.O., 2003, EL NINO PERU BIOL CU, P1; Egan D., 2001, HIST ECOLOGY HDB RES; Esteban R, 2009, PHOTOSYNTH RES, V101, P77, DOI 10.1007/s11120-009-9468-5; Eynard C, 2002, J ARID ENVIRON, V51, P79, DOI 10.1006/jare.2001.0923; Ferreyra R., 1983, Anales del Jardin Botanico de Madrid, V40, P241; FERREYRA R, 1986, GRAN GEOGRAFIA PERU, V2, P1; Fraker ME, 2008, ACTA OECOL, V33, P66, DOI 10.1016/j.actao.2007.09.001; Gebrekirstos A, 2006, FOREST ECOL MANAG, V229, P259, DOI 10.1016/j.foreco.2006.04.029; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hasse P, 2000, J ARID ENVIRON, V46, P79, DOI 10.1006/jare.2000.0657; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Huertas ML, 2007, SYST BOT, V32, P157, DOI 10.1600/036364407780360157; INRENA, 1995, MAP EC PER; Keefer DK, 1998, SCIENCE, V281, P1833, DOI 10.1126/science.281.5384.1833; Kherad-Pajouh S, 2010, COMPUT STAT DATA AN, V54, P1881, DOI 10.1016/j.csda.2010.02.015; KVIST LP, 2006, PLANTAS PSICOACTIVAS, P294; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Linares E., 1990, PREHISTORIA AREQUIPA, VII; Lira CF, 2003, MOL ECOL, V12, P3219, DOI 10.1046/j.1365-294X.2003.01991.x; Loveless MD, 2003, ECOL STU AN, V159, P9; Martorell C, 2007, OECOLOGIA, V151, P561, DOI 10.1007/s00442-006-0614-x; Masuda S., 1985, ANDEAN ECOLOGY CIVIL, P233; Meister J, 2005, BOT J LINN SOC, V148, P437, DOI 10.1111/j.1095-8339.2005.00421.x; Miller AJ, 2006, MOL ECOL, V15, P1467, DOI 10.1111/j.1365-294X.2006.02834.x; Murra John, 1985, ANDEAN ECOLOGY CIVIL, P3; OLIVARES E, 1992, J VEG SCI, V3, P383, DOI 10.2307/3235764; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Parker KC, 2010, MOL ECOL, V19, P1622, DOI 10.1111/j.1365-294X.2010.04593.x; PEFAUR JE, 1982, VEGETATIO, V49, P163, DOI 10.1007/BF00123840; Pinto R, 2006, J ARID ENVIRON, V65, P543, DOI 10.1016/j.jaridenv.2005.08.015; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; POTVIN C, 1990, ECOLOGY, V71, P1389, DOI 10.2307/1938276; R Core Team, 2020, R LANG ENV STAT COMP; Raez Luna E., 2016, AMBIENTE RECURSOS NA; Romao RL, 2000, GENET RESOUR CROP EV, V47, P207, DOI 10.1023/A:1008723706557; Rossini S., 2006, LAGASCALIA, V26, P119; Rostworowski Maria, 1981, RECURSOS NATURALES R; Sandquist DR, 2007, AM J BOT, V94, P1459, DOI 10.3732/ajb.94.9.1459; Schneider S, 2000, ARLEQUIN VER 2 00 SO; Schwinning S, 2001, J ECOL, V89, P464, DOI 10.1046/j.1365-2745.2001.00576.x; SER, 2022, US; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Simonin KA, 2009, PLANT CELL ENVIRON, V32, P882, DOI 10.1111/j.1365-3040.2009.01967.x; Simpson B.B., 2003, ADV LEGUME SYSTEMATI, P123; Smith S, 2003, CONSERV GENET, V4, P289, DOI 10.1023/A:1024077315820; Teketay D, 1996, FOREST ECOL MANAG, V80, P209, DOI 10.1016/0378-1127(95)03616-4; TORRES J, 2007, CLIMATE LAND DEGRADA, P501; TOWLE M, 2007, ETHNOBOTANY PRECOLUM; Villagran C., 2004, HIST NATURAL PARQUE, P3; VILLANUEVA C, 2007, TARA ORO VERDE INCAS; Villar-Salvador P, 2004, FOREST ECOL MANAG, V196, P257, DOI 10.1016/j.foreco.2004.02.061; Vittoz P, 2001, J VEG SCI, V12, P417, DOI 10.2307/3236856; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Wheeler B, 2010, LMPERM PERMUTATION T; Young OR, 2006, GLOBAL ENVIRON CHANG, V16, P304, DOI 10.1016/j.gloenvcha.2006.03.004; ZIMMERER KS, 1991, ECON BOT, V45, P176, DOI 10.1007/BF02862046	76	15	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23004	10.1371/journal.pone.0023004	http://dx.doi.org/10.1371/journal.pone.0023004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829680	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000293511900022
J	Cocozza, S; Akhtar, MM; Miele, G; Monticelli, A				Cocozza, Sergio; Akhtar, Most. Mauluda; Miele, Gennaro; Monticelli, Antonella			CpG Islands Undermethylation in Human Genomic Regions under Selective Pressure	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; CELLS; EPIGENETICS; SEQUENCE; EXPRESSION; ANIMALS; CULTURE	DNA methylation at CpG islands (CGIs) is one of the most intensively studied epigenetic mechanisms. It is fundamental for cellular differentiation and control of transcriptional potential. DNA methylation is involved also in several processes that are central to evolutionary biology, including phenotypic plasticity and evolvability. In this study, we explored the relationship between CpG islands methylation and signatures of selective pressure in Homo Sapiens, using a computational biology approach. By analyzing methylation data of 25 cell lines from the Encyclopedia of DNA Elements (ENCODE) Consortium, we compared the DNA methylation of CpG islands in genomic regions under selective pressure with the methylation of CpG islands in the remaining part of the genome. To define genomic regions under selective pressure, we used three different methods, each oriented to provide distinct information about selective events. Independently of the method and of the cell type used, we found evidences of undermethylation of CGIs in human genomic regions under selective pressure. Additionally, by analyzing SNP frequency in CpG islands, we demonstrated that CpG islands in regions under selective pressure show lower genetic variation. Our findings suggest that the CpG islands in regions under selective pressure seem to be somehow more "protected" from methylation when compared with other regions of the genome.	[Cocozza, Sergio; Akhtar, Most. Mauluda; Miele, Gennaro] Univ Napoli Federico II Univ Salerno, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy; [Cocozza, Sergio; Akhtar, Most. Mauluda] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol L Calif, Naples, Italy; [Miele, Gennaro] Univ Naples Federico 2, Dipartimento Sci Fis, Naples, Italy; [Miele, Gennaro] Ist Nazl Fis Nucl, Sez Napoli, I-80125 Naples, Italy; [Monticelli, Antonella] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Cocozza, S (corresponding author), Univ Napoli Federico II Univ Salerno, Grp Interdipartimentale Bioinformat & Biol Comput, Naples, Italy.	cocozza@unina.it	Miele, Gennaro/AAG-6782-2020; Cocozza, Sergio/F-6488-2010; Miele, Gennaro/F-3628-2010	Miele, Gennaro/0000-0002-2028-0578; Miele, Gennaro/0000-0002-2028-0578	University "Federico II", Naples	University "Federico II", Naples	This work was supported by Institutional funds by University "Federico II", Naples. MMA is a recipient of a fellowship by Doctorate of Computational Biology and Bioinformatics, University "Federico II", Naples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Duthie SJ, 2011, P NUTR SOC, V70, P47, DOI 10.1017/S0029665110003952; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fouse SD, 2010, EPIGENOMICS-UK, V2, P105, DOI 10.2217/EPI.09.35; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haaf T, 2006, CURR TOP MICROBIOL, V310, P13; Han L, 2007, CANCER BIOL THER, V6, P1284; Handel AE, 2010, TRENDS MOL MED, V16, P7, DOI 10.1016/j.molmed.2009.11.003; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Johnson LJ, 2010, HEREDITY, V105, P113, DOI 10.1038/hdy.2010.25; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Medvedeva YA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-48; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; PELIZZOLA M, 2010, FEBS LETT; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; R Core Team, 2020, R LANG ENV STAT COMP; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saferali A, 2010, EPIGENETICS-US, V5, P50, DOI 10.4161/epi.5.1.10436; Sanborn JZ, 2011, NUCLEIC ACIDS RES, V39, pD951, DOI 10.1093/nar/gkq1113; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P3418, DOI 10.1073/pnas.79.11.3418; Tomso DJ, 2003, J MOL BIOL, V327, P303, DOI 10.1016/S0022-2836(03)00120-7; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013798; Yi SV, 2009, EPIGENETICS-US, V4, P551, DOI 10.4161/epi.4.8.10345	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23156	10.1371/journal.pone.0023156	http://dx.doi.org/10.1371/journal.pone.0023156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829712	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511900030
J	Weinkopff, T; Lammie, P				Weinkopff, Tiffany; Lammie, Patrick			Lack of Evidence for the Direct Activation of Endothelial Cells by Adult Female and Microfilarial Excretory-Secretory Products	PLOS ONE			English	Article							HUMAN LYMPHATIC FILARIASIS; BRUGIA-MALAYI INFECTION; BANCROFTIAN FILARIASIS; NUDE-MICE; IMMUNE-RECONSTITUTION; PATHOLOGY; PAHANGI; HISTOPATHOLOGY; ABNORMALITIES; CHILDREN	Lymphangiectasia (dilation of the lymphatic vessel (LV)) is pathognomonic for lymphatic filariasis. In both infected humans and animal models of infection, lymphangiectasia is not restricted to the site of the worm nest, but is found along the infected vessel. These observations argue that soluble products secreted by the worm could be mediating this effect by activating the lymphatic endothelial cells (LEC) lining the vessel. We tested the ability of filarial Excretory-Secretory products to activate LECs, but were unable to detect a direct effect of the Excretory-Secretory products on the activation of LEC as assessed by a variety of approaches including cellular proliferation, cell surface molecule expression and cytokine and growth factor production (although other mediators used as positive controls did induce these effects). Collectively, these results do not support the hypothesis that Excretory-Secretory products directly activate LECs.	[Weinkopff, Tiffany] Univ Georgia, Dept Cell Biol, Athens, GA 30602 USA; [Lammie, Patrick] Ctr Dis Control & Prevent, Atlanta, GA USA	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA	Weinkopff, T (corresponding author), Univ Georgia, Dept Cell Biol, Athens, GA 30602 USA.	tiffany.weinkopff@unil.ch		Weinkopff, Tiffany/0000-0002-5239-2486	Center for Tropical and Emerging Infectious Diseases [T32 AI 060546]; Centers for Disease Control and Prevention's Emerging Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546] Funding Source: NIH RePORTER	Center for Tropical and Emerging Infectious Diseases; Centers for Disease Control and Prevention's Emerging Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by a training grant to the Center for Tropical and Emerging Infectious Diseases (T32 AI 060546) with additional support from the Centers for Disease Control and Prevention's Emerging Infectious Disease Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; AMARAL F, 1994, AM J TROP MED HYG, V50, P753, DOI 10.4269/ajtmh.1994.50.753; Bennuru S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000688; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; BUCK AA, 1991, HUNTERS TROPICAL MED, P711; CASE T, 1991, LYMPHOLOGY, V24, P174; Dreyer G, 2000, T ROY SOC TROP MED H, V94, P594, DOI 10.1016/S0035-9203(00)90200-1; Dreyer G, 2000, PARASITOL TODAY, V16, P544, DOI 10.1016/S0169-4758(00)01778-6; Figueredo-Silva J, 2002, ANN TROP MED PARASIT, V96, P531, DOI 10.1179/000349802125001348; FREEDMAN DO, 1994, J INFECT DIS, V170, P927, DOI 10.1093/infdis/170.4.927; FREEDMAN DO, 1995, J INFECT DIS, V171, P997, DOI 10.1093/infdis/171.4.997; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hu Xueqing, 2006, Lymphatic Research and Biology, V4, P191, DOI 10.1089/lrb.2006.4403; Moreno Y, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000326; NELSON FK, 1991, J EXP MED, V173, P659, DOI 10.1084/jem.173.3.659; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Nutman TB, 2001, PARASITE IMMUNOL, V23, P389, DOI 10.1046/j.1365-3024.2001.00399.x; Pegu A, 2008, J IMMUNOL, V180, P3399, DOI 10.4049/jimmunol.180.5.3399; Rao UR, 1996, J PARASITOL, V82, P550, DOI 10.2307/3283779; Sawa Y, 2007, J HISTOCHEM CYTOCHEM, V55, P721, DOI 10.1369/jhc.6A7171.2007; Shenoy RK, 2009, ANN TROP MED PARASIT, V103, P235, DOI 10.1179/136485909X398249; Shenoy R. K., 2008, Journal of Communicable Diseases, V40, P91; Shin JW, 2008, BLOOD, V112, P2318, DOI 10.1182/blood-2008-05-156331; VICKERY AC, 1983, J PARASITOL, V69, P478, DOI 10.2307/3281358; VICKERY AC, 1991, ACTA TROP, V49, P45, DOI 10.1016/0001-706X(91)90029-J; VICKERY AC, 1985, ACTA TROP, V42, P353; VINCENT AL, 1984, J PARASITOL, V70, P48, DOI 10.2307/3281924; VONLICHTENBERG F, 1957, J MT SINAI HOSP, V24, P983	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22282	10.1371/journal.pone.0022282	http://dx.doi.org/10.1371/journal.pone.0022282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829611	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511900004
J	Li, HH; Wang, YQ; Ding, L; Zheng, SJJ				Li, Haihua; Wang, Yongqiang; Ding, Lin; Zheng, Shijun J.			Staphylococcus sciuri Exfoliative Toxin C (ExhC) is a Necrosis-Inducer for Mammalian Cells	PLOS ONE			English	Article							HYICUS SUBSP HYICUS; MOLECULAR CHARACTERIZATION; EXUDATIVE EPIDERMITIS; SKIN; PIGS; STRAINS; CLONING	Staphylococcus sciuri (S. sciuri) is a rare pathogen in humans, but it can cause a wide array of human infections. Recently a S. sciuri isolate (HBXX06) was reported to cause fatal exudative epidermitis (EE) in piglets and thus considered as a potential zoonotic agent. To investigate the pathogenicity of this bacterium, we cloned exfoliative toxin C (ExhC), a major toxin of the S. sciuri isolate and performed functional analysis of the recombinant ExhC-his (rExhC) protein using in vitro cell cultures and newborn mice as models. We found that rExhC could induce necrosis in multiple cell lines and peritoneal macrophages as well as skin lesions in newborn mice, and that the rExhC-induced necrosis in cells or skin lesions in newborn mice could be completely abolished if amino acids 79-128 of rExhC were deleted or blocked with a monoclonal antibody (3E4), indicating aa 79-128 portion as an essential necrosis-inducing domain. This information contributes to further understandings of the mechanisms underlying S. sciuri infection.	[Li, Haihua] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; China Agr Univ, Coll Vet Med, Minist Agr, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Li, HH (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	sjzheng@cau.edu.cn			National Natural Science Foundation of China [30725026, 31072117]; National Basic Research Program of China [2006CB504303]; National High-tech Program of China [2006AA10A208-1-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High-tech Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (#30725026 and 31072117 to SJ Zheng), National Basic Research Program of China (#2006CB504303 to SJ Zheng) and National High-tech Program of China (#2006AA10A208-1-1 to SJ Zheng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens P, 2004, J BACTERIOL, V186, P1833, DOI 10.1128/JB.186.6.1833-1837.2004; Andresen LO, 1997, MICROB PATHOGENESIS, V22, P113, DOI 10.1006/mpat.1996.0097; Andresen LO, 1998, FEMS IMMUNOL MED MIC, V20, P301, DOI 10.1111/j.1574-695X.1998.tb01140.x; Andresen LO, 2005, VET REC, V157, P376, DOI 10.1136/vr.157.13.376; Andresen LO, 2005, VET MICROBIOL, V105, P291, DOI 10.1016/j.vetmic.2004.12.006; ANDRESEN LO, 1993, MICROB PATHOGENESIS, V15, P217, DOI 10.1006/mpat.1993.1072; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Couto I, 2000, J CLIN MICROBIOL, V38, P1136, DOI 10.1128/JCM.38.3.1136-1143.2000; Fudaba Y, 2005, MICROB PATHOGENESIS, V39, P171, DOI 10.1016/j.micpath.2005.08.003; Hedin G, 1998, EUR J CLIN MICROBIOL, V17, P673, DOI 10.1007/s100960050157; Horii T, 2001, SCAND J INFECT DIS, V33, P930, DOI 10.1080/00365540110076750; Iwatsuki K, 2006, J DERMATOL SCI, V42, P203, DOI 10.1016/j.jdermsci.2006.03.011; Kanbar T, 2008, J VET SCI, V9, P327, DOI 10.4142/jvs.2008.9.3.327; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Koh Eun-Mi, 2009, Immune Netw, V9, P203, DOI 10.4110/in.2009.9.5.203; Ladhani S, 2001, CLIN MICROBIOL INFEC, V7, P301, DOI 10.1046/j.1198-743x.2001.00258.x; Ladhani S, 1999, CLIN MICROBIOL REV, V12, P224, DOI 10.1128/CMR.12.2.224; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Nishifuji K, 2005, VET DERMATOL, V16, P315, DOI 10.1111/j.1365-3164.2005.00474.x; OKADA K, 1987, J GEN MICROBIOL, V133, P2279; POUTREL B, 1984, AM J VET RES, V45, P2084; Rahman MT, 2005, MICROB DRUG RESIST, V11, P205, DOI 10.1089/mdr.2005.11.205; Sato H, 2000, J BACTERIOL, V182, P4096, DOI 10.1128/JB.182.14.4096-4100.2000; SATO H, 1991, VET MICROBIOL, V27, P263, DOI 10.1016/0378-1135(91)90153-7; SATO H, 1991, VET MICROBIOL, V28, P157, DOI 10.1016/0378-1135(91)90090-3; Shittu A, 2004, J MED MICROBIOL, V53, P51, DOI 10.1099/jmm.0.05294-0; Smith JG, 2007, CLIN VACCINE IMMUNOL, V14, P527, DOI 10.1128/CVI.00435-06; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999; Stepanovic S, 2003, J CLIN MICROBIOL, V41, P5262, DOI 10.1128/JCM.41.11.5262-5264.2003; Stepanovic S, 2002, SCAND J INFECT DIS, V34, P685, DOI 10.1080/00365540110076949; Stepanovic S, 2001, VET MICROBIOL, V82, P177, DOI 10.1016/S0378-1135(01)00377-7; Stepanovic S, 2001, FEMS MICROBIOL LETT, V199, P47, DOI 10.1016/S0378-1097(01)00150-1; TAKEUCHI S, 1987, VET MICROBIOL, V14, P47, DOI 10.1016/0378-1135(87)90051-4; Wallet F, 2000, SCAND J INFECT DIS, V32, P697, DOI 10.1080/003655400459667	36	49	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23145	10.1371/journal.pone.0023145	http://dx.doi.org/10.1371/journal.pone.0023145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829591	Green Submitted, Green Published, gold			2022-12-27	WOS:000293286500078
J	Van den Hove, D; Jakob, SB; Schraut, KG; Kenis, G; Schmitt, AG; Kneitz, S; Scholz, CJ; Wiescholleck, V; Ortega, G; Prickaerts, J; Steinbusch, H; Lesch, KP				Van den Hove, Daniel; Jakob, Sissi Brigitte; Schraut, Karla-Gerlinde; Kenis, Gunter; Schmitt, Angelika Gertrud; Kneitz, Susanne; Scholz, Claus-Juergen; Wiescholleck, Valentina; Ortega, Gabriela; Prickaerts, Jos; Steinbusch, Harry; Lesch, Klaus-Peter			Differential Effects of Prenatal Stress in 5-Htt Deficient Mice: Towards Molecular Mechanisms of Gene x Environment Interactions	PLOS ONE			English	Article							SEROTONIN TRANSPORTER POLYMORPHISM; ACUTE TRYPTOPHAN DEPLETION; ANXIETY-LIKE BEHAVIOR; LONG-TERM DEPRESSION; KNOCK-OUT MICE; MAJOR DEPRESSION; INTERFERON-ALPHA; PHYSIOLOGICAL FUNCTIONS; RESTRAINT STRESS; BIPOLAR DISORDER	Prenatal stress (PS) has been shown to influence the development of the fetal brain and to increase the risk for the development of psychiatric disorders in later life. Furthermore, the variation of human serotonin transporter (5-HTT, SLC6A4) gene was suggested to exert a modulating effect on the association between early life stress and the risk for depression. In the present study, we used a 5-HttxPS paradigm to investigate whether the effects of PS are dependent on the 5-Htt genotype. For this purpose, the effects of PS on cognition, anxiety-and depression-related behavior were examined using a maternal restraint stress paradigm of PS in C57BL6 wild-type (WT) and heterozygous 5-Htt deficient (5-Htt +/-) mice. Additionally, in female offspring, a genome-wide hippocampal gene expression profiling was performed using the Affymetrix GeneChip (R) Mouse Genome 430 2.0 Array. 5-Htt +/- offspring showed enhanced memory performance and signs of reduced anxiety as compared to WT offspring. In contrast, exposure of 5-Htt +/- mice to PS was associated with increased depressive-like behavior, an effect that tended to be more pronounced in female offspring. Further, 5-Htt genotype, PS and their interaction differentially affected the expression of numerous genes and related pathways within the female hippocampus. Specifically, MAPK and neurotrophin signaling were regulated by both the 5-Htt +/- genotype and PS exposure, whereas cytokine and Wnt signaling were affected in a 5-Htt genotypexPS manner, indicating a genexenvironment interaction at the molecular level. In conclusion, our data suggest that although the 5-Htt +/- genotype shows clear adaptive capacity, 5-Htt +/- mice -particularly females-at the same time appear to be more vulnerable to developmental stress exposure when compared to WT offspring. Moreover, hippocampal gene expression profiles suggest that distinct molecular mechanisms mediate the behavioral effects of the 5-Htt genotype, PS exposure, and their interaction.	[Van den Hove, Daniel; Jakob, Sissi Brigitte; Schraut, Karla-Gerlinde; Ortega, Gabriela; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, Inst Mol Psychiat, Wurzburg, Germany; [Van den Hove, Daniel; Kenis, Gunter; Prickaerts, Jos; Steinbusch, Harry; Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurosci, Maastricht, Netherlands; [Kneitz, Susanne; Scholz, Claus-Juergen] Univ Wurzburg, Interdisciplinary Ctr Clin Res, Lab Microarray Applicat, Wurzburg, Germany; [Wiescholleck, Valentina] Ruhr Univ Bochum, Dept Neurophysiol, Bochum, Germany	University of Wurzburg; Maastricht University; University of Wurzburg; Ruhr University Bochum	Van den Hove, D (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, Inst Mol Psychiat, Wurzburg, Germany.	d.vandenhove@maastrichtuniversity.nl	Steinbusch, Heinrich/L-6950-2017; Scholz, Claus Jürgen/H-3202-2019; Lesch, Klaus-Peter/J-4906-2013	Scholz, Claus Jürgen/0000-0002-6406-7859; Lesch, Klaus-Peter/0000-0001-8348-153X; van den Hove, Daniel/0000-0003-4047-3198	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich Transregio (SFB TRR)58 Sonderforschungsbereich (SFB) 581, Klinische Forschergruppe (KFO) 125]; Interdisziplinaeres Zentrum fuer Klinische Forschung [(IZKF)-Z6]; European Commission (EC) [NEWMOOD LSHM-CT-2003-503474]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisziplinaeres Zentrum fuer Klinische Forschung; European Commission (EC)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereich Transregio (SFB TRR) 58, Sonderforschungsbereich (SFB) 581, Klinische Forschergruppe (KFO) 125 to KPL, Interdisziplinaeres Zentrum fuer Klinische Forschung (IZKF)-Z6 to SK and the European Commission (EC) (NEWMOOD LSHM-CT-2003-503474 to HWMS, KPL, GK, JP and DLAVDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Asaoka Y, 2010, J BIOCHEM, V148, P393, DOI 10.1093/jb/mvq098; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Behan AT, 2011, EUR NEUROPSYCHOPHARM, V21, P71, DOI 10.1016/j.euroneuro.2010.07.004; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Capuron L, 2000, J CLIN ONCOL, V18, P2143, DOI 10.1200/JCO.2000.18.10.2143; Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9; Capuron L, 2008, BIOL PSYCHIAT, V64, P896, DOI 10.1016/j.biopsych.2008.05.019; Carola V, 2008, BIOL PSYCHIAT, V63, P840, DOI 10.1016/j.biopsych.2007.08.013; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CASPI A, 2010, AM J PSYCHIAT; CHAPMAN RH, 1979, DEV PSYCHOBIOL, V12, P255, DOI 10.1002/dev.420120309; Chen Qi, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005008; Cizza G, 2008, BIOL PSYCHIAT, V64, P907, DOI 10.1016/j.biopsych.2008.05.035; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duman RS, 2000, BIOL PSYCHIAT, V48, P732, DOI 10.1016/S0006-3223(00)00935-5; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fredericks CA, 2010, BRAIN BEHAV IMMUN, V24, P350, DOI 10.1016/j.bbi.2009.10.014; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Gould TD, 2004, J CLIN PSYCHIAT, V65, P10; Gould TD, 2008, BEHAV BRAIN RES, V189, P117, DOI 10.1016/j.bbr.2007.12.028; Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266; Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W, 2002, BIOINFORMATICS, V18, pS96; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033; Jones KL, 2010, INT J DEV NEUROSCI, V28, P529, DOI 10.1016/j.ijdevneu.2010.05.002; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; KENIS G, 2010, INT J NEUROPSYCHOPH, V29, P1; Leonard BE, 2009, HUM PSYCHOPHARM CLIN, V24, P165, DOI 10.1002/hup.1011; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li HH, 2009, BEHAV BRAIN RES, V205, P32, DOI 10.1016/j.bbr.2009.06.036; Liu YF, 2004, J NEUROCHEM, V89, P1034, DOI 10.1111/j.1471-4159.2004.02391.x; Lotrich FE, 2009, BIOL PSYCHIAT, V65, P344, DOI 10.1016/j.biopsych.2008.08.009; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Martins-de-Souza D, 2010, J PSYCHIAT RES; Meller E, 2003, BRAIN RES, V979, P57, DOI 10.1016/S0006-8993(03)02866-X; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Olivier JDA, 2008, PSYCHOPHARMACOLOGY, V200, P243, DOI 10.1007/s00213-008-1201-0; Pallares ME, 2007, PHYSIOL BEHAV, V92, P951, DOI 10.1016/j.physbeh.2007.06.021; Patin V, 2002, DEV BRAIN RES, V139, P1, DOI 10.1016/S0165-3806(02)00491-1; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Persico AM, 2003, NEUROREPORT, V14, P341, DOI 10.1097/01.wnr.0000058244.21747.83; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Ravary A, 2001, EUR J NEUROSCI, V13, P1349, DOI 10.1046/j.0953-816x.2001.1511.x; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Robinson CM, 2005, J INTERF CYTOK RES, V25, P20, DOI 10.1089/jir.2005.25.20; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Taliaz D, 2010, MOL PSYCHIATR, V15, P80, DOI 10.1038/mp.2009.67; Tsao CW, 2006, PROG NEURO-PSYCHOPH, V30, P899, DOI 10.1016/j.pnpbp.2006.01.029; Turner CA, 2006, BIOL PSYCHIAT, V59, P1128, DOI 10.1016/j.biopsych.2006.02.026; van den Hove Daniel L A, 2010, Front Biosci (Elite Ed), V2, P43; Van Den Hove DLA, 2006, NEUROSCIENCE, V137, P145, DOI 10.1016/j.neuroscience.2005.08.060; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANMIERLO T, 2009, NEUROBIOL AGING; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Wu XJ, 2011, PSYCHONEUROENDOCRINO, V36, P266, DOI 10.1016/j.psyneuen.2010.07.017; Wu XJ, 2010, BRAIN BEHAV IMMUN, V24, P1340, DOI 10.1016/j.bbi.2010.06.012; Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Zeng H, 2007, MOL ENDOCRINOL, V21, P2795, DOI 10.1210/me.2007-0048; Zuena AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002170	91	64	64	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22715	10.1371/journal.pone.0022715	http://dx.doi.org/10.1371/journal.pone.0022715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857948	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500006
J	Moens, LN; De Rijk, P; Reumers, J; Van den Bossche, MJA; Glassee, W; De Zutter, S; Lenaerts, AS; Nordin, A; Nilsson, LG; Castello, IM; Norrback, KF; Goossens, D; Van Steen, K; Adolfsson, R; Del-Favero, J				Moens, Lotte N.; De Rijk, Peter; Reumers, Joke; Van den Bossche, Maarten J. A.; Glassee, Wim; De Zutter, Sonia; Lenaerts, An-Sofie; Nordin, Annelie; Nilsson, Lars-Goran; Castello, Ignacio Medina; Norrback, Karl-Fredrik; Goossens, Dirk; Van Steen, Kristel; Adolfsson, Rolf; Del-Favero, Jurgen			Sequencing of DISC1 Pathway Genes Reveals Increased Burden of Rare Missense Variants in Schizophrenia Patients from a Northern Swedish Population	PLOS ONE			English	Article							CHILDHOOD-ONSET SCHIZOPHRENIA; INTRINSICALLY DISORDERED PROTEINS; CASE-CONTROL ASSOCIATION; MAJOR MENTAL-ILLNESS; BIPOLAR DISORDER; CANDIDATE GENES; GRAY-MATTER; SUSCEPTIBILITY LOCUS; INTERACTION NETWORKS; STRUCTURAL VARIANTS	In recent years, DISC1 has emerged as one of the most credible and best supported candidate genes for schizophrenia and related neuropsychiatric disorders. Furthermore, increasing evidence - both genetic and functional - indicates that many of its protein interaction partners are also involved in the development of these diseases. In this study, we applied a pooled sample 454 sequencing strategy, to explore the contribution of genetic variation in DISC1 and 10 of its interaction partners (ATF5, Grb2, FEZ1, LIS-1, PDE4B, NDE1, NDEL1, TRAF3IP1, YWHAE, and ZNF365) to schizophrenia susceptibility in an isolated northern Swedish population. Mutation burden analysis of the identified variants in a population of 486 SZ patients and 514 control individuals, revealed that non-synonymous rare variants with a MAF<0.01 were significantly more present in patients compared to controls (8.64% versus 4.7%, P = 0.018), providing further evidence for the involvement of DISC1 and some of its interaction partners in psychiatric disorders. This increased burden of rare missense variants was even more striking in a subgroup of early onset patients (12.9% versus 4.7%, P = 0.0004), highlighting the importance of studying subgroups of patients and identifying endophenotypes. Upon investigation of the potential functional effects associated with the identified missense variants, we found that similar to 90% of these variants reside in intrinsically disordered protein regions. The observed increase in mutation burden in patients provides further support for the role of the DISC1 pathway in schizophrenia. Furthermore, this study presents the first evidence supporting the involvement of mutations within intrinsically disordered protein regions in the pathogenesis of psychiatric disorders. As many important biological functions depend directly on the disordered state, alteration of this disorder in key pathways may represent an intriguing new disease mechanism for schizophrenia and related neuropsychiatric diseases. Further research into this unexplored domain will be required to elucidate the role of the identified variants in schizophrenia etiology.	[Moens, Lotte N.; De Rijk, Peter; Van den Bossche, Maarten J. A.; Glassee, Wim; De Zutter, Sonia; Lenaerts, An-Sofie; Goossens, Dirk; Del-Favero, Jurgen] Flanders Inst Biotechnol VIB, Appl Mol Genom Grp, Dept Mol Genet, Flanders, Belgium; [Moens, Lotte N.; De Rijk, Peter; Van den Bossche, Maarten J. A.; Glassee, Wim; De Zutter, Sonia; Lenaerts, An-Sofie; Goossens, Dirk; Del-Favero, Jurgen] Univ Antwerp, B-2020 Antwerp, Belgium; [Reumers, Joke] Flanders Inst Biotechnol VIB, SWITCH Lab, Flanders, Belgium; [Reumers, Joke] Vrije Univ Brussel, Brussels, Belgium; [Nordin, Annelie; Norrback, Karl-Fredrik; Adolfsson, Rolf] Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden; [Nilsson, Lars-Goran] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Castello, Ignacio Medina] Prince Felipe Res Ctr CIPF, Funct Genom Unit, Bioinformat & Genom Dept, Valencia, Spain; [Van Steen, Kristel] Univ Liege, Syst & Modeling Unit, Montefiore Inst GIGA, Liege, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Umea University; Stockholm University; Prince Felipe Research Center; University of Liege	Moens, LN (corresponding author), Flanders Inst Biotechnol VIB, Appl Mol Genom Grp, Dept Mol Genet, Flanders, Belgium.	jurgen.delfavero@molgen.vib-ua.be	De Rijk, Peter/GXH-9837-2022	De Rijk, Peter/0000-0001-8558-9288; Del Favero, jurgen/0000-0002-7427-7489; Van Den Bossche, Maarten/0000-0002-2989-6600; Adolfsson, Rolf/0000-0001-9785-8473; /0000-0002-8114-7615; Goossens, Dirk/0000-0002-2080-7464; Van Steen, Kristel/0000-0001-9868-5033; Reumers, Joke/0000-0001-5434-6515	University of Antwerp; Fund for Scientific Research Flanders (FWO-F); Institute for Science and Technology-Flanders (IWT-F); Swedish Research Council [2006-4472, 2009-5269]; Medical Faculty, Umea University; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	University of Antwerp; Fund for Scientific Research Flanders (FWO-F)(FWO); Institute for Science and Technology-Flanders (IWT-F)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty, Umea University; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	This research was supported by the Special Research Fund of the University of Antwerp, the Fund for Scientific Research Flanders (FWO-F), the Institute for Science and Technology-Flanders (IWT-F), the Swedish Research Council (grants 2006-4472 and 2009-5269), the Medical Faculty, Umea University and the County Councils of Vasterbotten and Norrbotten, Sweden. LNM was supported by a postdoctoral fellowship from IWT-F, and MVDB holds a PhD fellowship of the IWT-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2007, MOL PSYCHIATR, V12, P195, DOI 10.1038/sj.mp.4001906; Addington AM, 2004, BIOL PSYCHIAT, V55, P976, DOI 10.1016/j.biopsych.2004.01.024; Addington AM, 2005, MOL PSYCHIATR, V10, P581, DOI 10.1038/sj.mp.4001599; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Betcheva ET, 2009, J HUM GENET, V54, P98, DOI 10.1038/jhg.2008.14; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Burdick KE, 2005, NEUROREPORT, V16, P1399, DOI 10.1097/01.wnr.0000175248.25535.f6; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Chen QY, 2007, J PSYCHIATR RES, V41, P428, DOI 10.1016/j.jpsychires.2006.01.001; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; CHILDS B, 1986, PERSPECT BIOL MED, V29, P437; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Curtis D, 2003, PSYCHIAT GENET, V13, P77, DOI 10.1097/01.ypg.0000056684.89558.d2; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Di Giorgio A, 2008, EUR J NEUROSCI, V28, P2129, DOI 10.1111/j.1460-9568.2008.06482.x; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eastwood SL, 2009, MOL PSYCHIATR, V14, P556, DOI 10.1038/mp.2009.13; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Ekelund J, 2004, MOL PSYCHIATR, V9, P1037, DOI 10.1038/sj.mp.4001536; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Gornick MC, 2005, J AUTISM DEV DISORD, V35, P831, DOI 10.1007/s10803-005-0028-3; Hamshere ML, 2005, ARCH GEN PSYCHIAT, V62, P1081, DOI 10.1001/archpsyc.62.10.1081; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hennah W, 2005, MOL PSYCHIATR, V10, P1097, DOI 10.1038/sj.mp.4001731; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hennah W, 2006, SCHIZOPHRENIA BULL, V32, P409, DOI 10.1093/schbul/sbj079; Hwu HG, 2003, MOL PSYCHIATR, V8, P445, DOI 10.1038/sj.mp.4001235; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Macgregor S, 2004, MOL PSYCHIATR, V9, P1083, DOI 10.1038/sj.mp.4001544; Maeda K, 2006, BIOL PSYCHIAT, V60, P929, DOI 10.1016/j.biopsych.2006.03.032; McClellan JM, 2007, BRIT J PSYCHIAT, V190, P194, DOI 10.1192/bjp.bp.106.025585; Midic U, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S12; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Mohan A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000497; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nakata K, 2009, P NATL ACAD SCI USA, V106, P15873, DOI 10.1073/pnas.0903413106; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Ogawa F, 2005, BIOCHEM BIOPH RES CO, V338, P771, DOI 10.1016/j.bbrc.2005.10.013; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Palo OM, 2007, HUM MOL GENET, V16, P2517, DOI 10.1093/hmg/ddm207; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P53, DOI 10.1001/archgenpsychiatry.2007.15; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu M, 2007, AM J MED GENET B, V144B, P266, DOI 10.1002/ajmg.b.30322; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Saetre P, 2008, SCHIZOPHR RES, V106, P237, DOI 10.1016/j.schres.2008.08.024; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schaefer C, 2010, BIOINFORMATICS, V26, P625, DOI 10.1093/bioinformatics/btq012; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shih RA, 2004, INT REV PSYCHIATR, V16, P260, DOI 10.1080/09540260400014401; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Thomson PA, 2005, NEUROSCI LETT, V389, P41, DOI 10.1016/j.neulet.2005.07.004; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Vyas NS, 2011, EARLY INTERV PSYCHIA, V5, P3, DOI 10.1111/j.1751-7893.2010.00253.x; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Williams HJ, 2009, J HUM GENET, V54, P9, DOI 10.1038/jhg.2008.7	92	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23450	10.1371/journal.pone.0023450	http://dx.doi.org/10.1371/journal.pone.0023450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853134	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400045
J	Cephas, KD; Kim, J; Mathai, RA; Barry, KA; Dowd, SE; Meline, BS; Swanson, KS				Cephas, Kimberly D.; Kim, Juhee; Mathai, Rose Ann; Barry, Kathleen A.; Dowd, Scot E.; Meline, Brandon S.; Swanson, Kelly S.			Comparative Analysis of Salivary Bacterial Microbiome Diversity in Edentulous Infants and Their Mothers or Primary Care Givers Using Pyrosequencing	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DENTAL-CARIES; CHILDREN; ACQUISITION; MICROFLORA; HABITATS; MUTANS	Bacterial contribution to oral disease has been studied in young children, but there is a lack of data addressing the developmental perspective in edentulous infants. Our primary objectives were to use pyrosequencing to phylogenetically characterize the salivary bacterial microbiome of edentulous infants and to make comparisons against their mothers. Saliva samples were collected from 5 edentulous infants (mean age = 4.661.2 mo old) and their mothers or primary care givers (mean age = 30.869.5 y old). Salivary DNA was extracted, used to generate DNA amplicons of the V4-V6 hypervariable region of the bacterial 16S rDNA gene, and subjected to 454-pyrosequencing. On average, over 80,000 sequences per sample were generated. High bacterial diversity was noted in the saliva of adults [1012 operational taxonomical units (OTU) at 3% divergence] and infants (578 OTU at 3% divergence). Firmicutes, Proteobacteria, Actinobacteria, and Fusobacteria were predominant bacterial phyla present in all samples. A total of 397 bacterial genera were present in our dataset. Of the 28 genera different (P<0.05) between infants and adults, 27 had a greater prevalence in adults. The exception was Streptococcus, which was the predominant genera in infant saliva (62.2% in infants vs. 20.4% in adults; P, 0.05). Veillonella, Neisseria, Rothia, Haemophilus, Gemella, Granulicatella, Leptotrichia, and Fusobacterium were also predominant genera in infant samples, while Haemophilus, Neisseria, Veillonella, Fusobacterium, Oribacterium, Rothia, Treponema, and Actinomyces were predominant in adults. Our data demonstrate that although the adult saliva bacterial microbiome had a greater OTU count than infants, a rich bacterial community exists in the infant oral cavity prior to tooth eruption. Streptococcus, Veillonella, and Neisseria are the predominant bacterial genera present in infants. Further research is required to characterize the development of oral microbiota early in life and identify environmental factors that impact colonization and oral and gastrointestinal disease risk.	[Cephas, Kimberly D.; Kim, Juhee; Mathai, Rose Ann; Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Kim, Juhee] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Barry, Kathleen A.; Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Dowd, Scot E.] Res & Testing Lab, Lubbock, TX USA; [Dowd, Scot E.] Med Biofilm Res Inst, Lubbock, TX USA; [Meline, Brandon S.] Dept Maternal & Child Hlth, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cephas, KD (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	ksswanso@illinois.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Swanson, Kelly/0000-0001-5518-3076	United States Department of Agriculture-Cooperative State Research, Education and Extension Service [ILLU-538-396]	United States Department of Agriculture-Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by the United States Department of Agriculture-Cooperative State Research, Education and Extension Service (project ILLU-538-396). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Booth V, 2004, J PERIODONTAL RES, V39, P213, DOI 10.1111/j.1600-0765.2004.00726.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CAUFIELD PW, 1993, J DENT RES, V72, P37, DOI 10.1177/00220345930720010501; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Dawes C, 2003, ARCH ORAL BIOL, V48, P329, DOI 10.1016/S0003-9969(03)00014-1; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gizani S, 2009, INT J PAEDIATR DENT, V19, P193, DOI 10.1111/j.1365-263X.2008.00956.x; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KONONEN E, 1994, ORAL MICROBIOL IMMUN, V9, P136, DOI 10.1111/j.1399-302X.1994.tb00049.x; KONONEN E, 1992, ORAL MICROBIOL IMMUN, V7, P28, DOI 10.1111/j.1399-302X.1992.tb00016.x; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Mantzourani M, 2009, CARIES RES, V43, P308, DOI 10.1159/000222659; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Paster Bruce J, 2002, Ann Periodontol, V7, P8, DOI 10.1902/annals.2002.7.1.8; Sanchez-Perez L, 2009, INT J PAEDIATR DENT, V19, P186, DOI 10.1111/j.1365-263X.2008.00941.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Tanner ACR, 2011, J CLIN MICROBIOL, V49, P1464, DOI 10.1128/JCM.02427-10; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	39	106	112	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23503	10.1371/journal.pone.0023503	http://dx.doi.org/10.1371/journal.pone.0023503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853142	gold, Green Published, Green Submitted			2022-12-27	WOS:000295454200090
J	Filosto, S; Khan, EM; Tognon, E; Becker, C; Ashfaq, M; Ravid, T; Goldkorn, T				Filosto, Simone; Khan, Elaine M.; Tognon, Emiliana; Becker, Cathleen; Ashfaq, Majid; Ravid, Tommer; Goldkorn, Tzipora			EGF Receptor Exposed to Oxidative Stress Acquires Abnormal Phosphorylation and Aberrant Activated Conformation That Impairs Canonical Dimerization	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; LIGAND-INDEPENDENT ACTIVATION; PULMONARY CELL APOPTOSIS; LUNG-CANCER; EPITHELIAL-CELLS; PERINUCLEAR TRAFFICKING; REVERSIBLE INACTIVATION; TYROSINE PHOSPHATASES; KINASE INHIBITORS; SIGNALING NETWORK	Crystallographic studies have offered understanding of how receptor tyrosine kinases from the ErbB family are regulated by their growth factor ligands. A conformational change of the EGFR (ErbB1) was shown to occur upon ligand binding, where a solely ligand-mediated mode of dimerization/activation was documented. However, this dogma of dimerization/activation was revolutionized by the discovery of constitutively active ligand-independent EGFR mutants. In addition, other ligand-independent activation mechanisms may occur. We have shown that oxidative stress (ox-stress), induced by hydrogen peroxide or cigarette smoke, activates EGFR differently than its ligand, EGF, thereby inducing aberrant phosphorylation and impaired trafficking and degradation of EGFR. Here we demonstrate that ox-stress activation of EGFR is ligand-independent, does not induce "classical" receptor dimerization and is not inhibited by the tyrosine kinase inhibitor AG1478. Thus, an unprecedented, apparently activated, state is found for EGFR under ox-stress. Furthermore, this activation mechanism is temperature-dependent, suggesting the simultaneous involvement of membrane structure. We propose that ceramide increase under ox-stress disrupts cholesterol-enriched rafts leading to EGFR re-localization into the rigid, ceramide-enriched rafts. This increase in ceramide also supports EGFR aberrant trafficking to a peri-nuclear region. Therefore, the EGFR unprecedented and activated conformation could be sustained by simultaneous alterations in membrane structure under ox-stress.	[Filosto, Simone; Khan, Elaine M.; Tognon, Emiliana; Becker, Cathleen; Ashfaq, Majid; Ravid, Tommer; Goldkorn, Tzipora] Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA	University of California System; University of California Davis	Filosto, S (corresponding author), Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA.	ttgoldkorn@ucdavis.edu		Filosto, Simone/0000-0002-7854-998X	National Institutes of Health [HL-71871, HL-66189]; Tobacco-Related Disease Research Program (TRDRP) [17RT-0131]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071871, R01HL066189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program (TRDRP)(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL-71871 and HL-66189 to T. G.) and from the Tobacco-Related Disease Research Program (TRDRP) (17RT-0131 to T. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KA, 2010, CELL PHYSIOL BIOCHEM, V26, P57, DOI 10.1159/000315106; Bublil EM, 2010, FASEB J; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Cai Z, 2010, SEMIN CELL DEV BIOL; Castillo SS, 2007, EXP CELL RES, V313, P2680, DOI 10.1016/j.yexcr.2007.04.002; Chan C, 2000, AM J RESP CELL MOL, V22, P460, DOI 10.1165/ajrcmb.22.4.3376; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; COCHET C, 1988, J BIOL CHEM, V263, P3290; Contreras FX, 2003, J BIOL CHEM, V278, P37169, DOI 10.1074/jbc.M303206200; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Egloff AM, 2008, SEMIN ONCOL, V35, P286, DOI 10.1053/j.seminoncol.2008.03.008; FILOSTO S, AM J RESP C IN PRESS; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goldkorn T, 1998, J CELL SCI, V111, P3209; Goldkorn T, 2010, AM J RESP CELL MOL, V43, P259, DOI 10.1165/rcmb.2010-0220RT; GOLDMAN R, 1990, BIOCHEMISTRY-US, V29, P11024, DOI 10.1021/bi00502a002; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Grassme H, 2002, J IMMUNOL, V168, P298, DOI 10.4049/jimmunol.168.1.298; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Harris LN, 2001, CLIN CANCER RES, V7, P1497; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ise N, 2010, BIOCHEM BIOPH RES CO, V394, P685, DOI 10.1016/j.bbrc.2010.03.052; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lambert S, 2006, J INVEST DERMATOL, V126, P954, DOI 10.1038/sj.jid.5700168; Lavrentiadou SN, 2001, AM J RESP CELL MOL, V25, P676, DOI 10.1165/ajrcmb.25.6.4321; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Lieu C, 2010, CLIN COLORECTAL CANC, V9, P89, DOI 10.3816/CCC.2010.n.012; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Megha, 2007, BBA-BIOMEMBRANES, V1768, P2205, DOI 10.1016/j.bbamem.2007.05.007; Ni CY, 2003, J BIOL CHEM, V278, P4561, DOI 10.1074/jbc.M210504200; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache Irina, 2006, Proc Am Thorac Soc, V3, P510, DOI 10.1513/pats.200603-071MS; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; RAVID T, 2002, J BIOL CHEM, V12, P12; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; REUTER S, 2010, FREE RADIC BIOL MED; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Sot J, 2008, FEBS LETT, V582, P3230, DOI 10.1016/j.febslet.2008.08.016; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yang CH, 2008, LUNG CANCER, V60, pS23, DOI 10.1016/S0169-5002(08)70102-8; Yang Y, 2010, EUR RESPIR J, V36, P417, DOI 10.1183/09031936.00095609; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	69	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23240	10.1371/journal.pone.0023240	http://dx.doi.org/10.1371/journal.pone.0023240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853092	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200055
J	Martiniere, A; Macia, JL; Bagnolini, G; Jridi, C; Bak, A; Blanc, S; Drucker, M				Martiniere, Alexandre; Macia, Jean-Luc; Bagnolini, Guillaume; Jridi, Chiraz; Bak, Aurelie; Blanc, Stephane; Drucker, Martin			VAPA, an Innovative "Virus-Acquisition Phenotyping Assay" Opens New Horizons in Research into the Vector-Transmission of Plant Viruses	PLOS ONE			English	Article							CAULIFLOWER-MOSAIC-VIRUS; APHID TRANSMISSION; TRANSMITTED VIRUSES; INCLUSION-BODIES; HELPER COMPONENT; YELLOWS VIRUS; POTYVIRUS; INOCULATION; SALIVATION; PROTEIN	Host-to-host transmission-a key step in plant virus infection cycles-is ensured predominantly by vectors, especially aphids and related insects. A deeper understanding of the mechanisms of virus acquisition, which is critical to vector-transmission, might help to design future virus control strategies, because any newly discovered molecular or cellular process is a potential target for hampering viral spread within host populations. With this aim in mind, an aphid membrane-feeding assay was developed where aphids transmitted two non-circulative viruses [ cauliflower mosaic virus (CaMV) and turnip mosaic virus] from infected protoplasts. In this assay, virus acquisition occurs exclusively from living cells. Most interestingly, we also show that CaMV is less efficiently transmitted by aphids in the presence of oryzalin-a microtubule-depolymerising drug. The example presented here demonstrates that our technically simple "virus-acquisition phenotyping assay" (VAPA) provides a first opportunity to implement correlative studies relating the physiological state of infected plant cells to vector-transmission efficiency.	[Martiniere, Alexandre; Macia, Jean-Luc; Bagnolini, Guillaume; Jridi, Chiraz; Bak, Aurelie; Blanc, Stephane; Drucker, Martin] INRA, Equipe CaGeTE, UMR BGPI, F-34060 Montpellier, France	INRAE	Drucker, M (corresponding author), INRA, Equipe CaGeTE, UMR BGPI, F-34060 Montpellier, France.	drucker@supagro.inra.fr	Drucker, Martin/S-6832-2019; Blanc, Stéphane/F-5873-2011; Martiniere, Alexandre/ABE-1857-2021	Blanc, Stéphane/0000-0002-3412-0989; Drucker, Martin/0000-0002-9765-1189	Agence Nationale Recherche [BLAN07-2-192768]	Agence Nationale Recherche(French National Research Agency (ANR))	This work was funded by a grant from Agence Nationale Recherche, BLAN07-2-192768, awarded to SB (www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANC S, 1993, VIROLOGY, V197, P283, DOI 10.1006/viro.1993.1589; Blanc S, 2011, CURR OPIN MICROBIOL, V14, P483, DOI 10.1016/j.mib.2011.07.008; Bruyere A, 1997, VIROLOGY, V230, P323, DOI 10.1006/viro.1997.8476; DELSENY M, 1983, PLASMID, V9, P31, DOI 10.1016/0147-619X(83)90029-X; Drucker M, 2002, P NATL ACAD SCI USA, V99, P2422, DOI 10.1073/pnas.042587799; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Hoh F, 2010, J VIROL, V84, P4706, DOI 10.1128/JVI.02662-09; Khelifa M, 2007, J GEN VIROL, V88, P2872, DOI 10.1099/vir.0.83009-0; MARKHAM PG, 1987, ANN APPL BIOL, V111, P571, DOI 10.1111/j.1744-7348.1987.tb02015.x; Martin B, 1997, J GEN VIROL, V78, P2701, DOI 10.1099/0022-1317-78-10-2701; Martiniere A, 2009, PLANT J, V58, P135, DOI 10.1111/j.1365-313X.2008.03768.x; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; Palacios I, 2002, J GEN VIROL, V83, P3163, DOI 10.1099/0022-1317-83-12-3163; Powell G, 2005, J GEN VIROL, V86, P469, DOI 10.1099/vir.0.80632-0; SAKO N, 1981, VIROLOGY, V112, P762, DOI 10.1016/0042-6822(81)90322-6; Sanchez F, 1998, VIRUS RES, V55, P207, DOI 10.1016/S0168-1702(98)00049-5; THORNBURY DW, 1985, VIROLOGY, V144, P260, DOI 10.1016/0042-6822(85)90322-8; Tian TY, 1999, J GEN VIROL, V80, P1111, DOI 10.1099/0022-1317-80-5-1111; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P187, DOI 10.1007/BF00361931; Uzest M, 2007, P NATL ACAD SCI USA, V104, P17959, DOI 10.1073/pnas.0706608104; Uzest M, 2010, ARTHROPOD STRUCT DEV, V39, P221, DOI 10.1016/j.asd.2010.02.005; van HOOF H. A., 1954, TIJDSCHR PLANTENZIEKTEN, V60, P267; Wang RY, 1998, J GEN VIROL, V79, P1519, DOI 10.1099/0022-1317-79-6-1519; Wang RY, 1996, J GEN VIROL, V77, P3145, DOI 10.1099/0022-1317-77-12-3145; Watson MA, 1939, PROC R SOC SER B-BIO, V127, P543, DOI 10.1098/rspb.1939.0039; WIDHOLM JM, 1972, STAIN TECHNOL, V47, P189, DOI 10.3109/10520297209116483	27	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23241	10.1371/journal.pone.0023241	http://dx.doi.org/10.1371/journal.pone.0023241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853093	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200056
J	Kishida, KT; Sandberg, SG; Lohrenz, T; Comair, YG; Saez, I; Phillips, PEM; Montague, PR				Kishida, Kenneth T.; Sandberg, Stefan G.; Lohrenz, Terry; Comair, Youssef G.; Saez, Ignacio; Phillips, Paul E. M.; Montague, P. Read			Sub-Second Dopamine Detection in Human Striatum	PLOS ONE			English	Article							REAL-TIME MEASUREMENT; FREELY MOVING RATS; NEURONS ENCODE; BEHAVING RATS; HUMAN-BRAIN; REWARD; COCAINE; VOLTAMMETRY; ANIMALS; NUCLEUS	Fast-scan cyclic voltammetry at carbon fiber microelectrodes allows rapid (sub-second) measurements of dopamine release in behaving animals. Herein, we report the modification of existing technology and demonstrate the feasibility of making sub-second measurements of dopamine release in the caudate nucleus of a human subject during brain surgery. First, we describe the modification of our electrodes that allow for measurements to be made in a human brain. Next, we demonstrate in vitro and in vivo, that our modified electrodes can measure stimulated dopamine release in a rat brain equivalently to previously determined rodent electrodes. Finally, we demonstrate acute measurements of dopamine release in the caudate of a human patient during DBS electrode implantation surgery. The data generated are highly amenable for future work investigating the relationship between dopamine levels and important decision variables in human decision-making tasks.	[Kishida, Kenneth T.; Saez, Ignacio; Montague, P. Read] Virginia Tech Caril Res Inst, Human Neuroimaging Lab, Roanoke, VA USA; [Sandberg, Stefan G.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Lohrenz, Terry] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Comair, Youssef G.] Amer Univ Beirut, Dept Surg, Div Neurosurg, Lebanon, NH USA; [Montague, P. Read] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Montague, P. Read] UCL, Wellcome Trust Ctr Neuroimaging, London WC1E 6BT, England; [Sandberg, Stefan G.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine; American University of Beirut; Virginia Polytechnic Institute & State University; University of London; University College London; University of Washington; University of Washington Seattle	Kishida, KT (corresponding author), Virginia Tech Caril Res Inst, Human Neuroimaging Lab, Roanoke, VA USA.	pemp@uw.edu; read@vt.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Saez, Ignacio/0000-0003-0651-2069	NIH [DA024140, DA11723, T32-NS43124]; Parkinson's Disease Foundation; Brown Foundation; Wellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723, R21DA024140] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson's Disease Foundation; Brown Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH DA024140 (PRM & PEMP), DA11723 (PRM), T32-NS43124 (KTK), the Parkinson's Disease Foundation (SGS), the Brown Foundation (PRM), and the Wellcome Trust Principal Research Fellowship (PRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Garris PA, 1997, J NEUROCHEM, V68, P152; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Kiyatkin EA, 2000, NEUROSCIENCE, V98, P729, DOI 10.1016/S0306-4522(00)00168-8; Kramer R., 1998, CHEMOMETRIC TECHNIQU; Lohrenz T, 2007, P NATL ACAD SCI USA, V104, P9493, DOI 10.1073/pnas.0608842104; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; REBEC GV, 1993, J NEUROSCI METH, V47, P53, DOI 10.1016/0165-0270(93)90021-I; Volkow ND, 1996, J NUCL MED, V37, P1242; WICKENS J, 1990, J NEURAL TRANSM-GEN, V80, P9, DOI 10.1007/BF01245020; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469; Zaghloul KA, 2009, SCIENCE, V323, P1496, DOI 10.1126/science.1167342	21	69	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23291	10.1371/journal.pone.0023291	http://dx.doi.org/10.1371/journal.pone.0023291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829726	Green Submitted, gold, Green Published			2022-12-27	WOS:000293561200063
J	Bager, P; Kapel, C; Roepstorff, A; Thamsborg, S; Arnved, J; Ronborg, S; Kristensen, B; Poulsen, LK; Wohlfahrt, J; Melbye, M				Bager, Peter; Kapel, Christian; Roepstorff, Allan; Thamsborg, Stig; Arnved, John; Ronborg, Steen; Kristensen, Bjarne; Poulsen, Lars K.; Wohlfahrt, Jan; Melbye, Mads			Symptoms after Ingestion of Pig Whipworm Trichuris suis Eggs in a Randomized Placebo-Controlled Double-Blind Clinical Trial	PLOS ONE			English	Article							INTESTINAL NEMATODE INFECTION; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; NECATOR-AMERICANUS; ULCERATIVE-COLITIS; THERAPY; MICE; IGE; SUPPRESSION; RESISTANCE	Symptoms after human infection with the helminth Trichuris suis have not previously been described. Exposure to helminths has been suggested as immune therapy against allergy and autoimmune diseases. We randomized adults with allergic rhinitis to ingest a dose of 2500 T. suis eggs or placebo every 21 days for 168 days (total 8 doses) in a double-blind clinical trial. In a previous publication, we reported a lack of efficacy and a high prevalence of adverse gastrointestinal reactions. The aim of the present study was to present a detailed description of the adverse event data and post-hoc analyses of gastrointestinal reactions. Adverse events and severity (mild, moderate, severe) were recorded daily by subjects, classified by organ using MedDRA 10.0, and event rates compared between subjects on T. suis treatment vs. subjects on placebo. T. suis-specific serum IgG antibodies were measured by a fluoroenzymeimmunoassay (Phadia ApS). During 163 days complete follow-up, subjects ingesting T. suis eggs (N = 49) had a three to 19-fold higher rate of events (median duration, 2 days) with gastrointestinal reactions (moderate to severe flatulence, diarrhea, and upper abdominal pain) compared with placebo subjects (N = 47). The highest incidence of affected subjects was seen from the first few days and until day 42 (3(rd) dose): 63% vs. 29% for placebo; day 163: 76% vs. 49% for placebo. Seroprevalences increased concurrently in the T. suis group: Day 59, 50%; day 90, 91%; day 170, 93%. The combined duration of episodes with onset before day 42 was <= 14 days in 80% of affected subjects. Age, gender, total IgE, and recent intestinal symptoms at baseline did not predict gastrointestinal side effects. In conclusion, during the first 2 months, repeated ingestions of 2500 T. suis eggs caused frequent gastrointestinal reactions lasting up to 14 days, whereas 4 months further treatment mainly provoked a subclinical stimulation.	[Bager, Peter; Wohlfahrt, Jan; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Kapel, Christian] Univ Copenhagen, Dept Agr & Ecol, Fac Life Sci, Frederiksberg, Denmark; [Roepstorff, Allan; Thamsborg, Stig] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Arnved, John; Ronborg, Steen] Pulmonol & Allergy Clin Copenhagen, Copenhagen, Denmark; [Kristensen, Bjarne] Phadia ApS, Allerod, Denmark; [Poulsen, Lars K.] Natl Univ Hosp, Allergy Clin, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; University of Copenhagen	Bager, P (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	pbg@ssi.dk	Poulsen, Lars K/J-3065-2019; Kapel, Christian M. O./G-9168-2014	Poulsen, Lars K/0000-0002-1730-847X; Kapel, Christian M. O./0000-0002-9539-457X; Bager, Peter/0000-0002-3577-8459; melbye, mads/0000-0001-8264-6785; Thamsborg, Stig Milan/0000-0003-3304-7422	Danish Medical Research Council; TrygFonden for Health; The A.P. Moller and Chastine McKinney Moller Foundation for Progress of Medical Sciences; Aase and Ejnar Danielsen's Foundation for Medical Sciences; The Hartmann Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); TrygFonden for Health; The A.P. Moller and Chastine McKinney Moller Foundation for Progress of Medical Sciences; Aase and Ejnar Danielsen's Foundation for Medical Sciences; The Hartmann Foundation	This work was supported by unrestricted grants from the Danish Medical Research Council, TrygFonden for Health, The A.P. Moller and Chastine McKinney Moller Foundation for Progress of Medical Sciences, Aase and Ejnar Danielsen's Foundation for Medical Sciences, and The Hartmann Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bager P, 2010, J ALLERGY CLIN IMMUN, V125, P123, DOI 10.1016/j.jaci.2009.08.006; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Bancroft AJ, 1998, J IMMUNOL, V160, P3453; BEER RJS, 1973, PARASITOLOGY, V67, P253, DOI 10.1017/S0031182000046497; BEER RJS, 1971, BRIT MED J, V2, P44, DOI 10.1136/bmj.2.5752.44; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; Croese J, 2006, TRENDS PARASITOL, V22, P547, DOI 10.1016/j.pt.2006.09.010; Croese J, 2006, GASTROENTEROLOGY, V131, P402, DOI 10.1053/j.gastro.2006.05.019; Faulkner H, 2002, J INFECT DIS, V185, P665, DOI 10.1086/339005; Feary JR, 2010, CLIN EXP ALLERGY, V40, P299, DOI 10.1111/j.1365-2222.2009.03433.x; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; HAGEL I, 1993, CLIN EXP IMMUNOL, V94, P80, DOI 10.1111/j.1365-2249.1993.tb05981.x; Hsu SJ, 2005, GASTROENTEROLOGY, V129, P768, DOI 10.1053/j.gastro.2005.06.038; Hubner MP, 2009, IMMUNOLOGY, V127, P512, DOI 10.1111/j.1365-2567.2008.02958.x; Kradin RL, 2006, ARCH PATHOL LAB MED, V130, P718; Kringel H, 2007, PARASITE IMMUNOL, V29, P327, DOI 10.1111/j.1365-3024.2007.00943.x; Kringel H, 2006, INT J PARASITOL, V36, P915, DOI 10.1016/j.ijpara.2006.04.008; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Nejsum P, 2009, HEREDITY, V102, P357, DOI 10.1038/hdy.2008.131; Salinas-Carmona MC, 2009, AUTOIMMUNITY, V42, P25, DOI 10.1080/08916930802228290; Shin JL, 2004, CAN J GASTROENTEROL, V18, P175, DOI 10.1155/2004/298064; SKOV PS, 1984, AGENTS ACTIONS, V14, P414, DOI 10.1007/BF01973840; Summers RW, 2005, INFLAMM BOWEL DIS, V11, P783, DOI 10.1097/01.MIB.0000179316.50002.f3; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Turner JD, 2005, MICROBES INFECT, V7, P990, DOI 10.1016/j.micinf.2005.03.036; Van Kruiningen HJ, 2005, INFLAMM BOWEL DIS, V11, P515, DOI 10.1097/01.MIB.0000160369.47671.a2; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; World Medical Association, 2008, DECL HELS ETH PRINC	33	53	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22346	10.1371/journal.pone.0022346	http://dx.doi.org/10.1371/journal.pone.0022346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829616	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511900005
J	Gill, PJ; Wang, KY; Mant, D; Hartling, L; Heneghan, C; Perera, R; Klassen, T; Harnden, A				Gill, Peter J.; Wang, Kay Yee; Mant, David; Hartling, Lisa; Heneghan, Carl; Perera, Rafael; Klassen, Terry; Harnden, Anthony			The Evidence Base for Interventions Delivered to Children in Primary Care: An Overview of Cochrane Systematic Reviews	PLOS ONE			English	Review							GENERAL-PRACTICE; QUALITY; HEALTH; METAANALYSES; CHILDHOOD; TRIALS; TRENDS	Background: As a first step in developing a framework to evaluate and improve the quality of care of children in primary care there is a need to identify the evidence base underpinning interventions relevant to child health. Our objective was to identify all Cochrane systematic reviews relevant to the management of childhood conditions in primary care and to assess the extent to which Cochrane reviews reflect the burden of childhood illness presenting in primary care. Methodology/Principal Findings: We used the Cochrane Child Health Field register of child-relevant systematic reviews to complete an overview of Cochrane reviews related to the management of children in primary care. We compared the proportion of systematic reviews with the proportion of consultations in Australia, US, Dutch and UK general practice in children. We identified 396 relevant systematic reviews; 358 included primary studies on children while 251 undertook a meta-analysis. Most reviews (n = 218, 55%) focused on chronic conditions and over half (n = 216, 57%) evaluated drug interventions. Since 2000, the percentage of pediatric primary care relevant reviews only increased by 2% (7% to 9%) compared to 18% (10% to 28%) in all child relevant reviews. Almost a quarter of reviews (n = 78, 23%) were published on asthma treatments which only account for 3-5% of consultations. Conversely, 15-23% of consultations are due to skin conditions yet they represent only 7% (n = 23) of reviews. Conclusions/Significance: Although Cochrane systematic reviews focus on clinical trials and do not provide a comprehensive picture of the evidence base underpinning the management of children in primary care, the mismatch between the focus of the published research and the focus of clinical activity is striking. Clinical trials are an important component of the evidence base and the lack of trial evidence to demonstrate intervention effectiveness in substantial areas of primary care for children should be addressed.	[Gill, Peter J.; Wang, Kay Yee; Mant, David; Heneghan, Carl; Perera, Rafael; Harnden, Anthony] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Gill, Peter J.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Hartling, Lisa] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Hartling, Lisa; Klassen, Terry] Univ Alberta, Dept Pediat, Cochrane Child Hlth Field, Edmonton, AB, Canada; [Klassen, Terry] Univ Manitoba, Dept Pediat & Child Hlth, Manitoba Inst Child Hlth, Winnipeg, MB R3T 2N2, Canada	University of Oxford; University of Alberta; University of Alberta; University of Alberta; University of Manitoba	Gill, PJ (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	peter.gill@phc.ox.ac.uk	Gill, Peter J./A-6021-2012; Gung, Amber/D-9842-2011	Gill, Peter J./0000-0002-6253-1312; Perera, Rafael/0000-0003-2418-2091; Klassen, Terry/0000-0002-5309-7091	Canadian Institutes of Health Research [13278]; Cochrane Child Health Field; Alberta Research Centre for Health Evidence (ARCHE); National Institute for Health Research [DRF-2009-02-145] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cochrane Child Health Field; Alberta Research Centre for Health Evidence (ARCHE); National Institute for Health Research(National Institute for Health Research (NIHR))	The creation of the Cochrane Child Health Field Reviews Register was funded by the Canadian Institutes of Health Research (grant 13278), the Cochrane Child Health Field and the Alberta Research Centre for Health Evidence (ARCHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AC MED SCI, 2009, RES GEN PRACT BRING; [Anonymous], GLOB BURD DIS 2004 U; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Beal AC, 2004, PEDIATRICS, V113, P199; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Bow Simon, 2010, BMC Pediatr, V10, P34, DOI 10.1186/1471-2431-10-34; Britt H, 2008, GEN PRACTICE ACTIVIT; Britt H, 2007, AUST FAM PHYSICIAN, V36, P36; Bruijnzeels MA, 1998, BRIT J GEN PRACT, V48, P880; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chalmers I, 2003, BRIT MED J, V327, P1017, DOI 10.1136/bmj.327.7422.1017; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Charles J, 2004, MED J AUSTRALIA, V180, P216, DOI 10.5694/j.1326-5377.2004.tb05888.x; Christensen ML, 1999, PEDIATRICS, V104, P593; Cramer Kristie, 2005, BMC Pediatr, V5, P38, DOI 10.1186/1471-2431-5-38; Fleming DM, 2010, J PUBLIC HEALTH-UK, V32, P90, DOI 10.1093/pubmed/fdp087; Fleming D M, 1999, Commun Dis Public Health, V2, P96; Freid V M, 1998, Vital Health Stat 13, P1; Garritty C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009914; Gill P, 1996, BRIT MED J, V312, P819; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Harnden A, 2009, BRIT J GEN PRACT, V59, P819, DOI 10.3399/bjgp09X472520; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Klassen TP, 2009, LANCET, V374, P1310, DOI 10.1016/S0140-6736(09)61803-1; Klassen TP, 2008, PLOS MED, V5, P1180, DOI 10.1371/journal.pmed.0050172; Loaiza E, 2008, LANCET, V372, P874, DOI 10.1016/S0140-6736(08)61378-1; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; Martinez-Castaldi C, 2008, PEDIATRICS, V122, P52, DOI 10.1542/peds.2007-2849; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Otters Hanneke B M, 2005, Eur J Gen Pract, V11, P17; *ROYAL COLL GEN PR, 2008, WEEKL RET SERV ANN P, P1; Rudolf MCJ, 1999, ARCH DIS CHILD, V80, P257, DOI 10.1136/adc.80.3.257; Saxena S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007484; Soler JK, 2008, FAM PRACT, V25, P312, DOI 10.1093/fampra/cmn028; Straus S, 2010, CAN MED ASSOC J, V182, P13, DOI 10.1503/cmaj.081849; Thomson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013106; United Nations Childrens Fund, 2007, STAT WORLDS CHILDR 2; Waters Kellie L, 2006, BMC Pediatr, V6, P26, DOI 10.1186/1471-2431-6-26; Wen J, 2008, J CLIN EPIDEMIOL, V61, P770, DOI 10.1016/j.jclinepi.2007.10.008; *WHO, 2011, INT CLASS PRIM CAR 2; World Health Organization, 2011, INT CLASS DIS ICD	44	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23051	10.1371/journal.pone.0023051	http://dx.doi.org/10.1371/journal.pone.0023051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829691	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200035
J	Stover, NA; Dixon, TA; Cavalcanti, ARO				Stover, Nicholas A.; Dixon, Thomas A.; Cavalcanti, Andre R. O.			Multiple Independent Fusions of Glucose-6-Phosphate Dehydrogenase with Enzymes in the Pentose Phosphate Pathway	PLOS ONE			English	Article							HEXOSE 6-PHOSPHATE DEHYDROGENASE; HEXOSE-6-PHOSPHATE DEHYDROGENASE; BIFUNCTIONAL ENZYME; SEQUENCE ALIGNMENT; GENOME-SEQUENCE; GENE FUSION; 6-PHOSPHOGLUCONOLACTONASE; CRYPTOSPORIDIUM; EVOLUTIONARY; DEHYDROGENASE-6-PHOSPHOGLUCONOLACTONASE	Fusions of the first two enzymes in the pentose phosphate pathway, glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconolactonase (6PGL), have been previously described in two distant clades, chordates and species of the malarial parasite Plasmodium. We have analyzed genome and expressed sequence data from a variety of organisms to identify the origins of these gene fusion events. Based on the orientation of the domains and range of species in which homologs can be found, the fusions appear to have occurred independently, near the base of the metazoan and apicomplexan lineages. Only one of the two metazoan paralogs of G6PD is fused, showing that the fusion occurred after a duplication event, which we have traced back to an ancestor of choanoflagellates and metazoans. The Plasmodium genes are known to contain a functionally important insertion that is not seen in the other apicomplexan fusions, highlighting this as a unique characteristic of this group. Surprisingly, our search revealed two additional fusion events, one that combined 6PGL and G6PD in an ancestor of the protozoan parasites Trichomonas and Giardia, and another fusing G6PD with phosphogluconate dehydrogenase (6PGD) in a species of diatoms. This study extends the range of species known to contain fusions in the pentose phosphate pathway to many new medically and economically important organisms.	[Stover, Nicholas A.] Bradley Univ, Dept Biol, Peoria, IL 61625 USA; [Dixon, Thomas A.] Pomona Coll, Dept Chem, Claremont, CA 91711 USA; [Cavalcanti, Andre R. O.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA	Bradley University; Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Stover, NA (corresponding author), Bradley Univ, Dept Biol, Peoria, IL 61625 USA.	aroc@pomona.edu	Cavalcanti, Andre RO/H-9777-2013	Cavalcanti, Andre RO/0000-0001-8708-6932	National Science Foundation [0920697]; Direct For Biological Sciences [0920697] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by National Science Foundation Award Number 0920697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; BEUTLER E, 1967, J BIOL CHEM, V242, P5289; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Clarke JL, 2003, MOL BIOCHEM PARASIT, V127, P1, DOI 10.1016/S0166-6851(02)00298-0; Clarke JL, 2003, ARCH BIOCHEM BIOPHYS, V415, P229, DOI 10.1016/S0003-9861(03)00229-7; Clarke JL, 2001, EUR J BIOCHEM, V268, P2013, DOI 10.1046/j.1432-1327.2001.02078.x; Collard F, 1999, FEBS LETT, V459, P223, DOI 10.1016/S0014-5793(99)01247-8; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Cui J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000782; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MATSUOKA N, 1980, COMP BIOCHEM PHYS B, V65, P191, DOI 10.1016/0305-0491(80)90002-4; MATSUOKA N, 1983, COMP BIOCHEM PHYS B, V76, P811, DOI 10.1016/0305-0491(83)90397-8; Miclet E, 2001, J BIOL CHEM, V276, P34840, DOI 10.1074/jbc.M105174200; MOCHIZUKI Y, 1976, COMP BIOCHEM PHYS B, V54, P489, DOI 10.1016/0305-0491(76)90127-9; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nash R, 2007, NUCLEIC ACIDS RES, V35, pD468, DOI 10.1093/nar/gkl931; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Okuda S, 2006, NUCLEIC ACIDS RES, V34, pD358, DOI 10.1093/nar/gkj037; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Senesi S, 2010, BIOL CHEM, V391, P1, DOI 10.1515/BC.2009.146; SHAW CR, 1968, ANN NY ACAD SCI, V151, P149, DOI 10.1111/j.1749-6632.1968.tb11884.x; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; STEGEMAN JJ, 1971, BIOCHEM GENET, V5, P579, DOI 10.1007/BF00485675; TAN SG, 1976, HUM HERED, V26, P113, DOI 10.1159/000152791; Templeton TJ, 2010, MOL BIOL EVOL, V27, P235, DOI 10.1093/molbev/msp226; Wasmuth J, 2009, GENOME RES, V19, P1202, DOI 10.1101/gr.083386.108; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; YAMAUCHI T, 1973, BIOCHEM GENET, V10, P121, DOI 10.1007/BF00485760; Zhu G, 2000, INT J SYST EVOL MICR, V50, P1673, DOI 10.1099/00207713-50-4-1673	51	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22269	10.1371/journal.pone.0022269	http://dx.doi.org/10.1371/journal.pone.0022269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829610	Green Submitted, gold, Green Published			2022-12-27	WOS:000293511200006
J	Cui, WC; Ma, JF; Wang, YL; Biswal, S				Cui, Wanchang; Ma, Jinfang; Wang, Yulei; Biswal, Shyam			Plasma miRNA as Biomarkers for Assessment of Total-Body Radiation Exposure Dosimetry	PLOS ONE			English	Article							CIRCULATING MICRORNAS; IONIZING-RADIATION; QUANTITATIVE DETECTION; SYSTEMIC RNAI; BLOOD; CANCER; MOUSE; DNA; EXPRESSION; VESICLES	The risk of radiation exposure, due to accidental or malicious release of ionizing radiation, is a major public health concern. Biomarkers that can rapidly identify severely-irradiated individuals requiring prompt medical treatment in mass-casualty incidents are urgently needed. Stable blood or plasma-based biomarkers are attractive because of the ease for sample collection. We tested the hypothesis that plasma miRNA expression profiles can accurately reflect prior radiation exposure. We demonstrated using a murine model that plasma miRNA expression signatures could distinguish mice that received total body irradiation doses of 0.5 Gy, 2 Gy, and 10 Gy (at 6 h or 24 h post radiation) with accuracy, sensitivity, and specificity of above 90%. Taken together, these data demonstrate that plasma miRNA profiles can be highly predictive of different levels of radiation exposure. Thus, plasma-based biomarkers can be used to assess radiation exposure after mass-casualty incidents, and it may provide a valuable tool in developing and implementing effective countermeasures.	[Cui, Wanchang; Ma, Jinfang; Biswal, Shyam] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Wang, Yulei] Life Technol, Genom Assays R&D, Foster City, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Thermo Fisher Scientific	Cui, WC (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	sbiswal@jhsph.edu		Cui, Wanchang/0000-0001-6408-8601; Wang, Yulei/0000-0002-9057-9786	National Institutes of Health [R33 AI080541, ES03819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI080541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health Grants R33 AI080541 and ES03819. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anno GH, 2003, HEALTH PHYS, V84, P565, DOI 10.1097/00004032-200305000-00001; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chaudhry MA, 2010, DNA CELL BIOL, V29, P553, DOI 10.1089/dna.2009.0978; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Coleman CN, 2004, SCIENCE, V304, P693, DOI 10.1126/science.1095956; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Cowan Matthew L, 2008, Expert Rev Proteomics, V5, P21, DOI 10.1586/14789450.5.1.21; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Ebert MPA, 2006, J PROTEOME RES, V5, P19, DOI 10.1021/pr050271e; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; Gougelet RM, 2010, HEALTH PHYS, V98, P118, DOI 10.1097/HP.0b013e3181a6de7d; GREENBERG ML, 1968, RADIAT RES, V35, P147, DOI 10.2307/3572441; HALL EJ, 2000, RADIOBIOLOGY RADIOLO, pR11; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muriithi EV, 2000, PLATELETS, V11, P33; Ooi AGL, 2010, P NATL ACAD SCI USA, V107, P21505, DOI 10.1073/pnas.1016218107; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang L, 2010, BRIT J RADIOL, V83, P694, DOI 10.1259/bjr/49886569; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	51	63	71	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22988	10.1371/journal.pone.0022988	http://dx.doi.org/10.1371/journal.pone.0022988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857976	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300010
J	Kasprowicz, VO; Mitchell, JE; Chetty, S; Govender, P; Huang, KHG; Fletcher, HA; Webster, DP; Brown, S; Kasmar, A; Millington, K; Day, CL; Mkhwanazi, N; McClurg, C; Chonco, F; Lalvani, A; Walker, BD; Ndung'u, T; Klenerman, P				Kasprowicz, Victoria O.; Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; Huang, Kuan-Hsiang Gary; Fletcher, Helen A.; Webster, Daniel P.; Brown, Sebastian; Kasmar, Anne; Millington, Kerry; Day, Cheryl L.; Mkhwanazi, Nompumelelo; McClurg, Cheryl; Chonco, Fundisiwe; Lalvani, Ajit; Walker, Bruce D.; Ndung'u, Thumbi; Klenerman, Paul			A Molecular Assay for Sensitive Detection of Pathogen-Specific T-Cells	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; IFN-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; DIAGNOSIS; IP-10; TOOLS; EXPRESSION; CHILDREN; DISEASE	Here we describe the development and validation of a highly sensitive assay of antigen-specific IFN-gamma production using real time quantitative PCR (qPCR) for two reporters monokine-induced by IFN-gamma (MIG) and the IFN-gamma inducible protein-10 (IP10). We developed and validated the assay and applied it to the detection of CMV, HIV and Mycobacterium tuberculosis (MTB) specific responses, in a cohort of HIV co-infected patients. We compared the sensitivity of this assay to that of the ex vivo RD1 (ESAT-6 and CFP-10)-specific IFN-gamma Elispot assay. We observed a clear quantitative correlation between the two assays (P<0.001). Our assay proved to be a sensitive assay for the detection of MTB-specific T cells, could be performed on whole blood samples of fingerprick (50 uL) volumes, and was not affected by HIV-mediated immunosuppression. This assay platform is potentially of utility in diagnosis of infection in this and other clinical settings.	[Kasprowicz, Victoria O.; Mitchell, Jessica E.; McClurg, Cheryl; Walker, Bruce D.; Ndung'u, Thumbi] Harvard Univ, Sch Med, Ragon Inst MGH MIT & Harvard, Boston, MA 02215 USA; [Kasprowicz, Victoria O.; Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; McClurg, Cheryl] Nelson R Mandela Sch Med, Kwazulu Natal Res Inst TB & HIV, Durban, South Africa; [Kasprowicz, Victoria O.; Mitchell, Jessica E.; Chetty, Shivan; Govender, Pamla; Day, Cheryl L.; Mkhwanazi, Nompumelelo; McClurg, Cheryl; Chonco, Fundisiwe; Walker, Bruce D.; Ndung'u, Thumbi] Nelson R Mandela Sch Med, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa; [Fletcher, Helen A.] Univ Oxford, Nuffield Dept Med, Jenner Inst, Oxford, England; [Huang, Kuan-Hsiang Gary; Webster, Daniel P.; Brown, Sebastian; Klenerman, Paul] Univ Oxford, Nuffield Dept Med, Oxford Biomed Res Ctr, Oxford, England; [Huang, Kuan-Hsiang Gary; Webster, Daniel P.; Brown, Sebastian; Klenerman, Paul] Univ Oxford, James Martin Sch 21st Century, Oxford, England; [Kasmar, Anne] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA; [Millington, Kerry; Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, TB Res Unit, Dept Resp Med, Natl Heart & Lung Inst, London, England	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; University of Kwazulu Natal; University of Oxford; Jenner Institute; University of Oxford; University of Oxford; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Imperial College London	Kasprowicz, VO (corresponding author), Harvard Univ, Sch Med, Ragon Inst MGH MIT & Harvard, Boston, MA 02215 USA.	vkasprowicz@partners.org	Fletcher, Helen/D-1470-2011; Day, Cheryl/GQQ-9720-2022; Day, Cheryl L/J-9844-2012	Day, Cheryl L/0000-0002-6497-4846; Ndung'u, Thumbi/0000-0003-2962-3992; klenerman, paul/0000-0003-4307-9161; Lalvani, Ajit/0000-0002-2396-246X; Fletcher, Helen/0000-0002-0435-1006; Brown, Sebastian/0000-0002-0627-880X	Howard Hughes Medical Institute; KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Wellcome Trust; James Martin School for 21st Century (Oxford); NIHR (Oxford); MRC; National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases [NIAID]) [1U19AI082630-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, P30AI060354, K08AI089858] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Wellcome Trust(Wellcome TrustEuropean Commission); James Martin School for 21st Century (Oxford); NIHR (Oxford)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases [NIAID])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank the Howard Hughes Medical Institute, the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), the Wellcome Trust, the James Martin School for 21st Century (Oxford), the NIHR Biomedical Research Centre Programme (Oxford), the MRC, and the National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases [NIAID] 1U19AI082630-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramo C, 2006, MICROBES INFECT, V8, P45, DOI 10.1016/j.micinf.2005.05.019; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Berthoud TK, 2009, VACCINE, V28, P21, DOI 10.1016/j.vaccine.2009.09.132; Brice GT, 2001, J IMMUNOL METHODS, V257, P55, DOI 10.1016/S0022-1759(01)00446-X; Campion S, 2011, EUR J IMMUNOL, V41, P255, DOI 10.1002/eji.201040296; Dunachie SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012557; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Fisher RA, 2009, TRANSPL INFECT DIS, V11, P195, DOI 10.1111/j.1399-3062.2009.00372.x; Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39; Klenerman P, 2002, NAT REV IMMUNOL, V2, P263, DOI 10.1038/nri777; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Trojan A, 2007, J CLIN VIROL, V40, P80, DOI 10.1016/j.jcv.2007.04.022; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901	20	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e20606	10.1371/journal.pone.0020606	http://dx.doi.org/10.1371/journal.pone.0020606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853018	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400003
J	Ren, P; Nicholls, MER; Ma, YY; Chen, L				Ren, Ping; Nicholls, Michael E. R.; Ma, Yuan-ye; Chen, Lin			Size Matters: Non-Numerical Magnitude affects the Spatial Coding of Response	PLOS ONE			English	Article							MENTAL NUMBER LINE; PARIETAL CORTEX; SPACE; TIME; REPRESENTATION; PERFORMANCE; PERCEPTION; MODULATION; LUMINANCE; QUANTITY	It is known that small and large numbers facilitate left/right respectively (the SNAR effect). Recently, it has been proposed that numerical magnitude is just one example of a range of quantitites, which have a common cognitive/neural representation. To investigate this proposition, response congruency effects were explored for stimuli which differed accoding to their: (a) numerical size, (b) physical size, (c) luminance, (d) conceptual size and (e) auditory eintensity. In a series of experiments, groups of undergraduate participants made two-alternative forced choice discriminiations with their left or right hands. There were clear interactions between magnitude and responding hand whereby rught hand responcses were faster for stimuli with (a) large numbers, (b) large physical size, (c) low luminance, and (d) a refernce to large objeects. There was no congruency effect for the auditory stimuli. The data demonstrate that the response congruency effect observed for numbers also occurs for a variety of other of non-numerical visual quntities. These results support model of general magnitude representation and suggest that the association between magnitude and the left/right sides of space may not be related to culture and/or directional reading habits.	[Ren, Ping; Ma, Yuan-ye] Chinese Acad Sci, State Key Lab Brain & Cognit, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Ren, Ping] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Nicholls, Michael E. R.] Flinders Univ S Australia, Sch Psychol, Adelaide, SA, Australia; [Ma, Yuan-ye; Chen, Lin] Chinese Acad Sci, State Key Lab Brain & Cognit, Inst Biophys, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Flinders University South Australia; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ren, P (corresponding author), Chinese Acad Sci, State Key Lab Brain & Cognit, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	yuanma0716@vip.sina.com	Ren, Ping/AFE-3916-2022; Ren, Ping/AAE-9560-2022	Nicholls, Mike/0000-0002-7072-3744	Ministry of Science and Technology of China [2005CB522800]; National Nature Science Foundation of China [30870825, 30770700, 30921064]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by 973 grant from the National Strategic Basic Research Program of the Ministry of Science and Technology of China (2005CB522800) and National Nature Science Foundation of China grants (30870825, 30770700, 30921064). The funders had no role in study design, data collection and analysis, decision ot publish, or preparation of the manuscript.	Belin P, 1998, J NEUROSCI, V18, P6388; Bryden PJ, 2007, LATERALITY, V12, P364, DOI 10.1080/13576500701356244; Cappelletti M, 2007, EXP BRAIN RES, V179, P631, DOI 10.1007/s00221-006-0820-0; Cappelletti M, 2009, NEUROIMAGE, V46, P522, DOI 10.1016/j.neuroimage.2009.02.016; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Di Luca S, 2006, Q J EXP PSYCHOL, V59, P1648, DOI 10.1080/17470210500256839; Fias W, 2001, COGNITIVE BRAIN RES, V12, P415, DOI 10.1016/S0926-6410(01)00078-7; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Gevers W, 2005, PSYCHOL SCI, V47, P10; Gevers Wim, 2004, Cortex, V40, P171, DOI 10.1016/S0010-9452(08)70938-9; Ito Y, 2004, MEM COGNITION, V32, P662, DOI 10.3758/BF03195857; Kadosh RC, 2008, CEREB CORTEX, V18, P337, DOI 10.1093/cercor/bhm058; Kadosh RC, 2007, CURR BIOL, V17, P689, DOI 10.1016/j.cub.2007.02.056; Knops A, 2006, NEUROPSYCHOLOGIA, V44, P2270, DOI 10.1016/j.neuropsychologia.2006.05.011; McMillan CT, 2006, BRAIN COGNITION, V62, P250, DOI 10.1016/j.bandc.2006.06.005; Nicholls MER, 2008, PSYCHON B REV, V15, P413, DOI 10.3758/PBR.15.2.413; Nuerk HC, 2005, EXP PSYCHOL, V52, P187, DOI 10.1027/1618-3169.52.3.187; Oliveri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007933; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Sato M, 2007, J COGNITIVE NEUROSCI, V19, P684, DOI 10.1162/jocn.2007.19.4.684; Schwarz W, 2006, EXP PSYCHOL, V53, P4, DOI 10.1027/1618-3169.53.1.4; Schwarz W, 2004, CELL, V66, P651; Schwarz W, 2009, J EXP PSYCHOL HUMAN, V35, P989, DOI 10.1037/a0013703; Vallesi A, 2011, CORTEX, V47, P148, DOI 10.1016/j.cortex.2009.09.005; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; WELCH RB, 1986, PERCEPT PSYCHOPHYS, V39, P294, DOI 10.3758/BF03204939; Wood G, 2008, CORTEX, V44, P353, DOI 10.1016/j.cortex.2008.01.002; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2; Zebian S, 2005, J COGN CULT, V5, P165, DOI 10.1163/1568537054068660; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	36	77	77	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23553	10.1371/journal.pone.0023553	http://dx.doi.org/10.1371/journal.pone.0023553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853151	gold, Green Published			2022-12-27	WOS:000293953400052
J	Ebrahimi, M; Lakizadeh, A; Agha-Golzadeh, P; Ebrahimie, E; Ebrahimi, M				Ebrahimi, Mansour; Lakizadeh, Amir; Agha-Golzadeh, Parisa; Ebrahimie, Esmaeil; Ebrahimi, Mahdi			Prediction of Thermostability from Amino Acid Attributes by Combination of Clustering with Attribute Weighting: A New Vista in Engineering Enzymes	PLOS ONE			English	Article							THERMAL-STABILITY; 3-ISOPROPYLMALATE DEHYDROGENASE; PROTEIN STABILITY; STRUCTURAL BASIS; EXPRESSION; XYLANASE; FEATURES; PATTERNS; DISCRIMINATION; STABILIZATION	The engineering of thermostable enzymes is receiving increased attention. The paper, detergent, and biofuel industries, in particular, seek to use environmentally friendly enzymes instead of toxic chlorine chemicals. Enzymes typically function at temperatures below 60 degrees C and denature if exposed to higher temperatures. In contrast, a small portion of enzymes can withstand higher temperatures as a result of various structural adaptations. Understanding the protein attributes that are involved in this adaptation is the first step toward engineering thermostable enzymes. We employed various supervised and unsupervised machine learning algorithms as well as attribute weighting approaches to find amino acid composition attributes that contribute to enzyme thermostability. Specifically, we compared two groups of enzymes: mesostable and thermostable enzymes. Furthermore, a combination of attribute weighting with supervised and unsupervised clustering algorithms was used for prediction and modelling of protein thermostability from amino acid composition properties. Mining a large number of protein sequences (2090) through a variety of machine learning algorithms, which were based on the analysis of more than 800 amino acid attributes, increased the accuracy of this study. Moreover, these models were successful in predicting thermostability from the primary structure of proteins. The results showed that expectation maximization clustering in combination with uncertainly and correlation attribute weighting algorithms can effectively (100%) classify thermostable and mesostable proteins. Seventy per cent of the weighting methods selected Gln content and frequency of hydrophilic residues as the most important protein attributes. On the dipeptide level, the frequency of Asn-Glu was the key factor in distinguishing mesostable from thermostable enzymes. This study demonstrates the feasibility of predicting thermostability irrespective of sequence similarity and will serve as a basis for engineering thermostable enzymes in the laboratory.	[Ebrahimi, Mansour] Univ Qom, Dept Biol, Qom, Iran; [Ebrahimi, Mansour; Lakizadeh, Amir] Univ Qom, Bioinformat Res Grp, Qom, Iran; [Lakizadeh, Amir] Univ Qom, Dept Comp Sci, Qom, Iran; [Agha-Golzadeh, Parisa; Ebrahimie, Esmaeil] Shiraz Univ, Coll Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran; [Ebrahimi, Mahdi] Max Planck Inst Informat, Saarbrucken, Germany	Shiraz University; Max Planck Society	Ebrahimi, M (corresponding author), Univ Qom, Dept Biol, Qom, Iran.	mebrahimi14@gmail.com	Ebrahimi, Mahdi/A-5042-2012; ebrahimi, mansour/D-9950-2011; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimi, Mahdi/0000-0002-3827-7369; Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Aghagolzadeh, Parisa/0000-0002-1519-5790; lakizadeh, amir/0000-0001-9870-3676	Bioinformatics Research Group	Bioinformatics Research Group	The work has been supported by Bioinformatics Research Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Akanuma S, 1997, FEBS LETT, V410, P141, DOI 10.1016/S0014-5793(97)00540-1; Asada Y, 2009, CHEM-BIOL INTERACT, V178, P117, DOI 10.1016/j.cbi.2008.09.018; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; ASHRAFI E, 2011, BIOINFORMAT IN PRESS; BALASUBRAMANIAN D, 2007, C P IEEE ENG MED BIO, P2134; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Baumgartner C, 2010, BIOINFORMATICS, V26, P1745, DOI 10.1093/bioinformatics/btq254; Bendova-Biedermannova L, 2008, PROTEINS, V72, P402, DOI 10.1002/prot.21938; Berens S, 1996, ANTON LEEUW INT J G, V69, P235, DOI 10.1007/BF00399612; Bijanzadeh E, 2010, AUST J CROP SCI, V4, P402; Billings SA, 2007, NEURAL NETWORKS, V20, P1081, DOI 10.1016/j.neunet.2007.09.017; Bogin O, 1998, PROTEIN SCI, V7, P1156, DOI 10.1002/pro.5560070509; Borovskii Genadii B, 2002, BMC Plant Biol, V2, P5, DOI 10.1186/1471-2229-2-5; Chantasingh D, 2006, PROTEIN EXPRES PURIF, V46, P143, DOI 10.1016/j.pep.2005.09.013; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Dancey D, 2007, IEEE T SYST MAN CY B, V37, P794, DOI 10.1109/TSMCB.2007.895334; De Bruyne Veronique, 2007, V382, P373, DOI 10.1007/978-1-59745-304-2_23; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Ebrahimi M, 2009, EXCLI J, V8, P218; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; EBRAHIMIE E, 2010, J CELL MOL RES, V2, P15; Ebrahimie Esmaeil, 2011, Saline Syst, V7, P1, DOI 10.1186/1746-1448-7-1; Fisher J, 2010, BRIEF FUNCT GENOMICS, V9, P79, DOI 10.1093/bfgp/elp054; Fu XJ, 2003, IEEE T SYST MAN CY B, V33, P399, DOI 10.1109/TSMCB.2003.810911; Georis J, 2000, PROTEIN SCI, V9, P466; Gromiha MM, 2008, PROTEINS, V70, P1274, DOI 10.1002/prot.21616; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; Gromiha MM, 2002, BIOPOLYMERS, V64, P210, DOI 10.1002/bip.10125; Gromiha MM, 2001, BIOPHYS CHEM, V91, P71, DOI 10.1016/S0301-4622(01)00154-5; Habashy HO, 2011, BREAST CANCER RES TR, V128, P315, DOI 10.1007/s10549-010-1073-y; Heider D, 2009, TECHNOL CANCER RES T, V8, P333, DOI 10.1177/153303460900800503; KIRINO H, 1994, EUR J BIOCHEM, V220, P275, DOI 10.1111/j.1432-1033.1994.tb18623.x; Lin HH, 2006, J LIPID RES, V47, P824, DOI 10.1194/jlr.M500530-JLR200; Lin Y, 2008, BIOINFORMATICS, V24, P2665, DOI 10.1093/bioinformatics/btn509; MASUI A, 1994, APPL ENVIRON MICROB, V60, P3579, DOI 10.1128/AEM.60.10.3579-3584.1994; McLachlan Geoffrey J., 2008, V453, P423, DOI 10.1007/978-1-60327-429-6_22; Miyazaki K, 2006, J BIOL CHEM, V281, P10236, DOI 10.1074/jbc.M511948200; Paloheimo M, 2007, APPL ENVIRON MICROB, V73, P3215, DOI 10.1128/AEM.02967-06; Rustici G. R., 2008, CURR PROTOC BIOINFOR; Singer GAC, 2003, GENE, V317, P39, DOI 10.1016/S0378-1119(03)00660-7; Sparks ME, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-381; THAI KM, 2009, MOL DIVERS; Valavanis IK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-453; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379; Waydo S, 2008, NEURAL COMPUT, V20, P1165, DOI 10.1162/neco.2007.03-07-493; Yang Hao-Meng, 2005, Sheng Wu Gong Cheng Xue Bao, V21, P6; Yang ZR, 2010, METHODS MOL BIOL, V609, P197, DOI 10.1007/978-1-60327-241-4_12; Ye XF, 2009, PHARMACOEPIDEM DR S, V18, P154, DOI 10.1002/pds.1695; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0	54	44	46	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23146	10.1371/journal.pone.0023146	http://dx.doi.org/10.1371/journal.pone.0023146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853079	Green Published, gold			2022-12-27	WOS:000295454200046
J	Ge, XY; Rameix-Welti, MA; Gault, E; Chase, G; Afonso, ED; Picard, D; Schwemmle, M; Naffakh, N				Ge, Xingyi; Rameix-Welti, Marie-Anne; Gault, Elyanne; Chase, Geoffrey; Afonso, Emmanuel dos Santos; Picard, Didier; Schwemmle, Martin; Naffakh, Nadia			Influenza Virus Infection Induces the Nuclear Relocalization of the Hsp90 Co-Chaperone p23 and Inhibits the Glucocorticoid Receptor Response	PLOS ONE			English	Article							A VIRUS; RNA-POLYMERASE; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; PROTEIN; IMPORT; ENDONUCLEASE; SUBUNIT; PB2; NUCLEOPROTEIN	The genomic RNAs of influenza A viruses are associated with the viral polymerase subunits (PB1, PB2, PA) and nucleoprotein (NP), forming ribonucleoprotein complexes (RNPs). Transcription/replication of the viral genome occurs in the nucleus of infected cells. A role for Hsp90 in nuclear import and assembly of newly synthetized RNA-polymerase subunits has been proposed. Here we report that the p23 cochaperone of Hsp90, which plays a major role in glucocorticoid receptor folding and function, associates with influenza virus polymerase. We show that p23 is not essential for viral multiplication in cultured cells but relocalizes to the nucleus in influenza virus-infected cells, which may alter some functions of p23 and Hsp90. Moreover, we show that influenza virus infection inhibits glucocorticoid receptor-mediated gene transactivation, and that this negative effect can occur through a p23-independent pathway. Viral-induced inhibition of the glucocorticoid receptor response might be of significant importance regarding the physiopathology of influenza infections in vivo.	[Ge, Xingyi; Rameix-Welti, Marie-Anne; Gault, Elyanne; Afonso, Emmanuel dos Santos; Naffakh, Nadia] Inst Pasteur, Unite Genet Mol Virus ARN, Dept Virol, Paris, France; [Ge, Xingyi; Rameix-Welti, Marie-Anne; Gault, Elyanne; Afonso, Emmanuel dos Santos; Naffakh, Nadia] CNRS, URA3015, Paris, France; [Ge, Xingyi; Rameix-Welti, Marie-Anne; Gault, Elyanne; Afonso, Emmanuel dos Santos; Naffakh, Nadia] Univ Paris Diderot, Unite Genet Mol Virus ARN, Paris, France; [Rameix-Welti, Marie-Anne; Gault, Elyanne] Univ Versailles St Quentin En Yvelines, Guyancourt, France; [Chase, Geoffrey; Schwemmle, Martin] Univ Freiburg, Inst Med Microbiol & Hyg, Dept Virol, D-7800 Freiburg, Germany; [Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; University of Geneva	Ge, XY (corresponding author), Inst Pasteur, Unite Genet Mol Virus ARN, Dept Virol, Paris, France.	nadia.naffakh@pasteur.fr	Rameix-Welti, Marie-Anne/H-7526-2019	Naffakh, Nadia/0000-0002-0424-0277; Rameix-Welti, Marie-Anne/0000-0002-5901-3856	EU [FLUINNATE SP5B-CT-2006-044161]	EU(European Commission)	Funding: Institut Pasteur (http://www.pasteur.fr), FLUINNATE SP5B-CT-2006-044161 EU program (http://www.fluinnate.org/), and FLUPHARM FP7-INFLUENZA-2010-259751 (http://flupharm.eu). X.G. was supported by a fellowship from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso EDS, 2005, VIROLOGY, V341, P34, DOI 10.1016/j.virol.2005.06.040; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Crescenzo-Chaigne B, 1999, VIROLOGY, V265, P342, DOI 10.1006/viro.1999.0059; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Ghoshal K, 2001, MOL CELL BIOL, V21, P8301, DOI 10.1128/MCB.21.24.8301-8317.2001; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hinzey A, 2010, ENDOCRINOLOGY; Hu JM, 2002, J VIROL, V76, P269, DOI 10.1128/JVI.76.1.269-279.2002; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Robb NC, 2011, J VIROL, V85, P5228, DOI 10.1128/JVI.02562-10; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schneider J, 2009, VACCINE, V27, P6312, DOI 10.1016/j.vaccine.2009.01.015; Shih SR, 1996, EMBO J, V15, P5415, DOI 10.1002/j.1460-2075.1996.tb00925.x; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Vignuzzi M, 2001, J GEN VIROL, V82, P1737, DOI 10.1099/0022-1317-82-7-1737; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	42	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23368	10.1371/journal.pone.0023368	http://dx.doi.org/10.1371/journal.pone.0023368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853119	gold, Green Published, Green Submitted			2022-12-27	WOS:000295454200076
J	Hahm, ER; Moura, MB; Kelley, EE; Van Houten, B; Shiva, S; Singh, SV				Hahm, Eun-Ryeong; Moura, Michelle B.; Kelley, Eric E.; Van Houten, Bennett; Shiva, Sruti; Singh, Shivendra V.			Withaferin A-Induced Apoptosis in Human Breast Cancer Cells Is Mediated by Reactive Oxygen Species	PLOS ONE			English	Article							WITHANIA-SOMNIFERA ASHWAGANDHA; ATP-CONSUMING PROCESSES; COMPOUND WITHAFERIN; DEPENDENT APOPTOSIS; BAX ACTIVATION; IN-VIVO; MITOCHONDRIAL; PREVENTION; DEATH; INFLAMMATION	Withaferin A (WA), a promising anticancer constituent of Ayurvedic medicinal plant Withania somnifera, inhibits growth of MDA-MB-231 and MCF-7 human breast cancer cells in culture and MDA-MB-231 xenografts in vivo in association with apoptosis induction, but the mechanism of cell death is not fully understood. We now demonstrate, for the first time, that WA-induced apoptosis is mediated by reactive oxygen species (ROS) production due to inhibition of mitochondrial respiration. WA treatment caused ROS production in MDA-MB-231 and MCF-7 cells, but not in a normal human mammary epithelial cell line (HMEC). The HMEC was also resistant to WA-induced apoptosis. WA-mediated ROS production as well as apoptotic histone-associated DNA fragment release into the cytosol was significantly attenuated by ectopic expression of Cu, Zn-superoxide dismutase in both MDA-MB-231 and MCF-7 cells. ROS production resulting from WA exposure was accompanied by inhibition of oxidative phosphorylation and inhibition of complex III activity. Mitochondrial DNA-deficient Rho-0 variants of MDA-MB-231 and MCF-7 cells were resistant to WA-induced ROS production, collapse of mitochondrial membrane potential, and apoptosis compared with respective wild-type cells. WA treatment resulted in activation of Bax and Bak in MDA-MB-231 and MCF-7 cells, and SV40 immortalized embryonic fibroblasts derived from Bax and Bak double knockout mouse were significantly more resistant to WA-induced apoptosis compared with fibroblasts derived from wildtype mouse. In conclusion, the present study provides novel insight into the molecular circuitry of WA-induced apoptosis involving ROS production and activation of Bax/Bak.	[Hahm, Eun-Ryeong; Moura, Michelle B.; Van Houten, Bennett; Shiva, Sruti; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Hahm, Eun-Ryeong; Moura, Michelle B.; Van Houten, Bennett; Singh, Shivendra V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Kelley, Eric E.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Shiva, Sruti] Univ Pittsburgh, Sch Med, Vasc Biol Inst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hahm, ER (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	singhs@upmc.edu	Van Houten, Bennett/K-2284-2019		National Cancer Institute [RO1 CA142604]; NATIONAL CANCER INSTITUTE [R01CA142604] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by the National Cancer Institute grant RO1 CA142604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1999, J ETHNOPHARMACOL, V67, P27, DOI 10.1016/S0378-8741(99)00065-3; Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antosiewicz J, 2008, PLANTA MED, V74, P1570, DOI 10.1055/s-2008-1081307; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Choi S, 2005, CANCER RES, V65, P2035, DOI 10.1158/0008-5472.CAN-04-3616; DEVI P U, 1992, Indian Journal of Experimental Biology, V30, P169; Devi P. Uma, 2000, Indian Journal of Experimental Biology, V38, P432; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gupta SK, 2004, MOL CELL BIOCHEM, V260, P39; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Owais M, 2005, PHYTOMEDICINE, V12, P229, DOI 10.1016/j.phymed.2003.07.012; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Rasool M, 2006, VASC PHARMACOL, V44, P406, DOI 10.1016/j.vph.2006.01.015; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Wieser W, 2001, BIOCHEM J, V355, P389, DOI 10.1042/0264-6021:3550389; Winters M, 2006, ALTERN MED REV, V11, P269; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Yang HJ, 2007, MOL PHARMACOL, V71, P426, DOI 10.1124/mol.106.030015; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	43	147	149	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23354	10.1371/journal.pone.0023354	http://dx.doi.org/10.1371/journal.pone.0023354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853114	Green Published, gold, Green Accepted			2022-12-27	WOS:000295454200071
J	Santer, RD; Hebets, EA				Santer, Roger D.; Hebets, Eileen A.			Evidence for Air Movement Signals in the Agonistic Behaviour of a Nocturnal Arachnid (Order Amblypygi)	PLOS ONE			English	Article							AFRICAN CAVE CRICKET; ESCAPE BEHAVIOR; FORELEGS WHIPS; SPIDER; HAIRS; TRICHOBOTHRIA; MORPHOLOGY; COURTSHIP; FEMALE	Many arthropods possess filiform hair sensilla (termed trichobothria in arachnids), which are extremely sensitive detectors of medium particle displacement. Electrophysiological evidence in some taxa suggests that these sensilla can detect air particle displacements resulting from intraspecific communication signals. However, it has not yet been shown for any species that the air particle displacements detected by the filiform hairs are themselves perceived as a 'signal' (i.e. that individuals make behavioural decisions based upon the responses of these organs to the displays of conspecifics). We investigate the agonistic behaviour of the whip spider Phrynus marginemaculatus and the role of its trichobothria in receiving agonistic signals. Whip spiders have extremely elongated 'antenniform' first legs, which they vibrate close to their opponents during agonistic interactions, inducing air movements that excite their opponents' trichobothria. We find that ablation of the trichobothria causes significant increases in: (I) contest duration, and (II) the probability of contest escalation past aggressive displays to physical fighting. Therefore, in the absence of air movement-sensitive sensilla, contest assessment is impaired. This suggests that whip spiders exploit true air movement signals during agonistic interactions, and that these are received by the trichobothria. Furthermore, these results indicate that, in whip spiders, such signals help mitigate the cost of agonistic interaction.	[Santer, Roger D.; Hebets, Eileen A.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Santer, Roger D.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	University of Nebraska System; University of Nebraska Lincoln; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Santer, RD (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	rds5@aber.ac.uk	/AAH-5543-2019		Searle Foundation	Searle Foundation	Dr. Hebets was awarded a Searle Foundation Scholars Program Grant (http://www.searlescholars.net/go.php?id = 5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth FG, 1999, PHILOS T R SOC B, V354, P183, DOI 10.1098/rstb.1999.0370; Barth FG, 2000, NATURWISSENSCHAFTEN, V87, P51, DOI 10.1007/s001140050010; BECK L, 1974, Zeitschrift fuer Tierpsychologie, V35, P173; Briers R., 2003, MANTEL XLA VBA ADD I; CAMHI JM, 1978, J COMP PHYSIOL, V128, P203, DOI 10.1007/BF00656853; Draud M, 2004, BEHAV ECOL, V15, P102, DOI 10.1093/beheco/arg081; Elias DO, 2010, BEHAV ECOL, V21, P868, DOI 10.1093/beheco/arq073; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fowler-Finn KD, 2006, J ARACHNOL, V34, P62, DOI 10.1636/S04-104.1; GORNER P, 1969, Z VERGL PHYSIOL, V64, P301, DOI 10.1007/BF00340548; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hebets EA, 2002, CAN J ZOOL, V80, P286, DOI 10.1139/z02-006; HEIDELBACH J, 1991, NATURWISSENSCHAFTEN, V78, P277, DOI 10.1007/BF01134358; Heidelbach J, 1997, ETHOLOGY, V103, P827; HERGENRODER R, 1983, J COMP PHYSIOL, V152, P347, DOI 10.1007/BF00606240; IGELMUND P, 1987, J MORPHOL, V193, P75, DOI 10.1002/jmor.1051930108; IGELMUND P, 1991, J COMP PHYSIOL A, V168, P75, DOI 10.1007/BF00217105; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Logue DM, 2010, P ROY SOC B-BIOL SCI, V277, P2571, DOI 10.1098/rspb.2010.0421; Lowry R, 2011, VASSAR STATS WEBSITE; Rillich J, 2007, ANIM BEHAV, V74, P823, DOI 10.1016/j.anbehav.2006.11.022; Rundus AS, 2010, BEHAV ECOL, V21, P701, DOI 10.1093/beheco/arq042; Santer RD, 2008, P ROY SOC B-BIOL SCI, V275, P363, DOI 10.1098/rspb.2007.1466; TAUTZ J, 1978, BEHAV ECOL SOCIOBIOL, V4, P101, DOI 10.1007/BF00302564; Tinbergen, 1951, STUDY INSTINCT; WEYGOLDT P, 1969, Z MORPHOL TIERE, V64, P338, DOI 10.1007/BF00298640; Weygoldt P., 2000, WHIP SPIDERS CHELICE; Weygoldt P., 1995, NEWSLETTER BRIT ARAC, V74, P6, DOI DOI 10.1636/ST07-139.1	29	14	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22473	10.1371/journal.pone.0022473	http://dx.doi.org/10.1371/journal.pone.0022473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853035	Green Published, gold			2022-12-27	WOS:000295454200012
J	Yukitake, H; Kimura, H; Suzuki, H; Tajima, Y; Sato, Y; Imaeda, T; Kajino, M; Takizawa, M				Yukitake, Hiroshi; Kimura, Haruhide; Suzuki, Hirobumi; Tajima, Yasukazu; Sato, Yoshimi; Imaeda, Toshihiro; Kajino, Masahiro; Takizawa, Masayuki			BTZO-15, an ARE-Activator, Ameliorates DSS- and TNBS-Induced Colitis in Rats	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; OXIDATIVE STRESS; RESPONSE ELEMENT; HEME OXYGENASE-1; GENE-EXPRESSION; MICE; MECHANISMS; MODELS; TARGET	Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders that are primarily represented by ulcerative colitis and Crohn's disease. The etiology of IBD is not well understood; however, oxidative stress is considered a potential etiological and/or triggering factor for IBD. We have recently reported the identification of BTZO-1, an activator of antioxidant response element (ARE)-mediated gene expression, which protects cardiomyocytes from oxidative stress-induced insults. Here we describe the potential of BTZO-15, an active BTZO-1 derivative for ARE-activation with a favorable ADME-Tox profile, for the treatment of IBD. BTZO-15 induced expression of heme oxygenase-1 (HO-1), an ARE-regulated cytoprotective protein, and inhibited NO-induced cell death in IEC-18 cells. Large intestine shortening, rectum weight gain, diarrhea, intestinal bleeding, and an increase in rectal myeloperoxidase (MPO) activity were observed in a dextran sulfate sodium (DSS)-induced colitis rat model. Oral administration of BTZO-15 induced HO-1 expression in the rectum and attenuated DSS-induced changes. Furthermore BTZO-15 reduced the ulcerated area and rectal MPO activity in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rats without affecting rectal TNF-alpha levels. These results suggest that BTZO-15 is a promising compound for a novel IBD therapeutic drug with ARE activation properties.	[Yukitake, Hiroshi; Kimura, Haruhide; Suzuki, Hirobumi; Tajima, Yasukazu; Sato, Yoshimi; Imaeda, Toshihiro; Takizawa, Masayuki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Kajino, Masahiro] Takeda Pharmaceut Co Ltd, Chem Mfg & Controls, Osaka, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Yukitake, H (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	kimura_haruhide@takeda.co.jp			Takeda Pharmaceutical Company Limited.	Takeda Pharmaceutical Company Limited.(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceutical Company Limited. All authors were employees of Takeda Pharmaceutical Company Limited and were paid as such, therefore Takeda Pharmaceutical Company Limited had a role in the study design, data collection and analysis, and decision to publish.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Arafa HMM, 2009, FOOD CHEM TOXICOL, V47, P1311, DOI 10.1016/j.fct.2009.03.003; Blonski W, 2007, INFLAMM BOWEL DIS, V13, P769, DOI 10.1002/ibd.20027; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Clapper ML, 1999, ALIMENT PHARM THER, V13, P389; Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dryden Gerald W Jr, 2005, Curr Gastroenterol Rep, V7, P308, DOI 10.1007/s11894-005-0024-y; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Foligne B, 2006, DIGEST DIS SCI, V51, P390, DOI 10.1007/s10620-006-3143-x; Hara H, 2003, MOL BRAIN RES, V119, P125, DOI 10.1016/j.molbrainres.2003.08.021; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kimura H, 2010, CHEM BIOL, V17, P1282, DOI 10.1016/j.chembiol.2010.10.011; Kimura H, 2010, CHEM BIOL, V17, P18, DOI 10.1016/j.chembiol.2009.12.012; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nishihira J, 2009, CURR PHARM DESIGN, V15, P2104, DOI 10.2174/138161209788489113; Ohkawara T, 2002, GASTROENTEROLOGY, V123, P256, DOI 10.1053/gast.2002.34236; Ohkawara T, 2006, IMMUNOL LETT, V107, P148, DOI 10.1016/j.imlet.2006.09.002; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Rosenberg LN, 2010, EXPERT OPIN DRUG SAF, V9, P573, DOI 10.1517/14740331003639412; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Varga C, 2007, EUR J PHARMACOL, V561, P164, DOI 10.1016/j.ejphar.2006.12.022; Vijayan V, 2010, WORLD J GASTROENTERO, V16, P3112, DOI 10.3748/wjg.v16.i25.3112; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xu CT, 2004, WORLD J GASTROENTERO, V10, P2311; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591	30	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23256	10.1371/journal.pone.0023256	http://dx.doi.org/10.1371/journal.pone.0023256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853095	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200057
J	Machado, MCR; Octacilio-Silva, S; Costa, MSA; Ramos, RGP				Rosa Machado, Maiaro Cabral; Octacilio-Silva, Shirlei; Costa, Mara Silvia A.; Ramos, Ricardo Guelerman P.			rst Transcriptional Activity Influences kirre mRNA Concentration in the Drosophila Pupal Retina during the Final Steps of Ommatidial Patterning	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; CHIASM-C-ROUGHEST; MYOBLAST FUSION; CELL-DEATH; AXONAL PROJECTIONS; EYE DEVELOPMENT; SLIT DIAPHRAGM; ADHESION; NEPHRIN; GENE	Background: Drosophila retinal architecture is laid down between 24-48 hours after puparium formation, when some of the still uncommitted interommatidial cells (IOCs) are recruited to become secondary and tertiary pigment cells while the remaining ones undergo apoptosis. This choice between survival and death requires the product of the roughest (rst) gene, an immunoglobulin superfamily transmembrane glycoprotein involved in a wide range of developmental processes. Both temporal misexpression of Rst and truncation of the protein intracytoplasmic domain, lead to severe defects in which IOCs either remain mostly undifferentiated and die late and erratically or, instead, differentiate into extra pigment cells. Intriguingly, mutants not expressing wild type protein often have normal or very mild rough eyes. Methodology/Principal Findings: By using quantitative real time PCR to examine rst transcriptional dynamics in the pupal retina, both in wild type and mutant alleles we showed that tightly regulated temporal changes in rst transcriptional rate underlie its proper function during the final steps of eye patterning. Furthermore we demonstrated that the unexpected wild type eye phenotype of mutants with low or no rst expression correlates with an upregulation in the mRNA levels of the rst paralogue kin-of-irre (kirre), which seems able to substitute for rst function in this process, similarly to their role in myoblast fusion. This compensatory upregulation of kirre mRNA levels could be directly induced in wild type pupa upon RNAi-mediated silencing of rst, indicating that expression of both genes is also coordinately regulated in physiological conditions. Conclusions/Significance: These findings suggest a general mechanism by which rst and kirre expression could be fine tuned to optimize their redundant roles during development and provide a clearer picture of how the specification of survival and apoptotic fates by differential cell adhesion during the final steps of retinal morphogenesis in insects are controlled at the transcriptional level.	[Rosa Machado, Maiaro Cabral; Octacilio-Silva, Shirlei; Costa, Mara Silvia A.; Ramos, Ricardo Guelerman P.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Sao Paulo, Brazil	Universidade de Sao Paulo	Machado, MCR (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, Sao Paulo, Brazil.	rgpramos@fmrp.usp.br	Ramos, Ricardo/F-7979-2015; Octacilio-Silva, Shirlei/AAV-6661-2020	Octacilio-Silva, Shirlei/0000-0001-5196-5484	Sao Paulo State Agency for Research Support FAPESP [2007/55984-4]; Brazilian Capes (Coordenadoria de aperfeicoamento de Pessoal de Ensino Superior)	Sao Paulo State Agency for Research Support FAPESP; Brazilian Capes (Coordenadoria de aperfeicoamento de Pessoal de Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Sao Paulo State Agency for Research Support FAPESP, grant # 2007/55984-4. MCRM was recipient of a MSc fellowship from the Brazilian Capes (Coordenadoria de aperfeicoamento de Pessoal de Ensino Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apitz H, 2004, DEV GENES EVOL, V214, P453, DOI 10.1007/s00427-004-0423-3; Araujo H, 2003, MECH DEVELOP, V120, P537, DOI 10.1016/S0925-4773(03)00040-6; Artero RD, 2001, DEVELOPMENT, V128, P4251; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BOSCHERT U, 1990, J NEUROGENET, V6, P153, DOI 10.3109/01677069009107107; Bour BA, 2000, GENE DEV, V14, P1498; Bulchand S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009374; Carthew RW, 2005, CURR OPIN GENET DEV, V15, P358, DOI 10.1016/j.gde.2005.06.002; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Duband JL, 2006, ADV EXP MED BIOL, V589, P45; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Grzeschik NA, 2005, DEVELOPMENT, V132, P2035, DOI 10.1242/dev.01800; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Lee HG, 2010, J CELL SCI, V123, P277, DOI 10.1242/jcs.056853; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Perez-Pomares JM, 2006, BIOESSAYS, V28, P809, DOI 10.1002/bies.20442; Ramos RGP, 2010, METHODS MOL BIOL, V588, P165, DOI 10.1007/978-1-59745-324-0_19; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Reddy GV, 1999, DEV GENES EVOL, V209, P581, DOI 10.1007/s004270050292; Reiter C, 1996, DEVELOPMENT, V122, P1931; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Simon CR, 2009, GENESIS, V47, P492, DOI 10.1002/dvg.20527; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Sugie A, 2010, DEVELOPMENT, V137, P3303, DOI 10.1242/dev.047332; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; WOLFF T, 1991, DEVELOPMENT, V113, P825; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22536	10.1371/journal.pone.0022536	http://dx.doi.org/10.1371/journal.pone.0022536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857931	Green Submitted, Green Published, gold			2022-12-27	WOS:000293773300006
J	Sasikumar, R; Rejitha, JR; Binumon, PK; Manoj, M				Sasikumar, Roschen; Rejitha, John Raji; Binumon, Ponthananiyil Kumaran; Manoj, Muraleedharan			Role of Heterozygous APC Mutation in Niche Succession and Initiation of Colorectal Cancer - A Computational Study	PLOS ONE			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; STEM-CELLS; SMALL-INTESTINE; CRYPT DYNAMICS; HUMAN COLON; ORIENTATION; TISSUE; MODEL; ORGANIZATION	Mutations in the adenomatous polyposis coli (APC) gene are found in most colorectal cancers. They cause constitutive activation of proliferative pathways when both alleles of the gene are mutated. However studies on individuals with familial adenomatous polyposis (FAP) have shown that a single mutated APC allele can also create changes in the precancerous colon crypt, like increased number of stem cells, increased crypt fission, greater variability of DNA methylation patterns, and higher somatic mutation rates. In this paper, using a computational model of colon crypt dynamics, we evolve and investigate a hypothesis on the effect of heterozygous APC mutation that explains these different observations. Based on previous reports and the results from the computational model we propose the hypothesis that heterozygous APC mutation has the effect of increasing the chances for a stem cell to divide symmetrically, producing two stem cell daughters. We incorporate this hypothesis into the model and perform simulation experiments to investigate the consequences of the hypothesis. Simulations show that this hypothesis links together the changes in FAP crypts observed in previous studies. The simulations also show that an APC(+/-) stem cell gets selective advantages for dominating the crypt and progressing to cancer. This explains why most colon cancers are initiated by APC mutation. The results could have implications for preventing or retarding the onset of colon cancer in people with inherited or acquired mutation of one APC allele. Experimental validation of the hypothesis as well as investigation into the molecular mechanisms of this effect may therefore be worth undertaking.	[Sasikumar, Roschen; Rejitha, John Raji; Binumon, Ponthananiyil Kumaran; Manoj, Muraleedharan] Natl Inst Interdisciplinary Sci & Technol CSIR, Computat Modeling & Simulat Grp, Trivandrum, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Sasikumar, R (corresponding author), Natl Inst Interdisciplinary Sci & Technol CSIR, Computat Modeling & Simulat Grp, Trivandrum, Kerala, India.	roschen.csir@gmail.com			Council of Scientific and Industrial Research - Inter Agency [IAP 0001]	Council of Scientific and Industrial Research - Inter Agency	Council of Scientific and Industrial Research - Inter Agency Project IAP 0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boman BM, 2008, CANCER RES, V68, P3304, DOI 10.1158/0008-5472.CAN-07-2061; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; Campbell F, 1998, HUM PATHOL, V29, P1531, DOI 10.1016/S0046-8177(98)90026-0; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Graham TA, 2010, BIOESSAYS, V32, P468, DOI 10.1002/bies.201000032; Hisamuddin IM, 2006, CURR COLORECT CANC R, V2, P53, DOI 10.1007/s11888-006-0002-2; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; JOHNSON RO, 1971, NAT C CANC COL RECT, P208; Kim KM, 2004, AM J PATHOL, V164, P1369, DOI 10.1016/S0002-9440(10)63223-3; Kim KM, 2002, ONCOGENE, V21, P5441, DOI 10.1038/sj.onc.1205604; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pepper JW, 2007, PLOS COMPUT BIOL, V3, P2532, DOI 10.1371/journal.pcbi.0030250; POTTEN CS, 1987, J THEOR BIOL, V127, P381, DOI 10.1016/S0022-5193(87)80136-4; Potten CS, 2003, CELL PROLIFERAT, V36, P115, DOI 10.1046/j.1365-2184.2003.00264.x; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Thorne BC, 2007, BRIEF BIOINFORM, V8, P245, DOI 10.1093/bib/bbm024; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Zhang JY, 2009, MOL BIOL CELL, V20, P2381, DOI 10.1091/mbc.E08-12-1206	23	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22720	10.1371/journal.pone.0022720	http://dx.doi.org/10.1371/journal.pone.0022720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21857949	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300018
J	He, QL; Shen, Y; Wang, MX; Huang, MR; Yang, RZ; Zhu, SJ; Wang, LS; Xu, YJ; Wu, RL				He, Qiuling; Shen, Ye; Wang, Mingxiu; Huang, Minren; Yang, Ruizhen; Zhu, Shuijin; Wang, Liangsheng; Xu, Yanjun; Wu, Rongling			Natural Variation in Petal Color in Lycoris longituba Revealed by Anthocyanin Components	PLOS ONE			English	Article							FLOWERS; COPIGMENTATION; BIOSYNTHESIS; CONVERGENCE; CULTIVARS; PIGMENTS	Lycoris longituba is one of the species belonging to the Amaryllidaceae family. Despite its limited distribution, endemic to central eastern China, this species displays an exceptionally wide diversity of flower colors from purple, red, orange, to yellow, in nature. We study the natural variation of floral color in L. longituba by testing the components of water-soluble vacuolar pigments - anthocyanins - in its petals using high-performance liquid chromatography coupled with photodiode array detection and electrospray ionization mass spectrometry. Four anthocyanins were identified, cyanidin-3-sophoroside (Cy3So), cyanidin-3-xylosylglucoside (Cy3XyGlc), cyanidin-3-sambubioside (Cy3Sa), and pelargonidin-3-xylosylglucoside (Pg3XyGlc), which occur at various amounts in L. longituba petals of different colors. A multivariate analysis was used to explore the relationship between pigments and flower color. Anthocyanins have been thought to play a major role in acting as a UV screen that protects the plant's DNA from sunlight damage and attracting insects for the purpose of pollination. Thus, knowledge about the content and type of anthocyanins determining the petal coloration of Lycoris longituba will help to study the adaptive evolution of flowers and provide useful information for the ornamental breeding of this species.	[He, Qiuling; Shen, Ye; Wang, Mingxiu; Huang, Minren] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Peoples R China; [He, Qiuling; Zhu, Shuijin] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Ruizhen; Wang, Liangsheng] Chinese Acad Sci, Beijing Bot Garden, Inst Bot, Beijing, Peoples R China; [Xu, Yanjun] China Agr Univ, Dept Appl Chem, Beijing 100094, Peoples R China; [Wu, Rongling] Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China; [Wu, Rongling] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Wu, Rongling] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China	Nanjing Forestry University; Zhejiang University; Chinese Academy of Sciences; Institute of Botany, CAS; China Agricultural University; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	He, QL (corresponding author), Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing, Peoples R China.	mrhuang@njfu.edu.cn; wanglsh@ibcas.ac.cn; rwu@hes.hmc.psu.edu			Graduate Research Innovation Project of Jiangsu Province; Excellent Doctoral Thesis Foundation of Nanjing Forestry University; Beijing Forestry University	Graduate Research Innovation Project of Jiangsu Province; Excellent Doctoral Thesis Foundation of Nanjing Forestry University; Beijing Forestry University	This research was supported by the Graduate Research Innovation Project of Jiangsu Province, the Excellent Doctoral Thesis Foundation of Nanjing Forestry University, and the Changjiang Scholars Award and the "One-thousand Person Plan'' Award at Beijing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARISUMI K, 1970, YAMAGUCHI DAIGAKU NO, V21, P65; ARISUMI K, 1971, YAMAGUCHI DAIGAKU NO, V22, P171; ASEN S, 1971, PHYTOCHEMISTRY, V10, P171, DOI 10.1016/S0031-9422(00)90266-8; BARRITT BH, 1973, J CHROMATOGR, V75, P151, DOI 10.1016/S0021-9673(01)83429-4; Berg A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1528; Buchert J, 2005, J SCI FOOD AGR, V85, P2548, DOI 10.1002/jsfa.2284; Byamukama R, 2006, SCI HORTIC-AMSTERDAM, V109, P262, DOI 10.1016/j.scienta.2006.05.007; Cunningham FX, 2005, PLANT J, V41, P478, DOI 10.1111/j.1365-313X.2004.02309.x; de Ancos B, 1999, Z LEBENSM UNTERS F A, V208, P33, DOI 10.1007/s002170050371; Deng CL, 2006, J GENET, V85, P205, DOI 10.1007/BF02935332; GONNET JF, 1992, J HORTIC SCI, V67, P663, DOI 10.1080/00221589.1992.11516297; Gonnet JF, 1998, FOOD CHEM, V63, P409, DOI 10.1016/S0308-8146(98)00053-3; Hada H, 2003, PLANT CELL ENVIRON, V26, P1691, DOI 10.1046/j.1365-3040.2003.01087.x; He QL, 2009, MOL ECOL RESOUR, V9, P278, DOI 10.1111/j.1755-0998.2008.02322.x; Hoch WA, 2001, TREE PHYSIOL, V21, P1; HRAZDINA G, 1988, BIOCHIM BIOPHYS ACTA, V955, P301, DOI 10.1016/0167-4838(88)90208-7; HU SY, 1976, ARNOLDIA, V35, P264; Kamffer Z, 2010, J AGR FOOD CHEM, V58, P6578, DOI 10.1021/jf1004308; Kishimoto S, 2005, BIOSCI BIOTECH BIOCH, V69, P2122, DOI 10.1271/bbb.69.2122; NIEUWHOF M, 1989, NETH J AGR SCI, V37, P365; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; STEYN WJ, 2009, SPRINGER SCI BUSINES, P85; Stintzing FC, 2003, EUR FOOD RES TECHNOL, V216, P303, DOI 10.1007/s00217-002-0657-0; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Thomson JD, 2008, INT J PLANT SCI, V169, P23, DOI 10.1086/523361; Tian QG, 2005, J CHROMATOGR A, V1091, P72, DOI 10.1016/j.chroma.2005.07.036; Wang LS, 2001, J PLANT RES, V114, P213, DOI 10.1007/PL00013985; White SA, 2005, J PLANT NUTR, V28, P1767, DOI 10.1080/01904160500250896; Whittall JB, 2006, MOL ECOL, V15, P4645, DOI 10.1111/j.1365-294X.2006.03114.x; Yang RZ, 2009, J CHROMATOGR A, V1216, P106, DOI 10.1016/j.chroma.2008.11.046; [No title captured]	33	47	56	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22098	10.1371/journal.pone.0022098	http://dx.doi.org/10.1371/journal.pone.0022098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829604	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200006
J	Whitehouse, AJO; Hickey, M; Ronald, A				Whitehouse, Andrew J. O.; Hickey, Martha; Ronald, Angelica			Are Autistic Traits in the General Population Stable across Development?	PLOS ONE			English	Article							EARLY-CHILDHOOD; REPETITIVE BEHAVIORS; SPECTRUM QUOTIENT; PRESCHOOL-CHILDREN; STABILITY; DISORDERS; AGE; HERITABILITY; TRAJECTORIES; IMPAIRMENT	There is accumulating evidence that autistic traits (AT) are on a continuum in the general population, with clinical autism representing the extreme end of a quantitative distribution. While the nature and severity of symptoms in clinical autism are known to persist over time, no study has examined the long-term stability of AT among typically developing toddlers. The current investigation measured AT in 360 males and 400 males from the general population close to two decades apart, using the Pervasive Developmental Disorder subscale of the Child Behavior Checklist in early childhood (M = 2.14 years; SD = 0.15), and the Autism-Spectrum Quotient in early adulthood (M = 19.50 years; SD = 0.70). Items from each scale were further divided into social (difficulties with social interaction and communication) and non-social (restricted and repetitive behaviours and interests) AT. The association between child and adult measurements of AT as well the influence of potentially confounding sociodemographic, antenatal and obstetric variables were assessed using Pearson's correlations and linear regression. For males, Total AT in early childhood were positively correlated with total AT (r = .16, p = .002) and social AT (r = .16, p = .002) in adulthood. There was also a positive correlation for males between social AT measured in early childhood and Total (r = .17, p = .001) and social AT (r = .16, p = .002) measured in adulthood. Correlations for non-social AT did not achieve significance in males. Furthermore, there was no significant longitudinal association in AT observed for males or females. Despite the constraints of using different measures and different raters at the two ages, this study found modest developmental stability of social AT from early childhood to adulthood in boys.	[Whitehouse, Andrew J. O.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Hickey, Martha] Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; [Ronald, Angelica] Univ London, Ctr Brain & Cognit Dev, Dept Psychol Sci, London, England	Telethon Kids Institute; University of Western Australia; University of Melbourne; University of London; Birkbeck University London	Whitehouse, AJO (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia.	awhitehouse@ichr.uwa.edu.au	Study, Raine/K-4517-2013; Ronald, Angelica/C-7812-2009; Study, Raine/G-9547-2015; Whitehouse, Andrew J.O./AGJ-2519-2022	Ronald, Angelica/0000-0002-9576-2176; Whitehouse, Andrew J.O./0000-0001-8722-1575; Hickey, Martha/0000-0002-3941-082X	National Health and Medical Research Council (NHMRC) [1003424, 1004065]; Telethon Institute for Child Health Research; University of Western Australia (UWA); UWA Faculty of Medicine, Dentistry and Health Sciences; Raine Medical Research Foundation; Women's and Infants Research Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Telethon Institute for Child Health Research; University of Western Australia (UWA); UWA Faculty of Medicine, Dentistry and Health Sciences; Raine Medical Research Foundation; Women's and Infants Research Foundation	The authors would like to acknowledge the National Health and Medical Research Council (NHMRC) and the Telethon Institute for Child Health Research for their long term contribution to funding of the study over the last 20 years. Core Management of the Raine study has been funded by the University of Western Australia (UWA), the UWA Faculty of Medicine, Dentistry and Health Sciences, the Raine Medical Research Foundation, the Telethon Institute for Child Health Research, and the Women's and Infants Research Foundation. The two-follow-up was funded by the NHMRC and the Raine Medical Research Foundation, and the 20 year follow-up was funded by NHMRC project grant #1003424. Andrew Whitehouse is supported by an NHMRC Career Development Fellowship (#1004065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, J ABNORM CHILD PSYCH, V15, P629, DOI 10.1007/BF00917246; Allison C, 2008, J AUTISM DEV DISORD, V38, P1414, DOI 10.1007/s10803-007-0509-7; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bartels A, 2004, DEV PSYCHOL, V40, P852, DOI 10.1037/0012-1649.40.5.852; Billstedt E, 2007, J CHILD PSYCHOL PSYC, V48, P1102, DOI 10.1111/j.1469-7610.2007.01774.x; Bishop D., 2009, COMMUNICATION CHECKL; Bishop D., 2003, CHILDRENS COMMUNICAT; Campbell SB, 1997, ADV CLIN CHILD PSYCH, V19, P1; Charman T, 2005, J CHILD PSYCHOL PSYC, V46, P500, DOI 10.1111/j.1469-7610.2004.00377.x; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Constantino JN, 2009, DEV PSYCHOPATHOL, V21, P127, DOI 10.1017/S095457940900008X; Cuccaro ML, 2003, CHILD PSYCHIAT HUM D, V34, P3, DOI 10.1023/A:1025321707947; Eaves LC, 1996, J AUTISM DEV DISORD, V26, P557, DOI 10.1007/BF02172276; Edelson LR, 2009, BEHAV GENET, V39, P255, DOI 10.1007/s10519-009-9270-3; Esbensen AJ, 2009, J AUTISM DEV DISORD, V39, P57, DOI 10.1007/s10803-008-0599-x; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Happe F, 2008, NEUROPSYCHOL REV, V18, P287, DOI 10.1007/s11065-008-9076-8; Hartley SL, 2009, J AUTISM DEV DISORD, V39, P1715, DOI 10.1007/s10803-009-0810-8; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Honey E, 2007, J AUTISM DEV DISORD, V37, P1107, DOI 10.1007/s10803-006-0253-4; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; JACOBSON JW, 1990, J AUTISM DEV DISORD, V20, P205, DOI 10.1007/BF02284719; Leekam S, 2007, J CHILD PSYCHOL PSYC, V48, P1131, DOI 10.1111/j.1469-7610.2007.01778.x; Mandy WPL, 2008, J CHILD PSYCHOL PSYC, V49, P795, DOI 10.1111/j.1469-7610.2008.01911.x; Matson JL, 2010, J DEV PHYS DISABIL, V22, P331, DOI 10.1007/s10882-010-9188-y; Mesman J, 2009, J ABNORM CHILD PSYCH, V37, P625, DOI 10.1007/s10802-009-9298-0; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Posserud MB, 2006, J CHILD PSYCHOL PSYC, V47, P167, DOI 10.1111/j.1469-7610.2005.01462.x; Richler J, 2010, DEV PSYCHOPATHOL, V22, P55, DOI 10.1017/S0954579409990265; Robinson EB, 2011, J AM ACAD CHILD PSY, V50, P376, DOI 10.1016/j.jaac.2011.01.005; Ronald A, 2005, DEVELOPMENTAL SCI, V8, P444, DOI 10.1111/j.1467-7687.2005.00433.x; RONALD A, MOL PSYCH IN PRESS; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Ronald A, 2010, J ABNORM CHILD PSYCH, V38, P185, DOI 10.1007/s10802-009-9366-5; Ronald A, 2008, EUR CHILD ADOLES PSY, V17, P473, DOI 10.1007/s00787-008-0689-5; Sikora DM, 2008, J AUTISM DEV DISORD, V38, P440, DOI 10.1007/s10803-007-0407-z; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; Smith CL, 2004, DEV PSYCHOL, V40, P29, DOI 10.1037/0012-1649.40.1.29; Spieker SJ, 1999, CHILD DEV, V70, P443, DOI 10.1111/1467-8624.00032; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; Whitehouse A., 2009, COMMUNICATION CHECKL; Whitehouse AJO, 2010, AUTISM, V14, P559, DOI 10.1177/1362361310382107; Whitehouse AJO, 2010, EARLY HUM DEV, V86, P487, DOI 10.1016/j.earlhumdev.2010.06.009; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P511, DOI 10.1080/13682820802708098; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751	49	47	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23029	10.1371/journal.pone.0023029	http://dx.doi.org/10.1371/journal.pone.0023029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829684	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000293561200044
J	Zhang, HW; Li, J; Zhang, XS; Wang, Y; Qiu, WJ; Ye, J; Han, LS; Gao, XL; Gu, XF				Zhang, Huiwen; Li, Jing; Zhang, Xinshun; Wang, Yu; Qiu, Wenjuan; Ye, Jun; Han, Lianshu; Gao, Xiaolan; Gu, Xuefan			Analysis of the IDS Gene in 38 Patients with Hunter Syndrome: The c.879G > A (p.Gln293Gln) Synonymous Variation in a Female Create Exonic Splicing	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-II; IDURONATE-2-SULFATASE GENE; MPS-II; MUTATION ANALYSIS; STRUCTURAL-ANALYSIS; JAPANESE PATIENTS; MOLECULAR-BASIS; DISEASE; DIAGNOSIS; MILD	Background: Hunter syndrome (mucopolysaccharidosis type II, MPS II) is a rare disease inherited in an X-linked autosomal recessive pattern. It is the prevailing form of the mucopolysaccharidoses in China. Here we investigated mutations of IDS (iduronate 2-sulfatase) gene in 38 unrelated Chinese patients, one of which is a female. Methods: Peripheral leucocytes were collected from the patients and the IDS gene was amplified to looking for the variations. For a female patient, the X chromosome status was analyzed by androgen receptor X-inactivation assay and the mutation impact on RNA level was further performed by reverse transcription polymerase chain reaction. Results: We discovered that point mutations constituted the major form while mutations in codon p.R468 defined the largest number of patients in our cohort. Consistent with data from other ethnic groups, exons 9 and 3 had comparatively more mutations, while exon 2 had quite a few mutations unique to Chinese patients. Of the 30 different mutations identified, only 9 were novel: one was a premature termination mutation, i.e., c.196C > T (p.Gln66X); three were missense mutations, i.e., c.200T > C (p.Leu67Pro), c.215T > C (p.Leu72Pro), c.389C > T (p.Thr130Ile); one was a small deletion, i.e., c.1104_1122del19 (p.Ser369ArgfsX16); and one was a deletion that spanned both exons 8 and 9 deletion leading to gross structural changes in the IDS gene. In addition, a synonymous mutation c.879G > A (p.Gln293Gln) was identified in a female Hunter disease patient, which resulted in loss of the original splicing site, activated a cryptic splicing site upstream, leading to a 28 bp deletion and a premature termination at p. Tyr285GlufsX47. Together with concurrent skewed X-inactivation this was believed to facilitate the development of Hunter disease in this girl. Conclusions: In conclusion, the molecular analysis of IDS gene in Chinese patients confirmed the Hunter disease diagnosis and expanded the mutation and clinical spectrum of this devastating disorder.	[Zhang, Huiwen; Li, Jing; Zhang, Xinshun; Wang, Yu; Qiu, Wenjuan; Ye, Jun; Han, Lianshu; Gao, Xiaolan; Gu, Xuefan] Shanghai Jiao Tong Univ, Sch Med,Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, HW (corresponding author), Shanghai Jiao Tong Univ, Sch Med,Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp, Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China.	huiwenzhang@yahoo.com; guxuefan@online.sh.cn			Shanghai Rising Star Program [09QA1404700]; National Natural Science Foundation of China [30801257]	Shanghai Rising Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Shanghai Rising Star Program (09QA1404700) and National Natural Science Foundation of China (30801257) to H. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2006, J INHERIT METAB DIS, V29, P743, DOI 10.1007/s10545-006-0403-z; Baehner F, 2005, J INHERIT METAB DIS, V28, P1011, DOI 10.1007/s10545-005-0112-z; BONDESON ML, 1995, EUR J HUM GENET, V3, P219; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615; Coelho JC, 1997, EUR J PEDIATR, V156, P650, DOI 10.1007/s004310050685; Crotty Paul L., 1992, Human Molecular Genetics, V1, P755, DOI 10.1093/hmg/1.9.755; Filocamo M, 2001, Hum Mutat, V18, P164, DOI 10.1002/humu.1169; Froissart R, 2002, ACTA PAEDIATR, V91, P82, DOI 10.1080/080352502762457996; Froissart R, 1998, CLIN GENET, V53, P362; Goldenfum SL, 1996, HUM MUTAT, V7, P76, DOI 10.1002/(SICI)1098-1004(1996)7:1<76::AID-HUMU14>3.3.CO;2-T; Gort L, 1998, J INHERIT METAB DIS, V21, P655, DOI 10.1023/A:1005432600871; HOPWOOD JJ, 1993, HUM MUTAT, V2, P435, DOI 10.1002/humu.1380020603; Isogai K, 1998, J INHERIT METAB DIS, V21, P60, DOI 10.1023/A:1005363414792; Karsten SL, 1997, GENOMICS, V43, P123, DOI 10.1006/geno.1997.4811; Kato T, 2005, J HUM GENET, V50, P395, DOI 10.1007/s10038-005-0266-4; KEERATICHAMROEN S, 2008, J INHERIT METAB DIS; Kim CH, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9128; Kloska A, 2010, CLIN GENET; Li PN, 1999, J MED GENET, V36, P21; Lin HY, 2009, AM J MED GENET A, V149A, P960, DOI 10.1002/ajmg.a.32781; Lin SP, 2006, CLIN CHIM ACTA, V369, P29, DOI 10.1016/j.cca.2006.01.001; Lualdi S, 2005, HUM MUTAT, V25, P491, DOI 10.1002/humu.20165; Lualdi S, 2010, HUM MUTAT, V31, pE1261, DOI 10.1002/humu.21208; Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350; Nelson J, 2003, AM J MED GENET A, V123A, P310, DOI 10.1002/ajmg.a.20314; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Rathmann M, 1996, AM J HUM GENET, V59, P1202; SCHAAP T, 1980, HUM GENET, V56, P221, DOI 10.1007/BF00295699; Sohn YB, 2010, AM J MED GENET A, V152A, P3129, DOI 10.1002/ajmg.a.33589; Sukegawa K, 1998, CLIN GENET, V53, P96; Sukegawa-Hayasaka K, 2006, J INHERIT METAB DIS, V29, P755, DOI 10.1007/s10545-006-0440-7; Vafiadaki E, 1998, ARCH DIS CHILD, V79, P237, DOI 10.1136/adc.79.3.237; Voznyi YV, 2001, J INHERIT METAB DIS, V24, P675, DOI 10.1023/A:1012763026526; YANO S, 2010, CLIN GENET; YATZIV S, 1977, CLIN GENET, V11, P319; Zhang Hui-Wen, 2009, Zhonghua Er Ke Za Zhi, V47, P276	36	30	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22951	10.1371/journal.pone.0022951	http://dx.doi.org/10.1371/journal.pone.0022951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829674	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200040
J	Huang, CT; Lin, HC; Chang, SC; Lee, WC				Huang, Ching-Tzu; Lin, Horng-Chyuan; Chang, Shi-Chuan; Lee, Wei-Chen			Pre-Operative Risk Factors Predict Post-Operative Respiratory Failure after Liver Transplantation	PLOS ONE			English	Article							ADSORBENT RECIRCULATING SYSTEM; INTENSIVE-CARE-UNIT; CHILD-TURCOTTE-PUGH; PULMONARY COMPLICATIONS; TRACHEAL EXTUBATION; HEPATIC-FAILURE; MELD SCORE; SURVIVAL; SURGERY; DISEASE	Objective: Post-operative pulmonary complications significantly affect patient survival rates, but there is still no conclusive evidence regarding the effect of post-operative respiratory failure after liver transplantation on patient prognosis. This study aimed to predict the risk factors for post-operative respiratory failure (PRF) after liver transplantation and the impact on short-term survival rates. Design: The retrospective observational cohort study was conducted in a twelve-bed adult surgical intensive care unit in northern Taiwan. The medical records of 147 liver transplant patients were reviewed from September 2002 to July 2007. Sixty-two experienced post-operative respiratory failure while the remaining 85 patients did not. Measurements and Main Results: Gender, age, etiology, disease history, pre-operative ventilator use, molecular adsorbent re-circulating system (MARS) use, source of organ transplantation, model for end-stage liver disease score (MELD) and Child-Turcotte-Pugh score calculated immediately before surgery were assessed for the two groups. The length of the intensive care unit stay, admission duration, and mortality within 30 days, 3 months, and 1 year were also evaluated. Using a logistic regression model, post-operative respiratory failure correlated with diabetes mellitus prior to liver transplantation, pre-operative impaired renal function, pre-operative ventilator use, pre-operative MARS use and deceased donor source of organ transplantation (p<0.05). Once liver transplant patients developed PRF, their length of ICU stay and admission duration were prolonged, significantly increasing their mortality and morbidity (p<0.001). Conclusions: The predictive pre-operative risk factors significantly influenced the occurrence of post-operative respiratory failure after liver transplantation.	[Huang, Ching-Tzu; Lin, Horng-Chyuan] Chang Gung Mem Hosp, Dept Resp Therapy, Tao Yuan, Taiwan; [Huang, Ching-Tzu; Chang, Shi-Chuan] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Lin, Horng-Chyuan] Chang Gung Mem Hosp, Dept Thorac Med, Tao Yuan, Taiwan; [Lin, Horng-Chyuan] Chang Gung Univ, Coll Med, Dept Chinese Med, Tao Yuan, Taiwan; [Chang, Shi-Chuan] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Lee, Wei-Chen] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Gen Surg, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, CT (corresponding author), Chang Gung Mem Hosp, Dept Resp Therapy, Tao Yuan, Taiwan.	lin53424@ms13.hinet.net; weichen@cgmh.org.tw						Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; BALIGA P, 1992, SURGERY, V112, P704; Biancofiore G, 2001, LIVER TRANSPLANT, V7, P777, DOI 10.1053/jlts.2001.23785; Bilbao I, 2003, CLIN TRANSPLANT, V17, P401, DOI 10.1034/j.1399-0012.2003.00068.x; Brown RS, 2002, LIVER TRANSPLANT, V8, P278, DOI 10.1053/jlts.2002.31340; Doria C, 2006, DIGEST DIS SCI, V51, P47, DOI 10.1007/s10620-006-3115-1; Farnsworth N, 2004, AM J SURG, V188, P580, DOI 10.1016/j.amjsurg.2004.07.034; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Findlay JY, 2002, LIVER TRANSPLANT, V8, P670, DOI 10.1053/jlts.2002.34678; Fukuhara T, 2010, J GASTROEN HEPATOL, V25, P978, DOI 10.1111/j.1440-1746.2009.06162.x; Ghobrial RM, 2002, ANN SURG, V236, P315, DOI 10.1097/00000658-200209000-00008; Glanemann M, 2001, J CLIN ANESTH, V13, P377, DOI 10.1016/S0952-8180(01)00290-2; Glanemann M, 2001, ACTA ANAESTH SCAND, V45, P333, DOI 10.1034/j.1399-6576.2001.045003333.x; Glanemann M, 2007, SWISS MED WKLY, V137, P187; Golfieri R, 2000, EUR RADIOL, V10, P1169, DOI 10.1007/s003309900268; Gonzalez E, 2006, Rev Esp Anestesiol Reanim, V53, P75; Habib S, 2006, LIVER TRANSPLANT, V12, P440, DOI 10.1002/lt.20721; Kotloff RM, 2005, CLIN CHEST MED, V26, P623, DOI 10.1016/j.ccm.2005.06.011; Kuiper JW, 2005, CRIT CARE MED, V33, P1408, DOI 10.1097/01.CCM.0000165808.30416.EF; Macedo FIB, 2010, EXP CLIN TRANSPLANT, V8, P202; Maluf DG, 2006, TRANSPLANTATION, V82, P1653, DOI 10.1097/01.tp.0000250571.41361.21; Mandell MS, 2007, LIVER TRANSPLANT, V13, P1557, DOI 10.1002/lt.21263; Mandell MS, 2002, LIVER TRANSPLANT, V8, P676, DOI 10.1053/jlts.2002.34379; Menon KVN, 2004, AM J TRANSPLANT, V4, P819, DOI 10.1111/j.1600-6143.2004.00433.x; MEYERS JR, 1975, ARCH SURG-CHICAGO, V110, P576; Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160; PREETI JR, 2001, HEPATOLOGY, V34, P889; Rodriguez-Ariza A, 2008, REV ESP ENFERM DIG, V100, P129, DOI 10.4321/s1130-01082008000300002; Saab S, 2003, LIVER TRANSPLANT, V9, P473, DOI 10.1053/jlts.2003.50090; Saliba F, 2006, CRIT CARE, V10, DOI 10.1186/cc4825; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; SVENSSON LG, 1991, J VASC SURG, V14, P271; Wong CS, 2010, LIVER TRANSPLANT, V16, P138, DOI 10.1002/lt.21969; WONG DH, 1995, ANESTH ANALG, V80, P276, DOI 10.1097/00000539-199502000-00013	34	48	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22689	10.1371/journal.pone.0022689	http://dx.doi.org/10.1371/journal.pone.0022689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829646	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511200019
J	Ramirez-Llodra, E; Tyler, PA; Baker, MC; Bergstad, OA; Clark, MR; Escobar, E; Levin, LA; Menot, L; Rowden, AA; Smith, CR; Van Dover, CL				Ramirez-Llodra, Eva; Tyler, Paul A.; Baker, Maria C.; Bergstad, Odd Aksel; Clark, Malcolm R.; Escobar, Elva; Levin, Lisa A.; Menot, Lenaick; Rowden, Ashley A.; Smith, Craig R.; Van Dover, Cindy L.			Man and the Last Great Wilderness: Human Impact on the Deep Sea	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; CORAL LOPHELIA-PERTUSA; OXYGEN MINIMUM ZONE; FINAL GLOBAL SINK; LONG-TERM CHANGE; OCEAN ACIDIFICATION; HABITAT HETEROGENEITY; NORTHEAST ATLANTIC; HYDROTHERMAL VENT; METHANE HYDRATE	The deep sea, the largest ecosystem on Earth and one of the least studied, harbours high biodiversity and provides a wealth of resources. Although humans have used the oceans for millennia, technological developments now allow exploitation of fisheries resources, hydrocarbons and minerals below 2000 m depth. The remoteness of the deep seafloor has promoted the disposal of residues and litter. Ocean acidification and climate change now bring a new dimension of global effects. Thus the challenges facing the deep sea are large and accelerating, providing a new imperative for the science community, industry and national and international organizations to work together to develop successful exploitation management and conservation of the deep-sea ecosystem. This paper provides scientific expert judgement and a semi-quantitative analysis of past, present and future impacts of human-related activities on global deep-sea habitats within three categories: disposal, exploitation and climate change. The analysis is the result of a Census of Marine Life - SYNDEEP workshop (September 2008). A detailed review of known impacts and their effects is provided. The analysis shows how, in recent decades, the most significant anthropogenic activities that affect the deep sea have evolved from mainly disposal (past) to exploitation (present). We predict that from now and into the future, increases in atmospheric CO2 and facets and consequences of climate change will have the most impact on deep-sea habitats and their fauna. Synergies between different anthropogenic pressures and associated effects are discussed, indicating that most synergies are related to increased atmospheric CO2 and climate change effects. We identify deep-sea ecosystems we believe are at higher risk from human impacts in the near future: benthic communities on sedimentary upper slopes, cold-water corals, canyon benthic communities and seamount pelagic and benthic communities. We finalise this review with a short discussion on protection and management methods.	[Ramirez-Llodra, Eva] CSIC, Inst Ciencias Mar, Barcelona, Spain; [Tyler, Paul A.; Baker, Maria C.] Univ Southampton, Natl Oceanog Ctr Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England; [Bergstad, Odd Aksel] Inst Marine Res, Flodevigen, Norway; [Clark, Malcolm R.; Rowden, Ashley A.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Escobar, Elva] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico; [Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Smith, Craig R.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Menot, Lenaick] IFREMER, Ctr Brest, DEEP LEP, F-29280 Plouzane, France; [Van Dover, Cindy L.] Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); NERC National Oceanography Centre; University of Southampton; Institute of Marine Research - Norway; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Universidad Nacional Autonoma de Mexico; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; Ifremer; Duke University	Ramirez-Llodra, E (corresponding author), CSIC, Inst Ciencias Mar, Barcelona, Spain.	ezr@icm.csic.es	Rowden, Ashley/ABG-6010-2020; Rowden, Ashley/O-9358-2019; MENOT, LENAICK/N-6899-2016	MENOT, LENAICK/0000-0002-8117-1607; Ramirez-Llodra, Eva/0000-0003-0137-1906; Van Dover, Cindy/0000-0001-9845-8391; Escobar Briones, Elva/0000-0002-8485-7495; Levin, Lisa/0000-0002-2858-8622; Rowden, Ashley/0000-0003-2975-2524; Bergstad, Odd Aksel/0000-0002-4096-0896	Alfred P. Sloan Foundation; Census of Marine Life Synthesis; Fondation Total (France); Division Of Ocean Sciences [0826254] Funding Source: National Science Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Census of Marine Life Synthesis; Fondation Total (France); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Alfred P. Sloan Foundation, Census of Marine Life Synthesis grant for the SYNDEEP project, Fondation Total (France), grant for the ChEss-Census of Marine Life Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert Ahmed, 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P299, DOI 10.1023/A:1009963912171; ALLER JY, 1989, DEEP-SEA RES, V36, P901, DOI 10.1016/0198-0149(89)90035-6; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Amato E, 2006, MAR BIOL, V149, P17, DOI 10.1007/s00227-005-0216-x; ANGEL MV, 1988, ENVIRONMENTALIST, V8, P19, DOI 10.1007/BF02240308; [Anonymous], 2010, MC2521 JAG; [Anonymous], 2004, KENIRY REPORT; [Anonymous], 2010, DEEPW HOR OIL SPILL; Archer D, 2007, BIOGEOSCIENCES, V4, P521, DOI 10.5194/bg-4-521-2007; Arico S., 2005, BIOPROSPECTING GENET; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Bailey DM, 2009, P ROY SOC B-BIOL SCI, V276, P1965, DOI 10.1098/rspb.2009.0098; Baker MC, 2009, OCEAN CHALLENGE, V16, P10; Ballard Robert D., 1987, DISCOVERY TITANIC EX, Vfirst; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Barry JP, 2004, J OCEANOGR, V60, P759, DOI 10.1007/s10872-004-5768-8; Barry JP, 2004, DEFG0301DF63065; Barry JP, 2005, J GEOPHYS RES C, V110, P1; Bell N, 1999, NATURE, V402, P601, DOI 10.1038/45127; Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Bensch A, 2008, 522 FAO, V522, P1; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bolt C, 2003, PLENTY BLEATING ANSW; BOTHNER MH, 1994, MAR ENVIRON RES, V38, P43, DOI 10.1016/0141-1136(94)90045-0; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Brewer PG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014727; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Bussau C, 1995, VIE MILIEU, V45, P39; BUTMAN CA, 1995, CONSERV BIOL, V9, P462, DOI 10.1046/j.1523-1739.1995.9020462.x; Byrnes M, 2003, CORMO DISASTER LEAVE; Cadien D. B., 2001, 20012 SCWRRP; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Camphuysen CJ, 1993, 19938 NIOZ; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Carney R, 1988, IEE EXPLORE, P96, DOI [10.1109/OCEANS.1988.794833, DOI 10.1109/OCEANS.1988.794833]; CHERRY RD, 1982, SCIENCE, V218, P54, DOI 10.1126/science.7123217; Chisholm SW, 2001, SCIENCE, V294, P309, DOI 10.1126/science.1065349; Choong AMF, 2006, J TOXICOL ENV HEAL A, V69, P1959, DOI 10.1080/15287390600751371; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Clark M. R., 1995, DEEP WATER FISHERIES, P251; Clark MR, 2009, LAT AM J AQUAT RES, V37, P501, DOI 10.3856/vol37-issue3-fulltext-17; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Clark MR, 2009, 8 INT SEAB AUTH; Cochonat P, 2007, DEEP SEA FRONTIER SC; Coleman FC, 2002, TRENDS ECOL EVOL, V17, P40, DOI 10.1016/S0169-5347(01)02330-8; Company JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001431; Continental Shelf Associates Inc, 2006, 2006044 OCS MMS US D, VI; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P859, DOI 10.1017/S0025315407056512; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; Danovaro R, 2004, ECOL LETT, V7, P821, DOI 10.1111/j.1461-0248.2004.00634.x; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; DEUSER WG, 1980, NATURE, V283, P364, DOI 10.1038/283364a0; Devey CW, 2007, OCEANOGRAPHY, V20, P162, DOI 10.5670/oceanog.2007.90; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DWL Douglas Westwood Ltd, 2005, MAR FOR SER MAR I; Erickson KL, 2009, DEEP-SEA RES PT II, V56, P1577, DOI 10.1016/j.dsr2.2009.05.002; FAO Food and Agriculture Organization of the United Nations; Rome, 2009, INT GUID MAN DEEP SE; Forbes E., 1844, REPORT BRIT ASS ADV, V1843, P129; Francis RICC, 2005, B MAR SCI, V76, P337; Froescheis O, 2000, CHEMOSPHERE, V40, P651, DOI 10.1016/S0045-6535(99)00461-0; Furness RW, 1996, AQUATIC PREDATORS AND THEIR PREY, P166; GAGE JD, 1993, NATURE, V365, P609, DOI 10.1038/365609a0; Gage JD, 2005, AM FISH S S, V41, P503; Gale J., 2001, ENV GEOSCI, V8, P160, DOI DOI 10.1046/J.1526-0984.2001.008003160.X; Galgani F, 2000, MAR POLLUT BULL, V40, P516, DOI 10.1016/S0025-326X(99)00234-9; Galil Bella S., 2004, P1; Galil Bella S., 2006, V83, P207, DOI 10.1007/978-1-4020-5047-3_6; GALIL BS, 1995, MAR POLLUT BULL, V30, P22, DOI 10.1016/0025-326X(94)00103-G; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; German C. R., 1995, GEOLOGICAL SOC SPECI, V87, P365, DOI [10.1144/GSL.SP.1995.087.01.28, DOI 10.1144/GSL.SP.1995.087.01.28]; Ghosh AK, 2000, MINERAL WEALTH OCEAN; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; GLOVER AG, 2003, ENVIRON CONSERV, V30, P1, DOI DOI 10.1017/S0376892903000225); Godet L, 2011, CONSERV BIOL, V25, P214, DOI 10.1111/j.1523-1739.2010.01642.x; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; Goldberg ED, 1975, ASSESSING POTENTIAL; Gooday AJ, 2009, DEEP-SEA RES PT II, V56, P488, DOI 10.1016/j.dsr2.2008.10.003; Gooday AJ, 2010, MAR ECOL-EVOL PERSP, V31, P125, DOI 10.1111/j.1439-0485.2009.00348.x; Gorman AR, 2004, NZ PETR C P 7 10 MAR, P1; GORNITZ V, 1994, GLOBAL BIOGEOCHEM CY, V8, P335, DOI 10.1029/94GB00766; Grange K, 1993, NZ MAR SCI S REV, V35, P15; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Grigg R. W., 1987, GEOPHYS MONOGR SER, V43, P379, DOI DOI 10.1029/GM043P0379; GRIMES DJ, 1984, WATER RES, V18, P613, DOI 10.1016/0043-1354(84)90212-4; Guglielmi, 2004, MEDITERRANEAN DEEP S, P39; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hareide NR, 2001, FISH RES, V51, P297, DOI 10.1016/S0165-7836(01)00253-3; HARVEY LDD, 1995, J GEOPHYS RES-ATMOS, V100, P2905, DOI 10.1029/94JD02829; Hearn CG, 2002, TRACKS OCEAN MF MAUR; Heezen B.C., 1971, FACE DEEP; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hein JR, 2009, MAR GEORESOUR GEOTEC, V27, P160, DOI 10.1080/10641190902852485; Hein JR, 2002, 3 INT SEAB AUTH, P36; Helson J, 2010, MAR POLICY, V34, P557, DOI 10.1016/j.marpol.2009.11.002; Herring PJ, 1999, NATURE, V398, P116, DOI 10.1038/18142; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; Hester KC, 2009, ANNU REV MAR SCI, V1, P303, DOI 10.1146/annurev.marine.010908.163824; Hoagland P, 2010, MAR POLICY, V34, P728, DOI 10.1016/j.marpol.2009.12.001; Hoibraten S, 1997, SCI TOTAL ENVIRON, V202, P67, DOI 10.1016/S0048-9697(97)00105-8; HOLLISTER CD, 1984, NATURE, V309, P220, DOI 10.1038/309220a0; Hudson IR, 2003, PROG OCEANOGR, V59, P381, DOI 10.1016/j.pocean.2003.11.002; Hughes DJ, 2006, NEW RECORD VESTIMENT; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; IPCC, 2007, CLIM CHANG 2007 PHYS; ISA, 2007, P INT SEAB AUTH WORK; Johansen O, 2003, MAR POLLUT BULL, V47, P360, DOI 10.1016/S0025-326X(03)00202-9; Johnson GC, 2007, J CLIMATE, V20, P5365, DOI 10.1175/2007JCLI1879.1; Johnson GC, 2009, DEEP-SEA RES PT I, V56, P827, DOI 10.1016/j.dsr.2008.12.011; Johnson M, 2005, NATURE, V433, P105, DOI 10.1038/433105a; Jorgensen BB, 1999, FEMS MICROBIOL ECOL, V28, P301, DOI 10.1016/S0168-6496(98)00122-6; Jorgensen LL, 2007, HYDROBIOLOGIA, V590, P47, DOI 10.1007/s10750-007-0756-9; JUMARS P A, 1981, Marine Mining, V3, P213; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keller AA, 2010, MAR POLLUT BULL, V60, P692, DOI 10.1016/j.marpolbul.2009.12.006; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Kennett JP, 2003, AM GEOPHYS UNION SPE, V54; KIDD RB, 1981, OCEANOL ACTA, V4, P99; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; KVENVOLDEN KA, 1988, CHEM GEOL, V71, P41, DOI 10.1016/0009-2541(88)90104-0; Kvenvolden KA, 2002, TERRA NOVA, V14, P302, DOI 10.1046/j.1365-3121.2002.00414.x; Lack M, 2003, MANAGING RISK UNCERT, P73; Lampadariou N, 2009, SCI MAR, V73, P337, DOI 10.3989/scimar.2009.73n2337; Leary D.K., 2004, MACQUARIE J INT COMP, V1, P137; LEE WY, 1983, MAR POLLUT BULL, V14, P150, DOI 10.1016/0025-326X(83)90070-X; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 2011, ECOSYSTEM P IN PRESS; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2009.00358.x; Levin LA, 2009, TRENDS ECOL EVOL, V24, P606, DOI 10.1016/j.tree.2009.04.012; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; Levin LA, 2009, DEEP-SEA RES PT II, V56, P449, DOI 10.1016/j.dsr2.2008.05.032; Livingston M, 1988, CATCH, V15, P16; LONSDALE P, 1979, NATURE, V281, P531, DOI 10.1038/281531a0; Looser R, 2000, CHEMOSPHERE, V40, P661, DOI 10.1016/S0045-6535(99)00462-2; MACDONALD GJ, 1990, ANNU REV ENERGY, V15, P53, DOI 10.1146/annurev.eg.15.110190.000413; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; Martin J, 2008, MAR GEOL, V252, P150, DOI 10.1016/j.margeo.2008.03.012; MAY RM, 1992, NATURE, V357, P278, DOI 10.1038/357278a0; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; McMurtry G, 2001, ENCY OCEAN SCI, P201; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; Miyake H., 2011, INTERDISCIPLINARY ST, P261; Morato T, 2006, J FISH BIOL, V68, P209, DOI 10.1111/j.0022-1112.2006.00894.x; Morato Telmo, 2007, Fish and Aquatic Resources Series, V12, P170; Morato T, 2010, OCEANOGRAPHY, V23, P190, DOI 10.5670/oceanog.2010.71; Morton B, 2003, MAR POLLUT BULL, V46, P379, DOI 10.1016/S0025-326X(02)00453-8; MULLINEAUX LS, 1987, DEEP-SEA RES, V34, P165, DOI 10.1016/0198-0149(87)90080-X; Nardin T.R., 1979, SPECIAL PUBLICATION, V27, P61; National Geographic, 2010, NATL GEOGRAPHIC  OCT; Nicol J.A.C, 1978, TOXICITY PUERTO RICA; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; O'Brine T, 2010, MAR POLLUT BULL, V60, P2279, DOI 10.1016/j.marpolbul.2010.08.005; O'Driscoll RL, 2005, NEW ZEAL J MAR FRESH, V39, P839, DOI 10.1080/00288330.2005.9517356; Oebius HU, 2001, DEEP-SEA RES PT II, V48, P3453, DOI 10.1016/S0967-0645(01)00052-2; OHLHORST C W, 1981, Environmental Monitoring and Assessment, V1, P143, DOI 10.1007/BF00395119; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oschlies A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041961; OSPAR, 2009, ASS IMPACT DUMP CONV; OSTERBERG C, 1963, NATURE, V200, P1276, DOI 10.1038/2001276a0; Palanques A, 2006, DEEP-SEA RES PT I, V53, P201, DOI 10.1016/j.dsr.2005.10.003; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Paull CK, 2003, GEO-MAR LETT, V22, P198, DOI 10.1007/s00367-002-0113-y; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Pawson D.L., 1982, AUSTRALIAN MUSEUM SYDNEY MEMOIR, V16, P129; PEELE ER, 1981, APPL ENVIRON MICROB, V41, P873, DOI 10.1128/AEM.41.4.873-879.1981; Penney A, 2008, SPRFMOVSWG09; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444; PEW Fellows in Marine Conservation, 2007, PEW FELLOWS MARINE C; Pitcher T. J, 2007, SEAMOUNTS ECOLOGY FI, P361, DOI DOI 10.1002/9780470691953.CH17; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; Probert P. Keith, 2007, Fish and Aquatic Resources Series, V12, P442; Purkey SG, 2010, J CLIMATE, V23, P6336, DOI 10.1175/2010JCLI3682.1; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2008, MAR BIOL, V153, P297, DOI 10.1007/s00227-007-0805-y; RENNINGER GH, 1995, BIOL BULL, V189, P69, DOI 10.2307/1542456; Rex M.A., 2010, BIOSCIENCE; Rice AL, 1998, DECOMMISSIONING BREN; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; Rodolfo-Metalpa R, 2010, MAR ECOL, V180, P197; Roether W, 1996, SCIENCE, V271, P333, DOI 10.1126/science.271.5247.333; Rogers A.D., 2008, SCI GUIDELINES SCI G; Rogers Alex D., 2007, Fish and Aquatic Resources Series, V12, P141; Rona PA, 2003, SCIENCE, V299, P673, DOI 10.1126/science.1080679; Rona PA, 2008, ORE GEOL REV, V33, P618, DOI 10.1016/j.oregeorev.2007.03.006; Rotllant G, 2006, DEEP-SEA RES PT I, V53, P1895, DOI 10.1016/j.dsr.2006.09.004; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Rowe G.T., 1979, Ambio Special Report, P19, DOI 10.2307/25099603; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2536, DOI 10.1016/j.dsr2.2008.09.002; Rowe GT, 2009039 OCS MMS US D; Ruhl HA, 2004, SCIENCE, V305, P513, DOI 10.1126/science.1099759; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Saido K, 2009, 238 AM CHEM SOC NAT; Sarda F, 2009, PROG OCEANOGR, V82, P227, DOI 10.1016/j.pocean.2009.07.001; Schaefer H, 2006, SCIENCE, V313, P1109, DOI 10.1126/science.1126562; Sellanes J, 2008, ICES J MAR SCI, V65, P1102, DOI 10.1093/icesjms/fsn099; Sharma R, 2001, DEEP-SEA RES PT II, V48, P3363, DOI 10.1016/S0967-0645(01)00046-7; Sheldon B, 1993, DEEP SEA RADIOLOGICA; Shotton R, 2003, C GOV MAN DEEP SEA F; Simpson D.C., 1981, Elsevier Oceanography Series, V27B, P379; Sissenwine M.P., 2007, FAO Fisheries Reports, V838, P61; Smith C. R., 2008, 3 ISA; Smith CR, 2000, DEEP-SEA RES PT II, V47, P227, DOI 10.1016/S0967-0645(99)00108-3; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Smith CR, 2008, 3 INT SEAB AUTH, P45; Smith CR, 1999, DEEP SEABED POLYMETA, P41; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Smith Craig R., 2008, P334, DOI 10.1017/CBO9780511751790.030; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Smith T, 2008, 45 NAT OC CTR SOUTH; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Soliman YS, 2008, DEEP-SEA RES PT II, V55, P2577, DOI 10.1016/j.dsr2.2008.07.007; Soloviev V.A., 2002, GEOL GEOFIZ+, V43, P609; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Spengler A, 2008, MAR POLLUT BULL, V56, P226, DOI 10.1016/j.marpolbul.2007.09.040; STEGEMAN JJ, 1986, SCIENCE, V231, P1287, DOI 10.1126/science.231.4743.1287; STEGEMAN JJ, 1983, CAN J FISH AQUAT SCI, V40, P78; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Stuart CT, 2003, ECOSY WORLD, V28, P295; Sumida PYG, 2008, DEEP-SEA RES PT II, V55, P2465, DOI 10.1016/j.dsr2.2008.06.006; Tamburri MN, 2000, MAR CHEM, V72, P95, DOI 10.1016/S0304-4203(00)00075-X; Teuten E, 2007, ENVIRON SCI TECHNOL, V35, P318; Thiel H, 2003, ECOSY WORLD, V28, P427; THIEL H, 1993, DEEP-SEA RES PT I, V40, P419, DOI 10.1016/0967-0637(93)90012-R; Thiel H, 2001, DEEP-SEA RES PT II, V48, P3869, DOI 10.1016/S0967-0645(01)00071-6; Thiel H, 2007, INT J HYDROBIOL, V77, P331; Thistle D, 2007, MAR ECOL PROG SER, V340, P9, DOI 10.3354/meps340009; Thistle D, 2005, MAR ECOL PROG SER, V289, P1, DOI 10.3354/meps289001; Thistle D, 2003, ECOSY WORLD, V28, P5; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054; Tievey M, 2009, WORKING GROUP UPDATE, V28, P48; Tittensor DP, 2010, MAR ECOL-EVOL PERSP, V31, P212, DOI 10.1111/j.1439-0485.2010.00393.x; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; TROFIMUK AA, 1973, DOKL AKAD NAUK SSSR+, V212, P931; Turley CM, 2007, CORAL REEFS, V26, P445, DOI 10.1007/s00338-007-0247-5; TURNER RD, 1973, SCIENCE, V180, P1377, DOI 10.1126/science.180.4093.1377; TYLER P, 1994, SARSIA, V79, P45, DOI 10.1080/00364827.1994.10413546; TYLER PA, 1982, J MAR BIOL ASSOC UK, V62, P45, DOI 10.1017/S0025315400020099; Tyler PA, 1995, OCEANOGR MAR BIOL, V33, P221; UNEP, 2009, MAR LITT GLOB CHALL; UNEP, 2007, UNEP WCMC BIOD SER; Unger MA, 2008, MAR POLLUT BULL, V56, P1498, DOI 10.1016/j.marpolbul.2008.04.018; Van den Hove S, 2007, ECOSYSTEMS BIODIVERS; Van der Vat D, 1988, ATLANTIC CAMPAIGN GR; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover C.L., 2011, ISA TECHNICAL STUDY, P90; Van Dover CL, 2011, ICES J MAR SCI, V68, P341, DOI 10.1093/icesjms/fsq086; VANDOVER CL, 1992, NATURE, V360, P153; VANPRAET M, 1990, PROG OCEANOGR, V24, P207, DOI 10.1016/0079-6611(90)90031-V; Vaquer-Sunyer R, 2011, GLOBAL CHANGE BIOL, V17, P1788, DOI 10.1111/j.1365-2486.2010.02343.x; Vetter EW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002617; Vogt PR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013488; Wade TL, 2008, DEEP-SEA RES PT II, V55, P2585, DOI 10.1016/j.dsr2.2008.07.006; Watters DL, 2010, MAR POLLUT BULL, V60, P131, DOI 10.1016/j.marpolbul.2009.08.019; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Wigham BD, 2003, PROG OCEANOGR, V59, P409, DOI 10.1016/j.pocean.2003.11.003; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; WILSON GDF, 1987, ANNU REV ECOL SYST, V18, P185, DOI 10.1146/annurev.es.18.110187.001153; Wolff T., 1980, P199; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; WOODWELL GM, 1971, SCIENCE, V174, P1101, DOI 10.1126/science.174.4014.1101; Woulds C, 2007, LIMNOL OCEANOGR, V52, P1698, DOI 10.4319/lo.2007.52.4.1698; Wright W, 2007, AGR HUM VALUES, V24, P133, DOI 10.1007/s10460-006-9056-7; Zajac RN, 2008, J EXP MAR BIOL ECOL, V366, P198, DOI 10.1016/j.jembe.2008.07.025; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104; Zhou H, 2007, POLYMETALLIC SULPHID, P257; Zweigel P., 2004, SPECIAL PUBLICATIONS, V233, P165, DOI DOI 10.1144/GSL.SP.2004.233.01.11	289	478	483	12	373	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22588	10.1371/journal.pone.0022588	http://dx.doi.org/10.1371/journal.pone.0022588			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829635	Green Published, gold, Green Accepted			2022-12-27	WOS:000293511200013
J	Volkmer, B; Heinemann, M				Volkmer, Benjamin; Heinemann, Matthias			Condition-Dependent Cell Volume and Concentration of Escherichia coli to Facilitate Data Conversion for Systems Biology Modeling	PLOS ONE			English	Article							FLOW-CYTOMETRY; GROWTH-RATE; BACTERIA; SIZE; METABOLOMICS; DIMENSIONS; CULTURES; FLUXES	Systems biology modeling typically requires quantitative experimental data such as intracellular concentrations or copy numbers per cell. In order to convert population-averaging omics measurement data to intracellular concentrations or cellular copy numbers, the total cell volume and number of cells in a sample need to be known. Unfortunately, even for the often studied model bacterium Escherichia coli this information is hardly available and furthermore, certain measures (e. g. cell volume) are also dependent on the growth condition. In this work, we have determined these basic data for E. coli cells when grown in 22 different conditions so that respective data conversions can be done correctly. First, we determine growth-rate dependent cell volumes. Second, we show that in a 1 ml E. coli sample at an optical density (600 nm) of 1 the total cell volume is around 3.6 mu l for all conditions tested. Third, we demonstrate that the cell number in a sample can be determined on the basis of the sample's optical density and the cells' growth rate. The data presented will allow for conversion of E. coli measurement data normalized to optical density into volumetric cellular concentrations and copy numbers per cell - two important parameters for systems biology model development.	[Volkmer, Benjamin; Heinemann, Matthias] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Volkmer, Benjamin] Life Sci Zurich PhD Program Syst Biol Complex Dis, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen	Volkmer, B (corresponding author), Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland.	m.heinemann@rug.nl	Heinemann, Matthias/B-9421-2008	Heinemann, Matthias/0000-0002-5512-9077; Volkmer, Benjamin/0000-0002-9945-9772	ETH Zurich	ETH Zurich(ETH Zurich)	ETH Zurich (INIT program project "Single cell metabolomics"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bouvier T, 2001, CYTOMETRY, V44, P188, DOI 10.1002/1097-0320(20010701)44:3<188::AID-CYTO1111>3.0.CO;2-C; BOYE E, 1983, J GEN MICROBIOL, V129, P973; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHURCHWARD G, 1981, J BACTERIOL, V145, P1232, DOI 10.1128/JB.145.3.1232-1238.1981; Fagerbakke KM, 1999, CAN J MICROBIOL, V45, P304, DOI 10.1139/cjm-45-4-304; Gonzalez O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000799; GROSSMAN N, 1982, J BACTERIOL, V152, P35; HELDAL M, 1985, APPL ENVIRON MICROB, V50, P1251, DOI 10.1128/AEM.50.5.1251-1257.1985; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; KUBITSCHEK HE, 1969, BIOPHYS J, V9, P792, DOI 10.1016/S0006-3495(69)86418-0; Lee SY, 2009, SYSTEMS BIOLOGY AND BIOTECHNOLOGY OF ESCHERICHIA COLI, P441, DOI 10.1007/978-1-4020-9394-4_20; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Nanchen A, 2006, APPL ENVIRON MICROB, V72, P1164, DOI 10.1128/AEM.72.2.1164-1172.2006; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; PIERUCCI O, 1978, J BACTERIOL, V135, P559, DOI 10.1128/JB.135.2.559-574.1978; Reshes G, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046001; SARDONINI CA, 1987, BIOTECHNOL BIOENG, V29, P469, DOI 10.1002/bit.260290410; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shapiro HH, 2000, J MICROBIOL METH, V42, P3, DOI 10.1016/S0167-7012(00)00167-6; Szymanski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007441; Usuda Y, 2010, J BIOTECHNOL, V147, P17, DOI 10.1016/j.jbiotec.2010.02.018; Yizhak K, 2010, BIOINFORMATICS, V26, pi255, DOI 10.1093/bioinformatics/btq183; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	32	207	209	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23126	10.1371/journal.pone.0023126	http://dx.doi.org/10.1371/journal.pone.0023126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829590	Green Published, gold, Green Submitted			2022-12-27	WOS:000293286500077
J	Janzen, DH; Hallwachs, W				Janzen, Daniel H.; Hallwachs, Winnie			Joining Inventory by Parataxonomists with DNA Barcoding of a Large Complex Tropical Conserved Wildland in Northwestern Costa Rica	PLOS ONE			English	Review							PARASITOID FLIES DIPTERA; BIODIVERSITY; GARDENIFICATION; LEPIDOPTERA; INTEGRATION; GENUS	Background: The many components of conservation through biodiversity development of a large complex tropical wildland, Area de Conservacion Guanacaste (ACG), thrive on knowing what is its biodiversity and natural history. For 32 years a growing team of Costa Rican parataxonomists has conducted biodiversity inventory of ACG caterpillars, their food plants, and their parasitoids. In 2003, DNA barcoding was added to the inventory process. Methodology/Principal Findings: We describe some of the salient consequences for the parataxonomists of barcoding becoming part of a field biodiversity inventory process that has centuries of tradition. From the barcoding results, the parataxonomists, as well as other downstream users, gain a more fine-scale and greater understanding of the specimens they find, rear, photograph, database and deliver. The parataxonomists also need to adjust to collecting more specimens of what appear to be the "same species" - cryptic species that cannot be distinguished by eye or even food plant alone while having to work with the name changes and taxonomic uncertainty that comes with discovering that what looked like one species may be many. Conclusions/Significance: These career parataxonomists, despite their lack of formal higher education, have proven very capable of absorbing and working around the additional complexity and requirements for accuracy and detail that are generated by adding barcoding to the field base of the ACG inventory. In the process, they have also gained a greater understanding of the fine details of phylogeny, relatedness, evolution, and species-packing in their own tropical complex ecosytems. There is no reason to view DNA barcoding as incompatible in any way with tropical biodiversity inventory as conducted by parataxonomists. Their year-round on-site inventory effort lends itself well to the sampling patterns and sample sizes needed to build a thorough barcode library. Furthermore, the biological understanding that comes with barcoding increases the scientific penetrance of biodiversity information, DNA understanding, evolution, and ecology into the communities in which the parataxonomists and their families are resident.	[Janzen, Daniel H.; Hallwachs, Winnie] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Janzen, DH (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	djanzen@sas.upenn.edu			United States National Science Foundation [BSR 9024770, DEB 9306296, 9400829, 9705072, 0072730, 0515699]; Wege Foundation; International Conservation Fund of Canada; Jessie B. Cox Charitable Trust; Blue Moon Fund; Guanacaste Dry Forest Conservation Fund; Area de Conservacion Guanacaste; University of Pennsylvania	United States National Science Foundation(National Science Foundation (NSF)); Wege Foundation; International Conservation Fund of Canada; Jessie B. Cox Charitable Trust; Blue Moon Fund; Guanacaste Dry Forest Conservation Fund; Area de Conservacion Guanacaste; University of Pennsylvania	This research was supported by United States National Science Foundation grants BSR 9024770 and DEB 9306296, 9400829, 9705072, 0072730, and 0515699, and grants from the Wege Foundation, International Conservation Fund of Canada, Jessie B. Cox Charitable Trust, Blue Moon Fund, Guanacaste Dry Forest Conservation Fund, Area de Conservacion Guanacaste, and University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Gomez L.D., 1983, P1; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hulcr J, 2007, MOL ECOL NOTES, V7, P549, DOI 10.1111/j.1471-8286.2007.01786.x; Janzen D, 1999, P NATL ACAD SCI USA, V96, P5987, DOI 10.1073/pnas.96.11.5987; Janzen D, 1998, SCIENCE, V279, P1312, DOI 10.1126/science.279.5355.1312; Janzen D. H., 1993, Biodiversity prospecting: using genetic resources for sustainable development., P223; Janzen D. H., 2000, Biodiversity, V1, P7; JANZEN D H, 1991, American Entomologist, V37, P159; Janzen Daniel H., 1993, P100; Janzen Daniel H., 2002, P559; Janzen DH, 2010, BIOTROPICA, V42, P540, DOI 10.1111/j.1744-7429.2010.00667.x; Janzen DH, 2010, P NATL ACAD SCI USA, V107, P11659, DOI 10.1073/pnas.0912122107; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; Janzen DH, 2008, RESTAURACION BOSQUES, P181; Janzen DH, 2011, PLOS ONE IN PRESS; Janzen DH, 1992, MEXICO ANTE RETOS BI, P243; Janzen DH, 1999, CIENCIAS AMBIENTALES, V16, P8; Janzen DH, 1988, REHABILITATING DAMAG, VII, P143; Miller JC, 2006, 100 CATERPILLARS; MILLER JC, 2007, 100 BUTTERFLIES MOTH; Pfeiffer Jeanine, 2003, Telopea, V10, P61; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stoeckle MY, 2008, SCI AM, V299, P82	36	91	93	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e18123	10.1371/journal.pone.0018123	http://dx.doi.org/10.1371/journal.pone.0018123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857894	gold, Green Published			2022-12-27	WOS:000294125500001
J	Accetto, T; Avgustin, G				Accetto, Tomaz; Avgustin, Gorazd			Inability of Prevotella bryantii to Form a Functional Shine-Dalgarno Interaction Reflects Unique Evolution of Ribosome Binding Sites in Bacteroidetes	PLOS ONE			English	Article							EXTENSIVE DNA INVERSIONS; ESCHERICHIA-COLI; MICROBIAL GENOMES; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNAS; XYLANASE GENE; TRANSLATION; INITIATION; SEQUENCE	The Shine-Dalgarno (SD) sequence is a key element directing the translation to initiate at the authentic start codons and also enabling translation initiation to proceed in 5' untranslated mRNA regions (5'-UTRs) containing moderately strong secondary structures. Bioinformatic analysis of almost forty genomes from the major bacterial phylum Bacteroidetes revealed, however, a general absence of SD sequence, drop in GC content and consequently reduced tendency to form secondary structures in 5'-UTRs. The experiments using the Prevotella bryantii TC1-1 expression system were in agreement with these findings: neither addition nor omission of SD sequence in the unstructured 5'-UTR affected the level of the reporter protein, non-specific nuclease NucB. Further, NucB level in P. bryantii TC1-1, contrary to hMGFP level in Escherichia coli, was five times lower when SD sequence formed part of the secondary structure with a folding energy -5,2 kcal/mol. Also, the extended SD sequences did not affect protein levels as in E. coli. It seems therefore that a functional SD interaction does not take place during the translation initiation in P. bryanttii TC1-1 and possibly other members of phylum Bacteroidetes although the anti SD sequence is present in 16S rRNA genes of their genomes. We thus propose that in the absence of the SD sequence interaction, the selection of genuine start codons in Bacteroidetes is accomplished by binding of ribosomal protein S1 to unstructured 5'-UTR as opposed to coding region which is inaccessible due to mRNA secondary structure. Additionally, we found that sequence logos of region preceding the start codons may be used as taxonomical markers. Depending on whether complete sequence logo or only part of it, such as information content and base proportion at specific positions, is used, bacterial genera or families and in some cases even bacterial phyla can be distinguished.	[Accetto, Tomaz; Avgustin, Gorazd] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia	University of Ljubljana	Accetto, T (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia.	tomaz.accetto@bf.uni-lj.si			Slovenian Research Agency [P4-0097]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Slovenian Research Agency, research project P4-0097 (http://www.arrs.gov.si/en/dobrodoslica.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetto T, 2007, MICROBIOL-SGM, V153, P2281, DOI 10.1099/mic.0.2007/005850-0; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; Chen S, 2007, APPL ENVIRON MICROB, V73, P1089, DOI 10.1128/AEM.01577-06; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DANIEL AS, 1995, J APPL BACTERIOL, V79, P417, DOI 10.1111/j.1365-2672.1995.tb03156.x; DESMIT MH, 1994, J MOL BIOL, V244, P144, DOI 10.1006/jmbi.1994.1714; DESMIT MH, 1994, J MOL BIOL, V235, P173, DOI 10.1016/S0022-2836(05)80024-5; Fargo DC, 1998, MOL GEN GENET, V257, P271; Gupta RS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-71; Hobson PN, 1969, METHODS MICROBIOLOGY, V3, P133, DOI DOI 10.1016/S0580-9517(08)70504-X; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Miyazaki K, 2003, J BACTERIOL, V185, P2219, DOI 10.1128/JB.185.7.2219-2226.2003; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Nakagawa S, 2010, P NATL ACAD SCI USA, V107, P6382, DOI 10.1073/pnas.1002036107; Nakamoto T, 2007, GENE, V403, P1, DOI 10.1016/j.gene.2007.08.006; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sakamoto M, 2006, INT J SYST EVOL MICR, V56, P1599, DOI 10.1099/ijs.0.64192-0; Salah P, 2009, NUCLEIC ACIDS RES, V37, P5578, DOI 10.1093/nar/gkp547; Salyers AA, 2000, METHODS, V20, P35, DOI 10.1006/meth.1999.0903; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; VANGYLSWYK NO, 1990, FEMS MICROBIOL ECOL, V73, P243, DOI 10.1016/0378-1097(90)90737-B; Vimberg V, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-100; Vingadassalom D, 2005, MOL MICROBIOL, V56, P888, DOI 10.1111/j.1365-2958.2005.04590.x; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zhu HQ, 2004, BIOINFORMATICS, V20, P3308, DOI 10.1093/bioinformatics/bth390; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22914	10.1371/journal.pone.0022914	http://dx.doi.org/10.1371/journal.pone.0022914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857964	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953500009
J	Zemlin, AE; Matsha, TE; Hassan, MS; Erasmus, RT				Zemlin, Annalise E.; Matsha, Tandi E.; Hassan, Mogamat S.; Erasmus, Rajiv T.			HbA1c of 6.5% to Diagnose Diabetes Mellitus - Does It Work for Us? - The Bellville South Africa Study	PLOS ONE			English	Article							GLYCATED HEMOGLOBIN; DISEASE; SENSITIVITY; COMMUNITY; GLUCOSE; A(1C); RISK; A1C	Background: HbA1c has been the gold standard for glycaemic control follow-up for decades. In 2009, a level of 6.5% (48 mmol/mol) was proposed as diagnostic for diabetes. We test this cut-off in our community. Methods: Participants (946) from a community-based study were screened for diabetes using either a fasting blood glucose or oral glucose tolerance test (OFTT). The HbA1c cut-off of 6.5% was tested for each group. A receiver operator characteristic (ROC) curve for both groups was generated to establish an optimal cut-off. Results: Our study included 224 (23.7%) males and 722 (76.3%) females. Using fasting blood glucose alone, 117 (14%) were diagnosed with diabetes -250% had an HbA1c value of >= 6.5% (48 mmol/mol). Using an OGTT, 147 (18%) were diagnosed with diabetes -246% had an HbA1c value of >= 6.5% (48 mmol/mol). ROC curves found a level of 6.1% (43 mmol/mol) to be optimal in both groups (AUC 0.85 and 0.82 respectively). The sensitivities were 80% and 75% and the specificities 77% and 78% respectively. Conclusions: A cut off of 6.5% (48 mmol/mol) is a good diagnostic tool with its high specificity; however the low sensitivity limits its use. We found a level of 6.1% (43 mmol/mol) to be optimal. This emphasizes the need for evidenced based values to be established in various population groups.	[Zemlin, Annalise E.; Erasmus, Rajiv T.] Natl Hlth Lab Serv, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa; [Zemlin, Annalise E.; Erasmus, Rajiv T.] Univ Stellenbosch, Cape Town, South Africa; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, Cape Town, South Africa; [Hassan, Mogamat S.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Nursing & Radiog, Cape Town, South Africa	Stellenbosch University; Cape Peninsula University of Technology; Cape Peninsula University of Technology	Zemlin, AE (corresponding author), Natl Hlth Lab Serv, Fac Hlth Sci, Div Chem Pathol, Cape Town, South Africa.	rte@sun.ac.za		Matsha, Tandi/0000-0001-5251-030X	Cape Peninsula University of Technology, South Africa; National Health Laboratory Services South Africa [94122]	Cape Peninsula University of Technology, South Africa; National Health Laboratory Services South Africa	This research was supported by grants from the University Research Fund of the Cape Peninsula University of Technology, South Africa and the National Health Laboratory Services South Africa (grant number 94122). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, DIABETES CARE S1, V33, pS62; American Diabetes Association: Diagnosis and classification of diabetes mellitus, 2005, DIABETES CARE S1, V28, P537; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P700; Charlton K E, 1997, S Afr Med J, V87, P364; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Goodall Ian, 2005, Clin Biochem Rev, V26, P5; Kumar PR, 2010, J CLIN ENDOCR METAB, V95, P2832, DOI 10.1210/jc.2009-2433; Levitt NS, 1999, DIABETIC MED, V16, P946, DOI 10.1046/j.1464-5491.1999.00185.x; Melchionda N, 2002, INT J OBESITY, V26, P90, DOI 10.1038/sj.ijo.0801847; MOLLEUTZE WF, 2006, CHRONIC DIS LIFESTYL, P190; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Rowley KG, 2005, DIABETIC MED, V22, P833, DOI 10.1111/j.1464-5491.2005.01447.x; Sacks DB, 2009, CLIN CHEM, V55, P1612, DOI 10.1373/clinchem.2009.132704; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Young IS, 2010, CLIN CHEM, V56, P547, DOI 10.1373/clinchem.2009.138677	19	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22558	10.1371/journal.pone.0022558	http://dx.doi.org/10.1371/journal.pone.0022558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857932	Green Published, gold			2022-12-27	WOS:000293953500004
J	Dutheil, S; Lacour, M; Tighilet, B				Dutheil, Sophie; Lacour, Michel; Tighilet, Brahim			Neurogenic Potential of the Vestibular Nuclei and Behavioural Recovery Time Course in the Adult Cat Are Governed by the Nature of the Vestibular Damage	PLOS ONE			English	Article							UNILATERAL LABYRINTHECTOMY; HIPPOCAMPAL NEUROGENESIS; STEREOLOGICAL METHODS; MOLECULAR-MECHANISMS; GABAERGIC CONTROL; INJURED BRAIN; TOTAL NUMBER; GUINEA-PIG; STEM-CELL; NEURONS	Functional and reactive neurogenesis and astrogenesis are observed in deafferented vestibular nuclei after unilateral vestibular nerve section in adult cats. The newborn cells survive up to one month and contribute actively to the successful recovery of posturo-locomotor functions. This study investigates whether the nature of vestibular deafferentation has an incidence on the neurogenic potential of the vestibular nuclei, and on the time course of behavioural recovery. Three animal models that mimic different vestibular pathologies were used: unilateral and permanent suppression of vestibular input by unilateral vestibular neurectomy (UVN), or by unilateral labyrinthectomy (UL, the mechanical destruction of peripheral vestibular receptors), or unilateral and reversible blockade of vestibular nerve input using tetrodotoxin (TTX). Neurogenesis and astrogenesis were revealed in the vestibular nuclei using bromodeoxyuridine (BrdU) as a newborn cell marker, while glial fibrillary acidic protein (GFAP) and glutamate decarboxylase 67 (GAD67) were used to identify astrocytes and GABAergic neurons, respectively. Spontaneous nystagmus and posturo-locomotor tests (static and dynamic balance performance) were carried out to quantify the behavioural recovery process. Results showed that the nature of vestibular loss determined the cellular plastic events occurring in the vestibular nuclei and affected the time course of behavioural recovery. Interestingly, the deafferented vestibular nuclei express neurogenic potential after acute and total vestibular loss only (UVN), while non-structural plastic processes are involved when the vestibular deafferentation is less drastic (UL, TTX). This is the first experimental evidence that the vestibular complex in the brainstem can become neurogenic under specific injury. These new data are of interest for understanding the factors favouring the expression of functional neurogenesis in adult mammals in a brain repair perspective, and are of clinical relevance in vestibular pathology.	[Dutheil, Sophie; Lacour, Michel; Tighilet, Brahim] Univ Aix Marseille 1, Dept Neurosci, UMR Neurosci Integrat & Adaptat 6149, CNRS Pole Comportement Cerveau Cognit 3C,Ctr St C, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Dutheil, S (corresponding author), Univ Aix Marseille 1, Dept Neurosci, UMR Neurosci Integrat & Adaptat 6149, CNRS Pole Comportement Cerveau Cognit 3C,Ctr St C, Marseille, France.	brahim.tighilet@univ-provence.fr		Dutheil, Sophie/0000-0002-2031-482X	Ministere de l'enseignement superieur et de la recherche; CNRS (UMR Universite de Provence/CNRS) [6149]	Ministere de l'enseignement superieur et de la recherche; CNRS (UMR Universite de Provence/CNRS)	This study was supported by grants from the "Ministere de l'enseignement superieur et de la recherche" and CNRS (UMR Universite de Provence/CNRS No 6149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; Brezun JM, 2000, EUR J NEUROSCI, V12, P391, DOI 10.1046/j.1460-9568.2000.00932.x; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campos-Torres A, 2005, NEUROSCIENCE, V130, P853, DOI 10.1016/j.neuroscience.2004.08.052; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Christensen JR, 2007, ANAT REC, V290, P330, DOI 10.1002/ar.20504; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Darlington CL, 2000, PROG NEUROBIOL, V62, P313, DOI 10.1016/S0301-0082(00)00002-2; DIERINGER N, 1995, PROG NEUROBIOL, V46, P97, DOI 10.1016/0301-0082(94)00063-N; Dutheil S, 2009, NEUROSCIENCE, V164, P1444, DOI 10.1016/j.neuroscience.2009.09.048; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Flohr H, 1985, Rev Oculomot Res, V1, P269; Gacek Richard R., 1998, Auris Nasus Larynx, V25, P193, DOI 10.1016/S0385-8146(98)00015-7; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gittis AH, 2006, CURR OPIN NEUROBIOL, V16, P385, DOI 10.1016/j.conb.2006.06.012; Gliddon CM, 2005, J PHARMACOL EXP THER, V313, P1126, DOI 10.1124/jpet.104.082172; Gliddon CM, 2005, PROG NEUROBIOL, V75, P53, DOI 10.1016/j.pneurobio.2004.11.001; Guilding C, 2005, NEUROREPORT, V16, P1415, DOI 10.1097/01.wnr.0000176519.42218.a6; Him A, 2001, BRAIN RES, V908, P58, DOI 10.1016/S0006-8993(01)02600-2; HOWARD CV, 2005, UNBIAISED STEREOLOGY; Jakubs K, 2008, J NEUROSCI, V28, P12477, DOI 10.1523/JNEUROSCI.3240-08.2008; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; LACOUR M, 1976, BRAIN RES, V113, P255, DOI 10.1016/0006-8993(76)90940-9; Lacour M, 2006, CURR MED RES OPIN, V22, P1651, DOI 10.1185/030079906X115694; Lacour M, 2010, RESTOR NEUROL NEUROS, V28, P19, DOI 10.3233/RNN-2010-0509; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Liberge M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-91; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Paterson JM, 2006, J PHYSIOL-LONDON, V575, P777, DOI 10.1113/jphysiol.2006.112409; Raivich G, 1999, ACTA NEUROCHIR SUPPL, V73, P21; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; REDON C, 2010, J CLIN PHARM; RIS L, 1995, J NEUROPHYSIOL, V74, P2087, DOI 10.1152/jn.1995.74.5.2087; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Saxon DW, 2001, NEUROREPORT, V12, P3051, DOI 10.1097/00001756-200110080-00014; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Tighilet B, 2009, NEUROSCIENCE, V160, P716, DOI 10.1016/j.neuroscience.2009.02.070; TIGHILET B, 1995, J VESTIBUL RES-EQUIL, V5, P187; Tighilet B, 2001, EUR J NEUROSCI, V13, P2255, DOI 10.1046/j.0953-816x.2001.01622.x; Tighilet B, 2007, EUR J NEUROSCI, V25, P47, DOI 10.1111/j.1460-9568.2006.05267.x; Tighilet B, 2006, J PHYSIOL-LONDON, V573, P723, DOI 10.1113/jphysiol.2006.107805; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; XERRI C, 1980, ACTA OTO-LARYNGOL, V90, P414, DOI 10.3109/00016488009131743; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zennou-Azogui Y, 1993, Acta Otolaryngol Suppl, V509, P1; Zheng YW, 2010, NEUROSCI LETT, V468, P85, DOI 10.1016/j.neulet.2009.10.070	60	33	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22262	10.1371/journal.pone.0022262	http://dx.doi.org/10.1371/journal.pone.0022262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853029	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953400005
J	Pulsford, RM; Cortina-Borja, M; Rich, C; Kinnafick, FE; Dezateux, C; Griffiths, LJ				Pulsford, Richard M.; Cortina-Borja, Mario; Rich, Carly; Kinnafick, Florence-Emilie; Dezateux, Carol; Griffiths, Lucy J.			Actigraph Accelerometer-Defined Boundaries for Sedentary Behaviour and Physical Activity Intensities in 7 Year Old Children	PLOS ONE			English	Article							ACTIVITY ENERGY-EXPENDITURE; OBJECTIVE MEASURES; ACTIVITY MONITORS; CALIBRATION; VALIDATION; VALIDITY; CURVES	Background: Accurate objective assessment of sedentary and physical activity behaviours during childhood is integral to the understanding of their relation to later health outcomes, as well as to documenting the frequency and distribution of physical activity within a population. Purpose: To calibrate the Actigraph GT1M accelerometer, using energy expenditure (EE) as the criterion measure, to define thresholds for sedentary behaviour and physical activity categories suitable for use in a large scale epidemiological study in young children. Methods: Accelerometer-based assessments of physical activity (counts per minute) were calibrated against EE measures (kcal.kg(-1).hr(-1)) obtained over a range of exercise intensities using a COSMED K4b(2) portable metabolic unit in 53 seven-year-old children. Children performed seven activities: lying down viewing television, sitting upright playing a computer game, slow walking, brisk walking, jogging, hopscotch and basketball. Threshold count values were established to identify sedentary behaviour and light, moderate and vigorous physical activity using linear discriminant analysis (LDA) and evaluated using receiver operating characteristic (ROC) curve analysis. Results: EE was significantly associated with counts for all non-sedentary activities with the exception of jogging. Threshold values for accelerometer counts (counts. minute(-1)) were <100 for sedentary behaviour and <= 2240, <= 3840 and >= 3841 for light, moderate and vigorous physical activity respectively. The area under the ROC curves for discrimination of sedentary behaviour and vigorous activity were 0.98. Boundaries for light and moderate physical activity were less well defined (0.61 and 0.60 respectively). Sensitivity and specificity were higher for sedentary (99% and 97%) and vigorous (95% and 91%) than for light (60% and 83%) and moderate (61% and 76%) thresholds. Conclusion: The accelerometer cut points established in this study can be used to classify sedentary behaviour and to distinguish between light, moderate and vigorous physical activity in children of this age.	[Pulsford, Richard M.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Cortina-Borja, Mario; Rich, Carly; Dezateux, Carol; Griffiths, Lucy J.] UCL, MRC, Ctr Epidemiol Child Hlth, Inst Child Hlth, London, England; [Kinnafick, Florence-Emilie] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England	University of Exeter; University of London; University College London; University of Birmingham	Pulsford, RM (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	l.griffiths@ich.ucl.ac.uk	Borja, Mario Cortina/A-3847-2009; Kinnafick, Florence/R-5545-2017	Borja, Mario Cortina/0000-0003-0627-2624; Kinnafick, Florence/0000-0002-3095-7116; Griffiths, Lucy/0000-0001-9230-624X; Rich, Carly/0000-0003-4717-5855; Pulsford, Richard/0000-0001-6880-7597; Dezateux, Carol/0000-0001-9787-6276	Wellcome Trust [084686/Z/08/A]; International Centre for Child Studies; Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health; Department of Health's National Institute for Health Research Biomedical Research Centres; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546B, G0400546] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); International Centre for Child Studies; Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study received external funding from the Wellcome Trust (grant 084686/Z/08/A) and the International Centre for Child Studies. The Centre for Paediatric Epidemiology and Biostatistics is supported in part by the Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health. Research at the UCL Institute of Child Health and Great Ormond Street Hospital for Children receives a proportion of the funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2011, R LANG ENV STAT COMP; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Bonomi AG, 2009, MED SCI SPORT EXER, V41, P1770, DOI 10.1249/MSS.0b013e3181a24536; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Corder K, 2007, MED SCI SPORT EXER, V39, P2180, DOI 10.1249/mss.0b013e318150dff8; de Vries SI, 2011, MED SCI SPORTS  0325; Ekelund U, 2004, AM J CLIN NUTR, V79, P851; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fletcher T. D., 2010, PSYCHOMETRIC APPL PS; FRIEDMAN JH, 1974, IEEE T COMPUT, VC 23, P881, DOI 10.1109/T-C.1974.224051; Grubbs F, 2010, ANN MATH STAT, V1, P27; Guinhouya CB, 2009, ACTA PAEDIATR, V98, P708, DOI 10.1111/j.1651-2227.2008.01187.x; Harrell JS, 2005, MED SCI SPORT EXER, V37, P329, DOI 10.1249/01.MSS.0000153115.33762.3F; Hubert M, 2008, COMPUT STAT DATA AN, V52, P5186, DOI 10.1016/j.csda.2007.11.008; Hughson RL, 2009, APPL PHYSIOL NUTR ME, V34, P840, DOI 10.1139/H09-088; Jago R, 2007, J SPORT SCI, V25, P937, DOI 10.1080/02640410600908027; Komsta L., 2011, OUTLIERS TESTS OUTLI; Leisch F, 2004, J STAT SOFTW, V11, P1, DOI DOI 10.18637/JSS.V011.I08; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; McArdle W., 2002, EXERCISE PHYSL ENERG; McLaughlin JE, 2001, INT J SPORTS MED, V22, P280, DOI 10.1055/s-2001-13816; Ott AE, 2000, PEDIATR EXERC SCI, V12, P360, DOI 10.1123/pes.12.4.360; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; Pfeiffer KA, 2006, MED SCI SPORT EXER, V38, P152, DOI 10.1249/01.mss.0000183219.44127.e7; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; Reilly JJ, 2003, OBES RES, V11, P1155, DOI 10.1038/oby.2003.158; Riddoch CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4544; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Ruch N, 2011, EUR J APPL PHYS 0120; Schmitz KH, 2005, MED SCI SPORT EXER, V37, P155, DOI 10.1249/01.MSS.0000150084.97823.F7; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; SIRARD JR, 2005, J PHYS ACT HEALTH, V3, P324; Sleap M, 1996, INT J SPORTS MED, V17, P248, DOI 10.1055/s-2007-972841; Staudenmayer J, 2009, J APPL PHYSIOL, V107, P1300, DOI 10.1152/japplphysiol.00465.2009; Stone MR, 2007, PEDIATR EXERC SCI, V19, P291, DOI 10.1123/pes.19.3.291; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Terrier P, 2001, ERGONOMICS, V44, P48, DOI 10.1080/00140130118289; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; VENABLES WN, 2003, MODERN APPL STAT	47	62	63	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e21822	10.1371/journal.pone.0021822	http://dx.doi.org/10.1371/journal.pone.0021822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853021	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400004
J	Chelouah, S; Monod-Wissler, C; Bailly, C; Barret, JM; Guilbaud, N; Vispe, S; Kas, E				Chelouah, Sonia; Monod-Wissler, Caroline; Bailly, Christian; Barret, Jean-Marc; Guilbaud, Nicolas; Vispe, Stephane; Kaes, Emmanuel			An Integrated Drosophila Model System Reveals Unique Properties for F14512, a Novel Polyamine-Containing Anticancer Drug That Targets Topoisomerase II	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; ORNITHINE-DECARBOXYLASE; CHROMATIN-STRUCTURE; DNA TOPOISOMERASES; GENE-EXPRESSION; ANTITUMOR DRUGS; EYE DEVELOPMENT; CELL-DEATH; IN-VIVO; MELANOGASTER	F14512 is a novel anti-tumor molecule based on an epipodophyllotoxin core coupled to a cancer-cell vectoring spermine moiety. This polyamine linkage is assumed to ensure the preferential uptake of F14512 by cancer cells, strong interaction with DNA and potent inhibition of topoisomerase II (Topo II). The antitumor activity of F14512 in human tumor models is significantly higher than that of other epipodophyllotoxins in spite of a lower induction of DNA breakage. Hence, the demonstrated superiority of F14512 over other Topo II poisons might not result solely from its preferential uptake by cancer cells, but could also be due to unique effects on Topo II interactions with DNA. To further dissect the mechanism of action of F14512, we used Drosophila melanogaster mutants whose genetic background leads to an easily scored phenotype that is sensitive to changes in Topo II activity and/or localization. F14512 has antiproliferative properties in Drosophila cells and stabilizes ternary Topo II/DNA cleavable complexes at unique sites located in moderately repeated sequences, suggesting that the drug specifically targets a select and limited subset of genomic sequences. Feeding F14512 to developing mutant Drosophila larvae led to the recovery of flies expressing a striking phenotype, "Eye wide shut," where one eye is replaced by a first thoracic segment. Other recovered F14512-induced gain- and loss-of-function phenotypes similarly correspond to precise genetic dysfunctions. These complex in vivo results obtained in a whole developing organism can be reconciled with known genetic anomalies and constitute a remarkable instance of specific alterations of gene expression by ingestion of a drug. " Drosophila-based anticancer pharmacology" hence reveals unique properties for F14512, demonstrating the usefulness of an assay system that provides a low-cost, rapid and effective complement to mammalian models and permits the elucidation of fundamental mechanisms of action of candidate drugs of therapeutic interest in humans.	[Chelouah, Sonia; Monod-Wissler, Caroline; Kaes, Emmanuel] Univ Toulouse 3, Univ Toulouse, Lab Biol Mol Eucaryote, Toulouse, France; [Chelouah, Sonia; Monod-Wissler, Caroline; Kaes, Emmanuel] CNRS, UMR5099, Lab Biol Mol Eucaryote, Toulouse, France; [Bailly, Christian; Barret, Jean-Marc; Guilbaud, Nicolas; Vispe, Stephane] Inst Rech Pierre Fabre, Ctr Rech Oncol Expt, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chelouah, S (corresponding author), CNRS, Inst Cancerol Gustave Roussy, UMR 8126, Villejuif, France.	stephane.vispe@pierre-fabre.com; kas@ibcg.biotoul.fr	BAILLY, Christian/AAK-2799-2021; Barret, Jean-Marc/AAN-6038-2020	BAILLY, Christian/0000-0002-2973-9357; CHELOUAH, SONIA/0000-0001-5137-9370	Centre National de la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer (ARC) [4897, ANR-06-BLAN-0419 CSD 8]; Ligue Nationale Contre le Cancer (LNCC); IRPF	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer (LNCC)(Ligue nationale contre le cancer); IRPF	EK was funded by the Centre National de la Recherche Scientifique (CNRS, http://www.cnrs.fr/), the Association pour la Recherche sur le Cancer (ARC, http://www.arc-cancer.net/, grant No. 4897), the Ligue Nationale Contre le Cancer (LNCC, http://www.ligue-cancer.net/) and the Agence Nationale de la Recherche (ANR, http://www.agence-nationale-recherche.fr/, grant DNAMOTORS No. ANR-06-BLAN-0419 CSD 8). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Commercial funding to EK was provided in part by the Institut de Recherche Pierre Fabre, which played a role in study design, part of data collection and analysis, decision to publish and contributed to preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Christian Bailly, Jean-Marc Barret, Nicolas Guilbaud and Stephane Vispe are fulltime employees of Institut de Recherche Pierre Fabre (IRPF), which developed F14512, a patented drug, and conducts its ongoing phase I clinical trials; Research in Emmanuel Kas's lab was funded in part by IRPF, of which EK is neither an employee nor a consultant and is not involved in patents, products in development or marketed products. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Aulner N, 2002, MOL CELL BIOL, V22, P1218, DOI 10.1128/MCB.22.4.1218-1232.2002; Barret JM, 2008, CANCER RES, V68, P9845, DOI 10.1158/0008-5472.CAN-08-2748; Blattes R, 2006, EMBO J, V25, P2397, DOI 10.1038/sj.emboj.7601125; Borgnetto ME, 1996, CANCER RES, V56, P1855; Borgnetto ME, 1999, J MOL BIOL, V285, P545, DOI 10.1006/jmbi.1998.2330; Byl JAW, 2001, BIOCHEMISTRY-US, V40, P712, DOI 10.1021/bi0021838; Casero RA, 2009, J MED CHEM, V52, P4551, DOI 10.1021/jm900187v; CHARCOSSET JY, 1993, B CANCER, V80, P923; CHEN GL, 1984, J BIOL CHEM, V259, P3560; Chern JJ, 2002, DEVELOPMENT, V129, P4005; El-Awady RA, 2008, SAUDI MED J, V29, P558; FANTI L, 1994, MOL GEN GENET, V244, P588, DOI 10.1007/BF00282748; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; FESEN M, 1989, J BIOL CHEM, V264, P11354; Fic W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000253; Gentry AC, 2011, BIOCHEMISTRY-US, V50, P3240, DOI 10.1021/bi200094z; GINDHART JG, 1995, GENETICS, V139, P797; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hasinoff BB, 2002, ANTI-CANCER DRUG, V13, P255, DOI 10.1097/00001813-200203000-00007; Hasinoff BB, 2001, MOL PHARMACOL, V59, P453, DOI 10.1124/mol.59.3.453; Heisig P, 2009, MUTAGENESIS, V24, P465, DOI 10.1093/mutage/gep035; Hu HY, 2005, WORLD J GASTROENTERO, V11, P2244, DOI 10.3748/wjg.v11.i15.2244; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; IMBERT T, 2005, POLY AMINOACETAMIDE; Janssen S, 2000, MOL CELL, V6, P1013, DOI 10.1016/S1097-2765(00)00100-3; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; JUDD BH, 1995, GENETICS, V141, P245; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; KAS E, 1993, EMBO J, V12, P115, DOI 10.1002/j.1460-2075.1993.tb05637.x; Kluza J, 2006, ANTI-CANCER DRUG, V17, P155, DOI 10.1097/00001813-200602000-00006; KRUCZYNSKI A, 2009, INVEST NEW DRUGS; Laemmli UK, 1992, CURR OPIN GENET DEV, V2, P275, DOI 10.1016/S0959-437X(05)80285-0; Larsen AK, 1998, BBA-GENE STRUCT EXPR, V1400, P257, DOI 10.1016/S0167-4781(98)00140-7; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Larsen Annette K, 2003, Prog Cell Cycle Res, V5, P295; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; Mafune K, 1999, CLIN CANCER RES, V5, P4073; Marchion DC, 2005, MOL CANCER THER, V4, P1993, DOI 10.1158/1535-7163.MCT-05-0194; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; MOTTUS R, 1980, MOL GEN GENET, V178, P465; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Nam C, 2010, HISTOL HISTOPATHOL, V25, P485, DOI 10.14670/HH-25.485; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Osman D, 2009, P NATL ACAD SCI USA, V106, P12043, DOI 10.1073/pnas.0902449106; Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802; POLJAK L, 1995, TRENDS CELL BIOL, V5, P348, DOI 10.1016/S0962-8924(00)89068-6; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; REUTER G, 1982, MOL GEN GENET, V188, P480, DOI 10.1007/BF00330052; Reymann S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-324; Schultz J, 1936, P NATL ACAD SCI USA, V22, P27, DOI 10.1073/pnas.22.1.27; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; SOLARY E, 1994, LEUKEMIA LYMPHOMA, V15, P21, DOI 10.3109/10428199409051674; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; Susbielle Guillaume, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P409, DOI 10.2174/1568011054222355; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Tian H, 2006, ACTA BIOCH BIOPH SIN, V38, P639, DOI 10.1111/j.1745-7270.2006.00204.x; Tsen C, 2008, J MED CHEM, V51, P324, DOI 10.1021/jm701198s; UDVARDY A, 1991, MOL CELL BIOL, V11, P4973, DOI 10.1128/MCB.11.10.4973; Utsugi T, 1996, CANCER RES, V56, P2809; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WYCKOFF E, 1989, J MOL BIOL, V205, P1, DOI 10.1016/0022-2836(89)90361-6; Yan TD, 2009, MOL CANCER THER, V8, P1075, DOI 10.1158/1535-7163.MCT-09-0139; Young L, 2006, J HISTOCHEM CYTOCHEM, V54, P223, DOI 10.1369/jhc.5A6672.2005	74	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23597	10.1371/journal.pone.0023597	http://dx.doi.org/10.1371/journal.pone.0023597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853156	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200100
J	Shin, A; Joo, J; Bak, J; Yang, HR; Kim, J; Park, S; Nam, BH				Shin, Aesun; Joo, Jungnam; Bak, Jeongin; Yang, Hye-Ryung; Kim, Jeongseon; Park, Sohee; Nam, Byung-Ho			Site-Specific Risk Factors for Colorectal Cancer in a Korean Population	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; BODY-MASS-INDEX; ALCOHOL-CONSUMPTION; RECTAL-CANCER; METABOLIC SYNDROME; POOLED ANALYSIS; JAPANESE MEN; COLON-CANCER; COHORT; METAANALYSIS	We investigated the association of colorectal cancer risk factors with different colorectal cancer subsites to assess etiological differences for cancers of the proximal colon, distal colon, and rectum. Included in this study were 869,725 men and 395,501 women who participated in a health examination provided by the Korean National Health System between 1996 and 1997. During up to 7 years of follow-up, 4,144 incident colorectal cancer cases were detected (3,051 men and 1,093 women). Greater height was associated with elevated risk for distal colon cancer and rectal cancer in both men and women. Family history of cancer was associated with higher risk for cancers of the proximal colon in men and distal colon in both men and women. Frequent alcohol consumption and consuming high amounts of alcohol were associated with elevated risk for distal colon cancer in men and higher risk for rectal cancer in women. Frequent meat consumption was associated with risk for proximal colon cancer in men and for rectal cancer in women. Our findings suggest that risk factors for colorectal cancer are different by subsites of colon and rectum, as well as by sex.	[Shin, Aesun; Kim, Jeongseon] Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea; [Joo, Jungnam; Bak, Jeongin; Yang, Hye-Ryung; Park, Sohee; Nam, Byung-Ho] Natl Canc Ctr, Canc Biostat Branch, Goyang Si, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Shin, A (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea.	byunghonam@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022; Shin, Aesun/E-9145-2014	Shin, Aesun/0000-0002-6426-1969	National Cancer Center, Korea [0810190-3]	National Cancer Center, Korea	This work was supported by the National Cancer Center, Korea (grant No. 0810190-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Akhter M, 2007, EUR J CANCER, V43, P383, DOI 10.1016/j.ejca.2006.09.020; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Bowers K, 2006, AM J EPIDEMIOL, V164, P652, DOI 10.1093/aje/kwj253; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Cho EY, 2004, ANN INTERN MED, V140, P603, DOI 10.7326/0003-4819-140-8-200404200-00007; Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; DELEON MP, 1989, CANCER RES, V49, P4344; GOLDBOHM RA, 1994, CANCER CAUSE CONTROL, V5, P95, DOI 10.1007/BF01830255; Inoue M, 2009, EUR J CANCER PREV, V18, P240, DOI 10.1097/CEJ.0b013e3283240460; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; *KOR MIN HLTH WELF, 2008, ANN REP CANC INC; Lagakos S. W., 1978, APPLIED STATISTICS, V27, P235, DOI DOI 10.2307/2347158; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; MCMICHAEL AJ, 1985, JNCI-J NATL CANCER I, V75, P185; Mizoue T, 2008, AM J EPIDEMIOL, V167, P1397, DOI 10.1093/aje/kwn073; NOMURA AMY, 1991, J NATL CANCER I, V83, P1403, DOI 10.1093/jnci/83.19.1403; Otani T, 2005, CANCER CAUSE CONTROL, V16, P839, DOI 10.1007/s10552-005-4573-z; PARK S, 2009, CANC RES TREAT, V14, pS11; Pedersen A, 2003, GUT, V52, P861, DOI 10.1136/gut.52.6.861; Pelucchi C, 2010, EUR J CANCER, V46, P1866, DOI 10.1016/j.ejca.2010.03.010; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Sharpe CR, 2002, CANCER CAUSE CONTROL, V13, P483, DOI 10.1023/A:1015700415808; Song YM, 2008, J CLIN ONCOL, V26, P3395, DOI 10.1200/JCO.2007.15.7867; Sturmer T, 2006, CANCER EPIDEM BIOMAR, V15, P2391, DOI 10.1158/1055-9965.EPI-06-0391; Sung J, 2009, AM J EPIDEMIOL, V170, P53, DOI 10.1093/aje/kwp088; Trevisan M, 2001, CANCER EPIDEM BIOMAR, V10, P937; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; 2001, JAMA, V285, P2486	36	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23196	10.1371/journal.pone.0023196	http://dx.doi.org/10.1371/journal.pone.0023196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853085	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200051
J	Suarez-Morales, E				Suarez-Morales, Eduardo			Diversity of the Monstrilloida (Crustacea: Copepoda)	PLOS ONE			English	Review							SARS CRUSTACEA; CARIBBEAN SEA; CYMBASOMA; REDESCRIPTION; RECORD; MEXICO; REEF; CALIFORNIA; NORWAY; BRAZIL	Monstrilloid copepods are protelean parasites of different groups of marine benthic invertebrates. Only their first naupliar, preadult, and adult phases are planktonic. Monstrilloids are currently represented by more than 115 nominal species contained in four genera. Its taxonomic knowledge has been hampered by nomenclatural and descriptive problems derived from their peculiar ontogeny and poor definitions of taxa. One of the most important difficulties is that of matching males to females. The only reliable methods to link the sexes of a species are the confirmation of particular apomorphies shared by both sexes, finding both sexes in the same host or as a pre-copulatory male-female pair in the plankton, or by the use of molecular markers. A general overview of the morphology of the group and its life cycle is provided herein. Recently, upgraded descriptive standards have been established and the relevance of redescribing taxa based on type and museum specimens has been demonstrated. The rate of species description per decade has had several peaks between 1840 and 2010: (19711980, 1991-2000, 2001-2010), each related to the activity of a few researchers. An analysis of the world distribution of published records of the Monstrilloida revealed that the Northeast Atlantic is the best studied region (45% of all records), followed by the Northwestern Atlantic (17%); the least surveyed areas include regions of the southern hemisphere (less than 3%). The Northeast Atlantic region harbors the highest number of known species (32 nominal species), followed by the Caribbean Sea/Gulf of Mexico (24), the Mediterranean/Black Sea (19), Indonesia-Malaysia-Philippines region (17), Japanese waters (17), and the Brazil-Argentina area (16). Other than these generalized patterns, little can be concluded concerning the biogeography of the group. Many species records are doubtful or improbable, and purportedly cosmopolitan nominal species are being revealed as species complexes yet to be studied.	Colegio Frontera Sur Unidad Chetumal, Chetmal, Quintana Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR)	Suarez-Morales, E (corresponding author), Colegio Frontera Sur Unidad Chetumal, Chetmal, Quintana Roo, Mexico.	esuarez@ecosur.mx			ES-M's institution; El Colegio de la Frontera Sur	ES-M's institution; El Colegio de la Frontera Sur	Funding was provided by ES-M's institution, El Colegio de la Frontera Sur through the author's personal institutional project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, COPEPOD EVOLUTION; Biancalana F, 2007, BRAZ J OCEANOGR, V55, P83, DOI 10.1590/S1679-87592007000200002; Boxshall GA, 2004, INTRO COPEPOD DIVERS, P966; Caullery Maurice, 1914, Bulletin Scientifique de la France et de la Belgique ser 7, V48; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Dana JD., 1849, AM J SCI ARTS, V8, P276; Davis C.C., 1984, P67; DAVIS CHARLES C., 1949, TRANS AMER MICROSC SOC, V68, P245, DOI 10.2307/3223221; DIAS CO, 2007, BIOTA NEOTROP, V7, P281; DIAS CO, 2005, BIOTA NEOTROPICA, V5; Dias Cristina de Oliveira, 2007, Pan-American Journal of Aquatic Sciences, V2, P270; FOSSHAGEN A, 1970, SARSIA, V42, P33; GIARD A, 1895, CR HEBD ACAD SCI, V120, P937; GIARD A, 1896, CR HEBD ACAD SCI, V123, P836; Giesbrecht W, 1893, FAUNA FLORA GOLF, V19, P1, DOI DOI 10.5962/BHL.TITLE.913; Grygier MJ, 2008, ZOOL J LINN SOC-LOND, V152, P459, DOI 10.1111/j.1096-3642.2007.00381.x; Grygier Mark J., 1995, Galaxea, V12, P1; GRYGIER MJ, 1995, J CRUSTACEAN BIOL, V15, P703, DOI 10.2307/1548820; GRYGIER MJ, 1993, SARSIA, V78, P235, DOI 10.1080/00364827.1993.10413537; GRYGIER MJ, 1994, HYDROBIOLOGIA, V293, P23; HARTMAN O, 1964, ZOOL ANZ, V167, P325; Ho JS, 2003, J CRUSTACEAN BIOL, V23, P582, DOI 10.1651/C-2391; Huys R, 2007, MOL PHYLOGENET EVOL, V43, P368, DOI 10.1016/j.ympev.2007.02.004; Isaac M.J., 1975, Fiches Ident Zooplancton, V144-145, P1; KROYER, 1842, VOYAGES COMMISSION S, P41; Leite NR, 2010, AN ACAD BRAS CIENC, V82, P577, DOI 10.1590/S0001-37652010000300005; MALAQUIN A, 1901, ARCH ZOOLOGIE EXPT G, V9, P81; MARIN V, 1985, J PLANKTON RES, V7, P961, DOI 10.1093/plankt/7.6.961; MCALICE BJ, 1985, J CRUSTACEAN BIOL, V5, P627, DOI 10.2307/1548240; PARK TS, 1967, T AM MICROSC SOC, V86, P144, DOI 10.2307/3224681; Pelseneer Paul, 1914, Bulletin Scientifique de la France et de la Belgique ser 7, V48; RAMIREZ F C, 1971, Physis (Buenos Aires), V30, P377; RAZOULS C, 1994, ANN I OCEANOGR PARIS, V70, P3; Razouls C, 1996, ANN I OCEANOGR PARIS, V72, P5; RAZOULS C, DIVERSITE REPARTITIO; SALE PF, 1976, MAR BIOL, V34, P59, DOI 10.1007/BF00390788; Sars G. O., 1921, ACCOUNT CRUSTACEA NO, V8; Suarez-Morales E, 1997, B MAR SCI, V61, P539; Suarez-Morales E, 2000, SARSIA, V85, P203, DOI 10.1080/00364827.2000.10414573; Suarez-Morales E., 2001, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V71, P53; Suarez-Morales E, 2006, HELGOLAND MAR RES, V60, P171, DOI 10.1007/s10152-005-0018-z; Suarez-Morales E., 2000, Beaufortia, V50, P139; Suarez-Morales E, 2004, ZOOL STUD, V43, P292; Suarez-Morales E, 2004, ARCTIC, V57, P37; Suarez-Morales E, 1999, P BIOL SOC WASH, V112, P189; Suarez-Morales E, 2001, CRUSTACEANA, V74, P689, DOI 10.1163/156854001750377966; Suarez-Morales E, 2001, J NAT HIST, V35, P1433, DOI 10.1080/002229301317067629; Suarez-Morales E, 2001, CAH BIOL MAR, V42, P243; Suarez-Morales E, 2000, J MAR BIOL ASSOC UK, V80, P1031, DOI 10.1017/S002531540000309X; Suarez-Morales E., 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V70, P107; Suarez-Morales E, 2007, ZOOTAXA, P25; Suarez-Morales E, 2006, ZOOL ANZ, V245, P95, DOI 10.1016/j.jcz.2006.05.002; Suarez-Morales E, 2010, ZOOTAXA, P55; Suarez-Morales Eduardo, 2001, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V72, P9; Suarez-Morales E, 2010, J MAR BIOL ASSOC UK, V90, P953, DOI 10.1017/S0025315409991391; SUAREZMORALES E, 1993, HYDROBIOLOGIA, V271, P45, DOI 10.1007/BF00005694; SUAREZMORALES E, 1990, UNIV CIENC, V7, P57; Walter TC, 2010, WORLD COPEPODA DATAB	58	27	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22915	10.1371/journal.pone.0022915	http://dx.doi.org/10.1371/journal.pone.0022915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853055	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200026
J	Zhang, X; He, JF; Li, LH; Zhu, XL; Ke, CW; Ni, HZ; Hou, NM; Zhong, HJ; Wu, J				Zhang, Xin; He, Jianfeng; Li, Linghui; Zhu, Xiaolan; Ke, Changwen; Ni, Hanzhong; Hou, Nianmei; Zhong, Haojie; Wu, Jie			Serologic Survey of the Pandemic H1N1 2009 Virus in Guangdong Province, China: A Cross Sectional Study	PLOS ONE			English	Article							HOUSEHOLD TRANSMISSION; INFLUENZA-VIRUS	Background: Relying on surveillance of clinical cases limits the ability to understand the full impact and severity of an epidemic, which urges a deep insight into the serological evidence of infection and transmission feature of pandemic H1N1 2009 (pH1N1) virus in Guangdong province. Methods: In this cross-sectional serological survey, serum samples were collected by multi-stage stratified random sampling in Jan 2010. Antibody titers were measured by hemagglutination inhibition (HI) assay. Age-specific and region-specific prevalence were calculated based on the results of HI assay (positive, HI titer >= 1:40). Results: A total of 4,319 serum samples had been collected from subjects without vaccination with pH1N1 vaccine. The seroprevalence was 22.82% (985/4,319). By contrast, there was a marked spatial heterogeneity in prevalence. The seroprevalence was 27.3% in large city, 21.4% in medium cities, higher than that of 20.2% in rural areas. The seroprevalence was highest in 11-20 age group (32.8%), however, in those above 60 years of age group, which was 12.6%, lower than other age groups. On the other hand, antibody titers to pH1N1 virus were highest in school children, which were followed by a gradual decrease in adult. However, in the elderly groups from cities, especially from large city, the antibody titer to pH1N1 increased significantly and reached a much higher level. Conclusion: Our results showed that the prevalence for pH1N1 was correlated with age and population density. Preexisting antibody may have protected the very old from pH1N1 infection, while original antigenic sin and immunosenescence may have contributed to greater severity once infected. These should be considered when studying the pathogenesis and transmission of influenza virus and formulating strategies on vaccination and treatment.	[Zhang, Xin; He, Jianfeng; Li, Linghui; Zhu, Xiaolan; Ke, Changwen; Ni, Hanzhong; Hou, Nianmei; Zhong, Haojie; Wu, Jie] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China		Zhang, X (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	zhangxinhui16@163.com			national transfer payments funding for the pandemic H1N1 serologic survey	national transfer payments funding for the pandemic H1N1 serologic survey	This study was supported by the national transfer payments funding for the pandemic H1N1 serologic survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; CHAN M, 2009, WHO WORLD NOW START; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; Collins SD, 1931, PUBLIC HEALTH REP, V46, P1909, DOI 10.2307/4580139; Committee for Proprietary Medicinal Products [CPMP], 1997, CPMPBWP21496, P1; DANUTA MS, 2011, JID, V203, P158; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jianfeng H, 2010, S CHINA J PREV MED, V36, P4; JIN HK, 2009, J IMMUNOL, V183, P3294; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; LINGHUI L, 2010, S CHINA J PREV MED, V36, P17; McSweeny Kirsten, 2007, N Z Med J, V120, pU2579; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pebody R, 2011, VACCINE, V29, P2613, DOI 10.1016/j.vaccine.2011.01.046; PHYLLIS JL, 2004, NAT IMMUNOL, V5, P133; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SHUANG L, 2009, MECH AGEING, V130, P538; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; *WHO, 2009, PANDEMIC A H1N1 UPDA, V59; World Health Organization, 2002, WHO MAN AN INFL DIAG	26	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23034	10.1371/journal.pone.0023034	http://dx.doi.org/10.1371/journal.pone.0023034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853064	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200035
J	Deibler, M; Spatz, JP; Kemkemer, R				Deibler, Martin; Spatz, Joachim P.; Kemkemer, Ralf			Actin Fusion Proteins Alter the Dynamics of Mechanically Induced Cytoskeleton Rearrangement	PLOS ONE			English	Article							CELL MECHANICS; CYCLIC STRETCH; STRESS FIBER; REORIENTATION; MODEL; REORGANIZATION; ORIENTATION; FORCE	Mechanical forces can regulate various functions in living cells. The cytoskeleton is a crucial element for the transduction of forces in cell-internal signals and subsequent biological responses. Accordingly, many studies in cellular biomechanics have been focused on the role of the contractile acto-myosin system in such processes. A widely used method to observe the dynamic actin network in living cells is the transgenic expression of fluorescent proteins fused to actin. However, adverse effects of GFP-actin fusion proteins on cell spreading, migration and cell adhesion strength have been reported. These shortcomings were shown to be partly overcome by fusions of actin binding peptides to fluorescent proteins. Nevertheless, it is not understood whether direct labeling by actin fusion proteins or indirect labeling via these chimaeras alters biomechanical responses of cells and the cytoskeleton to forces. We investigated the dynamic reorganization of actin stress fibers in cells under cyclic mechanical loading by transiently expressing either egfp-Lifeact or eyfp-actin in rat embryonic fibroblasts and observing them by means of live cell microscopy. Our results demonstrate that mechanically-induced actin stress fiber reorganization exhibits very different kinetics in EYFP-actin cells and EGFP-Lifeact cells, the latter showing a remarkable agreement with the reorganization kinetics of non-transfected cells under the same experimental conditions.	[Deibler, Martin; Spatz, Joachim P.; Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Deibler, Martin; Spatz, Joachim P.] Univ Heidelberg, Dept Biophys Chem, Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Deibler, M (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	ralf.kemkemer@is.mpg.de	Spatz, Joachim P/A-1107-2017	Spatz, Joachim P/0000-0003-3419-9807	Bundesministerium fur Bildung und Forschung (BMBF); Max Planck Society (MPG)	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society (MPG)(Max Planck Society)	Parts of the study were financially supported by the Bundesministerium fur Bildung und Forschung (BMBF project Systec MSC). The Max Planck Society (MPG) is acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmed WW, 2010, ACTA BIOMATER, V6, P2979, DOI 10.1016/j.actbio.2010.02.035; Aizawa H, 1997, CELL STRUCT FUNCT, V22, P335, DOI 10.1247/csf.22.335; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Feng ZQ, 2005, BIOMATERIALS, V26, P5348, DOI 10.1016/j.biomaterials.2005.01.069; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Forster B, 2004, MICROSC RES TECHNIQ, V65, P33, DOI 10.1002/jemt.20092; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Geiger RC, 2006, GENE THER, V13, P725, DOI 10.1038/sj.gt.3302693; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katoh K, 2008, VASC HEALTH RISK MAN, V4, P1273, DOI 10.2147/VHRM.S3933; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Luo YZ, 2008, J BIOMECH, V41, P2379, DOI 10.1016/j.jbiomech.2008.05.026; Neidlinger-Wilke C, 2002, J ORTHOPAED RES, V20, P953, DOI 10.1016/S0736-0266(02)00024-4; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang D, 2010, INTEGR BIOL-UK, V2, P288, DOI 10.1039/b920644b; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5	25	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22941	10.1371/journal.pone.0022941	http://dx.doi.org/10.1371/journal.pone.0022941			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850245	gold, Green Published, Green Submitted			2022-12-27	WOS:000293563300030
J	Lipinska, U; Hermans, K; Meulemans, L; Dumitrescu, O; Badiou, C; Duchateau, L; Haesebrouck, F; Etienne, J; Lina, G				Lipinska, Urszula; Hermans, Katleen; Meulemans, Lieve; Dumitrescu, Oana; Badiou, Cedric; Duchateau, Luc; Haesebrouck, Freddy; Etienne, Jerome; Lina, Gerard			Panton-Valentine Leukocidin Does Play a Role in the Early Stage of Staphylococcus aureus Skin Infections: A Rabbit Model	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; VIRULENCE DETERMINANT; CUTANEOUS INFECTIONS; STRAINS; USA300; INFLAMMATION; LEUCOCIDIN; PNEUMONIA; DISEASE; TOXINS	Despite epidemiological data linking necrotizing skin infections with the production of Panton-Valentine leukocidin (PVL), the contribution of this toxin to the virulence of S. aureus has been highly discussed as a result of inconclusive results of in vivo studies. However, the majority of these results originate from experiments using mice, an animal species which neutrophils - the major target cells for PVL - are highly insensitive to the action of this leukocidin. In contrast, the rabbit neutrophils have been shown to be as sensitive to PVL action as human cells, making the rabbit a better experimental animal to explore the PVL role. In this study we examined whether PVL contributes to S. aureus pathogenicity by means of a rabbit skin infection model. The rabbits were injected intradermally with 10(8) cfu of either a PVL positive community-associated methicillin-resistant S. aureus isolate, its isogenic PVL knockout or a PVL complemented knockout strain, and the development of skin lesions was observed. While all strains induced skin infection, the wild type strain produced larger lesions and a higher degree of skin necrosis compared to the PVL knockout strain in the first week after the infection. The PVL expression in the rabbits was indirectly confirmed by a raise in the serum titer of anti-LukS-PV antibodies observed only in the rabbits infected with PVL positive strains. These results indicate that the rabbit model is more suitable for studying the role of PVL in staphylococcal diseases than other animal models. Further, they support the epidemiological link between PVL producing S. aureus strains and necrotizing skin infections.	[Lipinska, Urszula; Hermans, Katleen; Meulemans, Lieve; Haesebrouck, Freddy] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Physiol & Biometry, Merelbeke, Belgium; [Dumitrescu, Oana; Badiou, Cedric; Etienne, Jerome; Lina, Gerard] Univ Lyon 1, Ctr Natl Reference Staphylocoques, F-69365 Lyon, France; [Dumitrescu, Oana; Badiou, Cedric; Etienne, Jerome; Lina, Gerard] INSERM, IFR128, U851, F-69008 Lyon, France; [Dumitrescu, Oana; Etienne, Jerome; Lina, Gerard] Hosp Civils Lyon, Lyon, France	Ghent University; Ghent University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Lipinska, U (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	urszula.lipinska@ugent.be	Haesebrouck, Freddy/M-3857-2014; Lina, Gerard J/L-9352-2014; Dumitrescu, Oana/C-6222-2013; ETIENNE, Jerome/C-5471-2014	Haesebrouck, Freddy/0000-0002-1709-933X; Dumitrescu, Oana/0000-0001-8193-1437; ETIENNE, Jerome/0000-0002-3348-3315; Lina, Gerard/0000-0002-9236-7998	Ghent University [01J.055.06]; European Community [EC 222718]; Pfizer; bioMerieux; Novartis	Ghent University(Ghent University); European Community(European Commission); Pfizer(Pfizer); bioMerieux; Novartis(Novartis)	This research was funded by the Special Research Fund of Ghent University (01J.055.06), the grant European Community (EC 222718), Pfizer, bioMerieux and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; COUPPIE P, 1994, ARCH DERMATOL, V130, P1208, DOI 10.1001/archderm.130.9.1208; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; CRIBIER B, 1992, DERMATOLOGY, V185, P175, DOI 10.1159/000247443; Croze M, 2009, CLIN MICROBIOL INFEC, V15, P144, DOI 10.1111/j.1469-0691.2008.02650.x; des Horts TB, 2010, INFECT IMMUN, V78, P260, DOI 10.1128/IAI.00843-09; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; GLADSTONE GP, 1957, BRIT J EXP PATHOL, V38, P123; HARCOURTBROWN F, 2002, TXB RABBIT MED, P52; Hermans K, 1999, VET MICROBIOL, V67, P37, DOI 10.1016/S0378-1135(99)00028-0; Hermans K, 2003, VET MICROBIOL, V91, P57, DOI 10.1016/S0378-1135(02)00260-2; Hongo I, 2009, J INFECT DIS, V200, P715, DOI 10.1086/605332; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1994, ZBL BAKT S, V24, P284; Szmigielski S, 1998, ZBL BAKT-INT J MED M, V288, P383; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Vancraeynest D, 2007, VET MICROBIOL, V121, P368, DOI 10.1016/j.vetmic.2006.12.011; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; WOODIN AM, 1959, BIOCHEM J, V73, P225, DOI 10.1042/bj0730225	30	71	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22864	10.1371/journal.pone.0022864	http://dx.doi.org/10.1371/journal.pone.0022864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850240	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300025
J	Werth, BB; Bashir, M; Chang, L; Werth, VP				Werth, Benjamin Boegel; Bashir, Muhammad; Chang, Laura; Werth, Victoria P.			Ultraviolet Irradiation Induces the Accumulation of Chondroitin Sulfate, but Not Other Glycosaminoglycans, in Human Skin	PLOS ONE			English	Article							DERMATAN SULFATE; HYALURONIC-ACID; HAIRLESS MOUSE; KAPPA-B; UVB; SERGLYCIN; INTERLEUKIN-1-BETA; TRANSLOCATION; INFLAMMATION; ACTIVATION	Ultraviolet (UV) light alters cutaneous structure and function. Prior work has shown loss of dermal hyaluronan after UV-irradiation of human skin, yet UV exposure increases total glycosaminoglycan (GAG) content in mouse models. To more fully describe UV-induced alterations to cutaneous GAG content, we subjected human volunteers to intermediate-term (5 doses/week for 4 weeks) or single-dose UV exposure. Total dermal uronyl-containing GAGs increased substantially with each of these regimens. We found that UV exposure substantially increased dermal content of chondroitin sulfate (CS), but not hyaluronan, heparan sulfate, or dermatan sulfate. UV induced the accumulation of both the 4-sulfated (C4S) and 6-sulfated (C6S) isoforms of CS, but in distinct distributions. Next, we examined several CS proteoglycan core proteins and found a significant accumulation of dermal and endothelial serglycin, but not of decorin or versican, after UV exposure. To examine regulation in vitro, we found that UVB in combination with IL-1 alpha, a cytokine upregulated by UV radiation, induced serglycin mRNA in cultured dermal fibroblasts, but did not induce the chondroitin sulfate synthases. Overall, our data indicate that intermediate-term and single-dose UVB exposure induces specific GAGs and proteoglycan core proteins in human skin in vivo. These molecules have important biologic functions and contribute to the cutaneous response to UV.	[Werth, Benjamin Boegel; Bashir, Muhammad; Chang, Laura; Werth, Victoria P.] Philadelphia Vet Adm Med Ctr, Philadelphia, PA USA; [Werth, Benjamin Boegel; Bashir, Muhammad; Chang, Laura; Werth, Victoria P.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania	Werth, BB (corresponding author), Philadelphia Vet Adm Med Ctr, Philadelphia, PA USA.	werth@mail.med.upenn.edu			Department of Veterans Affairs Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research and Development	Department of Veterans Affairs Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research and Development(US Department of Veterans Affairs)	This material is based upon work supported in part by a Merit Review Grant from the Department of Veterans Affairs Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Bassleer CT, 1998, OSTEOARTHR CARTILAGE, V6, P196, DOI 10.1053/joca.1998.0112; Bernstein EF, 1996, BRIT J DERMATOL, V135, P255, DOI 10.1111/j.1365-2133.1996.tb01156.x; BERNSTEIN EF, 1995, LAB INVEST, V72, P662; Bernstein EF, 1996, CLIN DERMATOL, V14, P143, DOI 10.1016/0738-081X(95)00149-A; Campo GM, 2008, OSTEOARTHR CARTILAGE, V16, P1474, DOI 10.1016/j.joca.2008.04.002; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103; HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538; Ikeda M, 2009, BIOCHEM BIOPH RES CO, V390, P1221, DOI 10.1016/j.bbrc.2009.10.125; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jomphe C, 2008, BASIC CLIN PHARMACOL, V102, P59, DOI 10.1111/j.1742-7843.2007.00158.x; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; KLIGMAN LH, 1989, J AM ACAD DERMATOL, V21, P623, DOI 10.1016/S0190-9622(89)70229-2; KLIGMAN LH, 1985, J INVEST DERMATOL, V84, P272, DOI 10.1111/1523-1747.ep12265353; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Koshiishi I, 1999, BBA-GEN SUBJECTS, V1428, P327, DOI 10.1016/S0304-4165(99)00081-1; Kulseth MA, 1999, BBA-GEN SUBJECTS, V1428, P225, DOI 10.1016/S0304-4165(99)00096-3; Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546; MARGELIN D, 1993, PHOTOCHEM PHOTOBIOL, V58, P211, DOI 10.1111/j.1751-1097.1993.tb09551.x; MENTER JM, 1983, PHOTOCHEM PHOTOBIOL, V38, P481, DOI 10.1111/j.1751-1097.1983.tb03371.x; Monfort J, 2008, ANN RHEUM DIS, V67, P735, DOI 10.1136/ard.2006.068882; Nabatian N, J INVEST DE IN PRESS; Pauloin T, 2009, MOL VIS, V15, P577; Rachmilewitz J, 1998, BLOOD, V92, P223, DOI 10.1182/blood.V92.1.223.413k15_223_229; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; SCHWARTZ E, 1988, J INVEST DERMATOL, V91, P158, DOI 10.1111/1523-1747.ep12464405; SHWORAK NW, 1994, J BIOL CHEM, V269, P24941; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; Titze J, 2004, AM J PHYSIOL-HEART C, V287, pH203, DOI 10.1152/ajpheart.01237.2003; Toida T, 2006, ADV PHARMACOL, V53, P403, DOI 10.1016/S1054-3589(05)53019-9; Waller JM, 2006, SKIN RES TECHNOL, V12, P145, DOI 10.1111/j.0909-752X.2006.00146.x; Werth VP, 1999, J INVEST DERMATOL, V113, P196, DOI 10.1046/j.1523-1747.1999.00681.x; Werth VP, 1997, J INVEST DERMATOL, V108, P290, DOI 10.1111/1523-1747.ep12286462; WILLEN MD, 1991, J INVEST DERMATOL, V96, P968, DOI 10.1111/1523-1747.ep12476335; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zhang L, 2010, CONNECT TISSUE RES, V51, P230, DOI 10.3109/03008200903288902	39	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e14830	10.1371/journal.pone.0014830	http://dx.doi.org/10.1371/journal.pone.0014830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829593	Green Submitted, gold, Green Published			2022-12-27	WOS:000293561200002
J	Newman, AM; Cooper, JB				Newman, Aaron M.; Cooper, James B.			Global Analysis of Proline-Rich Tandem Repeat Proteins Reveals Broad Phylogenetic Diversity in Plant Secretomes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CELL-WALL; GENE FAMILY; HYDROXYPROLINE; IDENTIFICATION; EXPRESSION; EXTENSIN; GLYCOPROTEIN; GROWTH; DIVERSIFICATION	Cell walls, constructed by precisely choreographed changes in the plant secretome, play critical roles in plant cell physiology and development. Along with structural polysaccharides, secreted proline-rich Tandem Repeat Proteins (TRPs) are important for cell wall function, yet the evolutionary diversity of these structural TRPs remains virtually unexplored. Using a systems-level computational approach to analyze taxonomically diverse plant sequence data, we identified 31 distinct Pro-rich TRP classes targeted for secretion. This analysis expands upon the known phylogenetic diversity of extensins, the most widely studied class of wall structural proteins, and demonstrates that extensins evolved before plant vascularization. Our results also show that most Pro-rich TRP classes have unexpectedly restricted evolutionary distributions, revealing considerable differences in plant secretome signatures that define unexplored diversity.	[Newman, Aaron M.; Cooper, James B.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Cooper, James B.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Newman, AM (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Ctr Study Macular Degenerat, Santa Barbara, CA 93106 USA.	jcooper@lifesci.ucsb.edu	Newman, Aaron M/ABE-1620-2021	Newman, Aaron M/0000-0002-1857-8172	University of California, Santa Barbara (UCSB)	University of California, Santa Barbara (UCSB)(University of California System)	This work was partially supported by a University of California, Santa Barbara (UCSB) Dissertation Fellowship awarded to Dr. Newman. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; Brewin NJ, 2004, CRIT REV PLANT SCI, V23, P293, DOI 10.1080/07352680490480734; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; COOPER JB, 1994, PLANT PHYSIOL, V104, P747, DOI 10.1104/pp.104.2.747; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Creighton T. E., 1993, PROTEINS STRUCTURES; Davies C, 2000, PLANT PHYSIOL, V122, P803, DOI 10.1104/pp.122.3.803; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; DOUGALL DK, 1960, PLANT PHYSIOL, V35, P396, DOI 10.1104/pp.35.3.396; Dvorakova L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-412; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EPSTEIN L, 1984, PHYTOCHEMISTRY, V23, P1241, DOI 10.1016/S0031-9422(00)80433-1; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; JOHNSON KL, 2003, PLANT CELL WALL, V8, P111; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; KIELISZEWSKI M, 1987, PLANT PHYSIOL, V85, P823, DOI 10.1104/pp.85.3.823; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; LAMPORT DTA, 1960, NATURE, V188, P665, DOI 10.1038/188665b0; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2007, PLANT PHYSIOL, V144, P1813, DOI 10.1104/pp.107.100891; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Quackenbush J, 2000, NUCLEIC ACIDS RES, V28, P141, DOI 10.1093/nar/28.1.141; RASHID A, 2011, THESIS U ALBERTA CAN; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Schnabelrauch LS, 1996, PLANT J, V9, P477, DOI 10.1046/j.1365-313X.1996.09040477.x; Schultz CJ, 2002, PLANT PHYSIOL, V129, P1448, DOI 10.1104/pp.003459; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; STIEFEL V, 1990, PLANT CELL, V2, P785, DOI 10.1105/tpc.2.8.785; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas P, 2003, PLANT CELL ENVIRON, V26, P1497, DOI 10.1046/j.1365-3040.2003.01071.x; Uchida K, 1998, PLANT J, V15, P813, DOI 10.1046/j.1365-313X.1998.00264.x; VANHOLST GJ, 1984, PLANT PHYSIOL, V74, P247, DOI 10.1104/pp.74.2.247; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhang XL, 2008, J EXP BOT, V59, P4045, DOI 10.1093/jxb/ern245	62	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23167	10.1371/journal.pone.0023167	http://dx.doi.org/10.1371/journal.pone.0023167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829715	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511900032
J	van Mourik, MSM; Groenwold, RHH; van der Sprenkel, JWB; van Solinge, WW; Troelstra, A; Bonten, MJM				van Mourik, Maaike S. M.; Groenwold, Rolf H. H.; van der Sprenkel, Jan Willem Berkelbach; van Solinge, Wouter W.; Troelstra, Annet; Bonten, Marc J. M.			Automated Detection of External Ventricular and Lumbar Drain-Related Meningitis Using Laboratory and Microbiology Results and Medication Data	PLOS ONE			English	Article							CEREBROSPINAL-FLUID INFECTION; SURGICAL SITE INFECTIONS; BLOOD-STREAM INFECTIONS; NOSOCOMIAL INFECTION; INTRAVENTRICULAR HEMORRHAGE; BACTERIAL-MENINGITIS; SERUM PROCALCITONIN; SURVEILLANCE SYSTEM; EARLY-DIAGNOSIS; VALIDATION	Objective: Monitoring of healthcare-associated infection rates is important for infection control and hospital benchmarking. However, manual surveillance is time-consuming and susceptible to error. The aim was, therefore, to develop a prediction model to retrospectively detect drain-related meningitis (DRM), a frequently occurring nosocomial infection, using routinely collected data from a clinical data warehouse. Methods: As part of the hospital infection control program, all patients receiving an external ventricular (EVD) or lumbar drain (ELD) (2004 to 2009; n = 742) had been evaluated for the development of DRM through chart review and standardized diagnostic criteria by infection control staff; this was the reference standard. Children, patients dying <24 hours after drain insertion or with <1 day follow-up and patients with infection at the time of insertion or multiple simultaneous drains were excluded. Logistic regression was used to develop a model predicting the occurrence of DRM. Missing data were imputed using multiple imputation. Bootstrapping was applied to increase generalizability. Results: 537 patients remained after application of exclusion criteria, of which 82 developed DRM (13.5/1000 days at risk). The automated model to detect DRM included the number of drains placed, drain type, blood leukocyte count, C-reactive protein, cerebrospinal fluid leukocyte count and culture result, number of antibiotics started during admission, and empiric antibiotic therapy. Discriminatory power of this model was excellent (area under the ROC curve 0.97). The model achieved 98.8% sensitivity (95% CI 88.0% to 99.9%) and specificity of 87.9% (84.6% to 90.8%). Positive and negative predictive values were 56.9% (50.8% to 67.9%) and 99.9% (98.6% to 99.9%), respectively. Predicted yearly infection rates concurred with observed infection rates. Conclusion: A prediction model based on multi-source data stored in a clinical data warehouse could accurately quantify rates of DRM. Automated detection using this statistical approach is feasible and could be applied to other nosocomial infections.	[van Mourik, Maaike S. M.; Troelstra, Annet; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Groenwold, Rolf H. H.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Sprenkel, Jan Willem Berkelbach] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands; [van Solinge, Wouter W.] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Mourik, MSM (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	m.s.m.vanmourik-2@umcutrecht.nl		Van Solinge, Wouter/0000-0003-2867-2581; Groenwold, Rolf/0000-0001-9238-6999; van Mourik, Maaike/0000-0003-2465-4132	Alexandre Suerman stipendium	Alexandre Suerman stipendium	MSMvM was supported by an Alexandre Suerman stipendium provided by the University Medical Centre Utrecht. The remaining authors did not receive funding for participation in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellini C, 2007, INFECT CONT HOSP EP, V28, P1030, DOI 10.1086/519861; Berger C, 2002, CRIT CARE MED, V30, P1778, DOI 10.1097/00003246-200208000-00017; Bolon MK, 2009, CLIN INFECT DIS, V48, P1223, DOI 10.1086/597584; Brossette SE, 2006, AM J CLIN PATHOL, V125, P34, DOI 10.1309/502AUPR8VE67MBDE; ECDC, 2008, ANN EP REP COMM DIS; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Ehrenkranz NJ, 1995, INFECT CONT HOSP EP, V16, P697; Gastmeier P, 1998, INFECT CONT HOSP EP, V19, P668; Graham PL, 2004, AM J INFECT CONTROL, V32, P232, DOI 10.1016/j.ajic.2003.07.008; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-20; Klompas M, 2009, CLIN INFECT DIS, V48, P1268, DOI 10.1086/597591; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Lopez-Cortes LF, 2000, CRIT CARE MED, V28, P215, DOI 10.1097/00003246-200001000-00035; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Pfausler B, 2004, ACTA NEUROCHIR, V146, P477, DOI 10.1007/s00701-004-0258-8; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; Platt R, 2002, EMERG INFECT DIS, V8, P1433, DOI 10.3201/eid0812.020039; Pokorny L, 2006, INFECT CONT HOSP EP, V27, P500, DOI 10.1086/502685; Rubin DB, 2004, MULTIPLE IMPUTATION; Rubin Michael A, 2008, AMIA Annu Symp Proc, P631; Sands K, 1999, J INFECT DIS, V179, P434, DOI 10.1086/314586; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Sundbarg G, 1988, Br J Neurosurg, V2, P485, DOI 10.3109/02688698809029603; ten Berg MJ, 2007, CLIN CHEM LAB MED, V45, P13, DOI 10.1515/CCLM.2007.009; Trick WE, 2004, EMERG INFECT DIS, V10, P1612, DOI 10.3201/eid1009.030978; Trick WE, 2008, AM J INFECT CONTROL, V36, pS75, DOI 10.1016/j.ajic.2007.07.004; van der Kooi TII, 2010, J HOSP INFECT, V75, P168, DOI 10.1016/j.jhin.2009.11.020; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Woeltje KF, 2008, INFECT CONT HOSP EP, V29, P842, DOI 10.1086/590261; Wong GK, 2008, J CLIN NEUROSCI, V15, P654, DOI 10.1016/j.jocn.2007.03.011; Yokoe DS, 2004, EMERG INFECT DIS, V10, P1924, DOI 10.3201/eid1011.040572	38	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22846	10.1371/journal.pone.0022846	http://dx.doi.org/10.1371/journal.pone.0022846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829659	Green Submitted, gold, Green Published			2022-12-27	WOS:000293511900016
J	LaBreche, HG; Meadows, SK; Nevins, JR; Chute, JP				LaBreche, Heather G.; Meadows, Sarah K.; Nevins, Joseph R.; Chute, John P.			Peripheral Blood Signatures of Lead Exposure	PLOS ONE			English	Article							LIVER-CELL PROLIFERATION; SET ENRICHMENT ANALYSIS; HUMAN BREAST-CANCER; GENE-EXPRESSION; PROTEIN; TOXICITY; PATHWAY; INHIBITION; APOPTOSIS; PROFILES	Background: Current evidence indicates that even low-level lead (Pb) exposure can have detrimental effects, especially in children. We tested the hypothesis that Pb exposure alters gene expression patterns in peripheral blood cells and that these changes reflect dose-specific alterations in the activity of particular pathways. Methodology/Principal Finding: Using Affymetrix Mouse Genome 430 2.0 arrays, we examined gene expression changes in the peripheral blood of female Balb/c mice following exposure to per os lead acetate trihydrate or plain drinking water for two weeks and after a two-week recovery period. Data sets were RMA-normalized and dose-specific signatures were generated using established methods of supervised classification and binary regression. Pathway activity was analyzed using the ScoreSignatures module from GenePattern. Conclusions/Significance: The low-level Pb signature was 93% sensitive and 100% specific in classifying samples a leave-one-out crossvalidation. The high-level Pb signature demonstrated 100% sensitivity and specificity in the leave-one-out crossvalidation. These two signatures exhibited dose-specificity in their ability to predict Pb exposure and had little overlap in terms of constituent genes. The signatures also seemed to reflect current levels of Pb exposure rather than past exposure. Finally, the two doses showed differential activation of cellular pathways. Low-level Pb exposure increased activity of the interferon-gamma pathway, whereas high-level Pb exposure increased activity of the E2F1 pathway.	[LaBreche, Heather G.; Nevins, Joseph R.; Chute, John P.] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA; [LaBreche, Heather G.; Nevins, Joseph R.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [LaBreche, Heather G.] Duke Univ, Program Genet & Genom, Durham, NC USA; [Meadows, Sarah K.; Chute, John P.] Duke Univ, Dept Med, Div Cellular Therapy, Durham, NC USA; [Chute, John P.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	LaBreche, HG (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA.	hgl@duke.edu			NIH/NIAID, Centers for Medical Countermeasures Against Radiation [U19-A1067798]	NIH/NIAID, Centers for Medical Countermeasures Against Radiation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the authors was provided by NIH/NIAID grant U19-A1067798 from the Centers for Medical Countermeasures Against Radiation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FS, 2002, J NEUROSCI RES, V67, P174, DOI 10.1002/jnr.10091; Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; BELLINGER D, 1994, PEDIATR ANN, V23, P600, DOI 10.3928/0090-4481-19941101-08; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bouton CMLS, 2001, TOXICOL APPL PHARM, V176, P34, DOI 10.1006/taap.2001.9274; CHOIE DD, 1974, LAB INVEST, V30, P647; COLUMBANO A, 1990, CARCINOGENESIS, V11, P771, DOI 10.1093/carcin/11.5.771; DAMSTRA T, 1977, Environmental Health Perspectives, V19, P297, DOI 10.2307/3428488; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Fischer Anna Barbara, 2001, Arhiv za Higijenu Rada i Toksikologiju, V52, P333; FU H, 1995, OCCUP ENVIRON MED, V52, P73, DOI 10.1136/oem.52.2.73; FUJIWARA Y, 1995, TOXICOLOGY, V98, P105, DOI 10.1016/0300-483X(94)02984-3; Garcia-Leston J, 2010, ENVIRON INT, V36, P623, DOI 10.1016/j.envint.2010.04.011; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; HARTWIG A, 1994, ENVIRON HEALTH PERSP, V102, P45, DOI 10.2307/3431762; Heo Y, 2007, TOXICOL SCI, V96, P92, DOI 10.1093/toxsci/kfl182; Hirsch HVB, 2010, PHYSIOL BEHAV, V99, P254, DOI 10.1016/j.physbeh.2009.09.014; HITZFELD B, 1989, BIOL TRACE ELEM RES, V21, P87, DOI 10.1007/BF02917240; Hossain MA, 2000, J BIOL CHEM, V275, P27874; IARC, 1987, IARC MON EV CARC R S, V7, P1, DOI DOI 10.1002/14356007.A04; Iavicoli I, 2006, TOXICOL APPL PHARM, V210, P94, DOI 10.1016/j.taap.2005.09.016; Iavicoli I, 2002, TOXICOL LETT, V129, P143, DOI 10.1016/S0378-4274(01)00525-2; Iavicoli I, 2009, J TOXICOL ENV HEAL B, V12, P206, DOI 10.1080/10937400902902062; Jayapal M, 2010, INT J BIOCHEM CELL B, V42, P230, DOI 10.1016/j.biocel.2009.10.007; Johnson FM, 1998, MUTAT RES-REV MUTAT, V410, P123, DOI 10.1016/S1383-5742(97)00032-X; Kasten-Jolly J, 2010, TOXICOL APPL PHARM, V247, P105, DOI 10.1016/j.taap.2010.06.003; LEDDACOLUMBANO GM, 1983, AM J PATHOL, V113, P315; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Liu JY, 1997, BIOCHEM MOL BIOL INT, V43, P355; LOCKITCH G, 1993, CLIN BIOCHEM, V26, P371, DOI 10.1016/0009-9120(93)90113-K; Loikkanen J, 2003, TOXICOL LETT, V144, P235, DOI 10.1016/S0378-4274(03)00220-0; Lu HL, 2001, J NEUROCHEM, V78, P590, DOI 10.1046/j.1471-4159.2001.00434.x; Lustberg M, 2002, ARCH INTERN MED, V162, P2443, DOI 10.1001/archinte.162.21.2443; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Oberto A, 1996, J PHARMACOL EXP THER, V279, P435; Orphanides G, 2003, TOXICOL LETT, V140, P145, DOI 10.1016/S0378-4274(02)00500-3; Qian YC, 2003, NEUROCHEM RES, V28, P153, DOI 10.1023/A:1021664632393; Razani-Boroujerdi S, 1999, J PHARMACOL EXP THER, V288, P714; ROY NK, 1992, MUTAT RES, V298, P97, DOI 10.1016/0165-1218(92)90034-W; Ruden DM, 2009, NEUROTOXICOLOGY, V30, P898, DOI 10.1016/j.neuro.2009.08.011; SILBERGELD EK, 1990, ENVIRON HEALTH PERSP, V89, P49, DOI 10.2307/3430896; Steenland K, 2000, AM J IND MED, V38, P295, DOI 10.1002/1097-0274(200009)38:3<295::AID-AJIM8>3.3.CO;2-C; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; *US DEP HHS, 2007, BOOK INT MAN BLOOD L; *US DEP HHS, 2007, TOX BOOK TOX PROF LE; Waters MD, 2003, MUTAT RES-REV MUTAT, V544, P415, DOI 10.1016/j.mrrev.2003.06.014; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; 2006, IARC MONOGR EVAL CAR, V87, P1; 2003, BOOK REPORT CARCINOG	52	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23043	10.1371/journal.pone.0023043	http://dx.doi.org/10.1371/journal.pone.0023043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829687	gold, Green Submitted, Green Published			2022-12-27	WOS:000293511200032
J	Little, DP				Little, Damon P.			DNA Barcode Sequence Identification Incorporating Taxonomic Hierarchy and within Taxon Variability	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC ANALYSIS; PLASTID MATK; SENSU-LATO; LAND PLANTS; RBCL; NUCLEAR; EVOLUTION; CHLOROPLAST; GENUS; BIOGEOGRAPHY	For DNA barcoding to succeed as a scientific endeavor an accurate and expeditious query sequence identification method is needed. Although a global multiple-sequence alignment can be generated for some barcoding markers (e. g. COI, rbcL), not all barcoding markers are as structurally conserved (e. g. matK). Thus, algorithms that depend on global multiple-sequence alignments are not universally applicable. Some sequence identification methods that use local pairwise alignments (e. g. BLAST) are unable to accurately differentiate between highly similar sequences and are not designed to cope with hierarchic phylogenetic relationships or within taxon variability. Here, I present a novel alignment-free sequence identification algorithm-BRONX-that accounts for observed within taxon variability and hierarchic relationships among taxa. BRONX identifies short variable segments and corresponding invariant flanking regions in reference sequences. These flanking regions are used to score variable regions in the query sequence without the production of a global multiple-sequence alignment. By incorporating observed within taxon variability into the scoring procedure, misidentifications arising from shared alleles/haplotypes are minimized. An explicit treatment of more inclusive terminals allows for separate identifications to be made for each taxonomic level and/or for user-defined terminals. BRONX performs better than all other methods when there is imperfect overlap between query and reference sequences (e. g. mini-barcode queries against a full-length barcode database). BRONX consistently produced better identifications at the genus-level for all query types.	New York Bot Garden, Lewis B & Dorothy Cullman Program Mol Systemat, Bronx, NY 10458 USA	New York Botanical Garden	Little, DP (corresponding author), New York Bot Garden, Lewis B & Dorothy Cullman Program Mol Systemat, Bronx, NY 10458 USA.	dlittle@nybg.org			Consortium for the Barcode of Life; Alfred P. Sloan Foundation; DIMACS	Consortium for the Barcode of Life(Smithsonian InstitutionSmithsonian National Museum of Natural History); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); DIMACS	The author received support from the Consortium for the Barcode of Life (travel grants; http://www.barcodeoflife.org/), Alfred P. Sloan Foundation (http://www.sloan.org/), and DIMACS (travel grants; http://dimacs.rutgers.edu/). There are no relevant grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson L, 2005, TAXON, V54, P17, DOI 10.2307/25065299; Andersson L, 2006, TAXON, V55, P270, DOI 10.2307/25065577; [Anonymous], 2007, NCBI BLAST COMPUTER; [Anonymous], 2009, MYSQL COMPUTER PROGR; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BARTLETT SE, 1992, BIOTECHNIQUES, V12, P408; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Cabrera LI, 2008, AM J BOT, V95, P1153, DOI 10.3732/ajb.0800073; Cameron KM, 2001, AM J BOT, V88, P1847, DOI 10.2307/3558361; Chandler GT, 2004, BOT J LINN SOC, V144, P123, DOI 10.1111/j.1095-8339.2003.00247.x; CONGER AJ, 1980, PSYCHOL BULL, V88, P322, DOI 10.1037/0033-2909.88.2.322; Crisp Michael D., 1996, Telopea, V6, P813; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; Dasgupta Bhaskar, 2005, Int J Bioinform Res Appl, V1, P145, DOI 10.1504/IJBRA.2005.007574; Der JP, 2008, SYST BOT, V33, P107, DOI 10.1600/036364408783887438; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Drabkova L, 2007, TAXON, V56, P95, DOI 10.2307/25065739; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erickson DL, 2008, TAXON, V57, P1304, DOI 10.1002/tax.574020; Farris J.S., 1983, Advances in Cladistics, V2, P7; FARRIS JS, 1979, SYST ZOOL, V28, P483, DOI 10.2307/2412562; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; Gamer M, 2010, IRR PACKAGE VERSION; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gish W, 2006, WU BLAST COMPUTER PR; Goldblatt P, 2008, SYST BOT, V33, P495, DOI 10.1600/036364408785679806; Goldman DH, 2001, SYST BOT, V26, P670; Goloboff PA, 1996, CLADISTICS, V12, P199, DOI 10.1111/j.1096-0031.1996.tb00009.x; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Hao DC, 2008, PLANT SYST EVOL, V276, P89, DOI 10.1007/s00606-008-0069-0; Harrell Jr. FE, 2010, HMISC PACKAGE VERSIO; Harrington MG, 2005, SYST BOT, V30, P366, DOI 10.1600/0363644054223549; Hayashi K, 1998, PLANT SPEC BIOL, V13, P129; Hayashi Kazuhiko, 2001, Plant Species Biology, V16, P119, DOI 10.1046/j.1442-1984.2001.00057.x; Hayashi Kazuhiko, 2000, Plant Species Biology, V15, P73, DOI 10.1046/j.1442-1984.2000.00025.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Kato M, 2003, AUST SYST BOT, V16, P177, DOI 10.1071/SB02020; Kita Y, 2004, J BIOGEOGR, V31, P1605, DOI 10.1111/j.1365-2699.2004.01047.x; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kocyan A, 2007, MOL PHYLOGENET EVOL, V44, P553, DOI 10.1016/j.ympev.2006.12.022; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Les DH, 2002, SYST BOT, V27, P221; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Little DP, 2006, SYST BOT, V31, P461, DOI 10.1600/036364406778388638; Lopez GG, 2002, INT J PLANT SCI, V163, P737, DOI 10.1086/342213; Malecot V, 2008, SYST BOT, V33, P97, DOI 10.1600/036364408783887384; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; McNeal JR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-55; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Muellner AN, 2003, AM J BOT, V90, P471, DOI 10.3732/ajb.90.3.471; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nakazawa M, 1997, J PLANT RES, V110, P265, DOI 10.1007/BF02509315; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nyffeler R, 2005, ORG DIVERS EVOL, V5, P109, DOI 10.1016/j.ode.2004.08.001; Ohi-Toma T, 2006, SYST BOT, V31, P481, DOI 10.1600/036364406778388656; Osaloo Shahrokh Kazempour, 1999, Plant Species Biology, V14, P75, DOI 10.1046/j.1442-1984.1999.00009.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Petersen G, 2002, AUST SYST BOT, V15, P181, DOI 10.1071/SB01007; Pirie MD, 2006, J BIOGEOGR, V33, P31, DOI 10.1111/j.1365-2699.2005.01388.x; Plunkett GM, 1997, AM J BOT, V84, P565, DOI 10.2307/2446032; R Development Core Team, 2007, R LANG ENV STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Renner SS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-58; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salazar GA, 2003, AM J BOT, V90, P777, DOI 10.3732/ajb.90.5.777; Sanchez A, 2008, SYST BOT, V33, P87, DOI 10.1600/036364408783887456; Sarkar IN, 2002, J BIOMED INFORM, V35, P111, DOI 10.1016/S1532-0464(02)00504-X; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; SAVIR D, 1975, IBM SYST J, V14, P16, DOI 10.1147/sj.141.0016; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sogo A, 2001, J PLANT RES, V114, P459, DOI 10.1007/PL00014011; Soltis DE, 2001, ANN MO BOT GARD, V88, P669, DOI 10.2307/3298639; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Su YCF, 2008, MOL PHYLOGENET EVOL, V48, P188, DOI 10.1016/j.ympev.2008.03.028; Tamura MN, 2004, J PLANT RES, V117, P109, DOI 10.1007/s10265-003-0133-3; Tanaka N, 1997, J PLANT RES, V110, P329, DOI 10.1007/BF02524931; Tippery NP, 2008, SYST BOT, V33, P598, DOI 10.1600/036364408785679851; Tokuoka T, 2008, J PLANT RES, V121, P253, DOI 10.1007/s10265-008-0153-0; Treutlein J, 2003, TAXON, V52, P193, DOI 10.2307/3647389; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Vidal-Russell R, 2008, MOL PHYLOGENET EVOL, V47, P523, DOI 10.1016/j.ympev.2008.01.016; Wagstaff SJ, 2004, J BIOGEOGR, V31, P1569, DOI 10.1111/j.1365-2699.2004.01066.x; Walter KS, 1998, 1997 IUCN RED LIST T; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; Wilkin P, 2005, SYST BOT, V30, P736, DOI 10.1600/036364405775097879; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Yokoyama J, 2000, MOL PHYLOGENET EVOL, V14, P11, DOI 10.1006/mpev.1999.0672; Zar J.H., 2010, BIOSTAT ANAL; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang LB, 2006, MOL PHYLOGENET EVOL, V39, P305, DOI 10.1016/j.ympev.2005.10.002; Zhang LB, 2006, SYST BOT, V31, P122, DOI 10.1600/036364406775971778	115	48	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e20552	10.1371/journal.pone.0020552	http://dx.doi.org/10.1371/journal.pone.0020552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857897	gold, Green Published, Green Submitted			2022-12-27	WOS:000294125500003
J	Toufeer, M; Bonnefont, CMD; Foulon, E; Caubet, C; Tasca, C; Aurel, MR; Robert-Granie, C; Rupp, R; Foucras, G				Toufeer, Mehdi; Bonnefont, Cecile M. D.; Foulon, Eliane; Caubet, Cecile; Tasca, Christian; Aurel, Marie-Rose; Robert-Granie, Christele; Rupp, Rachel; Foucras, Gilles			Gene Expression Profiling of Dendritic Cells Reveals Important Mechanisms Associated with Predisposition to Staphylococcus Infections	PLOS ONE			English	Article							AUREUS INFECTION; ACTIVATION; DIFFERENTIATION; IMMUNITY; MICE; COMPLEMENT; RESISTANCE; RECEPTORS; MODEL; SUSCEPTIBILITY	Background: Staphylococcus aureus is a major pathogen of humans and animals and emerging antibiotic-resistant strains have further increased the concern of this health issue. Host genetics influence susceptibility to S. aureus infections, and the genes determining the outcome of infections should be identified to find alternative therapies to treatment with antibiotics. Here, we used outbred animals from a divergent selection based on susceptibility towards Staphylococcus infection to explore host immunogenetics. Methodology/Principal Findings: We investigated how dendritic cells respond to heat-inactivated S. aureus and whether dendritic cells from animals showing different degrees of susceptibility had distinct gene expression profiles. We measured gene expression levels of in vitro S. aureus-stimulated bone marrow-derived dendritic cells at three different time points (0, 3 and 8 hrs) by using 15 k ovine Agilent microarrays. Furthermore, differential expression of a selected number of genes was confirmed by RT-qPCR. Gene signatures of stimulated DCs were obtained and showed that genes involved in the inflammatory process and T helper cell polarization were highly up-regulated upon stimulation. Moreover, a set of 204 genes were statistically differentially expressed between susceptible and resistant animals, and grouped them according to their predisposition to staphylococcal infection. Interestingly, over-expression of the C1q and Ido1 genes was observed in the resistant line and suggested a role of classical pathway of complement and early regulation of inflammation pathways, respectively. On the contrary, over expression of genes involved in the IL1R pathway was observed in susceptible animals. Furthermore, the leucocyte extravasation pathway was also found to be dominant in the susceptible line. Conclusion/Significance: We successfully obtained Staphylococcus aureus associated gene expression of ovine BM-DC in an 8-hour kinetics experiment. The distinct transcriptional profiles of dendritic cells obtained from resistant and susceptible animals may explain susceptibility towards S. aureus infections in a broader context.	[Toufeer, Mehdi; Bonnefont, Cecile M. D.; Foulon, Eliane; Caubet, Cecile; Tasca, Christian; Foucras, Gilles] Univ Toulouse, ENVT, INP, IHAP,UMR 1225, Toulouse, France; [Toufeer, Mehdi; Bonnefont, Cecile M. D.; Foulon, Eliane; Caubet, Cecile; Tasca, Christian; Foucras, Gilles] INRA, IHAP, UMR1225, F-31931 Toulouse, France; [Bonnefont, Cecile M. D.; Robert-Granie, Christele; Rupp, Rachel] INRA, SAGA, UR631, F-31326 Castanet Tolosan, France; [Aurel, Marie-Rose] INRA, UE321, Roquefort, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; INRAE; INRAE	Toufeer, M (corresponding author), Univ Toulouse, ENVT, INP, IHAP,UMR 1225, Toulouse, France.	g.foucras@envt.fr	FOUCRAS, Gilles/A-3061-2014	FOUCRAS, Gilles/0000-0002-0363-0337; Rupp, Rachel/0000-0003-3375-5816	Action Concertee Incitative (ACI); ANR; APIS-GENE; European Network of Excellence(EADGENE); Higher Education Commission, Pakistan	Action Concertee Incitative (ACI); ANR(French National Research Agency (ANR)); APIS-GENE; European Network of Excellence(EADGENE); Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	Studies were supported by Action Concertee Incitative (ACI) Microbiologie 2003, ANR Genanimal 2005 Genoma II, APIS-GENE, and European Network of Excellence(EADGENE). MT was supported by Higher Education Commission, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Balboa L, 2010, IMMUNOL CELL BIOL, V88, P716, DOI 10.1038/icb.2010.22; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Ben Zakour NL, 2008, J BACTERIOL, V190, P6302, DOI 10.1128/JB.01984-07; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Bogaerts A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-11; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; Catry B, 2010, EPIDEMIOL INFECT, V138, P626, DOI 10.1017/S0950268810000014; Cherfils-Vicini J, 2008, IMMUNOLOGY, V124, P562, DOI 10.1111/j.1365-2567.2008.02810.x; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cohn LA, 2010, J VET EMERG CRIT CAR, V20, P31, DOI 10.1111/j.1476-4431.2009.00497.x; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; Foulon E, 2008, J IMMUNOL METHODS, V339, P1, DOI 10.1016/j.jim.2008.07.012; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hope JC, 2000, SCAND J IMMUNOL, V51, P60; Houghton AM, 2009, NATURE, V460, P637, DOI 10.1038/nature08181; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Inaba Kayo, 2009, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0307s86; Jakob T, 1998, J IMMUNOL, V161, P3042; Jiang H, 2009, EXP HEMATOL, V37, P1201, DOI 10.1016/j.exphem.2009.07.010; Jin P, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-4; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kushwah R, 2010, EUR J IMMUNOL, V40, P1022, DOI 10.1002/eji.200939782; Kusuhara Koichi, 2010, Journal of UOEH, V32, P177; Langelaar MFM, 2005, VET IMMUNOL IMMUNOP, V107, P153, DOI 10.1016/j.vetimm.2005.04.009; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Liu XD, 2010, BLOOD, V115, P3520, DOI 10.1182/blood-2009-09-246124; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Nanda SK, 2009, VIROLOGY, V395, P223, DOI 10.1016/j.virol.2009.09.031; Nimura F, 2006, EXP BIOL MED, V231, P431, DOI 10.1177/153537020623100409; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Reis ES, 2007, IMMUNOBIOLOGY, V212, P151, DOI 10.1016/j.imbio.2006.11.010; Rescigno M, 2000, J CLIN IMMUNOL, V20, P161, DOI 10.1023/A:1006629328178; Ribeiro OG, 2003, J LEUKOCYTE BIOL, V74, P497, DOI 10.1189/jlb.0103039; Rozen S, 2000, Methods Mol Biol, V132, P365; Rupp R, 2009, J DAIRY SCI, V92, P1203, DOI 10.3168/jds.2008-1435; Sasaki S, 2000, INFECT IMMUN, V68, P2424, DOI 10.1128/IAI.68.5.2424-2430.2000; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Torri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009404; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; von Stebut E, 2003, J EXP MED, V198, P191, DOI 10.1084/jem.20030159; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010844; Wu K, 2010, CLIN MICROBIOL INFEC, V16, P245, DOI 10.1111/j.1469-0691.2009.02765.x; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu ZG, 2010, IMMUNOLOGY, V129, P133, DOI 10.1111/j.1365-2567.2009.03129.x; Zhang L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-87	64	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22147	10.1371/journal.pone.0022147	http://dx.doi.org/10.1371/journal.pone.0022147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857913	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500003
J	Chen, Z; Chen, X; Luo, YC				Chen, Zhi; Chen, Xiang; Luo, Yan-Cheng			Technical Modifications of Double-J Stenting for Retroperitoneal Laparoscopic Dismembered Pyeloplasty in Children under 5 Years Old	PLOS ONE			English	Article							ANTEGRADE; EXPERIENCE	Both antegrade stenting and retrograde stenting for retroperitoneal laparoscopic dismembered pyeloplasty in children have many disadvantages. In this work, we tried using an alternative technique of modified antegrade (MAG) double-J stenting for retroperitoneal laparoscopic dismembered pyeloplasty in children under 5 years old, analyzed our results using the conventional antegrade (CAG) and the MAG techniques of stent insertion for this procedure, and reported our experience with these techniques. Between December 2002 and July 2010, 77 children under 5 years old with ureteropelvic junction obstruction underwent retroperitoneal laparoscopic dismembered pyeloplasty. CAG and MAG double-J stenting were attempted, in the first 36 cases (mean age 27.1 months) and the following 41 cases (mean age 25.4 months), respectively. The stents were removed 4-6 weeks later via cystoscopy. Follow-up studies were performed with ultrasonography and intravenous urography at 3 and 12 months postoperatively. The results showed that successful stent placement without malpositioning was achieved in 31 of 36 (86%) and all 41 (100%) cases, in the CAG and MAG groups, respectively. The common factor of unsuccessful stent was the inability to across the ureterovesical junction. The mean stent insertion time was 10 min 54 s and 12 min 46 s in the CAG and MAG groups, respectively. The mean operating time was 176 min and 185 min in the CAG and MAG groups, respectively. No stent malpositioning occurred in the MAG group; in the CAG group, two children had a malpositioned stent in the distal ureter and one child presented with a severe hematuria. Twelve months follow-up showed no new onset of hydroureteronephrosis and hydronephrosis. Thus we concluded that the MAG double-J stenting seems more reliable than CAG stenting for retroperitoneal laparoscopic dismembered pyeloplasty in children under 5 years old, with greater success and lower complication rates.	[Chen, Zhi; Chen, Xiang; Luo, Yan-Cheng] Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University	Chen, X (corresponding author), Cent S Univ, Dept Urol, Xiangya Hosp, Changsha, Hunan, Peoples R China.	cxiang1007@126.com						Andreoni C, 2005, BJU INT, V96, P1139, DOI 10.1111/j.1464-410X.2005.05813.x; Arumainayagam N, 2008, J ENDOUROL, V22, P671, DOI 10.1089/end.2007.0210; Bauer JJ, 1999, J UROLOGY, V162, P692, DOI 10.1097/00005392-199909010-00016; Calvert RC, 2008, SURG ENDOSC, V22, P411, DOI 10.1007/s00464-007-9436-0; Chandrasekharam VVSS, 2005, UROLOGY, V66, P1301, DOI 10.1016/j.urology.2005.06.132; Davenport K, 2005, EUR UROL, V48, P973, DOI 10.1016/j.eururo.2005.08.004; Egan S C, 2001, Tech Urol, V7, P276; El-Shazly MA, 2007, J ENDOUROL, V21, P673, DOI 10.1089/end.2007.9952; Gaitonde K, 2008, J ENDOUROL, V22, P1199, DOI 10.1089/end.2008.0078; Inagaki T, 2005, BJU INT, V95, P102, DOI 10.1111/j.1464-410X.2005.05208.x; Jarrett TW, 2002, J UROLOGY, V167, P1253, DOI 10.1016/S0022-5347(05)65276-7; KAVOUSSI LR, 1993, J UROLOGY, V150, P1891, DOI 10.1016/S0022-5347(17)35926-8; Klingler HC, 2003, EUR UROL, V44, P340, DOI 10.1016/S0302-2838(03)00297-5; Lopez-Pujals A, 2004, J ENDOUROL, V18, P756, DOI 10.1089/end.2004.18.756; Mandhani A, 2004, J UROLOGY, V171, P1440, DOI 10.1097/01.ju.0000116546.06765.d1; Minervini A, 2009, SURG ENDOSC, V23, P1831, DOI 10.1007/s00464-008-0272-7; Moon DA, 2006, UROLOGY, V67, P932, DOI 10.1016/j.urology.2005.11.024; Notley R G, 1973, Br J Urol, V45, P464, DOI 10.1111/j.1464-410X.1973.tb06804.x; O'Reilly PH, 2001, BJU INT, V87, P287, DOI 10.1046/j.1464-410x.2001.00108.x; Rodrigues H, 2002, INT BRAZ J UROL, V28; Rodrigues Henrique, 2002, Int Braz J Urol, V28, P439; Siqueira TM, 2002, UROLOGY, V60, P973, DOI 10.1016/S0090-4295(02)02072-1; Wu ZH, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.03.067; Yurkanin JP, 2004, J ENDOUROL, V18, P765, DOI 10.1089/0892779042360616; Zhang X, 2005, UROLOGY, V66, P514, DOI 10.1016/j.urology.2005.04.007	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23073	10.1371/journal.pone.0023073	http://dx.doi.org/10.1371/journal.pone.0023073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853069	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953400023
J	Bartosova, J; Komarkova, M; Dubcova, J; Bartos, L; Pluhacek, J				Bartosova, Jitka; Komarkova, Martina; Dubcova, Jana; Bartos, Ludek; Pluhacek, Jan			Concurrent Lactation and Pregnancy: Pregnant Domestic Horse Mares Do Not Increase Mother-Offspring Conflict during Intensive Lactation	PLOS ONE			English	Article							ZEBRA EQUUS-BURCHELLI; REPRODUCTIVE SUCCESS; SOCIAL-ORGANIZATION; SUCKLING BEHAVIOR; MILK INTAKE; CABALLUS; AGGRESSION; RABBITS; HERD	Lactation is the most energy demanding part of parental care in mammals, so parent-offspring conflict arises over milk provided by the mother. In some species females commonly become pregnant shortly after parturition of previous young. This further intensifies mother-offspring conflict due to concurrent pregnancy and lactation. In equids it has been well established that pregnant females wean their foals earlier than non-pregnant ones. Intensified mother-offspring conflict was presumed to associate with pregnancy also during the period of intensive lactation, i.e., before the weaning process starts. We investigated the effect of pregnancy on suckling behaviour characteristics as indicators of mother-offspring conflict in domestic horses. Contrary to expectation, here we provide evidence of a decreased mother-offspring conflict related to pregnancy in lactating females during first two trimesters of pregnancy. Pregnant mares provided longer suckling bouts and did not reject or terminate suckling of their foals more often than non-pregnant mares. Our results suggest that pregnant mares cope with parallel investment into a nursed foal and a foetus through enhancing nursing behaviour in early stages of pregnancy before the initially low requirements of the foetus increase. They compensate their suckling foal with the perspective of its early weaning due to ongoing pregnancy.	[Bartosova, Jitka; Komarkova, Martina; Dubcova, Jana; Bartos, Ludek; Pluhacek, Jan] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Komarkova, Martina] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	Czech Research Institute of Animal Science; Charles University Prague	Bartosova, J (corresponding author), Inst Anim Sci, Dept Ethol, Prague, Czech Republic.	bartosova.jitka@vuzv.cz	Bartosova, Jitka/A-4908-2019; Pluhacek, Jan/F-1151-2019; Bartosova, Jitka/U-7255-2019	Bartosova, Jitka/0000-0002-4675-3310; , Jan/0000-0002-0864-4332; Komarkova, Martina/0000-0003-4645-3083	Ministry of Agriculture of the Czech Republic [MZe0002701404, QH92265]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The project was supported by the Ministry of Agriculture of the Czech Republic (Project Nos. MZe0002701404 and QH92265, http://eagri.cz/public/web/en/mze/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2001, REPRODUCTION, V121, P513, DOI 10.1530/rep.0.1210513; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; BARBER JA, 1994, APPL ANIM BEHAV SCI, V41, P161, DOI 10.1016/0168-1591(94)90021-3; BATESON P, 1994, TRENDS ECOL EVOL, V9, P399, DOI 10.1016/0169-5347(94)90066-3; BECKER CD, 1990, ANIM BEHAV, V40, P1111, DOI 10.1016/S0003-3472(05)80177-0; Berger J., 1986, WILD HORSES GREAT BA; Cameron EZ, 1998, ANIM BEHAV, V56, P521, DOI 10.1006/anbe.1998.0793; Cameron EZ, 1999, ANIM BEHAV, V57, P673, DOI 10.1006/anbe.1998.0997; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Crowell-Davis SL, 2007, HORM BEHAV, V52, P12, DOI 10.1016/j.yhbeh.2007.03.020; Crowell-Davis SL, 2005, Domestic Horse: The Origins, Development and Management of Its Behaviour, P126; CROWELLDAVIS SL, 1985, APPL ANIM BEHAV SCI, V14, P11, DOI 10.1016/0168-1591(85)90034-6; Davies Morel MCG, 2008, EQUINE REPROD PHYSL, V3rd; DUNCAN P, 1984, ANIM BEHAV, V32, P255, DOI 10.1016/S0003-3472(84)80345-0; Gonzalez-Mariscal G, 2009, WORLD RABBIT SCI, V17, P145; Heitor F, 2008, APPL ANIM BEHAV SCI, V113, P189, DOI 10.1016/j.applanim.2007.11.005; KLINGEL H, 1975, J REPROD FERTIL, P7; National Research Council Comittee on Nutrient Requirements of Horses, 2007, NUTR REQ HORS; PARTRIDGE GG, 1986, BRIT J NUTR, V56, P199, DOI 10.1079/BJN19860100; PENZHORN BL, 1984, Z TIERPSYCHOL, V64, P97; Pluhacek J, 2010, J ANIM SCI, V88, P131, DOI 10.2527/jas.2009-1982; Pluhacek J, 2007, APPL ANIM BEHAV SCI, V105, P192, DOI 10.1016/j.applanim.2006.05.019; Pluhacek J, 2006, APPL ANIM BEHAV SCI, V99, P315, DOI 10.1016/j.applanim.2005.11.003; Pluhacek J, 2010, APPL ANIM BEHAV SCI, V122, P127, DOI 10.1016/j.applanim.2009.11.009; Rehling A, 2008, ETHOLOGY, V114, P318, DOI 10.1111/j.1439-0310.2007.01465.x; RUTBERG AT, 1990, ANIM BEHAV, V40, P322, DOI 10.1016/S0003-3472(05)80927-3; TRIVERS RL, 1974, AM ZOOL, V14, P249; Tyler S.J., 1972, Animal Behav Monogr, V5, P85	29	10	10	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22068	10.1371/journal.pone.0022068	http://dx.doi.org/10.1371/journal.pone.0022068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853024	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200005
J	Hu, JM; Liu, XL; Hughes, D; Esteva, FJ; Liu, BL; Chandra, J; Li, SL				Hu, Jiemiao; Liu, Xinli; Hughes, Dennis; Esteva, Francisco J.; Liu, Bolin; Chandra, Joya; Li, Shulin			Herceptin Conjugates Linked by EDC Boost Direct Tumor Cell Death via Programmed Tumor Cell Necrosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; ACUTE MYELOID-LEUKEMIA; TRASTUZUMAB RESISTANCE; MONOCLONAL-ANTIBODIES; GENE AMPLIFICATION; APOPTOSIS; EXPRESSION; MECHANISMS; LYMPHOMA	Tumor-targeted antibody therapy is one of the safest biological therapeutics for cancer patients, but it is often ineffective at inducing direct tumor cell death and is ineffective against resistant tumor cells. Currently, the antitumor efficacy of antibody therapy is primarily achieved by inducing indirect tumor cell death, such as antibody-dependent cell cytotoxicity. Our study reveals that Herceptin conjugates, if generated via the crosslinker EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride), are capable of engendering human epidermal growth factor receptor 2 (Her2) positive tumor cells death. Using a high-performance liquid chromatography (HPLC) system, three peaks with estimated molecular weights of antibody monomer, dimer, and trimer were isolated. Both Herceptin trimer and dimer separated by HPLC induced significant levels of necrotic tumor cell death, although the trimer was more effective than the dimer. Notably, the Herceptin trimer also induced Herceptin-resistant tumor cell death. Surprisingly different from the known cell death mechanism that often results from antibody treatment, the Herceptin trimer elicited effective and direct tumor cell death via a novel mechanism: programmed cell necrosis. In Her2-positive cells, inhibition of necrosis pathways significantly reversed Herceptin trimer-induced cell death. In summary, the Herceptin trimer reported herein harbors great potential for overcoming tumor cell resistance to Herceptin treatment.	[Hu, Jiemiao; Hughes, Dennis; Chandra, Joya; Li, Shulin] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA; [Liu, Xinli] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Esteva, Francisco J.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Liu, Bolin] Univ Colorado Denver Sch Med, Dept Pathol, Aurora, CO USA	University of Texas System; UTMD Anderson Cancer Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Texas System; UTMD Anderson Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Hu, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA.	sli4@mdanderson.org	Li, Shulin/D-6478-2011; Chandra, Joya/ABC-7869-2021	Chandra, Joya/0000-0002-2077-9715; Esteva, Francisco J./0000-0003-2437-3920; Liu, Bolin/0000-0003-0150-8650	National Institutes of Health [R01CA120895-3S]; NATIONAL CANCER INSTITUTE [R01CA120895, P30CA016672, R01CA149501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health (grant R01CA120895-3S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadori S, 2005, LEUKEMIA, V19, P1768, DOI 10.1038/sj.leu.2403901; Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brandlein S, 2003, CANCER RES, V63, P7995; Brandlein Stephanie, 2002, Hum Antibodies, V11, P107; FENDLY BM, 1990, J BIOL RESP MODIF, V9, P449; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Ghetie MA, 1997, P NATL ACAD SCI USA, V94, P7509, DOI 10.1073/pnas.94.14.7509; Ghetie MA, 2001, BLOOD, V97, P1392, DOI 10.1182/blood.V97.5.1392; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Henson ES, 2006, CLIN CANCER RES, V12, P845, DOI 10.1158/1078-0432.CCR-05-0754; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; Hughes DPM, 2004, CANCER RES, V64, P2047, DOI 10.1158/0008-5472.CAN-03-3096; Imai M, 2005, CANCER RES, V65, P10562, DOI 10.1158/0008-5472.CAN-05-1894; ISHIGAMI T, 1992, J IMMUNOL, V148, P360; Kumar R, 2007, CLIN CANCER RES, V13, P4657, DOI 10.1158/1078-0432.CCR-07-1401; Kurai J, 2007, CLIN CANCER RES, V13, P1552, DOI 10.1158/1078-0432.CCR-06-1726; Larson RA, 2005, CANCER, V104, P1442, DOI 10.1002/cncr.21326; Lee S, 2002, CANCER RES, V62, P5703; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1612; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Okada N, 2005, MICROBIOL IMMUNOL, V49, P447, DOI 10.1111/j.1348-0421.2005.tb03749.x; Pandolfi PP, 2004, NEW ENGL J MED, V351, P2337, DOI 10.1056/NEJMcibr043143; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; Press MF, 2008, CLIN CANCER RES, V14, P7861, DOI 10.1158/1078-0432.CCR-08-1056; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; Witzig TE, 2002, J CLIN ONCOL, V20, P3262, DOI 10.1200/JCO.2002.11.017; WOLFF EA, 1993, CANCER RES, V53, P2560	38	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23270	10.1371/journal.pone.0023270	http://dx.doi.org/10.1371/journal.pone.0023270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853100	Green Submitted, gold, Green Published			2022-12-27	WOS:000295454200060
J	Januchowski-Hartley, FA; Graham, NAJ; Feary, DA; Morove, T; Cinner, JE				Januchowski-Hartley, Fraser A.; Graham, Nicholas A. J.; Feary, David A.; Morove, Tau; Cinner, Joshua E.			Fear of Fishers: Human Predation Explains Behavioral Changes in Coral Reef Fishes	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; KILLIFISH FUNDULUS-DIAPHANUS; TAKE MARINE RESERVES; PAPUA-NEW-GUINEA; ANTIPREDATOR BEHAVIOR; POECILIA-RETICULATA; ESCAPE RESPONSE; FORAGING BEHAVIOR; PREY CHOICE; RISK	Prey flight decisions in response to predation risk are increasingly being considered in conservation and management decisions in the terrestrial realm, but are rarely considered in marine systems. This field-based study investigated how the behavioral response of coral reef fish families varied along a gradient of subsistence fishing pressure in Papua New Guinea. Specifically, we examined how fishing pressure was related to pre-flight behavior and flight initiation distance (FID), and whether FID was influenced by body size (centimeters total length), group size (including both con-and hetero-specific individuals), or life-history phase. Fishing pressure was positively associated with higher FID, but only in families that were primarily targeted by spear guns. Among these families, there were variable responses in FID; some families showed increased FID monotonically with fishing pressure, while others showed increased FID only at the highest levels of fishing pressure. Body size was more significant in varying FID at higher levels of fishing pressure. Although family-level differences in pre-flight behavior were reported, such behavior showed low concordance with fishing pressure. FID shows promise as a tool by which compliance and effectiveness of management of reef fisheries can be assessed.	[Januchowski-Hartley, Fraser A.; Graham, Nicholas A. J.; Cinner, Joshua E.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Feary, David A.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia; [Morove, Tau] Papua New Guinea Marine Program, Wildlife Conservat Soc, Kavieng, New Ireland Pro, Guinea	James Cook University; University of Technology Sydney	Januchowski-Hartley, FA (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	f.a.hartley@gmail.com	Cinner, Joshua e/E-8966-2011; Graham, Nicholas AJ/C-8360-2014; Cinner, Joshua/AAA-6823-2021; Januchowski-Hartley, Fraser A./H-8904-2019	Cinner, Joshua e/0000-0003-2675-9317; Graham, Nicholas AJ/0000-0002-0304-7467; Januchowski-Hartley, Fraser A./0000-0003-2468-8199	Australian Research Council; National Geographic grant [8506-382 08]; James Cook University; David and Lucille Packard Foundation [2009-33893]	Australian Research Council(Australian Research Council); National Geographic grant(National Geographic Society); James Cook University; David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	This study was funded by the Australian Research Council and a National Geographic grant (#8506-382 08). Fraser Januchowski-Hartley is supported by a James Cook University International Postgraduate Studentship and Tau Morove by the David and Lucille Packard Foundation (Grant # 2009-33893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; BELLMAN KL, 1983, SCIENCE, V221, P779, DOI 10.1126/science.221.4612.779; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 2003, BIOL CONSERV, V110, P97, DOI 10.1016/S0006-3207(02)00180-5; Botham MS, 2008, ECOLOGY, V89, P3174, DOI 10.1890/07-0490.1; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; CARRIER G, 1981, J SOC OCEANISTES, V37, P205; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Choat JH, 1996, MAR ECOL PROG SER, V145, P33, DOI 10.3354/meps145033; Cinner JE, 2006, ENVIRON CONSERV, V33, P73, DOI 10.1017/S0376892906002748; COLE RG, 1994, BIOL CONSERV, V70, P93, DOI 10.1016/0006-3207(94)90276-3; Connell SD, 1998, AUST J ECOL, V23, P579, DOI 10.1111/j.1442-9993.1998.tb00768.x; Cooper WE, 1999, CAN J ZOOL, V77, P671; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Cooper WE, 2009, AMPHIBIA-REPTILIA, V30, P99, DOI 10.1163/156853809787392720; de Boer HY, 2004, WILDLIFE BIOL, V10, P35, DOI 10.2981/wlb.2004.007; Domenici P, 2002, MAR FRESHW BEHAV PHY, V35, P87, DOI 10.1080/10236240290025635; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; ELGAR MA, 1981, ANIM BEHAV, V29, P868, DOI 10.1016/S0003-3472(81)80022-X; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; GILES N, 1984, ANIM BEHAV, V32, P264, DOI 10.1016/S0003-3472(84)80346-2; Gill AB, 2003, J FISH BIOL, V63, P105, DOI 10.1111/j.1095-8649.2003.00214.x; GILL AB, 1994, ANIM BEHAV, V47, P921, DOI 10.1006/anbe.1994.1124; GODIN JGJ, 1995, P ROY SOC B-BIOL SCI, V259, P193, DOI 10.1098/rspb.1995.0028; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; GODIN JGJ, 1986, CAN J ZOOL, V64, P1675, DOI 10.1139/z86-251; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Guidetti P, 2008, J MAR BIOL ASSOC UK, V88, P625, DOI 10.1017/S0025315408000933; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Higgins RM, 2008, J NAT CONSERV, V16, P222, DOI 10.1016/j.jnc.2008.09.001; HUGHES RN, 1999, 6 DIET SELECTION BEH; HUNTINGFORD FA, 1989, BEHAV PROCESS, V19, P181, DOI 10.1016/0376-6357(89)90040-5; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Jennings S, 2000, REV FISH BIOL FISHER, V10, P209, DOI 10.1023/A:1016619102955; Kaly U., 2005, SMALL SCALE FISHERIE; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; KRAUSE J, 1994, ETHOLOGY, V98, P128; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; LICHT T, 1989, ETHOLOGY, V82, P238; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Madin EMP, 2010, ECOLOGY, V91, P3563, DOI 10.1890/09-2174.1; MAGURRAN AE, 1990, ANIM BEHAV, V39, P834, DOI 10.1016/S0003-3472(05)80947-9; MAGURRAN AE, 1988, ETHOLOGY, V78, P153; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McGill BJ, 2006, EVOL ECOL RES, V8, P691; NFA, 2007, REV FISH MAR RES NEW; PARRISH JD, 1987, TROPICAL SNAPPERS GR, P405; PITCHER TJ, 1986, J FISH BIOL, V28, P439, DOI 10.1111/j.1095-8649.1986.tb05181.x; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; SHPIGEL M, 1991, J FISH BIOL, V38, P887, DOI 10.1111/j.1095-8649.1991.tb03628.x; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Thiel D, 2007, J WILDLIFE MANAGE, V71, P1784, DOI 10.2193/2006-268; Trip EL, 2008, MAR ECOL PROG SER, V373, P97, DOI 10.3354/meps07755; Warner RR, 1998, J FISH BIOL, V53, P82, DOI 10.1111/j.1095-8649.1998.tb01019.x; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	64	89	91	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22761	10.1371/journal.pone.0022761	http://dx.doi.org/10.1371/journal.pone.0022761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853046	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000295454200019
J	de Barros, FSM; Honorio, NA; Arruda, ME				Monteiro de Barros, Fabio Saito; Honorio, Nildimar Alves; Arruda, Mercia Eliane			Survivorship of Anopheles darlingi (Diptera: Culicidae) in Relation with Malaria Incidence in the Brazilian Amazon	PLOS ONE			English	Article							FIELD OBSERVATIONS; GONOTROPHIC CYCLE; ROOT DIPTERA; TRANSMISSION; VECTOR; MOSQUITOS; BIONOMICS; PATTERNS; RONDONIA; VILLAGES	We performed a longitudinal study of adult survival of Anopheles darlingi, the most important vector in the Amazon, in a malarigenous frontier zone of Brazil. Survival rates were determined from both parous rates and multiparous dissections. Anopheles darlingi human biting rates, daily survival rates and expectation of life where higher in the dry season, as compared to the rainy season, and were correlated with malaria incidence. The biting density of mosquitoes that had survived long enough for completing at least one sporogonic cycle was related with the number of malaria cases by linear regression. Survival rates were the limiting factor explaining longitudinal variations in Plasmodium vivax malaria incidence and the association between adult mosquito survival and malaria was statistically significant by logistic regression (P<0.05). Survival rates were better correlated with malaria incidence than adult mosquito biting density. Mathematical modeling showed that P. falciparum and P. malariae were more vulnerable to changes in mosquito survival rates because of longer sporogonic cycle duration, as compared to P. vivax, which could account for the low prevalence of the former parasites observed in the study area. Population modeling also showed that the observed decreases in human biting rates in the wet season could be entirely explained by decreases in survival rates, suggesting that decreased breeding did not occur in the wet season, at the sites where adult mosquitoes were collected. For the first time in the literature, multivariate methods detected a statistically significant inverse relation (P<0.05) between the number of rainy days per month and daily survival rates, suggesting that rainfall may cause adult mortality.	[Monteiro de Barros, Fabio Saito] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil; [Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Imunoepidemiol, Recife, PE, Brazil; [Arruda, Mercia Eliane] Fiocruz MS, Inst Oswaldo Cruz, Dept Entomol, Lab Transmissores Hematozoarios, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	de Barros, FSM (corresponding author), Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil.	fsaito1@yahoo.com.br			Interamerican Institute for Global Change Research [048]	Interamerican Institute for Global Change Research	The Interamerican Institute for Global Change Research, grant CRN no. 048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, MANUAL PRACTICAL ENT; [Anonymous], 1993, MOSQUITO ECOLOGY FIE; Barros FSM, 2010, NEOTROP ENTOMOL, V39, P1039, DOI 10.1590/S1519-566X2010000600029; BARROS FSM, 2011, B ENTOMOL RES; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Bliss CI, 1967, STAT BIOL; BURKOT TR, 1990, AM J TROP MED HYG, V43, P321, DOI 10.4269/ajtmh.1990.43.321; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; CHARLWOOD JD, 1980, B ENTOMOL RES, V70, P685, DOI 10.1017/S0007485300007975; CHARLWOOD JD, 1979, B ENTOMOL RES, V69, P337, DOI 10.1017/S0007485300017818; CHARLWOOD JD, 1986, J MED ENTOMOL, V23, P361, DOI 10.1093/jmedent/23.4.361; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; CHARLWOOD JD, 1989, ANN TROP MED PARASIT, V83, P569, DOI 10.1080/00034983.1989.11812389; Chaves Sandra S., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P269, DOI 10.1590/S0036-46652000000500006; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; DEOLIVEIRAFERREIRA J, 1990, AM J TROP MED HYG, V43, P6, DOI 10.4269/ajtmh.1990.43.1.TM0430010006; Detinova T. S., 1945, MEDITSINSKA PARAZITOLOG[IMAGE] I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V14, P45; Dos Santos RL, 2002, J MED ENTOMOL, V39, P926, DOI 10.1603/0022-2585-39.6.926; Fouque F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-80; FOX AS, 1994, PARASITOL TODAY, V10, P19, DOI 10.1016/0169-4758(94)90349-2; FURLEY PA, OREST FRONTIER; GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71; GEHAN EA, 1973, J AM STAT ASSOC, V68, P848, DOI 10.2307/2284511; Gil LHS, 2003, J MED ENTOMOL, V40, P636, DOI 10.1603/0022-2585-40.5.636; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389; HOC TQ, 1995, MED VET ENTOMOL, V9, P16, DOI 10.1111/j.1365-2915.1995.tb00112.x; HOC TQ, 1990, MED VET ENTOMOL, V4, P227, DOI 10.1111/j.1365-2915.1990.tb00281.x; HOLM S, 1979, SCAND J STAT, V6, P65; HUGO RL, 2008, J MED ENTOMOL, V453, P353; Kakitani I, 2000, REV SAUDE PUBL, V34, P33, DOI 10.1590/S0034-89102000000100007; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KENNEDY A D, 1971, Computer Programs in Biomedicine, V1, P235, DOI 10.1016/0010-468X(71)90014-6; KLEIN TA, 1990, J AM MOSQUITO CONTR, V6, P700; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Lounibos LP, 1998, J VECTOR ECOL, V23, P195; Macdonald G., 1957, EPIDEMIOLOGY CONTROL, P201; Magris M, 2007, MEM I OSWALDO CRUZ, V102, P303, DOI 10.1590/S0074-02762007005000049; Molineaux L., 1988, P999; de Barros FSM, 2007, J VECTOR ECOL, V32, P54, DOI 10.3376/1081-1710(2007)32[54:PAACFA]2.0.CO;2; de Barros FSM, 2007, MEM I OSWALDO CRUZ, V102, P299, DOI 10.1590/S0074-02762007005000024; de Barros FSM, 2011, J VECTOR ECOL, V36, P159, DOI 10.1111/j.1948-7134.2011.00153.x; MOOR PPD, 1970, T ROY SOC TROP MED H, V64, P927; Moshkovsky S.D., 1951, EPIDEMIOLOGY MED PAR; ONORI E, 1980, B WORLD HEALTH ORGAN, V58, P91; PAAIJMANS KP, 2007, PLOS ONE, V11, P1; Pampana E. J., 1963, TXB MALARIA ERADICAT; Galardo AKR, 2007, AM J TROP MED HYG, V76, P461, DOI 10.4269/ajtmh.2007.76.461; ROBERTS DR, 1983, J MED ENTOMOL, V20, P189, DOI 10.1093/jmedent/20.2.189; Rosa-Freitas MG, 2007, MEM I OSWALDO CRUZ, V102, P349, DOI 10.1590/S0074-02762007005000052; Sawyer DR, 1988, FRONTIER MALARIA AMA; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Souza-Santos Reinaldo, 2002, Cad. Saúde Pública, V18, P1813, DOI 10.1590/S0102-311X2002000600039; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; *WHO, 1997, WHO WEEKLY EPIDEMIOL, V22, P161; Zar JH, 1999, BIOSTATISTICAL ANAL	58	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22388	10.1371/journal.pone.0022388	http://dx.doi.org/10.1371/journal.pone.0022388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857927	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300005
J	Chen, M; Forrester, JV; Xu, HP				Chen, Mei; Forrester, John V.; Xu, Heping			Dysregulation in Retinal Para-Inflammation and Age-Related Retinal Degeneration in CCL2 or CCR2 Deficient Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; FACTOR-H POLYMORPHISM; COMPLEMENT FACTOR-B; MACULAR DEGENERATION; SUBRETINAL MICROGLIA; ACCUMULATION; MIGRATION; CELLS; MODEL; MAINTENANCE	We have shown previously that a para-inflammatory response exists at the retinal/choroidal interface in the aging eye; and this response plays an important role in maintaining retinal homeostasis under chronic stress conditions. We hypothesized that dysregulation of the para-inflammatory response may result in an overt pro-inflammatory response inducing retinal degeneration. In this study, we examined this hypothesis in mice deficient in chemokine CCL2 or its cognate receptor CCR2. CCL2- or CCR2-deficient mice developed retinal degenerative changes with age, characterized as retinal pigment epithelial (RPE) cell and photoreceptor cell death. Retinal cell death was associated with significantly more subretinal microglial accumulation and increased complement activation. In addition, monocytes from CCL2- or CCR2-deficient mice had reduced capacity for phagocytosis and chemotaxis, expressed less IL-10 but more iNOS, IL-12 and TNF-alpha when compared to monocytes from WT mice. Complement activation at the site of RPE cell death resulted in C3b/C3d but not C5b-9 deposition, indicating only partial activation of the complement pathway. Our results suggest that altered monocyte functions may convert the protective para-inflammatory response into an overtly harmful inflammation at the retina/choroidal interface in CCL2- or CCR2-deficient mice, leading to RPE and photoreceptor degeneration. These data support a concept whereby a protective para-inflammatory response relies upon a normally functioning innate immune system. If the innate immune system is deficient chronic stress may tip the balance towards an overt inflammatory response causing cell/tissue damage.	[Chen, Mei; Xu, Heping] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland; [Forrester, John V.] Univ Aberdeen, Aberdeen, Scotland	Queens University Belfast; University of Aberdeen	Chen, M (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland.	heping.xu@qub.ac.uk	Xu, Heping/A-4430-2008	Xu, Heping/0000-0003-4000-931X	Tait family; RS McDonald Trust; NHS Endowment [09/31]; University of Aberdeen Development	Tait family; RS McDonald Trust; NHS Endowment; University of Aberdeen Development	This project was supported by the University of Aberdeen Development, through funds received from the Tait family, the RS McDonald Trust, and NHS Endowment (09/31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bressler NM, 2009, ARCH OPHTHALMOL-CHIC, V127, P13, DOI 10.1001/archophthalmol.2008.562; Chakravarthy U, 2006, OPHTHALMOLOGY, V113, P1508, DOI 10.1016/j.ophtha.2006.02.064; Chakravarthy U, 2007, OPHTHALMOLOGY, V114, P1157, DOI 10.1016/j.ophtha.2006.09.022; Chan-Ling T, 2007, MICROCIRCULATION, V14, P63, DOI 10.1080/10739680601073451; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Chen M, 2007, EXP EYE RES, V84, P635, DOI 10.1016/j.exer.2006.11.015; Chen M, 2010, EUR J IMMUNOL, V40, P2870, DOI 10.1002/eji.201040323; Chen M, 2008, EXP EYE RES, V87, P543, DOI 10.1016/j.exer.2008.09.005; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x; Despriet DDG, 2008, INVEST OPHTH VIS SCI, V49, P364, DOI 10.1167/iovs.07-0656; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hughes MS, 2006, OPHTHAL SURG LAS IM, V37, P446, DOI 10.3928/15428877-20061101-01; Jiang HR, 2002, J LEUKOCYTE BIOL, V72, P978; Kaushik S, 2008, AM J CLIN NUTR, V88, P1104, DOI 10.1093/ajcn/88.4.1104; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; LUTZ MB, 1999, J IMMUNOL METHODS, P22377; Margrain TH, 2004, PROG RETIN EYE RES, V23, P523, DOI 10.1016/j.preteyeres.2004.05.001; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Paques M, 2007, INVEST OPHTH VIS SCI, V48, P2769, DOI 10.1167/iovs.06-1099; Randolph GJ, 2001, SEMIN IMMUNOL, V13, P267, DOI 10.1006/smim.2001.0322; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Read RW, 2006, EXP EYE RES, V82, P389, DOI 10.1016/j.exer.2005.07.011; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Tan JSL, 2008, OPHTHALMOLOGY, V115, P334, DOI 10.1016/j.ophtha.2007.03.083; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; XU H, 2002, EXP EYE RES, P74403; XU H, 2004, J LEUKOCYTE BIOL, P75224; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001	45	79	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22818	10.1371/journal.pone.0022818	http://dx.doi.org/10.1371/journal.pone.0022818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850237	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300022
J	Kim, KH; Kim, EY; Kim, Y; Kim, E; Lee, HS; Yoon, SY; Lee, KA				Kim, Kyeoung-Hwa; Kim, Eun-Young; Kim, Yuna; Kim, Eunju; Lee, Hyun-Seo; Yoon, Sook-Young; Lee, Kyung-Ah			Gas6 Downregulation Impaired Cytoplasmic Maturation and Pronuclear Formation Independent to the MPF Activity	PLOS ONE			English	Article							PROMOTING FACTOR MPF; IN-VITRO MATURATION; MEIOTIC MATURATION; MOUSE OOCYTES; CELL-CYCLE; CA2+ OSCILLATIONS; BOVINE OOCYTES; SELECTIVE DEGRADATION; CYTOSTATIC FACTOR; GERMINAL VESICLE	Previously, we found that the growth arrest-specific gene 6 (Gas6) is more highly expressed in germinal vesicle (GV) oocytes than in metaphase II (MII) oocytes using annealing control primer (ACP)-PCR technology. The current study was undertaken to investigate the role of Gas6 in oocyte maturation and fertilization using RNA interference (RNAi). Interestingly, despite the specific and marked decrease in Gas6 mRNA and protein expression in GVs after Gas6 RNAi, nuclear maturation including spindle structures and chromosome segregation was not affected. The only discernible effect induced by Gas6 RNAi was a change in maturation promoting factor (MPF) activity. After parthenogenetic activation, Gas6 RNAi-treated oocytes at the MII stage had not developed further and arrested at MII (90.0%). After stimulation with Sr2+, Gas6-silenced MII oocytes had markedly reduced Ca2+ oscillation and exhibited no exocytosis of cortical granules. In these oocytes, sperm penetration occurred during fertilization but not pronucleus (PN) formation. By roscovitine and colcemid treatment, we found that the Gas6 knockdown affected cytoplasmic maturation directly, independent to the changed MPF activity. These results strongly suggest that 1) the Gas6 signaling itself is important to the cytoplasmic maturation, but not nuclear maturation, and 2) the decreased Gas6 expression and decreased MPF activity separately or mutually influence sperm head decondensation and PN formation.	[Kim, Kyeoung-Hwa; Kim, Eun-Young; Kim, Yuna; Kim, Eunju; Lee, Hyun-Seo; Yoon, Sook-Young; Lee, Kyung-Ah] CHA Univ, CHA Gen Hosp, CHA Res Inst, Dept Biomed Sci,Coll Life Sci,Fertil Ctr, Seoul, South Korea	Pochon Cha University	Kim, KH (corresponding author), CHA Univ, CHA Gen Hosp, CHA Res Inst, Dept Biomed Sci,Coll Life Sci,Fertil Ctr, Seoul, South Korea.	leeka@ovary.co.kr			Korean government [R01-2007-000-20451-0]; Ministry of Education, Science and Technology [2009-0093821]	Korean government(Korean Government); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (No. R01-2007-000-20451-0) and the Priority Research Centers Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2001, FRONT BIOSCI, V6, pD792, DOI 10.2741/Abbott; Ajduk A, 2008, REPRODUCTION, V136, P741, DOI 10.1530/REP-08-0271; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Collas P, 1997, J BIOL CHEM, V272, P21274, DOI 10.1074/jbc.272.34.21274; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; CROSBY IM, 1984, J EXP ZOOL, V229, P459, DOI 10.1002/jez.1402290313; Deng MQ, 2000, BIOL REPROD, V62, P873, DOI 10.1095/biolreprod62.4.873; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; DUCIBELLA T, 1990, DEV BIOL, V137, P46, DOI 10.1016/0012-1606(90)90006-5; Eppig J. J., 2004, OVARY, P113, DOI DOI 10.1016/B978-012444562-8/50008-2; Eppig JJ, 2000, BIOL REPROD, V63, P1014, DOI 10.1095/biolreprod63.4.1014; Evans JP, 2002, HUM REPROD UPDATE, V8, P297, DOI 10.1093/humupd/8.4.297; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023; Fulka J, 1998, MOL HUM REPROD, V4, P41, DOI 10.1093/molehr/4.1.41; Gandolfi TALB, 2001, THERIOGENOLOGY, V55, P1255, DOI 10.1016/S0093-691X(01)00481-2; Goruppi S, 1996, ONCOGENE, V12, P471; Gosden RG, 2002, MOL CELL ENDOCRINOL, V186, P149, DOI 10.1016/S0303-7207(01)00683-9; Goudet G, 1998, MOL HUM REPROD, V4, P563, DOI 10.1093/molehr/4.6.563; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; HAMPL A, 1995, MOL REPROD DEV, V40, P9, DOI 10.1002/mrd.1080400103; Hegele-Hartung C, 1999, BIOL REPROD, V61, P1362, DOI 10.1095/biolreprod61.5.1362; JONES KT, 1995, DEVELOPMENT, V121, P3259; Jones KT, 1998, INT J DEV BIOL, V42, P1; Josefsberg LBY, 2003, BIOL REPROD, V68, P1282, DOI 10.1095/biolreprod.102.006882; Kim KH, 2008, BIOL REPROD, V79, P1192, DOI 10.1095/biolreprod.108.068478; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Kotani T, 2002, DEV BIOL, V252, P271, DOI 10.1006/dbio.2002.0853; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Lee HS, 2010, FASEB J, V24, P2314, DOI 10.1096/fj.09-147314; LEE SH, 1988, DEVELOPMENT, V102, P595; Lequarre AS, 2004, BIOL REPROD, V71, P425, DOI 10.1095/biolreprod.103.026724; Li RH, 1996, J NEUROSCI, V16, P2012; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Marangos P, 2003, DEVELOPMENT, V130, P1461, DOI 10.1242/dev.00340; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; McLay DW, 2002, DEV BIOL, V241, P195, DOI 10.1006/dbio.2001.0499; McLay DW, 1997, DEV BIOL, V186, P73, DOI 10.1006/dbio.1997.8581; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; Nasr-Esfahani MH, 2007, REPROD BIOMED ONLINE, V14, P422, DOI 10.1016/S1472-6483(10)60888-7; Nganvongpanit K, 2006, REPRODUCTION, V131, P861, DOI 10.1530/rep.1.01040; Ozil JP, 2006, DEV BIOL, V300, P534, DOI 10.1016/j.ydbio.2006.08.041; Palmer A, 2000, Prog Cell Cycle Res, V4, P131; PERREAULT SD, 1992, MUTAT RES, V296, P43, DOI 10.1016/0165-1110(92)90031-4; PERREAULT SD, 1988, DEV BIOL, V125, P181, DOI 10.1016/0012-1606(88)90070-X; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; SORENSEN RA, 1976, DEV BIOL, V50, P531, DOI 10.1016/0012-1606(76)90172-X; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; SUSKOPARRISH JL, 1994, DEV BIOL, V166, P729, DOI 10.1006/dbio.1994.1351; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Swain JE, 2008, HUM REPROD UPDATE, V14, P431, DOI 10.1093/humupd/dmn025; SZYBEK K, 1972, J ENDOCRINOL, V54, P527, DOI 10.1677/joe.0.0540527; Tgarashi H, 2007, DEV BIOL, V312, P321, DOI 10.1016/j.ydbio.2007.09.028; THIBAULT C, 1977, J REPROD FERTIL, V51, P1; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wolfe BA, 1996, J REPROD FERTIL, V106, P135, DOI 10.1530/jrf.0.1060135; Wu XQ, 2006, ACTA PHARMACOL SIN, V27, P1353, DOI 10.1111/j.1745-7254.2006.00407.x; Yoon SJ, 2009, BIOL REPROD, V81, P497, DOI 10.1095/biolreprod.108.073759; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037; YOSHIMURA Y, 1987, FERTIL STERIL, V47, P22	68	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23304	10.1371/journal.pone.0023304	http://dx.doi.org/10.1371/journal.pone.0023304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850267	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300052
J	Ardura, A; Planes, S; Garcia-Vazquez, E				Ardura, Alba; Planes, Serge; Garcia-Vazquez, Eva			Beyond Biodiversity: Fish Metagenomes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MARINE; CONSERVATION; DIVERSITY; DEPLETION; SELECTION; ECOSYSTEM; REGION	Biodiversity and intra-specific genetic diversity are interrelated and determine the potential of a community to survive and evolve. Both are considered together in Prokaryote communities treated as metagenomes or ensembles of functional variants beyond species limits. Many factors alter biodiversity in higher Eukaryote communities, and human exploitation can be one of the most important for some groups of plants and animals. For example, fisheries can modify both biodiversity and genetic diversity (intra specific). Intra-specific diversity can be drastically altered by overfishing. Intense fishing pressure on one stock may imply extinction of some genetic variants and subsequent loss of intra-specific diversity. The objective of this study was to apply a metagenome approach to fish communities and explore its value for rapid evaluation of biodiversity and genetic diversity at community level. Here we have applied the metagenome approach employing the Barcoding target gene COI as a model sequence in catch from four very different fish assemblages exploited by fisheries: freshwater communities from the Amazon River and northern Spanish rivers, and marine communities from the Cantabric and Mediterranean seas. Treating all sequences obtained from each regional catch as a biological unit (exploited community) we found that metagenomic diversity indices of the Amazonian catch sample here examined were lower than expected. Reduced diversity could be explained, at least partially, by overexploitation of the fish community that had been independently estimated by other methods. We propose using a metagenome approach for estimating diversity in Eukaryote communities and early evaluating genetic variation losses at multi-species level.	[Ardura, Alba; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Planes, Serge] Univ Perpignan, CNRS, EPHE, URA 1453, F-66025 Perpignan, France; [Planes, Serge] EPHE Ctr Rech Insulaire, CNRS, USR 3278, Papetoai, Moorea, France; [Planes, Serge] Observ Environm CRIOBE BP, Papetoai, Moorea, France	University of Oviedo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Ardura, A (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Spain.	alarguti@hotmail.com	Garcia-Vazquez, Eva/Y-7293-2019; PLANES, Serge/ABF-1360-2021	Garcia-Vazquez, Eva/0000-0002-8429-838X; PLANES, Serge/0000-0002-5689-5371; Ardura Gutierrez, Alba/0000-0003-2598-6534	Spanish AECI (Agencia Espanola de Cooperacion Internacional) [D/023514/09]; FICYT (Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia) [IB09-0023]	Spanish AECI (Agencia Espanola de Cooperacion Internacional); FICYT (Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia)(Principality of Asturias)	This study has been funded by the Spanish AECI (Agencia Espanola de Cooperacion Internacional) Project D/023514/09 and the FICYT (Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia) IB09-0023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agostinho AA, 2005, CONSERV BIOL, V19, P646, DOI 10.1111/j.1523-1739.2005.00701.x; Ardura A, 2010, BIOL CONSERV, V143, P1438, DOI 10.1016/j.biocon.2010.03.019; Bearzi G, 2006, BIOL CONSERV, V127, P373, DOI 10.1016/j.biocon.2005.08.017; Borsa P, 2002, BIOL J LINN SOC, V75, P261, DOI 10.1111/j.1095-8312.2002.tb01426.x; Brown CJ, 2008, MAR ECOL PROG SER, V369, P257, DOI 10.3354/meps07601; Carr MH, 2003, ECOL APPL, V13, pS90; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Garcia A, 2009, FISH PHYSIOL BIOCHEM, V35, P53, DOI 10.1007/s10695-008-9212-7; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kennedy J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-27; Langridge G, 2009, NAT REV MICROBIOL, V7, P552, DOI 10.1038/nrmicro2188; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Singh B, 2008, ANAEROBE, V14, P138, DOI 10.1016/j.anaerobe.2008.03.002; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang SZ, 2002, CONSERV GENET, V3, P321, DOI 10.1023/A:1019925910992; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	37	18	19	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22592	10.1371/journal.pone.0022592	http://dx.doi.org/10.1371/journal.pone.0022592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829636	gold, Green Published, Green Submitted			2022-12-27	WOS:000293561200024
J	Lee, HS; Lee, SY; Lee, H; Hwang, YS; Cha, SW; Park, S; Lee, JY; Park, JB; Kim, S; Park, MJ; Kim, J				Lee, Hyun-Shik; Lee, Sung-Young; Lee, Hyosang; Hwang, Yoo-Seok; Cha, Sang-Wook; Park, Soochul; Lee, Jae-Yong; Park, Jae-Bong; Kim, SungChan; Park, Mae Ja; Kim, Jaebong			Direct Response Elements of BMP within the PV.1A Promoter Are Essential for Its Transcriptional Regulation during Early Xenopus Development	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; HOMEOBOX GENE; XVENT-2; MESODERM; INDUCTION; BINDING; EXPRESSION; EMBRYOS; FAMILY; XOM	Xvent homeobox genes encode transcription factors that repress organizer genes and are essential for dorsoventral specification during early embryogenesis in Xenopus. In contrast to the Xvent-2 gene subfamily, Xvent-1 subfamily members, including PV.1A, have been proposed as indirect targets of Bone Morphogenetic Protein-4 (BMP-4) signaling. Because PV.1A is a critical downstream mediator of, and tightly regulated by, BMP-4 signaling, we hypothesized that its promoter contains a direct BMP-4 response element to effect this transcriptional regulation. We demonstrate that direct regulation by BMP-4 is necessary for transcription of PV.1A: its proximal promoter contains cis-acting binding elements for Smads and Oaz crucial to induction in response to BMP-4 signaling. In addition to these direct cis-acting BMP-4 responsive elements, an indirect Xvent-2 response element and several repressive elements exist in the PV.1A promoter to regulate its transcription. In summary, PV.1A undergoes combinatorial regulation during early Xenopus development as both the direct target of BMP-4 signaling and as the direct and indirect target of positive and negative regulatory factors.	[Lee, Hyun-Shik; Lee, Sung-Young; Lee, Jae-Yong; Park, Jae-Bong; Kim, SungChan; Kim, Jaebong] Hallym Univ, Coll Med, Dept Biochem, Chunchon, Kangwon Do, South Korea; [Lee, Hyosang; Hwang, Yoo-Seok; Cha, Sang-Wook; Park, Mae Ja] Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu, South Korea; [Park, Soochul] Sookmyung Womens Univ, Coll Nat Sci, Dept Life Sci, Seoul, South Korea; [Lee, Hyun-Shik] Kyungpook Natl Univ, Sch Life Sci, Coll Nat Sci, Taegu, South Korea	Hallym University; Kyungpook National University; Sookmyung Women's University; Kyungpook National University	Lee, HS (corresponding author), Hallym Univ, Coll Med, Dept Biochem, Chunchon, Kangwon Do, South Korea.	jbkim@hallym.ac.kr	Kim, Jaebong/AAV-1986-2021; Lee, Hyun-Shik/G-3555-2011; Cha, Sang-Wook/D-3523-2016	Kim, Jaebong/0000-0003-1609-338X; , Hyosang/0000-0002-3200-8678	Ministry of Education, Science and Technology [KRF-2005-C00115, KRF-2005-015-C00390, 2010-0029642]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Basic Science Research Program (KRF-2005-C00115 and KRF-2005-015-C00390) and by the Priority Research Centers Program (2010-0029642) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault KT, 1996, P NATL ACAD SCI USA, V93, P6415, DOI 10.1073/pnas.93.13.6415; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Friedle H, 2002, J BIOL CHEM, V277, P23872, DOI 10.1074/jbc.M201831200; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; HARLAND RM, 1994, P NATL ACAD SCI USA, V91, P10243, DOI 10.1073/pnas.91.22.10243; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; HemmatiBrivanlou A, 1997, ANNU REV NEUROSCI, V20, P43, DOI 10.1146/annurev.neuro.20.1.43; Henningfeld KA, 2002, J BIOL CHEM, V277, P2097, DOI 10.1074/jbc.M108524200; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Ladher R, 1996, DEVELOPMENT, V122, P2385; Lee HS, 2002, BIOCHEM BIOPH RES CO, V298, P815, DOI 10.1016/S0006-291X(02)02570-6; Maeda R, 1997, DEVELOPMENT, V124, P2553; Melby AE, 1999, DEV BIOL, V211, P293, DOI 10.1006/dbio.1999.9296; Onichtchouk D, 1998, DEVELOPMENT, V125, P1447; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Papalopulu N, 1996, DEV BIOL, V174, P104, DOI 10.1006/dbio.1996.0055; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Rastegar S, 1999, MECH DEVELOP, V81, P139, DOI 10.1016/S0925-4773(98)00239-1; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Schuler-Metz A, 2000, J BIOL CHEM, V275, P34365, DOI 10.1074/jbc.M003915200; Trindade M, 1999, DEV BIOL, V216, P442, DOI 10.1006/dbio.1999.9507; Zhu CQC, 1999, CELL MOL BIOL, V45, P617; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	25	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22621	10.1371/journal.pone.0022621	http://dx.doi.org/10.1371/journal.pone.0022621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857938	Green Published, Green Submitted, gold			2022-12-27	WOS:000293558900022
J	Pe'er, G; Henle, K; Dislich, C; Frank, K				Pe'er, Guy; Henle, Klaus; Dislich, Claudia; Frank, Karin			Breaking Functional Connectivity into Components: A Novel Approach Using an Individual-Based Model, and First Outcomes	PLOS ONE			English	Article							ATLANTIC FOREST; LANDSCAPE CONNECTIVITY; DISPERSAL BEHAVIOR; FRAGMENTED LANDSCAPES; MATRIX HETEROGENEITY; PATCH CONNECTIVITY; BUTTERFLY MOVEMENT; SPATIAL STRUCTURE; PERCEPTUAL RANGE; UNDERSTORY BIRDS	Landscape connectivity is a key factor determining the viability of populations in fragmented landscapes. Predicting 'functional connectivity', namely whether a patch or a landscape functions as connected from the perspective of a focal species, poses various challenges. First, empirical data on the movement behaviour of species is often scarce. Second, animal-landscape interactions are bound to yield complex patterns. Lastly, functional connectivity involves various components that are rarely assessed separately. We introduce the spatially explicit, individual-based model FunCon as means to distinguish between components of functional connectivity and to assess how each of them affects the sensitivity of species and communities to landscape structures. We then present the results of exploratory simulations over six landscapes of different fragmentation levels and across a range of hypothetical bird species that differ in their response to habitat edges. i) Our results demonstrate that estimations of functional connectivity depend not only on the response of species to edges (avoidance versus penetration into the matrix), the movement mode investigated (home range movements versus dispersal), and the way in which the matrix is being crossed (random walk versus gap crossing), but also on the choice of connectivity measure (in this case, the model output examined). ii) We further show a strong effect of the mortality scenario applied, indicating that movement decisions that do not fully match the mortality risks are likely to reduce connectivity and enhance sensitivity to fragmentation. iii) Despite these complexities, some consistent patterns emerged. For instance, the ranking order of landscapes in terms of functional connectivity was mostly consistent across the entire range of hypothetical species, indicating that simple landscape indices can potentially serve as valuable surrogates for functional connectivity. Yet such simplifications must be carefully evaluated in terms of the components of functional connectivity they actually predict.	[Pe'er, Guy; Henle, Klaus] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Pe'er, Guy; Dislich, Claudia; Frank, Karin] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Pe'er, Guy] Univ Aegean, Dept Environm Studies, Biodivers Conservat Lab, Mitilini, Greece	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Aegean	Pe'er, G (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	guy.peer@ufz.de	Frank, Karin/D-6490-2015; Wrbka, Thomas/A-5699-2010; Henle, Klaus/I-6837-2013	Frank, Karin/0000-0002-2769-0692; Wrbka, Thomas/0000-0002-1451-9108; Henle, Klaus/0000-0002-6647-5362	German Federal Ministry of Education and Research (BMBF) [01 LB 0202 A1]; EU [226852]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	The work was conducted within GP's postdoctoral position at the Department of Ecological Modelling, as part of the BioCAPSP project "Biodiversity Conservation in Fragmented Landscapes at the Atlantic Plateau of Sao Paulo'' (funded by the German Federal Ministry of Education and Research (BMBF), project number 01 LB 0202 A1) and its onward development and application occurs within the EU FP7 Large-scale integrating project "SCALES'' (grant number 226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awade M, 2008, AUSTRAL ECOL, V33, P863, DOI 10.1111/j.1442-9993.2008.01857.x; Baguette M, 2000, J APPL ECOL, V37, P100, DOI 10.1046/j.1365-2664.2000.00478.x; Baldi A, 2005, FOLIA ZOOL, V54, P285; Baniya CB, 2009, PLANT ECOL, V201, P383, DOI 10.1007/s11258-008-9473-3; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Belisle M, 2001, ECOLOGY, V82, P1893, DOI 10.1890/0012-9658(2001)082[1893:IOFCOT]2.0.CO;2; Beltran JW, 2010, ORNITOL NEOTROP, V21, P409; Boscolo D, 2009, LANDSCAPE ECOL, V24, P907, DOI 10.1007/s10980-009-9370-8; Bowers MA, 1999, LANDSCAPE ECOL, V14, P381, DOI 10.1023/A:1008014426117; Braunisch V, 2010, MOL ECOL, V19, P3664, DOI 10.1111/j.1365-294X.2010.04703.x; Bronstein I. N., 2007, HDB MATH; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Cantrell RS, 2007, B MATH BIOL, V69, P2339, DOI 10.1007/s11538-007-9222-0; Crone EE, 2008, ECOLOGY, V89, P2061, DOI 10.1890/07-1173.1; Crooks K. R., 2006, CONNECTIVITY CONSERV; de Melo FPL, 2006, BIOL CONSERV, V132, P50, DOI 10.1016/j.biocon.2006.03.015; Delgado MD, 2009, BEHAV ECOL SOCIOBIOL, V64, P35, DOI 10.1007/s00265-009-0815-5; Delibes M, 2009, ANIM CONSERV, V12, P400, DOI 10.1111/j.1469-1795.2009.00263.x; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Desrochers A, 2000, OIKOS, V91, P376, DOI 10.1034/j.1600-0706.2000.910218.x; Develey PF, 2001, CONSERV BIOL, V15, P1416, DOI 10.1046/j.1523-1739.2001.00170.x; Doak DF, 1995, CONSERV BIOL, V9, P1370, DOI 10.1046/j.1523-1739.1995.09061370.x; Dover J, 2009, J INSECT CONSERV, V13, P3, DOI 10.1007/s10841-008-9135-8; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; FERRER M, 1993, IBIS, V135, P132, DOI 10.1111/j.1474-919X.1993.tb02824.x; Foguekem D, 2009, SCI RES ESSAYS, V4, P1423; Fonseca CR, 2007, RESTOR ECOL, V15, P613, DOI 10.1111/j.1526-100X.2007.00273.x; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Gagne C, 2007, FOREST ECOL MANAG, V252, P191, DOI 10.1016/j.foreco.2007.06.039; Gillies CS, 2010, J APPL ECOL, V47, P182, DOI 10.1111/j.1365-2664.2009.01756.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V., 2005, INDIVIDUAL BASED MOD; Grimm V, 2008, ECOLOGICAL MODELS, V3, P1959; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gruber B, 2008, OECOLOGIA, V154, P679, DOI 10.1007/s00442-007-0866-0; Haddad NM, 1999, AM NAT, V153, P215, DOI 10.1086/303163; Hansbauer MM, 2006, J ORNITHOL, V147, P178; Hansbauer MM, 2008, J TROP ECOL, V24, P291, DOI 10.1017/S0266467408005002; Hansbauer MM, 2008, BIOL CONSERV, V141, P782, DOI 10.1016/j.biocon.2008.01.002; Hansbauer MM, 2010, LANDSCAPE ECOL, V25, P407, DOI 10.1007/s10980-009-9418-9; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hanski Ilkka, 2001, P283; HANSSON L, 1991, BIOL J LINN SOC, V42, P89, DOI 10.1111/j.1095-8312.1991.tb00553.x; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; Haynes KJ, 2006, OIKOS, V113, P43, DOI 10.1111/j.0030-1299.2006.13977.x; Heinz SK, 2005, LANDSCAPE ECOL, V20, P83, DOI 10.1007/s10980-004-0678-0; Henle K, 2004, BIODIVERS CONSERV, V13, P1, DOI 10.1023/B:BIOC.0000004311.04226.29; Henle K, 2010, GAIA, V19, P187, DOI 10.14512/gaia.19.3.8; Hinsley SA, 2000, LANDSCAPE ECOL, V15, P765, DOI 10.1023/A:1008149403852; Hovestadt T, 2000, OIKOS, V90, P612, DOI 10.1034/j.1600-0706.2000.900320.x; Kark S, 2007, ENCY BIODIVERSITY, DOI DOI 10.1016/B978-012226865-6/00573-0; Kark S, 2006, ISR J ECOL EVOL, V52, P29, DOI 10.1560/IJEE.52.1.29; King AW, 2002, ECOL MODEL, V147, P23, DOI 10.1016/S0304-3800(01)00400-8; Kramer-Schadt S, 2004, J APPL ECOL, V41, P711, DOI 10.1111/j.0021-8901.2004.00933.x; Kuefler D, 2006, ECOGRAPHY, V29, P549, DOI 10.1111/j.0906-7590.2006.04574.x; Kunin WE, 2000, AM NAT, V156, P560, DOI 10.1086/303408; Laurance WF, 2000, TRENDS ECOL EVOL, V15, P134, DOI 10.1016/S0169-5347(00)01838-3; Lees AC, 2009, OIKOS, V118, P280, DOI 10.1111/j.1600-0706.2008.16842.x; Li YK, 2010, INT J PRIMATOL, V31, P609, DOI 10.1007/s10764-010-9416-4; Lookingbill TR, 2010, ECOL APPL, V20, P427, DOI 10.1890/09-0073.1; Luhrs ML, 2009, ANIM COGN, V12, P599, DOI 10.1007/s10071-009-0219-y; Macdonald DW, 2003, J BIOGEOGR, V30, P607, DOI 10.1046/j.1365-2699.2003.00874.x; Malanson George P., 1999, Diversity and Distributions, V5, P27, DOI 10.1046/j.1472-4642.1999.00035.x; Manolis JC, 2002, AUK, V119, P955, DOI 10.1642/0004-8038(2002)119[0955:EEONSO]2.0.CO;2; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; Mazerolle MJ, 2005, CAN J ZOOL, V83, P455, DOI 10.1139/Z05-032; McGarigal K, 2001, FRAGSTATS SPATIAL PA; Morales JM, 2002, ECOLOGY, V83, P2240; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Palmer SCF, 2011, METHODS ECOL EVOL, V2, P258, DOI 10.1111/j.2041-210X.2010.00073.x; Pe'er G, 2004, ANIM BEHAV, V68, P825, DOI 10.1016/j.anbehav.2004.02.006; Pe'er G, DIVERSITY D IN PRESS; Pe'er G, 2008, ECOL MODEL, V213, P73, DOI 10.1016/j.ecolmodel.2007.11.020; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Reif J, 2006, J ORNITHOL, V147, P236; Revilla E, 2004, AM NAT, V164, pE130, DOI 10.1086/424767; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Riitters K, 2009, LANDSCAPE ECOL, V24, P699, DOI 10.1007/s10980-009-9344-x; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Robertson OJ, 2009, AUSTRAL ECOL, V34, P435, DOI 10.1111/j.1442-9993.2009.01945.x; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Schtickzelle N, 2005, BIOL CONSERV, V126, P569, DOI 10.1016/j.biocon.2005.06.030; Schumaker NH, 1996, ECOLOGY, V77, P1210, DOI 10.2307/2265590; Semlitsch RD, 2007, CONSERV BIOL, V21, P159, DOI 10.1111/j.1523-1739.2006.00571.x; Stevens VM, 2008, CONSERV BIOL, V22, P1194, DOI 10.1111/j.1523-1739.2008.00990.x; Storch D, 2006, J ORNITHOL, V147, P33; Szemethy L, 2003, ACTA THERIOL, V48, P547, DOI 10.1007/BF03192500; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Turchin Peter, 1998; Turcotte Y, 2003, OIKOS, V100, P614, DOI 10.1034/j.1600-0706.2003.12234.x; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Visconti P, 2009, DIVERS DISTRIB, V15, P602, DOI 10.1111/j.1472-4642.2009.00564.x; Vogt P, 2009, ECOL INDIC, V9, P64, DOI 10.1016/j.ecolind.2008.01.011; Watts K, 2010, ECOL INDIC, V10, P552, DOI 10.1016/j.ecolind.2009.07.009; Wiegand K, 2002, CONSERV BIOL, V16, P117, DOI 10.1046/j.1523-1739.2002.99552.x; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; With KA, 1999, ECOLOGY, V80, P1340, DOI 10.1890/0012-9658(1999)080[1340:MRTPSI]2.0.CO;2; Zetterberg A, 2010, LANDSCAPE URBAN PLAN, V95, P181, DOI 10.1016/j.landurbplan.2010.01.002; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zollner PA, 1999, OIKOS, V84, P164, DOI 10.2307/3546878; Zurita GA, 2006, FOREST ECOL MANAG, V235, P164, DOI 10.1016/j.foreco.2006.08.009; Zurita GA, 2010, LANDSCAPE ECOL, V25, P147, DOI 10.1007/s10980-009-9410-4; Zurita GA, 2009, FOREST ECOL MANAG, V257, P271, DOI 10.1016/j.foreco.2008.08.032	120	53	54	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22355	10.1371/journal.pone.0022355	http://dx.doi.org/10.1371/journal.pone.0022355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829617	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200008
J	Zakiewicz, IM; van Dongen, YC; Leergaard, TB; Bjaalie, JG				Zakiewicz, Izabela M.; van Dongen, Yvette C.; Leergaard, Trygve B.; Bjaalie, Jan G.			Workflow and Atlas System for Brain-Wide Mapping of Axonal Connectivity in Rat	PLOS ONE			English	Article							ARCHITECTURE MANAGEMENT-SYSTEM; PRIMARY SOMATOSENSORY CORTEX; SOMATIC SENSORY CORTEX; CEREBRAL-CORTEX; LATERAL LEMNISCUS; BARREL CORTEX; MOUSE-BRAIN; CORTICOSTRIATAL PROJECTIONS; SOMATOTOPIC ORGANIZATION; CORTICOPONTINE NEURONS	Detailed knowledge about the anatomical organization of axonal connections is important for understanding normal functions of brain systems and disease-related dysfunctions. Such connectivity data are typically generated in neuroanatomical tract-tracing experiments in which specific axonal connections are visualized in histological sections. Since journal publications typically only accommodate restricted data descriptions and example images, literature search is a cumbersome way to retrieve overviews of brain connectivity. To explore more efficient ways of mapping, analyzing, and sharing detailed axonal connectivity data from the rodent brain, we have implemented a workflow for data production and developed an atlas system tailored for online presentation of axonal tracing data. The system is available online through the Rodent Brain WorkBench (www.rbwb.org; Whole Brain Connectivity Atlas) and holds experimental metadata and high-resolution images of histological sections from experiments in which axonal tracers were injected in the primary somatosensory cortex. We here present the workflow and the data system, and exemplify how the online image repository can be used to map different aspects of the brain-wide connectivity of the rat primary somatosensory cortex, including not only presence of connections but also morphology, densities, and spatial organization. The accuracy of the approach is validated by comparing results generated with our system with findings reported in previous publications. The present study is a contribution to a systematic mapping of rodent brain connections and represents a starting point for further large-scale mapping efforts.	[Zakiewicz, Izabela M.; van Dongen, Yvette C.; Leergaard, Trygve B.; Bjaalie, Jan G.] Univ Oslo, Inst Basic Med Sci, Ctr Mol Biol & Neurosci, Oslo, Norway	University of Oslo	Zakiewicz, IM (corresponding author), Univ Oslo, Inst Basic Med Sci, Ctr Mol Biol & Neurosci, Oslo, Norway.	j.g.bjaalie@medisin.uio.no	Bjaalie, Jan G. G./AAW-6445-2021	Bjaalie, Jan G. G./0000-0001-7899-906X; Leergaard, Trygve B./0000-0001-5965-8470	Research Council of Norway; EMBIO/MLS@UiO	Research Council of Norway(Research Council of Norway); EMBIO/MLS@UiO	This research was funded by the Research Council of Norway and EMBIO/MLS@UiO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Alloway KD, 1999, J NEUROSCI, V19, P10908, DOI 10.1523/JNEUROSCI.19-24-10908.1999; Bello M, 2005, LECT NOTES COMPUT SC, V3749, P254; Bjaalie JG, 2005, NEUROSCIENCE, V136, P681, DOI 10.1016/j.neuroscience.2005.06.036; BJAALIE JG, 2005, DATABASING BRAIN, P350; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Boline J, 2008, FRONT NEUROSCI-SWITZ, V2, P100, DOI 10.3389/neuro.01.012.2008; Bota M, 2005, NEUROINFORMATICS, V3, P15, DOI 10.1385/NI:3:1:015; BOTA M, 2008, 1 INCF WORKSH NEUR N; Bota M, 2007, J COMP NEUROL, V500, P807, DOI 10.1002/cne.21209; Bota M, 2006, NEUROINFORMATICS, V4, P275, DOI 10.1385/NI:4:4:275; Boy J, 2006, NEUROIMAGE, V33, P449, DOI 10.1016/j.neuroimage.2006.05.055; Brodal P, 1997, PROG BRAIN RES, V114, P227; Brown LL, 1998, J COMP NEUROL, V392, P468; Bug William, 2008, AMIA Annu Symp Proc, P1220; Canals S, 2008, NEUROIMAGE, V40, P458, DOI 10.1016/j.neuroimage.2007.12.007; Carson J, 2010, METHODS, V50, P85, DOI 10.1016/j.ymeth.2009.08.005; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Crasto Chiquito J, 2007, Methods Mol Biol, V401, P3, DOI 10.1007/978-1-59745-520-6_1; DONOGHUE JP, 1981, J COMP NEUROL, V201, P1, DOI 10.1002/cne.902010102; FABRI M, 1991, J COMP NEUROL, V311, P405, DOI 10.1002/cne.903110310; Fletcher M, 2008, NEURAL NETWORKS, V21, P1076, DOI 10.1016/j.neunet.2008.06.009; Gardner D, 2001, J AM MED INFORM ASSN, V8, P17, DOI 10.1136/jamia.2001.0080017; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Gibson F., 2009, MINIMUM INFORM NEURO; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; HAWRYLYCZ M, 2009, INCF DIGITAL ADASING; Hjornevik Trine, 2007, Front Neuroinform, V1, P4, DOI 10.3389/neuro.11.004.2007; Hoffer ZS, 2005, J COMP NEUROL, V488, P82, DOI 10.1002/cne.20579; Hoffer ZS, 2001, J COMP NEUROL, V439, P87, DOI 10.1002/cne.1337; Hoover JE, 2003, J NEUROPHYSIOL, V89, P1576, DOI 10.1152/jn.01009.2002; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Kennedy DN, 2010, NEUROINFORMATICS, V8, P61, DOI 10.1007/s12021-010-9070-1; KILLACKEY HP, 1989, J COMP NEUROL, V282, P428, DOI 10.1002/cne.902820309; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kotter R, 2004, NEUROINFORMATICS, V2, P127; LANCIEGO JL, 1994, NEUROSCIENCE PROTOCO; Lee SK, 2004, NEUROIMAGE, V22, P1826, DOI 10.1016/j.neuroimage.2004.04.028; Leergaard TB, 2000, J COMP NEUROL, V422, P246, DOI 10.1002/(SICI)1096-9861(20000626)422:2<246::AID-CNE7>3.0.CO;2-R; Leergaard TB, 2004, J COMP NEUROL, V478, P306, DOI 10.1002/cne.20289; Leergaard TB, 2003, ANAT EMBRYOL, V206, P149, DOI 10.1007/s00429-002-0272-7; Leergaard TB, 2007, FRONT NEUROSCI-SWITZ, V1, P211, DOI 10.3389/neuro.01.1.1.016.2007; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MacKenzie-Graham A, 2003, NEUROINFORMATICS, V1, P397, DOI 10.1385/NI:1:4:397; Malmierca MS, 1998, J NEUROSCI, V18, P10603; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Merchan MA, 1996, J COMP NEUROL, V372, P245; MERCHAN MA, 1994, J COMP NEUROL, V342, P259, DOI 10.1002/cne.903420209; MIHAILOFF GA, 1985, J COMP NEUROL, V237, P251, DOI 10.1002/cne.902370209; Moene IA, 2007, NEUROINFORMATICS, V5, P35, DOI 10.1385/NI:5:1:35; Nadkarni Prakash, 2007, Methods Mol Biol, V401, P37, DOI 10.1007/978-1-59745-520-6_3; Oberti D, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00024; Ohara S, 2009, FRONT NEUROSCI-SWITZ, V3, P344, DOI 10.3389/neuro.01.032.2009; OVERBY SE, 1989, EXP BRAIN RES, V77, P653; Paxinos G., 2004, J CHEM INF MODEL, V5th; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penfield W, 1950, CEREBRAL CORTEX MAN; Petrovicky P, 1972, Folia Morphol (Praha), V20, P161; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Reiner A, 2006, NEUROANATOMICAL TRACT-TRACING 3: MOLECULES, NEURONS, AND SYSTEMS, P304; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; SCHWARZ C, 1995, J NEUROSCI, V15, P3475; Staiger JF, 2009, BRAIN STRUCT FUNCT, V214, P1, DOI 10.1007/s00429-009-0225-5; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Thompson RH, 2010, P NATL ACAD SCI USA, V107, P15235, DOI 10.1073/pnas.1009112107; Vassbo K, 1999, J COMP NEUROL, V406, P109, DOI 10.1002/(SICI)1096-9861(19990329)406:1<109::AID-CNE7>3.0.CO;2-U; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WELKER E, 1988, EXP BRAIN RES, V73, P411, DOI 10.1007/BF00248234; WIESENDANGER R, 1982, J COMP NEUROL, V208, P227, DOI 10.1002/cne.902080303; WISE SP, 1979, NEUROSCIENCE, V4, P65, DOI 10.1016/0306-4522(79)90218-5; WISE SP, 1977, BRAIN RES, V133, P223, DOI 10.1016/0006-8993(77)90760-0; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wouterlood FG, 2008, J NEUROSCI METH, V171, P296, DOI 10.1016/j.jneumeth.2008.03.014	82	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22669	10.1371/journal.pone.0022669	http://dx.doi.org/10.1371/journal.pone.0022669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829640	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200015
J	Zhang, YH; Larsen, CA; Stadler, HS; Ames, JB				Zhang, Yonghong; Larsen, Christine A.; Stadler, H. Scott; Ames, James B.			Structural Basis for Sequence Specific DNA Binding and Protein Dimerization of HOXA13	PLOS ONE			English	Article							FOOT-GENITAL SYNDROME; POLYALANINE EXPANSION; LIGHT-SCATTERING; NMR STRUCTURES; HOMEODOMAIN; COMPLEX; DOMAIN; EXPRESSION; ASSIGNMENTS; HEXAPEPTIDE	The homeobox gene (HOXA13) codes for a transcription factor protein that binds to AT-rich DNA sequences and controls expression of genes during embryonic morphogenesis. Here we present the NMR structure of HOXA13 homeodomain (A13DBD) bound to an 11-mer DNA duplex. A13DBD forms a dimer that binds to DNA with a dissociation constant of 7.5 nM. The A13DBD/DNA complex has a molar mass of 35 kDa consistent with two molecules of DNA bound at both ends of the A13DBD dimer. A13DBD contains an N-terminal arm (residues 324 - 329) that binds in the DNA minor groove, and a C-terminal helix (residues 362 - 382) that contacts the ATAA nucleotide sequence in the major groove. The N370 side-chain forms hydrogen bonds with the purine base of A5* (base paired with T5). Side-chain methyl groups of V373 form hydrophobic contacts with the pyrimidine methyl groups of T5, T6* and T7*, responsible for recognition of TAA in the DNA core. I366 makes similar methyl contacts with T3* and T4*. Mutants (I366A, N370A and V373G) all have decreased DNA binding and transcriptional activity. Exposed protein residues (R337, K343, and F344) make intermolecular contacts at the protein dimer interface. The mutation F344A weakens protein dimerization and lowers transcriptional activity by 76%. We conclude that the non-conserved residue, V373 is critical for structurally recognizing TAA in the major groove, and that HOXA13 dimerization is required to activate transcription of target genes.	[Zhang, Yonghong; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Larsen, Christine A.; Stadler, H. Scott] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Larsen, Christine A.; Stadler, H. Scott] Shriners Hosp Children, Res Dept, Portland, OR 97201 USA	University of California System; University of California Davis; Oregon Health & Science University	Zhang, YH (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	ames@chem.ucdavis.edu			NIH [5R01EY012347, 5R01CA131458-03]; Shriners Hospitals for Children [85800]; Basic Research Training in Embryonic Development Award [5T32HD049309-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD049309] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA131458] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; Basic Research Training in Embryonic Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants 5R01EY012347 (J.B.A.) and 5R01CA131458-03 (HSS) from the NIH; Shriners Hospitals for Children Grant Award Number 85800 (HSS) and a Basic Research Training in Embryonic Development Award 5T32HD049309-05 (CAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Innis Jeffrey W, 2002, Hum Mutat, V19, P573; Innis JW, 2004, HUM MOL GENET, V13, P2841, DOI 10.1093/hmg/ddh306; Jorgensen EM, 2010, FERTIL STERIL, V94, P1235, DOI 10.1016/j.fertnstert.2009.05.057; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Knosp WM, 2007, J BIOL CHEM, V282, P6843, DOI 10.1074/jbc.M610775200; Knosp WM, 2004, DEVELOPMENT, V131, P4581, DOI 10.1242/dev.01327; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Longo A, 2007, BIOCHEMISTRY-US, V46, P2948, DOI 10.1021/bi060969l; Meyer M, 2003, BIOMACROMOLECULES, V4, P1727, DOI 10.1021/bm0341531; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Parker L, 2011, Foot Ankle Surg, V17, pe28, DOI 10.1016/j.fas.2010.12.003; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shanmugam K, 1997, J BIOL CHEM, V272, P19081, DOI 10.1074/jbc.272.30.19081; Shaut CA, 2007, DEV DYNAM, V236, P951, DOI 10.1002/dvdy.21077; Shaut CAE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000073; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; TREISMAN J, 1989, CELL, V59, P553; Utsch B, 2002, HUM GENET, V110, P488, DOI 10.1007/s00439-002-0712-8; Utsch B, 2007, AM J MED GENET A, V143A, P3161, DOI 10.1002/ajmg.a.31967; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Williams TM, 2005, DEV BIOL, V277, P457, DOI 10.1016/j.ydbio.2004.10.004; Williams TM, 2005, NUCLEIC ACIDS RES, V33, P4475, DOI 10.1093/nar/gki761; WYATT PJ, 1991, BIOCHEM SOC T, V19, P485, DOI 10.1042/bst0190485; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Zhang YH, 2010, BIOMOL NMR ASSIGN, V4, P97, DOI 10.1007/s12104-010-9216-y; Zhang YH, 2009, BIOMOL NMR ASSIGN, V3, P199, DOI 10.1007/s12104-009-9174-4; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	53	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23069	10.1371/journal.pone.0023069	http://dx.doi.org/10.1371/journal.pone.0023069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829694	gold, Green Published			2022-12-27	WOS:000293511200038
J	Romero-Romero, ML; Ingles-Prieto, A; Ibarra-Molero, B; Sanchez-Ruiz, JM				Luisa Romero-Romero, M.; Ingles-Prieto, Alvaro; Ibarra-Molero, Beatriz; Sanchez-Ruiz, Jose M.			Highly Anomalous Energetics of Protein Cold Denaturation Linked to Folding-Unfolding Kinetics	PLOS ONE			English	Article							C-TERMINAL DOMAIN; CHARGE INTERACTIONS; LOW-TEMPERATURE; HEAT; STABILITY; BARRIERS; STATE; COOPERATIVITY; TRANSITIONS; DEPENDENCE	Despite several careful experimental analyses, it is not yet clear whether protein cold-denaturation is just a "mirror image" of heat denaturation or whether it shows unique structural and energetic features. Here we report that, for a well-characterized small protein, heat denaturation and cold denaturation show dramatically different experimental energetic patterns. Specifically, while heat denaturation is endothermic, the cold transition (studied in the folding direction) occurs with negligible heat effect, in a manner seemingly akin to a gradual, second-order-like transition. We show that this highly anomalous energetics is actually an apparent effect associated to a large folding/unfolding free energy barrier and that it ultimately reflects kinetic stability, a naturally-selected trait in many protein systems. Kinetics thus emerges as an important factor linked to differential features of cold denaturation. We speculate that kinetic stabilization against cold denaturation may play a role in cold adaptation of psychrophilic organisms. Furthermore, we suggest that folding-unfolding kinetics should be taken into account when analyzing in vitro cold-denaturation experiments, in particular those carried out in the absence of destabilizing conditions.	[Luisa Romero-Romero, M.; Ingles-Prieto, Alvaro; Ibarra-Molero, Beatriz; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain	University of Granada	Romero-Romero, ML (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain.	sanchezr@ugr.es	Ingles-Prieto, Alvaro/A-4365-2017; Romero Romero, Maria Luisa/B-2136-2019; Sanchez-Ruiz, Jose/H-2849-2015	Ingles-Prieto, Alvaro/0000-0002-5409-8571; Romero Romero, Maria Luisa/0000-0003-3397-6758; Sanchez-Ruiz, Jose/0000-0002-9056-3928	Spanish Ministry of Science and Innovation [BIO2009-09562, CSD2009-00088]; FEDER ("Fondo Europeo de DEsarrollo Regional")	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER ("Fondo Europeo de DEsarrollo Regional")(European Commission)	This work was supported by FEDER ("Fondo Europeo de DEsarrollo Regional") funds and Grants BIO2009-09562 and CSD2009-00088 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal A, 2004, PROTEINS, V57, P142, DOI 10.1002/prot.20172; ANDOVER M, 2010, J AM CHEM SOC, V132, P16240; ANTONINO LC, 1991, P NATL ACAD SCI USA, V88, P7715, DOI 10.1073/pnas.88.17.7715; Ascolese E, 2008, CHEM PHYS LETT, V467, P150, DOI 10.1016/j.cplett.2008.10.078; Babu CR, 2004, NAT STRUCT MOL BIOL, V11, P352, DOI 10.1038/nsmb739; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; CHEN BL, 1989, BIOCHEMISTRY-US, V28, P685, DOI 10.1021/bi00428a041; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Costas M, 2009, J MOL BIOL, V385, P924, DOI 10.1016/j.jmb.2008.10.056; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; DELPINO IMP, 1992, BIOCHEMISTRY-US, V31, P11196, DOI 10.1021/bi00160a033; Dyer RB, 2005, BIOCHEMISTRY-US, V44, P10406, DOI 10.1021/bi050698z; FREIRE E, 1992, BIOCHEMISTRY-US, V31, P250, DOI 10.1021/bi00116a034; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; Georgescu RE, 2001, EUR J BIOCHEM, V268, P1477, DOI 10.1046/j.1432-1327.2001.02014.x; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; GRIKO YV, 1994, BIOPHYS J, V67, P356, DOI 10.1016/S0006-3495(94)80488-6; GRIKO YV, 1989, FEBS LETT, V244, P276, DOI 10.1016/0014-5793(89)80544-7; GRIKO YV, 1992, BIOCHEMISTRY-US, V31, P8810, DOI 10.1021/bi00152a017; GRIKO YV, 1988, P NATL ACAD SCI USA, V85, P3343, DOI 10.1073/pnas.85.10.3343; GRIKO YV, 1994, J MOL BIOL, V235, P1318, DOI 10.1006/jmbi.1994.1085; Halskau O, 2008, P NATL ACAD SCI USA, V105, P8625, DOI 10.1073/pnas.0709881105; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Huang GWS, 1996, BIOCHEMISTRY-US, V35, P6173, DOI 10.1021/bi960250l; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; Ibarra-Molero B, 1999, BBA-PROTEIN STRUCT M, V1429, P384, DOI 10.1016/S0167-4838(98)00252-0; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Lazar KL, 2010, MABS-AUSTIN, V2, P42, DOI 10.4161/mabs.2.1.10787; Li Y, 2007, J MOL BIOL, V368, P256, DOI 10.1016/j.jmb.2007.02.011; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Molski MA, 2010, J AM CHEM SOC, V132, P3658, DOI 10.1021/ja910903c; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; Perez-Jimenez R, 2004, BIOPHYS J, V86, P2414, DOI 10.1016/S0006-3495(04)74298-8; Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899; Pometun MS, 2006, J AM CHEM SOC, V128, P10652, DOI 10.1021/ja0628654; PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Richardson JM, 2000, BIOCHEMISTRY-US, V39, P11154, DOI 10.1021/bi000610b; Rodriguez-Larrea D, 2006, BIOPHYS J, V91, pL48, DOI 10.1529/biophysj.106.087932; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rodriguez-Larrea D, 2010, BIOCHEM J, V429, P243, DOI 10.1042/BJ20100386; Sadqi M, 2009, P NATL ACAD SCI USA, V106, P4127, DOI 10.1073/pnas.0812108106; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636; Shan B, 2010, J AM CHEM SOC, V132, P4669, DOI 10.1021/ja908104s; Shnyrov VL, 2000, BIOPHYS CHEM, V88, P61, DOI 10.1016/S0301-4622(00)00199-X; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Todgham AE, 2007, J COMP PHYSIOL B, V177, P857, DOI 10.1007/s00360-007-0183-2; Tur-Arlandis G, 2010, BIOPHYS J, V98, pL12, DOI 10.1016/j.bpj.2009.11.028; Whitten ST, 2006, BIOCHEMISTRY-US, V45, P10163, DOI 10.1021/bi060855+; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Yang WY, 2005, PHILOS T R SOC A, V363, P565, DOI 10.1098/rsta.2004.1508	54	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23050	10.1371/journal.pone.0023050	http://dx.doi.org/10.1371/journal.pone.0023050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829584	Green Published, Green Submitted, gold			2022-12-27	WOS:000293286500071
J	Arsnoe, DM; Ip, HS; Owen, JC				Arsnoe, Dustin M.; Ip, Hon S.; Owen, Jennifer C.			Influence of Body Condition on Influenza A Virus Infection in Mallard Ducks: Experimental Infection Data	PLOS ONE			English	Article							IMMUNE FUNCTION; SUSCEPTIBILITY; ASSAY; HOST; REPRODUCTION; ANTIBODIES; INCREASES; IMPAIRS	Migrating waterfowl are implicated in the global spread of influenza A viruses (IAVs), and mallards (Anas platyrhynchos) are considered a particularly important IAV reservoir. Prevalence of IAV infection in waterfowl peaks during autumn pre-migration staging and then declines as birds reach wintering areas. Migration is energetically costly and birds often experience declines in body condition that may suppress immune function. We assessed how body condition affects susceptibility to infection, viral shedding and antibody production in wild-caught and captive-bred juvenile mallards challenged with low pathogenic avian influenza virus (LPAIV) H5N9. Wild mallards (n = 30) were separated into three experimental groups; each manipulated through food availability to a different condition level (-20%, -10%, and normal +/- 5% original body condition), and captive-bred mallards (n = 10) were maintained at normal condition. We found that wild mallards in normal condition were more susceptible to LPAIV infection, shed higher peak viral loads and shed viral RNA more frequently compared to birds in poor condition. Antibody production did not differ according to condition. We found that wild mallards did not differ from captive-bred mallards in viral intensity and duration of infection, but they did exhibit lower antibody titers and greater variation in viral load. Our findings suggest that reduced body condition negatively influences waterfowl host competence to LPAIV infection. This observation is contradictory to the recently proposed condition-dependent hypothesis, according to which birds in reduced condition would be more susceptible to IAV infection. The mechanisms responsible for reducing host competency among birds in poor condition remain unknown. Our research indicates body condition may influence the maintenance and spread of LPAIV by migrating waterfowl.	[Arsnoe, Dustin M.; Owen, Jennifer C.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Ip, Hon S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Owen, Jennifer C.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Michigan State University; United States Department of the Interior; United States Geological Survey; Michigan State University	Arsnoe, DM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	arsnoed@gmail.com		Owen, Jennifer/0000-0003-1383-4816; Ip, Hon/0000-0003-4844-7533	Department of Fisheries and Wildlife at Michigan State University; American Museum of Natural History	Department of Fisheries and Wildlife at Michigan State University; American Museum of Natural History	This study was funded by the Department of Fisheries and Wildlife at Michigan State University and the American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MA, 2001, J AM COLL NUTR, V20, p384S, DOI 10.1080/07315724.2001.10719172; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Buehler DM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P561, DOI 10.1086/603635; Carney S.M., 1992, SPECIES AGE SEX IDEN; COOLEY AJ, 1989, VET PATHOL, V26, P1, DOI 10.1177/030098588902600101; Devries JH, 2008, AUK, V125, P618, DOI 10.1525/auk.2008.07055; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Flint PL, 2009, P ROY SOC B-BIOL SCI, V276, P2345, DOI 10.1098/rspb.2008.1962; Gregory NG, 1998, NEW ZEAL J AGR RES, V41, P555, DOI 10.1080/00288233.1998.9513338; Hangalapura BN, 2005, POULTRY SCI, V84, P1520, DOI 10.1093/ps/84.10.1520; Hanson BA, 2005, J WILDLIFE DIS, V41, P624, DOI 10.7589/0090-3558-41.3.624; Hanssen SA, 2005, P ROY SOC B-BIOL SCI, V272, P1039, DOI 10.1098/rspb.2005.3057; HOMME PJ, 1970, AVIAN DIS, V14, P285, DOI 10.2307/1588473; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Klasing KC, 2004, POULTRY SCI, V83, P444; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P2347, DOI 10.1098/rspb.2009.0275; Li W, 2006, J NUTR, V136, P2611, DOI 10.1093/jn/136.10.2611; Louria DB, 2007, CLIN INFECT DIS, V45, P470, DOI 10.1086/520026; MAUSER DM, 1992, WILDLIFE SOC B, V20, P299; Moon JA, 2007, J WILDLIFE MANAGE, V71, P218, DOI 10.2193/2005-596; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen JC, 2008, CAN J ZOOL, V86, P638, DOI 10.1139/Z08-038; PAWLINA IM, 1993, CAN J ZOOL, V71, P2275, DOI 10.1139/z93-319; Pedersen Janice C., 2008, V436, P53, DOI 10.1007/978-1-59745-279-3_8; POLLETT M, 1979, AUST J EXP BIOL MED, V57, P151, DOI 10.1038/icb.1979.16; Ritz BW, 2008, J NUTR, V138, P2269, DOI 10.3945/jn.108.093633; Robb JR, 2001, J WILDLIFE MANAGE, V65, P755, DOI 10.2307/3803026; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; SHERMAN P, 1985, AM J PHYSIOL, V248, pG418, DOI 10.1152/ajpgi.1985.248.4.G418; Simpson JW, 2005, CONDOR, V107, P898, DOI 10.1650/7739.1; Smirnov A, 2004, J NUTR, V134, P736, DOI 10.1093/jn/134.4.736; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SPRUNT DH, 1956, J EXP MED, V104, P687, DOI 10.1084/jem.104.5.687; Sprunt DH, 1942, J EXP MED, V75, P297, DOI 10.1084/jem.75.3.297; STEPHENSEN CB, 1993, J NUTR, V123, P823, DOI 10.1093/jn/123.5.823; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Wu R, 2007, VET RES COMMUN, V31, P631, DOI 10.1007/s11259-007-3510-x	49	35	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22633	10.1371/journal.pone.0022633	http://dx.doi.org/10.1371/journal.pone.0022633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857940	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500010
J	Lazcano, A				Lazcano, Antonio			Natural History, Microbes and Sequences: Shouldn't We Look Back Again to Organisms?	PLOS ONE			English	Review							CATALOG	The discussion on the existence of prokaryotic species is reviewed. The demonstration that several different mechanisms of genetic exchange and recombination exist has led some to a radical rejection of the possibility of bacterial species and, in general, the applicability of traditional classification categories to the prokaryotic domains. However, in spite of intense gene traffic, prokaryotic groups are not continuously variable but form discrete clusters of phenotypically coherent, well-defined, diagnosable groups of individual organisms. Molecularization of life sciences has led to biased approaches to the issue of the origins of biodiversity, which has resulted in the increasingly extended tendency to emphasize genes and sequences and not give proper attention to organismal biology. As argued here, molecular and organismal approaches that should be seen as complementary and not opposed views of biology.	Univ Nacl Autonoma Mexico, Fac Ciencias, Cd Univ, Mexico	Universidad Nacional Autonoma de Mexico	Lazcano, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Cd Univ, Mexico.	alar@ciencias.unam.mx		Lazcano, Antonio/0000-0001-7365-8557	Universidad Nacional Autonoma de Mexico; UC Mexus Conacyt Foundation; CONACYT Mexico [50520-Q]; DGAPA-UNAM; UC Mexus-CONACYT	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); UC Mexus Conacyt Foundation; CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); UC Mexus-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by the Universidad Nacional Autonoma de Mexico and UC Mexus Conacyt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support from CONACYT Mexico (Project 50520-Q) is gratefully acknowledged. Worked reported here was completed during a sabbatical leave of absence supported in part by DGAPA-UNAM and a UC Mexus-CONACYT Fellowship.	Becerra-Bracho A., 2000, ORIGINS BIG BANG BIO, P135; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hutchinson GE, 1975, TREATISE LIMNOLOGY; Kays R, 2010, BIOL LETTERS, V6, P89, DOI 10.1098/rsbl.2009.0575; Koerner L, 1999, LINNEAUS NATURE NATI; Lazcano A, 2010, COLD SPRING HARBOR P, P1; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mayr E., 1988, NEW PHILOS BIOL, P233; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nuttall GHF, 1904, BLOOD IMMUNITY BLOOD; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Peterson AT, 2010, SYST BIODIVERS, V8, P159, DOI 10.1080/14772001003739369; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Tekaia F, 1999, GENOME RES, V9, P550; TRENCH RK, 1973, PROC R SOC SER B-BIO, V184, P51, DOI 10.1098/rspb.1973.0030; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Whitman WB, 2009, J BACTERIOL, V191, P2000, DOI 10.1128/JB.00962-08; Wilkins JS, 2003, BIOL PHILOS, V18, P621, DOI 10.1023/A:1026390327482; WOESE CR, 1977, J MOL EVOL, V10, P1, DOI 10.1007/BF01796132; Yoon C. K., 2010, NAMING NATURE CLASH; Young D, 1992, DISCOVERY EVOLUTION; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	24	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e21334	10.1371/journal.pone.0021334	http://dx.doi.org/10.1371/journal.pone.0021334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857904	Green Submitted, Green Published, gold			2022-12-27	WOS:000294125500004
J	Favaro, LCD; de Melo, FL; Aguilar-Vildoso, CI; Araujo, WL				de Lima Favaro, Leia Cecilia; de Melo, Fernando Lucas; Aguilar-Vildoso, Carlos Ivan; Araujo, Welington Luiz			Polyphasic Analysis of Intraspecific Diversity in Epicoccum nigrum Warrants Reclassification into Separate Species	PLOS ONE			English	Article							POSTHARVEST BROWN-ROT; FUSARIUM-OXYSPORUM; VEGETATIVE COMPATIBILITY; NATURAL-POPULATIONS; GENETIC-VARIATION; PHOMA-EPICOCCINA; AFLP; PHYLOGENY; PCR; IDENTIFICATION	Background: Epicoccum nigrum Link (syn. E. purpurascens Ehrenb. ex Schlecht) is a saprophytic ascomycete distributed worldwide which colonizes a myriad of substrates. This fungus has been known as a biological control agent for plant pathogens and produces a variety of secondary metabolites with important biological activities as well as biotechnological application. E. nigrum produces darkly pigmented muriform conidia on short conidiophores on sporodochia and is a genotypically and phenotypically highly variable species. Since different isolates identified as E. nigrum have been evaluated as biological control agents and used for biocompound production, it is highly desirable that this species name refers to only one lineage. However, according to morphological and genetic variation, E. nigrum present two genotypes that may comprise more than one species. Methodology/Principal Findings: We report the application of combined molecular (ITS and beta-tubulin gene sequence analysis, PCR-RFLP and AFLP techniques), morphometric, physiological, genetic compatibility and recombination analysis to study the taxonomic relationships within an endophytic population that has been identified as E. nigrum. This combined analysis established two genotypes showing morphological, physiological and genetic divergence as well as genetic incompatibility characterized by colony inhibition, strongly indicating that these genotypes correspond to different species. Genotype 1 corresponds to E. nigrum while genotype 2 represents a new species, referred to in this study as Epicoccum sp. Conclusions/Significance: This research contributes to the knowledge of the Epicoccum genus and asserts that the classification of E. nigrum as a single variable species should be reassessed. In fact, based on the polyphasic approach we suggest the occurrence of cryptic species within E. nigrum and also that many of the sequences deposited as E. nigrum in GenBank and culture collection of microbial strains should be reclassified, including the reference strain CBS 161.73 sequenced in this work. In addition, this study provides valuable tools for differentiation of Epicoccum species.	[de Lima Favaro, Leia Cecilia] Brazilian Agr Res Corp, Empraba Agroenergia, Brasilia, DF, Brazil; [de Melo, Fernando Lucas] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Aguilar-Vildoso, Carlos Ivan] Brazilian Agr Res Corp, Empraba Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil; [Araujo, Welington Luiz] Univ Mogi das Cruzes, Lab Mol Biol & Microbial Ecol, NIB, Sao Paulo, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Mogi das Cruzes	Favaro, LCD (corresponding author), Brazilian Agr Res Corp, Empraba Agroenergia, Brasilia, DF, Brazil.	welingtonluiz@umc.br	DE LIMA FAVARO, LEIA CECILIA/F-7350-2012; Melo, Fernando Lucas/U-6535-2017; Araújo, Welington/G-4905-2012	DE LIMA FAVARO, LEIA CECILIA/0000-0003-3260-0310; Melo, Fernando Lucas/0000-0002-9591-0239; Araújo, Welington/0000-0002-2120-8172	FAPESP (State of Sao Paulo Research Foundation) [2002/14143-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	FAPESP (State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by FAPESP (State of Sao Paulo Research Foundation) (Grant 2002/14143-3). The authors also thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for a doctoral fellowship to LCLF (Graduate Program in Plant Genetics and Breeding, "Luiz de Queiroz" College of Agriculture, University of Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Lateff A, 2003, PLANTA MED, V69, P831, DOI 10.1055/s-2003-43209; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; APPEL DJ, 1995, EXP MYCOL, V19, P120, DOI 10.1006/emyc.1995.1014; Arenal F, 2004, MYCOTAXON, V89, P465; Arenal F, 2000, MYCOL RES, V104, P301, DOI 10.1017/S0953756299001537; Arenal F, 2002, J APPL MICROBIOL, V93, P36, DOI 10.1046/j.1365-2672.2002.01654.x; Arenal F, 1999, J APPL MICROBIOL, V87, P898, DOI 10.1046/j.1365-2672.1999.00946.x; Arie T, 2000, MOL PLANT MICROBE IN, V13, P1330, DOI 10.1094/MPMI.2000.13.12.1330; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Aveskamp MM, 2009, MYCOLOGIA, V101, P363, DOI 10.3852/08-199; Baayen RP, 2000, PHYTOPATHOLOGY, V90, P891, DOI 10.1094/PHYTO.2000.90.8.891; BAMFORD PHILIP C., 1961, TRANS BRIT MYCOL SOC, V44, P354; BAUTE MA, 1978, J ANTIBIOT, V31, P1099, DOI 10.7164/antibiotics.31.1099; Bell PJL, 2003, J AM CHEM SOC, V125, P9304, DOI 10.1021/ja035496+; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bruns TD, 2001, MYCOLOGIA S, V52; BRUTON BD, 1993, PLANT DIS, V77, P1060, DOI 10.1094/PD-77-1060; Favaro LCD, 2007, MYCOL RES, V111, P93, DOI 10.1016/j.mycres.2006.08.008; Coghlan DR, 2005, ORG LETT, V7, P2401, DOI 10.1021/ol050665b; Collado-Romero M, 2008, PHYTOPATHOLOGY, V98, P1019, DOI 10.1094/PHYTO-98-9-1019; Craven KD, 2008, EUKARYOT CELL, V7, P675, DOI 10.1128/EC.00423-07; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; De Cal A, 2009, J APPL MICROBIOL, V106, P592, DOI 10.1111/j.1365-2672.2008.04030.x; De Gruyter J, 2009, MYCOL RES, V113, P508, DOI 10.1016/j.mycres.2009.01.002; Douhan GW, 2008, MOL ECOL, V17, P2276, DOI 10.1111/j.1365-294X.2008.03753.x; Douhan GW, 2007, CURR GENET, V52, P191, DOI 10.1007/s00294-007-0150-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIS DH, 1978, T BRIT MYCOL SOC, V70, P170, DOI 10.1016/S0007-1536(78)80195-8; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; FREDERICK CB, 1981, BIOCHEMISTRY-US, V20, P2432, DOI 10.1021/bi00512a010; Garcia RA, 2002, MOL ECOL, V11, P355, DOI 10.1046/j.0962-1083.2001.01456.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Goloboff P, 2008, CLADISTICS, V24, P91; Guo HJ, 2009, J NAT PROD, V72, P2115, DOI 10.1021/np900654a; HANKIN L, 1975, MYCOLOGIA, V67, P597, DOI 10.2307/3758395; Hashem M., 2004, Archives of Phytopathology and Plant Protection, V37, P283, DOI 10.1080/03235400310001612955; HAWKSWORTH DL, 1995, AINSWORTH BISBYS DIC; IKAWA M, 1978, J ANTIBIOT, V31, P159, DOI 10.7164/antibiotics.31.159; Immanuel VY, 1996, WINBOOT PROGRAM PERF; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Jo YK, 2008, PHYTOPATHOLOGY, V98, P108, DOI 10.1094/PHYTO-98-1-0108; Kanai A, 2007, CHEM PHARM BULL, V55, P495, DOI 10.1248/cpb.55.495; Wangun HVK, 2007, ORG BIOMOL CHEM, V5, P1702, DOI 10.1039/b702378b; KILPATRICK JA, 1981, T BRIT MYCOL SOC, V77, P497, DOI 10.1016/S0007-1536(81)80097-6; Koopman WJM, 2008, AM J BOT, V95, P353, DOI 10.3732/ajb.95.3.353; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kueck Ulrich, 2009, Fungal Biology Reviews, V23, P86, DOI 10.1016/j.fbr.2009.10.004; Larena I, 2005, BIOL CONTROL, V32, P305, DOI 10.1016/j.biocontrol.2004.10.010; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lumbsch HT, 2008, MYCOL RES, V112, P423, DOI 10.1016/j.mycres.2008.02.002; Mari M, 2007, J SCI FOOD AGR, V87, P1271, DOI 10.1002/jsfa.2839; Milgroom MG, 2009, FUNGAL GENET BIOL, V46, P849, DOI 10.1016/j.fgb.2009.07.007; Mims CW, 2005, CAN J BOT, V83, P1354, DOI 10.1139/b05-137; Mishra PK, 2002, FEMS MICROBIOL LETT, V215, P291, DOI 10.1111/j.1574-6968.2002.tb11405.x; Moy M, 2000, SYMBIOSIS, V28, P291; Moy M, 2002, PLANT PHYSIOL, V130, P1298, DOI 10.1104/pp.010108; Murillo C, 2009, MYCOL RES, V113, P405, DOI 10.1016/j.mycres.2008.09.003; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pazoutova Sylvie, 2003, Czech Mycology, V54, P155; Pieckenstain FL, 2001, MYCOL RES, V105, P77, DOI 10.1017/S0953756200003129; Pimentel G, 2000, PHYTOPATHOLOGY, V90, P376, DOI 10.1094/PHYTO.2000.90.4.376; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Promputtha I, 2010, FUNGAL DIVERS, V41, P89, DOI 10.1007/s13225-010-0024-6; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Romao AS, 2007, MICOLOGIA AVANCOS CO, P150; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossman AY, 2008, PLANT DIS, V92, P1376, DOI 10.1094/PDIS-92-10-1376; Schneider S., 2000, ARLEQUIN VER 2 000 S; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; SCHOL-SCHWARZ M. BEATRICE, 1959, TRANS BRIT MYCOL SOC, V42, P149; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Seidl V, 2009, P NATL ACAD SCI USA, V106, P13909, DOI 10.1073/pnas.0904936106; Shu YZ, 1997, BIOORG MED CHEM LETT, V7, P2295, DOI 10.1016/S0960-894X(97)00407-1; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wangun HVK, 2008, EUR J ORG CHEM, V2008, P3781, DOI 10.1002/ejoc.200800447; Wangun HVK, 2007, J NAT PROD, V70, P1800, DOI 10.1021/np070245q; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhang Y, 2009, STUD MYCOL, P85, DOI 10.3114/sim.2009.64.04; Zhang YG, 2007, J NAT PROD, V70, P1522, DOI 10.1021/np070239u	93	33	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e14828	10.1371/journal.pone.0014828	http://dx.doi.org/10.1371/journal.pone.0014828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853017	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400002
J	Rojo, DR; Prough, DS; Falduto, MT; Boone, DR; Micci, MA; Kahrig, KM; Crookshanks, JM; Jimenez, A; Uchida, T; Cowart, JC; Hawkins, BE; Avila, M; DeWitt, DS; Hellmich, HL				Rojo, Daniel R.; Prough, Donald S.; Falduto, Michael T.; Boone, Deborah R.; Micci, Maria-Adelaide; Kahrig, Kristen M.; Crookshanks, Jeanna M.; Jimenez, Arnaldo; Uchida, Tatsuo; Cowart, Jeremy C.; Hawkins, Bridget E.; Avila, Marcela; DeWitt, Douglas S.; Hellmich, Helen L.			Influence of Stochastic Gene Expression on the Cell Survival Rheostat after Traumatic Brain Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FLUORO-JADE; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; MOLECULAR NETWORKS; MOUSE MODEL; HEAD-INJURY; DISEASE; DEATH; NEURONS	Experimental evidence suggests that random, spontaneous (stochastic) fluctuations in gene expression have important biological consequences, including determination of cell fate and phenotypic variation within isogenic populations. We propose that fluctuations in gene expression represent a valuable tool to explore therapeutic strategies for patients who have suffered traumatic brain injury (TBI), for which there is no effective drug therapy. We have studied the effects of TBI on the hippocampus because TBI survivors commonly suffer cognitive problems that are associated with hippocampal damage. In our previous studies we separated dying and surviving hippocampal neurons by laser capture microdissection and observed unexplainable variations in post-TBI gene expression, even though dying and surviving neurons were adjacent and morphologically identical. We hypothesized that, in hippocampal neurons that subsequently are subjected to TBI, randomly increased pre-TBI expression of genes that are associated with neuroprotection predisposes neurons to survival; conversely, randomly decreased expression of these genes predisposes neurons to death. Thus, to identify genes that are associated with endogenous neuroprotection, we performed a comparative, high-resolution transcriptome analysis of dying and surviving hippocampal neurons in rats subjected to TBI. We found that surviving hippocampal neurons express a distinct molecular signature - increased expression of networks of genes that are associated with regeneration, cellular reprogramming, development, and synaptic plasticity. In dying neurons we found decreased expression of genes in those networks. Based on these data, we propose a hypothetical model in which hippocampal neuronal survival is determined by a rheostat that adds injury-induced genomic signals to expression of pro-survival genes, which pre-TBI varies randomly and spontaneously from neuron to neuron. We suggest that pharmacotherapeutic strategies that co-activate multiple survival signals and enhance self-repair mechanisms have the potential to shift the cell survival rheostat to favor survival and therefore improve functional outcome after TBI.	[Rojo, Daniel R.; Prough, Donald S.; Boone, Deborah R.; Micci, Maria-Adelaide; Kahrig, Kristen M.; Crookshanks, Jeanna M.; Uchida, Tatsuo; Cowart, Jeremy C.; Hawkins, Bridget E.; Avila, Marcela; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Falduto, Michael T.] GenUs BioSyst, Northbrook, IL USA; [Jimenez, Arnaldo] Vel Lab Res, Missouri City, TX USA	University of Texas System; University of Texas Medical Branch Galveston	Rojo, DR (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013; Hawkins, Bridget/H-4933-2015	Prough, Donald S/0000-0001-7994-532X; Hawkins, Bridget/0000-0002-1887-3657	National Institutes of Health [RO1 NS052532]; Moody Foundation; Department of Anesthesiology, University of Texas Medical Branch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moody Foundation; Department of Anesthesiology, University of Texas Medical Branch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institutes of Health, RO1 NS052532 (to H.L.H), by a grant from the Moody Foundation and the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bast T, 2007, REV NEUROSCIENCE, V18, P253; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Benekareddy M, 2008, SYNAPSE, V62, P590, DOI 10.1002/syn.20529; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fontan- Lozano A, 2008, MOL NEUROBIOL, V27; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fraser D, 2009, MOL MICROBIOL, V71, P1333, DOI 10.1111/j.1365-2958.2009.06605.x; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim CM, 2009, J NEUROSCI RES, V87, P1037, DOI 10.1002/jnr.21899; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Nagy Z, 2000, NEUROBIOL AGING, V21, P761, DOI 10.1016/S0197-4580(00)00223-2; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Paizanis E, 2007, NEUROCHEM RES, V32, P1762, DOI 10.1007/s11064-007-9330-0; Palacios-Pelaez R, 2010, MOL NEUROBIOL, V41, P367, DOI 10.1007/s12035-010-8139-z; Papa L, 2009, CRIT CARE MED; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Roberge MC, 2008, NEUROSCIENCE, V156, P11, DOI 10.1016/j.neuroscience.2008.05.062; SAS Institute Inc, 2004, SAS STAT US GUID VER; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seo SY, 2004, J BIOL CHEM, V279, P42240, DOI 10.1074/jbc.M406775200; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weinreb O, 2009, NEUROTHERAPEUTICS, V6, P163, DOI 10.1016/j.nurt.2008.10.030; Winship IR, 2008, J NEUROSCI, V28, P6592, DOI 10.1523/JNEUROSCI.0622-08.2008; Ye XM, 2001, BRAIN RES PROTOC, V8, P104, DOI 10.1016/S1385-299X(01)00086-1; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	86	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23111	10.1371/journal.pone.0023111	http://dx.doi.org/10.1371/journal.pone.0023111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853077	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953400028
J	Krabberod, AK; Brate, J; Dolven, JK; Ose, RF; Klaveness, D; Kristensen, T; Bjorklund, KR; Shalchian-Tabrizi, K				Krabberod, Anders K.; Brate, Jon; Dolven, Jane K.; Ose, Randi F.; Klaveness, Dag; Kristensen, Tom; Bjorklund, Kjell R.; Shalchian-Tabrizi, Kamran			Radiolaria Divided into Polycystina and Spasmaria in Combined 18S and 28S rDNA Phylogeny	PLOS ONE			English	Article							STRONTIUM SULFATE CRYSTALS; STICHOLONCHE-ZANCLEA; EUKARYOTIC DIVERSITY; ACANTHARIA PROTOZOA; HAECKELS RADIOLARIA; SMALL-SUBUNIT; MIXED MODELS; CLASSIFICATION; CERCOZOA; SEQUENCES	Radiolarians are marine planktonic protists that belong to the eukaryote supergroup Rhizaria together with Foraminifera and Cercozoa. Radiolaria has traditionally been divided into four main groups based on morphological characters; i.e. Polycystina, Acantharia, Nassellaria and Phaeodaria. But recent 18S rDNA phylogenies have shown that Phaeodaria belongs within Cerocozoa, and that the previously heliozoan group Taxopodida should be included in Radiolaria. 18S rDNA phylogenies have not yet resolved the sister relationship between the main Radiolaria groups, but nevertheless suggests that Spumellaria, and thereby also Polycystina, are polyphyletic. Very few sequences other than 18S rDNA have so far been generated from radiolarian cells, mostly due to the fact that Radiolaria has been impossible to cultivate and single cell PCR has been hampered by low success rate. Here we have therefore investigated the mutual evolutionary relationship of the main radiolarian groups by using the novel approach of combining single cell whole genome amplification with targeted PCR amplification of the 18S and 28S rDNA genes. Combined 18S and 28S phylogeny of sequences obtained from single cells shows that Radiolaria is divided into two main lineages: Polycystina (Spumellaria+Nassellaria) and Spasmaria (Acantharia+Taxopodida). Further we show with high support that Foraminifera groups within Radiolaria supporting the Retaria hypothesis.	[Krabberod, Anders K.; Brate, Jon; Klaveness, Dag; Kristensen, Tom; Bjorklund, Kjell R.; Shalchian-Tabrizi, Kamran] Univ Oslo, Dept Biol, MERG, Oslo, Norway; [Bjorklund, Kjell R.] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Ose, Randi F.; Kristensen, Tom] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Dolven, Jane K.] Univ Oslo, Dept Geosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Krabberod, AK (corresponding author), Univ Oslo, Dept Biol, MERG, Oslo, Norway.	Kamran@bio.uio.no	Bråte, Jon/P-3939-2014; Kristensen, Tom/C-5873-2019	Bråte, Jon/0000-0003-0490-1175; Kristensen, Tom/0000-0002-2131-4469; Krabberod, Anders Kristian/0000-0001-9481-8396	Norwegian Research Council; UiO	Norwegian Research Council(Research Council of NorwayEuropean Commission); UiO	This work has been founded by grants from the Norwegian Research Council to KRB and UiO grants to KS-T and JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON OR, 1990, PHILOS T ROY SOC B, V329, P81, DOI 10.1098/rstb.1990.0152; Anderson R.O., 1983, RADIOLARIA; Bass D, 2005, PROTIST, V156, P149, DOI 10.1016/j.protis.2005.03.001; Berney C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-13; BURKI F, 2010, BMC EVOLUTIONARY BIO; CACHON J, 1977, J CELL BIOL, V72, P314, DOI 10.1083/jcb.72.2.314; CACHON J, 1978, ARCH PROTISTENKD, V120, P148, DOI 10.1016/S0003-9365(78)80019-0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Chantangsi C, 2010, MOL PHYLOGENET EVOL, V57, P518, DOI 10.1016/j.ympev.2010.07.007; De Wever P., 2001, RADIOLARIANS SEDIMEN; Dolven JK, 2007, PROTIST, V158, P65, DOI 10.1016/j.protis.2006.07.004; FEBVRE J, 1989, BIOL CELL, V67, P251, DOI 10.1016/0248-4900(89)90062-2; FEBVRE J, 1981, BIOSYSTEMS, V14, P327, DOI 10.1016/0303-2647(81)90039-3; Gilg IC, 2010, PROTIST, V161, P197, DOI 10.1016/j.protis.2009.09.002; Guillard RRL, 1973, HDB PHYCOLOGICAL MET, P69; HAECKEL E, 1887, REPORT SCI RESULTS V, P1; HUGHES NP, 1989, PROC R SOC SER B-BIO, V238, P223, DOI 10.1098/rspb.1989.0078; Keeling PJ, 2001, MOL BIOL EVOL, V18, P1551, DOI 10.1093/oxfordjournals.molbev.a003941; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; KUNITOMO Y, 2006, EUROPEAN J PROTISTOL, V42; LEVINE ND, 1980, J PROTOZOOL, V27, P37, DOI 10.1111/j.1550-7408.1980.tb04228.x; Longet D, 2003, INT J SYST EVOL MICR, V53, P1735, DOI 10.1099/ijs.0.02597-0; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Maddison W., 2018, MESQUITE MODULAR SYS; Marande W, 2009, ENVIRON MICROBIOL, V11, P3179, DOI 10.1111/j.1462-2920.2009.02023.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Spiess AN, 2004, CLIN CHEM, V50, P1256, DOI 10.1373/clinchem.2004.031336; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takahashi Osamu, 2004, Revue de Micropaleontologie, V47, P111, DOI 10.1016/j.revmic.2004.06.002; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Yuasa T, 2006, MAR MICROPALEONTOL, V59, P104, DOI 10.1016/j.marmicro.2006.01.003; Yuasa T, 2005, EUR J PROTISTOL, V41, P287, DOI 10.1016/j.ejop.2005.06.001; Yuasa T., 2004, JAP J PROTOZOOL, V37, P133; Yuasa T, 2009, MAR MICROPALEONTOL, V73, P129, DOI 10.1016/j.marmicro.2009.08.001; Zettler LA, 1997, P NATL ACAD SCI USA, V94, P11411, DOI 10.1073/pnas.94.21.11411; Zettler LAA, 1999, MAR MICROPALEONTOL, V36, P67, DOI 10.1016/S0377-8398(98)00028-0; [No title captured]	49	36	39	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23526	10.1371/journal.pone.0023526	http://dx.doi.org/10.1371/journal.pone.0023526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853146	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200094
J	Kumar, S; Bose, D; Suryawanshi, H; Sabharwal, H; Mapa, K; Maiti, S				Kumar, Santosh; Bose, Debojit; Suryawanshi, Hemant; Sabharwal, Harshana; Mapa, Koyeli; Maiti, Souvik			Specificity of RSG-1.2 Peptide Binding to RRE-IIB RNA Element of HIV-1 over Rev Peptide Is Mainly Enthalpic in Origin	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR EXPORT SIGNAL; DRUG-DNA INTERACTIONS; RESPONSE ELEMENT; GENE-EXPRESSION; MESSENGER-RNAS; RIBOSOMAL-RNA; STRUCTURAL-ANALYSIS; COMPLEX-FORMATION; ALPHA-HELIX	Rev is an essential HIV-1 regulatory protein which binds to the Rev responsive element (RRE) present within the env gene of HIV-1 RNA genome. This binding facilitates the transport of the RNA to the cytoplasm, which in turn triggers the switch between viral latency and active viral replication. Essential components of this complex have been localized to a minimal arginine rich Rev peptide and stem IIB region of RRE. A synthetic peptide known as RSG-1.2 binds with high binding affinity and specificity to the RRE-IIB than the Rev peptide, however the thermodynamic basis of this specificity has not yet been addressed. The present study aims to probe the thermodynamic origin of this specificity of RSG-1.2 over Rev Peptide for RRE-IIB. The temperature dependent melting studies show that RSG-1.2 binding stabilizes the RRE structure significantly (Delta T(m) = 4.3 degrees C), in contrast to Rev binding. Interestingly the thermodynamic signatures of the binding have also been found to be different for both the peptides. At pH 7.5, RSG-1.2 binds RRE-IIB with a K(a) = 16.2 +/- 0.6x10(-7) M(-1) where enthalpic change Delta H = -13.9 +/- 0.1 kcal/mol is the main driving force with limited unfavorable contribution from entropic change T Delta S = -2.8 +/- 0.1 kcal/mol. A large part of Delta H may be due to specific stacking between U72 and Arg15. In contrast binding of Rev (K(a) = 3.1 +/- 0.4x10(-7) M(-1)) is driven mainly by entropy (Delta H = 0 kcal/mol and T Delta S = 10.2 +/- 0.2 kcal/mol) which arises from major conformational changes in the RNA upon binding.	[Kumar, Santosh; Bose, Debojit; Suryawanshi, Hemant; Sabharwal, Harshana; Mapa, Koyeli; Maiti, Souvik] Inst Genom & Integrat Biol, CSIR, Prote & Struct Biol Unit, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Kumar, S (corresponding author), Inst Genom & Integrat Biol, CSIR, Prote & Struct Biol Unit, Delhi, India.	souvik@igib.res.in	Bose, Debojit/GRS-0554-2022; Kumar, Santosh/ABF-3590-2021; Bose, Debojit/H-9375-2019	Bose, Debojit/0000-0002-6862-3007; Kumar, Santosh/0000-0002-3594-4795; , Hemant/0000-0002-8102-9678	Council for Scientific and Industrial Research (CSIR) [NWP 0036]	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	SM acknowledges Council for Scientific and Industrial Research (CSIR, Project Title: NWP 0036). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIGO SJ, 1990, J VIROL, V64, P4585, DOI 10.1128/JVI.64.9.4585-4588.1990; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Barbieri CM, 2007, TETRAHEDRON, V63, P3567, DOI 10.1016/j.tet.2006.08.107; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; DAGOSTINO DM, 1992, MOL CELL BIOL, V12, P1375, DOI 10.1128/MCB.12.3.1375; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P10497, DOI 10.1021/bi00090a028; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; DELLING U, 1991, P NATL ACAD SCI USA, V88, P6234, DOI 10.1073/pnas.88.14.6234; EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025; Fischer U, 1999, NUCLEIC ACIDS RES, V27, P4128, DOI 10.1093/nar/27.21.4128; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; FURTADO MR, 1991, VIROLOGY, V185, P258, DOI 10.1016/0042-6822(91)90773-5; GAIT MJ, 1993, TRENDS BIOCHEM SCI, V18, P255, DOI 10.1016/0968-0004(93)90176-N; Gosser Y, 2001, NAT STRUCT BIOL, V8, P146, DOI 10.1038/84138; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; Haq I, 1997, J MOL BIOL, V271, P244, DOI 10.1006/jmbi.1997.1170; Haq I, 2000, METHOD ENZYMOL, V323, P373; Harada K, 1997, P NATL ACAD SCI USA, V94, P11887, DOI 10.1073/pnas.94.22.11887; HEAPHY S, 1991, P NATL ACAD SCI USA, V88, P7366, DOI 10.1073/pnas.88.16.7366; HOPE T, 1995, CURR TOP MICROBIOL, V193, P91; Indyk L, 1998, METHOD ENZYMOL, V295, P350; IWAI S, 1992, NUCLEIC ACIDS RES, V20, P6465, DOI 10.1093/nar/20.24.6465; Kingsman SM, 1996, EUR J BIOCHEM, V240, P491, DOI 10.1111/j.1432-1033.1996.0491h.x; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Luque I, 2002, PROTEINS, V49, P181, DOI 10.1002/prot.10208; MALIM MH, 1993, MOL CELL BIOL, V13, P6180, DOI 10.1128/MCB.13.10.6180; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; MARKY LA, 1983, BIOPOLYMERS, V22, P1247, DOI 10.1002/bip.360220416; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Mazur S, 2000, J MOL BIOL, V300, P321, DOI 10.1006/jmbi.2000.3869; Michael LA, 2009, J MOL BIOL, V392, P774, DOI 10.1016/j.jmb.2009.07.047; Nekhai S, 2006, FUTURE MICROBIOL, V1, P417, DOI 10.2217/17460913.1.4.417; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SHARP KA, 2000, THERMODYNAMICS BIOL, P113; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Suryawanshi H, 2010, J PHYS CHEM B, V114, P11155, DOI 10.1021/jp1000545; TAN RY, 1994, BIOCHEMISTRY-US, V33, P14579, DOI 10.1021/bi00252a025; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; Yedavalli VSRK, 2011, RNA BIOL, V8, P195, DOI 10.4161/rna.8.2.14803; Zhang Q, 2001, CHEM BIOL, V8, P511, DOI 10.1016/S1074-5521(01)00027-8	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23300	10.1371/journal.pone.0023300	http://dx.doi.org/10.1371/journal.pone.0023300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853108	Green Submitted, gold, Green Published			2022-12-27	WOS:000295454200068
J	Sher, RB; Cox, GA; Mills, KD; Sundberg, JP				Sher, Roger B.; Cox, Gregory A.; Mills, Kevin D.; Sundberg, John P.			Rhabdomyosarcomas in Aging A/J Mice	PLOS ONE			English	Article							ALVEOLAR RHABDOMYOSARCOMA; MYOGENIC DIFFERENTIATION; MOLECULAR PATHOGENESIS; SATELLITE CELLS; MUTANT MICE; DEFICIENCY; GENE; INACTIVATION; CHILDHOOD; PAX3	Rhabdomyosarcomas (RSCs) are skeletal muscle neoplasms found in humans and domestic mammals. The A/J inbred strain developed a high frequency (between 70-80%) of adult pleomorphic type (APT) RSC at.20 months of age while BALB/cByJ also develop RSC but less frequently. These neoplasms invaded skeletal muscle surrounding either the axial or proximal appendicular skeleton and were characterized by pleomorphic cells with abundant eosinophilic cytoplasm, multiple nuclei, and cross striations. The diagnosis was confirmed by detection of alpha-sarcomeric actin and myogenin in the neoplastic cells using immunocytochemistry. The A/J strain, but not the related BALB/c substrains, is also characterised by a progressive muscular dystrophy homologous to limb-girdle muscular dystrophy type 2B. The association between the development of RSC in similar muscle groups to those most severely affected by the progressive muscular dystrophy suggested that these neoplasms developed from abnormal regeneration of the skeletal muscle exacerbated by the dysferlin mutation. Transcriptome analyses of RSCs revealed marked downregulation of genes in muscular development and function signaling networks. Non-synonymous coding SNPs were found in Myl1, Abra, Sgca, Ttn, and Kcnj12 suggesting these may be important in the pathogenesis of RSC. These studies suggest that A strains of mice can be useful models for dissecting the molecular genetic basis for development, progression, and ultimately for testing novel anticancer therapeutic agents dealing with rhabdomyosarcoma.	[Sher, Roger B.; Cox, Gregory A.; Mills, Kevin D.; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Sher, RB (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	john.sundberg@jax.org			NCI NIH HHS [CA089713, R01 CA089713, P30 CA034196, CA34196] Funding Source: Medline; NIA NIH HHS [AG25707, P30 AG038070, P30 AG025707] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196, R01CA089713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038070, P30AG025707] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Asakura A, 2003, CANCER CELL, V4, P421, DOI 10.1016/S1535-6108(03)00313-1; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; BOOTH C, 1996, PATHOBIOLOGY AGING M, P51; Brodie SG, 2001, ONCOGENE, V20, P1445, DOI 10.1038/sj.onc.1204222; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; De Bortoli M, 2007, EUR J CANCER, V43, P1308, DOI 10.1016/j.ejca.2007.02.008; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; Ecke I, 2009, CANCER RES, V69, P887, DOI 10.1158/0008-5472.CAN-08-0946; Fernandez K, 2010, AM J PATHOL, V176, P416, DOI 10.2353/ajpath.2010.090405; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hawkins WG, 2001, CANCER-AM CANCER SOC, V91, P794, DOI 10.1002/1097-0142(20010215)91:4<794::AID-CNCR1066>3.0.CO;2-Q; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Huh Michael S., 2005, Birth Defects Research, V75, P180, DOI 10.1002/bdrc.20045; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Jahnke VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008637; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; KRAMER S, 1983, J NATL CANCER I, V70, P49; Kumar S, 2000, MODERN PATHOL, V13, P988, DOI 10.1038/modpathol.3880179; Li HG, 2007, CANCER LETT, V253, P215, DOI 10.1016/j.canlet.2007.01.020; Maas SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-132; Mercado GE, 2007, CURR MOL MED, V7, P47, DOI 10.2174/156652407779940440; Nanni P, 2003, CANCER RES, V63, P2728; Nanni P, 2009, MOL CANCER THER, V8, P754, DOI 10.1158/1535-7163.MCT-08-0678; Ognjanovic S, 2009, CANCER-AM CANCER SOC, V115, P4218, DOI 10.1002/cncr.24465; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Sabbioni S, 1997, CANCER RES, V57, P4493; SEYMOUR R, 2004, NECROPSY METHODS, P495; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; STEWART HL, 1959, PATHOLOGYAFIO, P83; Sundberg J. P., 2005, HDB GENETICALLY ENG, P223; Sundberg JP, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7179; SUNDBERG JP, 1991, VET PATHOL, V28, P200, DOI 10.1177/030098589102800303; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Tiffin N, 2003, BRIT J CANCER, V89, P327, DOI 10.1038/sj.bjc.6601040; Tsumura H, 2006, ONCOGENE, V25, P7673, DOI 10.1038/sj.onc.1209749; WANEBO HJ, 1966, SCIENCE, V154, P901, DOI 10.1126/science.154.3751.901; Wang ZQ, 2007, EXP MOL PATHOL, V82, P58, DOI 10.1016/j.yexmp.2006.09.004; Xia SJJ, 2002, CANCER BIOL THER, V1, P97, DOI 10.4161/cbt.51; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zibat A, 2009, CARCINOGENESIS, V30, P918, DOI 10.1093/carcin/bgp068	47	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23498	10.1371/journal.pone.0023498	http://dx.doi.org/10.1371/journal.pone.0023498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853140	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200089
J	Coll-Llado, M; Acinas, SG; Pujades, C; Pedros-Alio, C				Coll-Llado, Montserrat; Acinas, Silvia G.; Pujades, Cristina; Pedros-Alio, Carlos			Transcriptome Fingerprinting Analysis: An Approach to Explore Gene Expression Patterns in Marine Microbial Communities	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; INTERGENIC SPACER ANALYSIS; DIFFERENTIAL DISPLAY; MESSENGER-RNA; DIVERSITY; BACTERIOPLANKTON; OCEAN; ASSEMBLAGES; TARGET; DGGE	Microbial transcriptomics are providing new insights into the functional processes of microbial communities. However, analysis of each sample is still expensive and time consuming. A rapid and low cost method that would allow the identification of the most interesting samples for posterior in-depth metatranscriptomics analysis would be extremely useful. Here we present Transcriptome Fingerprinting Analysis (TFA) as an approach to fulfill this objective in microbial ecology studies. We have adapted the differential display technique for mRNA fingerprinting based on the PCR amplification of expressed transcripts to interrogate natural microbial eukaryotic communities. Unlike other techniques, TFA does not require prior knowledge of the mRNA sequences to be detected. We have used a set of arbitrary primers coupled with a fluorescence labeled primer targeting the poly(A) tail of the eukaryotic mRNA, with further detection of the resulting labeled cDNA products in an automated genetic analyzer. The output represented by electropherogram peak patterns allowed the comparison of a set of genes expressed at the time of sampling. TFA has been optimized by testing the sensitivity of the method for different initial RNA amounts, and the repeatability of the gene expression patterns with increasing time after sampling both with cultures and environmental samples. Results show that TFA is a promising approach to explore the dynamics of gene expression patterns in microbial communities.	[Coll-Llado, Montserrat; Acinas, Silvia G.; Pedros-Alio, Carlos] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Spain; [Pujades, Cristina] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Pompeu Fabra University	Coll-Llado, M (corresponding author), CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Spain.	cpedros@icm.csic.es	Pedrós-Alió, Carlos/H-1222-2011; Acinas, Silvia/F-7462-2016; Pujades, Cristina/F-7908-2014	Pedrós-Alió, Carlos/0000-0003-1009-4277; Acinas, Silvia/0000-0002-3439-0428; Pujades, Cristina/0000-0001-6423-7451; Coll-Llado, Montserrat/0000-0003-0169-4107	Spanish Ministry of Science and Innovation [CTM2007-63753-C02-01/MAR]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MC-L was the recipient of an FPI fellowship from the Spanish Ministry of Science and Innovation. This work was funded by grant GEMMA (CTM2007-63753-C02-01/MAR) from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 1997, FEMS MICROBIOL ECOL, V24, P27, DOI 10.1111/j.1574-6941.1997.tb00420.x; BROOKS EM, 1995, BIOTECHNIQUES, V19, P806; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Diez B, 2004, LIMNOL OCEANOGR, V49, P1022; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hewson I, 2010, ENVIRON MICROBIOL, V12, P1940, DOI 10.1111/j.1462-2920.2010.02198.x; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lo PK, 1999, ONCOGENE, V18, P7765, DOI 10.1038/sj.onc.1203167; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Olson R.J., 2018, HDB METHODS AQUATIC, P175, DOI DOI 10.1201/9780203752746; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; PORETSKY RS, 2009, JOVE-J VIS EXP, DOI DOI 10.3791/1086; Riemann L, 1999, DEEP-SEA RES PT II, V46, P1791, DOI 10.1016/S0967-0645(99)00044-2; Schauer M, 2000, FEMS MICROBIOL ECOL, V33, P51, DOI 10.1111/j.1574-6941.2000.tb00726.x; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tan S S, 1992, PCR Methods Appl, V2, P137; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; van Hannen EJ, 1998, J PHYCOL, V34, P206, DOI 10.1046/j.1529-8817.1998.340206.x	33	3	3	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22950	10.1371/journal.pone.0022950	http://dx.doi.org/10.1371/journal.pone.0022950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857972	Green Published, gold			2022-12-27	WOS:000293774300013
J	Kokolo, MB; Fergusson, DA; Cameron, DW				Kokolo, Madzouka B.; Fergusson, Dean A.; Cameron, D. William			HIV Pre-Exposure Prophylaxis (PrEP)-A Quantitative Ethics Appraisal	PLOS ONE			English	Article							PREVENTION; TRIAL; TRANSMISSION; AFRICA; IMPACT	Background: There is now strong evidence that preventive oral antiretroviral therapy can moderately reduce likelihood of HIV infection. This concept is called HIV pre-exposure prophylaxis (PrEP). Premature closures of some previous PrEP clinical trials, secondary to ethical concerns, did not stop research. We aimed to appraise the extent of ethics considerations reporting in PrEP study documents. Methods: We conducted a systematic quantitative ethics appraisal, grounded in PrEP literature and using eight principles proposed by Ezechiel Emanuel. We developed an a priori checklist of 101 evidence-based ethics items. We obtained protocols for eleven of nineteen clinical controlled studies identified. Two reviewers independently appraised study documents against the checklist. Ethics appraisal was synthesized using adjusted percentages of items reported. Results: On average, 58% of the 101 ethics items were mentioned or addressed in documents, with variations noted both across studies and across principles. Considerations pertaining to social value were least reported (43% of checklist items, on average) whereas considerations related to informed consent and favorable risk-benefit ratio were most reported (75% of checklist items, on average). Discussion: Some PrEP studies reportedly address more ethics considerations than others but, overall, ethics considerations reporting could be much improved. While this review does not allow us to comment on the actual execution of HIV PrEP trials, it is a reminder that optimism generated by potentially effective interventions should not overshadow the importance of ethics in research design and development. Improving ethics reporting might improve the perceived value of PrEP research and subsequent data.	[Kokolo, Madzouka B.; Fergusson, Dean A.; Cameron, D. William] Ottawa Hosp, Res Inst, Clin Epidemiol Programme, Ottawa, ON, Canada; [Fergusson, Dean A.; Cameron, D. William] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Kokolo, MB (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Programme, Ottawa, ON, Canada.	mkokolo@ohri.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Fergusson, Dean/0000-0002-3389-2485	University of Ottawa; Ontario Ministry of Health/Ontario HIV Treatment Network; Ottawa Hospital Research Institute	University of Ottawa; Ontario Ministry of Health/Ontario HIV Treatment Network(Ministry of Health and Long-Term Care, Ontario); Ottawa Hospital Research Institute	This study started as a graduate thesis project and, as such, a thesis proposal required initial approval by the University of Ottawa, from which MK received a scholarship. DWC is supported as a Career Scientist of the Ontario Ministry of Health/Ontario HIV Treatment Network. However, he received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; This study started as a graduate thesis project by Madzouka Kokolo, who received a scholarship from the University of Ottawa and a fellow stipend from the Ottawa Hospital Research Institute. These do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No other funding was specifically received for this study.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Anton P, 2009, 2 SITE PHASE 1 PARTI, V1; Anton P, 2010, NCT00984971; Aschengrau A, 2008, ESSENTIALS EPIDEMIOL; AVAC, 2008, ANT RES PREP TRIALS; Celum C, 2008, NCT00557245; Celum CL, 2007, PARALLEL COMP TENOFO, V3. 0; Center for Disease Control and Prevention (CDC), 2007, Q A CDCS CLIN STUD P; Center for Disease Control and Prevention (CDC), 2009, STAT BOTSW TDF2 STUD; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chillag K, 2007, NCT00131677; Chirenje Z, 2009, NCT00705679; Chirenje Z, 2008, PHASE 2B SAFETY EFFE, V1. 0; Choopanya K, 2008, NCT00119106; Choopanya K, 2007, STUDY SAFETY EFFICAC, V7; DAIDS Regulatory Affairs Board, 2004, INF CONS FORM HOP WO, V1; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; . Family Health International ( FHI), 2008, ENR CONS FORM, V1. 0; Family Health International (FHI), 2004, ENR CONS FORM, V2; Global Campaign for Microbicides, 2006, RES RASH LESS CAM PR; Global Campaign for Microbicides Global, PREV PREV TRIAL FAIL; Grant R, 2008, CHEMOPROPHYLAXIS HIV, V4; Grant R, 2008, SAMPLE CONSENT ENROL, V4. 0; Grant R, 2010, SAMPLE CONSENT ENROL, V4. 0; Grant R, 2009, NCT00458393; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grohskopf L, 2007, PHASE 2 EXTENDED SAF, V1. 6; Grosskurth H, 2009, NCT00931346; Hendrix C, 2007, PHASE 2 ADHERENCE PH, V1. 0; Hendrix C, 2008, NCT00592124; HIV Prevention Treatment Network, 2010, 066 HPTN; HIV Prevention Treatment Network, 2010, BEH ASP PREP COUNS I; HIV Vaccines and Microbicides Resource Tracking Working Group, 2000, PREP; Hoffman I, 2006, NCT00122512; Hosek S, 2010, NCT01033942; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Jackson JB, 2003, AIDS, V17, P547, DOI 10.1097/00002030-200303070-00010; [Joint United Nations Programme for HIV/ AIDS (UNAIDS) World Health Organization (WHO)], 2007, ETH COND BIOM HIV PR; Karim QB, 2006, AIDS, V20, pW1, DOI 10.1097/01.aids.0000218573.29930.67; Kokolo M, 2009, CAN J INFECT DIS SB, V20; Lagakos SW, 2008, METHODOLOGICAL CHALL; Mutua G, 2010, NCT00971230; Networking for Ethics on Biomedical Research in Africa ( NEBRA), 2006, NEBRA AN ENQ RAPP FI; New HIV Vaccines and Microbicides Advocacy Society (NHVMAS), 2009, OR TEN CONTR; Nyika A, 2009, J MED ETHICS, V35, P189, DOI 10.1136/jme.2008.025189; Page-Shafer K, 2005, LANCET, V366, P1499, DOI 10.1016/S0140-6736(05)67146-2; Page-Shafer K, 2004, STUDY DAILY ORAL TEN, V1; Page-Shafer K, 2008, NCT00078182; Paxton L, 2007, NCT00448669; Perrey C, 2009, DEV WORLD BIOETH, V9, P88, DOI 10.1111/j.1471-8847.2008.00229.x; Peterson L, 2006, NCT00122486; Peterson L, 2007, PHASE 2 STUDY TENOFO, V3.5; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Smith D, STUDY SAFETY EFFICAC, V2. 0; Smith D, 2007, NCT00111150; Smith Stephen M, 2004, Retrovirology, V1, P16, DOI 10.1186/1742-4690-1-16; Thigpen M, 2008, STUDY SAFETY EFFICAC, V3. 1; UNAIDS AVAC, 2007, GOOD PART PRACT GUID; Van Damme L, 2009, NCT00625404; Van Damme L, PHASE 3 MULTICENTER, V1. 0; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Wendler D. D., 2008, OXFORD TXB CLIN RES, P123; *WORLD MED ASS, 2000, DECL HELS ETH PRINC	65	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22497	10.1371/journal.pone.0022497	http://dx.doi.org/10.1371/journal.pone.0022497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850229	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300013
J	Korhonen, JJ; Wang, JJ; Soininen, J				Korhonen, Jenni J.; Wang, Jianjun; Soininen, Janne			Productivity-Diversity Relationships in Lake Plankton Communities	PLOS ONE			English	Article							SPECIES RICHNESS; MICROBIAL DIVERSITY; ZOOPLANKTON DIVERSITY; BIODIVERSITY; PATTERNS; STABILITY; PHYTOPLANKTON; HETEROGENEITY; CONSEQUENCES; ENVIRONMENTS	One of the most intriguing environmental gradients connected with variation in diversity is ecosystem productivity. The role of diversity in ecosystems is pivotal, because species richness can be both a cause and a consequence of primary production. However, the mechanisms behind the varying productivity-diversity relationships (PDR) remain poorly understood. Moreover, large-scale studies on PDR across taxa are urgently needed. Here, we examined the relationships between resource supply and phyto-, bacterio-, and zooplankton richness in 100 small boreal lakes. We studied the PDR locally within the drainage systems and regionally across the systems. Second, we studied the relationships between resource availability, species richness, biomass and resource ratio (N:P) in phytoplankton communities using Structural Equation Modeling (SEM) for testing the multivariate hypothesis of PDR. At the local scale, the PDR showed variable patterns ranging from positive linear and unimodal to negative linear relationships for all planktonic groups. At the regional scale, PDRs were significantly linear and positive for phyto- and zooplankton. Phytoplankton richness and the amount of chlorophyll a showed a positive linear relationship indicating that communities consisting of higher number of species were able to produce higher levels of biomass. According to the SEM, phytoplankton biomass was largely related to resource availability, yet there was a pathway via community richness. Finally, we found that species richness at all trophic levels was correlated with several environmental factors, and was also related to richness at the other trophic levels. This study showed that the PDRs in freshwaters show scale-dependency. We also documented that the PDR complies with the multivariate model showing that plant biomass is not mirroring merely the resource availability, but is also influenced by richness. This highlights the need for conserving diversity in order to maintain ecosystem processes in freshwaters.	[Korhonen, Jenni J.; Soininen, Janne] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Wang, Jianjun] Chinese Acad Sci, State Key Lab Lake Sci & Environm, Nanjing Inst Geog & Limnol, Nanjing, Peoples R China	University of Helsinki; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Korhonen, JJ (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	jenni.j.korhonen@helsinki.fi	Soininen, Janne/A-4205-2008	Soininen, Janne/0000-0002-8583-3137; Wang, Jianjun/0000-0001-7039-7136	University of Helsinki [2157010]; Academy of Finland [126718]	University of Helsinki; Academy of Finland(Academy of Finland)	This study was supported by grants from University of Helsinki (www.helsinki.fi/yliopisto, grant no. 2157010) and Academy of Finland (http://www.aka.fi/en-GB/A/, grant no. 126718). No additional external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 1999, CAN J FISH AQUAT SCI, V56, P739, DOI 10.1139/cjfas-56-5-739; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bond EM, 2002, ECOL LETT, V5, P467, DOI 10.1046/j.1461-0248.2002.00350.x; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Floder S, 1999, LIMNOL OCEANOGR, V44, P1114; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gamfeldt L, 2008, INT REV HYDROBIOL, V93, P550, DOI 10.1002/iroh.200711022; Grace JB., 2015, STRUCTURAL EQUATION; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Heino J, 2010, OIKOS, V119, P129, DOI 10.1111/j.1600-0706.2009.17778.x; Hessen DO, 2006, ECOLOGY, V87, P433, DOI 10.1890/05-0352; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillebrand H, 2001, OECOLOGIA, V126, P114, DOI 10.1007/s004420000492; Horner-Devine MC, 2003, ECOL LETT, V6, P613; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; KINZIG AP, 2001, MONOGRAPHS POPULATIO, V33; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LOREAU M, BIODIVERSITY ECOSYST; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Partel M, 2007, J ECOL, V95, P90, DOI 10.1111/j.1365-2745.2006.01185.x; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Ptacnik R, 2010, P ROY SOC B-BIOL SCI, V277, P3755, DOI 10.1098/rspb.2010.1158; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rosenzweig Michael L., 1993, P52; Shurin JB, 2007, ECOL LETT, V10, P127, DOI 10.1111/j.1461-0248.2006.01009.x; Shurin JB, 2010, ECOL LETT, V13, P453, DOI 10.1111/j.1461-0248.2009.01438.x; Smith VH, 2007, FEMS MICROBIOL ECOL, V62, P181, DOI 10.1111/j.1574-6941.2007.00381.x; Soininen J, 2004, ECOGRAPHY, V27, P330, DOI 10.1111/j.0906-7590.2004.03749.x; Soininen J, 2011, LIMNOL OCEANOGR, V56, P508, DOI 10.4319/lo.2011.56.2.0508; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Weis JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002825; Witman JD, 2008, ECOLOGY, V89, pS66, DOI 10.1890/07-1201.1; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	65	52	60	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22041	10.1371/journal.pone.0022041	http://dx.doi.org/10.1371/journal.pone.0022041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850218	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300002
J	van Hemert, FJ; van de Klundert, MAA; Lukashov, VV; Kootstra, NA; Berkhout, B; Zaaijer, HL				van Hemert, Formijn J.; van de Klundert, Maarten A. A.; Lukashov, Vladimir V.; Kootstra, Neeltje A.; Berkhout, Ben; Zaaijer, Hans L.			Protein X of Hepatitis B Virus: Origin and Structure Similarity with the Central Domain of DNA Glycosylase	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR FUNCTIONS; CRYSTAL-STRUCTURE; DOCKING; EVOLUTION; INFECTION; INTERACTS; PROGRAM; HBXIP; GENE	Orthohepadnavirus (mammalian hosts) and avihepadnavirus (avian hosts) constitute the family of Hepadnaviridae and differ by their capability and inability for expression of protein X, respectively. Origin and functions of X are unclear. The evolutionary analysis at issue of X indicates that present strains of orthohepadnavirus started to diverge about 25,000 years ago, simultaneously with the onset of avihepadnavirus diversification. These evolutionary events were preceded by a much longer period during which orthohepadnavirus developed a functional protein X while avihepadnavirus evolved without X. An in silico generated 3D-model of orthohepadnaviral X protein displayed considerable similarity to the tertiary structure of DNA glycosylases (key enzymes of base excision DNA repair pathways). Similarity is confined to the central domain of MUG proteins with the typical DNA-binding facilities but without the capability of DNA glycosylase enzymatic activity. The hypothetical translation product of a vestigial X reading frame in the genome of duck hepadnavirus could also been folded into a DNA glycosylase-like 3D-structure. In conclusion, the most recent common ancestor of ortho-and avihepadnavirus carried an X sequence with orthology to the central domain of DNA glycosylase.	[van Hemert, Formijn J.; Lukashov, Vladimir V.; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands; [Zaaijer, Hans L.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands; [van de Klundert, Maarten A. A.; Kootstra, Neeltje A.; Zaaijer, Hans L.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Immunol,Ctr Infect & Immun Amsterdam CIN, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Hemert, FJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands.	f.j.vanhemert@amc.uva.nl; v.lukashov@amc.uva.nl	van de Klundert, Maarten/AAD-6207-2019	van de Klundert, Maarten/0000-0001-6407-9481; Kootstra, Neeltje A./0000-0001-9429-7754				Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; DELIUS H, 1983, J VIROL, V47, P337, DOI 10.1128/JVI.47.2.337-343.1983; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Gearhart TL, 2010, J VIROL, V84, P2675, DOI 10.1128/JVI.02196-09; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kortemme T, 2004, SCI STKE, V2004, P1; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Lin B, 2000, INTERVIROLOGY, V43, P185, DOI 10.1159/000025037; Lin-Marq N, 2001, VIROLOGY, V287, P266, DOI 10.1006/viro.2001.1036; Ocama Ponsiano, 2005, Am J Med, V118, P1413, DOI 10.1016/j.amjmed.2005.06.021; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Park SG, 2003, EUR J BIOCHEM, V270, P2929, DOI 10.1046/j.1432-1033.2003.03650.x; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qadri I, 1996, J BIOL CHEM, V271, P15443, DOI 10.1074/jbc.271.26.15443; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shackelton LA, 2004, TRENDS MICROBIOL, V12, P458, DOI 10.1016/j.tim.2004.08.005; SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/pnas.72.11.4597; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Hemert FJ, 2008, VIROLOGY, V370, P362, DOI 10.1016/j.virol.2007.08.036; van Hemert FJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-146; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	47	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23392	10.1371/journal.pone.0023392	http://dx.doi.org/10.1371/journal.pone.0023392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850270	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300055
J	Joshi, NN; Kale, MD; Hake, SS; Kannan, S				Joshi, Narendra N.; Kale, Mithila D.; Hake, Sujata S.; Kannan, Sadhana			Transforming Growth Factor beta Signaling Pathway Associated Gene Polymorphisms May Explain Lower Breast Cancer Risk in Western Indian Women	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR-BETA-1 GENE; TGFBR1 POLYMORPHISMS; TGFBR1-ASTERISK-6A; SUSCEPTIBILITY; VARIANT; POPULATION; RESPONSES; DISEASE; PREDICT; GENOME	Transforming growth factor beta 1 (TGFB1) T29C and TGF beta receptor type 1 (TGFBR1) 6A/9A polymorphisms have been implicated in the modulation of risk for breast cancer in Caucasian women. We analyzed these polymorphisms and combinations of their genotypes, in pre menopausal breast cancer patients (N = 182) and healthy women (N = 236) from western India as well as in breast cancer patients and healthy women from the Parsi community (N = 48 & 171, respectively). Western Indian women were characterized by a higher frequency of TGFB1*C allele of the TGF beta T29C polymorphism (0.48 vs 0.44) and a significantly lower frequency of TGFBR1*6A allele of the TGFBR1 6A/9A polymorphism (0.02 vs 0.068, p<0.01) as compared to healthy Parsi women. A strong protective effect of TGFB1*29C allele was seen in younger western Indian women (<40 yrs; OR = 0.45, 95% CI 0.25-0.81). Compared to healthy women, the strikingly higher frequencies of low or intermediate TGF beta signalers in patients suggested a strong influence of the combination of these genotypes on the risk for breast cancer in Parsi women (for intermediate signalers, OR = 4.47 95% CI 1.01-19.69). The frequency of low signalers in Parsi healthy women, while comparable to that reported in Europeans and Americans, was three times higher than that in healthy women from western India (10.6% vs 3.3%, p<0.01). These observations, in conjunction with the low incidence rate of breast cancer in Indian women compared to White women, raise a possibility that the higher frequency of TGFB1*29C allele and lower frequency of TGFBR1*6A allele may represent important genetic determinants that together contribute to a lower risk of breast cancer in western Indian women.	[Joshi, Narendra N.; Kale, Mithila D.; Hake, Sujata S.] Tata Mem Ctr TMC, Adv Ctr Treatment Res & Educ Canc ACTREC, Canc Res Inst, Kharghar, Navi Mumbai, India; [Kannan, Sadhana] Tata Mem Ctr TMC, Adv Ctr Treatment Res & Educ Canc ACTREC, Clin Res Ctr, Epidemiol & Clin Trials Unit, Kharghar, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Joshi, NN (corresponding author), Tata Mem Ctr TMC, Adv Ctr Treatment Res & Educ Canc ACTREC, Canc Res Inst, Kharghar, Navi Mumbai, India.	njoshi@actrec.gov.in			Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR/1317/Med/09/213/98]; Lady Tata Memorial Trust; Women's Cancer Initiative (TMC); ACTREC, TMC	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Lady Tata Memorial Trust; Women's Cancer Initiative (TMC); ACTREC, TMC	This work was supported by grants from the Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/PR/1317/Med/09/213/98), The Lady Tata Memorial Trust, Women's Cancer Initiative (TMC), and Annual Scientific Fund, ACTREC, TMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Battle NC, 2007, AM J RESP CRIT CARE, V175, P881, DOI 10.1164/rccm.200607-992OC; Baxter SW, 2002, CANCER EPIDEM BIOMAR, V11, P211; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blackwell CC, 2005, J LEUKOCYTE BIOL, V78, P1242, DOI 10.1189/jlb.0505253; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; Chandalia M, 2003, J CLIN ENDOCR METAB, V88, P3773, DOI 10.1210/jc.2003-030301; Colleran G, 2010, BREAST CANCER RES TR, V119, P437, DOI 10.1007/s10549-009-0395-0; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Cox DG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-175; Desruisseau S, 2006, BRIT J CANCER, V94, P239, DOI 10.1038/sj.bjc.6602920; Dunning AM, 2003, CANCER RES, V63, P2610; Feigelson HS, 2006, CANCER EPIDEM BIOMAR, V15, P1236, DOI 10.1158/1055-9965.EPI-06-0163; Fischbacher CM, 2003, ARTERIOSCL THROM VAS, V23, P703, DOI 10.1161/01.ATV.0000060449.70345.8E; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hishida Asahi, 2003, Breast Cancer, V10, P63, DOI 10.1007/BF02967627; Hu YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-169; Kakarala M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-191; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Kaur G, 2007, TISSUE ANTIGENS, V69, P113, DOI 10.1111/j.1399-0039.2006.00740.x; Khalilzadeh O, 2010, CLIN EXP MED, V10, P123, DOI 10.1007/s10238-009-0078-5; Krippl P, 2003, CANCER LETT, V201, P181, DOI 10.1016/S0304-3835(03)00468-3; Kulkarni S, 2008, IMMUNOGENETICS, V60, P121, DOI 10.1007/s00251-008-0279-1; Le Marchand L, 2004, CANCER EPIDEM BIOMAR, V13, P412; Le Souef PN, 2000, LANCET, V356, P242; Liao RY, 2010, MOL BIOL REP, V37, P3227, DOI 10.1007/s11033-009-9906-7; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ma X, 2010, J CERAM PROCESS RES, V11, P392; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Muraoka-Cook RS, 2004, CANCER RES, V64, P9002, DOI 10.1158/0008-5472.CAN-04-2111; NANAVUTTY P, 1997, PARSIS; Notani PN, 2001, CURR SCI INDIA, V81, P465; Papadopoulou E, 2008, NEOPLASMA, V55, P229; Pasche B, 1999, CANCER RES, V59, P5678; Pasche B, 2005, JAMA-J AM MED ASSOC, V294, P1634, DOI 10.1001/jama.294.13.1634; Pasche B, 1998, CANCER RES, V58, P2727; Perrey C, 1999, TRANSPL IMMUNOL, V7, P127, DOI 10.1016/S0966-3274(99)80030-6; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; Qiu LX, 2010, BREAST CANCER RES TR, V123, P563, DOI 10.1007/s10549-010-0781-7; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rajkumar T, 2008, BREAST CANCER RES TR, V112, P81, DOI 10.1007/s10549-007-9821-3; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Sastry PSRK, 2003, MED HYPOTHESES, V60, P573, DOI 10.1016/S0306-9877(03)00030-6; Schirmer MA, 2009, PHARMACOGENET GENOM, V19, P249, DOI 10.1097/FPC.0b013e32831cb5a7; Taherkhani H, 2009, INT J IMMUNOGENET, V36, P345, DOI 10.1111/j.1744-313X.2009.00873.x; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Yeole Balkrishna B, 2003, Asian Pac J Cancer Prev, V4, P51; Yeole Balkrishna Bhika, 2001, Asian Pac J Cancer Prev, V2, P293; You W, 2007, J THORAC ONCOL, V2, P657, DOI 10.1097/JTO.0b013e318070ccd7; Ziv E, 2001, JAMA-J AM MED ASSOC, V285, P2859, DOI 10.1001/jama.285.22.2859	53	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e21866	10.1371/journal.pone.0021866	http://dx.doi.org/10.1371/journal.pone.0021866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829601	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200004
J	Kong, MYF; Li, Y; Oster, R; Gaggar, A; Clancy, JP				Kong, Michele Y. F.; Li, Yao; Oster, Robert; Gaggar, Amit; Clancy, J. P.			Early Elevation of Matrix Metalloproteinase-8 and-9 in Pediatric ARDS Is Associated with an Increased Risk of Prolonged Mechanical Ventilation	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; NEUTROPHIL MIGRATION; PREVENTS; INHIBITION; OUTCOMES	Background: Matrix metalloproteinases (MMP) -8 and -9 may play key roles in the modulation of neutrophilic lung inflammation seen in pediatric Acute Respiratory Distress Syndrome (ARDS). We aimed to perform a comprehensive analysis of MMP-8 and MMP-9 activity in tracheal aspirates of pediatric ARDS patients compared with non-ARDS controls, testing whether increased MMP-8 and -9 activities were associated with clinical outcomes. Methods: Tracheal aspirates were collected from 33 pediatric ARDS patients and 21 non-ARDS controls at 48 hours of intubation, and serially for those who remained intubated greater than five days. MMPs, tissue inhibitor of metalloproteinases (TIMPs), human neutrophil elastase (HNE) and myeloperoxidase (MPO) activity were measured by ELISA, and correlated with clinical indicators of disease severity such as PRISM (Pediatric Risk of Mortality) scores, oxygen index (OI), multi-organ system failure (MOSF) and clinical outcome measures including length of intubation, ventilator-free days (VFDs) and mortality in the Pediatric Intensive Care Unit (PICU). Results: Active MMP-9 was elevated early in pediatric ARDS subjects compared to non-ARDS controls. Higher MMP-8 and active MMP-9 levels at 48 hours correlated with a longer course of mechanical ventilation (r = 0.41, p = 0.018 and r = 0.75, p<0.001; respectively) and fewer number of VFDs (r = -0.43, p = 0.013 and r = -0.76, p<0.001; respectively), independent of age, gender and severity of illness. Patients with the highest number of ventilator days had the highest levels of active MMP-9. MMP-9 and to a lesser extent MMP-8 activities in tracheal aspirates from ARDS subjects were sensitive to blockade by small molecule inhibitors. Conclusions: Higher MMP-8 and active MMP-9 levels at 48 hours of disease onset are associated with a longer duration of mechanical ventilation and fewer ventilator-free days among pediatric patients with ARDS. Together, these results identify early biomarkers predictive of disease course and potential therapeutic targets for this life threatening disease.	[Kong, Michele Y. F.; Li, Yao] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Oster, Robert; Gaggar, Amit] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Clancy, J. P.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cincinnati Children's Hospital Medical Center	Kong, MYF (corresponding author), Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA.	mkong@peds.uab.edu		Oster, Robert/0000-0002-2247-8596	Kaul Pediatric Research Institute	Kaul Pediatric Research Institute	This study is funded by the Kaul Pediatric Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaiceta GM, 2008, AM J PHYSIOL-LUNG C, V294, pL535, DOI 10.1152/ajplung.00334.2007; Bendeck MP, 2002, AM J PATHOL, V160, P1089, DOI 10.1016/S0002-9440(10)64929-2; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Carney DE, 1999, CIRCULATION, V100, P400, DOI 10.1161/01.CIR.100.4.400; Carney DE, 2001, J SURG RES, V99, P245, DOI 10.1006/jsre.2001.6180; Cederqvist K, 2006, PEDIATR RES, V60, P395, DOI 10.1203/01.pdr.0000238342.16081.f9; Dahlem P, 2007, PAEDIATR RESPIR REV, V8, P348, DOI 10.1016/j.prrv.2007.03.001; Delclaux C, 1996, AM J RESP CELL MOL, V14, P288, DOI 10.1165/ajrcmb.14.3.8845180; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; Flori HR, 2007, PEDIATR CRIT CARE ME, V8, P96, DOI 10.1097/01.PCC.0000257097.42640.6F; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Golub L M, 1998, Adv Dent Res, V12, P12; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Keck T, 2002, GASTROENTEROLOGY, V122, P188, DOI 10.1053/gast.2002.30348; Kim JH, 2006, AM J PHYSIOL-LUNG C, V291, pL580, DOI 10.1152/ajplung.00270.2005; Kim JH, 2004, AM J PHYSIOL-LUNG C, V287, pL127, DOI 10.1152/ajplung.00047.2003; Kong MYF, 2009, INT J MED SCI, V6, P9; Lanchou J, 2003, CRIT CARE MED, V31, P536, DOI 10.1097/01.CCM.0000048626.02184.F8; Lukkarinen H, 2009, AM J RESP CELL MOL, V41, P59, DOI 10.1165/rcmb.2008-0179OC; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; Reel B, 2009, PEDIATR PULM, V44, P1118, DOI 10.1002/ppul.21111; Ricou B, 1996, AM J RESP CRIT CARE, V154, P346, DOI 10.1164/ajrccm.154.2.8756805; Sapru A, 2010, INTENS CARE MED, V36, P157, DOI 10.1007/s00134-009-1690-2; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Steinberg J, 2005, SHOCK, V24, P348, DOI 10.1097/01.shk.0000180619.06317.2c; Torii K, 1997, AM J RESP CRIT CARE, V155, P43, DOI 10.1164/ajrccm.155.1.9001287; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1	29	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22596	10.1371/journal.pone.0022596	http://dx.doi.org/10.1371/journal.pone.0022596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857935	Green Published, Green Submitted, gold			2022-12-27	WOS:000293558900019
J	Johansson, MA; Sjogren, YM; Persson, JO; Nilsson, C; Sverremark-Ekstrom, E				Johansson, Maria A.; Sjogren, Ylva M.; Persson, Jan-Olov; Nilsson, Caroline; Sverremark-Ekstrom, Eva			Early Colonization with a Group of Lactobacilli Decreases the Risk for Allergy at Five Years of Age Despite Allergic Heredity	PLOS ONE			English	Article							EARLY INTESTINAL COLONIZATION; GUT MICROBIOTA COMPOSITION; PLACEBO-CONTROLLED TRIAL; HOST IMMUNE-SYSTEM; FECAL MICROBIOTA; HEALTHY INFANTS; ATOPIC ECZEMA; PROBIOTICS; RESPONSES; CHILDREN	Background: Microbial deprivation early in life can potentially influence immune mediated disease development such as allergy. The aims of this study were to investigate the influence of parental allergy on the infant gut colonization and associations between infant gut microbiota and allergic disease at five years of age. Methods and Findings: Fecal samples were collected from 58 infants, with allergic or non-allergic parents respectively, at one and two weeks as well as at one, two and twelve months of life. DNA was extracted from the fecal samples and Real time PCR, using species-specific primers, was used for detection of Bifidobacterium (B.) adolescentis, B. breve, B. bifidum, Clostridium (C.) difficile, a group of Lactobacilli (Lactobacillus (L.) casei, L. paracasei and L. rhamnosus) as well as Staphylococcus (S.) aureus. Infants with non-allergic parents were more frequently colonized by Lactobacilli compared to infants with allergic parents (p = 0.014). However, non-allergic five-year olds acquired Lactobacilli more frequently during their first weeks of life, than their allergic counterparts, irrespectively of parental allergy (p = 0.009, p = 0.028). Further the non-allergic children were colonized with Lactobacilli on more occasions during the first two months of life (p = 0.038). Also, significantly more non-allergic children were colonized with B. bifidum at one week of age than the children allergic at five years (p = 0.048). Conclusion: In this study we show that heredity for allergy has an impact on the gut microbiota in infants but also that early Lactobacilli (L. casei, L. paracasei, L. rhamnosus) colonization seems to decrease the risk for allergy at five years of age despite allergic heredity.	[Johansson, Maria A.; Sjogren, Ylva M.; Sverremark-Ekstrom, Eva] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Immunol, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Persson, Jan-Olov] Stockholm Univ, Div Math Stat, Dept Math, S-10691 Stockholm, Sweden; [Nilsson, Caroline] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Nilsson, Caroline] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden	Stockholm University; Stockholm University; Karolinska Institutet; Karolinska Institutet	Johansson, MA (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Immunol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	maria.johansson@imun.su.se; eva.sverremark@imun.su.se	Sverremark-Ekström, Eva/A-2305-2016; Nilsson, Caroline/AAF-9663-2022; Nilsson, Caroline/AFK-2402-2022	Sverremark-Ekström, Eva/0000-0001-6271-8681; 	Swedish Research Council [57X-15160-05-2, 57X-15160-07-3]; Ekhaga Foundation; Cancer and Allergy Foundation; Mjolkdroppen Foundation; Magnus Bergvall Foundation; Konsul Th C Bergh foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ekhaga Foundation; Cancer and Allergy Foundation; Mjolkdroppen Foundation; Magnus Bergvall Foundation; Konsul Th C Bergh foundation	This work was supported by the Swedish Research Council (grants 57X-15160-05-2 and 57X-15160-07-3) and the Ekhaga Foundation, the Cancer and Allergy Foundation, the Mjolkdroppen Foundation, the Magnus Bergvall Foundation, and the Konsul Th C Bergh foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Adlerberth I, 2007, J ALLERGY CLIN IMMUN, V120, P343, DOI 10.1016/j.jaci.2007.05.018; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bottcher MF, 2003, CLIN EXP ALLERGY, V33, P295, DOI 10.1046/j.1365-2222.2003.01562.x; Bottcher MF, 2002, CLIN EXP ALLERGY, V32, P1293, DOI 10.1046/j.1365-2222.2002.01470.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dong P, 2010, EARLY HUM DEV, V86, P51, DOI 10.1016/j.earlhumdev.2010.01.002; Edelman SM, 2008, CURR OPIN GASTROEN, V24, P720, DOI 10.1097/MOG.0b013e32830c4355; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Garn H, 2007, IMMUNOBIOLOGY, V212, P441, DOI 10.1016/j.imbio.2007.03.006; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Ivory K, 2008, CLIN EXP ALLERGY, V38, P1282, DOI 10.1111/j.1365-2222.2008.03025.x; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kalliomaki M, 2001, J ALLERGY CLIN IMMUN, V107, P129, DOI 10.1067/mai.2001.111237; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Karlsson H, 2002, INFECT IMMUN, V70, P6688, DOI 10.1128/IAI.70.12.6688-6696.2002; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Lundell AC, 2007, CLIN EXP ALLERGY, V37, P62, DOI 10.1111/j.1365-2222.2006.02625.x; Martino DJ, 2008, CLIN EXP ALLERGY, V38, P69, DOI 10.1111/j.1365-2222.2007.02856.x; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Ouwehand AC, 2001, J ALLERGY CLIN IMMUN, V108, P144, DOI 10.1067/mai.2001.115754; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2010, MICROBIOL-SGM, V156, P3298, DOI 10.1099/mic.0.042069-0; Prescott SL, 2008, ALLERGY, V63, P1481, DOI 10.1111/j.1398-9995.2008.01778.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036; Thomas DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016577; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011	37	103	111	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23031	10.1371/journal.pone.0023031	http://dx.doi.org/10.1371/journal.pone.0023031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829685	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511200031
J	Drozdov, I; Svejda, B; Gustafsson, BI; Mane, S; Pfragner, R; Kidd, M; Modlin, IM				Drozdov, Ignat; Svejda, Bernhard; Gustafsson, Bjorn I.; Mane, Shrikant; Pfragner, Roswitha; Kidd, Mark; Modlin, Irvin M.			Gene Network Inference and Biochemical Assessment Delineates GPCR Pathways and CREB Targets in Small Intestinal Neuroendocrine Neoplasia	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; FUNCTIONAL-CHARACTERIZATION; CHROMOGRANIN-A; CELL-LINE; KRJ-I; EXPRESSION; TUMOR; TRANSCRIPTION; MICROARRAY; PHOSPHORYLATION	Small intestinal (SI) neuroendocrine tumors (NET) are increasing in incidence, however little is known about their biology. High throughput techniques such as inference of gene regulatory networks from microarray experiments can objectively define signaling machinery in this disease. Genome-wide co-expression analysis was used to infer gene relevance network in SI-NETs. The network was confirmed to be non-random, scale-free, and highly modular. Functional analysis of gene co-expression modules revealed processes including 'Nervous system development', 'Immune response', and 'Cell-cycle'. Importantly, gene network topology and differential expression analysis identified over-expression of the GPCR signaling regulators, the cAMP synthetase, ADCY2, and the protein kinase A, PRKAR1A. Seven CREB response element (CRE) transcripts associated with proliferation and secretion: BEX1, BICD1, CHGB, CPE, GABRB3, SCG2 and SCG3 as well as ADCY2 and PRKAR1A were measured in an independent SI dataset (n = 10 NETs; n = 8 normal preparations). All were up-regulated (p<0.035) with the exception of SCG3 which was not differently expressed. Forskolin (a direct cAMP activator, 10(-5) M) significantly stimulated transcription of pCREB and 3/7 CREB targets, isoproterenol (a selective beta-adrenergic receptor agonist and cAMP activator, 10(-5) M) stimulated pCREB and 4/7 targets while BIM-53061 (a dopamine D-2 and Serotonin [5-HT2] receptor agonist, 10(-6) M) stimulated 100% of targets as well as pCREB; CRE transcription correlated with the levels of cAMP accumulation and PKA activity; BIM-53061 stimulated the highest levels of cAMP and PKA (2.8-fold and 2.5-fold vs. 1.8-2-fold for isoproterenol and forskolin). Gene network inference and graph topology analysis in SI NETs suggests that SI NETs express neural GPCRs that activate different CRE targets associated with proliferation and secretion. In vitro studies, in a model NET cell system, confirmed that transcriptional effects are signaled through the cAMP/PKA/pCREB signaling pathway and that a SI NET cell line was most sensitive to a D-2 and 5-HT2 receptor agonist BIM-53061.	[Drozdov, Ignat] Kings Coll London, Div Cardiovasc, BHF Ctr Res Excellence, James Black Ctr, London WC2R 2LS, England; [Drozdov, Ignat] Kings Coll London, Ctr Bioinformat, Sch Phys Sci & Engn, London WC2R 2LS, England; [Svejda, Bernhard; Kidd, Mark; Modlin, Irvin M.] Yale Univ, Sch Med, Gastrointestinal Pathobiol Res Grp, New Haven, CT USA; [Gustafsson, Bjorn I.] St Olavs Hosp, Dept Gastroenterol, Trondheim, Norway; [Gustafsson, Bjorn I.] NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Mane, Shrikant] Yale Univ, Keck Affymetrix Facil, Sch Med, New Haven, CT USA; [Pfragner, Roswitha] Med Univ Graz, Inst Pathophysiol & Immunol, Ctr Mol Med, Graz, Austria	University of London; King's College London; University of London; King's College London; Yale University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Yale University; Medical University of Graz	Drozdov, I (corresponding author), Kings Coll London, Div Cardiovasc, BHF Ctr Res Excellence, James Black Ctr, London WC2R 2LS, England.	mark.kidd@yale.edu; imodlin@optonline.net		Drozdov, Ignat/0000-0001-6727-4688	British Heart Foundation (BHF); National Institutes of Health [CA097050, DK080871]; NATIONAL CANCER INSTITUTE [R01CA097050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080871] Funding Source: NIH RePORTER	British Heart Foundation (BHF)(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Parts of this work were supported by the British Heart Foundation (BHF) through a PhD studentship for ID, and by the National Institutes of Health: CA097050 (IMM) and DK080871 (MK). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; BARBER DL, 1986, AM J PHYSIOL, V250, pG385, DOI 10.1152/ajpgi.1986.250.3.G385; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boikos SA, 2007, HUM MOL GENET, V16, pR80, DOI 10.1093/hmg/ddm019; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; Boushey Robin P, 2002, Curr Treat Options Oncol, V3, P319, DOI 10.1007/s11864-002-0031-2; CETIN Y, 1994, P NATL ACAD SCI USA, V91, P2935, DOI 10.1073/pnas.91.8.2935; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Claussen M, 2005, ANN ANAT, V187, P539, DOI 10.1016/j.aanat.2005.07.004; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; DeRisi J, 1996, NAT GENET, V14, P457; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Drozdov I, 2009, CANCER-AM CANCER SOC, V115, P4934, DOI 10.1002/cncr.24533; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Faure C, 2010, GASTROENTEROLOGY, V139, P249, DOI 10.1053/j.gastro.2010.03.032; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; Florio T, 2008, FRONT BIOSCI-LANDMRK, V13, P822, DOI 10.2741/2722; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gustafsson BI, 2008, CURR OPIN ONCOL, V20, P1, DOI 10.1097/CCO.0b013e3282f1c595; He P, 2004, HUM PATHOL, V35, P1196, DOI 10.1016/j.humpath.2004.06.014; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hu YH, 2008, J BIOL CHEM, V283, P9328, DOI 10.1074/jbc.M705110200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JIN L, 1993, J CLIN ENDOCR METAB, V76, P728, DOI 10.1210/jc.76.3.728; Kidd M, 2006, AM J PHYSIOL-GASTR L, V291, pG778, DOI 10.1152/ajpgi.00552.2005; Kidd M, 2006, ANN SURG ONCOL, V13, P253, DOI 10.1245/ASO.2006.12.011; Kidd M, 2006, ANN SURG, V243, P273, DOI 10.1097/01.sla.0000197734.28551.0f; Kidd M, 2009, NEUROGASTROENT MOTIL, V21, P439, DOI 10.1111/j.1365-2982.2008.01210.x; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Kidd M, 2007, CANCER-AM CANCER SOC, V109, P2420, DOI 10.1002/cncr.22725; Kidd M, 2007, J MOL ENDOCRINOL, V38, P181, DOI 10.1677/jme.1.02037; Kimura N, 2002, ENDOCR PATHOL, V13, P117, DOI 10.1385/EP:13:2:117; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Mahapatra NR, 2006, J NEUROCHEM, V99, P119, DOI 10.1111/j.1471-4159.2006.04128.x; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Modlin IM, 2005, GASTROENTEROLOGY, V128, P1717, DOI 10.1053/j.gastro.2005.03.038; Modlin IM, 2007, AM J GASTROENTEROL, V102, P1464, DOI 10.1111/j.1572-0241.2007.01185.x; Modlin IM, 2006, J CLIN ENDOCR METAB, V91, P2340, DOI 10.1210/jc.2006-0110; Modlin IM, 2006, CLIN GASTROENTEROL H, V4, P526, DOI 10.1016/j.cgh.2005.12.008; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; National Cancer Institute's, SURV EP END RES SEER; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pfragner R, 1996, INT J ONCOL, V8, P513; Pigazzi M, 2007, HAEMATOLOGICA, V92, P1435, DOI 10.3324/haematol.11122; R Core Team, 2021, R LANGUAGE ENV STAT; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rodien P, 2003, ANN ENDOCRINOL-PARIS, V64, P12; Rolph MS, 2006, PHARMACOL THERAPEUT, V109, P284, DOI 10.1016/j.pharmthera.2005.08.009; ROTH KA, 1990, P NATL ACAD SCI USA, V87, P6408, DOI 10.1073/pnas.87.16.6408; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sutton R, 2003, ENDOCR-RELAT CANCER, V10, P469, DOI 10.1677/erc.0.0100469; Svejda B, 2010, CANCER-AM CANCER SOC, V116, P2902, DOI 10.1002/cncr.25049; Taniwaki M, 2006, INT J ONCOL, V29, P567; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Thomson ABR, 2001, DIGEST DIS SCI, V46, P2588, DOI 10.1023/A:1012746622735; van der Hiel B, 2003, EUR J ENDOCRINOL, V149, P479, DOI 10.1530/eje.0.1490479; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; WATERMAN M, 1985, SCIENCE, V229, P267, DOI 10.1126/science.2990047; Welford SM, 1998, NUCLEIC ACIDS RES, V26, P3059, DOI 10.1093/nar/26.12.3059; Xu DH, 2010, J SURG ONCOL, V102, P469, DOI 10.1002/jso.21530; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	70	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22457	10.1371/journal.pone.0022457	http://dx.doi.org/10.1371/journal.pone.0022457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853033	Green Published, gold			2022-12-27	WOS:000293953400008
J	Imanishi, H; Hattori, K; Wada, R; Ishikawa, K; Fukuda, S; Takenaga, K; Nakada, K; Hayashi, JI				Imanishi, Hirotake; Hattori, Keisuke; Wada, Reiko; Ishikawa, Kaori; Fukuda, Sayaka; Takenaga, Keizo; Nakada, Kazuto; Hayashi, Jun-Ichi			Mitochondrial DNA Mutations Regulate Metastasis of Human Breast Cancer Cells	PLOS ONE			English	Article							GENOME INVOLVEMENT; NUCLEAR-DNA; TUMORIGENICITY; TUMORS; MOUSE; PARAGANGLIOMA; EXPRESSION	Mutations in mitochondrial DNA (mtDNA) might contribute to expression of the tumor phenotypes, such as metastatic potential, as well as to aging phenotypes and to clinical phenotypes of mitochondrial diseases by induction of mitochondrial respiration defects and the resultant overproduction of reactive oxygen species (ROS). To test whether mtDNA mutations mediate metastatic pathways in highly metastatic human tumor cells, we used human breast carcinoma MDA-MB-231 cells, which simultaneously expressed a highly metastatic potential, mitochondrial respiration defects, and ROS overproduction. Since mitochondrial respiratory function is controlled by both mtDNA and nuclear DNA, it is possible that nuclear DNA mutations contribute to the mitochondrial respiration defects and the highly metastatic potential found in MDA-MB-231 cells. To examine this possibility, we carried out mtDNA replacement of MDA-MB-231 cells by normal human mtDNA. For the complete mtDNA replacement, first we isolated mtDNA-less (rho(0)) MDA-MB-231 cells, and then introduced normal human mtDNA into the rho(0) MDA-MB-231 cells, and isolated trans-mitochondrial cells (cybrids) carrying nuclear DNA from MDA-MB-231 cells and mtDNA from a normal subject. The normal mtDNA transfer simultaneously induced restoration of mitochondrial respiratory function and suppression of the highly metastatic potential expressed in MDA-MB-231 cells, but did not suppress ROS overproduction. These observations suggest that mitochondrial respiration defects observed in MDA-MB-231 cells are caused by mutations in mtDNA but not in nuclear DNA, and are responsible for expression of the high metastatic potential without using ROS-mediated pathways. Thus, human tumor cells possess an mtDNA-mediated metastatic pathway that is required for expression of the highly metastatic potential in the absence of ROS production.	[Imanishi, Hirotake; Hattori, Keisuke; Wada, Reiko; Ishikawa, Kaori; Fukuda, Sayaka; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Takenaga, Keizo] Shimane Univ, Fac Med, Izumo, Shimane, Japan	University of Tsukuba; Shimane University	Imanishi, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	jih45@biol.tsukuba.ac.jp		ISHIKAWA, Kaori/0000-0001-9895-5996	Japan Society for Promotion of Science (JSPS) [19100007]	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Scientific Research (S) from the Japan Society for Promotion of Science (JSPS http://www.jsps.go.jp/) grant number 19100007 to J.-I.H. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2005, BIOCHEM BIOPH RES CO, V327, P1028, DOI 10.1016/j.bbrc.2004.12.105; ALLEN JA, 1980, NATURE, V287, P244, DOI 10.1038/287244a0; BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; HAYASHI JI, 1986, CANCER RES, V46, P4001; HAYASHI JI, 1989, CANCER RES, V49, P4715; HAYASHI JI, 1994, J BIOL CHEM, V269, P6878; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; Ishikawa K, 2008, FEBS LETT, V582, P3525, DOI 10.1016/j.febslet.2008.09.024; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kirschmann DA, 2000, CANCER RES, V60, P3359; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Ma YW, 2010, BBA-BIOENERGETICS, V1797, P29, DOI 10.1016/j.bbabio.2009.07.008; MIYABAYASHI S, 1989, J INHERIT METAB DIS, V12, P373, DOI 10.1007/BF01799245; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	23	79	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23401	10.1371/journal.pone.0023401	http://dx.doi.org/10.1371/journal.pone.0023401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853128	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953400044
J	Peng, CH; Liao, CT; Peng, SC; Chen, YJ; Cheng, AJ; Juang, JL; Tsai, CY; Chen, TC; Chuang, YJ; Tang, CY; Hsieh, WP; Yen, TC				Peng, Chien-Hua; Liao, Chun-Ta; Peng, Shih-Chi; Chen, Yin-Ju; Cheng, Ann-Joy; Juang, Jyh-Lyh; Tsai, Chi-Ying; Chen, Tse-Ching; Chuang, Yung-Jen; Tang, Chuan-Yi; Hsieh, Wen-Ping; Yen, Tzu-Chen			A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; C-MYC; RISK-FACTORS; EMBRYONIC STEM; BREAST-CANCER; CAVITY CANCER; COPY NUMBER; EXPRESSION; TRANSCRIPTION; PROGRESSION	Molecular methods for predicting prognosis in patients with oral cavity squamous cell carcinoma (OSCC) are urgently needed, considering its high recurrence rate and tendency for metastasis. The present study investigated the genetic basis of variations in gene expression associated with poor prognosis in OSCC using Affymetrix SNP 6.0 and Affymetrix GeneChip Human Gene 1.0 ST arrays. We identified recurrent DNA amplifications scattered from 8q22.2 to 8q24.3 in 112 OSCC specimens. These amplicons demonstrated significant associations with increased incidence of extracapsular spread, development of second primary malignancies, and poor survival. Fluorescence in situ hybridization, in a validation panel consisting of 295 cases, confirmed these associations. Assessment of the effects of copy number variations (CNVs) on genome-wide variations in gene expression identified a total of 85 CNV-associated transcripts enriched in the MYC-centered regulatory network. Twenty-four transcripts associated with increased risk of second primary malignancies, tumor relapse, and poor survival. Besides MYC itself, a novel dysregulated MYC module plays a key role in OSCC carcinogenesis. This study identified a candidate molecular signature associated with poor prognosis in OSCC patients, which may ultimately facilitate patient-tailored selection of therapeutic strategies.	[Peng, Chien-Hua] Chang Gung Mem Hosp, Resource Ctr Clin Res, Tao Yuan, Taiwan; [Peng, Chien-Hua; Liao, Chun-Ta; Peng, Shih-Chi; Chen, Yin-Ju; Cheng, Ann-Joy; Tsai, Chi-Ying; Chen, Tse-Ching; Yen, Tzu-Chen] Chang Gung Univ, Tao Yuan, Taiwan; [Liao, Chun-Ta] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Tao Yuan, Taiwan; [Peng, Shih-Chi; Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan; [Peng, Shih-Chi; Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Tao Yuan, Taiwan; [Chen, Yin-Ju; Cheng, Ann-Joy] Chang Gung Mem Hosp, Dept Med Biotechnol, Tao Yuan, Taiwan; [Tsai, Chi-Ying] Chang Gung Mem Hosp, Dept Oral Maxillofacial Surg, Tao Yuan, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Chuang, Yung-Jen] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Hsieh, Wen-Ping] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Juang, Jyh-Lyh] Natl Hlth Res Inst, Div Mol, Miaoli, Taiwan; [Juang, Jyh-Lyh] Natl Hlth Res Inst, Div Genom Med, Miaoli, Taiwan; [Tang, Chuan-Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Providence University - Taiwan	Peng, CH (corresponding author), Chang Gung Mem Hosp, Resource Ctr Clin Res, Tao Yuan, Taiwan.	wphsieh@stat.nthu.edu.tw; yen1110@adm.cgmh.org.tw	Chuang, Yung-Jen/D-2362-2013; Cheng, Ann-Joy/AAI-4374-2020; Juang, Jyh-Lyh/E-3944-2010; Chun-Ta, Liao/B-9589-2011	Chuang, Yung-Jen/0000-0002-6022-0107; Cheng, Ann-Joy/0000-0002-1317-0725	National Council of Science [NSC 99-2118-M-007-006]	National Council of Science	This work was partly supported by the National Council of Science [NSC 99-2118-M-007-006](http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Broet P, 2009, CANCER RES, V69, P1055, DOI 10.1158/0008-5472.CAN-08-1116; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Cancela MD, 2009, COMMUNITY DENT ORAL, V37, P342, DOI 10.1111/j.1600-0528.2009.00475.x; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Foster JS, 2001, MOL CELL BIOL, V21, P794, DOI 10.1128/MCB.21.3.794-810.2001; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Garnis C, 2004, ORAL ONCOL, V40, P511, DOI 10.1016/j.oraloncology.2003.10.006; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Iwanami A, 2009, GENE DEV, V23, P1699, DOI 10.1101/gad.1832909; Kane SV, 2006, EJSO-EUR J SURG ONC, V32, P795, DOI 10.1016/j.ejso.2006.05.004; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liao CT, 2008, ANN SURG ONCOL, V15, P915, DOI 10.1245/s10434-007-9761-5; Liao CT, 2007, CANCER, V110, P1501, DOI 10.1002/cncr.22959; Liao CT, 2009, ANN SURG ONCOL, V16, P159, DOI 10.1245/s10434-008-0196-4; Liu CJ, 2004, J ORAL PATHOL MED, V33, P327, DOI 10.1111/j.1600-0714.2004.00092.x; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shah NG, 2007, INT J BIOL MARKER, V22, P132, DOI 10.1177/172460080702200207; Sparano A, 2006, LARYNGOSCOPE, V116, P735, DOI 10.1097/01.mlg.0000205141.54471.7f; Subapriya R, 2007, EUR J CANCER PREV, V16, P251, DOI 10.1097/01.cej.0000228402.53106.9e; Veiga LCD, 2003, CANCER GENET CYTOGEN, V146, P110, DOI 10.1016/S0165-4608(03)00132-8; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; YEN TC, 2010, ANN SURG ONCOL; Zhao L, 2003, MOL CANCER RES, V1, P195	43	126	127	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23452	10.1371/journal.pone.0023452	http://dx.doi.org/10.1371/journal.pone.0023452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853135	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953400046
J	Wu, ZLL				Wu, Zhengliang L.			Phosphatase-Coupled Universal Kinase Assay and Kinetics for First-Order-Rate Coupling Reaction	PLOS ONE			English	Article							ADENOSINE 5'-PHOSPHOSULFATE KINASE; BETA-CELL GLUCOKINASE; EXPRESSION; CD39L2; KINOME; IDENTIFICATION	Kinases use adenosine-5'-triphosphate (ATP) as the donor substrate and generate adenosine-5'-diphosphate (ADP) as a product. An ADP-based phosphatase-coupled kinase assay is described here. In this assay, CD39L2, a nucleotidase, is added into a kinase reaction to hydrolyze ADP to AMP and phosphate. The phosphate is subsequently detected using malachite green phosphate-detection reagents. As ADP hydrolysis by CD39L2 displays a first-order rate constant, relatively simple equations are derived to calculate the coupling rate and the lagging time of the coupling reaction, allowing one to obtain kinase kinetic parameters without the completion of the coupling reaction. ATP inhibition of CD39L2-catalyzed ADP hydrolysis is also determined for correction of the kinetic data. As examples, human glucokinase, P. chrysogenum APS kinase and human ERK1, kinases specific for sugar, nucleotide and protein respectively, are assayed. To assess the compatibility of the method for high-throughput assays, Z' factors >0.5 are also obtained for the three kinases.	R&D Syst Inc, Minneapolis, MN 55413 USA		Wu, ZLL (corresponding author), R&D Syst Inc, Minneapolis, MN 55413 USA.	leon.wu@rndsystems.com		Wu, Zhengliang/0000-0002-0700-0906				Anderson SN, 2004, J BIOMOL SCREEN, V9, P112, DOI 10.1177/1087057103260592; Brooijmans N, 2010, PROTEIN SCI, V19, P763, DOI 10.1002/pro.355; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chadwick BP, 1998, GENOMICS, V50, P357, DOI 10.1006/geno.1998.5317; CHAREST DL, 1993, MOL CELL BIOL, V13, P4679, DOI 10.1128/MCB.13.8.4679; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; GRANET RA, 1987, ANAL BIOCHEM, V163, P458, DOI 10.1016/0003-2697(87)90248-X; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Hong L, 2009, ANAL BIOCHEM, V391, P31, DOI 10.1016/j.ab.2009.04.033; Ivanenkov VV, 2003, BIOCHEMISTRY-US, V42, P11726, DOI 10.1021/bi035137r; Jia Yong, 2008, Curr Drug Discov Technol, V5, P59, DOI 10.2174/157016308783769414; Kleman-Leyer KM, 2009, ASSAY DRUG DEV TECHN, V7, P56, DOI 10.1089/adt.2008.175; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; LANGE AJ, 1991, BIOCHEM J, V277, P159, DOI 10.1042/bj2770159; Lansdon EB, 2002, BIOCHEMISTRY-US, V41, P13672, DOI 10.1021/bi026556b; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning Gerard, 2005, WormBook, P1; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; McDonald OB, 1999, ANAL BIOCHEM, V268, P318, DOI 10.1006/abio.1998.3030; Milanesi L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S20; RENOSTO F, 1989, J BIOL CHEM, V264, P9433; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; STORER AC, 1974, BIOCHEM J, V141, P205, DOI 10.1042/bj1410205; TAKEDA J, 1993, J BIOL CHEM, V268, P15200; von Ahsen O, 2005, CHEMBIOCHEM, V6, P481, DOI 10.1002/cbic.200400211; WEI YF, 1990, ANAL BIOCHEM, V190, P188, DOI 10.1016/0003-2697(90)90179-D; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Wu ZL, 2011, GLYCOBIOLOGY, V21, P727, DOI 10.1093/glycob/cwq187; XU LZ, 1995, J BIOL CHEM, V270, P9939, DOI 10.1074/jbc.270.17.9939; Yeung G, 2000, BIOCHEMISTRY-US, V39, P12916, DOI 10.1021/bi000959z; Zegzouti H, 2009, ASSAY DRUG DEV TECHN, V7, P560, DOI 10.1089/adt.2009.0222; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	37	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23172	10.1371/journal.pone.0023172	http://dx.doi.org/10.1371/journal.pone.0023172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853082	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400029
J	Bhattacharyya, D; Ramachandran, S; Sharma, S; Pathmasiri, W; King, CL; Baskerville-Abraham, I; Boysen, G; Swenberg, JA; Campbell, SL; Dokholyan, NV; Chaney, SG				Bhattacharyya, Debadeep; Ramachandran, Srinivas; Sharma, Shantanu; Pathmasiri, Wimal; King, Candice L.; Baskerville-Abraham, Irene; Boysen, Gunnar; Swenberg, James A.; Campbell, Sharon L.; Dokholyan, Nikolay V.; Chaney, Stephen G.			Flanking Bases Influence the Nature of DNA Distortion by Platinum 1,2-Intrastrand (GG) Cross-Links	PLOS ONE			English	Article							DOMAIN PROTEIN RECOGNITION; MISMATCH REPAIR-PROFICIENT; ANTICANCER DRUG CISPLATIN; NMR SOLUTION STRUCTURE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; DODECAMER DUPLEX; CARRIER LIGAND; SEX REVERSAL; OXALIPLATIN	The differences in efficacy and molecular mechanisms of platinum anti-cancer drugs cisplatin (CP) and oxaliplatin (OX) are thought to be partially due to the differences in the DNA conformations of the CP and OX adducts that form on adjacent guanines on DNA, which in turn influence the binding of damage-recognition proteins that control downstream effects of the adducts. Here we report a comprehensive comparison of the structural distortion of DNA caused by CP and OX adducts in the TGGT sequence context using nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics (MD) simulations. When compared to our previous studies in other sequence contexts, these structural studies help us understand the effect of the sequence context on the conformation of Pt-GG DNA adducts. We find that both the sequence context and the type of Pt-GG DNA adduct (CP vs. OX) play an important role in the conformation and the conformational dynamics of Pt-DNA adducts, possibly explaining their influence on the ability of many damage-recognition proteins to bind to Pt-DNA adducts.	[Bhattacharyya, Debadeep; Ramachandran, Srinivas; Sharma, Shantanu; Pathmasiri, Wimal; King, Candice L.; Campbell, Sharon L.; Dokholyan, Nikolay V.; Chaney, Stephen G.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Ramachandran, Srinivas] Univ N Carolina, Program Cellular & Mol Biophys, Chapel Hill, NC USA; [Baskerville-Abraham, Irene; Boysen, Gunnar; Swenberg, James A.] Univ N Carolina, Sch Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Swenberg, James A.; Campbell, Sharon L.; Dokholyan, Nikolay V.; Chaney, Stephen G.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bhattacharyya, D (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	campbesl@med.unc.edu; dokh@med.unc.edu; stephen_chaney@med.unc.edu	Boysen, Gunnar/U-3272-2019; Dokholyan, Nikolay/D-8081-2018	Boysen, Gunnar/0000-0001-8364-9881; Dokholyan, Nikolay/0000-0002-8225-4025; Sharma, Shantanu/0000-0002-4992-7291; Baskerville-Abraham, Irene/0000-0002-7458-5422; Pathmasiri, Wimal/0000-0002-5199-5744; Ramachandran, Srinivas/0000-0003-2929-1377; campbell, sharon/0000-0003-0311-409X	National Institutes of Health [CA84480]; National Institute of Environmental Health Sciences [P30ES10126]; NATIONAL CANCER INSTITUTE [R01CA084480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, P42ES005948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was originally supported by National Institutes of Health grant CA84480 and National Institute of Environmental Health Sciences grant P30ES10126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 1996, CANCER RES, V56, P3087; Anthoney DA, 1996, CANCER RES, V56, P1374; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Chaney SG, 1999, J INORG BIOCHEM, V77, P71, DOI 10.1016/S0162-0134(99)00149-X; Churchill MEA, 2010, J MOL BIOL, V403, P88, DOI 10.1016/j.jmb.2010.08.031; Chvalova K, 2008, J INORG BIOCHEM, V102, P242, DOI 10.1016/j.jinorgbio.2007.08.006; Cohen SM, 2000, BIOCHEMISTRY-US, V39, P11771, DOI 10.1021/bi001352l; Cohen SM, 2000, BIOCHEMISTRY-US, V39, P8259, DOI 10.1021/bi0004495; Drotschmann K, 2004, DNA REPAIR, V3, P729, DOI 10.1016/j.dnarep.2004.02.011; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Dunham SU, 1997, BIOCHEMISTRY-US, V36, P11428, DOI 10.1021/bi9709452; EASTMAN A, 1986, BIOCHEMISTRY-US, V25, P3912, DOI 10.1021/bi00361a026; Fink D, 1996, CANCER RES, V56, P4881; Fink D, 1997, CANCER RES, V57, P1841; Gelasco A, 1998, BIOCHEMISTRY-US, V37, P9230, DOI 10.1021/bi973176v; Gruschus JM, 1998, J MAGN RESON, V135, P87, DOI 10.1006/jmre.1998.1532; He Q, 2000, BIOCHEMISTRY-US, V39, P14426, DOI 10.1021/bi001700j; HERMAN F, 1990, EUR J BIOCHEM, V194, P119, DOI 10.1111/j.1432-1033.1990.tb19435.x; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; JENNERWEIN MM, 1989, CHEM-BIOL INTERACT, V70, P39, DOI 10.1016/0009-2797(89)90061-6; Jung YW, 2003, BIOCHEMISTRY-US, V42, P2664, DOI 10.1021/bi026972w; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lavery R, 1996, CURVES 5 1 HELICAL A; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Malina J, 2007, BIOPHYS J, V93, P3950, DOI 10.1529/biophysj.107.116996; Marzilli LG, 2001, J AM CHEM SOC, V123, P2764, DOI 10.1021/ja0007915; McANulty MM, 1996, MUTAT RES-DNA REPAIR, V362, P75, DOI 10.1016/0921-8777(95)00037-2; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Nehme A, 1997, CANCER RES, V57, P3253; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; PAGE JD, 1990, BIOCHEMISTRY-US, V29, P1016, DOI 10.1021/bi00456a026; Press W. H., 1992, ART SCI COMPUTING; Ramachandran S, 2009, NUCLEIC ACIDS RES, V37, P2434, DOI 10.1093/nar/gkp029; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Sharma S, 2007, J MOL BIOL, V373, P1123, DOI 10.1016/j.jmb.2007.07.079; Sixma TK, 2001, CURR OPIN STRUC BIOL, V11, P47, DOI 10.1016/S0959-440X(00)00169-X; Spingler B, 2001, INORG CHEM, V40, P5596, DOI 10.1021/ic010790t; Takahara PM, 1996, J AM CHEM SOC, V118, P12309, DOI 10.1021/ja9625079; Teletchea S, 2009, CHEM-EUR J, V15, P12320, DOI 10.1002/chem.200901158; Todd RC, 2010, J INORG BIOCHEM, V104, P902, DOI 10.1016/j.jinorgbio.2010.04.005; Travers A, 2000, CURR OPIN STRUC BIOL, V10, P102, DOI 10.1016/S0959-440X(99)00056-1; TREIBER DK, 1994, P NATL ACAD SCI USA, V91, P5672, DOI 10.1073/pnas.91.12.5672; Vaisman A, 1999, BIOCHEMISTRY-US, V38, P11026, DOI 10.1021/bi9909187; Vaisman A, 1998, CANCER RES, V58, P3579; Voland C, 2006, MOL CANCER THER, V5, P2149, DOI 10.1158/1535-7163.MCT-05-0212; Wei M, 2001, J BIOL CHEM, V276, P38774, DOI 10.1074/jbc.M106374200; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WERNER MH, 1995, BIOCHEMISTRY-US, V34, P11998, DOI 10.1021/bi00037a042; Woynarowski J. M., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P311; Wu YB, 2004, J MOL BIOL, V341, P1251, DOI 10.1016/j.jmb.2004.06.066; Wu YB, 2007, BIOCHEMISTRY-US, V46, P6477, DOI 10.1021/bi062291f; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YANG DZ, 1995, BIOCHEMISTRY-US, V34, P12912, DOI 10.1021/bi00039a054; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116; Zdraveski ZZ, 2002, J BIOL CHEM, V277, P1255, DOI 10.1074/jbc.M105382200; Zhai XQ, 1998, BIOCHEMISTRY-US, V37, P16307, DOI 10.1021/bi981708h	61	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23582	10.1371/journal.pone.0023582	http://dx.doi.org/10.1371/journal.pone.0023582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853154	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200098
J	Bialonski, S; Wendler, M; Lehnertz, K				Bialonski, Stephan; Wendler, Martin; Lehnertz, Klaus			Unraveling Spurious Properties of Interaction Networks with Tailored Random Networks	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD; COMPLEX NETWORKS; SEIZURE DYNAMICS; BRAIN NETWORKS; SURROGATE DATA; SYNCHRONIZATION; ARCHITECTURE; INFORMATION; RECORDINGS	We investigate interaction networks that we derive from multivariate time series with methods frequently employed in diverse scientific fields such as biology, quantitative finance, physics, earth and climate sciences, and the neurosciences. Mimicking experimental situations, we generate time series with finite length and varying frequency content but from independent stochastic processes. Using the correlation coefficient and the maximum cross-correlation, we estimate interdependencies between these time series. With clustering coefficient and average shortest path length, we observe unweighted interaction networks, derived via thresholding the values of interdependence, to possess non-trivial topologies as compared to Erdos-Renyi networks, which would indicate small-world characteristics. These topologies reflect the mostly unavoidable finiteness of the data, which limits the reliability of typically used estimators of signal interdependence. We propose random networks that are tailored to the way interaction networks are derived from empirical data. Through an exemplary investigation of multichannel electroencephalographic recordings of epileptic seizures - known for their complex spatial and temporal dynamics - we show that such random networks help to distinguish network properties of interdependence structures related to seizure dynamics from those spuriously induced by the applied methods of analysis.	[Bialonski, Stephan; Lehnertz, Klaus] Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany; [Bialonski, Stephan; Lehnertz, Klaus] Univ Bonn, Helmholtz Inst Radiat & Nucl Phys, D-5300 Bonn, Germany; [Bialonski, Stephan; Lehnertz, Klaus] Univ Bonn, Interdisciplinary Ctr Complex Syst, D-5300 Bonn, Germany; [Wendler, Martin] Ruhr Univ Bochum, Fak Math, D-4630 Bochum, Germany	University of Bonn; Helmholtz Association; University of Bonn; University of Bonn; Ruhr University Bochum	Bialonski, S (corresponding author), Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany.	bialonski@gmx.net	Bialonski, Stephan/C-8790-2012	Bialonski, Stephan/0000-0003-1150-8080; Lehnertz, Klaus/0000-0002-5529-8559	German National Academic Foundation; German Science Foundation [LE 660/4-2]	German National Academic Foundation; German Science Foundation(German Research Foundation (DFG))	MW and SB were supported by the German National Academic Foundation. SB and KL acknowledge support from the German Science Foundation (LE 660/4-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2006, NONLINEAR PROC GEOPH, V13, P145, DOI 10.5194/npg-13-145-2006; Abe S, 2004, PHYSICA A, V337, P357, DOI 10.1016/j.physa.2004.01.059; Antiqueira L, 2010, NEUROIMAGE, V53, P439, DOI 10.1016/j.neuroimage.2010.06.018; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Artzy-Randrup Y, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056708; Artzy-Randrup Yael, 2004, Science, V305, P1107; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bartolomei F, 2010, EPILEPSIA, V51, P2147, DOI 10.1111/j.1528-1167.2010.02690.x; Bialonski S, 2010, CHAOS, V20, DOI 10.1063/1.3360561; Blitzstein J, 2011, INTERNET MATH, V6, P489, DOI 10.1080/15427951.2010.557277; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Boginski V, 2005, COMPUT STAT DATA AN, V48, P431, DOI 10.1016/j.csda.2004.02.004; Breakspear M, 2003, PHYSICA D, V182, P1, DOI 10.1016/S0167-2789(03)00136-2; Brillinger D.R., 1981, TIME SERIES DATA ANA; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Del Genio CI, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010012, 10.1371/journal.pone.0015369]; Donges JF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48007; Donges JF, 2009, EUR PHYS J-SPEC TOP, V174, P157, DOI 10.1140/epjst/e2009-01098-2; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012884; Emmert-Streib F, 2010, COMPLEXITY, V16, P24, DOI 10.1002/cplx.20315; Franaszczuk PJ, 1998, ELECTROEN CLIN NEURO, V106, P513, DOI 10.1016/S0013-4694(98)00024-8; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Ioannides AA, 2007, CURR OPIN NEUROBIOL, V17, P161, DOI 10.1016/j.conb.2007.03.008; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Jimenez A, 2008, NONLINEAR PROC GEOPH, V15, P389, DOI 10.5194/npg-15-389-2008; Jouny CC, 2003, CLIN NEUROPHYSIOL, V114, P426, DOI 10.1016/S1388-2457(02)00344-9; Kantz H., 2003, NONLINEAR TIME SERIE; Kramer MA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061916; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lehnertz K, 2009, J NEUROSCI METH, V183, P42, DOI 10.1016/j.jneumeth.2009.05.015; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2004, SCIENCE, V305; Mohan TRK, 2011, J SEISMOL, V15, P71, DOI 10.1007/s10950-010-9208-5; Nakamura T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056216; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2004, EUR PHYS J B, V38, P353, DOI 10.1140/epjb/e2004-00128-7; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Press WH., 2002, NUMERICAL RECIPES C, V2; Qiu T, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043057; Rao A R, 1996, SANKHYA A, V58, P225; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roberts JM, 2000, SOC NETWORKS, V22, P273, DOI 10.1016/S0378-8733(00)00026-5; Romano MC, 2009, CHAOS, V19, DOI 10.1063/1.3072784; Schiff SJ, 2000, CLIN NEUROPHYSIOL, V111, P953, DOI 10.1016/S1388-2457(00)00259-5; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Schindler KA, 2008, CHAOS, V18, DOI 10.1063/1.2966112; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Small M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.188101; STEINHAEUSER K, 2011, STAT ANAL D IN PRESS, V4; Suzuki T, 2007, PHYSICA D, V231, P108, DOI 10.1016/j.physd.2007.04.006; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tsonis AA, 2004, PHYSICA A, V333, P497, DOI 10.1016/j.physa.2003.10.045; TSONIS AA, 2010, CLIM DYNAM IN PRESS; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yamasaki K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228501	72	46	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22826	10.1371/journal.pone.0022826	http://dx.doi.org/10.1371/journal.pone.0022826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850239	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300024
J	Hioe, CE; Tuen, M; Vasiliver-Shamis, G; Alvarez, Y; Prins, KC; Banerjee, S; Nadas, A; Cho, MW; Dustin, ML; Kachlany, SC				Hioe, Catarina E.; Tuen, Michael; Vasiliver-Shamis, Gaia; Alvarez, Yelina; Prins, Kathleen C.; Banerjee, Sagarika; Nadas, Arthur; Cho, Michael W.; Dustin, Michael L.; Kachlany, Scott C.			HIV Envelope gp120 Activates LFA-1 on CD4 T-Lymphocytes and Increases Cell Susceptibility to LFA-1-Targeting Leukotoxin (LtxA)	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIROLOGICAL SYNAPSE FORMATION; BLOOD MONONUCLEAR-CELLS; ANTIRETROVIRAL THERAPY; TYPE-1 INFECTION; TARGET-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; NEUTRALIZATION; ADHESION; VIREMIA	The cellular adhesion molecule LFA-1 and its ICAM-1 ligand play an important role in promoting HIV-1 infectivity and transmission. These molecules are present on the envelope of HIV-1 virions and are integral components of the HIV virological synapse. However, cellular activation is required to convert LFA-1 to the active conformation that has high affinity binding for ICAM-1. This study evaluates whether such activation can be induced by HIV itself. The data show that HIV-1 gp120 was sufficient to trigger LFA-1 activation in fully quiescent naive CD4 T cells in a CD4-dependent manner, and these CD4 T cells became more susceptible to killing by LtxA, a bacterial leukotoxin that preferentially targets leukocytes expressing high levels of the active LFA-1. Moreover, virus p24-expressing CD4 T cells in the peripheral blood of HIV-infected subjects were found to have higher levels of surface LFA-1, and LtxA treatment led to significant reduction of the viral DNA burden. These results demonstrate for the first time the ability of HIV to directly induce LFA-1 activation on CD4 T cells. Although LFA-1 activation may enhance HIV infectivity and transmission, it also renders the cells more susceptible to an LFA-1-targeting bacterial toxin, which may be harnessed as a novel therapeutic strategy to deplete virus reservoir in HIV-infected individuals.	[Hioe, Catarina E.; Tuen, Michael; Alvarez, Yelina; Prins, Kathleen C.; Banerjee, Sagarika] New York Univ Sch Med, Dept Pathol, New York, NY 10016 USA; [Hioe, Catarina E.; Tuen, Michael; Alvarez, Yelina; Prins, Kathleen C.; Banerjee, Sagarika] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Vasiliver-Shamis, Gaia; Prins, Kathleen C.; Dustin, Michael L.] New York Univ Sch Med, Program Mol Pathogenesis, Marty & Helen Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY USA; [Nadas, Arthur] New York Univ Sch Med, Dept Environm Med, New York, NY USA; [Cho, Michael W.] Iowa State Univ, Dept Biomed Sci, Coll Vet Med, Ames, IA USA; [Kachlany, Scott C.] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA; [Kachlany, Scott C.] Actinobac Biomed Inc, N Brunswick, NJ USA	New York University; New York University; New York University; Iowa State University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Hioe, CE (corresponding author), New York Univ Sch Med, Dept Pathol, Manhattan Campus, New York, NY 10016 USA.	catarina.hioe@nyumc.org	Banerjee, Sagarika/AAR-2682-2020; Dustin, Michael/AAM-4611-2020	Banerjee, Sagarika/0000-0002-4549-3342; Cho, Michael/0000-0003-0522-345X; Dustin, Michael/0000-0003-4983-6389	National Institutes of Health [AI71815, AI71815S, DE16133, AI080606, AI044931, AI080192, P01-AI074286, AI085958, AI1007647]; United States Department of Veterans Affairs, New York University Center for AIDS Research [AI-27742]; Training Program in TB and HIV Prevention and Treatment [D43 TWO1409]; FOGARTY INTERNATIONAL CENTER [D43TW001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044931, R01AI044931, R21AI080606, R21AI071815, P01AI074286, P01AI080192, P30AI027742, F31AI085958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs, New York University Center for AIDS Research(US Department of Veterans Affairs); Training Program in TB and HIV Prevention and Treatment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by National Institutes of Health grants AI71815 and AI71815S (CEH), DE16133 and AI080606 (SCK), AI044931 and AI080192 (MLD), P01-AI074286 (MWC), AI085958 (YA), AI1007647 (KCP), as well as a Merit Review Award and the Research Enhancement Award Program of the United States Department of Veterans Affairs, New York University Center for AIDS Research (AI-27742), and the Training Program in TB and HIV Prevention and Treatment (D43 TWO1409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achkar JM, 2000, J ACQ IMMUN DEF SYND, V24, P203; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bastiani L, 1997, J VIROL, V71, P3444, DOI 10.1128/JVI.71.5.3444-3450.1997; Brennan TP, 2009, J VIROL, V83, P8470, DOI 10.1128/JVI.02568-08; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; CAPOBIANCHI MR, 1994, J INFECT DIS, V169, P886, DOI 10.1093/infdis/169.4.886; Cho MW, 2001, J VIROL, V75, P2224, DOI 10.1128/JVI.75.5.2224-2234.2001; Cicala C, 2006, VIROLOGY, V345, P105, DOI 10.1016/j.virol.2005.09.052; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Di Mascio M, 2004, J VIROL, V78, P10566, DOI 10.1128/JVI.78.19.10566-10573.2004; Diaz R, 2006, MICROB PATHOGENESIS, V40, P48, DOI 10.1016/j.micpath.2005.10.005; Fischer M, 2000, AIDS RES HUM RETROV, V16, P1135, DOI 10.1089/088922200414974; Fortin JF, 2000, VIROLOGY, V268, P493, DOI 10.1006/viro.2000.0190; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Fortin JF, 1998, J VIROL, V72, P2105, DOI 10.1128/JVI.72.3.2105-2112.1998; Fortin JF, 1999, VIROLOGY, V257, P228, DOI 10.1006/viro.1999.9687; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hioe CE, 1998, AIDS RES HUM RETROV, V14, pS247; Hioe CE, 1999, AIDS RES HUM RETROV, V15, P523, DOI 10.1089/088922299311042; Hioe CE, 2001, J VIROL, V75, P1077, DOI 10.1128/JVI.75.2.1077-1082.2001; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jones LE, 2007, JAIDS-J ACQ IMM DEF, V45, P483, DOI 10.1097/QAI.0b013e3180654836; Kachlany SC, 2010, LEUKEMIA RES, V34, P777, DOI 10.1016/j.leukres.2009.08.022; Kaur G, 2007, VIROLOGY, V369, P214, DOI 10.1016/j.virol.2007.07.031; Kennedy PE, 2006, J LEUKOCYTE BIOL, V80, P1175, DOI 10.1189/jlb.0306139; Kinter AL, 2003, J IMMUNOL, V170, P2449, DOI 10.4049/jimmunol.170.5.2449; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Korman BD, 2009, ARCH DERMATOL, V145, P937, DOI 10.1001/archdermatol.2009.175; Losier M, 2003, CLIN IMMUNOL, V108, P111, DOI 10.1016/S1521-6616(03)00093-7; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; Misse D, 2005, AIDS, V19, P897, DOI 10.1097/01.aids.0000171403.07995.92; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Pessler F, 2004, GENES IMMUN, V5, P158, DOI 10.1038/sj.gene.6364047; Pincus SH, 2003, AIDS RES HUM RETROV, V19, P901, DOI 10.1089/088922203322493076; Rizzuto CD, 1997, J VIROL, V71, P4847, DOI 10.1128/JVI.71.6.4847-4851.1997; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; STENDERUP K, 2011, J INVEST DE IN PRESS, P11601; Tardif MR, 2009, ANTIMICROB AGENTS CH, V53, P4656, DOI 10.1128/AAC.00117-09; Vasiliver-Shamis G, 2008, J VIROL, V82, P9445, DOI 10.1128/JVI.00835-08; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09	50	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23202	10.1371/journal.pone.0023202	http://dx.doi.org/10.1371/journal.pone.0023202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850260	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300045
J	Watabe, S; Sakamoto, Y; Morikawa, M; Okada, R; Miura, T; Ito, E				Watabe, Satoshi; Sakamoto, Yuki; Morikawa, Mika; Okada, Ryuichi; Miura, Toshiaki; Ito, Etsuro			Highly Sensitive Determination of Hydrogen Peroxide and Glucose by Fluorescence Correlation Spectroscopy	PLOS ONE			English	Article							FLUOROMETRIC-DETERMINATION; HORSERADISH-PEROXIDASE; QUANTIFICATION; AMPLIFICATION; OXIDATION; TYROSINE; OXIDASE; WATER	Background: Because H2O2 is generated by various oxidase-catalyzed reactions, a highly sensitive determination method of H2O2 is applicable to measurements of low levels of various oxidases and their substrates such as glucose, lactate, glutamate, urate, xanthine, choline, cholesterol and NADPH. We propose herein a new, highly sensitive method for the measurement of H2O2 and glucose using fluorescence correlation spectroscopy (FCS). Methodology/Principal Findings: FCS has the advantage of allowing us to determine the number of fluorescent molecules. FCS measures the fluctuations in fluorescence intensity caused by fluorescent probe movement in a small light cavity with a defined volume generated by confocal illumination. We thus developed a highly sensitive determination system of H2O2 by FCS, where horseradish peroxidase (HRP) catalyzes the formation of a covalent bond between fluorescent molecules and proteins in the presence of H2O2. Our developed system gave a linear calibration curve for H2O2 in the range of 28 to 300 nM with the detection limit of 8 nM. In addition, by coupling with glucose oxidase (GOD)-catalyzed reaction, the method allows to measure glucose in the range of 80 nM to 1.5 mu M with detection limit of 24 nM. The method was applicable to the assay of glucose in blood plasma. The mean concentration of glucose in normal human blood plasma was determined to be 4.9 mM. Conclusions/Significance: In comparison with commercial available methods, the detection limit and the minimum value of determination for glucose are at least 2 orders of magnitude more sensitive in our system. Such a highly sensitive method leads the fact that only a very small amount of plasma (20 nL) is needed for the determination of glucose concentration in blood plasma.	[Watabe, Satoshi] BL Co Ltd, Shizuoka, Japan; [Sakamoto, Yuki; Morikawa, Mika; Okada, Ryuichi; Ito, Etsuro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Kagawa, Japan; [Miura, Toshiaki] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 060, Japan	Tokushima Bunri University; Hokkaido University	Watabe, S (corresponding author), BL Co Ltd, Shizuoka, Japan.	eito@kph.bunri-u.ac.jp			Ministry of Economy, Trade, and Industry of Japan; Hokkaido Bureau of Economy, Trade, and Industry; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Economy, Trade, and Industry of Japan; Hokkaido Bureau of Economy, Trade, and Industry; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly funded by a research grant of the "New Regional Consortium Research and Development Project" from the Ministry of Economy, Trade, and Industry of Japan and the Hokkaido Bureau of Economy, Trade, and Industry, and a research grant of the "Knowledge Cluster Initiative (2009)" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Satoshi Watabe is an employee of BL Co. Ltd. and contributed to all aspects of the study.	BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Boren Suzanne Austin, 2010, J Diabetes Sci Technol, V4, P84; DELAHARPE J, 1985, J IMMUNOL METHODS, V78, P323, DOI 10.1016/0022-1759(85)90089-4; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Hu YF, 2008, LUMINESCENCE, V23, P338, DOI 10.1002/bio.1042; HWANG H, 1985, ANAL CHIM ACTA, V170, P347, DOI 10.1016/S0003-2670(00)81761-4; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Kotzian P, 2005, ANAL LETT, V38, P1099, DOI 10.1081/AL-200057205; Luo W, 2010, TALANTA, V81, P901, DOI 10.1016/j.talanta.2010.01.035; Nagaraja P, 2009, ANAL BIOCHEM, V395, P231, DOI 10.1016/j.ab.2009.07.053; Nomura Y, 2007, CURR PHARM BIOTECHNO, V8, P286, DOI 10.2174/138920107782109958; Ohye H, 2010, EXP BIOL MED, V235, P424, DOI 10.1258/ebm.2009.009241; PRAVDA M, 1995, ELECTROANAL, V7, P619, DOI 10.1002/elan.1140070704; Serrano J, 2009, BIOCHEM BIOPH RES CO, V388, P443, DOI 10.1016/j.bbrc.2009.08.041; Speel EJM, 1999, J HISTOCHEM CYTOCHEM, V47, P281, DOI 10.1177/002215549904700302; Tang B, 2006, SPECTROCHIM ACTA A, V63, P609, DOI 10.1016/j.saa.2005.06.008; Tonyushkina Ksenia, 2009, J Diabetes Sci Technol, V3, P971; Tortora G. J., 2006, PRINCIPLES ANATOMY P; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; ZAITSU K, 1980, ANAL BIOCHEM, V109, P109, DOI 10.1016/0003-2697(80)90017-2; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	21	17	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22955	10.1371/journal.pone.0022955	http://dx.doi.org/10.1371/journal.pone.0022955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850246	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300031
J	Pieper, D; Schirmer, S; Prechtel, AT; Kehlenbach, RH; Hauber, J; Chemnitz, J				Pieper, Dorothea; Schirmer, Susann; Prechtel, Alexander T.; Kehlenbach, Ralph H.; Hauber, Joachim; Chemnitz, Jan			Functional Characterization of the HuR:CD83 mRNA Interaction	PLOS ONE			English	Article							REV TRANS-ACTIVATOR; HUR LIGAND APRIL; AU-RICH ELEMENTS; NUCLEAR EXPORT; DENDRITIC CELLS; LEPTOMYCIN B; GENE-EXPRESSION; IN-VITRO; CD83; BINDING	Maturation of dendritic cells (DC) is characterized by expression of CD83, a surface protein that appears to be necessary for the effective activation of naive T-cells and T-helper cells by DC. Lately it was shown that CD83 expression is regulated on the posttranscriptional level by interaction of the shuttle protein HuR with a novel posttranscriptional regulatory RNA element (PRE), which is located in the coding region of the CD83 transcript. Interestingly, this interaction commits the CD83 mRNA to efficient nuclear export via the CRM1 pathway. To date, however, the structural basis of this interaction, which potentially involves three distinct RNA recognition motifs (RRM1-3) in HuR and a complex three-pronged RNA stem-loop element in CD83 mRNA, has not been investigated in detail. In the present work we analyzed this interaction in vitro and in vivo using various HuR- and CD83 mRNA mutants. We are able to demonstrate that both, RRM1 and RRM2 are crucial for binding, whereas RRM3 as well as the HuR hinge region contributed only marginally to this protein: RNA interaction. Furthermore, mutation of uridine rich patches within the PRE did not disturb HuR:CD83 mRNA complex formation while, in contrast, the deletion of specific PRE subfragments from the CD83 mRNA prevented HuR binding in vitro and in vivo. Interestingly, the observed inhibition of HuR binding to CD83 mRNA does not lead to a nuclear trapping of the transcript but rather redirected this transcript from the CRM1-towards the NXF1/TAP-specific nuclear export pathway. Thus, the presence of a functional PRE permits nucleocytoplasmic trafficking of the CD83 transcript via the CRM1 pathway.	[Pieper, Dorothea; Schirmer, Susann; Prechtel, Alexander T.; Hauber, Joachim; Chemnitz, Jan] Leibniz Inst Expt Virol, Dept Cell Biol & Virol, Heinrich Pette Inst, Hamburg, Germany; [Kehlenbach, Ralph H.] Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Gottingen, Germany	Heinrich Pette Institute; University of Gottingen	Pieper, D (corresponding author), Leibniz Inst Expt Virol, Dept Cell Biol & Virol, Heinrich Pette Inst, Hamburg, Germany.	jan.chemnitz@hpi.uni-hamburg.de		Kehlenbach, Ralph/0000-0003-4920-9916	Wilhelm Sander-Stiftung [1003.033.1]; Deutsche Forschungsgemeinschaft [CH668/1-1]; Free and Hanseatic City of Hamburg; Federal Ministry of Health	Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Free and Hanseatic City of Hamburg; Federal Ministry of Health	This work received financial support from the Wilhelm Sander-Stiftung (grant 1003.033.1) and from the Deutsche Forschungsgemeinschaft (grant CH668/1-1). The Heinrich Pette Institute is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasoy U, 1998, J CELL SCI, V111, P3145; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Berchtold S, 2002, IMMUNOBIOLOGY, V205, P231, DOI 10.1078/0171-2985-00128; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Browne SK, 2006, J IMMUNOL, V177, P8612, DOI 10.4049/jimmunol.177.12.8612; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chemnitz J, 2010, IMMUNOBIOLOGY, V215, P370, DOI 10.1016/j.imbio.2009.05.008; Chemnitz J, 2009, EUR J IMMUNOL, V39, P267, DOI 10.1002/eji.200838619; Chung SM, 1996, J BIOL CHEM, V271, P11518, DOI 10.1074/jbc.271.19.11518; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P10497, DOI 10.1021/bi00090a028; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fries B, 2007, J BIOL CHEM, V282, P4504, DOI 10.1074/jbc.M608849200; Fujimoto Yoko, 2006, Journal of Medical and Dental Sciences, V53, P85; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Heger P, 1999, ONCOGENE, V18, P4080, DOI 10.1038/sj.onc.1202762; Higashino F, 2005, J CELL BIOL, V170, P15, DOI 10.1083/jcb.200405112; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jang BC, 2003, J BIOL CHEM, V278, P2773, DOI 10.1074/jbc.C200620200; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Kimura T, 2004, J CELL SCI, V117, P2259, DOI 10.1242/jcs.01076; Kimura T, 2010, MED MOL MORPHOL, V43, P145, DOI 10.1007/s00795-010-0492-5; KING PH, 1994, J NEUROSCI, V14, P1943; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lechmann M, 2002, INT ARCH ALLERGY IMM, V129, P113, DOI 10.1159/000065883; Lewis T, 1998, J BIOL CHEM, V273, P13781, DOI 10.1074/jbc.273.22.13781; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Prazma CM, 2008, IMMUNOL LETT, V115, P1, DOI 10.1016/j.imlet.2007.10.001; Prechtel AT, 2007, ARCH DERMATOL RES, V299, P59, DOI 10.1007/s00403-007-0743-z; Prechtel AT, 2006, J BIOL CHEM, V281, P10912, DOI 10.1074/jbc.M510306200; Rosorius O, 1999, BIOTECHNIQUES, V27, P350, DOI 10.2144/99272rr02; Schutz S, 2006, J MOL BIOL, V358, P997, DOI 10.1016/j.jmb.2006.02.041; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Strom AC, 2001, GENOME BIOL, V2; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; Tsai NP, 2010, J CELL BIOL, V188, P325, DOI 10.1083/jcb.200910083; Wodrich H, 2000, NUCLEIC ACIDS RES, V28, P901, DOI 10.1093/nar/28.4.901; Yi J, 2010, NUCLEIC ACIDS RES, V38, P1547, DOI 10.1093/nar/gkp1114; ZHOU LJ, 1992, J IMMUNOL, V149, P735; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	69	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23290	10.1371/journal.pone.0023290	http://dx.doi.org/10.1371/journal.pone.0023290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829725	gold, Green Submitted, Green Published			2022-12-27	WOS:000293561200062
J	Churchyard, GJ; Morgan, C; Adams, E; Hural, J; Graham, BS; Moodie, Z; Grove, D; Gray, G; Bekker, LG; McElrath, MJ; Tomaras, GD; Goepfert, P; Kalams, S; Baden, LR; Lally, M; Dolin, R; Blattner, W; Kalichman, A; Figueroa, JP; Pape, J; Schechter, M; Defawe, O; De Rosa, SC; Montefiori, DC; Nabel, GJ; Corey, L; Keefer, MC				Churchyard, Gavin J.; Morgan, Cecilia; Adams, Elizabeth; Hural, John; Graham, Barney S.; Moodie, Zoe; Grove, Doug; Gray, Glenda; Bekker, Linda-Gail; McElrath, M. Juliana; Tomaras, Georgia D.; Goepfert, Paul; Kalams, Spyros; Baden, Lindsey R.; Lally, Michelle; Dolin, Raphael; Blattner, William; Kalichman, Artur; Figueroa, J. Peter; Pape, Jean; Schechter, Mauro; Defawe, Olivier; De Rosa, Stephen C.; Montefiori, David C.; Nabel, Gary J.; Corey, Lawrence; Keefer, Michael C.		NIAID HIV Vaccine Trials Network	A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)	PLOS ONE			English	Article							MEMORY T-CELLS; IMMUNOGENICITY EVALUATION; CANDIDATE; RESPONSES; ANTIBODY; INFECTION; IMMUNITY; SAFETY; ASSAY; STEP	Background: The safety and immunogenicity of a vaccine regimen consisting of a 6-plasmid HIV-1 DNA prime (envA, envB, envC, gagB, polB, nefB) boosted by a recombinant adenovirus serotype-5 (rAd5) HIV-1 with matching inserts was evaluated in HIV-seronegative participants from South Africa, United States, Latin America and the Caribbean. Methods: 480 participants were evenly randomized to receive either: DNA (4 mg IM by Biojector) at 0, 1 and 2 months, followed by rAd5 (10(10) PU IM by needle/syringe) at 6 months; or placebo. Participants were monitored for reactogenicity and adverse events throughout the 12-month study. Peak and duration of HIV-specific humoral and cellular immune responses were evaluated after the prime and boost. Results: The vaccine was well tolerated and safe. T-cell responses, detected by interferon-gamma (IFN-gamma) ELISpot to global potential T-cell epitopes (PTEs) were observed in 70.8% (136/192) of vaccine recipients overall, most frequently to Gag (54.7%) and to Env (54.2%). In U.S. vaccine recipients T-cell responses were less frequent in Ad5 sero-positive versus seronegative vaccine recipients (62.5% versus 85.7% respectively, p = 0.035). The frequency of HIV-specific CD4+ and CD8+ T-cell responses detected by intracellular cytokine staining were similar (41.8% and 47.2% respectively) and most secreted >= 2 cytokines. The vaccine induced a high frequency (83.7%-94.6%) of binding antibody responses to consensus Group M, and Clades A, B and C gp140 Env oligomers. Antibody responses to Gag were elicited in 46% of vaccine recipients. Conclusion: The vaccine regimen was well-tolerated and induced polyfunctional CD4+ and CD8+ T-cells and multi-clade anti-Env binding antibodies.	[Churchyard, Gavin J.] Aurum Inst Hlth Res, Klerksdorp, South Africa; [Churchyard, Gavin J.] Univ KwaZulu Natal, CAPRISA, Durban, South Africa; [Morgan, Cecilia; Hural, John; Moodie, Zoe; Grove, Doug; McElrath, M. Juliana; Defawe, Olivier; De Rosa, Stephen C.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Adams, Elizabeth] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Graham, Barney S.; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Gray, Glenda] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Fdn, ZA-7925 Cape Town, South Africa; [Tomaras, Georgia D.] Duke Univ, Med Ctr, Durham, NC USA; [Goepfert, Paul] Univ Alabama Birmingham, Birmingham, AL USA; [Kalams, Spyros] Vanderbilt Univ, Nashville, TN USA; [Baden, Lindsey R.] Harvard Brigham & Womens Hosp, Boston, MA USA; [Lally, Michelle] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Lally, Michelle] Miriam Hosp, Providence, RI 02906 USA; [Dolin, Raphael] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Blattner, William] Univ Maryland, College Pk, MD 20742 USA; [Kalichman, Artur] Coordenacao Inst Pesquisa, Ctr Referencia & Treinamento DST AIDS, Sao Paulo, Brazil; [Figueroa, J. Peter] ERTU, Kingston, Jamaica; [Pape, Jean] Inst Natl Lab & Rech, Cornell GHESKIO, Port Au Prince, Haiti; [Schechter, Mauro] Univ Fed Rio de Janeiro, Hosp Escola Sao Francisco de Assis, Projeto Praca Onze, Rio De Janeiro, Brazil; [Montefiori, David C.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC USA; [Keefer, Michael C.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	University of Kwazulu Natal; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Witwatersrand; University of Cape Town; Duke University; University of Alabama System; University of Alabama Birmingham; Vanderbilt University; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University System of Maryland; University of Maryland College Park; Universidade Federal do Rio de Janeiro; Duke University; University of Rochester	Churchyard, GJ (corresponding author), Aurum Inst Hlth Res, Klerksdorp, South Africa.	gchurchyard@auruminstitute.org	Tomaras, Georgia/J-5041-2016; Corey, Lawrence/AAE-1796-2020; Bekker, Linda-Gail/AAZ-8929-2020; Lally, Michelle/I-4865-2016; Schechter, Mauro/AAG-7445-2020; Graham, Barney S./AAC-5898-2019	Corey, Lawrence/0000-0002-2179-2436; Lally, Michelle/0000-0003-0716-4668; Graham, Barney S./0000-0001-8112-0853; Churchyard, Gavin/0000-0002-4269-3699; BEKKER, LINDA-GAIL/0000-0002-0755-4386	National Institutes of Health (NIH) [AI046747/AI068614, AI046703/AI068635, AI046725/AI068618, AI047996/AI069452, AI048001/AI069447, AI048023/AI069412, AI047980/AI069511, AI047985/AI069439, AI046747, AI069420, AI069409, AI069469, AI069519, AI069414, AI069453, 30022/1U01AI069421/U01AI046747]; NIH Division of AIDS; VRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068614, UM1AI069511, U01AI069439, U01AI069511, U01AI068618, U01AI046703, ZIAAI005035, U01AI069412, U01AI069414, U01AI069420, UM1AI069452, U01AI047980, U01AI046747, UM1AI069409, UM1AI069439, U01AI047996, UM1AI068618, U01AI048023, U01AI069409, U01AI068635, U01AI046725, U01AI048001, U01AI047985, UM1AI069412, U01AI069447, U01AI069519, U01AI069453, U01AI069469, U01AI069452, U01AI069421, UM1AI069453, UM1AI069469, UM1AI069420, UM1AI068635, UM1AI069519, U01AI068614] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Division of AIDS; VRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grants from the National Institutes of Health (NIH) to the following respective institutions: AI046747/AI068614 (HVTN Core); AI046703/AI068635 (HVTN SCHARP); AI046725/AI068618 (HVTN Laboratory program); AI047996/AI069452 (University of Alabama at Birmingham); AI048001/AI069447 (University of Maryland Baltimore); AI048023/AI069412 (Brigham and Women's Hospital, Miriam Hospital); AI047980/AI069511 (University of Rochester); AI047985/AI069439 (Vanderbilt University); AI046747 (Centro de Referencia e Treinamento-DST/AIDS, ERTU, Klerksdorp, Desmond Tutu HIV Center at Cape Town, Hospital Escola Sao Francisco de Assi, and Perinatal HIV Research Unit); AI069420 (Centro de Referencia e Treinamento-DST/AIDS); AI069409 Epidemiology Research and Training Unit (ERTU); AI069469 (Klerksdorp); AI069519 (Desmond Tutu HIV Center); AI069414 (Hospital Escola Sao Francisco de Assi); AI069453 (Perinatal HIV Research Unit); 30022/1U01AI069421/U01AI046747 (GHESKIO). The funders provided input into the study design, analysis and preparation of the manuscript through the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), and (NIH).; We thank the NIH Division of AIDS and the VRC for their support during the conduct of the study. We thank all the study participants and the following research staff are gratefully acknowledged for their contribution to the successful conduct of this study: Mhorag Hay, Catherine Bunce, Xia Jin, Jane Kleinjan, Lizanne Noble, Robert Tucker, Michael Seaman, Julie O'Reilly, Lynne Kasiske, Patrick Fisher, Monica Barbosa de Souza, Carina Beppu Yoshida, Maria de Fatima Melo, Daniel Garcia Pereira Neto, Paulo Cesar Hammes, Jose Claudio Faulhaber, Ana Lucia Weinstein, Sandra Regina Barros Telles, Narda Nery Tebet, Mary Latka, Mampedi Bogoshi, Joseph Mohlakoana, Kathy Mngadi, Tanya Nielson, Sirlene Caminada, Gabriela Junqueira Calazans, Surita Roux, Eftyhia Vardas, Guy De Bruyn.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Cheng C, 2010, J VIROL, V84, P630, DOI 10.1128/JVI.00866-09; Eller MA, 2007, VACCINE, V25, P7737, DOI 10.1016/j.vaccine.2007.08.056; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization ( WHO), 2009, 2009 AIDS EP UPD; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Seaman MS, 2005, J VIROL, V79, P2956, DOI 10.1128/JVI.79.5.2956-2963.2005; Spentzou A, 2010, J INFECT DIS, V201, P720, DOI 10.1086/650492; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08	32	115	123	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e21225	10.1371/journal.pone.0021225	http://dx.doi.org/10.1371/journal.pone.0021225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857901	gold, Green Published, Green Submitted			2022-12-27	WOS:000293558900004
J	Moran, RJ; Jung, F; Kumagai, T; Endepols, H; Graf, R; Dolan, RJ; Friston, KJ; Stephan, KE; Tittgemeyer, M				Moran, Rosalyn J.; Jung, Fabienne; Kumagai, Tetsuya; Endepols, Heike; Graf, Rudolf; Dolan, Raymond J.; Friston, Karl J.; Stephan, Klaas E.; Tittgemeyer, Marc			Dynamic Causal Models and Physiological Inference: A Validation Study Using Isoflurane Anaesthesia in Rodents	PLOS ONE			English	Article							NEURAL MASS MODEL; PRIMARY AUDITORY-CORTEX; HIGH-RESOLUTION EEG; VOLATILE ANESTHETICS; EFFECTIVE CONNECTIVITY; GENERAL-ANESTHETICS; SPECTRAL RESPONSES; EVOKED-RESPONSES; ELECTROENCEPHALOGRAM; MECHANISMS	Generative models of neuroimaging and electrophysiological data present new opportunities for accessing hidden or latent brain states. Dynamic causal modeling (DCM) uses Bayesian model inversion and selection to infer the synaptic mechanisms underlying empirically observed brain responses. DCM for electrophysiological data, in particular, aims to estimate the relative strength of synaptic transmission at different cell types and via specific neurotransmitters. Here, we report a DCM validation study concerning inference on excitatory and inhibitory synaptic transmission, using different doses of a volatile anaesthetic agent (isoflurane) to parametrically modify excitatory and inhibitory synaptic processing while recording local field potentials (LFPs) from primary auditory cortex (A1) and the posterior auditory field (PAF) in the auditory belt region in rodents. We test whether DCM can infer, from the LFP measurements, the expected drug-induced changes in synaptic transmission mediated via fast ionotropic receptors; i.e., excitatory (glutamatergic) AMPA and inhibitory GABA(A) receptors. Cross-and auto-spectra from the two regions were used to optimise three DCMs based on biologically plausible neural mass models and specific network architectures. Consistent with known extrinsic connectivity patterns in sensory hierarchies, we found that a model comprising forward connections from A1 to PAF and backward connections from PAF to A1 outperformed a model with forward connections from PAF to A1 and backward connections from A1 to PAF and a model with reciprocal lateral connections. The parameter estimates from the most plausible model indicated that the amplitude of fast glutamatergic excitatory postsynaptic potentials (EPSPs) and inhibitory postsynaptic potentials (IPSPs) behaved as predicted by previous neurophysiological studies. Specifically, with increasing levels of anaesthesia, glutamatergic EPSPs decreased linearly, whereas fast GABAergic IPSPs displayed a nonlinear (saturating) increase. The consistency of our model-based in vivo results with experimental in vitro results lends further validity to the capacity of DCM to infer on synaptic processes using macroscopic neurophysiological data.	[Moran, Rosalyn J.; Dolan, Raymond J.; Friston, Karl J.; Stephan, Klaas E.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Stephan, Klaas E.] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Jung, Fabienne; Kumagai, Tetsuya; Endepols, Heike; Graf, Rudolf; Tittgemeyer, Marc] Max Planck Inst Neurol Res, Cologne, Germany	University of London; University College London; University of Zurich; Max Planck Society	Moran, RJ (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	r.moran@fil.ion.ucl.ac.uk	Endepols, Heike/AAG-7794-2020; Friston, Karl/D-9230-2011	Endepols, Heike/0000-0002-6166-4818; Friston, Karl/0000-0001-7984-8909; Moran, Rosalyn/0000-0002-2736-2621; Stephan, Klaas Enno/0000-0002-8594-9092; Dolan, Ray/0000-0001-9356-761X	Max Planck Society; SystemsX.ch; Wellcome Trust	Max Planck Society(Max Planck SocietyFoundation CELLEX); SystemsX.ch; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Max Planck Society (MT, FJ, TK, HE, RG, RJM), the NEUROCHOICE project of SystemsX.ch (KES), and the Wellcome Trust (RJD, KJF, RJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks MI, 1999, ANESTHESIOLOGY, V90, P120, DOI 10.1097/00000542-199901000-00018; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Breakspear M, 2003, NEUROIMAGE, V20, P466, DOI 10.1016/S1053-8119(03)00332-X; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Clearwater JM, 2008, J THEOR BIOL, V255, P287, DOI 10.1016/j.jtbi.2008.08.010; DASILVA L, 2004, MAGNETIC RESONANCE I, V22, P1533; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Detsch O, 1999, BRAIN RES, V829, P77, DOI 10.1016/S0006-8993(99)01341-4; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; ECCLES JC, 1951, ELECTROEN CLIN NEURO, V3, P449, DOI 10.1016/0013-4694(51)90033-8; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Flood P, 1997, ANESTHESIOLOGY, V86, P859, DOI 10.1097/00000542-199704000-00016; Foster BL, 2008, COGN NEURODYNAMICS, V2, P283, DOI 10.1007/s11571-008-9063-z; FRANKS NP, 1993, BRIT J ANAESTH, V71, P65, DOI 10.1093/bja/71.1.65; Freeman WJ, 2006, CLIN NEUROPHYSIOL, V117, P572, DOI 10.1016/j.clinph.2005.10.025; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; FRISTON KJ, 2010, NEURO IMAGE; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; HENSON RN, HUMAN BRAIN MAPPING; Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; JOHNSEN JB, 1992, ACTA ANAESTHESIOLOGI, V36, P350; KELLY JP, 1981, BRAIN RES, V212, P1, DOI 10.1016/0006-8993(81)90027-5; Kiebel SJ, 2006, NEUROIMAGE, V30, P1273, DOI 10.1016/j.neuroimage.2005.12.055; LANGMOEN IA, 1995, EUR J ANAESTH, V12, P51; Larsen M, 1998, BRIT J ANAESTH, V80, P634, DOI 10.1093/bja/80.5.634; Liley DTJ, 2005, J CLIN NEUROPHYSIOL, V22, P300; Lukatch HS, 2005, CEREB CORTEX, V15, P1322, DOI 10.1093/cercor/bhi015; Marreiros AC, 2009, NEUROIMAGE, V44, P701, DOI 10.1016/j.neuroimage.2008.10.008; MIAO N, 1995, ANESTHESIOLOGY, V83, P593, DOI 10.1097/00000542-199509000-00019; Moran RJ, 2008, NEUROIMAGE, V42, P272, DOI 10.1016/j.neuroimage.2008.01.025; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; Moran RJ, 2009, NEUROIMAGE, V44, P796, DOI 10.1016/j.neuroimage.2008.09.048; MORAN RJ, 2011, NEURO IMAGE; Nishikawa K, 2001, ANESTHESIOLOGY, V94, P340, DOI 10.1097/00000542-200102000-00025; Nishikawa K, 2000, ANESTHESIOLOGY, V92, P228, DOI 10.1097/00000542-200001000-00035; PANDYA DN, 1995, REV NEUROL, V151, P486; Pandya PK, 2008, CEREB CORTEX, V18, P301, DOI 10.1093/cercor/bhm055; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; RAMPIL IJ, 1988, ANESTHESIOLOGY, V69, P298, DOI 10.1097/00000542-198809000-00002; Ranft A, 2004, EUR J NEUROSCI, V20, P1276, DOI 10.1111/j.1460-9568.2004.03603.x; Riera J, 2005, PHILOS T ROY SOC B, V360, P1025, DOI 10.1098/rstb.2005.1646; Roberts SJ, 2002, IEEE T SIGNAL PROCES, V50, P2245, DOI 10.1109/TSP.2002.801921; Rouiller EM, 2004, NEUROSCI LETT, V358, P49, DOI 10.1016/j.neulet.2004.01.008; Sarkela Mika, 2002, J Clin Monit Comput, V17, P125, DOI 10.1023/A:1016393904439; Sleigh JW, 2004, PHYSIOL MEAS, V25, P921, DOI 10.1088/0967-3334/25/4/011; Sotero RC, 2007, NEURAL COMPUT, V19, P478, DOI 10.1162/neco.2007.19.2.478; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Steyn-Ross ML, 1999, PHYS REV E, V60, P7299, DOI 10.1103/PhysRevE.60.7299; Suffczynski P, 2001, INT J PSYCHOPHYSIOL, V43, P25, DOI 10.1016/S0167-8760(01)00177-5; Ursino M, 2007, BIOL CYBERN, V96, P351, DOI 10.1007/s00422-006-0122-4; Valdes-Sosa PA, 2009, HUM BRAIN MAPP, V30, P2701, DOI 10.1002/hbm.20704; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; WINGUTH SD, 1986, J COMP NEUROL, V248, P36, DOI 10.1002/cne.902480104; Zavaglia M, 2006, J NEUROSCI METH, V157, P317, DOI 10.1016/j.jneumeth.2006.04.022	61	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22790	10.1371/journal.pone.0022790	http://dx.doi.org/10.1371/journal.pone.0022790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829652	Green Published, gold			2022-12-27	WOS:000293511900014
J	Goldstein, JR				Goldstein, Joshua R.			A Secular Trend toward Earlier Male Sexual Maturity: Evidence from Shifting Ages of Male Young Adult Mortality	PLOS ONE			English	Article							REPRODUCTIVE MATURATION; NETHERLANDS; POPULATION; MENARCHE; GROWTH; BOYS	This paper shows new evidence of a steady long-term decline in age of male sexual maturity since at least the mid-eighteenth century. A method for measuring the timing of male maturity is developed based on the age at which male young adult mortality accelerates. The method is applied to mortality data from Sweden, Denmark, Norway, the United Kingdom, and Italy. The secular trend toward earlier male sexual maturity parallels the trend toward earlier menarche for females, suggesting that common environmental cues influence the speed of both males' and females' sexual maturation.	Max Planck Inst Demog Res, Rostock, Germany	Max Planck Society	Goldstein, JR (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	goldstein@demogr.mpg.de			University of California, Berkeley, Center for Economics and Demography of Aging NIH [P30 AG01283]	University of California, Berkeley, Center for Economics and Demography of Aging NIH(University of California System)	Research was supported by a subaward from University of California, Berkeley, Center for Economics and Demography of Aging NIH P30 AG01283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2003, AM J HUM BIOL, V15, P401, DOI 10.1002/ajhb.10157; Bodzsar Eva B., 2000, Acta Biologica Szegediensis, V44, P155; Bribiescas RG, 2001, YEARB PHYS ANTHROPOL, V44, P148, DOI 10.1002/ajpa.10025; Campbell B, 2006, ANN HUM BIOL, V33, P17, DOI 10.1080/03014460500424068; Campbell BC, 2004, ANN HUM BIOL, V31, P213, DOI 10.1080/03014460310001656604; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; DAW SF, 1970, HUM BIOL, V42, P87; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; Fedigan LM, 1997, AM J PHYS ANTHROPOL, V102, P161, DOI 10.1002/(SICI)1096-8644(199702)102:2<161::AID-AJPA2>3.0.CO;2-1; Fogel R., 2004, ESCAPE HUNGER PREMAT, DOI [10.1017/CBO9780511817649, DOI 10.1017/CBO9780511817649]; Frisch RE, 2006, SCIENCE, V311, P337; FRISCH RE, 1978, SCIENCE, V199, P22, DOI 10.1126/science.199.4324.22; Furstenberg F., 2004, CONTEXTS, V3, P33, DOI [10.1525/ctx.2004.3.3.33, DOI 10.1525/CTX.2004.3.3.33]; Gage TB, 1998, ANNU REV ANTHROPOL, V27, P197, DOI 10.1146/annurev.anthro.27.1.197; Heligman L., 1980, J I ACTUARIES, V107, P49, DOI DOI 10.1017/S0020268100040257; Helm P, 1998, ACTA OBSTET GYN SCAN, V77, P198, DOI 10.1034/j.1600-0412.1998.770213.x; Khadilkar VV, 2006, INDIAN PEDIATR, V43, P475; LEE R, 2003, POPULATION DEV REV, V29; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; LUDER HU, 1993, AM J PRIMATOL, V30, P139, DOI 10.1002/ajp.1350300206; Mul D, 2001, PEDIATR RES, V50, P479, DOI 10.1203/00006450-200110000-00010; PARKES AS, 1976, PATTERNS SEXUALITY R; Preston SH, 1976, MORTALITY PATTERNS N; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Statistics Norway, 2005, STAT YB NORW 2005; Stearns S.C., 1992, pi; Steckel RichardH., 1997, HLTH WELFARE IND; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; University of California Berkeley Max Planck Institute for Demographic Research Germany, HUM MORT DAT; Wachter K. W., 1990, CAMBRIDGE STUDIES PO; Wymelenberg S, 1990, SCI BABIES PRIVATE D	31	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e14826	10.1371/journal.pone.0014826	http://dx.doi.org/10.1371/journal.pone.0014826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810JJ	21857893	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300001
J	Ahmad, A; Dong, YZ; Cao, XF				Ahmad, Ayaz; Dong, Yuzhu; Cao, Xiaofeng			Characterization of the PRMT Gene Family in Rice Reveals Conservation of Arginine Methylation	PLOS ONE			English	Article							HISTONE METHYLATION; FLOWERING TIME; PROTEIN; METHYLTRANSFERASE; IDENTIFICATION; RNA; COACTIVATOR; SUBSTRATE; ENZYME; EXPRESSION	Post-translational methylation of arginine residues profoundly affects the structure and functions of protein and, hence, implicated in a myriad of essential cellular processes such as signal transduction, mRNA splicing and transcriptional regulation. Protein arginine methyltransferases (PRMTs), the enzymes catalyzing arginine methylation have been extensively studied in animals, yeast and, to some extent, in model plant Arabidopsis thaliana. Eight genes coding for the PRMTs were identified in Oryza sativa, previously. Here, we report that these genes show distinct expression patterns in various parts of the plant. In vivo targeting experiment demonstrated that GFP-tagged OsPRMT1, OsPRMT5 and OsPRMT10 were localized to both the cytoplasm and nucleus, whereas OsPRMT6a and OsPRMT6b were predominantly localized to the nucleus. OsPRMT1, OsPRMT4, OsPRMT5, OsPRMT6a, OsPRMT6b and OsPRMT10 exhibited in vitro arginine methyltransferase activity against myelin basic protein, glycine-arginine-rich domain of fibrillarin and calf thymus core histones. Furthermore, they depicted specificities for the arginine residues in histones H3 and H4 and were classified into type I and Type II PRMTs, based on the formation of type of dimethylarginine in the substrate proteins. The two homologs of OsPRMT6 showed direct interaction in vitro and further titrating different amounts of these proteins in the methyltransferase assay revealed that OsPRMT6a inhibits the methyltransferase activity of OsPRMT6b, probably, by the formation of heterodimer. The identification and characterization of PRMTs in rice suggests the conservation of arginine methylation in monocots and hold promise for gaining further insight into regulation of plant development.	[Ahmad, Ayaz; Dong, Yuzhu; Cao, Xiaofeng] Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China; [Ahmad, Ayaz; Dong, Yuzhu; Cao, Xiaofeng] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China; [Ahmad, Ayaz] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ahmad, A (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China.	xfcao@genetics.ac.cn	Ahmad, Ayaz/GVT-1025-2022	Ahmad, Ayaz/0000-0003-3555-4735	Higher Education Commission of Pakistan; National Basic Research Program of China [2011CB915400, 2009CB941500]; National Natural Science Foundation of China [30930048, 30621001]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The first author would like to cordially thank the Higher Education Commission of Pakistan for awarding him a scholarship for this study. This work was supported by National Basic Research Program of China (grant nos. 2011CB915400, 2009CB941500), by National Natural Science Foundation of China (grant nos. 30930048 and 30621001) to X.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, MOL PLANT, V3, P719, DOI 10.1093/mp/ssq026; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Choi S, 2008, BBA-GEN SUBJECTS, V1780, P1062, DOI 10.1016/j.bbagen.2008.05.010; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Deng XA, 2010, P NATL ACAD SCI USA, V107, P19114, DOI 10.1073/pnas.1009669107; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kzhyshkowska J, 2004, BIOCHEM J, V383, P259, DOI 10.1042/BJ20040210; Kzhyshkowska J, 2001, BIOCHEM J, V358, P305, DOI 10.1042/0264-6021:3580305; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marques CJ, 2010, FERTIL STERIL, V94, P585, DOI 10.1016/j.fertnstert.2009.02.051; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meyer R, 2007, J STEROID BIOCHEM, V107, P1, DOI 10.1016/j.jsbmb.2007.05.006; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Niu LF, 2008, PLANT PHYSIOL, V148, P490, DOI 10.1104/pp.108.124727; Niu LF, 2007, EMBO REP, V8, P1190, DOI 10.1038/sj.embor.7401111; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Sayegh J, 2008, BIOCHEM BIOPH RES CO, V372, P811, DOI 10.1016/j.bbrc.2008.05.121; Scebba F, 2007, PLANT J, V52, P210, DOI 10.1111/j.1365-313X.2007.03238.x; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yan D, 2007, BIOCHEM J, V408, P113, DOI 10.1042/BJ20070786; Zhang ZL, 2011, PLANT CELL, V23, P396, DOI 10.1105/tpc.110.081356	54	19	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22664	10.1371/journal.pone.0022664	http://dx.doi.org/10.1371/journal.pone.0022664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853042	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400010
J	Everson, CA; Szabo, A				Everson, Carol A.; Szabo, Aniko			Repeated Exposure to Severely Limited Sleep Results in Distinctive and Persistent Physiological Imbalances in Rats	PLOS ONE			English	Article							STARVATION-INDUCED CHANGES; GLUCOSE-METABOLISM; LEPTIN LEVELS; PLASMA-CORTICOSTERONE; INFLAMMATORY MARKERS; RECOVERY SLEEP; NORMAL HUMANS; DEPRIVATION; RESTRICTION; DURATION	Chronic sleep disruption in laboratory rats leads to increased energy expenditure, connective tissue abnormalities, and increased weights of major organs relative to body weight. Here we report on expanded findings and the extent to which abnormalities become long-lasting, potentially permanent changes to health status after apparent recuperation from chronic sleep disruption. Rats were exposed 6 times to long periods of disrupted sleep or control conditions during 10 weeks to produce adaptations and then were permitted nearly 4 months of undisturbed sleep. Measurements were made in tissues from these groups and in preserved tissue from the experimental and control groups of an antecedent study that lacked a lengthy recuperation period. Cycles of sleep restriction resulted in energy deficiency marked by a progressive course of hyperphagia and major (15%) weight loss. Analyses of tissue composition in chronically sleep-restricted rats indicated that protein and lipid amounts in internal organs were largely spared, while adipose tissue depots appeared depleted. This suggests high metabolic demands may have preserved the size of the vital organs relative to expectations of severe energy deficiency alone. Low plasma corticosterone and leptin concentrations appear to reflect low substrate availability and diminished adiposity. After nearly 4 months of recuperation, sleep-restricted rats were consuming 20% more food and 35% more water than did comparison control rats, despite normalized weight, normalized adipocytes, and elevated plasma leptin concentrations. Plasma cholesterol levels in recuperated sleep-restricted rats were diminished relative to those of controls. The chronically increased intake of nutriments and water, along with altered negative feedback regulation and substrate use, indicate that internal processes are modified long after a severe period of prolonged and insufficient sleep has ended.	[Everson, Carol A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Szabo, Aniko] Med Coll Wisconsin, Dept Populat Hlth, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Everson, CA (corresponding author), Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA.	ceverson@mcw.edu	Szabo, Aniko/F-9656-2012	Szabo, Aniko/0000-0002-8129-0614	National Heart, Lung, and Blood Institute [HL-086447, HL-080744]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Heart, Lung, and Blood Institute (http://www.nhlbi.nih.gov) Grants HL-086447 and HL-080744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Altemus M, 2001, J INVEST DERMATOL, V117, P309, DOI 10.1046/j.1523-1747.2001.01373.x; AX A, 1961, ARCH GEN PSYCHIAT, V4, P55; BARNETT SA, 1965, BIOL REV, V40, P5, DOI 10.1111/j.1469-185X.1965.tb00794.x; BERGMANN BM, 1989, SLEEP, V12, P5, DOI 10.1093/sleep/12.1.5; BERGMANN BM, 1989, SLEEP, V12, P31, DOI 10.1093/sleep/12.1.31; BJORKMAN O, 1985, J CLIN INVEST, V76, P87, DOI 10.1172/JCI111982; BONNET MH, 1991, J APPL PHYSIOL, V71, P1112, DOI 10.1152/jappl.1991.71.3.1112; Born J, 1997, J IMMUNOL, V158, P4454; Boutilier RG, 2001, J EXP BIOL, V204, P3171; BOYNE R, 1966, J PHYSIOL-LONDON, V183, P570, DOI 10.1113/jphysiol.1966.sp007884; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Caloin M, 2004, AM J PHYSIOL-ENDOC M, V287, pE790, DOI 10.1152/ajpendo.00414.2003; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chaput JP, 2007, OBESITY, V15, P253, DOI 10.1038/oby.2007.512; Convertino VA., 1987, CAN J SPORT SCI S, V12; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Duarte FO, 2008, NUTRITION, V24, P177, DOI 10.1016/j.nut.2007.10.012; Eiland MM, 2002, BRAIN RES, V945, P1, DOI 10.1016/S0006-8993(02)02448-4; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; EVERSON CA, 1994, J NEUROSCI, V14, P6769; EVERSON CA, 1993, AM J PHYSIOL, V265, pR1148, DOI 10.1152/ajpregu.1993.265.5.R1148; Everson CA, 2005, AM J PHYSIOL-REG I, V289, pR1054, DOI 10.1152/ajpregu.00021.2005; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; Everson CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE85, DOI 10.1152/ajpendo.00558.2001; EVERSON CA, 1989, SLEEP, V12, P60; EVERSON CA, 1995, ENDOCRINOLOGY, V136, P1426, DOI 10.1210/en.136.4.1426; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; EVERSON CA, 1993, AM J PHYSIOL, V264, pR376, DOI 10.1152/ajpregu.1993.264.2.R376; Everson CA, 2005, AM J PHYSIOL-REG I, V288, P274; Everson CA, 2009, AM J PHYSIOL-REG I, V297, pR1430, DOI 10.1152/ajpregu.00230.2009; Everson CA, 2008, AM J PHYSIOL-REG I, V295, pR2067, DOI 10.1152/ajpregu.90623.2008; Ferrell C.L., 1988, J ANIM SCI S3, V66, P23, DOI DOI 10.1093/ANSCI/66.SUPPLEMENT_3.23; FERY F, 1990, AM J PHYSIOL, V259, pE770, DOI 10.1152/ajpendo.1990.259.6.E770; FIORICA V, 1968, J APPL PHYSIOL, V24, P167, DOI 10.1152/jappl.1968.24.2.167; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Goodman MN, 1980, AM J PHYSIOL-ENDOC M, V239, P269; Goodman MN, 1984, AM J PHYSIOL, V246, P383; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Guyton AC, 2006, ENERGENTICS METABOLI, P881; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Harlan Laboratories, 2010, HSD SPRAG DAWL; HARRIS RBS, 1984, J NUTR, V114, P1143, DOI 10.1093/jn/114.6.1143; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Heiser P, 2000, EUR ARCH PSY CLIN N, V250, P16, DOI 10.1007/PL00007534; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hobson JA, 2005, NATURE, V437, P1254, DOI 10.1038/nature04283; Hu J, 2003, BRAIN BEHAV IMMUN, V17, P498, DOI 10.1016/j.bbi.2003.03.001; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Irwin MR, 2010, BRAIN BEHAV IMMUN, V24, P54, DOI 10.1016/j.bbi.2009.06.001; Johansen PB, 2000, GROWTH HORM IGF RES, V10, P342, DOI 10.1054/ghir.2000.0173; JOHNSON DE, 1990, J NUTR, V120, P649, DOI 10.1093/jn/120.6.649; Johnson DE, 2007, J NUTR, V137, P698, DOI 10.1093/jn/137.3.698; JOHNSON LC, 1965, PSYCHOSOM MED, V27, P415, DOI 10.1097/00006842-196509000-00003; Johnson LC, 1974, 193 AGARDOGRAPH NTIS; Jones S, 2008, J NEUROCHEM, V105, P46, DOI 10.1111/j.1471-4159.2007.05089.x; JORIS I, 1983, AM J PATHOL, V113, P341; KEENAN KP, 1994, TOXICOL PATHOL, V22, P300, DOI 10.1177/019262339402200308; Kerkhofs M, 2007, MATURITAS, V56, P212, DOI 10.1016/j.maturitas.2006.07.007; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Koban M, 2008, SLEEP, V31, P927; Kochan Z, 1997, METABOLISM, V46, P10, DOI 10.1016/S0026-0495(97)90160-8; KOLLAR EJ, 1966, PSYCHOSOM MED, V28, P101, DOI 10.1097/00006842-196603000-00002; KOLLAR EJ, 1969, AM J PSYCHIAT, V126, P488, DOI 10.1176/ajp.126.4.488; Laurberg P, 2005, HORM METAB RES, V37, P545, DOI 10.1055/s-2005-870420; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P1252, DOI 10.1139/y86-211; Mackiewicz M, 2008, ANN NY ACAD SCI, V1129, P335, DOI 10.1196/annals.1417.030; Magee CA, 2008, PUBLIC HEALTH, V122, P1373, DOI 10.1016/j.puhe.2008.05.010; MCCAY CM, 1989, NUTRITION, V5, P155; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; MENDELSON WB, 1974, PHARMACOL BIOCHEM BE, V2, P553, DOI 10.1016/0091-3057(74)90018-5; Mistlberger RE, 2002, J BIOL RHYTHM, V17, P227, DOI 10.1177/07430402017003006; MITEV Y, 1993, BRAIN RES BULL, V30, P7, DOI 10.1016/0361-9230(93)90033-8; MOLDOFSKY H, 1989, FASEB J, V3, P1972, DOI 10.1096/fasebj.3.8.2785942; Mosoni L, 1996, J NUTR, V126, P516, DOI 10.1093/jn/126.2.516; Naito H K, 1984, Lab Res Methods Biol Med, V10, P1; NAITOH P, 1990, OCCUP MED, V5, P209; NAITOH P, 1971, BIOL PSYCHIAT, V3, P309; Nedeltcheva AV, 2010, ANN INTERN MED, V153, P435, DOI 10.7326/0003-4819-153-7-201010050-00006; Nedeltcheva AV, 2009, J CLIN ENDOCR METAB, V94, P3242, DOI 10.1210/jc.2009-0483; Nedeltcheva AV, 2009, AM J CLIN NUTR, V89, P126, DOI 10.3945/ajcn.2008.26574; OBERMEYER W, 1991, SLEEP, V14, P285, DOI 10.1093/sleep/14.4.285; Ozturk L, 1999, Sleep Res Online, V2, P107; Palma BD, 2009, BRAZ J MED BIOL RES, V42, P299, DOI 10.1590/S0100-879X2009000300012; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; PILCHER JJ, 1990, SLEEP, V13, P218, DOI 10.1093/sleep/13.3.218; PILCHER JJ, 1991, SLEEP, V14, P201; POPPER DA, 1985, AM J PHYSIOL, V249, pG161, DOI 10.1152/ajpgi.1985.249.2.G161; RADOMSKI MW, 1992, AVIAT SPACE ENVIR MD, V63, P101; Ramsey JJ, 2006, J NUTR, V136, p1958S, DOI 10.1093/jn/136.7.1958S; RECHTSCHAFFEN A, 1995, BEHAV BRAIN RES, V69, P55, DOI 10.1016/0166-4328(95)00020-T; Rowlands DS, 2009, METABOLISM, V58, P1161, DOI 10.1016/j.metabol.2009.03.016; RUBIN RT, 1969, PSYCHOSOM MED, V31, P68, DOI 10.1097/00006842-196901000-00007; SAINZ RD, 1986, J NUTR, V116, P1529, DOI 10.1093/jn/116.8.1529; SALINPASCUAL RJ, 1988, SLEEP, V11, P362, DOI 10.1093/sleep/11.4.362; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schmid SM, 2007, J CLIN ENDOCR METAB, V92, P3044, DOI 10.1210/jc.2006-2788; Sgoifo A, 2006, PSYCHONEUROENDOCRINO, V31, P197, DOI 10.1016/j.psyneuen.2005.06.009; Shearer WT, 2001, J ALLERGY CLIN IMMUN, V107, P165, DOI 10.1067/mai.2001.112270; SNYDER F, 1969, Biological Psychiatry, V1, P271; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stamatakis KA, 2010, CHEST, V137, P95, DOI 10.1378/chest.09-0791; Suchecki D, 2000, PHYSIOL BEHAV, V68, P309, DOI 10.1016/S0031-9384(99)00181-X; SWANER JC, 1975, AM J PHYSIOL, V229, P365, DOI 10.1152/ajplegacy.1975.229.2.365; SZYMUSIAK R, 1981, PHYSIOL BEHAV, V26, P687, DOI 10.1016/0031-9384(81)90145-1; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Theorell-Haglow J, 2010, SLEEP, V33, P593; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thomas ML, 2007, AVIAT SPACE ENVIR MD, V78, pB144; TOBLER I, 1983, NEUROSCI LETT, V35, P297, DOI 10.1016/0304-3940(83)90333-6; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TOWNSEND WF, 1981, GUT, V22, P953, DOI 10.1136/gut.22.11.953; Turner N, 2006, CURR OPIN CLIN NUTR, V9, P691, DOI 10.1097/01.mco.0000247474.56908.79; TYLER DB, 1946, P SOC EXP BIOL MED, V62, P38; Van Cauter E., 1997, MONOGR CLIN NEUROSCI, V15, P144, DOI [10.1159/000061553, DOI 10.1159/000061553]; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van Dijk G, 2008, EUR J PHARMACOL, V585, P137, DOI 10.1016/j.ejphar.2007.11.079; van Leeuwen WMA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/108641; VANHAASTEREN GAC, 1995, J ENDOCRINOL, V145, P143, DOI 10.1677/joe.0.1450143; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; VOGEL GW, 1975, ARCH GEN PSYCHIAT, V32, P749; VONDRA K, 1986, EUR J APPL PHYSIOL, V55, P83, DOI 10.1007/BF00422899; Webb WB, 1979, FUNCTIONS SLEEP, P19; Weiss A, 2010, SLEEP, V33, P1201, DOI 10.1093/sleep/33.9.1201; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; WOODWARD CJH, 1991, BRIT J NUTR, V66, P117, DOI 10.1079/BJN19910015; WU JC, 1991, SLEEP, V14, P155; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; ZEPELIN H, 1974, BRAIN BEHAV EVOLUT, V10, P425, DOI 10.1159/000124330; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004; Zorrilla EP, 2005, AM J PHYSIOL-REG I, V288, pR1450, DOI 10.1152/ajpregu.00175.2004	138	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22987	10.1371/journal.pone.0022987	http://dx.doi.org/10.1371/journal.pone.0022987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853062	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953400022
J	Boutte, AM; McDonald, WH; Shyr, Y; Yang, L; Lin, PC				Boutte, Angela M.; McDonald, W. Hayes; Shyr, Yu; Yang, Li; Lin, P. Charles			Characterization of the MDSC Proteome Associated with Metastatic Murine Mammary Tumors Using Label-Free Mass Spectrometry and Shotgun Proteomics	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MYELOID CELLS; SUPPRESSOR-CELLS; BREAST-CANCER; TISSUE TRANSGLUTAMINASE; PEPTIDE IDENTIFICATION; TRANSFORMED-CELLS; CATHEPSIN-B; IN-VIVO; EXPRESSION	Expansion of Gr-1+/CD11b+ myeloid derived suppressor cells (MDSCs) is governed by the presence of increasingly metastatic, malignant primary tumors. Metastasis, not the primary tumor, is often the cause of mortality. This study sought to fully characterize the MDSC proteome in response to metastatic and non-metastatic mammary tumors using label-free mass spectrometry shotgun proteomics in a mouse model with tumor cell lines, 67NR and 4T1, derived from the same tumor. 67NR cells form only primary mammary tumors, whereas 4T1 cells readily metastasize to the lungs, lymph nodes, and blood. Overall analysis identified a total of 2825 protein groups with a 0.78% false discovery rate. Of the 2814 true identifications, 43 proteins were exclusive to the 67NR group, 153 were exclusive to the 4T1 group, and 2618 were shared. Among the shared cohort, 26 proteins were increased and 31 were decreased in the metastatic 4T1 cohort compared to non-metastatic 67NR controls after filtering. MDSCs selectively express proteins involved in the c-glutamyl transferase, glutathione synthase pathways, CREB transcription factor signaling, and other pathways involved in platelet aggregation, as well as lipid and amino acid metabolism, in response to highly metastatic 4T1 tumors. Cell cycle regulation dominated protein pathways and ontological groups of the 67NR non-metastatic group. Not only does this study provide a starting point to identify potential biomarkers of metastasis expressed by MDSCs; it identifies critical pathways that are unique to non-metastatic and metastatic conditions. Therapeutic interventions aimed at these pathways in MDSC may offer a new route to control malignancy and metastasis.	[Boutte, Angela M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37240 USA; [McDonald, W. Hayes] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA; [Shyr, Yu] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Yang, Li; Lin, P. Charles] NIH, Ctr Canc Res, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Boutte, AM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37240 USA.	angela.boutte@alumni.vanderbilt.edu; p.lin@nih.gov	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	NIH [1F32CA136118, UL1 RR 024975, CA108856, NS45888, AR053718]; NATIONAL CANCER INSTITUTE [R01CA108856, ZIABC011390, F32CA136118] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by grants from NIH (1F32CA136118 and UL1 RR 024975) to AMB and NIH (CA108856, NS45888 and AR053718) to PCL. No additional external funding was received for this study. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrethsen J, 2010, MOL CELL PROTEOMICS, V9, P988, DOI 10.1074/mcp.M900546-MCP200; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Asano T, 2008, J SURG RES, V146, P32, DOI 10.1016/j.jss.2007.02.011; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BAUVOIS B, 1995, CELL GROWTH DIFFER, V6, P1163; Boutte AM, 2011, FASEB J, V25, P2626, DOI 10.1096/fj.10-180604; Chen YC, 2005, CANCER RES, V65, P331; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Chung FY, 2006, AM J SURG PATHOL, V30, P969, DOI 10.1097/00000478-200608000-00006; Connolly MK, 2010, J LEUKOCYTE BIOL, V87, P713, DOI 10.1189/jlb.0909607; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; EISMAN R, 1990, BLOOD, V76, P336; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Finke J, 2011, INT IMMUNOPHARMACOL, V11, P856, DOI 10.1016/j.intimp.2011.01.030; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kirov Stefan A., 2007, V408, P19, DOI 10.1007/978-1-59745-547-3_2; Launay S, 1999, BLOOD, V93, P4395, DOI 10.1182/blood.V93.12.4395.412k06_4395_4405; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Middleton MK, 2006, J EXP MED, V203, P2529, DOI 10.1084/jem.20061444; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; MOORE JC, 1990, BRIT J HAEMATOL, V74, P457, DOI 10.1111/j.1365-2141.1990.tb06335.x; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; NIERODZIK ML, 1991, J CLIN INVEST, V87, P229, DOI 10.1172/JCI114976; NOZAKI H, 1987, Tokai Journal of Experimental and Clinical Medicine, V12, P223; Obrador E, 2002, HEPATOLOGY, V35, P74, DOI 10.1053/jhep.2002.30277; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sandoval Salemiz, 2009, Adv Hematol, V2009, P634292, DOI 10.1155/2009/634292; Saydam O, 2010, J PROTEOME RES, V9, P485, DOI 10.1021/pr900834h; Seth Late R K, 2003, Indian J Med Sci, V57, P350; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Tabb DL, 2008, J PROTEOME RES, V7, P45, DOI 10.1021/pr700728t; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tazi KA, 2009, HEPATOL RES, V39, P706, DOI 10.1111/j.1872-034X.2009.00498.x; Terraube V, 2007, THROMB RES, V120, pS64, DOI 10.1016/S0049-3848(07)70132-9; Trotter MJ, 2003, J CUTAN MED SURG, V7, P136, DOI 10.1007/s10227-002-0164-8; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Venkatesha S, 2006, MOL CANCER RES, V4, P821, DOI 10.1158/1541-7786.MCR-06-0110; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; Watson CJ, 2009, J MAMMARY GLAND BIOL, V14, P171, DOI 10.1007/s10911-009-9126-8; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	63	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22446	10.1371/journal.pone.0022446	http://dx.doi.org/10.1371/journal.pone.0022446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853032	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200010
J	Cho, Y; McQuade, T; Zhang, HB; Zhang, JK; Chan, FKM				Cho, YoungSik; McQuade, Thomas; Zhang, Haibing; Zhang, Jianke; Chan, Francis Ka-Ming			RIP1-Dependent and Independent Effects of Necrostatin-1 in Necrosis and T Cell Activation	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; DOMAIN KINASE RIP; PROGRAMMED NECROSIS; TNF-ALPHA; INDUCED APOPTOSIS; L929 CELLS; DEATH; NECROPTOSIS; IDENTIFICATION; MECHANISMS	Background: Programmed necrosis/necroptosis is an emerging form of cell death that plays important roles in mammalian development and the immune system. The pro-necrotic kinases in the receptor interacting protein (RIP) family are crucial mediators of programmed necrosis. Recent advances in necrosis research have been greatly aided by the identification of chemical inhibitors that block programmed necrosis. Necrostatin-1 (Nec-1) and its derivatives were previously shown to target the pro-necrotic kinase RIP1/RIPK1. The protective effect conferred by Nec-1 and its derivatives in many experimental model systems was often attributed to the inhibition of RIP1 function. Methodology/Principal Findings: We compared the effect of Nec-1 and siRNA-mediated silencing of RIP1 in the murine fibrosarcoma cell line L929. Treatment of L929 cells with the pan-caspase inhibitor zVAD-fmk or exogenous TNF induces necrosis. Strikingly, we found that siRNA-mediated silencing of RIP1 inhibited zVAD-fmk induced necrosis, but not TNF-induced necrosis. TNF-induced cell death in RIP1 knocked down L929 cells was inhibited by Nec-1, but not the caspase inhibitor zVAD-fmk. We found that PKA-C1 expression, but not Jnk or Erk activation, was moderately inhibited by Nec-1. Moreover, we found that Nec-1 inhibits proximal T cell receptor signaling independent of RIP1, leading to inhibition of T cell proliferation. Conclusions/Significance: Our results reveal that besides RIP1, Nec-1 also targets other factors crucial for necrosis induction in L929 cells. In addition, high doses of Nec-1 inhibit other signal transduction pathways such as that for T cell receptor activation. These results highlight the importance to independently validate results obtained using Nec-1 with other approaches such as siRNA-mediated gene silencing. We propose that some of the previous published results obtained using Nec-1 should be re-evaluated in light of our findings.	[Cho, YoungSik; McQuade, Thomas; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Program Immunol & Virol, Worcester, MA 01605 USA; [Zhang, Haibing; Zhang, Jianke] Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, UMass Diabet & Endocrinol Res Ctr, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Jefferson University; University of Massachusetts System; University of Massachusetts Worcester	Cho, Y (corresponding author), Keimyung Univ, Coll Pharm, Taegu, South Korea.	Francis.chan@umassmed.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; Zhang, Jianke/0000-0002-5822-2226	National Institutes of Health [AI088502, AI083497, DK32520, AI076788]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088502, R01AI083497, R03AI076788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health (AI088502, AI083497, and DK32520 to F. K. C. and AI076788 to J.Z.). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Challa S, 2010, CELL MOL LIFE SCI, V67, P3241, DOI 10.1007/s00018-010-0413-8; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Cho Y, 2011, ADV EXP MED BIOL, V691, P589, DOI 10.1007/978-1-4419-6612-4_62; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Trichonas G, 2010, P NATL ACAD SCI US; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Wang H, 2011, CELL SIGNAL, V23, P249, DOI 10.1016/j.cellsig.2010.09.009; Wu YT, 2011, CELL DEATH DIFFER, V18, P26, DOI 10.1038/cdd.2010.72; YOU Z, 2008, J CEREB BLOOD FLOW M; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2009, RIP3 ENERGY METABOLI; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	36	75	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23209	10.1371/journal.pone.0023209	http://dx.doi.org/10.1371/journal.pone.0023209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853090	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200053
J	Kasevich, RS; LaBerge, D				Kasevich, Ray S.; LaBerge, David			Theory of Electric Resonance in the Neocortical Apical Dendrite	PLOS ONE			English	Article							NEURONS; OSCILLATIONS; FREQUENCY; INFORMATION; PLASTICITY; LOCATION; CHANNEL; MODELS; NOISE; CAT	Pyramidal neurons of the neocortex display a wide range of synchronous EEG rhythms, which arise from electric activity along the apical dendrites of neocortical pyramidal neurons. Here we present a theoretical description of oscillation frequency profiles along apical dendrites which exhibit resonance frequencies in the range of 10 to 100 Hz. The apical dendrite is modeled as a leaky coaxial cable coated with a dielectric, in which a series of compartments act as coupled electric circuits that gradually narrow the resonance profile. The tuning of the peak frequency is assumed to be controlled by the average amplitude of voltage-gated outward currents, which in turn are regulated by the subthreshold noise in the thousands of synaptic spines that are continuously bombarded by local circuits. The results of simulations confirmed the ability of the model both to tune the peak frequency in the 10-100 Hz range and to gradually narrow the resonance profile. Considerable additional narrowing of the resonance profile is provided by repeated looping through the apical dendrite via the corticothalamocortical circuit, which reduced the width of each resonance curve (at half-maximum) to approximately 1 Hz. Synaptic noise in the neural circuit is discussed in relation to the ways it can influence the narrowing process.	[Kasevich, Ray S.] Stanley Lab Elect Phys, Great Barrington, MA 01230 USA; [LaBerge, David] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Kasevich, RS (corresponding author), Stanley Lab Elect Phys, Great Barrington, MA 01230 USA.	dlaberge@earthlink.net						Angelo E., 1964, POLE ZERO PATTERNS A; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Barlow H. M., 1962, RADIO SURFACE WAVES; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Collins RE, 1960, FIELD THEORY GUIDED, p[528, 529]; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Delogne P., 1982, LEAKY FEEDERS SUBSUR; Destexhe A, 2001, NEUROCOMPUTING, V38, P167, DOI 10.1016/S0925-2312(01)00428-3; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Heaviside Oliver, 1892, ELECT PAPERS; Higgs MH, 2009, J NEUROSCI, V29, P1285, DOI 10.1523/JNEUROSCI.3728-08.2009; HILLE B, 2003, ION CHANNELS EXCITAB; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jones E.G., 2007, THALAMUS, VVolume 1, P575; JONES EG, 1970, PHILOS T ROY SOC B, V257, P1, DOI 10.1098/rstb.1970.0003; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006; Keren N, 2005, J NEUROPHYSIOL, V94, P3730, DOI 10.1152/jn.00408.2005; Keren N, 2009, J PHYSIOL-LONDON, V587, P1413, DOI 10.1113/jphysiol.2008.167130; Koch Christof, 1999, P1; LABERGE D, 1992, NEURAL COMPUT, V4, P318, DOI 10.1162/neco.1992.4.3.318; LaBerge D, 2005, BRAIN RES REV, V50, P86, DOI 10.1016/j.brainresrev.2005.04.004; Larmor J., 1902, SCI WRITINGS LATE GF; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; London M, 1999, J NEUROSCI, V19, P8219; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Mountcastle V. B., 1998, CEREBRAL CORTEX; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Nunnaly J, 1978, PSYCHOMETRIC METHODS; Paik SB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000927; PETERS A, 1991, J COMP NEUROL, V306, P1, DOI 10.1002/cne.903060102; Pike FG, 2000, J PHYSIOL-LONDON, P205; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Segev C, 1989, METHODS NEURONAL MOD, P9; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; Stacey WC, 2009, J NEUROPHYSIOL, V102, P2342, DOI 10.1152/jn.00397.2009; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; van Elburg RAJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000781; Volman V, 2009, J NEUROPHYSIOL, V102, P3234, DOI 10.1152/jn.00260.2009; Volman V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060903; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23412	10.1371/journal.pone.0023412	http://dx.doi.org/10.1371/journal.pone.0023412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853129	gold, Green Published			2022-12-27	WOS:000295454200082
J	Oliveira, SDS; Quintas, LEM; Amaral, LS; Noel, F; Farsky, SH; Silva, CLM				Oliveira, Suellen D. S.; Quintas, Luis E. M.; Amaral, Luciana S.; Noel, Francois; Farsky, Sandra H.; Silva, Claudia L. M.			Increased Endothelial Cell-Leukocyte Interaction in Murine Schistosomiasis: Possible Priming of Endothelial Cells by the Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INFLAMMATORY-BOWEL-DISEASE; ADHESION MOLECULES; MANSONI INFECTION; EXPRESSION; MECHANISMS; MICE; ANGIOGENESIS; RECRUITMENT; INHIBITION	Background and Aims: Schistosomiasis is an intravascular parasitic disease associated with inflammation. Endothelial cells control leukocyte transmigration and vascular permeability being modulated by pro-inflammatory mediators. Recent data have shown that endothelial cells primed in vivo in the course of a disease keep the information in culture. Herein, we evaluated the impact of schistosomiasis on endothelial cell-regulated events in vivo and in vitro. Methodology and Principal Findings: The experimental groups consisted of Schistosoma mansoni-infected and age-matched control mice. In vivo infection caused a marked influx of leukocytes and an increased protein leakage in the peritoneal cavity, characterizing an inflamed vascular and cellular profile. In vitro leukocyte-mesenteric endothelial cell adhesion was higher in cultured cells from infected mice as compared to controls, either in the basal condition or after treatment with the pro-inflammatory cytokine tumor necrosis factor (TNF). Nitric oxide (NO) donation reduced leukocyte adhesion to endothelial cells from control and infected groups; however, in the later group the effect was more pronounced, probably due to a reduced NO production. Inhibition of control endothelial NO synthase (eNOS) increased leukocyte adhesion to a level similar to the one observed in the infected group. Besides, the adhesion of control leukocytes to endothelial cells from infected animals is similar to the result of infected animals, confirming that schistosomiasis alters endothelial cells function. Furthermore, NO production as well as the expression of eNOS were reduced in cultured endothelial cells from infected animals. On the other hand, the expression of its repressor protein, namely caveolin-1, was similar in both control and infected groups. Conclusion/Significance: Schistosomiasis increases vascular permeability and endothelial cell-leukocyte interaction in vivo and in vitro. These effects are partially explained by a reduced eNOS expression. In addition, our data show that the disease primes endothelial cells in vivo, which keep the acquired phenotype in culture.	[Oliveira, Suellen D. S.; Quintas, Luis E. M.; Amaral, Luciana S.; Noel, Francois; Silva, Claudia L. M.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Mol & Biochem Pharmacol, Rio De Janeiro, Brazil; [Farsky, Sandra H.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Oliveira, SDS (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Mol & Biochem Pharmacol, Rio De Janeiro, Brazil.	cmartins@farmaco.ufrj.br	Quintas, Luis Eduardo M/C-3308-2009; Silva, Claudia L. Martins/C-3168-2009; Noël, François/C-3402-2009; Oliveira, Suellen D'Arc/F-6276-2014; Farsky, Sandra HP/C-4044-2012	Quintas, Luis Eduardo M/0000-0002-0767-1240; Silva, Claudia L. Martins/0000-0001-9227-6036; Noël, François/0000-0001-6813-1347; Oliveira, Suellen D'Arc/0000-0002-7654-1909; 	CNPq, Brazil [472474/2010-3, 305460/2009-9]; FAPERJ, Brazil	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The study was supported by the following: CNPq, Brazil (www.cnpq.br) financial support (472474/2010-3) and fellowship (305460/2009-9); FAPERJ, Brazil (www.faperj.br): financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Angeli W, 2001, EUR J IMMUNOL, V31, P2751, DOI 10.1002/1521-4141(200109)31:9&lt;2751::AID-IMMU2751&gt;3.0.CO;2-4; Balcerczyk A, 2005, FREE RADICAL BIO MED, V39, P327, DOI 10.1016/j.freeradbiomed.2005.03.017; Binion DG, 1997, GASTROENTEROLOGY, V112, P1895, DOI 10.1053/gast.1997.v112.pm9178682; Binion DG, 1998, LANCET, V352, P1742, DOI 10.1016/S0140-6736(98)05050-8; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Carreau A, 2011, EXP CELL RES, V317, P29, DOI 10.1016/j.yexcr.2010.08.011; Cavalcanti DMH, 2007, BRIT J PHARMACOL, V152, P1291, DOI 10.1038/sj.bjp.0707512; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Dessy C, 2010, PFLUG ARCH EUR J PHY, V459, P817, DOI 10.1007/s00424-010-0815-3; Esterre P, 1998, PARASITE IMMUNOL, V20, P369, DOI 10.1046/j.1365-3024.1998.00168.x; Fish JE, 2006, CELL MOL LIFE SCI, V63, P144, DOI 10.1007/s00018-005-5421-8; Frid Maria G, 2004, Paediatr Respir Rev, V5 Suppl A, pS253, DOI 10.1016/S1526-0542(04)90048-6; Hickey MJ, 1997, EXP PHYSIOL, V82, P339, DOI 10.1113/expphysiol.1997.sp004029; Jacobs W, 1997, PARASITOL RES, V83, P405, DOI 10.1007/s004360050273; Kimura C, 2004, J PHYSIOL-LONDON, V554, P721, DOI 10.1113/jphysiol.2003.057059; Kubes P, 1997, AM J PHYSIOL-GASTR L, V273, pG628, DOI 10.1152/ajpgi.1997.273.3.G628; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUBES P, 1993, FASEB J, V7, P1293, DOI 10.1096/fasebj.7.13.8405815; KUROSE I, 1993, CIRC RES, V73, P164, DOI 10.1161/01.RES.73.1.164; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; Leite ACRM, 2009, BRIT J PHARMACOL, V156, P818, DOI 10.1111/j.1476-5381.2008.00094.x; Lenzi HL, 2006, MEM I OSWALDO CRUZ, V101, P219, DOI 10.1590/S0074-02762006000900034; Loeffler DA, 2002, J INFECT DIS, V185, P1650, DOI 10.1086/340416; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; PARAENSE W L, 1981, Memorias do Instituto Oswaldo Cruz, V76, P287, DOI 10.1590/S0074-02761981000300006; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Quintas LEM, 2010, J MOL CELL CARDIOL, V49, P525, DOI 10.1016/j.yjmcc.2010.04.015; Rabelink TJ, 2006, ARTERIOSCL THROM VAS, V26, P2585, DOI 10.1161/01.ATV.0000250932.24151.50; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Silva CLM, 2007, BRIT J PHARMACOL, V151, P195, DOI 10.1038/sj.bjp.0707225; Silva CLM, 1998, COMP BIOCHEM PHYS A, V120, P417, DOI 10.1016/S1095-6433(98)10041-7; Stevens Troy, 2001, American Journal of Physiology, V281, pC1422; Tamura EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013958; Venema RC, 2002, INT IMMUNOPHARMACOL, V2, P1755, DOI 10.1016/S1567-5769(02)00185-6; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x	41	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23547	10.1371/journal.pone.0023547	http://dx.doi.org/10.1371/journal.pone.0023547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853150	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200096
J	Salathe, RM; Schmid-Hempel, P				Salathe, Rahel M.; Schmid-Hempel, Paul			The Genotypic Structure of a Multi-Host Bumblebee Parasite Suggests a Role for Ecological Niche Overlap	PLOS ONE			English	Article							GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; PLASMODIUM-FALCIPARUM; POPULATION STRUCTURES; EVOLUTIONARY ECOLOGY; HOST HETEROGENEITY; TRYPANOSOMA-CRUZI; CRITHIDIA-BOMBI; RARE ALLELES; PATHOGEN	The genotypic structure of parasite populations is an important determinant of ecological and evolutionary dynamics of host-parasite interactions with consequences for pest management and disease control. Genotypic structure is especially interesting where multiple hosts co-exist and share parasites. We here analyze the natural genotypic distribution of Crithidia bombi, a trypanosomatid parasite of bumblebees (Bombus spp.), in two ecologically different habitats over a time period of three years. Using an algorithm to reconstruct genotypes in cases of multiple infections, and combining these with directly identified genotypes from single infections, we find a striking diversity of infection for both data sets, with almost all multilocus genotypes being unique, and are inferring that around half of the total infections are resulting from multiple strains. Our analyses further suggest a mixture of clonality and sexuality in natural populations of this parasite species. Finally, we ask whether parasite genotypes are associated with host species (the phylogenetic hypothesis) or whether ecological factors (niche overlap in flower choice) shape the distribution of parasite genotypes (the ecological hypothesis). Redundancy analysis demonstrates that in the region with relatively high parasite prevalence, both host species identity and niche overlap are equally important factors shaping the distribution of parasite strains, whereas in the region with lower parasite prevalence, niche overlap more strongly contributes to the distribution observed. Overall, our study underlines the importance of ecological factors in shaping the natural dynamics of host-parasite systems.	[Salathe, Rahel M.; Schmid-Hempel, Paul] ETH, Inst Integrat Biol IBZ, Zurich, Switzerland; [Salathe, Rahel M.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	ETH Zurich; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Salathe, RM (corresponding author), ETH, Inst Integrat Biol IBZ, Zurich, Switzerland.	rms55@psu.edu			Swiss NSF [3100A0-116057]; Australian ARC [DP0209447]; Genetic Diversity Centre of ETH Zurich (GDC); CCES	Swiss NSF(Swiss National Science Foundation (SNSF)); Australian ARC; Genetic Diversity Centre of ETH Zurich (GDC); CCES	The study was supported by Swiss NSF (grant nr. 3100A0-116057) and Australian ARC (grant nr. DP0209447). It was also supported by the Genetic Diversity Centre of ETH Zurich (GDC) and CCES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Babiker H. A., 1996, Annals of Tropical Medicine and Parasitology, V90, P410; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Belkhir K, 1998, 9060 CNRS UPR U MONT; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; BRIAN AD, 1957, J ANIM ECOL, V26, P71, DOI 10.2307/1782; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Cuervo P, 2002, MEM I OSWALDO CRUZ, V97, P877, DOI 10.1590/S0074-02762002000600023; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; de Roode JC, 2004, P ROY SOC B-BIOL SCI, V271, P1073, DOI 10.1098/rspb.2004.2695; Durrer Stephan, 1994, Proceedings of the Royal Society of London Series B Biological Sciences, V258, P299, DOI 10.1098/rspb.1994.0176; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLOGENETIC INFEREN; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson D, 2000, OIKOS, V91, P485, DOI 10.1034/j.1600-0706.2000.910309.x; Guerbouj S, 2001, PARASITOLOGY, V122, P25, DOI 10.1017/S0031182000007125; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hamilton R, 2005, P ROY SOC B-BIOL SCI, V272, P1647, DOI 10.1098/rspb.2005.3134; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Hess AE, 1991, BESTIMMUNGSSCHLUSSEL; HIDE G, 1994, PARASITOLOGY, V109, P95, DOI 10.1017/S0031182000077805; INOUYE DW, 1980, OECOLOGIA, V45, P197, DOI 10.1007/BF00346460; Ivey CT, 2001, INT J PLANT SCI, V162, P1327, DOI 10.1086/323476; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; Korner P, 2005, ENTOMOL SCI, V8, P151, DOI 10.1111/j.1479-8298.2005.00113.x; Ladd C, 2001, CROAT MED J, V42, P244; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Lythgoe KA, 2002, AM NAT, V159, P519, DOI 10.1086/339462; MacLeod A, 2005, MOL BIOCHEM PARASIT, V143, P12, DOI 10.1016/j.molbiopara.2005.04.009; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mortera J, 2003, THEOR POPUL BIOL, V63, P191, DOI 10.1016/S0040-5809(03)00006-6; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; Schmid-Hempel R, 2011, INFECT GENET EVOL, V11, P564, DOI 10.1016/j.meegid.2011.01.002; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; SCHMIDHEMPEL P, 1993, BEHAV ECOL SOCIOBIOL, V33, P319, DOI 10.1007/BF00172930; Seppala O, 2009, P ROY SOC B-BIOL SCI, V276, P691, DOI 10.1098/rspb.2008.1229; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Takezaki N, 1996, GENETICS, V144, P389; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thiele EA, 2008, INT J PARASITOL, V38, P389, DOI 10.1016/j.ijpara.2007.07.011; Tibayrenc M, 2005, TRENDS MICROBIOL, V13, P575, DOI 10.1016/j.tim.2005.09.004; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Tibayrenc M, 1999, MICROBES INFECT, V1, P465, DOI 10.1016/S1286-4579(99)80050-1; Tibayrenc M, 1999, ANNU REV GENET, V33, P449, DOI 10.1146/annurev.genet.33.1.449; Wakelin Derek, 1997, P30; Wilfert L, 2007, MOL ECOL, V16, P1327, DOI 10.1111/j.1365-294X.2007.03234.x	67	35	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22054	10.1371/journal.pone.0022054	http://dx.doi.org/10.1371/journal.pone.0022054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853023	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200004
J	Schimpl, M; Moore, C; Lederer, C; Neuhaus, A; Sambrook, J; Danesh, J; Ouwehand, W; Daumer, M				Schimpl, Michaela; Moore, Carmel; Lederer, Christian; Neuhaus, Anneke; Sambrook, Jennifer; Danesh, John; Ouwehand, Willem; Daumer, Martin			Association between Walking Speed and Age in Healthy, Free-Living Individuals Using Mobile Accelerometry-A Cross-Sectional Study	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; GAIT SPEED; CLINICAL-TRIALS; WHITEHALL II; OLDER-ADULTS; DISABILITY; DISTANCE; MS	Context: Walking speed is a fundamental parameter of human motion and is increasingly considered as an important indicator of individuals' health status. Objective: To evaluate the relationship of gait parameters, and demographic and physical characteristics in healthy men and women. Design, Setting, and Participants: Recruitment of a subsample (n = 358) of male and female blood donors taking part in the Cambridge CardioResource study. Collection of demographic data, measurement of physical characteristics (height, weight and blood pressure) and assessment of 7-day, free-living activity parameters using accelerometry and a novel algorithm to measure walking speed. Participants were a median (interquartile range[IQR]) age of 49 (16) years; 45% women; and had a median (IQR) BMI of 26 (5.4). Main Outcome Measure: Walking speed. Results: In this study, the hypothesis that walking speed declines with age was generated using an initial 'open' dataset. This was subsequently validated in a separate 'closed' dataset that showed a decrease of walking speed of -0.0037 m/s per year. This is equivalent to a difference of 1.2 minutes, when walking a distance of 1 km aged 20 compared to 60 years. Associations between walking speed and other participant characteristics (i.e. gender, BMI and blood pressure) were nonsignificant. BMI was negatively correlated with the number of walking and running steps and longest non-stop distance. Conclusion: This is the first study using accelerometry which shows an association between walking speed and age in free-living, healthy individuals. Absolute values of gait speed are comparable to published normal ranges in clinical settings. This study highlights the potential use of mobile accelerometry to assess gait parameters which may be indicative of future health outcomes in healthy individuals.	[Schimpl, Michaela; Lederer, Christian; Neuhaus, Anneke; Daumer, Martin] Human Mot Inst, Sylvia Lawry Ctr Multiple Sclerosis Res eV, Munich, Germany; [Schimpl, Michaela; Daumer, Martin] Trium Anal Online GmbH, Munich, Germany; [Moore, Carmel; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Sambrook, Jennifer; Ouwehand, Willem] Univ Cambridge, Dept Haematol, Cambridge, England; [Sambrook, Jennifer; Ouwehand, Willem] NHS Blood & Transplant, Cambridge, England	University of Cambridge; University of Cambridge	Schimpl, M (corresponding author), Human Mot Inst, Sylvia Lawry Ctr Multiple Sclerosis Res eV, Munich, Germany.	daumer@slcmsr.org		Ouwehand, Willem/0000-0002-7744-1790	German Ministry for Education and Research (BMBF) [01GI0920]; EU [215820-2, FP7-223865, 215820, 223865, LSHM-CT-2006-03759, LSHM-CT-2004-503485]; UK Medical Research Council/Wellcome Trust; Federal Ministry of Education and Research [01GI0920, 01GI0904]; Mayo Clinic Rochester; Federal Ministry of Economics and Technology [KF0564001KF7]; University of Oxford; Technical University of Munich; Hertie Foundation [1.01.1/07/015]; Bavarian Research Foundation; National Multiple Sclerosis Society (NMSS); Porticus Foundation [900.50578]; University of Rochester; GlaxoSmithKline; Merck; Novartis; Pfizer; MRC [MC_qA137933] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/09/012/28096] Funding Source: researchfish; Medical Research Council [MC_qA137933] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); UK Medical Research Council/Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Mayo Clinic Rochester; Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); University of Oxford; Technical University of Munich; Hertie Foundation; Bavarian Research Foundation; National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Porticus Foundation; University of Rochester; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was partly supported by grants from the German Ministry for Education and Research (BMBF, "German Competence Network Multiple Sclerosis" (KKNMS), 01GI0920), EU FP7 (NETSIM (215820-2) and VPHOP (FP7-223865)). The Cambridge CardioResource study was funded by the UK Medical Research Council/Wellcome Trust. Additional support was provided by NHS Blood and Transplant, National Institute for Health Research and British Heart Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Michaela Schimpl and Martin Daumer are employees of Trium Analysis Online GmbH and contributed to all aspects of the study. No additional external funding was received for this study.; Martin Daumer, Scientific Director of the Sylvia Lawry Centre for Multiple Sclerosis Research e. V. (SLC) and one of the two Managing Directors of Trium Analysis Online GmbH, serves on the Editorial Board of MedNous and holds Patent 10 2007 044 705.3-35, German patent and trademark office 307 19 449.3/09. The Sylvia Lawry Centre received honoraria for interviews of Dr. Daumer with Propagate Pharma Limited and Deerfield Research LLC; is Medical Advisor of the German Multiple Sclerosis Society; received honoraria for consultancy, statistical analysis and use of actibelt (R) technology from the following entities: Bayer Schering, Biopartners, Biogen Idec, Biogenerix, Bohringer-Ingelheim, EISAI Limited, Heron Evidence Development Ltd, Hoffmann-La Roche, Johnson & Johnson Pharmaceutical Research & Development LLC, Sanofi-Aventis U.S. INC., Novartis Pharma GmbH, University of Oxford, Imperial College London, University of Southampton, Charite Berlin, University of Vienna, Greencoat Ltd, University Medical Center Hamburg-Eppendorf; serves on the advisory board for EPOSA study and received research grants from the following governmental entities: Federal Ministry of Education and Research Grant No 01GI0904, 01GI0920, Mayo Clinic Rochester, European Union (for SLC and Trium) Grant No 215820, European Union (for SLC) Grant No 223865, Federal Ministry of Economics and Technology Grant No KF0564001KF7, University of Oxford, Technical University of Munich, Hertie Foundation Grant No 1.01.1/07/015, Bavarian Research Foundation, National Multiple Sclerosis Society (NMSS), Porticus Foundation Grant No 900.50578, European Union Grant No LSHM-CT-2006-03759, University of Rochester, European Union Grant No LSHM-CT-2004-503485. Michaela Schimpl is an employee of Trium Analysis Online GmbH. Anneke Neuhaus and Christian Lederer are employees of the Sylvia Lawry Centre for Multiple Sclerosis Research. John Danesh is a board member of Merck Sharp & Dohme UK Atherosclerosis Advisory Board and Novartis Cardiovascular & Metabolic Advisory Board. John Danesh has received payment for lectures including service on speakers bureaus as well as travel/accomodation/meeting expenses (unrelated to the activities listed) from GlaxoSmithKline, Merck, Novartis, Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; [Anonymous], GUIDANCE IND PATIENT; BALKE B, 1954, J APPL PHYSIOL, V7, P231, DOI 10.1152/jappl.1954.7.3.231; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brunner E, 2009, J GERONTOL A-BIOL, V64, P1082, DOI 10.1093/gerona/glp078; Chalmers I, 2008, SEM JOINTL ORG J LIN; Daumer M, 2009, NEUROLOGY, V72, P705, DOI 10.1212/01.wnl.0000336916.38629.43; Daumer M, 2008, INT C AMB MON PHYS A; Daumer M, 2007, BIOMED TECH, V52, P149, DOI 10.1515/BMT.2007.028; Daumer M, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-18; Dean CM, 2001, CLIN REHABIL, V15, P415, DOI 10.1191/026921501678310216; Department for Transport GMH, 2011, NAT TRAV SURV 2010 T; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Hamer M, 2010, HEART, V96, P380, DOI 10.1136/hrt.2009.183350; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Levine JA, 2008, DIABETES, V57, P548, DOI 10.2337/db07-0815; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Palombaro KM, 2006, PHYS THER, V86, P809, DOI 10.1093/ptj/86.6.809; Purser JL, 2005, J REHABIL RES DEV, V42, P535, DOI 10.1682/JRRD.2004.07.0087; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Scheermesser M, 2008, 2 INT C PERV COMP HE; Schimpl M, 2011, PLOS ONE IN PRESS; Schlesinger S, 2011, KLIN NEUROPHYSIOL, V42, P17, DOI 10.1055/s-0031-1271750; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Studenski S, 2009, J NUTR HEALTH AGING, V13, P878, DOI 10.1007/s12603-009-0245-0; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Vaney C, 1996, CLIN REHABIL, V10, P216, DOI DOI 10.1177/026921559601000306; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772	36	75	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23299	10.1371/journal.pone.0023299	http://dx.doi.org/10.1371/journal.pone.0023299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853107	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200067
J	Hoare, DJ; Humble, J; Jin, D; Gilding, N; Petersen, R; Cobb, M; McCrohan, C				Hoare, Derek J.; Humble, James; Jin, Ding; Gilding, Niall; Petersen, Rasmus; Cobb, Matthew; McCrohan, Catherine			Modeling Peripheral Olfactory Coding in Drosophila Larvae	PLOS ONE			English	Article							GAIN-CONTROL; NEURONS; PERCEPTION; MECHANISM	The Drosophila larva possesses just 21 unique and identifiable pairs of olfactory sensory neurons (OSNs), enabling investigation of the contribution of individual OSN classes to the peripheral olfactory code. We combined electrophysiological and computational modeling to explore the nature of the peripheral olfactory code in situ. We recorded firing responses of 19/21 OSNs to a panel of 19 odors. This was achieved by creating larvae expressing just one functioning class of odorant receptor, and hence OSN. Odor response profiles of each OSN class were highly specific and unique. However many OSN-odor pairs yielded variable responses, some of which were statistically indistinguishable from background activity. We used these electrophysiological data, incorporating both responses and spontaneous firing activity, to develop a Bayesian decoding model of olfactory processing. The model was able to accurately predict odor identity from raw OSN responses; prediction accuracy ranged from 12%-77% (mean for all odors 45.2%) but was always significantly above chance (5.6%). However, there was no correlation between prediction accuracy for a given odor and the strength of responses of wild-type larvae to the same odor in a behavioral assay. We also used the model to predict the ability of the code to discriminate between pairs of odors. Some of these predictions were supported in a behavioral discrimination (masking) assay but others were not. We conclude that our model of the peripheral code represents basic features of odor detection and discrimination, yielding insights into the information available to higher processing structures in the brain.	[Hoare, Derek J.; Humble, James; Jin, Ding; Gilding, Niall; Petersen, Rasmus; Cobb, Matthew; McCrohan, Catherine] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Hoare, DJ (corresponding author), Univ Nottingham, NIHR Natl Biomed Res Unit Hearing, Nottingham NG7 2RD, England.	Cathy.McCrohan@manchester.ac.uk	Humble, James/M-2145-2014	Humble, James/0000-0003-0695-8343; Cobb, Matthew/0000-0002-8258-4913; Hoare, Derek/0000-0002-8768-1392; McCrohan, Catherine/0000-0002-8855-1194; Gilding, Niall/0000-0002-3540-0712	Biotechnology and Biological Sciences Research Council; Medical Research Council; The Royal Society; Biotechnology and Biological Sciences Research Council [BB/H009914/]; Code analysis, repository, and modelling for e-Neuroscience; Engineering and Physical Sciences Research Council [EP/E002331/1; RP]; BBSRC [BB/H009914/1, BB/G020094/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G020094/1, BB/H009914/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Code analysis, repository, and modelling for e-Neuroscience; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by a Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk) studentship (DJH); a Medical Research Council (http://www.mrc.ac.uk) studentship (JH); The Royal Society (http://royalsociety.org) (CM and MC); Biotechnology and Biological Sciences Research Council grant BB/H009914/1 (CM and MC); and the CARMEN e-science project (Code analysis, repository, and modelling for e-Neuroscience; Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk) grant EP/E002331/1; RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Chaudhury D, 2009, J NEUROSCI, V29, P52, DOI 10.1523/JNEUROSCI.4036-08.2009; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Gomez-Marin A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00006; Grosmaitre X, 2006, P NATL ACAD SCI USA, V103, P1970, DOI 10.1073/pnas.0508491103; Guo S, 2010, PROTEINS, V78, P381, DOI 10.1002/prot.22556; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hoare DJ, 2008, J NEUROSCI, V28, P9710, DOI 10.1523/JNEUROSCI.1955-08.2008; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Stocker RF, 2008, ADV EXP MED BIOL, V628, P69, DOI 10.1007/978-0-387-78261-4_5; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022	23	11	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22996	10.1371/journal.pone.0022996	http://dx.doi.org/10.1371/journal.pone.0022996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857978	Green Published, gold, Green Submitted			2022-12-27	WOS:000293774300015
J	Obama, T; Nagaoka, S; Akagi, K; Kato, R; Horiuchi, N; Horai, Y; Aiuchi, T; Arata, S; Yamaguchi, T; Watanabe, M; Itabe, H				Obama, Takashi; Nagaoka, Sayaka; Akagi, Kazuki; Kato, Rina; Horiuchi, Naomi; Horai, Yasushi; Aiuchi, Toshihiro; Arata, Satoru; Yamaguchi, Tomohiro; Watanabe, Mitsuhiro; Itabe, Hiroyuki			Dietary Cholesterol Reduces Plasma Triacylglycerol in Apolipoprotein E-Null Mice: Suppression of Lipin-1 and-2 in the Glycerol-3-Phosphate Pathway	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID SYNTHESIS; GENE-EXPRESSION; BILE-ACIDS; ADIPOSE-TISSUE; KNOCKOUT MICE; LIVER; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; GLUCOCORTICOIDS	Background: Cholesterol metabolism is tightly regulated by both cholesterol and its metabolites in the mammalian liver, but the regulatory mechanism of triacylglycerol (TG) synthesis remains to be elucidated. Lipin, which catalyzes the conversion of phosphatidate to diacylglycerol, is a key enzyme involved in de novo TG synthesis in the liver via the glycerol-3-phosphate (G3P) pathway. However, the regulatory mechanisms for the expression of lipin in the liver are not well understood. Methodology/Principal Findings: Apolipoprotein E-knock out (apoE-KO) mice were fed a chow supplemented with 1.25% cholesterol (high-Chol diet). Cholesterol and bile acids were highly increased in the liver within a week. However, the amount of TG in very low-density lipoprotein (VLDL), but not in the liver, was reduced by 78%. The epididymal adipose tissue was almost eradicated in the long term. DNA microarray and real-time RT-PCR analyses revealed that the mRNA expression of all the genes in the G3P pathway in the liver was suppressed in the high-Chol diet apoE-KO mice. In particular, the mRNA and protein expression of lipin-1 and lipin-2 was markedly decreased, and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), which up-regulates the transcription of lipin-1, was also suppressed. In vitro analysis using HepG2 cells revealed that the protein expression of lipin-2 was suppressed by treatment with taurocholic acid. Conclusions/Significance: These data using apoE-KO mice indicate that cholesterol and its metabolites are involved in regulating TG metabolism through a suppression of lipin-1 and lipin-2 in the liver. This research provides evidence for the mechanism of lipin expression in the liver.	[Obama, Takashi; Nagaoka, Sayaka; Akagi, Kazuki; Kato, Rina; Horiuchi, Naomi; Aiuchi, Toshihiro; Yamaguchi, Tomohiro; Itabe, Hiroyuki] Showa Univ, Sch Pharm, Dept Biol Chem, Shinagawa Ku, Tokyo, Japan; [Horai, Yasushi; Watanabe, Mitsuhiro] Keio Univ, Sch Med, Div Mol Metab & Syst Med, Shinjuku Ku, Tokyo, Japan; [Arata, Satoru] Showa Univ, Ctr Biotechnol, Shinagawa Ku, Tokyo, Japan	Showa University; Keio University; Showa University	Obama, T (corresponding author), Showa Univ, Sch Pharm, Dept Biol Chem, Shinagawa Ku, Tokyo, Japan.	h-itabe@pharm.showa-u.ac.jp	板部板部, 洋之/ABC-7746-2020		Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT) [19590076, 20580103, 21590073, 21790092]; Japan Health Sciences Foundation; Showa University; Grants-in-Aid for Scientific Research [23790098, 22500390] Funding Source: KAKEN	Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation; Showa University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Technology, Sports, Sciences and Technology of Japan (MEXT) (No. 19590076, No. 20580103, No. 21590073 and No. 21790092), grants for the Private University High Technology Research Center Project from the MEXT, Research on Publicly Essential Drugs and Medical Devices from Japan Health Sciences Foundation, and Showa University Research Grant for Young Researchers. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Fukumoto Y, 2004, CIRCULATION, V110, P1953, DOI 10.1161/01.CIR.0000143174.41810.10; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; Kato R, 2009, ARTERIOSCL THROM VAS, V29, P33, DOI 10.1161/ATVBAHA.108.164723; Khalil MB, 2010, BBA-MOL CELL BIOL L, V1801, P1249, DOI 10.1016/j.bbalip.2010.07.008; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rehnmark S, 1998, J LIPID RES, V39, P2209; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; Sinal CJ, 2001, J BIOL CHEM, V276, P47154, DOI 10.1074/jbc.M107000200; Stein S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013539; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104	29	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22917	10.1371/journal.pone.0022917	http://dx.doi.org/10.1371/journal.pone.0022917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857965	Green Submitted, gold, Green Published			2022-12-27	WOS:000293774300011
J	Scharf, C; Krasniqi, N; Hellermann, J; Rahn, M; Sutsch, G; Brunckhorst, C; Duru, F				Scharf, Christoph; Krasniqi, Nazmi; Hellermann, Jens; Rahn, Mariette; Suetsch, Gabor; Brunckhorst, Corinna; Duru, Firat			Electrical Activation in the Coronary Sinus Branches as a Guide to Cardiac Resynchronisation Therapy: Rationale for a Coordinate System	PLOS ONE			English	Article							RESYNCHRONIZATION THERAPY; HEART-FAILURE; VENTRICULAR ACTIVATION; BLOCK; CONDUCTION; DELAY; NOMENCLATURE; CARDIOLOGY; STATEMENT; ANATOMY	Background: For successful cardiac resynchronisation therapy (CRT) a spatial and electrical separation of right and left ventricular electrodes is essential. The spatial distribution of electrical delays within the coronary sinus (CS) tributaries has not yet been identified. Objective: Electrical delays within the CS are described during sinus rhythm (SR) and right ventricular pacing (RVP). A coordinate system grading the mitral ring from 0 degrees to 360 degrees and three vertical segments is proposed to define the lead positions irrespective of individual CS branch orientation. Methods: In 13 patients undergoing implantation of a CRT device 6 +/- 2.5, (median 5) lead positions within the CS were mapped during SR and RVP. The delay to the onset and the peak of the local signal was measured from the earliest QRS activation or the pacing spike. Fluoroscopic positions were compared to localizations on a nonfluoroscopic electrode imaging system. Results: During SR, electrical delays in the CS were inhomogenous in patients with or without left bundle branch block (LBBB). During RVP, the delays increased by 44 +/- 32 ms (signal onset from 36 +/- 33 ms to 95 +/- 30 ms; p<0.001, signal peak from 105 +/- 44 ms to 156 +/- 30 ms; p<0.001). The activation pattern during RVP was homogeneous and predictable by taking the grading on the CS ring into account: (% QRS) = 78-0.002 (grade-162)(2), p<0.0001. This indicates that 78% of the QRS duration can be expected as a maximum peak delay at 162 degrees on the CS ring. Conclusion: Electrical delays within the CS vary during SR, but prolong and become predictable during RVP. A coordinate system helps predicting the local delays and facilitates interindividual comparison of lead positions irrespective of CS branch anatomy.	[Scharf, Christoph; Krasniqi, Nazmi; Hellermann, Jens; Rahn, Mariette; Suetsch, Gabor; Brunckhorst, Corinna; Duru, Firat] Univ Zurich Hosp, Ctr Cardiovasc, Clin Cardiol, Div Pacing & Electrophysiol, CH-8091 Zurich, Switzerland; [Scharf, Christoph] Clin Pk, Zurich, Switzerland; [Duru, Firat] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharf, C (corresponding author), Univ Zurich Hosp, Ctr Cardiovasc, Clin Cardiol, Div Pacing & Electrophysiol, CH-8091 Zurich, Switzerland.	christoph.scharf@gmail.com	Hellermann, Jens/ABB-2889-2020; Duru, Firat/F-7161-2011	Duru, Firat/0000-0002-4748-0158				Auricchio A, 2004, CIRCULATION, V109, P1133, DOI 10.1161/01.CIR.0000118502.91105.F6; CANNOM DS, 1980, CIRCULATION, V62, P621, DOI 10.1161/01.CIR.62.3.621; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Cosio FG, 1999, CIRCULATION, V100, pE31, DOI 10.1161/01.CIR.100.5.e31; Lambiase PD, 2004, HEART, V90, P44, DOI 10.1136/heart.90.1.44; Merchant FM, 2010, PACE, V33, P575, DOI 10.1111/j.1540-8159.2009.02624.x; Peichl P, 2004, PACE, V27, P1105, DOI 10.1111/j.1540-8159.2004.00592.x; Rodriguez LM, 2003, J CARDIOVASC ELECTR, V14, P135, DOI 10.1046/j.1540-8167.2003.02421.x; Sassone B, 2010, EUROPACE, V12, P78, DOI 10.1093/europace/eup347; Singh JP, 2005, J AM COLL CARDIOL, V46, P68, DOI 10.1016/j.jacc.2005.04.017; Tse HF, 2005, J CARDIOVASC ELECTR, V16, P690, DOI 10.1046/j.1540-8167.2005.40568.x; Turner MS, 2004, CIRCULATION, V109, P2544, DOI 10.1161/01.CIR.0000131184.40893.40; VASSALLO JA, 1984, CIRCULATION, V69, P914, DOI 10.1161/01.CIR.69.5.914; Wittkampf FHM, 1999, CIRCULATION, V99, P1312, DOI 10.1161/01.CIR.99.10.1312	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e19914	10.1371/journal.pone.0019914	http://dx.doi.org/10.1371/journal.pone.0019914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857896	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000293773300001
J	Zheng, LH; Michelson, Y; Freger, V; Avraham, Z; Venken, KJT; Bellen, HJ; Justice, MJ; Wides, R				Zheng, Lihua; Michelson, Yehudit; Freger, Vita; Avraham, Ziva; Venken, Koen J. T.; Bellen, Hugo J.; Justice, Monica J.; Wides, Ron			Drosophila Ten-m and Filamin Affect Motor Neuron Growth Cone Guidance	PLOS ONE			English	Article							PAIR-RULE GENE; PERIVENTRICULAR NODULAR HETEROTOPIA; ELEMENT INSERTION ALLELES; AXON GUIDANCE; P-ELEMENT; 3RD CHROMOSOME; MONOCLONAL-ANTIBODIES; COMMISSURAL AXONS; NETRIN-RECEPTOR; CEREBRAL-CORTEX	The Drosophila Ten-m (also called Tenascin-major, or odd Oz (odz)) gene has been associated with a pair-rule phenotype. We identified and characterized new alleles of Drosophila Ten-m to establish that this gene is not responsible for segmentation defects but rather causes defects in motor neuron axon routing. In Ten-m mutants the inter-segmental nerve (ISN) often crosses segment boundaries and fasciculates with the ISN in the adjacent segment. Ten-m is expressed in the central nervous system and epidermal stripes during the stages when the growth cones of the neurons that form the ISN navigate to their targets. Over-expression of Ten-m in epidermal cells also leads to ISN misrouting. We also found that Filamin, an actin binding protein, physically interacts with the Ten-m protein. Mutations in cheerio, which encodes Filamin, cause defects in motor neuron axon routing like those of Ten-m. During embryonic development, the expression of Filamin and Ten-m partially overlap in ectodermal cells. These results suggest that Ten-m and Filamin in epidermal cells might together influence growth cone progression.	[Zheng, Lihua; Venken, Koen J. T.; Bellen, Hugo J.; Justice, Monica J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Michelson, Yehudit; Freger, Vita; Avraham, Ziva; Wides, Ron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Program Dev Biol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Bar Ilan University; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zheng, LH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	mjustice@bcm.edu; ronwides@yahoo.com	Venken, Koen/B-9909-2013	Venken, Koen/0000-0003-0741-4698; Bellen, Hugo/0000-0001-5992-5989	NIH [U01 HD39372, P01 ES11253]; Israel Science Foundation [749_04]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD039372] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA115503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants U01 HD39372 and P01 ES11253 to MJJ.www.nih.gov/. This work was supported by Israel Science Foundation Grant 749_04 to RW. www.isf.org.il/english/. HJB is an investigator of the HHMI. www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following for invaluable technical support and help: Karen L. Schuzle, June Cao, Yuchun He, Hongling Pan, Amir Fayyazuddin, Rong Grace Zhai, Yael Kinel-Tahan, and Anna Levine. We thank Stefan Baumgartner, Allan Spradling, Lynn Cooley, Juan Pablo Labrador, Josh Dubnau, Tim Tully and the Bloomington Drosophila Stock Center for kindly providing reagents. Antibodies obtained from the Developmental Studies Hybridoma Bank (DSHB) were developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences.	Araujo SJ, 2003, NAT REV NEUROSCI, V4, P910, DOI 10.1038/nrn1243; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Deak P, 1997, GENETICS, V147, P1697; Dgany O, 2002, BIOCHEM J, V363, P633, DOI 10.1042/0264-6021:3630633; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Ferland RJ, 2009, HUM MOL GENET, V18, P497, DOI 10.1093/hmg/ddn377; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GORCZYCA MG, 1994, DEVELOPMENT, V120, P2143; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; KARPEN GH, 1992, GENETICS, V132, P737; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Kinel-Tahan Y, 2007, DEV DYNAM, V236, P2541, DOI 10.1002/dvdy.21284; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Levine A, 1997, GENE, V200, P59, DOI 10.1016/S0378-1119(97)00375-2; Lossie AC, 2005, GENETICS, V169, P285, DOI 10.1534/genetics.104.034967; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moro F, 2002, NEUROLOGY, V58, P916, DOI 10.1212/WNL.58.6.916; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Otaki JM, 1999, DEV BIOL, V212, P165, DOI 10.1006/dbio.1999.9310; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Robinson DN, 1997, GENETICS, V145, P1063; ROSEMAN RR, 1995, GENETICS, V141, P1061; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Salzberg A, 1997, GENETICS, V147, P1723; Sanchez-Soriano N, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-9; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Schmid A, 1999, DEVELOPMENT, V126, P4653; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; Sink H, 2001, CELL, V105, P57, DOI 10.1016/S0092-8674(01)00296-3; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Sokol NS, 1999, CURR BIOL, V9, P1221, DOI 10.1016/S0960-9822(99)80502-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	68	40	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22956	10.1371/journal.pone.0022956	http://dx.doi.org/10.1371/journal.pone.0022956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857973	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300015
J	Yuan, YY; Cao, PX; Smith, MA; Kramp, K; Huang, Y; Hisamoto, N; Matsumoto, K; Hatzoglou, M; Jin, H; Feng, ZY				Yuan, Yiyuan; Cao, Pengxiu; Smith, Mark A.; Kramp, Kristopher; Huang, Ying; Hisamoto, Naoki; Matsumoto, Kunihiro; Hatzoglou, Maria; Jin, Hui; Feng, Zhaoyang			Dysregulated LRRK2 Signaling in Response to Endoplasmic Reticulum Stress Leads to Dopaminergic Neuron Degeneration in C. elegans	PLOS ONE			English	Article							REPEAT KINASE 2; AUTOSOMAL-DOMINANT PARKINSONISM; UNFOLDED PROTEIN RESPONSE; ALPHA-SYNUCLEIN; CAENORHABDITIS-ELEGANS; CELL-DEATH; DROSOPHILA MODEL; UP-REGULATION; DISEASE; PHOSPHORYLATION	Mutation of leucine-rich repeat kinase 2 (LRRK2) is the leading genetic cause of Parkinson's Disease (PD), manifested as age-dependent dopaminergic neurodegeneration, but the underlying molecular mechanisms remain unclear. Multiple roles of LRRK2 may contribute to dopaminergic neurodegeneration. Endoplasmic reticulum (ER) stress has also been linked to PD pathogenesis, but its interactive mechanism with PD genetic factors is largely unknown. Here, we used C. elegans, human neuroblastoma cells and murine cortical neurons to determine the role of LRRK2 in maintaining dopaminergic neuron viability. We found that LRRK2 acts to protect neuroblastoma cells and C. elegans dopaminergic neurons from the toxicity of 6-hydroxydopamine and/or human alpha-synuclein, possibly through the p38 pathway, by supporting upregulation of GRP78, a key cell survival molecule during ER stress. A pathogenic LRRK2 mutant (G2019S), however, caused chronic p38 activation that led to death of murine neurons and age-related dopaminergic-specific neurodegeneration in nematodes. These observations establish a critical functional link between LRRK2 and ER stress.	[Yuan, Yiyuan; Cao, Pengxiu; Kramp, Kristopher; Huang, Ying; Jin, Hui; Feng, Zhaoyang] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Smith, Mark A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH USA; [Hisamoto, Naoki; Matsumoto, Kunihiro] Japan Sci & Technology Corp, Nagoya Solut Oriented Res Sci & Technol, Dept Mol Biol, Inst Adv Res,Grad Sch Sci,Chikusa Ku, Nagoya, Aichi, Japan; [Feng, Zhaoyang] Xi An Jiao Tong Univ, Dept Physiol, Coll Med, Xian 710049, Shaanxi, Peoples R China	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Japan Science & Technology Agency (JST); Xi'an Jiaotong University	Yuan, YY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	john.feng@case.edu	Cao, Pengxiu/I-5378-2012	Kramp, Kristopher/0000-0003-2121-9274; CAO, PENGXIU/0000-0002-5900-5645	Mt. Sinai Foundation; National Institutes of Health; Grants-in-Aid for Scientific Research [22020016] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060596, R01DK053307] Funding Source: NIH RePORTER	Mt. Sinai Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Mt. Sinai Foundation and the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao PX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009312; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dauer W, 2010, MOVEMENT DISORD, V25, pS40, DOI 10.1002/mds.22717; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Heo HY, 2009, EXP CELL RES; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Hsu CH, 2010, J NEUROCHEM; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kanao T, 2010, HUM MOL GENET; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kong ANT, 2000, ARCH PHARM RES, V23, P1, DOI 10.1007/BF02976458; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Krysov SV, 2007, MOL CANCER THER, V6, P703, DOI 10.1158/1535-7163.MCT-06-0544; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Kuwahara T, 2006, J BIOL CHEM, V281, P334, DOI 10.1074/jbc.M504860200; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; LEAVITT R, 1977, J VIROL, V21, P375, DOI 10.1128/JVI.21.1.375-385.1977; Lee BD, 2010, NAT MED; Lee SB, 2007, BIOCHEM BIOPH RES CO, V358, P534, DOI 10.1016/j.bbrc.2007.04.156; Lee YM, 2003, NEUROSCI LETT, V352, P17, DOI 10.1016/j.neulet.2003.08.018; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liou AKF, 2008, NEUROBIOL DIS, V32, P116, DOI 10.1016/j.nbd.2008.06.016; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Melrose H, 2006, NEUROSCIENCE, V139, P791, DOI 10.1016/j.neuroscience.2006.01.017; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Ng CH, 2009, J NEUROSCI, V29, P11257, DOI 10.1523/JNEUROSCI.2375-09.2009; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2009, HUM MUTAT, V30, P1153, DOI 10.1002/humu.21038; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Simon-Sanchez J, 2006, EUR J NEUROSCI, V23, P659, DOI 10.1111/j.1460-9568.2006.04616.x; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Varghese J, 2001, J IMMUNOL, V166, P6570, DOI 10.4049/jimmunol.166.11.6570; Vitte J, 2010, J NEUROPATH EXP NEUR, V69, P959, DOI 10.1097/NEN.0b013e3181efc01c; Wang DL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-3; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; White LR, 2007, J NEUROSCI RES, V85, P1288, DOI 10.1002/jnr.21240; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yabe T, 2005, DEVELOPMENT, V132, P3197, DOI 10.1242/dev.01909; Yamamuro A, 2006, NEUROCHEM RES, V31, P657, DOI 10.1007/s11064-006-9062-6; Yao C, 2010, NEUROBIOL DIS, V40, P73, DOI 10.1016/j.nbd.2010.04.002; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	78	59	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22354	10.1371/journal.pone.0022354	http://dx.doi.org/10.1371/journal.pone.0022354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857923	Green Published, Green Submitted, gold			2022-12-27	WOS:000293558900016
J	Yang, CJ; Kim, SH; Bianco, NR; Robbins, PD				Yang, Chenjie; Kim, Seon-Hee; Bianco, Nicole R.; Robbins, Paul D.			Tumor-Derived Exosomes Confer Antigen-Specific Immunosuppression in a Murine Delayed-Type Hypersensitivity Model	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; MEMBRANE-VESICLES; DENDRITIC CELLS; VIRAL IL-10; TGF-BETA; T-CELLS; EXPERIMENTAL ARTHRITIS; SUPPRESS INFLAMMATION; EFFICIENT INDUCTION; ANTITUMOR RESPONSE	Exosomes are endosome-derived small membrane vesicles that are secreted by most cell types including tumor cells. Tumor-derived exosomes usually contain tumor antigens and have been used as a source of tumor antigens to stimulate anti-tumor immune responses. However, many reports also suggest that tumor-derived exosomes can facilitate tumor immune evasion through different mechanisms, most of which are antigen-independent. In the present study we used a mouse model of delayed-type hypersensitivity (DTH) and demonstrated that local administration of tumor-derived exosomes carrying the model antigen chicken ovalbumin (OVA) resulted in the suppression of DTH response in an antigen-specific manner. Analysis of exosome trafficking demonstrated that following local injection, tumor-derived exosomes were internalized by CD11c+ cells and transported to the draining LN. Exosome-mediated DTH suppression is associated with increased mRNA levels of TGF-beta 1 and IL-4 in the draining LN. The tumor-derived exosomes examined were also found to inhibit DC maturation. Taken together, our results suggest a role for tumor-derived exosomes in inducing tumor antigen-specific immunosuppression, possibly by modulating the function of APCs.	[Yang, Chenjie; Kim, Seon-Hee; Bianco, Nicole R.; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yang, CJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	probb@pitt.edu			DOD [17-03-1-0488, 17-03-0412, U01 NS058451, P30 AG024827, R21 AG033907]; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033907, P30AG024827] Funding Source: NIH RePORTER	DOD(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by DOD grants 17-03-1-0488 and 17-03-0412 and U01 NS058451, P30 AG024827, and R21 AG033907 grants from the National Institutes of Health to PDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chen WL, 2006, EUR J IMMUNOL, V36, P1598, DOI 10.1002/eji.200535501; Clayton A, 2009, CURR ONCOL, V16, P187; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Cone RE, 2007, IMMUNOLOGY, V120, P112, DOI 10.1111/j.1365-2567.2006.02486.x; D'Orazio TJ, 1998, J IMMUNOL, V160, P2089; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; Dai SM, 2006, J MOL MED, V84, P1067, DOI 10.1007/s00109-006-0102-0; Dai SM, 2005, CLIN CANCER RES, V11, P7554, DOI 10.1158/1078-0432.CCR-05-0810; Denzer K, 2000, J CELL SCI, V113, P3365; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Ghivizzani SC, 1998, P NATL ACAD SCI USA, V95, P4613, DOI 10.1073/pnas.95.8.4613; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Jacysyn JF, 2003, IMMUNOL CELL BIOL, V81, P424, DOI 10.1046/j.1440-1711.2003.01194.x; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kim SH, 2007, J IMMUNOL, V179, P2235, DOI 10.4049/jimmunol.179.4.2235; Kim SH, 2000, ARTHRITIS RES, V2, P293, DOI 10.1186/ar104; Kim SH, 2006, MOL THER, V13, P289, DOI 10.1016/j.ymthe.2005.09.015; Kim SH, 2005, J IMMUNOL, V174, P6440, DOI 10.4049/jimmunol.174.10.6440; Lechman ER, 2003, GENE THER, V10, P2029, DOI 10.1038/sj.gt.3302109; Lechman ER, 1999, J IMMUNOL, V163, P2202; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; MEADE R, 1992, J IMMUNOL, V149, P521; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Navabi H, 2005, BLOOD CELL MOL DIS, V35, P149, DOI 10.1016/j.bcmd.2005.06.008; Ostman S, 2005, IMMUNOLOGY, V116, P464, DOI 10.1111/j.1365-2567.2005.02245.x; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Peche H, 2006, AM J TRANSPLANT, V6, P1541, DOI 10.1111/j.1600-6143.2006.01344.x; Prado N, 2008, J IMMUNOL, V181, P1519, DOI 10.4049/jimmunol.181.2.1519; Rock KL, 1996, J IMMUNOL, V156, P3721; Sack U, 1999, J AUTOIMMUN, V13, P335, DOI 10.1006/jaut.1999.0328; Seder RA, 1998, J IMMUNOL, V160, P5719; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Taylor DD, 2003, CLIN CANCER RES, V9, P5113; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Whalen JD, 2001, MOL THER, V4, P543, DOI 10.1006/mthe.2001.0492; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Xiu FM, 2007, J MOL MED, V85, P511, DOI 10.1007/s00109-006-0154-1; Yang YS, 2007, J CANCER RES CLIN, V133, P389, DOI 10.1007/s00432-006-0184-7; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zhang Y, 2010, INT J ONCOL, V36, P133, DOI 10.3892/ijo_00000484; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	57	75	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22517	10.1371/journal.pone.0022517	http://dx.doi.org/10.1371/journal.pone.0022517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829629	Green Published, gold, Green Accepted			2022-12-27	WOS:000293511900009
J	Hakze-van der Honing, RW; van Coillie, E; Antonis, AFG; van der Poel, WHM				Hakze-van der Honing, Renate W.; van Coillie, Els; Antonis, Adriaan F. G.; van der Poel, Wim H. M.			First Isolation of Hepatitis E Virus Genotype 4 in Europe through Swine Surveillance in the Netherlands and Belgium	PLOS ONE			English	Article							CROSS-SPECIES INFECTION; UNITED-STATES; RT-PCR; PREVALENCE; HEV; EPIDEMIOLOGY; TRANSMISSION; ANTIBODIES; SEQUENCES; HUMANS	Hepatitis E virus (HEV) genotypes 3 and 4 are a cause of human hepatitis and swine are considered the main reservoir. To study the HEV prevalence and characterize circulating HEV strains, fecal samples from swine in the Netherlands and Belgium were tested by RT-PCR. HEV prevalence in swine was 7-15%. The Dutch strains were characterized as genotype 3, subgroups 3a, 3c and 3f, closely related to sequences found in humans and swine earlier. The HEV strains found in Belgium belonged to genotypes 3f and 4b. The HEV genotype 4 strain was the first ever reported in swine in Europe and an experimental infection in pigs was performed to isolate the virus. The genotype 4 strain readily infected piglets and caused fever and virus shedding. Since HEV4 infections have been reported to run a more severe clinical course in humans this observation may have public health implications.	[Hakze-van der Honing, Renate W.; Antonis, Adriaan F. G.; van der Poel, Wim H. M.] Univ Wageningen & Res Ctr, Lelystad, Netherlands; [van Coillie, Els] Inst Agr & Fisheries Res ILVO, Melle, Belgium; [van der Poel, Wim H. M.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	Wageningen University & Research; Institute For Agricultural & Fisheries Research; University of Liverpool	Hakze-van der Honing, RW (corresponding author), Univ Wageningen & Res Ctr, Lelystad, Netherlands.	wim.vanderpoel@wur.nl			Dutch Ministry of Agriculture Nature and Foods as part of the Wageningen University and Research Centre	Dutch Ministry of Agriculture Nature and Foods as part of the Wageningen University and Research Centre	This study was commissioned by the Dutch Ministry of Agriculture Nature and Foods as part of the Wageningen University and Research Centre internal research program "Kennisbasis''. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; BALAYAN MS, 1990, J MED VIROL, V32, P58, DOI 10.1002/jmv.1890320110; Borgen K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-61; Bouwknegt M, 2008, EPIDEMIOL INFECT, V136, P567, DOI 10.1017/S0950268807008941; Bouwknegt M, 2007, J FOOD PROTECT, V70, P2889, DOI 10.4315/0362-028X-70.12.2889; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Dalton HR, 2007, J VIRAL HEPATITIS, V14, P304, DOI 10.1111/j.1365-2893.2006.00800.x; Drobeniuc J, 2001, J INFECT DIS, V184, P1594, DOI 10.1086/324566; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; EMERSON SU, 2004, VIRUS TAXONOMY, P853; Gyarmati P, 2007, J VIROL METHODS, V146, P226, DOI 10.1016/j.jviromet.2007.07.014; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Matsuda H, 2003, J INFECT DIS, V188, P944, DOI 10.1086/378074; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Meng XJ, 2003, CURR TOP MICROBIOL, V278, P185; Olsen BR, 2006, SCAND J INFECT DIS, V38, P55, DOI 10.1080/00365540500321470; Rutjes SA, 2007, J VIROL METHODS, V143, P112, DOI 10.1016/j.jviromet.2007.01.030; Rutjes SA, 2009, EMERG INFECT DIS, V15, P381, DOI 10.3201/eid1503.071472; Schlauder GG, 1999, J MED VIROL, V57, P243, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;243::AID-JMV6&gt;3.0.CO;2-R; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; van der Poel WHM, 2001, EMERG INFECT DIS, V7, P970, DOI 10.3201/eid0706.010608; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; Widdowson MA, 2003, CLIN INFECT DIS, V36, P29, DOI 10.1086/345439; Widen F, 2010, EPIDEMIOL INFECT, V14, P1; Withers MR, 2002, AM J TROP MED HYG, V66, P384, DOI 10.4269/ajtmh.2002.66.384; Worm HC, 2002, MICROBES INFECT, V4, P657, DOI 10.1016/S1286-4579(02)01584-8	34	95	99	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22673	10.1371/journal.pone.0022673	http://dx.doi.org/10.1371/journal.pone.0022673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829641	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511200016
J	Hong, YD; Xing, XR; Li, SJ; Bi, HL; Yang, CH; Zhao, F; Liu, Y; Ao, X; Chang, AK; Wu, HJ				Hong, Yongde; Xing, Xinrong; Li, Shujing; Bi, Hailian; Yang, Chunhua; Zhao, Feng; Liu, Ying; Ao, Xiang; Chang, Alan K.; Wu, Huijian			SUMOylation of DEC1 Protein Regulates Its Transcriptional Activity and Enhances Its Stability	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; TUMOR-SUPPRESSOR; MOLECULAR CLOCK; E-BOX; STRA13; SUMO; HYPOXIA; LOOP; PROMOTES; UBIQUITIN	Differentiated embryo-chondrocyte expressed gene 1 (DEC1, also known as sharp2, stra13, or BHLHB2) is a mammalian basic helix-loop-helix protein that is involved in many aspects of gene regulation through acting as a transcription factor. Changes in DEC1 expression levels have been implicated in the development of cancers. Using COS-7 cell, we showed that DEC1 can be modified by the small ubiquitin-like modifiers, SUMO1, 2 and 3. Two major SUMOylation sites (K(159) and K(279)) were identified in the C-terminal domain of DEC1. Substitution of either K(159) or K(279) with arginine reduced DEC1 SUMOylation, but substitution of both K(159) and K(279) abolished SUMOylation, and more protein appeared to be retained in the cytoplasm compared to wild-type DEC1. The expression of DEC1 was up-regulated after serum starvation as previously reported, but at the same time, serum starvation also led to more SUMOylation of DEC1. In MCF-7 cells SUMOylation also stabilized DEC1 through inhibiting its ubiquitination. Moreover, SUMOylation of DEC1 promoted its repression of CLOCK/BMAL1-mediated transcriptional activity through recruitment of histone deacetylase1. These findings suggested that posttranslational modification of DEC1 in the form of SUMOylation may serve as a key factor that regulates the function of DEC1 in vivo.	[Hong, Yongde; Xing, Xinrong; Li, Shujing; Bi, Hailian; Yang, Chunhua; Zhao, Feng; Liu, Ying; Ao, Xiang; Chang, Alan K.; Wu, Huijian] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Dalian University of Technology	Hong, YD (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China.	wuhj@dlut.edu.cn	Liu, Ying/ABF-6380-2021	Liu, Ying/0000-0003-1699-9309; Zhao, Feng/0000-0002-7959-0394	National Natural Science Foundation of China [30771221]; Ministry of Science and Technology of China [2011CB504201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants (30771221 to H.W.) from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default106.htm) and grants (973 Program 2011CB504201 to H.W.) from the Ministry of Science and Technology of China (http://www.most.gov.cn/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Cho Y, 2009, MOL PHARMACOL, V76, P1360, DOI 10.1124/mol.109.057000; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Currie MJ, 2004, J CLIN PATHOL, V57, P829, DOI 10.1136/jcp.2003.015644; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoffman AE, 2010, CANCER RES, V70, P1459, DOI 10.1158/0008-5472.CAN-09-3798; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Kohler M, 1999, EXP NEPHROL, V7, P290; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li YX, 2004, BIOCHEM J, V382, P895, DOI 10.1042/BJ20040592; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nakamura TJ, 2010, STEROIDS, V75, P203, DOI 10.1016/j.steroids.2010.01.007; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Noshiro M, 2009, GENES CELLS, V14, P29, DOI 10.1111/j.1365-2443.2008.01247.x; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Percherancier Y, 2009, J BIOL CHEM, V284, P16595, DOI 10.1074/jbc.M109.006387; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Teramoto M, 2001, J BIOCHEM-TOKYO, V129, P391, DOI 10.1093/oxfordjournals.jbchem.a002869; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Yagita K, 2000, GENE DEV, V14, P1353; Yamada K, 2005, FEBS LETT, V579, P1509, DOI 10.1016/j.febslet.2005.01.060; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Yunokawa M, 2007, ONCOL REP, V17, P871; Zheng Y, 2009, OMICS, V13, P301, DOI 10.1089/omi.2009.0014	51	34	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23046	10.1371/journal.pone.0023046	http://dx.doi.org/10.1371/journal.pone.0023046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829689	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200034
J	Uebanso, T; Taketani, Y; Yamamoto, H; Amo, K; Ominami, H; Arai, H; Takei, Y; Masuda, M; Tanimura, A; Harada, N; Yamanaka-Okumura, H; Takeda, E				Uebanso, Takashi; Taketani, Yutaka; Yamamoto, Hironori; Amo, Kikuko; Ominami, Hirokazu; Arai, Hidekazu; Takei, Yuichiro; Masuda, Masashi; Tanimura, Ayako; Harada, Nagakatsu; Yamanaka-Okumura, Hisami; Takeda, Eiji			Paradoxical Regulation of Human FGF21 by Both Fasting and Feeding Signals: Is FGF21 a Nutritional Adaptation Factor?	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-21; ELEMENT-BINDING PROTEIN; PPAR-ALPHA; METABOLIC REGULATOR; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ANOREXIA-NERVOSA; CARBOHYDRATE; FIBROBLAST-GROWTH-FACTOR-21; CHREBP	Fibroblast growth factor 21 (FGF21) has recently emerged as a metabolic hormone involved in regulating glucose and lipid metabolism in mouse, but the regulatory mechanisms and actions of FGF21 in humans remain unclear. Here we have investigated the regulatory mechanisms of the human FGF21 gene at the transcriptional level. A deletion study of the human FGF21 promoter (-1672 to +230 bp) revealed two fasting signals, including peroxisome proliferator-activated receptor alpha (PPAR alpha) and glucagon signals, that independently induced human FGF21 gene transcription in mouse primary hepatocytes. In addition, two feeding signals, glucose and xylitol, also dose-dependently induced human FGF21 gene transcription and mRNA expression in both human HepG2 cells and mouse primary hepatocytes. FGF21 protein expression and secretion were also induced by high glucose stimulation. The human FGF21 promoter (-1672 to +230 bp) was found to have a carbohydrate-responsive element at -380 to -366 bp, which is distinct from the PPAR response element (PPRE). Knock-down of the carbohydrate response element binding protein by RNAi diminished glucose-induced human FGF21 transcription. Moreover, we found that a region from -555 to -443 bp of the human FGF21 promoter region exerts an important role in the activation of basic transcription. In conclusion, human FGF21 gene expression is paradoxically and independently regulated by both fasting and feeding signals. These regulatory mechanisms suggest that human FGF21 is increased with nutritional crisis, including starvation and overfeeding.	[Uebanso, Takashi; Taketani, Yutaka; Yamamoto, Hironori; Amo, Kikuko; Ominami, Hirokazu; Takei, Yuichiro; Masuda, Masashi; Tanimura, Ayako; Yamanaka-Okumura, Hisami; Takeda, Eiji] Univ Tokushima, Dept Clin Nutr, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Uebanso, Takashi] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Res Inst, Tokyo, Japan; [Arai, Hidekazu] Univ Shizuoka, Sch Food & Nutr Sci, Lab Clin Nutr Management, Shizuoka 4228526, Japan; [Harada, Nagakatsu] Univ Tokushima, Dept Nutr & Metab, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan	Tokushima University; National Center for Global Health & Medicine - Japan; University of Shizuoka; Tokushima University	Uebanso, T (corresponding author), Univ Tokushima, Dept Clin Nutr, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	taketani@nutr.med.tokushima-u.ac.jp	Yamamoto, Hironori/E-3902-2015; Arai, Hidekazu/R-6636-2019	Arai, Hidekazu/0000-0001-8491-021X; Masuda, Masashi/0000-0003-3762-2770	Ministry of Education, Culture, Sports, Science, and Technology in Japan [19680030, 18790567, 22890244, 18300232, 22300237]; University of Tokushima, Tokushima, Japan; Grants-in-Aid for Scientific Research [22680053] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Tokushima, Tokushima, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research for Young Scientists (19680030, 18790567); for Research Activity Start-up (22890244) and for Scientific Research (B) (18300232, 22300237) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan; the 21st Century COE program "Human Nutritional Science and Stress Control"; and the Initiatives for Attractive Education in Graduate School from the University of Tokushima, Tokushima, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dostalova I, 2008, J CLIN ENDOCR METAB, V93, P3627, DOI 10.1210/jc.2008-0746; Fazeli PK, 2010, J CLIN ENDOCR METAB, V95, P369, DOI 10.1210/jc.2009-1730; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Mizuha Y, 2007, BIOFACTORS, V30, P105, DOI 10.1002/biof.5520300204; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Uebanso T, 2009, AM J PHYSIOL-ENDOC M, V297, pE76, DOI 10.1152/ajpendo.00014.2009; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	22	68	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22976	10.1371/journal.pone.0022976	http://dx.doi.org/10.1371/journal.pone.0022976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829679	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200029
J	Coleman, JL; Barclay, RMR				Coleman, Joanna L.; Barclay, Robert M. R.			Influence of Urbanization on Demography of Little Brown Bats (Myotis lucifugus) in the Prairies of North America	PLOS ONE			English	Article							INSECTIVOROUS BAT; REPRODUCTIVE SUCCESS; POSTNATAL-GROWTH; BREEDING ECOLOGY; URBAN; POPULATION; SURVIVAL; HABITAT; CONSERVATION; PIPISTRELLUS	Background: We address three key gaps in research on urban wildlife ecology: insufficient attention to (1) grassland biomes, (2) individual-and population-level effects, and (3) vertebrates other than birds. We hypothesized that urbanization in the North American Prairies, by increasing habitat complexity (via the proliferation of vertical structures such as trees and buildings), thereby enhancing the availability of day-roosts, tree cover, and insects, would benefit synanthropic bats, resulting in increased fitness among urban individuals. Methodology/Principal Findings: Over three years, we captured more than 1,600 little brown bats (Myotis lucifugus) in urban and non-urban riparian sites in and around Calgary, Alberta, Canada. This species dominated bat assemblages throughout our study area, but nowhere more so than in the city. Our data did not support most of our specific predictions. Increased numbers of urban bats did not reflect urbanization-related benefits such as enhanced body condition, reproductive rates, or successful production of juveniles. Instead, bats did best in the transition zone situated between strictly urban and rural areas. Conclusions/Significance: We reject our hypothesis and explore various explanations. One possibility is that urban and rural M. lucifugus exhibit increased use of anthropogenic roosts, as opposed to natural ones, leading to larger maternity colonies and higher population densities and, in turn, increased competition for insect prey. Other possibilities include increased stress, disease transmission and/or impacts of noise on urban bats. Whatever the proximate cause, the combination of greater bat population density with decreased body condition and production of juveniles indicates that Calgary does not represent a population source for Prairie bats. We studied a highly synanthropic species in a system where it could reasonably be expected to respond positively to urbanization, but failed to observe any apparent benefits at the individual level, leading us to propose that urban development may be universally detrimental to bats.	[Coleman, Joanna L.; Barclay, Robert M. R.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Coleman, JL (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	jcoleman@ucalgary.ca	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Coleman, Joanna/D-1787-2016; Barclay, Robert/D-5514-2012		Natural Sciences and Engineering Research Council of Canada [69-0424]; Killam Trusts; Bat Conservation International; University of Calgary; Canadian Tire	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Killam Trusts; Bat Conservation International; University of Calgary; Canadian Tire	Funding for this research was provided by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant #69-0424, www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp), Killam Trusts (www.killamtrusts.ca), Bat Conservation International (www.batcon.org/index.php/what-we-do/grants/student-research-scholarships), University of Calgary (www.ucalgary.ca), and Canadian Tire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Lowell W., 2005, Urban Ecosystems, V8, P139, DOI 10.1007/s11252-005-4377-7; ADAMS R, 2010, ECOLOGY IN PRESS; Adams RA, 1997, J MAMMAL, V78, P239, DOI 10.2307/1382657; [Anonymous], 1998, RURAL DEV PERSPECTIV; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; BARCLAY RMR, 1991, J ANIM ECOL, V60, P165, DOI 10.2307/5452; Barclay RMR, 2004, CAN J ZOOL, V82, P688, DOI 10.1139/Z04-057; BARCLAY RMR, 1985, J MAMMAL, V66, P782, DOI 10.2307/1380808; BARCLAY RMR, 1994, AM NAT, V144, P1021, DOI 10.1086/285723; BARROWCLOUGH GF, 1993, AM NAT, V141, P281, DOI 10.1086/285473; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Beckmann JP, 2003, J MAMMAL, V84, P594, DOI 10.1644/1545-1542(2003)084<0594:UBBTTI>2.0.CO;2; Boal CW, 1999, J WILDLIFE MANAGE, V63, P77, DOI 10.2307/3802488; Brunet-Rossinni Anja K., 2009, P315; BUCHLER ER, 1975, J MAMMAL, V56, P252, DOI 10.2307/1379630; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; COLEMAN J, 2010, EFFECTS URBANIZATION; Coleman JL, 2002, WILSON BULL, V114, P467, DOI 10.1676/0043-5643(2002)114[0467:HUAPOS]2.0.CO;2; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; DeStefano Stephen, 2005, P206; DICKMAN CR, 1989, J ANIM ECOL, V58, P119, DOI 10.2307/4989; Dobson FS, 2007, ECOSCIENCE, V14, P292, DOI 10.2980/1195-6860(2007)14[292:FASLHO]2.0.CO;2; DONCASTER CP, 1994, OIKOS, V69, P182, DOI 10.2307/3546136; Donovan TM, 2001, ECOL APPL, V11, P871; *EC STRAT WORK GRO, 1995, TERR EC EC EC CAN PR; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Garden J, 2006, AUSTRAL ECOL, V31, P126, DOI 10.1111/j.1442-9993.2006.01578.x; Gehrt SD, 2003, ECOL APPL, V13, P939, DOI 10.1890/02-5188; Gehrt SD, 2005, J MAMMAL, V86, P1164, DOI 10.1644/04-MAMM-A-173R2.1; GRAFEN A, 1982, NATURE, V298, P425, DOI 10.1038/298425a0; GRINDAL SD, 1992, AM MIDL NAT, V128, P339, DOI 10.2307/2426468; Harveson PM, 2007, BIOL CONSERV, V134, P321, DOI 10.1016/j.biocon.2006.07.022; Holloway GL, 2000, ECOSCIENCE, V7, P115, DOI 10.1080/11956860.2000.11682579; Hoying KM, 1998, J ZOOL, V245, P15, DOI 10.1111/j.1469-7998.1998.tb00067.x; HUMPHREY SR, 1975, J MAMMAL, V56, P321, DOI 10.2307/1379364; Humphries M. M., 2006, FUNCTIONAL EVOLUTION, P23; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; KEEN R, 1980, J MAMMAL, V61, P1, DOI 10.2307/1379951; Kittredge Vanessa C., 2006, Proceedings of the Oklahoma Academy of Science, V86, P33; Koehler CE, 2000, J MAMMAL, V81, P234, DOI 10.1644/1545-1542(2000)081<0234:PNGABB>2.0.CO;2; Kunz TH, 2003, BAT ECOLOGY, P3; KUNZ TH, 1974, ECOLOGY, V55, P693, DOI 10.2307/1934408; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; KURTA A, 1987, S ZOOL SOC LOND, V57, P79; Lausen CL, 2006, CAN J ZOOL, V84, P1079, DOI 10.1139/Z06-093; Lesinski G, 2009, ITAL J ZOOL, V76, P415, DOI 10.1080/11250000802589535; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Marzluff J. M., 2001, AVIAN CONSERV ECOL, P1, DOI DOI 10.1007/978-1-4615-1531-9; Marzluff JM, 2001, RESTOR ECOL, V9, P280, DOI 10.1046/j.1526-100x.2001.009003280.x; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; McCleery RA, 2008, J WILDLIFE MANAGE, V72, P133, DOI 10.2193/2007-138; MCGOWAN KJ, 2001, VIAN ECOLOGY CONSER, P365; McIntyre S, 1999, CONSERV BIOL, V13, P1282, DOI 10.1046/j.1523-1739.1999.97509.x; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Millsap BA, 2000, J WILDLIFE MANAGE, V64, P33, DOI 10.2307/3802972; MINOR WF, 1993, J FIELD ORNITHOL, V64, P433; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Potere D, 2009, INT J REMOTE SENS, V30, P6531, DOI 10.1080/01431160903121134; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; Racey P.A., 1988, P31; Racey PA, 2003, BAT ECOLOGY, P680; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; Ransome RD, 1995, PHILOS T ROY SOC B, V350, P153, DOI 10.1098/rstb.1995.0149; Riskin DK, 1998, CAN J ZOOL, V76, P767, DOI 10.1139/cjz-76-4-767; RYDELL J, 1989, OECOLOGIA, V80, P562, DOI 10.1007/BF00380082; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Sano Akira, 2000, Mammal Study, V25, P1, DOI 10.3106/mammalstudy.25.1; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; SODHI NS, 1992, CAN J ZOOL, V70, P1477, DOI 10.1139/z92-204; THOMAS DW, 1988, J WILDLIFE MANAGE, V52, P619, DOI 10.2307/3800920; TUTTLE MD, 1976, ECOLOGY, V57, P587, DOI 10.2307/1936443; United Nations. Department of Economic and Social Affairs, 2008, WORLD URB PROSP 2007, DOI 10.1007/BF03343625; van der Ree R, 2005, ANIM CONSERV, V8, P309, DOI 10.1017/S1367943005002258; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Verboom B, 1999, CAN J ZOOL, V77, P1393, DOI 10.1139/cjz-77-9-1393; Verboom B, 1997, LANDSCAPE ECOL, V12, P117, DOI 10.1007/BF02698211; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Willis C., 2006, FUNCTIONAL EVOLUTION, P38; Zahn A, 1999, J ZOOL, V247, P275, DOI 10.1111/j.1469-7998.1999.tb00991.x	83	21	24	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20483	10.1371/journal.pone.0020483	http://dx.doi.org/10.1371/journal.pone.0020483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21857890	Green Submitted, Green Published, gold			2022-12-27	WOS:000291006500065
J	Fenwick, N; Danielson, P; Griffin, G				Fenwick, Nicole; Danielson, Peter; Griffin, Gilly			Survey of Canadian Animal-Based Researchers' Views on the Three Rs: Replacement, Reduction and Refinement	PLOS ONE			English	Article							ETHICS; ATTITUDES; WELFARE; SCIENCE	The 'Three Rs' tenet (replacement, reduction, refinement) is a widely accepted cornerstone of Canadian and international policies on animal-based science. The Canadian Council on Animal Care (CCAC) initiated this web-based survey to obtain greater understanding of '`principal investigators' and 'other researchers' (i.e. graduate students, post-doctoral researchers etc.) views on the Three Rs, and to identify obstacles and opportunities for continued implementation of the Three Rs in Canada. Responses from 414 participants indicate that researchers currently do not view the goal of replacement as achievable. Researchers prefer to use enough animals to ensure quality data is obtained rather than using the minimum and potentially waste those animals if a problem occurs during the study. Many feel that they already reduce animal numbers as much as possible and have concerns that further reduction may compromise research. Most participants were ambivalent about re-use, but expressed concern that the practice could compromise experimental outcomes. In considering refinement, many researchers feel there are situations where animals should not receive pain relieving drugs because it may compromise scientific outcomes, although there was strong support for the Three Rs strategy of conducting animal welfare-related pilot studies, which were viewed as useful for both animal welfare and experimental design. Participants were not opposed to being offered "assistance'' to implement the Three Rs, so long as the input is provided in a collegial manner, and from individuals who are perceived as experts. It may be useful for animal use policymakers to consider what steps are needed to make replacement a more feasible goal. In addition, initiatives that offer researchers greater practical and logistical support with Three Rs implementation may be useful. Encouragement and financial support for Three Rs initiatives may result in valuable contributions to Three Rs knowledge and improve welfare for animals used in science.	[Fenwick, Nicole; Griffin, Gilly] Canadian Council Anim Care, Ottawa, ON, Canada; [Danielson, Peter] Univ British Columbia, W Maurice Young Ctr Appl Eth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Fenwick, N (corresponding author), Canadian Council Anim Care, Ottawa, ON, Canada.	ggriffin@ccac.ca			Canadian Council on Animal Care	Canadian Council on Animal Care	This study was initiated, funded and conducted by the Canadian Council on Animal Care, who employs NF and GG. These authors designed and performed the experiments, analyzed the data and wrote the paper.	Ahmad R, 2010, PUBLIC UNDERST SCI, V19, P155, DOI 10.1177/0963662508091806; *ANG REID, 2010, AN BRIT CALL HUNT AM; Caminiti R, 2009, NATURE, V457, P147, DOI 10.1038/457147a; *CAUT, 2010, CAUT ED REV, V12, P1; CCAC, 1997, CCAC GUID AN US PROT; *CCAC, 1989, CCAC POL STAT ETH AN; Coffey A., 1996, MAKING SENSE QUALITA; Danielson P, 2010, ETHICS INF TECHNOL, V12, P251, DOI 10.1007/s10676-009-9214-x; Danielson PA, 2010, DESIGN AND USE OF ASSISTIVE TECHNOLOGY: SOCIAL, TECHNICAL, ETHICAL, AND ECONOMIC CHALLENGES, P75, DOI 10.1007/978-1-4419-7031-2_9; de Boo J, 2005, ATLA-ALTERN LAB ANIM, V33, P369, DOI 10.1177/026119290503300404; FENWICK N, 2010, CHARACTERISTICS ANAL; Fenwick N, 2009, CAN VET J, V50, P523; Festing S, 2007, EMBO REP, V8, P526, DOI 10.1038/sj.embor.7400993; Gauthier C., 2008, ALTERN ANIM TEST EXP, V14, P197; GAUTHIER C, 2011, LAB ANIM IN PRESS; Griffin G, 2009, ATLA-ALTERN LAB ANIM, V37, P63, DOI 10.1177/026119290903702S09; Houde L, 2003, ETHICS BEHAV, V13, P333, DOI 10.1207/S15327019EB1304_2; Houde L, 2009, ATLA-ALTERN LAB ANIM, V37, P291, DOI 10.1177/026119290903700311; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Knight S, 2009, J SOC ISSUES, V65, P463, DOI 10.1111/j.1540-4560.2009.01609.x; Leenaars M, 2009, ATLA-ALTERN LAB ANIM, V37, P297, DOI 10.1177/026119290903700312; Lincon Y. S., 2000, HDB QUALITATIVE RES, P163; Lloyd MH, 2008, LAB ANIM-UK, V42, P284, DOI 10.1258/la.2007.007045; National Centre for Replacement Refinement and Reduction of Animals in Research (NC3Rs), 2008, VIEWS 3 RS SURV REP; *NC3RS, 2011, MISS STRAT; ORMANDY EH, 2009, 7 WORLD C ALT AN US; Pollo S, 2004, LAB ANIMAL, V33, P47, DOI 10.1038/laban0704-47; Purchase IFH, 2001, ATLA-ALTERN LAB ANIM, V29, P727, DOI 10.1177/026119290102900610; Russell WMS., 1959, MED J AUSTRALIA; Schuppli CA, 2005, ATLA-ALTERN LAB ANIM, V33, P487, DOI 10.1177/026119290503300511	30	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22478	10.1371/journal.pone.0022478	http://dx.doi.org/10.1371/journal.pone.0022478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857928	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300003
J	Brokx, SJ; Wernimont, AK; Dong, AP; Wasney, GA; Lin, YH; Lew, J; Vedadi, M; Lee, WH; Hui, R				Brokx, Stephen J.; Wernimont, Amy K.; Dong, Aiping; Wasney, Gregory A.; Lin, Yu-Hui; Lew, Jocelyne; Vedadi, Masoud; Lee, Wen Hwa; Hui, Raymond			Characterization of 14-3-3 Proteins from Cryptosporidium parvum	PLOS ONE			English	Article							AUTOMATED STRUCTURE SOLUTION; C-TERMINAL TAIL; STRUCTURAL BASIS; SUBCELLULAR-LOCALIZATION; DENSITY MODIFICATION; APICOMPLEXAN; BINDING; PHOSPHORYLATION; SPECIFICITY; REGULATORS	The parasite Cryptosporidium parvum has three 14-3-3 proteins: Cp14 epsilon, Cp14a and Cp14b, with only Cp14 epsilon similar to human 14-3-3 proteins in sequence, peptide-binding properties and structure. Structurally, Cp14a features the classical 14-3-3 dimer but with a uniquely wide pocket and a disoriented RRY triad potentially incapable of binding phosphopeptides. The Cp14b protein deviates from the norm significantly: (i) In one subunit, the phosphorylated C-terminal tail is bound in the binding groove like a phosphopeptide. This supports our binding study indicating this protein was stabilized by a peptide mimicking its last six residues. (ii) The other subunit has eight helices instead of nine, with alpha A and alpha B forming a single helix and occluding the peptide-binding cleft. (iii) The protein forms a degenerate dimer with the two binding grooves divided and facing opposite directions. These features conspire to block and disrupt the bicameral substrate-binding pocket, suggesting a possible tripartite auto-regulation mechanism that has not been observed previously.	[Brokx, Stephen J.; Wernimont, Amy K.; Dong, Aiping; Wasney, Gregory A.; Lin, Yu-Hui; Lew, Jocelyne; Vedadi, Masoud; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Lee, Wen Hwa] Univ Oxford, Struct Genom Consortium, Oxford, England	University of Toronto; Structural Genomics Consortium; University of Oxford	Brokx, SJ (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	Raymond.hui@utoronto.ca	Lee, Wen Hwa/G-1250-2013; Lee, Wen Hwa/GZA-8183-2022	Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trus	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trus(Wellcome Trust)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca), the Canadian Foundation for Innovation (http://www.innovation.ca), Genome Canada (http://www.genomecanada.ca) through the Ontario Genomics Institute (http://www.ontariogenomics.ca), GlaxoSmithKline (http://www.gsk.com), the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com), the Ontario Innovation Trust (http://www.oit.on.ca), the Ontario Ministry for Research and Innovation (http://www.mri.gov.on.ca), Merck & Co., Inc. (http://www.merck.com), the Novartis Research Foundation (http://www.novartis.com), the Petrus and Augusta Hedlund's Foundation (http://www.hedlundsstiftelse.se), the Swedish Agency for Innovation Systems (http://www.vinnova.se/en), the Swedish Foundation for Strategic Research (http://www.stratresearch.se/en) and the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assossou O, 2003, FEMS MICROBIOL LETT, V224, P161, DOI 10.1016/S0378-1097(03)00479-8; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Chen XM, 2004, INFECT IMMUN, V72, P6806, DOI 10.1128/IAI.72.12.6806-6816.2004; Clark RM, 2002, WATER RES, V36, P3141, DOI 10.1016/S0043-1354(02)00006-4; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Murshudov GN, 1996, J BIOL CHEM, V271, P8863, DOI 10.1074/jbc.271.15.8863; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Puiu D, 2004, NUCLEIC ACIDS RES, V32, pD329, DOI 10.1093/nar/gkh050; Ricci Karen A, 2006, Nature, V444 Suppl 1, P29; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Siles-Lucas M, 2003, VACCINE, V21, P431, DOI 10.1016/S0264-410X(02)00517-0; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e14827	10.1371/journal.pone.0014827	http://dx.doi.org/10.1371/journal.pone.0014827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853016	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400001
J	Heldens, L; Hensen, SMM; Onnekink, C; van Genesen, ST; Dirks, RP; Lubsen, NH				Heldens, Lonneke; Hensen, Sanne M. M.; Onnekink, Carla; van Genesen, Siebe T.; Dirks, Ron P.; Lubsen, Nicolette H.			An Atypical Unfolded Protein Response in Heat Shocked Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED GENE-EXPRESSION; ER STRESS; MESSENGER-RNA; TRANSCRIPTION FACTOR; TRANSLATIONAL CONTROL; MOLECULAR CHAPERONES; OXIDATIVE STRESS; MAMMALIAN-CELLS; NF-Y	Background: The heat shock response (HSR) and the unfolded protein response (UPR) are both activated by proteotoxic stress, although in different compartments, and share cellular resources. How these resources are allocated when both responses are active is not known. Insight in possible crosstalk will help understanding the consequences of failure of these systems in (age-related) disease. Results: In heat stressed HEK293 cells synthesis of the canonical UPR transcription factors XBP1s and ATF4 was detected as well as HSF1 independent activation of the promoters of the ER resident chaperones HSPA5 (BiP) and DNAJB9 (ERdj4). However, the heat stress activation of the DNAJB9 promoter, a XBP1s target, was not blocked in cells expressing a dominant negative IRE1a mutant, and thus did not require XBP1s. Furthermore, the DNA element required for heat stress activation of the DNAJB9 promoter is distinct from the ATF4 and ATF6 target elements; even though inhibition of eIF2a phosphorylation resulted in a decreased activation of the DNAJB9 promoter upon heat stress, suggesting a role for an eIF2a phosphorylation dependent product. Conclusions: The initial step in the UPR, synthesis of transcription factors, is activated by heat stress but the second step, transcriptional transactivation by these factors, is blocked and these pathways of the UPR are thus not productive. Expression of canonical ER chaperones is part of the response of heat stressed cells but another set of transcription factors has been recruited to regulate expression of these ER chaperones.	[Heldens, Lonneke; Hensen, Sanne M. M.; Onnekink, Carla; van Genesen, Siebe T.; Dirks, Ron P.; Lubsen, Nicolette H.] Radboud Univ Nijmegen, Dept Biomol Chem, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Heldens, L (corresponding author), Radboud Univ Nijmegen, Dept Biomol Chem, NL-6525 ED Nijmegen, Netherlands.	N.Lubsen@science.ru.nl			IOP Genomics [IGE03018, IGE07004]	IOP Genomics	This work was financially supported by IOP Genomics (project number IGE03018 and IGE07004, www.agentschapnl.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2009, PLOS ONE, V4, pA57, DOI 10.1371/journal.pone.0007719; Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Dirks RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010158; Doerwald L, 2006, CELL MOL LIFE SCI, V63, P735, DOI 10.1007/s00018-005-5582-5; Doerwald L, 2003, J BIOL CHEM, V278, P49743, DOI 10.1074/jbc.M302914200; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Heldens L, 2010, CELL MOL LIFE SCI, V67, P4035, DOI 10.1007/s00018-010-0430-7; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Matsumoto R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-141; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheper GC, 1998, BIOCHEM J, V334, P463, DOI 10.1042/bj3340463; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shang J, 2004, BIOCHEM BIOPH RES CO, V317, P390, DOI 10.1016/j.bbrc.2004.03.058; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Vries RGJ, 1997, J BIOL CHEM, V272, P32779, DOI 10.1074/jbc.272.52.32779; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	61	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23512	10.1371/journal.pone.0023512	http://dx.doi.org/10.1371/journal.pone.0023512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853144	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200092
J	Rae, J; Fontaine, F; Salim, AA; Lo, HP; Capon, RJ; Parton, RG; Martin, S				Rae, James; Fontaine, Frank; Salim, Angela A.; Lo, Harriet P.; Capon, Robert J.; Parton, Robert G.; Martin, Sally			High-Throughput Screening of Australian Marine Organism Extracts for Bioactive Molecules Affecting the Cellular Storage of Neutral Lipids	PLOS ONE			English	Article							CULTURED RAT HEPATOCYTES; DROPLET ACCUMULATION; DIACYLGLYCEROL ACYLTRANSFERASE; MOUSE MACROPHAGES; ADIPOSE-TISSUE; PROTEIN; INHIBITION; REVEALS; CHOLESTEROL; EXPRESSION	Mammalian cells store excess fatty acids as neutral lipids in specialised organelles called lipid droplets (LDs). Using a simple cell-based assay and open-source software we established a high throughput screen for LD formation in A431 cells in order to identify small bioactive molecules affecting lipid storage. Screening an n-butanol extract library from Australian marine organisms we identified 114 extracts that produced either an increase or a decrease in LD formation in fatty acid-treated A431 cells with varying degrees of cytotoxicity. We selected for further analysis a non-cytotoxic extract derived from the genus Spongia (Heterofibria). Solvent partitioning, HPLC fractionation and spectroscopic analysis (NMR, MS) identified a family of related molecules within this extract with unique structural features, a subset of which reduced LD formation. We selected one of these molecules, heterofibrin A1, for more detailed cellular analysis. Inhibition of LD biogenesis by heterofibrin A1 was observed in both A431 cells and AML12 hepatocytes. The activity of heterofibrin A1 was dose dependent with 20 mu M inhibiting LD formation and triglyceride accumulation by similar to 50% in the presence of 50 mM oleic acid. Using a fluorescent fatty acid analogue we found that heterofibrin A1 significantly reduces the intracellular accumulation of fatty acids and results in the formation of distinct fatty acid metabolites in both cultured cells and in embryos of the zebrafish Danio rerio. In summary we have shown using readily accessible software and a relatively simple assay system that we can identify and isolate bioactive molecules from marine extracts, which affect the formation of LDs and the metabolism of fatty acids both in vitro and in vivo.	[Rae, James; Lo, Harriet P.; Parton, Robert G.; Martin, Sally] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia; [Fontaine, Frank; Salim, Angela A.; Capon, Robert J.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Rae, J (corresponding author), Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia.	s.martin@uq.edu.au	Capon, Robert/G-9238-2012; Parton, Robert G/C-5673-2009; Salim, Angela/J-4884-2014; Lo, Harriet P/D-2052-2017; Martin, Sally/A-7150-2010	Capon, Robert/0000-0002-8341-7754; Parton, Robert G/0000-0002-7494-5248; Salim, Angela/0000-0002-8177-5689; Lo, Harriet P/0000-0002-3998-6132; Martin, Sally/0000-0001-9294-5404; Fontaine, Frank/0000-0002-3133-8093	National Health and Medical Research Council of Australia [455865]; Diabetes Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia; Australian Research Council(Australian Research Council)	The authors would like to acknowledge the Australian Research Council, National Health and Medical Research Council of Australia, The University of Queensland, The Australian Zebrafish Phenomics Facility and the Queensland State Government for investment in key instrumentation and infrastructure. The BD Pathway 855 high-content screening platform was purchased under the Australian Research Council "Linkage, Infrastructure, Equipment and Facilities" funding scheme. The Institute for Molecular Bioscience is a Special Research Centre of the Australian Research Council. This work was supported by grants from the National Health and Medical Research Council of Australia (RGP and SM. Grant ID 455865, http://www.nhmrc.gov.au) and from Diabetes Australia (SM, http://www.diabetesaustralia.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Andre M, 2000, INT J DEV BIOL, V44, P249; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHAM BE, 1976, J LIPID RES, V17, P176; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Gilham D, 2003, FASEB J, V17, P1685, DOI 10.1096/fj.02-0728fje; Grimard V, 2008, J LIPID RES, V49, P2427, DOI 10.1194/jlr.M800168-JLR200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hasegawa N, 2001, PHYTOTHER RES, V15, P172, DOI 10.1002/ptr.689; HATT HH, 1967, AUST J CHEM, V20, P2285, DOI 10.1071/CH9672285; Hermoso J, 1996, J BIOL CHEM, V271, P18007, DOI 10.1074/jbc.271.30.18007; Jones G P, 1999, Asia Pac J Clin Nutr, V8, P211, DOI 10.1046/j.1440-6047.1999.00112.x; Kim MS, 2003, J ALTERN COMPLEM MED, V9, P499, DOI 10.1089/107555303322284785; Koyama N, 2005, J ANTIBIOT, V58, P338, DOI 10.1038/ja.2005.42; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Liu YD, 1997, LIPIDS, V32, P965, DOI 10.1007/s11745-997-0125-x; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; MAYOREK N, 1989, EUR J BIOCHEM, V182, P395, DOI 10.1111/j.1432-1033.1989.tb14844.x; MAYOREK N, 1985, J BIOL CHEM, V260, P6528; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; MORAND O, 1982, BIOCHIM BIOPHYS ACTA, V711, P539, DOI 10.1016/0005-2760(82)90070-4; Morral N, 2003, TRENDS ENDOCRIN MET, V14, P169, DOI 10.1016/S1043-2760(03)00031-6; Namatame I, 2004, P NATL ACAD SCI USA, V101, P737, DOI 10.1073/pnas.0307757100; Namatame I, 1999, J BIOCHEM-TOKYO, V125, P319, DOI 10.1093/oxfordjournals.jbchem.a022289; Obata R, 2005, BIOORG MED CHEM LETT, V15, P4189, DOI 10.1016/j.bmcl.2005.06.070; Ohshiro T, 2005, BIOL PHARM BULL, V28, P1925, DOI 10.1248/bpb.28.1925; Salim AA, 2010, ORG BIOMOL CHEM, V8, P3188, DOI 10.1039/c003840g; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; Uchida R, 2006, J ANTIBIOT, V59, P93, DOI 10.1038/ja.2006.13; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yamazaki H, 2009, J ANTIBIOT, V62, P195, DOI 10.1038/ja.2009.18; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584	41	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22868	10.1371/journal.pone.0022868	http://dx.doi.org/10.1371/journal.pone.0022868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857959	gold, Green Submitted, Green Published			2022-12-27	WOS:000293773300011
J	Xiao, XS; Shi, DB; Liu, LQ; Wang, JS; Xie, XM; Kang, TB; Deng, WG				Xiao, Xiangsheng; Shi, Dingbo; Liu, Liqun; Wang, Jingshu; Xie, Xiaoming; Kang, Tiebang; Deng, Wuguo			Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling	PLOS ONE			English	Article							CANCER CELL-GROWTH; BREAST-CANCER; PROMOTER ACTIVATION; COLORECTAL-CANCER; CYCLE ARREST; C/EBP-BETA; APOPTOSIS; INHIBITION; PATHWAY; BINDING	Quercetin, a polyphenolic bioflavonoid, possesses multiple pharmacological actions including anti-inflammatory and antitumor properties. However, the precise action mechanisms of quercetin remain unclear. Here, we reported the regulatory actions of quercetin on cyclooxygenase-2 (COX-2), an important mediator in inflammation and tumor promotion, and revealed the underlying mechanisms. Quercetin significantly suppressed COX-2 mRNA and protein expression and prostaglandin (PG) E(2) production, as well as COX-2 promoter activation in breast cancer cells. Quercetin also significantly inhibited COX-2-mediated angiogenesis in human endothelial cells in a dose-dependent manner. The in vitro streptavidin-agarose pulldown assay and in vivo chromatin immunoprecipitation assay showed that quercetin considerably inhibited the binding of the transactivators CREB2, C-Jun, C/EBP beta and NF-kappa B and blocked the recruitment of the coactivator p300 to COX-2 promoter. Moreover, quercetin effectively inhibited p300 histone acetyltransferase (HAT) activity, thereby attenuating the p300-mediated acetylation of NF-kappa B. Treatment of cells with p300 HAT inhibitor roscovitine was as effective as quercetin at inhibiting p300 HAT activity. Addition of quercetin to roscovitine-treated cells did not change the roscovitine-induced inhibition of p300 HAT activity. Conversely, gene delivery of constitutively active p300 significantly reversed the quercetin-mediated inhibition of endogenous HAT activity. These results indicate that quercetin suppresses COX-2 expression by inhibiting the p300 signaling and blocking the binding of multiple transactivators to COX-2 promoter. Our findings therefore reveal a novel mechanism of action of quercetin and suggest a potential use for quercetin in the treatment of COX-2-mediated diseases such as breast cancers.	[Xiao, Xiangsheng; Shi, Dingbo; Wang, Jingshu; Xie, Xiaoming; Kang, Tiebang; Deng, Wuguo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Liqun] Sun Yat Sen Univ, Affiliated Hosp 1, Huangpu Hosp, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xiao, XS (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	dengwg@sysucc.org.cn	xiao, xiang/GWU-6035-2022		National Natural Science Foundation of China [81071687]; State Key Laboratory of Oncology in Southern China; Sun Yat-Sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oncology in Southern China; Sun Yat-Sen University	This work was supported partially by the funds from the National Natural Science Foundation of China (No. 81071687), the State Key Laboratory of Oncology in Southern China, and the "985 Project" of Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Boots AW, 2008, NUTRITION, V24, P703, DOI 10.1016/j.nut.2008.03.023; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen WS, 2007, CARCINOGENESIS, V28, P2114, DOI 10.1093/carcin/bgm133; Chiu WT, 2010, NEUROBIOL DIS, V37, P118, DOI 10.1016/j.nbd.2009.09.015; Choi EJ, 2008, ARCH PHARM RES, V31, P1281, DOI 10.1007/s12272-001-2107-0; Chou CC, 2010, ARCH PHARM RES, V33, P1181, DOI 10.1007/s12272-010-0808-y; de Groot DJA, 2007, CRIT REV ONCOL HEMAT, V61, P52, DOI 10.1016/j.critrevonc.2006.07.001; DEME DNA, 2007, INT J CANCER, V121, P929; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2002, FASEB J, V16, P1286, DOI 10.1096/fj.01-0844fje; Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352; Deng WG, 2006, BLOOD, V108, P518, DOI 10.1182/blood-2005-09-3691; DU G, 2009, CANC CHEMOTHER PHARM; Du GJ, 2010, INT IMMUNOPHARMACOL, V10, P819, DOI 10.1016/j.intimp.2010.04.018; Fu SL, 2004, WORLD J GASTROENTERO, V10, P1971; Gulati N, 2006, ANTICANCER RES, V26, P1177; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Jung YH, 2010, LIFE SCI, V86, P351, DOI 10.1016/j.lfs.2010.01.008; Kajita S, 2005, MODERN PATHOL, V18, P221, DOI 10.1038/modpathol.3800285; Kang CH, 2008, UROLOGY, V72, P153, DOI 10.1016/j.urology.2007.12.029; Kim WK, 2005, J NUTR BIOCHEM, V16, P155, DOI 10.1016/j.jnutbio.2004.10.010; Lee KM, 2010, J AGR FOOD CHEM, V58, P5815, DOI 10.1021/jf903698s; Lee YK, 2010, ONCOL REP, V24, P1493, DOI 10.3892/or_00001010; Lee YK, 2009, EXP MOL MED, V41, P201, DOI 10.3858/emm.2009.41.3.023; Linsalata M, 2010, ANTICANCER RES, V30, P3501; Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052; Onguru O, 2005, ENDOCR PATHOL, V16, P253, DOI 10.1385/EP:16:4:253; Persichini T, 2010, NEUROSCI LETT, V484, P133, DOI 10.1016/j.neulet.2010.08.034; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Russo M, 2010, BRIT J CANCER, V103, P642, DOI 10.1038/sj.bjc.6605794; Sanborn R, 2005, SEMIN ONCOL, V32, P69, DOI 10.1053/j.seminoncol.2004.09.035; Senthilkumar K, 2010, MOL CELL BIOCHEM, V344, P173, DOI 10.1007/s11010-010-0540-4; Singh B, 2002, J SURG RES, V108, P173, DOI 10.1006/jsre.2002.6532; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; Stachowska E, 2009, J PHYSIOL PHARMACOL, V60, P77; Thangasamy T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-282; Turner ND, 2009, ACTA HORTIC, V841, P237; Vijayababu MR, 2006, MOL CELL BIOCHEM, V287, P109, DOI 10.1007/s11010-005-9085-3; Vijayababu Marati R, 2006, J Carcinog, V5, P10, DOI 10.1186/1477-3163-5-10; Wang DZ, 2004, SEMIN ONCOL, V31, P64, DOI 10.1053/j.seminoncol.2004.01.008; Wu KK, 2003, THROMB RES, V110, P273, DOI 10.1016/S0049-3848(03)00412-2; Yang JH, 2006, DRUG METAB DISPOS, V34, P296, DOI 10.1124/dmd.105.005280; Yuan LW, 2001, BBA-MOL CELL RES, V1541, P161, DOI 10.1016/S0167-4889(01)00141-0	46	133	143	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22934	10.1371/journal.pone.0022934	http://dx.doi.org/10.1371/journal.pone.0022934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857970	gold, Green Submitted, Green Published			2022-12-27	WOS:000293773300013
J	Mamenko, M; Zaika, O; Jin, M; O'Neil, RG; Pochynyuk, O				Mamenko, Mykola; Zaika, Oleg; Jin, Min; O'Neil, Roger G.; Pochynyuk, Oleh			Purinergic Activation of Ca2+-Permeable TRPV4 Channels Is Essential for Mechano-Sensitivity in the Aldosterone-Sensitive Distal Nephron	PLOS ONE			English	Article							CORTICAL COLLECTING DUCT; EPITHELIAL SODIUM-CHANNEL; DEPENDENT K+ SECRETION; P2 RECEPTORS; INTERCALATED CELLS; WATER REABSORPTION; CONNECTING TUBULE; PRINCIPAL CELLS; NA+ CHANNEL; FLOW	Mechanical forces are known to induce increases of [Ca2+](i) in the aldosterone-sensitive distal nephron (ASDN) cells to regulate epithelial transport. At the same time, mechanical stress stimulates ATP release from ASDN cells. In this study, we combined ratiometric Fura-2 based monitoring of [Ca2+](i) in freshly isolated split-opened ASDN with targeted deletion of P2Y2 and TRPV4 in mice to probe a role for purinergic signaling in mediating mechano-sensitive responses in ASDN cells. ATP application causes a reproducible transient Ca2+ peak followed by a sustained plateau. Individual cells of the cortical collecting duct (CCD) and the connecting tubule (CNT) respond to purinergic stimulation with comparative elevations of [Ca2+](i). Furthermore, ATP-induced Ca2+-responses are nearly identical in both principal (AQP2-positive) and intercalated (AQP2-negative) cells as was confirmed using immunohistochemistry in split-opened ASDN. UTP application produces elevations of [Ca2+](i) similar to that observed with ATP suggesting a dominant role of P2Y2-like receptors in generation of [Ca2+](i) response. Indeed, genetic deletion of P2Y2 receptors decreases the magnitude of ATP-induced and UTP-induced Ca2+ responses by more than 70% and 90%, respectively. Both intracellular and extracellular sources of Ca2+ appeared to contribute to the generation of ATP-induced Ca2+ response in ASDN cells. Importantly, flow-and hypotonic-induced Ca2+ elevations are markedly blunted in P2Y2 -/- mice. We further demonstrated that activation of mechano-sensitive TRPV4 channel plays a major role in the sustained [Ca2+](i) elevation during purinergic stimulation. Consistent with this, ATP-induced Ca2+ plateau are dramatically attenuated in TRV4 -/- mice. Inhibition of TRPC channels with 10 mu M BTP2 also decreased ATP-induced Ca2+ plateau whilst to a lower degree than that observed with TRPV4 inhibition/genetic deletion. We conclude that stimulation of purinergic signaling by mechanical stimuli leads to activation of TRPV4 and, to a lesser extent, TRPCs channels, and this is an important component of mechano-sensitive response of the ASDN.	[Mamenko, Mykola; Zaika, Oleg; Jin, Min; O'Neil, Roger G.; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Mamenko, M (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA.	Oleh.M.Pochynyuk@uth.tmc.edu	Mamenko, Mykola/I-6061-2015	Mamenko, Mykola/0000-0001-8683-0715	American Heart Association [SDG2230391]; American Society of Nephrology; National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases [RO1-DK-70950]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070950] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Nephrology; National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the American Heart Association SDG2230391 (awarded to Dr. Pochynyuk), the Carl W. Gottschalk Research Scholar of the American Society of Nephrology (awarded to Dr. Pochynyuk), and National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases Grant RO1-DK-70950 (awarded to Dr. O'Neil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Deetjen P, 2000, J AM SOC NEPHROL, V11, P1798, DOI 10.1681/ASN.V11101798; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Goel M, 2010, AM J PHYSIOL-RENAL, V299, pF225, DOI 10.1152/ajprenal.00670.2009; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Holtzclaw JD, 2011, AM J PHYSIOL-RENAL, V300, pF1319, DOI 10.1152/ajprenal.00112.2011; Hovater MB, 2008, PURINERG SIGNAL, V4, P109, DOI 10.1007/s11302-008-9102-6; Hummler E, 2003, CURR HYPERTENS REP, V5, P11, DOI 10.1007/s11906-003-0005-1; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liu W, 2005, AM J PHYSIOL-RENAL, V289, pF978, DOI 10.1152/ajprenal.00260.2004; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Meneton P, 2004, AM J PHYSIOL-RENAL, V287, pF593, DOI 10.1152/ajprenal.00454.2003; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Palmer LG, 2007, CURR OPIN NEPHROL HY, V16, P477, DOI 10.1097/MNH.0b013e32820ac850; POCHYNYUK O, 2010, FASEB J; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Praetorius HA, 2009, ACTA PHYSIOL, V197, P241, DOI 10.1111/j.1748-1716.2009.02002.x; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Rieg T, 2009, AM J PHYSIOL-REG I, V296, pR419, DOI 10.1152/ajpregu.90784.2008; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Schild L, 1996, NEPHROLOGIE, V17, P395; Sipos A, 2009, J AM SOC NEPHROL, V20, P1724, DOI 10.1681/ASN.2008101099; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Stockand JD, 2010, J AM SOC NEPHROL, V21, P1903, DOI 10.1681/ASN.2010040377; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF10, DOI 10.1152/ajprenal.00432.2007; Welch BD, 2003, AM J PHYSIOL-RENAL, V285, pF711, DOI 10.1152/ajprenal.00096.2003; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443; Woda CB, 2002, AM J PHYSIOL-RENAL, V283, pF437, DOI 10.1152/ajprenal.00316.2001; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Zhang Y, 2008, AM J PHYSIOL-RENAL, V295, pF1715, DOI 10.1152/ajprenal.90311.2008	48	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22824	10.1371/journal.pone.0022824	http://dx.doi.org/10.1371/journal.pone.0022824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850238	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300023
J	Baker, J; Alcantara, A; Ruan, XM				Baker, Jack; Alcantara, Adelamar; Ruan, Xiaomin			A Stochastic Version of the Brass PF Ratio Adjustment of Age-Specific Fertility Schedules	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; POPULATION; TESTS; MODEL; IMMIGRATION	Estimates of age-specific fertility rates based on survey data are known to suffer down-bias associated with incomplete reporting. Previously, William Brass (1964, 1965, 1968) proposed a series of adjustments of such data to reflect more appropriate levels of fertility through comparison with data on children-ever-born by age, a measure of cohort-specific cumulative fertility. His now widely-used Parity/Fertility or PF ratio method makes a number of strong assumptions, which have been the focus of an extended discussion in the literature on indirect estimation. However, while it is clear that the measures used in making adjusted age-specific fertility estimates with this method are captured with statistical uncertainty, little discussion of the nature of this uncertainty around PF-ratio based estimates of fertility has been entertained in the literature. Since both age-specific risk of childbearing and cumulative parity (children ever born) are measured with statistical uncertainty, an unknown credibility interval must surround every PF ratio-based estimate. Using the standard approach, this is unknown, limiting the ability to make statistical comparisons of fertility between groups or to understand stochasticity in population dynamics. This paper makes use of approaches applied to similar problems in engineering, the natural sciences, and decision analysis-often discussed under the title of uncertainty analysis or stochastic modeling-to characterize this uncertainty and to present a new method for making PF ratio-based fertility estimates with 95 percent uncertainty intervals. The implications for demographic analysis, between-group comparisons of fertility, and the field of statistical demography are explored.	[Baker, Jack; Alcantara, Adelamar; Ruan, Xiaomin] Univ New Mexico, Albuquerque, NM 87131 USA	University of New Mexico	Baker, J (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.	kali@unm.edu			State of New Mexico	State of New Mexico	Funding for this research was provided by the State of New Mexico as part of an ongoing appropriation by the legislature to UNM's Census Data Dissemination and Demographic Analysis project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, DEMOGRAPHY TROPICAL; Arriaga E.E., 1994, POPULATION ANAL MICR; Barnard G., 1963, J R STAT SOC B, V25, P294; BARNTHOUSE LW, 1990, ENVIRON TOXICOL CHEM, V9, P297, DOI 10.1002/etc.5620090306; BESAG J, 1989, BIOMETRIKA, V76, P633; Brass W, 1965, WPCWP409 UN; Brass W, 1964, ECN14CAS7 UN; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Caswell, 2000, MATRIX POPULATION MO; Caswell W, 1998, ECOL APPL, V8, P1226, DOI 10.2307/2640975; CERONE P, 1987, DEMOGRAPHY, V24, P431, DOI 10.2307/2061308; COALE AJ, 1974, POPUL INDEX, V40, P185, DOI 10.2307/2733910; Cox D.C., 1981, RISK ANAL, V1, P251, DOI DOI 10.1111/J.1539-6924.1981.TB01425.X; Devroye L., 1986, NONUNIFORM RANDOM VA; DOLL JD, 1986, SCIENCE, V234, P1356, DOI 10.1126/science.234.4782.1356; DONG WM, 1987, COMPUT STRUCT, V26, P415, DOI 10.1016/0045-7949(87)90041-1; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; FEENEY G, 1983, POP STUD-J DEMOG, V37, P75, DOI 10.1080/00324728.1983.10405925; FISHMAN GS, 1986, MONTE CARLO CONCEPTS; Gardiner C. W., 1983, HDB STOCHASTIC METHO; George M.V., 2004, METHODS MAT DEMOGRAP, V2nd, P561; GOODMAN D, 1984, REP INT WHALING COMM, V6, P161; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Hogan H, 2008, APPLIED DEMOGRAPHY IN THE 21ST CENTURY, P13, DOI 10.1007/978-1-4020-8329-7_2; HORNBERGER GM, 1981, J ENVIRON MANAGE, V12, P7; JOCKEL KH, 1986, ANN STAT, V14, P336, DOI 10.1214/aos/1176349860; Jonzen N, 2010, J ANIM ECOL, V79, P109, DOI 10.1111/j.1365-2656.2009.01601.x; KALOS MH, 1986, MONTE CARLOS METHODS; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; KULKARNI VG, 2005, INTRO MODELING ANAL; LEE D, 1969, Yonsei Medical Journal, V10, P65; LEE RD, 1994, J AM STAT ASSOC, V89, P1175, DOI 10.2307/2290980; LINSTROM J, 2010, BMC ECOLOGY, V10, P4; Little R. J. A., 1987, STAT ANAL MISSING DA; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; MITRA S, 1983, DEMOGRAPHY, V20, P111, DOI 10.2307/2060905; MTURI A, 2001, P WORKSH PROSP FERT; Powell RA, 1996, CONSERV BIOL, V10, P224, DOI 10.1046/j.1523-1739.1996.10010224.x; RAGEN TJ, 1995, MAR MAMMAL SCI, V11, P275, DOI 10.1111/j.1748-7692.1995.tb00285.x; RAMBERG JS, 1979, TECHNOMETRICS, V21, P201, DOI 10.2307/1268517; Rubinstein R. Y., 1981, SIMULATION MONTE CAR; Sacks J., 1989, STAT SCI, V4, P409, DOI [10.1214/ss/1177012413, DOI 10.1214/SS/1177012413]; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Samuels ML, 1998, STAT LIFE SCI; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; SHYROCK H, 1980, METHODS MATERIALS DE, V2; Siegel, 2004, METHODS MAT DEMOGRAP; SMITH JE, 1993, MANAGE SCI, V39, P340, DOI 10.1287/mnsc.39.3.340; Sobol I., 1994, PRIMER MONTE CARLO M; Swanson DA., 2004, METHODS MAT DEMOGRAP, P523; *UN, 1983, UNM MAX X TECHN IND; WACHTER K, 2006, ESSENTIAL DEMO UNPUB; Wilson E. O., 1971, PRIMER POPULATION BI; YIMAMU E, 1990, INT STAT REV, V58, P191, DOI 10.2307/1403803	54	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23222	10.1371/journal.pone.0023222	http://dx.doi.org/10.1371/journal.pone.0023222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829718	gold, Green Published, Green Submitted			2022-12-27	WOS:000293561200056
J	Eklof, JS; van der Heide, T; Donadi, S; van der Zee, EM; O'Hara, R; Eriksson, BK				Eklof, Johan S.; van der Heide, Tjisse; Donadi, Serena; van der Zee, Els M.; O'Hara, Robert; Eriksson, Britas Klemens			Habitat-Mediated Facilitation and Counteracting Ecosystem Engineering Interactively Influence Ecosystem Responses to Disturbance	PLOS ONE			English	Article							SEAGRASS ZOSTERA-NOLTII; DUTCH WADDEN SEA; BRENT GEESE; COMMUNITY STRUCTURE; SEDIMENT STABILITY; ARENICOLA-MARINA; SCALE; ECOLOGY; ORGANISMS; BEDS	Recovery of an ecosystem following disturbance can be severely hampered or even shift altogether when a point disturbance exceeds a certain spatial threshold. Such scale-dependent dynamics may be caused by preemptive competition, but may also result from diminished self-facilitation due to weakened ecosystem engineering. Moreover, disturbance can facilitate colonization by engineering species that alter abiotic conditions in ways that exacerbate stress on the original species. Consequently, establishment of such counteracting engineers might reduce the spatial threshold for the disturbance, by effectively slowing recovery and increasing the risk for ecosystem shifts to alternative states. We tested these predictions in an intertidal mudflat characterized by a two-state mosaic of hummocks (humps exposed during low tide) dominated by the sediment-stabilizing seagrass Zostera noltii) and hollows (low-tide waterlogged depressions dominated by the bioturbating lugworm Arenicola marina). In contrast to expectations, seagrass recolonized both natural and experimental clearings via lateral expansion and seemed unaffected by both clearing size and lugworm addition. Near the end of the growth season, however, an additional disturbance (most likely waterfowl grazing and/or strong hydrodynamics) selectively impacted recolonizing seagrass in the largest (1 m(2)) clearings (regardless of lugworm addition), and in those medium (0.25 m(2)) clearings where lugworms had been added nearly five months earlier. Further analyses showed that the risk for the disturbance increased with hollow size, with a threshold of 0.24 m(2). Hollows of that size were caused by seagrass removal alone in the largest clearings, and by a weaker seagrass removal effect exacerbated by lugworm bioturbation in the medium clearings. Consequently, a sufficiently large disturbance increased the vulnerability of recolonizing seagrass to additional disturbance by weakening seagrass engineering effects (sediment stabilization). Meanwhile, the counteracting ecosystem engineering (lugworm bioturbation) reduced that threshold size. Therefore, scale-dependent interactions between habitat-mediated facilitation, competition and disturbance seem to maintain the spatial two-state mosaic in this ecosystem.	[Eklof, Johan S.; Donadi, Serena; Eriksson, Britas Klemens] Univ Groningen, Dept Marine Benth Ecol & Evolut, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [van der Heide, Tjisse] Univ Groningen, Community & Conservat Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [van der Zee, Els M.] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [van der Zee, Els M.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands; [O'Hara, Robert] Biodivers & Climate Res Ctr, Frankfurt, Germany	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Eklof, JS (corresponding author), Univ Gothenburg, Dept Marine Ecol, Gothenburg, Sweden.	johane@ecology.su.se	O'Hara, Bob/A-7499-2008; Eriksson, Britas Klemens/D-8601-2015; Donadi, Serena/I-5092-2019; Eklöf, Johan S/C-7722-2017; Eklöf, Johan/B-3099-2012; van der Heide, Tjisse/M-3000-2013	O'Hara, Bob/0000-0001-9737-3724; Eriksson, Britas Klemens/0000-0003-4752-922X; Donadi, Serena/0000-0002-8920-9630; Eklöf, Johan S/0000-0001-6936-0926; 	FORMAS [2008-839]; Netherlands Organization for Research (NWO)	FORMAS(Swedish Research Council Formas); Netherlands Organization for Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The study was financed by FORMAS (grant no. 2008-839), and by the ZKO project "Wadden engine: A human-driven regime shift through the loss of ecosystem engineers'' from The Netherlands Organization for Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarado JL, 2001, MAR ECOL PROG SER, V224, P93, DOI 10.3354/meps224093; Berkenbusch K, 2003, NEW ZEAL J ECOL, V27, P67; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bouma TJ, 2009, HELGOLAND MAR RES, V63, P95, DOI 10.1007/s10152-009-0146-y; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bustamante-Sanchez MA, 2011, J ECOL, V99, P288, DOI 10.1111/j.1365-2745.2010.01737.x; Clements F.E., 1916, PLANT SUCCESSION ANA; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; CRAN, 2010, R LANG ENV STAT COMP; Cromsigt JPGM, 2008, OIKOS, V117, P1444, DOI 10.1111/j.0030-1299.2008.16651.x; Eriksson BK, 2010, ECOSYSTEMS, V13, P752, DOI 10.1007/s10021-010-9352-3; FLACH EC, 1992, NETH J SEA RES, V30, P81, DOI 10.1016/0077-7579(92)90048-J; Folkard AM, 2005, LIMNOL OCEANOGR, V50, P1592, DOI 10.4319/lo.2005.50.5.1592; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fox AD, 1996, BIRD STUDY, V43, P257, DOI 10.1080/00063659609461018; Ganter B, 2000, HELGOLAND MAR RES, V54, P63, DOI 10.1007/s101520050003; Goldenheim W, 2008, OECOLOGIA, V158, P473, DOI 10.1007/s00442-008-1157-0; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; JACOBS RPWM, 1981, AQUAT BOT, V10, P241, DOI 10.1016/0304-3770(81)90026-7; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kuhnert J, 2010, J EXP MAR BIOL ECOL, V387, P36, DOI 10.1016/j.jembe.2010.03.001; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; Maltese A, 2007, J HYDRAUL ENG, V133, P750, DOI 10.1061/(ASCE)0733-9429(2007)133:7(750); Montserrat F, 2011, J SEA RES, V65, P170, DOI 10.1016/j.seares.2010.09.003; Nacken N, 2000, HELGOLAND MAR RES, V54, P87, DOI 10.1007/s101520050006; Norkko A, 2006, J EXP MAR BIOL ECOL, V330, P195, DOI 10.1016/j.jembe.2005.12.027; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Petraitis PS, 2009, OECOLOGIA, V161, P139, DOI 10.1007/s00442-009-1350-9; Petraitis PS, 1999, ECOLOGY, V80, P429, DOI 10.1890/0012-9658(1999)080[0429:TIOSIT]2.0.CO;2; PHILIPPART CJM, 1994, MAR ECOL PROG SER, V111, P251, DOI 10.3354/meps111251; PHILIPPART CJM, 1995, AQUAT BOT, V49, P255, DOI 10.1016/0304-3770(94)00431-K; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; Reise K, 2002, J SEA RES, V48, P127, DOI 10.1016/S1385-1101(02)00150-8; REISE K, 1983, MAR BIOL, V74, P327, DOI 10.1007/BF00403459; RHOADS D C, 1970, Journal of Marine Research, V28, P150; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Siebert T, 2007, J EXP MAR BIOL ECOL, V340, P11, DOI 10.1016/j.jembe.2006.08.007; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stewart AM, 2007, COMMUN SOIL SCI PLAN, V38, P895, DOI 10.1080/00103620701277718; SUCHANEK TH, 1983, J MAR RES, V41, P281, DOI 10.1357/002224083788520216; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Thrush SF, 1996, ECOLOGY, V77, P2472, DOI 10.2307/2265747; Tinkler E, 2009, J ZOOL, V278, P313, DOI 10.1111/j.1469-7998.2009.00578.x; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van Wesenbeeck BK, 2007, OIKOS, V116, P742, DOI [10.1111/j.2007.0030-1299.15485.x, 10.1111/j.0030-1299.2007.15485.x]; Vermaat JE, 1996, AQUAT BOT, V52, P259, DOI 10.1016/0304-3770(95)00510-2; Wernberg T, 2006, EUR J PHYCOL, V41, P105, DOI 10.1080/09670260500505524; WOODIN SA, 1978, ECOLOGY, V59, P274, DOI 10.2307/1936373	51	22	22	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23229	10.1371/journal.pone.0023229	http://dx.doi.org/10.1371/journal.pone.0023229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829719	Green Submitted, Green Published, gold			2022-12-27	WOS:000293561200057
J	Guo, T; Wang, WP; Zhang, H; Liu, YA; Chen, P; Ma, KT; Zhou, CY				Guo, Ting; Wang, Weiping; Zhang, Hui; Liu, Yinan; Chen, Ping; Ma, Kangtao; Zhou, Chunyan			ISL1 Promotes Pancreatic Islet Cell Proliferation	PLOS ONE			English	Article							HOMEOBOX GENE ISL-1; BETA-CELLS; ENDOCRINE PANCREAS; BINDING-PROTEIN; EXPRESSION; TRANSCRIPTION; DOMAIN; ADULT; HOMEODOMAIN; P53	Background: Islet 1 (ISL1), a LIM-homeodomain transcription factor is essential for promoting pancreatic islets proliferation and maintaining endocrine cells survival in embryonic and postnatal pancreatic islets. However, how ISL1 exerts the role in adult islets is, to date, not clear. Methodology/Principal Findings: Our results show that ISL1 expression was up-regulated at the mRNA level both in cultured pancreatic cells undergoing glucose oxidase stimulation as well in type 1 and type 2 diabetes mouse models. The knockdown of ISL1 expression increased the apoptosis level of HIT-T15 pancreatic islet cells. Using HIT-T15 and primary adult islet cells as cell models, we show that ISL1 promoted adult pancreatic islet cell proliferation with increased c-Myc and CyclinD1 transcription, while knockdown of ISL1 increased the proportion of cells in G(1) phase and decreased the proportion of cells in G(2)/M and S phases. Further investigation shows that ISL1 activated both c-Myc and CyclinD1 transcription through direct binding on their promoters. Conclusions/Significance: ISL1 promoted adult pancreatic islet cell proliferation and probably by activating c-Myc and CyclinD1 transcription through direct binding on their promoters. Our findings extend the knowledge about the crucial role of ISL1 in maintaining mature islet cells homeostasis. Our results also provide insights into the new regulation relationships between ISL1 and other growth factors.	[Guo, Ting; Wang, Weiping; Zhang, Hui; Liu, Yinan; Chen, Ping; Ma, Kangtao; Zhou, Chunyan] Peking Univ, Minist Educ China, Sch Basic Med Sci, Dept Biochem & Mol Biol,Key Lab Mol Cardiovasc Sc, Beijing 100871, Peoples R China	Ministry of Education, China; Peking University	Guo, T (corresponding author), Peking Univ, Minist Educ China, Sch Basic Med Sci, Dept Biochem & Mol Biol,Key Lab Mol Cardiovasc Sc, Beijing 100871, Peoples R China.	chunyanzhou@bjmu.edu.cn			National Natural Science Foundation of China [30871253, 90919022, 81071675]; 111 Project of China [B07001]; Specialized Research Fund for the Doctoral Program of Higher Education [20060001107, 20070001798]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project of China(Ministry of Education, China - 111 Project); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (30871253, 90919022, and 81071675), the 111 Project of China (B07001), and the Specialized Research Fund for the Doctoral Program of Higher Education (20060001107, 20070001798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzelay A, 2010, THROMB HAEMOSTASIS, V103, P188, DOI 10.1160/TH09-07-0433; Beger C, 1998, DIABETES, V47, P559, DOI 10.2337/diabetes.47.4.559; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; DONG JL, 1991, MOL ENDOCRINOL, V5, P1633, DOI 10.1210/mend-5-11-1633; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hashimoto T, 2005, J BIOL CHEM, V280, P1893, DOI 10.1074/jbc.M410759200; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Oren M, 2002, BIOCHEM PHARMACOL, V64, P865, DOI 10.1016/S0006-2952(02)01149-8; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Peng SY, 2005, BBA-GENE STRUCT EXPR, V1731, P154, DOI 10.1016/j.bbaexp.2005.08.013; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Shi Y, 2009, BIOCHEM BIOPH RES CO, V388, P506, DOI 10.1016/j.bbrc.2009.08.017; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; Wang M, 1996, MOL ENDOCRINOL, V10, P243, DOI 10.1210/me.10.3.243; WANG M, 1995, J BIOL CHEM, V270, P12646, DOI 10.1074/jbc.270.21.12584; Yu YM, 2009, J IMMUNOL METHODS, V350, P29, DOI 10.1016/j.jim.2009.07.008; Zhang H, 2009, J MOL BIOL, V392, P566, DOI 10.1016/j.jmb.2009.07.036	27	63	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22387	10.1371/journal.pone.0022387	http://dx.doi.org/10.1371/journal.pone.0022387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829621	gold, Green Submitted, Green Published			2022-12-27	WOS:000293561200017
J	Marques, RB; Dits, NF; Erkens-Schulze, S; van Ijcken, WFJ; van Weerden, WM; Jenster, G				Marques, Rute B.; Dits, Natasja F.; Erkens-Schulze, Sigrun; van Ijcken, Wilfred F. J.; van Weerden, Wytske M.; Jenster, Guido			Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TRANSCRIPTION FACTORS; BIOCHEMICAL RECURRENCE; GROWTH-INHIBITION; TUMOR PROGRESSION; MESSENGER-RNA; ACTIVATION; AMPLIFICATION; ERG; DEPRIVATION	Background: Prostate epithelial cells depend on androgens for survival and function. In (early) prostate cancer (PCa) androgens also regulate tumor growth, which is exploited by hormonal therapies in metastatic disease. The aim of the present study was to characterize the androgen receptor (AR) response in hormonal therapy-resistant PC346 cells and identify potential disease markers. Methodology/Principal Findings: Human 19K oligoarrays were used to establish the androgen-regulated expression profile of androgen-responsive PC346C cells and its derivative therapy-resistant sublines: PC346DCC (vestigial AR levels), PC346Flu1 (AR overexpression) and PC346Flu2 (T877A AR mutation). In total, 107 transcripts were differentially-expressed in PC346C and derivatives after R1881 or hydroxyflutamide stimulations. The AR-regulated expression profiles reflected the AR modifications of respective therapy-resistant sublines: AR overexpression resulted in stronger and broader transcriptional response to R1881 stimulation, AR down-regulation correlated with deficient response of AR-target genes and the T877A mutation resulted in transcriptional response to both R1881 and hydroxyflutamide. This AR-target signature was linked to multiple publicly available cell line and tumor derived PCa databases, revealing that distinct functional clusters were differentially modulated during PCa progression. Differentiation and secretory functions were up-regulated in primary PCa but repressed in metastasis, whereas proliferation, cytoskeletal remodeling and adhesion were overexpressed in metastasis. Finally, the androgen-regulated genes ENDOD1, MCCC2 and ACSL3 were selected as potential disease markers for RT-PCR quantification in a distinct set of human prostate specimens. ENDOD1 and ACSL3 showed down-regulation in high-grade and metastatic PCa, while MCCC2 was overexpressed in low-grade PCa. Conclusions/Significance: AR modifications altered the transcriptional response to (anti) androgens in therapy-resistant cells. Furthermore, selective down-regulation of genes involved in differentiation and up-regulation of genes promoting proliferation and invasion suggest a disturbed balance between the growth and differentiation functions of the AR pathway during PCa progression. These findings may have implications in the current treatment and development of novel therapeutical approaches for metastatic PCa.	[Marques, Rute B.; Dits, Natasja F.; Erkens-Schulze, Sigrun; van Weerden, Wytske M.; Jenster, Guido] Josephine Nefkens Inst, Dept Urol, Rotterdam, Netherlands; [van Ijcken, Wilfred F. J.] Erasmus MC, Erasmus Ctr Biom, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Marques, RB (corresponding author), Josephine Nefkens Inst, Dept Urol, Rotterdam, Netherlands.	g.jenster@erasmusmc.nl	van ijcken, willem/N-9805-2018	van ijcken, willem/0000-0002-0421-8301	Netherlands Organization for Scientific Research (NWO) [903-46-187]; Dutch Cancer Society (KWF) [NKB97-1479, DDHK 2001-2455]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	The work presented in this manuscript was financially supported by the Netherlands Organization for Scientific Research (NWO), through ZonMW grant 903-46-187, and by the Dutch Cancer Society (KWF), through grants NKB97-1479 and DDHK 2001-2455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2008, BRIT J CANCER, V99, P314, DOI 10.1038/sj.bjc.6604472; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; BOSTWICK DG, 1994, AM J CLIN PATHOL, V102, pS31; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Brown RSD, 2002, J PATHOL, V198, P237, DOI 10.1002/path.1206; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Compagno D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001006; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; CULIG Z, 1995, WORLD J UROL, V13, P285; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DePrimo SE, 2002, GENOME BIOL, V3; Devlin HL, 2009, CANCER LETT, V274, P177, DOI 10.1016/j.canlet.2008.06.007; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Frydenberg M, 1997, LANCET, V349, P1681, DOI 10.1016/S0140-6736(96)07393-X; Furutani T, 2005, BIOSCI BIOTECH BIOCH, V69, P2236, DOI 10.1271/bbb.69.2236; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IDA K, 1995, INT J CANCER, V63, P500, DOI 10.1002/ijc.2910630407; Jenster G, 1999, SEMIN ONCOL, V26, P407; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Koivisto P, 1997, CANCER RES, V57, P314; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Linja MJ, 2001, CANCER RES, V61, P3550; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marques RB, 2005, INT J CANCER, V117, P221, DOI 10.1002/ijc.21201; MARQUES RB, PLOS ONE, V5; MENDIRATTA P, 2009, J CLIN ONCOL; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Prins GS, 1998, J UROLOGY, V159, P641, DOI 10.1016/S0022-5347(01)63692-9; Rubin MA, 2005, CANCER EPIDEM BIOMAR, V14, P1424, DOI 10.1158/1055-9965.EPI-04-0801; SHIMIZU K, 1993, P NATL ACAD SCI USA, V90, P10280, DOI 10.1073/pnas.90.21.10280; Simpson S, 1997, ONCOGENE, V14, P2149, DOI 10.1038/sj.onc.1201058; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sterbis JR, 2008, CLIN CANCER RES, V14, P758, DOI 10.1158/1078-0432.CCR-07-1356; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Tararova ND, 2007, PROSTATE, V67, P1801, DOI 10.1002/pros.20662; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tomlins SA, 2009, EUR UROL, V56, P275, DOI 10.1016/j.eururo.2009.04.036; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Veldhoven A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-192; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Waghray A, 2001, CANCER RES, V61, P4283; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; York TP, 2005, MOL CARCINOGEN, V44, P242, DOI 10.1002/mc.20139; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	71	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23144	10.1371/journal.pone.0023144	http://dx.doi.org/10.1371/journal.pone.0023144			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829708	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200050
J	Fechner, P; Damdimopoulou, P; Gauglitz, G				Fechner, Peter; Damdimopoulou, Pauliina; Gauglitz, Guenter			Biosensors Paving the Way to Understanding the Interaction between Cadmium and the Estrogen Receptor Alpha	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; BREAST-CANCER CELL; ZINC-FINGER; POSTTRANSLATIONAL MODIFICATIONS; IN-VIVO; ACTIVATION; PHOSPHORYLATION; METALLOESTROGEN; REPLACEMENT; BINDING	Cadmium is a toxic heavy metal ubiquitously present in the environment and subsequently in the human diet. Cadmium has been proposed to disrupt the endocrine system, targeting in particular the estrogen signaling pathway already at environmentally relevant concentrations. Thus far, the reports on the binding affinity of cadmium towards human estrogen receptor alpha (hER alpha) have been contradicting, as have been the reports on the in vivo estrogenicity of cadmium. Hence, the mode of interaction between cadmium and the receptor remains unclear. Here, we investigated the interaction between cadmium and hER alpha on a molecular level by applying a novel, label-free biosensor technique based on reflectometric interference spectroscopy (RIfS). We studied the binding of cadmium to hER alpha, and the conformation of the receptor following cadmium treatment. Our data reveals that cadmium interacts with the ligand binding domain (LBD) of the ER alpha and affects the conformation of the receptor. However, the binding event, as well as the induced conformation change, greatly depends on the accessibility of the cysteine tails in the LBD. As the LBD cysteine residues have been reported as targets of post-translational modifications in vivo, we present a hypothesis according to which different cellular pools of ER alpha respond to cadmium differently. Our proposed theory could help to explain some of the previously contradicting results regarding estrogen-like activity of cadmium.	[Fechner, Peter; Gauglitz, Guenter] Univ Tubingen, Inst Phys & Theoret Chem, D-7400 Tubingen, Germany; [Damdimopoulou, Pauliina] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	Eberhard Karls University of Tubingen; Karolinska Institutet	Fechner, P (corresponding author), Univ Tubingen, Inst Phys & Theoret Chem, Morgenstelle 8, D-7400 Tubingen, Germany.	guenter.gauglitz@ipc.uni-tuebingen.de		Damdimopoulou, Pauliina/0000-0001-8458-0855	European Union [FOOD-CT-2004-506319]; Swedish Research Council	European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We kindly acknowledge financial support by the European Union project CASCADE Network of Excellence FOOD-CT-2004-506319 and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; ALI I, 2010, ENV HLTH PERSPECT; Ali I, 2010, ENVIRON HEALTH PERSP, V118, P1389, DOI 10.1289/ehp.1001967; Asano K, 2004, ANAL SCI, V20, P611, DOI 10.2116/analsci.20.611; Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Byrne C, 2009, TOXICOL APPL PHARM, V238, P266, DOI 10.1016/j.taap.2009.03.025; Choe SY, 2003, SCI TOTAL ENVIRON, V312, P15, DOI 10.1016/S0048-9697(03)00190-6; Denier X, 2009, TOXICOL IN VITRO, V23, P569, DOI 10.1016/j.tiv.2009.01.006; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.243r; FECHNER P, 2011, ANAL BIOANAL CHEM; Fechner P, 2010, TRAC-TREND ANAL CHEM, V29, P297, DOI 10.1016/j.trac.2009.12.009; Fechner P, 2009, ANAL BIOANAL CHEM, V393, P1579, DOI 10.1007/s00216-008-2480-3; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Hofer N, 2009, TOXICOL LETT, V191, P123, DOI 10.1016/j.toxlet.2009.08.014; International Agency for Research on Cancer (IARC), 1993, IARC MON EV CARC RIS, V58; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Le Guevel R, 2000, BIOL REPROD, V63, P259, DOI 10.1095/biolreprod63.1.259; Liu ZW, 2008, TOXICOL APPL PHARM, V228, P286, DOI 10.1016/j.taap.2007.12.017; Martinez-Campa C, 2006, J PINEAL RES, V40, P291, DOI 10.1111/j.1600-079X.2006.00315.x; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pillet S, 2006, TOXICOL SCI, V92, P423, DOI 10.1093/toxsci/kfl005; PREDKI PF, 1992, J BIOL CHEM, V267, P5842; PREDKI PF, 1994, ENVIRON HEALTH PERSP, V102, P195, DOI 10.2307/3431786; Rider CV, 2009, ENVIRON TOXICOL CHEM, V28, P2175, DOI 10.1897/09-018.1; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Schmitt HM, 1997, BIOSENS BIOELECTRON, V12, P809, DOI 10.1016/S0956-5663(97)00046-8; SIEWIT CL, 2010, MOL ENDOCRINOL; Silva E, 2006, TOXICOL APPL PHARM, V216, P20, DOI 10.1016/j.taap.2006.04.002; Stoica A, 2000, MOL ENDOCRINOL, V14, P545, DOI 10.1210/me.14.4.545; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Usami M, 2002, J STEROID BIOCHEM, V81, P47, DOI 10.1016/S0960-0760(02)00046-8; Webster KA, 2001, ANTIOXID REDOX SIGN, V3, P535, DOI 10.1089/15230860152542916; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Zang Y, 2009, TOXICOL LETT, V184, P134, DOI 10.1016/j.toxlet.2008.10.032; Zhang WC, 2007, TOXICOLOGY, V241, P84, DOI 10.1016/j.tox.2007.08.089	44	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23048	10.1371/journal.pone.0023048	http://dx.doi.org/10.1371/journal.pone.0023048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829690	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511900023
J	Tan, HW; Liu, GH; Dong, X; Lin, RQ; Song, HQ; Huang, SY; Yuan, ZG; Zhao, GH; Zhu, XQ				Tan, Hong-Wei; Liu, Guo-Hua; Dong, Xia; Lin, Rui-Qing; Song, Hui-Qun; Huang, Si-Yang; Yuan, Zi-Guo; Zhao, Guang-Hui; Zhu, Xing-Quan			The Complete Mitochondrial Genome of the Asiatic Cavity-Nesting Honeybee Apis cerana (Hymenoptera: Apidae)	PLOS ONE			English	Article							DNA SEQUENCE; EVOLUTIONARY HISTORY; GENE REARRANGEMENTS; BEES HYMENOPTERA; TRANSFER-RNAS; MELLIFERA; ORGANIZATION; INSECTA; ARRANGEMENT; PHYLOGENY	In the present study, we determined the complete mitochondrial DNA (mtDNA) sequence of Apis cerana, the Asiatic cavity-nesting honeybee. We present here an analysis of features of its gene content and genome organization in comparison with Apis mellifera to assess the variation within the genus Apis and among main groups of Hymenoptera. The size of the entire mt genome of A. cerana is 15,895 bp, containing 2 ribosomal RNA genes, 13 protein-coding genes, 22 transfer RNA (tRNA) genes and one control region. These genes are transcribed from both strands and have a nucleotide composition high in A and T. The contents of A+T of the complete genomes are 83.96% for A. cerana. The AT bias had a significant effect on both the codon usage pattern and amino acid composition of proteins. There are a total of 3672 codons in all 13 protein-coding genes, excluding termination codons. The most frequently used amino acid is Leu (15.52%), followed by Ile (12.85%), Phe (10.10%), Ser (9.15%) and Met (8.96%). Intergenic regions in the mt genome of A. cerana are 705 bp in total. The order and orientation of the gene arrangement pattern is identical to that of A. mellifera, except for the position of the tRNA-Ser((AGN)) gene. Phylogenetic analyses using concatenated amino acid sequences of 13 protein-coding genes, with three different computational algorithms (NJ, MP and ML), all revealed two distinct groups with high statistical support, indicating that A. cerana and A. mellifera are two separate species, consistent with results of previous morphological and molecular studies. The complete mtDNA sequence of A. cerana provides additional genetic markers for studying population genetics, systematics and phylogeographics of honeybees.	[Tan, Hong-Wei; Liu, Guo-Hua; Lin, Rui-Qing; Song, Hui-Qun; Huang, Si-Yang; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Liu, Guo-Hua; Zhu, Xing-Quan] Hunan Agr Univ, Coll Vet Med, Changsha, Hunan, Peoples R China; [Tan, Hong-Wei; Dong, Xia] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Yunnan Prov, Peoples R China; [Lin, Rui-Qing; Yuan, Zi-Guo] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Zhao, Guang-Hui] NW A&F Univ, Coll Vet Med, Yangling, Shaanxi Prov, Peoples R China; [Tan, Hong-Wei] Anim Husb Technol Promot Stn Chongqing, Chongqing, Peoples R China; [Zhu, Xing-Quan] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Heilongjiang Pr, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Hunan Agricultural University; Yunnan Agricultural University; South China Agricultural University; Northwest A&F University - China; Heilongjiang Bayi Agricultural University	Tan, HW (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	237855236@qq.com; xingquanzhu1@hotmail.com			State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences; Yunnan Provincial Program for Introducing High-Level Scientists [2009CI125]; National Natural Science Foundation of China [30960269]; Natural Science Foundation of Yunnan Province [2006C0035M]	State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences; Yunnan Provincial Program for Introducing High-Level Scientists; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work was supported, in part, by the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, the Yunnan Provincial Program for Introducing High-Level Scientists (Grant No. 2009CI125), the National Natural Science Foundation of China (Grant No. 30960269), and the Natural Science Foundation of Yunnan Province (Grant No. 2006C0035M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; Behura SK, 2007, MOL BIOL EVOL, V24, P1492, DOI 10.1093/molbev/msm068; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; CAMERON SA, 1993, P NATL ACAD SCI USA, V90, P8687, DOI 10.1073/pnas.90.18.8687; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; CANTATORE P, 1980, NUCLEIC ACIDS RES, V8, P2605, DOI 10.1093/nar/8.12.2605; Castro LR, 2005, MOL PHYLOGENET EVOL, V34, P469, DOI 10.1016/j.ympev.2004.11.005; Castro LR, 2006, GENOME, V49, P752, DOI 10.1139/G06-030; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; Chapman NC, 2008, J ECON ENTOMOL, V101, P272, DOI 10.1603/0022-0493(2008)101[272:PGOCAF]2.0.CO;2; Cook CE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-105; CORNUET JM, 1991, GENETICS, V128, P393; CROZIER RH, 1993, GENETICS, V133, P97; Cui P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-241; Dacke M, 2007, J EXP BIOL, V210, P845, DOI 10.1242/jeb.002089; De la Rua P, 2000, HEREDITY, V84, P124, DOI 10.1046/j.1365-2540.2000.00646.x; Dowton M, 2003, J MOL EVOL, V56, P517, DOI 10.1007/s00239-002-2420-3; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; Dowton M, 2009, MOL PHYLOGENET EVOL, V52, P512, DOI 10.1016/j.ympev.2009.04.001; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Engel MS, 1997, ANN ENTOMOL SOC AM, V90, P43, DOI 10.1093/aesa/90.1.43; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; GARNERY L, 1995, MOL ECOL, V4, P465, DOI 10.1111/j.1365-294X.1995.tb00240.x; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; GODDARD JM, 1980, NUCLEIC ACIDS RES, V8, P741; Hua JM, 2009, MOL BIOL REP, V36, P1757, DOI 10.1007/s11033-008-9379-0; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Lasalle John, 1993, P1; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li MW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-224; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Masta SE, 2000, MOL BIOL EVOL, V17, P1091, DOI 10.1093/oxfordjournals.molbev.a026390; Masta SE, 2010, GENE, V449, P9, DOI 10.1016/j.gene.2009.09.009; Nakao M, 2002, MITOCHONDRION, V1, P497, DOI 10.1016/S1567-7249(02)00040-5; Nakao M, 2007, PARASITOL RES, V101, P233, DOI 10.1007/s00436-006-0433-3; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Raffiudin R, 2007, MOL PHYLOGENET EVOL, V43, P543, DOI 10.1016/j.ympev.2006.10.013; Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Silvestre D, 2008, GENET MOL BIOL, V31, P451, DOI 10.1590/S1415-47572008000300010; Somanathan H, 2009, J EXP BIOL, V212, P2448, DOI 10.1242/jeb.031484; Songrarn O, 2006, BIOCHEM GENET, V44, P256, DOI 10.1007/s10528-006-9030-5; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wei SJ, 2010, MOL BIOL REP, V37, P1931, DOI 10.1007/s11033-009-9640-1; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Yatawara L, 2008, GENE, V424, P80, DOI 10.1016/j.gene.2008.07.026; Yatawara L, 2010, MOL BIOCHEM PARASIT, V173, P32, DOI 10.1016/j.molbiopara.2010.05.004; Yu ZN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-477; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7	59	46	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23008	10.1371/journal.pone.0023008	http://dx.doi.org/10.1371/journal.pone.0023008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857981	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500013
J	Zuccato, C; Marullo, M; Vitali, B; Tarditi, A; Mariotti, C; Valenza, M; Lahiri, N; Wild, EJ; Sassone, J; Ciammola, A; Bachoud-Levi, AC; Tabrizi, SJ; Di Donato, S; Cattaneo, E				Zuccato, Chiara; Marullo, Manuela; Vitali, Barbara; Tarditi, Alessia; Mariotti, Caterina; Valenza, Marta; Lahiri, Nayana; Wild, Edward J.; Sassone, Jenny; Ciammola, Andrea; Bachoud-Levi, Anne Catherine; Tabrizi, Sarah J.; Di Donato, Stefano; Cattaneo, Elena			Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease	PLOS ONE			English	Article							FACTOR BDNF LEVELS; PERIPHERAL-BLOOD; HUMAN PLATELETS; SERUM; EXPRESSION; PLASMA; TRANSCRIPTION; DEPRESSION; BIOMARKERS; CEP-1347	Reduced Brain-Derived Neurotrophic Factor (BDNF) levels have been described in a number of patho-physiological conditions, most notably, in Huntington's disease (HD), a progressive neurodegenerative disorder. Since BDNF is also produced in blood, we have undertaken the measurement of its peripheral levels in the attempt to identify a possible link with HD prognosis and/or its progression. Here we evaluated BDNF level in 398 blood samples including 138 controls, 56 preHD, and 204 HD subjects. We found that BDNF protein levels were not reliably different between groups, whether measured in plasma (52 controls, 26 preHD, 105 HD) or serum (39 controls, 5 preHD, 29 HD). Our experience, and a reanalysis of the literature highlighted that intra-group variability and methodological aspects affect this measurement, especially in serum. We also assessed BDNF mRNA levels in blood samples from 47 controls, 25 preHD, and 70 HD subjects, and found no differences among the groups. We concluded that levels of BDNF in human blood were not informative (mRNA levels or plasma protein level) nor reliable (serum protein levels) as HD biomarkers. We also wish to warn the scientific community in interpreting the significance of changes measured in BDNF protein levels in serum from patients suffering from different conditions.	[Zuccato, Chiara; Marullo, Manuela; Vitali, Barbara; Tarditi, Alessia; Valenza, Marta; Cattaneo, Elena] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Zuccato, Chiara; Marullo, Manuela; Vitali, Barbara; Tarditi, Alessia; Valenza, Marta; Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, Milan, Italy; [Mariotti, Caterina; Di Donato, Stefano] Natl Neurol Inst IRCCS Carlo Besta, Div Biochem & Genet, Milan, Italy; [Lahiri, Nayana; Wild, Edward J.; Tabrizi, Sarah J.] UCL, Dept Neurodegenerat Dis, UCL Inst Neurol, London, England; [Lahiri, Nayana; Wild, Edward J.; Tabrizi, Sarah J.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Sassone, Jenny; Ciammola, Andrea] IRCCS Ist Auxol Italiano, Milan, Italy; [Bachoud-Levi, Anne Catherine] GHU Chenevier Mondor, AP HP, Ctr Natl Reference Maladie Huntington, Creteil, France	University of Milan; University of Milan; IRCCS Istituto Neurologico Besta; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; IRCCS Istituto Auxologico Italiano; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Zuccato, C (corresponding author), Univ Milan, Dept Pharmacol Sci, Milan, Italy.	elena.cattaneo@unimi.it	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022; Di Donato, Stefano/B-9717-2012; Mariotti, Caterina/AAP-9425-2021; Wild, Edward/G-1436-2016; VALENZA, MARTA/B-7763-2017	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; Mariotti, Caterina/0000-0003-2405-3564; Wild, Edward/0000-0002-6921-7887; CATTANEO, ELENA/0000-0002-0755-4917; VALENZA, MARTA/0000-0002-7048-9257; Lahiri, Nayana/0000-0002-6260-7700; Tabrizi, Sarah/0000-0003-2716-2045; ZUCCATO, CHIARA/0000-0003-1771-3392	European Union [LsHM-CT-2004-512039, LsHB-CT-2006-037349]; CHDI Foundation (USA); Department of Health's NIHR Biomedical Research Centres; Gis - Maladies rares [A04159JS]; National Institute for Health Research [CL-2009-18-005] Funding Source: researchfish	European Union(European Commission); CHDI Foundation (USA); Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); Gis - Maladies rares; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported by the NeuroNE Sixth Framework Programme, European Union, LsHM-CT-2004-512039; the Stem-HD Sixth Framework Programme, European Union, LsHB-CT-2006-037349; and the CHDI Foundation (USA) to EC. Some of this work was undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. ACBL was supported by Gis - Maladies rares (A04159JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostol BL, 2008, MOL CELL NEUROSCI, V39, P8, DOI 10.1016/j.mcn.2008.04.007; Ayache S, 2006, AM J CLIN PATHOL, V126, P174, DOI 10.1309/3WM7XJ7RD8BCLNKX; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Buckley PF, 2007, SCHIZOPHR RES, V94, P1, DOI 10.1016/j.schres.2007.01.025; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Castren E, 2010, CNS DRUGS, V24, P1, DOI 10.2165/11530010-000000000-00000; Ciammola A, 2007, AM J MED GENET B, V144B, P574, DOI 10.1002/ajmg.b.30501; Conforti P, 2008, MOL CELL NEUROSCI, V39, P1, DOI 10.1016/j.mcn.2008.04.012; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Gonul AS, 2005, EUR ARCH PSY CLIN N, V255, P381, DOI 10.1007/s00406-005-0578-6; Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P499, DOI 10.1016/j.pnpbp.2005.01.007; HDCRG, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Katerberg H, 2009, AM J MED GENET B, V150B, P1050, DOI 10.1002/ajmg.b.30930; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lovrecic L, 2009, MOVEMENT DISORD, V24, P2277, DOI 10.1002/mds.22477; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; Mitoma M, 2008, PROG NEURO-PSYCHOPH, V32, P679, DOI 10.1016/j.pnpbp.2007.11.011; O'Mullan P, 2009, CLIN CHEM LAB MED, V47, P685, DOI 10.1515/CCLM.2009.003; OGORMAN MRG, 1995, CLIN DIAGN LAB IMMUN, V2, P205, DOI 10.1128/CDLI.2.2.205-208.1995; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; Runne H, 2007, P NATL ACAD SCI USA, V104, P14424, DOI 10.1073/pnas.0703652104; Squitieri F, 2009, EUR J NUCL MED MOL I, V36, P1113, DOI 10.1007/s00259-009-1103-3; Tang SW, 2008, NEUROSCI LETT, V431, P62, DOI 10.1016/j.neulet.2007.11.019; Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yi JZ, 2008, J PROTEOME RES, V7, P5112, DOI 10.1021/pr800396c; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	34	96	98	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22966	10.1371/journal.pone.0022966	http://dx.doi.org/10.1371/journal.pone.0022966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857974	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500010
J	Benam, KH; Kok, WL; McMichael, AJ; Ho, LP				Benam, Kambez Hajipouran; Kok, Wai Ling; McMichael, Andrew J.; Ho, Ling-Pei			Alternative Spliced CD1D Transcripts in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; NATURAL-KILLER-CELLS; I-LIKE MOLECULE; NK-T-CELLS; CUTTING EDGE; ANTIGEN PRESENTATION; MONONUCLEAR-CELLS; CRYSTAL-STRUCTURE; B-CELLS; EXPRESSION	CD1d is a MHC I like molecule which presents glycolipid to natural killer T (NKT) cells, a group of cells with diverse but critical immune regulatory functions in the immune system. These cells are required for optimal defence against bacterial, viral, protozoan, and fungal infections, and control of immune-pathology and autoimmune diseases. CD1d is expressed on antigen presenting cells but also found on some non-haematopoietic cells. However, it has not been observed on bronchial epithelium, a site of active host defence in the lungs. Here, we identify for the first time, CD1D mRNA variants and CD1d protein expression on human bronchial epithelial cells, describe six alternatively spliced transcripts of this gene in these cells; and show that these variants are specific to epithelial cells. These findings provide the basis for investigations into a role for CD1d in lung mucosal immunity.	[Benam, Kambez Hajipouran; Kok, Wai Ling; McMichael, Andrew J.; Ho, Ling-Pei] Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England	University of Oxford	Benam, KH (corresponding author), Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England.	Ling-pei.ho@imm.ox.ac.uk	Benam, Kambez/AAF-1750-2021; Ho, Ling-Pei/AAL-4776-2021	Benam, Kambez/0000-0001-9117-3959; Ho, Ling Pei/0000-0001-8319-301X	Medical Research Council (UK); Medical Research Council [G0600371] Funding Source: researchfish; National Institute for Health Research [DHCS/04/G121/68] Funding Source: researchfish; MRC [G0600371] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Amano M, 1998, J IMMUNOL, V161, P1710; Bainbridge D, 2001, TRENDS IMMUNOL, V22, P548, DOI 10.1016/S1471-4906(01)02031-2; BLUMBERG RS, 1991, J IMMUNOL, V147, P2518; Bonish B, 2000, J IMMUNOL, V165, P4076, DOI 10.4049/jimmunol.165.7.4076; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; CANCHIS PW, 1993, IMMUNOLOGY, V80, P561; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; FUJII T, 1994, J IMMUNOL, V153, P5516; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Ho LP, 2004, J IMMUNOL, V172, P7350, DOI 10.4049/jimmunol.172.12.7350; Jenkinson HJ, 1999, IMMUNOLOGY, V96, P649; Jin N, 2007, J IMMUNOL, V179, P2961, DOI 10.4049/jimmunol.179.5.2961; Kim HS, 1999, J BIOL CHEM, V274, P9289, DOI 10.1074/jbc.274.14.9289; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Kojo S, 2000, BIOCHEM BIOPH RES CO, V276, P107, DOI 10.1006/bbrc.2000.3450; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mars LT, 2002, J IMMUNOL, V168, P6007, DOI 10.4049/jimmunol.168.12.6007; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; MOREAU P, 1995, HUM IMMUNOL, V43, P231, DOI 10.1016/0198-8859(95)00009-S; Naumov YN, 2001, P NATL ACAD SCI USA, V98, P13838, DOI 10.1073/pnas.251531798; Nickoloff BJ, 1999, ARCH DERMATOL, V135, P546, DOI 10.1001/archderm.135.5.546; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; PISON U, 1994, EUR J CLIN INVEST, V24, P586, DOI 10.1111/j.1365-2362.1994.tb01110.x; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Tsuneyama K, 1998, HEPATOLOGY, V28, P620, DOI 10.1002/hep.510280303; van de Wal Y, 2003, GASTROENTEROLOGY, V124, P1420, DOI 10.1016/S0016-5085(03)00219-1; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; WOOLFSON A, 1994, P NATL ACAD SCI USA, V91, P6683, DOI 10.1073/pnas.91.14.6683; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zidi I, 2010, J PHYSIOL BIOCHEM, V66, P39, DOI 10.1007/s13105-010-0005-y	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22726	10.1371/journal.pone.0022726	http://dx.doi.org/10.1371/journal.pone.0022726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853044	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953400011
J	Seto, WK; Lee, CF; Lai, CL; Ip, PPC; Fong, DYT; Fung, J; Wong, DKH; Yuen, MF				Seto, Wai-Kay; Lee, Chun-Fan; Lai, Ching-Lung; Ip, Philip P. C.; Fong, Daniel Yee-Tak; Fung, James; Wong, Danny Ka-Ho; Yuen, Man-Fung			A New Model Using Routinely Available Clinical Parameters to Predict Significant Liver Fibrosis in Chronic Hepatitis B	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; TRANSIENT ELASTOGRAPHY; BIOCHEMICAL MARKERS; BIOPSY; CIRRHOSIS; IDENTIFICATION; INFLAMMATION; ALGORITHM; DISEASE; RISK	Objective: We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) based on routinely available clinical parameters. Methods: 237 treatment-naive CHB patients [58.4% hepatitis B e antigen (HBeAg)-positive] who had undergone liver biopsy were randomly divided into two cohorts: training group (n = 108) and validation group (n = 129). Liver histology was assessed for fibrosis. All common demographics, viral serology, viral load and liver biochemistry were analyzed. Results: Based on 12 available clinical parameters (age, sex, HBeAg status, HBV DNA, platelet, albumin, bilirubin, ALT, AST, ALP, GGT and AFP), a model to predict significant liver fibrosis (Ishak fibrosis score >= 3) was derived using the five best parameters (age, ALP, AST, AFP and platelet). Using the formula log(index+1) = 0.025+0.0031(age)+0.1483 log(ALP)+0.004 log(AST)+0.0908 log(AFP+1)-0.028 log(platelet), the PAPAS (Platelet/Age/Phosphatase/AFP/AST) index predicts significant ibrosis with an area under the receiving operating characteristics (AUROC) curve of 0.776 [0.797 for patients with ALT <2xupper limit of normal (ULN)] The negative predictive value to exclude significant fibrosis was 88.4%. This predictive power is superior to other non-invasive models using common parameters, including the AST/platelet/GGT/AFP (APGA) index, AST/platelet ratio index (APRI), and the FIB-4 index (AUROC of 0.757, 0.708 and 0.723 respectively). Using the PAPAS index, 67.5% of liver biopsies for patients being considered for treatment with ALT <2xULN could be avoided. Conclusion: The PAPAS index can predict and exclude significant fibrosis, and may reduce the need for liver biopsy in CHB patients.	[Seto, Wai-Kay; Lai, Ching-Lung; Fung, James; Wong, Danny Ka-Ho; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Lee, Chun-Fan] Singapore Clin Res Inst, Dept Biostat, Singapore, Singapore; [Lee, Chun-Fan] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Ip, Philip P. C.] Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Fong, Daniel Yee-Tak] Univ Hong Kong, Dept Nursing Studies, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Singapore Clinical Research Institute; National University of Singapore; University of Hong Kong; University of Hong Kong	Seto, WK (corresponding author), Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Ip, Philip/AAV-5995-2021; Fung, James/AAG-4832-2020; Wong, Danny/S-6230-2019; Fong, Daniel YT/C-4269-2009; SETO, Wai-Kay/H-4452-2012; Wong, Danny/H-6819-2016	Ip, Philip/0000-0002-0493-9838; Fong, Daniel YT/0000-0001-7365-9146; SETO, Wai-Kay/0000-0002-9012-313X; /0000-0001-9078-5005; Fung, James/0000-0002-1286-8902; Lai, Ching-Lung/0000-0002-5927-2436				ABDI W, 1979, ARCH INTERN MED, V139, P667, DOI 10.1001/archinte.139.6.667; Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Adinolfi LE, 2001, BRIT J HAEMATOL, V113, P590, DOI 10.1046/j.1365-2141.2001.02824.x; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2010, GUT, V59, P861, DOI 10.1136/gut.2010.214650; Castera L, 2010, J HEPATOL, V52, P191, DOI 10.1016/j.jhep.2009.11.008; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; Edirisooriya G, 1995, STEPWISE REGRESSION; Fleisher AS, 2008, NEUROLOGY, V70, P191, DOI 10.1212/01.wnl.0000287091.57376.65; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Freed MN, 1991, HDB STAT PROCEDURES; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2008, AM J GASTROENTEROL, V103, P1421, DOI 10.1111/j.1572-0241.2007.01751.x; Fung J, 2011, AM J GASTROENTEROL, V106, P492, DOI 10.1038/ajg.2010.463; Guo W, 2009, GENET EPIDEMIOL, V33, P308, DOI 10.1002/gepi.20382; Hui AY, 2005, AM J GASTROENTEROL, V100, P616, DOI 10.1111/j.1572-0241.2005.41289.x; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; KAMIMOTO Y, 1985, HEPATOLOGY, V5, P367, DOI 10.1002/hep.1840050305; Kim BK, 2007, LIVER INT, V27, P969, DOI 10.1111/j.1478-3231.2007.01519.x; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Mohamadnejad M, 2006, AM J GASTROENTEROL, V101, P2537, DOI 10.1111/j.1572-0241.2006.00788.x; Montazeri G, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-32; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Parkman HP, 2010, GASTROENTEROLOGY, V138, pS; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sebastiani G, 2009, HEPATOLOGY, V49, P1821, DOI 10.1002/hep.22859; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Wai CT, 2006, LIVER INT, V26, P666, DOI 10.1111/j.1478-3231.2006.01287.x; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Welge P, 1990, 3 REASONS WHY STEPWI; Wong GLH, 2010, ALIMENT PHARM THER, V31, P1095, DOI 10.1111/j.1365-2036.2010.04276.x; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960	48	60	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23077	10.1371/journal.pone.0023077	http://dx.doi.org/10.1371/journal.pone.0023077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853071	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953400025
J	Agatha, S				Agatha, Sabine			Global Diversity of Aloricate Oligotrichea (Protista, Ciliophora, Spirotricha) in Marine and Brackish Sea Water	PLOS ONE			English	Review							HALTERIA-GRANDINELLA MULLER; N. SP CILIOPHORA; CILIATES CILIOPHORA; COMMUNITY STRUCTURE; MOLECULAR EVIDENCE; COASTAL WATERS; GEOGRAPHIC-DISTRIBUTION; PHYLOGENETIC POSITION; HETEROSIGMA-AKASHIWO; GENETIC-DIVERGENCE	Oligotrichids and choreotrichids are ciliate taxa contributing to the multi-step microbial food web and episodically dominating the marine microzooplankton. The global diversity and distribution of aloricate Oligotrichea are unknown. Here, the geographic ranges of the 141 accepted species and their synonyms in marine and brackish sea water are analyzed, using hundreds of taxonomical and ecological studies; the quality of the records is simultaneously evaluated. The aloricate Oligotrichea match the moderate endemicity model, i.e., the majority (94) of morphospecies has a wide, occasionally cosmopolitan distribution, while 47 morphospecies show biogeographic patterns: they are restricted to single geographic regions and probably include 12 endemic morphospecies. These endemics are found in the Antarctic, North Pacific, and Black Sea, whereas the "flagship" species Strombidinopsis cercionis is confined to the Caribbean Sea. Concerning genera, again several geographic patterns are recognizable. The species richness is distinctly lower in the southern hemisphere than in the northern, ranging from nine morphospecies in the South Pacific to 95 in the North Atlantic; however, this pattern is probably caused by undersampling. Since the loss of species might affect higher trophical levels substantially, the aloricate Oligotrichea should not any longer be ignored in conservation issues. The ecophysiological diversity is considerably larger than the morphological, and even tops the richness of SSrRNA and ITS haplotypes, indicating that probably more than 83-89% of the diversity in aloricate Oligotrichea are unknown. The huge challenge to discover all these species can only be managed by combining the expertises of morphological taxonomists, molecular biologists, ecologists, and physiologists.	Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria	Salzburg University	Agatha, S (corresponding author), Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria.	sabine.agatha@sbg.ac.at	Agatha, Sabine/AAB-4836-2022	Agatha, Sabine/0000-0003-3083-9782	Austrian Science Foundation (FWF) [P20461-B17]	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	The study was supported by the Austrian Science Foundation (FWF; Project P20461-B17), which had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Agatha S, 1997, ARCH PROTISTENKD, V148, P445, DOI 10.1016/S0003-9365(97)80021-8; Agatha S, 2005, EUR J PROTISTOL, V41, P65, DOI 10.1016/j.ejop.2004.09.005; Agatha S, 2004, ACTA PROTOZOOL, V43, P201; Agatha S, 2004, ZOOLOGY, V107, P153, DOI 10.1016/j.zool.2004.02.003; Agatha S, 2004, J EUKARYOT MICROBIOL, V51, P267, DOI 10.1111/j.1550-7408.2004.tb00567.x; Agatha S, 2001, PATRIMOINES NATURELS, V50, P42; Agatha S, 2007, EUR J PROTISTOL, V43, P37, DOI 10.1016/j.ejop.2006.10.001; Agatha S, 2011, EUR J PROTISTOL, V47, P51, DOI 10.1016/j.ejop.2010.09.001; Agatha S, 2009, EUR J PROTISTOL, V45, P51, DOI 10.1016/j.ejop.2008.07.004; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Awerinzew S, 1901, T IMP S PETERB OBSHC, V31, P1; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baas Becking LGM, 1934, GEOBIOLOGIE INLEIDIN, P263; Barth D, 2006, J EUKARYOT MICROBIOL, V53, P20, DOI 10.1111/j.1550-7408.2005.00068.x; Bass D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-162; BELVISO S, 1990, LIMNOL OCEANOGR, V35, P1810, DOI 10.4319/lo.1990.35.8.1810; Benton MJ, 2001, TRENDS ECOL EVOL, V16, P405, DOI 10.1016/S0169-5347(01)02149-8; BLACKBOURN DJ, 1973, J PROTOZOOL, V20, P286, DOI 10.1111/j.1550-7408.1973.tb00877.x; Bonhommeau S, 2009, J FISH BIOL, V74, P1891, DOI 10.1111/j.1095-8649.2009.02298.x; Bouchet Philippe, 2006, P31; Brayard A, 2005, J ZOOL SYST EVOL RES, V43, P178, DOI 10.1111/j.1439-0469.2005.00311.x; Caron DA, 2009, AQUAT MICROB ECOL, V57, P227, DOI 10.3354/ame01352; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Chao A, 2006, OIKOS, V114, P479, DOI 10.1111/j.2006.0030-1299.14814.x; Christaki U, 1996, MAR ECOL PROG SER, V141, P119, DOI 10.3354/meps141119; Christaki U, 1998, LIMNOL OCEANOGR, V43, P458, DOI 10.4319/lo.1998.43.3.0458; Claessens M, 2010, MAR BIOL, V157, P483, DOI 10.1007/s00227-009-1334-7; Claessens M, 2008, AQUAT MICROB ECOL, V53, P181, DOI 10.3354/ame01243; Claparede E, 1859, MEM I NATN GENEV, V6, P261; Clough J, 2005, AQUAT MICROB ECOL, V39, P121, DOI 10.3354/ame039121; Song Weibo, 2003, Bulletin of Zoological Nomenclature, V60, P48; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Cotterill FPD, 2008, BIODIVERS CONSERV, V17, P427, DOI 10.1007/s10531-007-9261-8; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; DALE T, 1987, J PLANKTON RES, V9, P871, DOI 10.1093/plankt/9.5.871; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; de Fromentel E, 1874, ETUDES MICROZOAIRES, pi; de Vargas C, 2002, MAR MICROPALEONTOL, V45, P101, DOI 10.1016/S0377-8398(02)00037-3; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Doherty M, 2007, AQUAT MICROB ECOL, V48, P141, DOI 10.3354/ame048141; Doherty M, 2010, ENVIRON MICROBIOL, V12, P886, DOI 10.1111/j.1462-2920.2009.02133.x; Dolan JR, 2007, BIOGEOSCIENCES, V4, P297, DOI 10.5194/bg-4-297-2007; Dolan JR, 2009, J BIOGEOGR, V36, P887, DOI 10.1111/j.1365-2699.2008.02046.x; Dolan JR, 2006, HYDROBIOLOGIA, V555, P143, DOI 10.1007/s10750-005-1112-6; Dolan JR, 1997, MAR GEOL, V139, P109, DOI 10.1016/S0025-3227(96)00106-5; Dujardin F., 1841, HIST NATURELLE ZOOPH; EDWARDS ES, 1995, J PLANKTON RES, V17, P771, DOI 10.1093/plankt/17.4.771; FAURE-FREMIET E, 1970, Protistologica, V6, P207; FAURE-FREMIET E., 1950, BULL BIOL FRANCE BELGIQUE, V84, P35; FAURE-FREMIET E., 1948, BULL BIOL FRANCE ET BELGIQUE, V82, P3; Faure-Fremiet E., 1910, BULL SCI FR BELG, V45, P27; FAUREFREMIET E, 1948, J ANIM ECOL, V17, P127, DOI 10.2307/1474; Fenchel T., 1986, Progress in Protistology, V1, P65; Fenchel T, 1987, BERLIN BROCK SPRINGE, pi; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Fileman ES, 2002, J MAR BIOL ASSOC UK, V82, P359, DOI 10.1017/S0025315402005593; Finlay BJ, 2004, PROTIST, V155, P15, DOI 10.1078/1434461000160; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; FOISSNER W, 1987, ARCH PROTISTENKD, V133, P219, DOI 10.1016/S0003-9365(87)80054-4; Foissner W., 2007, JPN J PROTOZOOL, V40, P1; Foissner W, 2008, BIODIVERS CONSERV, V17, P345, DOI 10.1007/s10531-007-9254-7; Foissner W, 2008, BIODIVERS CONSERV, V17, P235, DOI 10.1007/s10531-007-9248-5; Foissner W, 2007, EUR J PROTISTOL, V43, P295, DOI 10.1016/j.ejop.2007.06.001; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Foissner Wilhelm, 2002, Bulletin of Zoological Nomenclature, V59, P165; Foissner Wilhelm, 2002, Denisia, V5, P1; Fox JW, 2006, COMMUNITY ECOL, V7, P143, DOI 10.1556/ComEc.7.2006.2.2; Gao S, 2009, SYST BIODIVERS, V7, P347, DOI 10.1017/S1477200009990077; Gao S, 2009, SYST BIODIVERS, V7, P235, DOI 10.1017/S1477200009002989; Gismervik I, 2005, AQUAT MICROB ECOL, V40, P163, DOI 10.3354/ame040163; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Graham SL, 2010, AQUAT MICROB ECOL, V59, P111, DOI 10.3354/ame01391; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Helbig AJ, 2005, HEREDITY, V95, P113, DOI 10.1038/sj.hdy.6800679; Heyman RP, 1983, COMP ATLAS ZOOPLANKT, P186; Hillebrand H, 2001, OECOLOGIA, V126, P114, DOI 10.1007/s004420000492; Holzer M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026232; Hubbell S.P., 2001, MG POP BIOL, V32; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ichinomiya M, 2004, AQUAT MICROB ECOL, V37, P305, DOI 10.3354/ame037305; Jeong HJ, 2007, MAR ECOL PROG SER, V349, P199, DOI 10.3354/meps07094; Jeong HJ, 1999, J EUKARYOT MICROBIOL, V46, P69, DOI 10.1111/j.1550-7408.1999.tb04586.x; Jeong HJ, 2004, J EUKARYOT MICROBIOL, V51, P451, DOI 10.1111/j.1550-7408.2004.tb00393.x; Johnson MD, 2003, LIMNOL OCEANOGR, V48, P238, DOI 10.4319/lo.2003.48.1.0238; JONSSON PR, 1986, MAR ECOL PROG SER, V33, P265, DOI 10.3354/meps033265; JONSSON PR, 1994, J EXP MAR BIOL ECOL, V175, P77, DOI 10.1016/0022-0981(94)90177-5; JONSSON PR, 1989, MAR ECOL PROG SER, V52, P39, DOI 10.3354/meps052039; Kahl A., 1932, Tierwelt Deutschlands Jena, V25, P399; Kahl A., 1935, Dahl Die Tierwelt Deutschlands, V30, P651; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kato Satoshi, 1993, Fisheries Oceanography, V2, P166, DOI 10.1111/j.1365-2419.1993.tb00132.x; Katz LA, 2005, AQUAT MICROB ECOL, V41, P55, DOI 10.3354/ame041055; Kent W.S., 1881, MANUAL INFUSORIA INC, VII; Kettle AJ, 2006, CAN J FISH AQUAT SCI, V63, P90, DOI 10.1139/F05-198; Kim JS, 2005, J EUKARYOT MICROBIOL, V52, P514, DOI 10.1111/j.1550-7408.2005.00062.x; Kim YO, 2002, J EUKARYOT MICROBIOL, V49, P338, DOI 10.1111/j.1550-7408.2002.tb00380.x; Kim YO, 1997, MAR BIOL, V128, P207, DOI 10.1007/s002270050084; KIM YO, 1995, AQUAT MICROB ECOL, V9, P149, DOI 10.3354/ame009149; Kim YO, 2010, J EUKARYOT MICROBIOL, V57, P48, DOI 10.1111/j.1550-7408.2009.00446.x; Kim YO, 2008, AQUAT MICROB ECOL, V53, P173, DOI 10.3354/ame01241; Knapp S, 2002, NATURE, V419, P559, DOI 10.1038/419559a; Koester JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-1; Laval-Peuto M., 1986, MAR MICROB FD WEBS, V1, P81; Laval-Peuto M, 1985, J PROTOZOOL, V32, p40A; Laval-Peuto M, 1983, EUROP C CILIATE BIOL, V5; LAVALPEUTO M, 1986, BIOSYSTEMS, V19, P137, DOI 10.1016/0303-2647(86)90026-2; LAZARUS D, 1983, PALEOBIOLOGY, V9, P327, DOI 10.1017/S0094837300007806; Li You-Xing, 2009, Open Paleontology Journal, V2, P10; Lowe CD, 2001, BR ECOL SOC B, V32, P24; Luo W, 2009, HYDROBIOLOGIA, V636, P233, DOI 10.1007/s10750-009-9953-z; LYNN DH, 1988, J MAR BIOL ASSOC UK, V68, P639, DOI 10.1017/S0025315400028770; Maeda M., 1985, BULL OCEAN RES INST, V19, P1, DOI [10.15625/2615-9023/15888, DOI 10.15625/2615-9023/15888]; Maeda M., 1986, B OCEAN RES I U TOKY, V21, P1, DOI [10.1007/978-3-319-23534-9_1, DOI 10.1007/978-3-319-23534-9_1]; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McManus GB, 2010, J EUKARYOT MICROBIOL, V57, P369, DOI 10.1111/j.1550-7408.2010.00485.x; Mcmanus GB, 2009, J PLANKTON RES, V31, P1119, DOI 10.1093/plankt/fbp061; Modeo L, 2003, J EUKARYOT MICROBIOL, V50, P175, DOI 10.1111/j.1550-7408.2003.tb00114.x; Modeo L, 2001, J EUKARYOT MICROBIOL, V48, P95, DOI 10.1111/j.1550-7408.2001.tb00420.x; Modigh M, 2005, J PLANKTON RES, V27, P845, DOI 10.1093/plankt/fbi053; Montagnes David J.S., 1998, British Ecological Society Bulletin, V29, P25; Montagnes DJS, 1996, MAR ECOL PROG SER, V130, P241, DOI 10.3354/meps130241; Montagnes DJS, 2002, J EUKARYOT MICROBIOL, V49, P329, DOI 10.1111/j.1550-7408.2002.tb00379.x; Montagnes DJS, 2002, AQUAT MICROB ECOL, V28, P55, DOI 10.3354/ame028055; Montagnes DJS, 1998, J EUKARYOT MICROBIOL, V45, P502, DOI 10.1111/j.1550-7408.1998.tb05108.x; Montagnes DJS, 1999, MAR BIOL, V134, P167, DOI 10.1007/s002270050535; Montresor M, 2003, POLAR BIOL, V26, P186, DOI 10.1007/s00300-002-0473-9; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Muller H, 2002, AQUAT MICROB ECOL, V29, P181, DOI 10.3354/ame029181; MULLER OF, 1773, VERMIUM TERRESTRIUM, P135; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pearson PN, 1997, J GEOL SOC LONDON, V154, P295, DOI 10.1144/gsjgs.154.2.0295; PETZ W, 1992, J PROTOZOOL, V39, P159, DOI 10.1111/j.1550-7408.1992.tb01296.x; PIERCE RW, 1992, REV AQUAT SCI, V6, P139; Pierce RW, 1997, MAR ECOL PROG SER, V149, P295, DOI 10.3354/meps149295; PIERCE RW, 1993, MAR ECOL PROG SER, V94, P11, DOI 10.3354/meps094011; Pine-Alloul Bemadette, 2007, P203, DOI 10.1007/978-1-4020-6216-2_8; Pitta P, 2000, MAR ECOL PROG SER, V194, P269, DOI 10.3354/meps194269; Ptacnik R, 2010, ADV ECOL RES, V43, P1, DOI 10.1016/S0065-2504(10)43001-9; RASSOULZADEGAN F, 1988, HYDROBIOLOGIA, V159, P75, DOI 10.1007/BF00007369; REID PC, 1987, MAR BIOL, V95, P221, DOI 10.1007/BF00409009; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Rosetta CH, 2003, HARMFUL ALGAE, V2, P109, DOI 10.1016/S1568-9883(03)00019-2; Rubino F, 2002, MAR ECOL-P S Z N I, V23, P329, DOI 10.1111/j.1439-0485.2002.tb00031.x; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Seberg O, 2003, TRENDS ECOL EVOL, V18, P63, DOI 10.1016/S0169-5347(02)00059-9; Secretariat of the Convention on Biological Diversity, 2008, CBD TECHN SER, P105; Secretariat of the Convention on Biological Diversity (CBD), 2005, HDB CONV BIOL DIV IN; Sexton PF, 2008, GEOLOGY, V36, P899, DOI 10.1130/G25232A.1; Shin MK, 2000, EUR J PROTISTOL, V36, P293, DOI 10.1016/S0932-4739(00)80005-X; Simon N, 2009, CR BIOL, V332, P159, DOI 10.1016/j.crvi.2008.09.009; Sitran R, 2009, J PLANKTON RES, V31, P153, DOI 10.1093/plankt/fbn111; Snoeyenbos-West OLO, 2002, INT J SYST EVOL MICR, V52, P1901, DOI 10.1099/00207713-52-5-1901; Song W, 1994, ANTARCT RES CHIN ED, V6, P53; Stoecker D.K., 1988, MAR MICROB FOOD WEBS, V3, P79; STOECKER DK, 1990, MAR BIOL, V107, P491, DOI 10.1007/BF01313434; STOECKER DK, 1988, MAR BIOL, V99, P415, DOI 10.1007/BF02112135; STOECKER DK, 1987, ANN NY ACAD SCI, V503, P562, DOI 10.1111/j.1749-6632.1987.tb40646.x; STOECKER DK, 1987, NATURE, V326, P790, DOI 10.1038/326790a0; Strom SL, 1998, J PLANKTON RES, V20, P831, DOI 10.1093/plankt/20.5.831; STROM SL, 1993, PROG OCEANOGR, V32, P185, DOI 10.1016/0079-6611(93)90013-4; Struder-Kypke MC, 2003, J ZOOL, V260, P87, DOI 10.1017/S0952836903003546; Strueder-Kypke Michaela C., 2008, Denisia, V23, P417; Tanaka T, 2002, DEEP-SEA RES PT II, V49, P2093, DOI 10.1016/S0967-0645(02)00029-2; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tsai SF, 2008, J EUKARYOT MICROBIOL, V55, P567, DOI 10.1111/j.1550-7408.2008.00364.x; Tyler PA, 1996, HYDROBIOLOGIA, V336, P127, DOI 10.1007/BF00010826; Verity PG, 1986, MAR ECOL PROG SER, V29, P195; Weisse T, 2006, J PLANKTON RES, V28, P55, DOI 10.1093/plankt/fbi100; Weisse T, 2008, BIODIVERS CONSERV, V17, P243, DOI 10.1007/s10531-007-9249-4; Weisse T, 2008, J EUKARYOT MICROBIOL, V55, P257, DOI 10.1111/j.1550-7408.2008.00330.x; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Xu Dapeng, 2008, Denisia, V23, P273; Xu DP, 2006, ZOOTAXA, P33; ZEITZSCHEL B, 1982, ANN I OCEANOGR PARIS, V58, P91; Zeitzschel B., 1990, P139; Zeitzschel B, 1969, METEOR FORSCHUNGSE D, V4, P47; ZEITZSCHEL BERNT, 1966, VEROEFFENTLICHUNGEN INST MEERESFORSCH BREMERHAVEN, V2, P293; Zhang QQ, 2010, CHIN J OCEANOL LIMN, V28, P769, DOI 10.1007/s00343-010-9096-0	192	74	78	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22466	10.1371/journal.pone.0022466	http://dx.doi.org/10.1371/journal.pone.0022466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853034	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200011
J	De Vito, C; Riggi, N; Suva, ML; Janiszewska, M; Horlbeck, J; Baumer, K; Provero, P; Stamenkovic, I				De Vito, Claudio; Riggi, Nicolo; Suva, Mario-Luca; Janiszewska, Michalina; Horlbeck, Janine; Baumer, Karine; Provero, Paolo; Stamenkovic, Ivan			Let-7a Is a Direct EWS- FLI-1 Target Implicated in Ewing's Sarcoma Development	PLOS ONE			English	Article							SELF-RENEWAL; TUMOR-GROWTH; MICRORNA; METASTASIS; EXPRESSION; LIN28; HMGA2; IDENTIFICATION; TRANSFORMATION; GENES	Ewing's sarcoma family tumors (ESFT) are the second most common bone malignancy in children and young adults, characterized by unique chromosomal translocations that in 85% of cases lead to expression of the EWS-FLI-1 fusion protein. EWS-FLI-1 functions as an aberrant transcription factor that can both induce and suppress members of its target gene repertoire. We have recently demonstrated that EWS-FLI-1 can alter microRNA (miRNA) expression and that miRNA145 is a direct EWS-FLI-1 target whose suppression is implicated in ESFT development. Here, we use miRNA arrays to compare the global miRNA expression profile of human mesenchymal stem cells (MSC) and ESFT cell lines, and show that ESFT display a distinct miRNA signature that includes induction of the oncogenic miRNA 17-92 cluster and repression of the tumor suppressor let-7 family. We demonstrate that direct repression of let-7a by EWS-FLI-1 participates in the tumorigenic potential of ESFT cells in vivo. The mechanism whereby let-7a expression regulates ESFT growth is shown to be mediated by its target gene HMGA2, as let-7a overexpression and HMGA2 repression both block ESFT cell tumorigenicity. Consistent with these observations, systemic delivery of synthetic let-7a into ESFT-bearing mice restored its expression in tumor cells, decreased HMGA2 expression levels and resulted in ESFT growth inhibition in vivo. Our observations provide evidence that deregulation of let-7a target gene expression participates in ESFT development and identify let-7a as promising new therapeutic target for one of the most aggressive pediatric malignancies.	[De Vito, Claudio; Riggi, Nicolo; Suva, Mario-Luca; Janiszewska, Michalina; Horlbeck, Janine; Baumer, Karine; Stamenkovic, Ivan] Univ Lausanne, CHU Vaudois, Inst Pathol, Fac Biol & Med, Lausanne, Switzerland; [Provero, Paolo] Univ Turin, Dept Biochem Mol Biol & Biotechnol, Turin, Italy	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Turin	De Vito, C (corresponding author), Univ Lausanne, CHU Vaudois, Inst Pathol, Fac Biol & Med, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Provero, Paolo/AAC-1930-2019; Suva, Mario/AAY-7798-2020	Suva, Mario/0000-0001-9898-5351	Swiss Fonds National pour la Recherche Scientifique (FNRS) [310030_130350]; NCCR Molecular Oncology; Italian Association for Cancer Research [IG9408]	Swiss Fonds National pour la Recherche Scientifique (FNRS)(Swiss National Science Foundation (SNSF)); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Swiss Fonds National pour la Recherche Scientifique (FNRS) grant No. 310030_130350 and the NCCR Molecular Oncology. PP gratefully acknowledges support from the Italian Association for Cancer Research under grant IG9408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Dreux N, 2010, MOD PATHOL; Droge P, 2008, CELL STEM CELL, V2, P8, DOI 10.1016/j.stem.2007.12.003; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Henriksen J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-329; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23592	10.1371/journal.pone.0023592	http://dx.doi.org/10.1371/journal.pone.0023592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853155	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200099
J	Van Spall, HGC; Atzema, C; Schull, MJ; Newton, GE; Mak, S; Chong, A; Tu, JV; Stukel, TA; Lee, DS				Van Spall, Harriette G. C.; Atzema, Clare; Schull, Michael J.; Newton, Gary E.; Mak, Susanna; Chong, Alice; Tu, Jack V.; Stukel, Therese A.; Lee, Douglas S.			Prediction of Emergent Heart Failure Death by Semi-Quantitative Triage Risk Stratification	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; LIFE EXPECTANCY; UNITED-STATES; MODEL; DISCORDANCE; VALIDATION; PHYSICIANS; MORTALITY; ADMISSION; JUDGMENT	Objectives: Generic triage risk assessments are widely used in the emergency department (ED), but have not been validated for prediction of short-term risk among patients with acute heart failure (HF). Our objective was to evaluate the Canadian Triage Acuity Scale (CTAS) for prediction of early death among HF patients. Methods: We included patients presenting with HF to an ED in Ontario from Apr 2003 to Mar 2007. We used the National Ambulatory Care Reporting System and vital statistics databases to examine care and outcomes. Results: Among 68,380 patients (76 +/- 12 years, 49.4% men), early mortality was stratified with death rates of 9.9%, 1.9%, 0.9%, and 0.5% at 1-day, and 17.2%, 5.9%, 3.8%, and 2.5% at 7-days, for CTAS 1, 2, 3, and 4-5, respectively. Compared to lower acuity (CTAS 4-5) patients, adjusted odds ratios (aOR) for 1-day death were 1.32 (95% CI; 0.93-1.88; p = 0.12) for CTAS 3, 2.41 (95% CI; 1.71-3.40; p < 0.001) for CTAS 2, and highest for CTAS 1: 9.06 (95% CI; 6.28-13.06; p < 0.001). Predictors of triage-critical (CTAS 1) status included oxygen saturation <90% (aOR 5.92, 95% CI; 3.09-11.81; p < 0.001), respiratory rate >24 breaths/minute (aOR 1.96, 95% CI; 1.05-3.67; p = 0.034), and arrival by paramedic (aOR 3.52, 95% CI; 1.70-8.02; p = 0.001). While age/sex-adjusted CTAS score provided good discrimination for ED (c-statistic = 0.817) and 1-day (c-statistic = 0.724) death, mortality prediction was improved further after accounting for cardiac and non-cardiac comorbidities (c-statistics 0.882 and 0.810, respectively; both p < 0.001). Conclusions: A semi-quantitative triage acuity scale assigned at ED presentation and based largely on respiratory factors predicted emergent death among HF patients.	[Van Spall, Harriette G. C.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Van Spall, Harriette G. C.] McMaster Univ, Hamilton, ON, Canada; [Atzema, Clare; Chong, Alice; Tu, Jack V.; Stukel, Therese A.; Lee, Douglas S.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Atzema, Clare; Schull, Michael J.; Tu, Jack V.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Stukel, Therese A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Newton, Gary E.; Mak, Susanna] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Newton, Gary E.; Mak, Susanna; Lee, Douglas S.] Univ Toronto, Toronto Gen Hosp, Toronto, ON M5G 1L7, Canada; [Newton, Gary E.; Mak, Susanna; Lee, Douglas S.] Univ Toronto, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	McMaster University; Population Health Research Institute; McMaster University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Van Spall, HGC (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.	dlee@ices.on.ca	Schull, Michael J/A-7955-2013; Mak, Susanna/C-4617-2015	Schull, Michael J/0000-0002-1318-6364; Atzema, Clare/0000-0002-7236-5522; Mak, Susanna/0000-0003-2193-602X; Tu, Jack/0000-0003-0111-722X; Van Spall, Harriette Gillian Christine/0000-0002-8370-4569; Lee, Douglas/0000-0001-7078-745X; Stukel, Therese/0000-0002-2951-1360	Ontario Ministry of Health and Long Term Care; Canadian Institutes of Health Research (CIHR) [MOP 114937]; Canada Research Chair in Health Services Research award	Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research award	The Institute for Clinical Evaluative Sciences is supported in part by a grant from the Ontario Ministry of Health and Long Term Care. The opinions, results and conclusions are those of the authors and no endorsement by the Ministry of Health and Long-Term Care or by the Institute for Clinical Evaluative Sciences is intended or should be inferred. This research was supported by an operating grant from the Canadian Institutes of Health Research (CIHR MOP 114937), a Canadian Institutes of Health Research clinician-scientist award to DL, and a Canada Research Chair in Health Services Research award to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Allen LA, 2008, JAMA-J AM MED ASSOC, V299, P2533, DOI 10.1001/jama.299.21.2533; Arnold JMO, 2007, CAN J CARDIOL, V23, P21, DOI 10.1016/S0828-282X(07)70211-8; Auble TE, 2005, ACAD EMERG MED, V12, P514, DOI 10.1197/j.aem.2004.11.026; Auble TE, 2007, ANN EMERG MED, V50, P127, DOI 10.1016/j.annemergmed.2007.02.017; Bullard MJ, 2008, CAN J EMERG MED, V10, P136; Chin MH, 1997, AM J CARDIOL, V79, P1640, DOI 10.1016/S0002-9149(97)00214-2; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Hugli O, 2005, AM J CARDIOL, V96, P1537, DOI 10.1016/j.amjcard.2005.07.064; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; KLEINMUNTZ B, 1990, PSYCHOL BULL, V107, P296, DOI 10.1037/0033-2909.107.3.296; Ko DT, 2008, AM HEART J, V155, P324, DOI 10.1016/j.ahj.2007.08.036; Lee DS, 2010, CIRC-HEART FAIL, V3, P228, DOI 10.1161/CIRCHEARTFAILURE.109.885285; Lee DS, 2009, CIRC-HEART FAIL, V2, P616, DOI 10.1161/CIRCHEARTFAILURE.109.869743; Lee DS, 2005, JAMA-J AM MED ASSOC, V294, P1240, DOI 10.1001/jama.294.10.1240; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Rector TS, 2006, J CARD FAIL, V12, P276, DOI 10.1016/j.cardfail.2006.02.004; Scott IA, 2007, MED J AUSTRALIA, V187, P153, DOI 10.5694/j.1326-5377.2007.tb01173.x; Seymann G, 2008, J EMERG MED, V34, P261, DOI 10.1016/j.jemermed.2007.05.050; Smith WR, 2002, CHEST, V121, P1610, DOI 10.1378/chest.121.5.1610; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; World Health Organization, 1992, INT STAT CLASS DIS R; Yamokoski LM, 2007, J CARD FAIL, V13, P8, DOI 10.1016/j.cardfail.2006.10.002; Yan AT, 2009, ARCH INTERN MED, V169, P372, DOI 10.1001/archinternmed.2008.563	27	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23065	10.1371/journal.pone.0023065	http://dx.doi.org/10.1371/journal.pone.0023065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853068	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200040
J	Qi, JP; Ding, YS; Zhu, Y; Wu, YZ				Qi, Jinpeng; Ding, Yongsheng; Zhu, Ying; Wu, Yizhi			Kinetic Theory Approach to Modeling of Cellular Repair Mechanisms under Genome Stress	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; STOCHASTIC GAME-THEORY; IMMUNE COMPETITION; P53; DNA; SYSTEMS; PARADIGMS; BEHAVIOR; LOOKING	Under acute perturbations from outer environment, a normal cell can trigger cellular self-defense mechanism in response to genome stress. To investigate the kinetics of cellular self-repair process at single cell level further, a model of DNA damage generating and repair is proposed under acute Ion Radiation (IR) by using mathematical framework of kinetic theory of active particles (KTAP). Firstly, we focus on illustrating the profile of Cellular Repair System (CRS) instituted by two sub-populations, each of which is made up of the active particles with different discrete states. Then, we implement the mathematical framework of cellular self-repair mechanism, and illustrate the dynamic processes of Double Strand Breaks (DSBs) and Repair Protein (RP) generating, DSB-protein complexes (DSBCs) synthesizing, and toxins accumulating. Finally, we roughly analyze the capability of cellular self-repair mechanism, cellular activity of transferring DNA damage, and genome stability, especially the different fates of a certain cell before and after the time thresholds of IR perturbations that a cell can tolerate maximally under different IR perturbation circumstances.	[Qi, Jinpeng; Ding, Yongsheng; Wu, Yizhi] Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China; [Zhu, Ying] CSIRO Plant Ind, Urrbrae, SA, Australia	Donghua University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Qi, JP (corresponding author), Donghua Univ, Coll Informat Sci & Technol, Shanghai, Peoples R China.	qipengkai@dhu.edu.cn	Qi, Jinpeng/HDL-6725-2022; Zhu, Ying/F-6663-2011		National Nature Science Foundation of China [60975059]; Ministry of Education of China [20090075110002]; Specialized Research Fund for Natural Science Foundation of Shanghai [10ZR1401600]; Shanghai Committee of Science and Technology [10JC1400200]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Specialized Research Fund for Natural Science Foundation of Shanghai; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported in part by the National Nature Science Foundation of China (No. 60975059), Specialized Research Fund for the Doctoral Program of Higher Education from Ministry of Education of China (No. 20090075110002), Specialized Research Fund for Natural Science Foundation of Shanghai (No. 10ZR1401600), and Project of the Shanghai Committee of Science and Technology (No. 10JC1400200). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Zhu Ying is an employee of CSIRO Plant Industry and contributed to the writing of the manuscript.	Bellomo N, 2008, MODEL SIMUL SCI ENG, P1, DOI 10.1007/978-0-8176-4600-4; Bellomo N, 2010, MATH COMPUT MODEL, V51, P441, DOI 10.1016/j.mcm.2009.12.002; Bellomo N, 2008, PHYS LIFE REV, V5, P183, DOI 10.1016/j.plrev.2008.07.001; Bellomo N, 2008, CURR TOP DEV BIOL, V81, P485, DOI 10.1016/S0070-2153(07)81017-9; Bellomo N, 2006, MATH MOD METH APPL S, V16, P1001, DOI 10.1142/S0218202506001443; Bellouquid A., 2006, MATH MODELING COMPLE; Bertotti ML, 2008, NONLINEAR ANAL-REAL, V9, P183, DOI 10.1016/j.nonrwa.2006.09.012; Bertotti ML, 2004, MATH MOD METH APPL S, V14, P1061, DOI 10.1142/S0218202504003544; Bonzani I, 2004, MATH COMPUT MODEL, V40, P1065, DOI 10.1016/j.mcm.2003.09.042; Brazzoli I, 2008, APPL MATH LETT, V21, P155, DOI 10.1016/j.aml.2007.02.018; Brazzoli I., 2006, COMPUT MATH METHOD M, V7, DOI [10.1080/10273660600968911, DOI 10.1080/10273660600968911]; Budman J, 2005, EMBO J, V24, P849, DOI 10.1038/sj.emboj.7600563; Cercignani C, 2007, MODEL SIMUL SCI ENG, P1, DOI 10.1007/978-0-8176-4554-0; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; De Angelis E, 2008, MATH COMPUT MODEL, V47, P196, DOI 10.1016/j.mcm.2007.02.016; Degond P, 2004, MODEL SIMUL SCI ENG, P3, DOI 10.1007/978-0-8176-8200-2_1; Deutsch A, 2005, CELLULAR AUTOMATON M; KURT W, 2005, BIOCH BIOPHYSICAL RE, V331, P816; Li L, 2001, INT J RADIAT ONCOL, V49, P1157, DOI 10.1016/S0360-3016(00)01524-8; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Pauklin S, 2005, BIOCHEM BIOPH RES CO, V334, P386, DOI 10.1016/j.bbrc.2005.06.097; PEREZ CA., 1998, PRINCIPLES PRACTICE, V3rd ed; Qi JP, 2007, BIOSYSTEMS, V90, P698, DOI 10.1016/j.biosystems.2007.02.007; Qi JP, 2007, AMINO ACIDS, V33, P75, DOI 10.1007/s00726-006-0454-3; Qi JP, 2008, APPL MATH COMPUT, V205, P73, DOI 10.1016/j.amc.2008.05.131; Qi JP, 2006, DYNAM CONT DIS SER B, V13, P11; Qi JP, 2009, PROG NAT SCI-MATER, V19, P1349, DOI 10.1016/j.pnsc.2009.03.008; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003	28	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22228	10.1371/journal.pone.0022228	http://dx.doi.org/10.1371/journal.pone.0022228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857915	Green Submitted, Green Published, gold			2022-12-27	WOS:000293774300003
J	Liu, B; Yan, SW; Gao, XF				Liu, Bo; Yan, Shiwei; Gao, Xingfa			Noise Amplification in Human Tumor Suppression following Gamma Irradiation	PLOS ONE			English	Article							SPATIAL COHERENCE RESONANCE; P53-MDM2 FEEDBACK LOOP; STOCHASTIC RESONANCE; NETWORK MOTIFS; TIME-DELAY; P53 PULSES; DYNAMICS; OSCILLATIONS; MODEL; BISTABILITY	The influence of noise on oscillatory motion is a subject of permanent interest, both for fundamental and practical reasons. Cells respond properly to external stimuli by using noisy systems. We have clarified the effect of intrinsic noise on the dynamics in the human cancer cells following gamma irradiation. It is shown that the large amplification and increasing mutual information with delay are due to coherence resonance. Furthermore, frequency domain analysis is used to study the mechanisms.	[Liu, Bo; Yan, Shiwei] Beijing Normal Univ, Key Lab Beam Technol & Mat Modificat, Minist Educ, Coll Nucl Sci & Technol, Beijing 100875, Peoples R China; [Liu, Bo; Gao, Xingfa] Chinese Acad Sci, Inst High Energy Phys, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China; [Yan, Shiwei] Beijing Radiat Ctr, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Liu, B (corresponding author), Beijing Normal Univ, Key Lab Beam Technol & Mat Modificat, Minist Educ, Coll Nucl Sci & Technol, Beijing 100875, Peoples R China.	yansw@bnu.edu.cn	Gao, Xingfa/E-5691-2010	Gao, Xingfa/0000-0002-1636-6336	National Natural Science Foundation of China [10975019]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Personnel of China [MOP2006138]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Personnel of China(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	SY acknowledges support from the National Natural Science Foundation of China under Grant No. 10975019, the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Personnel of China under Grant No. MOP2006138, and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jaoude W, 2009, J THEOR BIOL, V258, P561, DOI 10.1016/j.jtbi.2009.02.005; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Bulsara AR, 1996, PHYS REV E, V54, pR2185, DOI 10.1103/PhysRevE.54.R2185; Cai XD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2710253; Cai XD, 2009, J COMPUT BIOL, V16, P917, DOI 10.1089/cmb.2008.0231; Carrillo O, 2004, EUROPHYS LETT, V65, P452, DOI 10.1209/epl/i2003-10105-4; Cover T. M., 1991, ELEMENTS INFORM THEO; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GANG H, 1993, PHYS REV LETT, V71, P807, DOI 10.1103/PhysRevLett.71.807; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; Gosak M, 2007, BIOPHYS CHEM, V128, P210, DOI 10.1016/j.bpc.2007.04.007; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Kim S, 1999, PHYS REV LETT, V82, P1620, DOI 10.1103/PhysRevLett.82.1620; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Longtin A, 1997, PHYS REV E, V55, P868, DOI 10.1103/PhysRevE.55.868; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mihalas GI, 2000, J BIOL SYST, V8, P21, DOI 10.1142/S0218339000000031; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Munakata T, 2006, EUR PHYS J B, V53, P239, DOI [10.1140/epjb/e2006-00363-x, 10.1140/epjh/e2006-00363-x]; Munakata T, 2005, J PHYS SOC JPN, V74, P2094, DOI 10.1143/JPSJ.74.2094; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; NICOLIS C, 1981, TELLUS, V33, P225, DOI 10.1111/j.2153-3490.1981.tb01746.x; Ohira T, 1999, PHYS REV LETT, V82, P2811, DOI 10.1103/PhysRevLett.82.2811; Ouattara DA, 2010, J THEOR BIOL, V264, P1177, DOI 10.1016/j.jtbi.2010.03.031; Perc M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016207; Perc M, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/252; Perc M, 2005, CHEM PHYS LETT, V410, P49, DOI 10.1016/j.cplett.2005.05.042; Perc M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066205; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; Puszynski K, 2008, J THEOR BIOL, V254, P452, DOI 10.1016/j.jtbi.2008.05.039; RAPPEL WJ, 1994, PHYS REV E, V50, P3249, DOI 10.1103/PhysRevE.50.3249; RISKEN H, 1989, FOKKERPLANK EQUATION; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; SIGETI D, 1989, J STAT PHYS, V54, P1217, DOI 10.1007/BF01044713; Stegemann G, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016221; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Sun TZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-190; Sun XJ, 2008, CHAOS, V18, DOI 10.1063/1.2900402; Suzuki T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S52; Tanase-Nicola S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068102; Tiana G, 2002, EUR PHYS J B, V29, P135, DOI 10.1140/epjb/e2002-00271-1; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Tyson JJ, 2004, NAT GENET, V36, P113, DOI 10.1038/ng0204-113; Tyson JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100060; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Yan SW, 2007, J BIOL SYST, V15, P123, DOI 10.1142/S0218339007002167; Yan SW, 2006, PHYSICA D, V220, P157, DOI 10.1016/j.physd.2006.07.004; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yeung MKS, 1999, PHYS REV LETT, V82, P648, DOI 10.1103/PhysRevLett.82.648; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	78	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22487	10.1371/journal.pone.0022487	http://dx.doi.org/10.1371/journal.pone.0022487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850227	gold, Green Published, Green Submitted			2022-12-27	WOS:000293563300011
J	Wohl, SG; Schmeer, CW; Friese, T; Witte, OW; Isenmann, S				Wohl, Stefanie G.; Schmeer, Christian W.; Friese, Thomas; Witte, Otto W.; Isenmann, Stefan			In Situ Dividing and Phagocytosing Retinal Microglia Express Nestin, Vimentin, and NG2 In Vivo	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; CENTRAL-NERVOUS-SYSTEM; POSTNATAL RAT RETINA; MULLER GLIAL-CELLS; ADULT-MOUSE EYE; OPTIC-NERVE; GANGLION-CELLS; PROGENITOR CELLS; CILIARY BODY; NEURAL PROGENITORS	Background: Following injury, microglia become activated with subsets expressing nestin as well as other neural markers. Moreover, cerebral microglia can give rise to neurons in vitro. In a previous study, we analysed the proliferation potential and nestin re-expression of retinal macroglial cells such as astrocytes and Muller cells after optic nerve (ON) lesion. However, we were unable to identify the majority of proliferative nestin(+) cells. Thus, the present study evaluates expression of nestin and other neural markers in quiescent and proliferating microglia in naive retina and following ON transection in adult rats in vivo. Methodology/Principal Findings: For analysis of cell proliferation and cells fates, rats received BrdU injections. Microglia in retinal sections or isolated cells were characterized using immunofluorescence labeling with markers for microglia (e. g., Iba1, CD11b), cell proliferation, and neural cells (e. g., nestin, vimentin, NG2, GFAP, Doublecortin etc.). Cellular analyses were performed using confocal laser scanning microscopy. In the naive adult rat retina, about 60% of resting ramified microglia expressed nestin. After ON transection, numbers of nestin(+) microglia peaked to a maximum at 7 days, primarily due to in situ cell proliferation of exclusively nestin(+) microglia. After 8 weeks, microglia numbers re-attained control levels, but 20% were still BrdU(+) and nestin(+), although no further local cell proliferation occurred. In addition, nestin(+) microglia co-expressed vimentin and NG2, but not GFAP or neuronal markers. Fourteen days after injury and following retrograde labeling of retinal ganglion cells (RGCs) with Fluorogold (FG), nestin(+)NG2(+) microglia were positive for the dye indicating an active involvement of a proliferating cell population in phagocytosing apoptotic retinal neurons. Conclusions/Significance: The current study provides evidence that in adult rat retina, a specific resident population of microglia expresses proteins of immature neural cells that are involved in injury-induced cell proliferation and phagocytosis while transdifferentiation was not observed.	[Wohl, Stefanie G.; Schmeer, Christian W.; Friese, Thomas; Witte, Otto W.; Isenmann, Stefan] Jena Univ Hosp, Hans Berger Clin Neurol, Jena, Germany; [Isenmann, Stefan] HELIOS Klinikum Wuppertal, Dept Neurol, Wuppertal, Germany; [Wohl, Stefanie G.; Isenmann, Stefan] Univ Witten Herdecke, Witten, Germany	Friedrich Schiller University of Jena; Helios Kliniken; Witten Herdecke University	Wohl, SG (corresponding author), Jena Univ Hosp, Hans Berger Clin Neurol, Jena, Germany.	stefanie.wohl@med.uni-jena.de	Wohl, Stefanie/I-1590-2019; Isenmann, Stefan/AAJ-3788-2020; Witte, Otto/P-4127-2018	Wohl, Stefanie/0000-0003-2559-7678; Witte, Otto/0000-0003-2101-4105; Schmeer, Christian/0000-0002-2289-0126	Bundesministerium fur Bildung und Forschung (BMBF); Interdisciplinary Centre for Clinical Research Jena (IZKF); UWH (University of Witten/Herdecke)	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Centre for Clinical Research Jena (IZKF); UWH (University of Witten/Herdecke)	This study was supported by the Bundesministerium fur Bildung und Forschung (BMBF), and the Interdisciplinary Centre for Clinical Research Jena (IZKF). In addition, SW was supported by a UWH scholarship (University of Witten/Herdecke). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACARIN L, 1994, J HISTOCHEM CYTOCHEM, V42, P1033, DOI 10.1177/42.8.8027523; Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Alliot F, 1999, J NEUROSCI RES, V58, P367; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bodeutsch N, 2000, GLIA, V32, P91, DOI 10.1002/1098-1136(200010)32:1<91::AID-GLIA90>3.0.CO;2-X; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Chang ML, 2007, J ANAT, V210, P54, DOI 10.1111/j.1469-7580.2006.00671.x; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545; COSTA MR, 2010, BRAIN RES REV; Daniel C, 2008, LAB INVEST, V88, P387, DOI 10.1038/labinvest.2008.5; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Engelhardt M, 2004, EXP EYE RES, V78, P1025, DOI 10.1016/j.exer.2003.12.002; Fiedorowicz A, 2008, GLIA, V56, P209, DOI 10.1002/glia.20605; Fischer AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010774; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Gao LM, 2006, DEV BIOL, V290, P277, DOI 10.1016/j.ydbio.2005.11.007; Gao Q, 2010, NEUROSCIENCE, V165, P386, DOI 10.1016/j.neuroscience.2009.10.022; Garcia-Valenzuela E, 1999, J NEUROBIOL, V40, P55, DOI 10.1002/(SICI)1097-4695(199907)40:1<55::AID-NEU5>3.0.CO;2-E; Garcia-Valenzuela E, 2005, MOL VIS, V11, P225; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; GRAEBER MB, 1988, J NEUROCYTOL, V17, P573, DOI 10.1007/BF01189811; Gubert F, 2009, BRAIN RES, V1258, P43, DOI 10.1016/j.brainres.2008.12.021; Ha Y, 2003, ACTA NEUROCHIR, V145, P483, DOI 10.1007/s00701-003-0023-4; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hou B, 2004, INVEST OPHTH VIS SCI, V45, P662, DOI 10.1167/iovs.03-0281; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kretz A, 2006, NEUROBIOL DIS, V21, P421, DOI 10.1016/j.nbd.2005.08.003; KREUTZBERG GW, 1995, ARZNEIMITTEL-FORSCH, V45-1, P357; Ladeby R, 2005, GLIA, V50, P121, DOI 10.1002/glia.20159; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; Makagiansar IT, 2004, J BIOL CHEM, V279, P55262, DOI 10.1074/jbc.M411045200; Matsuda S, 2008, BIOCHEM BIOPH RES CO, V368, P971, DOI 10.1016/j.bbrc.2008.02.038; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; McMenamin PG, 1999, BRIT J OPHTHALMOL, V83, P598, DOI 10.1136/bjo.83.5.598; MCMENAMIN PG, 1994, INVEST OPHTH VIS SCI, V35, P3234; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mokry J, 1998, Acta Medica (Hradec Kralove), V41, P73; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nickerson PEB, 2007, INVEST OPHTH VIS SCI, V48, P5266, DOI 10.1167/iovs.07-0167; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; PERRY VH, 1990, J NEUROCYTOL, V19, P265, DOI 10.1007/BF01217304; Pouly S, 1999, GLIA, V27, P259, DOI 10.1002/(SICI)1098-1136(199909)27:3<259::AID-GLIA7>3.0.CO;2-8; Rakic S, 2003, GLIA, V41, P117, DOI 10.1002/glia.10140; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rao NA, 2003, INVEST OPHTH VIS SCI, V44, P22, DOI 10.1167/iovs.02-0199; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Sahlgren CM, 2001, J BIOL CHEM, V276, P16456, DOI 10.1074/jbc.M009669200; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Sergent-Tanguy S, 2006, J NEUROSCI RES, V83, P1515, DOI 10.1002/jnr.20846; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; SIRKO S, 2010, STEM CELLS; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; STALLCUP WB, 1987, J NEUROSCI, V7, P2737; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Takamori Y, 2009, BRAIN RES, V1270, P10, DOI 10.1016/j.brainres.2009.03.014; THANOS S, 1991, EUR J NEUROSCI, V3, P1189, DOI 10.1111/j.1460-9568.1991.tb00054.x; THANOS S, 1994, TRENDS NEUROSCI, V17, P177, DOI 10.1016/0166-2236(94)90098-1; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Walcott JC, 2003, CLIN EXP OPHTHALMOL, V31, P246, DOI 10.1046/j.1442-9071.2003.00638.x; Wiese C, 2006, STEM CELLS, V24, P2085, DOI 10.1634/stemcells.2006-0008; Wirenfeldt M, 2011, HISTOL HISTOPATHOL, V26, P519, DOI 10.14670/HH-26.519; Wohl SG, 2010, INVEST OPHTH VIS SCI, V51, P2686, DOI 10.1167/iovs.09-4537; Wohl SG, 2009, EXP NEUROL, V219, P175, DOI 10.1016/j.expneurol.2009.05.008; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Wu D, 2005, BRAIN RES, V1051, P183, DOI 10.1016/j.brainres.2005.05.054; Xu HX, 2007, INVEST OPHTH VIS SCI, V48, P1674, DOI 10.1167/iovs.06-1034; Xue LP, 2006, NEUROSCIENCE, V143, P117, DOI 10.1016/j.neuroscience.2006.07.044; Xue XJ, 2010, MOL CELL NEUROSCI, V45, P26, DOI 10.1016/j.mcn.2010.05.006; Yang P, 2003, BRAIN RES PROTOC, V12, P67, DOI 10.1016/S1385-299X(03)00073-4; Yokoyama A, 2006, GLIA, V53, P754, DOI 10.1002/glia.20332; Yokoyama A, 2004, GLIA, V45, P96, DOI 10.1002/glia.10306; Zhang C, 2003, J NEUROSCI RES, V73, P840, DOI 10.1002/jnr.10713; ZHU L, 2010, NEUROSCIENCE	99	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22408	10.1371/journal.pone.0022408	http://dx.doi.org/10.1371/journal.pone.0022408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850226	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300010
J	Humphreys, K; Grankvist, A; Leu, M; Hall, P; Liu, JJ; Ripatti, S; Rehnstrom, K; Groop, L; Klareskog, L; Ding, B; Gronberg, H; Xu, JF; Pedersen, NL; Lichtenstein, P; Mattingsdal, M; Andreassen, OA; O'Dushlaine, C; Purcell, SM; Sklar, P; Sullivan, PF; Hultman, CM; Palmgren, J; Magnusson, PKE				Humphreys, Keith; Grankvist, Alexander; Leu, Monica; Hall, Per; Liu, Jianjun; Ripatti, Samuli; Rehnstroem, Karola; Groop, Leif; Klareskog, Lars; Ding, Bo; Gronberg, Henrik; Xu, Jianfeng; Pedersen, Nancy L.; Lichtenstein, Paul; Mattingsdal, Morten; Andreassen, Ole A.; O'Dushlaine, Colm; Purcell, Shaun M.; Sklar, Pamela; Sullivan, Patrick F.; Hultman, Christina M.; Palmgren, Juni; Magnusson, Patrik K. E.			The Genetic Structure of the Swedish Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUBSTRUCTURE; RISK; LOCI	Patterns of genetic diversity have previously been shown to mirror geography on a global scale and within continents and individual countries. Using genome-wide SNP data on 5174 Swedes with extensive geographical coverage, we analyzed the genetic structure of the Swedish population. We observed strong differences between the far northern counties and the remaining counties. The population of Dalarna county, in north middle Sweden, which borders southern Norway, also appears to differ markedly from other counties, possibly due to this county having more individuals with remote Finnish or Norwegian ancestry than other counties. An analysis of genetic differentiation (based on pairwise F-st) indicated that the population of Sweden's southernmost counties are genetically closer to the HapMap CEU samples of Northern European ancestry than to the populations of Sweden's northernmost counties. In a comparison of extended homozygous segments, we detected a clear divide between southern and northern Sweden with small differences between the southern counties and considerably more segments in northern Sweden. Both the increased degree of homozygosity in the north and the large genetic differences between the south and the north may have arisen due to a small population in the north and the vast geographical distances between towns and villages in the north, in contrast to the more densely settled southern parts of Sweden. Our findings have implications for future genome-wide association studies (GWAS) with respect to the matching of cases and controls and the need for within-county matching. We have shown that genetic differences within a single country may be substantial, even when viewed on a European scale. Thus, population stratification needs to be accounted for, even within a country like Sweden, which is often perceived to be relatively homogenous and a favourable resource for genetic mapping, otherwise inferences based on genetic data may lead to false conclusions.	[Humphreys, Keith; Grankvist, Alexander; Leu, Monica; Hall, Per; Gronberg, Henrik; Pedersen, Nancy L.; Lichtenstein, Paul; Hultman, Christina M.; Palmgren, Juni; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Liu, Jianjun] Genome Inst Singapore, Human Genet Lab, Singapore, Singapore; [Ripatti, Samuli] Inst Mol Med, Helsinki, Finland; [Ripatti, Samuli] Univ Helsinki, FIMM, Helsinki, Finland; [Ripatti, Samuli] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Rehnstroem, Karola] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Klareskog, Lars; Ding, Bo] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Xu, Jianfeng] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA; [Xu, Jianfeng] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27109 USA; [Xu, Jianfeng] Wake Forest Univ, Sch Med, Ctr Canc Genom, Winston Salem, NC 27109 USA; [Mattingsdal, Morten; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Sect Psychiat, Oslo, Norway; [Mattingsdal, Morten] Sorlandet Hosp HF, Kristiansand, Norway; [Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [O'Dushlaine, Colm; Purcell, Shaun M.; Sklar, Pamela] MIT, Broad Inst, Cambridge, MA 02139 USA; [O'Dushlaine, Colm; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Cambridge, MA 02138 USA; [O'Dushlaine, Colm; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Palmgren, Juni] Stockholm Univ, Dept Math Stat, S-10691 Stockholm, Sweden; [Palmgren, Juni] Swedish eSci Res Ctr, Stockholm, Sweden	Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Helsinki; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; Lund University; Karolinska Institutet; Wake Forest University; Wake Forest University; Wake Forest University; University of Oslo; University of Oslo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; Stockholm University; Swedish e-Science Research Centre (SeRC)	Humphreys, K (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Patrik.Magnusson@ki.se	Liu, Jianjun/AAK-4989-2020; Mattingsdal, Morten/Q-9367-2016; Magnusson, Patrik KE/C-4458-2017; Ripatti, Samuli/H-9446-2014; Andreassen, Ole A./AAY-7531-2020	Liu, Jianjun/0000-0002-3255-3019; Mattingsdal, Morten/0000-0003-4440-0324; Magnusson, Patrik KE/0000-0002-7315-7899; Ripatti, Samuli/0000-0002-0504-1202; Klareskog, Lars/0000-0001-9601-6186; Andreassen, Ole A./0000-0002-4461-3568; Palmgren, Juni/0000-0002-9031-8615; lichtenstein, paul/0000-0003-3037-5287	Swedish Research Council [521-2009-2664, M-2005-1112, 523-2006-972]; Swedish Council for Working Life and Social Research [184/2000, 2001-2368]; National Institute of Mental Health [MH077139]; Stanley Center for Psychiatric Research; Stanley Medical Research Institute; Research Council of Norway [167153/V50]; South-East Norway Health Authority [2004-123]; National Institutes of Health [RO1 CA58427]; Agency for Science, Technology and Research (A*STAR; Singapore); Nordic Cancer Society; Marit and Hans Rausing's Initiative against Breast Cancer; Novartis Pharmaceuticals; Sigrid Juselius Foundation; European Commission [QLG2-CT-2002-01254]; Swedish Foundation for Strategic Research; Swedish Heart and Lung Foundation; NATIONAL CANCER INSTITUTE [R01CA058427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanley Center for Psychiatric Research; Stanley Medical Research Institute; Research Council of Norway(Research Council of Norway); South-East Norway Health Authority; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research (A*STAR; Singapore)(Agency for Science Technology & Research (A*STAR)); Nordic Cancer Society; Marit and Hans Rausing's Initiative against Breast Cancer; Novartis Pharmaceuticals(Novartis); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge support from the Swedish Research Council (grant 521-2009-2664), the Swedish Council for Working Life and Social Research (grants 184/2000, 2001-2368), the National Institute of Mental Health (grant MH077139) and the Stanley Center for Psychiatric Research, Broad Institute from a grant from the Stanley Medical Research Institute. The TOP study was supported by the Research Council of Norway (grant 167153/V50) and the South-East Norway Health Authority (grant 2004-123). The CAHRES study was supported by the National Institutes of Health (grant RO1 CA58427), the Agency for Science, Technology and Research (A*STAR; Singapore), the Nordic Cancer Society, and Marit and Hans Rausing's Initiative against Breast Cancer. The genotyping in the DGI study was funded by an unrestricted grant from Novartis Pharmaceuticals, whereas phenotyping was funded by grants from the Sigrid Juselius Foundation and the Swedish Research Council. The TWINGENE-SW study was supported by the GenomeEUtwin project under the European Commission Programme CEQuality of Life and Management of the Living Resources1 of 5th Framework Programme (grant QLG2-CT-2002-01254), the Swedish Research Council (grant M-2005-1112), Swedish Foundation for Strategic Research and the Swedish Heart and Lung Foundation. KH acknowledges support from the Swedish Research Council (grant 523-2006-972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Ammerman AJ, 1984, NEOLITHIC TRANSITION, P176; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Einarsdottir K, 2006, PLOS MED, V3, P895, DOI 10.1371/journal.pmed.0030168; Eurostat, 2008, NOM TERR UN STAT NUT; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hannelius U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-54; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Leu M, 2010, EUR J HUM GENET; Lewin-Koh NJ, 2009, **DATA OBJECT**; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; Moskvina V, 2010, HUM HERED, V70, P141, DOI 10.1159/000313854; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; O'Dushlaine CT, 2010, EUR J HUM GENET; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, 2020, R LANG ENV STAT COMP; Salmela E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016747; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	33	52	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22547	10.1371/journal.pone.0022547	http://dx.doi.org/10.1371/journal.pone.0022547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829632	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200022
J	de Koning, PJA; Kummer, JA; de Poot, SAH; Quadir, R; Broekhuizen, R; McGettrick, AF; Higgins, WJ; Devreese, B; Worrall, DM; Bovenschen, N				de Koning, Pieter J. A.; Kummer, J. Alain; de Poot, Stefanie A. H.; Quadir, Razi; Broekhuizen, Roel; McGettrick, Anne F.; Higgins, Wayne J.; Devreese, Bart; Worrall, D. Margaret; Bovenschen, Niels			Intracellular Serine Protease Inhibitor SERPINB4 Inhibits Granzyme M-Induced Cell Death	PLOS ONE			English	Article							MEDIATED APOPTOSIS; CARCINOMA ANTIGEN; MONOCLONAL-ANTIBODIES; ENDOGENOUS INHIBITOR; TUMOR-CELLS; B INHIBITOR; CATHEPSIN-G; EXPRESSION; LYMPHOCYTES; PROTEINS	Granzyme-mediated cell death is the major pathway for cytotoxic lymphocytes to kill virus-infected and tumor cells. In humans, five different granzymes (i.e. GrA, GrB, GrH, GrK, and GrM) are known that all induce cell death. Expression of intracellular serine protease inhibitors (serpins) is one of the mechanisms by which tumor cells evade cytotoxic lymphocyte-mediated killing. Intracellular expression of SERPINB9 by tumor cells renders them resistant to GrB-induced apoptosis. In contrast to GrB, however, no physiological intracellular inhibitors are known for the other four human granzymes. In the present study, we show that SERPINB4 formed a typical serpin-protease SDS-stable complex with both recombinant and native human GrM. Mutation of the P2-P1-P1' triplet in the SERPINB4 reactive center loop completely abolished complex formation with GrM and N-terminal sequencing revealed that GrM cleaves SERPINB4 after P1-Leu. SERPINB4 inhibited GrM activity with a stoichiometry of inhibition of 1.6 and an apparent second order rate constant of 1.3x10(4) M(-1) s(-1). SERPINB4 abolished cleavage of the macromolecular GrM substrates alpha-tubulin and nucleophosmin. Overexpression of SERPINB4 in tumor cells inhibited recombinant GrM-induced as well as NK cell-mediated cell death and this inhibition depended on the reactive center loop of the serpin. As SERPINB4 is highly expressed by squamous cell carcinomas, our results may represent a novel mechanism by which these tumor cells evade cytotoxic lymphocyte-induced GrM-mediated cell death.	[de Koning, Pieter J. A.] Univ Med Ctr Utrecht, Div Surg Specialties, Dept Pathol, Utrecht, Netherlands; [McGettrick, Anne F.; Higgins, Wayne J.; Worrall, D. Margaret] Univ Coll Dublin, Sch Biomol & Biochem Sci, Dublin 2, Ireland; [Devreese, Bart] Univ Ghent, Lab Prot Biochem & Biomol Engn, Dept Biochem & Microbiol, B-9000 Ghent, Belgium	Utrecht University; Utrecht University Medical Center; University College Dublin; Ghent University	de Koning, PJA (corresponding author), Univ Med Ctr Utrecht, Div Surg Specialties, Dept Pathol, Utrecht, Netherlands.	n.bovenschen@umcutrecht.nl	Devreese, Bart/B-2011-2009; Devreese, Bart/K-2841-2019	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581	Dutch Cancer Society (KWF) [UU-2004-3047, UU-2009-4302]; Netherlands Organization for Scientific Research (NWO) [916.66.044]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Dutch Cancer Society (KWF) (grant UU-2004-3047 to JAK and grant UU-2009-4302 to NB and JAK) and the Netherlands Organization for Scientific Research (NWO) (grant 916.66.044 to NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bade B, 2005, INT IMMUNOL, V17, P1419, DOI 10.1093/intimm/dxh320; BARNES RC, 1995, FEBS LETT, V373, P61, DOI 10.1016/0014-5793(95)01015-7; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bladergroen BA, 2002, BLOOD, V99, P232, DOI 10.1182/blood.V99.1.232; Bots M, 2005, BLOOD, V105, P1153, DOI 10.1182/blood-2004-03-0791; Bovenschen N, 2008, J IMMUNOL, V180, P8184, DOI 10.4049/jimmunol.180.12.8184; Bovenschen N, 2010, IMMUNOL REV, V235, P117, DOI 10.1111/j.0105-2896.2010.00889.x; Cataltepe S, 2000, J HISTOCHEM CYTOCHEM, V48, P113, DOI 10.1177/002215540004800112; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Cullen SP, 2009, J BIOL CHEM, V284, P5137, DOI 10.1074/jbc.M807913200; de Bruijn HWA, 1998, TUMOR BIOL, V19, P505, DOI 10.1159/000030044; de Koning PJA, 2010, MOL IMMUNOL, V47, P903, DOI 10.1016/j.molimm.2009.10.001; de Koning PJA, 2009, CRIT REV IMMUNOL, V29, P307, DOI 10.1615/CritRevImmunol.v29.i4.20; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; ESPANA F, 1991, BLOOD, V77, P1754; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hu DQ, 2010, J BIOL CHEM, V285, P18326, DOI 10.1074/jbc.M109.083170; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; KATO H, 1979, CANCER, V43, P585, DOI 10.1002/1097-0142(197902)43:2<585::AID-CNCR2820430227>3.0.CO;2-0; KATO H, 1987, JPN J CANCER RES, V78, P1246; KEIJER J, 1991, BLOOD, V78, P1254; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; KUMMER JA, 1993, J IMMUNOL METHODS, V163, P77, DOI 10.1016/0022-1759(93)90241-X; Lu HX, 2006, J IMMUNOL, V177, P1171, DOI 10.4049/jimmunol.177.2.1171; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; McGettrick AF, 2001, EUR J BIOCHEM, V268, P5868, DOI 10.1046/j.0014-2956.2001.02535.x; Murakami A, 2001, BRIT J CANCER, V84, P851, DOI 10.1054/bjoc.2000.1683; Patston PA, 2004, METHODS, V32, P93, DOI 10.1016/S1046-2023(03)00201-9; Pegram HJ, 2010, CANCER IMMUNOL IMMUN, V59, P1235, DOI 10.1007/s00262-010-0848-7; Sayers TJ, 2001, J IMMUNOL, V166, P765, DOI 10.4049/jimmunol.166.2.765; Schechter NM, 2004, METHODS, V32, P159, DOI 10.1016/S1046-2023(03)00207-X; Schick C, 1997, J BIOL CHEM, V272, P1849, DOI 10.1074/jbc.272.3.1849; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Smyth MJ, 1996, J IMMUNOL, V156, P4174; Smyth MJ, 2001, J LEUKOCYTE BIOL, V70, P18; Suck G, 2005, EXP HEMATOL, V33, P1160, DOI 10.1016/j.exphem.2005.06.024; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; ten Berge RL, 2002, BLOOD, V99, P4540, DOI 10.1182/blood.V99.12.4540; van Houdt IS, 2005, CLIN CANCER RES, V11, P6400, DOI 10.1158/1078-0432.CCR-05-0306; WACHTFOGEL YT, 1989, BLOOD, V73, P468; Yagita M, 2000, LEUKEMIA, V14, P922, DOI 10.1038/sj.leu.2401769; Young JL, 2000, J EXP MED, V191, P1535, DOI 10.1084/jem.191.9.1535; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	49	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22645	10.1371/journal.pone.0022645	http://dx.doi.org/10.1371/journal.pone.0022645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857942	gold, Green Published, Green Submitted			2022-12-27	WOS:000293558900024
J	Seipke, RF; Barke, J; Brearley, C; Hill, L; Yu, DW; Goss, RJM; Hutchings, MI				Seipke, Ryan F.; Barke, Joerg; Brearley, Charles; Hill, Lionel; Yu, Douglas W.; Goss, Rebecca J. M.; Hutchings, Matthew I.			A Single Streptomyces Symbiont Makes Multiple Antifungals to Support the Fungus Farming Ant Acromyrmex octospinosus	PLOS ONE			English	Article							LEAF-CUTTING ANTS; GENE-CLUSTER; MICROBE SYMBIOSIS; GROWING ANTS; BACTERIA; BIOSYNTHESIS; CLONING; COEVOLUTION; ESCOVOPSIS; COMMUNITY	Attine ants are dependent on a cultivated fungus for food and use antibiotics produced by symbiotic Actinobacteria as weedkillers in their fungus gardens. Actinobacterial species belonging to the genera Pseudonocardia, Streptomyces and Amycolatopsis have been isolated from attine ant nests and shown to confer protection against a range of microfungal weeds. In previous work on the higher attine Acromyrmex octospinosus we isolated a Streptomyces strain that produces candicidin, consistent with another report that attine ants use Streptomyces-produced candicidin in their fungiculture. Here we report the genome analysis of this Streptomyces strain and identify multiple antibiotic biosynthetic pathways. We demonstrate, using gene disruptions and mass spectrometry, that this single strain has the capacity to make candicidin and multiple antimycin compounds. Although antimycins have been known for > 60 years we report the sequence of the biosynthetic gene cluster for the first time. Crucially, disrupting the candicidin and antimycin gene clusters in the same strain had no effect on bioactivity against a co-evolved nest pathogen called Escovopsis that has been identified in similar to 30% of attine ant nests. Since the Streptomyces strain has strong bioactivity against Escovopsis we conclude that it must make additional antifungal(s) to inhibit Escovopsis. However, candicidin and antimycins likely offer protection against other microfungal weeds that infect the attine fungal gardens. Thus, we propose that the selection of this biosynthetically prolific strain from the natural environment provides A. octospinosus with broad spectrum activity against Escovopsis and other microfungal weeds.	[Seipke, Ryan F.; Barke, Joerg; Brearley, Charles; Yu, Douglas W.; Hutchings, Matthew I.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Hill, Lionel] John Innes Ctr, Norwich, Norfolk, England; [Yu, Douglas W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources, Kunming, Peoples R China; [Goss, Rebecca J. M.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Yu, Douglas W.] Chinese Acad Sci, Kunming Inst Zool, Evolut Ecol Conservat & Environm Ctr, Kunming, Peoples R China	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia; Chinese Academy of Sciences; Kunming Institute of Zoology	Seipke, RF (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	r.seipke@uea.ac.uk; m.hutchings@uea.ac.uk	Yu, Douglas W./D-2536-2009; Hutchings, Matt/D-1923-2009	Yu, Douglas W./0000-0001-8551-5609; Hutchings, Matt/0000-0001-6628-5940; Brearley, Charles/0000-0001-6179-9109; Seipke, Ryan/0000-0002-6156-8498	Medical Research Council [G0801721]; BBSRC [BB/F010591/1] Funding Source: UKRI; MRC [G0801721] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F010591/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Medical Research Council Milstein Award (grant G0801721) to MIH, RJMG and DWY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Barke Joerg, 2011, Communicative & Integrative Biology, V4, P41, DOI 10.4161/cib.4.1.13552; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chen S, 2003, CHEM BIOL, V10, P1065, DOI 10.1016/j.chembiol.2003.10.007; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; DUNSHEE BR, 1949, J AM CHEM SOC, V71, P2436, DOI 10.1021/ja01175a057; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kost C, 2007, NATURWISSENSCHAFTEN, V94, P821, DOI 10.1007/s00114-007-0262-y; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Maconi P, 1976, ANN SCLAVO, V18, P61; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; PANDEY RC, 1981, J ANTIBIOT, V34, P1389, DOI 10.7164/antibiotics.34.1389; Reynolds HT, 2004, MYCOLOGIA, V96, P955, DOI 10.2307/3762079; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Schoenian I, 2011, P NATL ACAD SCI USA, V108, P1955, DOI 10.1073/pnas.1008441108; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Seipke RF, 2011, J BACTERIOL, V193, P4270, DOI 10.1128/JB.05275-11; Sen R, 2009, P NATL ACAD SCI USA, V106, P17805, DOI 10.1073/pnas.0904827106; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u	27	119	125	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22028	10.1371/journal.pone.0022028	http://dx.doi.org/10.1371/journal.pone.0022028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857911	Green Published, Green Submitted, gold			2022-12-27	WOS:000293558900009
J	Maciej, P; Fischer, J; Hammerschmidt, K				Maciej, Peter; Fischer, Julia; Hammerschmidt, Kurt			Transmission Characteristics of Primate Vocalizations: Implications for Acoustic Analyses	PLOS ONE			English	Article							SOUND-TRANSMISSION; LOUD CALLS; ANIMAL VOCALIZATION; GRUNT VOCALIZATIONS; BODY-SIZE; BABOONS; COMMUNICATION; ADAPTATION; FEATURES; HABITAT	Acoustic analyses have become a staple method in field studies of animal vocal communication, with nearly all investigations using computer-based approaches to extract specific features from sounds. Various algorithms can be used to extract acoustic variables that may then be related to variables such as individual identity, context or reproductive state. Habitat structure and recording conditions, however, have strong effects on the acoustic structure of sound signals. The purpose of this study was to identify which acoustic parameters reliably describe features of propagated sounds. We conducted broadcast experiments and examined the influence of habitat type, transmission height, and re-recording distance on the validity (deviation from the original sound) and reliability (variation within identical recording conditions) of acoustic features of different primate call types. Validity and reliability varied independently of each other in relation to habitat, transmission height, and re-recording distance, and depended strongly on the call type. The smallest deviations from the original sounds were obtained by a visually-controlled calculation of the fundamental frequency. Start-and end parameters of a sound were most susceptible to degradation in the environment. Because the recording conditions can have appreciable effects on acoustic parameters, it is advisable to validate the extraction method of acoustic variables from recordings over longer distances before using them in acoustic analyses.	[Maciej, Peter; Fischer, Julia; Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany	Deutsches Primatenzentrum (DPZ)	Fischer, J (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	Peter_Maciej@gmx.de	Fischer, Julia/B-6674-2008	Fischer, Julia/0000-0002-5807-0074	Deutsche Forschungsgemeinschaft [Fi 707/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft: Fi 707/9 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma P., 1993, P I PHONETIC SCI, V17, P97; Bradbury Jack W., 1998, pi; Brown C.H., 1988, P51; BROWN CH, 1995, ANIM BEHAV, V50, P945, DOI 10.1016/0003-3472(95)80096-4; CHENEY DL, 1995, ANIM BEHAV, V50, P249, DOI 10.1006/anbe.1995.0237; Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193; Ey E, 2009, BIOACOUSTICS, V19, P21, DOI 10.1080/09524622.2009.9753613; Ey E, 2007, INT J PRIMATOL, V28, P947, DOI 10.1007/s10764-007-9139-3; Ey E, 2009, ETHOLOGY, V115, P493, DOI 10.1111/j.1439-0310.2009.01638.x; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ANIM BEHAV, V61, P925, DOI 10.1006/anbe.2000.1687; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fonseca PJ, 2002, J COMP PHYSIOL A, V187, P971, DOI 10.1007/s00359-001-0267-5; Freitas SR, 2002, BRAZ J BIOL, V62, P795, DOI 10.1590/S1519-69842002000500008; GERHARDT HC, 1975, J COMP PHYSIOL, V102, P1, DOI 10.1007/BF00657481; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Hall K. R. L., 1965, P53; Hammerschmidt K, 1998, ETHOLOGY, V104, P203; Kipper S, 2006, ANIM BEHAV, V71, P211, DOI 10.1016/j.anbehav.2005.04.011; Kitchen DM, 2003, BEHAV ECOL SOCIOBIOL, V53, P374, DOI 10.1007/s00265-003-0588-1; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Markel J., 1976, LINEAR PREDICTION SP; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P291, DOI 10.1007/BF00299741; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McCowan B, 1999, ANIM BEHAV, V57, P409, DOI 10.1006/anbe.1998.1000; MCCOWAN B, 1995, ETHOLOGY, V100, P177; Meise K, 2011, J ACOUST SOC AM, V129, P1631, DOI 10.1121/1.3531944; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Naguib M, 2001, ETHOLOGY, V107, P341, DOI 10.1046/j.1439-0310.2001.00669.x; Naguib M, 2001, ANIM BEHAV, V62, P825, DOI 10.1006/anbe.2001.1860; Naguib M, 1997, ETHOLOGY, V103, P723, DOI 10.1111/j.1439-0310.1997.tb00181.x; Nelson BS, 2003, J ACOUST SOC AM, V113, P2901, DOI 10.1121/1.1564817; NELSON DA, 1994, P NATL ACAD SCI USA, V91, P10498, DOI 10.1073/pnas.91.22.10498; Nemeth E, 2006, J ACOUST SOC AM, V119, P620, DOI 10.1121/1.2139072; Nemeth E, 2001, J ACOUST SOC AM, V110, P3263, DOI 10.1121/1.1420385; Neumann C, 2010, ANIM BEHAV, V79, P187, DOI 10.1016/j.anbehav.2009.10.026; OWENS JL, 2007, J ACOUST SOC AM, V119, P620; OWREN MJ, 1995, CURRENT TOPICS IN PRIMATE VOCAL COMMUNICATION, P1; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; Rendall D, 1999, ANIM BEHAV, V57, P583, DOI 10.1006/anbe.1998.1031; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Ripmeester EAP, 2010, BEHAV ECOL SOCIOBIOL, V64, P409, DOI 10.1007/s00265-009-0857-8; Sabatini V, 2008, INT J PRIMATOL, V29, P207, DOI 10.1007/s10764-008-9240-2; SCHRADER L, 1997, BIOACOUSTICS, V7, P274; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Stewart KEJ, 2001, J APPL ECOL, V38, P1148, DOI 10.1046/j.1365-2664.2001.00658.x; Townsend SW, 2010, ANIM BEHAV, V80, P133, DOI 10.1016/j.anbehav.2010.04.010; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; WASER PM, 1984, BEHAV ECOL SOCIOBIOL, V15, P73, DOI 10.1007/BF00310219; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047	56	38	38	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23015	10.1371/journal.pone.0023015	http://dx.doi.org/10.1371/journal.pone.0023015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829682	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200030
J	Plucinski, MM; Starfield, R; Almeida, RPP				Plucinski, Mateusz M.; Starfield, Richard; Almeida, Rodrigo P. P.			Inferring Social Network Structure from Bacterial Sequence Data	PLOS ONE			English	Article							POPULATION; EVOLUTION; VIRUS; IDENTIFICATION; TRANSMISSION; VIRULENCE; DYNAMICS; OUTBREAK; SPREAD; CLONES	Using DNA sequence data from pathogens to infer transmission networks has traditionally been done in the context of epidemics and outbreaks. Sequence data could analogously be applied to cases of ubiquitous commensal bacteria; however, instead of inferring chains of transmission to track the spread of a pathogen, sequence data for bacteria circulating in an endemic equilibrium could be used to infer information about host contact networks. Here, we show-using simulated data-that multilocus DNA sequence data, based on multilocus sequence typing schemes (MLST), from isolates of commensal bacteria can be used to infer both local and global properties of the contact networks of the populations being sampled. Specifically, for MLST data simulated from small-world networks, the small world parameter controlling the degree of structure in the contact network can robustly be estimated. Moreover, we show that pairwise distances in the network-degrees of separation-correlate with genetic distances between isolates, so that how far apart two individuals in the network are can be inferred from MLST analysis of their commensal bacteria. This result has important consequences, and we show an example from epidemiology: how this result could be used to test for infectious origins of diseases of unknown etiology.	[Plucinski, Mateusz M.; Starfield, Richard; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Plucinski, Mateusz M.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Plucinski, MM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mateusz@berkeley.edu	Almeida, Rodrigo/GZH-0682-2022	Almeida, Rodrigo/0000-0003-2888-9617; Plucinski, Mateusz/0000-0002-7322-4625	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	MMP was funded by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2002, GENETICS, V162, P2025; Buckee CO, 2010, INFECTIOUS DISEASE INFORMATICS, P167, DOI 10.1007/978-1-4419-1327-2_8; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Day NPJ, 2001, SCIENCE, V292, P114, DOI 10.1126/science.1056495; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Hanage WP, 2004, INFECT IMMUN, V72, P76, DOI 10.1128/IAI.72.1.76-81.2004; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Spada E, 2004, J CLIN MICROBIOL, V42, P4230, DOI 10.1128/JCM.42.9.4230-4236.2004; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	19	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22685	10.1371/journal.pone.0022685	http://dx.doi.org/10.1371/journal.pone.0022685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829645	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200018
J	Porceddu, A; Camiolo, S				Porceddu, Andrea; Camiolo, Salvatore			Spatial Analyses of Mono, Di and Trinucleotide Trends in Plant Genes	PLOS ONE			English	Article							CODON USAGE; EUKARYOTIC GENOMES; ISOCHORES; HETEROGENEITY; TRANSCRIPTION; SEQUENCES; EVOLUTION; BIAS	Genomic DNA sequences display compositional heterogeneity on many scales. In this paper we analyzed tendencies and anomalies in the occurence of mono, di and trinucleotides in structural regions of plant genes. Representation of these trends as a function of position along genic sequences highlighted compositional features peculiar of either monocots or eudicots that were remarkably uniform within these two evolutionary clades. The most evident of these features appeared in the form of gradient of base content along the direction of transcription. The robustness of such a representation was validated in sequences sub-datasets generated considering structural and compositional features such as total length of cds, overall GC content and genic orientation in the genome. Piecewise regression analyses indicated that the gradients could be conveniently approximated to a two segmented model where a first region featuring a steep slope is followed by a second segment fitting a milder variation. In general, monocots species showed steeper segments than eudicots. The guanine gradient was the most distinctive feature between the two evolutionary clades, being moderately increasing in eudicots and firmly decreasing in monocots. Single gene investigation revealed that a high proportion of genes show compositional trends compatible with a segmented model suggesting that these features are essential attributes of gene organization. Dinucleotide and trinucleotide biases were referred to expectation based on a random union of the component elements. The average bias at dinucleotide level identified a significant undererpresentation of some dinucleotide and the overrepresention of others. The bias at trinucleotide level was on average low. Finally, the analysis of bryophyte coding sequences showed mononucleotide, dinucleotide and trinucleotide compositional trends resembling those of higher plants. This finding suggested that the emergenge of compositional bias is an ancient event in evolution which was already present at the time of land conquest by green plants.	[Porceddu, Andrea; Camiolo, Salvatore] Univ Sassari, Dipartimento Sci Agron & Genet Vegetale Agr, I-07100 Sassari, Italy	University of Sassari	Porceddu, A (corresponding author), Univ Sassari, Dipartimento Sci Agron & Genet Vegetale Agr, I-07100 Sassari, Italy.	aporceddu@uniss.it		Camiolo, Salvatore/0000-0002-8874-9993	University of Sassari	University of Sassari	University of Sassari - PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BULMER M, 1991, GENETICS, V129, P897; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Clay O, 1996, MOL PHYLOGENET EVOL, V5, P2, DOI 10.1006/mpev.1996.0002; Costantini M, 2008, P NATL ACAD SCI USA, V105, P13971, DOI 10.1073/pnas.0803916105; De Amicis F, 2000, NUCLEIC ACIDS RES, V28, P3339, DOI 10.1093/nar/28.17.3339; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; FILIPSKI J, 1987, FEBS LETT, V217, P184, DOI 10.1016/0014-5793(87)80660-9; Fujimori S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-26; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12837, DOI 10.1073/pnas.91.26.12837; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12832, DOI 10.1073/pnas.91.26.12832; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Nekrutenko A, 2000, GENOME RES, V10, P1986, DOI 10.1101/gr.10.12.1986; Niimura Y, 2003, NUCLEIC ACIDS RES, V31, P5195, DOI 10.1093/nar/gkg701; Qin H, 2004, GENETICS, V168, P2245, DOI 10.1534/genetics.104.030866; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; ROSEWILSON LJ, 2007, BMC EVOL BIOL, V7, P66; Ryan S.E, 2007, TUTORIAL PIECEWISE R, DOI [10.2737/rmrs-gtr-189, DOI 10.2737/RMRS-GTR-189]; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Wong GKS, 2002, GENOME RES, V12, P851, DOI 10.1101/gr.189102; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101; 2010, NATURE, V463, P763, DOI DOI 10.1038/NATURE08747	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22855	10.1371/journal.pone.0022855	http://dx.doi.org/10.1371/journal.pone.0022855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829660	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200022
J	Zhao, XX; Ogunwobi, OO; Liu, C				Zhao, Xiangxuan; Ogunwobi, Olorunseun O.; Liu, Chen			Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							FAMILY INHIBITOR; DOWN-REGULATION; MESSENGER-RNA; LUNG-CANCER; IN-VITRO; YM155; ERK; EXPRESSION; ABT-263; LIVER	Our study aims to study the therapeutic effects of a novel Bcl-2 inhibitor, ABT-263, on hepatocellular carcinoma (HCC) and to provide primary preclinical data for future clinical trial with ABT-263. In this study we showed that Bcl-xL and survivin were up-regulated in HCC cell lines and human liver cancer tissues. Clinic used ABT-263 single treatment had no apoptotic effects on HCC cells whereas higher doses of ABT-263 did. Interestingly, the combination treatment of ABT-263 with survivin inhibitor YM-155 could result in significant apoptosis in HCC cells. Survivin inhibition through gene silencing significantly enhanced ABT-263 to induce apoptosis in HCC cells. We found that low dose of ABT-263 single treatment resulted in ERK activation and survivin up-regulation, which might be involved in the resistance of HCC cells to ABT-263 since blockade of ERK activation sensitized ABT-263-induced apoptosis. Importantly, ABT-263 and YM-155 combination treatment had no apoptotic effects on normal human hepatocytes. Taken together, these data suggest the combination treatment of Bcl-2 inhibitor and survivin inhibition may have a great potential for liver cancer therapy.	[Zhao, Xiangxuan; Ogunwobi, Olorunseun O.; Liu, Chen] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Zhao, XX (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	liu@pathology.ufl.edu	Ogunwobi, Olorunseun/F-3172-2010	Ogunwobi, Olorunseun/0000-0003-3388-2137	National Institutes of Health [R01CA133086]; University of Florida; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant R01CA133086 to CL. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackler S, 2008, MOL CANCER THER, V7, P3265, DOI 10.1158/1535-7163.MCT-08-0268; Ackler S, 2010, CANCER CHEMOTH PHARM, V66, P869, DOI 10.1007/s00280-009-1232-1; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Feng Deyun, 1999, Hunan Yike Daxue Xuebao, V24, P325; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fiorentino M, 1999, DIAGN MOL PATHOL, V8, P189, DOI 10.1097/00019606-199912000-00004; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gandhi L, 2011, J CLIN ONCOL, V2010, P6208; Garcia EJ, 2002, APPL IMMUNOHISTO M M, V10, P210, DOI 10.1097/00022744-200209000-00004; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Guo XZ, 2002, WORLD J GASTROENTERO, V8, P1059, DOI 10.3748/wjg.v8.i6.1059; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hosseinimehr SJ, 2004, J RADIAT RES, V45, P557, DOI 10.1269/jrr.45.557; Ito T, 2000, HEPATOLOGY, V31, P1080, DOI 10.1053/he.2000.6496; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; Kita A, 2011, LEUK RES S, VS0145-2126, P00561; Kita Aya, 2010, Folia Pharmacologica Japonica, V136, P198; Kumar P, 2007, CANCER RES, V67, P1193, DOI 10.1158/0008-5472.CAN-06-2265; Li L, 2008, CANCER LETT, V272, P61, DOI 10.1016/j.canlet.2008.06.033; Mamori S, 2007, WORLD J GASTROENTERO, V13, P5306, DOI 10.3748/wjg.v13.i40.5306; Montorsi M, 2007, HEPATO-GASTROENTEROL, V54, P2040; Nair HK, 2004, CLIN DIAGN LAB IMMUN, V11, P63, DOI 10.1128/CDLI.11.1.63-69.2004; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Peroukides S, 2010, HISTOL HISTOPATHOL, V25, P299, DOI 10.14670/HH-25.299; Ravazoula P, 2002, ANTICANCER RES, V22, P1799; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Siddiqa A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-129; Tahir SK, 2010, MOL CANCER THER, V9, P545, DOI 10.1158/1535-7163.MCT-09-0651; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Wang Q, 2011, CANC LETT S, VS0304-3835, P00566; Yan Ge, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P712; Yang Y, 2011, MED ONCOL, V28, P796, DOI 10.1007/s12032-010-9519-y; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	37	40	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e21980	10.1371/journal.pone.0021980	http://dx.doi.org/10.1371/journal.pone.0021980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829603	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200004
J	Minocha, N; Kumar, D; Rajanala, K; Saha, S				Minocha, Neha; Kumar, Devanand; Rajanala, Kalpana; Saha, Swati			Characterization of Leishmania donovani MCM4: Expression Patterns and Interaction with PCNA	PLOS ONE			English	Article							DNA-POLYMERASE-ALPHA; REPLICATION INITIATION PROTEINS; PARASITE PLASMODIUM-FALCIPARUM; RECOGNITION COMPLEX SUBUNIT-1; XENOPUS EGG EXTRACTS; S-PHASE PROGRESSION; SACCHAROMYCES-CEREVISIAE; ORIGIN RECOGNITION; CELL-CYCLE; PREREPLICATION COMPLEX	Events leading to origin firing and fork elongation in eukaryotes involve several proteins which are mostly conserved across the various eukaryotic species. Nuclear DNA replication in trypanosomatids has thus far remained a largely uninvestigated area. While several eukaryotic replication protein orthologs have been annotated, many are missing, suggesting that novel replication mechanisms may apply in this group of organisms. Here, we characterize the expression of Leishmania donovani MCM4, and find that while it broadly resembles other eukaryotes, noteworthy differences exist. MCM4 is constitutively nuclear, signifying that, unlike what is seen in S. cerevisiae, varying subcellular localization of MCM4 is not a mode of replication regulation in Leishmania. Overexpression of MCM4 in Leishmania promastigotes causes progress through S phase faster than usual, implicating a role for MCM4 in the modulation of cell cycle progression. We find for the first time in eukaryotes, an interaction between any of the proteins of the MCM2-7 (MCM4) and PCNA. MCM4 colocalizes with PCNA in S phase cells, in keeping with the MCM2-7 complex being involved not only in replication initiation, but fork elongation as well. Analysis of a LdMCM4 mutant indicates that MCM4 interacts with PCNA via the PIP box motif of MCM4 - perhaps as an integral component of the MCM2-7 complex, although we have no direct evidence that MCM4 harboring a PIP box mutation can still functionally associate with the other members of the MCM2-7 complex-and the PIP box motif is important for cell survival and viability. In Leishmania, MCM4 may possibly help in recruiting PCNA to chromatin, a role assigned to MCM10 in other eukaryotes.	[Minocha, Neha; Kumar, Devanand; Saha, Swati] Univ Delhi S Campus, Dept Microbiol, New Delhi, India; [Rajanala, Kalpana] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Minocha, N (corresponding author), Univ Delhi S Campus, Dept Microbiol, New Delhi, India.	ss5gp@yahoo.co.in			Council of Scientific and Industrial Research (CSIR), India [37/1341/08]; Department of Biotechnology (DBT), India [BT/PR11029/BRB/10/629/200837/1341/08]; University of Delhi; DBT	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); University of Delhi(University of Delhi); DBT(Department of Biotechnology (DBT) India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR), India (Grant No:37/1341/08); the Department of Biotechnology (DBT), India (Grant No: BT/PR11029/BRB/10/629/200837/1341/08); and the University Research Fund from University of Delhi. N.M. is a University Grants Commission Senior Research Fellow. D. K. is a Senior Research Fellow supported from the DBT grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Brand N, 2007, MOL GENET GENOMICS, V278, P623, DOI 10.1007/s00438-007-0278-1; Braun KA, 2007, MOL BIOL CELL, V18, P1447, DOI 10.1091/mbc.E06-09-0792; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Claycomb JM, 2002, J CELL BIOL, V159, P225, DOI 10.1083/jcb.200207046; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Donti TR, 2009, EMBO J, V28, P223, DOI 10.1038/emboj.2008.282; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Gupta A, 2008, MOL MICROBIOL, V69, P646, DOI 10.1111/j.1365-2958.2008.06316.x; Gupta A, 2006, FEMS MICROBIOL LETT, V261, P12, DOI 10.1111/j.1574-6968.2006.00324.x; Gupta A, 2009, EUKARYOT CELL, V8, P1341, DOI 10.1128/EC.00170-09; Hart EA, 2002, CURR GENET, V41, P342, DOI 10.1007/s00294-002-0316-9; Homesley L, 2000, GENE DEV, V14, P913; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kawasaki Y, 2000, GENES CELLS, V5, P975, DOI 10.1046/j.1365-2443.2000.00387.x; Komamura-Kohno Y, 2006, FEBS J, V273, P1224, DOI 10.1111/j.1742-4658.2006.05146.x; Krude T, 1996, J CELL SCI, V109, P309; Kumar D, 2009, MICROBIOL-SGM, V155, P3748, DOI 10.1099/mic.0.033217-0; Kumar D, 2008, BIOCHEM BIOPH RES CO, V375, P74, DOI 10.1016/j.bbrc.2008.07.125; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masuda T, 2003, GENES CELLS, V8, P145, DOI 10.1046/j.1365-2443.2003.00621.x; Mehra P, 2005, BIOCHEM BIOPH RES CO, V337, P955, DOI 10.1016/j.bbrc.2005.09.131; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; MINOCHA N, 2011, J EUKARYOT MICROBIOL, DOI DOI 10.1111/J.1550-7408.2011.00539X; Mohammad MM, 2007, EMBO J, V26, P5048, DOI 10.1038/sj.emboj.7601919; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morrison TL, 2005, MOL BIOL CELL, V16, P2624, DOI 10.1091/mbc.E05-02-0107; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Siegel TN, 2008, MOL BIOCHEM PARASIT, V160, P171, DOI 10.1016/j.molbiopara.2008.04.004; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; SINHA P, 1986, J MOL BIOL, V192, P805, DOI 10.1016/0022-2836(86)90030-6; THOMMES P, 1992, NUCLEIC ACIDS RES, V20, P1069, DOI 10.1093/nar/20.5.1069; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	60	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23107	10.1371/journal.pone.0023107	http://dx.doi.org/10.1371/journal.pone.0023107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829589	Green Published, Green Submitted, gold			2022-12-27	WOS:000293286500076
J	Khameneh, HJ; Isa, SABM; Min, L; Nih, FW; Ruedl, C				Khameneh, Hanif Javanmard; Isa, Siti Aminah Bte Mohammad; Min, Lin; Nih, Fam Wee; Ruedl, Christiane			GM-CSF Signalling Boosts Dramatically IL-1Production	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NF-KAPPA-B; INFLAMMATORY RESPONSE; NLRP3 INFLAMMASOME; GENE-EXPRESSION; MICE DEFICIENT; BETA SUBUNIT; IN-VIVO; ACTIVATION; RECEPTOR	CSF is mostly known for its capacity to promote bone marrow progenitor differentiation, to mobilize and mature myeloid cells as well as to enhance host immune responses. However the molecular actions of GM-CSF are still poorly characterized. Here we describe a new surprising facet of this "old" growth factor as a key regulator involved in IL-1 beta secretion. We found that IL-1 beta release, a pivotal component of the triggered innate system, is heavily dependent on the signaling induced by GM-CSF in such an extent that in its absence IL-1 beta is only weakly secreted. GM-CSF synergizes with LPS for IL-1 beta secretion mainly at the level of pro-IL-1 beta production via strengthening the NF-kappa B signaling. In addition, we show that expression of Rab39a, a GTPase required for caspase-1 dependent IL-1 beta secretion is greatly augmented by LPS and GMCSF co-stimulation suggesting a potential GM-CSF contribution in enhancing IL-1 beta exocytosis. The role of GM-CSF in regulating IL-1 beta secretion is extended also in vivo, since GM-CSF R-/- mice are more resistant to LPS-mediated septic shock. These results identify GM-CSF as a key regulator of IL-1 beta production and indicate GM-CSF as a previously underestimated target for therapeutic intervention.	[Khameneh, Hanif Javanmard; Isa, Siti Aminah Bte Mohammad; Min, Lin; Nih, Fam Wee; Ruedl, Christiane] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Khameneh, HJ (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	Ruedl@ntu.edu.sg	Khameneh, Hanif Javanmard/L-5679-2019; Ruedl, christiane/A-2219-2011	Khameneh, Hanif Javanmard/0000-0002-1737-0388; Ruedl, christiane/0000-0002-5599-6541	Academic Research Fund Tier1	Academic Research Fund Tier1	This work was supported by an Academic Research Fund Tier1 grant to CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 1997, J IMMUNOL, V159, P1412; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Beinart Garth, 2005, Clin Prostate Cancer, V4, P55, DOI 10.3816/CGC.2005.n.013; Bergamini A, 2000, IMMUNOLOGY, V101, P254, DOI 10.1046/j.1365-2567.2000.00117.x; BURGESS AW, 1980, BLOOD, V56, P947; DINARELLO CA, 1993, JAMA-J AM MED ASSOC, V269, P1829, DOI 10.1001/jama.269.14.1829; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Ebner K, 2003, BLOOD, V102, P192, DOI 10.1182/blood-2002-12-3753; Evans TG, 2000, CLIN NEPHROL, V54, P138; Fernandez MC, 1996, J LEUKOCYTE BIOL, V59, P598, DOI 10.1002/jlb.59.4.598; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hamilton JA, 2004, GROWTH FACTORS, V22, P225, DOI 10.1080/08977190412331279881; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hartoonian C, 2009, CYTOKINE, V46, P43, DOI 10.1016/j.cyto.2008.12.007; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meads MB, 2010, J IMMUNOL, V185, P1606, DOI 10.4049/jimmunol.0902026; Min L, 2010, J IMMUNOL, V184, P4625, DOI 10.4049/jimmunol.0903873; Nakamura T, 2002, J BIOL CHEM, V277, P6254, DOI 10.1074/jbc.M109878200; Osiecki K, 2005, AIDS RES HUM RETROV, V21, P125, DOI 10.1089/aid.2005.21.125; Parker SE, 2001, GENE THER, V8, P1011, DOI 10.1038/sj.gt.3301491; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Ribas A, 2003, J CLIN ONCOL, V21, P2415, DOI 10.1200/JCO.2003.06.041; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; SMITH RJ, 1990, INFLAMMATION, V14, P83, DOI 10.1007/BF00914032; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TIEGS G, 1994, J CLIN INVEST, V93, P2616, DOI 10.1172/JCI117274; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5	40	30	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e23025	10.1371/journal.pone.0023025	http://dx.doi.org/10.1371/journal.pone.0023025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829580	Green Submitted, Green Published, gold			2022-12-27	WOS:000293284600072
J	Sanchez, V; Hernandez-Banos, BE; Cordero, C				Sanchez, Victor; Estela Hernandez-Banos, Blanca; Cordero, Carlos			The Evolution of a Female Genital Trait Widely Distributed in the Lepidoptera: Comparative Evidence for an Effect of Sexual Coevolution	PLOS ONE			English	Article							MATRIX REPRESENTATION; SELECTION; BUTTERFLIES; HELICONIUS; POLYANDRY; NOCTUIDAE; SEQUENCES; FECUNDITY; INSECTS; CHOICE	Background: Sexual coevolution is considered responsible for the evolution of many male genital traits, but its effect on female genital morphology is poorly understood. In many lepidopterans, females become temporarily unreceptive after mating and the length of this refractory period is inversely related to the amount of spermatophore remaining in their genital tracts. Sperm competition can select for males that delay female remating by transferring spermatophores with thick spermatophore envelopes that take more time to be broken. These envelopes could select for signa, sclerotized sharp structures located within the female genital tract, that are used for breaking spermatophores. Thus, this hypothesis predicts that thick spermatophore envelopes and signa evolve in polyandrous species, and that these adaptations are lost when monandry evolves subsequently. Here we test the expected associations between female mating pattern and presence/absence of signa, and review the scant information available on the thickness of spermatophore envelopes. Methodology/Principal Findings: We made a literature review and found information on female mating pattern (monandry/polyandry), presence/absence of signa and phylogenetic position for 37 taxa. We built a phylogenetic supertree for these taxa, mapped both traits on it, and tested for the predicted association by using Pagel's test for correlated evolution. We found that, as predicted by our hypothesis, monandry evolved eight times and in five of them signa were lost; preliminary evidence suggests that at least in two of the three exceptions males imposed monandry on females by means of specially thick spermatophore envelopes. Previously published data on six genera of Papilionidae is in agreement with the predicted associations between mating pattern and the characteristics of spermatophore envelopes and signa. Conclusions/Significance: Our results support the hypothesis that signa are a product of sexually antagonistic coevolution with spermatophore envelopes.	[Sanchez, Victor; Cordero, Carlos] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Estela Hernandez-Banos, Blanca] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Evolut Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Sanchez, V (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	cordero@miranda.ecologia.unam.mx			Posgrado en Ciencias Biologicas (Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia; Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica/Universidad Nacional Autonoma de Mexico [IN223508]; Programa de Apoyo para la Superacion del Personal Academico/Direccion General de Asuntos del Personal Academico (Universidad Nacional Autonoma de Mexico); Posgrado en Ciencias Biologicas (UNAM)	Posgrado en Ciencias Biologicas (Universidad Nacional Autonoma de Mexico)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica/Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Programa de Apoyo para la Superacion del Personal Academico/Direccion General de Asuntos del Personal Academico (Universidad Nacional Autonoma de Mexico)(Universidad Nacional Autonoma de Mexico); Posgrado en Ciencias Biologicas (UNAM)(Universidad Nacional Autonoma de Mexico)	VS was supported by the Posgrado en Ciencias Biologicas (Universidad Nacional Autonoma de Mexico) and a Consejo Nacional de Ciencia y Tecnologia scholarship. Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica/Universidad Nacional Autonoma de Mexico (IN223508) and Programa de Apoyo para la Superacion del Personal Academico/Direccion General de Asuntos del Personal Academico (Universidad Nacional Autonoma de Mexico) provided funds to CC, and Consejo Nacional de Ciencia y Tecnologia and Programa de Apoyo para la Superacion del Personal Academico/Direccion General de Asuntos del Personal Academico (Universidad Nacional Autonoma de Mexico) to BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Raul Cueva and Rogelio Macias for useful discussion; two anonymous reviewers provided very useful criticism and suggestions. Raul Martinez and Alejandro Gordillo Martinez provided valuable technical help. This paper is part of the doctoral thesis of Victor Sanchez and he thanks the Posgrado en Ciencias Biologicas (UNAM) for support.	Ackery P. R., 1984, BIOL BUTTERFLIES, V11, P9; Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Arnqvist Goran, 2005, pUnpaginated; Bininda-Emonds ORP, 2004, TRENDS ECOL EVOL, V19, P315, DOI 10.1016/j.tree.2004.03.015; Bininda-Emonds ORP, 1998, SYST BIOL, V47, P497; BOGGS CL, 1990, AM NAT, V136, P598, DOI 10.1086/285118; Brennan PLR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000418; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Brower AVZ, 1997, P ROY SOC B-BIOL SCI, V264, P969, DOI 10.1098/rspb.1997.0134; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; CALLAGHAN CJ, 1988, B ALLYN MUSEUM, V119, P1; CHANG V. C. S., 1963, J RES LEPIDOTERA, V2, P97; CLENCH HARRY K., 1964, J RES LEPIDOPTERA, V3, P73; Cordero C, 2005, EVOL ECOL, V19, P111, DOI 10.1007/s10682-004-7918-2; Cordero C, 2005, J THEOR BIOL, V232, P443, DOI 10.1016/j.jtbi.2004.08.031; CORDERO C, 2000, J LEPID SOC, V53, P170; COUTSIS J G, 1986, Journal of the Lepidopterists' Society, V40, P97; Coutsis JG, 1983, J RES LEPIDOPTERA, V22, P161; Drummmond B.A. III, 1984, P291; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; EHRLICH A H, 1978, Journal of the Kansas Entomological Society, V51, P666; FREEMAN T N, 1967, Journal of Research on the Lepidoptera, V6, P19; Gage MJG, 2002, P ROY SOC B-BIOL SCI, V269, P2309, DOI 10.1098/rspb.2002.2154; Galicia I, 2008, ANN ENTOMOL SOC AM, V101, P786, DOI 10.1603/0013-8746(2008)101[786:OTFOSA]2.0.CO;2; Grimaldi David, 2005, pi; Hill Ryan I., 2002, Journal of the Lepidopterists' Society, V56, P199; Hinton H. E., 1964, P95; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Johnson K, 1977, Bulletin Allyn Mus., VNo. 43, P1; KARLSSON B, 1995, EVOLUTION, V263, P187; Matsumoto Kazuma, 1995, P145; MILLER JS, 1987, B AM MUS NAT HIST, V186, P365; Minder AM, 2005, J EVOLUTION BIOL, V18, P60, DOI 10.1111/j.1420-9101.2004.00799.x; ORR AG, 1991, J NAT HIST, V25, P703, DOI 10.1080/00222939100770461; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Parker G.A., 1979, P123; Penz CM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)374<0001:PAOMBN>2.0.CO;2; PENZ CM, 1999, ZOOLOGICAL J LINNEAN, V127, P278; Pogue MG, 2000, ANN ENTOMOL SOC AM, V93, P1019, DOI 10.1603/0013-8746(2000)093[1019:SOLNAN]2.0.CO;2; Powell J.A., 2003, ENCY INSECTS, P631; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Reinhardt K, 2010, GENETICA, V138, P119, DOI 10.1007/s10709-009-9360-4; ROBBINS R K, 1986, Journal of the Lepidopterists' Society, V40, P79; RODRIGUEZ GMA, 2000, THESIS U CONCEPCION; ROGERS SH, 1984, J MORPHOL, V180, P213, DOI 10.1002/jmor.1051800305; Scott J.A., 1972, Journal Res Lepid, V11, P99; Simmons L. W., 2001, MG BEH ECOL; Speidel W, 1996, SYST ENTOMOL, V21, P219, DOI 10.1046/j.1365-3113.1996.d01-14.x; STEINHAUSER SR, 1981, B ALLYN MUSEUM, V62, P1; SVARD L, 1989, BEHAV ECOL SOCIOBIOL, V24, P395, DOI 10.1007/BF00293267; Torres-Vila LM, 2004, BEHAV ECOL SOCIOBIOL, V55, P315, DOI 10.1007/s00265-003-0712-2; Torres-Vila LM, 2001, ANN ENTOMOL SOC AM, V94, P226, DOI 10.1603/0013-8746(2001)094[0226:MMAMAA]2.0.CO;2; Torres-Vila LM, 2005, BEHAV ECOL SOCIOBIOL, V57, P318, DOI 10.1007/s00265-004-0857-7; TSCHUDIREIN K, 1990, ANN ENTOMOL SOC AM, V83, P1158, DOI 10.1093/aesa/83.6.1158; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Wedell N, 2005, J EXP BIOL, V208, P3433, DOI 10.1242/jeb.01774; Weller SJ, 1996, ANN ENTOMOL SOC AM, V89, P184, DOI 10.1093/aesa/89.2.184; WIKLUND C, 2004, E COMMUNICATION 0407; Yela J.L., 1984, SHILAP Revista de Lepidopterologia, V12, P35; [No title captured]	66	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22642	10.1371/journal.pone.0022642	http://dx.doi.org/10.1371/journal.pone.0022642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857941	Green Submitted, Green Published, gold			2022-12-27	WOS:000294121300007
J	Warner, CV; Syc, SB; Stankiewicz, AM; Hiremath, G; Farrell, SK; Crainiceanu, CM; Conger, A; Frohman, TC; Bisker, ER; Balcer, LJ; Frohman, EM; Calabresi, PA; Saidha, S				Warner, Christina V.; Syc, Stephanie B.; Stankiewicz, Aleksandra M.; Hiremath, Girish; Farrell, Sheena K.; Crainiceanu, Ciprian M.; Conger, Amy; Frohman, Teresa C.; Bisker, Esther R.; Balcer, Laura J.; Frohman, Elliot M.; Calabresi, Peter A.; Saidha, Shiv			The Impact of Utilizing Different Optical Coherence Tomography Devices for Clinical Purposes and in Multiple Sclerosis Trials	PLOS ONE			English	Article							NERVE-FIBER LAYER; LESION LOAD MEASUREMENTS; SPECTRAL-DOMAIN; TIME-DOMAIN; THICKNESS MEASUREMENTS; INTERSCANNER VARIATION; BRAIN ATROPHY; AXONAL-INJURY; STRATUS OCT; NEURITIS	Optical coherence tomography (OCT) derived retinal measures, particularly peri-papillary retinal nerve fiber layer (RNFL) thickness, have been proposed as outcome measures in remyelinating and neuroprotective trials in multiple sclerosis (MS). With increasing utilization of multiple centers to improve power, elucidation of the impact of different OCT technologies is crucial to the design and interpretation of such studies. In this study, we assessed relation and agreement between RNFL thickness and total macular volume (in MS and healthy controls) derived from three commonly used OCT devices: Stratus time-domain OCT, and Cirrus HD-OCT and Spectralis, two spectral-domain (SD) OCT devices. OCT was performed on both Cirrus HD-OCT and Stratus in 229 participants and on both Cirrus HD-OCT and Spectralis in a separate cohort of 102 participants. Pearson correlation and Bland-Altman analyses were used to assess correlation and agreement between devices. All OCT retinal measures correlated highly between devices. The mean RNFL thickness was 7.4 mu m lower on Cirrus HD-OCT than Stratus, indicating overall poor agreement for this measurement between these machines. Further, the limits of agreement (LOA) between Cirrus HD-OCT and Stratus were wide (-4.1 to 18.9 mu m), indicating poor agreement at an individual subject level. The mean RNFL thickness was 1.94 mm (LOA: -5.74 to 9.62 mu m) higher on Spectralis compared to Cirrus HD-OCT, indicating excellent agreement for this measurement across this cohort. Although these data indicate that these three devices agree poorly at an individual subject level (evidenced by wide LOA in both study cohorts) precluding their co-utilization in everyday practice, the small difference for mean measurements between Cirrus HD-OCT and Spectralis indicate pooled results from these two SD-devices could be used as outcome measures in clinical trials, provided patients are scanned on the same machine throughout the trial, similar to the utilization of multiple different MRI platforms in MS clinical trials.	[Warner, Christina V.; Syc, Stephanie B.; Stankiewicz, Aleksandra M.; Hiremath, Girish; Farrell, Sheena K.; Calabresi, Peter A.; Saidha, Shiv] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Crainiceanu, Ciprian M.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Conger, Amy; Frohman, Teresa C.; Frohman, Elliot M.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Bisker, Esther R.; Balcer, Laura J.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Warner, CV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	calabresi@jhmi.edu; ssaidha2@jhmi.edu	Saidha, Shiv/S-1771-2019; Calabresi, Peter A./AAF-2288-2019	Saidha, Shiv/0000-0001-6387-0714; Syc-Mazurek, Stephanie/0000-0002-9549-6648	National Multiple Sclerosis Society [TR 3760-A-3, RG 4212-A-4]; National Eye Institute [R01 EY 014993, R01 EY 019473]; Braxton Debbie Angela Dillon and Skip (DADS) Donor Advisor Fund; Biogen Idec.; Biogen Idec; TEVA; Athena; Abbott Laboratories; MedicalLogix; EMD-Serono; Biogen-IDEC; Genentech; Bayer; Abbott; Vertex; NATIONAL EYE INSTITUTE [R01EY014993, R01EY019473] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Braxton Debbie Angela Dillon and Skip (DADS) Donor Advisor Fund; Biogen Idec.(Biogen); Biogen Idec(Biogen); TEVA(Teva Pharmaceutical Industries); Athena; Abbott Laboratories(Abbott Laboratories); MedicalLogix; EMD-Serono; Biogen-IDEC(Biogen); Genentech(Roche HoldingGenentech); Bayer(Bayer AG); Abbott(Abbott Laboratories); Vertex(Vertex Pharmaceuticals); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Multiple Sclerosis Society (TR 3760-A-3 to P.A.C. and RG 4212-A-4 to L.J.B.), National Eye Institute (R01 EY 014993 and R01 EY 019473 to L.J.B.), and Braxton Debbie Angela Dillon and Skip (DADS) Donor Advisor Fund (to P.A.C., L.J.B., and E.M.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Laura Balcer has served as a consultant to Biogen Idec for development of visual outcome measures for MS trials. She is also on the advisory board for an MS trial sponsored by Biogen Idec. Dr. Elliot Frohman has received speaker honoraria and consulting fees from Biogen Idec, TEVA, and Athena. He has also received consulting fees from Abbott Laboratories. Dr. Shiv Saidha has received consulting fees from MedicalLogix for the development of continuing medical education programs. Dr. Peter Calabresi has provided consultation services to Novartis, Teva, Biogen-IDEC, and has received grant support from EMD-Serono, Teva, Biogen-IDEC, Genentech, Bayer, Abbott, and Vertex. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AG Heckenlively JR, PRINCIPLES PRACTICES, P25; ALTMAN DG, 1986, J EPIDEMIOL COMMUN H, V40, P274, DOI 10.1136/jech.40.3.274; Arthur SN, 2011, EYE, V25, P192, DOI 10.1038/eye.2010.178; Balcer LJ, 2006, NEW ENGL J MED, V354, P1273, DOI 10.1056/NEJMcp053247; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bock M, 2010, MULT SCLER J, V16, P893, DOI 10.1177/1352458510365156; Budenz DL, 2008, OPHTHALMOLOGY, V115, P661, DOI 10.1016/j.ophtha.2007.05.035; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Cettomai D, 2008, ARCH NEUROL-CHICAGO, V65, P1218, DOI 10.1001/archneur.65.9.1218; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Comi G, 2011, ANN NEUROL, V69, P75, DOI 10.1002/ana.22316; Costa RA, 2004, INVEST OPHTH VIS SCI, V45, P2399, DOI 10.1167/iovs.04-0155; Costa RA, 2006, PROG RETIN EYE RES, V25, P325, DOI 10.1016/j.preteyeres.2006.03.001; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; de Boer JF, 2003, OPT LETT, V28, P2067, DOI 10.1364/OL.28.002067; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Filippi M, 1997, NEUROLOGY, V49, P371, DOI 10.1212/WNL.49.2.371; Filippi M, 1999, AM J NEURORADIOL, V20, P133; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Garcia-Martin E, 2011, INVEST OPHTH VIS SCI, V52, P4124, DOI 10.1167/iovs.10-6643; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; Grover S, 2009, INVEST OPHTHALMOL VI; Hsu IJ, 2003, APPL OPTICS, V42, P227, DOI 10.1364/AO.42.000227; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; IKUTA F, 1976, NEUROLOGY, V26, P26, DOI 10.1212/WNL.26.6_Part_2.26; Jeoung JW, 2010, INVEST OPHTH VIS SCI, V51, P938, DOI 10.1167/iovs.08-3335; Keane PA, 2009, BRIT J OPHTHALMOL, V93, P1461, DOI 10.1136/bjo.2008.155846; Knight OJ, 2009, OPHTHALMOLOGY, V116, P1271, DOI 10.1016/j.ophtha.2008.12.032; Kornek B, 1999, BRAIN PATHOL, V9, P651; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Langenegger SJ, 2011, INVEST OPHTH VIS SCI, V52, P3338, DOI 10.1167/iovs.10-6611; Leite MT, 2011, AM J OPHTHALMOL, V151, P85, DOI 10.1016/j.ajo.2010.06.041; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Madigan MC, 1996, NEUROL RES, V18, P233; Menke MN, 2009, OPHTHALMOLOGICA, V223, P352, DOI 10.1159/000226600; Minneboo A, 2009, MULT SCLER, V15, P632, DOI 10.1177/1352458509102617; Naismith RT, 2010, NEUROLOGY, V74, P1702, DOI 10.1212/WNL.0b013e3181e0434d; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; PERRY VH, 1990, J NEUROCYTOL, V19, P265, DOI 10.1007/BF01217304; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pons ME, 2005, OPHTHALMOLOGY, V112, P1079, DOI 10.1016/j.ophtha.2004.11.061; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Radue EW, 2010, J NEUROL SCI, V292, P28, DOI 10.1016/j.jns.2010.02.012; Ratchford JN., 2010, CML MULTIPLE SCLEROS, V2, P33; Rawes JA, 1997, MULT SCLER, V3, P363, DOI 10.1177/135245859700300601; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Schuman JS, 2007, INVEST OPHTH VIS SCI, V48, P3645, DOI 10.1167/iovs.06-0876; Seibold LK, 2010, AM J OPHTHALMOL, V150, P807, DOI 10.1016/j.ajo.2010.06.024; Shindler KS, 2008, EXP EYE RES, V87, P208, DOI 10.1016/j.exer.2008.05.017; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Syc SB, 2010, MULT SCLER J, V16, P829, DOI 10.1177/1352458510371640; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Tan BB, 2011, J GLAUCOMA, DOI 1097/IJG.0b013e3182071cdd; TOUSSAINT D, 1983, J CLIN NEURO-OPHTHAL, V3, P211; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; Villoslada P, 2008, NEUROLOGY, V71, P1747, DOI 10.1212/01.wnl.0000339375.92578.7e; Vizzeri G, 2009, BRIT J OPHTHALMOL, V93, P775, DOI 10.1136/bjo.2008.150698; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023	69	56	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22947	10.1371/journal.pone.0022947	http://dx.doi.org/10.1371/journal.pone.0022947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853058	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400019
J	Chong, R; Squires, R; Swiss, R; Agaisse, H				Chong, Ryan; Squires, Raynal; Swiss, Rachel; Agaisse, Herve			RNAi Screen Reveals Host Cell Kinases Specifically Involved in Listeria monocytogenes Spread from Cell to Cell	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; ARP2/3 COMPLEX; VIRULENCE FACTOR; PHOSPHOLIPASE-C; PROTEIN; RICKETTSIA; GENE; IDENTIFICATION; PATHOGENS; SEQUENCE	Intracellular bacterial pathogens, such as Listeria monocytogenes and Rickettsia conorii display actin-based motility in the cytosol of infected cells and spread from cell to cell through the formation of membrane protrusions at the cell cortex. Whereas the mechanisms supporting cytosolic actin-based motility are fairly well understood, it is unclear whether specific host factors may be required for supporting the formation and resolution of membrane protrusions. To address this gap in knowledge, we have developed high-throughput fluorescence microscopy and computer-assisted image analysis procedures to quantify pathogen spread in human epithelial cells. We used the approach to screen a siRNA library covering the human kinome and identified 7 candidate kinases whose depletion led to severe spreading defects in cells infected with L. monocytogenes. We conducted systematic validation procedures with redundant silencing reagents and confirmed the involvement of the serine/threonine kinases, CSNK1A1 and CSNK2B. We conducted secondary assays showing that, in contrast with the situation observed in CSNK2B-depleted cells, L. monocytogenes formed wild-type cytosolic tails and displayed wild-type actin-based motility in the cytosol of CSNK1A1-depleted cells. Furthermore, we developed a protrusion formation assay and showed that the spreading defect observed in CSNK1A1-depleted cells correlated with the formation of protrusion that did not resolve into double-membrane vacuoles. Moreover, we developed sending and receiving cell-specific RNAi procedures and showed that CSNK1A was required in the sending cells, but was dispensable in the receiving cells, for protrusion resolution. Finally, we showed that the observed defects were specific to Listeria monocytogenes, as Rickettsia conorii displayed wild-type cell-to-cell spread in CSNK1A1- and CSNK2B-depleted cells. We conclude that, in addition to the specific host factors supporting cytosolic actin-based motility, such as CSNK2B, Listeria monocytogenes requires specific host factors, such as CSNK1A1 in order to form productive membrane protrusions and spread from cell to cell.	[Chong, Ryan; Squires, Raynal; Swiss, Rachel; Agaisse, Herve] Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Chong, R (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA.	herve.agaisse@yale.edu			National Institutes of Health [T32 AI-07640, R01 AI-073904]; Mallinckrodt foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007640, R01AI073904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the Mallinckrodt foundation (H.A.), the National Institutes of Health training Grant T32 AI-07640 (R.C.) and Grant R01 AI-073904 (H.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman Nicole C, 2008, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03a05s11; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b; CAMILLI A, 1991, J EXP MED, V173, P751, DOI 10.1084/jem.173.3.751; CAMILLI A, 1989, P NATL ACAD SCI USA, V86, P5522, DOI 10.1073/pnas.86.14.5522; Chong R, 2009, CELL HOST MICROBE, V6, P268, DOI 10.1016/j.chom.2009.08.006; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; MENGAUD J, 1987, INFECT IMMUN, V55, P3225, DOI 10.1128/IAI.55.12.3225-3227.1987; MENGAUD J, 1991, MOL MICROBIOL, V5, P367, DOI 10.1111/j.1365-2958.1991.tb02118.x; Monack DM, 2001, CELL MICROBIOL, V3, P633, DOI 10.1046/j.1462-5822.2001.00143.x; Montes LR, 2004, BIOCHEMISTRY-US, V43, P3688, DOI 10.1021/bi0352522; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rajabian T, 2009, NAT CELL BIOL, V11, P1212, DOI 10.1038/ncb1964; Serio AW, 2010, CELL HOST MICROBE, V7, P388, DOI 10.1016/j.chom.2010.04.008; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23399	10.1371/journal.pone.0023399	http://dx.doi.org/10.1371/journal.pone.0023399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853127	Green Submitted, gold, Green Published			2022-12-27	WOS:000295454200081
J	Ellerkamp, V; Armeanu-Ebinger, S; Wenz, J; Warmann, SW; Schafer, J; Ruck, P; Fuchs, J				Ellerkamp, Verena; Armeanu-Ebinger, Sorin; Wenz, Julia; Warmann, Steven W.; Schaefer, Juergen; Ruck, Peter; Fuchs, Joerg			Successful Establishment of an Orthotopic Hepatoblastoma In Vivo Model in NOD/LtSz-scid IL2R gamma null Mice	PLOS ONE			English	Article							IMMUNODEFICIENT MICE; CELL-LINE; HEPATOCELLULAR-CARCINOMA; TUMOR-GROWTH; NUDE RATS; LIVER; TRANSPLANTATION; ADENOCARCINOMA; DOXORUBICIN; METASTASIS	Investigation of hepatoblastoma in experimental conditions contributes relevantly to a detailed understanding of tumor biology and the investigation of new treatment approaches. Most systematical analyses currently use subcutaneous xenografts. We established a reproducible intrahepatic model with the hepatoblastoma-cell lines HuH6 and HepT1. The cells were stably transfected with a plasmid vector encoding for Gaussia luciferase. HuH6 and HepT1 were injected intrasplenically in NOD/LtSz-scid IL2R gamma null mice. Mice were splenectomized in order to avoid intrasplenical tumor growth. Multifocal intrahepatic tumor growth was observed in 85% (11/13) of HuH6 tumors and 55% (5/9) of HepT1 tumors. Serum Alpha-fetoprotein and Gaussia luciferase increased 5 weeks after tumor-cell inoculation. Tumors were detected by MRI at this time point. Immunhistochemical analysis such as vascularity (CD31), proliferation index (Ki-67), cytokeratin 7 and distribution of beta - catenin in intrahepatic tumors were different to subcutaneous tumors. We established a reproducible xenograft model for intrahepatic hepatoblastoma growth with a high tumor incidence. Monitoring of tumor cell viability was optimized by measuring GLuc. This model enables further experimental investigations of HB in a more physiological milieu as emphasized by the beta-catenin distribution.	[Ellerkamp, Verena; Armeanu-Ebinger, Sorin; Wenz, Julia; Warmann, Steven W.; Fuchs, Joerg] Childrens Univ Hosp Tuebingen, Dept Pediat Surg, Tubingen, Germany; [Schaefer, Juergen] Childrens Univ Hosp Tuebingen, Dept Pediat Radiol, Tubingen, Germany; [Ruck, Peter] Inst Pathol Leonberg, Leonberg, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Ellerkamp, V (corresponding author), Childrens Univ Hosp Tuebingen, Dept Pediat Surg, Tubingen, Germany.	verenaellerkamp@googlemail.com	Ellerkamp, Verena/ABB-1100-2021	Ellerkamp, Verena/0000-0003-0221-5841	Lore Klaus Klosseck [10,000]	Lore Klaus Klosseck	Funding was provided by the Lore & Klaus Klosseck Start-Up Price (10,000(sic)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders are private funders who donated the money for the Start-up-price for young researchers of the university.	Alves F, 2001, PANCREAS, V23, P227, DOI 10.1097/00006676-200110000-00002; ARMENGOL C, 2009, INT J BIOCH CELL BIO; Belnoue E, 2004, J IMMUNOL, V173, P4882, DOI 10.4049/jimmunol.173.8.4882; Chung E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008316; DOI I, 1976, GANN, V67, P1; Freimuth J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-94; Fuchs J, 1996, J PEDIATR SURG, V31, P1241, DOI 10.1016/S0022-3468(96)90242-0; KERBEL RS, 1991, CANCER METAST REV, V10, P201, DOI 10.1007/BF00050792; Kim YR, 2005, CANCER RES, V65, P9253, DOI 10.1158/0008-5472.CAN-03-2619; LEDUC EH, 1959, CANCER RES, V19, P1091; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malogolowkin MH, 2008, J CLIN ONCOL, V26, P2379, DOI 10.1200/JCO.2006.09.7204; Martiniova L, 2009, J MAGN RESON IMAGING, V29, P685, DOI 10.1002/jmri.21654; McCrudden KW, 2003, J PEDIATR SURG, V38, P308, DOI 10.1053/jpsu.2003.50099; Melder RJ, 2002, NEOPLASIA, V4, P3, DOI 10.1038/sj.neo.7900209; MEN S, 1995, PEDIATR RADIOL, V25, P507, DOI 10.1007/BF02015780; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Perilongo G, 2004, EUR J CANCER, V40, P411, DOI 10.1016/j.ejca.2003.06.003; Perilongo G, 2009, NEW ENGL J MED, V361, P1662, DOI 10.1056/NEJMoa0810613; Pietsch T, 1996, LAB INVEST, V74, P809; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Schmitz V, 2004, J HEPATOL, V40, P787, DOI 10.1016/j.jhep.2004.01.010; Schnater JM, 2006, J HEPATOL, V45, P377, DOI 10.1016/j.jhep.2006.03.018; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; TANAKA M, 1983, BIOCHEM BIOPH RES CO, V110, P837, DOI 10.1016/0006-291X(83)91037-9; Till H, 2006, EUR J PEDIATR SURG, V16, P231, DOI 10.1055/s-2006-924373; Till H, 2005, SURG ENDOSC, V19, P1483, DOI 10.1007/s00464-005-0316-1; Varga N. L., 2010, STEM CELL STUD, V1, pe5, DOI DOI 10.4081/SCS.2010.E5; Warmann SW, 2007, CURR PHARM BIOTECHNO, V8, P93, DOI 10.2174/138920107780487456; Westwood JA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-42; Yamaoka H, 2006, ONCOL REP, V15, P551; Yamazaki M, 2004, HEPATOL RES, V30, P182, DOI 10.1016/j.hepres.2004.08.001; ZSIROS J, 2010, J CLIN ONCOL    0420	33	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23419	10.1371/journal.pone.0023419	http://dx.doi.org/10.1371/journal.pone.0023419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853130	gold, Green Published, Green Submitted			2022-12-27	WOS:000295454200083
J	Fragkos, M; Beard, P				Fragkos, Michalis; Beard, Peter			Mitotic Catastrophe Occurs in the Absence of Apoptosis in p53-Null Cells with a Defective G1 Checkpoint	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; TUMOR-CELLS; ADENOASSOCIATED VIRUS; INK4A/ARF LOCUS; CYCLE CONTROL; DEATH; AUTOPHAGY; CASPASES; PATHWAY; ARREST	Cell death occurring during mitosis, or mitotic catastrophe, often takes place in conjunction with apoptosis, but the conditions in which mitotic catastrophe may exhibit features of programmed cell death are still unclear. In the work presented here, we studied mitotic cell death by making use of a UV-inactivated parvovirus (adeno-associated virus; AAV) that has been shown to induce a DNA damage response and subsequent death of p53-defective cells in mitosis, without affecting the integrity of the host genome. Osteosarcoma cells (U2OSp53DD) that are deficient in p53 and lack the G1 cell cycle checkpoint respond to AAV infection through a transient G2 arrest. We found that the infected U2OSp53DD cells died through mitotic catastrophe with no signs of chromosome condensation or DNA fragmentation. Moreover, cell death was independent of caspases, apoptosis-inducing factor (AIF), autophagy and necroptosis. These findings were confirmed by time-lapse microscopy of cellular morphology following AAV infection. The assays used readily revealed apoptosis in other cell types when it was indeed occurring. Taken together the results indicate that in the absence of the G1 checkpoint, mitotic catastrophe occurs in these p53-null cells predominantly as a result of mechanical disruption induced by centrosome overduplication, and not as a consequence of a suicide signal.	[Fragkos, Michalis; Beard, Peter] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Fragkos, M (corresponding author), CNRS, Inst Human Genet, Montpellier, France.	peter.beard@epfl.ch	Fragkos, Michalis/GQQ-1030-2022	Fragkos, Michalis/0000-0003-2721-4327	Swiss National Science Foundation [31003A 124980]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by Swiss National Science Foundation grant number 31003A 124980, www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CW, 2000, RADIAT RES, V154, P473, DOI 10.1667/0033-7587(2000)154[0473:HTFTMG]2.0.CO;2; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; DEGTEREV A, 2008, CHEM BIOL, V5, P313; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; DOU QP, 1995, P NATL ACAD SCI USA, V92, P9019, DOI 10.1073/pnas.92.20.9019; Emanuele S, 2004, EUR J CANCER, V40, P1441, DOI 10.1016/j.ejca.2004.01.039; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Fikaris AJ, 2005, J BIOL CHEM, V280, P32107, DOI 10.1074/jbc.M504432200; Finkel E, 1999, SCIENCE, V286, P2256, DOI 10.1126/science.286.5448.2256; Fragkos M, 2008, J VIROL, V82, P7379, DOI 10.1128/JVI.00358-08; Fragkos M, 2009, MOL CELL BIOL, V29, P2828, DOI 10.1128/MCB.01830-08; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Garner E, 2008, CELL CYCLE, V7, P277, DOI 10.4161/cc.7.3.5328; Garner E, 2007, CANCER RES, V67, P7631, DOI 10.1158/0008-5472.CAN-07-0334; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huang HM, 2008, CANCER RES, V68, P3724, DOI 10.1158/0008-5472.CAN-08-0479; Ingemarsdotter C, 2010, VIROLOGY, V400, P271, DOI 10.1016/j.virol.2010.02.003; Ivanchuk SM, 2001, J NEURO-ONCOL, V51, P219, DOI 10.1023/A:1010632309113; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jin Y, 2005, CELL RES, V15, P695, DOI 10.1038/sj.cr.7290339; Jordan MA, 1996, CANCER RES, V56, P816; Jurvansuu J, 2005, J VIROL, V79, P569, DOI 10.1128/JVI.79.1.569-580.2005; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; Kim JS, 2000, ONCOGENE, V19, P6082, DOI 10.1038/sj.onc.1204008; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lock RB, 1996, CANCER RES, V56, P4006; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Meier P, 2007, MOL CELL, V28, P746, DOI 10.1016/j.molcel.2007.11.016; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Shapiro GI, 2000, CELL BIOCHEM BIOPHYS, V33, P189, DOI 10.1385/CBB:33:2:189; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Xie Q, 2004, J VIROL METHODS, V122, P17, DOI 10.1016/j.jviromet.2004.07.007; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	53	44	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22946	10.1371/journal.pone.0022946	http://dx.doi.org/10.1371/journal.pone.0022946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853057	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200029
J	Albaugh, VL; Singareddy, R; Mauger, D; Lynch, CJ				Albaugh, Vance L.; Singareddy, Ravi; Mauger, David; Lynch, Christopher J.			A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; CATIE SCHIZOPHRENIA TRIAL; MINIMAL MODEL ANALYSIS; GLUCOSE-TOLERANCE TEST; FATTY-ACID OXIDATION; LONG-TERM TREATMENT; ANTIPSYCHOTIC TREATMENT; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; BODY-WEIGHT	Background and Rationale: Atypical antipsychotics exhibit metabolic side effects including diabetes mellitus and obesity. The adverse events are preceded by acute worsening of oral glucose tolerance (oGTT) along with reduced plasma free fatty acids (FFA) and leptin in animal models. It is unclear whether the same acute effects occur in humans. Methodology/Principal Findings: A double blind, randomized, placebo-controlled crossover trial was conducted to examine the potential metabolic effects of olanzapine in healthy volunteers. Participants included male (8) and female (7) subjects [18-30 years old, BMI 18.5-25]. Subjects received placebo or olanzapine (10 mg/day) for three days prior to oGTT testing. Primary endpoints included measurement of plasma leptin, oral glucose tolerance, and plasma free fatty acids (FFA). Secondary metabolic endpoints included: triglycerides, total cholesterol, high-and low-density lipoprotein cholesterol, heart rate, blood pressure, body weight and BMI. Olanzapine increased glucose Area Under the Curve (AUC) by 42% (2808 +/- 474 vs. 3984 +/- 444 mg/dl.min; P = 0.0105) during an oGTT. Fasting plasma leptin and triglycerides were elevated 24% (Leptin: 6.8 +/- 1.3 vs. 8.4 +/- 1.7 ng/ml; P = 0.0203) and 22% (Triglycerides: 88.9 +/- 10.1 vs. 108.2 +/- 11.6 mg/dl; P = 0.0170), whereas FFA and HDL declined by 32% (FFA: 0.38 +/- 0.06 vs. 0.26 +/- 0.04 mM; P = 0.0166) and 11% (54.2 +/- 4.7 vs. 48.9 +/- 4.3 mg/dl; P = 0.0184), respectively after olanzapine. Other measures were unchanged. Conclusions/Significance: Olanzapine exerts some but not all of the early endocrine/metabolic changes observed in rodent models of the metabolic side effects, and this suggest that antipsychotic effects are not limited to perturbations in glucose metabolism alone. Future prospective clinical studies should focus on identifying which reliable metabolic alterations might be useful as potential screening tools in assessing patient susceptibility to weight gain and diabetes caused by atypical antipsychotics.	[Albaugh, Vance L.; Lynch, Christopher J.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA; [Singareddy, Ravi] Penn State Univ, Coll Med, Dept Psychiat, Hershey, PA USA; [Mauger, David] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Albaugh, VL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA.	clynch@psu.edu	Albaugh, Vance L./AAO-3966-2020; Albaugh, Vance L/J-7973-2016	Albaugh, Vance L./0000-0002-5267-8951; Albaugh, Vance L/0000-0002-5267-8951; Lynch, Christopher/0000-0003-2453-5838	NIH [DK084428]; Pennsylvania Department of Health; National Institutes of Health [M01RR10732]; GCRC [C06RR016499]; American Medical Association, Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016499, M01RR010732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084428] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Medical Association, Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH (DK084428, www.NIH.gov) and the Pennsylvania Department of Health (www.portal.state.pa.us) using Tobacco Settlement Funds. The Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. Also supported in part by a General Clinical Research Center grant from the National Institutes of Health (M01RR10732) and GCRC Construction Grant (C06RR016499) awarded to the Pennsylvania State University College of Medicine. VLA is the recipient of a seed grant from the American Medical Association, Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, MOL PSYCHIATR, V16, P569, DOI 10.1038/mp.2010.33; Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Albaugh VL, 2012, SCHIZOPHRENIA BULL, V38, P153, DOI 10.1093/schbul/sbq053; Assie MB, 2008, EUR J PHARMACOL, V592, P160, DOI 10.1016/j.ejphar.2008.06.105; Barnett AH, 2007, J PSYCHOPHARMACOL, V21, P357, DOI 10.1177/0269881107075509; Boden G, 1996, DIABETES, V45, P1044, DOI 10.2337/diabetes.45.8.1044; Chintoh AF, 2008, J CLIN PSYCHOPHARM, V28, P494, DOI 10.1097/JCP.0b013e318184b4c5; Cooper GD, 2007, J PSYCHOPHARMACOL, V21, P405, DOI 10.1177/0269881106069637; Cooper GD, 2010, J PSYCHOPHARMACOL, V24, P1069, DOI 10.1177/0269881109102543; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Eder U, 2001, AM J PSYCHIAT, V158, P1719, DOI 10.1176/appi.ajp.158.10.1719; Fell MJ, 2007, PSYCHOPHARMACOLOGY, V194, P221, DOI 10.1007/s00213-007-0833-9; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Hagg S, 2001, J CLIN PSYCHIAT, V62, P843, DOI 10.4088/JCP.v62n1102; Haupt DW, 2005, NEUROPSYCHOPHARMACOL, V30, P184, DOI 10.1038/sj.npp.1300563; Henderson DC, 2006, J CLIN PSYCHIAT, V67, P789, DOI 10.4088/JCP.v67n0513; Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19; HERPER M, 2006, BEST SELLING DRUGS A; Herran A, 2001, BRIT J PSYCHIAT, V179, P59, DOI 10.1192/bjp.179.1.59; Houseknecht KL, 2007, NEUROPSYCHOPHARMACOL, V32, P289, DOI 10.1038/sj.npp.1301209; JOKINEN MP, 1985, EXP MOL PATHOL, V42, P1, DOI 10.1016/0014-4800(85)90015-2; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P534, DOI 10.1192/bjp.183.6.534; Melkersson KI, 2001, PSYCHOPHARMACOLOGY, V154, P205, DOI 10.1007/s002130000639; Meyer JM, 2008, SCHIZOPHR RES, V103, P104, DOI 10.1016/j.schres.2008.04.023; Meyer JM, 2008, SCHIZOPHR RES, V101, P273, DOI 10.1016/j.schres.2007.12.487; Minet-Ringuet J, 2006, APPETITE, V46, P254, DOI 10.1016/j.appet.2006.01.008; Muoio DM, 2008, DIABETES, V57, P1455, DOI 10.2337/db08-0281; *NAT CTR FOR HLTH, 2010, PREV UND AD AG 20 YE; Newcomer JW, 2007, AM J MANAG CARE, V13, pS170; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P20; Newcomer JW, 2006, J CLIN PSYCHIAT, V67, P25, DOI 10.4088/JCP.1106e16; Newcomer JW, 2005, CNS DRUGS, V19, P1; Patel JK, 2009, SCHIZOPHR RES, V111, P9, DOI 10.1016/j.schres.2009.03.025; Perez-Iglesias R, 2007, J CLIN PSYCHIAT, V68, P1733, DOI 10.4088/JCP.v68n1113; Sacher J, 2008, NEUROPSYCHOPHARMACOL, V33, P1633, DOI 10.1038/sj.npp.1301541; Seeman MV, 2009, SCHIZOPHRENIA BULL, V35, P937, DOI 10.1093/schbul/sbn023; Senn S, 2002, CROSS OVER TRIALS CL; Smith RC, 2009, J CLIN PSYCHIAT, V70, P1501, DOI 10.4088/JCP.08m04446yel; Sowell M, 2003, J CLIN ENDOCR METAB, V88, P5875, DOI 10.1210/jc.2002-021884; Sowell MO, 2002, J CLIN ENDOCR METAB, V87, P2918, DOI 10.1210/jc.87.6.2918; Thakore JH, 2005, BRIT J PSYCHIAT, V186, P455, DOI 10.1192/bjp.186.6.455; Van Winkel R, 2008, J CLIN PSYCHIAT, V69, P472, DOI 10.4088/JCP.v69n0320; Vidarsdottir S, 2010, J CLIN ENDOCR METAB, V95, P118, DOI 10.1210/jc.2008-1815; WALDHAUSL W, 1989, DIABETES RES CLIN PR, V6, pS17, DOI 10.1016/0168-8227(89)90074-0; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P9, DOI 10.1177/1359786810382149	48	78	79	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22662	10.1371/journal.pone.0022662	http://dx.doi.org/10.1371/journal.pone.0022662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857944	Green Submitted, gold, Green Published			2022-12-27	WOS:000293774300005
J	Huang, T; Niu, S; Xu, ZP; Huang, Y; Kong, XY; Cai, YD; Chou, KC				Huang, Tao; Niu, Shen; Xu, Zhongping; Huang, Yun; Kong, Xiangyin; Cai, Yu-Dong; Chou, Kuo-Chen			Predicting Transcriptional Activity of Multiple Site p53 Mutants Based on Hybrid Properties	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; FEATURE-SELECTION; PROTEIN; CANCER; MUTATION; SUPPRESSOR; TUMOR; GENE; RESIDUES; FEATURES	As an important tumor suppressor protein, reactivate mutated p53 was found in many kinds of human cancers and that restoring active p53 would lead to tumor regression. In this work, we developed a new computational method to predict the transcriptional activity for one-, two-, three-and four-site p53 mutants, respectively. With the approach from the general form of pseudo amino acid composition, we used eight types of features to represent the mutation and then selected the optimal prediction features based on the maximum relevance, minimum redundancy, and incremental feature selection methods. The Mathew's correlation coefficients (MCC) obtained by using nearest neighbor algorithm and jackknife cross validation for one-, two-, three-and four-site p53 mutants were 0.678, 0.314, 0.705, and 0.907, respectively. It was revealed by the further optimal feature set analysis that the 2D (two-dimensional) structure features composed the largest part of the optimal feature set and maybe played the most important roles in all four types of p53 mutant active status prediction. It was also demonstrated by the optimal feature sets, especially those at the top level, that the 3D structure features, conservation, physicochemical and biochemical properties of amino acid near the mutation site, also played quite important roles for p53 mutant active status prediction. Our study has provided a new and promising approach for finding functionally important sites and the relevant features for in-depth study of p53 protein and its action mechanism.	[Huang, Tao; Niu, Shen] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Xu, Zhongping; Huang, Yun; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Xu, Zhongping; Huang, Yun; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University; Chinese Academy of Sciences; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [31070752]; National Basic Research Program of China [2011CB510102, 2011CB510101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Natural Science Foundation of China (Grant No. 31070752) and National Basic Research Program of China (2011CB510102, 2011CB510101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Cai YD, 2012, AMINO ACIDS, V42, P1387, DOI 10.1007/s00726-011-0835-0; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Danziger SA, 2006, IEEE ACM T COMPUT BI, V3, P114, DOI 10.1109/TCBB.2006.22; Danziger SA, 2007, BIOINFORMATICS, V23, pI104, DOI 10.1093/bioinformatics/btm166; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Joshi RR, 2010, PROTEIN PEPTIDE LETT, V17, P1198; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Martin ACR, 2002, HUM MUTAT, V19, P149, DOI 10.1002/humu.10032; Meng L, 1999, MUTAT RES-DNA REPAIR, V435, P263, DOI 10.1016/S0921-8777(99)00053-1; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mukhopadhyay UK, 2009, CELL CYCLE, V8, P2481, DOI 10.4161/cc.8.16.9269; Niu S, 2010, J PROTEOME RES, V9, P6490, DOI 10.1021/pr1007152; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; QI JP, 2010, HEALTH, V2, P137; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Yang ZH, 2003, GENETICS, V165, P695; Yi XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012495; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	49	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22940	10.1371/journal.pone.0022940	http://dx.doi.org/10.1371/journal.pone.0022940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857971	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300014
J	Selvadurai, HJ; Mason, JO				Selvadurai, Hayden J.; Mason, John O.			Wnt/beta-catenin Signalling Is Active in a Highly Dynamic Pattern during Development of the Mouse Cerebellum	PLOS ONE			English	Article							RHOMBIC-LIP; GABAERGIC INTERNEURONS; SONIC HEDGEHOG; WHITE-MATTER; INT-1 PROTOONCOGENE; NEURAL PROGENITORS; MURINE CEREBELLUM; PURKINJE-CELLS; BETA-CATENIN; EXPRESSION	The adult cerebellum is composed of several distinct cell types with well defined developmental origins. However, the molecular mechanisms that govern the generation of these cell types are only partially resolved. Wnt/beta-catenin signalling has a wide variety of roles in generation of the central nervous system, though the specific activity of this pathway during cerebellum development is not well understood. Here, we present data that delineate the spatio-temporal specific pattern of Wnt/beta-catenin signaling during mouse cerebellum development between E12.5 and P21. Using the BAT-gal Wnt/beta-catenin reporter mouse, we found that Wnt/beta-catenin activity is present transiently at the embryonic rhombic lip but not at later stages during the expansion of cell populations that arise from there. At late embryonic and early postnatal stages, Wnt/beta-catenin activity shifts to the cerebellar ventricular zone and to cells arising from this germinal centre. Subsequently, the expression pattern becomes progressively restricted to Bergmann glial cells, which show expression of the reporter at P21. These results indicate a variety of potential functions for Wnt/beta-catenin activity during cerebellum development.	[Selvadurai, Hayden J.; Mason, John O.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Selvadurai, HJ (corresponding author), Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	john.mason@ed.ac.uk	Mason, John O/A-1926-2010	Mason, John O/0000-0002-0489-2400	Wellcome Trust [083209/Z/07/A]; National Institute of Child Health and Human Development	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by award number 083209/Z/07/A from the Wellcome Trust, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Tom Pratt for useful comments on the manuscript. We are grateful to the staff of the University of Edinburgh Biological Research Resource facility for expert animal care. The mouse anti-beta-galactosidase antibody was developed by J. Sanes, and obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa (Department of Biological Sciences, Iowa City, IA).	Altman J, 1997, DEV CEREBELLAR SYSTE; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Englund C, 2006, J NEUROSCI, V26, P9184, DOI 10.1523/JNEUROSCI.1610-06.2006; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Fischer T, 2007, NEUROSCIENCE, V147, P693, DOI 10.1016/j.neuroscience.2007.04.060; Fotaki V, 2006, J NEUROSCI, V26, P9282, DOI 10.1523/JNEUROSCI.2673-06.2006; Fotaki V, 2011, J COMP NEUROL, V519, P1640, DOI 10.1002/cne.22592; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Grimaldi P, 2009, DEV BIOL, V328, P422, DOI 10.1016/j.ydbio.2009.02.008; Hachem S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-17; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hashimoto M, 2003, J NEUROSCI, V23, P11342; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; LANDRY CF, 1989, MOL BRAIN RES, V6, P251, DOI 10.1016/0169-328X(89)90071-5; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leto K, 2009, J NEUROSCI, V29, P7079, DOI 10.1523/JNEUROSCI.0957-09.2009; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Milosevic A, 2004, MOL CELL NEUROSCI, V26, P342, DOI 10.1016/j.mcn.2004.02.008; Milosevic A, 2002, J COMP NEUROL, V452, P192, DOI 10.1002/cne.10384; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Zurawel RH, 1998, CANCER RES, V58, P896	45	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e23012	10.1371/journal.pone.0023012	http://dx.doi.org/10.1371/journal.pone.0023012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857982	Green Submitted, Green Published, gold			2022-12-27	WOS:000293773300016
J	Beal, J; Lu, T; Weiss, R				Beal, Jacob; Lu, Ting; Weiss, Ron			Automatic Compilation from High-Level Biologically-Oriented Programming Language to Genetic Regulatory Networks	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; CONSTRUCTION; EXPRESSION	Background: The field of synthetic biology promises to revolutionize our ability to engineer biological systems, providing important benefits for a variety of applications. Recent advances in DNA synthesis and automated DNA assembly technologies suggest that it is now possible to construct synthetic systems of significant complexity. However, while a variety of novel genetic devices and small engineered gene networks have been successfully demonstrated, the regulatory complexity of synthetic systems that have been reported recently has somewhat plateaued due to a variety of factors, including the complexity of biology itself and the lag in our ability to design and optimize sophisticated biological circuitry. Methodology/Principal Findings: To address the gap between DNA synthesis and circuit design capabilities, we present a platform that enables synthetic biologists to express desired behavior using a convenient high-level biologically-oriented programming language, Proto. The high level specification is compiled, using a regulatory motif based mechanism, to a gene network, optimized, and then converted to a computational simulation for numerical verification. Through several example programs we illustrate the automated process of biological system design with our platform, and show that our compiler optimizations can yield significant reductions in the number of genes (similar to 50%) and latency of the optimized engineered gene networks. Conclusions/Significance: Our platform provides a convenient and accessible tool for the automated design of sophisticated synthetic biological systems, bridging an important gap between DNA synthesis and circuit design capabilities. Our platform is user-friendly and features biologically relevant compiler optimizations, providing an important foundation for the development of sophisticated biological systems.	[Beal, Jacob] BBN Technol, Cambridge, MA 02138 USA; [Lu, Ting; Weiss, Ron] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lu, Ting; Weiss, Ron] MIT, Dept Elect Engn, Cambridge, MA 02139 USA; [Lu, Ting; Weiss, Ron] MIT, Dept Comp Engn, Cambridge, MA 02139 USA	Raytheon Technologies; Raytheon BBN Technologies; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Beal, J (corresponding author), BBN Technol, Cambridge, MA 02138 USA.	jakebeal@bbn.com		Beal, Jacob/0000-0002-1663-5102	NIH [7R01GM74712-5]; DARPA [HR0011-10-C-0168]; NSF [0968682]; BBN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074712] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); BBN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH R01: "Engineering Synthetic Multicellular Systems" (Grant # 7R01GM74712-5) (http://nih.gov). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially sponsored by DARPA under contract HR0011-10-C-0168, and by an NSF CAREER award 0968682; the views and conclusions contained in this document are those of the authors and not DARPA or the U.S. Government. Jacob Beal is an employee of BBN Technologies and his work on this manuscript submission was partially internally funded by BBN. The funder, BBN Technologies, therefore played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. BBN Technologies operates on a university-like Primary Investigator model, where the dominant product is scientific research results. As a PI, Dr. Beal organizes his own research program and funds it through external grants and contracts, typically with government funding agencies. This study aids BBN Technologies financially in the same way that it would aid a university: publication of high-quality work certified by ones' scientific peers aids in securing funding for future research.	Abelson H, 2000, COMMUN ACM, V43, P74, DOI 10.1145/332833.332842; Alon U, 2007, INTRO SYSTEMS BIOL D; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; BACHRACH J, 2007, IEEE SASO 2007; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Batt G, 2007, BIOINFORMATICS, V23, P2415, DOI 10.1093/bioinformatics/btm362; Beal J, 2006, IEEE INTELL SYST, V21, P10, DOI 10.1109/MIS.2006.29; BEAL J, 2010, 45 AS C SIGN SYST CO; BEAL J, 2008, SPAT COMP WORKSH; *BERK SOFTW 2009 I, 2009, EUG; BRAUN D, 2005, IEEE INT C AC SPEECH; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; CZAR M, 2009, NUCL ACIDS RES, V37; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Feng XJ, 2004, BIOPHYS J, V87, P2195, DOI 10.1529/biophysj.104.044131; Finney A, 2006, SYSTEM MODELING CELL; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Garny A, 2008, PHILOS T R SOC A, V366, P3017, DOI 10.1098/rsta.2008.0094; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Katz R. H., 1994, CONT LOGIC DESIGN; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kittleson JT, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-10; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lu T, 2004, SYSTEMS BIOL, V1, P121, DOI 10.1049/sb:20045016; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lu T, 2007, P NATL ACAD SCI USA, V104, P18982, DOI 10.1073/pnas.0706115104; Lu T, 2006, BIOPHYS J, V91, P84, DOI 10.1529/biophysj.105.074914; Lu T, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036006; Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205; Mirschel S, 2009, BIOINFORMATICS, V25, P687, DOI 10.1093/bioinformatics/btp029; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Shetty R.P., 2008, J BIOL ENG, V2; Smith LP, 2009, BIOINFORMATICS, V25, P2452, DOI 10.1093/bioinformatics/btp401; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; SUBRAMANIAN S, 2007, THESIS PRINCETON U; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; YAMAN F, 2011, 3 INT WORKSH BIOD AU; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	53	75	75	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22490	10.1371/journal.pone.0022490	http://dx.doi.org/10.1371/journal.pone.0022490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850228	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300012
J	Hess, J; Goldman, N				Hess, Jaqueline; Goldman, Nick			Addressing Inter-Gene Heterogeneity in Maximum Likelihood Phylogenomic Analysis: Yeasts Revisited	PLOS ONE			English	Article							MODEL SELECTION; SEQUENCE EVOLUTION; NUCLEOTIDE SUBSTITUTION; INFORMATION CRITERION; PROTEIN EVOLUTION; CUG CODON; SCALE; TREES; PHYLOGENETICS; INFERENCE	Phylogenomic approaches to the resolution of inter-species relationships have become well established in recent years. Often these involve concatenation of many orthologous genes found in the respective genomes followed by analysis using standard phylogenetic models. Genome-scale data promise increased resolution by minimising sampling error, yet are associated with well-known but often inappropriately addressed caveats arising through data heterogeneity and model violation. These can lead to the reconstruction of highly-supported but incorrect topologies. With the aim of obtaining a species tree for 18 species within the ascomycetous yeasts, we have investigated the use of appropriate evolutionary models to address inter-gene heterogeneities and the scalability and validity of supermatrix analysis as the phylogenetic problem becomes more difficult and the number of genes analysed approaches truly phylogenomic dimensions. We have extended a widely-known early phylogenomic study of yeasts by adding additional species to increase diversity and augmenting the number of genes under analysis. We have investigated sophisticated maximum likelihood analyses, considering not only a concatenated version of the data but also partitioned models where each gene constitutes a partition and parameters are free to vary between the different partitions (thereby accounting for variation in the evolutionary processes at different loci). We find considerable increases in likelihood using these complex models, arguing for the need for appropriate models when analyzing phylogenomic data. Using these methods, we were able to reconstruct a well-supported tree for 18 ascomycetous yeasts spanning about 250 million years of evolution.	[Hess, Jaqueline] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hess, Jaqueline; Goldman, Nick] EMBL European Bioinformat Inst, Hinxton, England	Harvard University; European Molecular Biology Laboratory (EMBL)	Hess, J (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	jhess@oeb.harvard.edu		Goldman, Nick/0000-0001-8486-2211; Hess, Jaqueline/0000-0003-3281-5434	Biotechnology and Biological Sciences Research Council; AstraZeneca; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); Wellcome Trust(Wellcome TrustEuropean Commission)	JH was supported by a Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) CASE studentship with AstraZeneca (www.astrazeneca.com) and was a member of Clare Hall College, Univeristy of Cambridge. NG is supported by the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOFKIN L, 2005, THESIS U CAMBRIDGE; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delsuc F, 2003, SCIENCE, V301, P1482; Diezmann S, 2004, J CLIN MICROBIOL, V42, P5624, DOI 10.1128/JCM.42.12.5624-5635.2004; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Goldman N, 2002, MOL BIOL EVOL, V19, P1821, DOI 10.1093/oxfordjournals.molbev.a004007; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HESS J, 2011, THESIS U CAMBRIDGE; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; JUKES T H, 1969, P21; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kuramae EE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-134; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Le SQ, 2010, SYST BIOL, V59, P277, DOI 10.1093/sysbio/syq002; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Marcet-Houben M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004357; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Nishihara H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r199; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Ren FR, 2009, GENE, V441, P119, DOI 10.1016/j.gene.2008.04.002; Ripplinger J, 2008, SYST BIOL, V57, P76, DOI 10.1080/10635150801898920; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas Antonis, 2008, V422, P1, DOI 10.1007/978-1-59745-581-7_1; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sugita T, 1999, J GEN APPL MICROBIOL, V45, P193, DOI 10.2323/jgam.45.193; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tsui CKM, 2008, FEMS YEAST RES, V8, P651, DOI 10.1111/j.1567-1364.2007.00342.x; UZZELL T, 1971, SCIENCE, V172, P1089, DOI 10.1126/science.172.3988.1089; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2003, BIOINFORMATICS, V19, P1556, DOI 10.1093/bioinformatics/btg188; Whelan S, 2008, MOL BIOL EVOL, V25, P1683, DOI 10.1093/molbev/msn119; Whelan S, 2007, SYSTEMATIC BIOL, V56, P727, DOI 10.1080/10635150701611134; Wu Q, 2008, FEMS YEAST RES, V8, P641, DOI 10.1111/j.1567-1364.2008.00362.x; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2009, PAML PHYLOGENETIC AN; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	69	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22783	10.1371/journal.pone.0022783	http://dx.doi.org/10.1371/journal.pone.0022783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850235	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300020
J	Hussain, F; Morton, PE; Snippe, M; Sullivan, J; Farmer, C; Martin-Fernandez, ML; Parsons, M; Santis, G				Hussain, Fawziyah; Morton, Penny E.; Snippe, Marjolein; Sullivan, Janis; Farmer, Charlotte; Martin-Fernandez, Marisa L.; Parsons, Maddy; Santis, George			CAR Modulates E-Cadherin Dynamics in the Presence of Adenovirus Type 5	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULE; CELL-CELL ADHESION; RECEPTOR CAR; TIGHT JUNCTION; IMMUNOGLOBULIN SUPERFAMILY; ADHERENS JUNCTIONS; IN-VIVO; COXSACKIE; PROTEIN; BINDING	Adenovirus (Ad) serotype 5 (Ad5) fiber competitively binds to the coxsackievirus and Ad receptor (CAR) to attach Ad5 to target cells and also disrupts cell junctions and facilitates virus escape at a late stage in Ad5 infection. Here we demonstrate that paracellular permeability in MCF7 and CAR overexpressing MCF7 (FLCARMCF7) cells is increased within minutes following the addition of Ad5 to cells. This is brought about, at least in part, by altering the molecular dynamics of E-cadherin, a key component of the cell-cell adhesion complex. We also demonstrate that the increase in E-cadherin mobility is constitutively altered by the presence of CAR at FLCARMCF7 cell junctions. As increased paracellular permeability was observed early after the addition of Ad5 to cells, we postulate that this may represent a mechanism by which Ad5 could disrupt cell junctions to facilitate further access to its cell receptors.	[Hussain, Fawziyah; Morton, Penny E.; Snippe, Marjolein; Sullivan, Janis; Farmer, Charlotte; Santis, George] Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England; [Martin-Fernandez, Marisa L.] Sci & Technol Facil Council, Rutherford Appleton Lab, Oxford, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of London; King's College London	Hussain, F (corresponding author), Kings Coll London, Div Asthma Allergy & Lung Biol, London WC2R 2LS, England.	george.santis@kcl.ac.uk	Parsons, Maddy/B-2203-2013	Parsons, Maddy/0000-0002-2021-8379; martin-fernandez, marisa/0000-0001-5496-6300	Medical Research Council UK; Biotechnology and Biological Sciences Research Council UK; Royal Society of Medicine UK; National Institute Health Research Comprehensive Biomedical Research Centre at Guy's and St Thomas' and King's College London; Biotechnology and Biological Sciences Research Council [BB/G006911/1] Funding Source: researchfish; BBSRC [BB/G006911/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society of Medicine UK(Royal Society of London); National Institute Health Research Comprehensive Biomedical Research Centre at Guy's and St Thomas' and King's College London; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Medical Research Council UK, Biotechnology and Biological Sciences Research Council UK, Royal Society of Medicine UK, and the National Institute Health Research Comprehensive Biomedical Research Centre at Guy's and St Thomas' and King's College London. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Aurrand-Lions MA, 2000, CURR TOP MICROBIOL, V251, P91; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; BYERS SW, 1995, J CELL SCI, V108, P2053; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cohen CJ, 2001, J BIOL CHEM, V276, P25392, DOI 10.1074/jbc.M009531200; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Davis B, 2004, MOL THER, V10, P500, DOI 10.1016/j.ymthe.2004.05.032; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Farmer C, 2009, EXP CELL RES, V315, P2637, DOI 10.1016/j.yexcr.2009.06.008; Fok PT, 2007, J BIOL CHEM, V282, P7512, DOI 10.1074/jbc.M607230200; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Honda M, 2000, GENE THER, V7, P978, DOI 10.1038/sj.gt.3301203; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Kirby I, 1999, J VIROL, V73, P9508, DOI 10.1128/JVI.73.11.9508-9514.1999; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Konopka G, 2007, J BIOL CHEM, V282, P28137, DOI 10.1074/jbc.M703592200; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Nasdala I, 2002, J BIOL CHEM, V277, P16294, DOI 10.1074/jbc.M111999200; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Serrels A, 2009, CANCER RES, V69, P2714, DOI 10.1158/0008-5472.CAN-08-4308; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Veena MS, 2009, LAB INVEST, V89, P875, DOI 10.1038/labinvest.2009.56; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang CQF, 2007, EXP CELL RES, V313, P1373, DOI 10.1016/j.yexcr.2007.01.017; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774	39	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23056	10.1371/journal.pone.0023056	http://dx.doi.org/10.1371/journal.pone.0023056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850251	Green Submitted, gold, Green Published			2022-12-27	WOS:000293563300036
J	Chen, WT; Hayward, C; Wright, AF; Hicks, AA; Vitart, V; Knott, S; Wild, SH; Pramstaller, PP; Wilson, JF; Rudan, I; Porteous, DJ				Chen, Wanting; Hayward, Caroline; Wright, Alan F.; Hicks, Andrew A.; Vitart, Veronique; Knott, Sara; Wild, Sarah H.; Pramstaller, Peter P.; Wilson, James F.; Rudan, Igor; Porteous, David J.			Copy Number Variation across European Populations	PLOS ONE			English	Article							RECENT SEGMENTAL DUPLICATIONS; ASSOCIATION; GENE; DELETIONS; IDENTIFICATION; POLYMORPHISM; NUCLEOTIDE; EXPRESSION; DIVERSITY; EVOLUTION	Genome analysis provides a powerful approach to test for evidence of genetic variation within and between geographical regions and local populations. Copy number variants which comprise insertions, deletions and duplications of genomic sequence provide one such convenient and informative source. Here, we investigate copy number variants from genome wide scans of single nucleotide polymorphisms in three European population isolates, the island of Vis in Croatia, the islands of Orkney in Scotland and the South Tyrol in Italy. We show that whereas the overall copy number variant frequencies are similar between populations, their distribution is highly specific to the population of origin, a finding which is supported by evidence for increased kinship correlation for specific copy number variants within populations.	[Chen, Wanting; Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Ctr Mol Med,Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Hayward, Caroline; Wright, Alan F.; Vitart, Veronique] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Med Univ Lubeck, Affiliated Inst, D-23538 Lubeck, Germany; [Knott, Sara] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Wild, Sarah H.; Wilson, James F.; Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia	University of Edinburgh; University of Edinburgh; European Academy of Bozen-Bolzano; University of Lubeck; University of Edinburgh; University of Edinburgh; Krankenhaus Bozen; University of Lubeck; University of Split	Chen, WT (corresponding author), Univ Edinburgh, Western Gen Hosp, Med Genet Sect, Ctr Mol Med,Inst Genet & Mol Med, Crewe Rd S, Edinburgh, Midlothian, Scotland.	david.porteous@ed.ac.uk	Porteous, David/AAA-3446-2021; Rudan, Igor/I-1467-2012; Hayward, Caroline/M-8818-2016; Knott, Sara A/H-2466-2013; Porteous, David J/C-7289-2013; Wilson, James F/A-5704-2009; Pramstaller, Peter P/C-2357-2008; Hicks, Andrew Anthony/E-9518-2017; chen, want/GRX-0662-2022	Porteous, David/0000-0003-1249-6106; Rudan, Igor/0000-0001-6993-6884; Hayward, Caroline/0000-0002-9405-9550; Knott, Sara A/0000-0002-4568-2928; Porteous, David J/0000-0003-1249-6106; Wilson, James F/0000-0001-5751-9178; Hicks, Andrew Anthony/0000-0001-6320-0411; Pramstaller, Peter P/0000-0002-9831-8302	Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; Office of the Scottish Government; Royal Society; European Union [LSHG-CT-2006-018947]; Medical Research Council (UK); Wellcome Trust; Republic of Croatia Ministry of Science, Education and Sports [108-1080315-0302]; P.R. [196-1962766-2751]; Scottish Executive Health Department, Chief Scientist Office [CZB/4/285]; MRC [MC_PC_U127561128, MC_U127561128] Funding Source: UKRI; Medical Research Council [G0700704B, MC_PC_U127561128, MC_U127561128] Funding Source: researchfish; Chief Scientist Office [CZB/4/710, CZD/16/6/2] Funding Source: researchfish	Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; Office of the Scottish Government; Royal Society(Royal Society of London); European Union(European Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Republic of Croatia Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); P.R.; Scottish Executive Health Department, Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The MICROS study in South Tyrol was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. ORCADES was supported by the Chief Scientist Office of the Scottish Government(http://www.cso.scot.nhs.uk/), the Royal Society (http://royalsociety.org/) and the European Union framework program 6 EUROSPAN project (http://cordis.europa.eu/fp6/dc/index.cfm?fuseaction=UserSite.FP6HomePage contract no. LSHG-CT-2006-018947) (I.R., H.C., J.F.W.). VIS study research was funded by grants from the Medical Research Council (UK)(http://www.mrc.ac.uk/index.htm), the Wellcome Trust (http://www.wellcome.ac.uk/), Republic of Croatia Ministry of Science, Education and Sports grants to I.R. (108-1080315-0302), P.R. (196-1962766-2751). It is now components of the EU Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) (A.F.W.) W. Chen's PhD study was supported by Generation Scotland project which was funded by a project grant from the Scottish Executive Health Department, Chief Scientist Office (CZB/4/285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2008, CYTOGENET GENOME RES, V123, P234, DOI 10.1159/000184713; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cowell JK, 2009, METHODS MOL BIOL, V556, P47, DOI 10.1007/978-1-60327-192-9_5; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cronin S, 2008, HUM MOL GENET, V17, P3392, DOI 10.1093/hmg/ddn233; Cutler G, 2008, CYTOGENET GENOME RES, V123, P297, DOI 10.1159/000184721; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Franke L, 2008, AM J HUM GENET, V82, P1316, DOI 10.1016/j.ajhg.2008.05.008; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kamatani Y, 2008, J HUM GENET, V53, P64, DOI 10.1007/s10038-007-0219-1; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Mascalzoni D, 2010, EUR J HUM GENET, V18, P296, DOI 10.1038/ejhg.2009.155; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Nguyen DQ, 2008, GENOME RES, V18, P1711, DOI 10.1101/gr.077289.108; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Peltonen L, 2000, HUM HERED, V50, P66, DOI 10.1159/000022892; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pielberg G, 2002, GENETICS, V160, P305; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Vitart V, 2006, EUR J HUM GENET, V14, P478, DOI 10.1038/sj.ejhg.5201589; Vitart V, 2010, INVEST OPHTH VIS SCI, V51, P737, DOI 10.1167/iovs.09-3720; WANG J, 2008, CYTOGENET GENOME RES, V123, P322; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Winchester L, 2008, CYTOGENET GENOME RES, V123, P322, DOI 10.1159/000184724; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Yang SZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004474; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	50	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23087	10.1371/journal.pone.0023087	http://dx.doi.org/10.1371/journal.pone.0023087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829696	Green Submitted, gold, Green Published			2022-12-27	WOS:000293561200046
J	Jakobsen, JC; Hansen, JL; Storebo, OJ; Simonsen, E; Gluud, C				Jakobsen, Janus Christian; Hansen, Jane Lindschou; Storebo, Ole Jakob; Simonsen, Erik; Gluud, Christian			The Effects of Cognitive Therapy Versus 'Treatment as Usual' in Patients with Major Depressive Disorder	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MENTAL-HEALTH-TREATMENT; COLLABORATIVE RESEARCH-PROGRAM; BEHAVIORAL TREATMENT; NATIONAL-INSTITUTE; NIMH TREATMENT; RATING-SCALE; ANTIDEPRESSANT MEDICATION; TREATING DEPRESSION; TREATMENT RESPONSE	Background: Major depressive disorder afflicts an estimated 17% of individuals during their lifetimes at tremendous suffering and costs. Cognitive therapy may be an effective treatment option for major depressive disorder, but the effects have only had limited assessment in systematic reviews. Methods/Principal Findings: Cochrane systematic review methodology, with meta-analyses and trial sequential analyses of randomized trials, are comparing the effects of cognitive therapy versus 'treatment as usual' for major depressive disorder. To be included the participants had to be older than 17 years with a primary diagnosis of major depressive disorder. Altogether, we included eight trials randomizing a total of 719 participants. All eight trials had high risk of bias. Four trials reported data on the 17-item Hamilton Rating Scale for Depression and four trials reported data on the Beck Depression Inventory. Meta-analysis on the data from the Hamilton Rating Scale for Depression showed that cognitive therapy compared with 'treatment as usual' significantly reduced depressive symptoms (mean difference -2.15 (95% confidence interval -3.70 to -0.60; P < 0.007, no heterogeneity)). However, meta-analysis with both fixed-effect and random-effects model on the data from the Beck Depression Inventory (mean difference with both models -1.57 (95% CL -4.30 to 1.16; P = 0.26, I-2 = 0) could not confirm the Hamilton Rating Scale for Depression results. Furthermore, trial sequential analysis on both the data from Hamilton Rating Scale for Depression and Becks Depression Inventory showed that insufficient data have been obtained. Discussion: Cognitive therapy might not be an effective treatment for major depressive disorder compared with 'treatment as usual'. The possible treatment effect measured on the Hamilton Rating Scale for Depression is relatively small. More randomized trials with low risk of bias, increased sample sizes, and broader more clinically relevant outcomes are needed.	[Jakobsen, Janus Christian; Storebo, Ole Jakob; Simonsen, Erik] Copenhagen Univ Hosp, Psychiat Res Unit, Roskilde, Denmark; [Jakobsen, Janus Christian; Hansen, Jane Lindschou; Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit,Dept 3344, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen	Jakobsen, JC (corresponding author), Copenhagen Univ Hosp, Psychiat Res Unit, Roskilde, Denmark.	janusjakobsen@mac.com	Jakobsen, Janus Christian/N-2419-2013; Simonsen, Erik/N-6615-2014; Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022	Jakobsen, Janus Christian/0000-0002-3642-2120; Simonsen, Erik/0000-0002-6134-2392; Gluud, Christian/0000-0002-8861-0799; 				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arnow BA, 2003, J CLIN PSYCHOL, V59, P893, DOI 10.1002/jclp.10181; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; Barber JP, 1996, J CONSULT CLIN PSYCH, V64, P951, DOI 10.1037/0022-006X.64.5.951; Barnhofer T, 2009, BEHAV RES THER, V47, P366, DOI 10.1016/j.brat.2009.01.019; Bech P, STRESS LIVSKVALITET; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT, 1979, AUST NZ J PSYCHIAT, V36, P275; BLACKBURN IM, 1983, BRIT J PSYCHIAT, V143, P609, DOI 10.1192/bjp.143.6.609; BLACKBURN IM, 1981, BRIT J PSYCHIAT, V139, P181, DOI 10.1192/bjp.139.3.181; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; BOWERS WA, 1990, BRIT J PSYCHIAT, V156, P73, DOI 10.1192/bjp.156.1.73; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Chakraborty R, 2007, INTERNET J MENTAL HL, V4; Cipriani A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006532.pub2; Clark LA, REDUCING RELAPSE REC; COMASDIAZ L, 1981, J CONSULT CLIN PSYCH, V49, P627, DOI 10.1037/0022-006X.49.5.627; COVI L, 1987, PSYCHOPHARMACOL BULL, V23, P173; Davidson KW, 2010, ARCH INTERN MED, V170, P600, DOI 10.1001/archinternmed.2010.29; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Dobson KS, 2008, J CONSULT CLIN PSYCH, V76, P468, DOI 10.1037/0022-006X.76.3.468; Dozois DJA, 2009, J CONSULT CLIN PSYCH, V77, P1078, DOI 10.1037/a0016886; ELKIN I, 1985, ARCH GEN PSYCHIAT, V42, P305; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; Embling S, 1987, NURSING STANDARD, V17, P33; FAWCETT J, 1993, INT CLIN PSYCHOPHARM, V8, P217, DOI 10.1097/00004850-199300840-00002; FITZGIBBON ML, 1988, J CLIN PSYCHOL, V44, P372, DOI 10.1002/1097-4679(198805)44:3<372::AID-JCLP2270440310>3.0.CO;2-E; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Gluud C, 2006, J HEPATOL, V44, P607, DOI 10.1016/j.jhep.2005.12.006; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Gonzalez SG, 2006, PSICOTHEMA, V18, P471; Gordon V C, 1988, Arch Psychiatr Nurs, V2, P218; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HARPIN RE, 1982, J NERV MENT DIS, V170, P295, DOI 10.1097/00005053-198205000-00007; Hautzinger M, 1996, Z KLIN PSYCHOL-FORSC, V25, P146; Hautzinger M, 2004, VERHALTENSTHERAPIE P, V36, P789; Heo M, 2007, AM J GERIAT PSYCHIAT, V15, P899, DOI 10.1097/JGP.0b013e318098614e; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; HOLLON SD, 1992, ARCH GEN PSYCHIAT, V49, P774; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Horowitz JL, 2007, J CONSULT CLIN PSYCH, V75, P693, DOI 10.1037/0022-006X.75.5.693; Howard M, 2006, ARCH WOMEN MENT HLTH, V9, P213, DOI 10.1007/s00737-006-0135-y; IMBER SD, 1990, J CONSULT CLIN PSYCH, V58, P352, DOI 10.1037/0022-006X.58.3.352; JACOBSON NS, 1993, J CONSULT CLIN PSYCH, V61, P516, DOI 10.1037/0022-006X.61.3.516; Jakobsen J, 2010, EFFECT COGNITIVE THE; Jarrett RB, 1999, ARCH GEN PSYCHIAT, V56, P431, DOI 10.1001/archpsyc.56.5.431; Kendrick T, 2010, BRIT J PSYCHIAT, V197, P345, DOI 10.1192/bjp.bp.109.074575; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Keus F, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-90; King M, 2000, HLTH TECHNOLOGY ASSE, V4, P1; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Levav I, 2002, ISRAEL J PSYCHIAT, V39, P50; Maynard C K, 1993, Arch Psychiatr Nurs, V7, P277, DOI 10.1016/0883-9417(93)90005-H; MILLER IW, 1990, COMPR PSYCHIAT, V31, P62, DOI 10.1016/0010-440X(90)90055-W; MILLER IW, 1989, AM J PSYCHIAT, V146, P1274; MILLER IW, 1989, BEHAV THER, V20, P25, DOI 10.1016/S0005-7894(89)80116-9; Mirabel-Sarron C, 1992, PSYCHOL FR, V37, P277; Miranda J, 2006, J CONSULT CLIN PSYCH, V74, P99, DOI 10.1037/0022-006X.74.1.99; Miranda J, 2003, PSYCHIAT SERV, V54, P219, DOI 10.1176/appi.ps.54.2.219; Miranda J, 2003, JAMA-J AM MED ASSOC, V290, P57, DOI 10.1001/jama.290.1.57; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MURPHY GE, 1984, ARCH GEN PSYCHIAT, V41, P33; PACE TM, 1993, J COUNS PSYCHOL, V40, P288, DOI 10.1037/0022-0167.40.3.288; Paykel ES, 1999, ARCH GEN PSYCHIAT, V56, P829, DOI 10.1001/archpsyc.56.9.829; Revicki DA, 2005, ARCH GEN PSYCHIAT, V62, P868, DOI 10.1001/archpsyc.62.8.868; Rohan KJ, 2007, J CONSULT CLIN PSYCH, V75, P489, DOI 10.1037/0022-006X.75.3.489; Rohan KJ, 2009, BEHAV THER, V40, P225, DOI 10.1016/j.beth.2008.06.004; Rose S, PSYCHOL DEBRIEFING P; ROSS M, 1985, J ROY COLL GEN PRACT, V35, P239; Sado M, 2009, AUST NZ J PSYCHIAT, V43, P539, DOI 10.1080/00048670902873664; SCOTT AIF, 1992, BRIT MED J, V304, P883, DOI 10.1136/bmj.304.6831.883; Scott C, 1997, BRIT J PSYCHIAT, V171, P131, DOI 10.1192/bjp.171.2.131; Scott J, 2000, BRIT J PSYCHIAT, V177, P440, DOI 10.1192/bjp.177.5.440; SCOTT MJ, 1990, BEHAV PSYCHOTHER, V18, P1, DOI 10.1017/S014134730001795X; Shamsaei F, 2008, HONG KONG J PSYCHIAT, V18, P76; SHEA MT, 1990, AM J PSYCHIAT, V147, P711; SHEA MT, 1992, ARCH GEN PSYCHIAT, V49, P782, DOI 10.1001/archpsyc.1992.01820100026006; SIMONS AD, 1984, J AFFECT DISORDERS, V6, P163, DOI 10.1016/0165-0327(84)90021-1; Sofuoglu M, 2010, EXP CLIN PSYCHOPHARM, V18, P109, DOI 10.1037/a0019295; SOTSKY SM, 1991, AM J PSYCHIAT, V148, P997; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Stewart JW, 1998, J CLIN PSYCHOPHARM, V18, P429, DOI 10.1097/00004714-199812000-00002; TEASDALE JD, 1984, BRIT J PSYCHIAT, V144, P400, DOI 10.1192/bjp.144.4.400; The Nordic Cochrane Centre TCC, 2008, REV MAN REVMAN COMP, V5.0; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Usaf SO, 1990, J COGN PSYCHOTHER, V4, P51; Verduyn C, 2003, BRIT J PSYCHIAT, V183, P342, DOI 10.1192/bjp.183.4.342; Vittengl JR, 2004, J PERS ASSESS, V83, P235, DOI 10.1207/s15327752jpa8303_07; Walwyn R, 2010, STAT METHODS MED RES, V19, P291, DOI 10.1177/0962280209105017; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; WHISMAN MA, 1991, J CONSULT CLIN PSYCH, V59, P282, DOI 10.1037/0022-006X.59.2.282; Wiles NJ, 2008, BEHAV COGN PSYCHOTH, V36, P21, DOI 10.1017/S135246580700389X; Wilkins CH, 2009, CLIN INTERV AGING, V4, P51; WILSON PH, 1983, COGNITIVE THER RES, V7, P111, DOI 10.1007/BF01190064; Wong DFK, 2008, DEPRESS ANXIETY, V25, P142, DOI 10.1002/da.20286; Wong DFK, 2009, BEHAV CHANGE, V26, P130; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 1992, INT STAT CLASS DIS R; Wright JH, 2005, AM J PSYCHIAT, V162, P1158, DOI 10.1176/appi.ajp.162.6.1158	106	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22890	10.1371/journal.pone.0022890	http://dx.doi.org/10.1371/journal.pone.0022890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829664	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200035
J	Mann, RP				Mann, Richard P.			Bayesian Inference for Identifying Interaction Rules in Moving Animal Groups	PLOS ONE			English	Article							COLLECTIVE MOTION; LEADERSHIP; INFORMATION; BEHAVIOR; PIGEONS; SYSTEM	The emergence of similar collective patterns from different self-propelled particle models of animal groups points to a restricted set of "universal'' classes for these patterns. While universality is interesting, it is often the fine details of animal interactions that are of biological importance. Universality thus presents a challenge to inferring such interactions from macroscopic group dynamics since these can be consistent with many underlying interaction models. We present a Bayesian framework for learning animal interaction rules from fine scale recordings of animal movements in swarms. We apply these techniques to the inverse problem of inferring interaction rules from simulation models, showing that parameters can often be inferred from a small number of observations. Our methodology allows us to quantify our confidence in parameter fitting. For example, we show that attraction and alignment terms can be reliably estimated when animals are milling in a torus shape, while interaction radius cannot be reliably measured in such a situation. We assess the importance of rate of data collection and show how to test different models, such as topological and metric neighbourhood models. Taken together our results both inform the design of experiments on animal interactions and suggest how these data should be best analysed.	Uppsala Univ, Ctr Interdisciplinary Math, Uppsala, Sweden	Uppsala University	Mann, RP (corresponding author), Uppsala Univ, Ctr Interdisciplinary Math, Uppsala, Sweden.	rmann@math.uu.se	Mann, Richard/N-9779-2014	Mann, Richard/0000-0003-0701-1274	Centre for Interdisciplinary Mathematics at Uppsala University; ERC	Centre for Interdisciplinary Mathematics at Uppsala University; ERC(European Research Council (ERC)European Commission)	The author is primarily funded by the Centre for Interdisciplinary Mathematics at Uppsala University. This work was also in part funded by an ERC starting grant to David Sumpter (ref: IDCAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2010, J R SOC INTERFACE, V7, P1441, DOI 10.1098/rsif.2010.0175; AKOS Z, 2008, NATURE, V105, P4139; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Bergman G., 1964, Acta Zoologica Fennica, VNo. 105, P1; BERNARDO JM, 2007, BAYESIAN THEORY BARN; Biro D, 2002, J EXP BIOL, V205, P3833; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; BURGI C, 1999, THESIS SWISS FEDERAL; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Eriksson A, 2010, BEHAV ECOL, V21, P1106, DOI 10.1093/beheco/arq118; Freeman R, 2011, BIOL LETTERS, V7, P63, DOI 10.1098/rsbl.2010.0627; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Kudrolli A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058001; Li YX, 2008, PHYSICA D, V237, P699, DOI 10.1016/j.physd.2007.10.009; Lochmatter T, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P4004, DOI 10.1109/IROS.2008.4650937; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; MacKay D. J. C., 2003, INFORM THEORY INFERE; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P2635, DOI 10.1098/rspb.2009.0350; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shibata T, 1999, PHYS REV LETT, V82, P4424, DOI 10.1103/PhysRevLett.82.4424; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Steager EB, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2953245; Strombom D, 2011, J THEOR BIOL, V283, P145, DOI 10.1016/j.jtbi.2011.05.019; Sumpter D, 2008, THEOR BIOSCI, V127, P177, DOI 10.1007/s12064-008-0040-1; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; VICSEK T, 2010, COLLECTIVE MOTION; WIKELSKI M, 2008, GLOBAL SATELLITE TRA; Wilkin TA, 2009, J AVIAN BIOL, V40, P135, DOI 10.1111/j.1600-048X.2009.04362.x	34	43	46	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22827	10.1371/journal.pone.0022827	http://dx.doi.org/10.1371/journal.pone.0022827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829657	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200033
J	Schonecker, B; Freimanis, T; Sorensen, IV				Schonecker, Bryan; Freimanis, Tonny; Sorensen, Irene Vejgaard			Diabetes in Danish Bank Voles (M. glareolus): Survivorship, Influence on Weight, and Evaluation of Polydipsia as a Screening Tool for Hyperglycaemia	PLOS ONE			English	Article							LJUNGAN VIRUS; MYODES-GLAREOLUS; CLETHRIONOMYS-GLAREOLUS; LEW.1AR1/ZTM-IDDM RAT; PANCREATIC-ISLETS; LIFE-EXPECTANCY; STOOL SAMPLES; ANIMAL-MODELS; WILD-CAUGHT; TYPE-1	Background: Previous studies have concluded that the development of polydipsia (PD, a daily water intake >= 21 ml) among captive Danish bank voles, is associated with the development of a type 1 diabetes (T1D), based on findings of hyperglycaemia, glucosuria, ketonuria/-emia, lipemia, destroyed beta cells, and presence of autoantibodies against GAD65, IA-2, and insulin. Aim and Methods: We retrospectively analysed data from two separate colonies of Danish bank voles in order to 1) estimate survivorship after onset of PD, 2) evaluate whether the weight of PD voles differed from non-PD voles, and, 3), evaluate a state of PD as a practical and non-invasive tool to screen for voles with a high probability of hypeglycaemia. In addition, we discuss regional differences related to the development of diabetes in Scandinavian bank voles and the relevance of the Ljungan virus as proposed etiological agent. Results: We found that median survival after onset of PD is at least 91 days (lower/upper quartiles = 57/134 days) with a maximum recording of at least 404 days survivorship. The development of PD did not influence the weight of Danish bank voles. The measures of accuracy when using PD as predictor of hyperglycaemia, i.e. sensitivity, specificity, positive predictive value, and negative predictive value, equalled 69%, 97%, 89%, and 89%, respectively. Conclusion: The relatively long survival of Danish PD bank voles suggests potentials for this model in future studies of the long-term complications of diabetes, of which some observations are mentioned. Data also indicates that diabetes in Danish bank is not associated with a higher body weight. Finally, the method of using measurements of daily water intake to screen for voles with a high probability of hyperglycaemia constitutes a considerable refinement when compared to the usual, invasive, methods.	[Schonecker, Bryan; Freimanis, Tonny] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Sorensen, Irene Vejgaard] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Schonecker, B (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	bryan@clethrionomys.info			Danish Research Council; Apodemus AB; Swedish company (Apodemus AB)	Danish Research Council(Det Frie Forskningsrad (DFF)); Apodemus AB; Swedish company (Apodemus AB)	This study was in part supported by donations from the Danish Research Council and Apodemus AB, neither of which had any influence on either study, analysis, interpretations, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study was in part supported by donations from a private Swedish company (Apodemus AB), which have had no influence on either the study, analysis, interpretations, decision to publish, or preparation of the manuscript. The donations were used to pay a minor part of the expenses to keep the colony (rent, food and woodcutting). However, Bo Niklasson (CEO and co-owner of Apodemus AB) assisted Schonecker on one single occasion where Niklasson performed the actual orbital bleedings on 128 Danish bank voles, which then were analysed for blood glucose by Schonecker. Neither the brief funding from Apodemus AB, nor this one-time assistance, does in any way alter the authors adherence to all the PLoS ONE policies on sharing data and materials. The authors have declared that no further potential competing interests exist.	Amaral S, 2008, CURR DIABETES REV, V4, P46, DOI 10.2174/157339908783502398; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Babik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-390; BENNETT PH, 1983, ANNU REV MED, V34, P295, DOI 10.1146/annurev.me.34.020183.001455; Blixt M, 2007, GEN COMP ENDOCR, V154, P41, DOI 10.1016/j.ygcen.2007.06.019; Blixt M, 2010, J ENDOCRINOL, V206, P47, DOI 10.1677/JOE-10-0074; Blixt M, 2009, MOL CELL ENDOCRINOL, V305, P1, DOI 10.1016/j.mce.2009.02.010; Boettler T, 2010, INT IMMUNOPHARMACOL, V10, P1491, DOI 10.1016/j.intimp.2010.07.008; Bollyky J, 2008, MT SINAI J MED, V75, P385, DOI 10.1002/msj.20054; Bonifacio E, 2001, DIABETES, V50, P2451, DOI 10.2337/diabetes.50.11.2451; Burner TW, 2009, CURR OPIN RHEUMATOL, V21, P50, DOI 10.1097/BOR.0b013e32831bc0c4; BUSCHARD K, 2003, HDB LAB ANIMAL SCI A, P157; Cebioglu Melanie, 2008, Infectious Disorders - Drug Targets, V8, P76; Christensen SD, 2009, LAB ANIM-UK, V43, P65, DOI 10.1258/la.2008.007075; Cooper JJ, 1996, ANIM WELFARE, V5, P245; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Deedwania Prakash, 2008, Expert Rev Cardiovasc Ther, V6, P127, DOI 10.1586/14779072.6.1.127; Donmez FY, 2008, ACTA RADIOL, V49, P673, DOI 10.1080/02841850802105269; Ekstrom JO, 2007, VIRUS RES, V130, P129, DOI 10.1016/j.virusres.2007.06.004; ENGEL L, 1998, PRACTICAL DIABETES I, V15, P15, DOI DOI 10.1002/pdi.1960150110; Flores JE, 2008, MOL IMAGING BIOL, V10, P192, DOI 10.1007/s11307-008-0137-4; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Freimanis Tonny, 2003, Int J Exp Diabesity Res, V4, P21; FURDELL EL, 2009, FATAL THIRST DIABETE, P194; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Hageman Ida, 1994, P103; Hauffe HC, 2010, J WILDLIFE DIS, V46, P262, DOI 10.7589/0090-3558-46.1.262; Holmberg R, 2009, MICROBIOL IMMUNOL, V53, P567, DOI 10.1111/j.1348-0421.2009.00160.x; In't Veld P, 2009, DIABETES, V58, P1257, DOI 10.2337/db09-0345; Intagliata Nicolas, 2007, Curr Gastroenterol Rep, V9, P270, DOI 10.1007/s11894-007-0030-3; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Jorns A, 2004, VIRCHOWS ARCH, V444, P183, DOI 10.1007/s00428-003-0956-2; KAWANO K, 1991, DIABETES, V40, P1375, DOI 10.2337/diabetes.40.11.1375; KEEN H, 1982, CLIN ENDOCRINOL META, V11, P279, DOI 10.1016/S0300-595X(82)80017-0; KOLB H, 1987, DIABETES METAB REV, V3, P751, DOI 10.1002/dmr.5610030308; Komeda K, 1998, ENDOCR J, V45, P737, DOI 10.1507/endocrj.45.737; Krous HF, 2010, BIRTH DEFECTS RES A, V88, P947, DOI 10.1002/bdra.20728; Leal J, 2009, EUR HEART J, V30, P834, DOI 10.1093/eurheartj/ehn567; LEITER EH, 1987, AM J PATHOL, V128, P380; Lenzen S, 2001, DIABETOLOGIA, V44, P1189, DOI 10.1007/s001250100625; Lernmark A, 2004, AUTOIMMUNITY, V37, P341, DOI 10.1080/08916930410001726012; Leslie RDG, 2004, DIABETES, V53, P3033, DOI 10.2337/diabetes.53.12.3033; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; LORENZEN T, 1994, DIABETOLOGIA, V37, P321, DOI 10.1007/BF00398061; Makino S, 1980, Jikken Dobutsu, V29, P1; Maria H, 2005, J CLIN VIROL, V33, P158, DOI 10.1016/j.jcv.2004.12.009; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mathews CE, 2005, PEDIATR DIABETES, V6, P165, DOI 10.1111/j.1399-543X.2005.00123.x; Meier JJ, 2008, DIABETOLOGIA, V51, P703, DOI 10.1007/s00125-008-0936-9; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; MORDES JP, 1987, DIABETES METAB REV, V3, P725, DOI 10.1002/dmr.5610030307; NAKHOODA AF, 1977, DIABETES, V26, P100, DOI 10.2337/diabetes.26.2.100; NAKHOODA AF, 1978, DIABETOLOGIA, V14, P199, DOI 10.1007/BF00429781; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nemirov K, 2010, J GEN VIROL, V91, P1262, DOI 10.1099/vir.0.016618-0; Niklasson B, 2003, ANN NY ACAD SCI, V1005, P170, DOI 10.1196/annals.1288.020; Niklasson B, 1998, EMERG INFECT DIS, V4, P187, DOI 10.3201/eid0402.980206; Niklasson B, 1999, VIROLOGY, V255, P86, DOI 10.1006/viro.1998.9557; NIKLASSON B, Patent No. 1432990; NIKLASSON B, Patent No. 7560609; Niklasson B, 2006, OECOLOGIA, V150, P1, DOI 10.1007/s00442-006-0493-1; Niklasson Bo, 2003, Int J Exp Diabesity Res, V4, P35; Niklasson B, 2009, BIRTH DEFECTS RES A, V85, P542, DOI 10.1002/bdra.20568; Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08; Odberg F.O., 1978, P 1 WORLD C ETH APPL, V1, P475; ODBERG FO, 1987, BEHAV PROCESS, V14, P155, DOI 10.1016/0376-6357(87)90042-8; Ojetti V, 2009, EUR REV MED PHARMACO, V13, P419; Ostman J, 2008, J INTERN MED, V263, P386, DOI 10.1111/j.1365-2796.2007.01896.x; PORTH CM, 1998, PATHOPHYSIOLOGY CONC, P815; Roep BO, 2007, ANN NY ACAD SCI, V1103, P1, DOI 10.1196/annals.1394.018; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; ROZA AM, 1992, AM J SURG, V163, P417, DOI 10.1016/0002-9610(92)90044-R; Schoenecker B, 2000, APPL ANIM BEHAV SCI, V68, P339, DOI 10.1016/S0168-1591(00)00114-3; Schoenecker B, 2000, APPL ANIM BEHAV SCI, V68, P349, DOI 10.1016/S0168-1591(00)00108-8; Schonecker B, 2009, APPL ANIM BEHAV SCI, V121, P55, DOI 10.1016/j.applanim.2009.08.003; Shier D, 2010, HOLES HUMAN ANATOMY, P482; Sima AAF, 2006, ANN NY ACAD SCI, V1084, P235, DOI 10.1196/annals.1372.004; SORENSEN G, 1986, STRESS MEDICINE, V2, P103; TANIGUCHI H, 2007, ANIMAL MODELS DIABET, P41; Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283; Tapia G, 2010, DIABETES CARE, V33, P1069, DOI 10.2337/dc09-1951; Thrower SL, 2009, DIABETES OBES METAB, V11, P931, DOI 10.1111/j.1463-1326.2009.01064.x; van Duinen MA, 2007, INT J NEUROPSYCHOPH, V10, P797; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; van Herck H, 2000, LAB ANIM, V34, P10, DOI 10.1258/002367700780577993; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; Zhao Y, 2010, J DIABETES COMPLICAT, V24, P9, DOI 10.1016/j.jdiacomp.2008.09.001; YSI 2700 SELECT BIOC	90	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22893	10.1371/journal.pone.0022893	http://dx.doi.org/10.1371/journal.pone.0022893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829666	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200037
J	Yu, L; Lu, JB				Yu, Lin; Lu, Jianbo			Does Landscape Fragmentation Influence Sex Ratio of Dioecious Plants? A Case Study of Pistacia chinensis in the Thousand-Island Lake Region of China	PLOS ONE			English	Article							HABITAT FRAGMENTATION; RESOURCE-ALLOCATION; PATERNITY ANALYSIS; POLLEN DISPERSAL; POPULATION-SIZE; POLLINATOR; PATTERNS; ECOSYSTEM; CONSEQUENCES; DENSITY	The Thousand-Island Lake region in Zhejiang Province, China is a highly fragmented landscape with a clear point-in-time of fragmentation as a result of flooding to form the reservoir. Islands in the artificial lake were surveyed to examine how population sex ratio of a dioecious plant specie Pistacia chinensis B. was affected by landscape fragmentation. A natural population on the mainland near the lake was also surveyed for comparison. Population size, sex ratio and diameter at breast height (DBH) of individuals were measured over 2 years. More than 1,500 individuals, distributed in 31 populations, were studied. Soil nitrogen in the different populations was measured to identify the relationship between sex ratio and micro-environmental conditions. In accordance with the results of many other reports on biased sex ratio in relation to environmental gradient, we found that poor soil nitrogen areas fostered male-biased populations. In addition, the degree of sex ratio bias increased with decreasing population size and population connectivity. The biased sex ratios were only found in younger individuals (less than 50 years old) in small populations, while a stable 1:1 sex ratio was found in the large population on the mainland. We concluded that the effects of landscape fragmentation on the dioecious population sex ratio were mainly achieved in relation to changing soil nitrogen conditions in patches and pollen limitation within and among populations. Large populations could maintain a more suitable environment in terms of nutrient conditions and pollen flow, subsequently maintaining a stable sex ratio in dioecious plant populations. Both micro-environmental factors and spatial structure should be considered in fragmented landscape for the conservation of dioecious plant species.	[Yu, Lin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Jianbo] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University	Yu, L (corresponding author), Zhejiang Univ, Coll Life Sci, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	jianbo.lu63@gmail.com			National Natural Science Foundation of China [30570320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (30570320). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN J, 1988, ECOLOGY, V69, P962, DOI 10.2307/1941251; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Banuelos MJ, 2004, EVOL ECOL RES, V6, P397; Bertiller MB, 2002, BIODIVERS CONSERV, V11, P69, DOI 10.1023/A:1014084024145; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Cairns J, 1997, INT J SUST DEV WORLD, V4, P153, DOI 10.1080/13504509709469951; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; DANELL K, 1991, OIKOS, V62, P145, DOI 10.2307/3545259; DANELL K, 1985, OIKOS, V44, P82, DOI 10.2307/3544047; de Jong TJ, 2004, PLANT BIOLOGY, V6, P616, DOI 10.1055/s-2004-821177; ELMQVIST T, 1988, OIKOS, V51, P259, DOI 10.2307/3565306; Espirito-Santo MM, 2003, ANN BOT-LONDON, V91, P13, DOI 10.1093/aob/mcg001; Fisher RA, 1930, GENETICAL THEORY NAT; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; GEHRING JL, 1993, INT J PLANT SCI, V154, P152, DOI 10.1086/297100; GIBSON DJ, 1994, J VEG SCI, V5, P337, DOI 10.2307/3235857; HANCOCK JF, 1980, EVOLUTION, V34, P762, DOI 10.1111/j.1558-5646.1980.tb04015.x; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Harrison S, 1999, OECOLOGIA, V121, P99, DOI 10.1007/s004420050910; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Hilfiker K, 2004, CAN J BOT, V82, P219, DOI [10.1139/B03-136, 10.1139/b03-136]; [侯新村 HOU Xincun], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P3524; Iszkulo G, 2009, PLANT ECOL, V200, P229, DOI 10.1007/s11258-008-9447-5; KOLMAN WA, 1960, AM NAT, V94, P373, DOI 10.1086/282139; KORPELAINEN H, 1992, OECOLOGIA, V89, P133, DOI 10.1007/BF00319025; KRISCHIK VA, 1990, OECOLOGIA, V83, P176, DOI 10.1007/BF00317749; KUNIN WE, 1993, ECOLOGY, V74, P2145, DOI 10.2307/1940859; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; LEIGH EG, 1970, AM NAT, V104, P205, DOI 10.1086/282650; Li CY, 2005, PLANT SCI, V168, P1365, DOI 10.1016/j.plantsci.2005.02.001; Lian CL, 2001, HEREDITY, V87, P88, DOI 10.1046/j.1365-2540.2001.00913.x; Liu Q, 1999, J HENAN FORESTRY SCI, V19, P2; Massei G, 2006, ACTA OECOL, V29, P135, DOI 10.1016/j.actao.2005.08.004; Mustajarvi K, 2001, J ECOL, V89, P80, DOI 10.1046/j.1365-2745.2001.00521.x; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oster M, 2007, ECOSCIENCE, V14, P387, DOI 10.2980/1195-6860(2007)14[387:SRMPLI]2.0.CO;2; OYAMA K, 2005, PLANT SPEC BIOL, V3, P27; POPP JW, 1988, AM J BOT, V75, P1732, DOI 10.2307/2444688; Portela R, 2001, ECOL MODEL, V143, P115, DOI 10.1016/S0304-3800(01)00359-3; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; RENNER SS, 1998, EFFECTS HABITAT FRAG, P339; Retuerto R, 2000, FUNCT ECOL, V14, P529, DOI 10.1046/j.1365-2435.2000.t01-1-00454.x; Robledo-Arnuncio JJ, 2005, HEREDITY, V94, P13, DOI 10.1038/sj.hdy.6800542; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sawyer NW, 1998, RHODORA, V100, P1; Schuster WSF, 2000, HEREDITY, V84, P348, DOI 10.1046/j.1365-2540.2000.00684.x; Seifert, 2000, AUSTR GEOGRAPHICAL S, V38, P263, DOI [https://doi.org/10.1111/1467-8470.00115, DOI 10.1111/1467-8470.00115]; Stehlik I, 2008, P NATL ACAD SCI USA, V105, P10847, DOI 10.1073/pnas.0801964105; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Sun Q, 2008, BIODIVERSITY SCI, V51, P1099; [孙雀 SUN Que], 2009, [生态学报, Acta Ecologica Sinica], V29, P2195; Taylor DR, 1999, EVOLUTION, V53, P1028, DOI 10.1111/j.1558-5646.1999.tb04518.x; THOMAS SC, 1993, ECOLOGY, V74, P1529, DOI 10.2307/1940080; VASILIAUSKAS SA, 1992, ECOLOGY, V73, P622, DOI 10.2307/1940768; Wang K, 2001, FOR SCI, V70, P259; WILLSON MF, 1983, OIKOS, V41, P27, DOI 10.2307/3544342; Zohary M., 1952, Palestine Journal of Botany (Jerusalem Series), V5, P187	61	29	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22903	10.1371/journal.pone.0022903	http://dx.doi.org/10.1371/journal.pone.0022903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829667	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200038
J	Johnson, S; Prendergast, G; Hymers, M; Green, G				Johnson, Sam; Prendergast, Garreth; Hymers, Mark; Green, Gary			Examining the Effects of One- and Three-Dimensional Spatial Filtering Analyses in Magnetoencephalography	PLOS ONE			English	Article							HUMAN BRAIN; MEG; BEAMFORMERS	Spatial filtering, or beamforming, is a commonly used data-driven analysis technique in the field of Magnetoencephalography (MEG). Although routinely referred to as a single technique, beamforming in fact encompasses several different methods, both with regard to defining the spatial filters used to reconstruct source-space time series and in terms of the analysis of these time series. This paper evaluates two alternative methods of spatial filter construction and application. It demonstrates how encoding different requirements into the design of these filters has an effect on the results obtained. The analyses presented demonstrate the potential value of implementations which examine the timeseries projections in multiple orientations at a single location by showing that beamforming can reconstruct predominantly radial sources in the case of a multiple-spheres forward model. The accuracy of source reconstruction appears to be more related to depth than source orientation. Furthermore, it is shown that using three 1-dimensional spatial filters can result in inaccurate source-space time series reconstruction. The paper concludes with brief recommendations regarding reporting beamforming methodologies in order to help remove ambiguity about the specifics of the techniques which have been used.	[Johnson, Sam; Prendergast, Garreth; Hymers, Mark; Green, Gary] Univ York, York NeuroImaging Ctr, York YO10 5DD, N Yorkshire, England; [Prendergast, Garreth; Green, Gary] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK	Johnson, S (corresponding author), Univ York, York NeuroImaging Ctr, York YO10 5DD, N Yorkshire, England.	mark.hymers@ynic.york.ac.uk	Green, Gary GR/D-3543-2009	Green, Gary GR/0000-0003-1977-7509; Prendergast, Garreth/0000-0002-7255-6708	York NeuroImaging Centre, Department of Psychology, University of York	York NeuroImaging Centre, Department of Psychology, University of York	All authors are full-time employees of the University of York and/or Hull York Medical School. This study was internally funded by the York NeuroImaging Centre, Department of Psychology, University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardouille T, 2008, NEUROIMAGE, V42, P323, DOI 10.1016/j.neuroimage.2008.04.176; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hadjipapas A, 2009, NEUROIMAGE, V44, P1290, DOI 10.1016/j.neuroimage.2008.10.035; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hymers M, 2010, NEUROIMAGE, V49, P1385, DOI 10.1016/j.neuroimage.2009.09.055; JOHNSON S, 2005, THESIS U NEWCASTLE T; Prendergast G, 2011, NEUROIMAGE, V54, P906, DOI 10.1016/j.neuroimage.2010.08.005; Prendergast G, 2010, EUR J NEUROSCI, V32, P1599, DOI 10.1111/j.1460-9568.2010.07423.x; ROBINSON SE, 2004, NEUROL CLIN NEUROPHY, P109; ROBINSON SE, 1998, BIOMAG; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Sekihara K, 2004, IEEE T BIO-MED ENG, V51, P1726, DOI 10.1109/TBME.2004.827926; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; VRBA J, 2000, BIOMAG 2000	21	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22251	10.1371/journal.pone.0022251	http://dx.doi.org/10.1371/journal.pone.0022251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857916	Green Published, Green Submitted, gold			2022-12-27	WOS:000293558900012
J	Busse, JW; Walji, R; Wilson, K				Busse, Jason W.; Walji, Rishma; Wilson, Kumanan			Parents' Experiences Discussing Pediatric Vaccination with Healthcare Providers: A Survey of Canadian Naturopathic Patients	PLOS ONE			English	Article							CAUSAL ASSOCIATION; AUTISM; ATTITUDES; MEASLES; MUMPS; MMR; SEE	Background: Parents who choose to selectively vaccinate or avoid vaccination for their children may do so at risk of compromising relations with their family physician or pediatrician. Groups that are associated with reduced rates of pedicatic vaccination, such as parents who access naturopathic care, may be particularly vulnerable to this issue. Methodology/Principal Findings: In March through September 2010, we administered a 26-item cross-sectional survey to 129 adult patients, all of whom were parents with children <= 16 years of age, presenting for naturopathic care in Ontario, Canada. Ninety-five parents completed the survey (response rate 74%), and only 50.5% (48 of 95) reported that their children had received all recommended vaccines. Most parents (50.5%; 48 of 95) reported feeling pressure to vaccinate from their allopathic physician and, of those who discussed vaccination with their physician, 25.9% (21 of 81) were less comfortable continuing care as a result. Five percent (4 of 81) of respondents were advised by their physician that their children would be refused care if they decided against vaccination. In our adjusted generalized linear model, feeling pressure to vaccinate (odds ratio [OR] = 3.07; 95% confidence interval [CI] = 1.14 to 8.26) or endorsing a naturopathic physician as their most trusted source of information regarding vaccination (OR = 3.57; 95% CI = 1.22 to 10.44) were associated with greater odds of having a partially vaccinated or unvaccinated child. The majority (69.6%; 32 of 46) of parent's with partially vaccinated or unvaccinated children reported a willingness to re-consider this decision. Conclusions/Significance: Use of naturopathic care should be explored among parents in order to identify this high-risk group and engage them in discussion regarding pediatric vaccination to encourage evidence-based, shared decision making. Physicians should ensure that discussions regarding vaccination are respectful, even if parents are determined not to vaccinate their children.	[Busse, Jason W.] Inst Work & Hlth, Toronto, ON, Canada; [Busse, Jason W.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Walji, Rishma] McMaster Univ, Dept Hlth & Aging & Soc, Hamilton, ON, Canada; [Walji, Rishma] Canadian Coll Naturopath Med, Toronto, ON, Canada; [Wilson, Kumanan] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada	Institute for Work & Health; McMaster University; McMaster University; University of Ottawa; Ottawa Hospital Research Institute	Busse, JW (corresponding author), Inst Work & Hlth, Toronto, ON, Canada.	jbusse@iwh.on.ca	Busse, Jason/CAH-3696-2022	Busse, Jason/0000-0002-0178-8712	Canadian Institutes of Health Research; Canadian Chiropractic Research Foundation; Canadian Health Services and Research Foundation; Canada Research Chair in public health policy	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Chiropractic Research Foundation; Canadian Health Services and Research Foundation; Canada Research Chair in public health policy	Dr. Busse is funded by a New Investigator Award from the Canadian Institutes of Health Research and Canadian Chiropractic Research Foundation. Dr. Walji is funded by a doctoral fellowship from the Canadian Health Services and Research Foundation. Dr. Wilson is supported by the Canada Research Chair in public health policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, SOC SCI MED; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Busse JW, 2005, J MANIP PHYSIOL THER, V28, P367, DOI 10.1016/j.jmpt.2005.04.011; Campbell JB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e43; Cherkin Daniel C, 2002, J Am Board Fam Pract, V15, P463; Denzin N., 1994, HDB QUALITATIVE RES; Downey L, 2010, MATERN CHILD HLTH J, V14, P922, DOI 10.1007/s10995-009-0519-5; Ernst E, 2001, VACCINE, V20, pS90, DOI 10.1016/S0264-410X(01)00290-0; Farrington CP, 2001, VACCINE, V19, P3632, DOI 10.1016/S0264-410X(01)00097-4; Flanagan-Klygis EA, 2005, ARCH PEDIAT ADOL MED, V159, P929, DOI 10.1001/archpedi.159.10.929; Fortune J, 2007, CAN FAM PHYSICIAN, V53, P2083; Fredrickson DD, 2004, FAM MED, V36, P431; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Godlee F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7452; Griffith LE, 1999, J CLIN EPIDEMIOL, V52, P997, DOI 10.1016/S0895-4356(99)00106-7; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Lee ACC, 2000, ARCH PEDIAT ADOL MED, V154, P75; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; MILLER WL, 1992, RES METH PR, V3, P3; Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002; *NAT I COMPL ALT M, INTR NAT; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wilson K, 2005, PEDIATRICS, V115, pE338, DOI 10.1542/peds.2004-1901; Wilson K, 2004, VACCINE, V22, P329, DOI 10.1016/j.vaccine.2003.08.014; 2006, CANADA COMMUNICABLE; [No title captured]	28	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22737	10.1371/journal.pone.0022737	http://dx.doi.org/10.1371/journal.pone.0022737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829648	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511900012
J	Lima, ABC; Macedo, LT; Sasse, AD				Costa Lima, Andre Bacellar; Macedo, Ligia T.; Sasse, Andre Deeke			Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PHASE-III TRIAL; PLUS CARBOPLATIN; 1ST-LINE THERAPY; PACLITAXEL; RECURRENT; NSCLC; HYPERTENSION; COMBINATION; SURVIVAL; SAFETY	Introduction: Recently, studies have demonstrated that the addition of bevacizumab to chemotherapy could be associated with better outcomes in patients with advanced non-small cell lung cancer (NSCLC). However, the benefit seems to be dependent on the drugs used in the chemotherapy regimens. This systematic review evaluated the strength of data on efficacy of the addition of bevacizumab to chemotherapy in advanced NSCLC. Methods: PubMed, EMBASE, and Cochrane databases were searched. Eligible studies were randomized clinical trials (RCTs) that evaluated chemotherapy with or without bevacizumab in patients with advanced NSCLC. The outcomes included overall survival (OS), progression-free survival (PFS), response rate (RR), toxicities and treatment related mortality. Hazard ratios (HR) and odds ratios (OR) were used for the meta-analysis and were expressed with 95% confidence intervals (CI). Results: We included results reported from five RCTs, with a total of 2,252 patients included in the primary analysis, all of them using platinum-based chemotherapy regimens. Compared to chemotherapy alone, the addition of bevacizumab to chemotherapy resulted in a significant longer OS (HR 0.89; 95% CI 0.79 to 0.99; p = 0.04), longer PFS (HR 0.73; 95% CI 0.66 to 0.82; p<0.00001) and higher response rates (OR 2.34; 95% CI 1.89 to 2.89; p<0.00001). We found no heterogeneity between trials, in all comparisons. There was a slight increase in toxicities in bevacizumab group, as well as an increased rate of treatment-related mortality. Conclusions: The addition of bevacizumab to chemotherapy in patients with advanced NSCLC prolongs OS, PFS and RR. Considering the toxicities added, and the small absolute benefits found, bevacizumab plus platinum-based chemotherapy can be considered an option in selected patients with advanced NSCLC. However, risks and benefits should be discussed with patients before decision making.	[Costa Lima, Andre Bacellar; Macedo, Ligia T.; Sasse, Andre Deeke] Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Clin Med, Sao Paulo, Brazil; [Costa Lima, Andre Bacellar; Macedo, Ligia T.; Sasse, Andre Deeke] Ctr Evidencias Oncol CEVON, Sao Paulo, Brazil	Universidade Estadual de Campinas	Lima, ABC (corresponding author), Univ Estadual Campinas UNICAMP, Fac Ciencias Med, Dept Clin Med, Sao Paulo, Brazil.	sasse@cevon.com.br	Macedo, Ligia Traldi/N-5432-2019; Sasse, Andre/P-7272-2019; Sasse, Andre D/B-3375-2009; Macedo, Ligia T Traldi/P-8122-2018; Macedo, Ligia Traldi/L-8432-2019	Macedo, Ligia Traldi/0000-0003-0575-586X; Sasse, Andre D/0000-0002-3038-3933; Macedo, Ligia T Traldi/0000-0003-0575-586X; Costa Lima, Andre Bacellar/0000-0002-7726-5002				ALBERTI W, 1995, BRIT MED J, V311, P899; Besse B, 2010, CLIN CANCER RES, V16, P269, DOI 10.1158/1078-0432.CCR-09-2439; Chen F, 2007, CANCER EPIDEM BIOMAR, V16, P2724, DOI 10.1158/1055-9965.EPI-07-0455; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; Crino L, 2010, LANCET ONCOL, V11, P733, DOI 10.1016/S1470-2045(10)70151-0; Dahlberg SE, 2010, J CLIN ONCOL, V28, P949, DOI 10.1200/JCO.2009.25.4482; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Garrido P, 2009, EJC SUPPL, V7, P557, DOI 10.1016/S1359-6349(09)71883-X; Gressett SM, 2009, ANN PHARMACOTHER, V43, P490, DOI 10.1345/aph.1L426; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hood JD, 1998, AM J PHYSIOL-HEART C, V274, pH1054; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Lynch T, 2008, ANN ONCOL, V19, P93; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mourad JJ, 2008, ANN ONCOL, V19, P927, DOI 10.1093/annonc/mdm550; NISHIO M, 2009, J CLIN ONCOL, V27; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; RECK M, 2010, ANN ONCOL       0211; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Sandler AB, 2006, J CLIN ONCOL, V24, p381S; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Sterne JAC, 2001, SYSTEMATIC REV HLTH, P347, DOI [DOI 10.1002/9780470693926.CH18, 10.1002/9780470693926.ch18]; Thatcher N, 2009, J THORAC ONCOL, V4, pS358; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tsai C, 2009, EJC SUPPL, V7, P557, DOI 10.1016/S1359-6349(09)71884-1; van Heeckeren WJ, 2007, J CLIN ONCOL, V25, P2993, DOI 10.1200/JCO.2007.11.5113; Yuan A, 2001, J CLIN ONCOL, V19, P432, DOI 10.1200/JCO.2001.19.2.432	35	72	75	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22681	10.1371/journal.pone.0022681	http://dx.doi.org/10.1371/journal.pone.0022681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829644	gold, Green Submitted, Green Published			2022-12-27	WOS:000293511900011
J	de Almeida, LA; Carvalho, NB; Oliveira, FS; Lacerda, TLS; Vasconcelos, AC; Nogueira, L; Bafica, A; Silva, AM; Oliveira, SC				de Almeida, Leonardo A.; Carvalho, Natalia B.; Oliveira, Fernanda S.; Lacerda, Thais L. S.; Vasconcelos, Anilton C.; Nogueira, Lucas; Bafica, Andre; Silva, Aristobolo M.; Oliveira, Sergio C.			MyD88 and STING Signaling Pathways Are Required for IRF3-Mediated IFN-beta Induction in Response to Brucella abortus Infection	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; DENDRITIC CELL MATURATION; I INTERFERON-PRODUCTION; RIG-I; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSES; GAMMA-INTERFERON; MICE LACKING; RNA; ALPHA/BETA	Type I interferons (IFNs) are cytokines that orchestrate diverse immune responses to viral and bacterial infections. Although typically considered to be most important molecules in response to viruses, type I IFNs are also induced by most, if not all, bacterial pathogens. In this study, we addressed the role of type I IFN signaling during Brucella abortus infection, a facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans. Herein, we have shown that B. abortus induced IFN-beta in macrophages and splenocytes. Further, IFN-beta induction by Brucella was mediated by IRF3 signaling pathway and activates IFN-stimulated genes via STAT1 phosphorylation. In addition, IFN-beta expression induced by Brucella is independent of TLRs and TRIF signaling but MyD88-dependent, a pathway not yet described for Gram-negative bacteria. Furthermore, we have identified Brucella DNA as the major bacterial component to induce IFN-beta and our study revealed that this molecule operates through a mechanism dependent on RNA polymerase III to be sensed probably by an unknown receptor via the adaptor molecule STING. Finally, we have demonstrated that IFN-alpha beta R KO mice are more resistant to infection suggesting that type I IFN signaling is detrimental to host control of Brucella. This resistance phenotype is accompanied by increased IFN-gamma and NO production by IFN-alpha beta Rho R KO spleen cells and reduced apoptosis.	[de Almeida, Leonardo A.; Carvalho, Natalia B.; Oliveira, Fernanda S.; Lacerda, Thais L. S.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Vasconcelos, Anilton C.] Univ Fed Minas Gerais, Dept Pathol, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Silva, Aristobolo M.] Univ Fed Minas Gerais, Dept Morphol, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Nogueira, Lucas; Bafica, Andre] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Santa Catarina (UFSC)	de Almeida, LA (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Belo Horizonte, MG, Brazil.	scozeus@icb.ufmg.br	Vasconcelos, Anilton ACV/L-9861-2014; Bafica, Andre/ABF-5986-2020; Silva, Aristóbolo/AAA-2239-2021; de+Lima+Nogueira, Lucas/AAD-3447-2020; de Almeida, Leonardo A/G-2482-2012; Silva, Aristobolo/CAF-4874-2022; Carvalho, Natalia/H-3977-2015; Oliveira, Sergio Costa/AAG-5408-2021	Vasconcelos, Anilton ACV/0000-0001-6202-580X; Bafica, Andre/0000-0002-5148-600X; Silva, Aristóbolo/0000-0001-7473-7433; de+Lima+Nogueira, Lucas/0000-0003-3907-777X; de Almeida, Leonardo A/0000-0003-1886-5080; Carvalho, Natalia/0000-0003-2586-7877; Oliveira, Sergio Costa/0000-0003-4062-5577	Brazilian Council of Science and Technology (CNPq); CNPq/ANPCyT [490528/2008-2]; Research Foundation of the State of Minas Gerais (FAPEMIG); Brazilian Agency for Development of Graduate Courses (CAPES/PNPD); CNPq/MAPA; CNPq/REPENSA; National Institute of Science and Technology on Vaccines (INCTV)	Brazilian Council of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/ANPCyT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)ANPCyT); Research Foundation of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian Agency for Development of Graduate Courses (CAPES/PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/MAPA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/REPENSA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology on Vaccines (INCTV)	This work was supported by the Brazilian Council of Science and Technology (CNPq), CNPq/ANPCyT (# 490528/2008-2), Research Foundation of the State of Minas Gerais (FAPEMIG), Brazilian Agency for Development of Graduate Courses (CAPES/PNPD), CNPq/MAPA, CNPq/REPENSA and National Institute of Science and Technology on Vaccines (INCTV) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Al Moussawi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000722; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; BIEGER CD, 1989, J BACTERIOL, V171, P141, DOI 10.1128/jb.171.1.141-147.1989; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; den Hartigh AB, 2008, J BACTERIOL, V190, P4427, DOI 10.1128/JB.00406-08; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Glomski IJ, 2007, CELL MICROBIOL, V9, P502, DOI 10.1111/j.1462-5822.2006.00806.x; Gold JA, 2004, INFECT IMMUN, V72, P1291, DOI 10.1128/IAI.72.3.1291-1297.2004; Golding B, 2001, MICROBES INFECT, V3, P43, DOI 10.1016/S1286-4579(00)01350-2; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang LY, 2005, J IMMUNOL, V175, P3964, DOI 10.4049/jimmunol.175.6.3964; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Lapaque N, 2009, MICROB PATHOGENESIS, V47, P299, DOI 10.1016/j.micpath.2009.09.005; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Nagarajan UM, 2008, INFECT IMMUN, V76, P4642, DOI 10.1128/IAI.00629-08; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Oliveira SC, 2008, MICROBES INFECT, V10, P1005, DOI 10.1016/j.micinf.2008.07.005; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Schiavoni G, 2004, J IMMUNOL, V173, P1266, DOI 10.4049/jimmunol.173.2.1266; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Wilson K, 1990, CURRENT PROTOCOLS MO, P241; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	57	57	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23135	10.1371/journal.pone.0023135	http://dx.doi.org/10.1371/journal.pone.0023135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829705	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511900028
J	Westreich, D; Cole, SR; Nagar, S; Maskew, M; van der Horst, C; Sanne, I				Westreich, Daniel; Cole, Stephen R.; Nagar, Shashi; Maskew, Mhairi; van der Horst, Charles; Sanne, Ian			Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; SINGLE-DOSE NEVIRAPINE; TO-CHILD TRANSMISSION; DISEASE PROGRESSION; PROSPECTIVE COHORT; CLINICAL-TRIALS; HIV-INFECTION; VIRAL LOAD; WOMEN; SURVIVAL	Background: Although women of reproductive age are the largest group of HIV-infected individuals in sub-Saharan Africa, little is known about the impact of pregnancy on response to highly active antiretroviral therapy (HAART) in that setting. We examined the effect of incident pregnancy after HAART initiation on virologic response to HAART. Methods and Findings: We evaluated a prospective clinical cohort of adult women who initiated HAART in Johannesburg, South Africa between 1 April 2004 and 30 September 2009, and followed up until an event, death, transfer, drop-out, or administrative end of follow-up on 31 March 2010. Women over age 45 and women who were pregnant at HAART initiation were excluded from the study; final sample size for analysis was 5,494 women. Main exposure was incident pregnancy, experienced by 541 women; main outcome was virologic failure, defined as a failure to suppress virus to <= 400 copies/ml by six months or virologic rebound >400 copies/ml thereafter. We calculated adjusted hazard ratios using marginal structural Cox proportional hazards models and weighted lifetable analysis to calculate adjusted five-year risk differences. The weighted hazard ratio for the effect of pregnancy on time to virologic failure was 1.34 (95% confidence limit [CL] 1.02, 1.78). Sensitivity analyses generally confirmed these main results. Conclusions: Incident pregnancy after HAART initiation was associated with modest increases in both relative and absolute risks of virologic failure, although uncontrolled confounding cannot be ruled out. Nonetheless, these results reinforce that family planning is an essential part of care for HIV-positive women in sub-Saharan Africa. More work is needed to confirm these findings and to explore specific etiologic pathways by which such effects may operate.	[Westreich, Daniel] Duke Univ, Dept Obstet & Gynecol, Duke Global Hlth Inst, Durham, NC 27710 USA; [Westreich, Daniel; Cole, Stephen R.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Nagar, Shashi; Maskew, Mhairi; Sanne, Ian] Univ Witwatersrand, Clin HIV Res Unit, Johannesburg, South Africa; [Nagar, Shashi; Maskew, Mhairi; Sanne, Ian] Right Care, Johannesburg, South Africa; [van der Horst, Charles] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill	Westreich, D (corresponding author), Duke Univ, Dept Obstet & Gynecol, Duke Global Hlth Inst, Durham, NC 27710 USA.	daniel.westreich@duke.edu	Sanne, Ian/ABH-2231-2020	Westreich, Daniel/0000-0003-3069-1650; MASKEW, MHAIRI/0000-0003-4238-0200	National and Gauteng Department of Health; United States Agency for International Development to Right to Care and the Institution [674-A-00-08-00007-00]; National Institutes of Health, Eunice Kennedy Shriver NICHD [K99-HD-06-3961, 4R00-HD-06-3961-02]; National Institute of Allergy and Infectious Diseases [P30-AI-50410]; University of North Carolina Center for AIDS Research; University of North Carolina-GlaxoSmithKline Center for Excellence in Pharmacoepidemiology and Public Health; GlaxoSmithKline for examining IV zanamavir for influenza; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD063961] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD063961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National and Gauteng Department of Health; United States Agency for International Development to Right to Care and the Institution(United States Agency for International Development (USAID)); National Institutes of Health, Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of North Carolina Center for AIDS Research; University of North Carolina-GlaxoSmithKline Center for Excellence in Pharmacoepidemiology and Public Health; GlaxoSmithKline for examining IV zanamavir for influenza; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The clinical activities of the Helen Joseph Hospital are supported by the National and Gauteng Department of Health and the United States President's Emergency Plan for AIDS Relief in a grant by United States Agency for International Development to Right to Care and the Institution (674-A-00-08-00007-00). The research activities of this publication are supported by the National Institutes of Health in a grant from the Eunice Kennedy Shriver NICHD K99-HD-06-3961 and 4R00-HD-06-3961-02, and National Institute of Allergy and Infectious Diseases P30-AI-50410 to the University of North Carolina Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DW received an unrestricted educational training grant from the University of North Carolina-GlaxoSmithKline Center for Excellence in Pharmacoepidemiology and Public Health from 2006-2008. CvdH has conducted research studies funded by GlaxoSmithKline for examining IV zanamavir for influenza. All other authors have declared that no competing interests exist. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.	AWEEKA F, 2007, 14 C RETR OPP INF LO; Black V, 2008, JAIDS-J ACQ IMM DEF, V49, P276, DOI 10.1097/QAI.0b013e318189a769; Burns DN, 1998, AM J OBSTET GYNECOL, V178, P355, DOI 10.1016/S0002-9378(98)80025-2; Chi BH, 2007, AIDS, V21, P957, DOI 10.1097/QAD.0b013e32810996b2; Coffie PA, 2008, CLIN INFECT DIS, V46, P611, DOI 10.1086/526780; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Floridia M, 2008, PHARMACOL RES, V58, P173, DOI 10.1016/j.phrs.2008.07.007; French R, 1998, BRIT J OBSTET GYNAEC, V105, P827, DOI 10.1111/j.1471-0528.1998.tb10226.x; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Keiser O, 2008, AIDS, V22, P2323, DOI 10.1097/QAD.0b013e3283189bf1; Kumar RM, 1997, J REPROD MED, V42, P429; MacCarthy S, 2009, AIDS BEHAV; Melekhin VV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006961; Minkoff H, 2003, AM J OBSTET GYNECOL, V189, P552, DOI 10.1067/S0002-9378(03)00467-8; Mirochnick M, 2004, CLIN PHARMACOKINET, V43, P1071, DOI 10.2165/00003088-200443150-00002; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Petersen ML, 2006, JAIDS-J ACQ IMM DEF, V43, pS96, DOI 10.1097/01.qai.0000248344.95135.8d; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Prins M, 2005, AIDS, V19, P357, DOI 10.1097/01.aids.0000161765.75663.27; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Roustit M, 2008, BRIT J CLIN PHARMACO, V66, P179, DOI 10.1111/j.1365-2125.2008.03220.x; Saada M, 2000, AIDS, V14, P2355, DOI 10.1097/00002030-200010200-00017; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Sha BE, 2011, HIV CLIN TRIALS, V12, P9, DOI 10.1310/hct1201-9; Stek AM, 2006, AIDS, V20, P1931, DOI 10.1097/01.aids.0000247114.43714.90; Tai JH, 2007, J INFECT DIS, V196, P1044, DOI 10.1086/520814; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; *UNAIDS WHO, 2007, AIDS EP UPD 2007; Van der Paal L, 2007, TROP MED INT HEALTH, V12, P920, DOI [10.1111/j.1365-3156.2007.01873.x, 10.1111/j.1365-3156.2007.001873.x]; Watts DH, 2009, INFECT DIS OBSTET GY, V2009; Westreich D, 2007, J INFECT DIS, V195, P837, DOI 10.1086/511276; Westreich D, 2010, AM J EPIDEMIOL, V171, P691, DOI 10.1093/aje/kwp418; Westreich D, 2010, AM J EPIDEMIOL, V171, P674, DOI 10.1093/aje/kwp436; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; Westreich DJ, 2009, CLIN INFECT DIS, V48, P1617, DOI 10.1086/598977; *WHO, 2006, ANT DRUGS PREV MOTH; Zhang MJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-82	47	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22778	10.1371/journal.pone.0022778	http://dx.doi.org/10.1371/journal.pone.0022778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829650	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511900013
J	Huwiler, A; Bourquin, F; Kotelevets, N; Pastukhov, O; Capitani, G; Grutter, MG; Zangemeister-Wittke, U				Huwiler, Andrea; Bourquin, Florence; Kotelevets, Nataliya; Pastukhov, Oleksandr; Capitani, Guido; Gruetter, Markus G.; Zangemeister-Wittke, Uwe			A Prokaryotic S1P Lyase Degrades Extracellular S1P In Vitro and In Vivo: Implication for Treating Hyperproliferative Disorders	PLOS ONE			English	Article							MESANGIAL CELL-PROLIFERATION; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE LYASE; FUNCTIONAL EXPRESSION; ENDOTHELIAL-CELLS; KINASE PATHWAY; CANCER; GROWTH; RECEPTOR; ANGIOGENESIS	Sphingosine-1-phosphate (S1P) regulates a broad spectrum of fundamental cellular processes like proliferation, death, migration and cytokine production. Therefore, elevated levels of S1P may be causal to various pathologic conditions including cancer, fibrosis, inflammation, autoimmune diseases and aberrant angiogenesis. Here we report that S1P lyase from the prokaryote Symbiobacterium thermophilum (StSPL) degrades extracellular S1P in vitro and in blood. Moreover, we investigated its effect on cellular responses typical of fibrosis, cancer and aberrant angiogenesis using renal mesangial cells, endothelial cells, breast (MCF-7) and colon (HCT 116) carcinoma cells as disease models. In all cell types, wild-type StSPL, but not an inactive mutant, disrupted MAPK phosphorylation stimulated by exogenous S1P. Functionally, disruption of S1P receptor signaling by S1P depletion inhibited proliferation and expression of connective tissue growth factor in mesangial cells, proliferation, migration and VEGF expression in carcinoma cells, and proliferation and migration of endothelial cells. Upon intravenous injection of StSPL in mice, plasma S1P levels rapidly declined by 70% within 1 h and then recovered to normal 6 h after injection. Using the chicken chorioallantoic membrane model we further demonstrate that also under in vivo conditions StSPL, but not the inactive mutant, inhibited tumor cell-induced angiogenesis as an S1P-dependent process. Our data demonstrate that recombinant StSPL is active under extracellular conditions and holds promise as a new enzyme therapeutic for diseases associated with increased levels of S1P and S1P receptor signaling.	[Huwiler, Andrea; Kotelevets, Nataliya; Pastukhov, Oleksandr; Zangemeister-Wittke, Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Bourquin, Florence; Gruetter, Markus G.; Zangemeister-Wittke, Uwe] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Capitani, Guido] Paul Scherrer Inst, Villigen, Switzerland	University of Bern; University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Huwiler, A (corresponding author), Univ Bern, Inst Pharmacol, Bern, Switzerland.	uwe.zangemeister@pki.unibe.ch			Wilhelm Sander-Stiftung; Krebsliga of the Kanton Bern	Wilhelm Sander-Stiftung; Krebsliga of the Kanton Bern	This work was supported by the Wilhelm Sander-Stiftung (www.sanst.de) and the Krebsliga of the Kanton Bern (www.bernischekrebsliga.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3; Alexander SPH, 2008, BRIT J PHARMACOL, V153, pS1, DOI 10.1038/sj.bjp.0707746; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; Bourquin F, 2010, STRUCTURE, V18, P1054, DOI 10.1016/j.str.2010.05.011; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Claus RA, 2009, CURR MED CHEM, V16, P1978, DOI 10.2174/092986709788682182; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gellings Lowe N, 2009, CARDIOVASC RES, V82, P303, DOI 10.1093/cvr/cvp056; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hanafusa N, 2002, NEPHROL DIAL TRANSPL, V17, P580, DOI 10.1093/ndt/17.4.580; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; HUWILER A, 1994, BRIT J PHARMACOL, V113, P1455, DOI 10.1111/j.1476-5381.1994.tb17160.x; Huwiler A, 2007, CRIT REV ONCOL HEMAT, V63, P150, DOI 10.1016/j.critrevonc.2007.04.010; Kariya Y, 2005, GENES CELLS, V10, P605, DOI 10.1111/j.1365-2443.2005.00862.x; Katsuma S, 2002, GENES CELLS, V7, P1217, DOI 10.1046/j.1365-2443.2002.00594.x; Kim MR, 2009, MOL CANCER THER, V8, P2163, DOI 10.1158/1535-7163.MCT-08-1061; Kumar A, 2011, CELL SIGNAL, V23, P1144, DOI 10.1016/j.cellsig.2011.02.009; Leong WI, 2010, BIOCHIMIE, V92, P716, DOI 10.1016/j.biochi.2010.02.014; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Phanish MK, 2005, NEPHRON EXP NEPHROL, V100, pE156, DOI 10.1159/000085445; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Pujals S, 2008, ADV DRUG DELIVER REV, V60, P473, DOI 10.1016/j.addr.2007.09.012; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2009, CELL SIGNAL, V21, P14, DOI 10.1016/j.cellsig.2008.08.008; Randriamboavonjy V, 2009, BASIC RES CARDIOL, V104, P333, DOI 10.1007/s00395-008-0769-1; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; SATTLER KJ, 2010, BASIC RES CARDIOL; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Schwalm S, 2008, BIOCHEM BIOPH RES CO, V368, P1020, DOI 10.1016/j.bbrc.2008.01.132; Shimamura K, 2004, EUR J PHARMACOL, V486, P141, DOI 10.1016/j.ejphar.2003.12.022; Sofka M, 2006, IEEE T MED IMAGING, V25, P1531, DOI 10.1109/TMI.2006.884190; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yonesu K, 2009, BIOCHEM PHARMACOL, V77, P1011, DOI 10.1016/j.bcp.2008.12.007; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	56	17	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22436	10.1371/journal.pone.0022436	http://dx.doi.org/10.1371/journal.pone.0022436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829623	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200009
J	Koshino, H; Minamoto, T; Ikeda, T; Osaka, M; Otsuka, Y; Osaka, N				Koshino, Hideya; Minamoto, Takehiro; Ikeda, Takashi; Osaka, Mariko; Otsuka, Yuki; Osaka, Naoyuki			Anterior Medial Prefrontal Cortex Exhibits Activation during Task Preparation but Deactivation during Task Execution	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CONSCIOUS RESTING STATE; BLOOD-FLOW CHANGES; TOP-DOWN CONTROL; WORKING-MEMORY; HUMAN BRAIN; FRONTOPOLAR CORTEX; DEFAULT NETWORK; EPISODIC MEMORY; HUMAN COGNITION	Background: The anterior prefrontal cortex (PFC) exhibits activation during some cognitive tasks, including episodic memory, reasoning, attention, multitasking, task sets, decision making, mentalizing, and processing of self-referenced information. However, the medial part of anterior PFC is part of the default mode network (DMN), which shows deactivation during various goal-directed cognitive tasks compared to a resting baseline. One possible factor for this pattern is that activity in the anterior medial PFC (MPFC) is affected by dynamic allocation of attentional resources depending on task demands. We investigated this possibility using an event related fMRI with a face working memory task. Methodology/Principal Findings: Sixteen students participated in a single fMRI session. They were asked to form a task set to remember the faces (Face memory condition) or to ignore them (No face memory condition), then they were given 6 seconds of preparation period before the onset of the face stimuli. During this 6-second period, four single digits were presented one at a time at the center of the display, and participants were asked to add them and to remember the final answer. When participants formed a task set to remember faces, the anterior MPFC exhibited activation during a task preparation period but deactivation during a task execution period within a single trial. Conclusions/Significance: The results suggest that the anterior MPFC plays a role in task set formation but is not involved in execution of the face working memory task. Therefore, when attentional resources are allocated to other brain regions during task execution, the anterior MPFC shows deactivation. The results suggest that activation and deactivation in the anterior MPFC are affected by dynamic allocation of processing resources across different phases of processing.	[Koshino, Hideya] Calif State Univ San Bernardino, Dept Psychol, San Bernardino, CA 92407 USA; [Minamoto, Takehiro; Otsuka, Yuki; Osaka, Naoyuki] Kyoto Univ, Dept Psychol, Kyoto, Japan; [Ikeda, Takashi; Osaka, Mariko] Osaka Univ, Dept Human Sci, Osaka, Japan	California State University System; California State University San Bernardino; Kyoto University; Osaka University	Koshino, H (corresponding author), Calif State Univ San Bernardino, Dept Psychol, San Bernardino, CA 92407 USA.	hkoshino@csusb.edu		Koshino, Hideya/0000-0001-6889-1856	Japan Society of promotion Science [20113136]; Grants-in-Aid for Scientific Research [23800034] Funding Source: KAKEN	Japan Society of promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Society of promotion Science #20113136 (N.O., M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Bengtsson SL, 2009, CEREB CORTEX, V19, P1929, DOI 10.1093/cercor/bhn222; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1292, DOI 10.1016/S0028-3932(00)00026-9; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; DREVETS WC, 1995, NATURE, V373, P249, DOI 10.1038/373249a0; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; MacLeod AK, 1998, NEUROIMAGE, V7, P41, DOI 10.1006/nimg.1997.0308; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Matsuyoshi D, 2010, NEUROPSYCHOLOGIA, V48, P3094, DOI 10.1016/j.neuropsychologia.2010.06.021; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Minamoto T, 2010, BRAIN RES, V1335, P63, DOI 10.1016/j.brainres.2010.03.088; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; Nyberg L, 1996, P NATL ACAD SCI USA, V93, P11280, DOI 10.1073/pnas.93.20.11280; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pessoa L, 2003, J NEUROSCI, V23, P3990; Pollmann S, 2000, J COGNITIVE NEUROSCI, V12, P480, DOI 10.1162/089892900562156; Pollmann S, 2001, NEUROIMAGE, V14, pS118, DOI 10.1006/nimg.2001.0837; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rameson LT, 2010, NEUROIMAGE, V50, P701, DOI 10.1016/j.neuroimage.2009.12.098; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Rowe JB, 2007, J NEUROSCI, V27, P13303, DOI 10.1523/JNEUROSCI.2349-07.2007; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Serences JT, 2004, J NEUROPHYSIOL, V92, P3538, DOI 10.1152/jn.00435.2004; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; Todd JJ, 2005, PSYCHOL SCI, V16, P965, DOI 10.1111/j.1467-9280.2005.01645.x; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Velanova K, 2003, J NEUROSCI, V23, P8460; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Zysset S, 2003, NEUROSCI LETT, V335, P183, DOI 10.1016/S0304-3940(02)01196-5	86	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22909	10.1371/journal.pone.0022909	http://dx.doi.org/10.1371/journal.pone.0022909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	802LA	21829668	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200025
J	Gomez-Hurtado, I; Santacruz, A; Peiro, G; Zapater, P; Gutierrez, A; Perez-Mateo, M; Sanz, Y; Frances, R				Gomez-Hurtado, Isabel; Santacruz, Arlette; Peiro, Gloria; Zapater, Pedro; Gutierrez, Ana; Perez-Mateo, Miguel; Sanz, Yolanda; Frances, Ruben			Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis	PLOS ONE			English	Article							GROUP-SPECIFIC PRIMERS; PREDOMINANT BACTERIA; HEMORRHAGIC-SHOCK; SEMINESTED PCR; IDENTIFICATION; LACTOBACILLUS; CIRRHOSIS; RATS; INHIBITION; DIVERSITY	Background: Gut is the major source of endogenous bacteria causing infections in advanced cirrhosis. Intestinal barrier dysfunction has been described in cirrhosis and account for an increased bacterial translocation rate. Hypothesis and Aims: We hypothesize that microbiota composition may be affected and change along with the induction of experimental cirrhosis, affecting the inflammatory response. Animals and Methods: Progressive liver damage was induced in Balb/c mice by weight-controlled oral administration of carbon tetrachloride. Laparotomies were performed at weeks 6, 10, 13 and 16 in a subgroup of treated mice (n = 6/week) and control animals (n = 4/week). Liver tissue specimens, mesenteric lymph nodes, intestinal content and blood were collected at laparotomies. Fibrosis grade, pro-fibrogenic genes expression, gut bacterial composition, bacterial translocation, host's specific butyrate-receptor GPR-43 and serum cytokine levels were measured. Results: Expression of pro-fibrogenic markers was significantly increased compared with control animals and correlated with the accumulated dose of carbon tetrachloride. Bacterial translocation episodes were less frequent in control mice than in treated animals. Gram-positive anaerobic Clostridia spp count was decreased in treated mice compared with control animals and with other gut common bacterial species, altering the aerobic/anaerobic ratio. This fact was associated with a decreased gene expression of GPR43 in neutrophils of treated mice and inversely correlated with TNF-alpha and IL-6 up-regulation in serum of treated mice along the study protocol. This pro-inflammatory scenario favoured blood bacterial translocation in treated animals, showing the highest bacterial translocation rate and aerobic/anaerobic ratio at the same weeks. Conclusions: Gut microbiota alterations are associated with the development of an inflammatory environment, fibrosis progression and bacterial translocation in carbon tetrachloride-treated mice.	[Gomez-Hurtado, Isabel; Zapater, Pedro; Gutierrez, Ana; Perez-Mateo, Miguel; Frances, Ruben] Hosp Gen Univ, Unidad Hepat, Alicante, Spain; [Gomez-Hurtado, Isabel; Zapater, Pedro; Frances, Ruben] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Santacruz, Arlette; Sanz, Yolanda] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Peiro, Gloria] Hosp Gen Univ, Unidad Invest, Alicante, Spain	General University Hospital of Alicante; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); General University Hospital of Alicante	Gomez-Hurtado, I (corresponding author), Hosp Gen Univ, Unidad Hepat, Alicante, Spain.	frances_rub@gva.es	Zapater, Pedro/H-7277-2017; Francés, Rubén/V-4120-2019; Gomez-Hurtado, Isabel/AAA-5815-2019; Sanz, Yolanda/H-5498-2012; Gutiérrez, Ana/V-5129-2019; Zapater, Pedro/H-8450-2019	Zapater, Pedro/0000-0001-7927-858X; Francés, Rubén/0000-0001-5105-1201; Gomez-Hurtado, Isabel/0000-0003-4305-9427; Sanz, Yolanda/0000-0002-1615-1976; Gutiérrez, Ana/0000-0002-5460-4139; Zapater, Pedro/0000-0001-7927-858X; Santacruz, Arlette/0000-0001-5580-3108	Instituto de Salud Carlos III, Madrid, Spain [CP05/0005, PI10/0340]; Ministry of Science and Innovation, Spain [CSD2007-00063]; Conselleria de Sanitat, Generalitat Valenciana, Spain [AP-026/09, AP-124/09]; Fundacion FCVI-HGUA, Alicante, Spain [C-5]; CONACYT (Mexico)	Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria de Sanitat, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Fundacion FCVI-HGUA, Alicante, Spain; CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work has been supported by grants CP05/0005 and PI10/0340 from the Instituto de Salud Carlos III, Madrid, Spain; AGL2008-01440/ALI and Consolider Fun-C-Food CSD2007-00063 from the Ministry of Science and Innovation, Spain; AP-026/09 and AP-124/09 from Conselleria de Sanitat, Generalitat Valenciana, Spain; and C-5 from Fundacion FCVI-HGUA, Alicante, Spain. The scholarship from CONACYT (Mexico) to A. Santacruz is fully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BERG RD, 1992, J MED, V23, P217; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Chakrabarti P, 2009, INDIAN J MED RES, V129, P182; DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P185; DUBOS R, 1965, J EXP MED, V122, P67, DOI 10.1084/jem.122.1.67; Frances R, 2007, J HEPATOL, V46, P797, DOI 10.1016/j.jhep.2006.11.018; Garcia-Tsao G, 2004, BEST PRACT RES CL GA, V18, P353, DOI 10.1016/j.bpg.2003.10.005; Garcia-Tsao G, 2001, J HEPATOL, V34, P150, DOI 10.1016/S0168-8278(00)00006-4; Goldman G, 2001, EUR J SURG, V167, P299; Guarner C, 2005, EUR J GASTROEN HEPAT, V17, P27, DOI 10.1097/00042737-200501000-00006; Guarner C, 1997, J HEPATOL, V26, P1372, DOI 10.1016/S0168-8278(97)80474-6; Guarner C, 2006, HEPATOLOGY, V44, P633, DOI 10.1002/hep.21286; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hecht GA, 2009, GASTROENTEROLOGY, V136, P1849, DOI 10.1053/j.gastro.2009.03.057; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Inamura T, 2003, IMMUNOL LETT, V90, P3, DOI 10.1016/j.imlet.2003.05.002; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Klampfer L, 2003, MOL CANCER RES, V1, P855; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Luhrs H, 2001, INT J COLORECTAL DIS, V16, P195, DOI 10.1007/s003840100295; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Martineau F, 2001, J CLIN MICROBIOL, V39, P2541, DOI 10.1128/JCM.39.7.2541-2547.2001; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; RUSELERVANEMBDEN JGH, 1995, SCAND J GASTROENTERO, V30, P675, DOI 10.3109/00365529509096312; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Shimizu T, 2001, SHOCK, V16, P59, DOI 10.1097/00024382-200116010-00011; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Theron J, 2001, WATER RES, V35, P869, DOI 10.1016/S0043-1354(00)00348-1; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632	41	89	95	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23037	10.1371/journal.pone.0023037	http://dx.doi.org/10.1371/journal.pone.0023037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829583	Green Published, Green Submitted, gold			2022-12-27	WOS:000293286500070
J	Gagnadoux, F; Le Vaillant, M; Goupil, F; Pigeanne, T; Chollet, S; Masson, P; Humeau, MP; Bizieux-Thaminy, A; Meslier, N				Gagnadoux, Frederic; Le Vaillant, Marc; Goupil, Francois; Pigeanne, Thierry; Chollet, Sylvaine; Masson, Philippe; Humeau, Marie-Pierre; Bizieux-Thaminy, Acya; Meslier, Nicole		IRSR Sleep Cohort Grp	Influence of Marital Status and Employment Status on Long-Term Adherence with Continuous Positive Airway Pressure in Sleep Apnea Patients	PLOS ONE			English	Article							CPAP USE; DAYTIME SLEEPINESS; APNOEA/HYPOPNOEA SYNDROME; THERAPY; PREDICTORS; MODERATE; REDUCTION; DIAGNOSIS; HYPOPNEA; QUALITY	Background: Long-term adherence is a major issue in patients receiving home continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea-hypopnea syndrome (OSAHS). In a multicenter prospective cohort (the Institut de Recherche en Sante Respiratoire des Pays de la Loire [IRSR] sleep cohort) of consecutive OSAHS patients in whom CPAP had been prescribed for at least 90 days, we studied the impact on long-term treatment adherence of socioeconomic factors, patients and disease characteristics prior to CPAP initiation. Methods and Principal Findings: Among 1,141 patients in whom CPAP had been prescribed for an average of 5046251 days (range: 91 to 1035), 674 (59%) were adherent with a mean daily use of CPAP >= 4 h (mean: 6.42 +/- 61.35 h). Stepwise regression analysis identified 4 independent factors of CPAP adherence including apnea-hypopnea index (AHI) (OR: 1.549, 95% CI 1.163 to 2.062 for AHI >= 30 vs. AHI < 30; p = 0.003), body mass index (BMI) (OR: 1.786, 95% CI 1.131 to 2.822 for BMI >= 25 and <30 kg/m(2), p = 0.01; OR: 1.768, 95% CI 1.145-2.731 for BMI >= 30 kg/m(2), p = 0.01 vs. BMI < 25 kg/m(2)), employment status (OR: 1.414, 95% CI 1.097-1.821 for retired vs. employed; p = 0.007) and marital status (OR: 1.482, 95% CI 1.088-2.019 for married or living as a couple vs. living alone; p = 0.01). Age, gender, Epworth sleepiness scale, depressive syndrome, associated cardiovascular morbidities, educational attainment and occupation category did not influence CPAP adherence. Conclusions: Marital status and employment status are independent factors of CPAP adherence in addition to BMI and disease severity. Patients living alone and/or working patients are at greater risk of non-adherence, whereas adherence is higher in married and retired patients. These findings suggest that the social context of daily life should be taken into account in risk screening for CPAP non-adherence. Future interventional studies targeting at-risk patients should be designed to address social motivating factors and work-related barriers to CPAP adherence.	[Gagnadoux, Frederic; Meslier, Nicole] LUNAM Univ, Angers, France; [Gagnadoux, Frederic; Meslier, Nicole] Univ Angers, CHU Angers, Dept Pneumol, Angers, France; [Le Vaillant, Marc] EHESS, INSERM, U988, CNRS,UMR8211,CERMES, Villejuif, France; [Goupil, Francois] Ctr Hosp, Serv Pneumol, Le Mans, France; [Pigeanne, Thierry] Unite Pneumol, Olonne Sur Mer, France; [Chollet, Sylvaine] Hop Laennec, Inst Thorax, Nantes, France; [Masson, Philippe] Ctr Hosp, Serv Pneumol, Cholet, France; [Humeau, Marie-Pierre] Nouvelles Clin Nantaises, Pneumol, Nantes, France; [Bizieux-Thaminy, Acya] Ctr Hosp, Serv Pneumol, La Roche Sur Yon, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Le Mans; Nantes Universite; CHU de Nantes; CHD Vendee	Gagnadoux, F (corresponding author), LUNAM Univ, Angers, France.	frgagnadoux@chu-angers.fr	Pelletier-Fleury, Nathalie/R-4220-2018	Pelletier-Fleury, Nathalie/0000-0002-4821-4863	Institut de Recherche en Sante Respiratoire des Pays de la Loire	Institut de Recherche en Sante Respiratoire des Pays de la Loire	The study was funded by the Institut de Recherche en Sante Respiratoire des Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Antic NA, 2009, AM J RESP CRIT CARE, V179, P501, DOI 10.1164/rccm.200810-1558OC; Ayas NT, 2004, SLEEP, V27, P249, DOI 10.1093/sleep/27.2.249; BARON KG, 2010, SLEEP BREATH; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Buchner NJ, 2007, AM J RESP CRIT CARE, V176, P1274, DOI 10.1164/rccm.200611-1588OC; Cartwright R, 2008, J CLIN SLEEP MED, V4, P123; Chai CL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005308.pub2; DEBONIS M, 1991, J AFFECT DISORDERS, V22, P55, DOI 10.1016/0165-0327(91)90084-6; Ediger JP, 2007, AM J GASTROENTEROL, V102, P1417, DOI 10.1111/j.1572-0241.2007.01212.x; Engleman HM, 2003, SLEEP MED REV, V7, P81, DOI 10.1053/smrv.2001.0197; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; Giles T. L., 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001103.PUB3; Greenberg Harly, 2004, Sleep Breath, V8, P185, DOI 10.1055/s-2004-860895; Haniffa M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003531.PUB2; *INSEE, 2003, PCS 2003; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kohler M, 2010, THORAX, V65, P829, DOI 10.1136/thx.2010.135848; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Lewis KE, 2004, SLEEP, V27, P134, DOI 10.1093/sleep/27.1.134; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McArdle N, 1999, AM J RESP CRIT CARE, V159, P1108, DOI 10.1164/ajrccm.159.4.9807111; McArdle N, 2001, THORAX, V56, P513, DOI 10.1136/thorax.56.7.513; McDaid C, 2009, HEALTH TECHNOL ASSES, V13, P1; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mulgrew AT, 2007, SLEEP MED, V9, P42, DOI 10.1016/j.sleep.2007.01.009; Mulgrew AT, 2007, ANN INTERN MED, V146, P157, DOI 10.7326/0003-4819-146-3-200702060-00004; Nguyen XL, 2010, SLEEP MED, V11, P777, DOI 10.1016/j.sleep.2010.04.008; Olsen S, 2008, EUR RESPIR J, V32, P710, DOI 10.1183/09031936.00127507; Pelletier-Fleury N, 2001, SLEEP MED, V2, P225, DOI 10.1016/S1389-9457(00)00063-0; Pepin JL, 2009, CHEST, V136, P490, DOI 10.1378/chest.08-2646; Pepin JL, 1999, AM J RESP CRIT CARE, V160, P1124, DOI 10.1164/ajrccm.160.4.9802027; Platt AB, 2008, PHARMACOEPIDEM DR S, V17, P853, DOI 10.1002/pds.1556; Platt AB, 2009, SLEEP, V32, P799, DOI 10.1093/sleep/32.6.799; Rakotonanahary D, 2001, CHEST, V119, P460, DOI 10.1378/chest.119.2.460; Richards D, 2007, SLEEP, V30, P635, DOI 10.1093/sleep/30.5.635; Ryan S, 2011, J SLEEP RES, V20, P367, DOI 10.1111/j.1365-2869.2010.00873.x; SANDERS MH, 1994, CHEST, V106, P774, DOI 10.1378/chest.106.3.774; Sawyer AM, 2010, QUAL HEALTH RES, V20, P873, DOI 10.1177/1049732310365502; Simon-Tuval T, 2009, SLEEP, V32, P545, DOI 10.1093/sleep/32.4.545; Societe de Pneumologie de Langue Francaise, 2010, Rev Mal Respir, V27, P806, DOI 10.1016/j.rmr.2010.05.011; Stradling JR, 2000, SLEEP, V23, pS150; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711; Weaver TE, 2010, INDIAN J MED RES, V131, P245; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zonato AI, 2004, BRAZ J MED BIOL RES, V37, P69, DOI 10.1590/S0100-879X2004000100010	47	80	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22503	10.1371/journal.pone.0022503	http://dx.doi.org/10.1371/journal.pone.0022503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857929	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300004
J	Espinal, J; Aldana, M; Guerrero, A; Wood, C; Darszon, A; Martinez-Mekler, G				Espinal, Jesus; Aldana, Maximino; Guerrero, Adan; Wood, Christopher; Darszon, Alberto; Martinez-Mekler, Gustavo			Discrete Dynamics Model for the Speract-Activated Ca2+ Signaling Network Relevant to Sperm Motility	PLOS ONE			English	Article							SEA-URCHIN SPERM; GENETIC REGULATORY NETWORKS; EGG PEPTIDE SPERACT; GUANYLATE-CYCLASE; CALCIUM-CHANNELS; K+ CHANNELS; CHEMOTAXIS; FLAGELLAR; SPERMATOZOA; CGMP	Understanding how spermatozoa approach the egg is a central biological issue. Recently a considerable amount of experimental evidence has accumulated on the relation between oscillations in intracellular calcium ion concentration ([Ca2+](i)) in the sea urchin sperm flagellum, triggered by peptides secreted from the egg, and sperm motility. Determination of the structure and dynamics of the signaling pathway leading to these oscillations is a fundamental problem. However, a biochemically based formulation for the comprehension of the molecular mechanisms operating in the axoneme as a response to external stimulus is still lacking. Based on experiments on the S. purpuratus sea urchin spermatozoa, we propose a signaling network model where nodes are discrete variables corresponding to the pathway elements and the signal transmission takes place at discrete time intervals according to logical rules. The validity of this model is corroborated by reproducing previous empirically determined signaling features. Prompted by the model predictions we performed experiments which identified novel characteristics of the signaling pathway. We uncovered the role of a high voltage-activated Ca2+ channel as a regulator of the delay in the onset of fluctuations after activation of the signaling cascade. This delay time has recently been shown to be an important regulatory factor for sea urchin sperm reorientation. Another finding is the participation of a voltage-dependent calcium-activated K+ channel in the determination of the period of the [Ca2+](i) fluctuations. Furthermore, by analyzing the spread of network perturbations we find that it operates in a dynamically critical regime. Our work demonstrates that a coarse-grained approach to the dynamics of the signaling pathway is capable of revealing regulatory sperm navigation elements and provides insight, in terms of criticality, on the concurrence of the high robustness and adaptability that the reproduction processes are predicted to have developed throughout evolution.	[Espinal, Jesus; Aldana, Maximino; Martinez-Mekler, Gustavo] Univ Nacl Autonoma Mexico, Inst Ciencias Fs, Cuernavaca 62191, Morelos, Mexico; [Espinal, Jesus; Aldana, Maximino; Martinez-Mekler, Gustavo] Ctr Ciencias Complejidad, Mexico City, DF, Mexico; [Guerrero, Adan; Wood, Christopher; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62191, Morelos, Mexico; [Martinez-Mekler, Gustavo] Ctr Int Ciencias, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Espinal, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fs, Cuernavaca 62191, Morelos, Mexico.	mekler@fis.unam.mx	Cardenas, Adan Oswaldo Guerrero/AAQ-9036-2021; Guerrero, Adán/I-4892-2013; Aldana, Maximino/D-9372-2017; Wood, Christopher D/H-5606-2012	Cardenas, Adan Oswaldo Guerrero/0000-0002-4389-5516; Guerrero, Adán/0000-0002-4389-5516; Aldana, Maximino/0000-0002-3419-6641; Wood, Christopher D/0000-0001-7175-7121; Martinez-Mekler, Gustavo/0000-0002-1192-9769; Darszon, Alberto/0000-0002-2502-0505	Consejo Nacional de Ciencia y Tecnologia (Mexico) [49113]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IN211907, IN109210-3, IN112407]	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	Grant 49113 from Consejo Nacional de Ciencia y Tecnologia (Mexico), and grants IN211907, IN109210-3, and IN112407 from Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, are acknowledged. J. Espinal and A. Guerrero thank the Consejo Nacional de Ciencia y Tecnologia (Mexico) for a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Alon U, 2007, INTRO SYSTEMS BIOL D; BABCOCK DF, 1992, P NATL ACAD SCI USA, V89, P6001, DOI 10.1073/pnas.89.13.6001; Balleza E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002456; Beltran C, 1996, BIOCHEMISTRY-US, V35, P7591, DOI 10.1021/bi952806v; BENTLEY JK, 1986, J BIOL CHEM, V261, P4859; Bonigk W, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000516; Bohmer M, 2005, EMBO J, V24, P2741, DOI 10.1038/sj.emboj.7600744; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Brokaw CJ, 2009, CELL MOTIL CYTOSKEL, V66, P425, DOI 10.1002/cm.20313; Carteret HA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.218702; Chialvo DR, 2006, NAT PHYS, V2, P301, DOI 10.1038/nphys300; COOK SP, 1993, J BIOL CHEM, V268, P22408; COOK SP, 1993, J BIOL CHEM, V268, P22402; DANGOTT LJ, 1984, J BIOL CHEM, V259, P3712; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2008, INT J DEV BIOL, V52, P595, DOI 10.1387/ijdb.072550ad; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; DERRIDA B, 1986, EUROPHYS LETT, V1, P45, DOI 10.1209/0295-5075/1/2/001; Elgeti J, 2010, BIOPHYS J, V99, P1018, DOI 10.1016/j.bpj.2010.05.015; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Galindo BE, 2007, BIOCHEM BIOPH RES CO, V354, P668, DOI 10.1016/j.bbrc.2007.01.035; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; Galindo BE, 2005, BIOCHEM BIOPH RES CO, V334, P96, DOI 10.1016/j.bbrc.2005.06.074; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; GARBERS DL, 1976, J BIOL CHEM, V251, P4071; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Granados-Gonzalez G, 2005, FEBS LETT, V579, P6667, DOI 10.1016/j.febslet.2005.10.035; GRAY J, 1955, J EXP BIOL, V32, P802; Greenwood IA, 2007, TRENDS PHARMACOL SCI, V28, P1, DOI 10.1016/j.tips.2006.11.004; Guerrero A, 2010, BIOCHEM SOC T, V38, P1270, DOI 10.1042/BST0381270; Guerrero A, 2010, DEV BIOL, V344, P52, DOI 10.1016/j.ydbio.2010.04.013; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P1447; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; LEE HC, 1986, J BIOL CHEM, V261, P6026; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lindemann CB, 2010, J CELL SCI, V123, P519, DOI 10.1242/jcs.051326; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Nishigaki T, 2004, DEV BIOL, V272, P376, DOI 10.1016/j.ydbio.2004.04.035; Nykter M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058702; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Riedel-Kruse IH, 2007, HFSP J, V1, P192, DOI 10.2976/1.2773861; Rodriguez E, 2003, J PHYSIOL-LONDON, V546, P89, DOI 10.1113/jphysiol.2002.030510; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Su YH, 2002, P NATL ACAD SCI USA, V99, P6743, DOI 10.1073/pnas.102186699; SUZUKI N, 1995, ZOOL SCI, V12, P13, DOI 10.2108/zsj.12.13; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wood CD, 2005, J CELL BIOL, V169, P725, DOI 10.1083/jcb.200411001; Wood CD, 2003, J CELL BIOL, V161, P89, DOI 10.1083/jcb.200212053; Wood CD, 2007, DEV BIOL, V306, P525, DOI 10.1016/j.ydbio.2007.03.036	61	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22619	10.1371/journal.pone.0022619	http://dx.doi.org/10.1371/journal.pone.0022619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857937	Green Published, Green Submitted, gold			2022-12-27	WOS:000294125500009
J	Jo, HH; Pan, RK; Kaski, K				Jo, Hang-Hyun; Pan, Raj Kumar; Kaski, Kimmo			Emergence of Bursts and Communities in Evolving Weighted Networks	PLOS ONE			English	Article							HEAVY TAILS	Understanding the patterns of human dynamics and social interaction and the way they lead to the formation of an organized and functional society are important issues especially for techno-social development. Addressing these issues of social networks has recently become possible through large scale data analysis of mobile phone call records, which has revealed the existence of modular or community structure with many links between nodes of the same community and relatively few links between nodes of different communities. The weights of links, e.g., the number of calls between two users, and the network topology are found correlated such that intra-community links are stronger compared to the weak inter-community links. This feature is known as Granovetter's "The strength of weak ties'' hypothesis. In addition to this inhomogeneous community structure, the temporal patterns of human dynamics turn out to be inhomogeneous or bursty, characterized by the heavy tailed distribution of time interval between two consecutive events, i.e., inter-event time. In this paper, we study how the community structure and the bursty dynamics emerge together in a simple evolving weighted network model. The principal mechanisms behind these patterns are social interaction by cyclic closure, i.e., links to friends of friends and the focal closure, links to individuals sharing similar attributes or interests, and human dynamics by task handling process. These three mechanisms have been implemented as a network model with local attachment, global attachment, and priority-based queuing processes. By comprehensive numerical simulations we show that the interplay of these mechanisms leads to the emergence of heavy tailed inter-event time distribution and the evolution of Granovetter-type community structure. Moreover, the numerical results are found to be in qualitative agreement with empirical analysis results from mobile phone call dataset.	[Jo, Hang-Hyun; Pan, Raj Kumar; Kaski, Kimmo] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland	Aalto University	Jo, HH (corresponding author), Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland.	joh1@aalto.fi	Pan, Raj Kumar/B-4352-2010; Kaski, Kimmo K K/G-8067-2012; Kaski, Kimmo/AAO-4320-2021; Jo, Hang-Hyun/F-4666-2012	Pan, Raj Kumar/0000-0001-9803-6332; Kaski, Kimmo/0000-0002-3805-9687; Jo, Hang-Hyun/0000-0002-4214-9204	Aalto University; Academy of Finland; Finnish Center of Excellence program [129670]	Aalto University; Academy of Finland(Academy of Finland); Finnish Center of Excellence program	Financial support by Aalto University postdoctoral program (Hang-Hyun Jo), by the Academy of Finland, the Finnish Center of Excellence program 2006-2011, project no. 129670 (Raj Kumar Pan, Kimmo Kaski) are gratefully acknowledged. Center of Excellence: http://www.aka.fi/en-GB/A/Centres-ofExcellence-/Ongoing/Centres-of-Excellence-in-Research-in-2006-2011/CoE-in-Computational-Complex-Systems-Research/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi A.-L., 2010, BURSTS HIDDEN PATTER; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cho WK, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066109; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Goyal Sanjeev, 2007, CONNECTIONS INTRO EC; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; Iniguez G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066119; Jo HH, 2011, ARXIV11010377; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kovanen L, 2009, THESIS AALTO U ESPOO; Kumpula JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228701; Kwak H., 2010, WEB C 2010 P WORLD W, P591; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Min B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036102; Min B, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056110; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oliveira JG, 2009, PHYSICA A, V388, P187, DOI 10.1016/j.physa.2008.08.022; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Zhao K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056109	36	42	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22687	10.1371/journal.pone.0022687	http://dx.doi.org/10.1371/journal.pone.0022687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857946	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500005
J	Isaji, M; Lenartowska, M; Noguchi, T; Frank, DJ; Miller, KG				Isaji, Mamiko; Lenartowska, Marta; Noguchi, Tatsuhiko; Frank, Deborah J.; Miller, Kathryn G.			Myosin VI Regulates Actin Structure Specialization through Conserved Cargo-Binding Domain Sites	PLOS ONE			English	Article							DROSOPHILA SPERMATID INDIVIDUALIZATION; COCHLEAR HAIR-CELLS; UNCONVENTIONAL MYOSIN; MEDIATED ENDOCYTOSIS; GOLGI-COMPLEX; PROTEIN; MOTOR; MEMBRANE; SPERMATOGENESIS; LOCALIZATION	Actin structures are often stable, remaining unchanged in organization for the lifetime of a differentiated cell. Little is known about stable actin structure formation, organization, or maintenance. During Drosophila spermatid individualization, long-lived actin cones mediate cellular remodeling. Myosin VI is necessary for building the dense meshwork at the cones' fronts. We test several ideas for myosin VI's mechanism of action using domain deletions or site-specific mutations of myosin VI. The head (motor) and globular tail (cargo-binding) domains were both needed for localization at the cone front and dense meshwork formation. Several conserved partner-binding sites in the globular tail previously identified in vertebrate myosin VI were critical for function in cones. Localization and promotion of proper actin organization were separable properties of myosin VI. A vertebrate myosin VI was able to localize and function, indicating that functional properties are conserved. Our data eliminate several models for myosin VI's mechanism of action and suggest its role is controlling organization and action of actin assembly regulators through interactions at conserved sites. The Drosophila orthologues of interaction partners previously identified for vertebrate myosin VI are likely not required, indicating novel partners mediate this effect. These data demonstrate that generating an organized and functional actin structure in this cell requires multiple activities coordinated by myosin VI.	[Isaji, Mamiko; Frank, Deborah J.; Miller, Kathryn G.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Lenartowska, Marta] Nicholas Copernicus Univ, Fac Biol & Earth Sci, Inst Gen & Mol Biol, Dev Biol Lab, Torun, Poland; [Noguchi, Tatsuhiko] RIKEN Kobe, Lab Morphogenet Signaling, Ctr Dev Biol, Kobe, Hyogo, Japan	Washington University (WUSTL); Nicolaus Copernicus University; RIKEN	Isaji, M (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	miller@wustl.edu	Lenartowska, Marta/G-5203-2014; Lenartowska, Marta/S-4545-2019	Lenartowska, Marta/0000-0002-5886-2493; Lenartowska, Marta/0000-0002-5886-2493	National Institutes of Health [GM-60494]; Polish Ministry of Science and Higher Education [NN303 816240]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM-60494 (to K.G.M.), http://www.nih.gov/; and Polish Ministry of Science and Higher Education grant NN303 816240 (to M.L.), http://www.nauka.gov.pl/home/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; Breshears LM, 2007, CURR BIOL, V17, pR915, DOI 10.1016/j.cub.2007.09.003; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Djiane A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011228; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; Fabian L, 2010, MOL BIOL CELL, V21, P1546, DOI 10.1091/mbc.E09-07-0582; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Finan D, 2011, P NATL ACAD SCI USA, V108, P5566, DOI 10.1073/pnas.1101415108; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hicks JL, 1999, MOL BIOL CELL, V10, P4341, DOI 10.1091/mbc.10.12.4341; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Lin HP, 2007, DEV BIOL, V311, P423, DOI 10.1016/j.ydbio.2007.08.043; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Millo H, 2004, MECH DEVELOP, V121, P1335, DOI 10.1016/j.mod.2004.06.007; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Noguchi T, 2006, MOL BIOL CELL, V17, P2559, DOI 10.1091/mbc.E06-01-0031; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; Noguchi T, 2008, MOL BIOL CELL, V19, P2363, DOI 10.1091/mbc.E07-08-0840; Noguchi T, 2009, MOL BIOL CELL, V20, P358, DOI 10.1091/mbc.E08-07-0776; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; Rogat AD, 2002, J CELL SCI, V115, P4855, DOI 10.1242/jcs.00149; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Sweeney HL, 2010, CELL, V141, P573, DOI 10.1016/j.cell.2010.04.028; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V127, P492, DOI 10.1007/BF00306868; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wu HJ, 2002, J BIOL CHEM, V277, P30928, DOI 10.1074/jbc.M203735200	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22755	10.1371/journal.pone.0022755	http://dx.doi.org/10.1371/journal.pone.0022755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853045	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400012
J	Ortiz, T; Poch, J; Santos, JM; Requena, C; Martinez, AM; Ortiz-Teran, L; Turrero, A; Barcia, J; Nogales, R; Calvo, A; Martinez, JM; Cordoba, JL; Pascual-Leone, A				Ortiz, Tomas; Poch, Joaquin; Santos, Juan M.; Requena, Carmen; Martinez, Ana M.; Ortiz-Teran, Laura; Turrero, Agustin; Barcia, Juan; Nogales, Ramon; Calvo, Agustin; Martinez, Jose M.; Cordoba, Jose L.; Pascual-Leone, Alvaro			Recruitment of Occipital Cortex during Sensory Substitution Training Linked to Subjective Experience of Seeing in People with Blindness	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; VISUAL-CORTEX; CONGENITALLY BLIND; EFFECTIVE CONNECTIVITY; ACTIVATION PATTERNS; CORTICAL ACTIVITY; HUMAN BRAIN; HUMANS; PERCEPTION; TACTILE	Over three months of intensive training with a tactile stimulation device, 18 blind and 10 blindfolded seeing subjects improved in their ability to identify geometric figures by touch. Seven blind subjects spontaneously reported 'visual qualia', the subjective sensation of seeing flashes of light congruent with tactile stimuli. In the latter subjects tactile stimulation evoked activation of occipital cortex on electroencephalography (EEG). None of the blind subjects who failed to experience visual qualia, despite identical tactile stimulation training, showed EEG recruitment of occipital cortex. None of the blindfolded seeing humans reported visual-like sensations during tactile stimulation. These findings support the notion that the conscious experience of seeing is linked to the activation of occipital brain regions in people with blindness. Moreover, the findings indicate that provision of visual information can be achieved through non-visual sensory modalities which may help to minimize the disability of blind individuals, affording them some degree of object recognition and navigation aid.	[Ortiz, Tomas; Santos, Juan M.; Martinez, Ana M.; Ortiz-Teran, Laura] Univ Complutense, Fac Med, Dept Psychiat, E-28040 Madrid, Spain; [Poch, Joaquin] Hosp Clin Univ San Carlos, Dept Ear Nose & Throat ENT, Madrid, Spain; [Santos, Juan M.] Spanish Res Network Mental Hlth, CIBERSAM Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Requena, Carmen] Univ Leon, Dept Psychol, E-24071 Leon, Spain; [Ortiz-Teran, Laura] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Turrero, Agustin] Univ Complutense, Fac Med, Dept Stat, E-28040 Madrid, Spain; [Barcia, Juan] Hosp Clin Univ San Carlos, Dept Neurosurg, Madrid, Spain; [Nogales, Ramon; Calvo, Agustin; Martinez, Jose M.; Cordoba, Jose L.] Univ Complutense, Fac Med, Vis Tactile Project, E-28040 Madrid, Spain; [Pascual-Leone, Alvaro] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Berenson Allen Ctr Noninvas Brain Stimulat,Dept N, Boston, MA 02215 USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Guttman Neurorehabil, E-08193 Barcelona, Spain	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidad de Leon; Harvard University; Massachusetts General Hospital; Complutense University of Madrid; Complutense University of Madrid; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Autonomous University of Barcelona	Ortiz, T (corresponding author), Univ Complutense, Fac Med, Dept Psychiat, E-28040 Madrid, Spain.	tortiz@med.ucm.es	Requena, Carmen/ABG-6994-2020; Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011; Requena, Carmen MC/J-6849-2014	Requena, Carmen/0000-0003-2427-8608; Pascual-Leone, Alvaro/0000-0001-8975-0382; Requena, Carmen MC/0000-0003-2427-8608; Barcia Albacar, Juan Antonio/0000-0001-6562-4568	Fundacion Esther Koplowitz [EK-4131306]; Instituto Madrileno de Desarrollo (IMADE)/Madrid Regional Government (Spain) [IMADE-4131307]	Fundacion Esther Koplowitz; Instituto Madrileno de Desarrollo (IMADE)/Madrid Regional Government (Spain)	This research has been made possible through grants from the Fundacion Esther Koplowitz (grant #EK-4131306) and Instituto Madrileno de Desarrollo (IMADE)/Madrid Regional Government (Spain) (grant #IMADE-4131307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Amedi A, 2010, RESTOR NEUROL NEUROS, V28, P143, DOI [10.3233/RNN-2010-0503, 10.3233/RNN-2010-0497]; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; De Santis L, 2007, NEUROIMAGE, V37, P890, DOI 10.1016/j.neuroimage.2007.05.052; De Santis L, 2007, CEREB CORTEX, V17, P9, DOI 10.1093/cercor/bhj119; De Volder AG, 1999, BRAIN RES, V826, P128, DOI 10.1016/S0006-8993(99)01275-5; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Hotting K, 2003, EXP BRAIN RES, V148, P26, DOI 10.1007/s00221-002-1261-z; Kitada R, 2006, J NEUROSCI, V26, P7491, DOI 10.1523/JNEUROSCI.0822-06.2006; Kupers R, 2006, P NATL ACAD SCI USA, V103, P13256, DOI 10.1073/pnas.0602925103; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lacey S, 2010, NEUROIMAGE, V49, P1977, DOI 10.1016/j.neuroimage.2009.10.081; Lacey S, 2009, BRAIN TOPOGR, V21, P269, DOI 10.1007/s10548-009-0087-4; Lewis LB, 2010, J NEUROPHYSIOL, V104, P2995, DOI 10.1152/jn.00983.2009; Llinas R R, 1998, Adv Neurol, V77, P95; Lucan JN, 2010, HUM BRAIN MAPP, V31, P1813, DOI 10.1002/hbm.20983; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Merabet LB, 2004, J NEURO-OPHTHALMOL, V24, P109, DOI 10.1097/00041327-200406000-00003; Murray MM, 2009, BRAIN COGNITION, V69, P47, DOI 10.1016/j.bandc.2008.05.004; Noppeney U, 2007, NEUROSCI BIOBEHAV R, V31, P1169, DOI 10.1016/j.neubiorev.2007.04.012; Ortiz T, 2010, REV NEUROLOGIA, V50, pS19; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pedroarena C, 1997, P NATL ACAD SCI USA, V94, P724, DOI 10.1073/pnas.94.2.724; Peltier S, 2007, NEUROPSYCHOLOGIA, V45, P476, DOI 10.1016/j.neuropsychologia.2006.03.003; Poirier C, 2007, NEUROSCI BIOBEHAV R, V31, P1064, DOI 10.1016/j.neubiorev.2007.05.010; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito M, 2008, EXP BRAIN RES, V187, P41, DOI 10.1007/s00221-008-1273-4; Ptito Maurice, 2005, Journal of Integrative Neuroscience, V4, P479, DOI 10.1142/S0219635205000951; Ribary U, 2005, PROG BRAIN RES, V150, P127, DOI 10.1016/S0079-6123(05)50010-4; Rosburg T, 2008, PSYCHIAT RES, V161, P259, DOI 10.1016/j.psychres.2008.03.017; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sathian K, 2010, RESTOR NEUROL NEUROS, V28, P271, DOI 10.3233/RNN-2010-0534; Sehatpour P, 2008, P NATL ACAD SCI USA, V105, P4399, DOI 10.1073/pnas.0708418105; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Stilla R, 2008, J VISION, V8, DOI 10.1167/8.10.13; UHL F, 1991, NEUROSCI LETT, V124, P256, DOI 10.1016/0304-3940(91)90107-5; Ward J, 2010, CONSCIOUS COGN, V19, P492, DOI 10.1016/j.concog.2009.10.006; Wittenberg GF, 2004, EUR J NEUROSCI, V20, P1923, DOI 10.1111/j.1460-9568.2004.03630.x	58	43	43	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23264	10.1371/journal.pone.0023264	http://dx.doi.org/10.1371/journal.pone.0023264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853098	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000295454200059
J	Creevey, CJ; Doerks, T; Fitzpatrick, DA; Raes, J; Bork, P				Creevey, Christopher J.; Doerks, Tobias; Fitzpatrick, David A.; Raes, Jeroen; Bork, Peer			Universally Distributed Single-Copy Genes Indicate a Constant Rate of Horizontal Transfer	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; LATERAL TRANSFER; EVOLUTION; TREE; BARRIERS; BACTERIA; GENOMES; LIFE; RECONSTRUCTION	Single copy genes, universally distributed across the three domains of life and encoding mostly ancient parts of the translation machinery, are thought to be only rarely subjected to horizontal gene transfer (HGT). Indeed it has been proposed to have occurred in only a few genes and implies a rare, probably not advantageous event in which an ortholog displaces the original gene and has to function in a foreign context (orthologous gene displacement, OGD). Here, we have utilised an automatic method to identify HGT based on a conservative statistical approach capable of robustly assigning both donors and acceptors. Applied to 40 universally single copy genes we found that as many as 68 HGTs (implying OGDs) have occurred in these genes with a rate of 1.7 per family since the last universal common ancestor (LUCA). We examined a number of factors that have been claimed to be fundamental to HGT in general and tested their validity in the subset of universally distributed single copy genes. We found that differing functional constraints impact rates of OGD and the more evolutionarily distant the donor and acceptor, the less likely an OGD is to occur. Furthermore, species with larger genomes are more likely to be subjected to OGD. Most importantly, regardless of the trends above, the number of OGDs increases linearly with time, indicating a neutral, constant rate. This suggests that levels of HGT above this rate may be indicative of positively selected transfers that may allow niche adaptation or bestow other benefits to the recipient organism.	[Creevey, Christopher J.] TEAGASC, Anim & Biosci Res Dept, Dunsany, Meath, Ireland; [Doerks, Tobias; Bork, Peer] European Mol Biol Lab, Heidelberg, Germany; [Fitzpatrick, David A.] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Raes, Jeroen] Vrije Univ Brussel, VIB Dept Mol & Cellular Interact, Brussels, Belgium	Teagasc; European Molecular Biology Laboratory (EMBL); Maynooth University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Creevey, CJ (corresponding author), TEAGASC, Anim & Biosci Res Dept, Dunsany, Meath, Ireland.	bork@embl.de	raes, jeroen/D-7835-2018; Bork, Peer/F-1813-2013; Creevey, Christopher James/A-1836-2013	raes, jeroen/0000-0002-1337-041X; Bork, Peer/0000-0002-2627-833X; Creevey, Christopher James/0000-0001-7183-1555; Fitzpatrick, David/0000-0001-7345-6998	EU [HEALTH-F4-2007-201052]; Science Foundation Ireland (SFI) [07/SK/B1236A]	EU(European Commission); Science Foundation Ireland (SFI)(Science Foundation Ireland)	This project was funded under the EU 7th Framework Programme (number: HEALTH-F4-2007-201052). CJC is funded under the Science Foundation Ireland (SFI) Stokes Lecturer Scheme (number: 07/SK/B1236A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapteste E, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-34; Brochier C, 2000, TRENDS GENET, V16, P529, DOI 10.1016/S0168-9525(00)02142-9; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Bull JJ, 2007, MOL BIOL EVOL, V24, P900, DOI 10.1093/molbev/msm006; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Copley SD, 2002, GENOME BIOL, V3; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fall S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001055; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fox J, 2002, COX PROPORTIONAL HAZ; Friedrich MW, 2002, J BACTERIOL, V184, P278, DOI 10.1128/JB.184.1.278-289.2002; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haggerty LS, 2009, PHILOS T R SOC B, V364, P2209, DOI 10.1098/rstb.2009.0042; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Kunin V, 2003, BIOINFORMATICS, V19, P1412, DOI 10.1093/bioinformatics/btg174; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Makarova KS, 1999, GENOME RES, V9, P608; Medrano-Soto A, 2004, MOL BIOL EVOL, V21, P1884, DOI 10.1093/molbev/msh202; Poptsova MS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-45; Raymond J, 2003, PHILOS T R SOC B, V358, P223, DOI 10.1098/rstb.2002.1181; Sanderson MJ, 2003, MOL BIOL EVOL, V20, P1036, DOI 10.1093/molbev/msg115; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SNEL B, 2005, ANN REV MICROBIOL, P11601; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wellner A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r156	44	61	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22099	10.1371/journal.pone.0022099	http://dx.doi.org/10.1371/journal.pone.0022099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850220	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000293563300004
J	Davis, FM; Kenny, PA; Soo, ETL; van Denderen, BJW; Thompson, EW; Cabot, PJ; Parat, MO; Roberts-Thomson, SJ; Monteith, GR				Davis, Felicity M.; Kenny, Paraic A.; Soo, Eliza T-L; van Denderen, Bryce J. W.; Thompson, Erik W.; Cabot, Peter J.; Parat, Marie-Odile; Roberts-Thomson, Sarah J.; Monteith, Gregory R.			Remodeling of Purinergic Receptor-Mediated Ca2+ Signaling as a Consequence of EGF-Induced Epithelial-Mesenchymal Transition in Breast Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; SMOOTH-MUSCLE; ACTIVATED RECEPTOR-2; EXTRACELLULAR ATP; PROSTATE-CANCER; P2X(5) RECEPTOR; CARCINOMA CELLS; P2 RECEPTORS; METASTASIS; MIGRATION	Background: The microenvironment plays a pivotal role in tumor cell proliferation, survival and migration. Invasive cancer cells face a new set of environmental challenges as they breach the basement membrane and colonize distant organs during the process of metastasis. Phenotypic switching, such as that which occurs during epithelial-mesenchymal transition (EMT), may be associated with a remodeling of cell surface receptors and thus altered responses to signals from the tumor microenvironment. Methodology/Principal Findings: We assessed changes in intracellular Ca2+ in cells loaded with Fluo-4 AM using a fluorometric imaging plate reader (FLIPRTETRA) and observed significant changes in the potency of ATP (EC50 0.175 mu M (-EGF) versus 1.731 mu M (+EGF), P < 0.05), and the nature of the ATP-induced Ca2+ transient, corresponding with a 10-fold increase in the mesenchymal marker vimentin (P < 0.05). We observed no change in the sensitivity to PAR2-mediated Ca2+ signaling, indicating that these alterations are not simply a consequence of changes in global Ca2+ homeostasis. To determine whether changes in ATP-mediated Ca2+ signaling are preceded by alterations in the transcriptional profile of purinergic receptors, we analyzed the expression of a panel of P2X ionotropic and P2Y metabotropic purinergic receptors using real-time RT-PCR and found significant and specific alterations in the suite of ATP-activated purinergic receptors during EGF-induced EMT in breast cancer cells. Our studies are the first to show that P2X(5) ionotropic receptors are enriched in the mesenchymal phenotype and that silencing of P2X(5) leads to a significant reduction (25%, P < 0.05) in EGF-induced vimentin protein expression. Conclusions: The acquisition of a new suite of cell surface purinergic receptors is a feature of EGF-mediated EMT in MDA-MB-468 breast cancer cells. Such changes may impart advantageous phenotypic traits and represent a novel mechanism for the targeting of cancer metastasis.	[Davis, Felicity M.; Cabot, Peter J.; Parat, Marie-Odile; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Kenny, Paraic A.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Soo, Eliza T-L; van Denderen, Bryce J. W.; Thompson, Erik W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Soo, Eliza T-L; Thompson, Erik W.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia; [van Denderen, Bryce J. W.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	University of Queensland; Yeshiva University; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Monteith, GR (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	gregm@uq.edu.au	Davis, Felicity M/P-1387-2016; Parat, Marie-Odile/G-4410-2010; Cabot, Peter John/B-2424-2013; Thompson, Erik/GPK-2067-2022; Roberts-Thomson, Sarah J/B-4282-2011; Thompson, Erik W/A-1425-2009; Monteith, Gregory/B-1626-2008; Roberts-Thomson, Sarah/W-5676-2019; van Denderen, Bryce/AAW-5454-2021	Davis, Felicity M/0000-0001-9112-118X; Parat, Marie-Odile/0000-0003-4895-7381; Cabot, Peter John/0000-0003-1778-3753; Thompson, Erik/0000-0002-9723-4924; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Thompson, Erik W/0000-0002-9723-4924; Monteith, Gregory/0000-0002-4345-530X; Roberts-Thomson, Sarah/0000-0001-8202-5786; 	National Health and Medical Research Council (NHMRC) [569645]; Susan G. Komen for the Cure [KG100888]; Cancer Australia - National Breast Cancer Foundation [628720]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Cancer Australia - National Breast Cancer Foundation	This work was partially supported by the National Health and Medical Research Council (NHMRC) (569645) and an NHMRC Biomedical Postgraduate Research Scholarship to FD, www.nhmrc.gov.au. PK was supported by Susan G. Komen for the Cure (KG100888), www.komen.org. ET was funded by Cancer Australia - National Breast Cancer Foundation (628720), www.nbcf.org.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Bohm SK, 1996, BIOCHEM J, V314, P1009; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Briand P, 1996, CANCER RES, V56, P2039; BRIAND P, 1987, IN VITRO CELL DEV B, V23, P181, DOI 10.1007/BF02623578; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Erlinge D, 1998, BIOCHEM BIOPH RES CO, V248, P864, DOI 10.1006/bbrc.1998.9083; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gilles C, 1999, J CELL SCI, V112, P4615; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Hugo HJ, 2011, CELLS TISSUES ORGANS, V193, P23, DOI 10.1159/000320174; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Khakh BS, 2001, PHARMACOL REV, V53, P107; Leinonen P, 2007, CELL COMMUN ADHES, V14, P125, DOI 10.1080/15419060701557065; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; NEYLON CB, 1994, CIRC RES, V75, P733, DOI 10.1161/01.RES.75.4.733; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Price JT, 1999, CANCER RES, V59, P5475; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Bilbao PS, 2010, ARCH BIOCHEM BIOPHYS, V499, P40, DOI 10.1016/j.abb.2010.05.001; Shabbir M, 2008, BJU INT, V101, P352, DOI 10.1111/j.1464-410X.2007.07293.x; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Suchanek KM, 2002, MOL CARCINOGEN, V34, P165, DOI 10.1002/mc.10061; Suzuki M, 2006, AM J PATHOL, V169, P673, DOI 10.2353/ajpath.2006.060053; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	54	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23464	10.1371/journal.pone.0023464	http://dx.doi.org/10.1371/journal.pone.0023464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850275	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300060
J	Ecklund, EH; Lincoln, AE				Ecklund, Elaine Howard; Lincoln, Anne E.			Scientists Want More Children	PLOS ONE			English	Article								Scholars partly attribute the low number of women in academic science to the impact of the science career on family life. Yet, the picture of how men and women in science - at different points in the career trajectory - compare in their perceptions of this impact is incomplete. In particular, we know little about the perceptions and experiences of junior and senior scientists at top universities, institutions that have a disproportionate influence on science, science policy, and the next generation of scientists. Here we show that having fewer children than wished as a result of the science career affects the life satisfaction of science faculty and indirectly affects career satisfaction, and that young scientists (graduate students and postdoctoral fellows) who have had fewer children than wished are more likely to plan to exit science entirely. We also show that the impact of science on family life is not just a woman's problem; the effect on life satisfaction of having fewer children than desired is more pronounced for male than female faculty, with life satisfaction strongly related to career satisfaction. And, in contrast to other research, gender differences among graduate students and postdoctoral fellows disappear. Family factors impede talented young scientists of both sexes from persisting to research positions in academic science. In an era when the global competitiveness of US science is at risk, it is concerning that a significant proportion of men and women trained in the select few spots available at top US research universities are considering leaving science and that such desires to leave are related to the impact of the science career on family life. Results from our study may inform university family leave policies for science departments as well as mentoring programs in the sciences.	[Ecklund, Elaine Howard] Rice Univ, Dept Sociol, Houston, TX 77251 USA; [Lincoln, Anne E.] So Methodist Univ, Dept Sociol, Dallas, TX 75275 USA	Rice University; Southern Methodist University	Ecklund, EH (corresponding author), Rice Univ, Dept Sociol, Houston, TX 77251 USA.	ehe@rice.edu	Lincoln, Anne E./B-4281-2011		National Science Foundation [0920837]	National Science Foundation(National Science Foundation (NSF))	The authors received grant support from the National Science Foundation (GSE Grant 0920837, Elaine Howard Ecklund, PI, and Anne E. Lincoln, Co-PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; Glimcher LH, 2009, NAT IMMUNOL, V10, P559, DOI 10.1038/ni0609-559; LADD EC, 1972, SCIENCE, V176, P1091, DOI 10.1126/science.176.4039.1091; Mason MA, 2002, ACADEME, V88, P21, DOI 10.2307/40252436; MASON MA, 2009, ACADEME, V95, P11; Preston AE., 2004, LEAVING SCI; van Anders SM, 2004, SEX ROLES, V51, P511, DOI 10.1007/s11199-004-5461-9; Xie Y., 2003, WOMEN SCI CAREER PRO	8	45	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22590	10.1371/journal.pone.0022590	http://dx.doi.org/10.1371/journal.pone.0022590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803EC	21850232	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300016
J	Kelly, H; Peck, HA; Laurie, KL; Wu, P; Nishiura, H; Cowling, BJ				Kelly, Heath; Peck, Heidi A.; Laurie, Karen L.; Wu, Peng; Nishiura, Hiroshi; Cowling, Benjamin J.			The Age-Specific Cumulative Incidence of Infection with Pandemic Influenza H1N1 2009 Was Similar in Various Countries Prior to Vaccination	PLOS ONE			English	Article							ANTIBODY-RESPONSE; HEMAGGLUTINATION INHIBITION; HOSPITAL STAFF; PREGNANT-WOMEN; RISK-FACTORS; ATTACK RATE; VIRUS; PREVALENCE; SEROCONVERSION; CHILDREN	Background: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infection were needed to guide vaccination policies and inform other control measures. Serological studies are the most reliable way to measure influenza infection independent of symptoms. We reviewed all published serological studies that estimated the cumulative incidence of infection with pandemic influenza H1N1 2009 prior to the initiation of population-based vaccination against the pandemic strain. Methodology and Principal Findings: We searched for studies that estimated the cumulative incidence of pandemic influenza infection in the wider community. We excluded studies that did not include both pre- and post-pandemic serological sampling and studies that included response to vaccination. We identified 47 potentially eligible studies and included 12 of them in the review. Where there had been a significant first wave, the cumulative incidence of pandemic influenza infection was reported in the range 16%-28% in pre-school aged children, 34%-43% in school aged children and 12%-15% in young adults. Only 2%-3% of older adults were infected. The proportion of the entire population infected ranged from 11%-18%. We re-estimated the cumulative incidence to account for the small proportion of infections that may not have been detected by serology, and performed direct age-standardisation to the study population. For those countries where it could be calculated, this suggested a population cumulative incidence in the range 11%-21%. Conclusions and Significance: Around the world, the cumulative incidence of infection (which is higher than the cumulative incidence of clinical disease) was below that anticipated prior to the pandemic. Serological studies need to be routine in order to be sufficiently timely to provide support for decisions about vaccination.	[Kelly, Heath; Peck, Heidi A.; Laurie, Karen L.] WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic, Australia; [Wu, Peng; Nishiura, Hiroshi; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Victorian Infectious Diseases Reference Laboratory; World Health Organization; University of Hong Kong; Japan Science & Technology Agency (JST)	Kelly, H (corresponding author), WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic, Australia.	heath.kelly@mh.org.au	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Nishiura, Hiroshi/0000-0003-0941-8537; Wu, Peng/0000-0003-1157-9401; Laurie, Karen/0000-0001-5186-8342	Australian Government Department of Health and Ageing	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2010, EUROSURVEILLANCE, V15; AHO M, 2010, EURO SURVEILL, V15; Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; *AUSTR BUR STAT, 2010, AUSTR DEM STAT SEP 2; Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CENS STAT DEP HON, 2011, STAT TABL TABL 002 P; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M, 2009, WORLD NOW START INFL; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chang SC, 2010, CLIN INFECT DIS, V51, P1465, DOI 10.1086/657406; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012474; Chen MIC, 2010, EMERG INFECT DIS, V16, P1554, DOI 10.3201/eid1610.100516; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; *DEP STAT SING, 2010, YB STAT SING 2010 3; Department of Health, 2007, PAND FLU NAT FRAM RE; Dowse GK, 2011, MED J AUSTRALIA, V194, P68, DOI 10.5694/j.1326-5377.2011.tb04170.x; Flahault A, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1140; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; GREENBAUM JA, 2009, P NATL ACAD SCI 1118; Grills N, 2010, AUST NZ J PUBL HEAL, V34, P228, DOI 10.1111/j.1753-6405.2010.00518.x; Gurav YK, 2010, INDIAN J MED RES, V132, P67; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; *HLTH PROT AG UK, 2010, SER PROGR SAMPL COLL; Hung IFN, 2010, CLIN INFECT DIS, V51, P274, DOI 10.1086/653940; Ikonen N, 2010, EURO SURVEILL, V15; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jiang T, 2010, CLIN INFECT DIS, V50, P285, DOI 10.1086/649552; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Lee VJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-164; LEE VJ, 2011, AM J EPIDEM IN PRESS; Liu WT, 2010, CLIN INFECT DIS, V51, P251, DOI 10.1086/653680; Mahmud SM, 2010, CAN MED ASSOC J, V182, P1522, DOI 10.1503/cmaj.100488; Mak GC, 2010, J MED VIROL, V82, P1809, DOI 10.1002/jmv.21895; McVernon J, 2010, EURO SURVEILL, V15, pii; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *MIN HLTH FAM WELF, 2009, SECT A POP VIT STAT; Moghadami M, 2010, IRAN J IMMUNOL, V7, P39, DOI IJIv7i1A5; Nishiura H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017908; *OFF NAT STAT UK, 2011, VIT STAT POP HLTH RE; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Ross T, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1148; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; *STAT NORW, 2010, POP AG COUNT; *STAT NZ, 2010, NAT POP EST JUN 2010; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Tang JW, 2010, EMERG INFECT DIS, V16, P874, DOI 10.3201/eid1605.091678; Tian LL, 2011, PREV MED, V52, P71, DOI 10.1016/j.ypmed.2010.10.006; Tsai T.F., 2010, EURO SURVEILL, V15; WHO, 2009, GLOB INFL PROGR PAND; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; Wilson N, 2009, EUROSURVEILLANCE, V14; Wiwanitkit V, 2010, IRAN J IMMUNOL, V7, P130, DOI IJIv7i2A9; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yang P, 2011, INT J INFECT DIS, V15, pE151, DOI 10.1016/j.ijid.2010.11.001; Zhang RQ, 2011, SCAND J INFECT DIS, V43, P216, DOI 10.3109/00365548.2010.539258; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; [No title captured]	69	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e21828	10.1371/journal.pone.0021828	http://dx.doi.org/10.1371/journal.pone.0021828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850217	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300001
J	Lin, YT; Chern, YJ; Shen, CKJ; Wen, HL; Chang, YC; Li, H; Cheng, TH; Hsieh-Li, HM				Lin, Yuan-Ta; Chern, Yijuang; Shen, Che-Kun James; Wen, Hsin-Lan; Chang, Ya-Chin; Li, Hung; Cheng, Tzu-Hao; Hsieh-Li, Hsiu Mei			Human Mesenchymal Stem Cells Prolong Survival and Ameliorate Motor Deficit through Trophic Support in Huntington's Disease Mouse Models	PLOS ONE			English	Article							MARROW STROMAL CELLS; FETAL STRIATAL TRANSPLANTATION; BONE-MARROW; NEURAL TRANSPLANTATION; EXCITOTOXIC LESION; QUINOLINIC ACID; RAT STRIATUM; ADULT BRAIN; STROKE; EXPRESSION	We investigated the therapeutic potential of human bone marrow-derived mesenchymal stem cells (hBM-MSCs) in Huntington's disease (HD) mouse models. Ten weeks after intrastriatal injection of quinolinic acid (QA), mice that received hBM-MSC transplantation showed a significant reduction in motor function impairment and increased survival rate. Transplanted hBM-MSCs were capable of survival, and inducing neural proliferation and differentiation in the QA-lesioned striatum. In addition, the transplanted hBM-MSCs induced microglia, neuroblasts and bone marrow-derived cells to migrate into the QA-lesioned region. Similar results were obtained in R6/2-J2, a genetically-modified animal model of HD, except for the improvement of motor function. After hBM-MSC transplantation, the transplanted hBM-MSCs may integrate with the host cells and increase the levels of laminin, Von Willebrand Factor (VWF), stromal cell-derived factor-1 (SDF-1), and the SDF-1 receptor Cxcr4. The p-Erk1/2 expression was increased while Bax and caspase-3 levels were decreased after hBM-MSC transplantation suggesting that the reduced level of apoptosis after hBM-MSC transplantation was of benefit to the QA-lesioned mice. Our data suggest that hBM-MSCs have neural differentiation improvement potential, neurotrophic support capability and an anti-apoptotic effect, and may be a feasible candidate for HD therapy.	[Lin, Yuan-Ta; Li, Hung; Cheng, Tzu-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Lin, Yuan-Ta; Shen, Che-Kun James; Wen, Hsin-Lan; Li, Hung] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Ya-Chin; Hsieh-Li, Hsiu Mei] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan Normal University	Lin, YT (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	hmhsieh@ntnu.edu.tw	chern, yijuang/S-7013-2018	chern, yijuang/0000-0002-5842-5429	Academia Sinica [AS-94-TP-B17, AS-97-TP-B02]; National Science Council [NSC 97-2320-B-003-003-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica Grants AS-94-TP-B17, AS-97-TP-B02, and National Science Council Grant NSC 97-2320-B-003-003-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Alberti E, 2009, MED SCI MONITOR, V15, pBR47; Amann B, 2009, CELL TRANSPLANT, V18, P371, DOI 10.3727/096368909788534942; Amin EM, 2008, NEUROL RES, V30, P1086, DOI 10.1179/174313208X327955; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BJORKLUND A, 1993, NATURE, V362, P414, DOI 10.1038/362414a0; Capetian P, 2009, NEUROSCIENCE, V160, P661, DOI 10.1016/j.neuroscience.2009.02.035; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chindewa Rattiya, 2008, Journal of the Medical Association of Thailand, V91, P208; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Cicchetti F, 2009, P NATL ACAD SCI USA, V106, P12483, DOI 10.1073/pnas.0904239106; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; DUSART I, 1991, NEUROSCIENCE, V45, P541, DOI 10.1016/0306-4522(91)90269-T; Edalatmanesh MA, 2010, NEUROL RES, V32, P166, DOI 10.1179/174313209X409025; Emerich DF, 2006, NEUROBIOL DIS, V23, P471, DOI 10.1016/j.nbd.2006.04.014; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gaura V, 2004, BRAIN, V127, P65, DOI 10.1093/brain/awh003; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Hauser RA, 2002, NEUROLOGY, V58, P687, DOI 10.1212/WNL.58.5.687; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Hernandez-Lopez C, 2008, IMMUNOL LETT, V120, P72, DOI 10.1016/j.imlet.2008.07.006; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jin HK, 2002, J CLIN INVEST, V109, P1183, DOI 10.1072/JCI200214862; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Keene CD, 2007, NEUROLOGY, V68, P2093, DOI 10.1212/01.wnl.0000264504.14301.f5; Keene CD, 2009, ACTA NEUROPATHOL, V117, P329, DOI 10.1007/s00401-008-0465-0; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Kordower JH, 1997, J COMP NEUROL, V387, P96, DOI 10.1002/(SICI)1096-9861(19971013)387:1<96::AID-CNE8>3.0.CO;2-I; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krystkowiak P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000166; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lee ST, 2008, J NEUROCHEM, V104, P1190, DOI 10.1111/j.1471-4159.2007.05044.x; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; Lescaudron L, 2003, INT J NEUROSCI, V113, P945, DOI 10.1080/00207450390207759; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Marco S, 2002, EXP NEUROL, V174, P243, DOI 10.1006/exnr.2001.7859; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2000, BIOCHEM SOC T, V28, P341, DOI 10.1042/0300-5127:0280341; Ramaswamy S, 2007, CELL TRANSPLANT, V16, P301, DOI 10.3727/000000007783464687; Reuter I, 2008, J NEUROL NEUROSUR PS, V79, P948, DOI 10.1136/jnnp.2007.142380; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; Sadan O, 2008, STEM CELLS, V26, P2542, DOI 10.1634/stemcells.2008-0240; SANBERG PR, 1984, CRC CR REV CL NEUROB, V1, P1; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; Shyu WC, 2008, J CLIN INVEST, V118, P2482, DOI 10.1172/JCI34363; Snyder BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009347; STRAUSS S, 1994, NEUROSCI LETT, V168, P193, DOI 10.1016/0304-3940(94)90448-0; Stumm RK, 2003, J NEUROSCI, V23, P5123; Tanabe S, 1997, J IMMUNOL, V159, P905; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Yanagawa Y, 2001, IMMUNOLOGY, V104, P43, DOI 10.1046/j.1365-2567.2001.01292.x; Zand L, 2005, NEUROREPORT, V16, P129, DOI 10.1097/00001756-200502080-00011; ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I	70	74	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22924	10.1371/journal.pone.0022924	http://dx.doi.org/10.1371/journal.pone.0022924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850243	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300028
J	Peter, H; Ylla, I; Gudasz, C; Romani, AM; Sabater, S; Tranvik, LJ				Peter, Hannes; Ylla, Irene; Gudasz, Cristian; Romani, Anna M.; Sabater, Sergi; Tranvik, Lars J.			Multifunctionality and Diversity in Bacterial Biofilms	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; SPECIES RICHNESS; FRESH-WATER; BIODIVERSITY; REDUNDANCY; SELECTION; INCREASE	Bacteria are highly diverse and drive a bulk of ecosystem processes. Analysis of relationships between diversity and single specific ecosystem processes neglects the possibility that different species perform multiple functions at the same time. The degradation of dissolved organic carbon (DOC) followed by respiration is a key bacterial function that is modulated by the availability of DOC and the capability to produce extracellular enzymes. In freshwater ecosystems, biofilms are metabolic hotspots and major sites of DOC degradation. We manipulated the diversity of biofilm forming communities which were fed with DOC differing in availability. We characterized community composition using molecular fingerprinting (T-RFLP) and measured functioning as oxygen consumption rates, the conversion of DOC in the medium, bacterial abundance and the activities of five specific enzymes. Based on assays of the extracellular enzyme activity, we calculated how the likelihood of sustaining multiple functions was affected by reduced diversity. Carbon source and biofilm age were strong drivers of community functioning, and we demonstrate how the likelihood of sustaining multifunctionality decreases with decreasing diversity.	[Peter, Hannes; Gudasz, Cristian; Tranvik, Lars J.] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Ylla, Irene; Romani, Anna M.; Sabater, Sergi] Univ Girona, Inst Aquat Ecol, Dept Environm Sci, Girona, Spain; [Sabater, Sergi] Catalan Inst Water Res ICRA, Girona, Spain	Uppsala University; Universitat de Girona; Institut Catala de Recerca de l'Aigua (ICRA)	Peter, H (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	hannes.peter@ebc.uu.se	Romaní, Anna M/L-7572-2014; Sabater, Sergi/A-7549-2008; Tranvik, Lars J/H-2222-2011	Romaní, Anna M/0000-0001-5183-8231; Sabater, Sergi/0000-0003-3730-0261; Tranvik, Lars J./0000-0003-3509-8266	Malmens Stiftelse; Swedish Research Council; Generalitat de Catalunya	Malmens Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya)	The study was financially supported by grants from the Malmens Stiftelse to HP, the Swedish Research Council to LJT, and from the Generalitat de Catalunya (beques per estades de recerca fora de Catalunya) to IY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Arnosti C., 2003, AQUATIC ECOSYSTEMS I, P315; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bastviken D, 2004, LIMNOL OCEANOGR, V49, P109, DOI 10.4319/lo.2004.49.1.0109; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bent SJ, 2007, APPL ENVIRON MICROB, V73, P2399, DOI 10.1128/AEM.02383-06; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CHROST RJ, 1990, ERGEB LIMNOL, V34, P93; Comte J, 2010, ECOLOGY, V91, P1466, DOI 10.1890/09-0848.1; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Eriksson L., 2006, MULTI MEGAVARIATE 1; Fischer H, 2006, ARCH HYDROBIOL, V166, P79, DOI 10.1127/0003-9136/2006/0166-0079; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; He JZ, 2009, J SOIL SEDIMENT, V9, P547, DOI 10.1007/s11368-009-0120-y; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hillebrand H, 2004, ECOL LETT, V7, P192, DOI 10.1111/j.1461-0248.2004.00570.x; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Jiang L, 2007, ECOLOGY, V88, P1075, DOI 10.1890/06-1556; KAPLAN LA, 1995, WATER RES, V29, P2696, DOI 10.1016/0043-1354(95)00135-8; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MEYER JL, 1994, MICROBIAL ECOL, V28, P195, DOI 10.1007/BF00166808; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Perdue E.M., 2009, ENCY INLAND WATERS, P806, DOI 10.1016/B978-012370626-3.00114-9; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Romani AM, 1999, AQUAT SCI, V61, P122, DOI 10.1007/s000270050057; Singer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009988; Sinsabaugh R.L., 2003, AQUATIC ECOSYSTEMS I; SINSABAUGH RL, 1994, J N AM BENTHOL SOC, V13, P160, DOI 10.2307/1467235; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Szabo KE, 2007, AQUAT MICROB ECOL, V47, P1, DOI 10.3354/ame047001; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	44	82	86	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23225	10.1371/journal.pone.0023225	http://dx.doi.org/10.1371/journal.pone.0023225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850263	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300048
J	Dubois, CL; Shih, HP; Seymour, PA; Patel, NA; Behrmann, JM; Ngo, V; Sander, M				Dubois, Claire L.; Hung Ping Shih; Seymour, Philip A.; Patel, Nisha A.; Behrmann, James M.; Ngo, Victoria; Sander, Maike			Sox9-Haploinsufficiency Causes Glucose Intolerance in Mice	PLOS ONE			English	Article							BETA-CELL APOPTOSIS; TRANSCRIPTION FACTOR; PANCREAS DEVELOPMENT; INSULIN GENE; DIABETES-MELLITUS; PROGENITOR CELLS; GLUCOKINASE GENE; SOX9 EXPRESSION; MUTATIONS; MOUSE	The HMG box transcription factor Sox9 plays a critical role in progenitor cell expansion during pancreas organogenesis and is required for proper endocrine cell development in the embryo. Based on in vitro studies it has been suggested that Sox9 controls expression of a network of important developmental regulators, including Tcf2/MODY5, Hnf6, and Foxa2, in pancreatic progenitor cells. Here, we sought to: 1) determine whether Sox9 regulates this transcriptional network in vivo and 2) investigate whether reduced Sox9 gene dosage leads to impaired glucose homeostasis in adult mice. Employing two genetic models of temporally-controlled Sox9 inactivation in pancreatic progenitor cells, we demonstrate that contrary to in vitro findings, Sox9 is not required for Tcf2, Hnf6, or Foxa2 expression in vivo. Moreover, our analysis revealed a novel role for Sox9 in maintaining the expression of Pdx1/MODY4, which is an important transcriptional regulator of beta-cell development. We further show that reduced beta-cell mass in Sox9-haploinsufficient mice leads to glucose intolerance during adulthood. Sox9-haploinsufficient mice displayed 50% reduced beta-cell mass at birth, which recovered partially via a compensatory increase in beta-cell proliferation early postnatally. Endocrine islets from mice with reduced Sox9 gene dosage exhibited normal glucose stimulated insulin secretion. Our findings show Sox9 plays an important role in endocrine development by maintaining Ngn3 and Pdx1 expression. Glucose intolerance in Sox9-haploinsufficient mice suggests that mutations in Sox9 could play a role in diabetes in humans.	[Dubois, Claire L.; Hung Ping Shih; Seymour, Philip A.; Patel, Nisha A.; Behrmann, James M.; Ngo, Victoria; Sander, Maike] Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Dubois, CL (corresponding author), Univ Calif San Diego, Dept Pediat & Cellular & Mol Med, La Jolla, CA 92093 USA.	masander@ucsd.edu	; Sander, Maike/N-6615-2016	Seymour, Philip/0000-0001-5782-6020; Sander, Maike/0000-0001-5308-7785	NIH/NIDDK [RO1 DK078803, RO1 DK68471]; JDRF; CIRM; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068471, R01DK078803] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); CIRM(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH/NIDDK (RO1 DK078803 and RO1 DK68471) to M.S., by postdoctoral fellowships from the JDRF to P.A.S. and H.P.S., and a graduate student fellowship from the CIRM to C.L.D and N.A.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Badea TC, 2003, J NEUROSCI, V23, P2314; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Barbacci E, 2004, HUM MOL GENET, V13, P3139, DOI 10.1093/hmg/ddh338; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Edghill EL, 2006, DIABETIC MED, V23, P1301, DOI 10.1111/j.1464-5491.2006.01999.x; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kilic G, 2006, DEV DYNAM, V235, P1659, DOI 10.1002/dvdy.20729; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; Manolio TA, 2009, PHARMACOGENOMICS, V10, P235, DOI 10.2217/14622416.10.2.235; Mayer C, 2008, METABOLISM, V57, P416, DOI 10.1016/j.metabol.2007.11.001; Nyqvist D, 2005, J ENDOCRINOL, V186, P333, DOI 10.1677/joe.1.06204; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Piper K, 2002, MECH DEVELOP, V116, P223, DOI 10.1016/S0925-4773(02)00145-4; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Stoffers DA, 1997, TRENDS ENDOCRIN MET, V8, P145, DOI 10.1016/S1043-2760(97)00008-8; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	45	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23131	10.1371/journal.pone.0023131	http://dx.doi.org/10.1371/journal.pone.0023131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829703	Green Submitted, Green Published			2022-12-27	WOS:000293511900027
J	Antunes, LCS; Imperi, F; Carattoli, A; Visca, P				Antunes, Luisa C. S.; Imperi, Francesco; Carattoli, Alessandra; Visca, Paolo			Deciphering the Multifactorial Nature of Acinetobacter baumannii Pathogenicity	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; PATHOGENESIS; VIRULENCE; IDENTIFICATION; OUTBREAK; SURFACES; SURVIVAL; MUTANTS; STRAINS	Background: Acinetobacter baumannii is an emerging bacterial pathogen that causes a broad array of infections, particularly in hospitalized patients. Many studies have focused on the epidemiology and antibiotic resistance of A. baumannii, but little is currently known with respect to its virulence potential. Methodology/Principal Findings: The aim of this work was to analyze a number of virulence-related traits of four A. baumannii strains of different origin and clinical impact for which complete genome sequences were available, in order to tentatively identify novel determinants of A. baumannii pathogenicity. Clinical strains showed comparable virulence in the Galleria mellonella model of infection, irrespective of their status as outbreak or sporadic strains, whereas a non-human isolate was avirulent. A combined approach of genomic and phenotypic analyses led to the identification of several virulence factors, including exoproducts with hemolytic, phospholipase, protease and iron-chelating activities, as well as a number of multifactorial phenotypes, such as biofilm formation, surface motility and stress resistance, which were differentially expressed and could play a role in A. baumannii pathogenicity. Conclusion/Significance: This work provides evidence of the multifactorial nature of A. baumannii virulence. While A. baumannii clinical isolates could represent a selected population of strains adapted to infect the human host, subpopulations of highly genotypically and phenotypically diverse A. baumannii strains may exist outside the hospital environment, whose relevance and distribution deserve further investigation.	[Antunes, Luisa C. S.; Imperi, Francesco; Visca, Paolo] Univ Roma Tre, Dept Biol, Rome, Italy; [Carattoli, Alessandra] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Roma Tre University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Antunes, LCS (corresponding author), Univ Roma Tre, Dept Biol, Rome, Italy.	visca@uniroma3.it	Visca, Paolo/G-8977-2014; Carattoli, Alessandra/A-1324-2009; Imperi, Francesco/AAA-3671-2021	Carattoli, Alessandra/0000-0002-6120-6526; Visca, Paolo/0000-0002-6128-7039	Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/43420/2008]	Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology)	The study was supported by a PhD fellowship to L.C.S.A. from the Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) (grant SFRH/BD/43420/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCS, 2011, RES MICROBIOL, V162, P279, DOI 10.1016/j.resmic.2010.10.010; Arnow LE, 1937, J BIOL CHEM, V118, P531; BERKA RM, 1981, INFECT IMMUN, V34, P1071, DOI 10.1128/IAI.34.3.1071-1074.1981; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Cevahir N, 2008, J MICROBIOL IMMUNOL, V41, P513; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Falagas ME, 2007, CRIT CARE, V11, DOI 10.1186/cc5911; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; GILLAM AH, 1981, ANAL CHEM, V53, P841, DOI 10.1021/ac00229a023; HUNT DE, 1969, APPL MICROBIOL, V17, P329, DOI 10.1128/AEM.17.2.329-330.1969; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Imperi F, 2011, IUBMB LIFE IN PRESS, V63, pxxx; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; Landman D, 2002, ARCH INTERN MED, V162, P1515, DOI 10.1001/archinte.162.13.1515; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merritt JH, 2005, CURR PROTOC MICROBIO; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; OHMAN DE, 1980, INFECT IMMUN, V28, P899; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; PHILLIPS PK, 1984, J CLIN PATHOL, V37, P329, DOI 10.1136/jcp.37.3.329; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Russo TA, 2009, J INFECT DIS, V199, P513, DOI 10.1086/596317; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; VISCA P, 1992, EPIDEMIOL INFECT, V108, P323, DOI 10.1017/S0950268800049797; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/s002030050133; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	46	160	164	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22674	10.1371/journal.pone.0022674	http://dx.doi.org/10.1371/journal.pone.0022674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829642	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200017
J	Gullo, D; Latina, A; Frasca, F; Le Moli, R; Pellegriti, G; Vigneri, R				Gullo, Damiano; Latina, Adele; Frasca, Francesco; Le Moli, Rosario; Pellegriti, Gabriella; Vigneri, Riccardo			Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients	PLOS ONE			English	Article							THYROXINE PLUS TRIIODOTHYRONINE; HORMONE REPLACEMENT THERAPY; PRIMARY HYPOTHYROIDISM; TISSUE HYPOTHYROIDISM; COMBINATION THERAPY; THYROID-HORMONES; COMMON VARIATION; DOUBLE-BLIND; BIOCHEMISTRY; THYROTROPIN	Context: Levothyroxine monotherapy is the treatment of choice for hypothyroid patients because peripheral T4 to T3 conversion is believed to account for the overall tissue requirement for thyroid hormones. However, there are indirect evidences that this may not be the case in all patients. Objective: To evaluate in a large series of athyreotic patients whether levothyroxine monotherapy can normalize serum thyroid hormones and thyroid-pituitary feedback. Design: Retrospective study. Setting: Academic hospital. Patients: 1,811 athyreotic patients with normal TSH levels under levothyroxine monotherapy and 3,875 euthyroid controls. Measurements: TSH, FT4 and FT3 concentrations by immunoassays. Results: FT4 levels were significantly higher and FT3 levels were significantly lower (p < 0.001 in both cases) in levothyroxine-treated athyreotic patients than in matched euthyroid controls. Among the levothyroxine-treated patients 15.2% had lower serum FT3 and 7.2% had higher serum FT4 compared to euthyroid controls. A wide range of FT3/FT4 ratios indicated a major heterogeneity in the peripheral T3 production capacity in different individuals. The correlation between thyroid hormones and serum TSH levels indicated an abnormal feedback mechanism in levothyroxine-treated patients. Conclusions: Athyreotic patients have a highly heterogeneous T3 production capacity from orally administered levothyroxine. More than 20% of these patients, despite normal TSH levels, do not maintain FT3 or FT4 values in the reference range, reflecting the inadequacy of peripheral deiodination to compensate for the absent T3 secretion. The long-term effects of chronic tissue exposure to abnormal T3/T4 ratio are unknown but a sensitive marker of target organ response to thyroid hormones (serum TSH) suggests that this condition causes an abnormal pituitary response. A more physiological treatment than levothyroxine monotherapy may be required in some hypothyroid patients.	[Gullo, Damiano; Latina, Adele; Frasca, Francesco; Le Moli, Rosario; Pellegriti, Gabriella; Vigneri, Riccardo] Univ Catania, Sch Med, Garibaldi Nesima Hosp, Endocrine Unit,Dept Clin & Mol Biomed, Catania, Italy	Presidio Ospedaliero Garibaldi-Nesima; University of Catania	Gullo, D (corresponding author), Univ Catania, Sch Med, Garibaldi Nesima Hosp, Endocrine Unit,Dept Clin & Mol Biomed, Catania, Italy.	damiano.gullo@poste.it	Gullo, Damiano/GNP-5649-2022; Pellegriti, Gabriella/J-7923-2012; Pellegriti, Gabriella/CAH-1780-2022; Frasca, Francesco/J-1332-2018; Vigneri, Riccardo/M-3968-2017	Pellegriti, Gabriella/0000-0001-6102-379X; Pellegriti, Gabriella/0000-0001-6102-379X; Frasca, Francesco/0000-0002-5556-3201; Vigneri, Riccardo/0000-0002-4401-3140; Gullo, Damiano/0000-0002-4034-6378	University of Catania; AIRC (Associazione Italiana Ricerca Cancro)	University of Catania; AIRC (Associazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro)	This study has been sponsored by the University of Catania and was supported also by a grant from AIRC (Associazione Italiana Ricerca Cancro) to RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA BM, 2010, F1000 MED REP   0511, P485; Alevizaki M, 2005, WIEN KLIN WOCHENSCHR, V117, P636, DOI 10.1007/s00508-005-0421-0; Appelhof BC, 2005, J CLIN ENDOCR METAB, V90, P2666, DOI 10.1210/jc.2004-2111; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Cooper DS, 2008, JAMA-J AM MED ASSOC, V299, P817, DOI 10.1001/jama.299.7.817; Davey R, 1997, CLIN CHEM, V43, P2143; Dayan CM, 2009, NAT REV ENDOCRINOL, V5, P211, DOI 10.1038/nrendo.2009.19; de Jong FJ, 2007, J CLIN ENDOCR METAB, V92, P636, DOI 10.1210/jc.2006-1331; EscobarMorreale HF, 1995, J CLIN INVEST, V96, P2828, DOI 10.1172/JCI118353; Fadeyev Valentin V, 2005, Hormones (Athens), V4, P101; Grozinsky-Glasberg S, 2006, J CLIN ENDOCR METAB, V91, P2592, DOI 10.1210/jc.2006-0448; Hennemann G, 2004, THYROID, V14, P271, DOI 10.1089/105072504323030924; Iverson Jennifer F, 2008, Endocr Pract, V14, P550; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; Kohrle J, 2005, ENDOCR REV, V26, P944, DOI 10.1210/er.2001-0034; Kratzsch J, 2005, CLIN CHEM, V51, P1480, DOI 10.1373/clinchem.2004.047399; Ma C, 2009, NUCL MED COMMUN, V30, P586, DOI 10.1097/MNM.0b013e32832c79e0; Meier C, 2003, BRIT MED J, V326, P311, DOI 10.1136/bmj.326.7384.311; Nygaard B, 2009, EUR J ENDOCRINOL, V161, P895, DOI 10.1530/EJE-09-0542; Panicker V, 2008, J CLIN ENDOCR METAB, V93, P3075, DOI 10.1210/jc.2008-0397; Panicker V, 2009, J CLIN ENDOCR METAB, V94, P1623, DOI 10.1210/jc.2008-1301; Regalbuto C, 2010, J ENDOCRINOL INVEST, V33, P300, DOI [10.1007/BF03346590, 10.3275/6715]; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; VISSER TJ, 1990, TRENDS ENDOCRIN MET, V1, P211, DOI 10.1016/1043-2760(90)90055-8; Wekking EM, 2005, EUR J ENDOCRINOL, V153, P747, DOI 10.1530/eje.1.02025; Wiersinga WM, 2001, HORM RES, V56, P74, DOI 10.1159/000048140; Woeber KA, 2002, J ENDOCRINOL INVEST, V25, P106, DOI 10.1007/BF03343972; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	30	176	183	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22552	10.1371/journal.pone.0022552	http://dx.doi.org/10.1371/journal.pone.0022552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829633	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200012
J	Reichardt, J; Alamino, R; Saad, D				Reichardt, Joerg; Alamino, Roberto; Saad, David			The Interplay between Microscopic and Mesoscopic Structures in Complex Networks	PLOS ONE			English	Article							STOCHASTIC BLOCKMODELS; PREDICTION; MODELS; GRAPHS	Understanding a complex network's structure holds the key to understanding its function. The physics community has contributed a multitude of methods and analyses to this cross-disciplinary endeavor. Structural features exist on both the microscopic level, resulting from differences between single node properties, and the mesoscopic level resulting from properties shared by groups of nodes. Disentangling the determinants of network structure on these different scales has remained a major, and so far unsolved, challenge. Here we show how multiscale generative probabilistic exponential random graph models combined with efficient, distributive message-passing inference techniques can be used to achieve this separation of scales, leading to improved detection accuracy of latent classes as demonstrated on benchmark problems. It sheds new light on the statistical significance of motif-distributions in neural networks and improves the link-prediction accuracy as exemplified for gene-disease associations in the highly consequential Online Mendelian Inheritance in Man database.	[Reichardt, Joerg] Univ Calif Davis, Complex Sci Ctr, Davis, CA 95616 USA; [Reichardt, Joerg] Univ Wurzburg, Inst Theoret Phys, Wurzburg, Germany; [Alamino, Roberto; Saad, David] Aston Univ, Nonlinear & Complex Res Grp, Birmingham B4 7ET, W Midlands, England	University of California System; University of California Davis; University of Wurzburg; Aston University	Reichardt, J (corresponding author), Univ Calif Davis, Complex Sci Ctr, Davis, CA 95616 USA.	jreichardt@ucdavis.edu		Saad, David/0000-0001-9821-2623; Alamino, Roberto/0000-0001-8224-2801	Volkswagen Foundation; DAAD; The Leverhulme Trust [F/00 250/M]; British Council ARC [1324]; German Research Foundation (DFG); University of Wuerzburg; Engineering and Physical Sciences Research Council [EP/E049516/1] Funding Source: researchfish; EPSRC [EP/E049516/1] Funding Source: UKRI	Volkswagen Foundation(Volkswagen); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); The Leverhulme Trust(Leverhulme Trust); British Council ARC; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by the Volkswagen Foundation through a Fellowship Computational Sciences for J.R. and DAAD travel grants; support from The Leverhulme Trust (F/00 250/M) and the British Council ARC (1324) is acknowledged (D. S. and R. A.). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2008, J MACH LEARN RES, V9, P1981; [Anonymous], 2007, ADV EXPONENTIAL RAND, V29; Artzy-Randrup Y, 2004, SCIENCE, V305; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Bianconi G, 2009, P NATL ACAD SCI USA, V106, P11433, DOI 10.1073/pnas.0811511106; Bickel PJ, 2009, P NATL ACAD SCI USA, V106, P21068, DOI 10.1073/pnas.0907096106; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Daudin JJ, 2008, STAT COMPUT, V18, P173, DOI 10.1007/s11222-007-9046-7; Davis A., 1941, DEEP S SOCIAL ANTHR; Doreian P, 2005, GENERALIZED BLOCKMOD; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Fienberg SE, 1981, CATEGORICAL DATA ANA, P156; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fred ALN, 2003, PROC CVPR IEEE, P128; Freeman LC, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P39; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Hoff PD, 2002, J AM STAT ASSOC, V97, P460; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Kemp C, 2006, P 21 NAT C ART INT; Krivitsky PN, 2009, SOC NETWORKS, V31, P204, DOI 10.1016/j.socnet.2009.04.001; MacKay D. J. C., 2003, INFORM THEORY INFERE; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morup M, 2009, NIPS WORKSH AN NETW; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Nowicki K, 2001, J AM STAT ASSOC, V96, P1077, DOI 10.1198/016214501753208735; Opper M, 2001, ADV MEAN FIELD METHO; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Snijders TAB, 1997, J CLASSIF, V14, P75, DOI 10.1007/s003579900004; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547	43	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e21282	10.1371/journal.pone.0021282	http://dx.doi.org/10.1371/journal.pone.0021282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829597	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000293511200002
J	Ren, YX; Liu, B; Feng, YX; Shu, L; Cao, XJ; Karaplis, A; Goltzman, D; Miao, DS				Ren, Yongxin; Liu, Bo; Feng, Yuxu; Shu, Lei; Cao, Xiaojian; Karaplis, Andrew; Goltzman, David; Miao, Dengshun			Endogenous PTH Deficiency Impairs Fracture Healing and Impedes the Fracture-Healing Efficacy of Exogenous PTH(1-34)	PLOS ONE			English	Article							PARATHYROID-HORMONE 1-34; BONE-MINERAL DENSITY; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN-D 1-ALPHA-HYDROXYLASE; PRIMARY HYPERPARATHYROIDISM; POSTMENOPAUSAL WOMEN; SKELETAL; OSTEOPOROSIS; CALCIUM; MICE	Background: Although the capacity of exogenous PTH1-34 to enhance the rate of bone repair is well established in animal models, our understanding of the mechanism(s) whereby PTH induces an anabolic response during skeletal repair remains limited. Furthermore it is unknown whether endogenous PTH is required for fracture healing and how the absence of endogenous PTH would influence the fracture-healing capacity of exogenous PTH. Methodology/Principal Findings: Closed mid-diaphyseal femur fractures were created and stabilized with an intramedullary pin in 8-week-old wild-type and Pth null (Pth(-/-)) mice. Mice received daily injections of vehicle or of PTH1-34 (80 mu g/kg) for 1-4 weeks post-fracture, and callus tissue properties were analyzed at 1, 2 and 4 weeks post-fracture. Cartilaginous callus areas were reduced at 1 week post-fracture, but were increased at 2 weeks post-fracture in vehicle-treated and PTH-treated Pth(-/-) mice compared to vehicle-treated and PTH-treated wild-type mice respectively. The mineralized callus areas, bony callus areas, osteoblast number and activity, osteoclast number and surface in callus tissues were all reduced in vehicle-treated and PTH-treated Pth(-/-) mice compared to vehicle-treated and PTH-treated wild-type mice, but were increased in PTH-treated wild-type and Pth(-/-) mice compared to vehicle-treated wild-type and Pth(-/-) mice. Conclusions/Significance: Absence of endogenous PTH1-84 impedes bone fracture healing. Exogenous PTH1-34 can act in the absence of endogenous PTH but callus formation, including accelerated endochondral bone formation and callus remodeling as well as mechanical strength of the bone are greater when endogenous PTH is present. Results of this study suggest a complementary role for endogenous PTH1-84 and exogenous PTH1-34 in accelerating fracture healing.	[Ren, Yongxin; Liu, Bo; Feng, Yuxu; Cao, Xiaojian] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Nanjing, Peoples R China; [Liu, Bo] Liyang Peoples Hosp, Dept Orthopaed, Changzhou, Peoples R China; [Ren, Yongxin; Feng, Yuxu; Shu, Lei; Miao, Dengshun] Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, Nanjing, Peoples R China; [Karaplis, Andrew; Goltzman, David] McGill Univ, Dept Med, Montreal, PQ, Canada	Nanjing Medical University; Nanjing Medical University; McGill University	Ren, YX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Nanjing, Peoples R China.	dsmiao@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502	National Natural Science Foundation of China [30901528, 30830103]; Kidney Foundation of Canada; Canadian Institutes for Health Research, Canada	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kidney Foundation of Canada; Canadian Institutes for Health Research, Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by National Natural Science Foundation of China to YX Ren (No. 30901528) and D Miao (No. 30830103), the Kidney Foundation of Canada to A Karaplis, and the Canadian Institutes for Health Research, Canada to D Goltzman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhiary YM, 2005, J BONE JOINT SURG AM, V87A, P731, DOI 10.2106/JBJS.D.02115; Andreassen TT, 1999, J BONE MINER RES, V14, P960, DOI 10.1359/jbmr.1999.14.6.960; Fukuhara H, 1989, Nihon Seikeigeka Gakkai Zasshi, V63, P100; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Hodsman AB, 2003, J CLIN ENDOCR METAB, V88, P5212, DOI 10.1210/jc.2003-030768; Holzer G, 1999, CLIN ORTHOP RELAT R, P258, DOI 10.1097/00003086-199909000-00033; Jahng JS, 2000, ORTHOPEDICS, V23, P1089; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kim H W, 1999, Iowa Orthop J, V19, P71; LAW WM, 1984, J CLIN ENDOCR METAB, V59, P394, DOI 10.1210/jcem-59-3-394; Liu H, 2009, J ENDOCRINOL, V203, P203, DOI 10.1677/JOE-09-0247; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Miao DS, 2002, BMC MUSCULOSKELET DI, V3, DOI 10.1186/1471-2474-3-16; Miao DS, 2001, ENDOCRINOLOGY, V142, P926, DOI 10.1210/en.142.2.926; Nakajima A, 2002, J BONE MINER RES, V17, P2038, DOI 10.1359/jbmr.2002.17.11.2038; Nakazawa T, 2005, BONE, V37, P711, DOI 10.1016/j.bone.2005.06.013; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; PARISIEN M, 1990, J CLIN ENDOCR METAB, V70, P930, DOI 10.1210/jcem-70-4-930; Schmidmaier G, 2004, EUR J TRAUMA, V30, P35; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; Sun W, 2010, DEVELOPMENT, V137, P985, DOI 10.1242/dev.045898; Xue YB, 2005, HUM MOL GENET, V14, P1515, DOI 10.1093/hmg/ddi160; Zhou H, 2001, J BONE MINER RES, V16, P1300, DOI 10.1359/jbmr.2001.16.7.1300	27	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23060	10.1371/journal.pone.0023060	http://dx.doi.org/10.1371/journal.pone.0023060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829585	gold, Green Published, Green Submitted			2022-12-27	WOS:000293286500072
J	Roselli, F; Livrea, P; Almeida, OFX				Roselli, Francesco; Livrea, Paolo; Almeida, Osborne F. X.			CDK5 Is Essential for Soluble Amyloid beta-Induced Degradation of GKAP and Remodeling of the Synaptic Actin Cytoskeleton	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; POSTSYNAPTIC DENSITY; ALZHEIMERS-DISEASE; DENDRITIC SPINES; LIGHT-CHAIN; PROTEIN; PHOSPHORYLATION; PEPTIDE; FAMILY; PSD-95	The early stages of Alzheimer's disease are marked by synaptic dysfunction and loss. This process results from the disassembly and degradation of synaptic components, in particular of scaffolding proteins that compose the post-synaptic density (PSD), namely PSD95, Homer and Shank. Here we investigated in rat frontal cortex dissociated culture the mechanisms involved in the downregulation of GKAP (SAPAP1), which links the PSD95 complex to the Shank complex and cytoskeletal structures within the PSD. We show that A beta causes the rapid loss of GKAP from synapses through a pathway that critically requires cdk5 activity, and is set in motion by NMDAR activity and Ca2+ influx. We show that GKAP is a direct substrate of cdk5 and that its phosphorylation results in polyubiquitination and proteasomal degradation of GKAP and remodeling (collapse) of the synaptic actin cytoskeleton; the latter effect is abolished in neurons expressing GKAP mutants that are resistant to phosphorylation by cdk5. Given that cdk5 also regulates degradation of PSD95, these results underscore the central position of cdk5 in mediating A beta-induced PSD disassembly and synapse loss.	[Roselli, Francesco; Almeida, Osborne F. X.] Max Planck Inst Psychiat, Neuroadaptat Grp, D-80804 Munich, Germany; [Roselli, Francesco; Livrea, Paolo] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy	Max Planck Society; Universita degli Studi di Bari Aldo Moro	Roselli, F (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	Francesco.Roselli@fmi.ch; osa@mpipsykl.mpg.de	Almeida, Osborne F.X. F/E-8402-2010; roselli, francesco/O-8847-2019; roselli, francesco/G-6701-2013	Almeida, Osborne F.X. F/0000-0001-7331-6928; roselli, francesco/0000-0001-9935-6899; Livrea, Paolo/0000-0001-7410-3860	Max Planck Institute of Psychiatry; University of Bari	Max Planck Institute of Psychiatry(Max Planck Society); University of Bari	FR was supported by a Max Planck Institute of Psychiatry fellowship and by the University of Bari PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAO F, 2011, NEUROBIOL AGING; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bongiorno-Borbone L, 2005, BIOCHEM BIOPH RES CO, V337, P641, DOI 10.1016/j.bbrc.2005.09.099; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Cambon K, 2003, NEUROSCIENCE, V122, P183, DOI 10.1016/S0306-4522(03)00597-9; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Edbauer D, 2009, MOL CELL PROTEOMICS, V8, P681, DOI 10.1074/mcp.M800233-MCP200; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Futter M, 2005, P NATL ACAD SCI USA, V102, P3489, DOI 10.1073/pnas.0409802102; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hirao K, 2000, GENES CELLS, V5, P203, DOI 10.1046/j.1365-2443.2000.00318.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Humbert S, 2000, J CELL SCI, V113, P975; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lopes JP, 2010, AGING CELL, V9, P64, DOI 10.1111/j.1474-9726.2009.00536.x; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Ma QL, 2008, J BIOL CHEM, V283, P14132, DOI 10.1074/jbc.M708034200; Medeiros R, 2007, J NEUROSCI, V27, P5394, DOI 10.1523/JNEUROSCI.5047-06.2007; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Prediger RDS, 2007, BEHAV BRAIN RES, V177, P205, DOI 10.1016/j.bbr.2006.11.032; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires-Jones TL, 2007, AM J PATHOL, V171, P1304, DOI 10.2353/ajpath.2007.070055; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tirard M, 2004, J MOL ENDOCRINOL, V32, P825, DOI 10.1677/jme.0.0320825; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463	79	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23097	10.1371/journal.pone.0023097	http://dx.doi.org/10.1371/journal.pone.0023097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829588	gold, Green Published, Green Submitted			2022-12-27	WOS:000293286500075
J	Naeem, H; Kuffner, R; Zimmer, R				Naeem, Haroon; Kueffner, Robert; Zimmer, Ralf			MIRTFnet: Analysis of miRNA Regulated Transcription Factors	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; GENE-EXPRESSION; TARGET RECOGNITION; PROTEIN-SYNTHESIS; MICRORNA; FAMILY; CANCER; IDENTIFICATION; SIGNATURES; APOPTOSIS	Background: Several expression datasets of miRNA transfection experiments are available to analyze the regulatory mechanisms downstream of miRNA effects. The miRNA induced regulatory effects can be propagated via transcription factors (TFs). We propose the method MIRTFnet to identify miRNA controlled TFs as active regulators if their downstream target genes are differentially expressed. Methodology/Principal Findings: MIRTFnet enables the determination of active transcription factors (TFs) and is sensitive enough to exploit the small expression changes induced by the activity of miRNAs. For this purpose, different statistical tests were evaluated and compared. Based on the identified TFs, databases, computational predictions and the literature we construct regulatory models downstream of miRNA actions. Transfecting miRNAs are connected to active regulators via a network of miRNA-TF, miRNA-kinase-TF as well as TF-TF relationships. Based on 43 transfection experiments involving 17 cancer relevant miRNAs we show that MIRTFnet detects active regulators reliably. Conclusions/Significance: The consensus of the individual regulatory models shows that the examined miRNAs induce activity changes in a common core of transcription factors involved in cancer related processes such as proliferation or apoptosis.	[Naeem, Haroon; Kueffner, Robert; Zimmer, Ralf] Univ Munich, Inst Informat, D-80539 Munich, Germany	University of Munich	Naeem, H (corresponding author), Univ Munich, Inst Informat, D-80539 Munich, Germany.	robert.kueffner@bio.ifi.lmu.de	Zimmer, Ralf/L-9295-2019	Naeem, Haroon/0000-0001-9019-8345	German Federal Ministry of Education and Research [FKZ 01GS0801]; Deutscher Akademischer Austausch Dienst [442, A/07/96865]; Higher Education Commission of Pakistan [442, A/07/96865]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work has been supported in part by the German Federal Ministry of Education and Research (FKZ 01GS0801). HN is supported by the Deutscher Akademischer Austausch Dienst in cooperation with Higher Education Commission of Pakistan (Referat 442, Code A/07/96865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Barh D, 2010, CURR ONCOL, V17, P70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; Benjamini Y, 2001, ANN STAT, V29, P1165; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Foissac S, 2009, INTEGROMICS WHITE PA, P1; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu George E., 2008, Genomics Proteomics & Bioinformatics, V6, P129, DOI 10.1016/S1672-0229(09)60001-2; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S5; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; PAPPAS PA, 2004, P SE SAS US GROUP C; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SIEGEL S., 1956, NONPARAMETRIC STAT B; Sohler F, 2005, BIOINFORMATICS, V21, P115, DOI 10.1093/bioinformatics/bti11120; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Subramanian S, 2010, J CELL PHYSIOL, V223, P289, DOI 10.1002/jcp.22066; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tschan MP, 2008, ONCOGENE, V27, P3489, DOI 10.1038/sj.onc.1211004; Tu K, 2009, NUCLEIC ACIDS RES, V37, P5969, DOI 10.1093/nar/gkp638; Volinia S, 2010, BIOINFORMATICS, V26, P91, DOI 10.1093/bioinformatics/btp598; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851	71	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22519	10.1371/journal.pone.0022519	http://dx.doi.org/10.1371/journal.pone.0022519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857930	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300005
J	Fang, Z; Zhou, LN; Bao, YY; Ding, W; Shi, HM; Luo, XP; Hu, RM				Fang, Zhou; Zhou, Linuo; Bao, Yuanyuan; Ding, Wei; Shi, Haiming; Luo, Xinping; Hu, Renming			Association of NT-proBNP and Multiple Biomarkers with Severity of Angiographic Coronary Artery Disease in Diabetic and Pre-Diabetic Chinese Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LONG-TERM MORTALITY; NATRIURETIC PEPTIDE; RISK PREDICTION; HEART-DISEASE; ISCHEMIA; ANGINA; WOMEN; MEN	Background: Little is known about the plasma levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), and the relationship between the severity of coronary heart disease (CHD) with NT-proBNP and multiple biomarkers in diabetic and pre-diabetic patients, compared to individuals with normal glucose levels. Methods: Four hundred and fifteen consecutive Chinese patients of both sexes were assigned to three groups on the basis of the new hemoglobin (Hb) A1c (HbA1c) cut-off points for diagnosis of diabetes and pre-diabetes. The three groups were divided into tertiles according to NT-proBNP, hs-CRP, cystatin C, and troponin T levels. Gensini scores were compared among the three groups and biomarker tertiles. Receiver operating characteristic (ROC) curves were used to obtain the angiographic CHD cut-off points for each biomarker. Stepwise multivariate linear correlation analysis was applied to examine the association between the severity of CHD and biomarker levels. Results: Gensini scores increased with increasing biomarker tertile levels and HbA1c. Gensini scores were significantly different in the middle and upper NT-proBNP tertiles of the diabetic, pre-diabetic and control groups. NT-proBNP had the highest positive and negative predictive values and area under the curve for CHD. Only NT-proBNP was identified as an independent variable for Gensini score. Conclusions: Plasma NT-proBNP may be an important biomarker to evaluate the severity of CHD and screen for CHD in diabetic or pre-diabetic patients.	[Fang, Zhou] Inst Endocrinol & Diabeteol, Shanghai, Peoples R China; [Zhou, Linuo; Bao, Yuanyuan; Ding, Wei; Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Shi, Haiming; Luo, Xinping] Fudan Univ, Huashan Hosp, Dept Cardiol, Shanghai 200433, Peoples R China; [Fang, Zhou] State Key Lab Genet Engn, Shanghai, Peoples R China	Fudan University; Fudan University	Fang, Z (corresponding author), Inst Endocrinol & Diabeteol, Shanghai, Peoples R China.	nally_zhou@yahoo.com.cn		Fang, Zhou/0000-0002-5231-6539	Grant of Shanghai Science and Technology [10411961200]; China National Grant on Science and Technology [30570740, 30270627]	Grant of Shanghai Science and Technology; China National Grant on Science and Technology	This research was supported by the Grant of Shanghai Science and Technology (10411961200) and China National Grant on Science and Technology (30570740, 30270627). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Curhan G, 2005, CLIN CHEM, V51, P293, DOI 10.1373/clinchem.2004.044388; de Graaf FR, 2010, AM J CARDIOL, V106, P1747, DOI 10.1016/j.amjcard.2010.08.015; De Sutter J, 2005, EUR HEART J, V26, P2644, DOI 10.1093/eurheartj/ehi502; Dong X, 2008, METABOLISM, V57, P24, DOI 10.1016/j.metabol.2007.08.004; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Goetze JP, 2003, FASEB J, V17, P1105, DOI 10.1096/fj.02-0796fje; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Nakagawa K, 2004, CIRC J, V68, P923, DOI 10.1253/circj.68.923; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Peer A, 2009, HEART, V95, P297, DOI 10.1136/hrt.2008.145425; Sadanandan S, 2004, J AM COLL CARDIOL, V44, P564, DOI 10.1016/j.jacc.2004.03.072; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Sattar N, 2010, ATHEROSCLEROSIS, V209, P295, DOI 10.1016/j.atherosclerosis.2009.09.016; Shanghai investigation group of heart failure, 2002, J CHINESE CARDIOVASC, V30, P24; Singh HS, 2009, CLIN CARDIOL, V32, P447, DOI 10.1002/clc.20569; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Weber M, 2004, AM HEART J, V148, P612, DOI 10.1016/j.ahj.2004.04.021; Wilkins John T, 2010, Prev Cardiol, V13, P160, DOI 10.1111/j.1751-7141.2010.00081.x; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	25	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22563	10.1371/journal.pone.0022563	http://dx.doi.org/10.1371/journal.pone.0022563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857933	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500008
J	DeRose-Wilson, L; Gaut, BS				DeRose-Wilson, Leah; Gaut, Brandon S.			Mapping Salinity Tolerance during Arabidopsis thaliana Germination and Seedling Growth	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BETAINE ALDEHYDE DEHYDROGENASE; NATURAL GENETIC-VARIATION; ACID SIGNAL-TRANSDUCTION; RECOMBINANT INBRED LINES; GENOME-WIDE ASSOCIATION; PLANT SALT TOLERANCE; ABSCISIC-ACID; OSMOTIC-STRESS; FREEZING TOLERANCE	To characterize and dissect genetic variation for salinity tolerance, we assessed variation in salinity tolerance during germination and seedling growth for a worldwide sample of Arabidopsis thaliana accessions. By combining QTL mapping, association mapping and expression data, we identified genomic regions involved in salinity response. Among the worldwide sample, we found germination ability within a moderately saline environment (150 mM NaCl) varied considerable, from >90% among the most tolerant lines to complete inability to germinate among the most susceptible. Our results also demonstrated wide variation in salinity tolerance within A. thaliana RIL populations and identified multiple genomic regions that contribute to this variation. These regions contain known candidate genes, but at least four of the regions contain loci not yet associated with salinity tolerance response phenotypes. Our observations suggest A. thaliana natural variation may be an underutilized resource for investigating salinity stress response.	[DeRose-Wilson, Leah; Gaut, Brandon S.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	DeRose-Wilson, L (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	bgaut@uci.edu			NIH; NSF [DEB-0723860]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was supported in part by an NIH Bioinformatics Training Grant and by NSF grant DEB-0723860 to B.S. Gaut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel G, 1963, CROP SCI, V3, P159; Abercrombie JM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-87; Alonso-Blanco C, 2005, PLANT PHYSIOL, V139, P1304, DOI 10.1104/pp.105.068510; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Barrero JM, 2006, PLANT CELL ENVIRON, V29, P2000, DOI 10.1111/j.1365-3040.2006.01576.x; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Becker RA, 1988, NEW S LANGUAGE, P451; BEGUM F, 1992, PLANT CELL PHYSIOL, V33, P1009; Ben Hassine A, 2008, J EXP BOT, V59, P1315, DOI 10.1093/jxb/ern040; BIANCHI G, 1991, PLANT J, V1, P355, DOI 10.1046/j.1365-313X.1991.t01-11-00999.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buchanan CD, 2005, PLANT MOL BIOL, V58, P699, DOI 10.1007/s11103-005-7876-2; CHURCHILL GA, 1994, GENETICS, V138, P963; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Culley TM, 2006, NEW PHYTOL, V169, P589, DOI 10.1111/j.1469-8137.2005.01588.x; Doerge RW, 1996, GENETICS, V142, P285; Easlon HM, 2009, AM J BOT, V96, P605, DOI 10.3732/ajb.0800189; EHRET DL, 1999, ENV STRESS CROP PLAN, P69; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; Foolad MR, 1999, PLANT BREEDING, V118, P49, DOI 10.1046/j.1439-0523.1999.118001049.x; Fujii H, 2009, MOL PLANT, V2, P183, DOI 10.1093/mp/ssn087; Geber MA, 2003, INT J PLANT SCI, V164, pS21, DOI 10.1086/368233; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gong ZZ, 2001, PLANT PHYSIOL, V126, P363, DOI 10.1104/pp.126.1.363; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hausmann NJ, 2005, EVOLUTION, V59, P81; Heschel MS, 2004, INT J PLANT SCI, V165, P817, DOI 10.1086/421477; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; HORVATH DP, 1993, PLANT PHYSIOL, V103, P1047, DOI 10.1104/pp.103.4.1047; Hu XL, 2006, PLANT CELL PHYSIOL, V47, P1484, DOI 10.1093/pcp/pcl014; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; ISHITANI M, 1995, PLANT MOL BIOL, V27, P307, DOI 10.1007/BF00020185; Johnson D. A., 1993, Stable isotopes and plant carbon-water relations., P269; JOHNSON DW, 1992, THEOR APPL GENET, V83, P833, DOI 10.1007/BF00226705; Juenger TE, 2006, MOL ECOL, V15, P1351, DOI 10.1111/j.1365-294X.2006.02774.x; Juenger TE, 2005, GENETICA, V123, P87, DOI 10.1007/s10709-003-2717-1; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumar D., 1983, Sabrao Journal, V15, P71; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Lowry DB, 2009, NEW PHYTOL, V183, P776, DOI 10.1111/j.1469-8137.2009.02901.x; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; MCCUE KF, 1992, PLANT MOL BIOL, V18, P1, DOI 10.1007/BF00018451; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Nelson DE, 1998, GENET ENG P, V20, P153; NI BR, 1993, PLANT PHYSIOL, V101, P607, DOI 10.1104/pp.101.2.607; NIENHUIS J, 1994, AM J BOT, V81, P943, DOI 10.2307/2445286; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; NORDIN K, 1993, PLANT MOL BIOL, V21, P641, DOI 10.1007/BF00014547; Peters JL, 2001, PLANT PHYSIOL, V127, P1579, DOI 10.1104/pp.010504; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quesada V, 2000, GENETICS, V154, P421; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Seki M, 2003, CURR OPIN BIOTECH, V14, P194, DOI 10.1016/S0958-1669(03)00030-2; Sherrard ME, 2009, EVOLUTION, V63, P702, DOI 10.1111/j.1558-5646.2008.00580.x; Shinozaki K, 2002, PLANT CELL PHYSIOL, V43, pS19; Sreenivasulu N, 2007, GENE, V388, P1, DOI 10.1016/j.gene.2006.10.009; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Taji T, 1999, PLANT CELL PHYSIOL, V40, P119, DOI 10.1093/oxfordjournals.pcp.a029469; Teixeira J, 2007, ENVIRON EXP BOT, V60, P121, DOI 10.1016/j.envexpbot.2006.09.003; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Thorlby G, 1999, PLANT J, V17, P445, DOI 10.1046/j.1365-313X.1999.00395.x; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; VOLKER U, 1992, J GEN MICROBIOL, V138, P2125, DOI 10.1099/00221287-138-10-2125; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157; WERNER JE, 1995, PHYSIOL PLANTARUM, V93, P659, DOI 10.1111/j.1399-3054.1995.tb05114.x; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; YOSHIBA Y, 1995, PLANT J, V7, P751, DOI 10.1046/j.1365-313X.1995.07050751.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhen Y, 2008, MOL BIOL EVOL, V25, P2547, DOI 10.1093/molbev/msn196; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	108	53	55	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22832	10.1371/journal.pone.0022832	http://dx.doi.org/10.1371/journal.pone.0022832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857956	Green Published, gold			2022-12-27	WOS:000293953500007
J	Huang, YC; Lien, RI; Su, LH; Chou, YH; Lin, TY				Huang, Yhu-Chering; Lien, Rey-In; Su, Lin-Hui; Chou, Yi-Hong; Lin, Tzou-Yien			Successful Control of Methicillin-Resistant Staphylococcus aureus in Endemic Neonatal Intensive Care Units-A 7-Year Campaign	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; NASAL CARRIAGE; SURVEILLANCE CULTURES; INTRANASAL MUPIROCIN; TAIWANESE CHILDREN; HOSPITAL ADMISSION; CLINICAL-FEATURES; NORTHERN TAIWAN; DOUBLE-BLIND; COLONIZATION	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is among the most important nosocomial pathogens in the intensive care unit (ICU) worldwide, including Taiwan. Since 1997, our neonatal ICUs (NICUs) had become endemic for MRSA. Methodology/Principal Findings: To control MRSA spread in our NICUs, we implemented a series of infection control measures stepwise, including reinforcement of hand hygiene since January 2000, augmentation of aseptic care over the insertion site of central venous catheter since July 2001, introduction of alcohol-based handrubs since April 2003, surveillance culture for MRSA and cohort care for the colonized patients between March 2003 and February 2004, and surveillance culture with subsequent decolonization of MRSA between August 2005 and July 2006. After implementation of these measures, MRSA healthcare-associated infection (HAI) density reduced by 92%, from 5.47 episodes per 1000 patient-days in 1999 to 0.45 episodes per 1000 patient-days in 2006; MRSA bloodstream infection reduced from 40 cases in 1999 to only one case in 2006. Compared to those obtained during the period of surveillance culture without decolonization, both rates of MRSA colonization (8.6% vs. 41%, p<0.001) and infection (1.1% vs. 12%, p<0.001) decreased significantly during the period of surveillance and decolonization. Molecular analysis of the clinical isolates during the study period showed that the endemic clone, which dominated between 1998 and 2005, almost disappeared in 2006, while the community clones increased significantly in 2006-2007. Conclusion/Significance: Through infection control measures, MRSA HAIs can be successfully controlled, even in areas with high levels of endemic MRSA infections such as our NICUs.	[Huang, Yhu-Chering; Lin, Tzou-Yien] Chang Gung Mem Hosp Linkou, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Lien, Rey-In; Chou, Yi-Hong] Chang Gung Mem Hosp Linkou, Div Neonatol, Tao Yuan, Taiwan; [Huang, Yhu-Chering; Su, Lin-Hui; Lin, Tzou-Yien] Chang Gung Mem Hosp Linkou, Comm Infect Control, Tao Yuan, Taiwan; [Su, Lin-Hui] Chang Gung Mem Hosp Linkou, Dept Lab Med, Tao Yuan, Taiwan; [Huang, Yhu-Chering; Lien, Rey-In; Su, Lin-Hui; Lin, Tzou-Yien] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, YC (corresponding author), Chang Gung Mem Hosp Linkou, Div Pediat Infect Dis, Tao Yuan, Taiwan.	ychuang@cgmh.org.tw			National Science Council (NSC) [94-2314-B-182A-090, 96-2314-B-182A-022]; Chang Gung Memorial Hospital [CMRPG 33128]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from the National Science Council (NSC 94-2314-B-182A-090, 96-2314-B-182A-022) and Chang Gung Memorial Hospital (CMRPG 33128). The funders had no role in study design, data collection and analysis, decision to publish.	Aly H, 2005, PEDIATRICS, V115, P1513, DOI 10.1542/peds.2004-1785; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; CHANG SC, 1988, J FORMOS MED ASSOC, V87, P157; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chen CJ, 2009, DIAGN MICR INFEC DIS, V65, P199, DOI 10.1016/j.diagmicrobio.2009.05.020; Chen ML, 1999, J FORMOS MED ASSOC, V98, P426; Chuang YY, 2004, ACTA PAEDIATR, V93, P786, DOI [10.1111/j.1651-2227.2004.tb03019.x, 10.1080/08035250410028084]; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Garrouste-Orgeas M, 2001, INFECT CONT HOSP EP, V22, P687, DOI 10.1086/501846; Gregory ML, 2009, PEDIATRICS, V123, pE790, DOI 10.1542/peds.2008-1526; Harbarth S, 1999, ANTIMICROB AGENTS CH, V43, P1412, DOI 10.1128/AAC.43.6.1412; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hsueh PR, 2002, EMERG INFECT DIS, V8, P132; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2005, INFECT CONT HOSP EP, V26, P157, DOI 10.1086/502520; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang Yhu-Chering, 2005, Acta Paediatrica Taiwanica, V46, P156; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Laupland KB, 2003, CLIN INFECT DIS, V37, P933, DOI 10.1086/377735; Mody L, 2003, CLIN INFECT DIS, V37, P1467, DOI 10.1086/379325; *NAT COMM CLIN LAB, 2000, PERF STAND ANT DISK; O'Brien FG, 1999, J CLIN MICROBIOL, V37, P2858; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Raineri E, 2007, J HOSP INFECT, V67, P308, DOI 10.1016/j.jhin.2007.08.013; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Roghmann MC, 2001, J HOSP INFECT, V47, P98, DOI 10.1053/jhin.2000.0903; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Santos RP, 2008, CLIN INFECT DIS, V47, P110, DOI 10.1086/588789; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9	44	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e23001	10.1371/journal.pone.0023001	http://dx.doi.org/10.1371/journal.pone.0023001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857979	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953500012
J	Dick, JM; Shock, EL				Dick, Jeffrey M.; Shock, Everett L.			Calculation of the Relative Chemical Stabilities of Proteins as a Function of Temperature and Redox Chemistry in a Hot Spring	PLOS ONE			English	Article							PARTIAL MOLAL PROPERTIES; YELLOWSTONE-NATIONAL-PARK; AMINO-ACID-COMPOSITION; THERMODYNAMIC PROPERTIES; HIGH-PRESSURES; TRANSPORT-PROPERTIES; HYDROTHERMAL ECOSYSTEMS; UNFOLDED PROTEINS; SOFTWARE PACKAGE; MICROBIAL MATS	Uncovering the chemical and physical links between natural environments and microbial communities is becoming increasingly amenable owing to geochemical observations and metagenomic sequencing. At the hot spring known as Bison Pool in Yellowstone National Park, the cooling of the water in the outflow channel is associated with an increase in oxidation potential estimated from multiple field-based measurements. Representative groups of proteins whose sequences were derived from metagenomic data also exhibit an increase in average oxidation state of carbon in the protein molecules with distance from the hot-spring source. The energetic requirements of reactions to form selected proteins used in the model were computed using amino-acid group additivity for the standard molal thermodynamic properties of the proteins, and the relative chemical stabilities of the proteins were investigated by varying temperature, pH and oxidation state, expressed as activity of dissolved hydrogen. The relative stabilities of the proteins were found to track the locations of the sampling sites when the calculations included a function for hydrogen activity that increases with temperature and is higher, or more reducing, than values consistent with measurements of dissolved oxygen, sulfide and oxidation-reduction potential in the field. These findings imply that spatial patterns in the amino acid compositions of proteins can be linked, through energetics of overall chemical reactions representing the formation of the proteins, to the environmental conditions at this hot spring, even if microbial cells maintain considerably different internal conditions. Further applications of the thermodynamic calculations are possible for other natural microbial ecosystems.	[Dick, Jeffrey M.; Shock, Everett L.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Shock, Everett L.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Dick, JM (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	jmdick@asu.edu	Dick, Jeffrey M/K-1619-2013	Dick, Jeffrey M/0000-0002-0687-5890; Shock, Everett/0000-0002-4283-0163	National Science Foundation [EAR-0847616]; Directorate For Geosciences [0826588] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This material is based upon work supported by the National Science Foundation under grant EAR-0847616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquisti C, 2007, NATURE, V445, P47, DOI 10.1038/nature05450; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Amend JP, 1998, SCIENCE, V281, P1659, DOI 10.1126/science.281.5383.1659; Amend JP, 2000, BIOPHYS CHEM, V84, P105, DOI 10.1016/S0301-4622(00)00116-2; Bard A. J., 1985, STANDARD POTENTIALS; Barton MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011935; Bowers TS, 1984, EQUILIBRIUM ACTIVITY, P397; Boyd ES, 2010, ISME J, P1; Buvet R, 1983, E MAJORANA INT SCI S, V11, P15; CALVERT JG, 1990, PURE APPL CHEM, V62, P2167, DOI 10.1351/pac199062112167; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; Curtis RA, 1998, BIOTECHNOL BIOENG, V57, P11, DOI 10.1002/(SICI)1097-0290(19980105)57:1<11::AID-BIT2>3.0.CO;2-Y; de Vendittis E, 2008, J THEOR BIOL, V250, P156, DOI 10.1016/j.jtbi.2007.09.006; Dick JM, 2006, BIOGEOSCIENCES, V3, P311, DOI 10.5194/bg-3-311-2006; Dick JM, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-10; Donder Th. De, 1927, AFFINITE; Drever J. I., 1988, GEOCHEMISTRY NATURAL; Duval S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-206; Engel T., 2006, THERMODYNAMICS STAT; Erol A, 2002, EXTREMOPHILES, V6, P351, DOI 10.1007/s00792-001-0264-1; Haar L, 1984, NBS NRC STEAM TABLES; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Havig JR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001415; HELGESON HC, 1981, AM J SCI, V281, P1249, DOI 10.2475/ajs.281.10.1249; Hendrickson JB, 1970, ORGANIC CHEM; Hoehler TM, 1998, GEOCHIM COSMOCHIM AC, V62, P1745, DOI 10.1016/S0016-7037(98)00106-9; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Huber R, 1998, APPL ENVIRON MICROB, V64, P3576; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; International Union of Pure and Applied Chemistry, IUPAC COMP CHEM TERM; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; JOHNSON JW, 1991, AM J SCI, V291, P541, DOI 10.2475/ajs.291.6.541; Kondepudi D, 1998, MODERN THERMODYNAMIC; Kroll JH, 2011, NATURE CHEM, P948; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LaRowe DE, 2011, GEOCHIM COSMOCHIM AC, V75, P2030, DOI 10.1016/j.gca.2011.01.020; LYNCH JM, 1979, MICROBIAL ECOLOGY CO; Mallick P, 2002, P NATL ACAD SCI USA, V99, P9679, DOI 10.1073/pnas.142310499; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Masiello CA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000534; McCollom TM, 2005, GEOBIOLOGY, V3, P135, DOI 10.1111/j.1472-4669.2005.00045.x; McDonald JH, 2001, MOL BIOL EVOL, V18, P741, DOI 10.1093/oxfordjournals.molbev.a003856; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Meyer- Dombard DR, 2011, ENV MICROBI IN PRESS; Nakashima H, 2003, J BIOCHEM, V133, P507, DOI 10.1093/jb/mvg067; NELSON PG, 1986, J CHEM EDUC, V63, P852, DOI 10.1021/ed063p852; Oijerholm J, 2009, J ELECTROCHEM SOC, V156, pP56, DOI 10.1149/1.3056125; Pfeil W., 1998, PROTEIN STABILITY FO; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RUFFROBERTS AL, 1994, APPL ENVIRON MICROB, V60, P697, DOI 10.1128/AEM.60.2.697-704.1994; Schulte MD, 2001, GEOCHIM COSMOCHIM AC, V65, P3919, DOI 10.1016/S0016-7037(01)00717-7; SENGERS JMHL, 1983, J PHYS CHEM REF DATA, V12, P1, DOI 10.1063/1.555676; Shock E, 2010, GEOFLUIDS, V10, P161, DOI 10.1111/j.1468-8123.2010.00277.x; SHOCK EL, 1992, J CHEM SOC FARADAY T, V88, P803, DOI 10.1039/ft9928800803; SHOCK EL, 1988, GEOCHIM COSMOCHIM AC, V52, P2009, DOI 10.1016/0016-7037(88)90181-0; SHOCK EL, 1989, GEOCHIM COSMOCHIM AC, V53, P2157, DOI 10.1016/0016-7037(89)90341-4; Shock EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4005, DOI 10.1016/j.gca.2009.08.036; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Swayer D.T., 1974, EXPT ELECTROCHEMISTR; TANGER JC, 1988, AM J SCI, V288, P19, DOI 10.2475/ajs.288.1.19; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	67	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22782	10.1371/journal.pone.0022782	http://dx.doi.org/10.1371/journal.pone.0022782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853048	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400013
J	Geiser, V; Cahir-McFarland, E; Kieff, E				Geiser, Vicki; Cahir-McFarland, Ellen; Kieff, Elliott			Latent Membrane Protein 1 Is Dispensable for Epstein-Barr Virus Replication in Human Embryonic Kidney 293 cells	PLOS ONE			English	Article							ORAL HAIRY LEUKOPLAKIA; NF-KAPPA-B; GROWTH TRANSFORMATION; IN-VIVO; SV40 TC-II(KAPPA-B); ACTIVATED CD40; INFECTION; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION	Epstein Barr Virus (EBV) replicates in oral epithelial cells and gains entry to B-lymphocytes. In B-lymphocytes, EBV expresses a restricted subset of genes, the Latency III program, which converts B-lymphocytes to proliferating lymphoblasts. Latent Membrane Protein 1 (LMP1) and the other Latency III associated proteins are also expressed during virus replication. LMP1 is essential for virus replication and egress from Akata Burkitt Lymphoma cells, but a role in epithelial cell replication has not been established. Therefore, we have investigated whether LMP1 enhances EBV replication and egress from HEK293 cells, a model epithelial cell line used for EBV recombinant molecular genetics. We compared wild type (wt) and LMP1-deleted (LMP1 Delta) EBV bacterial artificial chromosome (BAC) based virus replication and egress from HEK293. Following EBV immediate early Zta protein induction of EBV replication in HEK293 cells, similar levels of EBV proteins were expressed in wt-and LMP1 Delta-infected HEK293 cells. LMP1 deletion did not impair EBV replication associated DNA replication, DNA encapsidation, or mature virus release. Indeed, virus from LMP1 Delta-infected HEK293 cells was as infectious as EBV from wt EBV infected HEK cells. Trans-complementation with LMP1 reduced Rta expression and subsequent virus production. These data indicate that LMP1 is not required for EBV replication and egress from HEK293 cells.	[Geiser, Vicki] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Geiser, V (corresponding author), Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	ekieff@rics.bwh.harvard.edu			National Institutes of Health [CA085180]; NATIONAL CANCER INSTITUTE [R01CA085180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Public Health Service grant CA085180. VG is a fellow of the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2005, J VIROL, V79, P4415, DOI 10.1128/JVI.79.7.4415-4424.2005; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Chang Y, 2004, J VIROL, V78, P13028, DOI 10.1128/JVI.78.23.13028-13036.2004; Chen A, 2005, J VIROL, V79, P4506, DOI 10.1128/JVI.79.7.4506-4509.2005; Chen A, 2006, J VIROL, V80, P10139, DOI 10.1128/JVI.00854-06; DAWSON CW, 1990, NATURE, V344, P777, DOI 10.1038/344777a0; Dirmeier U, 2003, CANCER RES, V63, P2982; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; HUEN DS, 1995, ONCOGENE, V10, P549; Johnson AS, 2005, J VIROL, V79, P13769, DOI 10.1128/JVI.79.21.13769-13777.2005; KANNO M, 1989, EMBO J, V8, P4205, DOI 10.1002/j.1460-2075.1989.tb08606.x; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; KISHIMOTO T, 1977, CLIN EXP IMMUNOL, V30, P62; Kutok JL, 2004, J VIROL, V78, P3455, DOI 10.1128/JVI.78.7.3455-3461.2004; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Lu CC, 2006, VIROLOGY, V345, P358, DOI 10.1016/j.virol.2005.09.064; MACCHI M, 1989, EMBO J, V8, P4215, DOI 10.1002/j.1460-2075.1989.tb08607.x; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; PARKER BD, 1990, VIROLOGY, V179, P339, DOI 10.1016/0042-6822(90)90302-8; Pich D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn273; Rickinson AB, 2006, FIELDS VIROLOGY, P2511; Seifi A, 2011, VIROLOGY, V410, P17, DOI 10.1016/j.virol.2010.10.023; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Song YJ, 2008, P NATL ACAD SCI USA, V105, P18448, DOI 10.1073/pnas.0809933105; Walling DM, 2004, J INFECT DIS, V190, P396, DOI 10.1086/422039; WANG D, 1988, J VIROL, V62, P2337, DOI 10.1128/JVI.62.7.2337-2346.1988; Webster-Cyriaque J, 1998, VIROLOGY, V248, P53, DOI 10.1006/viro.1998.9268; Webster-Cyriaque J, 2000, J VIROL, V74, P7610, DOI 10.1128/JVI.74.16.7610-7618.2000; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006; ZimberStrobl U, 1996, EMBO J, V15, P7070, DOI 10.1002/j.1460-2075.1996.tb01098.x	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22929	10.1371/journal.pone.0022929	http://dx.doi.org/10.1371/journal.pone.0022929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853056	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953400018
J	Watanabe, Y; Castoro, RJ; Kim, HS; North, B; Oikawa, R; Hiraishi, T; Ahmed, SS; Chung, W; Cho, MY; Toyota, M; Itoh, F; Estecio, MRH; Shen, LL; Jelinek, J; Issa, JPJ				Watanabe, Yoshiyuki; Castoro, Ryan J.; Kim, Hyun Soo; North, Brittany; Oikawa, Ritsuko; Hiraishi, Tetsuya; Ahmed, Saira S.; Chung, Woonbok; Cho, Mee-Yon; Toyota, Minoru; Itoh, Fumio; Estecio, Marcos R. H.; Shen, Lanlan; Jelinek, Jaroslav; Issa, Jean-Pierre J.			Frequent Alteration of MLL3 Frameshift Mutations in Microsatellite Deficient Colorectal Cancer	PLOS ONE			English	Article							DNA METHYLATION; COLON-CANCER; GASTRIC-CANCER; REGION; GENE; PSEUDOGENES; INSTABILITY; LEUKEMIA; MAPS; P53	Background: MLL3 is a histone 3-lysine 4 methyltransferase with tumor-suppressor properties that belongs to a family of chromatin regulator genes potentially altered in neoplasia. Mutations in MLL3 were found in a whole genome analysis of colorectal cancer but have not been confirmed by a separate study. Methods and Results: We analyzed mutations of coding region and promoter methylation in MLL3 using 126 cases of colorectal cancer. We found two isoforms of MLL3 and DNA sequencing revealed frameshift and other mutations affecting both isoforms of MLL3 in colorectal cancer cells and 19 of 134 (14%) primary colorectal samples analyzed. Moreover, frameshift mutations were more common in cases with microsatellite instability (31%) both in CRC cell lines and primary tumors. The largest isoform of MLL3 is transcribed from a CpG island-associated promoter that has highly homology with a pseudo-gene on chromosome 22 (psiTPTE22). Using an assay which measured both loci simultaneously we found prominent age related methylation in normal colon (from 21% in individuals less than 25 years old to 56% in individuals older than 70, R = 0.88, p<0.001) and frequent hypermethylation (83%) in both CRC cell lines and primary tumors. We next studied the two loci separately and found that age and cancer related methylation was solely a property of the pseudogene CpG island and that the MLL3 loci was unmethylated. Conclusions: We found that frameshift mutations of MLL3 in both CRC cells and primary tumor that were more common in cases with microsatellite instability. Moreover, we have shown CpG island-associated promoter of MLL3 gene has no DNA methylation in CRC cells but also primary tumor and normal colon, and this region has a highly homologous of pseudo gene (psiTPTE22) that was age relate DNA methylation.	[Watanabe, Yoshiyuki; Castoro, Ryan J.; Kim, Hyun Soo; North, Brittany; Ahmed, Saira S.; Chung, Woonbok; Estecio, Marcos R. H.; Shen, Lanlan; Jelinek, Jaroslav; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Watanabe, Yoshiyuki; Oikawa, Ritsuko; Hiraishi, Tetsuya; Itoh, Fumio] St Marianna Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Kanagawa, Japan; [Cho, Mee-Yon] Yonsei Univ, Dept Pathol, Wonju Coll Med, Wonju, South Korea; [Toyota, Minoru] Sapporo Med Univ, Dept Biochem, Sapporo, Hokkaido, Japan	University of Texas System; UTMD Anderson Cancer Center; Saint Marianna University; Yonsei University; Sapporo Medical University	Watanabe, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	ponponta@marianna-u.ac.jp	Jelinek, Jaroslav/D-2282-2012; Jelinek, Jaroslav/O-6876-2019	Jelinek, Jaroslav/0000-0002-2533-0220; Castoro, Ryan/0000-0003-3619-484X; Issa, Jean-Pierre/0000-0003-2258-5030; Castoro, Ryan/0000-0002-3242-3775; Estecio, Marcos/0000-0002-6874-7413	National Institutes of Health [CA098006, CA105346, CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA098006, R01CA105346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants #CA098006 and CA105346. J-PJI is an American Cancer Society Clinical Research Professor supported by a generous gift from the F. M. Kirby Foundation. DNA sequencing in the Core Sequencing facility at the M. D. Anderson Cancer Center is supported by Core Grant #CA16672 from the National Institutes of Health. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2007, APMIS, V115, P859, DOI 10.1111/j.1600-0463.2007.apm_696.x; Ahuja N, 1998, CANCER RES, V58, P5489; Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Chen HM, 1999, HUM GENET, V105, P399, DOI 10.1007/s004390051122; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Liang QY, 2010, INT J CANCER, V127, P1833, DOI 10.1002/ijc.25213; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Melcher R, 2002, CYTOGENET GENOME RES, V98, P22, DOI 10.1159/000068544; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; Shen L, 2003, GASTROENTEROLOGY, V124, P626, DOI 10.1053/gast.2003.50102; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wang G, 2004, GENOME RES, V14, P2357, DOI 10.1101/gr.2813404; Watanabe Y, 2007, CLIN CANCER RES, V13, P4786, DOI 10.1158/1078-0432.CCR-07-0305; Watanabe Y, 2009, GASTROENTEROLOGY, V136, P2149, DOI 10.1053/j.gastro.2009.02.085	19	53	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23320	10.1371/journal.pone.0023320	http://dx.doi.org/10.1371/journal.pone.0023320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853109	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953400037
J	Auvert, B; Mahiane, GS; Lissouba, P; Moreau, T				Auvert, Bertran; Mahiane, Guy Severin; Lissouba, Pascale; Moreau, Thierry			Statistical Power and Estimation of Incidence Rate Ratios Obtained from BED Incidence Testing for Evaluating HIV Interventions among Young People	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INFECTION; RISK	Background: The objectives of this study were to determine the capacity of BED incidence testing to a) estimate the effect of a HIV prevention intervention and b) provide adequate statistical power, when used among young people from sub-Saharan African settings with high HIV incidence rates. Methods: Firstly, after having elaborated plausible scenarios based on empirical data and the characteristics of the BED HIV-1 Capture EIA (BED) assay, we conducted statistical calculations to determine the BED theoretical power and HIV incidence rate ratio (IRR) associated with an intervention when using BED incidence testing. Secondly, we simulated a cross-sectional study conducted in a population among whom an HIV intervention was rolled out. Simulated data were analyzed using a log-linear Poisson model to recalculate the IRR and its confidence interval, and estimate the BED practical power. Calculations were conducted with and without corrections for misclassifications. Results: Calculations showed that BED incidence testing can yield a BED theoretical power of 75% or more of the power that can be obtained in a classical cohort study conducted over a duration equal to the BED window period. Statistical analyses using simulated populations showed that the effect of a prevention intervention can be estimated with precision using classical statistical analysis of BED incidence testing data, even with an imprecise knowledge of the characteristics of the BED assay. The BED practical power was lower but of the same magnitude as the BED theoretical power. Conclusions: BED incidence testing can be applied to reasonably small samples to achieve good statistical power when used among young people to estimate IRR.	[Auvert, Bertran; Lissouba, Pascale] CESP INSERM UVSQ UMRS 1018, Villejuif, France; [Auvert, Bertran] Univ Versailles St Quentin, Versailles, France; [Auvert, Bertran] Hop Ambroise Pare, Assistance Publ Hop Paris, Boulogne, France; [Auvert, Bertran] IUF, Paris, France; [Mahiane, Guy Severin] Univ Stellenbosch, SACEMA, Stellenbosh, South Africa; [Moreau, Thierry] CESP INSERM Paris 11 UMRS 1018, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Stellenbosch University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Auvert, B (corresponding author), CESP INSERM UVSQ UMRS 1018, Villejuif, France.	bertran.auvert@uvsq.fr	Lissouba, Pascale/ABB-8815-2021	Lissouba, Pascale/0000-0002-4751-6894	Agence Nationale de Recherches sur le Sida et les hepatites virales (France) [ANRS-1265, ANRS-12126]; SACEMA; Stellenbosch University (South Africa); INSERM (France); University of Versailles - Saint-Quentin (France)	Agence Nationale de Recherches sur le Sida et les hepatites virales (France)(ANRS); SACEMA; Stellenbosch University (South Africa); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Versailles - Saint-Quentin (France)	Supported by ANRS-1265 and ANRS-12126, Agence Nationale de Recherches sur le Sida et les hepatites virales (France), SACEMA, Stellenbosch University (South Africa), INSERM (France) and the University of Versailles - Saint-Quentin (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAXIMA COMPUTER ALGE; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; BERRY G, 1983, BIOMETRICS, V39, P173, DOI 10.2307/2530817; Braunstein SL, 2009, AIDS REV, V11, P140; Brookmeyer R, 2009, J ACQ IMMUN DEF SYND, V54, P406; Fiamma A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-137; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; HOLFORD TR, 1980, BIOMETRICS, V36, P299, DOI 10.2307/2529982; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2009, AIDS, V23, P2064, DOI 10.1097/QAD.0b013e32832eff6e; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Team RDC, 2005, R LANG ENV STAT COMP; UNAIDS Reference Group on Estimates MaP, 2006, STAT US BED ASS EST; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; Welte A, 2009, AIDS RES HUM RETROV, V25, P125, DOI 10.1089/aid.2008.0150	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e21149	10.1371/journal.pone.0021149	http://dx.doi.org/10.1371/journal.pone.0021149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853019	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200001
J	Brauner, R; Neve, M; Allali, S; Trivin, C; Lottmann, H; Bashamboo, A; McElreavey, K				Brauner, Raja; Neve, Mathieu; Allali, Slimane; Trivin, Christine; Lottmann, Henri; Bashamboo, Anu; McElreavey, Ken			Clinical, Biological and Genetic Analysis of Anorchia in 26 Boys	PLOS ONE			English	Article							TESTICULAR REGRESSION SYNDROME; BILATERAL CONGENITAL ANORCHIA; MULLERIAN-INHIBITING SUBSTANCE; 46,XY; CRYPTORCHIDISM; EXPRESSION; MANAGEMENT; ENDOCRINE; SIBLINGS; SPECTRUM	Background: Anorchia is defined as the absence of testes in a 46, XY individual with a male phenotype. The cause is unknown. Methods: We evaluated the clinical and biological presentation, and family histories of 26 boys with anorchia, and sequenced their SRY, NR5A1, INSL3, MAMLD1 genes and the T222P variant for LGR8. Results: No patient had any associated congenital anomaly. At birth, testes were palpable bilaterally or unilaterally in 13 cases and not in 7; one patient presented with bilateral testicular torsion immediately after birth. The basal plasma concentrations of anti-Mullerian hormone (AMH, n = 15), inhibin B (n = 7) and testosterone (n = 19) were very low or undetectable in all the patients evaluated, as were the increases in testosterone after human chorionic gonadotropin (hCG, n = 12). The basal plasma concentrations of follicle stimulating hormone (FSH) were increased in 20/25, as was that of luteinising hormone in 10/22 cases. Family members of 7/26 cases had histories of primary ovarian failure in the mother (n = 2), or sister 46, XX, together with fetal malformations of the only boy with microphallus and secondary foot edema (n = 1), secondary infertility in the father (n = 2), or cryptorchidism in first cousins (n = 2). The sequences of all the genes studied were normal. Conclusion: Undetectable plasma concentrations of AMH and inhibin B and an elevated plasma FSH, together with 46, XY complement are sufficient for diagnosis of anorchia. The hCG test is unnecessary. NR5A1 and other genes implicated in gonadal development and testicle descent were not mutated, which suggests that other genes involved in these developments contribute to the phenotypes.	[Brauner, Raja; Neve, Mathieu; Allali, Slimane] Univ Paris 05, Le Kremlin Bicetre, France; [Brauner, Raja; Neve, Mathieu; Allali, Slimane] Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France; [Trivin, Christine] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France; [Lottmann, Henri] Hop Necker Enfants Malad, AP HP, Serv Chirurg Viscerale Pediat, Paris, France; [Bashamboo, Anu; McElreavey, Ken] Inst Pasteur, Human Dev Genet Unit, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brauner, R (corresponding author), Univ Paris 05, Le Kremlin Bicetre, France.	raja.brauner@wanadoo.fr	Allali, Slimane/AGW-0037-2022	Allali, Slimane/0000-0001-7068-4530				ABEYARATNE MR, 1969, LANCET, V2, P822; AYNSLEYGREEN A, 1976, CLIN ENDOCRINOL, V5, P381, DOI 10.1111/j.1365-2265.1976.tb01966.x; BOBROW M, 1970, LANCET, V1, P366; DEGROUCHY J, 1985, ANN GENET-PARIS, V28, P154; DeRosa M, 1996, ANDROLOGIA, V28, P281; Dumic M, 2008, J CLIN ENDOCR METAB, V93, P182, DOI 10.1210/jc.2007-2155; EDMAN CD, 1977, OBSTET GYNECOL, V49, P208; Ferlin A, 2008, JAMA-J AM MED ASSOC, V300, P2271, DOI 10.1001/jama.2008.668; GRANAT M, 1983, FERTIL STERIL, V40, P215; JOSSO N, 1980, J PEDIATR-US, V97, P200, DOI 10.1016/S0022-3476(80)80474-4; KENNERKNECHT I, 1993, AM J MED GENET, V47, P1166, DOI 10.1002/ajmg.1320470807; Kubini K, 2000, J CLIN ENDOCR METAB, V85, P134, DOI 10.1210/jc.85.1.134; Lee MM, 1997, NEW ENGL J MED, V336, P1480, DOI 10.1056/NEJM199705223362102; LOBACCARO JM, 1993, CLIN ENDOCRINOL, V38, P197, DOI 10.1111/j.1365-2265.1993.tb00993.x; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; MARCANTONIO SM, 1994, AM J MED GENET, V49, P1, DOI 10.1002/ajmg.1320490102; Misra M, 2002, J CLIN ENDOCR METAB, V87, P3598, DOI 10.1210/jc.87.8.3598; NAFFAH J, 1989, B ACAD NAT MED PARIS, V173, P709; Parigi GB, 1999, EUR J PEDIATR SURG, V9, P312, DOI 10.1055/s-2008-1072271; Philibert P, 2007, HUM REPROD, V22, P3255, DOI 10.1093/humrep/dem278; PIERSON M, 1983, ARCH FR PEDIATR, V40, P767; RAI M, 1994, CLIN PEDIATR, V33, P367, DOI 10.1177/000992289403300610; SARTO GE, 1973, J MED GENET, V10, P288, DOI 10.1136/jmg.10.3.288; SMITH NM, 1991, HISTOPATHOLOGY, V19, P269, DOI 10.1111/j.1365-2559.1991.tb00033.x; Vinci G, 2004, J CLIN ENDOCR METAB, V89, P6282, DOI 10.1210/jc.2004-0891; Yerkes EB, 2005, J UROLOGY, V174, P1579, DOI 10.1097/01.ju.0000179542.05953.11; Zenaty D, 2006, J PEDIATR-US, V149, P687, DOI 10.1016/j.jpeds.2006.07.044; Zenteno JC, 2001, AM J MED GENET, V99, P244, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1170>3.0.CO;2-A	28	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23292	10.1371/journal.pone.0023292	http://dx.doi.org/10.1371/journal.pone.0023292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853106	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200066
J	Fujimura, Y; Kurihara, K; Ida, M; Kosaka, R; Miura, D; Wariishi, H; Maeda-Yamamoto, M; Nesumi, A; Saito, T; Kanda, T; Yamada, K; Tachibana, H				Fujimura, Yoshinori; Kurihara, Kana; Ida, Megumi; Kosaka, Reia; Miura, Daisuke; Wariishi, Hiroyuki; Maeda-Yamamoto, Mari; Nesumi, Atsushi; Saito, Takeshi; Kanda, Tomomasa; Yamada, Koji; Tachibana, Hirofumi			Metabolomics-Driven Nutraceutical Evaluation of Diverse Green Tea Cultivars	PLOS ONE			English	Article							CAMELLIA-SINENSIS L.; PU-ERH TEA; ENDOTHELIAL DYSFUNCTION; QUALITY ASSESSMENT; BLACK TEA; EXTRACT; PATHWAY; SYSTEMS; MODELS; MS	Background: Green tea has various health promotion effects. Although there are numerous tea cultivars, little is known about the differences in their nutraceutical properties. Metabolic profiling techniques can provide information on the relationship between the metabolome and factors such as phenotype or quality. Here, we performed metabolomic analyses to explore the relationship between the metabolome and health-promoting attributes (bioactivity) of diverse Japanese green tea cultivars. Methodology/Principal Findings: We investigated the ability of leaf extracts from 43 Japanese green tea cultivars to inhibit thrombin-induced phosphorylation of myosin regulatory light chain (MRLC) in human umbilical vein endothelial cells (HUVECs). This thrombin-induced phosphorylation is a potential hallmark of vascular endothelial dysfunction. Among the tested cultivars, Cha Chuukanbohon Nou-6 (Nou-6) and Sunrouge (SR) strongly inhibited MRLC phosphorylation. To evaluate the bioactivity of green tea cultivars using a metabolomics approach, the metabolite profiles of all tea extracts were determined by high-performance liquid chromatography-mass spectrometry (LC-MS). Multivariate statistical analyses, principal component analysis (PCA) and orthogonal partial least-squares-discriminant analysis (OPLS-DA), revealed differences among green tea cultivars with respect to their ability to inhibit MRLC phosphorylation. In the SR cultivar, polyphenols were associated with its unique metabolic profile and its bioactivity. In addition, using partial least-squares (PLS) regression analysis, we succeeded in constructing a reliable bioactivity-prediction model to predict the inhibitory effect of tea cultivars based on their metabolome. This model was based on certain identified metabolites that were associated with bioactivity. When added to an extract from the non-bioactive cultivar Yabukita, several metabolites enriched in SR were able to transform the extract into a bioactive extract. Conclusions/Significance: Our findings suggest that metabolic profiling is a useful approach for nutraceutical evaluation of the health promotion effects of diverse tea cultivars. This may propose a novel strategy for functional food design.	[Fujimura, Yoshinori; Miura, Daisuke; Wariishi, Hiroyuki; Tachibana, Hirofumi] Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 812, Japan; [Kurihara, Kana; Ida, Megumi; Kosaka, Reia; Wariishi, Hiroyuki; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 812, Japan; [Wariishi, Hiroyuki; Tachibana, Hirofumi] Kyushu Univ, Bioarchitecture Ctr, Higashi Ku, Fukuoka 812, Japan; [Maeda-Yamamoto, Mari; Nesumi, Atsushi] Natl Agr & Food Res Org, Natl Inst Vegetable & Tea Sci, Shizuoka, Japan; [Saito, Takeshi; Kanda, Tomomasa] Asahi Brewery Co Ltd, Moriya, Ibaraki, Japan	Kyushu University; Kyushu University; Kyushu University; National Agriculture & Food Research Organization - Japan; Asahi Group Holdings Ltd.	Fujimura, Y (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Higashi Ku, Fukuoka 812, Japan.	tatibana@agr.kyushu-u.ac.jp	fujimura, yoshinori/E-4684-2012; Miura, Daisuke/H-1517-2019; Fujimura, Yoshinori/AAG-4403-2019	Maeda-Yamamoto, Mari/0000-0002-4494-7509; Fujimura, Yoshinori/0000-0003-0798-0649	Ministry of Agriculture, Forestry and Fisheries, Japan [23005, 22228002]	Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by research and development projects for application in promoting new policy of agriculture forestry and fisheries, Ministry of Agriculture, Forestry and Fisheries, Japan (Grant No. 23005) to HT and Grants-in-Aid for Scientific Research (S) (Grant 22228002) to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewicz MR, 2006, METABOLOMICS, V2, P41, DOI 10.1007/s11306-006-0018-2; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; CHISAKA T, 1988, CHEM PHARM BULL, V36, P227; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; Cuadros-Inostroza A, 2010, ANAL CHEM, V82, P3573, DOI 10.1021/ac902678t; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fujiwara M, 2006, ANAL SCI, V22, P1307, DOI 10.2116/analsci.22.1307; Heuberger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012915; Hodgson JM, 1999, J HYPERTENS, V17, P457, DOI 10.1097/00004872-199917040-00002; Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004; Honma D, 2010, J SCI FOOD AGR, V90, P168, DOI 10.1002/jsfa.3807; Ku KM, 2010, J AGR FOOD CHEM, V58, P418, DOI 10.1021/jf902929h; Ku KM, 2010, J AGR FOOD CHEM, V58, P345, DOI 10.1021/jf902818c; Kurihara K, 2010, FOOD SCI TECHNOL RES, V16, P263, DOI 10.3136/fstr.16.263; Kurita I, 2010, J AGR FOOD CHEM, V58, P1903, DOI 10.1021/jf904335g; Le Gall G, 2004, J AGR FOOD CHEM, V52, P692, DOI 10.1021/jf034828r; Lee JE, 2010, J AGR FOOD CHEM, V58, P10582, DOI 10.1021/jf102415m; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; Luthria DL, 2008, J AGR FOOD CHEM, V56, P9819, DOI 10.1021/jf801606x; Maeda-Yamamoto M, 2007, CYTOTECHNOLOGY, V55, P135, DOI 10.1007/s10616-007-9112-1; Okazaki K, 2008, PLANT CELL PHYSIOL, V49, P170, DOI 10.1093/pcp/pcm173; Pongsuwan W, 2008, J AGR FOOD CHEM, V56, P10705, DOI 10.1021/jf8018003; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; SANO M, 1995, BIOL PHARM BULL, V18, P1006, DOI 10.1248/bpb.18.1006; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Sitia S, 2010, AUTOIMMUN REV, V9, P830, DOI 10.1016/j.autrev.2010.07.016; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Wang QM, 2010, CIRC J, V74, P294, DOI 10.1253/circj.CJ-09-0543; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Xie GX, 2009, J AGR FOOD CHEM, V57, P3046, DOI 10.1021/jf804000y; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	33	74	78	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23426	10.1371/journal.pone.0023426	http://dx.doi.org/10.1371/journal.pone.0023426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853132	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200085
J	Gray, LK; Hamann, A				Gray, Laura K.; Hamann, Andreas			Strategies for Reforestation under Uncertain Future Climates: Guidelines for Alberta, Canada	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; POPULATION DIFFERENTIATION; FOREST TREES; GROWTH; CONSERVATION; IMPACTS; DIEBACK	Background: Commercial forestry programs normally use locally collected seed for reforestation under the assumption that tree populations are optimally adapted to local environments. However, in western Canada this assumption is no longer valid because of climate trends that have occurred over the last several decades. The objective of this study is to show how we can arrive at reforestation recommendations with alternative species and genotypes that are viable under a majority of climate change scenarios. Methodology/Principal Findings: In a case study for commercially important tree species of Alberta, we use an ecosystem-based bioclimate envelope modeling approach for western North America to project habitat for locally adapted populations of tree species using multi-model climate projections for the 2020s, 2050s and 2080s. We find that genotypes of species that are adapted to drier climatic conditions will be the preferred planting stock over much of the boreal forest that is commercially managed. Interestingly, no alternative species that are currently not present in Alberta can be recommended with any confidence. Finally, we observe large uncertainties in projections of suitable habitat that make reforestation planning beyond the 2050s difficult for most species. Conclusion/Significance: More than 50,000 hectares of forests are commercially planted every year in Alberta. Choosing alternative planting stock, suitable for expected future climates, could therefore offer an effective climate change adaptation strategy at little additional cost. Habitat projections for locally adapted tree populations under observed climate change conform well to projections for the 2020s, which suggests that it is a safe strategy to change current reforestation practices and adapt to new climatic realities through assisted migration prescriptions.	[Gray, Laura K.; Hamann, Andreas] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Gray, LK (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	lkgray@gmail.com		Hamann, Andreas/0000-0003-2046-4550; Gray, Laura/0000-0003-0477-2705	Natural Sciences and Engineering Research Council of Canada (NSERC) [CRDPJ 349100-06]; Alberta Forest Research Institute; Alberta-Pacific Forest Industries; Ainsworth Engineered Canada LP; Daishowa-Marubeni International Ltd.; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Forest Research Institute; Alberta-Pacific Forest Industries; Ainsworth Engineered Canada LP; Daishowa-Marubeni International Ltd.; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	This study was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC)/Industry Collaborative Development Grant CRDPJ 349100-06. Government funders included the NSERC and the Alberta Forest Research Institute. Industry co-sponsors included Alberta-Pacific Forest Industries, Ainsworth Engineered Canada LP, Daishowa-Marubeni International Ltd., Western Boreal Aspen Corporation, and Weyerhaeuser Company Ltd.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; AH received a research grant and LKG received a graduate student stipend that was co-funded by the commercial companies listed in the financial disclosure. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bechtold W.A., 2005, ENHANCED FOREST INVE, P85, DOI [10.2737/SRS-GTR-80, DOI 10.2737/SRS-GTR-80]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; EPA, 2007, EC MAPS GIS RES; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; *FLOR N AM ED COMM, 1993, FLOR N AM MEX; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; *GOV ALB, 2008, EC SIT INF SYST ESIS; Gray LK, 2011, ECOL APPL, V21, P1591, DOI 10.1890/10-1054.1; GRAY LK, 2011, THESIS U ALBERTA; Hamann A, 2005, CAN J FOREST RES, V35, P2553, DOI [10.1139/x05-181, 10.1139/X05-181]; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Hamann A, 2011, TREE GENET GENOMES, V7, P399, DOI 10.1007/s11295-010-0341-7; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Hogg EH, 2008, CAN J FOREST RES, V38, P1373, DOI 10.1139/X08-001; Hogg EH, 1997, AGR FOREST METEOROL, V84, P115, DOI 10.1016/S0168-1923(96)02380-5; Hogg EH, 2002, CAN J FOREST RES, V32, P823, DOI [10.1139/x01-152, 10.1139/X01-152]; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mbogga M., 2010, COMPREHENSIVE SET IN; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; Mbogga MS, 2009, AGR FOREST METEOROL, V149, P881, DOI 10.1016/j.agrformet.2008.11.009; MEIDINGER D, 1991, SPECIAL REPORT RES B, V6; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; NRC, 2006, NAT REG SUBR ALB; R Core Team, 2021, R LANGUAGE ENV STAT; Rweyongeza DM, 2010, SILVAE GENET, V59, P158, DOI 10.1515/sg-2010-0019; Rweyongeza DM, 2007, CAN J BOT, V85, P545, DOI 10.1139/B07-053; Selby CJ, 1996, NATL ECOLOGICAL FRAM; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; *SRD, 2005, STAND TREE IMPR ALB; SRD, 2009, ALB FOR GEN RES MAN; Volney WJA, 2000, AGR ECOSYST ENVIRON, V82, P283, DOI 10.1016/S0167-8809(00)00232-2; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Ying CC, 2006, FOREST ECOL MANAG, V227, P1, DOI 10.1016/j.foreco.2006.02.028	38	60	61	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22977	10.1371/journal.pone.0022977	http://dx.doi.org/10.1371/journal.pone.0022977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853061	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200031
J	Harvey, BK; Airavaara, M; Hinzman, J; Wires, EM; Chiocco, MJ; Howard, DB; Shen, H; Gerhardt, G; Hoffer, BJ; Wang, Y				Harvey, Brandon K.; Airavaara, Mikko; Hinzman, Jason; Wires, Emily M.; Chiocco, Matthew J.; Howard, Douglas B.; Shen, Hui; Gerhardt, Greg; Hoffer, Barry J.; Wang, Yun			Targeted Over-Expression of Glutamate Transporter 1 (GLT-1) Reduces Ischemic Brain Injury in a Rat Model of Stroke	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; NMDA RECEPTOR; UP-REGULATION; ASPARTATE; DAMAGE; NEUROPROTECTION; INDUCTION; TOLERANCE; ELEVATION; BLOCKADE	Following the onset of an ischemic brain injury, the excitatory neurotransmitter glutamate is released. The excitotoxic effects of glutamate are a major contributor to the pathogenesis of a stroke. The aim of this study was to examine if overexpression of a glutamate transporter (GLT-1) reduces ischemic brain injury in a rat model of stroke. We generated an adeno-associated viral (AAV) vector expressing the rat GLT-1 cDNA (AAV-GLT1). Functional expression of AAV-GLT1 was confirmed by increased glutamate clearance rate in non-stroke rat brain as measured by in vivo amperometry. AAV-GLT1 was injected into future cortical region of infarction 3 weeks prior to 60 min middle cerebral artery occlusion (MCAo). Tissue damage was assessed at one and two days after MCAo using TUNEL and TTC staining, respectively. Behavioral testing was performed at 2, 8 and 14 days post-stroke. Animals receiving AAV-GLT1, compared to AAV-GFP, showed significant decreases in the duration and magnitude of extracellular glutamate, measured by microdialysis, during the 60 minute MCAo. A significant reduction in brain infarction and DNA fragmentation was observed in the region of AAV-GLT1 injection. Animals that received AAV-GLT1 showed significant improvement in behavioral recovery following stroke compared to the AAV-GFP group. We demonstrate that focal overexpression of the glutamate transporter, GLT-1, significantly reduces ischemia-induced glutamate overflow, decreases cell death and improves behavioral recovery. These data further support the role of glutamate in the pathogenesis of ischemic damage in brain and demonstrate that targeted gene delivery to decrease the ischemia-induced glutamate overflow reduces the cellular and behavioral deficits caused by stroke.	[Harvey, Brandon K.; Airavaara, Mikko; Wires, Emily M.; Chiocco, Matthew J.; Howard, Douglas B.; Shen, Hui; Hoffer, Barry J.; Wang, Yun] Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD USA; [Hinzman, Jason; Gerhardt, Greg] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Ctr Microelectrode Technol, Lexington, KY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University of Kentucky	Harvey, BK (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, NIH, Baltimore, MD USA.	bharvey@mail.nih.gov	Harvey, Brandon Keith/AAY-4080-2021; Harvey, Brandon K/A-5559-2010	Harvey, Brandon Keith/0000-0002-4036-1383; Howard, Doug/0000-0002-4163-5956; Airavaara, Mikko/0000-0002-2026-1609	National Institute on Drug Abuse;  [F31NS067899];  [DA017186]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS067899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZICDA000555, ZIADA000461, R01DA017186, ZIADA000443, ZIADA000429, ZIADA000576] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Intramural Program of the National Institute on Drug Abuse. In addition, support was received from F31NS067899 (Jason Hinzman) and DA017186 (Greg Gerhardt). Because Greg Gerhardt is an owner of Quanteon, LLC, where the microelectrodes were purchased, it could be considered a funder, although no money was received from Quanteon, LLC. Microelectrodes were purchased from Quanteon, LLC because it is the only company that makes this type of multielectrode for in vivo amperometry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2010, EXP NEUROL, V225, P104, DOI 10.1016/j.expneurol.2010.05.020; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Baker DA, 2003, ANN NY ACAD SCI, V1003, P349, DOI 10.1196/annals.1300.023; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Behar TN, 1999, J NEUROSCI, V19, P4449; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chu K, 2006, STROKE, V37, P730; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Garber K, 2007, NAT BIOTECHNOL, V25, P837, DOI 10.1038/nbt0807-838; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Lin SZ, 1996, STROKE, V27, P747, DOI 10.1161/01.STR.27.4.747; Lowery RL, 2009, DEV NEUROBIOL, V69, P674, DOI 10.1002/dneu.20735; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; MARTIN RL, 1994, TRENDS NEUROSCI, V17, P251, DOI 10.1016/0166-2236(94)90008-6; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rao VLR, 2001, NEUROCHEM RES, V26, P497; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Wang Y, 2003, J NEUROSCI, V23, P7958; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yang YJ, 2010, GLIA, V58, P277, DOI 10.1002/glia.20922; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zhou FC, 1996, J NEUROSCI, V16, P6965	35	76	82	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22135	10.1371/journal.pone.0022135	http://dx.doi.org/10.1371/journal.pone.0022135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853027	gold, Green Published, Green Submitted			2022-12-27	WOS:000295454200008
J	Looi, CY; Imanishi, M; Takaki, S; Sato, M; Chiba, N; Sasahara, Y; Futaki, S; Tsuchiya, S; Kumaki, S				Looi, Chung Yeng; Imanishi, Miki; Takaki, Satoshi; Sato, Miki; Chiba, Natsuko; Sasahara, Yoji; Futaki, Shiroh; Tsuchiya, Shigeru; Kumaki, Satoru			Octa-Arginine Mediated Delivery of Wild-Type Lnk Protein Inhibits TPO-Induced M-MOK Megakaryoblastic Leukemic Cell Growth by Promoting Apoptosis	PLOS ONE			English	Article							MEMBRANE-PERMEABLE PEPTIDES; SCID GENE-THERAPY; ADAPTER PROTEIN; MYELOPROLIFERATIVE NEOPLASMS; INSERTIONAL MUTAGENESIS; SIGNALING PATHWAYS; POLYCYTHEMIA-VERA; RICH PEPTIDES; JAK2; TRANSDUCTION	Background: Lnk plays a non-redundant role by negatively regulating cytokine signaling of TPO, SCF or EPO. Retroviral expression of Lnk has been shown to suppress hematopoietic leukemic cell proliferation indicating its therapeutic value in cancer therapy. However, retroviral gene delivery carries risks of insertional mutagenesis. To circumvent this undesired consequence, we fused a cell permeable peptide octa-arginine to Lnk and evaluated the efficacy of inhibition of leukemic cell proliferation in vitro. Methodology/Principal Findings: In this study, proliferation assays, flow cytometry, Western Blot analyses were performed on wild-type (WT), mutant Lnk R8 or BSA treated M-MOK cells. We found that delivered WT, but not mutant Lnk R8 blocked TPO-induced M-MOK megakaryoblastic leukemic cell proliferation. In contrast, WT Lnk R8 showed no growth inhibitive effect on non-hematopoietic HELA or COS-7 cell. Moreover, we demonstrated that TPO-induced M-MOK cell growth inhibition by WT Lnk R8 was dose-dependent. Penetrated WT Lnk R8 induced cell cycle arrest and apoptosis. Immunoprecipitation and Western blots data indicated WT Lnk R8 interacted with endogeneous Jak2 and downregulated Jak-Stat and MAPK phosphorylation level in M-MOK cells after TPO stimulation. Treatment with specific inhibitors (TG101348 and PD98059) indicated Jak-Stat and MAPK pathways were crucial for TPO-induced proliferation of M-MOK cells. Further analyses using TF-1 and HEL leukemic cell-lines showed that WT Lnk R8 inhibited Jak2-dependent cell proliferation. Using cord blood-derived CD34+ stem cells, we found that delivered WT Lnk R8 blocked TPO-induced megakaryopoiesis in vitro. Conclusions/Significance: Intracellular delivery of WT Lnk R8 fusion protein efficiently inhibited TPO-induced M-MOK leukemic cell growth by promoting apoptosis. WT Lnk R8 protein delivery may provide a safer and more practical approach to inhibit leukemic cell growth worthy of further development.	[Looi, Chung Yeng; Sato, Miki; Sasahara, Yoji; Tsuchiya, Shigeru; Kumaki, Satoru] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; [Imanishi, Miki; Futaki, Shiroh] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Takaki, Satoshi] Int Med Ctr Japan, Res Inst, Tokyo, Japan; [Chiba, Natsuko] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Sendai, Miyagi 980, Japan	Tohoku University; Kyoto University; National Center for Global Health & Medicine - Japan; Tohoku University	Looi, CY (corresponding author), Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan.	kumakis@gmail.com	Looi, Chung Yeng/A-2623-2013	Looi, Chung Yeng/0000-0002-4830-3495; Futaki, Shiroh/0000-0002-0124-4002; Imanishi, Miki/0000-0002-4172-0966	Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was financially supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, and a grant from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran-Marszak F, 2010, BLOOD, V116, P5961, DOI 10.1182/blood-2009-12-256768; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Chikh GG, 2001, J IMMUNOL, V167, P6462, DOI 10.4049/jimmunol.167.11.6462; Drexler HG, 1997, LEUKEMIA, V11, P541, DOI 10.1038/sj.leu.2400621; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Ford KG, 2001, GENE THER, V8, P1, DOI 10.1038/sj.gt.3301383; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Gery S, 2007, BLOOD, V110, P3360, DOI 10.1182/blood-2007-05-089326; Gery S, 2009, J LEUKOCYTE BIOL, V85, P957, DOI 10.1189/jlb.0908575; Gery S, 2009, EXP HEMATOL, V37, P585, DOI 10.1016/j.exphem.2009.01.009; Gueller S, 2008, BIOCHEM J, V415, P241, DOI 10.1042/BJ20080102; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; ITANO M, 1995, EXP HEMATOL, V23, P1301; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Joliot A, 2005, M S-MED SCI, V21, P309, DOI 10.1051/medsci/2005213309; KAUSHANSKY K, 1995, BLOOD, V86, P419, DOI 10.1182/blood.V86.2.419.bloodjournal862419; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Noguchi H, 2006, ACTA MED OKAYAMA, V60, P1; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Pardanani A, 2010, LEUKEMIA, V24, P1713, DOI 10.1038/leu.2010.163; Pike-Overzet K, 2007, MOL THER, V15, P1910, DOI 10.1038/sj.mt.6300297; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Quentmeier H, 2008, LEUKEMIA, V22, P2169, DOI 10.1038/leu.2008.226; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Simon C, 2008, BLOOD, V112, P1039, DOI 10.1182/blood-2008-05-154849; Takaki S, 2003, J IMMUNOL, V170, P703, DOI 10.4049/jimmunol.170.2.703; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Takenobu T, 2002, MOL CANCER THER, V1, P1043; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Tong W, 2004, J EXP MED, V200, P569, DOI 10.1084/jem.20040762; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Uchiyama T, 2006, BIOCHEM BIOPH RES CO, V341, P391, DOI 10.1016/j.bbrc.2005.12.199; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wendling F, 1998, EUR CYTOKINE NETW, V9, P221; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Y, 2008, BLOOD, V112, P2474, DOI 10.1182/blood-2007-12-130211	48	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23640	10.1371/journal.pone.0023640	http://dx.doi.org/10.1371/journal.pone.0023640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853157	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200101
J	Marais, GAB; Forrest, A; Kamau, E; Kafer, J; Daubin, V; Charlesworth, D				Marais, Gabriel A. B.; Forrest, Alan; Kamau, Esther; Kaefer, Jos; Daubin, Vincent; Charlesworth, Deborah			Multiple Nuclear Gene Phylogenetic Analysis of the Evolution of Dioecy and Sex Chromosomes in the Genus Silene	PLOS ONE			English	Article							Y-CHROMOSOME; PLANT SILENE; CHLOROPLAST DNA; RETICULATE EVOLUTION; SUBSTITUTION RATES; BREEDING SYSTEM; CARYOPHYLLACEAE; LATIFOLIA; SELECTION; MODEL	In the plant genus Silene, separate sexes and sex chromosomes are believed to have evolved twice. Silene species that are wholly or largely hermaphroditic are assumed to represent the ancestral state from which dioecy evolved. This assumption is important for choice of outgroup species for inferring the genetic and chromosomal changes involved in the evolution of dioecy, but is mainly based on data from a single locus (ITS). To establish the order of events more clearly, and inform outgroup choice, we therefore carried out (i) multi-nuclear-gene phylogenetic analyses of 14 Silene species (including 7 hermaphrodite or gynodioecious species), representing species from both Silene clades with dioecious members, plus a more distantly related outgroup, and (ii) a BayesTraits character analysis of the evolution of dioecy. We confirm two origins of dioecy within this genus in agreement with recent work on comparing sex chromosomes from both clades with dioecious species. We conclude that sex chromosomes evolved after the origin of Silene and within a clade that includes only S. latifolia and its closest relatives. We estimate that sex chromosomes emerged soon after the split with the ancestor of S. viscosa, the probable closest non-dioecious S. latifolia relative among the species included in our study.	[Marais, Gabriel A. B.; Kaefer, Jos; Daubin, Vincent] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Forrest, Alan; Kamau, Esther; Charlesworth, Deborah] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Edinburgh	Marais, GAB (corresponding author), Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	gabriel.marais@univ-lyon1.fr	Käfer, Jos/AAR-1547-2021; Käfer, Jos/E-7714-2017	Käfer, Jos/0000-0002-0561-8008; Käfer, Jos/0000-0002-0561-8008; Daubin, Vincent/0000-0001-8269-9430; Forrest, Alan/0000-0003-2752-4819	Natural Environment Research Council (United Kingdom); Agence National de la Recherche [ANR-08-JCJC-0109]; BBSRC [BB/E020909/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020909/1] Funding Source: researchfish	Natural Environment Research Council (United Kingdom)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Agence National de la Recherche(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DC, AF and EK acknowledge support from Natural Environment Research Council (United Kingdom), and GM and JK from Agence National de la Recherche (grant number ANR-08-JCJC-0109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassov I, 2001, MOL BIOL EVOL, V18, P2162, DOI 10.1093/oxfordjournals.molbev.a003762; Bergero R, 2008, GENETICS, V178, P2045, DOI 10.1534/genetics.107.084566; Bergero R, UNPUB; Bergero R, 2007, GENETICS, V175, P1945, DOI 10.1534/genetics.106.070110; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth B., 1999, SEX DETERMINATION PL, P25; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Criscuolo A, 2006, SYST BIOL, V55, P740, DOI 10.1080/10635150600969872; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Darwin C, 1877, EFFECTS CROSS SELF F; Desfeux C, 1996, CR ACAD SCI III-VIE, V319, P351; Desfeux C, 1996, P ROY SOC B-BIOL SCI, V263, P409, DOI 10.1098/rspb.1996.0062; Dorken ME, 2004, P ROY SOC B-BIOL SCI, V271, P213, DOI 10.1098/rspb.2003.2580; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Eggens F, 2007, AM J BOT, V94, P210, DOI 10.3732/ajb.94.2.210; Erixon P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001386; Erixon P, 2008, MOL PHYLOGENET EVOL, V48, P313, DOI 10.1016/j.ympev.2008.04.015; Filatov DA, 2000, NATURE, V404, P388, DOI 10.1038/35006057; Filatov DA, 2005, GENETICS, V170, P975, DOI 10.1534/genetics.104.037069; Filatov DA, 2002, MOL BIOL EVOL, V19, P898, DOI 10.1093/oxfordjournals.molbev.a004147; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Frajman B, 2007, MOL PHYLOGENET EVOL, V43, P140, DOI 10.1016/j.ympev.2006.11.003; Frajman B, 2009, SYST BIOL, V58, P328, DOI 10.1093/sysbio/syp030; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heilbuth JC, 2000, AM NAT, V156, P221, DOI 10.1086/303389; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jurgens A, 2002, SEX PLANT REPROD, V14, P279, DOI 10.1007/s00497-001-0124-2; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kejnovsky E, 2006, GENETICA, V128, P167, DOI 10.1007/s10709-005-5701-0; Laporte V, 2005, J EVOLUTION BIOL, V18, P337, DOI 10.1111/j.1420-9101.2004.00833.x; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Li GL, 2008, SYST BIOL, V57, P647, DOI 10.1080/10635150802203898; Liden M, 2000, NORD J BOT, V20, P513, DOI 10.1111/j.1756-1051.2000.tb01595.x; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Liu L, 2010, BIOINFORMATICS, V26, P962, DOI 10.1093/bioinformatics/btq062; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Mabberley DJ, 1997, PLANT BOOK; Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023; Markova M, 2007, CHROMOSOME RES, V15, P1051, DOI 10.1007/s10577-007-1180-8; Matsunaga S, 2003, MOL BIOL EVOL, V20, P1062, DOI 10.1093/molbev/msg114; Matsunaga S, 2002, GENOME, V45, P745, DOI 10.1139/G02-026; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Mrackova M, 2008, GENETICS, V179, P1129, DOI 10.1534/genetics.107.085670; Muir G, 2007, GENETICS, V177, P1239, DOI 10.1534/genetics.107.071969; Nicolas M, 2005, PLOS BIOL, V3, P47, DOI 10.1371/journal.pbio.0030004; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; OXELMAN B, 1995, TAXON, V44, P525, DOI 10.2307/1223498; Oxelman B, 2000, NORD J BOT, V20, P743, DOI 10.1111/j.1756-1051.2000.tb00760.x; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Popp M, 2004, SYST BIOL, V53, P914, DOI 10.1080/10635150490888840; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiu S, 2010, P ROY SOC B-BIOL SCI, V277, P3283, DOI 10.1098/rspb.2010.0606; Rannala B, 2003, GENETICS, V164, P1645; Rautenberg A, 2010, MOL PHYLOGENET EVOL, V57, P978, DOI 10.1016/j.ympev.2010.08.003; Rautenberg A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-299; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Renner SS, 2001, SYST BIOL, V50, P700, DOI 10.1080/106351501753328820; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Salisbury BA, 2001, SYST BIOL, V50, P557, DOI 10.1080/106351501750435103; Sloan DB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-260; Spigler RB, 2008, HEREDITY, V101, P507, DOI 10.1038/hdy.2008.100; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Touzet P, 2009, GENETICS, V181, P631, DOI 10.1534/genetics.108.092411; WESTERGAARD M, 1958, ADV GENET, V9, P217, DOI 10.1016/S0065-2660(08)60163-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zluvova J, 2005, EVOL DEV, V7, P327, DOI 10.1111/j.1525-142X.2005.05038.x	75	27	27	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e21915	10.1371/journal.pone.0021915	http://dx.doi.org/10.1371/journal.pone.0021915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853022	gold, Green Published, Green Submitted			2022-12-27	WOS:000295454200003
J	Klein, T; Henn, C; Negri, M; Frotscher, M				Klein, Tobias; Henn, Claudia; Negri, Matthias; Frotscher, Martin			Structural Basis for Species Specific Inhibition of 17 beta-Hydroxysteroid Dehydrogenase Type 1 (17 beta-HSD1): Computational Study and Biological Validation	PLOS ONE			English	Article							SELECTIVE NONSTEROIDAL INHIBITORS; ESTROGEN-DEPENDENT DISEASES; MOLECULAR-DYNAMICS; AROMATASE INHIBITORS; PROTEIN STRUCTURES; ALPHA-HELICES; 3D QSAR; DESIGN; POTENT; DEHYDROGENASE	17 beta-Hydroxysteroid dehydrogenase type 1 (17 beta-HSD1) catalyzes the reduction of estrone to estradiol, which is the most potent estrogen in humans. Inhibition of 17 beta-HSD1 and thereby reducing the intracellular estradiol concentration is thus a promising approach for the treatment of estrogen dependent diseases. In the past, several steroidal and non-steroidal inhibitors of 17 beta-HSD1 have been described but so far there is no cocrystal structure of the latter in complex with 17 beta-HSD1. However, a distinct knowledge of active site topologies and protein-ligand interactions is a prerequisite for structure-based drug design and optimization. An elegant strategy to enhance this knowledge is to compare inhibition values obtained for one compound toward ortholog proteins from various species, which are highly conserved in sequence and differ only in few residues. In this study the inhibitory potencies of selected members of different non-steroidal inhibitor classes toward marmoset 17 beta-HSD1 were determined and the data were compared with the values obtained for the human enzyme. A species specific inhibition profile was observed in the class of the (hydroxyphenyl)naphthols. Using a combination of computational methods, including homology modelling, molecular docking, MD simulation, and binding energy calculation, a reasonable model of the three-dimensional structure of marmoset 17 beta-HSD1 was developed and inhibition data were rationalized on the structural basis. In marmoset 17 beta-HSD1, residues 190 to 196 form a small alpha-helix, which induces conformational changes compared to the human enzyme. The docking poses suggest these conformational changes as determinants for species specificity and energy decomposition analysis highlighted the outstanding role of Asn152 as interaction partner for inhibitor binding. In summary, this strategy of comparing the biological activities of inhibitors toward highly conserved ortholog proteins might be an alternative to laborious x-ray or site-directed mutagenesis experiments in certain cases. Additionally, it facilitates inhibitor design and optimization by offering new information on protein-ligand interactions.	[Klein, Tobias; Henn, Claudia; Negri, Matthias; Frotscher, Martin] Univ Saarland, D-6600 Saarbrucken, Germany; [Klein, Tobias; Henn, Claudia; Negri, Matthias] Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat, Saarbrucken, Germany	Saarland University; Helmholtz Association	Klein, T (corresponding author), Univ Saarland, D-6600 Saarbrucken, Germany.	m.frotscher@mx.uni-saarland.de			Saarland University	Saarland University	The study was founded by financial resources of Saarland University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Azzi A, 1996, NAT STRUCT BIOL, V3, P665, DOI 10.1038/nsb0896-665; Baston E, 2000, EUR J MED CHEM, V35, P931, DOI 10.1016/S0223-5234(00)01167-3; Baston E, 1999, BIOORG MED CHEM LETT, V9, P1601, DOI 10.1016/S0960-894X(99)00234-6; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bey E, 2008, J MED CHEM, V51, P6725, DOI 10.1021/jm8006917; Bey E, 2008, BIOORGAN MED CHEM, V16, P6423, DOI 10.1016/j.bmc.2008.04.073; Bey E, 2009, J MED CHEM, V52, P6724, DOI 10.1021/jm901195w; Brozic P, 2008, CURR MED CHEM, V15, P137; Case D, 2006, AMBER 9; Cavalli A, 2005, J MED CHEM, V48, P7282, DOI 10.1021/jm058042r; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Day JM, 2010, MINERVA ENDOCRINOL, V35, P87; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; DIZEREGA GS, 1980, FERTIL STERIL, V33, P649; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Frotscher MT, 2008, J MED CHEM, V51, P2158, DOI 10.1021/jm701447v; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; Gobbi S, 2006, J MED CHEM, V49, P4777, DOI 10.1021/jm060186y; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karkola S, 2008, CHEMMEDCHEM, V3, P461, DOI 10.1002/cmdc.200700271; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kruchten P, 2009, CR CHIM, V12, P1110, DOI 10.1016/j.crci.2009.05.005; Kruchten P, 2009, MOL CELL ENDOCRINOL, V301, P154, DOI 10.1016/j.mce.2008.09.035; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonetti F, 2004, J MED CHEM, V47, P6792, DOI 10.1021/jm049535j; Lilienkampf A, 2009, J MED CHEM, V52, P6660, DOI 10.1021/jm900928k; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marchais-Oberwinkler S, 2008, J MED CHEM, V51, P4685, DOI 10.1021/jm800367k; Marchais-Oberwinkler S, 2011, J MED CHEM, V54, P534, DOI 10.1021/jm1009082; Marchais-Oberwinkler S, 2009, MOL CELL ENDOCRINOL, V301, P205, DOI 10.1016/j.mce.2008.09.024; MARCHAISOBERWIN.S, 2010, J STEROID BIOCHEM, V125, P66; MAZUMDAR M, MOL BASIS SEX STEROI; Messinger J, 2006, MOL CELL ENDOCRINOL, V248, P192, DOI 10.1016/j.mce.2005.11.044; Messinger J, 2009, MOL CELL ENDOCRINOL, V301, P216, DOI 10.1016/j.mce.2008.10.022; Moller G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010969; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NEGRI M, 2011, J COMPUT AIDED UNPUB; Negri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012026; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oster A, 2011, CHEMMEDCHEM, V6, P476, DOI 10.1002/cmdc.201000457; Oster A, 2010, J MED CHEM, V53, P8176, DOI 10.1021/jm101073q; Oster A, 2010, BIOORGAN MED CHEM, V18, P3494, DOI 10.1016/j.bmc.2010.03.065; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; Picard F, 2002, BIOORGAN MED CHEM, V10, P437, DOI 10.1016/S0968-0896(01)00293-0; Poirier D, 2009, ANTI-CANCER AGENT ME, V9, P642, DOI 10.2174/187152009788680000; Poutanen M, 1995, J STEROID BIOCHEM, V55, P525, DOI 10.1016/0960-0760(95)00201-4; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saloniemi T, 2010, AM J PATHOL, V176, P1443, DOI 10.2353/ajpath.2010.090325; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Travis RC, 2003, BREAST CANCER RES, V5, P239, DOI 10.1186/bcr628; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weiser J, 1999, BIOPOLYMERS, V50, P373, DOI 10.1002/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U; Wetzel M, 2011, BIOORGAN MED CHEM, V19, P807, DOI 10.1016/j.bmc.2010.12.013	65	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22990	10.1371/journal.pone.0022990	http://dx.doi.org/10.1371/journal.pone.0022990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857977	Green Published, gold, Green Submitted			2022-12-27	WOS:000293774300014
J	Chander, H; Halpern, M; Resnick-Silverman, L; Manfredi, JJ; Germain, D				Chander, Harish; Halpern, Max; Resnick-Silverman, Lois; Manfredi, James J.; Germain, Doris			Skp2B Overexpression Alters a Prohibitin-p53 Axis and the Transcription of PAPP-A, the Protease of Insulin-Like Growth Factor Binding Protein 4	PLOS ONE			English	Article							GENE-EXPRESSION; MUTANT P53; EARLY RECURRENCE; GADD45 GENE; WILD-TYPE; GAIN; IGF; ACTIVATION; MECHANISM; CHAPERONE	Background: We previously reported that the degradation of prohibitin by the SCFSkp2B ubiquitin ligase results in a defect in the activity of p53. We also reported that MMTV-Skp2B transgenic mice develop mammary gland tumors that are characterized by an increased proteolytic cleavage of the insulin-like growth factor binding protein 4 (IGFBP-4), an inhibitor of IGF signaling. However, whether a link exists between a defect in p53 activity and proteolysis of IGFBP-4 was not established. Methods and Results: We analyzed the levels of pregnancy-associated plasma protein A (PAPP-A), the protease of IGFBP-4, in MMTV-Skp2B transgenic mice and found that PAPP-A levels are elevated. Further, we found a p53 binding site in intron 1 of the PAPP-A gene and that both wild type and mutant p53 bind to this site. However, binding of wild type p53 results in the transcriptional repression of PAPP-A, while binding of mutant p53 results in the transcriptional activation of PAPP-A. Since MMTV-Skp2B mice express wild type p53 and yet show elevated levels of PAPP-A, at first, these observations appeared contradictory. However, further analysis revealed that the defect in p53 activity in Skp2B overexpressing cells does not only abolish the activity of wild type of p53 but actually mimics that of mutant p53. Our results suggest that in absence of prohibitin, the half-life of p53 is increased and like mutant p53, the conformation of p53 is denatured. Conclusions: These observations revealed a novel function of prohibitin as a chaperone of p53. Further, they suggest that binding of denatured p53 in intron 1 causes an enhancer effect and increases the transcription of PAPP-A. Therefore, these findings indicate that the defect in p53 function and the increased proteolysis of IGFBP-4, we had observed, represent two components of the same pathway, which contributes to the oncogenic function of Skp2B.	[Chander, Harish; Halpern, Max; Germain, Doris] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA; [Resnick-Silverman, Lois; Manfredi, James J.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chander, H (corresponding author), Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, New York, NY 10029 USA.	doris.germain@mssm.edu			NIH [CA109482, CA086001]; NATIONAL CANCER INSTITUTE [R01CA086001, R01CA109482] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by an NIH RO1 grant # CA109482 to D.G. and by an NIH R01 grant # CA086001 to J.M. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Bulut I, 2009, AM J MED SCI, V337, P241, DOI 10.1097/MAJ.0b013e31818967a3; Butler JS, 2006, PROTEIN SCI, V15, P2457, DOI 10.1110/ps.062324206; Chander H, 2010, EMBO REP, V11, P220, DOI 10.1038/embor.2010.2; Chin PL, 1997, ONCOGENE, V15, P87, DOI 10.1038/sj.onc.1201161; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Graunke DM, 1999, NUCLEIC ACIDS RES, V27, P3881, DOI 10.1093/nar/27.19.3881; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Janus F, 1999, MOL CELL BIOL, V19, P2155; Kobayashi S, 2008, BREAST CANCER-TOKYO, V15, P153, DOI 10.1007/s12282-008-0034-3; KUHAJDA FP, 1985, AM J PATHOL, V121, P342; KUHAJDA FP, 1985, LAB INVEST, V53, P101; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIN TM, 1974, AM J OBSTET GYNECOL, V118, P223, DOI 10.1016/0002-9378(74)90553-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshman E, 2002, BREAST CANCER RES, V4, P231, DOI 10.1186/bcr535; Mussi P, 2006, P NATL ACAD SCI USA, V103, P16716, DOI 10.1073/pnas.0607768103; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Pugacheva EN, 2002, ONCOGENE, V21, P4595, DOI 10.1038/sj.onc.1205704; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tanaka Y, 2004, INT J CANCER, V109, P336, DOI 10.1002/ijc.11700; Umanskaya K, 2007, MOL CELL BIOL, V27, P7615, DOI 10.1128/MCB.01239-07; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Yang XL, 1999, ONCOGENE, V18, P4546, DOI 10.1038/sj.onc.1202843; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724	35	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22456	10.1371/journal.pone.0022456	http://dx.doi.org/10.1371/journal.pone.0022456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829624	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200019
J	Yip, WK; Cheng, ASL; Zhu, RX; Lung, RWM; Tsang, DPF; Lau, SSK; Chen, YC; Sung, JG; Lai, PBS; Ng, EKO; Yu, J; Wong, N; To, KF; Wong, VWS; Sung, JJY; Chan, HLY				Yip, Wing-Kit; Cheng, Alfred Sze-Lok; Zhu, Ranxu; Lung, Raymond Wai-Ming; Tsang, Daisy Pui-Fong; Lau, Suki Shuk-Kei; Chen, Yangchao; Sung, Jonathan Gabriel; Lai, Paul Bo-San; Enders Kai-On Ng; Yu, Jun; Wong, Nathalie; To, Ka-Fai; Wong, Vincent Wai-Sun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen			Carboxyl-Terminal Truncated HBx Regulates a Distinct MicroRNA Transcription Program in Hepatocellular Carcinoma Development	PLOS ONE			English	Article							VIRUS-X PROTEIN; HEPATITIS-B; UP-REGULATION; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; DOWN-REGULATION; INCREASED RISK; LIVER-CANCER; EXPRESSION; GROWTH	Background: The biological pathways and functional properties by which misexpressed microRNAs (miRNAs) contribute to liver carcinogenesis have been intensively investigated. However, little is known about the upstream mechanisms that deregulate miRNA expressions in this process. In hepatocellular carcinoma (HCC), hepatitis B virus (HBV) X protein (HBx), a transcriptional trans-activator, is frequently expressed in truncated form without carboxyl-terminus but its role in miRNA expression and HCC development is unclear. Methods: Human non-tumorigenic hepatocytes were infected with lentivirus-expressing full-length and carboxyl-terminal truncated HBx (Ct-HBx) for cell growth assay and miRNA profiling. Chromatin immunoprecipitation microarray was performed to identify the miRNA promoters directly associated with HBx. Direct transcriptional control was verified by luciferase reporter assay. The differential miRNA expressions were further validated in a cohort of HBV-associated HCC tissues using real-time PCR. Results: Hepatocytes expressing Ct-HBx grew significantly faster than the full-length HBx counterparts. Ct-HBx decreased while full-length HBx increased the expression of a set of miRNAs with growth-suppressive functions. Interestingly, Ct-HBx bound to and inhibited the transcriptional activity of some of these miRNA promoters. Notably, some of the examined repressed-miRNAs (miR-26a, -29c, -146a and -190) were also significantly down-regulated in a subset of HCC tissues with carboxyl-terminal HBx truncation compared to their matching non-tumor tissues, highlighting the clinical relevance of our data. Conclusion: Our results suggest that Ct-HBx directly regulates miRNA transcription and in turn promotes hepatocellular proliferation, thus revealing a viral contribution of miRNA deregulation during hepatocarcinogenesis.	[Yip, Wing-Kit; Cheng, Alfred Sze-Lok; Zhu, Ranxu; Tsang, Daisy Pui-Fong; Lau, Suki Shuk-Kei; Sung, Jonathan Gabriel; Lai, Paul Bo-San; Enders Kai-On Ng; Yu, Jun; To, Ka-Fai; Wong, Vincent Wai-Sun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China; [Yip, Wing-Kit; Zhu, Ranxu; Tsang, Daisy Pui-Fong; Chen, Yangchao; Sung, Jonathan Gabriel; Yu, Jun; Wong, Vincent Wai-Sun; Sung, Joseph Jao-Yiu; Chan, Henry Lik-Yuen] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Lung, Raymond Wai-Ming; Wong, Nathalie; To, Ka-Fai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China; [Lai, Paul Bo-San] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Yip, WK (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China.	alfredcheng@cuhk.edu.hk	Chen, Yangchao/AAG-2127-2019; Ng, Enders/T-3881-2019; Cheng, Alfred SL/C-3327-2014; Sung, Joseph J. Y./R-3203-2018; Yu, Jun/D-8569-2015; Wong, Vincent WS/K-3864-2014; Ng, Enders K.O./F-2787-2010; LUNG, Raymond Wai-ming/D-1274-2014; Lai, Paul BS/K-8556-2015; Raymond, Lung/G-3200-2011; Sung, Jonathan/ABB-9563-2021; Chan, Henry Lik-Yuen/B-9636-2008	Chen, Yangchao/0000-0002-0249-3414; Ng, Enders/0000-0002-6955-0030; Cheng, Alfred SL/0000-0003-2345-6951; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153; Wong, Vincent WS/0000-0003-2215-9410; Ng, Enders K.O./0000-0002-6955-0030; LUNG, Raymond Wai-ming/0000-0002-0813-7429; Lai, Paul BS/0000-0002-9469-6728; Raymond, Lung/0000-0002-0813-7429; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Ng, Enders Kai-on/0000-0002-5293-3529	Hong Kong Government [08070332, 09080042]; Research Grants Council [09/060/GRF, 462309]; Collaborative Research Fund [CUHK04/CRF/08]	Hong Kong Government; Research Grants Council(Hong Kong Research Grants Council); Collaborative Research Fund	This work was supported by grants from the Hong Kong Government Research Fund for the Control of Infectious Diseases (08070332) to AS-LC, JJ-YS and HL-YC; (09080042) to AS-LC and JJ-YS; from the Research Grants Council General Research Fund (09/060/GRF and 462309) to AS-LC and JJ-YS; and from the Collaborative Research Fund (CUHK04/CRF/08) to AS-LC, NW and K-FT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI K, 1990, JPN J CANCER RES, V81, P1265, DOI 10.1111/j.1349-7006.1990.tb02689.x; Bock CT, 2008, INTERVIROLOGY, V51, P432, DOI 10.1159/000209672; Braconi C, 2010, CLIN CANCER RES, V16, P957, DOI 10.1158/1078-0432.CCR-09-2123; Brown JJ, 2000, HEPATOLOGY, V31, P173, DOI 10.1002/hep.510310126; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chan HLY, 2006, SEMIN LIVER DIS, V26, P153, DOI 10.1055/s-2006-939753; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen YC, 2007, HEPATOLOGY, V46, P200, DOI 10.1002/hep.21668; Cheng ASL, 2008, BIOCHEM BIOPH RES CO, V374, P175, DOI 10.1016/j.bbrc.2008.06.098; Cheng ASL, 2007, CANCER LETT, V253, P43, DOI 10.1016/j.canlet.2007.01.004; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Cheng ASL, 2004, MODERN PATHOL, V17, P1169, DOI 10.1038/modpathol.3800196; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Cheng B, 2010, LIVER INT, V30, P319, DOI 10.1111/j.1478-3231.2009.02167.x; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Diao JY, 2001, J BIOL CHEM, V276, P8328, DOI 10.1074/jbc.M006026200; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; Fabbri M, 2008, CURR OPIN INVEST DR, V9, P583; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Feitelson MA, 1997, AM J PATHOL, V150, P1141; Han JQ, 2006, NUCLEIC ACIDS RES, V34, P3095, DOI 10.1093/nar/gkl389; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Iavarone M, 2003, J HEPATOL, V39, P253, DOI 10.1016/S0168-8278(03)00217-4; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Lee ATC, 2005, J BIOL CHEM, V280, P33525, DOI 10.1074/jbc.M506628200; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; MA YL, 2010, J CELL MOL IN PRESS; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; QADRI I, 1995, P NATL ACAD SCI USA, V92, P1003, DOI 10.1073/pnas.92.4.1003; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Sirma H, 1999, ONCOGENE, V18, P4848, DOI 10.1038/sj.onc.1202867; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Su JM, 2007, HEPATOLOGY, V46, P402, DOI 10.1002/hep.21675; Sung JJY, 2008, J VIROL, V82, P3604, DOI 10.1128/JVI.01197-07; Sung WK, 2009, J BIOL CHEM, V284, P21941, DOI 10.1074/jbc.M109.014563; Tsang DPF, 2011, J GASTROEN HEPATOL, V26, P19, DOI 10.1111/j.1440-1746.2010.06447.x; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Tu H, 2001, CANCER RES, V61, P7803; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893	68	64	67	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22888	10.1371/journal.pone.0022888	http://dx.doi.org/10.1371/journal.pone.0022888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829663	gold, Green Published, Green Submitted			2022-12-27	WOS:000293561200034
J	Preston, CM; Harris, A; Ryan, JP; Roman, B; Marin, R; Jensen, S; Everlove, C; Birch, J; Dzenitis, JM; Pargett, D; Adachi, M; Turk, K; Zehr, JP; Scholin, CA				Preston, Christina M.; Harris, Adeline; Ryan, John P.; Roman, Brent; Marin, Roman, III; Jensen, Scott; Everlove, Cheri; Birch, James; Dzenitis, John M.; Pargett, Douglas; Adachi, Masao; Turk, Kendra; Zehr, Jonathon P.; Scholin, Christopher A.			Underwater Application of Quantitative PCR on an Ocean Mooring	PLOS ONE			English	Article							AUTOMATED DNA PURIFICATION; RNA-TARGETED PROBES; RIBOSOMAL-RNA; MARINE BACTERIOPLANKTON; AUTONOMOUS DETECTION; MOLECULAR-DETECTION; HARMFUL ALGAE; MONTEREY BAY; REAL-TIME; ARCHAEAL	The Environmental Sample Processor (ESP) is a device that allows for the underwater, autonomous application of DNA and protein probe array technologies as a means to remotely identify and quantify, in situ, marine microorganisms and substances they produce. Here, we added functionality to the ESP through the development and incorporation of a module capable of solid-phase nucleic acid extraction and quantitative PCR (qPCR). Samples collected by the instrument were homogenized in a chaotropic buffer compatible with direct detection of ribosomal RNA (rRNA) and nucleic acid purification. From a single sample, both an rRNA community profile and select gene abundances were ascertained. To illustrate this functionality, we focused on bacterioplankton commonly found along the central coast of California and that are known to vary in accordance with different oceanic conditions. DNA probe arrays targeting rRNA revealed the presence of 16S rRNA indicative of marine crenarchaea, SAR11 and marine cyanobacteria; in parallel, qPCR was used to detect 16S rRNA genes from the former two groups and the large subunit RuBisCo gene (rbcL) from Synecchococcus. The PCR-enabled ESP was deployed on a coastal mooring in Monterey Bay for 28 days during the spring-summer upwelling season. The distributions of the targeted bacterioplankon groups were as expected, with the exception of an increase in abundance of marine crenarchaea in anomalous nitrate-rich, low-salinity waters. The unexpected co-occurrence demonstrated the utility of the ESP in detecting novel events relative to previously described distributions of particular bacterioplankton groups. The ESP can easily be configured to detect and enumerate genes and gene products from a wide range of organisms. This study demonstrated for the first time that gene abundances could be assessed autonomously, underwater in near real-time and referenced against prevailing chemical, physical and bulk biological conditions.	[Preston, Christina M.; Harris, Adeline; Ryan, John P.; Roman, Brent; Marin, Roman, III; Jensen, Scott; Everlove, Cheri; Birch, James; Pargett, Douglas; Scholin, Christopher A.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Dzenitis, John M.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Adachi, Masao] Kochi Univ, Lab Aquat Environm Sci, Kochi 780, Japan; [Turk, Kendra; Zehr, Jonathon P.] Univ Calif Santa Cruz, Dept Ocean Sci & Earth & Marine Sci, Santa Cruz, CA 95064 USA	Monterey Bay Aquarium Research Institute; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Kochi University; University of California System; University of California Santa Cruz	Preston, CM (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	preston@mbari.org	Zehr, Jonathan P/B-3513-2014	Zehr, Jonathan P/0000-0002-5691-5408; Ryan, John Phillip/0000-0001-7954-5369	David and Lucille Packard Foundation; MBARI; NSF [OCE-0314222, EF-0424599]; Gordon and Betty Moore Foundation [ERG731]; NASA Astrobiology [NNG06GB34G, NNX09AB78G]; Microbial Environmental, Genomics, Application, Modeling, Experimental, Remote sensing (MEGAMER) facility	David and Lucille Packard Foundation(The David & Lucile Packard Foundation); MBARI; NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA Astrobiology; Microbial Environmental, Genomics, Application, Modeling, Experimental, Remote sensing (MEGAMER) facility	This work was supported in part by grants from the David and Lucille Packard Foundation allocated by the MBARI (CAS), NSF (OCE-0314222 and EF-0424599 to CAS) Gordon and Betty Moore Foundation (JPZ and ERG731 to CAS), NASA Astrobiology (NNG06GB34G and NNX09AB78G to CAS), and Microbial Environmental, Genomics, Application, Modeling, Experimental, Remote sensing (MEGAMER) facility (JPZ). No additional external funding was received for this study. This is LLNL manuscript number LLNL-JRNL-480573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors CE, 2006, CLIN CHIM ACTA, V365, P78, DOI 10.1016/j.cca.2005.07.030; Belgrader P, 2003, ANAL CHEM, V75, P3446, DOI 10.1021/ac034062u; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; Bruckner-Lea CJ, 2002, ANAL CHIM ACTA, V469, P129, DOI 10.1016/S0003-2670(01)01438-6; Casper ET, 2007, HARMFUL ALGAE, V6, P112, DOI 10.1016/j.hal.2006.11.001; Chandler DP, 2004, APPL ENVIRON MICROB, V70, P2621, DOI 10.1128/AEM.70.5.2621-2631.2004; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; DeLong EF, 2009, NATURE, V459, P200, DOI 10.1038/nature08059; Dong LF, 2009, APPL ENVIRON MICROB, V75, P3171, DOI 10.1128/AEM.02511-08; Doucette GJ, 2009, HARMFUL ALGAE, V8, P880, DOI 10.1016/j.hal.2009.04.006; Fasham MJR, 2001, AMBIO, P4; Fukuba T, 2004, CHEM ENG J, V101, P151, DOI 10.1016/j.cej.2003.11.016; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Goffredi SK, 2006, MAR BIOTECHNOL, V8, P149, DOI 10.1007/s10126-005-5016-2; Greenfield DI, 2006, LIMNOL OCEANOGR-METH, V4, P426, DOI 10.4319/lom.2006.4.426; Greenfield DI, 2008, LIMNOL OCEANOGR-METH, V6, P667, DOI 10.4319/lom.2008.6.667; Haywood AJ, 2007, J PHYCOL, V43, P1271, DOI 10.1111/j.1529-8817.2007.00407.x; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Hindson BJ, 2008, ANALYST, V133, P248, DOI 10.1039/b713332d; Hindson BJ, 2004, ANAL CHEM, V76, P3492, DOI 10.1021/ac035365r; Hindson BJ, 2005, ANAL CHEM, V77, P284, DOI 10.1021/ac0489014; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Jones WJ, 2008, MOL ECOL RESOUR, V8, P540, DOI 10.1111/j.1471-8286.2007.02021.x; Karl DM, 2002, TRENDS MICROBIOL, V10, P410, DOI 10.1016/S0966-842X(02)02430-7; Karl DM., 2001, OCEANOGRAPHY, V14, P6, DOI [10.5670/oceanog.2001.02, DOI 10.5670/0CEAN0G.2001.02]; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; LaGier MJ, 2007, MAR POLLUT BULL, V54, P757, DOI 10.1016/j.marpolbul.2006.12.017; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Ottesen EA, 2011, ISME J; Paerl R.W., ENV MICROBI IN PRESS; Paerl RW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00059; Paul J, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.50; Preston CM, 2009, ENVIRON MICROBIOL, V11, P1168, DOI 10.1111/j.1462-2920.2009.01848.x; Regan JF, 2008, ANAL CHEM, V80, P7422, DOI 10.1021/ac801125x; Roman B, 2005, OCEANS 2005 MTS IEEE, P1; Roman B, 2007, J AM LAB AUTOM, V12, P56, DOI DOI 10.1016/J.JALA.2006.07.013; Rowan AK, 2005, APPL ENVIRON MICROB, V71, P8481, DOI 10.1128/AEM.71.12.8481-8490.2005; Ruzicka J, 1990, ANAL CHIM ACTA, V237, P39; Ryan J, 2011, LIMNOL OCEANOGR, V56, P1255, DOI 10.4319/lo.2011.56.4.1255; Ryan JP, 2010, LIMNOL OCEANOGR-METH, V8, P394, DOI 10.4319/lom.2010.8.394; Ryan JP, 2010, CONT SHELF RES, V30, P7, DOI 10.1016/j.csr.2009.10.017; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Scholin CA, 2010, OCEAN SCI, V6, P51, DOI 10.5194/os-6-51-2010; Scholin C. A., 2001, US patent, Patent No. 6187530; Scholin C.A., 2008, PROSPECTS DEV AUTOMA, P413; Scholin CA, 1998, DEV APPL MOL PROBES, P367; Scholin C, 2009, OCEANOGRAPHY, V22, P158, DOI 10.5670/oceanog.2009.46; Short SM, 2005, METHOD ENZYMOL, V397, P380, DOI 10.1016/S0076-6879(05)97023-7; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Straub TM, 2005, J MICROBIOL METH, V62, P303, DOI 10.1016/j.mimet.2005.04.012; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Suzuki MT, 2001, AQUAT MICROB ECOL, V24, P117, DOI 10.3354/ame024117; Tyrrell JV, 2001, PHYCOLOGIA, V40, P457, DOI 10.2216/i0031-8884-40-5-457.1; Whitman RL, 2010, ENVIRON SCI TECHNOL, V44, P5049, DOI 10.1021/es9028974; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Zehr JP, 2009, OCEAN SCI, V5, P101, DOI 10.5194/os-5-101-2009	58	64	66	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22522	10.1371/journal.pone.0022522	http://dx.doi.org/10.1371/journal.pone.0022522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829630	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511200011
J	Malik, A; Korol, A; Hubner, S; Hernandez, AG; Thimmapuram, J; Ali, S; Glaser, F; Paz, A; Avivi, A; Band, M				Malik, Assaf; Korol, Abraham; Huebner, Sariel; Hernandez, Alvaro G.; Thimmapuram, Jyothi; Ali, Shahjahan; Glaser, Fabian; Paz, Arnon; Avivi, Aaron; Band, Mark			Transcriptome Sequencing of the Blind Subterranean Mole Rat, Spalax galili: Utility and Potential for the Discovery of Novel Evolutionary Patterns	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; HEART-RATE; EHRENBERGI; HYPOXIA; TOLERANCE; EXPRESSION; SYSTEM; GROWTH; GENES; IDENTIFICATION	The blind subterranean mole rat (Spalax ehrenbergi superspecies) is a model animal for survival under extreme environments due to its ability to live in underground habitats under severe hypoxic stress and darkness. Here we report the transcriptome sequencing of Spalax galili, a chromosomal type of S. ehrenbergi. cDNA pools from muscle and brain tissues isolated from animals exposed to hypoxic and normoxic conditions were sequenced using Sanger, GS FLX, and GS FLX Titanium technologies. Assembly of the sequences yielded over 51,000 isotigs with homology to similar to 12,000 mouse, rat or human genes. Based on these results, it was possible to detect large numbers of splice variants, SNPs, and novel transcribed regions. In addition, multiple differential expression patterns were detected between tissues and treatments. The results presented here will serve as a valuable resource for future studies aimed at identifying genes and gene regions evolved during the adaptive radiation associated with underground life of the blind mole rat.	[Malik, Assaf; Korol, Abraham; Huebner, Sariel; Avivi, Aaron] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Hernandez, Alvaro G.; Thimmapuram, Jyothi; Ali, Shahjahan; Band, Mark] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL 61801 USA; [Glaser, Fabian] Technion Israel Inst Technol, Bioinformat Knowledge Unit, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Haifa, Israel; [Paz, Arnon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	University of Haifa; University of Illinois System; University of Illinois Urbana-Champaign; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine	Malik, A (corresponding author), Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel.	aaron@research.haifa.ac.il; markband@illinois.edu			United States-Israel Binational Scientific Foundation (BSF) [2005346]	United States-Israel Binational Scientific Foundation (BSF)(US-Israel Binational Science Foundation)	This study was supported by grant no. 2005346 from The United States-Israel Binational Scientific Foundation (BSF), www.bsf.org.il, to Aaron Avivi, Mark Band and Alvaro Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARIELI R, 1981, PHYSIOL ZOOL, V54, P14, DOI 10.1086/physzool.54.1.30155800; ARIELI R, 1991, COMP BIOCHEM PHYS A, V100, P543, DOI 10.1016/0300-9629(91)90367-L; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Avivi A, 2007, ONCOGENE, V26, P2507, DOI 10.1038/sj.onc.1210045; Avivi A, 2005, FASEB J, V19, P1314, DOI 10.1096/fj.04-3414fje; Avivi A, 2002, P NATL ACAD SCI USA, V99, P11718, DOI 10.1073/pnas.182423299; Avivi A, 2001, P NATL ACAD SCI USA, V98, P13751, DOI 10.1073/pnas.181484498; Avivi A, 1999, FEBS LETT, V452, P133, DOI 10.1016/S0014-5793(99)00584-0; Avivi A, 2010, P NATL ACAD SCI US; Avivi A, 2006, PHYSIOL GENOMICS, V27, P54, DOI 10.1152/physiolgenomics.00001.2006; Band M, 2010, J MOL EVOL, V70, P1, DOI 10.1007/s00239-009-9306-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENSHLOMO R, 1995, BEHAV GENET, V25, P239, DOI 10.1007/BF02197182; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; Catania KC, 2002, P NATL ACAD SCI USA, V99, P5692, DOI 10.1073/pnas.072097999; Chuang CK, 2010, NAT STRUCT MOL BIOL, V17, P990, DOI 10.1038/nsmb.1870; COOPER HM, 1993, NATURE, V361, P156, DOI 10.1038/361156a0; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Frahm HD, 1997, J BRAIN RES, V38, P209; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gerlach F, 2006, ISR J ECOL EVOL, V52, P389, DOI 10.1560/IJEE_52_3-4_389; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GURNETT AM, 1984, J PROTEIN CHEM, V3, P445, DOI 10.1007/BF01025063; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hough RB, 2002, P NATL ACAD SCI USA, V99, P8145, DOI 10.1073/pnas.122231099; Jubb AM, 2004, J CLIN PATHOL, V57, P504, DOI 10.1136/jcp.2003.012963; Jubb AM, 2003, J PATHOL, V200, P577, DOI 10.1002/path.1371; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KLEINSCHMIDT T, 1984, H-S Z PHYSIOL CHEM, V365, P531, DOI 10.1515/bchm2.1984.365.1.531; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Mark B, 2010, CELL CYCLE, V9, P3347, DOI 10.4161/cc.9.16.12712; Marks Jeremy D., 2009, P3, DOI 10.1007/978-1-60327-579-8_1; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Nasser NJ, 2009, P NATL ACAD SCI USA, V106, P2253, DOI 10.1073/pnas.0812846106; Nasser NJ, 2005, P NATL ACAD SCI USA, V102, P15161, DOI 10.1073/pnas.0507279102; NECKER R, 1992, NEUROREPORT, V3, P505, DOI 10.1097/00001756-199206000-00012; Nevo, 1999, MOSAIC EVOLUTION SUB; NEVO E, 1989, HEREDITY, V62, P85, DOI 10.1038/hdy.1989.11; NEVO E., 2001, ADAPTIVE RAD BLIND S; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shams I, 2005, COMP BIOCHEM PHYS A, V142, P376, DOI 10.1016/j.cbpa.2005.09.003; Shams I, 2004, P NATL ACAD SCI USA, V101, P9698, DOI 10.1073/pnas.0403540101; Shams Imad, 2005, FASEB J, V19, P307; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STORIER D, 1981, J COMP PHYSIOL, V142, P533, DOI 10.1007/BF00688986; Takahashi H, 2007, NEURON, V53, P53, DOI 10.1016/j.neuron.2006.11.023; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wetterbom A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r78; Widmer HR, 1997, P NATL ACAD SCI USA, V94, P2062, DOI 10.1073/pnas.94.5.2062	63	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e21227	10.1371/journal.pone.0021227	http://dx.doi.org/10.1371/journal.pone.0021227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857902	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500001
J	Zare, H; Kaveh, M; Khodursky, A				Zare, Hossein; Kaveh, Mostafa; Khodursky, Arkady			Inferring a Transcriptional Regulatory Network from Gene Expression Data Using Nonlinear Manifold Embedding	PLOS ONE			English	Article							RECONSTRUCTION; MICROARRAY	Transcriptional networks consist of multiple regulatory layers corresponding to the activity of global regulators, specialized repressors and activators as well as proteins and enzymes shaping the DNA template. Such intrinsic complexity makes uncovering connections difficult and it calls for corresponding methodologies, which are adapted to the available data. Here we present a new computational method that predicts interactions between transcription factors and target genes using compendia of microarray gene expression data and documented interactions between genes and transcription factors. The proposed method, called Kernel Embedding of Regulatory Networks (KEREN), is based on the concept of generegulon association, and captures hidden geometric patterns of the network via manifold embedding. We applied KEREN to reconstruct transcription regulatory interactions on a genome-wide scale in the model bacteria Escherichia coli (E. coli). Application of the method not only yielded accurate predictions of verifiable interactions, which outperformed on certain metrics comparable methodologies, but also demonstrated the utility of a geometric approach in the analysis of highdimensional biological data. We also described possible applications of kernel embedding techniques to other function and network discovery algorithms.	[Zare, Hossein] NIH, Bethesda, MD 20892 USA; [Kaveh, Mostafa] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN USA; [Khodursky, Arkady] Univ Minnesota, Dept Biochem Biophys & Mol Biol, St Paul, MN 55108 USA	National Institutes of Health (NIH) - USA; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zare, H (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	khodu001@umn.edu	zare, hossein/ABB-5871-2021					Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Belkin M., 2002, ADV NEURAL INFORM PR, V14; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Butte AJ, 2002, PAC S BIOC, P418; Chen G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r4; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Ernst J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000044; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Ham J, 2004, P 21 INT C MACH LEAR, P69; Kim S, 2004, BIOSYSTEMS, V75, P57, DOI 10.1016/j.biosystems.2004.03.004; Lemmens K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r37; Lerman G, 2007, P NATL ACAD SCI USA, V104, P11334, DOI 10.1073/pnas.0702965104; Li H, 2008, BIOINFORMATICS, V24, P1874, DOI 10.1093/bioinformatics/btn332; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; Scholkopf B, KERNEL METHODS COMPU; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Thomas MC, 2006, ELEMENTS INFORM THEO; Zare H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-39	26	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e21969	10.1371/journal.pone.0021969	http://dx.doi.org/10.1371/journal.pone.0021969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857910	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953500002
J	Zhang, Y; van Deursen, J; Galardy, PJ				Zhang, Ying; van Deursen, Jan; Galardy, Paul J.			Overexpression of Ubiquitin Specific Protease 44 (USP44) Induces Chromosomal Instability and Is Frequently Observed in Human T-Cell Leukemia	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; SPINDLE-ASSEMBLY CHECKPOINT; AGING-ASSOCIATED PHENOTYPES; MITOTIC CHECKPOINT; SECURIN DEGRADATION; TUMOR-SUPPRESSOR; ANEUPLOIDY; BUBR1; TUMORIGENESIS; DRIVES	Cdc20-anaphase promoting complex/cyclosome (Cdc20-APC/C) E3 ubiquitin ligase activity is essential for orderly mitotic progression. The deubiqituinase USP44 was identified as a key regulator of APC/C and has been proposed to suppress Cdc20-APC/C activity by maintaining its association with the inhibitory protein Mad2 until all chromosomes are properly attached to the mitotic spindle. However, this notion has been challenged by data in which a lysine-less mutant of Cdc20 leads to premature anaphase, suggesting that it's ubiquitination is not required for APC/C activation. To further evaluate its role in checkpoint function and chromosome instability, we studied the consequences of over-expression of mouse Usp44 in non-transformed murine embryonic fibroblasts. Here we show that cells with high Usp44 are prone to chromosome segregation errors and aneuploidization. We find that high Usp44 promotes association of Mad2 with Cdc20 and reinforces the mitotic checkpoint. Surprisingly, the APC/C-Cdc20 substrate cyclin B1 is stabilized in G2 when Usp44 is over-expressed, but is degraded with normal kinetics once cells enter mitosis. Furthermore, we show that USP44 expression is elevated in subset of T-cell leukemias. These data are consistent with an important role for USP44 in regulating Cdc20-APC/C activity and suggest that high levels of this enzyme may contribute to the pathogenesis of T-ALL.	[Zhang, Ying; van Deursen, Jan; Galardy, Paul J.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Zhang, Ying; van Deursen, Jan; Galardy, Paul J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Zhang, Y (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	Galardy.paul@mayo.edu	Galardy, Paul/AAE-9297-2019		Howard Hughes Medical Institute; Mayo Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mayo Foundation	P.J.G. received funds for this work from the Howard Hughes Medical Institute Physician-Scientist Early Career Award (www.hhmi.org) and the Mayo Foundation (www.MayoClinic.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baker DJ, 2006, J CELL BIOL, V172, P529, DOI 10.1083/jcb.200507081; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan KL, 2009, CELL CYCLE, V8, P3065, DOI 10.4161/cc.8.19.9513; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; De Keersmaecker K, 2010, NAT MED, V16, P1321, DOI 10.1038/nm.2246; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Izawa D, 2011, NAT CELL BIOL, V13, P633, DOI 10.1038/ncb0511-633a; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Sofueva S, 2011, NUCLEIC ACIDS RES, V39, P6568, DOI 10.1093/nar/gkr340; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suresh B, 2010, CELL BIOL INT, V34, P799, DOI 10.1042/CBI20090144; Taylor SS, 2001, J CELL SCI, V114, P4385; TODARO GJ, 1966, P NATL ACAD SCI USA, V55, P302, DOI 10.1073/pnas.55.2.302; van Ree JH, 2010, J CELL BIOL, V188, P83, DOI 10.1083/jcb.200906147; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	40	43	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23389	10.1371/journal.pone.0023389	http://dx.doi.org/10.1371/journal.pone.0023389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853124	Green Published, gold, Green Submitted			2022-12-27	WOS:000293953400043
J	Furtbauer, I; Heistermann, M; Schulke, O; Ostner, J				Fuertbauer, Ines; Heistermann, Michael; Schuelke, Oliver; Ostner, Julia			Concealed Fertility and Extended Female Sexuality in a Non-Human Primate (Macaca assamensis)	PLOS ONE			English	Article							OVARIAN CYCLE PHASE; MATE CHOICE; COPULATION CALLS; MULTIPLE MALES; MACAQUES; EVOLUTION; PATERNITY; PROMISCUITY; SWELLINGS; BEHAVIOR	In numerous primates living in mixed-sex groups, females display probabilistic cues of fertility to simultaneously concentrate paternity to dominant males while diluting it amongst others as a means to reduce the risk of infanticide and to increase male care for offspring. A few species, however, lack these cues and potentially conceal fertility from males; yet, to date, little is known about mating patterns and their underlying proximate mechanisms in such species. Here, we investigated mating activity and sexual consortships relative to female reproductive state in wild Assamese macaques (Macaca assamensis), a species where females lack prominent anogenital swellings and copulation calls. During two mating seasons (2837 contact hours) we recorded sexual and social behaviors, sexual consortships, and collected 1178 fecal samples (n = 15 females) which were analyzed for progestogen concentrations to assess female reproductive state and to determine the timing of ovulation and conception. Although mostly conceiving in their first ovarian cycle, females were sexually receptive throughout the entire 4-month mating season, and within-cycle mating frequencies were not increased during fertile phases. Dominant males did not monopolize fertile matings, and consortships by high-ranking males lasted for long periods, which were not exclusively linked to female fertile phases. Furthermore, females copulated promiscuously but not randomly, i.e. for almost every female, matings were concentrated to a certain male, irrespective of male rank. Collectively, we demonstrate that fertility is undisclosed to males. The extreme extended female sexuality facilitated by concealed fertility may allow females to create differentiated mating relationships within a promiscuous mating system. Our study provides important new insight into the plasticity of female sexuality in non-human primates.	[Fuertbauer, Ines; Ostner, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Gottingen, Germany; [Fuertbauer, Ines; Heistermann, Michael] German Primate Ctr, Reprod Biol Unit, Gottingen, Germany; [Fuertbauer, Ines; Schuelke, Oliver; Ostner, Julia] Max Planck Inst Evolutionary Anthropol, Integrat Primate Socioecol Grp, Leipzig, Germany	University of Gottingen; Deutsches Primatenzentrum (DPZ); Max Planck Society	Furtbauer, I (corresponding author), Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Gottingen, Germany.	ifuertb@uni-goettingen.de		Furtbauer, Ines/0000-0003-1404-6280	Max Planck Society for the Advancement of Science; German Initiative of Excellence	Max Planck Society for the Advancement of Science(Max Planck Society); German Initiative of Excellence	The study was supported by funds from the Max Planck Society for the Advancement of Science to Julia Ostner used to conduct the experiments and from the German Initiative of Excellence to Georg August University Gottingen for data analyses and writing of the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDELMAN SJ, 1987, AM NAT, V129, P785, DOI 10.1086/284675; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BEHBOODI E, 1991, J MED PRIMATOL, V20, P229; Borries C, 1999, BEHAV ECOL SOCIOBIOL, V46, P350, DOI 10.1007/s002650050629; Borries C., 2002, Natural History Bulletin of the Siam Society, V50, P75; Brauch K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1453, DOI 10.1007/s00265-008-0575-7; Brauch K, 2007, HORM BEHAV, V52, P375, DOI 10.1016/j.yhbeh.2007.06.001; BURT A, 1992, FOLIA PRIMATOL, V58, P1, DOI 10.1159/000156600; BUSSE CD, 1985, AM ZOOL, V25, P873; Carosi M, 1999, HORM BEHAV, V36, P252, DOI 10.1006/hbeh.1999.1545; Clarke Parry, 2009, P42; Connor R. C., 2009, SEXUAL COERCION PRIM; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Emery MA, 2003, BEHAV ECOL SOCIOBIOL, V54, P340, DOI 10.1007/s00265-003-0648-6; Engelhardt A, 2004, ANIM BEHAV, V67, P915, DOI 10.1016/j.anbehav.2003.09.006; Furtbauer I, 2010, INT J PRIMATOL, V31, P501, DOI 10.1007/s10764-010-9409-3; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Heape W, 1900, Q J MICROSC SCI, V44, P1; HEISTERMANN M, 1993, J REPROD FERTIL, V99, P243; Heistermann M, 2001, P ROY SOC B-BIOL SCI, V268, P2445, DOI 10.1098/rspb.2001.1833; Heistermann M, 2008, AM J PRIMATOL, V70, P44, DOI 10.1002/ajp.20455; Higham JP, 2008, HORM BEHAV, V53, P452, DOI 10.1016/j.yhbeh.2007.11.019; Hoelzer G. A., 1996, P3; Hrdy S.B., 1987, P370; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Li Jin-Hua, 2005, Acta Zoologica Sinica, V51, P365; Cerda-Molina AL, 2006, INT J PRIMATOL, V27, P791, DOI 10.1007/s10764-006-9045-0; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; Maestripieri D, 2005, BEHAV ECOL, V16, P106, DOI 10.1093/beheco/arh120; MANSON JH, 1992, ANIM BEHAV, V44, P405, DOI 10.1016/0003-3472(92)90051-A; Manson JH, 1997, CURR ANTHROPOL, V38, P353, DOI 10.1086/204623; MARSON J, 1989, J REPROD FERTIL, V85, P43; Matsubara M, 2004, INT J PRIMATOL, V25, P901, DOI 10.1023/B:IJOP.0000029128.00559.91; MCCARTHY MM, 2002, BEHAV ENDOCRINOLOGY, P117; Moscovice LR, 2010, ANIM BEHAV, V79, P1007, DOI 10.1016/j.anbehav.2010.01.013; Muller MN, 2011, BEHAV ECOL SOCIOBIOL, V65, P921, DOI 10.1007/s00265-010-1093-y; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Nunn CL, 1999, BEHAV ECOL SOCIOBIOL, V46, P1, DOI 10.1007/s002650050586; Nunn CL, 1999, ANIM BEHAV, V58, P229, DOI 10.1006/anbe.1999.1159; Nunn CL, 2000, SCIENCE, V290, P1168, DOI 10.1126/science.290.5494.1168; O'Neill AC, 2004, AM J PHYS ANTHROPOL, V125, P352, DOI 10.1002/ajpa.20024; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Ostner J, 2006, AM J PRIMATOL, V68, P701, DOI 10.1002/ajp.20260; Ostner J, 2011, HORM BEHAV, V59, P105, DOI 10.1016/j.yhbeh.2010.10.017; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; Pradhan GR, 2008, BEHAVIOUR, V145, P251, DOI 10.1163/156853907783244710; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; R Core Team, 2018, R LANG ENV STAT COMP; REYNOLDS JD, 1990, AM NAT, V136, P230, DOI 10.1086/285093; Rodriguez-Girones MA, 2001, ANIM BEHAV, V61, P695, DOI 10.1006/anbe.2000.1630; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Semple S, 2002, AM J PRIMATOL, V56, P43, DOI 10.1002/ajp.1062; Semple S, 2000, P ROY SOC B-BIOL SCI, V267, P707, DOI 10.1098/rspb.2000.1060; Setchell JM, 2010, J EVOLUTION BIOL, V23, P136, DOI 10.1111/j.1420-9101.2009.01880.x; SHIDELER SE, 1993, BIOL REPROD, V48, P1290, DOI 10.1095/biolreprod48.6.1290; SMALL MF, 1988, CURR ANTHROPOL, V29, P81, DOI 10.1086/203615; SMALL MF, 1990, AM J PRIMATOL, V20, P267, DOI 10.1002/ajp.1350200403; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Soltis J, 2000, BEHAV ECOL SOCIOBIOL, V48, P195, DOI 10.1007/s002650000224; Soltis J, 2002, EVOL ANTHROPOL, V11, P187, DOI 10.1002/evan.10025; Soltis J, 1999, AM J PRIMATOL, V47, P263, DOI 10.1002/(SICI)1098-2345(1999)47:4<263::AID-AJP1>3.0.CO;2-F; STACEY PB, 1982, AM NAT, V120, P51, DOI 10.1086/283969; Taub D.M., 1980, P287; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; Thornhill R., 2008, EVOLUTIONARY BIOL HU; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; VAN HOOF J. A. R. A. M., 1967, P7; van Noordwijk Maria A., 2000, P322, DOI 10.1017/CBO9780511542312.016; van Schaik C.P., 2000, INFANTICIDE MALES IT; van Schaik Carel P., 1999, P204, DOI 10.1017/CBO9780511542466.011; van Schaik Carel P., 2004, P131, DOI 10.1017/CBO9780511542459.010; van Schaik Carel P., 2000, P361, DOI 10.1017/CBO9780511542312.017; Van Schaik CP, 2000, PRIMATE MALES, P34; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Ziegler T, 2000, AM J PRIMATOL, V51, P119, DOI 10.1002/(SICI)1098-2345(200006)51:2<119::AID-AJP2>3.0.CO;2-O; Zinner D, 2000, AM J PRIMATOL, V52, P157, DOI 10.1002/1098-2345(200012)52:4<157::AID-AJP1>3.0.CO;2-L	86	33	34	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23105	10.1371/journal.pone.0023105	http://dx.doi.org/10.1371/journal.pone.0023105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853074	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200043
J	King, M; Marston, L; Svab, I; Maaroos, HI; Geerlings, MI; Xavier, M; Benjamin, V; Torres-Gonzalez, F; Bellon-Saameno, JA; Rotar, D; Aluoja, A; Saldivia, S; Correa, B; Nazareth, I				King, Michael; Marston, Louise; Svab, Igor; Maaroos, Heidi-Ingrid; Geerlings, Mirjam I.; Xavier, Miguel; Benjamin, Vicente; Torres-Gonzalez, Francisco; Angel Bellon-Saameno, Juan; Rotar, Danica; Aluoja, Anu; Saldivia, Sandra; Correa, Bernardo; Nazareth, Irwin			Development and Validation of a Risk Model for Prediction of Hazardous Alcohol Consumption in General Practice Attendees: The PredictAL Study	PLOS ONE			English	Article							USE DISORDERS; PRIMARY-CARE; DRINKING; HEALTH; INTERVIEW; IDENTIFICATION; PERFORMANCE; PREVALENCE; DEPRESSION; MANAGEMENT	Background: Little is known about the risk of progression to hazardous alcohol use in people currently drinking at safe limits. We aimed to develop a prediction model (predictAL) for the development of hazardous drinking in safe drinkers. Methods: A prospective cohort study of adult general practice attendees in six European countries and Chile followed up over 6 months. We recruited 10,045 attendees between April 2003 to February 2005. 6193 European and 2462 Chilean attendees recorded AUDIT scores below 8 in men and 5 in women at recruitment and were used in modelling risk. 38 risk factors were measured to construct a risk model for the development of hazardous drinking using stepwise logistic regression. The model was corrected for over fitting and tested in an external population. The main outcome was hazardous drinking defined by an AUDIT score >= 8 in men and >= 5 in women. Results: 69.0% of attendees were recruited, of whom 89.5% participated again after six months. The risk factors in the final predictAL model were sex, age, country, baseline AUDIT score, panic syndrome and lifetime alcohol problem. The predictAL model's average c-index across all six European countries was 0.839 (95% CI 0.805, 0.873). The Hedge's g effect size for the difference in log odds of predicted probability between safe drinkers in Europe who subsequently developed hazardous alcohol use and those who did not was 1.38 (95% CI 1.25, 1.51). External validation of the algorithm in Chilean safe drinkers resulted in a c-index of 0.781 (95% CI 0.717, 0.846) and Hedge's g of 0.68 (95% CI 0.57, 0.78). Conclusions: The predictAL risk model for development of hazardous consumption in safe drinkers compares favourably with risk algorithms for disorders in other medical settings and can be a useful first step in prevention of alcohol misuse.	[King, Michael] UCL, Dept Mental Hlth Sci, London, England; [Nazareth, Irwin] Med Res Council Gen Practice Res Framework, London, England; [Marston, Louise; Nazareth, Irwin] UCL, Dept Primary Care & Populat Hlth, London, England; [Torres-Gonzalez, Francisco] Univ Granada, Dept Psychiat, Granada, Spain; [Angel Bellon-Saameno, Juan] El Palo Hlth Ctr, Dept Prevent Med, Malaga, Spain; [Svab, Igor; Rotar, Danica] Univ Ljubljana, Dept Family Med, Ljubljana, Slovenia; [Maaroos, Heidi-Ingrid; Aluoja, Anu] Univ Tartu, Fac Med, EE-50090 Tartu, Estonia; [Geerlings, Mirjam I.] Univ Med Ctr, Utrecht, Netherlands; [Xavier, Miguel; Correa, Bernardo] Univ Nova Lisboa, Ctr Estudos Doencas Cron, Fac Ciencias Med, P-1200 Lisbon, Portugal; [Benjamin, Vicente; Saldivia, Sandra] Univ Concepcion, Dept Psiquiatria & Salud Mental, Concepcion, Chile	University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of Granada; University of Ljubljana; University of Tartu; Utrecht University; Utrecht University Medical Center; Universidade Nova de Lisboa; Universidad de Concepcion	King, M (corresponding author), UCL, Dept Mental Hlth Sci, London, England.	i.nazareth@ucl.ac.uk	Geerlings, Mirjam I/F-4087-2015; Marston, Louise/A-8535-2012; King, Michael B/D-7477-2011; Saldivia, Sandra/F-3488-2013; Barahona-Correa, Bernardo/I-5611-2017	Geerlings, Mirjam I/0000-0002-4037-036X; Marston, Louise/0000-0002-9973-1131; King, Michael B/0000-0003-4715-7171; Saldivia, Sandra/0000-0002-7594-7069; Nazareth, Irwin/0000-0003-2146-9628; Barahona-Correa, Bernardo/0000-0001-8558-3126; Xavier, Miguel/0000-0003-2698-1284; Bellon Saameno, Juan Angel/0000-0002-4268-4979	European Commission [PREDICT-QL4-CT2002-00683]; FONDEF in Chile [DO2I-1140]; Estonian Scientific Foundation [5696]; Slovenian Ministry for Research [4369-1027]; Spanish Ministry of Health [PI041980, PI041771, PI042450]; Spanish Network of Primary Care Research; red de Investigacion en Actividades Preventivas y Promocion de la salud [ISCIII-RETIC RD06/0018]; SAMSERAP group; United Kingdom National Health Service Research and Development office in the United Kingdom; MRC [MC_U122797163] Funding Source: UKRI; Medical Research Council [MC_U122797163] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); FONDEF in Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Estonian Scientific Foundation; Slovenian Ministry for Research; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Network of Primary Care Research; red de Investigacion en Actividades Preventivas y Promocion de la salud; SAMSERAP group; United Kingdom National Health Service Research and Development office in the United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study in Europe was funded by a European Commission Vth Framework grant (PREDICT-QL4-CT2002-00683). Funding in Chile was provided by project FONDEF DO2I-1140. The authors are grateful for part support in Europe from: the Estonian Scientific Foundation (grant 5696); the Slovenian Ministry for Research (grant 4369-1027); the Spanish Ministry of Health (FIS references: PI041980, PI041771, PI042450) and the Spanish Network of Primary Care Research, red de Investigacion en Actividades Preventivas y Promocion de la salud (ISCIII-RETIC RD06/0018) and SAMSERAP group, and the United Kingdom National Health Service Research and Development office for service support costs in the United Kingdom. The funders had no direct role in the design or conduct of the study, interpretation of the data or review of the manuscript.	Aalto M, 2009, DRUG ALCOHOL DEPEN, V103, P25, DOI 10.1016/j.drugalcdep.2009.02.013; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Anderson P, 2003, ALCOHOL ALCOHOLISM, V38, P597, DOI 10.1093/alcalc/agg119; [Anonymous], 1997, COMP INT DIAGN INT C; BARBOR TF, 1989, ALCOHOL USE DISORDER; Berner MM, 2007, ALCOHOL ALCOHOLISM, V42, P308, DOI 10.1093/alcalc/agm013; Blaxter M., 1990, HLTH LIFESTYLES; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; COPAS JB, 1983, J R STAT SOC B, V45, P311; Coulton S, 2006, BMJ-BRIT MED J, V332, P511, DOI 10.1136/bmj.38743.421574.7C; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FINK LA, 1995, AM J PSYCHIAT, V152, P1329, DOI 10.1176/ajp.152.9.1329; Griffin KW, 2010, CHILD ADOL PSYCH CL, V19, P505, DOI 10.1016/j.chc.2010.03.005; Halme JT, 2008, ALCOHOL CLIN EXP RES, V32, P1615, DOI 10.1111/j.1530-0277.2008.00740.x; Harrell FE, 2001, REGRESSION MODELING; Harrison ELR, 2008, ALCOHOL CLIN EXP RES, V32, P2081, DOI 10.1111/j.1530-0277.2008.00796.x; Janssen I, 2003, BRIT J PSYCHIAT, V182, P71, DOI 10.1192/bjp.182.1.71; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Karasek R, 1990, HLTH WORK STRESS PRO; KING M, 1995, PSYCHOL MED, V25, P1125, DOI 10.1017/S0033291700033109; King M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-6; King M, 2008, ARCH GEN PSYCHIAT, V65, P1368, DOI 10.1001/archpsyc.65.12.1368; Koopman C, 2003, AM J HEALTH PROMOT, V17, P259, DOI 10.4278/0890-1171-17.4.259; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-21; McCarty CA, 2004, PEDIATRICS, V114, P714, DOI 10.1542/peds.2003-0864-L; McKenzie DP, 2006, ADDICT BEHAV, V31, P1683, DOI 10.1016/j.addbeh.2005.12.027; MOREAU D, 1993, CHILD ADOLESCENT PSY, V2, P581; Orwin R.G., 1994, HDB RES SYNTHESIS; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Qureshi N, 2005, FAM PRACT, V22, P663, DOI 10.1093/fampra/cmi073; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Smothers BA, 2004, ARCH INTERN MED, V164, P749, DOI 10.1001/archinte.164.7.749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stata Corporation, 2009, STAT STAT SOFTW REL; TAYLOR JF, 1994, ARCH SEX BEHAV, V23, P627, DOI 10.1007/BF01541816; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Tyrer P, 1990, MEASURING HUMAN PROB, P119; Weich S, 1998, BMJ-BRIT MED J, V317, P115, DOI 10.1136/bmj.317.7151.115; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	45	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22175	10.1371/journal.pone.0022175	http://dx.doi.org/10.1371/journal.pone.0022175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	827UM	21853028	Green Published, gold			2022-12-27	WOS:000295454200009
J	McDonald, AT				McDonald, Andrew T.			A Subadult Specimen of Rubeosaurus ovatus (Dinosauria: Ceratopsidae), with Observations on Other Ceratopsids from the Two Medicine Formation	PLOS ONE			English	Article							JUDITH RIVER FORMATION; PHYLOGENETIC ANALYSIS; OLDMAN-FORMATION; NORTH-AMERICA; MONTANA; ALBERTA; ORNITHISCHIA; AVACERATOPS; SYSTEMATICS; ONTOGENY	Background: Centrosaurine ceratopsids are well known from the middle Campanian Upper Two Medicine Formation of Montana. Four taxa have been named: Brachyceratops montanensis, Rubeosaurus ovatus, Einiosaurus procurvicornis, and Achelousaurus horneri. Rubeosaurus has been historically the most enigmatic of these taxa; only two specimens, the holotype caudal parietal bar and a referred incomplete skull, have been assigned to Rubeosaurus. Methodology/Principal Findings: A revised interpretation of the parietal processes of USNM 14765, the partial skeleton of a subadult centrosaurine formerly referred to Brachyceratops, indicates that it shares a P5 spike with the holotype of Rubeosaurus ovatus and should therefore be referred to that taxon. Brachyceratops is considered a nomen dubium. Conclusions/Significance: USNM 14765 provides additional anatomical information for Rubeosaurus ovatus. These new data are incorporated into a recent phylogenetic analysis of centrosaurine relationships; Rubeosaurus appears as the sister taxon of a clade composed of Einiosaurus, Achelousaurus, and Pachyrhinosaurus.	Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	McDonald, AT (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	mcandr@sas.upenn.edu			Department of Earth and Environmental Science, University of Pennsylvania	Department of Earth and Environmental Science, University of Pennsylvania	The author's research was facilitated by travel funds from the Department of Earth and Environmental Science, University of Pennsylvania (http://www.sas.upenn.edu/earth/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Currie Philip J., 2008, P1; Dodson P., 1990, P231, DOI 10.1017/CBO9780511608377.020; DODSON P, 1986, P ACAD NAT SCI PHILA, V138, P305; FARKE AA, ACTA PALAEO IN PRESS; Gilmore, 1917, US GEOLOGICAL SURVEY, V103, P1; Gilmore C. W., 1914, Smithsonian Institution Miscellaneous Collection, V63; GILMORE CHARLES W., 1930, PROC U S NATION MUS, V77, P1; GILMORE CHARLES W., 1939, PROC V S NATION MUS, V87, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2008, NEWSL STRATIGR, V43, P5, DOI 10.1127/0078-0421/2008/0043-0005; Kirkland James I., 2010, P117; Lambe L. M., 1913, Ottawa Naturalist, V27; LAMBE LM, 1915, B NATL MUSEUM CANADA, V24, P1; LAMBE LM, 1904, OTTAWA NATURALIST, V18, P81; LANGSTON W, 1975, CAN J EARTH SCI, V12, P1576, DOI 10.1139/e75-142; LUND E, 2010, J VERTEBRATE PALE S3, V30, pA125; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; McDonald Andrew T., 2010, P156; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Penkalski P, 1999, J VERTEBR PALEONTOL, V19, P692, DOI 10.1080/02724634.1999.10011182; ROGERS RR, 1993, CAN J EARTH SCI, V30, P1066, DOI 10.1139/e93-090; Ryan M, 2009, J VERTEBR PALEONTOL, V29, p174A; Ryan MJ, 2007, J VERTEBR PALEONTOL, V27, P944, DOI 10.1671/0272-4634(2007)27[944:AROTLC]2.0.CO;2; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Ryan MJ, 2005, CAN J EARTH SCI, V42, P1369, DOI 10.1139/E05-029; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; STERNBERG C. M., 1950, NATION MUS CANADA MUS BULL, V118, P109; Tumarkin-Deratzian Allison R., 2010, P251; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5	34	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22710	10.1371/journal.pone.0022710	http://dx.doi.org/10.1371/journal.pone.0022710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853043	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200018
J	Taaseh, N; Yaron, A; Nelken, I				Taaseh, Nevo; Yaron, Amit; Nelken, Israel			Stimulus-Specific Adaptation and Deviance Detection in the Rat Auditory Cortex	PLOS ONE			English	Article							MISMATCH NEGATIVITY; CORTICAL-NEURONS; ANESTHETIZED RAT; POTENTIALS; REPRESENTATION; SYSTEM; PITCH	Stimulus-specific adaptation (SSA) is the specific decrease in the response to a frequent ('standard') stimulus, which does not generalize, or generalizes only partially, to another, rare stimulus ('deviant'). Stimulus-specific adaptation could result simply from the depression of the responses to the standard. Alternatively, there may be an increase in the responses to the deviant stimulus due to the violation of expectations set by the standard, indicating the presence of true deviance detection. We studied SSA in the auditory cortex of halothane-anesthetized rats, recording local field potentials and multi-unit activity. We tested the responses to pure tones of one frequency when embedded in sequences that differed from each other in the frequency and probability of the tones composing them. The responses to tones of the same frequency were larger when deviant than when standard, even with inter-stimulus time intervals of almost 2 seconds. Thus, SSA is present and strong in rat auditory cortex. SSA was present even when the frequency difference between deviants and standards was as small as 10%, substantially smaller than the typical width of cortical tuning curves, revealing hyper-resolution in frequency. Strong responses were evoked also by a rare tone presented by itself, and by rare tones presented as part of a sequence of many widely spaced frequencies. On the other hand, when presented within a sequence of narrowly spaced frequencies, the responses to a tone, even when rare, were smaller. A model of SSA that included only adaptation of the responses in narrow frequency channels predicted responses to the deviants that were substantially smaller than the observed ones. Thus, the response to a deviant is at least partially due to the change it represents relative to the regularity set by the standard tone, indicating the presence of true deviance detection in rat auditory cortex.	[Taaseh, Nevo; Yaron, Amit; Nelken, Israel] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Taaseh, N (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel.	Israel@cc.huji.ac.il	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X	EU (NOVELTUNE consortium); Israel Science Foundation [219/05, 72/09]; Gatsby Charitable Foundation	EU (NOVELTUNE consortium)(European Commission); Israel Science Foundation(Israel Science Foundation); Gatsby Charitable Foundation	Funding: This study was supported by an EU FP6 grant (NOVELTUNE consortium, http://cordis.europa.eu/fp6), by grants from the Israel Science Foundation (219/05 and 72/09) to I.N. (http://www.isf.org.il/), and by a grant from the Gatsby Charitable Foundation to the Interdisciplinary Center for Neural Computation at the Hebrew University (http://www.gatsby.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Haidarliu S, 1996, PHYSIOL BEHAV, V60, P111, DOI 10.1016/0031-9384(95)02257-0; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jacobsen T, 2003, NEUROSCI LETT, V344, P79, DOI 10.1016/S0304-3940(03)00408-7; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; PICTON TW, 1978, ELECTROEN CLIN NEURO, V45, P198, DOI 10.1016/0013-4694(78)90004-4; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; SAMS M, 1983, BIOL PSYCHOL, V17, P41, DOI 10.1016/0301-0511(83)90065-0; SAMS M, 1985, ELECTROEN CLIN NEURO, V61, P254, DOI 10.1016/0013-4694(85)91092-2; Storace DA, 2011, J COMP NEUROL, V519, P177, DOI 10.1002/cne.22501; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Winkler I, 2006, EUR J NEUROSCI, V24, P625, DOI 10.1111/j.1460-9568.2006.04925.x; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003	27	158	160	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23369	10.1371/journal.pone.0023369	http://dx.doi.org/10.1371/journal.pone.0023369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853120	gold, Green Published			2022-12-27	WOS:000295454200077
J	Michelfelder, S; Varadi, K; Raupp, C; Hunger, A; Korbelin, J; Pahrmann, C; Schrepfer, S; Muller, OJ; Kleinschmidt, JA; Trepel, M				Michelfelder, Stefan; Varadi, Karl; Raupp, Christina; Hunger, Agnes; Koerbelin, Jakob; Pahrmann, Christiane; Schrepfer, Sonja; Mueller, Oliver J.; Kleinschmidt, Juergen A.; Trepel, Martin			Peptide Ligands Incorporated into the Threefold Spike Capsid Domain to Re-Direct Gene Transduction of AAV8 and AAV9 In Vivo	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; VIRAL VECTORS; LIVER TRANSDUCTION; PHAGE DISPLAY; THERAPY; LIBRARIES; DELIVERY; TROPISM; SEROTYPE-8; SELECTION	Efficiency and specificity of viral vectors are vital issues in gene therapy. Insertion of peptide ligands into the adeno-associated viral (AAV) capsid at receptor binding sites can re-target AAV2-derived vectors to alternative cell types. Also, the use of serotypes AAV8 and -9 is more efficient than AAV2 for gene transfer to certain tissues in vivo. Consequently, re-targeting of these serotypes by ligand insertion could be a promising approach but has not been explored so far. Here, we generated AAV8 and -9 vectors displaying peptides in the threefold spike capsid domain. These peptides had been selected from peptide libraries displayed on capsids of AAV serotype 2 to optimize systemic gene delivery to murine lung tissue and to breast cancer tissue in PymT transgenic mice (PymT). Such peptide insertions at position 590 of the AAV8 capsid and position 589 of the AAV9 capsid changed the transduction properties of both serotypes. However, both peptides inserted in AAV8 did not result in the same changes of tissue tropism as they did in AAV2. While the AAV2 peptides selected on murine lung tissue did not alter tropism of serotypes 8 and -9, insertion of the AAV2-derived peptide selected on breast cancer tissue augmented tumor gene delivery in both serotypes. Further, this peptide mediated a strong but unspecific in vivo gene transfer for AAV8 and abrogated transduction of various control tissues for AAV9. Our findings indicate that peptide insertion into defined sites of AAV8 and -9 capsids can change and improve their efficiency and specificity compared to their wild type variants and to AAV2, making these insertion sites attractive for the generation of novel targeted vectors in these serotypes.	[Michelfelder, Stefan; Hunger, Agnes; Koerbelin, Jakob; Trepel, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Hematol & Oncol, Hubertus Wald Canc Ctr, Hamburg, Germany; [Pahrmann, Christiane; Schrepfer, Sonja] Univ Med Ctr Hamburg Eppendorf, Transplant & Stem Cell Immunobiol Lab, Hamburg, Germany; [Varadi, Karl; Mueller, Oliver J.] Univ Med Ctr Heidelberg, Heidelberg, Germany; [Raupp, Christina; Kleinschmidt, Juergen A.] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Michelfelder, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hematol & Oncol, Hubertus Wald Canc Ctr, Hamburg, Germany.	m.trepel@uke.de	Müller, Oliver J./H-4739-2016; Körbelin, Jakob/ABG-2863-2020; Müller, Oliver/AAA-4399-2021	Körbelin, Jakob/0000-0002-5435-7182; Müller, Oliver/0000-0001-8223-2638; Michelfelder, Stefan/0000-0001-8678-1546	Deutsche Forschungsgemeinschaft [TR448/5-3, Mu1654/3-2, KL 516/8-2]; Wilhelm-Sander Stiftung [2005.114.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Sander Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft, http://www.dfg.de (grants TR448/5-3 to MT, Mu1654/3-2 to OJM and JAK, and KL 516/8-2 to JAK), as well as the Wilhelm-Sander Stiftung, http://www.wilhelm-sander-stiftung.de (grant 2005.114.1), to MT and JAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Boutin S, 2010, HUM GENE THER; Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Girod A, 1999, NAT MED, V5, P1052, DOI 10.1038/12491; Grifman M, 2001, MOL THER, V3, P964, DOI 10.1006/mthe.2001.0345; GRIMM D, 2008, J VIROL; Huttner NA, 2003, GENE THER, V10, P2139, DOI 10.1038/sj.gt.3302123; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Koerber JT, 2008, MOL THER, V16, P1703, DOI 10.1038/mt.2008.167; Koerber JT, 2007, HUM GENE THER, V18, P367, DOI 10.1089/hum.2006.139; Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5472.CAN-05-2748; Kolonin MG, 2006, FASEB J, V20, P979, DOI 10.1096/fj.05-5186fje; Li W, 2008, MOL THER, V16, P1252, DOI 10.1038/mt.2008.100; Lochrie MA, 2006, J VIROL, V80, P821, DOI 10.1128/JVI.80.2.821-834.2006; Manfredsson FP, 2009, MOL THER, V17, P403, DOI 10.1038/mt.2009.15; Michelfelder S, 2007, EXP HEMATOL, V35, P1766, DOI 10.1016/j.exphem.2007.07.018; Michelfelder S, 2009, ADV GENET, V67, P29, DOI 10.1016/S0065-2660(09)67002-4; Michelfelder S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005122; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Paneda A, 2009, HUM GENE THER, V20, P908, DOI 10.1089/hum.2009.031; Park K, 2008, FRONT BIOSCI-LANDMRK, V13, P2653, DOI 10.2741/2872; Perabo L, 2003, MOL THER, V8, P151, DOI 10.1016/S1525-0016(03)00123-0; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Shen X, 2007, MOL THER, V15, P1955, DOI 10.1038/sj.mt.6300293; Shi WF, 2003, MOL THER, V7, P515, DOI 10.1016/S1525-0016(03)00042-X; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Waterkamp DA, 2006, J GENE MED, V8, P1307, DOI 10.1002/jgm.967; White K, 2008, GENE THER, V15, P443, DOI 10.1038/sj.gt.3303077; White SJ, 2004, CIRCULATION, V109, P513, DOI 10.1161/01.CIR.0000109697.68832.5D; Work LM, 2006, MOL THER, V13, P683, DOI 10.1016/j.ymthe.2005.11.013; Work LM, 2004, MOL THER, V9, P198, DOI 10.1016/j.ymthe.2003.11.006; Wright JF, 2008, GENE THER, V15, P840, DOI 10.1038/gt.2008.65; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; YING Y, 2010, GENE THER; YU CY, 2009, GENE THER, P11601; ZINCARELLI C, 2008, MOL THER	50	32	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23101	10.1371/journal.pone.0023101	http://dx.doi.org/10.1371/journal.pone.0023101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850255	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300040
J	Sheldon, AL; Zhang, JM; Fei, H; Levitan, IB				Sheldon, Amanda L.; Zhang, Jiaming; Fei, Hong; Levitan, Irwin B.			SLOB, a SLOWPOKE Channel Binding Protein, Regulates Insulin Pathway Signaling and Metabolism in Drosophila	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; DEPENDENT POTASSIUM CHANNEL; FEEDING-BEHAVIOR; LOCOMOTOR-ACTIVITY; SCHNEIDER CELLS; AMINO-ACIDS; FAT-BODY; GROWTH; RECEPTOR; GENE	There is ample evidence that ion channel modulation by accessory proteins within a macromolecular complex can regulate channel activity and thereby impact neuronal excitability. However, the downstream consequences of ion channel modulation remain largely undetermined. The Drosophila melanogaster large conductance calcium-activated potassium channel SLOWPOKE (SLO) undergoes modulation via its binding partner SLO-binding protein (SLOB). Regulation of SLO by SLOB influences the voltage dependence of SLO activation and modulates synaptic transmission. SLO and SLOB are expressed especially prominently in median neurosecretory cells (mNSCs) in the pars intercerebralis (PI) region of the brain; these cells also express and secrete Drosophila insulin like peptides (dILPs). Previously, we found that flies lacking SLOB exhibit increased resistance to starvation, and we reasoned that SLOB may regulate aspects of insulin signaling and metabolism. Here we investigate the role of SLOB in metabolism and find that slob null flies exhibit changes in energy storage and insulin pathway signaling. In addition, slob null flies have decreased levels of dilp3 and increased levels of takeout, a gene known to be involved in feeding and metabolism. Targeted expression of SLOB to mNSCs rescues these alterations in gene expression, as well as the metabolic phenotypes. Analysis of fly lines mutant for both slob and slo indicate that the effect of SLOB on metabolism and gene expression is via SLO. We propose that modulation of SLO by SLOB regulates neurotransmission in mNSCs, influencing downstream insulin pathway signaling and metabolism.	[Sheldon, Amanda L.; Zhang, Jiaming; Fei, Hong; Levitan, Irwin B.] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA	Jefferson University	Sheldon, AL (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA.	Irwin.Levitan@Jefferson.edu	Zhang, Jiaming/GSD-8224-2022		U.S. National Institutes of Health	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant to IBL from the U.S. National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Atkinson NS, 2000, J NEUROSCI, V20, P2988; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Benito J, 2010, P NATL ACAD SCI USA, V107, P2544, DOI 10.1073/pnas.0906422107; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Engel JE, 1998, J NEUROSCI, V18, P2254; Fridell YWC, 2009, AGING-US, V1, P699, DOI 10.18632/aging.100067; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; GHO M, 1992, J EXP BIOL, V170, P93; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Jaramillo AM, 2006, J NEUROPHYSIOL, V95, P1957, DOI 10.1152/jn.00427.2005; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kim SE, 2004, CELL SIGNAL, V16, P1309, DOI 10.1016/j.cellsig.2004.04.004; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Klowden M. J., 2002, PHYSL SYSTEMS INSECT; Kreneisz O, 2010, NEUROREPORT, V21, P1116, DOI 10.1097/WNR.0b013e3283409200; Kwon HB, 2002, J BIOL CHEM, V277, P14853, DOI 10.1074/jbc.M110366200; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Ma HF, 2011, J GEN PHYSIOL, V137, P225, DOI 10.1085/jgp.201010439; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Proks P, 2006, CURR PHARM DESIGN, V12, P485, DOI 10.2174/138161206775474431; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Shahidullah M, 2009, J NEUROSCI, V29, P13328, DOI 10.1523/JNEUROSCI.3024-09.2009; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Veelaert D, 1998, INT REV CYTOL, V182, P249, DOI 10.1016/S0074-7696(08)62171-3; Wang J, 1999, J Neurosci, V19, pRC4; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Zeng HY, 2005, J GEN PHYSIOL, V125, P631, DOI 10.1085/jgp.200509252; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106; Zhou Y, 2002, J NEUROSCI, V22, P3855, DOI 10.1523/JNEUROSCI.22-10-03855.2002; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zinke I, 1999, DEVELOPMENT, V126, P5275	64	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23343	10.1371/journal.pone.0023343	http://dx.doi.org/10.1371/journal.pone.0023343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850269	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300054
J	Halsey, LG; Jones, TT; Jones, DR; Liebsch, N; Booth, DT				Halsey, Lewis G.; Jones, T. Todd; Jones, David R.; Liebsch, Nikolai; Booth, David T.			Measuring Energy Expenditure in Sub-Adult and Hatchling Sea Turtles via Accelerometry	PLOS ONE			English	Article							DOUBLY LABELED WATER; DIVING GREAT CORMORANTS; JUVENILE GREEN TURTLES; CHELONIA-MYDAS L.; HEART-RATE; OXYGEN-CONSUMPTION; METABOLIC-RATE; CARDIOVASCULAR ADJUSTMENTS; DERMOCHELYS-CORIACEA; LOGGERHEAD TURTLES	Measuring the metabolic of sea turtles is fundamental to understanding their ecology yet the presently available methods are limited. Accelerometry is a relatively new technique for estimating metabolic rate that has shown promise with a number of species but its utility with air-breathing divers is not yet established. The present study undertakes laboratory experiments to investigate whether rate of oxygen uptake (<(V)over dot>o(2)) at the surface in active sub-adult green turtles Chelonia mydas and hatchling loggerhead turtles Caretta caretta correlates with overall dynamic body acceleration (ODBA), a derivative of acceleration used as a proxy for metabolic rate. Six green turtles (25-44 kg) and two loggerhead turtles (20 g) were instrumented with tri-axial acceleration logging devices and placed singly into a respirometry chamber. The green turtles were able to submerge freely within a 1.5 m deep tank and the loggerhead turtles were tethered in water 16 cm deep so that they swam at the surface. A significant prediction equation for mean <(V)over dot>o(2) over an hour in a green turtle from measures of ODBA and mean flipper length (R-2 = 0.56) returned a mean estimate error across turtles of 8.0%. The range of temperatures used in the green turtle experiments (22-30 degrees C) had only a small effect on <(V)over dot>o(2). A <(V)over dot>o(2)-ODBA equation for the loggerhead hatchling data was also significant (R-2 = 0.67). Together these data indicate the potential of the accelerometry technique for estimating energy expenditure in sea turtles, which may have important applications in sea turtle diving ecology, and also in conservation such as assessing turtle survival times when trapped underwater in fishing nets.	[Halsey, Lewis G.] Roehampton Univ, Dept Life Sci, London, England; [Jones, T. Todd] Univ Hawaii Manoa, NOAA, Kewalo Res Facil, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Jones, David R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Liebsch, Nikolai] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Booth, David T.] Univ Queensland, Sch Biol Sci, Physiol Ecol Grp, St Lucia, Qld, Australia	Roehampton University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; University of British Columbia; University of Queensland; University of Queensland	Halsey, LG (corresponding author), Roehampton Univ, Dept Life Sci, London, England.	l.halsey@roehampton.ac.uk	Booth, David T./A-7184-2012; Halsey, Lewis/B-8498-2011	Booth, David T./0000-0002-3801-0488; Halsey, Lewis/0000-0002-0786-7585	NSERC; Percy Sladen Memorial Fund; Linnaean Society of London	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Percy Sladen Memorial Fund; Linnaean Society of London	This project was partly funded by an NSERC Discovery Grant to Professor Dave Jones, and partly funded by the Percy Sladen Memorial Fund, care of The Linnaean Society of London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Booth DT, 2009, J EXP BIOL, V212, P50, DOI 10.1242/jeb.019778; BOYD IL, 1995, FUNCT ECOL, V9, P151, DOI 10.2307/2390559; Brand SJ, 1999, MAR FRESHWATER RES, V50, P145, DOI 10.1071/MF98033; BUTLER PJ, 1984, J COMP PHYSIOL, V154, P167, DOI 10.1007/BF00684141; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; DAVENPORT J, 1982, J ZOOL, V198, P399; deLeeuw JJ, 1996, CAN J ZOOL, V74, P2131, DOI 10.1139/z96-242; Enstipp MR, 2006, J EXP BIOL, V209, P845, DOI 10.1242/jeb.02064; Epperly S, 2002, 490 NOAA NMFSSEFSC U; Fahlman A, 2008, J EXP BIOL, V211, P3573, DOI 10.1242/jeb.023655; Fahlman A, 2008, AQUAT BIOL, V2, P75, DOI 10.3354/ab00039; Fedak M.A., 1986, DIVING ANIMALS MAN, P11; Fossette S, J EXPT BIOL IN PRESS, V213; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Green J, 2005, CAN J ZOOL, V83, P445, DOI 10.1139/Z05-035; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Green JA, 2001, J EXP BIOL, V204, P673; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; Gremillet D, 1998, FUNCT ECOL, V12, P386, DOI 10.1046/j.1365-2435.1998.00199.x; Gremillet D, 2005, J AVIAN BIOL, V36, P57, DOI 10.1111/j.0908-8857.2005.03331.x; Halsey LG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P230, DOI 10.1086/658636; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2007, ZOOLOGY, V110, P81, DOI 10.1016/j.zool.2006.09.001; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Halsey LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010170; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Halsey LG, 2005, PHYSIOL BIOCHEM ZOOL, V78, P273, DOI 10.1086/427053; Hays GC, 2001, J EXP BIOL, V204, P4093; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hays GC, 2000, ANIM BEHAV, V59, P577, DOI 10.1006/anbe.1999.1326; Hochscheid S, 1999, MAR ECOL PROG SER, V185, P101, DOI 10.3354/meps185101; Hochscheid S, 2003, J EXP MAR BIOL ECOL, V297, P123, DOI 10.1016/j.jembe.2003.07.004; Jones TT, 2007, COMP BIOCHEM PHYS A, V147, P313, DOI 10.1016/j.cbpa.2006.09.013; Jones TT, 2009, J EXP BIOL, V212, P2635, DOI 10.1242/jeb.029330; Kooyman G. L., 1989, DIVERSE DIVERS; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lighton JRB, 2011, COMP BIOCHEM PHYS A, V158, P265, DOI 10.1016/j.cbpa.2010.11.026; LUTCAVAGE ME, 1991, J EXP MAR BIOL ECOL, V147, P287, DOI 10.1016/0022-0981(91)90187-2; Lutcavage Molly E., 1997, P277; LUTZ PL, 1985, COPEIA, P671, DOI 10.2307/1444761; Makowski C, 2006, MAR BIOL, V148, P1167, DOI 10.1007/s00227-005-0150-y; Payne N, 2010, J ANIMAL ECOLOGY ONL; Richman SE, 2008, J COMP PHYSIOL B, V178, P321, DOI 10.1007/s00360-007-0225-9; SALMON M, 1987, J EXP MAR BIOL ECOL, V109, P137, DOI 10.1016/0022-0981(87)90012-8; SATO K, 1994, MAR BIOL, V118, P343, DOI 10.1007/BF00349802; SHELTON G, 1982, J EXP BIOL, V100, P245; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Southwood AL, 2006, CAN J ZOOL, V84, P125, DOI 10.1139/Z05-185; Southwood AL, 2003, J EXP BIOL, V206, P4521, DOI 10.1242/jeb.00689; Southwood AL, 1999, J EXP BIOL, V202, P1115; STANDORA EA, 1982, J THERM BIOL, V7, P159, DOI 10.1016/0306-4565(82)90006-7; Taquet C, 2006, MAR ECOL PROG SER, V306, P295, DOI 10.3354/meps306295; Wallace BP, 2005, J EXP BIOL, V208, P3873, DOI 10.1242/jeb.01860; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x	59	34	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22311	10.1371/journal.pone.0022311	http://dx.doi.org/10.1371/journal.pone.0022311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829613	gold, Green Published			2022-12-27	WOS:000293561200012
J	Kiok, K; Sun, H; Clancy, H; Bose, S; Kluz, T; Wu, F; Costa, M				Kiok, Kathrin; Sun, Hong; Clancy, Hailey; Bose, Sutapa; Kluz, Thomas; Wu, Fen; Costa, Max			Liprin-alpha 4 Is Required for Nickel Induced Receptor Protein Tyrosine Phosphatase-Leukocyte Antigen Related Receptor F (RPTP-LAR) Activity	PLOS ONE			English	Article							CELL-LINE; MAINTENANCE; BINDING; SYSTEM; ALPHA; GRIP; A549	Liprin-alpha 4 was strongly induced following nickel (II) chloride exposure in a variety of cell types including BEAS-2B, A549, BEP2D and BL41 cells. Liprin-alpha 4, a member of the Liprin alpha family, has seven isoforms but only three of these variants were detected in BEAS-2B cells (004, 201 and 202). The level of Liprin-alpha 4 variants 201 and 004 were highly increased in BEAS-2B cells in response to nickel. We showed that Liprin-alpha 4 bound directly to the cytoplasmic region of RPTP-LAR (receptor protein tyrosine phosphatase-leukocyte antigen-related receptor F). The cytoplasmic region of RPTP-LAR contains two phosphatase domains but only the first domain shows activity. The second domain interacts with other proteins. The phosphatase activity was increased both following nickel treatment and also in the presence of nickel ions in cell extracts. Liprin-alpha 4 knock-down lines with decreased expression of Liprin-alpha 4 variants 004 and 201 exhibited greater nickel toxicity compared to controls. The RPTP-LAR phosphatase activity was only slightly increased in a Liprin-alpha 4 knock-down line. Liprin-alpha 4 appeared necessary for the nickel induced tyrosine phosphatase activity. The presence of Liprin-alpha 4 and nickel increased tyrosine phosphatase activity that reduced the global levels of tyrosine phosphorylation in the cell.	[Kiok, Kathrin; Sun, Hong; Clancy, Hailey; Bose, Sutapa; Kluz, Thomas; Wu, Fen; Costa, Max] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA	New York University	Kiok, K (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA.	Max.Costa@nyumc.org	Wu, Fen/G-1569-2010; costa, max/H-1754-2012	BOSE, SUTAPA/0000-0002-6569-4643	National Institutes of Environmental Health Sciences [ES000260, ES010344, ES014454, ES005512]; National Cancer Institute [CA16087]; National Center for Research Resources [RR029893]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014454, R01ES005512, P42ES010344, P30ES000260] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant numbers ES000260, ES010344, ES014454, ES005512 from the National Institutes of Environmental Health Sciences and from grant number CA16087 from National Cancer Institute and RR029893 from National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran R, 2002, NEURON, V34, P1, DOI 10.1016/S0896-6273(02)00649-9; Busch W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-65; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Davidson TL, 2006, MOL CARCINOGEN, V45, P479, DOI 10.1002/mc.20176; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; KO J, 2003, J NEUROSCIENCE, V23; Lewis JB, 2006, BIOMATERIALS, V27, P5348, DOI 10.1016/j.biomaterials.2006.06.007; LI Q, 2006, EFFECTS 12 METAL ION; MAPARA MY, 1995, EUR J IMMUNOL, V25, P2506, DOI 10.1002/eji.1830250915; Mattauch S, 2010, EXP CELL RES, V316, P2883, DOI 10.1016/j.yexcr.2010.06.022; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Piche B, 2010, CELL MOL LIFE SCI, V67, P1987, DOI 10.1007/s00018-010-0312-z; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; REDDEL RR, 1988, CANCER RES, V48, P1904; Salnikow K, 2000, CANCER RES, V60, P38; Serra-Pages C, 2005, BIOCHEMISTRY-US, V44, P15715, DOI 10.1021/bi051434f; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; SHIN H, 2003, J BIOL CHEM, V278; SMITH BT, 1977, AM REV RESPIR DIS, V115, P285; TEMPEST PR, 1986, CARCINOGENESIS, V7, P2051, DOI 10.1093/carcin/7.12.2051; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Ying WT, 2003, PROTEOMICS, V3, P64, DOI 10.1002/pmic.200390010	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22764	10.1371/journal.pone.0022764	http://dx.doi.org/10.1371/journal.pone.0022764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829649	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200029
J	Aranha, MM; Santos, DM; Sola, S; Steer, CJ; Rodrigues, CMP				Aranha, Marcia M.; Santos, Daniela M.; Sola, Susana; Steer, Clifford J.; Rodrigues, Cecilia M. P.			miR-34a Regulates Mouse Neural Stem Cell Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOTHELIAL-CELLS; P53; RESVERATROL; MICRORNAS; APOPTOSIS; TRANSCRIPTION; CONTRIBUTES; ACTIVATION; TARGET	Background: MicroRNAs (miRNAs or miRs) participate in the regulation of several biological processes, including cell differentiation. Recently, miR-34a has been implicated in the differentiation of monocyte-derived dendritic cells, human erythroleukemia cells, and mouse embryonic stem cells. In addition, members of the miR-34 family have been identified as direct p53 targets. However, the function of miR-34a in the control of the differentiation program of specific neural cell types remains largely unknown. Here, we investigated the role of miR-34a in regulating mouse neural stem (NS) cell differentiation. Methodology/Principal Findings: miR-34a overexpression increased postmitotic neurons and neurite elongation of mouse NS cells, whereas anti-miR-34a had the opposite effect. SIRT1 was identified as a target of miR-34a, which may mediate the effect of miR-34a on neurite elongation. In addition, acetylation of p53 (Lys 379) and p53-DNA binding activity were increased and cell death unchanged after miR-34a overexpression, thus reinforcing the role of p53 during neural differentiation. Interestingly, in conditions where SIRT1 was activated by pharmacologic treatment with resveratrol, miR-34a promoted astrocytic differentiation, through a SIRT1-independent mechanism. Conclusions: Our results provide new insight into the molecular mechanisms by which miR-34a modulates neural differentiation, suggesting that miR-34a is required for proper neuronal differentiation, in part, by targeting SIRT1 and modulating p53 activity.	[Aranha, Marcia M.; Santos, Daniela M.; Sola, Susana; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1699 Lisbon, Portugal; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Universidade de Lisboa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Aranha, MM (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1699 Lisbon, Portugal.	cmprodrigues@ff.ul.pt	Solá, Susana/M-5251-2013; iMed.ULisboa, CellFun/A-4244-2014; Solá, Susana/AAI-4580-2021; Santos, Daniela/W-3903-2019; Rodrigues, Cecilia MP/M-3572-2013; Aranha, Marcia/AAO-7240-2021	Solá, Susana/0000-0003-2036-797X; Solá, Susana/0000-0003-2036-797X; Rodrigues, Cecilia MP/0000-0002-4829-754X; Moutinho Dos Santos, Daniela/0000-0002-3740-1305; Aranha, Marcia/0000-0001-9842-4335	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal [PTDC/BIA-BCM/67922/2006, PTDC/SAU-GMG/099162/2008]; FCT, Portugal [SFRH/BD/28429/2006, SFRH/BD/42008/2007]	Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grant PTDC/BIA-BCM/67922/2006 and PTDC/SAU-GMG/099162/2008 from Fundacao para a Ciencia e a Tecnologia (FCT), Lisbon, Portugal. MM Aranha and DM Santos are recipients of PhD fellowships from FCT, Portugal (SFRH/BD/28429/2006 and SFRH/BD/42008/2007, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2000, MOL CARCINOGEN, V28, P129, DOI 10.1002/1098-2744(200007)28:3&lt;129::AID-MC1&gt;3.0.CO;2-0; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Brakenhielm E, 2001, FASEB J, V15, P1798, DOI 10.1096/fj.01-0028fje; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Brynczka C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-139; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Ichimura A, 2010, MOL PHARMACOL, V77, P1016, DOI 10.1124/mol.109.063321; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mantel C, 2008, CURR OPIN HEMATOL, V15, P326, DOI 10.1097/MOH.0b013e3283043819; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Milagre I, 2008, J NEUROCHEM, V106, P835, DOI 10.1111/j.1471-4159.2008.05442.x; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Ou XA, 2011, BLOOD, V117, P440, DOI 10.1182/blood-2010-03-273011; Pezzuto JM, 2006, OXIDAT STRESS DIS, V20, P233; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schutte B, 1998, J NEUROSCI METH, V86, P63, DOI 10.1016/S0165-0270(98)00147-2; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; WANG Y, 1995, MOL CELL BIOL, V15, P2157; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Zhang J, 2006, CELL DEATH DIFFER, V13, P2118, DOI 10.1038/sj.cdd.4401972	63	145	155	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e21396	10.1371/journal.pone.0021396	http://dx.doi.org/10.1371/journal.pone.0021396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857907	gold, Green Submitted, Green Published			2022-12-27	WOS:000293558900008
J	Hostager, BS; Kashiwada, M; Colgan, JD; Rothman, PB				Hostager, Bruce S.; Kashiwada, Masaki; Colgan, John D.; Rothman, Paul B.			HOIL-1L Interacting Protein (HOIP) Is Essential for CD40 Signaling	PLOS ONE			English	Article							CHAIN ASSEMBLY COMPLEX; KAPPA-B ACTIVATION; MONOCLONAL-ANTIBODY; T-CELLS; NEMO; LYMPHOCYTES; EXPRESSION; INDUCTION; MECHANISM; APOPTOSIS	CD40 is a cell surface receptor important in the activation of antigen-presenting cells during immune responses. In macrophages and dendritic cells, engagement of CD40 by its ligand CD154 provides signals critical for anti-microbial and T cell-mediated immune responses, respectively. In B cells, CD40 signaling has a major role in regulating cell proliferation, antibody production, and memory B cell development. CD40 engagement results in the formation of a receptor-associated complex that mediates activation of NF-kappa B, stress-activated protein kinases, and other signaling molecules. However, the mechanisms that link CD40 to these signaling events have been only partially characterized. Known components of the CD40 signaling complex include members of the TNF receptor-associated factor (TRAF) family of proteins. We previously showed that the TRAF family member TRAF2 mediates recruitment of HOIL-1L-interacting protein (HOIP) to the cytoplasmic domain of CD40, suggesting that HOIP has a role in the CD40 signaling pathway. To determine the role of HOIP in CD40 signaling, we used somatic cell gene targeting to generate mouse B cell lines deficient in HOIP. We found that the CD40-induced upregulation of CD80 and activation of germline immunoglobulin epsilon transcription were defective in HOIP-deficient cells. We also found that the CD40-mediated activation of NF-kappa B and c-Jun kinase was impaired. Recruitment of I kappa B kinase proteins to the CD40 signaling complex was undetectable in HOIP-deficient cells, potentially explaining the defect in NF-kappa B activation. Restoration of HOIP expression reversed the defects in cellular activation and signaling. These results reveal HOIP as a key component of the CD40 signaling pathway.	[Hostager, Bruce S.; Kashiwada, Masaki; Colgan, John D.; Rothman, Paul B.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Hostager, BS (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	bruce-hostager@uiowa.edu		Colgan, John/0000-0001-9273-2644	National Institute of Health [R01AI054821, R01AI077516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054821, R01AI067489, R01AI077516] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institute of Health grants R01AI054821 (P.B.R) and R01AI077516 (P.B.R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hostager BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011380; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1996, J IMMUNOL, V157, P1047; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; KIM KJ, 1979, J IMMUNOL, V122, P549; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; MCKEAN DJ, 1983, J IMMUNOL, V131, P2726; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Prajapati S, 2002, J BIOL CHEM, V277, P24331, DOI 10.1074/jbc.M201393200; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; SILKE J, CELL DEATH DIFFER, V17, P35; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wiedemann P, 1996, J BIOL CHEM, V271, P29915, DOI 10.1074/jbc.271.47.29915; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2008, CYTOKINE GROWTH F R, V19, P199, DOI 10.1016/j.cytogfr.2008.04.002	33	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23061	10.1371/journal.pone.0023061	http://dx.doi.org/10.1371/journal.pone.0023061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829693	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511200037
J	Fang, QJ; Kani, K; Faca, VM; Zhang, WX; Zhang, Q; Jain, A; Hanash, S; Agus, DB; McIntosh, MW; Mallick, P				Fang, Qiaojun; Kani, Kian; Faca, Vitor M.; Zhang, Wenxuan; Zhang, Qing; Jain, Anjali; Hanash, Sam; Agus, David B.; McIntosh, Martin W.; Mallick, Parag			Impact of Protein Stability, Cellular Localization, and Abundance on Proteomic Detection of Tumor-Derived Proteins in Plasma	PLOS ONE			English	Article							MASS-SPECTROMETRY; QUANTITATIVE-ANALYSIS; STATISTICAL-MODEL; ANALYSIS-SYSTEM; BREAST-CANCER; BIOMARKERS; DISCOVERY; MS/MS; SERUM	Tumor-derived, circulating proteins are potentially useful as biomarkers for detection of cancer, for monitoring of disease progression, regression and recurrence, and for assessment of therapeutic response. Here we interrogated how a protein's stability, cellular localization, and abundance affect its observability in blood by mass-spectrometry-based proteomics techniques. We performed proteomic profiling on tumors and plasma from two different xenograft mouse models. A statistical analysis of this data revealed protein properties indicative of the detection level in plasma. Though 20% of the proteins identified in plasma were tumor-derived, only 5% of the proteins observed in the tumor tissue were found in plasma. Both intracellular and extracellular tumor proteins were observed in plasma; however, after normalizing for tumor abundance, extracellular proteins were seven times more likely to be detected. Although proteins that were more abundant in the tumor were also more likely to be observed in plasma, the relationship was nonlinear: Doubling the spectral count increased detection rate by only 50%. Many secreted proteins, even those with relatively low spectral count, were observed in plasma, but few low abundance intracellular proteins were observed. Proteins predicted to be stable by dipeptide composition were significantly more likely to be identified in plasma than less stable proteins. The number of tryptic peptides in a protein was not significantly related to the chance of a protein being observed in plasma. Quantitative comparison of large versus small tumors revealed that the abundance of proteins in plasma as measured by spectral count was associated with the tumor size, but the relationship was not one-to-one; a 3-fold decrease in tumor size resulted in a 16-fold decrease in protein abundance in plasma. This study provides quantitative support for a tumor-derived marker prioritization strategy that favors secreted and stable proteins over all but the most abundant intracellular proteins.	[Fang, Qiaojun; Faca, Vitor M.; Zhang, Qing; Hanash, Sam; McIntosh, Martin W.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Kani, Kian; Agus, David B.; Mallick, Parag] Univ So Calif, Los Angeles, CA USA; [Mallick, Parag] Stanford Univ, Stanford, CA 94305 USA; [Zhang, Wenxuan; Jain, Anjali] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	Fred Hutchinson Cancer Center; University of Southern California; Stanford University; Cedars Sinai Medical Center	Fang, QJ (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	mmcintos@fhcrc.org; mallick@usc.edu	Faça, Vitor M/A-3989-2013	Agus, David B./0000-0002-7499-7822; FACA, VITOR MARCEL/0000-0003-3205-7944; Kani, Kian/0000-0001-7774-265X	National Cancer Institute (NCI) [U54 CA119367]; NATIONAL CANCER INSTITUTE [U54CA119367] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is a part of the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR) project which is funded by the National Cancer Institute (NCI grant number: U54 CA119367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Cho JY, 2009, EXPERT REV PROTEOMIC, V6, P27, DOI 10.1586/14789450.6.1.27; Creighton C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r46; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Faca V, 2006, J PROTEOME RES, V5, P2009, DOI 10.1021/pr060102+; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; FANG Q, 2008, MOL CELL PROTEOMICS; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hawkridge AM, 2009, ANNU REV ANAL CHEM, V2, P265, DOI 10.1146/annurev.anchem.1.031207.112942; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; Jang JH, 2003, PROTEOMICS, V3, P1947, DOI 10.1002/pmic.200300563; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lutz AM, 2008, PLOS MED, V5, P1287, DOI 10.1371/journal.pmed.0050170; McIntosh MW, 2002, BIOMETRICS, V58, P657, DOI 10.1111/j.0006-341X.2002.00657.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Pitteri SJ, 2008, J PROTEOME RES, V7, P1481, DOI 10.1021/pr7007994; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Wang H, 2005, MOL CELL PROTEOMICS, V4, P618, DOI 10.1074/mcp.M400126-MCP200; Whiteaker JR, 2007, J PROTEOME RES, V6, P3962, DOI 10.1021/pr070202v	23	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23090	10.1371/journal.pone.0023090	http://dx.doi.org/10.1371/journal.pone.0023090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829587	Green Published, gold, Green Submitted			2022-12-27	WOS:000293286500074
J	Gammelsaeter, R; Coppola, T; Marcaggi, P; Storm-Mathisen, J; Chaudhry, FA; Attwell, D; Regazzi, R; Gundersen, V				Gammelsaeter, Runhild; Coppola, Thierry; Marcaggi, Paikan; Storm-Mathisen, Jon; Chaudhry, Farrukh A.; Attwell, David; Regazzi, Romano; Gundersen, Vidar			A Role for Glutamate Transporters in the Regulation of Insulin Secretion	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; EXOGENOUS D-ASPARTATE; RAT-BRAIN; VESICULAR GLUTAMATE; DIFFERENTIAL EXPRESSION; NERVE-ENDINGS; AMINO-ACIDS; EXOCYTOSIS; ISLETS; IMMUNOCYTOCHEMISTRY	In the brain, glutamate is an extracellular transmitter that mediates cell-to-cell communication. Prior to synaptic release it is pumped into vesicles by vesicular glutamate transporters (VGLUTs). To inactivate glutamate receptor responses after release, glutamate is taken up into glial cells or neurons by excitatory amino acid transporters (EAATs). In the pancreatic islets of Langerhans, glutamate is proposed to act as an intracellular messenger, regulating insulin secretion from beta-cells, but the mechanisms involved are unknown. By immunogold cytochemistry we show that insulin containing secretory granules express VGLUT3. Despite the fact that they have a VGLUT, the levels of glutamate in these granules are low, indicating the presence of a protein that can transport glutamate out of the granules. Surprisingly, in beta-cells the glutamate transporter EAAT2 is located, not in the plasma membrane as it is in brain cells, but exclusively in insulin-containing secretory granules, together with VGLUT3. In EAAT2 knock out mice, the content of glutamate in secretory granules is higher than in wild type mice. These data imply a glutamate cycle in which glutamate is carried into the granules by VGLUT3 and carried out by EAAT2. Perturbing this cycle by knocking down EAAT2 expression with a small interfering RNA, or by over-expressing EAAT2 or a VGLUT in insulin granules, significantly reduced the rate of granule exocytosis. Simulations of granule energetics suggest that VGLUT3 and EAAT2 may regulate the pH and membrane potential of the granules and thereby regulate insulin secretion. These data suggest that insulin secretion from beta-cells is modulated by the flux of glutamate through the secretory granules.	[Gammelsaeter, Runhild; Storm-Mathisen, Jon; Chaudhry, Farrukh A.; Gundersen, Vidar] Univ Oslo, Dept Anat, Oslo, Norway; [Gammelsaeter, Runhild; Storm-Mathisen, Jon; Chaudhry, Farrukh A.; Gundersen, Vidar] Univ Oslo, CMBN, Oslo, Norway; [Coppola, Thierry] Univ Nice, Inst Pharmacol Mol & Cellulaire, Nice, France; [Marcaggi, Paikan; Attwell, David] UCL, Dept Physiol, London, England; [Regazzi, Romano] Univ Lausanne, Dept Biol Cellulaire & Morphol, Lausanne, Switzerland; [Chaudhry, Farrukh A.] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Gundersen, Vidar] Univ Oslo, Rikshosp, Dept Neurol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; UDICE-French Research Universities; Universite Cote d'Azur; University of London; University College London; University of Lausanne; University of Oslo; University of Oslo; National Hospital Norway	Gammelsaeter, R (corresponding author), Univ Oslo, Dept Anat, Oslo, Norway.	vidar.gundersen@medisin.uio.no	Attwell, David/ABE-6750-2020; Marcaggi, Païkan/P-5855-2016; Marcaggi, Païkan/GYU-1658-2022; Coppola, Thierry/I-5036-2016	Marcaggi, Païkan/0000-0003-3575-8340; Coppola, Thierry/0000-0003-1018-722X; Regazzi, Romano/0000-0002-9773-2915; Storm-Mathisen, Jon/0000-0002-2930-3262	Medical Faculty, University of Oslo; Norwegian Research Council; Norwegian Diabetes Association; EU (DECG) [QLG3-CT-2001-2004]; Wellcome Trust [017948, 075232]	Medical Faculty, University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Diabetes Association; EU (DECG)(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by grants from the Medical Faculty, University of Oslo, the Norwegian Research Council, the Norwegian Diabetes Association, the EU (DECG,QLG3-CT-2001-2004), and the Wellcome Trust (grants 017948 and 075232 to D. Attwell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BALCAR VJ, 1972, J NEUROCHEM, V19, P2657, DOI 10.1111/j.1471-4159.1972.tb01325.x; Barg S, 2001, J CELL SCI, V114, P2145; Beckstrom H, 1999, J NEUROSCI RES, V55, P218, DOI 10.1002/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.3.CO;2-C; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bergersen LH, 2008, NAT PROTOC, V3, P144, DOI 10.1038/nprot.2007.525; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Gammelsaeter R, 2004, J CELL SCI, V117, P3749, DOI 10.1242/jcs.01209; Gammelsaeter R, 2009, BIOCHEM BIOPH RES CO, V381, P378, DOI 10.1016/j.bbrc.2009.02.062; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; GUNDERSEN V, 1993, NEUROSCIENCE, V57, P97, DOI 10.1016/0306-4522(93)90114-U; Gundersen V, 1998, J NEUROSCI, V18, P6059; GUNDERSEN V, 1995, J NEUROSCI, V15, P4417; Hamann M, 2002, EUR J NEUROSCI, V15, P308, DOI 10.1046/j.0953-816x.2001.01861.x; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; INAGAKI N, 1995, FASEB J, V9, P686, DOI 10.1096/fasebj.9.8.7768362; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LEVY LM, 1995, EUR J NEUROSCI, V7, P2036, DOI 10.1111/j.1460-9568.1995.tb00626.x; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; MANFRAS BJ, 1994, BBA-BIOMEMBRANES, V1195, P185, DOI 10.1016/0005-2736(94)90026-4; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; OTTERSEN OP, 1989, J CHEM NEUROANAT, V2, P57; OTTERSEN OP, 1984, J COMP NEUROL, V229, P374, DOI 10.1002/cne.902290308; OTTERSEN OP, 1987, EXP BRAIN RES, V69, P167; Rubi B, 2001, J BIOL CHEM, V276, P36391, DOI 10.1074/jbc.M104999200; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Thirion S, 1999, P NATL ACAD SCI USA, V96, P3206, DOI 10.1073/pnas.96.6.3206; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Weiss L, 1988, CELL TISSUE BIOL TXB	48	41	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22960	10.1371/journal.pone.0022960	http://dx.doi.org/10.1371/journal.pone.0022960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853059	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400020
J	Kawada, H; Dida, GO; Ohashi, K; Komagata, O; Kasai, S; Tomita, T; Sonye, G; Maekawa, Y; Mwatele, C; Njenga, SM; Mwandawiro, C; Minakawa, N; Takagi, M				Kawada, Hitoshi; Dida, Gabriel O.; Ohashi, Kazunori; Komagata, Osamu; Kasai, Shinji; Tomita, Takashi; Sonye, George; Maekawa, Yoshihide; Mwatele, Cassian; Njenga, Sammy M.; Mwandawiro, Charles; Minakawa, Noboru; Takagi, Masahiro			Multimodal Pyrethroid Resistance in Malaria Vectors, Anopheles gambiae s.s., Anopheles arabiensis, and Anopheles funestus s.s. in Western Kenya	PLOS ONE			English	Article							DIPTERA-CULICIDAE; INSECTICIDE RESISTANCE; NYANZA PROVINCE; ALLELE; NETS; SUSCEPTIBILITY; POPULATIONS; COVERAGE; BEHAVIOR; DDT	Anopheles gambiae s.s., Anopheles arabiensis, and Anopheles funestus s.s. are the most important species for malaria transmission. Pyrethroid resistance of these vector mosquitoes is one of the main obstacles against effective vector control. The objective of the present study was to monitor the pyrethroid susceptibility in the 3 major malaria vectors in a highly malaria endemic area in western Kenya and to elucidate the mechanisms of pyrethroid resistance in these species. Gembe East and West, Mbita Division, and 4 main western islands in the Suba district of the Nyanza province in western Kenya were used as the study area. Larval and adult collection and bioassay were conducted, as well as the detection of point mutation in the voltage-gated sodium channel (1014L) by using direct DNA sequencing. A high level of pyrethroid resistance caused by the high frequency of point mutations (L1014S) was detected in An. gambiae s.s. In contrast, P450-related pyrethroid resistance seemed to be widespread in both An. arabiensis and An. funestus s.s. Not a single L1014S mutation was detected in these 2 species. A lack of cross-resistance between DDT and permethrin was also found in An. arabiensis and An. funestus s.s., while An. gambiae s.s. was resistant to both insecticides. It is noteworthy that the above species in the same area are found to be resistant to pyrethroids by their unique resistance mechanisms. Furthermore, it is interesting that 2 different resistance mechanisms have developed in the 2 sibling species in the same area individually. The cross resistance between permethrin and DDT in An. gambiae s.s. may be attributed to the high frequency of kdr mutation, which might be selected by the frequent exposure to ITNs. Similarly, the metabolic pyrethroid resistance in An. arabiensis and An. funestus s.s. is thought to develop without strong selection by DDT.	[Kawada, Hitoshi; Maekawa, Yoshihide; Minakawa, Noboru; Takagi, Masahiro] Nagasaki Univ, Dept Vector Ecol & Environm, Inst Trop Med, Nagasaki 852, Japan; [Minakawa, Noboru] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Dida, Gabriel O.] Maseno Univ, Sch Publ Hlth, Kisumu, Kenya; [Dida, Gabriel O.; Sonye, George] Springs Hope, Mbita, Kenya; [Ohashi, Kazunori] Sumitomo Chem Co Ltd, Agr Chem Res Lab, Takarazuka, Hyogo, Japan; [Komagata, Osamu; Kasai, Shinji; Tomita, Takashi] Natl Inst Infect Dis, Tokyo, Japan; [Mwatele, Cassian; Njenga, Sammy M.] Eastern & So Africa Ctr Int Parasite Control, Nairobi, Kenya; [Mwandawiro, Charles] Kenya Govt Med Res Ctr, Nairobi, Kenya	Nagasaki University; Nagasaki University; Maseno University; Sumitomo Chem Co Ltd; National Institute of Infectious Diseases (NIID); Kenya Medical Research Institute	Kawada, H (corresponding author), Nagasaki Univ, Dept Vector Ecol & Environm, Inst Trop Med, Nagasaki 852, Japan.	vergiss@nagasaki-u.ac.jp	Komagata, Osamu/J-2771-2013	Komagata, Osamu/0000-0002-8175-6402; , Noboru/0000-0003-3664-9605; O Dida, Gabriel/0000-0003-2442-0352; Njenga, Sammy/0000-0001-6309-476X	Nagasaki University; Sumitomo Chemical Co., Ltd.	Nagasaki University; Sumitomo Chemical Co., Ltd.(Sumitomo Chem Co Ltd)	This study was funded by Nagasaki University and Sumitomo Chemical Co., Ltd. for the creation of field and semi-field bioassay systems for insecticide delivering technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; BERTRAM DS, 1969, T ROY SOC TROP MED H, V63, P125, DOI 10.1016/0035-9203(69)90093-5; Bliss CI, 1934, P NATL ACAD SCI USA, V79, P38; BRUCECHWATT LJ, 1985, ESSENTIAL MALARIOLOG, P452; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Futami K, 2010, MAL J IN PRESS; Gillies M, 1987, ANOPHELINAE AFRICA S; Gouagna L C, 2003, East Afr Med J, V80, P627; HEMINGWAY J, 1983, T ROY SOC TROP MED H, V77, P477, DOI 10.1016/0035-9203(83)90118-9; Hougard JM, 2002, J MED ENTOMOL, V39, P526, DOI 10.1603/0022-2585-39.3.526; Kamau L, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.1101; Kawada H., 2009, ACS S BOOK, V1014; Kawada H., 2009, PLOS NEGLECT TROP D, V3; Kawada Hitoshi, 1993, Japanese Journal of Sanitary Zoology, V44, P349; Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527; Kerah-Hinzoumbe C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-192; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Munhenga G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-247; Muriu SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-43; Mzilahowa T, 2008, MED VET ENTOMOL, V22, P258, DOI 10.1111/j.1365-2915.2008.00736.x; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nazni W A, 2005, Trop Biomed, V22, P63; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Okara RM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-69; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Service MW, 1993, MOSQUITO ECOLOGY FIE, V1993, P210, DOI [10.1007/978-94-015-8113-4_3, DOI 10.1007/978-94-015-8113-4_3]; Siegert PY, 2009, J ECON ENTOMOL, V102, P2061, DOI 10.1603/029.102.0607; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Wacira DG, 2007, TROP MED INT HEALTH, V12, P140, DOI 10.1111/j.1365-3156.2006.01759.x; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738; Zaim M., 2007, GLOBAL INSECTICIDE U	44	69	73	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22574	10.1371/journal.pone.0022574	http://dx.doi.org/10.1371/journal.pone.0022574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853038	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400009
J	Kroner, A; Hamelin, G; Andrivon, D; Val, F				Kroener, Alexander; Hamelin, Gaelle; Andrivon, Didier; Val, Florence			Quantitative Resistance of Potato to Pectobacterium atrosepticum and Phytophthora infestans: Integrating PAMP-Triggered Response and Pathogen Growth	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; HYPERSENSITIVE RESPONSE; TUBER TISSUE; LATE BLIGHT; SUSCEPTIBILITY; ACTIVATION; EXPRESSION; INDUCTION; CULTIVARS; INFECTION	While the mechanisms underlying quantitative resistance of plants to pathogens are still not fully elucidated, the Pathogen-Associated Molecular Patterns (PAMPs)-triggered response model suggests that such resistance depends on a dynamic interplay between the plant and the pathogen. In this model, the pathogens themselves or elicitors they produce would induce general defense pathways, which in turn limit pathogen growth and host colonisation. It therefore suggests that quantitative resistance is directly linked to a common set of general host defense mechanisms, but experimental evidence is still inconclusive. We tested the PAMP-triggered model using two pathogens (Pectobacterium atrosepticum and Phytophthora infestans) differing by their infectious processes and five potato cultivars spanning a range of resistance levels to each pathogen. Phenylalanine ammonia-lyase (PAL) activity, used as a defense marker, and accumulation of phenolics were measured in tuber slices challenged with lipopolysaccharides from P. atrosepticum or a concentrated culture filtrate from P. infestans. PAL activity increased following treatment with the filtrate but not with lipopolysaccharides, and varied among cultivars. It was positively related to tuber resistance to P. atrosepticum, but negatively related to tuber resistance to P. infestans. It was also positively related to the accumulation of total phenolics. Chlorogenic acid, the main phenolic accumulated, inhibited growth of both pathogens in vitro, showing that PAL induction caused active defense against each of them. Tuber slices in which PAL activity had been induced before inoculation showed increased resistance to P. atrosepticum, but not to P. infestans. Our results show that inducing a general defense mechanism does not necessarily result in quantitative resistance. As such, they invalidate the hypothesis that the PAMP-triggered model alone can explain quantitative resistance. We thus designed a more complex model integrating physiological host response and a key pathogen life history trait, pathogen growth, to explain the differences between the two pathosystems.	[Kroener, Alexander; Hamelin, Gaelle; Andrivon, Didier; Val, Florence] Univ Rennes 1, INRA French Natl Inst Agr Res, UMR 1099 BiO3P, Rennes, France	INRAE; Universite de Rennes	Kroner, A (corresponding author), Univ Rennes 1, INRA French Natl Inst Agr Res, UMR 1099 BiO3P, Agrocampus Ouest, Rennes, France.	Florence.Val@agrocampus-ouest.fr	, AGROCAMPUS OUEST/O-6651-2016	, AGROCAMPUS OUEST/0000-0002-1800-4558	Agrocampus Ouest; Regional Council of Bretagne	Agrocampus Ouest; Regional Council of Bretagne(Region Bretagne)	Alexander Kroner is supported by a Ph.D. scholarship from Agrocampus Ouest and the Regional Council of Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Andreu A, 2001, POTATO RES, V44, P1, DOI 10.1007/BF02360281; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Bariya HS, 2011, INDIAN J EXP BIOL, V49, P151; BHATIA SK, 1985, AM POTATO J, V62, P471, DOI 10.1007/BF02854520; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Desender S, 2006, PLANT BIOLOGY, V8, P636, DOI 10.1055/s-2006-924102; Desender S, 2007, CELL MICROBIOL, V9, P21, DOI 10.1111/j.1462-5822.2006.00831.x; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Folin O, 1927, J BIOL CHEM, V73, P627; FRIEND J, 1973, PHYSIOL PLANT PATHOL, V3, P495, DOI 10.1016/0048-4059(73)90060-X; GUPTA RP, 1976, INDIAN J EXP BIOL, V14, P365; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; KEENAN P, 1985, PHYSIOL PLANT PATHOL, V26, P343, DOI 10.1016/0048-4059(85)90009-8; KUMAR A, 1991, POTATO RES, V34, P9, DOI 10.1007/BF02358090; Kumar G, 2010, AGE INDUCED LOSS WOU, P1; Montarry J, 2007, FUNCT ECOL, V21, P603, DOI 10.1111/j.1365-2435.2007.01252.x; Navarre DA, 2011, FOOD CHEM IN PRESS; Niemira BA, 1999, PLANT DIS, V83, P469, DOI 10.1094/PDIS.1999.83.5.469; PARLEVLIET JE, 1979, ANNU REV PHYTOPATHOL, V17, P203, DOI 10.1146/annurev.py.17.090179.001223; Pasco C., 2006, POTATO RES, V49, P91, DOI [DOI 10.1007/S11540-006-9006-1, 10.1007/s11540-006-9006-1]; R Core Team, 2020, R LANG ENV STAT COMP; RUMEAU D, 1990, PLANT PHYSIOL, V93, P1134, DOI 10.1104/pp.93.3.1134; STOLLE K, 1984, POTATO RES, V27, P173, DOI 10.1007/BF02357462; Swiezynski KM, 2001, POTATO RES, V44, P97, DOI 10.1007/BF02360291; Trognitz F, 2002, MOL PLANT MICROBE IN, V15, P587, DOI 10.1094/MPMI.2002.15.6.587; Vanderplank JE., 1968, DIS RESISTANCE PLANT; VAYDA ME, 1992, AM POTATO J, V69, P239, DOI 10.1007/BF02853878; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; Wang X, 2008, PLANT PATHOL, V57, P1026, DOI 10.1111/j.1365-3059.2008.01866.x; Yang YL, 2011, AGR SCI CHINA, V10, P238, DOI 10.1016/S1671-2927(09)60310-2; YAO KN, 1995, PLANT CELL, V7, P1787, DOI 10.1105/tpc.7.11.1787; Yoshioka H, 1996, PLANT CELL PHYSIOL, V37, P81, DOI 10.1093/oxfordjournals.pcp.a028917; ZUCKER M, 1968, PLANT PHYSIOL, V43, P365, DOI 10.1104/pp.43.3.365	36	20	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23331	10.1371/journal.pone.0023331	http://dx.doi.org/10.1371/journal.pone.0023331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853112	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953400038
J	Dececchi, TA; Larsson, HCE				Dececchi, T. Alexander; Larsson, Hans C. E.			Assessing Arboreal Adaptations of Bird Antecedents: Testing the Ecological Setting of the Origin of the Avian Flight Stroke	PLOS ONE			English	Article							EARLY EVOLUTION; TREE-KANGAROO; SUBSTRATE USE; THEROPOD; DINOSAUR; MORPHOLOGY; FORELIMB; ANATOMY; CHINA; ARCHAEOPTERYX	The origin of avian flight is a classic macroevolutionary transition with research spanning over a century. Two competing models explaining this locomotory transition have been discussed for decades: ground up versus trees down. Although it is impossible to directly test either of these theories, it is possible to test one of the requirements for the trees-down model, that of an arboreal paravian. We test for arboreality in non-avian theropods and early birds with comparisons to extant avian, mammalian, and reptilian scansors and climbers using a comprehensive set of morphological characters. Non-avian theropods, including the small, feathered deinonychosaurs, and Archaeopteryx, consistently and significantly cluster with fully terrestrial extant mammals and ground-based birds, such as ratites. Basal birds, more advanced than Archaeopteryx, cluster with extant perching ground-foraging birds. Evolutionary trends immediately prior to the origin of birds indicate skeletal adaptations opposite that expected for arboreal climbers. Results reject an arboreal capacity for the avian stem lineage, thus lending no support for the trees-down model. Support for a fully terrestrial ecology and origin of the avian flight stroke has broad implications for the origin of powered flight for this clade. A terrestrial origin for the avian flight stroke challenges the need for an intermediate gliding phase, presents the best resolved series of the evolution of vertebrate powered flight, and may differ fundamentally from the origin of bat and pterosaur flight, whose antecedents have been postulated to have been arboreal and gliding.	[Dececchi, T. Alexander; Larsson, Hans C. E.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	McGill University	Dececchi, TA (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	hans.ce.larsson@mcgill.ca	Larsson, Hans/AAD-4579-2019	Larsson, Hans/0000-0002-6377-4770; Dececchi, Thomas Alexander/0000-0001-7972-3866	Fonds Quebecois de la Recherche sur la Nature et les Technologies; Natural Sciences and Engineering Research Council [261796]; Canada Research Chair	Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This research was supported by a Fonds Quebecois de la Recherche sur la Nature et les Technologies doctoral fellowship to TAD, and a Natural Sciences and Engineering Research Council Discovery Grant (261796) and Canada Research Chair to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; ALEXANDER DE, 2010, P NATL ACAD SCI USA, P1; Alexander R, 2003, CLIMBING AND WALKING ROBOTS: AND THEIR SUPPORTING TECHNOLOGIES, P777; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Bassarova M, 2009, J MAMM EVOL, V16, P1, DOI 10.1007/s10914-008-9093-7; Bennett MB, 2008, COMP BIOCHEM PHYS A, V150, P159, DOI 10.1016/j.cbpa.2006.06.011; Bennett S. Christopher, 1997, Historical Biology, V12, P265; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BINJEFFERY A, 2009, J VERTEBR PALEONTOL, V29, pA64; Bishop Nicolas, 1997, Proceedings of the Linnean Society of New South Wales, V117, P17; Blob RW, 2001, J EXP BIOL, V204, P1099; Brougham J, 2010, P NATL ACAD SCI USA, V107, pE155, DOI 10.1073/pnas.1004977107; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; Callison G., 1984, Journal of Vertebrate Paleontology, V3, P200; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Cartmill M., 1985, P73; Cartmill M, 2002, ZOOL J LINN SOC-LOND, V136, P401, DOI 10.1046/j.1096-3642.2002.00038.x; CHATTERJEE S, 2004, STUDIES TRANSITION D, P251; Chatterjee S., 1997, THE RISE OF BIRDS; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Chen XM, 2005, J MORPHOL, V266, P167, DOI 10.1002/jmor.10370; Chiappe Luis M., 2006, Journal of the Paleontological Society of Korea, V22, P133; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Clark James M., 1999, American Museum Novitates, V3265, P1; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; de Muizon Christian, 2003, P43; Dial KP, 2008, TRENDS ECOL EVOL, V23, P394, DOI 10.1016/j.tree.2008.03.005; Dial KP, 2008, NATURE, V451, P985, DOI 10.1038/nature06517; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Dudley R, 2007, ANNU REV ECOL EVOL S, V38, P179, DOI 10.1146/annurev.ecolsys.37.091305.110014; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; FARROW JO, 2002, PALEONTOLOGICAL SOC, V8, P251; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; FEENEY S, 1999, THESIS UMASS AMHERST; Fischer MS, 2010, ZOOLOGY, V113, P67, DOI 10.1016/j.zool.2009.07.001; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; Gebo Daniel L., 1993, Journal of Vertebrate Paleontology, V13, P125; Glen CL, 2007, CURR BIOL, V17, pR911, DOI 10.1016/j.cub.2007.09.026; GRAND TI, 1990, ANAT EMBRYOL, V182, P85; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEILMANN G, 1926, ORIGIN BIRDS; Heinrich RE, 2006, J VERTEBR PALEONTOL, V26, P422, DOI 10.1671/0272-4634(2006)26[422:PAOVMC]2.0.CO;2; HENDENSTROM A, 2009, BIOINSPIR BIOMIM, V4, P1; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Huxley TH, 1868, GEOLOGY MAGAZINE, V5, P357, DOI [10.1017/S0016756800207784, DOI 10.1017/S0016756800207784]; Hwang S.H., 2002, NEW SPECIMENS MICROR, P1; Iwaniuk AN, 1998, AUST J ZOOL, V46, P235, DOI 10.1071/ZO98004; Iwaniuk AN, 1999, CAN J ZOOL, V77, P1064, DOI 10.1139/cjz-77-7-1064; JENKINS FA, 1984, J MORPHOL, V182, P197, DOI 10.1002/jmor.1051820207; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Johansson LC, 2010, J R SOC INTERFACE, V7, P61, DOI 10.1098/rsif.2008.0541; Kear Benjamin P., 2008, P25, DOI 10.1007/978-1-4020-6997-0_2; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Lemelin P, 1999, J ZOOL, V247, P165, DOI 10.1017/S0952836999002046; Lemelin P, 2003, J ZOOL, V260, P423, DOI 10.1017/S0952836903003856; Li PP, 2007, P NATL ACAD SCI USA, V104, P5507, DOI 10.1073/pnas.0609552104; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Manning PL, 2009, ANAT REC, V292, P1397, DOI 10.1002/ar.20986; Mayr G, 2007, AUK, V124, P1450, DOI 10.1642/0004-8038(2007)124[1450:TFOART]2.0.CO;2; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; MEIRI S, 2010, J ZOOL, P1; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; Milner ARC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004591; Newell GR, 1999, BIOL CONSERV, V87, P1, DOI 10.1016/S0006-3207(98)00052-4; NORBERG RA, 1986, ORNIS SCAND, V17, P191, DOI 10.2307/3676828; NORBERG UM, 1979, PHILOS T ROY SOC B, V287, P131, DOI 10.1098/rstb.1979.0054; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; OSTROM JH, 1973, NATURE, V242, P136, DOI 10.1038/242136a0; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; PADIAN K, 2001, P INT S HON JH OSTR, P255; PERLE S, 1979, T SESTNAYA SOVETSKO, P45; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Pike AVL, 2004, J ZOOL, V262, P73, DOI 10.1017/S0952836903004382; Polly P. David, 2007, P245; Porfiri Juan D., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P545; PRIDEAUX GJ, 2008, J VERTEBR PALEONTOL, V225, P1, DOI DOI 10.1671/0272-4634(2008)28[463:ANPTDM]2.0.C0;2; PROCTERGRAY E, 1986, J MAMMAL, V67, P343, DOI 10.2307/1380888; Prum RO, 2002, AUK, V119, P1, DOI 10.1642/0004-8038(2002)119[0001:WOSCAT]2.0.CO;2; Reilly SM, 2000, J MORPHOL, V243, P173, DOI 10.1002/(SICI)1097-4687(200002)243:2<173::AID-JMOR6>3.3.CO;2-5; RENESTO S, 1994, J VERTEBR PALEONTOL, V14, P38, DOI 10.1080/02724634.1994.10011537; RICHARDSON FRANK, 1942, UNIV CALIFORNIA PUBL ZOOL, V46, P317; ROSE KD, 1987, SCIENCE, V236, P314, DOI 10.1126/science.3426662; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; Russell AP, 2001, COMP BIOCHEM PHYS A, V131, P89, DOI 10.1016/S1095-6433(01)00469-X; Samuels JX, 2008, J MORPHOL, V269, P1387, DOI 10.1002/jmor.10662; Sasaki M, 2005, ANN ANAT, V187, P153, DOI 10.1016/j.aanat.2004.10.001; Schaller NU, 2009, J ANAT, V214, P830, DOI 10.1111/j.1469-7580.2009.01083.x; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; SERENO PC, 1992, SCIENCE, V255, P845, DOI 10.1126/science.255.5046.845; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; SERENO PC, 1991, SOC VERTEBRATE PALEO, V2, P1, DOI DOI 10.2307/3889336; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Simpson G. G., 1944, P1; Sullivan C, 2010, P ROY SOC B-BIOL SCI, V277, P2027, DOI 10.1098/rspb.2009.2281; TAYLOR ME, 1976, J MORPHOL, V148, P227, DOI 10.1002/jmor.1051480208; Team RDC, 2010, R LANG ENV STAT COMP; Tobalske BW, 2007, J EXP BIOL, V210, P1742, DOI 10.1242/jeb.001701; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Van Valkenburgh B, 2002, PALEOBIOLOGY, V28, P527, DOI 10.1666/0094-8373(2002)028<0527:DAMPC>2.0.CO;2; VANVALKENBURGH B, 1985, PALEOBIOLOGY, V11, P406, DOI 10.1017/S0094837300011702; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Warburton NM, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P137; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x; Zanno LE, 2006, J VERTEBR PALEONTOL, V26, P636, DOI 10.1671/0272-4634(2006)26[636:TPGAFO]2.0.CO;2; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2006, ZOOL SCR, V35, P363, DOI 10.1111/j.1463-6409.2006.00234.x	128	36	40	1	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22292	10.1371/journal.pone.0022292	http://dx.doi.org/10.1371/journal.pone.0022292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857918	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300004
J	Champoux, F; Shiller, DM; Zatorre, RJ				Champoux, Francois; Shiller, Douglas M.; Zatorre, Robert J.			Feel What You Say: An Auditory Effect on Somatosensory Perception	PLOS ONE			English	Article							SPEECH-PERCEPTION; FEEDBACK; HEARING; RESPONSES; TOUCH	In the present study, we demonstrate an audiotactile effect in which amplitude modulation of auditory feedback during voiced speech induces a throbbing sensation over the lip and laryngeal regions. Control tasks coupled with the examination of speech acoustic parameters allow us to rule out the possibility that the effect may have been due to cognitive factors or motor compensatory effects. We interpret the effect as reflecting the tight interplay between auditory and tactile modalities during vocal production.	[Champoux, Francois] Inst Raymond Dewar, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Champoux, Francois; Shiller, Douglas M.] Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada; [Shiller, Douglas M.] CHU St Justine, Ctr Rech, Montreal, PQ, Canada; [Shiller, Douglas M.] CRLMB, Montreal, PQ, Canada; [Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Zatorre, Robert J.] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Universite de Montreal	Champoux, F (corresponding author), Inst Raymond Dewar, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada.	francois.champoux@umontreal.ca			Canadian Institutes of Health Research; Canada Fund for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Fund for Innovation(Canada Foundation for Innovation)	This work was supported by funding from the Canadian Institutes of Health Research and the Canada Fund for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer JJ, 2006, J ACOUST SOC AM, V119, P2363, DOI 10.1121/1.2173513; BERNSTEIN LE, 1991, J ACOUST SOC AM, V90, P2971, DOI 10.1121/1.401771; DICK B, 2008, J ACOUST SOC AM, V123, pEL72; FERNALD A, 1989, J CHILD LANG, V16, P477, DOI 10.1017/S0305000900010679; FOWLER CA, 1991, J EXP PSYCHOL HUMAN, V17, P816, DOI 10.1037/0096-1523.17.3.816; Foxe JJ, 2000, COGNITIVE BRAIN RES, V10, P77, DOI 10.1016/S0926-6410(00)00024-0; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; HORST JW, 1989, J ACOUST SOC AM, V85, P2022, DOI 10.1121/1.397999; Hotting K, 2004, PSYCHOL SCI, V15, P60, DOI 10.1111/j.0963-7214.2004.01501010.x; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; LANE H, 1971, J SPEECH HEAR RES, V14, P677, DOI 10.1044/jshr.1404.677; Larson CR, 2008, EXP BRAIN RES, V187, P613, DOI 10.1007/s00221-008-1330-z; Liu HJ, 2007, J ACOUST SOC AM, V122, P2405, DOI 10.1121/1.2773955; MCCLEAN MD, 1983, BRAIN RES, V264, P293, DOI 10.1016/0006-8993(83)90827-2; Soto-Faraco S, 2009, BEHAV BRAIN RES, V196, P145, DOI 10.1016/j.bbr.2008.09.018; Tremblay S, 2003, NATURE, V423, P866, DOI 10.1038/nature01710; Zampini M, 2004, J SENS STUD, V19, P347, DOI 10.1111/j.1745-459x.2004.080403.x	19	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22829.	10.1371/journal.pone.0022829	http://dx.doi.org/10.1371/journal.pone.0022829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	806AM	21857955	gold, Green Published			2022-12-27	WOS:000293773300008
J	Narusyte, J; Ropponen, A; Silventoinen, K; Alexanderson, K; Kaprio, J; Samuelsson, A; Svedberg, P				Narusyte, Jurgita; Ropponen, Annina; Silventoinen, Karri; Alexanderson, Kristina; Kaprio, Jaakko; Samuelsson, Asa; Svedberg, Pia			Genetic Liability to Disability Pension in Women and Men: A Prospective Population-Based Twin Study	PLOS ONE			English	Article							ENVIRONMENTAL-INFLUENCES; FOLLOW-UP; ABILITIES; DISORDER; SAMPLE; HEALTH; TIME	A Background: Previous studies of risk factors for disability pension (DP) have mainly focused on psychosocial, or environmental, factors, while the relative importance of genetic effects has been less studied. Sex differences in biological mechanisms have not been investigated at all. Methods: The study sample included 46,454 Swedish twins, consisting of 23,227 complete twin pairs, born 1928-1958, who were followed during 1993-2008. Data on DP, including diagnoses, were obtained from the National Social Insurance Agency. Within-pair similarity in liability to DP was assessed by calculating intraclass correlations. Genetic and environmental influences on liability to DP were estimated by applying discrete-time frailty modeling. Results: During follow-up, 7,669 individuals were granted DP (18.8% women and 14.1% men). Intraclass correlations were generally higher in MZ pairs than DZ pairs, while DZ same-sexed pairs were more similar than opposite-sexed pairs. The best-fitting model indicated that genetic factors contributed 49% (95% CI: 39-59) to the variance in DP due to mental diagnoses, 35% (95% CI: 29-41) due to musculoskeletal diagnoses, and 27% (95% CI: 20-33) due to all other diagnoses. In both sexes, genetic effects common to all ages explained one-third, whereas age-specific factors almost two-thirds, of the total variance in liability to DP irrespective of diagnosis. Sex differences in liability to DP were indicated, in that partly different sets of genes were found to operate in women and men, even though the magnitude of genetic variance explained was equal for both sexes. Conclusions: The findings of the study suggest that genetic effects are important for liability to DP due to different diagnoses. Moreover, genetic contributions to liability to DP tend to differ between women and men, even though the overall relative contribution of genetic influences does not differ by sex. Hence, the pathways leading to DP might differ between women and men.	[Narusyte, Jurgita; Alexanderson, Kristina; Samuelsson, Asa; Svedberg, Pia] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Ropponen, Annina] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Silventoinen, Karri] Univ Helsinki, Populat Res Unit, Dept Social Res, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Subst Abuse Serv, Helsinki, Finland	Karolinska Institutet; University of Eastern Finland; University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Narusyte, J (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.	jurgita.narusyte@ki.se	Kaprio, Jaakko/A-1820-2008; Alexanderson, Kristina A/J-3429-2013	Kaprio, Jaakko/0000-0002-3716-2455; Ropponen, Annina/0000-0003-3031-5823; Silventoinen, Karri/0000-0003-1759-3079; Alexanderson, Kristina/0000-0002-9313-3413	Swedish Research Council [521-2008-3054]; Swedish Council for Working Life and Social Research [2007-0830, 2007-1762]; Karolinska Institutet - Public and International Health Research Network; Centre for Health Care Science; Magnus Bergvalls Foundation; Swedish Society of Medicine; Ministry for Higher Education; AstraZeneca; Academy of Finland [122080]; Academy of Finland Centre of Excellence in Complex Disease Genetics	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet - Public and International Health Research Network; Centre for Health Care Science; Magnus Bergvalls Foundation; Swedish Society of Medicine; Ministry for Higher Education; AstraZeneca(AstraZeneca); Academy of Finland(Academy of Finland); Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland)	This study was financially supported by the Swedish Research Council (521-2008-3054), the Swedish Council for Working Life and Social Research (2007-0830 and 2007-1762), Karolinska Institutet - Public and International Health Research Network, and the Centre for Health Care Science, Magnus Bergvalls Foundation, and the Swedish Society of Medicine. The Swedish Twin Registry is supported by the Swedish Research Council, the Ministry for Higher Education, and AstraZeneca. AR is supported by the Academy of Finland, researcher grant (# 122080). JK is supported by the Academy of Finland Centre of Excellence in Complex Disease Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen K, 2007, SCAND J PUBLIC HEALT, V35, P78, DOI 10.1080/14034940600858474; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P256, DOI 10.1080/14034950410021925; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Alexanderson Kristina A E, 2005, Work, V25, P115; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; [Anonymous], 2003, SAS SYST VERS 9 1; BALTES PB, 1980, ANNU REV PSYCHOL, V31, P65, DOI 10.1146/annurev.ps.31.020180.000433; Battie MC, 2007, PAIN, V131, P272, DOI 10.1016/j.pain.2007.01.010; Christensen K, 2000, J GERONTOL A-BIOL, V55, pM446, DOI 10.1093/gerona/55.8.M446; Christensen K, 2003, BEHAV GENET, V33, P125, DOI 10.1023/A:1022501817781; Evans A, 2003, TWIN RES, V6, P432, DOI 10.1375/136905203770326439; Gravseth HM, 2007, EUR J EPIDEMIOL, V22, P533, DOI 10.1007/s10654-007-9139-9; Harkonmaki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003402; HARRIS JR, 1992, J GERONTOL, V47, pP213, DOI 10.1093/geronj/47.3.P213; Hettema JM, 2001, J NERV MENT DIS, V189, P413, DOI 10.1097/00005053-200107000-00001; Karlsson Nadine, 2006, Work, V27, P173; Kendler KS, 1999, ARCH GEN PSYCHIAT, V56, P39, DOI 10.1001/archpsyc.56.1.39; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Laivoranta-Nyman S, 2001, ANN RHEUM DIS, V60, P413, DOI 10.1136/ard.60.4.413; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Muthen B, 2005, J EDUC BEHAV STAT, V30, P27, DOI 10.3102/10769986030001027; Muthen L.K., 2009, MPLUS USERS GUIDE; Orstavik RE, 2007, J AFFECT DISORDERS, V99, P181, DOI 10.1016/j.jad.2006.09.011; Prescott CA, 1999, ALCOHOL CLIN EXP RES, V23, P1136, DOI 10.1111/j.1530-0277.1999.tb04270.x; Reinholdt S, 2010, WORK, V37, P41, DOI 10.3233/WOR-2010-1055; Reinholdt S, 2009, WORK, V34, P251, DOI 10.3233/WOR-2009-0923; Reynolds CA, 2005, DEV PSYCHOL, V41, P3, DOI 10.1037/0012-1649.41.1.3; SINGER JD, 1993, J EDUC STAT, V18, P155, DOI 10.2307/1165085; Svedberg P, 2001, J GERONTOL B-PSYCHOL, V56, pS171, DOI 10.1093/geronb/56.3.S171; Svedberg P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-763; Upmark M, 2002, SCAND J PUBLIC HEALT, V30, P191, DOI 10.1080/14034940210133861; WHO, 2004, GEND MENT HLTH RES W; WHO, 2019, INT STAT CLASS DIS R, V10th	34	52	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23143	10.1371/journal.pone.0023143	http://dx.doi.org/10.1371/journal.pone.0023143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803EC	21850258	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300043
J	Zuo, L; Youtz, DJ; Wold, LE				Zuo, Li; Youtz, Dane J.; Wold, Loren E.			Particulate Matter Exposure Exacerbates High Glucose-Induced Cardiomyocyte Dysfunction through ROS Generation	PLOS ONE			English	Article							REACTIVE OXYGEN; AIR-POLLUTION; NADPH OXIDASE; VENTRICULAR MYOCYTES; OXIDATIVE STRESS; DIABETIC CARDIOMYOPATHY; ULTRAFINE PARTICLES; HOSPITAL ADMISSIONS; ELECTRON-TRANSPORT; HEART	Diabetes mellitus and fine particulate matter from diesel exhaust (DEP) are both important contributors to the development of cardiovascular disease (CVD). Diabetes mellitus is a progressive disease with a high mortality rate in patients suffering from CVD, resulting in diabetic cardiomyopathy. Elevated DEP levels in the air are attributed to the development of various CVDs, presumably since fine DEP (<2.5 mu m in diameter) can be inhaled and gain access to the circulatory system. However, mechanisms defining how DEP affects diabetic or control cardiomyocyte function remain poorly understood. The purpose of the present study was to evaluate cardiomyocyte function and reactive oxygen species (ROS) generation in isolated rat ventricular myocytes exposed overnight to fine DEP (0.1 mu g/ml), and/or high glucose (HG, 25.5 mM). Our hypothesis was that DEP exposure exacerbates contractile dysfunction via ROS generation in cardiomyocytes exposed to HG. Ventricular myocytes were isolated from male adult Sprague-Dawley rats cultured overnight and sarcomeric contractile properties were evaluated, including: peak shortening normalized to baseline (PS), time-to-90% shortening (TPS90), time-to-90% relengthening (TR90) and maximal velocities of shortening/relengthening (+/- dL/dt), using an IonOptix field-stimulator system. ROS generation was determined using hydroethidine/ethidium confocal microscopy. We found that DEP exposure significantly increased TR90, decreased PS and +/- dL/dt, and enhanced intracellular ROS generation in myocytes exposed to HG. Further studies indicated that co-culture with antioxidants (0.25 mM Tiron and 0.5 mM N-Acetyl-L-cysteine) completely restored contractile function in DEP, HG and HG+DEP-treated myocytes. ROS generation was blocked in HG-treated cells with mitochondrial inhibition, while ROS generation was blocked in DEP-treated cells with NADPH oxidase inhibition. Our results suggest that DEP exacerbates myocardial dysfunction in isolated cardiomyocytes exposed to HG-containing media, which is potentially mediated by various ROS generation pathways.	[Zuo, Li; Youtz, Dane J.; Wold, Loren E.] Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA; [Zuo, Li; Wold, Loren E.] Ohio State Univ Coll Med, Dept Pediat, Columbus, OH USA; [Wold, Loren E.] Ohio State Univ Coll Med, Dept Physiol & Cell Biol, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Zuo, L (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA.	Loren.Wold@nationwidechildrens.org	Wold, Loren E/E-4320-2011		American Heart Association [0835298N]; Research Institute at Nationwide Children's Hospital; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019923] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by an American Heart Association Scientific Development Grant to Dr. Loren E. Wold (No. 0835298N) as well as funds from the Research Institute at Nationwide Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2010, AGING-US, V2, P1012, DOI 10.18632/aging.100261; AlMehdi AB, 1997, AM J PHYSIOL-LUNG C, V272, pL294, DOI 10.1152/ajplung.1997.272.2.L294; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Clanton TL, 1999, P SOC EXP BIOL MED, V222, P253, DOI 10.1046/j.1525-1373.1999.d01-142.x; Costa VM, 2009, TOXICOLOGY, V260, P84, DOI 10.1016/j.tox.2009.03.012; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dominici F, 2003, AM J EPIDEMIOL, V157, P1055, DOI 10.1093/aje/kwg087; Donaldson K, 2001, INT J HYG ENVIR HEAL, V203, P411, DOI 10.1078/1438-4639-00059; GALDERISI M, 1991, AM J CARDIOL, V68, P85, DOI 10.1016/0002-9149(91)90716-X; Godenschwege T, 2009, GENETICS, V183, P175, DOI 10.1534/genetics.109.103515; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Li R, 2009, FREE RADICAL BIO MED, V46, P775, DOI 10.1016/j.freeradbiomed.2008.11.025; Menon SG, 2007, CANCER RES, V67, P6392, DOI 10.1158/0008-5472.CAN-07-0225; Mo YQ, 2009, TOXICOL APPL PHARM, V236, P183, DOI 10.1016/j.taap.2009.01.017; MohazzabH KM, 1997, CIRCULATION, V96, P614; Monforton C, 2006, AM J PUBLIC HEALTH, V96, P271, DOI 10.2105/AJPH.2005.064410; Nethery D, 1999, J APPL PHYSIOL, V87, P792, DOI 10.1152/jappl.1999.87.2.792; Pani G, 2010, AGING-US, V2, P514, DOI 10.18632/aging.100182; Pope CA, 2008, AM J CARDIOL, V102, P1230, DOI 10.1016/j.amjcard.2008.06.044; Privratsky JR, 2003, HYPERTENSION, V42, P206, DOI 10.1161/01.HYP.0000082814.62655.85; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; Ren J, 1997, AM J PHYSIOL-HEART C, V272, pH148, DOI 10.1152/ajpheart.1997.272.1.H148; Ren J, 1999, DIABETES, V48, P2059, DOI 10.2337/diabetes.48.10.2059; Ren J, 1997, AM J PHYSIOL-HEART C, V273, pH2876, DOI 10.1152/ajpheart.1997.273.6.H2876; Ren Jun, 1997, Circulation, V96, pI314; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Schaffer SW, 1997, MOL CELL BIOCHEM, V176, P219, DOI 10.1023/A:1006801128850; Schaffer SW, 1997, CARDIOVASC RES, V34, P129, DOI 10.1016/S0008-6363(97)00020-5; SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Simkhovich BZ, 2007, BASIC RES CARDIOL, V102, P467, DOI 10.1007/s00395-007-0681-0; Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967; Sun QH, 2008, INHAL TOXICOL, V20, P127, DOI [10.1080/08958370701821482, 10.1080/08958370701821482 ]; Sunyer J, 2003, EUR HEART J, V24, P752, DOI 10.1016/S0195-668X(02)00808-4; SYROVY I, 1992, GEN PHYSIOL BIOPHYS, V11, P301; Vinciguerra M, 2010, AGING-US, V2, P43; Wang Jianxun, 2006, Review of Diabetic Studies, V3, P108, DOI 10.1900/RDS.2006.3.108; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; Wold LE, 2001, J MOL CELL CARDIOL, V33, P1719, DOI 10.1006/jmcc.2001.1431; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Zhu XH, 2007, ANTIOXID REDOX SIGN, V9, P447, DOI 10.1089/ars.2006.1389; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031; Zuo L, 2003, ANTIOXID REDOX SIGN, V5, P667, DOI 10.1089/152308603770310347; Zuo L, 2002, METHOD ENZYMOL, V352, P307; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058; Zuo L, 2009, J PHARMACOL EXP THER, V329, P515, DOI 10.1124/jpet.108.143479	53	45	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23116	10.1371/journal.pone.0023116	http://dx.doi.org/10.1371/journal.pone.0023116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850256	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300041
J	Kim, CS; Keum, SJ; Jang, SK				Kim, Chon Saeng; Keum, Sun Ju; Jang, Sung Key			Generation of a Cell Culture-Adapted Hepatitis C Virus with Longer Half Life at Physiological Temperature	PLOS ONE			English	Article							INFECTION IN-VITRO; ION-CHANNEL; P7 PROTEIN; COMPENSATORY MUTATIONS; ENVELOPE GLYCOPROTEIN; CORE PROTEIN; LOCALIZATION; BINDING; REPLICATION; POLYPEPTIDE	Background: We previously reported infectious HCV clones that contain the convenient reporters, green fluorescent protein (GFP) and Renilla luciferase (Rluc), in the NS5a-coding sequence. Although these viruses were useful in monitoring viral proliferation and screening of anti-HCV drugs, the infectivity and yield of the viruses were low. Methodology/Principal Findings: In order to obtain a highly efficient HCV cultivation system, we transfected Huh7.5.1 cells [1] with JFH 5a-GFP RNA and then cultivated cells for 20 days. We found a highly infectious HCV clone containing two cell culture-adapted mutations. Two cell culture-adapted mutations which were responsible for the increased viral infectivity were located in E2 and p7 protein coding regions. The viral titer of the variant was similar to 100-fold higher than that of the parental virus. The mutation in the E2 protein increased the viability of virus at 37 degrees C by acquiring prolonged interaction capability with a HCV receptor CD81. The wild-type and p7-mutated virus had a half-life of similar to 2.5 to 3 hours at 37 degrees C. In contrast, the half-life of viruses, which contained E2 mutation singly and combination with the p7 mutation, was 5 to 6 hours at 37 degrees C. The mutation in the p7 protein, either singly or in combination with the E2 mutation, enhanced infectious virus production about 10-50-fold by facilitating an early step of virion production. Conclusion/Significance: The mutation in the E2 protein generated by the culture system increases virion viability at 37 degrees C. The adaptive mutation in the p7 protein facilitates an earlier stage of virus production, such as virus assembly and/or morphogenesis. These reporter-containing HCV viruses harboring adaptive mutations are useful in investigations of the viral life cycle and for developing anti-viral agents against HCV.	[Kim, Chon Saeng; Keum, Sun Ju; Jang, Sung Key] Pohang Univ Sci & Technol, Mol Virol Lab, POSTECH Biotech Ctr, Dept Life Sci, Pohang, Kyungbuk, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Kyungbuk, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Biotechnol Res Ctr, Pohang, Kyungbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, CS (corresponding author), Pohang Univ Sci & Technol, Mol Virol Lab, POSTECH Biotech Ctr, Dept Life Sci, Pohang, Kyungbuk, South Korea.	sungkey@postech.ac.kr	Jang, Sung K/P-1230-2017		MEST [FPR08B1-220]; NRF [20100028447, 2010-0019706, 2010-0018167]; Korea government (MEST) [R31-2009-000-10105-0]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); NRF; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported in part by a grant FPR08B1-220 of the 21C Frontier Functional Proteomics Project from MEST, NRF NCRC grant (no. 20100028447), NRF BRL grant (no. 2010-0019706), Bio R&D program through the NRF grant (no. 2010-0018167) and WCU program through the NRF grant (no. R31-2009-000-10105-0) funded by the Korea government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bartenschlager R, 2001, ANTIVIR RES, V52, P1, DOI 10.1016/S0166-3542(01)00164-4; Bartenschlager R, 2005, P NATL ACAD SCI USA, V102, P9739, DOI 10.1073/pnas.0504296102; Carrere-Kremer S, 2002, J VIROL, V76, P3720, DOI 10.1128/JVI.76.8.3720-3730.2002; Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P231, DOI 10.1053/j.gastro.2005.11.010; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Griffin SDC, 2004, J GEN VIROL, V85, P451, DOI 10.1099/vir.0.19634-0; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Heathcote J, 2005, J VIRAL HEPATITIS, V12, P223, DOI 10.1111/j.1365-2893.2005.00600.x; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Kim CS, 2007, J VIROL, V81, P8814, DOI 10.1128/JVI.02824-06; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Layden TJ, 2000, SEMIN LIVER DIS, V20, P173, DOI 10.1055/s-2000-9940; LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Nakai K, 2006, J VIROL, V80, P11265, DOI 10.1128/JVI.01203-06; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sakai A, 2003, P NATL ACAD SCI USA, V100, P11646, DOI 10.1073/pnas.1834545100; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	39	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22808	10.1371/journal.pone.0022808	http://dx.doi.org/10.1371/journal.pone.0022808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829654	Green Submitted, gold, Green Published			2022-12-27	WOS:000293561200032
J	McMillan, DJ; Kaul, SY; Bramhachari, PV; Smeesters, PR; Vu, T; Karmarkar, MG; Shaila, MS; Sriprakash, KS				McMillan, David J.; Kaul, Santosh Y.; Bramhachari, P. V.; Smeesters, Pierre R.; Vu, Therese; Karmarkar, M. G.; Shaila, Melkote S.; Sriprakash, Kadaba S.			Recombination Drives Genetic Diversification of Streptococcus dysgalactiae Subspecies equisimilis in a Region of Streptococcal Endemicity	PLOS ONE			English	Article							BETA-HEMOLYTIC STREPTOCOCCI; GROUP-A; HORIZONTAL TRANSFER; EMM TYPES; GROUP-C; PYOGENES; INFECTIONS; DIVERSITY; DISEASE; PROTEIN	Infection of the skin or throat by Streptococcus dysgalactiae subspecies equisimilis (SDSE) may result in a number of human diseases. To understand mechanisms that give rise to new genetic variants in this species, we used multi-locus sequence typing (MLST) to characterise relationships in the SDSE population from India, a country where streptococcal disease is endemic. The study revealed Indian SDSE isolates have sequence types (STs) predominantly different to those reported from other regions of the world. Emm-ST combinations in India are also largely unique. Split decomposition analysis, the presence of emm-types in unrelated clonal complexes, and analysis of phylogenetic trees based on concatenated sequences all reveal an extensive history of recombination within the population. The ratio of recombination to mutation (r/m) events (11:1) and per site r/m ratio (41:1) in this population is twice as high as reported for SDSE from non-endemic regions. Recombination involving the emm-gene is also more frequent than recombination involving housekeeping genes, consistent with diversification of M proteins offering selective advantages to the pathogen. Our data demonstrate that genetic recombination in endemic regions is more frequent than non-endemic regions, and gives rise to novel local SDSE variants, some of which may have increased fitness or pathogenic potential.	[McMillan, David J.; Sriprakash, Kadaba S.] Queensland Inst Med Res, Bacterial Pathogenesis Lab, Brisbane, Qld 4006, Australia; [McMillan, David J.; Vu, Therese] Griffith Med Res Coll, Brisbane, Qld, Australia; [Kaul, Santosh Y.; Karmarkar, M. G.] King Edward Mem Hosp, Dept Microbiol, Bombay, Maharashtra, India; [Bramhachari, P. V.; Shaila, Melkote S.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Smeesters, Pierre R.] Univ Libre Bruxelles, Fac Sci, Inst Biol & Med Mol, Lab Genet & Physiol Bacterienne, Brussels, Belgium	QIMR Berghofer Medical Research Institute; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Indian Institute of Science (IISC) - Bangalore; Universite Libre de Bruxelles	McMillan, DJ (corresponding author), Queensland Inst Med Res, Bacterial Pathogenesis Lab, Brisbane, Qld 4006, Australia.	david.mcmillan@qimr.edu.au	McMillan, David/P-5582-2016; Smeesters, Pierre/I-7723-2012; Chari, Pallaval Veera Bramha/AAL-3587-2020	McMillan, David/0000-0002-9339-0639; Smeesters, Pierre/0000-0002-2642-9919; Chari, Pallaval Veera Bramha/0000-0003-0084-4652; Sriprakash, Kadaba/0000-0001-7844-323X; Vu, Therese/0000-0003-2831-2957; Vu, Therese/0000-0002-5924-9359	Australian Government National Health and Medical Research Council; National and International Alliance Program of Queensland, Australia; India-Australia Strategic Research Fund; Department of Biotechnology, India	Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National and International Alliance Program of Queensland, Australia; India-Australia Strategic Research Fund; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by an Australian Government National Health and Medical Research Council, National and International Alliance Program of Queensland, Australia, and India-Australia Strategic Research Fund and Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, J CLIN MICROBIOL, V47, P2046, DOI 10.1128/JCM.00246-09; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bramhachari PV, 2010, J MED MICROBIOL, V59, P220, DOI 10.1099/jmm.0.015644-0; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Broyles LN, 2009, CLIN INFECT DIS, V48, P706, DOI 10.1086/597035; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chhatwal G. S., 2006, Gram-positive pathogens, P213; Cohen-Poradosu R, 2004, EMERG INFECT DIS, V10, P1455, DOI 10.3201/eid1008.030840; Davies MR, 2007, CLIN INFECT DIS, V44, P1442, DOI 10.1086/516780; Davies MR, 2009, J BACTERIOL, V191, P2257, DOI 10.1128/JB.01624-08; Dey N, 2005, CLIN INFECT DIS, V40, P46, DOI 10.1086/426443; Efstratiou A, 1997, J APPL MICROBIOL, V83, pS72, DOI 10.1046/j.1365-2672.83.s1.8.x; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hartas J, 1998, J CLIN MICROBIOL, V36, P1428, DOI 10.1128/JCM.36.5.1428-1429.1998; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ikebe T, 2004, EPIDEMIOL INFECT, V132, P145, DOI 10.1017/S0950268803001262; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopardo HA, 2005, J CLIN MICROBIOL, V43, P802, DOI 10.1128/JCM.43.2.802-807.2005; McDonald M, 2007, EMERG INFECT DIS, V13, P1694, DOI 10.3201/eid1311.061258; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; McMillan DJ, 2010, EUR J CLIN MICROBIOL, V29, P585, DOI 10.1007/s10096-010-0899-x; McMillan DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011741; Menon T, 2008, J MED MICROBIOL, V57, P540, DOI 10.1099/jmm.0.47726-0; Padmavati S, 2001, HEART, V86, P127, DOI 10.1136/heart.86.2.127; Panchaud A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-198; Pinho MD, 2006, J CLIN MICROBIOL, V44, P841, DOI 10.1128/JCM.44.3.841-846.2006; Shet Anita, 2004, Indian Journal of Pediatrics, V71, P41, DOI 10.1007/BF02725655; SIMPSON WJ, 1992, INFECT IMMUN, V60, P1890, DOI 10.1128/IAI.60.5.1890-1893.1992; SKOGBERG K, 1988, SCAND J INFECT DIS, V20, P119, DOI 10.3109/00365548809032427; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Sriprakash KS, 1996, MICROB PATHOGENESIS, V20, P275, DOI 10.1006/mpat.1996.0026; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Towers RJ, 2004, J CLIN MICROBIOL, V42, P5357, DOI 10.1128/JCM.42.11.5357-5361.2004	42	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e21346	10.1371/journal.pone.0021346	http://dx.doi.org/10.1371/journal.pone.0021346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857905	Green Published, Green Accepted, gold			2022-12-27	WOS:000293558900006
J	Iguchi, N; Ohkuri, T; Slack, JP; Zhong, P; Huang, LQ				Iguchi, Naoko; Ohkuri, Tadahiro; Slack, Jay P.; Zhong, Ping; Huang, Liquan			Sarco/Endoplasmic Reticulum Ca2+-ATPases (SERCA) Contribute to GPCR-Mediated Taste Perception	PLOS ONE			English	Article							MAMMALIAN TASTE; RECEPTOR-CELLS; UMAMI TASTE; SWEET TASTE; SIGNAL-TRANSDUCTION; TRANSIENT RECEPTOR; CALCIUM LEVELS; MICE LACKING; ACID TASTE; MOUSE	The sense of taste is important for providing animals with valuable information about the qualities of food, such as nutritional or harmful nature. Mammals, including humans, can recognize at least five primary taste qualities: sweet, umami (savory), bitter, sour, and salty. Recent studies have identified molecules and mechanisms underlying the initial steps of tastant-triggered molecular events in taste bud cells, particularly the requirement of increased cytosolic free Ca2+ concentration ([Ca2+](c)) for normal taste signal transduction and transmission. Little, however, is known about the mechanisms controlling the removal of elevated [Ca2+](c) from the cytosol of taste receptor cells (TRCs) and how the disruption of these mechanisms affects taste perception. To investigate the molecular mechanism of Ca2+ clearance in TRCs, we sought the molecules involved in [Ca2+](c) regulation using a single-taste-cell transcriptome approach. We found that Serca3, a member of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) family that sequesters cytosolic Ca2+ into endoplasmic reticulum, is exclusively expressed in sweet/umami/bitter TRCs, which rely on intracellular Ca2+ release for signaling. Serca3-knockout (KO) mice displayed significantly increased aversive behavioral responses and greater gustatory nerve responses to bitter taste substances but not to sweet or umami taste substances. Further studies showed that Serca2 was mainly expressed in the T1R3-expressing sweet and umami TRCs, suggesting that the loss of function of Serca3 was possibly compensated by Serca2 in these TRCs in the mutant mice. Our data demonstrate that the SERCA family members play an important role in the Ca2+ clearance in TRCs and that mutation of these proteins may alter bitter and perhaps sweet and umami taste perception.	[Iguchi, Naoko; Ohkuri, Tadahiro; Huang, Liquan] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Slack, Jay P.; Zhong, Ping] Givaudan Flavors Corp, Cincinnati, OH USA	Monell Chemical Senses Center; Givaudan SA	Iguchi, N (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	lhuang@monell.org		Huang, Liquan/0000-0003-3400-0685; Iguchi, Nao/0000-0001-6244-7404	Givaudan Flavors Corporation; National Institutes of Health/National Institute on Deafness and Other Communication Disorders [DC007487]; National Science Foundation [DBJ-0216310]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007487] Funding Source: NIH RePORTER	Givaudan Flavors Corporation; National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was in part supported by Givaudan Flavors Corporation (http://www.givaudan.com/) and by grants from National Institutes of Health/National Institute on Deafness and Other Communication Disorders (DC007487 to L.H.)(http://www.nidcd.nih.gov/) and from the National Science Foundation (DBJ-0216310 to N. Rawson)(http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Bobe R, 2005, PLATELETS, V16, P133, DOI 10.1080/09537100400016847; BURK SE, 1989, J BIOL CHEM, V264, P18561; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chandrasekera PC, 2009, AM J PHYSIOL-CELL PH, V296, pC1105, DOI 10.1152/ajpcell.00650.2008; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Hacker K, 2008, J NEUROPHYSIOL, V100, P2177, DOI 10.1152/jn.90534.2008; Hennings JK, 2008, J NEUROCHEM, V106, P2249, DOI 10.1111/j.1471-4159.2008.05563.x; Hisatsune C, 2007, J BIOL CHEM, V282, P37225, DOI 10.1074/jbc.M705641200; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YA, 2008, J NEUROSCI, V28, P13088, DOI 10.1523/JNEUROSCI.4187-08.2008; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Laskowski AI, 2009, J PHYSIOL-LONDON, V587, P4077, DOI 10.1113/jphysiol.2009.173567; Lawton DM, 2000, EUR J NEUROSCI, V12, P3163, DOI 10.1046/j.1460-9568.2000.00207.x; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Liu LH, 1997, J BIOL CHEM, V272, P30538, DOI 10.1074/jbc.272.48.30538; Martin V, 2002, J BIOL CHEM, V277, P24442, DOI 10.1074/jbc.M202011200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Medler KF, 2010, CHEM SENSES, V35, P753, DOI 10.1093/chemse/bjq082; Medler KF, 2003, J NEUROSCI, V23, P2608; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ogura T, 1999, J NEUROPHYSIOL, V82, P2657, DOI 10.1152/jn.1999.82.5.2657; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Richter TA, 2003, J PHYSIOL-LONDON, V547, P475, DOI 10.1113/jphysiol.2002.033811; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Roper SD, 2007, PFLUG ARCH EUR J PHY, V454, P759, DOI 10.1007/s00424-007-0247-x; Seta Y, 2007, HISTOCHEM CELL BIOL, V127, P415, DOI 10.1007/s00418-006-0257-3; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shindo Y, 2008, BIOCHEM BIOPH RES CO, V376, P504, DOI 10.1016/j.bbrc.2008.09.035; Szebenyi SA, 2010, J NEUROPHYSIOL, V104, P529, DOI 10.1152/jn.00118.2010; Tizzano M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-110; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Weaver DL, 1999, METH MOL B, V97, P601, DOI 10.1385/1-59259-270-8:601; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	62	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23165	10.1371/journal.pone.0023165	http://dx.doi.org/10.1371/journal.pone.0023165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829714	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511900031
J	Shi, FT; Cheung, AP; Huang, HF; Leung, PCK				Shi, Feng-Tao; Cheung, Anthony P.; Huang, He-Feng; Leung, Peter C. K.			Growth Differentiation Factor 9 (GDF9) Suppresses Follistatin and Follistatin-Like 3 Production in Human Granulosa-Lutein Cells	PLOS ONE			English	Article							ACTIVIN-BINDING PROTEIN; POLYCYSTIC-OVARY-SYNDROME; IN-VITRO; PROGESTERONE PRODUCTION; HEPARAN-SULFATE; PITUITARY-CELLS; MENSTRUAL-CYCLE; HOMOLOG GDF-9B; FACTOR-BETA; EXPRESSION	Background: We have demonstrated that growth differentiation factor 9 (GDF9) enhances activin A-induced inhibin beta(B)-subunit mRNA levels in human granulosa-lutein (hGL) cells by regulating receptors and key intracellular components of the activin signaling pathway. However, we could not exclude its effects on follistatin (FST) and follistatin-like 3 (FSTL3), well recognized extracellular inhibitors of activin A. Methodology: hGL cells from women undergoing in vitro fertilization (IVF) treatment were cultured with and without siRNA transfection of FST, FSTL3 or GDF9 and then treated with GDF9, activin A, FST, FSTL3 or combinations. FST, FSTL3 and inhibin beta(B)-subunit mRNA, and FST, FSTL3 and inhibin B protein levels were assessed with real-time RT-PCR and ELISA, respectively. Data were log transformed before ANOVA followed by Tukey's test. Principal Findings: GDF9 suppressed basal FST and FSTL3 mRNA and protein levels in a time-and dose-dependent manner and inhibited activin A-induced FST and FSTL3 mRNA and protein expression, effects attenuated by BMPR2 extracellular domain (BMPR2 ECD), a GDF9 antagonist. After GDF9 siRNA transfection, basal and activin A-induced FST and FSTL3 mRNA and protein levels increased, but changes were reversed by adding GDF9. Reduced endogenous FST or FSTL3 expression with corresponding siRNA transfection augmented activin A-induced inhibin beta(B)-subunit mRNA levels as well as inhibin B levels (P values all <0.05). Furthermore, the enhancing effects of GDF9 in activin A-induced inhibin beta(B)-subunit mRNA and inhibin B production were attenuated by adding FST. Conclusion: GDF9 decreases basal and activin A-induced FST and FSTL3 expression, and this explains, in part, its enhancing effects on activin A-induced inhibin beta(B)-subunit mRNA expression and inhibin B production in hGL cells.	[Shi, Feng-Tao; Cheung, Anthony P.; Leung, Peter C. K.] Univ British Columbia, Dept Obstet & Gynaecol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Huang, He-Feng] Zhejiang Univ, Sch Med, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China	Child & Family Research Institute; University of British Columbia; Zhejiang University	Shi, FT (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	peleung@interchange.ubc.ca	Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020; Huang, He-Feng/AAN-7985-2020	Huang, He-Feng/0000-0003-4344-8019; Leung, Peter/0000-0003-3152-3800; Cheung, Anthony P/0000-0002-3266-494X	Canadian Institutes of Health Research; NSFC; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSFC(National Natural Science Foundation of China (NSFC)); Child and Family Research Institute	This study was supported by an operating grant from the Canadian Institutes of Health Research to P. C. K. L. and a grant from the CIHR and NSFC Joint Health Research Initiative ( to P. C. K. L. and H.-F.H.). P. C. K. L. is a recipient of a Distinguished Scientist Award of the Child and Family Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1999, J CLIN ENDOCR METAB, V84, P2744, DOI 10.1210/jc.84.8.2744; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; CATALDO NA, 1994, J CLIN ENDOCR METAB, V79, P272, DOI 10.1210/jc.79.1.272; DEMURA R, 1993, J CLIN ENDOCR METAB, V76, P1080, DOI 10.1210/jc.76.4.1080; DePaolo LV, 1997, P SOC EXP BIOL MED, V214, P328; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Eldar-Geva T, 2001, HUM REPROD, V16, P2552, DOI 10.1093/humrep/16.12.2552; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Gilchrist RB, 2004, BIOL REPROD, V71, P732, DOI 10.1095/biolreprod.104.028852; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Hashimoto O, 1997, J BIOL CHEM, V272, P13835, DOI 10.1074/jbc.272.21.13835; Hayashi M, 1999, ENDOCRINOLOGY, V140, P1236, DOI 10.1210/en.140.3.1236; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; HUTCHINSON LA, 1987, BIOCHEM BIOPH RES CO, V146, P1405, DOI 10.1016/0006-291X(87)90806-0; INOUYE S, 1991, ENDOCRINOLOGY, V129, P815, DOI 10.1210/endo-129-2-815; Jaatinen R, 1999, MOL CELL ENDOCRINOL, V156, P189, DOI 10.1016/S0303-7207(99)00100-8; Jardin F, 2011, BRIT J HAEMATOL, V153, P413, DOI 10.1111/j.1365-2141.2010.08556.x; KOGAWA K, 1991, ENDOCRINOLOGY, V128, P1434, DOI 10.1210/endo-128-3-1434; Liu ZH, 1996, ENDOCR J, V43, P321, DOI 10.1507/endocrj.43.321; Magill C, 1987, PROG BRAIN RES <D>, V71, P391; McConnell DS, 1998, J CLIN ENDOCR METAB, V83, P851, DOI 10.1210/jc.83.3.851; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; MICHEL U, 1990, BIOCHEM BIOPH RES CO, V173, P401, DOI 10.1016/S0006-291X(05)81072-1; MIRO F, 1991, ENDOCRINOLOGY, V129, P3388, DOI 10.1210/endo-129-6-3388; Myers M, 2008, J ENDOCRINOL, V199, P201, DOI 10.1677/JOE-08-0302; Myers M, 2007, ENDOCRINOLOGY, V148, P3730, DOI 10.1210/en.2007-0244; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Phillips DJ, 2000, BIOESSAYS, V22, P689, DOI 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5; Saito S, 2005, ENDOCRINOLOGY, V146, P5052, DOI 10.1210/en.2005-0833; Schneyer AL, 1996, ENDOCRINOLOGY, V137, P240, DOI 10.1210/en.137.1.240; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; Shi FT, 2010, J CLIN ENDOCR METAB, V95, pE172, DOI 10.1210/jc.2010-0477; Shi FT, 2009, J CLIN ENDOCR METAB, V94, P5108, DOI 10.1210/jc.2009-1047; Shi FT, 2009, ENDOCRINOLOGY, V150, P3540, DOI 10.1210/en.2009-0267; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Shintani Y, 1997, ENDOCRINOLOGY, V138, P2544, DOI 10.1210/en.138.6.2544; SHUKOVSKI L, 1990, ENDOCRINOLOGY, V126, P2222, DOI 10.1210/endo-126-4-2222; Sidis Y, 2002, ENDOCRINOLOGY, V143, P1613, DOI 10.1210/en.143.5.1613; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; SUGINO K, 1993, J BIOL CHEM, V268, P15579; SUMITOMO S, 1995, BIOCHEM BIOPH RES CO, V208, P1, DOI 10.1006/bbrc.1995.1297; TANO M, 1995, MOL CELL ENDOCRINOL, V109, P167, DOI 10.1016/0303-7207(95)03499-W; Teixeira FL, 2002, J CLIN ENDOCR METAB, V87, P1337, DOI 10.1210/jc.87.3.1337; Thadhani R, 2010, DIABETES CARE, V33, P664, DOI 10.2337/dc09-1745; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Urbanek M, 2000, J CLIN ENDOCR METAB, V85, P4455, DOI 10.1210/jc.85.12.4455; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Welt CK, 2004, SEMIN REPROD MED, V 22, P187, DOI 10.1055/s-2004-831894	54	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22866	10.1371/journal.pone.0022866	http://dx.doi.org/10.1371/journal.pone.0022866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829661	gold, Green Submitted, Green Published			2022-12-27	WOS:000293511200023
J	Jalanka-Tuovinen, J; Salonen, A; Nikkila, J; Immonen, O; Kekkonen, R; Lahti, L; Palva, A; de Vos, WM				Jalanka-Tuovinen, Jonna; Salonen, Anne; Nikkila, Janne; Immonen, Outi; Kekkonen, Riina; Lahti, Leo; Palva, Airi; de Vos, Willem M.			Intestinal Microbiota in Healthy Adults: Temporal Analysis Reveals Individual and Common Core and Relation to Intestinal Symptoms	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; 16S RIBOSOMAL-RNA; REAL-TIME PCR; GASTROINTESTINAL-TRACT MICROBIOTA; HUMAN FECAL SAMPLES; QUALITY-OF-LIFE; PHYLOGENETIC MICROARRAY; GUT MICROBIOTA; HUMAN FECES; OXALOBACTER-FORMIGENES	Background: While our knowledge of the intestinal microbiota during disease is accumulating, basic information of the microbiota in healthy subjects is still scarce. The aim of this study was to characterize the intestinal microbiota of healthy adults and specifically address its temporal stability, core microbiota and relation with intestinal symptoms. We carried out a longitudinal study by following a set of 15 healthy Finnish subjects for seven weeks and regularly assessed their intestinal bacteria and archaea with the Human Intestinal Tract (HIT) Chip, a phylogenetic microarray, in conjunction with qPCR analyses. The health perception and occurrence of intestinal symptoms was recorded by questionnaire at each sampling point. Principal Findings: A high overall temporal stability of the microbiota was observed. Five subjects showed transient microbiota destabilization, which correlated not only with the intake of antibiotics but also with overseas travelling and temporary illness, expanding the hitherto known factors affecting the intestinal microbiota. We identified significant correlations between the microbiota and common intestinal symptoms, including abdominal pain and bloating. The most striking finding was the inverse correlation between Bifidobacteria and abdominal pain: subjects who experienced pain had over five-fold less Bifidobacteria compared to those without pain. Finally, a novel computational approach was used to define the common core microbiota, highlighting the role of the analysis depth in finding the phylogenetic core and estimating its size. The in-depth analysis suggested that we share a substantial number of our intestinal phylotypes but as they represent highly variable proportions of the total community, many of them often remain undetected. Conclusions/Significance: A global and high-resolution microbiota analysis was carried out to determine the temporal stability, the associations with intestinal symptoms, and the individual and common core microbiota in healthy adults. The findings provide new approaches to define intestinal health and to further characterize the microbial communities inhabiting the human gut.	[Jalanka-Tuovinen, Jonna; Salonen, Anne; Nikkila, Janne; Immonen, Outi; Lahti, Leo; Palva, Airi; de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Kekkonen, Riina] Valio Ltd, Res & Dev, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands	University of Helsinki; Valio; Wageningen University & Research	Jalanka-Tuovinen, J (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	anne.salonen@helsinki.fi	Salonen, Anne/AAW-1858-2020; Lahti, Leo/G-3170-2010	Salonen, Anne/0000-0002-6960-7447; Lahti, Leo/0000-0001-5537-637X; jalanka, jonna/0000-0002-3847-8136	Finnish Funding Agency for Technology and Innovation [40274/06]	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was funded by the Finnish Funding Agency for Technology and Innovation (TEKES; grant number 40274/06). http://www.tekes.fi/en/community/Home/351/Home/473. One of the authors (RAK) is employed by a commercial company (Valio Ltd) and contributed to study design and sample collection. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto A, 1999, STAKES RES REPORTS, V101; Abell Guy C. J., 2006, Microbial Ecology in Health and Disease, V18, P154, DOI 10.1080/08910600601048969; Amouretti M, 2006, GASTROEN CLIN BIOL, V30, P241, DOI 10.1016/S0399-8320(06)73160-8; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Becker R, 1988, COMPUTER SCI SERIES; Bischoff SC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-24; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CLAESSON MJ, 2010, P NATL ACAD SCI U S1, V15, P4586; Cochetiere DL, 2005, J CLIN MICROBIOL, V43, P5588, DOI [10.1128/jcm.43.11.5588-5592.2005, DOI 10.1128/JCM.43.11.5588-5592.2005]; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Engelbrektson A, 2009, J MED MICROBIOL, V58, P663, DOI 10.1099/jmm.0.47615-0; Engelbrektson AL, 2006, FEMS MICROBIOL ECOL, V57, P239, DOI 10.1111/j.1574-6941.2006.00112.x; Faraway J.J., 2002, PRACTICAL REGRESSION; Fletcher Astrid, 1992, British Medical Journal, V305, P1145; Gralnek IM, 2000, GASTROENTEROLOGY, V119, P654, DOI 10.1053/gast.2000.16484; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; KOENIG JE, 2010, P NATL ACAD SCI U S1, V15, P4578; Lahti L, 2011, IEEE ACM T COMPUT BI, V8, P217, DOI 10.1109/TCBB.2009.38; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Malinen E, 2010, WORLD J GASTROENTERO, V16, P4532, DOI 10.3748/wjg.v16.i36.4532; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Maukonen J, 2006, FEMS MICROBIOL ECOL, V58, P517, DOI 10.1111/j.1574-6941.2006.00179.x; McKernan DP, 2010, NEUROGASTROENT MOTIL, V22, P1029, DOI 10.1111/j.1365-2982.2010.01520.x; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Myles H, 1973, NONPARAMETRIC STAT M, P68; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Pinheiro J, 2001, MIXED EFFECTS MODELS; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Salonen A, 2010, MICROBIOL-SGM, V156, P3205, DOI 10.1099/mic.0.043257-0; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sandler RS, 2000, DIGEST DIS SCI, V45, P1166, DOI 10.1023/A:1005554103531; Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Sidhu H, 1998, LANCET, V352, P1026, DOI 10.1016/S0140-6736(98)03038-4; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Stewart CS, 2004, FEMS MICROBIOL LETT, V230, P1, DOI 10.1016/S0378-1097(03)00864-4; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; The R Development CT, 2010, R LANG ENV STAT COMP; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ufnar JA, 2006, J APPL MICROBIOL, V101, P44, DOI 10.1111/j.1365-2672.2006.02989.x; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; VLIEG JEV, 2011, CURR OPIN BIOTECHNOL; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wong E, 1998, EUR J SURG, V164, P50, DOI 10.1080/11024159850191247; Wooley JC, 2010, J COMPUT SCI TECH-CH, V25, P71, DOI 10.1007/s11390-010-9306-4; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	69	235	245	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e23035	10.1371/journal.pone.0023035	http://dx.doi.org/10.1371/journal.pone.0023035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829582	gold, Green Published, Green Submitted			2022-12-27	WOS:000293284600074
J	Feng, SR; Cen, JN; Huang, YH; Shen, HJ; Yao, L; Wang, YY; Chen, ZX				Feng, Saran; Cen, Jiannong; Huang, Yihong; Shen, Hongjie; Yao, Li; Wang, Yuanyuan; Chen, Zixing			Matrix Metalloproteinase-2 and-9 Secreted by Leukemic Cells Increase the Permeability of Blood-Brain Barrier by Disrupting Tight Junction Proteins	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; FOCAL CEREBRAL-ISCHEMIA; INVASIVE CAPACITY; ENDOTHELIAL-CELLS; MEDIATED DISRUPTION; MONOCYTIC LEUKEMIA; CANCER METASTASIS; TISSUE INHIBITORS; OCCLUDIN	Central nervous system (CNS) involvement remains an important cause of morbidity and mortality in acute leukemia, the mechanisms of leukemic cell infiltration into the CNS have not yet been elucidated. The blood-brain barrier (BBB) makes CNS become a refugee to leukemic cells and serves as a resource of cells that seed extraneural sites. How can the leukemic cells disrupt this barrier and invasive the CNS, even if many of the currently available chemotherapies can not cross the BBB? Tight junction in endothelial cells occupies a central role in the function of the BBB. Except the well known role of degrading extracellular matrix in metastasis of cancer cells, here we show matrix metalloproteinase (MMP)-2 and -9, secreted by leukemic cells, mediate the BBB opening by disrupting tight junction proteins in the CNS leukemia. We demonstrated that leukemic cells impaired tight junction proteins ZO-1, claudin-5 and occludin resulting in increased permeability of the BBB. However, these alterations reduced when MMP-2 and -9 activities were inhibited by RNA interference strategy or by MMP inhibitor GM6001 in an in vitro BBB model. We also found that the disruption of the BBB in company with the downregulation of ZO-1, claudin-5 and occludin and the up-regulation of MMP-2 and -9 in mouse brain tissues with leukemic cell infiltration by confocal imaging and the assay of in situ gelatin zymography. Besides, GM6001 protected all mice against CNS leukemia. Our findings suggest that the degradation of tight junction proteins ZO-1, claudin-5 and occludin by MMP-2 and -9 secreted by leukemic cells constitutes an important mechanism in the BBB breakdown which contributes to the invasion of leukemic cells to the CNS in acute leukemia.	[Feng, Saran; Cen, Jiannong; Shen, Hongjie; Yao, Li; Wang, Yuanyuan; Chen, Zixing] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol,Leukemia Res Unit, Key Lab Thrombosis & Hemostasis,Minist Hlth, Suzhou, Peoples R China; [Huang, Yihong] Xuzhou Med Coll, Affiliated Hosp, Dept Hematol, Xuzhou, Peoples R China; [Feng, Saran] Xuzhou Cent Hosp, Dept Hematol, Xuzhou, Peoples R China	Soochow University - China; Xuzhou Medical University	Feng, SR (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol,Leukemia Res Unit, Key Lab Thrombosis & Hemostasis,Minist Hlth, Suzhou, Peoples R China.	szchenzx@263.net	Lv, Yuanjie/AER-0767-2022		The National Natural Scientific Foundation of China [30670905]	The National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by a grant (30670905) from The National Natural Scientific Foundation of China, http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Chen KM, 2006, INT J EXP PATHOL, V87, P113, DOI 10.1111/j.0959-9673.2006.00459.x; Chen SD, 2005, INT J ELEC POWER, V27, P53, DOI 10.1016/j.ijepes.2004.08.008; Cunnea P, 2010, ACTA NEUROPATHOL, V119, P601, DOI 10.1007/s00401-009-0618-9; Demers M, 2005, CRIT REV IMMUNOL, V25, P493, DOI 10.1615/CritRevImmunol.v25.i6.30; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fedwick JP, 2005, INFECT IMMUN, V73, P7844, DOI 10.1128/IAI.73.12.7844-7852.2005; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Janowska-Wieczorek A, 1999, BRIT J HAEMATOL, V105, P402, DOI 10.1046/j.1365-2141.1999.01352.x; Johnston DL, 2005, J CLIN ONCOL, V23, P9172, DOI 10.1200/JCO.2005.02.7482; Klein G, 2004, CRIT REV ONCOL HEMAT, V50, P87, DOI 10.1016/j.critevonc.2003.09.001; Laningham FH, 2007, NEURORADIOLOGY, V49, P873, DOI 10.1007/s00234-007-0300-7; Latorre IJ, 2005, J CELL SCI, V118, P4283, DOI 10.1242/jcs.02560; Li ZJ, 2006, EUR J HAEMATOL, V77, P128, DOI 10.1111/j.1600-0609.2006.00686.x; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Lin LI, 2002, BRIT J HAEMATOL, V117, P835, DOI 10.1046/j.1365-2141.2002.03510.x; Lischper M, 2010, BRAIN RES, V1326, P114, DOI 10.1016/j.brainres.2010.02.054; Liu WL, 2009, J NEUROCHEM, V108, P811, DOI 10.1111/j.1471-4159.2008.05821.x; Martin TA, 2002, J CELL PHYSIOL, V192, P268, DOI 10.1002/jcp.10133; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Paupert J, 2008, CELL CYCLE, V7, P1047, DOI 10.4161/cc.7.8.5645; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; Reikvam H, 2010, EUR J HAEMATOL, V84, P239, DOI 10.1111/j.1600-0609.2009.01382.x; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Sancho JM, 2006, CANCER-AM CANCER SOC, V106, P2540, DOI 10.1002/cncr.21948; Seelbach M, 2010, ENVIRON HEALTH PERSP, V118, P479, DOI 10.1289/ehp.0901334; Sulminoe A, 2007, LEUKEMIA RES, V31, P1437, DOI 10.1016/j.leukres.2007.01.015; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Wang CL, 2010, LEUKEMIA RES, V34, P1083, DOI 10.1016/j.leukres.2010.01.016; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	44	151	167	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e20599	10.1371/journal.pone.0020599	http://dx.doi.org/10.1371/journal.pone.0020599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857898	gold, Green Published, Green Submitted			2022-12-27	WOS:000294121300002
J	Li, B; Zhong, L; Yang, XL; Andersson, T; Huang, M; Tang, SJ				Li, Bei; Zhong, Ling; Yang, Xiangling; Andersson, Tommy; Huang, Min; Tang, Shao-Jun			WNT5A Signaling Contributes to A beta-Induced Neuroinflammation and Neurotoxicity	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; NF-KAPPA-B; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; PRESENILIN-1 TRANSGENES; BEHAVIORAL IMPAIRMENTS; FRIZZLED HOMOLOGS; HYDROGEN-PEROXIDE; GLIAL-CELLS; MOUSE MODEL	Neurodegenration is a pathological hallmark of Alzheimer's disease (AD), but the underlying molecular mechanism remains elusive. Here, we present evidence that reveals a crucial role of Wnt5a signaling in this process. We showed that Wnt5a and its receptor Frizzled-5 (Fz5) were up-regulated in the AD mouse brain, and that beta-amyloid peptide (A beta), a major constituent of amyloid plaques, stimulated Wnt5a and Fz5 expression in primary cortical cultures; these observations indicate that Wnt5a signaling could be aberrantly activated during AD pathogenesis. In support of such a possibility, we observed that inhibition of Wnt5a signaling attenuated while activation of Wnt5a signaling enhanced A beta-evoked neurotoxicity, suggesting a role of Wnt5a signaling in AD-related neurodegeneration. Furthermore, we also demonstrated that A beta-induced neurotoxicity depends on inflammatory processes, and that activation of Wnt5a signaling elicited the expression of proinflammatory cytokines IL-1 beta and TNF-alpha whereas inhibition of Wnt5a signaling attenuated the A beta-induced expression of the cytokines in cortical cultures. Our findings collectively suggest that aberrantly up-regulated Wnt5a signaling is a crucial pathological step that contributes to AD-related neurodegeneration by regulating neuroinflammation.	[Li, Bei; Tang, Shao-Jun] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Li, Bei; Zhong, Ling; Yang, Xiangling; Huang, Min] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Andersson, Tommy] Lund Univ, Dept Lab Med, Clin Res Ctr, Skane Univ Hosp, Malmo, Sweden	University of Texas System; University of Texas Medical Branch Galveston; Sun Yat Sen University; Lund University; Skane University Hospital	Li, B (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	shtang@utmb.edu			University of Texas Medical Branch; National Natural Science Foundation of China [30873457]; Scientific Technology Project of Guangdong Province of China [2008A060202010, 2010B050700019]; China Scholarship Council	University of Texas Medical Branch; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Project of Guangdong Province of China; China Scholarship Council(China Scholarship Council)	This work was supported by the start-up funds from the University of Texas Medical Branch to S-JT and by grant No. 30873457 from the National Natural Science Foundation of China and No. 2008A060202010 and 2010B050700019 from the Scientific Technology Project of Guangdong Province of China to LZ. BL is a Ph.D. student fellow supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Camilli TC, 2010, BIOCHEM PHARMACOL, V80, P702, DOI 10.1016/j.bcp.2010.03.002; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Carter MD, 2010, CLIN PHARMACOL THER, V88, P475, DOI 10.1038/clpt.2010.165; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chong YH, 1997, LIFE SCI, V61, P2323, DOI 10.1016/S0024-3205(97)00936-3; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; CRAWLEY JN, 2007, SHORT PROTOCOLS NEUR, P2; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Giovannini MG, 2002, NEUROBIOL DIS, V11, P257, DOI 10.1006/nbdi.2002.0538; GITTER BD, 1995, P NATL ACAD SCI USA, V92, P10738, DOI 10.1073/pnas.92.23.10738; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Gorlovoy P, 2009, FASEB J, V23, P2502, DOI 10.1096/fj.08-123877; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Kang DE, 1999, J NEUROSCI, V19, P4229; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Ma FY, 2011, ARQ NEURO-PSIQUIAT, V69, P105, DOI 10.1590/S0004-282X2011000100020; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Meda L, 1999, J NEUROIMMUNOL, V93, P45, DOI 10.1016/S0165-5728(98)00188-X; Parachikova A, 2010, J ALZHEIMERS DIS, V21, P527, DOI 10.3233/JAD-2010-100204; Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Scali C, 2003, NEUROSCIENCE, V117, P909, DOI 10.1016/S0306-4522(02)00839-4; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Suarez-Farinas M, 2011, J INVEST DERMATOL, V131, P391, DOI 10.1038/jid.2010.280; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Tang SJ, 2007, SYNAPSE, V61, P866, DOI 10.1002/syn.20434; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	67	55	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22920	10.1371/journal.pone.0022920	http://dx.doi.org/10.1371/journal.pone.0022920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857966	Green Published, Green Submitted, gold			2022-12-27	WOS:000294121300008
J	Dou, ZH; Xu, JH; Jiao, JH; Ma, Y; Durako, S; Yu, L; Zhao, Y; Zhang, FJ				Dou, Zhihui; Xu, Jiahong; Jiao, Jin Hua; Ma, Ye; Durako, Stephen; Yu, Lan; Zhao, Yan; Zhang, Fujie			Gender Difference in 2-Year Mortality and Immunological Response to ART in an HIV-Infected Chinese Population, 2006-2008	PLOS ONE			English	Article							UNITED-STATES; RNA LEVELS; PROGRESSION; WOMEN; AIDS	Background: Since it was initiated in 2002, the China Free Antiretroviral Treatment (ART) Program has been progressing from an emergency response to a standardized treatment and care system. As of December 31, 2009, a total of 81,880 patients in 31 provinces, autonomous regions, and special municipalities received free ART. Gender differences, however, in mortality and immunological response to ART in this cohort have never been described. Objective: To understand whether women and men who enrolled in the China National Free ART Program responded equally well to the treatment. Methods: A retrospective analysis of the national free ART databases from June 2006-December 2008 was performed. HIV-infected subjects who were 18 years or older, ART naive at baseline, and on a 3TC regimen enrolled in the program from June 1 to December 31, 2006, were included in this study, then followed up to 2 years. Results: Among 3457 enrolled subjects who met the inclusion criteria, 59.2% were male and 40.8% female. The majority of the subjects were 19-44 years old (77%) and married (72%). Over the full 24 months of follow-up, the mortality rate was 19.0% in males and 11.4% in females (p = 0.0014). Males on therapy for 3-24 months were more likely to die than females (HR = 1.46, 95% CI: 1.04-2.06, p = 0.0307) after adjusting for baseline characteristics. Compared to men, women had higher CD4+ counts over time after initiating ART (p < 0.0001). Conclusions: Our study showed that women had an overall lower mortality and higher CD4+ counts than men in response to ART treatment, which may be attributed to adherence, biological factors, social, cultural and economic reasons. Further study is needed to explore these factors that might contribute to the gender differences in mortality and immunological response to ART.	[Dou, Zhihui; Ma, Ye; Yu, Lan; Zhao, Yan; Zhang, Fujie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Xu, Jiahong; Jiao, Jin Hua; Durako, Stephen] Westat Corp, Rockville, MD USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Westat	Dou, ZH (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	treatment@chinaaids.cn			Chinese National Antiretroviral Treatment Program; U.S. National Institutes of Health [1R03TW008203-01]; FOGARTY INTERNATIONAL CENTER [R03TW008203] Funding Source: NIH RePORTER	Chinese National Antiretroviral Treatment Program; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Chinese National Antiretroviral Treatment Program, and by U.S. National Institutes of Health Research Grants (1R03TW008203-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhail A, 2010, UGANDA INT J WOMENS, V2, P45; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Heath KV, 2002, INT J EPIDEMIOL, V31, P1016, DOI 10.1093/ije/31.5.1016; Jain MK, 2003, CLIN INFECT DIS, V36, P1030, DOI 10.1086/368186; Joint United Nations Program on HIV/AIDS (UNAIDS), 2007, UNAIDS0727EJC1322E W; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Ma Y., 2009, P IEEE WORLD NONGR C, P1, DOI DOI 10.1109/NAPS.2009.5484048; Moore J, 1999, AIDS, V13, P2459, DOI 10.1097/00002030-199912030-00018; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Rotger Margalida, 2006, Curr HIV/AIDS Rep, V3, P118, DOI 10.1007/BF02696655; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; van Leth F, 2005, AIDS, V19, P463, DOI 10.1097/01.aids.0000162334.12815.5b; van Sighem AI, 2003, AIDS, V17, P2227, DOI 10.1097/00002030-200310170-00011; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	20	21	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22707	10.1371/journal.pone.0022707	http://dx.doi.org/10.1371/journal.pone.0022707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857947	Green Published, gold, Green Submitted			2022-12-27	WOS:000294125500011
J	Cervelli, T; Backovic, A; Galli, A				Cervelli, Tiziana; Backovic, Ana; Galli, Alvaro			Formation of AAV Single Stranded DNA Genome from a Circular Plasmid in Saccharomyces cerevisiae	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS; IN-VITRO REPLICATION; CIS-ACTING ELEMENT; TERMINAL REPEATS; YEAST-CELLS; NONDIVIDING CELLS; BINDING-PROTEIN; MODEL HOST; GENE	Adeno-associated virus (AAV)-based vectors are promising tools for targeted transfer in gene therapy studies. Many efforts have been accomplished to improve production and purification methods. We thought to develop a simple eukaryotic system allowing AAV replication which could provide an excellent opportunity for studying AAV biology and, more importantly, for AAV vector production. It has been shown that yeast Saccharomyces cerevisiae is able to replicate and form the capsid of many viruses. We investigated the ability of the yeast Saccharomyces cerevisiae to carry out the replication of a recombinant AAV (rAAV). When a plasmid containing a rAAV genome in which the cap gene was replaced with the S. cerevisiae URA3 gene, was co-transformed in yeast with a plasmid expressing Rep68, a significant number of URA3(+) clones were scored (more than 30-fold over controls). Molecular analysis of low molecular weight DNA by Southern blotting revealed that single stranded DNA is formed and that the plasmid is entirely replicated. The ssDNA contains the ITRs, URA3 gene and also vector sequences suggesting the presence of two distinct molecules. Its formation was dependent on Rep68 expression and ITR. These data indicate that DNA is not obtained by the canonical AAV replication pathway.	[Cervelli, Tiziana; Galli, Alvaro] CNR, Ist Fisiol Clin, Lab Terapia Gen & Mol, I-56100 Pisa, Italy; [Backovic, Ana] Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Scuola Normale Superiore di Pisa	Cervelli, T (corresponding author), CNR, Ist Fisiol Clin, Lab Terapia Gen & Mol, I-56100 Pisa, Italy.	alvaro.galli@ifc.cnr.it	Galli, Alvaro/K-3146-2018; Galli, Alvaro/AAL-7247-2020	Galli, Alvaro/0000-0002-9091-5639; 	Telethon-Italy [GGP09166]	Telethon-Italy(Fondazione Telethon)	The work was supported by the Grant n. GGP09166 assigned from Telethon-Italy to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER IE, 1994, J VIROL, V68, P8282, DOI 10.1128/JVI.68.12.8282-8287.1994; Alexander IE, 1996, HUM GENE THER, V7, P841, DOI 10.1089/hum.1996.7.7-841; Alves-Rodrigues I, 2006, VIRUS RES, V120, P49, DOI 10.1016/j.virusres.2005.11.018; Angeletti PC, 2005, METH MOLEC MED, V119, P247; Angeletti PC, 2002, J VIROL, V76, P3350, DOI 10.1128/JVI.76.7.3350-3358.2002; BLAKESLEY RW, 1977, J BIOL CHEM, V252, P7300; Cathomen T, 2000, J VIROL, V74, P2372, DOI 10.1128/JVI.74.5.2372-2382.2000; Cervelli T, 2008, J CELL SCI, V121, P349, DOI 10.1242/jcs.003632; CHEJANOVSKY N, 1989, VIROLOGY, V173, P120, DOI 10.1016/0042-6822(89)90227-4; Conrad CK, 1996, GENE THER, V3, P658; Delan-Forino C, 2011, J VIROL, V85, P3229, DOI 10.1128/JVI.01320-10; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; Galli A, 2003, GENETICS, V164, P65; Galli A, 1998, GENETICS, V149, P1235; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; GOTTLIEB J, 1988, MOL CELL BIOL, V8, P2513, DOI 10.1128/MCB.8.6.2513; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; HONG G, 1992, P NATL ACAD SCI USA, V89, P4673, DOI 10.1073/pnas.89.10.4673; Hughes Timothy R, 2002, Funct Integr Genomics, V2, P199, DOI 10.1007/s10142-002-0059-1; IM DS, 1992, J VIROL, V66, P1119, DOI 10.1128/JVI.66.2.1119-1128.1992; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; KYOSTIO SRM, 1995, J VIROL, V69, P6787; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Manivasakam P, 1998, MOL CELL BIOL, V18, P1736, DOI 10.1128/MCB.18.3.1736; Musatov S, 2002, J VIROL, V76, P12792, DOI 10.1128/JVI.76.24.12792-12802.2002; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; NI TH, 1994, J VIROL, V68, P1128, DOI 10.1128/JVI.68.2.1128-1138.1994; NISHIGAKI K, 1985, NUCLEIC ACIDS RES, V13, P5747, DOI 10.1093/nar/13.16.5747; Nony P, 2001, J VIROL, V75, P9991, DOI 10.1128/JVI.75.20.9991-9994.2001; Raghavan V, 2004, J VIROL, V78, P2405, DOI 10.1128/JVI.78.5.2405-2413.2004; Ryan JH, 1996, J VIROL, V70, P1542, DOI 10.1128/JVI.70.3.1542-1553.1996; SAMULSKI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P2077, DOI 10.1073/pnas.79.6.2077; SAMULSKI RJ, 1983, CELL, V33, P135, DOI 10.1016/0092-8674(83)90342-2; SCHIESTL RH, 1991, P NATL ACAD SCI USA, V88, P7585, DOI 10.1073/pnas.88.17.7585; SCHIESTL RH, 1993, MOL CELL BIOL, V13, P2697, DOI 10.1128/MCB.13.5.2697; Schwartz RA, 2007, J VIROL, V81, P12936, DOI 10.1128/JVI.01523-07; Smith RH, 1998, J VIROL, V72, P4874, DOI 10.1128/JVI.72.6.4874-4881.1998; Stanley M, 2007, BRIT J CANCER, V96, P1320, DOI 10.1038/sj.bjc.6603695; Surosky RT, 1997, J VIROL, V71, P7951, DOI 10.1128/JVI.71.10.7951-7959.1997; Tullis GE, 2000, J VIROL, V74, P11511, DOI 10.1128/JVI.74.24.11511-11521.2000; Urabe M, 2006, J VIROL, V80, P1874, DOI 10.1128/JVI.80.4.1874-1885.2006; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; WANG XS, 1995, J MOL BIOL, V250, P573, DOI 10.1006/jmbi.1995.0398; Wang XS, 1996, J VIROL, V70, P1668, DOI 10.1128/JVI.70.3.1668-1677.1996; Ward P, 2003, J VIROL, V77, P11480, DOI 10.1128/JVI.77.21.11480-11490.2003; WARD P, 1991, J MOL BIOL, V218, P791, DOI 10.1016/0022-2836(91)90267-A; WARD P, 1994, J VIROL, V68, P6029, DOI 10.1128/JVI.68.9.6029-6037.1994; Xiao X, 1997, J VIROL, V71, P941, DOI 10.1128/JVI.71.2.941-948.1997; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396; YALKINOGLU AO, 1991, J VIROL, V65, P3175, DOI 10.1128/JVI.65.6.3175-3184.1991; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001; Zhou CH, 1999, BBA-GENE STRUCT EXPR, V1444, P371, DOI 10.1016/S0167-4781(99)00014-7	58	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23474	10.1371/journal.pone.0023474	http://dx.doi.org/10.1371/journal.pone.0023474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853137	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200088
J	Choudhury, SR; Bisht, NC; Thompson, R; Todorov, O; Pandey, S				Choudhury, Swarup Roy; Bisht, Naveen C.; Thompson, Rheannon; Todorov, Oleg; Pandey, Sona			Conventional and Novel G gamma Protein Families Constitute the Heterotrimeric G-Protein Signaling Network in Soybean	PLOS ONE			English	Article							GTP-BINDING PROTEINS; ARABIDOPSIS-THALIANA; G-BETA; EXTRA-LARGE; NATURAL VARIATION; COUPLED RECEPTOR; CONTROL REGION; BLUE-LIGHT; SUBUNIT; ACID	Heterotrimeric G-proteins comprised of G alpha, G beta and G gamma proteins are important signal transducers in all eukaryotes. The G gamma protein of the G-protein heterotrimer is crucial for its proper targeting at the plasma membrane and correct functioning. G gamma proteins are significantly smaller and more diverse than the G alpha and G beta proteins. In model plants Arabidopsis and rice that have a single G alpha and G beta protein, the presence of two canonical G gamma proteins provide some diversity to the possible heterotrimeric combinations. Our recent analysis of the latest version of the soybean genome has identified ten G gamma proteins which belong to three distinct families based on their C-termini. We amplified the full length cDNAs, analyzed their detailed expression profile by quantitative PCR, assessed their localization and performed yeast-based interaction analysis to evaluate interaction specificity with different G beta proteins. Our results show that ten G gamma genes are retained in the soybean genome and have interesting expression profiles across different developmental stages. Six of the newly identified proteins belong to two plant-specific G gamma protein families. Yeast-based interaction analyses predict some degree of interaction specificity between different G beta and G gamma proteins. This research thus identifies a highly diverse G-protein network from a plant species. Homologs of these novel proteins have been previously identified as QTLs for grain size and yield in rice.	[Choudhury, Swarup Roy; Bisht, Naveen C.; Thompson, Rheannon; Todorov, Oleg; Pandey, Sona] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Choudhury, SR (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.		Pandey, Sona/M-2847-2013	Pandey, Sona/0000-0002-5570-3120	National Institute for Plant Genome Research, India; National Science Foundation [0851838]; United States Department of Agriculture/Agriculture and Food Research Initiative [2010-65116-20454]	National Institute for Plant Genome Research, India; National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture/Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	NB was supported by a visiting scholar fellowship from National Institute for Plant Genome Research, India and RT was supported by an National Science Foundation-Research Experiences for Undergraduates grant, (0851838). This work was supported by a United States Department of Agriculture/Agriculture and Food Research Initiative grant to SP, (2010-65116-20454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Bisht NC, 2011, NEW PHYTOL, V190, P35, DOI 10.1111/j.1469-8137.2010.03581.x; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen Jin-Gui, 2008, Front Biosci, V13, P3321; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Crowell DN, 2009, TRENDS PLANT SCI, V14, P163, DOI 10.1016/j.tplants.2008.12.001; De Los Santos-Briones C, 2009, PHYSIOL PLANTARUM, V135, P237, DOI 10.1111/j.1399-3054.2008.01184.x; den Hartog M, 2001, PLANT J, V25, P55, DOI 10.1046/j.1365-313x.2001.00931.x; Ding L, 2008, PLANT J, V53, P248, DOI 10.1111/j.1365-313X.2007.03335.x; Dingus J, 2005, BIOCHEMISTRY-US, V44, P11882, DOI 10.1021/bi0504254; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; FUKADA Y, 1995, METHOD ENZYMOL, V250, P91; Gautam N, 2003, STRUCTURE, V11, P359, DOI 10.1016/S0969-2126(03)00054-6; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kato C, 2004, PLANT J, V38, P320, DOI 10.1111/j.1365-313X.2004.02046.x; Kelly MN, 2003, PLANTA, V216, P674, DOI 10.1007/s00425-002-0900-8; Kino T, 2005, EUR J CLIN INVEST, V35, P508, DOI 10.1111/j.1365-2362.2005.01539.x; Lee YRJ, 1999, PLANT MOL BIOL, V40, P55, DOI 10.1023/A:1026483823176; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; McIntire WE, 2009, NEUROSIGNALS, V17, P82, DOI 10.1159/000186692; Misra S, 2007, PLANT J, V51, P656, DOI 10.1111/j.1365-313X.2007.03169.x; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Pandey S, 2008, PLANT J, V55, P311, DOI 10.1111/j.1365-313X.2008.03506.x; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Pingret JL, 1998, PLANT CELL, V10, P659; Prinz WA, 2009, CRIT REV BIOCHEM MOL, V44, P278, DOI 10.1080/10409230903183472; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Subramanian S, 2004, PLANT MOL BIOL, V54, P623, DOI 10.1023/B:PLAN.0000040814.28507.35; Sun J, 2007, PLANT PHYSIOL, V144, P695, DOI 10.1104/pp.106.093294; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Trusov Y, 2008, PLANT PHYSIOL, V147, P636, DOI 10.1104/pp.108.117655; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Ueguchi-Tanaka M, 2000, P NATL ACAD SCI USA, V97, P11638, DOI 10.1073/pnas.97.21.11638; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Warpeha KM, 2008, PLANT CELL ENVIRON, V31, P1756, DOI 10.1111/j.1365-3040.2008.01878.x; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; WILCOX MD, 1995, J BIOL CHEM, V270, P4189, DOI 10.1074/jbc.270.9.4189; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583	59	47	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23361	10.1371/journal.pone.0023361	http://dx.doi.org/10.1371/journal.pone.0023361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853116	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200073
J	Henk, DA; Fisher, MC				Henk, Daniel A.; Fisher, Matthew C.			Genetic Diversity, Recombination, and Divergence in Animal Associated Penicillium dipodomyis	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; TERVERTICILLATE PENICILLIA; SEXUAL REPRODUCTION; CHEEK POUCHES; ASPERGILLUS; IDENTIFICATION; CHRYSOGENUM; SPECIATION; DISCOVERY; EVOLUTION	Penicillium dipodomyis is thought to be an exclusively asexual fungus associated with Kangaroo Rats, Dipodomys species, and is unique among Penicillium species in growing at 37 degrees C but producing no known toxins. Lack of recombination within P. dipodomyis would result in limited adaptive flexibility but possibly enhance local adaptation and host selection via maintenance of favourable genotypes. Here, analysis of DNA sequence data from five protein-coding genes shows that recombination occurs within P. dipodomyis on a small spatial scale. Furthermore, detection of mating-type alleles supports outcrossing and a sexual cycle in P. dipodomyis. P. dipodomyis was a weaker competitor in in vitro assays with other Penicillium species found in association with Kanagaroo rats. Bayesian species level analysis suggests that the P. dipodomyis lineage diverged from closely related species also found in cheek pouches of Kangaroo Rats and their stored seeds about 11 million years ago, a similar divergence time as Dipodomys from its sister rodent taxa.	[Henk, Daniel A.; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Henk, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	d.henk@imperial.ac.uk	Fisher, Matthew/B-9094-2011	Fisher, Matthew/0000-0002-1862-6402	Leverhulme Trust [F/07/058/AJ]; Wellcome Trust [084616/A/08/Z]	Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants to Dr. Matthew Fisher's lab at Imperial College London from the Leverhulme Trust [F/07/058/AJ] (http://www.leverhulme.ac.uk/) and the Wellcome Trust [084616/A/08/Z] (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MD, 2009, MICROSC RES TECHNIQ, V72, P482, DOI 10.1002/jemt.20695; Banke S, 1997, MYCOL RES, V101, P617, DOI 10.1017/S0953756296003048; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eagle C, 2009, MATING TYPE GENES SE, P371; Frisvad JC, 2004, STUD MYCOL, P1; FRISVAD JC, 1987, CAN J BOT, V65, P765, DOI 10.1139/b87-102; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Hafner JC, 2007, J MAMMAL, V88, P1129, DOI 10.1644/06-MAMM-A-413R1.1; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Heitman Joseph, 2011, Fungal Biology Reviews, V25, P48, DOI 10.1016/j.fbr.2011.01.003; Heitman J, 2010, CELL HOST MICROBE, V8, P86, DOI 10.1016/j.chom.2010.06.011; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hoff B, 2008, EUKARYOT CELL, V7, P465, DOI 10.1128/EC.00430-07; Houbraken J, 2008, APPL ENVIRON MICROB, V74, P1613, DOI 10.1128/AEM.01761-07; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maddison WPDRM, 2002, MACCLADE VER 4 0 COM; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Poggeler S, 2002, CURR GENET, V42, P153, DOI 10.1007/s00294-002-0338-3; REICHMAN OJ, 1986, ANIM BEHAV, V34, P221, DOI 10.1016/0003-3472(86)90026-6; REICHMAN OJ, 1985, ANIM BEHAV, V33, P726, DOI 10.1016/S0003-3472(85)80003-8; Scazzocchio C, 2006, TRENDS GENET, V22, P521, DOI 10.1016/j.tig.2006.08.004; Scott J, 2004, MYCOLOGIA, V96, P1095, DOI 10.2307/3762092; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; WICKLOW DT, 1988, MYCOLOGIA, V80, P750, DOI 10.2307/3807732	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22883	10.1371/journal.pone.0022883	http://dx.doi.org/10.1371/journal.pone.0022883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850241	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300026
J	Schimpl, M; Lederer, C; Daumer, M				Schimpl, Michaela; Lederer, Christian; Daumer, Martin			Development and Validation of a New Method to Measure Walking Speed in Free-Living Environments Using the Actibelt (R) Platform	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; STATISTICAL-METHODS; ASSESSING AGREEMENT; ENERGY-EXPENDITURE; ACTIVITY MONITOR; RELIABILITY; DISABILITY; VALIDITY; PARAMETERS; ADULTS	Walking speed is a fundamental indicator for human well-being. In a clinical setting, walking speed is typically measured by means of walking tests using different protocols. However, walking speed obtained in this way is unlikely to be representative of the conditions in a free-living environment. Recently, mobile accelerometry has opened up the possibility to extract walking speed from long-time observations in free-living individuals, but the validity of these measurements needs to be determined. In this investigation, we have developed algorithms for walking speed prediction based on 3D accelerometry data (actibelt (R)) and created a framework using a standardized data set with gold standard annotations to facilitate the validation and comparison of these algorithms. For this purpose 17 healthy subjects operated a newly developed mobile gold standard while walking/running on an indoor track. Subsequently, the validity of 12 candidate algorithms for walking speed prediction ranging from well-known simple approaches like combining step length with frequency to more sophisticated algorithms such as linear and non-linear models was assessed using statistical measures. As a result, a novel algorithm employing support vector regression was found to perform best with a concordance correlation coefficient of 0.93 (95% CI 0.92-0.94) and a coverage probability CP1 of 0.46 (95% CI 0.12-0.70) for a deviation of 0.1 m/s (CP2 0.78, CP3 0.94) when compared to the mobile gold standard while walking indoors. A smaller outdoor experiment confirmed those results with even better coverage probability. We conclude that walking speed thus obtained has the potential to help establish walking speed in free-living environments as a patient-oriented outcome measure.	[Schimpl, Michaela; Daumer, Martin] Trium Anal Online GmbH, Munich, Germany; [Schimpl, Michaela; Lederer, Christian; Daumer, Martin] Sylvia Lawry Ctr Multiple Sclerosis Res eV, Human Mot Inst, Munich, Germany		Schimpl, M (corresponding author), Trium Anal Online GmbH, Munich, Germany.	daumer@slcmsr.org			German Ministry for Education and Research (BMBF) [01GI0920]; EU [NETSIM (215820-2), VPHOP (FP7-223865)]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	This work was supported by grants from the German Ministry for Education and Research (BMBF, "German Competence Network Multiple Sclerosis" (KKNMS), 01GI0920), EU FP7 (NETSIM (215820-2) and VPHOP (FP7-223865)). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Bautmans I, 2011, GAIT POSTURE, V33, P366, DOI 10.1016/j.gaitpost.2010.12.003; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonomi AG, 2010, OBESITY, V18, P1845, DOI 10.1038/oby.2010.34; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; Boyd LA, 1997, GAIT POSTURE, V5, P165, DOI DOI 10.1016/S0966-6362(97)83397-8; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Czabke A, 2009, AMBIENT ASSISTED LIV; Daumer M, 2007, BIOMED TECH, V52, P149, DOI 10.1515/BMT.2007.028; Dimitriadou E, 2010, E1071 TU WIEN; Dobkin BH, 2011, STROKE; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Foster R, 2008, P I MECH ENG P-J SPO, V222, P53, DOI 10.1243/17543371JSET3; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Gijbels D, 2010, MULT SCLER J, V16, P618, DOI 10.1177/1352458510361357; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; Graham SE, 2004, J EXPO ANAL ENV EPID, V14, P23, DOI 10.1038/sj.jea.7500293; Hoogervorst ELJ, 2003, J NEUROL NEUROSUR PS, V74, P439, DOI 10.1136/jnnp.74.4.439; Lin L, 2002, J AM STAT ASSOC, V97, P257, DOI 10.1198/016214502753479392; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; R Core Team, 2021, R LANGUAGE ENV STAT; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Salzman SH, 2009, CHEST, V135, P1345, DOI 10.1378/chest.07-1682; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171; Scheermesser Mandy, 2008, 2008 Second International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth), P205, DOI 10.1109/PCTHEALTH.2008.4571071; Schimpl M, 2011, PLOS ONE IN PRESS; Sekiya N, 1998, GAIT POSTURE, V7, P225, DOI 10.1016/S0966-6362(98)00009-5; Studenski S, 2009, J NUTR HEALTH AGING, V13, P878, DOI 10.1007/s12603-009-0245-0; Terrier Philippe, 2005, J Neuroeng Rehabil, V2, P28, DOI 10.1186/1743-0003-2-28; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Vaney C, 1996, CLIN REHABIL, V10, P216, DOI DOI 10.1177/026921559601000306; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Yeoh WS, 2008, IEEE ENG MED BIO, P5184, DOI 10.1109/IEMBS.2008.4650382; Zhang K, 2003, OBES RES, V11, P33, DOI 10.1038/oby.2003.7; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	39	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23080	10.1371/journal.pone.0023080	http://dx.doi.org/10.1371/journal.pone.0023080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850254	Green Submitted, gold, Green Published			2022-12-27	WOS:000293563300039
J	Scyphers, SB; Powers, SP; Heck, KL; Byron, D				Scyphers, Steven B.; Powers, Sean P.; Heck, Kenneth L., Jr.; Byron, Dorothy			Oyster Reefs as Natural Breakwaters Mitigate Shoreline Loss and Facilitate Fisheries	PLOS ONE			English	Article							MULTIVARIATE-ANALYSIS; RELATIVE IMPORTANCE; ECOSYSTEM SERVICES; CHESAPEAKE BAY; HABITAT; RESTORATION; ESTUARINE; FISH; CONSERVATION; PREDATION	Shorelines at the interface of marine, estuarine and terrestrial biomes are among the most degraded and threatened habitats in the coastal zone because of their sensitivity to sea level rise, storms and increased human utilization. Previous efforts to protect shorelines have largely involved constructing bulkheads and seawalls which can detrimentally affect nearshore habitats. Recently, efforts have shifted towards "living shoreline" approaches that include biogenic breakwater reefs. Our study experimentally tested the efficacy of breakwater reefs constructed of oyster shell for protecting eroding coastal shorelines and their effect on nearshore fish and shellfish communities. Along two different stretches of eroding shoreline, we created replicated pairs of subtidal breakwater reefs and established unaltered reference areas as controls. At both sites we measured shoreline and bathymetric change and quantified oyster recruitment, fish and mobile macro-invertebrate abundances. Breakwater reef treatments mitigated shoreline retreat by more than 40% at one site, but overall vegetation retreat and erosion rates were high across all treatments and at both sites. Oyster settlement and subsequent survival were observed at both sites, with mean adult densities reaching more than eighty oysters m 22 at one site. We found the corridor between intertidal marsh and oyster reef breakwaters supported higher abundances and different communities of fishes than control plots without oyster reef habitat. Among the fishes and mobile invertebrates that appeared to be strongly enhanced were several economically-important species. Blue crabs (Callinectes sapidus) were the most clearly enhanced (+297%) by the presence of breakwater reefs, while red drum (Sciaenops ocellatus) (+108%), spotted seatrout (Cynoscion nebulosus) (+88%) and flounder (Paralichthys sp.) (+79%) also benefited. Although the vertical relief of the breakwater reefs was reduced over the course of our study and this compromised the shoreline protection capacity, the observed habitat value demonstrates ecological justification for future, more robust shoreline protection projects.	[Scyphers, Steven B.; Powers, Sean P.; Heck, Kenneth L., Jr.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Scyphers, Steven B.; Powers, Sean P.; Heck, Kenneth L., Jr.; Byron, Dorothy] Dauphin Isl Sea Lab, Dauphin Isl, AL USA	University of South Alabama; Dauphin Island Sea Lab	Scyphers, SB (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	sscyphers@disl.org		Powers, Sean/0000-0002-4770-9944; Byron, Dorothy/0000-0002-0274-5220	National Oceanic and Atmospheric Administration Fisheries Office of Habitat Restoration through the University of South Alabama; Northern Gulf Institute	National Oceanic and Atmospheric Administration Fisheries Office of Habitat Restoration through the University of South Alabama; Northern Gulf Institute	Funding for this project was provided by the National Oceanic and Atmospheric Administration Fisheries Office of Habitat Restoration through the University of South Alabama's Oyster Restoration Program and the Northern Gulf Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bilkovic DM, 2008, MAR ECOL PROG SER, V358, P27, DOI 10.3354/meps07279; Bostrom C, 1999, OECOLOGIA, V120, P162, DOI 10.1007/s004420050845; Brumbaugh R. D., 2008, BASINS COASTS NEWS, V2, P8; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2000, OECOLOGIA, V122, P98, DOI 10.1007/PL00008841; Chambers J.R., 1991, STEMMING TIDE COASTA; Coen LD, 1998, AM FISH S S, V22, P438; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CRAN, 2010, R LANG ENV STAT COMP; DAME RF, 1981, MAR ECOL PROG SER, V5, P115, DOI 10.3354/meps005115; Douglass S.L., 1999, SHORE BEACH, V67, P19; GARTON D, 1980, BIOL BULL, V158, P49, DOI 10.2307/1540757; Geraldi NR, 2009, MAR ECOL PROG SER, V389, P171, DOI 10.3354/meps08224; GOREAU TF, 1979, SCI AM, V241, P124, DOI 10.1038/scientificamerican0879-124; Gorley C.K., 2006, GETTING STARTED PRIM; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; GRABOWSKI JH, 2007, ECOSYSTEM ENG, V4; Gregalis KC, 2008, J SHELLFISH RES, V27, P1163, DOI 10.2983/0730-8000-27.5.1163; Gunter G., 1967, P621; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jordan SJ, 2009, ECOL SOC, V14; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; KIM CK, 2010, J GEOPHYS RES, V115, P1; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Mann R, 2007, J SHELLFISH RES, V26, P905, DOI 10.2983/0730-8000(2007)26[905:WORGIT]2.0.CO;2; Meyer DL, 1997, RESTOR ECOL, V5, P93, DOI 10.1046/j.1526-100X.1997.09710.x; Micheli F, 1999, CONSERV BIOL, V13, P869, DOI 10.1046/j.1523-1739.1999.98233.x; Minton MD, 1998, AM FISH S S, V22, P405; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Moksnes PO, 2006, MAR ECOL PROG SER, V308, P165, DOI 10.3354/meps308165; National Research Council (NRC), 2007, MITIGATING SHORE ERO; ORTH RJ, 1977, ECOLOGY MARINE BENTH, P281; Peterson CH, 2003, MAR ECOL PROG SER, V264, P297, DOI 10.3354/meps264297; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Pilkey O. H., 1988, J COASTAL RES, VSI4, P41, DOI DOI 10.2112/JCOASTRES-D-14A-00011.1; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; Roland RM, 2005, J COASTAL RES, V21, P453, DOI 10.2112/03-0079.1; Ronnback P, 1999, ECOL ECON, V29, P235, DOI 10.1016/S0921-8009(99)00016-6; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; ROZAS LP, 1987, MAR ECOL PROG SER, V38, P101, DOI 10.3354/meps038101; SCHROEDER WW, 1985, MISSISSIPPI ALABAMA, P102; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; THAYER GW, 2003, NOAA COASTAL OCEAN P, V23; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Vitousek P., 1997, SCIENCE, V277; WELLS HW, 1961, ECOL MONOGR, V31, P239, DOI 10.2307/1948554; WITTMAN J, 1985, NEW ENGLAND ECOLOGIC, V55, P421	58	208	216	18	223	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22396	10.1371/journal.pone.0022396	http://dx.doi.org/10.1371/journal.pone.0022396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850223	gold, Green Published			2022-12-27	WOS:000293563300007
J	Swaty, R; Blankenship, K; Hagen, S; Fargione, J; Smith, J; Patton, J				Swaty, Randy; Blankenship, Kori; Hagen, Sarah; Fargione, Joseph; Smith, Jim; Patton, Jeannie			Accounting for Ecosystem Alteration Doubles Estimates of Conservation Risk in the Conterminous United States	PLOS ONE			English	Article							SPECIES RICHNESS; HISTORICAL RANGE; FIRE; BIODIVERSITY; SIMULATION; MANAGEMENT; DIVERSITY; DYNAMICS; USA; COMMUNITIES	Previous national and global conservation assessments have relied on habitat conversion data to quantify conservation risk. However, in addition to habitat conversion to crop production or urban uses, ecosystem alteration (e.g., from logging, conversion to plantations, biological invasion, or fire suppression) is a large source of conservation risk. We add data quantifying ecosystem alteration on unconverted lands to arrive at a more accurate depiction of conservation risk for the conterminous United States. We quantify ecosystem alteration using a recent national assessment based on remote sensing of current vegetation compared with modeled reference natural vegetation conditions. Highly altered (but not converted) ecosystems comprise 23% of the conterminous United States, such that the number of critically endangered ecoregions in the United States is 156% higher than when calculated using habitat conversion data alone. Increased attention to natural resource management will be essential to address widespread ecosystem alteration and reduce conservation risk.	[Swaty, Randy] Nature Conservancy, Marquette, MI 49855 USA; [Blankenship, Kori] Nature Conservancy, Bend, OR USA; [Hagen, Sarah; Fargione, Joseph] Nature Conservancy, Minneapolis, MN USA; [Smith, Jim] Nature Conservancy, Jacksonville, FL USA; [Patton, Jeannie] Nature Conservancy, Boulder, CO USA	Nature Conservancy; Nature Conservancy; Nature Conservancy	Swaty, R (corresponding author), Nature Conservancy, Marquette, MI 49855 USA.	rswaty@tnc.org		Fargione, Joseph/0000-0002-0636-5380	TNC-LANDFIRE [10-CA-11132543-054]; U.S. Forest Service and Dept. of the Interior	TNC-LANDFIRE; U.S. Forest Service and Dept. of the Interior	This work was funded by the TNC-LANDFIRE Cooperative Agreement 10-CA-11132543-054 with the U.S. Forest Service and Dept. of the Interior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; [Anonymous], 2009, NATURESERVE CONS STA; BAILEY RG, 1983, ENVIRON MANAGE, V7, P365, DOI 10.1007/BF01866919; BAILEY RG, 1989, ENVIRON CONSERV, V16, P307, DOI 10.1017/S0376892900009711; Bradley BA, 2005, REMOTE SENS ENVIRON, V94, P204, DOI 10.1016/j.rse.2004.08.016; Brooks ML, 2006, J ARID ENVIRON, V67, P100, DOI 10.1016/j.jaridenv.2006.09.021; Carey AB, 2000, ECOL APPL, V10, P248, DOI 10.1890/1051-0761(2000)010[0248:EONFMS]2.0.CO;2; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cleland D. T, 2007, WO76 USDA FOR SERV, VWO-76; Dinerstein E., 1995, CONSERVATION ASSESSM; Donovan GH, 2007, FRONT ECOL ENVIRON, V5, P73, DOI 10.1890/1540-9295(2007)5[73:BCWYWF]2.0.CO;2; Fox BJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P19, DOI 10.1046/j.1365-2699.2000.00184.x; Groves C., 2000, DESIGNING GEOGRAPHY; Guyette RP, 2002, ECOSYSTEMS, V5, P472, DOI 10.1007/s10021-002-0115-7; Hann WJ, 2001, INT J WILDLAND FIRE, V10, P389, DOI 10.1071/WF01037; HERKERT JR, 1994, ECOL APPL, V4, P461, DOI 10.2307/1941950; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hurteau M, 2009, FRONT ECOL ENVIRON, V7, P409, DOI 10.1890/080049; Joern A, 2005, ECOLOGY, V86, P861, DOI 10.1890/04-0135; Keane RE, 2002, ECOL MODEL, V151, P29, DOI 10.1016/S0304-3800(01)00470-7; Knick ST, 2011, STUD AVIAN BIOL, P1; *LANDFIRE, 2009, LANDFIRE 1 0 0 VEG D; *LANDFIRE, 2007, LANDFIRE 1 1 0 FIR R; *LANDFIRE, 2009, LANDFIRE NAT W MIL O; *LANDFIRE, 2010, LANDFIRE NAT E MIL O; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Nicholson E, 2009, CONSERV BIOL, V23, P259, DOI 10.1111/j.1523-1739.2008.01158.x; Nonaka E, 2005, ECOL APPL, V15, P1727, DOI 10.1890/04-0902; Noss RF, 2006, RESTOR ECOL, V14, P4, DOI 10.1111/j.1526-100X.2006.00099.x; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; NOSS RF, 1995, NATL BIOL SERV, P1; Rodriguez JP, 2011, CONSERV BIOL, V25, P21, DOI 10.1111/j.1523-1739.2010.01598.x; Pratt S, 2006, LANDFIRE PROTOTYPE P, P277; Rodriguez JP, 2007, BIODIVERS CONSERV, V16, P183, DOI 10.1007/s10531-006-9102-1; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Shang BZ, 2004, ECOL MODEL, V180, P89, DOI 10.1016/j.ecolmodel.2004.01.020; Smith JE, 2002, CAN J BOT, V80, P186, DOI [10.1139/b02-003, 10.1139/B02-003]; Spies TA, 2007, ECOL APPL, V17, P48, DOI 10.1890/1051-0761(2007)017[0048:PEOFPO]2.0.CO;2; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Sullivan TP, 2001, J APPL ECOL, V38, P1234, DOI 10.1046/j.0021-8901.2001.00674.x; TEMPLETON AR, 2001, ECOLOGICAL APPL, V18, P1212; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; WDPA, 2009, WORLD DAT PROT AR AN; WIEDINMYER C, 2010, ENVIRON SCI TECHNOL, V44, P1962; YANG J, 2008, ECOLOGICAL APPLICATI, V18, DOI DOI 10.1016/J.RSE.2004.08.016; Zavaleta Erika, 2000, P261	47	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23002	10.1371/journal.pone.0023002	http://dx.doi.org/10.1371/journal.pone.0023002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850248	Green Published, gold			2022-12-27	WOS:000293563300033
J	Agwale, SM; Forbi, JC; Notka, F; Wrin, T; Wild, J; Wagner, R; Wolf, H				Agwale, Simon M.; Forbi, Joseph C.; Notka, Frank; Wrin, Terri; Wild, Jens; Wagner, Ralf; Wolf, Hans			Broad Antibody Mediated Cross-Neutralization and Preclinical Immunogenicity of New Codon-Optimized HIV-1 Clade CRF02_AG and G Primary Isolates	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INJECTION-DRUG USERS; VACCINE; DNA; INFECTION; STRAINS; TRIAL; USAGE; PREVALENCE; EXPRESSION	Creation of an effective vaccine for HIV has been an elusive goal of the scientific community for almost 30 years. Neutralizing antibodies are assumed to be pivotal to the success of a prophylactic vaccine but previous attempts to make an immunogen capable of generating neutralizing antibodies to primary "street strain'' isolates have resulted in responses of very limited breadth and potency. The objective of the study was to determine the breadth and strength of neutralizing antibodies against autologous and heterologous primary isolates in a cohort of HIV-1 infected Nigerians and to characterize envelopes from subjects with particularly broad or strong immune responses for possible use as vaccine candidates in regions predominated by HIV-1 CRF02_AG and G subtypes. Envelope vectors from a panel of primary Nigerian isolates were constructed and tested with plasma/sera from the same cohort using the PhenoSense HIV neutralizing antibody assay (Monogram Biosciences Inc, USA) to assess the breadth and potency of neutralizing antibodies. The immediate goal of this study was realized by the recognition of three broadly cross-neutralizing sera: (NG2-clade CRF02_AG, NG3-clade CRF02_AG and NG9-clade G). Based on these findings, envelope gp140 sequences from NG2 and NG9, complemented with a gag sequence (Clade G) and consensus tat (CRF02_AG and G) antigens have been codon-optimized, synthesized, cloned and evaluated in BALB/c mice. The intramuscular administration of these plasmid DNA constructs, followed by two booster DNA immunizations, induced substantial specific humoral response against all constructs and strong cellular responses against the gag and tat constructs. These preclinical findings provide a framework for the design of candidate vaccine for use in regions where the HIV-1 epidemic is driven by clades CRF02_AG and G.	[Agwale, Simon M.; Forbi, Joseph C.] Innovat Biotech, Clin Virol Lab, Keffi Abuja, Nigeria; [Agwale, Simon M.; Forbi, Joseph C.] Innovat Biotech, Frederick Innovat Technol Ctr, Frederick, MD USA; [Notka, Frank; Wagner, Ralf] GeneArt AG, Regensburg, Germany; [Wrin, Terri] Monogram Biosci Inc, San Francisco, CA USA; [Wild, Jens; Wagner, Ralf; Wolf, Hans] Univ Regensburg, Mol Microbiol & Gene Therapy Unit, Inst Med Microbiol & Hyg, Regensburg, Germany	University of Regensburg	Agwale, SM (corresponding author), Innovat Biotech, Clin Virol Lab, Keffi Abuja, Nigeria.	sagwale@innovativebiotechng.com		Wild, Jens/0000-0001-9880-7897				Agwale SM, 2006, AIDS RES HUM RETROV, V22, P22, DOI 10.1089/aid.2006.22.22; Agwale SM, 2002, P NATL ACAD SCI USA, V99, P10037, DOI 10.1073/pnas.152313899; Agwale SM, 2002, VACCINE, V20, P2131, DOI 10.1016/S0264-410X(02)00059-2; Andre S, 1998, J VIROL, V72, P1497; Bojak A, 2002, DRUG DISCOV TODAY, V7, P36, DOI 10.1016/S1359-6446(01)02081-5; Bojak A, 2002, INTERVIROLOGY, V45, P275, DOI 10.1159/000067919; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; Carr JK, 2001, VIROLOGY, V286, P168, DOI 10.1006/viro.2001.0976; CARROW EW, 1991, AIDS RES HUM RETROV, V7, P831, DOI 10.1089/aid.1991.7.831; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Frost SDW, 2008, CURR OPIN HIV AIDS, V3, P45, DOI 10.1097/COH.0b013e3282f310ae; GIACCONE G, 1992, CANCER RES, V52, pS2732; Graf M, 2000, J VIROL, V74, P10822, DOI 10.1128/JVI.74.22.10822-10826.2000; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haigwood N L, 1998, AIDS, V12 Suppl A, pS121; Haigwood Nancy L, 2003, AIDS, V17 Suppl 4, pS67, DOI 10.1097/00002030-200317004-00008; Kent SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000331; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Schultz AM, 2001, AIDS, V15, pS147, DOI 10.1097/00002030-200100005-00018; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Taiwo OO, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-19; UNAIDS, 2009, AIDS EPIDEMIC UPDATE; *UNAIDS, 2007, REP GLOB HIV AIDS EP, P18; *UNAIDS, 2009, LARG EV HIV VACC TRI; VOGEL T, 1994, J IMMUNOL, V153, P1895; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wayne C Koff, 2010, N Engl J Med, V363, pe7, DOI 10.1056/NEJMp1007629; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23233	10.1371/journal.pone.0023233	http://dx.doi.org/10.1371/journal.pone.0023233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829720	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200058
J	Anderson, DJ; Durieux, JK; Song, K; Alvarado, R; Jackson, PK; Hatzivassiliou, G; Ludlam, MJC				Anderson, Daniel J.; Durieux, Jenni K.; Song, Kyung; Alvarado, Ryan; Jackson, Peter K.; Hatzivassiliou, Georgia; Ludlam, Mary J. C.			Live-Cell Microscopy Reveals Small Molecule Inhibitor Effects on MAPK Pathway Dynamics	PLOS ONE			English	Article							RAS ACTIVATION; LIVING CELLS; HUMAN CANCER; NUCLEAR TRANSLOCATION; C-RAF; B-RAF; KINASE; GROWTH; BRAF; PHOSPHORYLATION	Oncogenic mutations in the mitogen activated protein kinase (MAPK) pathway are prevalent in human tumors, making this pathway a target of drug development efforts. Recently, ATP-competitive Raf inhibitors were shown to cause MAPK pathway activation via Raf kinase priming in wild-type BRaf cells and tumors, highlighting the need for a thorough understanding of signaling in the context of small molecule kinase inhibitors. Here, we present critical improvements in cell-line engineering and image analysis coupled with automated image acquisition that allow for the simultaneous identification of cellular localization of multiple MAPK pathway components (KRas, CRaf, Mek1 and Erk2). We use these assays in a systematic study of the effect of small molecule inhibitors across the MAPK cascade either as single agents or in combination. Both Raf inhibitor priming as well as the release from negative feedback induced by Mek and Erk inhibitors cause translocation of CRaf to the plasma membrane via mechanisms that are additive in pathway activation. Analysis of Erk activation and sub-cellular localization upon inhibitor treatments reveals differential inhibition and activation with the Raf inhibitors AZD628 and GDC0879 respectively. Since both single agent and combination studies of Raf and Mek inhibitors are currently in the clinic, our assays provide valuable insight into their effects on MAPK signaling in live cells.	[Anderson, Daniel J.; Durieux, Jenni K.; Jackson, Peter K.; Ludlam, Mary J. C.] Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA; [Song, Kyung; Alvarado, Ryan; Hatzivassiliou, Georgia] Genentech Inc, Dept Canc Signaling, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Anderson, DJ (corresponding author), Genentech Inc, Dept Cell Regulat, San Francisco, CA 94080 USA.	anderson.daniel@gene.com		Anderson, Daniel/0000-0002-3249-2439; Jackson, Peter/0000-0002-1742-2539	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	The studies in this manuscript were fully funded by Genentech, Inc. All authors are employees of Genentech, Inc. The funder, Genentech, Inc., approved the manuscript for public disclosure, however studies were conducted in an academic fashion, independently from Genentech's financial interests.	Ananthanarayanan B, 2007, J BIOL CHEM, V282, P36634, DOI 10.1074/jbc.M706227200; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bivona TG, 2006, METHOD ENZYMOL, V407, P128, DOI 10.1016/S0076-6879(05)07012-6; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; BOS JL, 1989, CANCER RES, V49, P4682; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Flaherty K, 2009, J CLIN ONCOL, V27; Gonzalez-Perez Vanessa, 2010, J Mol Signal, V5, P2, DOI 10.1186/1750-2187-5-2; Gorman C, 1996, J BIOL CHEM, V271, P6713, DOI 10.1074/jbc.271.12.6713; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hibino K, 2009, BIOPHYS J, V97, P1277, DOI 10.1016/j.bpj.2009.05.048; JUNG V, 1994, MOL CELL BIOL, V14, P3707, DOI 10.1128/MCB.14.6.3707; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kim JS, 2004, CANCER RES, V64, P1932, DOI 10.1158/0008-5472.CAN-03-3862; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; Kupzig S, 2006, METHOD ENZYMOL, V407, P64, DOI 10.1016/S0076-6879(05)07007-2; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Martinez-botella, 2006, PYRROLE INHIBITORS E; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rosen LS, 2008, J CLIN ONCOLOGY; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schwartz GK, 2009, ONCOLOGY JOC, P3513; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22607	10.1371/journal.pone.0022607	http://dx.doi.org/10.1371/journal.pone.0022607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829637	Green Submitted, Green Published, gold			2022-12-27	WOS:000293561200025
J	Margus, T; Remm, M; Tenson, T				Margus, Tonu; Remm, Maido; Tenson, Tanel			A Computational Study of Elongation Factor G (EFG) Duplicated Genes: Diverged Nature Underlying the Innovation on the Same Structural Template	PLOS ONE			English	Article							THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RECYCLING FACTOR; TUF GENES; SEQUENCE; RIBOSOME; EVOLUTION; GTPASES; PROTEINS	Background: Elongation factor G (EFG) is a core translational protein that catalyzes the elongation and recycling phases of translation. A more complex picture of EFG's evolution and function than previously accepted is emerging from analyzes of heterogeneous EFG family members. Whereas the gene duplication is postulated to be a prominent factor creating functional novelty, the striking divergence between EFG paralogs can be interpreted in terms of innovation in gene function. Methodology/Principal Findings: We present a computational study of the EFG protein family to cover the role of gene duplication in the evolution of protein function. Using phylogenetic methods, genome context conservation and insertion/deletion (indel) analysis we demonstrate that the EFG gene copies form four subfamilies: EFG I, spdEFG1, spdEFG2, and EFG II. These ancient gene families differ by their indispensability, degree of divergence and number of indels. We show the distribution of EFG subfamilies and describe evidences for lateral gene transfer and recent duplications. Extended studies of the EFG II subfamily concern its diverged nature. Remarkably, EFG II appears to be a widely distributed and a much-diversified subfamily whose subdivisions correlate with phylum or class borders. The EFG II subfamily specific characteristics are low conservation of the GTPase domain, domains II and III; absence of the trGTPase specific G2 consensus motif "RGITI''; and twelve conserved positions common to the whole subfamily. The EFG II specific functional changes could be related to changes in the properties of nucleotide binding and hydrolysis and strengthened ionic interactions between EFG II and the ribosome, particularly between parts of the decoding site and loop I of domain IV. Conclusions/Significance: Our work, for the first time, comprehensively identifies and describes EFG subfamilies and improves our understanding of the function and evolution of EFG duplicated genes.	[Margus, Tonu; Remm, Maido] Univ Tartu, Dept Bioinformat, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Margus, Tonu; Remm, Maido] Estonian Bioctr, Tartu, Estonia; [Tenson, Tanel] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu; Estonian Biocentre; University of Tartu	Margus, T (corresponding author), Univ Tartu, Dept Bioinformat, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	tonu.margus@ut.ee	Remm, Maido/L-9072-2019; Tenson, Tanel/I-6431-2015	Remm, Maido/0000-0003-3966-8422; Tenson, Tanel/0000-0002-0260-3601; Margus, Tonu/0000-0003-4966-1291	Estonian Ministry of Education and Research [SF0180026s09, SF0180166s08]; EU through the Estonian Centre of Excellence in Genomics and through the Center of Excellence in Chemical Biology	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); EU through the Estonian Centre of Excellence in Genomics and through the Center of Excellence in Chemical Biology	This work was funded by grants SF0180026s09 and SF0180166s08 from the Estonian Ministry of Education and Research and by the EU through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics and through the Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim F, 1996, J MOL BIOL, V260, P506, DOI 10.1006/jmbi.1996.0418; Aevarsson A, 1995, J MOL EVOL, V41, P1096; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; ATKINSON GC, 2010, MOL BIOL EVOL; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Berglund-Sonnhammer AC, 2006, J MOL EVOL, V63, P240, DOI 10.1007/s00239-005-0096-1; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Connell SR, 2003, EMBO J, V22, P945, DOI 10.1093/emboj/cdg093; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; De Vendittis E, 1999, EUR J BIOCHEM, V262, P600, DOI 10.1046/j.1432-1327.1999.00428.x; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Felsenstein J, PHYLIP PHYLOGENY INF; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; HAMEL E, 1972, J BIOL CHEM, V247, P805; Hauryliuk V, 2008, BIOPHYS J, V95, P1704, DOI 10.1529/biophysj.107.127290; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; Hirokawa G, 2006, TRENDS BIOCHEM SCI, V31, P143, DOI 10.1016/j.tibs.2006.01.007; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes T, 2007, J MOL EVOL, V65, P574, DOI 10.1007/s00239-007-9041-9; Inagaki Y, 2002, CURR BIOL, V12, P772, DOI 10.1016/S0960-9822(02)00816-3; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JASKUNAS SR, 1977, J BIOL CHEM, V252, P7323; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kovtun A A, 2006, Mol Biol (Mosk), V40, P850; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lathe WC, 2001, FEBS LETT, V502, P113, DOI 10.1016/S0014-5793(01)02639-4; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; LILJAS A, STRUCTURAL ASPECTS P; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Martemyanov KA, 1999, FEBS LETT, V452, P155, DOI 10.1016/S0014-5793(99)00635-3; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; *NCBI, 2008, BACT SEQ DAT; Nechifor R, 2007, J BIOL CHEM, V282, P36998, DOI 10.1074/jbc.M707179200; NISHIZUKA Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Owens RM, 2004, EMBO J, V23, P3375, DOI 10.1038/sj.emboj.7600343; Pandit SB, 2003, PROTEINS, V52, P585, DOI 10.1002/prot.10420; PESTKA S, 1968, P NATL ACAD SCI USA, V61, P726, DOI 10.1073/pnas.61.2.726; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; RHEINBERGER HJ, 1983, P NATL ACAD SCI-BIOL, V80, P4213, DOI 10.1073/pnas.80.14.4213; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Seshadri A, 2009, TUBERCULOSIS, V89, P453, DOI 10.1016/j.tube.2009.06.003; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUEMATSU T, 2010, MOL MICROBIOL; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023	71	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22789	10.1371/journal.pone.0022789	http://dx.doi.org/10.1371/journal.pone.0022789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829651	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200030
J	Payan, CAM; Viallet, F; Landwehrmeyer, BG; Bonnet, AM; Borg, M; Durif, F; Lacomblez, L; Bloch, F; Verny, M; Fermanian, J; Agid, Y; Ludolph, AC; Leigh, PN; Bensimon, G				Payan, Christine A. M.; Viallet, Francois; Landwehrmeyer, Bernhard G.; Bonnet, Anne-Marie; Borg, Michel; Durif, Franck; Lacomblez, Lucette; Bloch, Frederic; Verny, Marc; Fermanian, Jacques; Agid, Yves; Ludolph, Albert C.; Leigh, Peter N.; Bensimon, Gilbert		NNIPPS Study Grp	Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS - PARKINSON PLUS SCALE	PLOS ONE			English	Article							RATING-SCALE; NATURAL-HISTORY; DIAGNOSTIC-CRITERIA; SAMPLE-SIZE; SURVIVAL; RELIABILITY	Background: The Natural History and Neuroprotection in Parkinson Plus Syndromes (NNIPPS) study was a large phase III randomized placebo-controlled trial of riluzole in Progressive Supranuclear Palsy (PSP, n = 362) and Multiple System Atrophy (MSA, n = 398). To assess disease severity and progression, we constructed and validated a new clinical rating scale as an ancillary study. Methods and Findings: Patients were assessed at entry and 6-montly for up to 3 years. Evaluation of the scale's psychometric properties included reliability (n = 116), validity (n = 760), and responsiveness (n = 642). Among the 85 items of the initial scale, factor analysis revealed 83 items contributing to 15 clinically relevant dimensions, including Activity of daily Living/Mobility, Axial bradykinesia, Limb bradykinesia, Rigidity, Oculomotor, Cerebellar, Bulbar/Pseudo-bulbar, Mental, Orthostatic, Urinary, Limb dystonia, Axial dystonia, Pyramidal, Myoclonus and Tremor. All but the Pyramidal dimension demonstrated good internal consistency (Cronbach alpha >= 0.70). Inter-rater reliability was high for the total score (Intra-class coefficient = 0.94) and 9 dimensions (Intra-class coefficient = 0.80-0.93), and moderate (Intra-class coefficient = 0.54-0.77) for 6. Correlations of the total score with other clinical measures of severity were good (rho >= 0.70). The total score was significantly and linearly related to survival (p<0.0001). Responsiveness expressed as the Standardized Response Mean was high for the total score slope of change (SRM = 1.10), though higher in PSP (SRM = 1.25) than in MSA (SRM = 1.0), indicating a more rapid progression of PSP. The slope of change was constant with increasing disease severity demonstrating good linearity of the scale throughout disease stages. Although MSA and PSP differed quantitatively on the total score at entry and on rate of progression, the relative contribution of clinical dimensions to overall severity and progression was similar. Conclusions: The NNIPPS-PPS has suitable validity, is reliable and sensitive, and therefore is appropriate for use in clinical studies with PSP or MSA.	[Payan, Christine A. M.; Bensimon, Gilbert] Hop La Pitie Salpetriere, AP HP, Dept Clin Pharmacol, UPMC Pharmacol,UMR 7211, Paris 6, France; [Viallet, Francois] Ctr Hosp Pays Aix, Serv Neurol, Aix En Provence, France; [Landwehrmeyer, Bernhard G.; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Bonnet, Anne-Marie; Bloch, Frederic; Agid, Yves] UPMC Univ Paris 6, Paris, France; [Borg, Michel] Hop Louis Pasteur, Serv Neurol, F-06002 Nice, France; [Durif, Franck] Hop Gabriel Montpied, Serv Neurol, Clermont Ferrand, France; [Lacomblez, Lucette] Hop La Pitie Salpetriere, AP HP, INSERM, Dept Neurol,UPMC,UMR S 678, Paris 6, France; [Verny, Marc] Grp Hosp Pitie Salpetriere, Ctr Geriatrie, F-75634 Paris, France; [Verny, Marc] Univ Paris 06, Assistance Publ Hop Paris, UPMC, Paris, France; [Fermanian, Jacques] Hop Necker Enfants Malad, AP HP, Serv Biostat, Paris, France; [Leigh, Peter N.] Univ Sussex, Brighton & Sussex Med Sch, Trafford Ctr Biomed Res, Clin Neurosci, Falmer, England; [Bonnet, Anne-Marie; Bloch, Frederic; Agid, Yves] Hop La Pitie Salpetriere, AP HP, INSERM, Ctr Invest Clin CIC9503, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ulm University; UDICE-French Research Universities; Sorbonne Universite; CHU Nice; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Brighton; University of Sussex; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Payan, CAM (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Clin Pharmacol, UPMC Pharmacol,UMR 7211, Paris 6, France.	bsms2899@bsms.ac.uk; gilbert.bensimon@psl.aphp.fr	Durif, Franck/CAA-1077-2022; Schulz, Jörg B/D-9786-2012; Winner, Beate/K-3730-2012; Murphy, Caroline L/C-9635-2013; Broussolle, Emmanuel/H-1592-2017; Winner, Beate/O-8213-2019; Brown, Richard G/A-9599-2010; Gasser, Thomas/GNH-5293-2022; PHAM, Hang-Phuong/E-1479-2012; Leigh, Peter/AAD-5638-2019; Fressinaud, Catherine/K-4393-2015; Gröschel, Klaus/ABC-4777-2021; Landwehrmeyer, Georg Bernhard/AHB-4443-2022	Schulz, Jörg B/0000-0002-8903-0593; Winner, Beate/0000-0002-6909-0564; Broussolle, Emmanuel/0000-0002-0410-9519; Winner, Beate/0000-0002-6909-0564; Brown, Richard G/0000-0001-9021-0172; Gasser, Thomas/0000-0002-1069-1146; Gröschel, Klaus/0000-0002-0244-6116; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Verny, Marc/0000-0001-7960-9705; Schrader, Christoph/0000-0001-5323-8299	European Union [QLG1-CT-2000-01262]; French Health Ministry; Hospitalier de Recherche Clinique [AOM97073, AOM01125]; Sanofi-Aventis affiliates in the UK; Sanofi-Aventis affiliates in the France; Sanofi-Aventis affiliates in the Germany; Sanofi Aventis; Institute of Psychiatry, King's College London; Assistance Publique-Hopitaux de Paris; University of Ulm; CHDI; GSK; Novartis; Merz; Allergan; GlaxoSmithKline; Teva; Sanofi; Trophos; Boehringer-Ingelheim; ComtecMed; Lundbeck; ONO; Santhera; Schwarz Pharma; Bayer Vital; Acceleron pharma; NeuroNova; ONO Pharma	European Union(European Commission); French Health Ministry; Hospitalier de Recherche Clinique; Sanofi-Aventis affiliates in the UK; Sanofi-Aventis affiliates in the France; Sanofi-Aventis affiliates in the Germany; Sanofi Aventis(Sanofi-Aventis); Institute of Psychiatry, King's College London(General Electric); Assistance Publique-Hopitaux de Paris; University of Ulm; CHDI; GSK(GlaxoSmithKline); Novartis(Novartis); Merz; Allergan(AbbVieAllergan); GlaxoSmithKline(GlaxoSmithKline); Teva(Teva Pharmaceutical Industries); Sanofi; Trophos; Boehringer-Ingelheim(Boehringer Ingelheim); ComtecMed; Lundbeck(Lundbeck Corporation); ONO; Santhera; Schwarz Pharma; Bayer Vital(Bayer AG); Acceleron pharma; NeuroNova; ONO Pharma	NNIPPS was an academic-led study with core funding from the European Union 5th Framework programme (QLG1-CT-2000-01262); support from French Health Ministry, Programme Hospitalier de Recherche Clinique (AOM97073, AOM01125) and from Sanofi-Aventis affiliates in the UK, France and Germany providing an unconditional research grant and drug supply throughout the study. Sanofi Aventis provided an unconditional research grant to fund the drug supply and data entry and to help with miscellaneous and travel expenses. Three academic institutions (Institute of Psychiatry, King's College London; Assistance Publique-Hopitaux de Paris; and University of Ulm) were sponsors of the study in each country, and jointly own the data. Dr. C.A.M. Payan was funded by EU-FP5-grant QLG1-CT-2000-01262 and by the French Health Ministry, Programme Hospitalier de Recherche Clinique (AOM97073 and AOM01125). Dr. F. Bloch was funded by a grant from the French Health Ministry, Programme Hospitalier de Recherche Clinique (AOM97073 and AOM01125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sanofi-Aventis affiliates in the UK, France and Germany provided an unconditional research grant and drug supply throughout the study. Sanofi-Aventis provided an unconditional research grant to fund the drug supply and data entry and to help with miscellaneous and travel expenses. Pr. F. Viallet reports personal compensation from GSK for speaking, from Novartis, Orkyn, Solvay, Servier, Teva-Lundbeck, Eisai for serving on a scientific advisory board and Boehringer as investigator in clinical trials. Dr. G.B. Landwehrmeyer, who serves on a scientific advisory board of Sienna Biotech, received funding from CHDI as research support. Dr. A.M. Bonnet serves as consultant for Medtronic-France. Dr. M. Borg received funding for research support from GSK and Novartis. Pr. F. Durif serves on scientific advisory boards for Novartis, Glaxo-SmithKline, Orkyn, Solvay, Servier, Teva-Lundbeck and Boehringer and receives research support from Novartis, Merz and Allergan. Dr. L. Lacomblez serves on scientific advisory boards for Novartis, Eisai and receives unrestricted research support from GlaxoSmithKline, Novartis, Teva, Sanofi and Trophos. Pr. M. Verny serves on a scientific advisory board for Novartis and Eisai. Pr. J. Fermanian reports no disclosures. Pr. Y. Agid serves as consultant for Servier. Pr. A. C. Ludolph serves on Scientific Advisory Boards for Lundbeck, F. Hoffmann La Roche, Knopp Neurosciences. Received funding for travel expenses and/or honoraria for lectures from Boehringer-Ingelheim, Teva, ComtecMed, Lundbeck, Sanofi, ONO, Santhera, Schwarz Pharma, GlaxoSmithKline, Bayer Vital and Sanofi. Pr. P.N. Leigh has received payments for consultancy from GlaxoSmithKline, Acceleron pharma, NeuroNova, Trophos, and Teva and has received funding for clinical trials from GlaxoSmithKline, Teva, ONO Pharma, Trophos, and Sanofi-Aventis. Dr. G. Bensimon is presently a consultant for LTK-pharma, Allon pharma and TauRx pharma, and received funding for trial-related travel expenses from Sanofi-Aventis. Three academic institutions (Institute of Psychiatry, King's College London; Assistance Publique-Hopitaux de Paris; and University of Ulm) were sponsors of the study in each country, and jointly own the data. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AERTS M, 2010, BRAIN 8, V133, P2382, DOI DOI 10.1093/BRAIN/AWQ158; American Psychiatric Association, 1999, STAND ED PSYCH TEST; BenShlomo Y, 1997, NEUROLOGY, V48, P384, DOI 10.1212/WNL.48.2.384; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Brown RG, 2010, BRAIN, V133, P2382, DOI 10.1093/brain/awq158; Burk K, 2006, MOVEMENT DISORD, V21, P772, DOI 10.1002/mds.20802; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J.E., 1988, STAT POWER ANAL BEHA; COX DR, 1972, J R STAT SOC B, V34, P187; Cubo E, 2000, MOVEMENT DISORD, V15, P276, DOI 10.1002/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO;2-Q; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geser F, 2006, MOVEMENT DISORD, V21, P179, DOI 10.1002/mds.20678; Geser F, 2005, J NEURAL TRANSM, V112, P1677, DOI 10.1007/s00702-005-0328-y; Gilman S, 2008, NEUROLOGY, V70, pA229, DOI 10.1212/01.wnl.0000324625.00404.15; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; Golbe LI, 1999, NEUROLOGY, V52, pA227; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Jenkinson C, 1997, PSYCHOL HEALTH, V12, P805, DOI 10.1080/08870449708406741; Kroonenberg Pieter M, 2006, BMC Med Res Methodol, V6, P26, DOI 10.1186/1471-2288-6-26; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Litvan I, 1996, J NEUROL NEUROSUR PS, V60, P615, DOI 10.1136/jnnp.60.6.615; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Lyoo CH, 2008, BRAIN, V131, P438, DOI 10.1093/brain/awm328; May S, 2007, MOVEMENT DISORD, V22, P2371, DOI 10.1002/mds.21734; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; ROBBINS TW, 1994, J NEUROL NEUROSUR PS, V57, P79, DOI 10.1136/jnnp.57.1.79; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Schrag A, 2008, MOVEMENT DISORD, V23, P294, DOI 10.1002/mds.21839; Schwab R.S., 1969, 3 S PARK DIS, P152; Seppi K, 2005, J NEUROL, V252, P91, DOI 10.1007/s00415-005-0617-2; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523; Testa D, 2001, NEUROL SCI, V22, P247, DOI 10.1007/s100720100021; Tison F, 2002, MOVEMENT DISORD, V17, P701, DOI 10.1002/mds.10171; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; VANDERHORST V, 2010, BRAIN 8, V133, P2382, DOI DOI 10.1093/BRAIN/AWQ158; Wenning GK, 2004, MOVEMENT DISORD, V19, P1391, DOI 10.1002/mds.20255; WU MC, 1988, CONTROL CLIN TRIALS, V9, P32, DOI 10.1016/0197-2456(88)90007-4	44	55	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22293	10.1371/journal.pone.0022293	http://dx.doi.org/10.1371/journal.pone.0022293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829612	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000293561200011
J	Regier, JC; Zwick, A				Regier, Jerome C.; Zwick, Andreas			Sources of Signal in 62 Protein-Coding Nuclear Genes for Higher-Level Phylogenetics of Arthropods	PLOS ONE			English	Article							BASE-COMPOSITIONAL HETEROGENEITY; NUCLEOTIDE COMPOSITION; AMINO-ACID; MITOCHONDRIAL; INFERENCE; EVOLUTION; BIAS; SUPPORT; TREE; ACCURACY	Background: This study aims to investigate the strength of various sources of phylogenetic information that led to recent seemingly robust conclusions about higher-level arthropod phylogeny and to assess the role of excluding or downweighting synonymous change for arriving at those conclusions. Methodology/Principal Findings: The current study analyzes DNA sequences from 68 gene segments of 62 distinct protein-coding nuclear genes for 80 species. Gene segments analyzed individually support numerous nodes recovered in combined-gene analyses, but few of the higher-level nodes of greatest current interest. However, neither is there support for conflicting alternatives to these higher-level nodes. Gene segments with higher rates of nonsynonymous change tend to be more informative overall, but those with lower rates tend to provide stronger support for deeper nodes. Higher-level nodes with bootstrap values in the 80% - 99% range for the complete data matrix are markedly more sensitive to substantial drops in their bootstrap percentages after character subsampling than those with 100% bootstrap, suggesting that these nodes are likely not to have been strongly supported with many fewer data than in the full matrix. Data set partitioning of total data by (mostly) synonymous and (mostly) nonsynonymous change improves overall node support, but the result remains much inferior to analysis of (unpartitioned) nonsynonymous change alone. Clusters of genes with similar nonsynonymous rate properties (e. g., faster vs. slower) show some distinct patterns of node support but few conflicts. Synonymous change is shown to contribute little, if any, phylogenetic signal to the support of higher-level nodes, but it does contribute nonphylogenetic signal, probably through its underlying heterogeneous nucleotide composition. Analysis of seemingly conservative indels does not prove useful. Conclusions: Generating a robust molecular higher-level phylogeny of Arthropoda is currently possible with large amounts of data and an exclusive reliance on nonsynonymous change.	[Regier, Jerome C.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Regier, Jerome C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Regier, Jerome C.; Zwick, Andreas] Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; [Zwick, Andreas] State Museum Nat Hist, Stuttgart, Germany	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; University of Maryland College Park	Regier, JC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.	regier@umd.edu; andreas.zwick@smns-bw.de	Zwick, Andreas/A-5735-2015	Zwick, Andreas/0000-0002-7532-1752	National Science Foundation, U.S.A. [1042845, 0120635]; Division Of Environmental Biology [1042845] Funding Source: National Science Foundation	National Science Foundation, U.S.A.(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by grants from the National Science Foundation, U.S.A. (grant numbers 1042845 and 0120635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu M, 2008, MOL BIOL EVOL, V25, P2521, DOI 10.1093/molbev/msn224; Aleshin VV, 2009, MOL BIOL+, V43, P804, DOI 10.1134/S0026893309050124; Baurain D, 2007, MOL BIOL EVOL, V24, P6, DOI 10.1093/molbev/msl137; Bazinet A. L, 2009, DISTRIBUTED GRID COM; Belinky F, 2010, MOL BIOL EVOL, V27, P441, DOI 10.1093/molbev/msp263; Bjorklund M, 1999, CLADISTICS, V15, P191, DOI 10.1111/j.1096-0031.1999.tb00261.x; Brenneis G, 2008, EVOL DEV, V10, P717, DOI 10.1111/j.1525-142X.2008.00285.x; Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; CHO S, 2011, SYST BIOL IN PRESS; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Conant GC, 2001, MOL BIOL EVOL, V18, P1024, DOI 10.1093/oxfordjournals.molbev.a003874; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; Davalos LA, 2008, GENOMICS, V91, P433, DOI 10.1016/j.ygeno.2008.01.006; Delisle I, 2005, MOL PHYLOGENET EVOL, V37, P192, DOI 10.1016/j.ympev.2005.04.025; Delsuc F, 2003, SCIENCE, V301, P1482; Dietz L, 2011, MOL PHYLOGENET EVOL, V58, P553, DOI 10.1016/j.ympev.2010.12.016; Dunlop JA, 2005, J ZOOL SYST EVOL RES, V43, P8, DOI 10.1111/j.1439-0469.2004.00284.x; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; Ertas B, 2009, MOL BIOL EVOL, V26, P2711, DOI 10.1093/molbev/msp186; Fanenbruck M, 2004, P NATL ACAD SCI USA, V101, P3868, DOI 10.1073/pnas.0306212101; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; GALTIER N, 1995, P NATL ACAD SCI USA, V92, P11317, DOI 10.1073/pnas.92.24.11317; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Gowri-Shankar V, 2006, MOL BIOL EVOL, V23, P352, DOI 10.1093/molbev/msj040; Gruber KF, 2007, SYST BIOL, V56, P83, DOI 10.1080/10635150601182939; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Herbeck JT, 2005, MOL BIOL EVOL, V22, P520, DOI 10.1093/molbev/msi036; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; Holder MT, 2008, PHILOS T R SOC B, V363, P4013, DOI 10.1098/rstb.2008.0162; Inagaki Y, 2006, MOL PHYLOGENET EVOL, V40, P428, DOI 10.1016/j.ympev.2006.03.020; Inagaki Y, 2009, MOL BIOL EVOL, V26, P1171, DOI 10.1093/molbev/msp036; Jayaswal V, 2007, SYSTEMATIC BIOL, V56, P155, DOI 10.1080/10635150701247921; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; Kallersjo M, 1999, CLADISTICS, V15, P91; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Koenemann S, 2010, ARTHROPOD STRUCT DEV, V39, P88, DOI 10.1016/j.asd.2009.10.003; Kolaczkowski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007891; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; LOCKHART PJ, 1992, J MOL EVOL, V34, P153; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Naylor GJP, 1998, SYST BIOL, V47, P61, DOI 10.1080/106351598261030; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; PHILIPPE H, 2009, P ROY SOC LOND B BIO, V267, P1213; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Pisani D, 2004, SYST BIOL, V53, P978, DOI 10.1080/10635150490888877; Pratt RC, 2009, MOL BIOL EVOL, V26, P313, DOI 10.1093/molbev/msn248; Rannala B, 2008, ANNU REV GENOM HUM G, V9, P217, DOI 10.1146/annurev.genom.9.081307.164407; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Rosenberg MS, 2003, MOL BIOL EVOL, V20, P610, DOI 10.1093/molbev/msg067; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; Seo TK, 2008, SYST BIOL, V57, P367, DOI 10.1080/10635150802158670; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; Simmons MP, 2004, MOL PHYLOGENET EVOL, V32, P913, DOI 10.1016/j.ympev.2004.04.011; SNODGRASS R. E., 1938, SMITHSONIAN MISC COLL, V97, P1; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Susko E, 2007, MOL BIOL EVOL, V24, P2139, DOI 10.1093/molbev/msm144; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Tarrio R, 2001, MOL BIOL EVOL, V18, P1464, DOI 10.1093/oxfordjournals.molbev.a003932; Tarrio R, 2000, MOL PHYLOGENET EVOL, V16, P344, DOI 10.1006/mpev.2000.0813; Taylor DJ, 2004, MOL BIOL EVOL, V21, P1534, DOI 10.1093/molbev/msh156; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Whelan S, 2008, MOL BIOL EVOL, V25, P1683, DOI 10.1093/molbev/msn119; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; ZWICK A, 2010, SYST ENTOMO IN PRESS; Zwickl DJ., 2006, THESIS	90	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23408	10.1371/journal.pone.0023408	http://dx.doi.org/10.1371/journal.pone.0023408			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829732	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200069
J	Oliveira, DC; de Lencastre, H				Oliveira, Duarte C.; de Lencastre, Herminia			Methicillin-Resistance in Staphylococcus aureus Is Not Affected by the Overexpression in Trans of the mecA Gene Repressor: A Surprising Observation	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE DETERMINATION; MULTIPLEX PCR STRATEGY; TRANSCRIPTIONAL REGULATION; ANTIBIOTIC-RESISTANCE; BETA-LACTAMASE; EXPRESSION; CHROMOSOME; EVOLUTION; STRAINS; REGION	Methicillin-resistant Staphylococcus aureus (MRSA) is intrinsically cross-resistant to virtually all beta-lactam antibiotics. The central determinant for the MRSA phenotype is the mecA gene, whose transcriptional control may be mediated by a repressor (mecI) and a sensor/inducer (mecR1). The mecI-mecR1-mediated induction of mecA takes several hours rendering the strains phenotypically susceptible in spite of the presence of the resistance gene. Therefore, it has been proposed that the full resistance to beta-lactams observed in many contemporary clinical MRSA strains requires a non-functional mecI-mecR1 regulatory system. The mecA gene is embedded in a large chromosomal cassette (the SCCmec element) for which several structural types have been described. Some epidemic MRSA clones, typically expressing full beta-lactam resistance, carry SCCmec elements that contain an intact mecI-mecR1 locus (e.g. SCCmec types II and III). We have addressed this apparent contradiction by first sequencing the mecI coding region and mecA promoter sequences in a collection of prototype MRSA strains characterized by different SCCmec types. A conserved non-sense mutation within mecI was detected in all SCCmec type III strains tested, presumably responsible for a non-functional truncated MecI protein and, therefore, explaining the full resistance phenotype. In SCCmec type II strains no conserved mutations were found. We next transformed a collection of prototype MRSA epidemic strains with a recombinant plasmid overexpressing a wild-type copy of mecI. Surprisingly, for the great majority of the strains no significant alterations in the phenotypic expression of beta-lactam resistance could be detected. These findings were confirmed and further explored, challenging the currently accepted mechanism of mecA transcriptional control. Our observations suggest the existence of yet unidentified additional determinants involved in the transcriptional control of mecA gene and point to a revision of the mecA regulatory mechanism in contemporary MRSA strains.	[Oliveira, Duarte C.; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Oliveira, Duarte C.; de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Rockefeller University	Oliveira, DC (corresponding author), Univ Nova Lisboa, Dept Life Sci, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Caparica, Portugal.	dco@fct.unl.pt	Oliveira, Duarte/B-4097-2008	Oliveira, Duarte/0000-0002-9591-1039; /0000-0001-6816-8932	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal [POCI/BIA-MIC/60320/2004, PTDC/BIA-MIC/64071/2006]; European Commission [223031]; U.S. Public Health Service [RO1AI045738]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045738] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Partial support for this study was provided by Projects POCI/BIA-MIC/60320/2004 and PTDC/BIA-MIC/64071/2006 from Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, awarded to D. C. Oliveira; Project TROCAR, contract number 223031 from the European Commission awarded to H. de Lencastre; and grant RO1AI045738 from the U.S. Public Health Service awarded to A. Tomasz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER GL, 1994, ANTIMICROB AGENTS CH, V38, P447, DOI 10.1128/AAC.38.3.447; Archer GL, 2001, SCIENCE, V291, P1915, DOI 10.1126/science.1059671; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; COHEN S, 1968, J BACTERIOL, V95, P1368, DOI 10.1128/JB.95.4.1368-1374.1968; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DELENCASTRE H, 1991, ANTIMICROB AGENTS CH, V35, P632, DOI 10.1128/AAC.35.4.632; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; Dickinson TM, 2000, ANTIMICROB AGENTS CH, V44, P1616, DOI 10.1128/AAC.44.6.1616-1623.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Garcia-Castellanos R, 2004, J BIOL CHEM, V279, P17888, DOI 10.1074/jbc.M313123200; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HARTMAN B, 1981, ANTIMICROB AGENTS CH, V19, P726, DOI 10.1128/AAC.19.5.726; HARTMAN BJ, 1986, ANTIMICROB AGENTS CH, V29, P85, DOI 10.1128/AAC.29.1.85; HIRAMATSU K, 1992, FEBS LETT, V298, P133, DOI 10.1016/0014-5793(92)80039-J; HURLIMANNDALEL RL, 1992, ANTIMICROB AGENTS CH, V36, P2617, DOI 10.1128/AAC.36.12.2617; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Kobayashi N, 1998, ANTIMICROB AGENTS CH, V42, P717, DOI 10.1128/AAC.42.3.717; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; KuwaharaArai K, 1996, ANTIMICROB AGENTS CH, V40, P2680, DOI 10.1128/AAC.40.12.2680; Mallorqui-Fernandez G, 2004, FEMS MICROBIOL LETT, V235, P1, DOI 10.1016/j.femsle.2004.04.035; McKinney TK, 2001, J BACTERIOL, V183, P6862, DOI 10.1128/JB.183.23.6862-6868.2001; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; OSHIDA T, 1992, J BACTERIOL, V174, P4952, DOI 10.1128/JB.174.15.4952-4959.1992; Pinho MG, 1998, J BACTERIOL, V180, P6077; Rosato AE, 2003, J BACTERIOL, V185, P3446, DOI 10.1128/JB.185.11.3446-3452.2003; Rosato AE, 2003, ANTIMICROB AGENTS CH, V47, P1460, DOI 10.1128/AAC.47.4.1460-1463.2003; RYFFEL C, 1992, ANTIMICROB AGENTS CH, V36, P25, DOI 10.1128/AAC.36.1.25; Sambrook J., 2002, MOL CLONING LAB MANU; Sharma VK, 1998, J BACTERIOL, V180, P2160, DOI 10.1128/JB.180.8.2160-2166.1998; Shukla SK, 2004, ANTIMICROB AGENTS CH, V48, P3080, DOI 10.1128/AAC.48.8.3080-3085.2004; SONG MD, 1987, FEBS LETT, V221, P167, DOI 10.1016/0014-5793(87)80373-3; SUZUKI E, 1993, ANTIMICROB AGENTS CH, V37, P1219, DOI 10.1128/AAC.37.6.1219; Weller TMA, 1999, J ANTIMICROB CHEMOTH, V43, P15, DOI 10.1093/jac/43.1.15; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	43	38	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23287	10.1371/journal.pone.0023287	http://dx.doi.org/10.1371/journal.pone.0023287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829724	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511900033
J	Sharafieh, R; Lemire, Y; Powell, S; O'Rourke, J; Cone, RE				Sharafieh, Roshanak; Lemire, Yen; Powell, Sabrina; O'Rourke, James; Cone, Robert E.			Immune Amplification of Murine CD8(+) Suppressor T Cells Induced via An Immune-Privileged Site: Quantifying Suppressor T Cells Functionally	PLOS ONE			English	Article							TGF-BETA; INDUCTION; EYE; HYPERSENSITIVITY; GENERATION; TOLERANCE; RESPONSES; ANTIGEN; CD4(+); ACAID	Background: CD8(+) suppressor T cells exert antigen-specific suppression of the expression of hypersensitivity by activated T cells. Therefore, CD8(+) suppressor T cells serve a major regulatory role for the control of active immunity. Accordingly, the number and/or activity of CD8(+) suppressor T cells should be influenced by an immune response to the antigen. To test this hypothesis we used an adoptive transfer assay that measures the suppression of the expression of delayed-type hypersensitivity (DTH) by CD8(+) suppressor T cells to quantify the antigen-specific suppression of DTH by these suppressor T cells. Methods: Suppressor T cells were induced in the spleens of mice by the injection of antigen into the anterior chamber of an eye. Following this injection, the mice were immunized by the same antigen injected into the anterior chamber. Spleen cells recovered from these mice (AC-SPL cells) were titrated in an adoptive transfer assay to determine the number of AC-SPL cells required to effect a 50% reduction of antigen-induced swelling (Sw50) in the footpad of immunized mice challenged by antigen. Results: Suppression of the expression of DTH is proportional to the number of AC-SPL cells injected into the site challenged by antigen. The number of AC-SPL cells required for a 50% reduction in DTH-induced swelling is reduced by injecting a cell population enriched for CD8(+) AC-SPL cells. Immunizing the mice receiving intracameral antigen to the same antigen decreases the RSw50 of AC-SPL cells required to inhibit the expression of DTH. Conclusions: The results provide the first quantitative demonstration that the numbers of antigen-specific splenic CD8(+) suppressor T cells are specifically amplified by antigen during an immune response.	[Sharafieh, Roshanak; Lemire, Yen; Powell, Sabrina; O'Rourke, James; Cone, Robert E.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA	University of Connecticut	Sharafieh, R (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA.	Cone@UCHC.EDU			United States Public Health Service [EY 017237, EY 017289]; Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY017289, R03EY017237] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by United States Public Health Service grants EY 017237 and EY 017289 and the Connecticut Lions Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; Bhowmick S, 2009, J LEUKOCYTE BIOL, V86, P1275, DOI 10.1189/jlb.0209107; Cantor H, 2004, NAT IMMUNOL, V5, P347, DOI 10.1038/ni0404-347; Cone RE, 2010, OPHTHALMOL EYE DIS, V2, P57, DOI 10.4137/OED.S6113; Cone RE, 2009, INT IMMUNOL, V21, P567, DOI 10.1093/intimm/dxp023; Cone RE, 2009, IMMUNOL CELL BIOL, V87, P241, DOI 10.1038/icb.2008.102; Cone RE, 2007, IMMUNOLOGY, V120, P112, DOI 10.1111/j.1365-2567.2006.02486.x; D'Orazio TJ, 1998, J IMMUNOL, V160, P2089; Faunce DE, 2001, J IMMUNOL, V166, P313, DOI 10.4049/jimmunol.166.1.313; HAO H, 2008, BMC IMMUNOL, V9, P53; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; Jiang H, 2004, ADV IMMUNOL, V83, P253; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; Jiang LQ, 2009, GRAEF ARCH CLIN EXP, V247, P87, DOI 10.1007/s00417-008-0947-8; Kapp JA, 2006, INT IMMUNOL, V18, P1549, DOI 10.1093/intimm/dxl088; Keino H, 2006, INVEST OPHTH VIS SCI, V47, P1047, DOI 10.1167/iovs.05-0110; Kezuka T, 2000, INVEST OPHTH VIS SCI, V41, P1803; Li X, 2006, IMMUNOLOGY, V117, P566, DOI 10.1111/j.1365-2567.2006.02333.x; LI X, 2006, IMMUNOLOGY, V113, P44; MARCHAL G, 1982, J IMMUNOL, V129, P954; Myers L, 2005, J IMMUNOL, V174, P7625, DOI 10.4049/jimmunol.174.12.7625; Niederkorn JY, 2002, CRIT REV IMMUNOL, V22, P13; Sarantopoulos S, 2004, J CLIN INVEST, V114, P1218, DOI 10.1172/JCI200423152; Tang XL, 2007, J IMMUNOL, V178, P6043, DOI 10.4049/jimmunol.178.10.6043; Wang YF, 2001, J LEUKOCYTE BIOL, V69, P741; WILBANKS GA, 1991, J IMMUNOL, V146, P3018; WILBANKS GA, 1990, REG IMMUNOL, V4, P130	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22496	10.1371/journal.pone.0022496	http://dx.doi.org/10.1371/journal.pone.0022496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829628	Green Submitted, gold, Green Published			2022-12-27	WOS:000293511900008
J	Yang, CH; Cheng, CH; Chen, GD; Liao, WH; Chen, YC; Huang, KY; Hwang, PP; Hwang, SPL; Huang, CJ				Yang, Chung-Hsiang; Cheng, Chia-Hsiung; Chen, Gen-Der; Liao, Wei-Hao; Chen, Yi-Chung; Huang, Kai-Yun; Hwang, Pung-Pung; Hwang, Sheng-Ping L.; Huang, Chang-Jen			Zona Pellucida Domain-Containing Protein beta-Tectorin is Crucial for Zebrafish Proper Inner Ear Development	PLOS ONE			English	Article							HEARING IMPAIRMENT; MOLECULAR-CLONING; MATRIX PROTEINS; ALPHA-TECTORIN; MESSENGER-RNA; EXPRESSION; GENE; MOUSE; FERTILIZATION; MUTATIONS	Background: The zona pellucida (ZP) domain is part of many extracellular proteins with diverse functions from structural components to receptors. The mammalian beta-tectorin is a protein of 336 amino acid residues containing a single ZP domain and a putative signal peptide at the N-terminus of the protein. It is 1 component of a gel-like structure called the tectorial membrane which is involved in transforming sound waves into neuronal signals and is important for normal auditory function. beta-Tectorin is specifically expressed in the mammalian and avian inner ear. Methodology/Principal Findings: We identified and cloned the gene encoding zebrafish beta-tectorin. Through whole-mount in situ hybridization, we demonstrated that beta-tectorin messenger RNA was expressed in the otic placode and specialized sensory patch of the inner ear during zebrafish embryonic stages. Morpholino knockdown of zebrafish beta-tectorin affected the position and number of otoliths in the ears of morphants. Finally, swimming behaviors of beta-tectorin morphants were abnormal since the development of the inner ear was compromised. Conclusions/Significance: Our results reveal that zebrafish beta-tectorin is specifically expressed in the zebrafish inner ear, and is important for regulating the development of the zebrafish inner ear. Lack of zebrafish beta-tectorin caused severe defects in inner ear formation of otoliths and function.	[Yang, Chung-Hsiang; Huang, Kai-Yun; Huang, Chang-Jen] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan; [Yang, Chung-Hsiang; Cheng, Chia-Hsiung; Chen, Gen-Der; Liao, Wei-Hao; Chen, Yi-Chung; Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hwang, Pung-Pung; Hwang, Sheng-Ping L.] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Yang, CH (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan.	cjibc@gate.sinica.edu.tw	hwang, pp/A-3641-2011; Hwang, Pung-Pung/AEQ-4633-2022; Cheng, Chia-Hsiung/A-6044-2019; Hwang, Sheng-Ping/F-2882-2014; Hwang, Pung-Pung/AAH-1538-2022	Cheng, Chia-Hsiung/0000-0003-0307-9650; Chen, Yi-Chun/0000-0002-2237-9416	Academia Sinica [AS-99-TP-B08]; National Science Council, Taipei, Taiwan [97-2313-B-001-002-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (AS-99-TP-B08) from Academia Sinica and a grant (97-2313-B-001-002-MY3) from National Science Council, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen YC, 2009, DEV DYNAM, V238, P746, DOI 10.1002/dvdy.21877; Coutinho P, 1999, HEARING RES, V130, P62, DOI 10.1016/S0378-5955(98)00213-5; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Granato M, 1996, DEVELOPMENT, V123, P399; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; KILLICK R, 1995, J CELL BIOL, V129, P535, DOI 10.1083/jcb.129.2.535; Kwak SJ, 2006, DEV DYNAM, V235, P3026, DOI 10.1002/dvdy.20961; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Meyer NC, 2007, AM J MED GENET A, V143A, P1623, DOI 10.1002/ajmg.a.31718; Meyers JR, 2003, J NEUROSCI, V23, P4054; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; POPPER AN, 1993, BRAIN BEHAV EVOLUT, V41, P14, DOI 10.1159/000113821; Rau A, 1999, J COMP NEUROL, V405, P271; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Tanimoto M, 2011, J NEUROSCI, V31, P3784, DOI 10.1523/JNEUROSCI.5554-10.2011; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073	29	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23078	10.1371/journal.pone.0023078	http://dx.doi.org/10.1371/journal.pone.0023078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829695	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511900024
J	Kim, DM; Yun, NR; Neupane, GP; Shin, SH; Ryu, SY; Yoon, HJ; Wie, SH; Kim, WJ; Lee, CY; Choi, JS; Yang, TY				Kim, Dong-Min; Yun, Na Ra; Neupane, Ganesh Prasad; Shin, Sung Heui; Ryu, So Yeon; Yoon, Hee Jung; Wie, Seong Heon; Kim, Woo Jin; Lee, Chang Youl; Choi, Jong Soo; Yang, Tae Young			Differences in Clinical Features According to Boryoung and Karp Genotypes of Orientia tsutsugamushi	PLOS ONE			English	Article							SCRUB TYPHUS; GEOGRAPHIC-DISTRIBUTION; VIRULENCE; SEROTYPES; THAILAND; HUMANS	Background: Scrub typhus is an infectious disease caused by Orientia tsutsugamushi. The differences in virulence of O. tsutsugamushi prototypes in humans are still unknown. We investigated whether there are any differences in the clinical features of the Boryoung and Karp genotypes. Methodology/Principal Findings: Patients infected with O. tsutsugamushi, as Boryoung and Karp clusters, who had visited 6 different hospitals in southwestern Korea were prospectively compared for clinical features, complications, laboratory parameters, and treatment responses. Infected patients in the Boryoung cluster had significantly more generalized weakness, eschars, skin rashes, conjunctival injection, high albumin levels, and greater ESR and fibrinogen levels compared to the Karp cluster. The treatment response to current antibiotics was significantly slower in the Karp cluster as compared to the Boryoung cluster. Conclusion: The frequency of occurrence of eschars and rashes may depend on the genotype of O. tsutsugamushi.	[Kim, Dong-Min; Yun, Na Ra; Neupane, Ganesh Prasad] Chosun Univ, Sch Med, Dept Internal Med, Div Infect Dis, Kwangju, South Korea; [Shin, Sung Heui] Chosun Univ, Sch Med, Dept Microbiol, Kwangju, South Korea; [Ryu, So Yeon] Chosun Univ, Sch Med, Dept Prevent Med, Kwangju, South Korea; [Yoon, Hee Jung] Eulji Univ, Coll Med, Dept Internal Med, Taejon, South Korea; [Wie, Seong Heon] Catholic Univ Korea, St Vincents Hosp, Dept Internal Med, Sch Med, Suwon, South Korea; [Kim, Woo Jin] Kangwon Natl Univ, Dept Internal Med, Chunchon, South Korea; [Lee, Chang Youl] Hallym Univ, Med Ctr, Chuncheon Sacred Heart Hosp, Div Pulm Allergy & Crit Care Med,Dept Internal Me, Chunchon, South Korea; [Choi, Jong Soo] Univ Ulsan, Coll Med, Dept Internal Med, Gangneung Asan Hosp, Kangnung, South Korea; [Choi, Jong Soo] Haenam Gen Hosp, Dept Internal Med, Haenam, South Korea; [Kim, Dong-Min; Shin, Sung Heui] MRC, Res Ctr Resistant Cells, Kwangju, South Korea	Chosun University; Chosun University; Chosun University; Eulji University; Catholic University of Korea; Kangwon National University; Hallym University; University of Ulsan	Kim, DM (corresponding author), Chosun Univ, Sch Med, Dept Internal Med, Div Infect Dis, Kwangju, South Korea.	drongkim@chosun.ac.kr; wiesh@chollian.net		Kim, Dong-Min/0000-0001-6373-0922				Agrawal S, 1999, Indian J Gastroenterol, V18, P5; BERMAN SJ, 1973, ANN INTERN MED, V79, P26, DOI 10.7326/0003-4819-79-1-26; BLAKE FG, 1945, AM J PUBLIC HEALTH, V35, P1121; Chang Woo-Hyun, 1995, Journal of Korean Medical Science, V10, P227; Chu H, 2010, J MICROBIOL, V48, P124, DOI 10.1007/s12275-009-0267-7; Enatsu T, 1999, FEMS MICROBIOL LETT, V180, P163, DOI 10.1111/j.1574-6968.1999.tb08791.x; Fournier PE, 2008, CLIN MICROBIOL INFEC, V14, P168, DOI 10.1111/j.1469-0691.2007.01889.x; GROVES MG, 1978, INFECT IMMUN, V19, P583, DOI 10.1128/IAI.19.2.583-588.1978; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kim DM, 2007, AM J TROP MED HYG, V76, P806; Kim DM, 2006, CLIN INFECT DIS, V43, P1296, DOI 10.1086/508464; Manosroi J, 2006, DIAGN MICR INFEC DIS, V55, P185, DOI 10.1016/j.diagmicrobio.2006.01.014; Nagano I, 1996, MICROBIOL IMMUNOL, V40, P743, DOI 10.1111/j.1348-0421.1996.tb01135.x; Parola P, 2008, EMERG INFECT DIS, V14, P1483, DOI 10.3201/eid1409.071259; Premaratna R, 2006, Clin Infect Dis, V42, pe6, DOI 10.1086/498747; Ree HI, 2001, AM J TROP MED HYG, V65, P528, DOI 10.4269/ajtmh.2001.65.528; Saini Ritu, 2004, J Am Acad Dermatol, V51, pS137, DOI 10.1016/j.jaad.2004.03.036; SAYEN JJ, 1946, MEDICINE, V25, P155, DOI 10.1097/00005792-194605000-00003; Shishime E, 1987, Kansenshogaku Zasshi, V61, P297; Silpapojakul K, 2004, T ROY SOC TROP MED H, V98, P354, DOI 10.1016/j.trstmh.2003.10.011; SILPAPOJAKUL K, 1991, PEDIATR INFECT DIS J, V10, P200, DOI 10.1097/00006454-199103000-00006; SIPE JD, 1995, SEMIN ARTHRITIS RHEU, V25, P75, DOI 10.1016/S0049-0172(95)80020-4; TAMURA A, 1995, INT J SYST BACTERIOL, V45, P589, DOI 10.1099/00207713-45-3-589; Tamura A, 2001, MICROBIOL IMMUNOL, V45, P439, DOI 10.1111/j.1348-0421.2001.tb02643.x; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Yu MJ, 2000, CRIT CARE MED, V28, P1777, DOI 10.1097/00003246-200006000-00013	26	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e22731	10.1371/journal.pone.0022731	http://dx.doi.org/10.1371/journal.pone.0022731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21857951	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953700001
J	Ahmed, AA; Mooar, PA; Kleiner, M; Torg, JS; Miyamoto, CT				Ahmed, Awad A.; Mooar, Pekka A.; Kleiner, Matthew; Torg, Joseph S.; Miyamoto, Curtis T.			Hypertensive Patients Show Delayed Wound Healing following Total Hip Arthroplasty	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; BLOOD-PRESSURE; PREVENTION; INFECTION; REPLACEMENT; ENOXAPARIN; THROMBOSIS; EFFICACY; DRAINAGE	Background: Prolonged wound-discharge following total hip arthroplasty (THA) is associated with an increased risk of infection. However, the potential role of hypertension in prolonging the duration of wound healing in this population has not yet been investigated. The aim of the present study was to compare healing in this population that has not yet been investigated. The aim of the present study was to compare hypertensive and normotensive THA patients in terms of the length of time required to achieve a dry wound and the length of stay in the hospital. Methods: One hundred and twenty primary THA patients were evaluated. Pre-operative clinical history and physical examination revealed that 29 were hypertensive and 91 were normotensive. The two groups were statistically matched using optimal propensity score matching. The outcomes of interest were the number of days until a dry wound was observed and the duration of hospital stay. Results: The average systolic blood pressures were 150.1 mmHg and 120.3 mmHg for the hypertensive and normotensive groups, respectively. The mean number of days until the wound was dry was 3.79 for the hypertensive group and 2.03 for the normotensive group. Hypertensive patients required more days for their wounds to dry than normotensive patients (odds ratio = 1.65, p<0.05). No significant difference in the duration of hospital stay was found between the two groups. Conclusions: Hypertensive patients had a higher risk of prolonged wound discharge after THA than their normotensive counterparts. Patients with prolonged wound drainage are at greater risk for infection. Clinicians should pay particular attention to infection-prevention strategies in hypertensive THA patients.	[Ahmed, Awad A.] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Mooar, Pekka A.; Kleiner, Matthew; Torg, Joseph S.] Temple Univ Hosp & Med Sch, Dept Orthopaed & Sports Med, Philadelphia, PA 19140 USA; [Miyamoto, Curtis T.] Temple Univ Hosp & Med Sch, Dept Radiat Oncol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ahmed, AA (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.	awad.ahmed@temple.edu	ahmed, awad/K-4914-2019	ahmed, awad/0000-0002-9710-779X	John Lachman Research Fund	John Lachman Research Fund	Funding for this study was provided by the John Lachman Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HLTH US 2009 SPECIAL; Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; Chen J, 2002, HYPERTENSION, V40, P810, DOI 10.1161/01.HYP.0000039962.68332.59; CHOONARA IA, 1988, BRIT J CLIN PHARMACO, V25, P1; CLAGETT GP, 1992, CHEST, V102, pS391, DOI 10.1378/chest.102.4_Supplement.391S; Colwell CW, 2010, J BONE JOINT SURG AM, V92A, P527, DOI 10.2106/JBJS.I.00047; Colwell CW, 1999, J BONE JOINT SURG AM, V81A, P932, DOI 10.2106/00004623-199907000-00005; COLWELL CW, 1994, J BONE JOINT SURG AM, V76A, P3, DOI 10.2106/00004623-199401000-00002; Cordero-Ampuero J, 2010, CLIN ORTHOP RELAT R, V468, P3268, DOI 10.1007/s11999-010-1411-8; ERIKSSON BI, 1991, THROMB RES, V62, P55, DOI 10.1016/0049-3848(91)90668-M; Fareed J, 1998, AM J CARDIOL, V82, p3L, DOI 10.1016/S0002-9149(98)00105-2; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; HALL MJ, 2010, 29 NAT HLTH STAT; Hanssen AD, 1998, J BONE JOINT SURG AM, V80A, P910, DOI 10.2106/00004623-199806000-00016; Hirsh J, 1998, CHEST, V114, p489S, DOI 10.1378/chest.114.5_Supplement.489S; Imai K, 2008, LOGIT LOGISTIC REGRE; Jain NB, 2005, CLIN ORTHOP RELAT R, P232, DOI 10.1097/01.blo.0000156479.97488.a2; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Lai K, 2007, J ARTHROPLASTY, V22, P651, DOI 10.1016/j.arth.2006.09.002; LAVIE CJ, 1988, AM HEART J, V116, P1146, DOI 10.1016/0002-8703(88)90179-2; Lubbeke A, 2007, ARTHRIT RHEUM-ARTHR, V57, P327, DOI 10.1002/art.22542; Murray DW, 1996, J BONE JOINT SURG BR, V78B, P863, DOI 10.1302/0301-620X78B6.6714; Patel VP, 2007, J BONE JOINT SURG AM, V89A, P33, DOI 10.2106/JBJS.F.00163; Ridgeway S, 2005, J BONE JOINT SURG BR, V87B, P844, DOI 10.1302/0301-620X.87B6.15121; ROSENBAUM PR, 1989, J AM STAT ASSOC, V84, P1024, DOI 10.2307/2290079; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Spencer A P, 2000, Curr Treat Options Cardiovasc Med, V2, P1, DOI 10.1007/s11936-000-0001-6; Steiner M, 1999, NUTR REV, V57, P306, DOI 10.1111/j.1753-4887.1999.tb06903.x; Stuart EA, 2008, DEV PSYCHOL, V44, P395, DOI 10.1037/0012-1649.44.2.395; SURIN VV, 1983, J BONE JOINT SURG BR, V65, P412, DOI 10.1302/0301-620X.65B4.6874711; Weiss A P, 1993, J Arthroplasty, V8, P285, DOI 10.1016/S0883-5403(06)80091-4	34	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23224	10.1371/journal.pone.0023224	http://dx.doi.org/10.1371/journal.pone.0023224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853091	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953400033
J	Fisker, AB; Aaby, P; Rodrigues, A; Frydenberg, M; Bibby, BM; Benn, CS				Fisker, Ane Baerent; Aaby, Peter; Rodrigues, Amabelia; Frydenberg, Morten; Bibby, Bo Martin; Benn, Christine Stabell			Vitamin A Supplementation at Birth Might Prime the Response to Subsequent Vitamin A Supplements in Girls. Three Year Follow-Up of a Randomized Trial	PLOS ONE			English	Article							CHILD-MORTALITY; BCG VACCINE; MORBIDITY; IMPACT	Objectives: Within a randomised trial of neonatal vitamin A supplementation (VAS) in Guinea-Bissau, neonatal VAS did not affect overall infant mortality. We conducted a post-hoc analysis to test the hypothesis that neonatal VAS primes the response to subsequent vitamin A. Methods: All trial children were offered VAS after follow-up ended at 1 year of age (FU-VAS). We compared mortality between 1 and 3 years of age according to initial randomization to neonatal VAS or placebo in Cox-regression models; we expected that children randomized to neonatal VAS compared with those randomized to placebo would have lower mortality after reception of FU-VAS. Results: Of 4345 infants enrolled in the original trial, 3646 lived in the study area at 1 year of age and 2958 received FU-VAS. Between 1 and 3 years of age, 112 children died. After FU-VAS, neonatal VAS was associated with lower mortality than placebo: Mortality Rate Ratio (MRR) = 0.54 (95% CI: 0.31-0.94). The effect was more pronounced in girls (MRR = 0.37 (0.16-0.89)) than boys (MRR = 0.73 (0.35-1.51)). The beneficial effect of neonatal VAS may have been particularly strong for girls who received both VAS in a campaign and FU-VAS (MRR = 0.15 (0.03-0.67)). Among children who had not received FU-VAS, mortality in the second and third year of life did not differ according to reception of neonatal VAS or placebo. Hence, in the second and third year of life the effect of neonatal VAS versus placebo was different in girls who had or had not received FU-VAS (p for homogeneity = 0.01). Conclusions: The present results suggest that neonatal VAS primes the response in girls such that they get a beneficial effect after a subsequent dose of VAS.	[Fisker, Ane Baerent; Aaby, Peter; Rodrigues, Amabelia; Benn, Christine Stabell] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Fisker, Ane Baerent; Aaby, Peter; Benn, Christine Stabell] Statens Serum Inst, Bandim Hlth Project, DK-2300 Copenhagen S, Denmark; [Fisker, Ane Baerent; Frydenberg, Morten; Bibby, Bo Martin] Univ Aarhus, Dept Biostat, Inst Publ Hlth, Aarhus, Denmark	Statens Serum Institut; Aarhus University	Fisker, AB (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	a.fisker@bandim.org	Fisker, Ane B/E-9283-2019	Fisker, Ane B/0000-0002-8521-0992; Aaby, Peter/0000-0001-8331-1389	EU [ICA4-CT-2002-10053]; Danish Medical Research Council; University of Copenhagen; March of Dimes; Ville Heise Foundation; DANIDA; Danish National Research Foundation; Novo Nordisk Foundation; Codan foundation; Grosserer Ludvig Berlin og Froken Marie Poulsens Fond	EU(European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen; March of Dimes(March of Dimes); Ville Heise Foundation; DANIDA; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Codan foundation; Grosserer Ludvig Berlin og Froken Marie Poulsens Fond	This work was supported by the EU (ICA4-CT-2002-10053), the Danish Medical Research Council, University of Copenhagen, March of Dimes, and the Ville Heise Foundation. ABF received funding for courses to be able to analyze the data from Codan foundation and 'Grosserer Ludvig Berlin og Froken Marie Poulsens Fond'. The Bandim Health Project received support from DANIDA and the Danish National Research Foundation. PA holds a research professorship grant from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Wkly Epidemiol Rec, V74, P1; Beaton G., 1993, EFFECTIVENESS VITAMI; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; Benn CS, 2005, BMJ-BRIT MED J, V331, P1428, DOI 10.1136/bmj.38670.639340.55; Csaba G, 2007, CELL BIOCHEM FUNCT, V25, P717, DOI 10.1002/cbf.1381; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Fisker AB, 2011, J TROP MED IN PRESS; Fisker AB, 2007, AM J CLIN NUTR, V86, P1032, DOI 10.1093/ajcn/86.4.1032; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; HERRERA MG, 1992, LANCET, V340, P267, DOI 10.1016/0140-6736(92)92357-L; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Nante JE, 2008, EUR J CLIN NUTR, V62, P842, DOI 10.1038/sj.ejcn.1602796; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; ROSS DA, 1995, AM J PUBLIC HEALTH, V85, P1246, DOI 10.2105/AJPH.85.9.1246; SOMMER A, 1986, LANCET, V1, P1169; Benn CS, 2006, J INFECT DIS, V194, P719, DOI 10.1086/506457; VIJAYARAGHAVAN K, 1990, LANCET, V336, P1342, DOI 10.1016/0140-6736(90)92895-O; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6	19	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23265	10.1371/journal.pone.0023265	http://dx.doi.org/10.1371/journal.pone.0023265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853099	gold, Green Published, Green Submitted			2022-12-27	WOS:000293953400036
J	Bever, GS; Brusatte, SL; Balanoff, AM; Norell, MA				Bever, Gabe S.; Brusatte, Stephen L.; Balanoff, Amy M.; Norell, Mark A.			Variation, Variability, and the Origin of the Avian Endocranium: Insights from the Anatomy of Alioramus altai (Theropoda: Tyrannosauroidea)	PLOS ONE			English	Article							TARBOSAURUS-BATAAR THEROPODA; EVOLUTION; DINOSAUR; BRAIN; PHYLOGENY; COMPLEX	The internal braincase anatomy of the holotype of Alioramus altai, a relatively small-bodied tyrannosauroid from the Late Cretaceous of Mongolia, was studied using high-resolution computed tomography. A number of derived characters strengthen the diagnosis of this taxon as both a tyrannosauroid and a unique, new species (e.g., endocranial position of the gasserian ganglion, internal ramification of the facial nerve). Also present are features intermediate between the basal theropod and avialan conditions that optimize as the ancestral condition for Coelurosauria-a diverse group of derived theropods that includes modern birds. The expression of several primitive theropod features as derived character states within Tyrannosauroidea establishes previously unrecognized evolutionary complexity and morphological plasticity at the base of Coelurosauria. It also demonstrates the critical role heterochrony may have played in driving patterns of endocranial variability within the group and potentially reveals stages in the evolution of neuroanatomical development that could not be inferred based solely on developmental observations of the major archosaurian crown clades. We discuss the integration of paleontology with variability studies, especially as applied to the nature of morphological transformations along the phylogenetically long branches that tend to separate the crown clades of major vertebrate groups.	[Bever, Gabe S.] Yale Univ, Dept Geol & Geophys, New Haven, CT USA; [Bever, Gabe S.; Brusatte, Stephen L.; Balanoff, Amy M.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Brusatte, Stephen L.; Balanoff, Amy M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA	Yale University; American Museum of Natural History (AMNH); Columbia University	Bever, GS (corresponding author), New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.	gbever@nyit.edu	Brusatte, Stephen/O-9663-2014	Brusatte, Stephen/0000-0001-7525-7319	American Museum of Natural History; National Science Foundation [DEB 1110357, DEB 0909970, DEB-9300700, ATOL 0228693]; Yale University	American Museum of Natural History; National Science Foundation(National Science Foundation (NSF)); Yale University	Funding: This work was funded by the American Museum of Natural History, Yale University, and the National Science Foundation (Graduate Research Fellowship to SLB, Doctoral Dissertation Improvement Grants DEB 1110357 and DEB 0909970 to SLB and MAN and AMB and MAN, respectively, and DEB-9300700 and ATOL 0228693 to MAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali F, 2008, J VERTEBR PALEONTOL, V28, P123, DOI 10.1671/0272-4634(2008)28[123:HOTECO]2.0.CO;2; Bever GS, 2011, EVOL DEV, V13, P269, DOI 10.1111/j.1525-142X.2011.00478.x; Bever GS, 2009, B AM MUS NAT HIST, P3; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Bever GS, 2009, J MORPHOL, V270, P97, DOI 10.1002/jmor.10677; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Clabaut C, 2009, EVOL DEV, V11, P636, DOI 10.1111/j.1525-142X.2009.00371.x; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Currie P.J., 1997, ENCY DINOSAURS, P81; DONOGHUE MJ, 1989, ANNU REV ECOL SYST, V20, P431, DOI 10.1146/annurev.es.20.110189.002243; Emerson S.B., 1993, SKULL, V3, P384; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Evans H. E., 1993, HDB AVIAN ANATOMY NO, P585; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; JERISON HJ, 1969, AM NAT, V103, P575, DOI 10.1086/282627; Kallersjo M, 1999, CLADISTICS, V15, P91; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Klembara J, 2008, ACTA ZOOLOGICA, V89, P275; Kurzanov S. M., 1976, SOVMESTNAA SOVETSKO, V3, P93; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; Lewontin R., 2000, TRIPLE HELIX GENE OR, DOI 10.5061/dryad.f7m0cfxx6; Marugan-Lobon J, 2009, ANAT REC, V292, P364, DOI 10.1002/ar.20865; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Salazar-Ciudad I, 2006, J EXP ZOOL PART B, V306B, P107, DOI 10.1002/jez.b.21078; SAMPSON SD, 2007, SOC VERTEBRATE PALEO, V8, P225; Sanderson Michael J., 1996, P67, DOI 10.1016/B978-012618030-5/50005-8; Saveliev SV, 2007, PALEONTOL J+, V41, P281, DOI 10.1134/S0031030107030070; Sedlmayr, 2002, THESIS OHIO U; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wagner G. P., 2001, CHARACTER CONCEPT EV, P1; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wagner GP, 2003, J EXP ZOOL PART B, V300B, P1, DOI 10.1002/jez.b.00041; Witmer Lawrence M., 2010, Kirtlandia, V57, P61; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Young RL, 2011, DEV DYNAM, V240, P1042, DOI 10.1002/dvdy.22595; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	53	34	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23393	10.1371/journal.pone.0023393	http://dx.doi.org/10.1371/journal.pone.0023393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853125	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200079
J	Erlandsson, L; Rosenstierne, MW; McLoughlin, K; Jaing, C; Fomsgaard, A				Erlandsson, Lena; Rosenstierne, Maiken W.; McLoughlin, Kevin; Jaing, Crystal; Fomsgaard, Anders			The Microbial Detection Array Combined with Random Phi29-Amplification Used as a Diagnostic Tool for Virus Detection in Clinical Samples	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; MULTIPLE DISPLACEMENT AMPLIFICATION; ROLLING-CIRCLE AMPLIFICATION; POLYMERASE CHAIN-REACTION; PHI-29 DNA-POLYMERASE; REAL-TIME PCR; HUMAN CORONAVIRUS; MICROARRAY; IDENTIFICATION; HYBRIDIZATION	A common technique used for sensitive and specific diagnostic virus detection in clinical samples is PCR that can identify one or several viruses in one assay. However, a diagnostic microarray containing probes for all human pathogens could replace hundreds of individual PCR-reactions and remove the need for a clear clinical hypothesis regarding a suspected pathogen. We have established such a diagnostic platform for random amplification and subsequent microarray identification of viral pathogens in clinical samples. We show that Phi29 polymerase-amplification of a diverse set of clinical samples generates enough viral material for successful identification by the Microbial Detection Array, demonstrating the potential of the microarray technique for broad-spectrum pathogen detection. We conclude that this method detects both DNA and RNA virus, present in the same sample, as well as differentiates between different virus subtypes. We propose this assay for diagnostic analysis of viruses in clinical samples.	[Erlandsson, Lena; Rosenstierne, Maiken W.; Fomsgaard, Anders] Statens Serum Inst, Dept Virol, Virus Res & Dev, DK-2300 Copenhagen, Denmark; [McLoughlin, Kevin; Jaing, Crystal] Lawrence Livermore Natl Lab, Livermore, CA USA	Statens Serum Institut; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Erlandsson, L (corresponding author), Statens Serum Inst, Dept Virol, Virus Res & Dev, DK-2300 Copenhagen, Denmark.	lao@ssi.dk		Fomsgaard, Anders/0000-0003-4304-0603; Erlandsson, Lena/0000-0003-4350-5909; McLoughlin, Kevin/0000-0001-9651-4951; Jaing, Crystal/0000-0001-9933-3005; Tripp, Ralph/0000-0002-2924-9956	Lawrence Livermore National Laboratory under the U.S. Department of Energy [LLNL02-SI-008, DE-AC52-07NA27344]	Lawrence Livermore National Laboratory under the U.S. Department of Energy	The project was supported by the Laboratory Directed Research and Development Program at the Lawrence Livermore National Laboratory [Project LLNL02-SI-008 under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344 to CJ, KM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Clem AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-65; Compston LI, 2008, J VIROL METHODS, V151, P47, DOI 10.1016/j.jviromet.2008.03.023; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Jaing C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002163; Jasmine F, 2008, CANCER EPIDEM BIOMAR, V17, P3499, DOI 10.1158/1055-9965.EPI-08-0482; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Lasken RS, 2003, TRENDS BIOTECHNOL, V21, P531, DOI 10.1016/j.tibtech.2003.09.010; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x; Oh T, 2004, J CLIN MICROBIOL, V42, P3272, DOI 10.1128/JCM.42.7.3272-3280.2004; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Schollkopf C, 2008, INT J CANCER, V122, P1885, DOI 10.1002/ijc.23416; Silander Kaisa, 2008, V439, P1, DOI 10.1007/978-1-59745-188-8_1; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; VOSBERG HP, 1989, HUM GENET, V83, P1, DOI 10.1007/BF00274139; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wolf S, 2010, APPL ENVIRON MICROB, V76, P1388, DOI 10.1128/AEM.02249-09; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Xing JC, 2008, GENOMICS, V92, P452, DOI 10.1016/j.ygeno.2008.08.007	33	31	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22631	10.1371/journal.pone.0022631	http://dx.doi.org/10.1371/journal.pone.0022631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853040	gold, Green Published, Green Submitted			2022-12-27	WOS:000295454200016
J	Liang, GY; Schernhammer, E; Qi, L; Gao, X; De Vivo, I; Han, JL				Liang, Geyu; Schernhammer, Eva; Qi, Lu; Gao, Xiang; De Vivo, Immaculata; Han, Jiali			Associations between Rotating Night Shifts, Sleep Duration, and Telomere Length in Women	PLOS ONE			English	Article							LIFE-STYLE FACTORS; BREAST-CANCER; OXIDATIVE DAMAGE; RISK; WORK; MELATONIN; COHORT	Background: Telomere length has been proposed as a marker of aging. However, our knowledge of lifestyle risk factors determining telomere length is limited. Methods: We evaluated the associations between years of rotating night shifts, self-reported sleep duration, and telomere length in 4,117 female participants from the Nurses' Health Study. Telomere length in peripheral blood leukocytes was determined by Real-Time PCR assay. Information on rotating night shifts and sleep duration was collected via questionnaires prior to blood collection. We used multivariable linear regression to investigate the associations between rotating night shifts, sleep duration, and telomere length. Results: Compared with women in the category (9 hours), those in the lowest category of sleep duration (<6 hours) had a 0.12 unit decrease in z score after adjustment for age, BMI and cigarette smoking (equivalent to 9-year telomere attrition, P for trend = 0.05). Significant positive association between sleep duration and telomere length was seen among women under age of 50 (P for trend = 0.004), but not among those over 50 (P for trend = 0.33) (P for interaction = 0.005). In addition, we observed that women with a longer history of rotating night shifts tended to have shorter telomere length, but this relation was not statistically significant (P for trend = 0.36). Conclusion: We found that sleep duration was positively associated with telomere length among women under 50 years old. Further research is needed to confirm the observed associations.	[Liang, Geyu] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; [Liang, Geyu] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Peoples R China; [Schernhammer, Eva; Qi, Lu; Gao, Xiang; De Vivo, Immaculata; Han, Jiali] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Schernhammer, Eva; De Vivo, Immaculata; Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schernhammer, Eva] VIEnna CEADDP, LBI ACR, Vienna, Austria; [Schernhammer, Eva] VIEnna CEADDP, ACR ITR, Vienna, Austria; [Qi, Lu; Gao, Xiang] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Southeast University - China; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liang, GY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA.	jiali.han@channing.harvard.edu	Schernhammer, Eva S/L-7898-2018	Schernhammer, Eva S/0000-0002-4337-9415; , Xiang/0000-0003-2617-6509; De Vivo, Immaculata/0000-0002-7185-7402	National Institutes of Health [CA133914, CA87969, CA49449]; NATIONAL CANCER INSTITUTE [U01CA049449, P01CA087969, R03CA133914, R01CA049449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants CA133914, CA87969, and CA49449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach D, 2003, J CLIN ENDOCR METAB, V88, P26, DOI 10.1210/jc.2002-020827; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Barcelo A, 2010, RESP MED, V104, P1225, DOI 10.1016/j.rmed.2010.03.025; Blask DE, 2005, ENDOCRINE, V27, P179, DOI 10.1385/ENDO:27:2:179; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Chen HL, 2006, AM J EPIDEMIOL, V163, P726, DOI 10.1093/aje/kwj096; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Conlon M, 2007, EPIDEMIOLOGY, V18, P182, DOI 10.1097/01.ede.0000249519.33978.31; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Hernandez C, 2007, EUR RESPIR J, V30, P496, DOI 10.1183/09031936.00051906; Hou LF, 2009, CANCER EPIDEM BIOMAR, V18, P3103, DOI 10.1158/1055-9965.EPI-09-0347; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009; Ozen OA, 2008, SYST BIOL REPROD MED, V54, P169, DOI 10.1080/19396360802422402; Page JH, 2008, CLIN CHEM, V54, P1682, DOI 10.1373/clinchem.2008.105825; Parks CG, 2011, OCCUP ENV MED; Pinheiro SP, 2006, CANCER RES, V66, P5521, DOI 10.1158/0008-5472.CAN-05-4652; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Pronk A, 2010, AM J EPIDEMIOL, V171, P953, DOI 10.1093/aje/kwq029; Reiter RJ, 2004, J PINEAL RES, V37, P213, DOI 10.1111/j.1600-079X.2004.00165.x; Rocca WA, 2010, NEURODEGENER DIS, V7, P163, DOI 10.1159/000289229; Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Schernhammer ES, 2011, J NATL CANCER I, V103, P602, DOI 10.1093/jnci/djr044; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P649, DOI 10.1093/gerona/glq017; Thompson CL, 2011, CANCER-AM CANCER SOC, V117, P841, DOI 10.1002/cncr.25507; Verkasalo PK, 2005, CANCER RES, V65, P9595, DOI 10.1158/0008-5472.CAN-05-2138; Viswanathan AN, 2007, CANCER RES, V67, P10618, DOI 10.1158/0008-5472.CAN-07-2485; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; Wu AH, 2008, CARCINOGENESIS, V29, P1244, DOI 10.1093/carcin/bgn100; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	40	60	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23462	10.1371/journal.pone.0023462	http://dx.doi.org/10.1371/journal.pone.0023462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853136	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200087
J	Lirman, D; Schopmeyer, S; Manzello, D; Gramer, LJ; Precht, WF; Muller-Karger, F; Banks, K; Barnes, B; Bartels, E; Bourque, A; Byrne, J; Donahue, S; Duquesnel, J; Fisher, L; Gilliam, D; Hendee, J; Johnson, M; Maxwell, K; McDevitt, E; Monty, J; Rueda, D; Ruzicka, R; Thanner, S				Lirman, Diego; Schopmeyer, Stephanie; Manzello, Derek; Gramer, Lewis J.; Precht, William F.; Muller-Karger, Frank; Banks, Kenneth; Barnes, Brian; Bartels, Erich; Bourque, Amanda; Byrne, James; Donahue, Scott; Duquesnel, Janice; Fisher, Louis; Gilliam, David; Hendee, James; Johnson, Meaghan; Maxwell, Kerry; McDevitt, Erin; Monty, Jamie; Rueda, Digna; Ruzicka, Rob; Thanner, Sara			Severe 2010 Cold-Water Event Caused Unprecedented Mortality to Corals of the Florida Reef Tract and Reversed Previous Survivorship Patterns	PLOS ONE			English	Article							CALCIFICATION RATE; LOW-TEMPERATURES; STRESSORS; COMMUNITIES; TOLERANCE; SURVIVAL; IMPACTS; DISEASE; BAHAMAS; QUALITY	Background: Coral reefs are facing increasing pressure from natural and anthropogenic stressors that have already caused significant worldwide declines. In January 2010, coral reefs of Florida, United States, were impacted by an extreme cold-water anomaly that exposed corals to temperatures well below their reported thresholds (16 degrees C), causing rapid coral mortality unprecedented in spatial extent and severity. Methodology/Principal Findings: Reef surveys were conducted from Martin County to the Lower Florida Keys within weeks of the anomaly. The impacts recorded were catastrophic and exceeded those of any previous disturbances in the region. Coral mortality patterns were directly correlated to in-situ and satellite-derived cold-temperature metrics. These impacts rival, in spatial extent and intensity, the impacts of the well-publicized warm-water bleaching events around the globe. The mean percent coral mortality recorded for all species and subregions was 11.5% in the 2010 winter, compared to 0.5% recorded in the previous five summers, including years like 2005 where warm-water bleaching was prevalent. Highest mean mortality (15%-39%) was documented for inshore habitats where temperatures were < 11 degrees C for prolonged periods. Increases in mortality from previous years were significant for 21 of 25 coral species, and were 1-2 orders of magnitude higher for most species. Conclusions/Significance: The cold-water anomaly of January 2010 caused the worst coral mortality on record for the Florida Reef Tract, highlighting the potential catastrophic impacts that unusual but extreme climatic events can have on the persistence of coral reefs. Moreover, habitats and species most severely affected were those found in high-coral cover, inshore, shallow reef habitats previously considered the "oases" of the region, having escaped declining patterns observed for more offshore habitats. Thus, the 2010 cold-water anomaly not only caused widespread coral mortality but also reversed prior resistance and resilience patterns that will take decades to recover.	[Lirman, Diego; Schopmeyer, Stephanie] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Manzello, Derek; Gramer, Lewis J.; Hendee, James] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Precht, William F.] NOAA, Key Largo, FL USA; [Muller-Karger, Frank; Barnes, Brian; Rueda, Digna] Univ S Florida, Coll Marine Sci, Inst Marine Remote Sensing IMaRS, St Petersburg, FL 33701 USA; [Banks, Kenneth] Broward Cty Nat Resources Planning & Management D, Plantation, FL USA; [Bartels, Erich] Ctr Coral Reef Res, Mote Marine Lab, Summerland Key, FL USA; [Bourque, Amanda] Biscayne Natl Pk, Homestead, FL USA; [Byrne, James; Johnson, Meaghan] Nature Conservancy, Summerland Key, FL USA; [Donahue, Scott] NOAA, Key West, FL USA; [Duquesnel, Janice] Florida Pk Serv, Islamorada, FL USA; [Fisher, Louis] Broward Cty Environm Protect & Growth Management, Plantation, FL USA; [Gilliam, David] Nova SE Univ, Oceanog Ctr, Natl Coral Reef Inst, Dania, FL USA; [Maxwell, Kerry] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marathon, FL USA; [McDevitt, Erin] Florida Fish & Wildlife Conservat Commiss, W Palm Beach, FL USA; [Monty, Jamie] Florida Gulf Coast Univ, Florida Dept Environm Protect, Coral Reef Conservat Program, Miami, FL USA; [Ruzicka, Rob] Fish & Wildlife Res Inst, St Petersburg, FL USA; [Thanner, Sara] Dept Environm Resources Management, Miami, FL USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; University of South Florida; Mote Marine Laboratory & Aquarium; Nature Conservancy; National Oceanic Atmospheric Admin (NOAA) - USA; Nova Southeastern University; Florida Fish & Wildlife Conservation Commission; Florida Fish & Wildlife Conservation Commission; State University System of Florida; Florida Gulf Coast University; Florida Fish & Wildlife Conservation Commission	Lirman, D (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	dlirman@rsmas.miami.edu	Rueda-Roa, Digna/AHD-3202-2022; Rueda, Digna/J-8045-2019; Manzello, Derek P/A-8661-2014; Hendee, James C/E-6358-2010; Gramer, Lewis James/A-5620-2010	Rueda-Roa, Digna/0000-0003-4621-009X; Manzello, Derek P/0000-0002-0720-3041; Hendee, James C/0000-0002-4799-5354; Gramer, Lewis James/0000-0003-4772-1991; Schopmeyer, Stephanie/0000-0003-4717-465X	NOAA; Nature Conservancy; ARRA program	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Nature Conservancy; ARRA program	This publication was made possible with support from NOAA's Coral Reef Conservation Program, The Nature Conservancy, and the ARRA program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault JS, 2006, B MAR SCI, V78, P633; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barnes BB, 2011, IEEE GEOSCI REMOTE S, V8, P769, DOI 10.1109/LGRS.2011.2111353; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; Dana F. D., 1843, AM J SCI, V45, P130; DAVIS GE, 1982, B MAR SCI, V32, P608; Dustan P., 1999, NAT RESOUR FORUM, V23, P147; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Ginsburg RN, 2001, B MAR SCI, V69, P1149; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; HENDEE JC, 2009, P 11 INT COR REEF S, P534; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265, DOI 10.4319/lo.2005.50.1.0265; Hu CM, 2009, IEEE T GEOSCI REMOTE, V47, P2071, DOI 10.1109/TGRS.2009.2024992; HUDSON JH, 1976, GEOLOGY, V4, P361, DOI 10.1130/0091-7613(1976)4<361:SATFIP>2.0.CO;2; HUDSON JH, 1981, P 4 INT COR REEF S M, P444; IPCC, 2007, CLIM CHANG 2007; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Kleypas JA, 1999, AM ZOOL, V39, P146; Kodra E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047103; Kramer P.R., 2003, ATOLL RES B, V496, P611, DOI DOI 10.5479/SI.00775630.496-34.611; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lirman D, 2003, ECOL MODEL, V161, P169, DOI 10.1016/S0304-3800(02)00346-0; Lirman D, 2007, MAR POLLUT BULL, V54, P779, DOI 10.1016/j.marpolbul.2006.12.014; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MACINTYRE IG, 1969, SCIENCE, V166, P374, DOI 10.1126/science.166.3903.374; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Mayer A.G., 1915, YB CARNEGIE I WASH, V14, P212; MAYOR AG, 1914, CARNEGIE I PUB 183, V6, P1; Miller MW, 2000, CORAL REEFS, V19, P115, DOI 10.1007/s003380000079; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; OGDEN JC, 1994, B MAR SCI, V54, P1059; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Palandro D, 2003, CAN J REMOTE SENS, V29, P201, DOI 10.5589/m02-095; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Porter James W., 2002, P749; PORTER JW, 1992, AM ZOOL, V32, P625; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; PORTER JW, 1982, P NATL ACAD SCI-BIOL, V79, P1678, DOI 10.1073/pnas.79.5.1678; Precht William F., 2007, V192, P237, DOI 10.1007/978-0-387-33537-7_9; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; ROBERTS HH, 1982, J SEDIMENT PETROL, V52, P145; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Shenkar N, 2005, MAR ECOL PROG SER, V294, P181, DOI 10.3354/meps294181; SHINN E. A., 1966, J PALEONTOL, V40, P233; Teece MA, 2011, LIMNOL OCEANOGR, V56, P1285, DOI 10.4319/lo.2011.56.4.1285; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; van Hooidonk R, 2009, CORAL REEFS, V28, P579, DOI 10.1007/s00338-009-0502-z; Van Oppen MJH, 2009, CORAL BLEACHING PATT; VAUGHAN TW, 1918, CARNEGIE I WASHINGTO, V213, P321; VAUGHAN TW, 1919, ANN REP SMITHSON I, V17, P189; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Walker N.D., 1982, Coral Reefs, V1, P83, DOI 10.1007/BF00301689; WANG C, 2010, ATMOSPHERIC SCI LETT; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W	72	145	145	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23047	10.1371/journal.pone.0023047	http://dx.doi.org/10.1371/journal.pone.0023047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853066	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200037
J	Rochlin, I; Turbow, D; Gomez, F; Ninivaggi, DV; Campbell, SR				Rochlin, Ilia; Turbow, David; Gomez, Frank; Ninivaggi, Dominick V.; Campbell, Scott R.			Predictive Mapping of Human Risk for West Nile Virus (WNV) Based on Environmental and Socioeconomic Factors	PLOS ONE			English	Article							EQUINE ENCEPHALOMYELITIS VIRUS; ST-LOUIS ENCEPHALITIS; LAND-USE; SPATIAL AUTOCORRELATION; NEW-YORK; INFECTION; EPIDEMIOLOGY; SURVEILLANCE; DIPTERA; VECTOR	A West Nile virus (WNV) human risk map was developed for Suffolk County, New York utilizing a case-control approach to explore the association between the risk of vector-borne WNV and habitat, landscape, virus activity, and socioeconomic variables derived from publically available datasets. Results of logistic regression modeling for the time period between 2000 and 2004 revealed that higher proportion of population with college education, increased habitat fragmentation, and proximity to WNV positive mosquito pools were strongly associated with WNV human risk. Similar to previous investigations from north-central US, this study identified middle class suburban neighborhoods as the areas with the highest WNV human risk. These results contrast with similar studies from the southern and western US, where the highest WNV risk was associated with low income areas. This discrepancy may be due to regional differences in vector ecology, urban environment, or human behavior. Geographic Information Systems (GIS) analytical tools were used to integrate the risk factors in the 2000-2004 logistic regression model generating WNV human risk map. In 2005-2010, 41 out of 46 (89%) of WNV human cases occurred either inside of (30 cases) or in close proximity (11 cases) to the WNV high risk areas predicted by the 2000-2004 model. The novel approach employed by this study may be implemented by other municipal, local, or state public health agencies to improve geographic risk estimates for vector-borne diseases based on a small number of acute human cases.	[Rochlin, Ilia; Ninivaggi, Dominick V.] Suffolk Cty Vector Control, Yaphank, NY 11980 USA; [Turbow, David; Gomez, Frank] TUI Univ, Coll Hlth Sci, Cypress, CA USA; [Campbell, Scott R.] Suffolk Cty Arthropod Borne Dis Lab, Yaphank, NY USA		Rochlin, I (corresponding author), Suffolk Cty Vector Control, Yaphank, NY 11980 USA.	ilia.rochlin@suffolkcountyny.gov						Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Cooke William H 3rd, 2006, Int J Health Geogr, V5, P36, DOI 10.1186/1476-072X-5-36; Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Eidson M, 2001, EMERG INFECT DIS, V7, P631, DOI 10.3201/eid0704.010405; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; ELDRIDGE BF, 1987, AM J TROP MED HYG, V37, pS77, DOI 10.4269/ajtmh.1987.37.77S; Grillet ME, 2010, AM J TROP MED HYG, V82, P194, DOI 10.4269/ajtmh.2010.09-0040; Gu WD, 2006, VECTOR-BORNE ZOONOT, V6, P91, DOI 10.1089/vbz.2006.6.91; Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Haneuse S, 2008, STAT MED, V27, P864, DOI 10.1002/sim.2979; Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; HAY SI, 2000, REMOTE SENSING GEOGR; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Johnson GD, 2006, AM J EPIDEMIOL, V163, P171, DOI 10.1093/aje/kwj023; King RJ, 2004, EMERG INFECT DIS, V10, P598, DOI 10.3201/eid1004.030241; Konrad SK, 2009, VECTOR-BORNE ZOONOT, V9, P267, DOI 10.1089/vbz.2008.0084; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kutz FW, 2003, J AM MOSQUITO CONTR, V19, P190; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Liu A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-67; Liu H, 2009, ENVIRON MONIT ASSESS, V159, P143, DOI 10.1007/s10661-008-0618-6; Liu H, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-66; Meehan PJ, 2000, EPIDEMIOL INFECT, V125, P181, DOI 10.1017/S0950268899004227; Meyer TE, 2007, EMERG INFECT DIS, V13, P1500, DOI 10.3201/eid1310.070442; Moncayo AC, 2000, J MED ENTOMOL, V37, P701, DOI 10.1603/0022-2585-37.5.701; Patnaik JL, 2007, EMERG INFECT DIS, V13, P1788, DOI 10.3201/eid1311.070506; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Pradier S, 2008, VECTOR-BORNE ZOONOT, V8, P253, DOI 10.1089/vbz.2007.0178; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; Rios J, 2006, J AM MOSQUITO CONTR, V22, P254, DOI 10.2987/8756-971X(2006)22[254:DASAOW]2.0.CO;2; Rochlin I, 2008, J MED ENTOMOL, V45, P563, DOI 10.1603/0022-2585(2008)45[563:CAODAA]2.0.CO;2; Rochlin I, 2010, THESIS; Rochlin I, 2009, AM J TROP MED HYG, V80, P661, DOI 10.4269/ajtmh.2009.80.661; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Thomson MC, 1999, AM J TROP MED HYG, V61, P2, DOI 10.4269/ajtmh.1999.61.2; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Vanwambeke SO, 2010, VECTOR-BORNE ZOONOT, V10, P497, DOI 10.1089/vbz.2009.0116; Ward MR, 2006, J WILDLIFE DIS, V42, P92, DOI 10.7589/0090-3558-42.1.92	58	49	49	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23280	10.1371/journal.pone.0023280	http://dx.doi.org/10.1371/journal.pone.0023280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853103	Green Submitted, gold, Green Published			2022-12-27	WOS:000295454200063
J	Chang, CQ; Hu, MJ; Zhu, ZH; Lo, LJ; Chen, J; Peng, JR				Chang, Changqing; Hu, Minjie; Zhu, Zhihui; Lo, Li Jan; Chen, Jun; Peng, Jinrong			liver-enriched gene 1a and 1b Encode Novel Secretory Proteins Essential for Normal Liver Development in Zebrafish	PLOS ONE			English	Article							DIGESTIVE ORGANS; EXPRESSION; CELLS; MORPHOGENESIS; REGENERATION; DELTA-113P53; ENDODERM; PANCREAS; GROWTH	liver-enriched gene 1 (leg1) is a liver-enriched gene in zebrafish and encodes a novel protein. Our preliminary data suggested that Leg1 is probably involved in early liver development. However, no detailed characterization of Leg1 has been reported thus far. We undertook both bioinformatic and experimental approaches to study leg1 gene structure and its role in early liver development. We found that Leg1 identifies a new conserved protein superfamily featured by the presence of domain of unknown function 781 (DUF781). There are two copies of leg1 in zebrafish, namely leg1a and leg1b. Both leg1a and leg1b are expressed in the larvae and adult liver with leg1a being the predominant form. Knockdown of Leg1a or Leg1b by their respective morpholinos specifically targeting their 59-UTR each resulted in a small liver phenotype, demonstrating that both Leg1a and Leg1b are important for early liver development. Meanwhile, we found that injection of leg1-ATG(MO), a morpholino which can simultaneously block the translation of Leg1a and Leg1b, caused not only a small liver phenotype but hypoplastic exocrine pancreas and intestinal tube as well. Further examination of leg1-ATG(MO) morphants with early endoderm markers and early hepatic markers revealed that although depletion of total Leg1 does not alter the hepatic and pancreatic fate of the endoderm cells, it leads to cell cycle arrest that results in growth retardation of liver, exocrine pancreas and intestine. Finally, we proved that Leg1 is a secretory protein. This intrigued us to propose that Leg1 might act as a novel secreted regulator that is essential for liver and other digestive organ development in zebrafish.	[Chang, Changqing; Hu, Minjie; Zhu, Zhihui; Lo, Li Jan; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chang, CQ (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	pengjr@zju.edu.cn	Hu, Minjie/AAP-4915-2020	Peng, Jinrong/0000-0002-0793-4848	National Natural Science Foundation of China [30825025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Natural Science Foundation of China (30825025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen J, 2009, GENE DEV, V23, P278, DOI 10.1101/gad.1761609; Chen Y, 2003, MECH DEVELOP, V120, P277, DOI 10.1016/S0925-4773(02)00460-4; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Jochheim A, 2003, DIFFERENTIATION, V71, P62, DOI 10.1046/j.1432-0436.2003.700606.x; Kan NG, 2009, FASEB J, V23, P3516, DOI 10.1096/fj.09-131730; Kawamoto S, 1996, GENE, V174, P151, DOI 10.1016/0378-1119(96)00512-4; Matthews RP, 2004, DEV BIOL, V274, P245, DOI 10.1016/j.ydbio.2004.06.016; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Petkov PM, 2004, HEPATOLOGY, V39, P617, DOI 10.1002/hep.20088; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Stuckenholz C, 2009, GASTROENTEROLOGY, V137, P1321, DOI 10.1053/j.gastro.2009.06.050; Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wallace KN, 2001, GENESIS, V30, P141, DOI 10.1002/gene.1050; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zorn AM, 2001, MECH DEVELOP, V103, P153, DOI 10.1016/S0925-4773(01)00341-0	28	32	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22910	10.1371/journal.pone.0022910	http://dx.doi.org/10.1371/journal.pone.0022910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857963	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300010
J	Hartemink, N; Vanwambeke, SO; Heesterbeek, H; Rogers, D; Morley, D; Pesson, B; Davies, C; Mahamdallie, S; Ready, P				Hartemink, Nienke; Vanwambeke, Sophie O.; Heesterbeek, Hans; Rogers, David; Morley, David; Pesson, Bernard; Davies, Clive; Mahamdallie, Shazia; Ready, Paul			Integrated Mapping of Establishment Risk for Emerging Vector-Borne Infections: A Case Study of Canine Leishmaniasis in Southwest France	PLOS ONE			English	Article							PHLEBOTOMUS-PERNICIOSUS DIPTERA; BASIC REPRODUCTION NUMBER; ARIASI TONNOIR; SAND FLIES; TRANSMISSION; EPIDEMIOLOGY; INFANTUM; DISEASES; ECOLOGY; DOGS	Background: Zoonotic visceral leishmaniasis is endemic in the Mediterranean Basin, where the dog is the main reservoir host. The disease's causative agent, Leishmania infantum, is transmitted by blood-feeding female sandflies. This paper reports an integrative study of canine leishmaniasis in a region of France spanning the southwest Massif Central and the northeast Pyrenees, where the vectors are the sandflies Phlebotomus ariasi and P. perniciosus. Methods: Sandflies were sampled in 2005 using sticky traps placed uniformly over an area of approximately 100 by 150 km. High-and low-resolution satellite data for the area were combined to construct a model of the sandfly data, which was then used to predict sandfly abundance throughout the area on a pixel by pixel basis (resolution of c. 1 km). Using literature-and expert-derived estimates of other variables and parameters, a spatially explicit R-0 map for leishmaniasis was constructed within a Geographical Information System. R-0 is a measure of the risk of establishment of a disease in an area, and it also correlates with the amount of control needed to stop transmission. Conclusions: To our knowledge, this is the first analysis that combines a vector abundance prediction model, based on remotely-sensed variables measured at different levels of spatial resolution, with a fully mechanistic process-based temperature-dependent R-0 model. The resulting maps should be considered as proofs-of-principle rather than as ready-to-use risk maps, since validation is currently not possible. The described approach, based on integrating several modeling methods, provides a useful new set of tools for the study of the risk of outbreaks of vector-borne diseases.	[Hartemink, Nienke; Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Hartemink, Nienke; Vanwambeke, Sophie O.] Catholic Univ Louvain, Georges Lemaitre Earth & Climate Res, Earth & Life Inst, B-1348 Louvain, Belgium; [Rogers, David; Morley, David] Dept Zool, Spatial Ecol & Epidemiol Res Grp, Oxford OX1 3PS, England; [Pesson, Bernard] Univ Strasbourg, Dept Parasitol, Strasbourg, France; [Davies, Clive] London Sch Hyg & Trop Med, London WC1, England; [Mahamdallie, Shazia; Ready, Paul] Nat Hist Museum, Dept Entomol, London SW7 5BD, England	Utrecht University; Universite Catholique Louvain; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; London School of Hygiene & Tropical Medicine; Natural History Museum London	Hartemink, N (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.	n.a.hartemink@uu.nl	hartemink, nienke/B-4304-2012	Heesterbeek, Hans/0000-0001-8537-6418; Vanwambeke, Sophie/0000-0001-6620-6173; hartemink, nienke/0000-0001-9820-7699	EU [1.1.6.3]; Global Change and Ecosystems (European Commission) [GOCECT-2003-010284 EDEN]	EU(European Commission); Global Change and Ecosystems (European Commission)(European CommissionEuropean Commission Joint Research Centre)	This publication was funded under the EU 6th Framework Program for Research, Technological Development and Demonstration, Priority 1.1.6.3. Global Change and Ecosystems (European Commission, DG Research, GOCECT-2003-010284 EDEN) and is officially catalogued by the EDEN Steering Committee as EDEN218. The content of this paper does not represent the official position of the European Commission and is entirely under the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1957, ANNU REV ENTOMOL, V2, P203, DOI 10.1146/annurev.en.02.010157.001223; Adler S, 1935, PROC R SOC SER B-BIO, V116, P516, DOI 10.1098/rspb.1935.0007; Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Anderson R M, 1990, Lancet, V335, P641; Aransay AM, 2004, PARASITOL RES, V94, P416, DOI 10.1007/s00436-004-1231-4; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Bongiorno G, 2003, ACTA TROP, V88, P109, DOI 10.1016/S0001-706X(03)00190-6; CHAMAILLE L, PARASITES VECTORS, V3, P31; DECOLMENARES M, 1995, J MED ENTOMOL, V32, P229, DOI 10.1093/jmedent/32.3.229; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; DIEKMANN O, 1990, J MATH BIOL, V28, P365; DIEKMANN O, 2000, MATH EPIDEMIOLOGY IN, P3; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; DYE C, 1992, PARASITOLOGY, V105, P35, DOI 10.1017/S0031182000073662; DYE C, 1987, MED VET ENTOMOL, V1, P417, DOI 10.1111/j.1365-2915.1987.tb00372.x; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Guarga JL, 2000, RES VET SCI, V69, P249, DOI 10.1053/rvsc.2000.0419; GUILVARD E, 1980, ANN PARASITOLOGIE, V6, P659; GUY MW, 1984, ANN PARASIT HUM COMP, V59, P449, DOI 10.1051/parasite/1984595449; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Killick-Kendrick R., 2002, Parassitologia (Rome), V44, P67; Killick-Kendrick R., 1999, Canine leishmaniasis: an update. Proceedings of the International Canine Leishmaniasis Forum, Barcelona, Spain, 1999., P26; Marsella R, 1998, INT J DERMATOL, V37, P801, DOI 10.1046/j.1365-4362.1998.00449.x; Martin S., 2007, POPULATION RESETTLEM, P1; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Moreno I, 2007, MICROBES INFECT, V9, P1574, DOI 10.1016/j.micinf.2007.09.009; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Pasquau F, 2005, EUR J CLIN MICROBIOL, V24, P411, DOI 10.1007/s10096-005-1342-6; Quinnell RJ, 1997, PARASITOLOGY, V115, P143, DOI 10.1017/S0031182097001200; Racloz V, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-42; Ready PD, 2008, TRENDS PARASITOL, V24, P151, DOI 10.1016/j.pt.2008.03.001; READY PD, 2010, EURO SURVEILLANCE, V15; Riera C, 1999, VET PARASITOL, V84, P33, DOI 10.1016/S0304-4017(99)00084-9; Rioux J.A., 1969, EPIDEMIOLOGIE LEISHM; RIOUX JA, 1979, ANN PARASIT HUM COMP, V54, P401, DOI 10.1051/parasite/1979544401; Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5; Rogers DJ, 1996, ANN TROP MED PARASIT, V90, P225, DOI 10.1080/00034983.1996.11813049; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; Rossi E, 2008, ACTA TROP, V105, P158, DOI 10.1016/j.actatropica.2007.10.005; Sacks DL, 2001, CELL MICROBIOL, V3, P189, DOI 10.1046/j.1462-5822.2001.00115.x; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Schroder W, 2008, PARASITOL RES, V103, pS55, DOI 10.1007/s00436-008-1051-z; Sobrino R, 2008, VET PARASITOL, V155, P198, DOI 10.1016/j.vetpar.2008.05.003; Takken W, 2007, ECOL CONT VECTOR-BOR, V1, P1; Trotz-Williams L, 2003, IN PRACTICE, V25, P190, DOI 10.1136/inpract.25.4.190	49	61	63	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e20817	10.1371/journal.pone.0020817	http://dx.doi.org/10.1371/journal.pone.0020817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857899	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000293774300001
J	Ding, CB; Zhang, JP; Zhao, Y; Peng, ZG; Song, DQ; Jiang, JD				Ding, Cun-Bao; Zhang, Jing-Pu; Zhao, Ye; Peng, Zong-Gen; Song, Dan-Qing; Jiang, Jian-Dong			Zebrafish as a Potential Model Organism for Drug Test Against Hepatitis C Virus	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ANIMAL-MODEL; EXPRESSION; INFECTION; THERAPY; HEPATOCYTES; REPLICATION; STEATOSIS; DISEASE; EMBRYOS	Screening and evaluating anti-hepatitis C virus (HCV) drugs in vivo is difficult worldwide, mainly because of the lack of suitable small animal models. We investigate whether zebrafish could be a model organism for HCV replication. To achieve NS5B-dependent replication an HCV sub-replicon was designed and created with two vectors, one with HCV ns5b and fluorescent rfp genes, and the other containing HCV's 5'UTR, core, 3'UTR and fluorescent gfp genes. The vectors containing sub-replicons were co-injected into zebrafish zygotes. The sub-replicon amplified in liver showing a significant expression of HCV core RNA and protein. The sub-replicon amplification caused no abnormality in development and growth of zebrafish larvae, but induced gene expression change similar to that in human hepatocytes. As the amplified core fluorescence in live zebrafish was detectable microscopically, it rendered us an advantage to select those with replicating sub-replicon for drug experiments. Ribavirin and oxymatrine, two known anti-HCV drugs, inhibited sub-replicon amplification in this model showing reduced levels of HCV core RNA and protein. Technically, this method had a good reproducibility and is easy to operate. Thus, zebrafish might be a model organism to host HCV, and this zebrafish/HCV (sub-replicon) system could be an animal model for anti-HCV drug screening and evaluation.	[Ding, Cun-Bao; Zhang, Jing-Pu; Zhao, Ye; Peng, Zong-Gen; Song, Dan-Qing; Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Ding, Cun-Bao; Zhang, Jing-Pu; Zhao, Ye; Peng, Zong-Gen; Song, Dan-Qing; Jiang, Jian-Dong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ding, Cun-Bao] Hebei Polytech Univ, Coll Chem Engn & Biotechnol, Tangshan, Hebei, Peoples R China; [Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Ding, CB (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	zjp5577@126.com; jiang.jdong@163.com	Peng, Zong-Gen/GVU-2327-2022	Peng, Zong-Gen/0000-0001-7662-6892; Zhao, Ye/0000-0002-2852-7432	Ministry of Science and Technology [2009ZX09301-003]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the National S&T Major Special Project, 11th 5-Year Plan "New Drug R&D Program", the Ministry of Science and Technology, (2009ZX09301-003, J.D. Jiang and J.P. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2008, J HEPATOL, V49, P134, DOI 10.1016/j.jhep.2008.03.012; Blais DR, 2010, J PROTEOME RES, V9, P912, DOI 10.1021/pr900788a; Boonstra A, 2009, HEPATOLOGY, V50, P1646, DOI 10.1002/hep.23138; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Chak Eric, 2010, Curr Hepat Rep, V9, P147, DOI 10.1007/s11901-010-0047-1; Chang ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-109; Chen Yan-xi, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P335; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gallego J, 2002, BIOCHEM SOC T, V30, P140, DOI 10.1042/BST0300140; Gates AT, 2004, VIRUS RES, V100, P213, DOI 10.1016/j.virusres.2003.12.029; Guevin C, 2009, ANTIVIR RES, V84, P14, DOI 10.1016/j.antiviral.2009.07.009; Harris D, 2006, MOL CELL PROTEOMICS, V5, P1006, DOI 10.1074/mcp.M500429-MCP200; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Koike K, 2010, HEPATOL RES, V40, P69, DOI 10.1111/j.1872-034X.2009.00593.x; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Li J, 1998, Zhongguo Zhong Xi Yi Jie He Za Zhi, V18, P227; Ling JY, 2007, J CHROMATOGR A, V1145, P123, DOI 10.1016/j.chroma.2007.01.080; Liu JP, 2003, AM J GASTROENTEROL, V98, P538, DOI 10.1111/j.1572-0241.2003.07298.x; Lu LG, 2003, WORLD J GASTROENTERO, V9, P2480; Mancuso ME, 2009, J THROMB HAEMOST, V7, P1997, DOI 10.1111/j.1538-7836.2009.03624.x; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Park IW, 2009, BIOCHEM BIOPH RES CO, V387, P489, DOI 10.1016/j.bbrc.2009.07.076; Piai G, 2006, DIGEST DIS SCI, V51, P1619, DOI 10.1007/s10620-006-9110-8; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Qureshi SA, 2007, MED RES REV, V27, P353, DOI 10.1002/med.20063; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; Suzuki T, 2007, ADV DRUG DELIVER REV, V59, P1200, DOI 10.1016/j.addr.2007.04.014; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson AJV, 2009, ALIMENT PHARM THER, V29, P689, DOI 10.1111/j.1365-2036.2009.03927.x; Tumurbaatar B, 2007, J VIROL METHODS, V146, P5, DOI 10.1016/j.jviromet.2007.05.025; Walker Michelle P., 2003, Antiviral Chemistry & Chemotherapy, V14, P1; Webster DP, 2009, LANCET INFECT DIS, V9, P108, DOI 10.1016/S1473-3099(09)70020-9; [姚玉娜 Yao Yuna], 2004, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V16, P110	38	30	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22921	10.1371/journal.pone.0022921	http://dx.doi.org/10.1371/journal.pone.0022921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857967	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300012
J	Brisson, D; Baxamusa, N; Schwartz, I; Wormser, GP				Brisson, Dustin; Baxamusa, Nilofer; Schwartz, Ira; Wormser, Gary P.			Biodiversity of Borrelia burgdorferi Strains in Tissues of Lyme Disease Patients	PLOS ONE			English	Article							SENSU-STRICTO; GENETIC DIVERSITY; TICK VECTOR; ARTHRITIS; GENOTYPES; OSPC	Plant and animal biodiversity are essential to ecosystem health and can provide benefits to humans ranging from aesthetics to maintaining air quality. Although the importance of biodiversity to ecology and conservation biology is obvious, such measures have not been applied to strains of an invasive bacterium found in human tissues during infection. In this study, we compared the strain biodiversity of Borrelia burgdorferi found in tick populations with that found in skin, blood, synovial fluid or cerebrospinal fluid of Lyme disease patients. The biodiversity of B. burgdorferi strains is significantly greater in tick populations than in the skin of patients with erythema migrans. In turn, strains from skin are significantly more diverse than strains at any of the disseminated sites. The cerebrospinal fluid of patients with neurologic Lyme disease harbored the least pathogen biodiversity. These results suggest that human tissues act as niches that can allow entry to or maintain only a subset of the total pathogen population. These data help to explain prior clinical observations on the natural history of B. burgdorferi infection and raise several questions that may help to direct future research to better understand the pathogenesis of this infection.	[Brisson, Dustin] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Baxamusa, Nilofer; Wormser, Gary P.] New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA; [Schwartz, Ira] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	University of Pennsylvania; New York Medical College; New York Medical College	Brisson, D (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	dbrisson@sas.upenn.edu	Brisson, Dustin/B-2428-2008	Brisson, Dustin/0000-0002-9493-7579	NIH [AR41511, AI076342]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041511] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by NIH grants AR41511 and AI076342. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2006, APPL ENVIRON MICROB, V72, P5331, DOI 10.1128/AEM.00014-06; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Brisson D, 2006, AM J TROP MED HYG, V74, P615, DOI 10.4269/ajtmh.2006.74.615; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Hubalek Z, 2000, FOLIA ZOOL, V49, P241; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; Jones KL, 2009, ARTHRITIS RHEUM-US, V60, P2174, DOI 10.1002/art.24812; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; LIVERIS D, 2011, J CLIN MICROBIOLOGY; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nowakowski J, 2009, CLIN INFECT DIS, V49, P1733, DOI 10.1086/648076; Qiu WG, 2002, GENETICS, V160, P833; REGINATO AJ, 1993, RHEUM DIS CLIN N AM, V19, P379; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Wang IN, 1999, GENETICS, V151, P15; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	27	46	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22926	10.1371/journal.pone.0022926	http://dx.doi.org/10.1371/journal.pone.0022926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829670	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200039
J	Chae, MH; Chen, JJ				Chae, Minho; Chen, James J.			Reordering Hierarchical Tree Based on Bilateral Symmetric Distance	PLOS ONE			English	Article							GENE-EXPRESSION; PATTERNS	Background: In microarray data analysis, hierarchical clustering (HC) is often used to group samples or genes according to their gene expression profiles to study their associations. In a typical HC, nested clustering structures can be quickly identified in a tree. The relationship between objects is lost, however, because clusters rather than individual objects are compared. This results in a tree that is hard to interpret. Methodology/Principal Findings: This study proposes an ordering method, HC-SYM, which minimizes bilateral symmetric distance of two adjacent clusters in a tree so that similar objects in the clusters are located in the cluster boundaries. The performance of HC-SYM was evaluated by both supervised and unsupervised approaches and compared favourably with other ordering methods. Conclusions/Significance: The intuitive relationship between objects and flexibility of the HC-SYM method can be very helpful in the exploratory analysis of not only microarray data but also similar high-dimensional data.	[Chae, Minho; Chen, James J.] US FDA, Div Personalized Nutr & Med, Natl Ctr Toxicol Res, Jefferson, AR USA; [Chae, Minho] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Chen, James J.] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Chen, James J.] China Med Univ, Ctr Biostat, Taichung, Taiwan	US Food & Drug Administration (FDA); University of Texas System; University of Texas Southwestern Medical Center Dallas; China Medical University Taiwan; China Medical University Taiwan	Chae, MH (corresponding author), US FDA, Div Personalized Nutr & Med, Natl Ctr Toxicol Res, Jefferson, AR USA.	jamesj.chen@fda.hhs.gov			FDA at the NCTR	FDA at the NCTR	Dr. Minho Chae was supported by the FDA Research Participation Program at the NCTR administered by the Oak Ridge Associated Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CH, 2002, STAT SINICA, V12, P7; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Eisen MB, 1999, P NATL ACAD SCI USA, V96, P10943; GRUVAEUS G, 1972, BRIT J MATH STAT PSY, V25, P200, DOI 10.1111/j.2044-8317.1972.tb00491.x; Hahsler M, 2008, J STAT SOFTW, V25, P1; HUBERT L, COMBINATORIAL DATA A; Liu L, 2003, P NATL ACAD SCI USA, V100, P13167, DOI 10.1073/pnas.1733249100; MIRKIN B, 2005, CLUSTERING DATA MINI, P75; R Core Team, 2018, R LANG ENV STAT COMP; Rajaram S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-45; Robinson WS, 1951, AM ANTIQUITY, V16, P293, DOI 10.2307/276978; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Tien YJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-155; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141	16	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22546	10.1371/journal.pone.0022546	http://dx.doi.org/10.1371/journal.pone.0022546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829631	Green Published, gold			2022-12-27	WOS:000293561200021
J	de Lorgeril, J; Zenagui, R; Rosa, RD; Piquemal, D; Bachere, E				de Lorgeril, Julien; Zenagui, Reda; Rosa, Rafael D.; Piquemal, David; Bachere, Evelyne			Whole Transcriptome Profiling of Successful Immune Response to Vibrio Infections in the Oyster Crassostrea gigas by Digital Gene Expression Analysis	PLOS ONE			English	Article							TNF-ALPHA FACTOR; PACIFIC OYSTER; EXTRACELLULAR PRODUCTS; INNATE IMMUNITY; SEQUENCE TAGS; PATHOGEN; PROTEIN; BINDING; LETHALITY; HEMOCYTES	The cultivated Pacific oyster Crassostrea gigas has suffered for decades large scale summer mortality phenomenon resulting from the interaction between the environment parameters, the oyster physiological and/or genetic status and the presence of pathogenic microorganisms including Vibrio species. To obtain a general picture of the molecular mechanisms implicated in C. gigas immune responsiveness to circumvent Vibrio infections, we have developed the first deep sequencing study of the transcriptome of hemocytes, the immunocompetent cells. Using Digital Gene Expression (DGE), we generated a transcript catalog of up-regulated genes from oysters surviving infection with virulent Vibrio strains (Vibrio splendidus LGP32 and V. aestuarianus LPi 02/41) compared to an avirulent one, V. tasmaniensis LMG 20012 T. For that an original experimental infection protocol was developed in which only animals that were able to survive infections were considered for the DGE approach. We report the identification of cellular and immune functions that characterize the oyster capability to survive pathogenic Vibrio infections. Functional annotations highlight genes related to signal transduction of immune response, cell adhesion and communication as well as cellular processes and defence mechanisms of phagocytosis, actin cytosqueleton reorganization, cell trafficking and autophagy, but also antioxidant and anti-apoptotic reactions. In addition, quantitative PCR analysis reveals the first identification of pathogen-specific signatures in oyster gene regulation, which opens the way for in depth molecular studies of oyster-pathogen interaction and pathogenesis. This work is a prerequisite for the identification of those physiological traits controlling oyster capacity to survive a Vibrio infection and, subsequently, for a better understanding of the phenomenon of summer mortality.	[de Lorgeril, Julien; Zenagui, Reda; Rosa, Rafael D.; Bachere, Evelyne] IFREMER, Lab UMR Ecolag, F-34095 Montpellier, France; [Rosa, Rafael D.] Univ Montpellier 2, Montpellier, France; [Rosa, Rafael D.] Inst Rech Dev, UMR Ecol Syst Marins Cotiers 5119, Montpellier, France; [Piquemal, David] ZAC Euromed II, Skuld Tech, Cap Delta, Grabels, France	Ifremer; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	de Lorgeril, J (corresponding author), IFREMER, Lab UMR Ecolag, 2 Pl Eugene Batallion, F-34095 Montpellier, France.	ebachere@ifremer.fr	de Lorgeril, Julien/O-7488-2014; Bachere, Evelyne/O-6117-2014; Rosa, Rafael Diego/L-6944-2019	de Lorgeril, Julien/0000-0002-6400-5455; Rosa, Rafael Diego/0000-0002-4076-3163; Piquemal, David/0000-0002-5870-4276	Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer); Centre National de la Recherche Scientifique (Cnrs); ANR (Agence Nationale de la Recherche) [07/5210875/F]	Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer); Centre National de la Recherche Scientifique (Cnrs)(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR))	Funding from the Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer) and the Centre National de la Recherche Scientifique (Cnrs) grant from ANR (Agence Nationale de la Recherche) Genanimal project Cg-Physiogene (No07/5210875/F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Allam B, 2006, FISH SHELLFISH IMMUN, V20, P374, DOI 10.1016/j.fsi.2005.05.012; Bachere E., 1991, DEV COMP IMMUNOL, V15, pS102; Binesse J, 2008, APPL ENVIRON MICROB, V74, P7108, DOI 10.1128/AEM.01261-08; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Fleury E, 2010, MAR BIOTECHNOL, V12, P326, DOI 10.1007/s10126-009-9227-9; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Garnier M, 2007, MICROB ECOL, V53, P187, DOI 10.1007/s00248-006-9061-9; Garnier M, 2008, SYST APPL MICROBIOL, V31, P358, DOI 10.1016/j.syapm.2008.06.003; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Gonzalez M, 2005, BIOCHEM BIOPH RES CO, V338, P1089, DOI 10.1016/j.bbrc.2005.10.075; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Guillou F, 2007, DEV COMP IMMUNOL, V31, P657, DOI 10.1016/j.dci.2006.10.001; Kanekiyo M, 2002, BIOCHEM J, V361, P363, DOI 10.1042/0264-6021:3610363; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Labreuche Y, 2006, DEV COMP IMMUNOL, V30, P367, DOI 10.1016/j.dci.2005.05.003; Labreuche Y, 2006, MICROBES INFECT, V8, P2715, DOI 10.1016/j.micinf.2006.07.020; Labreuche Y, 2010, FISH SHELLFISH IMMUN, V29, P753, DOI 10.1016/j.fsi.2010.07.007; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Montagnani C, 2008, DEV COMP IMMUNOL, V32, P182, DOI 10.1016/j.dci.2007.06.001; Montagnani C, 2007, DEV COMP IMMUNOL, V31, P1, DOI 10.1016/j.dci.2006.04.002; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Ochieng J, 2010, J HEALTH CARE POOR U, V21, P51, DOI 10.1353/hpu.0.0257; Park EM, 2008, FISH SHELLFISH IMMUN, V24, P11, DOI 10.1016/j.fsi.2007.07.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piquemal D, 2002, GENOMICS, V80, P361, DOI 10.1006/geno.2002.6836; Rottner K, 2004, J PATHOL, V204, P396, DOI 10.1002/path.1638; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Saulnier D, 2000, DIS AQUAT ORGAN, V40, P109, DOI 10.3354/dao040109; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Schwarz RS, 2007, IMMUNOGENETICS, V59, P233, DOI 10.1007/s00251-006-0179-1; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Terahara K, 2006, DEV COMP IMMUNOL, V30, P667, DOI 10.1016/j.dci.2005.09.009; Thompson FL, 2003, SYST APPL MICROBIOL, V26, P65, DOI 10.1078/072320203322337326; Travers MA, 2009, J CELL BIOCHEM, V106, P152, DOI 10.1002/jcb.21990; van Spriel AB, 2010, MICROBES INFECT, V12, P106, DOI 10.1016/j.micinf.2009.11.001; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Xue QG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-213; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003; Zhang LL, 2011, FISH SHELLFISH IMMUN, V30, P653, DOI 10.1016/j.fsi.2010.12.023; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	59	88	88	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23142	10.1371/journal.pone.0023142	http://dx.doi.org/10.1371/journal.pone.0023142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829707	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200049
J	Hecht, I; Levine, H; Rappel, WJ; Ben-Jacob, E				Hecht, Inbal; Levine, Herbert; Rappel, Wouter-Jan; Ben-Jacob, Eshel			"Self-Assisted" Amoeboid Navigation in Complex Environments	PLOS ONE			English	Article							TUMOR-CELL INVASION; EXTRACELLULAR-MATRIX; MIGRATION; CHEMOTAXIS; CANCER; EXPRESSION; DICTYOSTELIUM; ACTIVATION; MECHANISMS; MOVEMENT	Background: Living cells of many types need to move in response to external stimuli in order to accomplish their functional tasks; these tasks range from wound healing to immune response to fertilization. While the directional motion is typically dictated by an external signal, the actual motility is also restricted by physical constraints, such as the presence of other cells and the extracellular matrix. The ability to successfully navigate in the presence of obstacles is not only essential for organisms, but might prove relevant in the study of autonomous robotic motion. Methodology/Principal Findings: We study a computational model of amoeboid chemotactic navigation under differing conditions, from motion in an obstacle-free environment to navigation between obstacles and finally to moving in a maze. We use the maze as a simple stand-in for a motion task with severe constraints, as might be expected in dense extracellular matrix. Whereas agents using simple chemotaxis can successfully navigate around small obstacles, the presence of large barriers can often lead to agent trapping. We further show that employing a simple memory mechanism, namely secretion of a repulsive chemical by the agent, helps the agent escape from such trapping. Conclusions/Significance: Our main conclusion is that cells employing simple chemotactic strategies will often be unable to navigate through maze-like geometries, but a simple chemical marker mechanism ( which we refer to as "self-assistance") significantly improves success rates. This realization provides important insights into mechanisms that might be employed by real cells migrating in complex environments as well as clues for the design of robotic navigation strategies. The results can be extended to more complicated multi-cellular systems and can be used in the study of mammalian cell migration and cancer metastasis.	[Hecht, Inbal; Ben-Jacob, Eshel] Tel Aviv Univ, Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Levine, Herbert; Rappel, Wouter-Jan; Ben-Jacob, Eshel] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	Tel Aviv University; University of California System; University of California San Diego	Hecht, I (corresponding author), Tel Aviv Univ, Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	inbal.hecht@gmail.com; eshelbj@gmail.com	Levine, Herbert/C-1704-2008	Levine, Herbert/0000-0002-8819-9055	European Community; Tauber Family Foundation; Tel Aviv University; National Institutes of Health [PO1 GM078586]; National Science Foundation [PHY-0822283]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078586] Funding Source: NIH RePORTER	European Community(European Commission); Tauber Family Foundation; Tel Aviv University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I.H. acknowledges support by a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme. E.B.J. acknowledges support by the Tauber Family Foundation and the Maguy-Glass chair in Physics of Complex Systems at Tel Aviv University. H.L. and W.-J.R. acknowledge support by the National Institutes of Health (PO1 GM078586) and by the National Science Foundation-sponsored Center for Theoretical Biological Physics (CTBP) at the University of California San Diego (grant no. PHY-0822283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambravaneswaran V, 2010, INTEGR BIOL-UK, V2, P639, DOI 10.1039/c0ib00011f; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006842; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; BUENEMANN M, BIOPHYS J, V99, P50; Choset HM., 2005, PRINCIPLES ROBOT MOT; Deisboeck TS, 2009, BIOESSAYS, V31, P190, DOI 10.1002/bies.200800084; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; FALCIONI R, 1994, EXP CELL RES, V210, P113, DOI 10.1006/excr.1994.1017; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; Guy AG, 2008, ANIM BEHAV, V76, P585, DOI 10.1016/j.anbehav.2008.04.004; HECHT I, 2011, PLOS COMP B IN PRESS; Hecht I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158301; Ilina O, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015010; Jaspars LH, 1996, J PATHOL, V178, P36, DOI 10.1002/(SICI)1096-9896(199601)178:1<36::AID-PATH426>3.0.CO;2-S; Kraus AC, 2002, ONCOGENE, V21, P8683, DOI 10.1038/sj.onc.1205939; Latombe J.C, 1991, ROBOT MOTION PLANNIN; Mineo R, 2004, ENDOCRINOLOGY, V145, P4355, DOI 10.1210/en.2003-1762; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Nishimura SI, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000310; OLGA I, 2011, PHYS BIOL, V8; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Reynolds AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.062901; Rintoul RC, 2001, LANCET ONCOL, V2, P437, DOI 10.1016/S1470-2045(00)00421-6; Romanczuk P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.010602; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Satulovsky J, 2008, BIOPHYS J, V94, P3671, DOI 10.1529/biophysj.107.117002; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; SONG KT, 1991, ON LINE MOTION PLANN, V422, P423; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; VAIDYA U, 2008, MOTION PLANNING USIN, P850; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zhang S, 2008, CURR BIOL, V18, P1587, DOI 10.1016/j.cub.2008.08.069	48	17	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e21955	10.1371/journal.pone.0021955	http://dx.doi.org/10.1371/journal.pone.0021955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829602	gold, Green Published, Green Submitted			2022-12-27	WOS:000293561200005
J	Kim, S; Balakrishnan, K; Gross, DS				Kim, Sunyoung; Balakrishnan, Kripa; Gross, David S.			p53 Interacts with RNA Polymerase II through Its Core Domain and Impairs Pol II Processivity In Vivo	PLOS ONE			English	Article							HEAT-SHOCK FACTOR; TUMOR-SUPPRESSOR; MUTANT P53; TRANSCRIPTION ELONGATION; CTD PHOSPHORYLATION; DNA-BINDING; GENE; ACTIVATION; COMPLEX; MUTATIONS	The tumor suppressor p53 principally functions as a gene-specific transcription factor. p53 triggers a variety of anti-proliferative programs by activating or repressing the transcription of effector genes in response to genotoxic stress. To date, much effort has been placed on understanding p53's ability to affect transcription in the context of its DNA-binding activity. How p53 regulates transcriptional output independent of DNA binding is less well understood. Here we provide evidence that human p53 can physically interact with the large subunit of RNA polymerase II (Pol II) both in in vitro interaction assays and in whole cell extracts, and that this interaction is mediated ( at least in part) through p53's core DNA-binding domain and the Ser5-phosphorylated CTD of Pol II. Ectopic expression of p53, combined with mutations in transcription elongation factors or exposure to drugs that inhibit Pol II elongation, elicit sickness or lethality in yeast cells. These phenotypes are suppressed by oncogenic point mutations within p53's core domain. The growth phenotypes raise the possibility that p53 impairs Pol II elongation. Consistent with this, a p53-dependent increase in Pol II density is seen at constitutively expressed genes without a concomitant increase in transcript accumulation. Additionally, p53-expressing yeast strains exhibit reduced transcriptional processivity at an episomal reporter gene; this inhibitory activity is abolished by a core domain point mutation. Our results suggest a novel mechanism by which p53 can regulate gene transcription, and a new biological function for its core domain that is susceptible to inactivation by oncogenic point mutations.	[Kim, Sunyoung; Balakrishnan, Kripa; Gross, David S.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Kim, S (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.	dgross@lsuhsc.edu			National Science Foundation [MCB-0747227, MCB-025025]; Feist-Weiller Cancer Center	National Science Foundation(National Science Foundation (NSF)); Feist-Weiller Cancer Center	This work was supported by grants awarded to D.S.G. from the National Science Foundation (MCB-0747227, MCB-025025) and the Feist-Weiller Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Deng LW, 2002, J BIOL CHEM, V277, P33922, DOI 10.1074/jbc.M111349200; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gridasova AA, 2005, MOL CELL BIOL, V25, P3247, DOI 10.1128/MCB.25.8.3247-3260.2005; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LEE SW, 1993, MOL CELL BIOL, V13, P727, DOI 10.1128/MCB.13.2.727; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Merrill GF, 1999, CANCER RES, V59, P3175; Morillo-Huesca M, 2006, FEBS J, V273, P756, DOI 10.1111/j.1742-4658.2005.05108.x; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shinobu N, 1999, J BIOL CHEM, V274, P17003, DOI 10.1074/jbc.274.24.17003; Sigal A, 2000, CANCER RES, V60, P6788; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Venturi CB, 2000, MOL CELL BIOL, V20, P6435, DOI 10.1128/MCB.20.17.6435-6448.2000; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	40	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22183	10.1371/journal.pone.0022183	http://dx.doi.org/10.1371/journal.pone.0022183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829606	gold, Green Published, Green Submitted			2022-12-27	WOS:000293561200007
J	Laskar, S; Bhattacharyya, MK; Shankar, R; Bhattacharyya, S				Laskar, Shyamasree; Bhattacharyya, Mrinal K.; Shankar, Rama; Bhattacharyya, Sunanda			HSP90 Controls SIR2 Mediated Gene Silencing	PLOS ONE			English	Article							AFFECT TELOMERE LENGTH; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; PROTEIN-KINASE; YEAST; BINDING; P23; HETEROCHROMATIN; REQUIREMENT; EXPRESSION	In recent years, Hsp90 is found to interact with several telomeric proteins at various phases of cell cycle. The Hsp90 chaperone system controls assembly and disassembly of telomere structures and thus maintains the dynamic state of telomere. Here, for the first time we report that the activity of another telomeric protein Sir2p is modulated by Hsp82, the ortholog of Hsp90 from budding yeast (Saccharomyces cerevisiae). In a temperature sensitive Hsp90 deficient yeast strain (iG170Dhsp82), less abundant Sir2p is observed, resulting in de-repression of telomere silencing and a complete loss of mating type silencing. Intriguingly, over expression of Hsp90, either by exposing cells to heat shock or by introducing HSP82 overexpression plasmid also yields reduced level of Sir2p, with a consequential loss of telomere silencing. Thus, Hsp90 homeostasis maintains the cellular pool of Sir2p and thereby controls the reversible nature of telomere silencing. Interestingly, such regulation is independent of one of its major co-chaperones Sba1 (human ortholog of p23).	[Laskar, Shyamasree; Shankar, Rama; Bhattacharyya, Sunanda] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Bhattacharyya, Mrinal K.] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Laskar, S (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India.	sbtsl@uohyd.ernet.in		Laskar, Shyamasree/0000-0002-0497-0309	CSIR (Council for Scientific and Industrial Research), India [37/1343/08/EMR-II]; University of Hyderabad	CSIR (Council for Scientific and Industrial Research), India(Council of Scientific & Industrial Research (CSIR) - India); University of Hyderabad(University of Hyderabad)	This work was supported by a grant from CSIR (Council for Scientific and Industrial Research), India to MKB (Grant number 37/1343/08/EMR-II); and Purse grant from University of Hyderabad to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Bhattacharyya MK, 2008, CHROMOSOMA, V117, P357, DOI 10.1007/s00412-008-0153-9; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Caplan Avrom J., 2003, EMBO Reports, V4, P126, DOI 10.1038/sj.embor.embor742; Chiosis G, 2003, MOL CANCER THER, V2, P123; Cox MB, 2004, CELL STRESS CHAPERON, V9, P4, DOI 10.1379/1466-1268(2004)009<0004:COHSPA>2.0.CO;2; DeZwaan DC, 2010, TRENDS BIOCHEM SCI, V35, P384, DOI 10.1016/j.tibs.2010.02.005; DeZwaan DC, 2009, NAT STRUCT MOL BIOL, V16, P711, DOI 10.1038/nsmb.1616; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Grandin N, 2001, MOL GENET GENOMICS, V265, P126, DOI 10.1007/s004380000398; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Hickman M, 2007, J MOL BIOL, V367, P1246, DOI 10.1016/j.jmb.2007.01.044; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; KIRK N, 1991, YEAST, V7, P539, DOI 10.1002/yea.320070602; Konieczny I, 1999, GENET ENG P, V21, P95; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Louvion JF, 1998, MOL BIOL CELL, V9, P3071, DOI 10.1091/mbc.9.11.3071; Lustig AJ, 1996, MICROBIAL GENOME MET, P37; Lydall D, 2009, EMBO J, V28, P2174, DOI 10.1038/emboj.2009.176; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; WILSON KL, 1984, MOL CELL BIOL, V4, P2420, DOI 10.1128/MCB.4.11.2420; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	38	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23406	10.1371/journal.pone.0023406	http://dx.doi.org/10.1371/journal.pone.0023406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829731	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200068
J	Kouokam, JC; Huskens, D; Schols, D; Johannemann, A; Riedell, SK; Walter, W; Walker, JM; Matoba, N; O'Keefe, BR; Palmer, KE				Kouokam, Joseph Calvin; Huskens, Dana; Schols, Dominique; Johannemann, Andrew; Riedell, Shonna K.; Walter, Wendye; Walker, Janice M.; Matoba, Nobuyuki; O'Keefe, Barry R.; Palmer, Kenneth E.			Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate	PLOS ONE			English	Article							ANTI-HIV ACTIVITY; ANTIVIRAL PROTEIN GRIFFITHSIN; ENTRY INHIBITOR GRIFFITHSIN; FALSE DISCOVERY RATE; CYANOVIRIN-N; INACTIVATING PROTEIN; CARBOHYDRATE-BINDING; GENE-EXPRESSION; VIRUS-INFECTIONS; NONOXYNOL-9	Many natural product-derived lectins such as the red algal lectin griffithsin (GRFT) have potent in vitro activity against viruses that display dense clusters of oligomannose N-linked glycans (NLG) on their surface envelope glycoproteins. However, since oligomannose NLG are also found on some host proteins it is possible that treatment with antiviral lectins may trigger undesirable side effects. For other antiviral lectins such as concanavalin A, banana lectin and cyanovirin-N (CV-N), interactions between the lectin and as yet undescribed cellular moieties have been reported to induce undesirable side effects including secretion of inflammatory cytokines and activation of host T-cells. We show that GRFT, unlike CV-N, binds the surface of human epithelial and peripheral blood mononuclear cells (PBMC) through an exclusively oligosaccharide-dependent interaction. In contrast to several other antiviral lectins however, GRFT treatment induces only minimal changes in secretion of inflammatory cytokines and chemokines by epithelial cells or human PBMC, has no measureable effect on cell viability and does not significantly upregulate markers of T-cell activation. In addition, GRFT appears to retain antiviral activity once bound to the surface of PBMC. Finally, RNA microarray studies show that, while CV-N and ConA regulate expression of a multitude of cellular genes, GRFT treatment effects only minimal alterations in the gene expression profile of a human ectocervical cell line. These studies indicate that GRFT has an outstanding safety profile with little evidence of induced toxicity, T-cell activation or deleterious immunological consequence, unique attributes for a natural product-derived lectin.	[Kouokam, Joseph Calvin; Johannemann, Andrew; Riedell, Shonna K.; Walter, Wendye; Walker, Janice M.; Matoba, Nobuyuki; Palmer, Kenneth E.] Univ Louisville, Sch Med, Owensboro Canc Res Program, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Kouokam, Joseph Calvin; Johannemann, Andrew; Riedell, Shonna K.; Walter, Wendye; Walker, Janice M.; Matoba, Nobuyuki; Palmer, Kenneth E.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Huskens, Dana; Schols, Dominique] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [O'Keefe, Barry R.] NCI, Mol Targets Lab, Ctr Canc Res, Frederick, MD 21701 USA	University of Louisville; University of Louisville; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kouokam, JC (corresponding author), Univ Louisville, Sch Med, Owensboro Canc Res Program, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	kepalm02@louisville.edu	Schols, Dominique/AAC-1309-2021; Schols, Dominique/S-9057-2017	Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850; Matoba, Nobuyuki/0000-0001-7231-3004; Palmer, Kenneth Edward/0000-0002-2811-1111	National Institutes of Health [AI076169]; National Center for Research Resources [INBRE-P20 RR016481, COBRE-P20RR018733]; James Graham Brown Foundation; K. U. Leuven; GOA [10/014, 10/018, G.485.08]; CHAARM; Dormeur Investment Service Ltd.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481, P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); James Graham Brown Foundation; K. U. Leuven(KU Leuven); GOA; CHAARM; Dormeur Investment Service Ltd.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI076169 to KEP. Part of this work was performed with the assistance of the University of Louisville Brown Cancer Center Microarray Facility, which is supported by the National Center for Research Resources IDeA Awards INBRE-P20 RR016481 and COBRE-P20RR018733, the James Graham Brown Foundation, and user fees. DH was supported by a PDM from the K. U. Leuven. The work at the K. U. Leuven was supported by the GOA no. 10/014, PF no. 10/018, FWO no. G.485.08, the CHAARM project, and the Dormeur Investment Service Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre KB, 2010, VIROLOGY, V402, P187, DOI 10.1016/j.virol.2010.03.021; Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004; Balzarini J, 2005, J BIOL CHEM, V280, P41005, DOI 10.1074/jbc.M508801200; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Barrientos LG, 2003, ANTIVIR RES, V58, P47, DOI 10.1016/S0166-3542(02)00183-3; Beer BE, 2006, ANTIMICROB AGENTS CH, V50, P713, DOI 10.1128/AAC.50.2.713-723.2006; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Breitling R, 2006, BBA-GENE STRUCT EXPR, V1759, P319, DOI 10.1016/j.bbaexp.2006.06.003; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Chu CS, 2009, PROTEOMICS, V9, P1939, DOI 10.1002/pmic.200800249; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Francois KO, 2012, MED RES REV, V32, P349, DOI 10.1002/med.20216; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Huskens D, 2010, J BIOL CHEM, V285, P24845, DOI 10.1074/jbc.M110.128546; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Li ZQ, 2008, J IMMUNOL, V181, P5147, DOI 10.4049/jimmunol.181.7.5147; Liu YA, 2009, BIOPOLYMERS, V92, P194, DOI 10.1002/bip.21173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marais D, 2006, VIRUS RES, V121, P220, DOI 10.1016/j.virusres.2006.04.009; Matei E, 2010, J BIOL CHEM, V285, P13057, DOI 10.1074/jbc.M109.094938; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mori T, 1998, PROTEIN EXPRES PURIF, V12, P151, DOI 10.1006/prep.1997.0838; Moulaei T, 2010, STRUCTURE, V18, P1104, DOI 10.1016/j.str.2010.05.016; O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Sharon N, 2007, LECTINS; Smee DF, 2008, ANTIVIR RES, V80, P266, DOI 10.1016/j.antiviral.2008.06.003; Stafford MK, 1998, J ACQ IMMUN DEF SYND, V17, P327, DOI 10.1097/00042560-199804010-00006; Takahashi A, 2010, J ANTIBIOT, V63, P661, DOI 10.1038/ja.2010.106; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; VanDamme EJM, 1996, FEBS LETT, V397, P352, DOI 10.1016/S0014-5793(96)01211-2; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	48	88	91	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22635	10.1371/journal.pone.0022635	http://dx.doi.org/10.1371/journal.pone.0022635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829638	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511900010
J	Li, CX; Han, JP; Ren, WY; Ji, AQ; Xu, XL; Hu, L				Li, Cai-xia; Han, Jun-ping; Ren, Wen-yan; Ji, An-quan; Xu, Xiu-lan; Hu, Lan			DNA Profiling of Spermatozoa by Laser Capture Microdissection and Low Volume-PCR	PLOS ONE			English	Article							CELLS; AMPLIFICATION; VALIDATION	Genetic profiling of sperm from complex biological mixtures such as sexual assault casework samples requires isolation of a pure sperm population and the ability to analyze low abundant samples. Current standard procedure for sperm isolation includes preferential lysis of epithelial contaminants followed by collection of intact sperm by centrifugation. While effective for samples where sperm are abundant, this method is less effective when samples contain few spermatozoa. Laser capture microdissection (LCM) is a proven method for the isolation of cells biological mixtures, even when found in low abundance. Here, we demonstrate the efficacy of LCM coupled with on-chip low volume PCR (LV-PCR) for the isolation and genotyping of low abundance sperm samples. Our results indicate that this method can obtain complete profiles (13-16 loci) from as few as 15 sperm cells with 80% reproducibility, whereas at least 40 sperm cells are required to profile 13-16 loci by standard 'in-tube' PCR. Further, LCM and LV-PCR of a sexual assault casework sample generated a DNA genotype that was consistent with that of the suspect. This method was unable, however, to analyze a casework sample from a gang rape case in which two or more sperm contributors were in a mixed population. The results indicate that LCM and LV-PCR is sensitive and effective for genotyping sperm from sperm/epithelial cell mixtures when epithelial lysis may be insufficient due to low abundance of sperm; LCM and LV-PCR, however, failed in a casework sample when spermatozoa from multiple donors was present, indicating that further study is necessitated.	[Li, Cai-xia; Ji, An-quan; Xu, Xiu-lan; Hu, Lan] Minist Publ Secur, Inst Forens Sci, Beijing, Peoples R China; [Li, Cai-xia; Ji, An-quan; Xu, Xiu-lan; Hu, Lan] Minist Publ Secur, Key Lab Forens Genet, Beijing, Peoples R China; [Han, Jun-ping; Ren, Wen-yan] Chinese Peoples Publ Secur Univ, Beijing, Peoples R China	Institute of Forensic Science Ministry of Justice PRC; Ministry of Public Security (China); Ministry of Public Security (China); People's Public Security University of China	Li, CX (corresponding author), Minist Publ Secur, Inst Forens Sci, Beijing, Peoples R China.	licaixia@tsinghua.org.cn; hulan328@yahoo.com			National Science & Technology Pillar Program via a grant of Key Projects in the Eleventh Five-year Plan Period [2006BAK07B01]	National Science & Technology Pillar Program via a grant of Key Projects in the Eleventh Five-year Plan Period	This study was supported by the National Science & Technology Pillar Program via a grant of Key Projects in the Eleventh Five-year Plan Period (No. 2006BAK07B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anslinger K, 2007, INT J LEGAL MED, V121, P54, DOI 10.1007/s00414-005-0065-7; Budimlija ZM, 2005, CROAT MED J, V46, P549; Budowle B, 2009, CROAT MED J, V50, P207, DOI 10.3325/cmj.2009.50.207; Caragine T, 2009, CROAT MED J, V50, P250, DOI 10.3325/cmj.2009.50.250; Di Martino D, 2004, FORENSIC SCI INT, V146, pS155, DOI 10.1016/j.forsciint.2004.09.047; Elliott K, 2003, FORENSIC SCI INT, V137, P28, DOI 10.1016/S0379-0738(03)00267-6; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Gill P, 2000, FORENSIC SCI INT, V112, P17, DOI 10.1016/S0379-0738(00)00158-4; Li CX, 2009, FORENS SCI INT-GEN S, V2, P516, DOI 10.1016/j.fsigss.2009.08.016; Lutz-Bonengel S, 2007, INT J LEGAL MED, V121, P68, DOI 10.1007/s00414-006-0125-7; McAlister C, 2011, FORENSIC SCI INT-GEN, V5, P69, DOI 10.1016/j.fsigen.2010.04.008; Miyazaki T, 2008, FORENS SCI INT-GEN S, V1, P437, DOI 10.1016/j.fsigss.2007.10.074; Sanders CT, 2006, J FORENSIC SCI, V51, P748, DOI 10.1111/j.1556-4029.2006.00180.x; Schmidt U, 2006, INT J LEGAL MED, V120, P42, DOI 10.1007/s00414-005-0041-2; Vandewoestyne M, 2009, INT J LEGAL MED, V123, P169, DOI 10.1007/s00414-008-0271-1	15	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22316	10.1371/journal.pone.0022316	http://dx.doi.org/10.1371/journal.pone.0022316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853031	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953400007
J	Liu, ZD; Xu, BB; Li, L; Sun, JH				Liu, Zhudong; Xu, Bingbing; Li, Li; Sun, Jianghua			Host-Size Mediated Trade-Off in a Parasitoid Sclerodermus harmandi	PLOS ONE			English	Article							SEX-RATIOS; STAGE SELECTION; HYMENOPTERA; WASPS; EVOLUTION; STRATEGIES; FITNESS; BRACONIDAE; BETHYLIDAE; APHIDIIDAE	Optimality models of host-parasitoid relationships have traditionally assumed that host quality increases as a function of host size at parasitism. However, trade-offs may play a crucial role in species evolution and should be found in host-parasitoid interactions where the host quality may differ between different sizes. Here, we investigated the effects of host size differences of Monochamus alternatus larva on foraging decisions, parasitism and related fitness in a gregarious ectoparasitoid, Sclerodermus harmandi. Two-choice and non-choice experiments were conducted with M. alternatus larvae to evaluate preference and performance of S. harmandi, respectively. Results from two-choice test showed that adult females prefer to attack large larvae rather than small larvae. In no-choice tests, adult females needed more time to paralyze large larvae than small larvae before laying eggs on the body surface of M. alternatus larvae and had lower survival and parasitism rate on those large larvae. Foraging decisions of S. harmandi led to the selection of the most profitable host size for parasitoid development, which showed more offspring gained on large M. alternatus larvae than on small larvae and got higher body weight on those large hosts. This study demonstrates the existence of trade-off occurring during host-parasitoids interactions according to host size related quality.	[Liu, Zhudong; Xu, Bingbing; Li, Li; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Li, Li] Guizhou Normal Univ, Sch Life Sci, Guiyang, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Guizhou Normal University	Liu, ZD (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunjh@ioz.ac.cn		sun, jianghua/0000-0002-9465-3672	National Basic Research Program [2009CB119204]	National Basic Research Program(National Basic Research Program of China)	The research was supported by the National Basic Research Program (2009CB119204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; CHARNOV E L, 1982; CHARNOV EL, 1984, FLA ENTOMOL, V67, P5, DOI 10.2307/3494101; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; CHARNOV EL, 1985, ENVIRON ENTOMOL, V14, P383, DOI 10.1093/ee/14.4.383; Chau A, 2001, CAN ENTOMOL, V133, P549, DOI 10.4039/Ent133549-4; Chong JH, 2006, ENTOMOL EXP APPL, V121, P39, DOI 10.1111/j.1570-8703.2006.00460.x; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; Ding Y, 2001, CHIN J APPL ECOL, V12, P351; EVANS HOWARD E., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V132, P1; Gauld I. D., 1988, HYMENOPTERA; Gauld Ian D., 1995, P464; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; Jervis M. A., 1996, P63; KING BH, 1989, OECOLOGIA, V78, P420, DOI 10.1007/BF00379119; KING BH, 1987, Q REV BIOL, V62, P367, DOI 10.1086/415618; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Lauziere I, 2001, BIOL CONTROL, V21, P128, DOI 10.1006/bcon.2000.0909; Li BP, 2004, ENTOMOL EXP APPL, V110, P249, DOI 10.1111/j.0013-8703.2004.00144.x; Li L, 2011, PLOS ONE, V6; Li L, 2010, BIOCONTROL, V55, P465, DOI 10.1007/s10526-010-9270-5; Li L, 2009, ECOL ENTOMOL, V34, P725, DOI 10.1111/j.1365-2311.2009.01120.x; Mackauer M., 1997, Ecological Studies, V130, P191; Mackauer M., 1993, PARASITES PATHOGENS, V1, P1; Nicol CMY, 1999, ENTOMOL EXP APPL, V90, P83, DOI 10.1023/A:1003546731081; Ode PJ, 2002, BIOL CONTROL, V24, P31, DOI 10.1016/S1049-9644(02)00003-8; Pandey S, 1999, ENTOMOL EXP APPL, V90, P61, DOI 10.1023/A:1003558416329; Roitberg BD, 2001, CAN ENTOMOL, V133, P429, DOI 10.4039/Ent133429-3; SRIVASTAVA M, 1995, BIOL AGRIC HORTIC, V12, P15, DOI 10.1080/01448765.1995.9754720; STRAND MR, 1983, ENVIRON ENTOMOL, V12, P1114, DOI 10.1093/ee/12.4.1114; Strand MR, 2000, PARASITOID POPULATION BIOLOGY, P139; Van Alphen J. J. M., 1996, P1; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; Waage J.K., 1986, Symposia of the Royal Entomological Society of London, P63; Walker AM, 2003, J ECON ENTOMOL, V96, P1685, DOI 10.1603/0022-0493-96.6.1685; ZHANG WG, 2004, THESIS U SHANDONG AG; Zhou Zuji, 1997, Scientia Silvae Sinicae, V33, P475	40	35	54	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23260	10.1371/journal.pone.0023260	http://dx.doi.org/10.1371/journal.pone.0023260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853096	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953400035
J	Jiang, X; Barmada, MM; Cooper, GF; Becich, MJ				Jiang, Xia; Barmada, M. Michael; Cooper, Gregory F.; Becich, Michael J.			A Bayesian Method for Evaluating and Discovering Disease Loci Associations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; ALZHEIMER-DISEASE; AFRICAN-AMERICAN; FALSE; FGFR2; RISK; APOE; VARIANTS; ALLELES	Background: A genome-wide association study (GWAS) typically involves examining representative SNPs in individuals from some population. A GWAS data set can concern a million SNPs and may soon concern billions. Researchers investigate the association of each SNP individually with a disease, and it is becoming increasingly commonplace to also analyze multi-SNP associations. Techniques for handling so many hypotheses include the Bonferroni correction and recently developed Bayesian methods. These methods can encounter problems. Most importantly, they are not applicable to a complex multilocus hypothesis which has several competing hypotheses rather than only a null hypothesis. A method that computes the posterior probability of complex hypotheses is a pressing need. Methodology/Findings: We introduce the Bayesian network posterior probability (BNPP) method which addresses the difficulties. The method represents the relationship between a disease and SNPs using a directed acyclic graph (DAG) model, and computes the likelihood of such models using a Bayesian network scoring criterion. The posterior probability of a hypothesis is computed based on the likelihoods of all competing hypotheses. The BNPP can not only be used to evaluate a hypothesis that has previously been discovered or suspected, but also to discover new disease loci associations. The results of experiments using simulated and real data sets are presented. Our results concerning simulated data sets indicate that the BNPP exhibits both better evaluation and discovery performance than does a p-value based method. For the real data sets, previous findings in the literature are confirmed and additional findings are found. Conclusions/Significance: We conclude that the BNPP resolves a pressing problem by providing a way to compute the posterior probability of complex multi-locus hypotheses. A researcher can use the BNPP to determine the expected utility of investigating a hypothesis further. Furthermore, we conclude that the BNPP is a promising method for discovering disease loci associations.	[Jiang, Xia; Cooper, Gregory F.; Becich, Michael J.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [Barmada, M. Michael] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Cooper, Gregory F.] Univ Pittsburgh, Intelligent Syst Program, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jiang, X (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	xij6@pitt.edu		Barmada, M Michael/0000-0002-3604-6460	National Library of Medicine at the National Institutes of Health [1K99LM010822-01, R01-LM010020]; NATIONAL LIBRARY OF MEDICINE [K99LM010822, R01LM010020, R00LM010822] Funding Source: NIH RePORTER	National Library of Medicine at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by [grant number 1K99LM010822-01] and [grant number R01-LM010020] from the National Library of Medicine at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J MINISTRY AGR; [Anonymous], 2008, POLICY SHARING DATA; Barnholtz-Sloan JS, 2010, CARCINOGENESIS, V31, P1417, DOI 10.1093/carcin/bgq128; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonifaci N, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-62; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fallin MD, 2010, NEUROGENETICS, V11, P335, DOI 10.1007/s10048-010-0234-9; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Heckerman D, 1995, MSRTR9409; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jiang X, 2011, BMC BIOINFO IN PRESS; Jiang Xia, 2010, AMIA Annu Symp Proc, V2010, P341; Jiang X, 2010, GENET EPIDEMIOL, V34, P575, DOI 10.1002/gepi.20514; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Liang XY, 2009, HUM MUTAT, V30, P463, DOI 10.1002/humu.20953; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Moffa AB, 2007, J CELL PHYSIOL, V210, P720, DOI 10.1002/jcp.20880; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Neapolitan RE, 2009, PROBABILISTIC METHODS FOR BIOINFORMATICS WITH AN INTRODUCTION TO BAYESIAN NETWORKS, P1; Neapolitan RE, 2008, INNOVATIONS BAYESIAN; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sebastiani Paola, 2010, Science, V2010, DOI 10.1126/science.1190532; Shi H, 2010, INT J MOL EPIDEMIOL, V1, P53; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tycko B, 2004, ARCH NEUROL-CHICAGO, V61, P1434, DOI 10.1001/archneur.61.9.1434; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Visweswaran Shyam, 2009, AMIA Annu Symp Proc, V2009, P673; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wakefield J, 2008, INT J EPIDEMIOL, V37, P641, DOI 10.1093/ije/dym257; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	44	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22075	10.1371/journal.pone.0022075	http://dx.doi.org/10.1371/journal.pone.0022075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853025	Green Published, Green Accepted, gold			2022-12-27	WOS:000295454200006
J	Krumsiek, J; Marr, C; Schroeder, T; Theis, FJ				Krumsiek, Jan; Marr, Carsten; Schroeder, Timm; Theis, Fabian J.			Hierarchical Differentiation of Myeloid Progenitors Is Encoded in the Transcription Factor Network	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; LINEAGE-COMMITMENT; FACTOR GATA-1; C/EBP-ALPHA; MICE LACKING; REGULATORY NETWORKS; LOGICAL ANALYSIS; MOUSE EMBRYOS; FETAL LIVER; FACTOR EKLF	Hematopoiesis is an ideal model system for stem cell biology with advanced experimental access. A systems view on the interactions of core transcription factors is important for understanding differentiation mechanisms and dynamics. In this manuscript, we construct a Boolean network to model myeloid differentiation, specifically from common myeloid progenitors to megakaryocytes, erythrocytes, granulocytes and monocytes. By interpreting the hematopoietic literature and translating experimental evidence into Boolean rules, we implement binary dynamics on the resulting 11-factor regulatory network. Our network contains interesting functional modules and a concatenation of mutual antagonistic pairs. The state space of our model is a hierarchical, acyclic graph, typifying the principles of myeloid differentiation. We observe excellent agreement between the steady states of our model and microarray expression profiles of two different studies. Moreover, perturbations of the network topology correctly reproduce reported knockout phenotypes in silico. We predict previously uncharacterized regulatory interactions and alterations of the differentiation process, and line out reprogramming strategies.	[Krumsiek, Jan; Marr, Carsten; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Munich, Germany; [Schroeder, Timm] Helmholtz Zentrum Munchen, Inst Stem Cell Res, Munich, Germany; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Krumsiek, J (corresponding author), Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Munich, Germany.	fabian.theis@helmholtz-muenchen.de	Theis, Fabian J/ABD-5212-2021; Schroeder, Timm/F-8448-2010; Marr, Carsten/B-3696-2013; Krumsiek, Jan/B-3961-2013	Theis, Fabian J/0000-0002-2419-1943; Schroeder, Timm/0000-0001-9320-0252; Marr, Carsten/0000-0003-2154-4552; 	Helmholtz Association within the Helmholtz Alliance on Systems Biology	Helmholtz Association within the Helmholtz Alliance on Systems Biology	This research was partially supported by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (project CoReNe). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Barbeau B, 1999, ONCOGENE, V18, P5535, DOI 10.1038/sj.onc.1202913; BOCKAMP EO, 1995, BLOOD, V86, P1502, DOI 10.1182/blood.V86.4.1502.bloodjournal8641502; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; CLECH ML, 2006, J MOL BIOL, V355, P9; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Du J, 2002, J BIOL CHEM, V277, P43481, DOI 10.1074/jbc.M204777200; Duan ZJ, 2005, TRENDS MOL MED, V11, P49, DOI 10.1016/j.molmed.2004.12.003; Elagib KE, 2007, CRIT REV EUKAR GENE, V17, P271, DOI 10.1615/CritRevEukarGeneExpr.v17.i4.20; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Huang DY, 2004, NUCLEIC ACIDS RES, V32, P3935, DOI 10.1093/nar/gkh719; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kawada H, 2001, INT J HEMATOL, V73, P463, DOI 10.1007/BF02994008; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Lim SK, 1997, BLOOD, V90, P1291, DOI 10.1182/blood.V90.3.1291.1291_1291_1299; MACKEY MC, MATH MODELS HEMATOPO, P149; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; McCormack MP, 2006, BLOOD, V108, P2248, DOI 10.1182/blood-2006-02-002188; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Minegishi N, 2003, BLOOD, V102, P896, DOI 10.1182/blood-2002-12-3809; Moroni E, 2000, J BIOL CHEM, V275, P10567, DOI 10.1074/jbc.275.14.10567; MOUSSA O, 2010, MOL CELL BIOL; Narula J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000771; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; ORKIN SH, 1992, BLOOD, V80, P575; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; PERKINS AC, 1995, NATURE, V375, P318; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; RADDE N, 2009, INT J SYST SCI; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rieger MA, 2009, J CELL BIOCHEM, V108, P343, DOI 10.1002/jcb.22273; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Scherf M, 2005, BRIEF BIOINFORM, V6, P287, DOI 10.1093/bib/6.3.287; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Takayama M, 2010, MOL CELL BIOL, V30, P2668, DOI 10.1128/MCB.01304-09; TAOUDI S, 2011, GENES DEV; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; Tokita K, 2007, CANCER SCI, V98, P1752, DOI 10.1111/j.1349-7006.2007.00597.x; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wittmann DM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000569; Yamaguchi Y, 1998, BLOOD, V91, P450, DOI 10.1182/blood.V91.2.450.450_450_457; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang YJ, 2005, STEM CELLS, V23, P852, DOI 10.1634/stemcells.2004-0260	95	99	100	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22649	10.1371/journal.pone.0022649	http://dx.doi.org/10.1371/journal.pone.0022649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853041	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200017
J	Perez, D; Martin, S; Fernandez-Lorente, G; Filice, M; Guisan, JM; Ventosa, A; Garcia, MT; Mellado, E				Perez, Dolores; Martin, Sara; Fernandez-Lorente, Gloria; Filice, Marco; Manuel Guisan, Jose; Ventosa, Antonio; Teresa Garcia, Maria; Mellado, Encarnacion			A Novel Halophilic Lipase, LipBL, Showing High Efficiency in the Production of Eicosapentaenoic Acid (EPA)	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; INTERFACIAL ADSORPTION; SELECTIVE ADSORPTION; FISH-OIL; PURIFICATION; IMMOBILIZATION; EXTREMOPHILES; HYDROLYSIS; ENRICHMENT; INDUSTRIAL	Background: Among extremophiles, halophiles are defined as microorganisms adapted to live and thrive in diverse extreme saline environments. These extremophilic microorganisms constitute the source of a number of hydrolases with great biotechnological applications. The interest to use extremozymes from halophiles in industrial applications is their resistance to organic solvents and extreme temperatures. Marinobacter lipolyticus SM19 is a moderately halophilic bacterium, isolated previously from a saline habitat in South Spain, showing lipolytic activity. Methods and Findings: A lipolytic enzyme from the halophilic bacterium Marinobacter lipolyticus SM19 was isolated. This enzyme, designated LipBL, was expressed in Escherichia coli. LipBL is a protein of 404 amino acids with a molecular mass of 45.3 kDa and high identity to class C beta-lactamases. LipBL was purified and biochemically characterized. The temperature for its maximal activity was 80 degrees C and the pH optimum determined at 25 degrees C was 7.0, showing optimal activity without sodium chloride, while maintaining 20% activity in a wide range of NaCl concentrations. This enzyme exhibited high activity against short-medium length acyl chain substrates, although it also hydrolyzes olive oil and fish oil. The fish oil hydrolysis using LipBL results in an enrichment of free eicosapentaenoic acid (EPA), but not docosahexaenoic acid (DHA), relative to its levels present in fish oil. For improving the stability and to be used in industrial processes LipBL was immobilized in different supports. The immobilized derivatives CNBr-activated Sepharose were highly selective towards the release of EPA versus DHA. The enzyme is also active towards different chiral and prochiral esters. Exposure of LipBL to buffer-solvent mixtures showed that the enzyme had remarkable activity and stability in all organic solvents tested. Conclusions: In this study we isolated, purified, biochemically characterized and immobilized a lipolytic enzyme from a halophilic bacterium M. lipolyticus, which constitutes an enzyme with excellent properties to be used in the food industry, in the enrichment in omega-3 PUFAs.	[Perez, Dolores; Martin, Sara; Ventosa, Antonio; Teresa Garcia, Maria; Mellado, Encarnacion] Univ Seville, Fac Pharm, Dept Microbiol & Parasitol, Seville, Spain; [Fernandez-Lorente, Gloria] CSIC, Inst Fermentac Ind, E-28006 Madrid, Spain; [Filice, Marco; Manuel Guisan, Jose] CSIC, Dept Biocatalysis, Inst Catalysis & Petrochem, Madrid, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fermentaciones Industriales (IFI); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP)	Perez, D (corresponding author), Univ Seville, Fac Pharm, Dept Microbiol & Parasitol, Seville, Spain.	emellado@us.es	Ventosa, Antonio/K-8239-2017; Filice, Marco/O-2892-2019; MELLADO, ENCARNACIÓN/K-8665-2014; Fernandez-Lorente, Gloria/M-8455-2013; Guisan, Jose M/K-4110-2016; Filice, Marco/L-4848-2014; GARCÍA GUTIÉRREZ, MARIA TERESA/K-6515-2014	Ventosa, Antonio/0000-0002-7573-0556; Filice, Marco/0000-0001-8142-4566; MELLADO, ENCARNACIÓN/0000-0002-7135-1428; Guisan, Jose M/0000-0003-1627-6522; Filice, Marco/0000-0001-8142-4566; GARCÍA GUTIÉRREZ, MARIA TERESA/0000-0002-0916-6256; Lorente, Fernandez/0000-0002-0756-439X	Spanish Ministerio de Ciencia e Innovacion [BIO2006-06927, CTM2006-03310]; Junta de Andalucia [P06-CVI-01829, P08-RNM-3515]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia)	This study was supported by grants from Spanish Ministerio de Ciencia e Innovacion (BIO2006-06927 and CTM2006-03310) and Junta de Andalucia (P06-CVI-01829 and P08-RNM-3515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bastida A, 1998, BIOTECHNOL BIOENG, V58, P486, DOI 10.1002/(SICI)1097-0290(19980605)58:5<486::AID-BIT4>3.0.CO;2-9; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Chakraborty K, 2008, J AGR FOOD CHEM, V56, P1428, DOI 10.1021/jf073176u; CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064; Diaz P, 1999, BIOTECHNIQUES, V27, P696, DOI 10.2144/99274bm14; Fernandez-Lorente G, 2005, BIOTECHNOL BIOENG, V92, P773, DOI 10.1002/bit.20656; Fernandez-Lorente G, 2008, BIOMACROMOLECULES, V9, P2553, DOI 10.1021/bm800609g; HOHN B, 1980, GENE, V11, P291, DOI 10.1016/0378-1119(80)90069-4; HOSHINO T, 1990, AGR BIOL CHEM TOKYO, V54, P1459, DOI 10.1080/00021369.1990.10870149; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; JORIS B, 1988, BIOCHEM J, V250, P313, DOI 10.1042/bj2500313; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; LAANE C, 1987, BIOTECHNOL BIOENG, V30, P81, DOI 10.1002/bit.260300112; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linder M, 2005, MAR BIOTECHNOL, V7, P70, DOI 10.1007/s10126-004-0149-2; Makrides M, 2010, NESTLE NUTR WORKS SE, V65, P123, DOI 10.1159/000281154; Martin S, 2003, INT J SYST EVOL MICR, V53, P1383, DOI 10.1099/ijs.0.02528-0; Martin S, 2006, THESIS U SEVILLE; Mellado E, 2005, MICROORGANISMS IND E, P25; Oh K, 2005, CANCER EPIDEM BIOMAR, V14, P835, DOI 10.1158/1055-9965.EPI-04-0545; Okada T, 2008, J FOOD SCI, V73, pC146, DOI 10.1111/j.1750-3841.2008.00661.x; Oren A, 2010, ENVIRON TECHNOL, V31, P825, DOI 10.1080/09593330903370026; Palomo JM, 2004, BIOTECHNOL PROGR, V20, P630, DOI 10.1021/bp0342957; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Sabuquillo P, 1998, BBA-PROTEIN STRUCT M, V1388, P337, DOI 10.1016/S0167-4838(98)00183-6; Salameh M, 2007, ADV APPL MICROBIOL, V61, P253, DOI 10.1016/S0065-2164(06)61007-1; Sambrook J., 2001, MOL CLONING LAB MANU; Schmitt-Rozieres M, 2000, J AM OIL CHEM SOC, V77, P329, DOI 10.1007/s11746-000-0053-1; Segura RL, 2004, BIOTECHNOL PROGR, V20, P825, DOI 10.1021/bp034363p; Shahidi F, 1998, TRENDS FOOD SCI TECH, V9, P230, DOI 10.1016/S0924-2244(98)00044-2; Shimada Y, 2001, J BIOSCI BIOENG, V91, P529, DOI 10.1263/jbb.91.529; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; TANAKA Y, 1992, J AM OIL CHEM SOC, V69, P1210, DOI 10.1007/BF02637682; UPTON C, 1995, TRENDS BIOCHEM SCI, V20, P178, DOI 10.1016/S0968-0004(00)89002-7; VENTOSA A, 1982, J GEN MICROBIOL, V128, P1959; Wanasundara UN, 1998, J AM OIL CHEM SOC, V75, P945, DOI 10.1007/s11746-998-0271-9; Wijendran V, 2004, ANNU REV NUTR, V24, P597, DOI 10.1146/annurev.nutr.24.012003.132106; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Xu XB, 2000, EUR J LIPID SCI TECH, V102, P287; [郑毅 Zheng Yi], 2005, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V11, P571	44	54	62	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23325	10.1371/journal.pone.0023325	http://dx.doi.org/10.1371/journal.pone.0023325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853111	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200070
J	Chen, S; Lai, CH; Wu, XX; Lu, YZ; Han, DS; Guo, WZ; Fu, LC; Andrieu, JM; Lu, W				Chen, Song; Lai, Chunhui; Wu, Xiaoxiang; Lu, Yaozheng; Han, Daishu; Guo, Weizhong; Fu, Linchun; Andrieu, Jean-Marie; Lu, Wei			Variability of Bio-Clinical Parameters in Chinese-Origin Rhesus Macaques Infected with Simian Immunodeficiency Virus: A Nonhuman Primate AIDS Model	PLOS ONE			English	Article							DISEASE PROGRESSION; HOMOSEXUAL-MEN; MACACA-MULATTA; HIV VACCINE; VIRAL LOAD; MONKEYS; REPLICATION; PATHOGENESIS; FREQUENCIES; SIVMAC239	Background: Although Chinese-origin Rhesus macaques (Ch RhMs) infected with simian immunodeficiency virus (SIV) have been used for many years to evaluate the efficacy of AIDS vaccines and therapeutics, the bio-clinical variability of such a nonhuman primate AIDS model was so far not established. Methodology/Principal Findings: By randomizing 150 (78 male and 72 female) Ch RhMs with diverse MHC class I alleles into 3 groups (50 animals per group) challenged with intrarectal (ir) SIVmac239, intravenous (iv) SIVmac239, or iv SIVmac251, we evaluated variability in bio-clinical endpoints for 118 weeks. All SIV-challenged Ch RhMs became seropositive for SIV during 1-2 weeks. Plasma viral load (VL) peaked at weeks 1-2 and then declined to set-point levels as from week 5. The set-point VL was 30 fold higher in SIVmac239 (ir or iv)-infected than in SIVmac251 (iv)-infected animals. This difference in plasma VL increased overtime (>100 fold as from week 68). The rates of progression to AIDS or death were more rapid in SIVmac239 (ir or iv)-infected than in SIVmac251 (iv)-infected animals. No significant difference in bio-clinical endpoints was observed in animals challenged with ir or iv SIVmac239. The variability (standard deviation) in peak/set-point VL was nearly one-half lower in animals infected with SIVmac239 (ir or iv) than in those infected with SIVmac251 (iv), allowing that the same treatment-related difference can be detected with one-half fewer animals using SIVmac239 than using SIVmac251. Conclusion/Significance: These results provide solid estimates of variability in bio-clinical endpoints needed when designing studies using the Ch RhM SIV model and contribute to the improving quality and standardization of preclinical studies.	[Chen, Song; Wu, Xiaoxiang; Lu, Yaozheng; Han, Daishu; Lu, Wei] Peking Union Med Coll, Sinofrench Collaborat Ctr AIDS Res, Beijing 100021, Peoples R China; [Chen, Song; Wu, Xiaoxiang; Lu, Yaozheng; Han, Daishu; Lu, Wei] Peking Union Med Coll, Dept Cell Biol, Beijing 100021, Peoples R China; [Chen, Song; Wu, Xiaoxiang; Lu, Yaozheng; Han, Daishu; Lu, Wei] Tsinghua Univ, Chinese Acad Med Sci, Beijing 100084, Peoples R China; [Chen, Song; Lai, Chunhui; Guo, Weizhong; Fu, Linchun; Lu, Wei] Guangzhou Univ Chinese Med, IRD China Branch Trop Med Inst UMI233, Guangzhou, Guangdong, Peoples R China; [Andrieu, Jean-Marie] Univ Paris 05, Inst Rech Vaccins & Immunotherapie Canc & Sida, St Peres Biomed Ctr, Paris, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Tsinghua University; Guangzhou University of Chinese Medicine; UDICE-French Research Universities; Universite Paris Cite	Chen, S (corresponding author), Peking Union Med Coll, Sinofrench Collaborat Ctr AIDS Res, Beijing 100021, Peoples R China.	louis.luwei@ird.fr		CHEN, Song/0000-0003-2521-717X	Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Institut de Recherche pour le Developpement (IRD)	Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Institut de Recherche pour le Developpement (IRD)	This work was supported by the Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS) and the Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AC NRCON, 2011, GUID CAR US LAB AN, P11601; Champoux M, 1997, DEV PSYCHOBIOL, V31, P49, DOI 10.1002/(SICI)1098-2302(199707)31:1<49::AID-DEV5>3.3.CO;2-A; Clarke MR, 1999, AM J PRIMATOL, V47, P335, DOI 10.1002/(SICI)1098-2345(1999)47:4<335::AID-AJP5>3.0.CO;2-Y; Doxiadis GGM, 2003, IMMUNOGENETICS, V55, P540, DOI 10.1007/s00251-003-0590-9; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Jiang Xuelong, 1991, Zoological Research, V12, P241; JOAG SV, 1994, VIROLOGY, V200, P436, DOI 10.1006/viro.1994.1207; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; LI J, 1992, J ACQ IMMUN DEF SYND, V5, P639; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Ling B, 2007, AIDS, V21, P2377, DOI 10.1097/QAD.0b013e3282f08b32; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; Morgan C, 2008, PLOS MED, V5, P1200, DOI 10.1371/journal.pmed.0050173; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Muhl T, 2002, J IMMUNOL, V169, P3438, DOI 10.4049/jimmunol.169.6.3438; Otting N, 2007, IMMUNOGENETICS, V59, P367, DOI 10.1007/s00251-007-0201-2; Parker RA, 2001, J VIROL, V75, P11234, DOI 10.1128/JVI.75.22.11234-11238.2001; Pehrson P, 1997, AIDS, V11, P1007, DOI 10.1097/00002030-199708000-00009; Penedo MCT, 2005, IMMUNOGENETICS, V57, P198, DOI 10.1007/s00251-005-0787-1; RERKSNGARM S, 2009, N ENGL J MED; Robb ML, 2008, LANCET, V372, P1857, DOI 10.1016/S0140-6736(08)61593-7; Robinson TM, 2007, J MED PRIMATOL, V36, P276, DOI 10.1111/j.1600-0684.2007.00245.x; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Trichel AM, 2002, J MED PRIMATOL, V31, P171, DOI 10.1034/j.1600-0684.2002.02003.x; TSAI CC, 1993, LAB ANIM SCI, V43, P411; Viray J, 2001, COMPARATIVE MED, V51, P555; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Westmoreland SV, 1998, J NEUROVIROL, V4, P260, DOI 10.3109/13550289809114527; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; WOLFS TFW, 1989, VOX SANG, V57, P127, DOI 10.1111/j.1423-0410.1989.tb01149.x; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; ZHANG R, 1991, Acta Theriologica Sinica, V11, P171	35	15	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23177	10.1371/journal.pone.0023177	http://dx.doi.org/10.1371/journal.pone.0023177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850259	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300044
J	Seta, F; Rahmani, M; Turner, PV; Funk, CD				Seta, Francesca; Rahmani, Mahboubeh; Turner, Patricia V.; Funk, Colin D.			Pulmonary Oxidative Stress Is Increased in Cyclooxygenase-2 Knockdown Mice with Mild Pulmonary Hypertension Induced by Monocrotaline	PLOS ONE			English	Article							BOVINE CORONARY-ARTERIES; CONGENITAL HEART-DISEASE; VASCULAR SMOOTH-MUSCLE; NADPH OXIDASE ACTIVITY; PROSTACYCLIN SYNTHASE; INTRAVASCULAR THROMBOSIS; PLATELET-AGGREGATION; ENDOTHELIAL INJURY; TRANSGENIC MICE; CELLS	The aim of this study was to examine the role of cyclooxygenase-2 (COX-2) and downstream signaling of prostanoids in the pathogenesis of pulmonary hypertension (PH) using mice with genetically manipulated COX-2 expression. COX-2 knockdown (KD) mice, characterized by 80-90% suppression of COX-2, and wild-type (WT) control mice were treated weekly with monocrotaline (MCT) over 10 weeks. Mice were examined for cardiac hypertrophy/function and right ventricular pressure. Lung histopathological analysis was performed and various assays were carried out to examine oxidative stress, as well as gene, protein, cytokine and prostanoid expression. We found that MCT increased right ventricular systolic and pulmonary arterial pressures in comparison to saline-treated mice, with no evidence of cardiac remodeling. Gene expression of endothelin receptor A and thromboxane synthesis, regulators of vasoconstriction, were increased in MCT-treated lungs. Bronchoalveolar lavage fluid and lung sections demonstrated mild inflammation and perivascular edema but activation of inflammatory cells was not predominant under the experimental conditions. Heme oxygenase-1 (HO-1) expression and indicators of oxidative stress in lungs were significantly increased, especially in COX-2 KD MCT-treated mice. Gene expression of NOX-4, but not NOX-2, two NADPH oxidase subunits crucial for superoxide generation, was induced by similar to 4-fold in both groups of mice by MCT. Vasodilatory and anti-aggregatory prostacyclin was reduced by similar to 85% only in MCT-treated COX-2 KD mice. This study suggests that increased oxidative stress-derived endothelial dysfunction, vasoconstriction and mild inflammation, exacerbated by the lack of COX-2, contribute to the pathogenesis of early stages of PH when mild hemodynamic changes are evident and not yet accompanied by vascular and cardiac remodeling.	[Seta, Francesca; Rahmani, Mahboubeh; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Turner, Patricia V.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	Queens University - Canada; University of Guelph	Seta, F (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	funkc@queensu.ca	Seta, Francesca/ABB-1566-2020	Funk, Colin/0000-0001-7029-4233; Seta, Francesca/0000-0001-7985-5615	CIHR [MOP-79459, MOP-93689]; Canadian Foundation for Innovation; Heart and Stroke Foundation of Ontario	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This research was supported by CIHR grants (MOP-79459 and MOP-93689) and a Canadian Foundation for Innovation Leading Opportunity Fund award. CDF holds a Tier I Canada Research Chair in Molecular, Cellular and Physiological Medicine and is recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Aliotta JM, 2009, STEM CELLS DEV, V18, P773, DOI 10.1089/scd.2008.0237; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; BUTLER WH, 1970, J PATHOL, V102, P15, DOI 10.1002/path.1711020104; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; CELERMAJER DS, 1994, CIRCULATION, V89, P2041, DOI 10.1161/01.CIR.89.5.2041; CELERMAJER DS, 1993, CIRCULATION, V87, P440, DOI 10.1161/01.CIR.87.2.440; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; CZER GT, 1986, J APPL PHYSIOL, V60, P464, DOI 10.1152/jappl.1986.60.2.464; DEYO JA, 1994, TOXICOLOGY, V94, P209, DOI 10.1016/0300-483X(94)90039-6; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Dumitrascu Rio, 2008, BMC Pulm Med, V8, P25, DOI 10.1186/1471-2466-8-25; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Farber HW, 1999, J LAB CLIN MED, V134, P561, DOI 10.1016/S0022-2143(99)90094-X; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; Fredenburgh LE, 2009, TRENDS CARDIOVAS MED, V19, P31, DOI 10.1016/j.tcm.2009.04.003; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Friedman R, 1997, CIRCULATION, V96, P2782, DOI 10.1161/01.CIR.96.9.2782; FUSE S, 1994, CIRCULATION, V90, P2952, DOI 10.1161/01.CIR.90.6.2952; Gaine S, 2000, JAMA-J AM MED ASSOC, V284, P3160, DOI 10.1001/jama.284.24.3160; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; GEORGE J, 2010, J HYPERTENS; Geraci M, 1998, CHEST, V114, p99S, DOI 10.1378/chest.114.1_Supplement.99S; Geraci MW, 1999, J CLIN INVEST, V103, P1509, DOI 10.1172/JCI5911; Goto J, 2002, ANTIOXID REDOX SIGN, V4, P563, DOI 10.1089/15230860260220058; Grobe AC, 2006, AM J PHYSIOL-LUNG C, V290, pL1069, DOI 10.1152/ajplung.00408.2005; GRYGLEWSKI RJ, 1978, NATURE, V273, P765, DOI 10.1038/273765a0; HASSOUN PM, 1992, P SOC EXP BIOL MED, V199, P165; Hoshikawa Y, 2001, AM J RESP CRIT CARE, V164, P314, DOI 10.1164/ajrccm.164.2.2010150; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kim-Mitsuyama S, 2005, STROKE, V36, P1077, DOI 10.1161/01.STR.0000163084.16505.e3; Konduri GG, 2007, AM J PHYSIOL-HEART C, V292, pH1812, DOI 10.1152/ajpheart.00425.2006; Lee JD, 2005, CHEST, V128, p575S, DOI 10.1016/S0012-3692(15)30992-2; Li HG, 2006, J AM COLL CARDIOL, V47, P2536, DOI 10.1016/j.jacc.2006.01.071; Lodi F, 2006, EUR J PHARMACOL, V544, P97, DOI 10.1016/j.ejphar.2006.06.028; Matsumoto H, 1997, BIOCHEM BIOPH RES CO, V230, P110, DOI 10.1006/bbrc.1996.5894; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; MEYRICK B, 1980, AM J PHYSIOL, V239, pH692, DOI 10.1152/ajpheart.1980.239.5.H692; MIRANDA CL, 1981, CHEM-BIOL INTERACT, V37, P95, DOI 10.1016/0009-2797(81)90168-X; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Mukhopadhyay S, 2006, TOXICOL APPL PHARM, V211, P209, DOI 10.1016/j.taap.2005.06.004; Nishii Y, 2006, J THROMB HAEMOST, V4, P2331, DOI 10.1111/j.1538-7836.2006.02174.x; OHLSTEIN EH, 1992, EUR J PHARM-MOLEC PH, V225, P347, DOI 10.1016/0922-4106(92)90109-9; Pidgeon GP, 2004, CIRCULATION, V110, P2701, DOI 10.1161/01.CIR.0000145613.01188.0B; Qin L, 2010, J THROMB HAEMOST, V8, P808, DOI 10.1111/j.1538-7836.2010.03751.x; Raoul W, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-8; Reid MJ, 1998, J BIOCHEM MOL TOXIC, V12, P157; ROSENBERG HC, 1988, AM J PHYSIOL, V255, pH1484, DOI 10.1152/ajpheart.1988.255.6.H1484; Rudic RD, 2005, CIRC RES, V96, P1240, DOI 10.1161/01.RES.0000170888.11669.28; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; Shah M, 2005, AM J PHYSIOL-CELL PH, V288, pC850, DOI 10.1152/ajpcell.00327.2004; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Song YL, 2008, AM J PHYSIOL-HEART C, V295, pH677, DOI 10.1152/ajpheart.91519.2007; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; TOPORSIAN M, ARTERIOSCLER THROMB, V30, P509; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; Wunderlich C, 2008, PULM PHARMACOL THER, V21, P507, DOI 10.1016/j.pupt.2007.11.005; Yamazato Y, 2009, HYPERTENSION, V54, P365, DOI 10.1161/HYPERTENSIONAHA.108.125468; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; Zanetti M, 2005, METH MOLEC MED, V108, P65; Zou MH, 1999, J EXP MED, V190, P135, DOI 10.1084/jem.190.1.135; Zou MH, 1999, BRIT J PHARMACOL, V126, P1283, DOI 10.1038/sj.bjp.0702434	69	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23439	10.1371/journal.pone.0023439	http://dx.doi.org/10.1371/journal.pone.0023439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850273	Green Published, gold			2022-12-27	WOS:000293563300058
J	Kim, TH; Lee, JY; Park, JS; Park, SW; Jang, AS; Lee, JY; Byun, JY; Uh, ST; Koh, ES; Chung, IY; Park, CS				Kim, Tae-Hoon; Lee, Ji-Yeon; Park, Jong-Sook; Park, Sung-Woo; Jang, An-Soo; Lee, Jae-Yong; Byun, Jang-Yul; Uh, Soo-Taek; Koh, Eun-Suk; Chung, Il Yup; Park, Choon-Sik			Fatty Acid Binding Protein 1 Is Related with Development of Aspirin-Exacerbated Respiratory Disease	PLOS ONE			English	Article							INTOLERANT ASTHMA; ASSOCIATION ANALYSIS; GENE POLYMORPHISMS; CHRONIC SINUSITIS; ARACHIDONIC-ACID; HYPERSENSITIVITY; DIAGNOSIS; SUSCEPTIBILITY; IDENTIFICATION; PROTEOMICS	Background: Aspirin-exacerbated respiratory disease (AERD) refers to the development of bronchoconstriction in asthmatics following the ingestion of aspirin. Although alterations in eicosanoid metabolites play a role in AERD, other immune or inflammatory mechanisms may be involved. We aimed to identify proteins that were differentially expressed in nasal polyps between patients with AERD and aspirin-tolerant asthma (ATA). Methodology/Principal Findings: Two-dimensional electrophoresis was adopted for differential display proteomics. Proteins were identified by liquid chromatography-tandem mass spectrometry (LC-MS). Western blotting and immunohistochemical staining were performed to compare the amount of fatty acid-binding protein 1 (FABP1) in the nasal polyps of patients with AERD and ATA. Fifteen proteins were significantly up-(seven spots) or down-regulated in the nasal polyps of patients with AERD (n = 5) compared to those with ATA (n = 8). LC-MS revealed an increase in seven proteins expression and a decrease in eight proteins expression in patients with AERD compared to those with ATA (P = 0.003-0.045). FABP1-expression based on immunoblotting and immunohistochemical analysis was significantly higher in the nasal polyps of patients with AERD compared to that in patients with ATA. FABP1 was observed in epithelial, eosinophils, macrophages, and the smooth-muscle cells of blood vessels in the polyps. Conclusions/Significance: Our results indicate that alterations in 15 proteins, including FABP1, may be related to the development of AERD.	[Kim, Tae-Hoon; Lee, Ji-Yeon; Park, Jong-Sook; Park, Sung-Woo; Jang, An-Soo; Park, Choon-Sik] Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, Puchon, Gyeonggi Do, South Korea; [Lee, Jae-Yong; Byun, Jang-Yul] Soonchunhyang Univ, Bucheon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Puchon, Gyeonggi Do, South Korea; [Uh, Soo-Taek] Soonchunhyang Univ Hosp, Div Allergy & Resp Med, Seoul, South Korea; [Koh, Eun-Suk] Soonchunhyang Univ, Bucheon Hosp, Dept Pathol, Puchon, Gyeonggi Do, South Korea; [Chung, Il Yup] Hanyang Univ, Div Mol & Life Sci, Coll Sci & Technol, Ansan, Gyeonggi Do, South Korea	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University Hospital; Soonchunhyang University; Hanyang University	Kim, TH (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, 1174 Jung Dong, Puchon, Gyeonggi Do, South Korea.	mdcspark@unitel.co.kr	Gung, Amber/D-9842-2011	Park, Choon-Sik/0000-0003-2977-0255	Ministry of Health, Welfare and Family Affairs, Republic of Korea [A010249]	Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Health 21 R&D project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (A010249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Badaai Y, 2009, J OTOLARYNGOL-HEAD N, V38, P381, DOI 10.2310/7070.2009.080089; Balakumar P, 2010, PHARMACOL RES, V61, P482, DOI 10.1016/j.phrs.2010.02.008; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; CHEONG HS, 2010, ALLERGY IN PRESS; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Cormican LJ, 2005, CLIN EXP ALLERGY, V35, P717, DOI 10.1111/j.1365-2222.2005.02261.x; Deroee AF, 2009, AM J RHINOL ALLERGY, V23, P480, DOI 10.2500/ajra.2009.23.3385; Ek BA, 1997, BBA-LIPID LIPID MET, V1346, P75, DOI 10.1016/S0005-2760(97)00021-0; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kim BS, 2010, PHARMACOGENET GENOM, V20, P748, DOI 10.1097/FPC.0b013e3283402155; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kowalski Marek L, 2007, Clin Allergy Immunol, V19, P147; Lee SH, 2006, AM J RESP CRIT CARE, V173, P370, DOI 10.1164/rccm.200505-740OC; Meng M, 2009, PLANT CELL PHYSIOL, V50, P998, DOI 10.1093/pcp/pcp052; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Oh SH, 2009, ALLERGY ASTHMA IMMUN, V1, P30, DOI 10.4168/aair.2009.1.1.30; Park BL, 2010, BMB REP, V43, P445, DOI 10.5483/BMBRep.2010.43.6.445; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Perez-G M, 2002, J IMMUNOL, V168, P1428, DOI 10.4049/jimmunol.168.3.1428; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Schachtrup C, 2004, BIOCHEM J, V382, P239, DOI 10.1042/BJ20031340; Sekigawa T, 2009, CLIN EXP ALLERGY, V39, P972, DOI 10.1111/j.1365-2222.2009.03229.x; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stankovic KM, 2008, LARYNGOSCOPE, V118, P881, DOI 10.1097/MLG.0b013e31816b4b6f; Stevenson DD, 2006, J ALLERGY CLIN IMMUN, V118, P773, DOI 10.1016/j.jaci.2006.07.024; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Wu MM, 2009, OTOLARYNG HEAD NECK, V141, P364, DOI 10.1016/j.otohns.2009.04.022; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zimmer JSD, 2004, J LIPID RES, V45, P2138, DOI 10.1194/jlr.M400240-JLR200	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22711	10.1371/journal.pone.0022711	http://dx.doi.org/10.1371/journal.pone.0022711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829647	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200027
J	Wan, X; Shin, SS; Wang, Q; Raymond, HF; Liu, HL; Ding, D; Yang, GH; Novotny, TE				Wan, Xia; Shin, Sanghyuk S.; Wang, Qian; Raymond, H. Fisher; Liu, Huilin; Ding, Ding; Yang, Gonghuan; Novotny, Thomas E.			Smoking among Young Rural to Urban Migrant Women in China: A Cross-Sectional Survey	PLOS ONE			English	Article								Background: Rural-to-urban migrant women may be vulnerable to smoking initiation as they are newly exposed to risk factors in the urban environment. We sought to identify correlates of smoking among rural-to-urban migrant women in China. Methods/Principal Findings: A cross-sectional survey of rural-to-urban migrant women working in restaurants and hotels (RHW) and those working as commercial sex workers (CSW) was conducted in ten provincial capital cities in China. Multiple logistic regression was conducted to identify correlates of smoking. We enrolled 2229 rural-to-urban migrant women (1697 RHWs aged 18-24 years and 532 CSWs aged 18-30 years). Of these, 18.4% RHWs and 58.3% CSWs reported ever tried smoking and 3.2% RHWs and 41.9% CSWs reported current smoking. Participants who first tried smoking after moving to the city were more likely to be current smokers compared to participants who first tried smoking before moving to the city (25.3% vs. 13.8% among RHWs, p = 0.02; 83.6% vs. 58.6% among CSWs, p = < 0.01). Adjusting for other factors, "tried female cigarette brands'' had the strongest association with current smoking (OR 5.69, 95% CI 3.44 to 9.41) among participants who had ever tried smoking. Conclusions/Significance: Exposure to female cigarette brands may increase the susceptibility to smoking among rural-to-urban migrant women. Smoke-free policies and increased taxes may be effective in preventing rural-to-urban migrant women from smoking initiation.	[Wan, Xia; Wang, Qian; Yang, Gonghuan] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing 100730, Peoples R China; [Shin, Sanghyuk S.; Ding, Ding] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Publ Hlth, San Diego, CA 92103 USA; [Raymond, H. Fisher] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Liu, Huilin; Yang, Gonghuan] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Novotny, Thomas E.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; California State University System; San Diego State University; University of California System; University of California San Diego; San Francisco Department of Public Health; Chinese Center for Disease Control & Prevention; California State University System; San Diego State University	Wan, X (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing 100730, Peoples R China.	tnovotny@mail.sdsu.edu	Ding, Ding/AAF-9985-2021	Ding, Ding/0000-0001-9850-9224; Raymond, Henry/0000-0001-8621-2749	NIH [1 R03 TW008361-01]; FOGARTY INTERNATIONAL CENTER [R03TW008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R36DA033152] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding comes from NIH (NO. 1 R03 TW008361-01) http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Chaloupka FJ, 2000, TOBACCO CONTROL DEVE, P237; Chen XG, 2004, PREV MED, V39, P666, DOI 10.1016/j.ypmed.2004.02.033; Chinese Academy of Preventive Medicine, 1997, SMOK HLTH CHIN 1996; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Finch K, 2010, ASIA-PAC J PUBLIC HE, V22, P342, DOI 10.1177/1010539509335034; Global Adult Tobacco Survey, 2010, GATS FACT SHEET CHIN; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Ho MG, 2007, TOB CONTROL, V16, P359, DOI 10.1136/tc.2007.022061; Ho MG, 2010, TOB CONTROL, V19, P13, DOI 10.1136/tc.2009.030981; JIANG Y, 2009, CHINESE J HLTH ED, V25, P411; Li Xiaoming, 2006, World Health Popul, V8, P14; NOVOTNY TE, 2006, WORLD C TOB HLTH JUL; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; Taylor AL, 2000, TOBACCO CONTROL DEV, P343; WAGENKNECHT LE, 1992, AM J PUBLIC HEALTH, V82, P33, DOI 10.2105/AJPH.82.1.33; *WHO DEP GEND WOM, 2007, SIFT EV GEND TOB CON; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, 2009, WHO REP GLOB TOB EP; Wright AA, 2007, NEW ENGL J MED, V356, P1493, DOI 10.1056/NEJMp078018; Yang, 2005, DEATHS THEIR RISK FA; Yang T, 2009, PUBLIC HEALTH, V123, P743, DOI 10.1016/j.puhe.2009.09.021; INCREASING TOBACCO T	23	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23028	10.1371/journal.pone.0023028	http://dx.doi.org/10.1371/journal.pone.0023028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829683	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200043
J	Wang, ML; Wang, SS; Song, ZF; Ji, XM; Zhang, ZD; Zhou, JW; Ni, CH				Wang, Meilin; Wang, Shasha; Song, Zhifang; Ji, Xiaoming; Zhang, Zhengdong; Zhou, Jianwei; Ni, Chunhui			Associations of IL-4, IL-4R, and IL-13 Gene Polymorphisms in Coal Workers' Pneumoconiosis in China: A Case-Control Study	PLOS ONE			English	Article							RECEPTOR-ALPHA-CHAIN; ILE50VAL VARIANT; IGE SYNTHESIS; ASTHMA; INTERLEUKIN-4; ATOPY; SILICOSIS; RISK; TRANSCRIPTION; ARTHRITIS	Background: The IL-4, IL-4 receptor (IL4R), and IL-13 genes are crucial immune factors and may influence the course of various diseases. In the present study, we investigated the association between the potential functional polymorphisms in IL-4, IL-4R, and IL-13 and coal workers' pneumoconiosis (CWP) risk in a Chinese population. Methods: Six polymorphisms (C-590T in IL-4, Ile50Val, Ser478Pro, and Gln551Arg in IL-4R, C-1055T and Arg130Gln in IL-13) were genotyped and analyzed in a case-control study of 556 CWP and 541 control subjects. Results: Our results revealed that the IL-4 CT/CC genotypes were associated with a significantly decreased risk of CWP (odds ratio (OR) = 0.74, 95% confidence interval (CI) = 0.58-0.95), compared with the TT genotype, particularly among subgroups of age <65 years (OR = 0.68, 95%CI = 0.46-0.99) and dust exposure years >= 26 years (OR = 0.69, 95%CI = 0.50-0.94). Moreover, the polymorphism was significantly associated with risk of CWP patients with stage I. In addition, a combined effect was observed in a dose-dependent manner with increasing numbers of risk variant alleles (P-trend = 0.023), and individuals with 11-12 risk alleles had a 47% higher risk of CWP than those with 0-8 risk alleles (OR = 1.47, 95%CI = 1.05-2.05). Conclusions: Our results suggest that the IL-4 C-590T polymorphism is involved in the etiology of CWP and susceptibility to this disease. Larger studies are warranted to validate our findings.	[Wang, Meilin; Wang, Shasha; Zhang, Zhengdong; Zhou, Jianwei; Ni, Chunhui] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Peoples R China; [Song, Zhifang; Ji, Xiaoming] Xuzhou Min Business Grp Co Ltd, Gen Hosp, Xuzhou, Peoples R China	Nanjing Medical University	Wang, ML (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Peoples R China.	chni@njmu.edu.cn	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [30872093, 81072282]; Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions	This study was partly supported by the National Natural Science Foundation of China (30872093, 81072282) and the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates I, 2008, AM J IND MED, V51, P741, DOI 10.1002/ajim.20632; Beghe B, 2003, CLIN EXP ALLERGY, V33, P1111, DOI 10.1046/j.1365-2222.2003.01731.x; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Chang KC, 2001, INT J TUBERC LUNG D, V5, P177; Choi BS, 2010, J KOREAN MED SCI, V25, pS13, DOI 10.3346/jkms.2010.25.S.S13; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Cisneros-Lira J, 2003, AM J PHYSIOL-LUNG C, V285, pL949, DOI 10.1152/ajplung.00074.2003; Elias JA, 2003, AM J RESP CELL MOL, V28, P401, DOI 10.1165/rcmb.F264; Franjkovic I, 2005, IMMUNOGENETICS, V56, P808, DOI 10.1007/s00251-004-0763-1; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hessel PA, 2003, SCAND J WORK ENV HEA, V29, P329, DOI 10.5271/sjweh.739; Huang X, 2008, J TOXICOL ENV HEAL B, V11, P45, DOI 10.1080/10937400701600552; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kruse S, 1999, IMMUNOLOGY, V96, P365; Liu B, 2007, CHINESE J IND MED, V20, P3; Miossec P, 1997, ARTHRITIS RHEUM-US, V40, P2105, DOI 10.1002/art.1780401203; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Mitsuyasu H, 1999, J IMMUNOL, V162, P1227; Modesto C, 2001, CLIN EXP RHEUMATOL, V19, P211; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nawrot TS, 2008, AM J RESP CRIT CARE, V177, P696, DOI 10.1164/rccm.200801-116UP; NG TP, 1991, THORAX, V46, P229, DOI 10.1136/thx.46.4.229; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Song ZM, 1996, J IMMUNOL, V156, P424; Vercelli D, 2002, CURR OPIN ALLERGY CL, V2, P389, DOI 10.1097/00130832-200210000-00004; Wang ML, 2010, J HUM GENET, V55, P13, DOI 10.1038/jhg.2009.112; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yucesoy B, 2001, TOXICOL APPL PHARM, V172, P75, DOI 10.1006/taap.2001.9124; Zhu SK, 2000, AM J RESP CRIT CARE, V161, P1655, DOI 10.1164/ajrccm.161.5.9906086	36	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22624	10.1371/journal.pone.0022624	http://dx.doi.org/10.1371/journal.pone.0022624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857939	Green Submitted, gold, Green Published			2022-12-27	WOS:000293558900023
J	Nelson, BR; Ueki, Y; Reardon, S; Karl, MO; Georgi, S; Hartman, BH; Lamba, DA; Reh, TA				Nelson, Branden R.; Ueki, Yumi; Reardon, Sara; Karl, Mike O.; Georgi, Sean; Hartman, Byron H.; Lamba, Deepak A.; Reh, Thomas A.			Genome-Wide Analysis of Muller Glial Differentiation Reveals a Requirement for Notch Signaling in Postmitotic Cells to Maintain the Glial Fate	PLOS ONE			English	Article							RETINAL PROGENITOR CELLS; MOUSE RETINA; GENE-EXPRESSION; DELTA-LIKE; PROLIFERATION; TRANSCRIPTOME; MECHANISMS; RECEPTOR; PROGRAM; SYSTEM	Previous studies have shown that Muller glia are closely related to retinal progenitors; these two cell types express many of the same genes and after damage to the retina, Muller glia can serve as a source for new neurons, particularly in non-mammalian vertebrates. We investigated the period of postnatal retinal development when progenitors are differentiating into Muller glia to better understand this transition. FACS purified retinal progenitors and Muller glia from various ages of Hes5-GFP mice were analyzed by Affymetrix cDNA microarrays. We found that genes known to be enriched/expressed by Muller glia steadily increase over the first three postnatal weeks, while genes associated with the mitotic cell cycle are rapidly downregulated from P0 to P7. Interestingly, progenitor genes not directly associated with the mitotic cell cycle, like the proneural genes Ascl1 and Neurog2, decline more slowly over the first 10-14 days of postnatal development, and there is a peak in Notch signaling several days after the presumptive Muller glia have been generated. To confirm that Notch signaling continues in the postmitotic Muller glia, we performed in situ hybridization, immunolocalization for the active form of Notch, and immunofluorescence for BrdU. Using genetic and pharmacological approaches, we found that sustained Notch signaling in the postmitotic Muller glia is necessary for their maturation and the stabilization of the glial identity for almost a week after the cells have exited the mitotic cell cycle.	[Nelson, Branden R.; Ueki, Yumi; Reardon, Sara; Karl, Mike O.; Georgi, Sean; Hartman, Byron H.; Lamba, Deepak A.; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nelson, BR (corresponding author), Seattle Childrens Res Inst, Ctr Integrated Brain Res, Seattle, WA USA.	tomreh@u.washington.edu	Karl, Mike O./E-7246-2010	Karl, Mike O./0000-0002-0926-6556	NIH [R01 EY013475]; German Research Foundation (DFG) [KA 2794/1-1]; ProRetina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013475, P30EY001730] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); ProRetina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH R01 EY013475 to TAR, by a Postdoctoral Fellowship by the German Research Foundation (DFG, KA 2794/1-1) and ProRetina Travel Grants to MOK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Brzezinski J., 2010, ENCY EYE, P73, DOI DOI 10.1016/B978-0-12-374203-2.00251-7; Burrows RT, 2000, DEV NEUROSCI-BASEL, V22, P7, DOI 10.1159/000017422; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cherry TJ, 2009, P NATL ACAD SCI USA, V106, P9495, DOI 10.1073/pnas.0903264106; Close JL, 2006, GLIA, V54, P94, DOI 10.1002/glia.20361; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Georgi SA, 2011, DEV NEUROBIOL, V71, P1153, DOI 10.1002/dneu.20899; Goureau O, 2004, DEV NEUROSCI-BASEL, V26, P359, DOI 10.1159/000082278; Hauck SM, 2003, GLIA, V44, P251, DOI 10.1002/glia.10292; Hojo M, 2000, DEVELOPMENT, V127, P2515; Jacobson M., 2013, DEV NEUROBIOL; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; Lundkvist J, 2001, TRENDS NEUROSCI, V24, P492, DOI 10.1016/S0166-2236(00)01888-9; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Nelson BR, 2008, DEV DYNAM, V237, P1565, DOI 10.1002/dvdy.21550; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Omori Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019685; Petros TJ, 2006, MOL CELL NEUROSCI, V32, P49, DOI 10.1016/j.mcn.2006.02.002; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Roger J, 2006, DEV BIOL, V298, P527, DOI 10.1016/j.ydbio.2006.07.003; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Satow T, 2001, J NEUROSCI, V21, P1265; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Vetter ML, 2001, DEV DYNAM, V221, P146, DOI 10.1002/dvdy.1145; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	41	88	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22817	10.1371/journal.pone.0022817	http://dx.doi.org/10.1371/journal.pone.0022817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829655	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511900015
J	Lanteri, MC; Kaidarova, Z; Peterson, T; Cate, S; Custer, B; Wu, SQ; Agapova, M; Law, JP; Bielawny, T; Plummer, F; Tobler, LH; Loeb, M; Busch, MP; Bramson, J; Luo, M; Norris, PJ				Lanteri, Marion C.; Kaidarova, Zhanna; Peterson, Trevor; Cate, Steven; Custer, Brian; Wu, Shiquan; Agapova, Maria; Law, Jacqueline P.; Bielawny, Thomas; Plummer, Frank; Tobler, Leslie H.; Loeb, Mark; Busch, Michael P.; Bramson, Jonathan; Luo, Ma; Norris, Philip J.			Association between HLA Class I and Class II Alleles and the Outcome of West Nile Virus Infection: An Exploratory Study	PLOS ONE			English	Article							DENGUE HEMORRHAGIC-FEVER; GUILLAIN-BARRE-SYNDROME; T-CELL RESPONSES; BEHCETS-DISEASE; UNITED-STATES; HOST GENETICS; EXON-2 DNA; ENCEPHALITIS; FREQUENCIES; SEVERITY	Background: West Nile virus (WNV) infection is asymptomatic in most individuals, with a minority developing symptoms ranging from WNV fever to serious neuroinvasive disease. This study investigated the impact of host HLA on the outcome of WNV disease. Methods: A cohort of 210 non-Hispanic mostly white WNV+ subjects from Canada and the U. S. were typed for HLA-A, B, C, DP, DQ, and DR. The study subjects were divided into three WNV infection outcome groups: asymptomatic (AS), symptomatic (S), and neuroinvasive disease (ND). Allele frequency distribution was compared pair-wise between the AS, S, and ND groups using chi(2) and Fisher's exact tests and P values were corrected for multiple comparisons (Pc). Allele frequencies were compared between the groups and the North American population (NA) used as a control group. Logistic regression analysis was used to evaluate the potential synergistic effect of age and HLA allele phenotype on disease outcome. Results: The alleles HLA-A*68, C*08 and DQB*05 were more frequently associated with severe outcomes (ND vs. AS, P-A*68 = 0.013/Pc = 0.26, P-C*08 = 0.0075/Pc = 0.064, and P-DQB1*05 = 0.029/Pc = 0.68), However the apparent DQB1*05 association was driven by age. The alleles HLA-B*40 and C*03 were more frequently associated with asymptomatic outcome (AS vs. S, P-B*40 = 0.021/Pc = 0.58 and AS vs. ND P-C*03 = 0.039/Pc = 0.64) and their frequencies were lower within WNV+ subjects with neuroinvasive disease than within the North American population (NA vs. S, P-B*40 = 0.029 and NA vs. ND, P-C*03 = 0.032). Conclusions: Host HLA may be associated with the outcome of WNV disease; HLA-A*68 and C*08 might function as "susceptible" alleles, whereas HLA-B*40 and C*03 might function as "protective" alleles.	[Lanteri, Marion C.; Kaidarova, Zhanna; Custer, Brian; Wu, Shiquan; Agapova, Maria; Law, Jacqueline P.; Tobler, Leslie H.; Busch, Michael P.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA 94101 USA; [Peterson, Trevor; Bielawny, Thomas; Plummer, Frank; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Cate, Steven] Univ Oklahoma, Hlth Sci Ctr, HLA Clin Lab, Oklahoma City, OK USA; [Loeb, Mark; Bramson, Jonathan] McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada; [Plummer, Frank; Luo, Ma] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Custer, Brian] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Custer, Brian; Busch, Michael P.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Vitalant; Vitalant Research Institute; Public Health Agency of Canada; University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; University of Manitoba; McMaster University; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lanteri, MC (corresponding author), Blood Syst Res Inst, San Francisco, CA 94101 USA.	mlanteri@bloodsystems.org		Bramson, Jonathan/0000-0003-2874-6886	Centers for Disease Control and Prevention [R01-C1000214]; National Institutes of Health/National Heart Lung and Blood Institute [RC2HL101632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101632] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Centers for Disease Control and Prevention R01-C1000214, and National Institutes of Health/National Heart Lung and Blood Institute RC2HL101632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Falcon-Lezama JA, 2009, ACTA TROP, V112, P193, DOI 10.1016/j.actatropica.2009.07.025; Abraham Alon, 2011, J Clin Neuromuscul Dis, V12, P113, DOI 10.1097/CND.0b013e318209ef9a; Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029; Axelsson-Robertson R, 2011, CLIN VACCINE IMMUNOL, V18, P125, DOI 10.1128/CVI.00302-10; BADEDOEDING C, 2010, HAEMATOLOGICA, V96, P110; Barzon L, 2009, EURO SURVEILL, V14, P19384; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Campbell GL, 2001, ANN NY ACAD SCI, V951, P94; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; *CONTR CFD, 2010, W NIL VIR ACT HUM DI; Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x; Depoortere E, 2004, TROP MED INT HEALTH, V9, P730, DOI 10.1111/j.1365-3156.2004.01253.x; deRezende PA, 1996, ARQ NEURO-PSIQUIAT, V54, P439, DOI 10.1590/S0004-282X1996000300013; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Elamin NE, 2010, TISSUE ANTIGENS, V76, P487, DOI 10.1111/j.1399-0039.2010.01547.x; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Healy BC, 2010, NEUROLOGY, V75, P634, DOI 10.1212/WNL.0b013e3181ed9c9c; Hraber P, 2007, HEPATOLOGY, V46, P1713, DOI 10.1002/hep.21889; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Jean CM, 2007, EMERG INFECT DIS, V13, P1918, DOI 10.3201/eid1312.061265; Jupp PG, 2001, ANN NY ACAD SCI, V951, P143, DOI 10.1111/j.1749-6632.2001.tb02692.x; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Koga M, 1998, J NEUROIMMUNOL, V88, P62, DOI 10.1016/S0165-5728(98)00072-1; Kuhn L, 2004, AIDS, V18, P1281, DOI 10.1097/00002030-200406180-00006; Kumar D, 2004, AM J TRANSPLANT, V4, P1883, DOI 10.1111/j.1600-6143.2004.00592.x; LaFleur C, 2002, HUM IMMUNOL, V63, P1039, DOI 10.1016/S0198-8859(02)00682-1; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Lee SI, 2007, VACCINE, V25, P7047, DOI 10.1016/j.vaccine.2007.07.062; LICHTMAN AKA, 2005, CELLULAR MOL IMMUNOL; Link J, 2010, J NEUROIMMUNOL, V226, P172, DOI 10.1016/j.jneuroim.2010.07.006; Louie L, 1999, EMERG INFECT DIS, V5, P672, DOI 10.3201/eid0505.990508; Luo M, 1999, TISSUE ANTIGENS, V54, P69, DOI 10.1034/j.1399-0039.1999.540108.x; Luo M, 2001, HUM IMMUNOL, V62, P1294, DOI 10.1016/S0198-8859(01)00339-1; Ma JJ, 1998, NEUROLOGY, V51, P379, DOI 10.1212/WNL.51.2.379; Monini Marina, 2010, Open Virol J, V4, P42, DOI 10.2174/1874357901004020042; Monos DS, 1997, J INFECT DIS, V176, pS180, DOI 10.1086/513786; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; *NCBI DBMHC, ANTHR DBMHC DAT DNA; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Palma MJC, 1996, MED CLIN-BARCELONA, V106, P121; Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Polizel JR, 2004, MEM I OSWALDO CRUZ, V99, P559, DOI 10.1590/S0074-02762004000600003; Pollard K, 1999, Popul Today, V27, P7; Prydun M, 1983, J Neurosurg Nurs, V15, P27; ROMAN JS, 1992, MED CLIN-BARCELONA, V98, P366; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Schreuder GMT, 2001, EUR J IMMUNOGENET, V28, P565, DOI 10.1046/j.0960-7420.2001.00284.x; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; 't Hart BA, 2009, TRENDS MOL MED, V15, P235, DOI 10.1016/j.molmed.2009.04.001; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959	66	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22948	10.1371/journal.pone.0022948	http://dx.doi.org/10.1371/journal.pone.0022948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829673	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200028
J	Vanaerschot, M; De Doncker, S; Rijal, S; Maes, L; Dujardin, JC; Decuypere, S				Vanaerschot, Manu; De Doncker, Simonne; Rijal, Suman; Maes, Louis; Dujardin, Jean-Claude; Decuypere, Saskia			Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; VITRO SUSCEPTIBILITY; MILTEFOSINE; GLUCONATE; TRANSPORTER; NEPAL; DRUG	Leishmania donovani is an intracellular protozoan parasite that causes visceral leishmaniasis (VL). Antimonials (SSG) have long been the first-line treatment against VL, but have now been replaced by miltefosine (MIL) in the Indian subcontinent due to the emergence of SSG-resistance. Our previous study hypothesised that SSG-resistant L. donovani might have increased in vivo survival skills which could affect the efficacy of other treatments such as MIL. The present study attempts to validate these hypotheses. Fourteen strains derived from Nepalese clinical isolates with documented SSG-susceptibility were infected in BALB/c mice to study their survival capacity in drug free conditions (non-treated mice) and in MIL-treated mice. SSG-resistant parasites caused a significant higher in vivo parasite load compared to SSG-sensitive parasites. However, this did not seem to affect the strains' response to MIL-treatment since parasites from both phenotypes responded equally well to in vivo MIL exposure. We conclude that there is a positive association between SSG-resistance and in vivo survival skills in our sample of L. donovani strains which could suggest a higher virulence of SSG-R strains compared to SSG-S strains. These greater in vivo survival skills of SSG-R parasites do not seem to directly affect their susceptibility to MIL. However, it cannot be excluded that repeated MIL exposure will elicit different adaptations in these SSG-R parasites with superior survival skills compared to the SSG-S parasites. Our results therefore highlight the need to closely monitor drug efficacy in the field, especially in the context of the Kala-azar elimination programme ongoing in the Indian subcontinent.	[Vanaerschot, Manu; De Doncker, Simonne; Dujardin, Jean-Claude; Decuypere, Saskia] Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, B-2000 Antwerp, Belgium; [Vanaerschot, Manu; Maes, Louis; Dujardin, Jean-Claude] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal	Institute of Tropical Medicine (ITM); University of Antwerp; B.P. Koirala Institute of Health Sciences	Vanaerschot, M (corresponding author), Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, B-2000 Antwerp, Belgium.	jcdujardin@itg.be	Maes, Louis JRM/A-2384-2017; Vanaerschot, Manu/B-6812-2013; Dujardin, Jean-Claude/AAO-1783-2021	Maes, Louis JRM/0000-0002-2324-9509; Vanaerschot, Manu/0000-0002-9141-2347; Decuypere, Saskia/0000-0001-5036-4601	LeishNatDrug-R [ICA4-CT-2001-10076]; FWO Flanders [G.0103.06]; EC [222895]; Agency for Innovation; Science and Technology in Flanders (IWT); Baillet-Latour Foundation	LeishNatDrug-R; FWO Flanders(FWO); EC(European CommissionEuropean Commission Joint Research Centre); Agency for Innovation; Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Baillet-Latour Foundation	This research was funded by the EC-INCO-Dev project LeishNatDrug-R (contract ICA4-CT-2001-10076), the FWO Flanders (contract G.0103.06) and the EC-FP7 project Kaladrug-R (contract 222895). Manu Vanaerschot has a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT) and Saskia Decuypere has a grant from the Baillet-Latour Foundation. (EC: http://cordis.europa.eu/home_en.html, FWO Flanders: http://www.fwo.be/, IWT: http://www.iwt.be/, Baillet-Latour Foundation: http://www.inbevbailletlatour.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Ouakad M, 2011, PARASITOLOGY, V138, P1392, DOI 10.1017/S0031182011001120; Perez-Victoria FJ, 2006, DRUG RESIST UPDATE, V9, P26, DOI 10.1016/j.drup.2006.04.001; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Seifert K, 2003, INT J ANTIMICROB AG, V22, P380, DOI 10.1016/S0924-8579(03)00125-0; Seifert K, 2007, INT J ANTIMICROB AG, V30, P229, DOI 10.1016/j.ijantimicag.2007.05.007; Sereno D, 1997, ANTIMICROB AGENTS CH, V41, P1898, DOI 10.1128/AAC.41.9.1898; Silva N, 2004, PARASITOLOGY, V128, P629, DOI 10.1017/S0031182004005098; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; Thakur CP, 2003, T ROY SOC TROP MED H, V97, P409, DOI 10.1016/S0035-9203(03)90071-X; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; van Meirvenne N., 1975, Annales Soc belge Med trop, V55, P1; Vanaerschot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012211; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Yardley V, 2005, AM J TROP MED HYG, V73, P272, DOI 10.4269/ajtmh.2005.73.272	27	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23120	10.1371/journal.pone.0023120	http://dx.doi.org/10.1371/journal.pone.0023120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829701	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200040
J	Zou, LH; Sun, YM; Wang, MR; Zhan, QM				Zou, Lihui; Sun, Yimin; Wang, Mingrong; Zhan, Qimin			Aurora-A Interacts with AP-2 alpha and Down Regulates Its Transcription Activity	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; APOPTOSIS INDUCTION; GENE-EXPRESSION; FACTOR AP-2; KINASE; AP-2-GAMMA; PROTEIN; FAMILY; GROWTH	Aurora-A is a serine/threonine protein kinase and plays an important role in the control of mitotic progression. Dysregulated expression of Aurora-A impairs centrosome separation and maturation, which lead to disrupted cell cycle progression and tumorigenesis. However, the molecular mechanism by which Aurora-A causes cell malignant transformation remains to be further defined. In this report, using transcription factors array and mRNA expression profiling array, we found that overexpression of Aurora-A suppressed transcription activity of AP-2 alpha, a tumor suppressor that is often downregulated in variety of tumors, and inhibited expression of AP-2 alpha-regulated downstream genes. These array-based observations were further confirmed by microwell colorimetric TF assay and luciferase reporter assay. Downregulated transcription activity of AP-2 alpha by Aurora-A was found to be associated with reduced AP-2 alpha protein stability, which appeared to be mediated by Aurora-A enhanced ubiquitin-dependent proteasomal degradation of AP-2 alpha protein. Interestingly, Aurora-A-mediated AP-2 alpha degradation was likely dependent Aurora-A kinase activity since inhibition of Aurora-A kinase activity was able to rescue Aurora-A-induced degradation of AP-2 alpha. Moreover, we defined a physical interaction between Aurora-A and AP-2 alpha, and such interaction might bridge the suppressive effect of Aurora-A on AP-2 alpha protein stability. These findings provide new insights into molecular mechanism by which Aurora-A acts as an oncogenic molecule in tumor occurrence and malignant development.	[Zou, Lihui; Wang, Mingrong; Zhan, Qimin] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Zou, Lihui; Wang, Mingrong; Zhan, Qimin] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Zou, Lihui; Wang, Mingrong; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Yimin] CapitalBio Corp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zou, LH (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	ZhanQimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [81021061]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by funding from the 973 National Key Fundamental Research Program of China (2009CB521801) and the National Natural Science Foundation of China (81021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Bosher JM, 1996, ONCOGENE, V13, P1701; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Douglas DB, 2004, CANCER RES, V64, P1611, DOI 10.1158/0008-5472.CAN-0318-2; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Friedrichs N, 2005, MODERN PATHOL, V18, P431, DOI 10.1038/modpathol.3800292; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Garcia MA, 1999, FEBS LETT, V444, P27, DOI 10.1016/S0014-5793(99)00021-6; Giet R, 1999, J CELL SCI, V112, P3591; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; HUNG L, 2006, INT J CANC, V118; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; Li H, 2006, ONCOGENE, V25, P5405, DOI 10.1038/sj.onc.1209534; Li HL, 2006, NEOPLASIA, V8, P568, DOI 10.1593/neo.06367; Li QJ, 2004, J BIOL CHEM, V279, P45669, DOI 10.1074/jbc.M405025200; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Orso F, 2008, FASEB J, V22, P2702, DOI 10.1096/fj.08-106492; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Qiao JY, 2008, J PROTEOME RES, V7, P2769, DOI 10.1021/pr700883t; Qina L, 2009, CANCER LETT, V275, P77, DOI 10.1016/j.canlet.2008.10.011; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Ruiz M, 2004, CANCER RES, V64, P631, DOI 10.1158/0008-5472.CAN-03-2751; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Shao W, 2005, J PROTEOME RES, V4, P1451, DOI 10.1021/pr050053l; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Turner BC, 1998, CANCER RES, V58, P5466; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wang XX, 2006, CELL RES, V16, P356, DOI 10.1038/sj.cr.7310046; Wang Y, 2008, BIOCHEM BIOPH RES CO, V370, P201, DOI 10.1016/j.bbrc.2008.03.031; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; Yang H, 2004, CANCER RES, V64, P463, DOI 10.1158/0008-5472.CAN-03-2907	44	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23110	10.1371/journal.pone.0023110	http://dx.doi.org/10.1371/journal.pone.0023110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829699	gold, Green Published, Green Submitted			2022-12-27	WOS:000293511200039
J	Law, MR; Ystma, A; Morgan, SG				Law, Michael R.; Ystma, Alison; Morgan, Steven G.			The Short-Term Impact of Ontario's Generic Pricing Reforms	PLOS ONE			English	Article								Background: Canadians pay amongst the highest generic drug prices in the world. In July 2010, the province of Ontario enacted a policy that halved reimbursement for generic drugs from the public drug plan, and substantially lowered prices for private purchases. We quantified the impact of this policy on overall generic drug expenditures in the province, and projected the impact in other provinces had they mimicked this pricing change. Methods: We used quarterly prescription generic drug dispensing data from the IMS-Brogan CompuScript Audit. We used the price per unit in both the pre- and post-policy period and two economics price indexes to estimate the expenditure reduction in Ontario. Further, we used the post-policy Ontario prices to estimate the potential reduction in other provinces. Results: We estimate that total expenditure on generic drugs in Ontario during the second half of 2010 was between $ 181 and $ 194 million below what would be expected if prices had remained at pre-policy level. Over half of the reduction in spending was due to savings on just 10 generic ingredients. If other provinces had matched Ontario's prices, their expenditures over during the latter half of 2010 would have been $ 445 million lower. Discussion: We found that if Ontario's pricing scheme were adopted nationally, overall spending on generic drugs in Canada would drop at least $ 1.28 billion annually-a 5% decrease in total prescription drug expenditure. Other provinces should seriously consider both changes to their generic drug prices and the use of more competitive bulk purchasing policies.	[Law, Michael R.; Ystma, Alison; Morgan, Steven G.] Univ British Columbia, Ctr Hlth Serv & Policy Res, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Law, MR (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	mlaw@chspr.ubc.ca	Morgan, Steven/J-8814-2015	Morgan, Steven/0000-0002-7529-0028	Canadian Institutes of Health Researc; Peter Wall Institute	Canadian Institutes of Health Researc(Canadian Institutes of Health Research (CIHR)); Peter Wall Institute	Data access for this work was supported by an operating grant from the Canadian Institutes of Health Research ("For Whom the Bill Tolls: Private Drug Insurance in Canada", P. I.: Michael R. Law). Dr. Law receives salary support through a New Investigator Award from the Canadian Institutes of Health Research and an Early Career Scholar Award from the Peter Wall Institute for Advanced Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canadian Cancer Society, 2009, CANC DRUG ACC CAN; Canadian Institute for Health Information, 2010, NAT HLTH EXP TRENDS; Competition Bureau Canada, 2007, GEN DRUG SECT STUD; Competition Bureau Canada, 2008, BEN GEN DRUG COMP CA; Diewert W., 1993, ESSAYS INDEX NUMBER; *GOV ONT, 2010, REF ONT DRUG SYST; Grootendorst P, 2011, MANAGING PHARM EXPEN; *HLTH CAN, 2006, NAT PHARM STRAT; Howlett K., 2010, GLOBE MAIL; *IMS BROG, 2009, RET PHARM PROV TERR; Law Michael R, 2011, Healthc Policy, V6, P36; MCCOMB G, 2010, PUBLIC DRUG PLAN PRO; Morgan Steve, 2007, Healthc Policy, V3, pe121; *PMPRB, 2010, GEN DRUGS CAN PRIC T; Statistics Canada, 2010, ANN DEM EST CAN PROV	15	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2011	6	7							e23030	10.1371/journal.pone.0023030	http://dx.doi.org/10.1371/journal.pone.0023030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KC	21829581	Green Published, Green Submitted, gold			2022-12-27	WOS:000293284600073
J	Martin, NK; Pitcher, AB; Vickerman, P; Vassall, A; Hickman, M				Martin, Natasha K.; Pitcher, Ashley B.; Vickerman, Peter; Vassall, Anna; Hickman, Matthew			Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention amongst a Population of Injecting Drug Users	PLOS ONE			English	Article							CANCER-CHEMOTHERAPY; ECONOMIC-EVALUATION; COST-EFFECTIVENESS; VIRUS; HIV; INFECTION; MODEL; HCV; PREVALENCE; THERAPY	In most developed countries, HCV is primarily transmitted by injecting drug users (IDUs). HCV antiviral treatment is effective, and deemed cost-effective for those with no re-infection risk. However, few active IDUs are currently treated. Previous modelling studies have shown antiviral treatment for active IDUs could reduce HCV prevalence, and there is emerging interest in developing targeted IDU treatment programmes. However, the optimal timing and scale-up of treatment is unknown, given the real-world constraints commonly existing for health programmes. We explore how the optimal programme is affected by a variety of policy objectives, budget constraints, and prevalence settings. We develop a model of HCV transmission and treatment amongst active IDUs, determine the optimal treatment programme strategy over 10 years for two baseline chronic HCV prevalence scenarios (30% and 45%), a range of maximum annual budgets (50,000-300,000 pound per 1,000 IDUs), and a variety of objectives: minimising health service costs and health utility losses; minimising prevalence at 10 years; minimising health service costs and health utility losses with a final time prevalence target; minimising health service costs with a final time prevalence target but neglecting health utility losses. The largest programme allowed for a given budget is the programme which minimises both prevalence at 10 years, and HCV health utility loss and heath service costs, with higher budgets resulting in greater cost-effectiveness (measured by cost per QALY gained compared to no treatment). However, if the objective is to achieve a 20% relative prevalence reduction at 10 years, while minimising both health service costs and losses in health utility, the optimal treatment strategy is an immediate expansion of coverage over 5-8 years, and is less cost-effective. By contrast, if the objective is only to minimise costs to the health service while attaining the 20% prevalence reduction, the programme is deferred until the final years of the decade, and is the least cost-effective of the scenarios.	[Martin, Natasha K.; Vickerman, Peter; Hickman, Matthew] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Martin, Natasha K.; Vickerman, Peter; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Pitcher, Ashley B.] Ecole Hautes Etud Sci Sociales, Ctr Anal & Math Sociales, Paris, France	University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Martin, NK (corresponding author), Univ Bristol, Dept Social Med, Bristol, Avon, England.	natasha.martin@bristol.ac.uk; ashley.pitcher@balliol.oxon.org	Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; Martin, Natasha/0000-0001-8344-1810; Vassall, Anna/0000-0002-2911-1375; Vickerman, Peter/0000-0002-8291-5890	Scottish Government Hepatitis C Action Plan and Centre for Research on Drugs; Health Behaviour NIHR; French National Agency for Research [ANR-08-SYSC-008]; MRC; Medical Research Council [G0701627] Funding Source: researchfish; MRC [G0701627] Funding Source: UKRI	Scottish Government Hepatitis C Action Plan and Centre for Research on Drugs; Health Behaviour NIHR; French National Agency for Research(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NKM is supported by the Scottish Government Hepatitis C Action Plan and Centre for Research on Drugs and Health Behaviour NIHR Grant. ABP is supported by the 'DyXi' project of the SYSCOMM programme of the French National Agency for Research (grant number ANR-08-SYSC-008). PV is supported by a MRC New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACMD, 2009, PRIM PREV HEP C INJ; Alberti A, 2003, J HEPATOL, V38, pS104, DOI 10.1016/S0168-8278(03)00008-4; Ambruster B, 2010, MATH BIOSCI, V224, P35; Australian Goverment Department of Health, 2010, 3 NAT HEP C STRAT 20; Batt K, 2004, B WORLD HEALTH ORGAN, V82, P689; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Bryson A.E, 1969, APPL OPTIMAL CONTROL; Burden T, 2004, DISCRETE CONT DYN-B, V4, P135; Caetano MAL, 2001, OPTIM CONTR APPL MET, V22, P63, DOI 10.1002/oca.683; Chack E, 2010, CURRENT HEPATITIS RE, V9, P147; Corluka A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-81; Curtis L, 2019, UNIT COSTS HLTH SOCI; Davis GL, 1998, J VIRAL HEPATITIS, V5, P313, DOI 10.1046/j.1365-2893.1998.00119.x; De Angelis D, 2004, AM J EPIDEMIOL, V160, P994, DOI 10.1093/aje/kwh306; ECMDDA, 2004, HEP C INJ DRUG US IM; Fister KR, 2000, SIAM J APPL MATH, V60, P1059, DOI 10.1137/S0036139998338509; Fleming W.H., 2012, DETERMINISTIC STOCHA; Grebely J, 2006, J HEPATOL, V44, pS214, DOI 10.1016/S0168-8278(06)80578-7; Grieve R, 2002, ACTA GASTRO-ENT BELG, V65, P104; Guinness L, 2005, B WORLD HEALTH ORGAN, V83, P747; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Health Protection Scotland, 2010, NEEDL EXCH SURV IN N; Hickman M, 2007, J VIRAL HEPATITIS, V14, P645, DOI 10.1111/j.1365-2893.2007.00855.x; Hickman M, 2009, J PUBLIC HEALTH-UK, V31, P374, DOI 10.1093/pubmed/fdp067; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Jacobs P, 1999, COST EFFECTIVENESS S; Johns B, 2004, HEALTH ECON, V13, P1117, DOI 10.1002/hec.880; Joshi HR, 2002, OPTIM CONTR APPL MET, V23, P199, DOI 10.1002/oca.710; Judd A, 2005, BMJ-BRIT MED J, V330, P24, DOI 10.1136/bmj.38286.841227.7C; Jung E, 2002, DISCRETE CONT DYN-B, V2, P473; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; KOPP RE, 1965, AIAA J, V3, P1439, DOI 10.2514/3.3165; Kumaranayake L, 2008, AIDS, V22, pS23, DOI 10.1097/01.aids.0000327620.47103.1d; Ledzewicz U, 2007, MATH BIOSCI, V206, P320, DOI 10.1016/j.mbs.2005.03.013; Lenhart S., 2007, OPTIMAL CONTROL APPL; Litwin AH, 2009, J SUBST ABUSE TREAT, V37, P32, DOI 10.1016/j.jsat.2008.09.009; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; MCDANELL JP, 1971, SIAM J CONTROL, V9, P161, DOI 10.1137/0309014; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nanda S, 2007, MATH BIOSCI, V210, P143, DOI 10.1016/j.mbs.2007.05.003; National Institutes of Health, 2002, MAN HEP C 2002; Neilan RLM, 2010, B MATH BIOL, V72, P2004, DOI 10.1007/s11538-010-9521-8; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; NICE, 2009, GUID MAN 2009; NICE, 2004, GUID METH TECHN APPR; NICE, 2006, PEG ALF RIB TREATM M; NICE, 2000, INT ALF PEG NONP RIA; NICE, 2009, COST STAT NEEDL SYR; Noah N D, 1983, Community Med, V5, P140; Nordt C, 2006, LANCET, V367, P1830, DOI 10.1016/S0140-6736(06)68804-1; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Pegurri E, 2005, VACCINE, V23, P1624, DOI 10.1016/j.vaccine.2004.02.029; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Public Health Wales, 2008, BLOOD BOURN VIR HEP; Seal KH, 2005, J GEN INTERN MED, V20, P171; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Sutton AJ, 2008, J VIRAL HEPATITIS, V15, P809, DOI 10.1111/j.1365-2893.2008.01041.x; Sweeting MJ, 2009, STAT METHODS MED RES, V18, P381, DOI 10.1177/0962280208094704; Sweeting MJ, 2009, AM J EPIDEMIOL, V170, P352, DOI 10.1093/aje/kwp141; The London Joint Working Group for Substance Misuse and Hepatitis C, 2011, TACKL PROBL HEP C SU; The Scottish Government, 2008, HEP C ACT PLAN SCOTL; Vickerman P., 2008, ASSESSING COST EFFEC, P1; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Vickerman P, 2011, DRUG ALCOHOL DEPEN, V113, P83, DOI 10.1016/j.drugalcdep.2010.08.001; Vincent TL., 1997, NONLINEAR OPTIMAL CO; World Bank, 2009, GROSS DOM PROD PPP; Zeiler I, 2010, DRUG ALCOHOL DEPEN, V110, P228, DOI 10.1016/j.drugalcdep.2010.03.006	74	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22309	10.1371/journal.pone.0022309	http://dx.doi.org/10.1371/journal.pone.0022309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853030	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000293953400006
J	Tjomsland, V; Ellegard, R; Che, K; Hinkula, J; Lifson, JD; Larsson, M				Tjomsland, Veronica; Ellegard, Rada; Che, Karlhans; Hinkula, Jorma; Lifson, Jeffrey D.; Larsson, Marie			Complement Opsonization of HIV-1 Enhances the Uptake by Dendritic Cells and Involves the Endocytic Lectin and Integrin Receptor Families	PLOS ONE			English	Article							CD4 T-CELLS; DC-SIGN; APOPTOTIC CELLS; INFECTION; ADHESION; VIRUS; ANTIBODY; MEDIATE; CR3; VISUALIZATION	Interaction with the complement system is an underappreciated aspect of HIV-1 infection; even in primary infection, complement fragments are found on virions with potential to affect the interplay between the virus and dendritic cells (DC). Since opsonization may affect the efficiency of uptake and the type of receptors utilized, we compared the interactions of DC with free HIV-1 (F-HIV) and complement opsonized HIV-1 (C-HIV). We demonstrate that C-HIV significantly enhanced the uptake by immature DC (IDC) and mature DC (MDC) and that the internalization rate was dependent on both opsonization of the virus and DC maturation state. Increased DC uptake of C-HIV was not due to opsonization related increased binding of virus to the surface of DC but rather increased internalization of C-HIV despite utilizing a similar repertoire of receptors as F-HIV. Both F-HIV and C-HIV interacted with C-type lectins, integrins, and CD4 and blocking these receptor families prevented HIV-1 from binding to DC at 4 degrees C. Blocking integrins significantly reduced the binding and uptake of F-HIV and C-HIV implicating the involvement of several integrins such as beta 1-integrin, CR3, LFA-1, and alpha 4 beta 7. Distinctive for C-HIV was usage of beta 1-integrin and for F-HIV, usage of beta 7-integrin, whereas both F-HIV and C-HIV utilized both integrin chains of CR3. We have in this study identified the receptor types used by both F-HIV and C-HIV to bind to DC. Noteworthy, C-HIV was internalized more efficiently by DC than F-HIV, probably via receptor mediated endocytosis, which may entail different intracellular processing of the virus leading to both elevated infection and altered activation of HIV specific immune responses.	[Tjomsland, Veronica; Ellegard, Rada; Che, Karlhans; Hinkula, Jorma; Larsson, Marie] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA	Linkoping University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Tjomsland, V (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	marie.larsson@liu.se	Hinkula, Jorma/P-6849-2018	Larsson, Marie/0000-0002-4524-0177; Hinkula, Jorma/0000-0003-1908-5609	Swedish Research Council [ML: AI52731]; Swedish, Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova; Linkoping University Hospital; C ALF; Swedish Society of Medicine; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052731, R01AI052731] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish, Physicians against AIDS Research Foundation; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova(Vinnova); Linkoping University Hospital; C ALF; Swedish Society of Medicine; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by grants through: ML: AI52731, The Swedish Research Council, The Swedish, Physicians against AIDS Research Foundation, The Swedish International Development Cooperation Agency; SIDA SARC, VINNMER for Vinnova, Linkoping University Hospital Research Fund, C ALF, and The Swedish Society of Medicine; also in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E (JDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilyo G, 2010, EUR J IMMUNOL, V40, P699, DOI 10.1002/eji.200838951; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bajtay Z, 2004, J IMMUNOL, V173, P4775, DOI 10.4049/jimmunol.173.8.4775; Ballana E, 2009, BLOOD, V113, P1278, DOI 10.1182/blood-2008-06-161869; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Bouhlal H, 2002, J IMMUNOL, V169, P3301, DOI 10.4049/jimmunol.169.6.3301; Bouhlal H, 2007, J IMMUNOL, V178, P1086, DOI 10.4049/jimmunol.178.2.1086; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CARPENTIER JL, 1991, CELL REGUL, V2, P41, DOI 10.1091/mbc.2.1.41; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Cummings KL, 2007, VIRAL IMMUNOL, V20, P505, DOI 10.1089/vim.2007.0061; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Gilbert C, 2007, J VIROL, V81, P7672, DOI 10.1128/JVI.02810-06; Guay LA, 2002, AIDS, V16, P1391, DOI 10.1097/00002030-200207050-00011; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Larsson M, 2005, SPRINGER SEMIN IMMUN, V26, P309, DOI 10.1007/s00281-004-0178-y; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Pruenster M, 2005, EUR J IMMUNOL, V35, P2691, DOI 10.1002/eji.200425940; Rahimi A, 1999, AM J REPROD IMMUNOL, V41, P330; Sattentau Q, 2008, NAT IMMUNOL, V9, P225, DOI 10.1038/ni0308-225; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Stoiber H, 2005, MOL IMMUNOL, V42, P153, DOI 10.1016/j.molimm.2004.06.024; Stoiber H, 2008, VACCINE, V26, P3046, DOI 10.1016/j.vaccine.2007.12.003; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; THIEBLEMONT N, 1993, IMMUNOPHARMACOLOGY, V25, P87, DOI 10.1016/0162-3109(93)90012-F; Turville S, 2003, J LEUKOCYTE BIOL, V74, P710, DOI 10.1189/jlb.0503208; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Wilflingseder D, 2007, J IMMUNOL, V178, P7840, DOI 10.4049/jimmunol.178.12.7840; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	40	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23542	10.1371/journal.pone.0023542	http://dx.doi.org/10.1371/journal.pone.0023542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853149	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953400051
J	Cai, X; Zhang, J; Chen, ML; Wu, Y; Wang, XQ; Chen, JY; Zhang, JQ; Shen, X; Qu, D; Jiang, HL				Cai, Xia; Zhang, Jian; Chen, Mingliang; Wu, Yang; Wang, Xueqing; Chen, Jiayu; Zhang, Junqin; Shen, Xu; Qu, Di; Jiang, Hualiang			The Effect of the Potential PhoQ Histidine Kinase Inhibitors on Shigella flexneri Virulence	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; SMALL MOLECULES; SENSOR; ACTIVATION; COMMUNICATION; CONSTRUCTION; INVOLVEMENT; EXPRESSION; STRATEGIES; BACTERIA	PhoQ/PhoP is an important two-component system that regulates Shigella virulence. We explored whether the PhoQ/PhoP system is a promising target for new antibiotics against S. flexneri infection. By using a high-throughput screen and enzymatic activity coupled assay, four compounds were found as potential PhoQ inhibitors. These compounds not only inhibited the activity of SF-PhoQc autophosphorylation but also displayed high binding affinities to the SF-PhoQc protein in the Surface Plasmon Resonance response. A S. flexneri cell invasion assay showed that three of these potential PhoQ inhibitors inhibit the invasion of HeLa cells by S. flexneri 9380. In a Mouse Sereny test, mice inoculated with S. flexneri 9380 pre-treated with the potential PhoQ inhibitors 1, 2, 3 or 4 displayed no inflammation, whereas mice inoculated with S. flexneri 9380 alone displayed severe keratoconjunctival inflammation. All four potential PhoQ inhibitors showed no significant cytotoxicity or hemolytic activity. These data suggest that the four potential PhoQ inhibitors inhibited the virulence of S. flexneri and that PhoQ/PhoP is a promising target for the development of drugs against S. flexneri infection.	[Cai, Xia; Wu, Yang; Wang, Xueqing; Chen, Jiayu; Zhang, Junqin; Qu, Di] Fudan Univ, Inst Med Microbiol, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Cai, Xia; Wu, Yang; Wang, Xueqing; Chen, Jiayu; Zhang, Junqin; Qu, Di] Fudan Univ, Inst Med Microbiol, Minist Hlth, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Cai, Xia; Wu, Yang; Wang, Xueqing; Chen, Jiayu; Zhang, Junqin; Qu, Di] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Jian; Shen, Xu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med,Grad Sch, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai, Peoples R China; [Chen, Mingliang] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Shanghai Center for Disease Control & Prevention	Cai, X (corresponding author), Fudan Univ, Inst Med Microbiol, Minist Educ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	dqu@fudan.edu.cn; hljiang@mail.shcnc.ac.cn	Chen, Jiayu/ABF-3722-2021; Zhang, Jian/GXA-1303-2022; Qu, Di/AAO-4590-2020	Chen, Jiayu/0000-0003-4755-8901; Zhang, Jian/0000-0002-6558-791X; 	Ministry of Science and Technology of China [2009ZX09303-005, 2008ZX10003-016, 2010DFA32100]; National Natural Science Foundation of China [30800036, J0730860]; Scientific Technology Development Foundation of Shanghai [10410700600, 09DZ1908602, 08JC1401600]; Fudan University [09FQ43]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Development Foundation of Shanghai; Fudan University	This work was supported by the Program of Ministry of Science and Technology of China (2009ZX09303-005, 2008ZX10003-016, 2010DFA32100), the National Natural Science Foundation of China (30800036, J0730860), the Scientific Technology Development Foundation of Shanghai (10410700600, 09DZ1908602, 08JC1401600), and the Research Initiation Grant for Young Faculty of Fudan University (09FQ43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg V, 2007, ORG BIOMOL CHEM, V5, P1827, DOI 10.1039/b702397a; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chu YW, 1998, ANTIMICROB AGENTS CH, V42, P440; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Derzelle S, 2004, J BACTERIOL, V186, P1270, DOI 10.1128/JB.186.5.1270-1279.2004; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Giacometti A, 2005, PEPTIDES, V26, P169, DOI 10.1016/j.peptides.2004.09.018; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; HAUKKA K, 2007, EPIDEMIOLOGY INFECT, V136; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Kim SK, 1996, MOL MICROBIOL, V22, P135, DOI 10.1111/j.1365-2958.1996.tb02663.x; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lyon GJ, 2003, CHEM BIOL, V10, P1007, DOI 10.1016/j.chembiol.2003.11.003; Macielag MJ, 2000, EXPERT OPIN INV DRUG, V9, P2351, DOI 10.1517/13543784.9.10.2351; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Matsubara M, 1999, BIOSCI BIOTECH BIOCH, V63, P408, DOI 10.1271/bbb.63.408; MILLER SI, 1990, J BACTERIOL, V172, P6; Miura M, 2006, INFECT IMMUN, V74, P2587, DOI 10.1128/IAI.74.5.2587-2595.2006; Miyoshi SI, 1997, INFECT IMMUN, V65, P1830, DOI 10.1128/IAI.65.5.1830-1835.1997; Monsalveo JC, 2008, GAC SANIT, V22, P35, DOI 10.1157/13115108; Moss JE, 2000, CELL MICROBIOL, V2, P443, DOI 10.1046/j.1462-5822.2000.00065.x; Muller Simone, 2001, Expert Opin Ther Targets, V5, P327, DOI 10.1517/14728222.5.3.327; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; MURAYAMA SY, 1986, INFECT IMMUN, V51, P696, DOI 10.1128/IAI.51.2.696-698.1986; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Qin ZQ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-96; Raffa RB, 2005, J PHARMACOL EXP THER, V312, P417, DOI 10.1124/jpet.104.075150; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; ROYCHOUDHURY S, 1993, P NATL ACAD SCI USA, V90, P965, DOI 10.1073/pnas.90.3.965; Silva JC, 1998, P NATL ACAD SCI USA, V95, P11951, DOI 10.1073/pnas.95.20.11951; Terajima J, 1999, MICROB PATHOGENESIS, V27, P223, DOI 10.1006/mpat.1999.0300; Venkatesan MM, 2002, INFECT IMMUN, V70, P2950, DOI 10.1128/IAI.70.6.2950-2958.2002; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Walsh DP, 2006, CHEM REV, V106, P2476, DOI 10.1021/cr0404141; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; Ward GE, 2002, CELL MICROBIOL, V4, P471, DOI 10.1046/j.1462-5822.2002.00205.x	50	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23100	10.1371/journal.pone.0023100	http://dx.doi.org/10.1371/journal.pone.0023100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853073	gold, Green Submitted, Green Published			2022-12-27	WOS:000295454200042
J	Franco, A; Hendriksen, RS; Lorenzetti, S; Onorati, R; Gentile, G; Dell'Omo, G; Aarestrup, FM; Battisti, A				Franco, Alessia; Hendriksen, Rene S.; Lorenzetti, Serena; Onorati, Roberta; Gentile, Gabriele; Dell'Omo, Giacomo; Aarestrup, Frank M.; Battisti, Antonio			Characterization of Salmonella Occurring at High Prevalence in a Population of the Land Iguana Conolophus subcristatus in Galapagos Islands, Ecuador	PLOS ONE			English	Article							SEROVARS; SUSCEPTIBILITY; RESISTANCE; INFECTION; REPTILES	The aim of the study was to elucidate the association between the zoonotic pathogen Salmonella and a population of land iguana, Colonophus subcristatus, endemic to Galapagos Islands in Ecuador. We assessed the presence of Salmonella subspecies and serovars and estimated the prevalence of the pathogen in that population. Additionally, we investigated the genetic relatedness among isolates and serovars utilising pulsed field gel electrophoresis (PFGE) on XbaI-digested DNA and determined the antimicrobial susceptibility to a panel of antimicrobials. The study was carried out by sampling cloacal swabs from animals (n = 63) in their natural environment on in the island of Santa Cruz. A high prevalence (62/63, 98.4%) was observed with heterogeneity of Salmonella subspecies and serovars, all known to be associated with reptiles and with reptile-associated salomonellosis in humans. Serotyping revealed 14 different serovars among four Salmonella enterica subspecies: S. enterica subsp. enterica (n = 48), S. enterica subsp. salamae (n = 2), S. enterica subsp. diarizonae (n = 1), and S. enterica subsp. houtenae (n = 7). Four serovars were predominant: S. Poona (n = 18), S. Pomona (n = 10), S. Abaetetuba (n = 8), and S. Newport (n = 5). The S. Poona isolates revealed nine unique XbaI PFGE patterns, with 15 isolates showing a similarity of 70%. Nine S. Pomona isolates had a similarity of 84%. One main cluster with seven (88%) indistinguishable isolates of S. Abaetetuba was observed. All the Salmonella isolates were pan-susceptible to antimicrobials representative of the most relevant therapeutic classes. The high prevalence and absence of clinical signs suggest a natural interaction of the different Salmonella serovars with the host species. The interaction may have been established before any possible exposure of the iguanas and the biocenosis to direct or indirect environmental factors influenced by the use of antimicrobials in agriculture, in human medicine or in veterinary medicine.	[Franco, Alessia; Lorenzetti, Serena; Onorati, Roberta; Battisti, Antonio] Ist Zooprofilatt Sperimentale Reg Lazio & Toscana, Rome, Italy; [Hendriksen, Rene S.; Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst DTU Food, DK-2800 Lyngby, Denmark; [Gentile, Gabriele] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Dell'Omo, Giacomo] Ornis Italica, Rome, Italy	IZS Lazio e Toscana; Technical University of Denmark; University of Rome Tor Vergata	Franco, A (corresponding author), Ist Zooprofilatt Sperimentale Reg Lazio & Toscana, Rome, Italy.	antonio.battisti@izslt.it	Gentile, Gabriele/E-8945-2013; Battisti, Antonio/AAQ-9243-2021; Hendriksen, Rene/A-5755-2013	Gentile, Gabriele/0000-0002-1045-6816; Battisti, Antonio/0000-0003-1308-199X; Hendriksen, Rene S./0000-0003-2934-8214; Aarestrup, Frank/0000-0002-7116-2723; Dell'Omo, Giacomo/0000-0002-9601-9675	Italian Ministry of Education, University and Research (MIUR); Ornis italica; Galapagos National Park	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ornis italica; Galapagos National Park	The research was supported by the Italian Ministry of Education, University and Research (MIUR), with a grant MIUR (2003) to Gabriele Gentile. Giacomo Dell'Omo was supported by Ornis italica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Ms. Cinzia Onorati, Ms. Carmela Buccella, Ms. Roberta Amoruso, Ms. Tamara Cerci (IZSLT), and Mrs. Christina Aaby Svendsen (DTU-Food) for outstanding technical assistance. Additionally, we would like to thank Dr. Karl Pedersen, Mrs. Gitte Sorensen and the zoonosis laboratorium (DTU-Food) for re-testing some of the isolates. We thank the Galapagos National Park for its support.	AIKEN AM, 2010, EUROSURVEILLANCE, P15; [Anonymous], 2002, MICROBIOLOGY FOOD AN; Bohme H, 2009, KLIN PADIATR, V221, P74, DOI 10.1055/s-0028-1112157; Burnham BR, 1998, J AM VET MED ASSOC, V213, P48; Chambers DL, 2006, APPL ENVIRON MICROB, V72, P3771, DOI 10.1128/AEM.72.5.3771-3773.2006; CHIODINI RJ, 1981, AM J EPIDEMIOL, V113, P494, DOI 10.1093/oxfordjournals.aje.a113124; Costantini D, 2005, COMP BIOCHEM PHYS B, V142, P239, DOI 10.1016/j.cbpb.2005.07.011; Cummings KJ, 2009, J DAIRY SCI, V92, P3766, DOI 10.3168/jds.2009-2093; Fabiani A, 2011, ANIM CONSERV, V14, P419, DOI 10.1111/j.1469-1795.2011.00442.x; Gaertner JP, 2008, J WILDLIFE DIS, V44, P519, DOI 10.7589/0090-3558-44.2.519; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hendriksen RS, 2009, J CLIN MICROBIOL, V47, P79, DOI 10.1128/JCM.00894-08; Hidalgo-Vila J, 2008, VET REC, V162, P218, DOI 10.1136/vr.162.7.218; Hidalgo-Vila J, 2007, VET MICROBIOL, V119, P311, DOI 10.1016/j.vetmic.2006.08.012; Hoag JB, 2005, SOUTH MED J, V98, P1123, DOI 10.1097/01.smj.0000177346.07719.00; Kitadai N, 2010, J VET MED SCI, V72, P939, DOI 10.1292/jvms.09-0576; Kodjo A, 1997, J VET MED B, V44, P625, DOI 10.1111/j.1439-0450.1997.tb01016.x; Lourenço Maria Cristina S., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P169, DOI 10.1590/S0036-46652004000300009; Maciel BM, 2010, ZOONOSES PUBLIC HLTH, V57, pE26, DOI 10.1111/j.1863-2378.2009.01283.x; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; Milstone AM, 2006, OBSTET GYNECOL, V107, P516, DOI 10.1097/01.AOG.0000187950.37065.87; Molla W, 2006, TROP ANIM HEALTH PRO, V38, P455, DOI 10.1007/s11250-006-4325-4; OBOEGBULEM SI, 1990, J WILDLIFE DIS, V26, P119, DOI 10.7589/0090-3558-26.1.119; Pedersen K, 2009, ZOONOSES PUBLIC HLTH, V56, P238, DOI 10.1111/j.1863-2378.2008.01196.x; PIHIER N, 2005, EUROSURVEILLANCE, V11, P270; Popoff MY, 2001, GUIDELINES PREPARATI; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Schroter M, 2004, APPL ENVIRON MICROB, V70, P613, DOI 10.1128/AEM.70.1.613-615.2004; Sivapalasingam S, 2003, CLIN INFECT DIS, V37, P1585, DOI 10.1086/379710; TABARANI CM, 2010, J PEDIAT, V156, P22; TAUXE RV, 1985, JAMA-J AM MED ASSOC, V12, P237; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Warwick C, 2001, J ROY SOC MED, V94, P124, DOI 10.1177/014107680109400306; Wheeler E, 2011, ENV MICROBIOL REP, V3, P166, DOI 10.1111/j.1758-2229.2010.00203.x; Woodward DL, 1997, J CLIN MICROBIOL, V35, P2786, DOI 10.1128/JCM.35.11.2786-2790.1997	35	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23147	10.1371/journal.pone.0023147	http://dx.doi.org/10.1371/journal.pone.0023147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853080	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200047
J	Genet, F; Jourdan, C; Lautridou, C; Chehensse, C; Minooee, K; Denormandie, P; Schnitzler, A				Genet, Francois; Jourdan, Claire; Lautridou, Christine; Chehensse, Clement; Minooee, Kambiz; Denormandie, Philippe; Schnitzler, Alexis			The Impact of Preoperative Hip Heterotopic Ossification Extent on Recurrence in Patients with Head and Spinal Cord Injury: A Case Control Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; BONE-FORMATION; EARLY EXCISION; RESECTION; ELBOW; HEMIPLEGIA; ANTIGENS; COMA; KNEE	Background: The preoperative Heterotopic Ossification (HO) extent is usually one of the main used criteria to predict the recurrence before excision. Brooker et al built a radiologic scale to assess this pre operative extent around the hip. The aim of this study is to investigate the relationship between the recurrence risk after hip HO excision in Traumatic Brain Injury (TBI) and Spinal Cord Injury (SCI) patients and the preoperative extent of HO. Methodology/Principal Findings: A case control study including TBI or SCI patients following surgery for troublesome hip HO with (case, n = 19) or without (control, n = 76) recurrence. Matching criteria were: sex, pathology (SCI or TBI) and age at the time of surgery (+/-4.5 years). For each etiology (TBI and SCI), the residual cognitive and functional status (Garland classification), the preoperative extent (Brooker status), the modified radiological and functional status (GCG-BD classification), HO localization, side, mean age at the CNS damage, mean delay for the first HO surgery, and for the case series, the mean operative delay for recurrence after the first surgical intervention were noted. Conclusions/Significance: The median delay for first HO surgery was 38.6 months (range 4.5 to 414.5;) for the case subgroup and 17.6 months (range 5.7 to 339.6) for the control group. No significant link was found between recurrence and operative delay (p = 0.51); the location around the joint (0.07); the Brooker (p = 0.52) or GCG-BD status (p = 0.79). Including all the matching factors, no significant relationship was found between the recurrence HO risk and the preoperative extent of troublesome hip HO using Brooker status (OR = 1.56(95% CI: 0.47-5.19)) or GCG-BD status (OR class 3 versus 2 = 0.67(95% CI: 0.11-4.24) and OR class 4 versus 2 = 0.79(95% CI: 0.09-6.91)). Until the pathophysiology of HO development is understood, it will be difficult to create tools which can predict HO recurrence.	[Genet, Francois; Jourdan, Claire; Chehensse, Clement; Schnitzler, Alexis] CHU R Poincare, Serv Med Phys & Readaptat, Garches, France; [Lautridou, Christine; Denormandie, Philippe] CHU R Poincare, Serv Chirurg Orthoped, Garches, France; [Minooee, Kambiz] CHU Erasme, Serv Rhumatol & Med Phys, Brussels, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Universite Libre de Bruxelles	Genet, F (corresponding author), CHU R Poincare, Serv Med Phys & Readaptat, Garches, France.	francois.genet@rpc.aphp.fr						BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Denormandie P, 1999, Chir Main, V18, P99; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Frischhut B, 1993, Acta Neurol (Napoli), V15, P114; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Ippolito E, 1999, J HAND SURG-AM, V24A, P546; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MINAIRE P, 1980, ARCH PHYS MED REHAB, V61, P214; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; ROSIN AJ, 1975, ANN RHEUM DIS, V34, P499, DOI 10.1136/ard.34.6.499; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; Seegenschmiedt MH, 2008, MED RADIOL RADIAT ON, P333, DOI 10.1007/978-3-540-68943-0_18; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Sorriaux G, 2005, REV CHIR ORTHOP, V91, P415, DOI 10.1016/S0035-1040(05)84358-2; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	33	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23129	10.1371/journal.pone.0023129	http://dx.doi.org/10.1371/journal.pone.0023129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853078	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200044
J	Ji, WD; Yang, JH; Wang, DM; Cao, L; Tan, WF; Qian, HH; Sun, B; Qian, QJ; Yin, ZF; Wu, MC; Su, CQ				Ji, Weidan; Yang, Jiahe; Wang, Duanming; Cao, Lu; Tan, Weifeng; Qian, Haihua; Sun, Bin; Qian, Qijun; Yin, Zhengfeng; Wu, Mengchao; Su, Changqing			hSulf-1 Gene Exhibits Anticancer Efficacy through Negatively Regulating VEGFR-2 Signaling in Human Cancers	PLOS ONE			English	Article							HEPARAN-SULFATE GLYCOSAMINOGLYCANS; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; BREAST-CANCER; OVARIAN-CANCER; TUMOR-GROWTH; IN-VIVO; CELLS; EXPRESSION; BINDING	Background: Human sulfatase 1 (hSulf-1) is a heparin-degrading endosulfatase that desulfates cell surface heparan sulfate proteoglycans (HSPGs) in extracellular matrix and negatively modulates heparin-binding growth factor and cytokine signaling in cell proliferation. But hSulf-1 function is more complicated, and its molecular mechanism has not been well known. Principal Findings: To further investigate the functions of hSulf-1 gene in regulating the vascular endothelial growth factor receptor (VEGFR) signaling, a series of vectors expressing hSulf-1, hSulf-1 small hairpin RNA (shRNA) and VEGFR-2 shRNA were generated. hSulf-1 re-expression could downregualte the VEGFR-2 phosphorylation and inhibit cancer cell proliferation both in ovarian and hepatocellular cancer cell lines. Knockdown of hSulf-1 expression by hSulf-1 shRNA enhanced the recovery of high levels of phosphorylated VEGFR-2, and knockdown of VEGFR-2 expression by VEGFR-2 shRNA inhibited the proliferation activity of cancer cells in vitro to some extent. In human cancer xenografts in nude mice, tumor growth was inhibited markedly after injections of adenovirus expressing hSulf-1, with the tumor inhibition rates of 46.19% and 49.56% in ovarian and hepatocellular tumor models, respectively. hSulf-1 expression significantly reduced tumor microvessel density. Conclusions: The results demonstrated that hSulf-1 re-expression both in ovarian and hepatocellular cancer cells induces antitumor efficacy by attenuating the phosphorylation of VEGFR-2 and suppressing angiogenesis. Therefore, hSulf-1-mediated antiproliferation and antiangiogenesis could be a reasonable approach for cancer therapy.	[Ji, Weidan; Yang, Jiahe; Cao, Lu; Tan, Weifeng; Qian, Haihua; Sun, Bin; Qian, Qijun; Yin, Zhengfeng; Wu, Mengchao; Su, Changqing] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp & Inst, Dept Mol Oncol, Shanghai, Peoples R China; [Ji, Weidan; Su, Changqing] Soochow Univ, Coll Med, Med Genet Lab, Suzhou, Peoples R China; [Wang, Duanming] Shihezi Univ, Coll Anim Sci & Technol, Xinjiang, Peoples R China	Naval Medical University; Soochow University - China; Shihezi University	Ji, WD (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp & Inst, Dept Mol Oncol, Shanghai, Peoples R China.	suchangqing@gmail.com	sun, bin/GLR-1711-2022	sun, bin/0000-0002-5082-3326; Su, Changqing/0000-0002-3396-7248	National Natural Scientific Foundation of China [81071866, 30872998]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Scientific Foundation of China (81071866, 30872998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiatari I, 2006, J CLIN PATHOL, V59, P1052, DOI 10.1136/jcp.2005.031716; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Chen Z, 2009, INT J CANCER, V124, P739, DOI 10.1002/ijc.23960; Fang L, 2010, HEPATOL RES, V40, P216, DOI 10.1111/j.1872-034X.2009.00580.x; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Hu HZ, 2011, GUT, V60, P710, DOI 10.1136/gut.2010.220020; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Lai JP, 2006, GASTROENTEROLOGY, V130, P2130, DOI 10.1053/j.gastro.2006.02.056; Lai Jin-Ping, 2008, J Gastrointest Cancer, V39, P149, DOI 10.1007/s12029-009-9058-y; Lai JP, 2008, FUTURE ONCOL, V4, P803, DOI 10.2217/14796694.4.6.803; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Liu DF, 2002, SEMIN THROMB HEMOST, V28, P67, DOI 10.1055/s-2002-20565; Liu P, 2009, CANCER RES, V69, P4843, DOI 10.1158/0008-5472.CAN-08-3065; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Perego P, 2010, BIOCHEM PHARMACOL, V80, P1459, DOI 10.1016/j.bcp.2010.07.030; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; SOKER S, 1994, BIOCHEM BIOPH RES CO, V203, P1339, DOI 10.1006/bbrc.1994.2329; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Thakker GD, 1999, J BIOL CHEM, V274, P10002, DOI 10.1074/jbc.274.15.10002; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; Weigand Melanie, 2005, Angiogenesis, V8, P197, DOI 10.1007/s10456-005-9010-0; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zhao TT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012563	35	21	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23274	10.1371/journal.pone.0023274	http://dx.doi.org/10.1371/journal.pone.0023274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853101	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200061
J	Yende, S; D'Angelo, G; Mayr, F; Kellum, JA; Weissfeld, L; Kaynar, AM; Young, T; Irani, K; Angus, DC				Yende, Sachin; D'Angelo, Gina; Mayr, Florian; Kellum, John A.; Weissfeld, Lisa; Kaynar, A. Murat; Young, Tammy; Irani, Kaikobad; Angus, Derek C.		GenIMS Investigators	Elevated Hemostasis Markers after Pneumonia Increases One-Year Risk of All-Cause and Cardiovascular Deaths	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-TRACT INFECTIONS; C-REACTIVE PROTEIN; OLD MANS FRIEND; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; TERM SURVIVAL; SEVERE SEPSIS; MORTALITY; DISEASE	Background: Acceleration of chronic diseases, particularly cardiovascular disease, may increase long-term mortality after community-acquired pneumonia (CAP), but underlying mechanisms are unknown. Persistence of the prothrombotic state that occurs during an acute infection may increase risk of subsequent atherothrombosis in patients with pre-existing cardiovascular disease and increase subsequent risk of death. We hypothesized that circulating hemostasis markers activated during CAP persist at hospital discharge, when patients appear to have recovered clinically, and are associated with higher mortality, particularly due to cardiovascular causes. Methods: In a cohort of survivors of CAP hospitalization from 28 US sites, we measured D-Dimer, thrombin-antithrombin complexes [TAT], Factor IX, antithrombin, and plasminogen activator inhibitor-1 at hospital discharge, and determined 1-year all-cause and cardiovascular mortality. Results: Of 893 subjects, most did not have severe pneumonia (70.6% never developed severe sepsis) and only 13.4% required intensive care unit admission. At discharge, 88.4% of subjects had normal vital signs and appeared to have clinically recovered. D-dimer and TAT levels were elevated at discharge in 78.8% and 30.1% of all subjects, and in 51.3% and 25.3% of those without severe sepsis. Higher D-dimer and TAT levels were associated with higher risk of all-cause mortality (range of hazard ratios were 1.66-1.17, p = 0.0001 and 1.46-1.04, p = 0.001 after adjusting for demographics and comorbid illnesses) and cardiovascular mortality (p = 0.009 and 0.003 in competing risk analyses). Conclusions: Elevations of TAT and D-dimer levels are common at hospital discharge in patients who appeared to have recovered clinically from pneumonia and are associated with higher risk of subsequent deaths, particularly due to cardiovascular disease.	[Yende, Sachin; Mayr, Florian; Kellum, John A.; Kaynar, A. Murat; Young, Tammy; Angus, Derek C.] Univ Pittsburgh, Syst Modeling Acute Illness Ctr, Pittsburgh, PA 15260 USA; [D'Angelo, Gina] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Weissfeld, Lisa] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Irani, Kaikobad] Univ Pittsburgh, Div Cardiol, Pittsburgh, PA 15261 USA; [Yende, Sachin; Mayr, Florian; Kellum, John A.; Weissfeld, Lisa; Kaynar, A. Murat; Young, Tammy; Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yende, S (corresponding author), Univ Pittsburgh, Syst Modeling Acute Illness Ctr, Pittsburgh, PA 15260 USA.	yendes@upmc.edu	Angus, Derek C/E-9671-2012; Kellum, John A/HCH-2944-2022; Kaynar, Ata Murat/ABI-6877-2020; Kellum, John/AAP-3072-2020	Kellum, John A/0000-0003-1995-2653; Kaynar, Ata Murat/0000-0001-8847-0450; Kellum, John/0000-0003-1995-2653; Irani, Kaikobad/0000-0001-9194-7387	National Institute of General Medical Sciences (NIGMS) [R01 GM61992, K23 GM083215]; GlaxoSmithKline; Diagnostic Products Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061992, K23GM083215] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); GlaxoSmithKline(GlaxoSmithKline); Diagnostic Products Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GenIMS was funded by National Institute of General Medical Sciences (NIGMS) [R01 GM61992] with additional support from GlaxoSmithKline for enrollment and clinical data collection, and Diagnostic Products Corporation for the cytokine assays. Dr. Yende is supported by NIGMS [K23 GM083215]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bordon J, 2010, CHEST, V138, P279, DOI 10.1378/chest.09-2702; BRANCATI FL, 1993, LANCET, V342, P30, DOI 10.1016/0140-6736(93)91887-R; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clayton TC, 2008, EUR HEART J, V29, P96, DOI 10.1093/eurheartj/ehm516; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Doody MM, 2001, ANN EPIDEMIOL, V11, P46, DOI 10.1016/S1047-2797(00)00177-0; Epstein SE, 2009, CIRCULATION, V119, P3133, DOI 10.1161/CIRCULATIONAHA.109.849455; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Halm EA, 2002, NEW ENGL J MED, V347, P2039, DOI 10.1056/NEJMcp020499; HEDLUND JU, 1993, THORAX, V48, P785, DOI 10.1136/thx.48.8.785; Hsu JL, 2011, INT J INFECT DIS, V15, pE382, DOI 10.1016/j.ijid.2011.02.002; Kannel WB, 2005, LIPIDS, V40, P1215, DOI 10.1007/s11745-005-1488-8; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kasal J, 2004, CRIT CARE MED, V32, P700, DOI 10.1097/01.CCM.0000114819.37569.4B; Keller TT, 2007, J THROMB HAEMOST, V5, P1567, DOI 10.1111/j.1538-7836.2007.02580.x; Keller TT, 2006, CIRC RES, V99, P1261, DOI 10.1161/01.RES.0000250834.29108.1a; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Kinasewitz GT, 2004, CRIT CARE, V8, pR82, DOI 10.1186/cc2459; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Koivula I, 1999, ARCH INTERN MED, V159, P1550, DOI 10.1001/archinte.159.14.1550; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Milbrandt EB, 2009, MOL MED, V15, P438, DOI 10.2119/molmed.2009.00091; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; TOSCHKE AM, 2008, AGE AGEING AFN232; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; NATL DEATH INDEX	41	72	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22847	10.1371/journal.pone.0022847	http://dx.doi.org/10.1371/journal.pone.0022847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853050	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000295454200023
J	Backer, JA; Nodelijk, G				Backer, Jantien A.; Nodelijk, Gonnie			Transmission and Control of African Horse Sickness in The Netherlands: A Model Analysis	PLOS ONE			English	Article							CULICOIDES-VARIIPENNIS DIPTERA; BLUETONGUE VIRUS; SIMULATION; EPIDEMIC; EFFICACY	African horse sickness (AHS) is an equine viral disease that is spread by Culicoides spp. Since the closely related disease bluetongue established itself in The Netherlands in 2006, AHS is considered a potential threat for the Dutch horse population. A vector-host model that incorporates the current knowledge of the infection biology is used to explore the effect of different parameters on whether and how the disease will spread, and to assess the effect of control measures. The time of introduction is an important determinant whether and how the disease will spread, depending on temperature and vector season. Given an introduction in the most favourable and constant circumstances, our results identify the vector-to-host ratio as the most important factor, because of its high variability over the country. Furthermore, a higher temperature accelerates the epidemic, while a higher horse density increases the extent of the epidemic. Due to the short infectious period in horses, the obvious clinical signs and the presence of non-susceptible hosts, AHS is expected to invade and spread less easily than bluetongue. Moreover, detection is presumed to be earlier, which allows control measures to be targeted towards elimination of infection sources. We argue that recommended control measures are euthanasia of infected horses with severe clinical signs and vector control in infected herds, protecting horses from midge bites in neighbouring herds, and (prioritized) vaccination of herds farther away, provided that transport regulations are strictly applied. The largest lack of knowledge is the competence and host preference of the different Culicoides species present in temperate regions.	[Backer, Jantien A.; Nodelijk, Gonnie] Cent Vet Inst Wageningen UR, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands	Wageningen University & Research	Backer, JA (corresponding author), Cent Vet Inst Wageningen UR, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands.	jantien.backer@wur.nl			Dutch Ministry of Economic Affairs, Agriculture and Innovation [BO-08-010-021]	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This work was funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation (BO-08-010-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis M, 2008, MED VET ENTOMOL, V22, P228, DOI 10.1111/j.1365-2915.2008.00732.x; Commission of the European Communities, 2001, OFFICIAL J EUROPEA L, V311, P1; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Gubbins S, 2010, EPIDEMICS, V2; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; HEESTERBEEK JAP, 1995, J BIOL SYST, V3, P779, DOI DOI 10.1016/JMBS.2004.10.013; HOUSE JA, 1994, VACCINE, V12, P142, DOI 10.1016/0264-410X(94)90052-3; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; LILLIE TH, 1981, CAN ENTOMOL, V113, P419, DOI 10.4039/Ent113419-5; Lord CC, 1996, J MED ENTOMOL, V33, P328, DOI 10.1093/jmedent/33.3.328; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; Lord CC, 1997, VACCINE, V15, P519, DOI 10.1016/S0264-410X(97)00220-X; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2008, PREV VET MED, V87, P98, DOI 10.1016/j.prevetmed.2008.06.013; MELLOR PS, 1990, EPIDEMIOL INFECT, V105, P447, DOI 10.1017/S0950268800048020; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MULLENS BA, 1991, J AM MOSQUITO CONTR, V7, P588; Rijksen C, 2005, INVENTARISATIE PAARD; RODRIGUEZ M, 1992, VET MICROBIOL, V33, P129, DOI 10.1016/0378-1135(92)90041-Q; Roy P, 1996, J GEN VIROL, V77, P2053, DOI 10.1099/0022-1317-77-9-2053; Scanlen M, 2002, VACCINE, V20, P1079, DOI 10.1016/S0264-410X(01)00445-5; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCOTTER DR, 1970, ECOLOGY, V52, P174; Sloet van Oldruitenborgh MM, 2009, INVENTARISATION PRES; Szmaragd C, 2010, EPIDEMICS, V2; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Wittmann EJ, 2002, VACCINE, V20, P1079	31	31	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23066	10.1371/journal.pone.0023066	http://dx.doi.org/10.1371/journal.pone.0023066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850252	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300037
J	Ma, Y; Jiang, WJ; Liu, QB; Ryuko, S; Kuno, T				Ma, Yan; Jiang, Weijuan; Liu, Qingbin; Ryuko, Sayomi; Kuno, Takayoshi			Genome-Wide Screening for Genes Associated with FK506 Sensitivity in Fission Yeast	PLOS ONE			English	Article							PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; 1,3-BETA-D-GLUCAN SYNTHASE; SCHIZOSACCHAROMYCES-POMBE; CALCINEURIN PHOSPHATASE; DISTINCT PHENOTYPES; EXPRESSION; MEMBRANE; PATHWAY; STRESS	We have been studying calcineurin signal transduction pathway in fission yeast Schizosaccharomyces pombe (S. pombe) by developing a genetic screen for mutants that show hypersensitivity to the immunosuppressive calcineurin inhibitor FK506 (tacrolimus). In the present study, to identify nonessential genes that are functionally related to the calcineurin signaling pathway, we performed a genome-wide screen of 3004 haploid deletion strains and confirmed 72 deletion strains to be FK506 sensitive. These 72 genes are classified into nine functional groups to include membrane trafficking (16 genes), signal transduction (10 genes), ubiquitination (8 genes), chromatin remodeling (6 genes), cytokinesis (4 genes), ribosomal protein (3 genes), RNA binding protein (3 genes), and a variety of other known functions (17 genes) or still unknown functions (5 genes) in the biological system. In our previous screening of FK506-sensitive mutants we isolated several membrane-trafficking mutants showing defective cell wall integrity. Here, we further examined the vacuolar fusion, the v-SNARE synaptobrevin Syb1 localization, and the sensitivity to the beta-glucan synthase inhibitor micafungin in these 72 FK506-sensitive strains. Results showed that 25 deletion strains exhibited abnormal vacuole fusion, 19 deletion strains exhibited Syb1 mislocalization, and 14 deletion strains exhibited both abnormal vacuole fusion and Syb1 mislocalization, while 42 deletion strains showed both normal vacuole fusion and Syb1 localization. Likewise, 16 deletion strains showed sensitivity to micafungin. Altogether, our present study indicates that calcineurin mediates a plethora of physiological processes in fission yeast, and that calcineurin is extensively involved in cross-talk between signaling pathways.	[Ma, Yan; Jiang, Weijuan; Liu, Qingbin; Ryuko, Sayomi; Kuno, Takayoshi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan	Kobe University	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol Pharmacol & Pharmacogen, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [22390048, 21790241]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this study was provided by Grant-in-Aid for Scientific Research, on Scientific Research (B) to Takayoshi Kuno (No. 22390048) and on Grant-in-Aid for Young Scientists (B) to Yan Ma (No. 21790241), from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanapola SL, 2009, J CELL SCI, V122, P3856, DOI 10.1242/jcs.053959; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; Edamatsu M, 2003, BIOCHEM BIOPH RES CO, V301, P641, DOI 10.1016/S0006-291X(03)00017-2; EIDELMAN BH, 1991, TRANSPLANT P, V23, P3175; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Fujita M, 2002, GENETICS, V161, P971; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; He Y, 2006, GENES CELLS, V11, P207, DOI 10.1111/j.1365-2443.2006.00935.x; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Iwaki T, 2004, YEAST, V21, P867, DOI 10.1002/yea.1134; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Knoll GA, 2009, AM J KIDNEY DIS, V54, P1131, DOI 10.1053/j.ajkd.2009.06.031; Lu YB, 2002, GENES CELLS, V7, P1009, DOI 10.1046/j.1365-2443.2002.00582.x; Ma Y, 2006, GENETICS, V174, P1259, DOI 10.1534/genetics.106.064709; Ma Y, 2010, MOL GENET GENOMICS, V284, P161, DOI 10.1007/s00438-010-0550-7; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; MAZUR P, 1995, MOL CELL BIOL, V15, P5671; McCourtie AS, 2010, ANN THORAC SURG, V89, P1766, DOI 10.1016/j.athoracsur.2010.02.068; NAKAMURA T, 1993, EMBO J, V12, P4063, DOI 10.1002/j.1460-2075.1993.tb06090.x; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Park SY, 2001, J BIOL CHEM, V276, P28694, DOI 10.1074/jbc.M101185200; Parsons SA, 2007, J BIOL CHEM, V282, P10068, DOI 10.1074/jbc.M609368200; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Toda T, 1996, MOL CELL BIOL, V16, P6752; Ulrich C, 2008, AM J TRANSPLANT, V8, P2192, DOI 10.1111/j.1600-6143.2008.02386.x; Webster AC, 2008, AM J TRANSPLANT, V8, P2185, DOI 10.1111/j.1600-6143.2008.02385.x; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013	47	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23422	10.1371/journal.pone.0023422	http://dx.doi.org/10.1371/journal.pone.0023422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850271	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300056
J	Ruckert, IM; Heier, M; Rathmann, W; Baumeister, SE; Doring, A; Meisinger, C				Rueckert, Ina-Maria; Heier, Margit; Rathmann, Wolfgang; Baumeister, Sebastian E.; Doering, Angela; Meisinger, Christa			Association between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: The KORA-F4-Study	PLOS ONE			English	Article							CATALYTIC-ACTIVITY CONCENTRATIONS; GAMMA-GLUTAMYL-TRANSFERASE; APPROVED RECOMMENDATION 1985; ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; 2-OXOGLUTARATE AMINOTRANSFERASE; METABOLIC SYNDROME; FASTING GLUCOSE; IFCC METHODS	Objective: To investigate whether the elevated liver enzymes gamma-glutamyltransferase (GGT), glutamate-pyruvate transaminase (GPT), glutamate-oxalacetate transaminase (GOT) and alkaline phosphatase (AP) and non-alcoholic fatty liver disease (NAFLD) respectively are independently associated with pre-diabetic states, namely impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) or known and newly diagnosed diabetes (NDD), in men and women from the general German population. Methods: The study was based on 3009 subjects (1556 females, 1453 males) aged 32 to 81 years who participated in the KORA-F4-Study in 2006/2008 in Augsburg, Southern Germany. All non-diabetic participants underwent an oral glucose tolerance test to assess disturbances in glucose metabolism. NAFLD was estimated by liver enzyme concentrations and the Bedogni Fatty Liver Index (FLI). Results: 229 participants (7.6%) reported known diabetes, 106 had NDD (3.5%), 107 (3.6%) had IFG, 309 (10.3%) had IGT, 69 (2.3%) were affected with both metabolic disorders (IFG/IGT) and 74 (2.5%) could not be classified. GGT and GPT were significantly elevated in persons with pre-diabetes and diabetes (GGT in diabetic persons OR = 1.76, [1.47-2.09], in IFG OR = 1.79 [1.50-2.13], GPT in diabetic persons OR = 1.51, [1.30-1.74], in NDD OR = 1.77 [1.52-2.06]), GOT and AP only inconsistently in some pre-diabetes groups. The effects were sharpened in models using an increase of two or three out of three enzymes as an estimate of fatty liver and especially in models using the FLI. Overall frequency of NAFLD applying the index was 39.8% (women: 27.3% and men: 53.2%). In participants with fatty liver disease, the OR for NDD adjusted for sex and age was 8.48 [5.13-14.00], 6.70 [3.74-12.01] for combined IFG and IGT and 4.78 [3.47-6.59] for known diabetes respectively. Conclusions: Elevated GGT and GPT-values as well as estimates of fatty liver disease are significantly associated with prediabetes and diabetes and thus very useful first indicators of a disturbed glucose metabolism.	[Rueckert, Ina-Maria; Heier, Margit; Doering, Angela; Meisinger, Christa] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, Neuherberg, Germany; [Heier, Margit; Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Rathmann, Wolfgang] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Baumeister, Sebastian E.] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Doering, Angela] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 1, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ruckert, IM (corresponding author), Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol 2, Neuherberg, Germany.	ina-maria.rueckert@helmholtz-muenchen.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Baumeister, Sebastian-Edgar/P-7894-2019	Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen; German Research Center for Environmental Health (GmbH); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Diabetes Foundation [RA 459/2-1]; Nationales Aktionsforum Diabetes mellitus (NAFDM); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health (GmbH); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Diabetes Foundation; Nationales Aktionsforum Diabetes mellitus (NAFDM); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia	The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. The Diabetes Study was funded by a German Diabetes Foundation project grant to W. Rathmann (RA 459/2-1) and by a grant from the Nationales Aktionsforum Diabetes mellitus (NAFDM). The German Diabetes Center is funded by the German Federal Ministry of Health, and the Ministry of School, Science and Research of the State of North-Rhine-Westfalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alisi A, 2009, ANN HEPATOL, V8, pS44, DOI 10.1016/S1665-2681(19)31826-5; [Anonymous], 1995, PHYS STAT US INT ANT; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P497; BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P481; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Caldwell SH, 2007, J GASTROEN HEPATOL, V22, pS11, DOI 10.1111/j.1440-1746.2006.04639.x; Center SA, 2007, VET CLIN N AM-SMALL, V37, P297, DOI 10.1016/j.cvsm.2006.11.009; Doi Y, 2007, OBESITY, V15, P1841, DOI 10.1038/oby.2007.218; Forouhi NG, 2006, DIABETOLOGIA, V49, P822, DOI 10.1007/s00125-006-0189-4; Fraser A, 2007, HEPATOLOGY, V46, P158, DOI 10.1002/hep.21667; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Grant Lafaine M, 2004, Ann Hepatol, V3, P93; Hanley AJG, 2004, DIABETES, V53, P2623, DOI 10.2337/diabetes.53.10.2623; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Manco M, 2008, HEPATOLOGY, V48, P2087, DOI 10.1002/hep.22631; Meisinger C, 2005, J INTERN MED, V258, P527, DOI 10.1111/j.1365-2796.2005.01572.x; Messier V, 2010, METABOLISM, V59, P20, DOI 10.1016/j.metabol.2009.06.020; Mohan V, 2009, DIABETES RES CLIN PR, V84, P84, DOI 10.1016/j.diabres.2008.11.039; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Schumann G, 2002, CLIN CHEM LAB MED, V40, P734, DOI 10.1515/CCLM.2002.126; Schumann G, 2002, CLIN CHEM LAB MED, V40, P725, DOI 10.1515/CCLM.2002.125; Schumann G, 2002, CLIN CHEM LAB MED, V40, P718, DOI 10.1515/CCLM.2002.124; Schumann G, 2006, CLIN CHEM LAB MED, V44, P1146, DOI 10.1515/CCLM.2006.212; Shin JY, 2009, DIABETES RES CLIN PR, V84, P152, DOI 10.1016/j.diabres.2009.02.004; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; THOMAS L, 2005, J LAB MED, V29, P301, DOI DOI 10.1515/JLM.2005.041; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Yun JW, 2009, LIVER INT, V29, P525, DOI 10.1111/j.1478-3231.2008.01920.x	38	51	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22932	10.1371/journal.pone.0022932	http://dx.doi.org/10.1371/journal.pone.0022932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850244	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300029
J	Smaldino, PE; Lubell, M				Smaldino, Paul E.; Lubell, Mark			An Institutional Mechanism for Assortment in an Ecology of Games	PLOS ONE			English	Article							COOPERATION; PUNISHMENT; EVOLUTION; REPUTATION; EMERGENCE	Recent research has revived Long's "ecology of games" model to analyze how social actors cooperate in the context of multiple political and social games. However, there is still a paucity of theoretical work that considers the mechanisms by which large-scale cooperation can be promoted in a dynamic institutional landscape, in which actors can join new games and leave old ones. This paper develops an agent-based model of an ecology of games where agents participate in multiple public goods games. In addition to contribution decisions, the agents can leave and join different games, and these processes are de-coupled. We show that the payoff for cooperation is greater than for defection when limits to the number of actors per game ("capacity constraints") structure the population in ways that allow cooperators to cluster, independent of any complex individual-level mechanisms such as reputation or punishment. Our model suggests that capacity constraints are one effective mechanism for producing positive assortment and increasing cooperation in an ecology of games. The results suggest an important trade-off between the inclusiveness of policy processes and cooperation: Fully inclusive policy processes reduce the chances of cooperation.	[Smaldino, Paul E.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Lubell, Mark] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Smaldino, PE (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	pesmaldino@ucdavis.edu	Lubell, Mark/H-5018-2012	Smaldino, Paul/0000-0002-7133-5620; Lubell, Mark/0000-0001-5757-7116	National Science Foundation [0921904]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Grant 0921904 (to ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SWIMMING UPSTREAM CO, DOI DOI 10.7551/MITPRESS/6577.001.0001; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Cao XB, 2010, PHYSICA A, V389, P1273, DOI 10.1016/j.physa.2009.11.044; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Giddens A, 1984, CONSTITUTION SOC OUT; Gigerenzer G., 2008, RATIONALITY MORTALS; Gintis H., 2000, GAME THEORY EVOLVING; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Li YX, 2010, PHYSICA A, V389, P1090, DOI 10.1016/j.physa.2009.11.010; LONG NE, 1958, AM J SOCIOL, V64, P251, DOI 10.1086/222468; Lubell M, 2010, AM J POLIT SCI, V54, P287, DOI 10.1111/j.1540-5907.2010.00431.x; McElreath R., 2007, MATH MODELS SOCIAL E; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; North D. C., 1990, I I CHANGE EC PERFOR; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; O'Leary R, 2006, PUBLIC ADMIN REV, V66, P6, DOI 10.1111/j.1540-6210.2006.00661.x; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; OLSON M., 1971, LOGIC COLLECTIVE ACT; Ostrom E., 1990, GOVERNING COMMONS EV; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pepper JW, 2007, ARTIF LIFE, V13, P1, DOI 10.1162/artl.2007.13.1.1; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.057101; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Skyrms B, 2009, SPRINGER SER GAME TH, P105, DOI 10.1007/978-3-540-85436-4_6; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Williamson O.E., 1983, MARKETS HIERARCHIES; Wu T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026121; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006	40	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23019	10.1371/journal.pone.0023019	http://dx.doi.org/10.1371/journal.pone.0023019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803EC	21850249	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300034
J	Arnaout, R; Lee, W; Cahill, P; Honan, T; Sparrow, T; Weiand, M; Nusbaum, C; Rajewsky, K; Koralov, SB				Arnaout, Ramy; Lee, William; Cahill, Patrick; Honan, Tracey; Sparrow, Todd; Weiand, Michael; Nusbaum, Chad; Rajewsky, Klaus; Koralov, Sergei B.			High-Resolution Description of Antibody Heavy-Chain Repertoires in Humans	PLOS ONE			English	Article							SOMATIC HYPERMUTATION; V-H; NEUTRALIZING ANTIBODIES; CAPSULAR POLYSACCHARIDE; V(D)J RECOMBINATION; GENE REPERTOIRE; B-CELLS; IMMUNOGLOBULIN; MEMORY; DIVERSITY	Antibodies' protective, pathological, and therapeutic properties result from their considerable diversity. This diversity is almost limitless in potential, but actual diversity is still poorly understood. Here we use deep sequencing to characterize the diversity of the heavy-chain CDR3 region, the most important contributor to antibody binding specificity, and the constituent V, D, and J segments that comprise it. We find that, during the stepwise D-J and then V-DJ recombination events, the choice of D and J segments exert some bias on each other; however, we find the choice of the V segment is essentially independent of both. V, D, and J segments are utilized with different frequencies, resulting in a highly skewed representation of VDJ combinations in the repertoire. Nevertheless, the pattern of segment usage was almost identical between two different individuals. The pattern of V, D, and J segment usage and recombination was insufficient to explain overlap that was observed between the two individuals' CDR3 repertoires. Finally, we find that while there are a near-infinite number of heavy-chain CDR3s in principle, there are about 3-9 million in the blood of an adult human being.	[Arnaout, Ramy] Brigham & Womens Hosp, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Arnaout, Ramy; Lee, William; Cahill, Patrick; Honan, Tracey; Sparrow, Todd; Weiand, Michael; Nusbaum, Chad] MIT, Genome Sequencing & Anal Program, Broad Inst, Cambridge, MA 02139 USA; [Rajewsky, Klaus; Koralov, Sergei B.] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Rajewsky, Klaus; Koralov, Sergei B.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Arnaout, Ramy; Lee, William; Cahill, Patrick; Honan, Tracey; Sparrow, Todd; Weiand, Michael; Nusbaum, Chad] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University	Arnaout, R (corresponding author), Brigham & Womens Hosp, Dept Pathol, Beth Israel Deaconess Med Ctr, 75 Francis St, Boston, MA 02115 USA.	rarnaout@bidmc.harvard.edu		Koralov, Sergei/0000-0002-4843-3791; Rajewsky, Klaus/0000-0002-6633-6370	NIH [AI054636]; Ruth L. Kirchstein National Research Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054636] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirchstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	KR and SK were supported by NIH grant AI054636. RA was supported by a Ruth L. Kirchstein National Research Service Award Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDERSON EE, 1992, J CLIN INVEST, V89, P729, DOI 10.1172/JCI115649; ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Arnaout RA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-148; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; Deulofeut H, 1997, HUM IMMUNOL, V57, P54, DOI 10.1016/S0198-8859(97)00181-X; Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998; Feeney A J, 1992, Int Rev Immunol, V8, P113, DOI 10.3109/08830189209055567; Fischer N, 2011, MABS, V3, P16; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Hadzidimitriou A, 2006, HAEMATOLOGICA, V91, P781; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Klein U, 1998, IMMUNOL REV, V162, P261; Koralov SB, 2005, J EXP MED, V201, P341, DOI 10.1084/jem.20041577; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; Lucas AH, 1999, IMMUNOL REV, V171, P89, DOI 10.1111/j.1600-065X.1999.tb01343.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miles JJ, 2010, J IMMUNOL; Ohlin M, 2003, MOL IMMUNOL, V40, P1, DOI 10.1016/S0161-5890(03)00099-3; OHNO S, 1985, P NATL ACAD SCI USA, V82, P2945, DOI 10.1073/pnas.82.9.2945; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Quigley MF, 2010, P NATL ACAD SCI USA, V107, P19414, DOI 10.1073/pnas.1010586107; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; RAJEWSKY K, 1987, SCIENCE, V238, P1088, DOI 10.1126/science.3317826; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Recher M, 2004, CURR OPIN MICROBIOL, V7, P426, DOI 10.1016/j.mib.2004.06.008; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Rohatgi S, 2009, J IMMUNOL, V182, P5570, DOI 10.4049/jimmunol.0803254; Rosner K, 2001, IMMUNOLOGY, V103, P179, DOI 10.1046/j.1365-2567.2001.01220.x; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Zhou JH, 2002, INFECT IMMUN, V70, P4083, DOI 10.1128/IAI.70.8.4083-4091.2002	49	152	171	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22365	10.1371/journal.pone.0022365	http://dx.doi.org/10.1371/journal.pone.0022365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829618	Green Submitted, Green Published, gold			2022-12-27	WOS:000293561200015
J	Laufer, I; Negishi, M; Lacadie, CM; Papademetris, X; Constable, RT				Laufer, Ilan; Negishi, Michiro; Lacadie, Cheryl M.; Papademetris, Xenophon; Constable, R. Todd			Dissociation between the Activity of the Right Middle Frontal Gyrus and the Middle Temporal Gyrus in Processing Semantic Priming	PLOS ONE			English	Article							REPETITION SUPPRESSION; COGNITIVE MECHANISMS; CONCEPTUAL RELATIONS; BRAIN ACTIVITY; FMRI; SPEECH; WORDS; NETWORK; ORGANIZATION; RECOGNITION	The aim of this event-related functional magnetic resonance imaging (fMRI) study was to test whether the right middle frontal gyrus (MFG) and middle temporal gyrus (MTG) would show differential sensitivity to the effect of prime-target association strength on repetition priming. In the experimental condition (RP), the target occurred after repetitive presentation of the prime within an oddball design. In the control condition (CTR), the target followed a single presentation of the prime with equal probability of the target as in RP. To manipulate semantic overlap between the prime and the target both conditions (RP and CTR) employed either the onomatopoeia "oink" as the prime and the referent "pig" as the target (OP) or vice-versa (PO) since semantic overlap was previously shown to be greater in OP. The results showed that the left MTG was sensitive to release of adaptation while both the right MTG and MFG were sensitive to sequence regularity extraction and its verification. However, dissociated activity between OP and PO was revealed in RP only in the right MFG. Specifically, target "pig" (OP) and the physically equivalent target in CTR elicited comparable deactivations whereas target "oink" (PO) elicited less inhibited response in RP than in CTR. This interaction in the right MFG was explained by integrating these effects into a competition model between perceptual and conceptual effects in priming processing.	[Laufer, Ilan; Negishi, Michiro; Lacadie, Cheryl M.; Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Dept Biomed Engn, New Haven, CT USA	Yale University; Yale University	Laufer, I (corresponding author), Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA.	ilan.laufer@yale.edu	Constable, R. Todd/ABE-8038-2021	Constable, R. Todd/0000-0001-5661-9521	NIH [R01 NS051622]; National Institutes of Health (NIH)/National Institute of Biomedical Imaging and Bioengineering (NIBIB) [1 R01 EB006494-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051622] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)/National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (http://www.nih.gov/) R01 NS051622. The authors acknowledge support for the Bioimagesuite software used in the fMRI analysis from the National Institutes of Health (NIH)/National Institute of Biomedical Imaging and Bioengineering (NIBIB) under grant 1 R01 EB006494-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alain C, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00202; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Benoit MM, 2010, HUM BRAIN MAPP, V31, P526, DOI 10.1002/hbm.20884; Bubic A, 2009, J COGNITIVE NEUROSCI, V21, P155, DOI 10.1162/jocn.2009.21013; Buhler M, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-30; Chang EF, 2011, J COGNITIVE NEUROSCI, V23, P1437, DOI 10.1162/jocn.2010.21466; Copland DA, 2003, NEUROIMAGE, V20, P302, DOI 10.1016/S1053-8119(03)00279-9; Copland DA, 2007, BRAIN RES, V1131, P163, DOI 10.1016/j.brainres.2006.11.016; De Lucia M, 2010, CEREB CORTEX, V20, P1676, DOI 10.1093/cercor/bhp230; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Friedman D, 2003, COGNITIVE BRAIN RES, V18, P58, DOI 10.1016/j.cogbrainres.2003.09.002; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gagnepain P, 2008, J NEUROSCI, V28, P5281, DOI 10.1523/JNEUROSCI.0565-08.2008; Ghuman AS, 2008, P NATL ACAD SCI USA, V105, P8405, DOI 10.1073/pnas.0710674105; Giesbrecht B, 2004, CEREB CORTEX, V14, P521, DOI 10.1093/cercor/bhh014; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hill H, 2002, INT J PSYCHOPHYSIOL, V44, P197, DOI 10.1016/S0167-8760(01)00202-1; Huettel SA, 2004, NEUROIMAGE, V23, P402, DOI 10.1016/j.neuroimage.2004.04.031; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; Kircher T, 2009, HUM BRAIN MAPP, V30, P4116, DOI 10.1002/hbm.20833; Kotz SA, 2002, NEUROIMAGE, V17, P1761, DOI 10.1006/nimg.2002.1316; Kreher DA, 2006, PSYCHOPHYSIOLOGY, V43, P550, DOI 10.1111/j.1469-8986.2006.00460.x; Kveraga K, 2007, BRAIN COGNITION, V65, P145, DOI 10.1016/j.bandc.2007.06.007; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Laufer I, 2008, BRAIN STRUCT FUNCT, V212, P427, DOI 10.1007/s00429-007-0167-8; Laufer I, 2009, NEUROIMAGE, V44, P546, DOI 10.1016/j.neuroimage.2008.09.010; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Matsumoto A, 2005, NEUROIMAGE, V24, P624, DOI 10.1016/j.neuroimage.2004.09.008; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; Noppeney U, 2008, CEREB CORTEX, V18, P598, DOI 10.1093/cercor/bhm091; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Opitz B, 2005, EUR J NEUROSCI, V21, P531, DOI 10.1111/j.1460-9568.2005.03839.x; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Pariyadath V, 2008, NAT PREC; Peelle JE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00051; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Raposo A, 2006, NEUROPSYCHOLOGIA, V44, P2284, DOI 10.1016/j.neuropsychologia.2006.05.017; Rissman J, 2003, J COGNITIVE NEUROSCI, V15, P1160, DOI 10.1162/089892903322598120; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Sachs O, 2008, BRAIN RES, V1218, P194, DOI 10.1016/j.brainres.2008.03.045; Sachs O, 2011, J COGNITIVE NEUROSCI, V23, P1263, DOI 10.1162/jocn.2010.21483; Sass K, 2009, BRAIN RES, V1270, P78, DOI 10.1016/j.brainres.2009.03.013; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Talairach J., 1988, COPLANAR STEREOTAXIS; Tivarus ME, 2006, COGN BEHAV NEUROL, V19, P194; Vossel S, 2011, J COGNITIVE NEUROSCI, V23, P414, DOI 10.1162/jocn.2010.21441; Wheatley T, 2005, J COGNITIVE NEUROSCI, V17, P1871, DOI 10.1162/089892905775008689; Whitney C, 2011, CEREB CORTEX, V21, P1066, DOI 10.1093/cercor/bhq180; Whitney C, 2011, CEREB CORTEX, V21, P831, DOI 10.1093/cercor/bhq148; Wible CG, 2006, BRAIN LANG, V97, P294, DOI 10.1016/j.bandl.2005.11.006; Wig GS, 2009, J NEUROPHYSIOL, V101, P2632, DOI 10.1152/jn.91213.2008; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Zevin JD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-4	62	15	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22368	10.1371/journal.pone.0022368	http://dx.doi.org/10.1371/journal.pone.0022368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829619	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200016
J	Meskaldji, DE; Ottet, MC; Cammoun, L; Hagmann, P; Meuli, R; Eliez, S; Thiran, JP; Morgenthaler, S				Meskaldji, Djalel Eddine; Ottet, Marie-Christine; Cammoun, Leila; Hagmann, Patric; Meuli, Reto; Eliez, Stephan; Thiran, Jean Philippe; Morgenthaler, Stephan			Adaptive Strategy for the Statistical Analysis of Connectomes	PLOS ONE			English	Article							CARDIO-FACIAL-SYNDROME; FALSE DISCOVERY RATE; VELOCARDIOFACIAL SYNDROME; SYNDROME DELETION; BRAIN; CONNECTIVITY; ARCHITECTURE; ADOLESCENTS; CHILDREN; 22Q11.2	We study an adaptive statistical approach to analyze brain networks represented by brain connection matrices of interregional connectivity (connectomes). Our approach is at a middle level between a global analysis and single connections analysis by considering subnetworks of the global brain network. These subnetworks represent either the inter-connectivity between two brain anatomical regions or by the intra-connectivity within the same brain anatomical region. An appropriate summary statistic, that characterizes a meaningful feature of the subnetwork, is evaluated. Based on this summary statistic, a statistical test is performed to derive the corresponding p-value. The reformulation of the problem in this way reduces the number of statistical tests in an orderly fashion based on our understanding of the problem. Considering the global testing problem, the p-values are corrected to control the rate of false discoveries. Finally, the procedure is followed by a local investigation within the significant subnetworks. We contrast this strategy with the one based on the individual measures in terms of power. We show that this strategy has a great potential, in particular in cases where the subnetworks are well defined and the summary statistics are properly chosen. As an application example, we compare structural brain connection matrices of two groups of subjects with a 22q11.2 deletion syndrome, distinguished by their IQ scores.	[Meskaldji, Djalel Eddine; Cammoun, Leila; Thiran, Jean Philippe] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland; [Ottet, Marie-Christine; Eliez, Stephan] Off Medicopedag OMP, Lausanne, Switzerland; [Hagmann, Patric; Meuli, Reto] Univ Lausanne CHUV UNIL, Lausanne, Switzerland; [Hagmann, Patric; Meuli, Reto] Univ Hosp Ctr, Dept Radiol, Lausanne, Switzerland; [Morgenthaler, Stephan] Ecole Polytech Fed Lausanne, Inst Math, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Meskaldji, DE (corresponding author), Ecole Polytech Fed Lausanne, Signal Proc Lab LTS5, Lausanne, Switzerland.	djalel.meskaldji@epfl.ch		Thiran, Jean-Philippe/0000-0003-2938-9657	Swiss National Science Foundation [205321-121945]; Centre d'imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL),; Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaire de Geneve (HUG); Leenaards and the Jeantet Foundations; Swiss SNF SPUM [33CM30-124089]; Swiss National Research Funds [32473B-121996]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre d'imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL),; Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaire de Geneve (HUG); Leenaards and the Jeantet Foundations; Swiss SNF SPUM; Swiss National Research Funds(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation under grant number 205321-121945, by the Centre d'imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaire de Geneve (HUG), the Leenaards and the Jeantet Foundations, the Swiss SNF SPUM project number 33CM30-124089 and the Swiss National Research Funds to Dr. Stephan Eliez number 32473B-121996. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2007, J AM STAT ASSOC, V102, P1272, DOI 10.1198/016214507000000941; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; BRILLINGER DR, 1990, SURV METHODOL, V16, P255; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; De Smedt B, 2007, J INTELL DISABIL RES, V51, P666, DOI 10.1111/j.1365-2788.2007.00955.x; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DUDOIT S, 2008, SPRINGER SER STAT; Dunnett C.W., 2004, LECT NOTES MONOGRAPH, V47, P48; EINOT I, 1975, J AM STAT ASSOC, V70, P574, DOI 10.2307/2285935; Eliez S, 2002, BIOL PSYCHIAT, V52, P68, DOI 10.1016/S0006-3223(02)01361-6; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Genovese CR, 1999, BAYESIAN STATISTICS 6, P255; Gothelf D, 2007, SCHIZOPHR RES, V96, P72, DOI 10.1016/j.schres.2007.07.021; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P., 2005, DIFFUSION MRI BRAIN; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hochberg Y., 1987, WILEY SERIES PROBABI; Kates WR, 2004, J CHILD NEUROL, V19, P337, DOI 10.1177/088307380401900506; Kwong KS, 2002, J STAT PLAN INFER, V104, P351, DOI 10.1016/S0378-3758(01)00252-X; Logan BR, 2004, NEUROIMAGE, V22, P95, DOI 10.1016/j.neuroimage.2003.12.047; Penny W, 2003, IEEE T MED IMAGING, V22, P504, DOI 10.1109/TMI.2003.809140; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sarkar SK, 2008, TEST-SPAIN, V17, P450, DOI 10.1007/s11749-008-0129-3; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Swillen A, 1997, J MED GENET, V34, P453, DOI 10.1136/jmg.34.6.453; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	34	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23009	10.1371/journal.pone.0023009	http://dx.doi.org/10.1371/journal.pone.0023009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829681	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200042
J	de Sousa, TN; Carvalho, LH; de Brito, CFA				de Sousa, Tais Nobrega; Carvalho, Luzia Helena; Alves de Brito, Cristiana Ferreira			Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; POPULATION-STRUCTURE; LIGAND DOMAIN; INHIBITORY ANTIBODIES; NATURAL-SELECTION; BLOOD-GROUP; ANTIGEN; INFECTION; POLYMORPHISMS; TRANSMISSION	The dependence of Plasmodium vivax on invasion mediated by Duffy binding protein (DBP) makes this protein a prime candidate for development of a vaccine. However, the development of a DBP-based vaccine might be hampered by the high variability of the protein ligand (DBPII), known to bias the immune response toward a specific DBP variant. Here, the hypothesis being investigated is that the analysis of the worldwide DBPII sequences will allow us to determine the minimum number of haplotypes (MNH) to be included in a DBP-based vaccine of broad coverage. For that, all DBPII sequences available were compiled and MNH was based on the most frequent nonsynonymous single nucleotide polymorphisms, the majority mapped on B and T cell epitopes. A preliminary analysis of DBPII genetic diversity from eight malaria-endemic countries estimated that a number between two to six DBP haplotypes (17 in total) would target at least 50% of parasite population circulating in each endemic region. Aiming to avoid region-specific haplotypes, we next analyzed the MNH that broadly cover worldwide parasite population. The results demonstrated that seven haplotypes would be required to cover around 60% of DBPII sequences available. Trying to validate these selected haplotypes per country, we found that five out of the eight countries will be covered by the MNH (67% of parasite populations, range 48-84%). In addition, to identify related subgroups of DBPII sequences we used a Bayesian clustering algorithm. The algorithm grouped all DBPII sequences in six populations that were independent of geographic origin, with ancestral populations present in different proportions in each country. In conclusion, in this first attempt to undertake a global analysis about DBPII variability, the results suggest that the development of DBP-based vaccine should consider multi-haplotype strategies; otherwise a putative P. vivax vaccine may not target some parasite populations.	[de Sousa, Tais Nobrega; Carvalho, Luzia Helena; Alves de Brito, Cristiana Ferreira] Ctr Pesquisa Rene Rachou Fiocruz, Lab Malaria, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	de Sousa, TN (corresponding author), Ctr Pesquisa Rene Rachou Fiocruz, Lab Malaria, Belo Horizonte, MG, Brazil.	cristiana@cpqrr.fiocruz.br	Carvalho, Luzia H/AAW-3461-2021; carvalho, luzia H/C-4087-2013; de Sousa, Tais Nobrega/AAG-6225-2019	de Sousa, Tais Nobrega/0000-0002-6874-9427	Research Foundation of Minas Gerais State (FAPEMIG); The Brazilian National Research Council (CNPq); Oswaldo Cruz Foundation (FIOCRUZ, PAPES V); Malaria Network/Support Program for Centers of Excellence - Pronex (MS/DECIT, CNPq, FAPEMIG, FAPEMAT and FAPERJ); CNPq (TNS, LHC and CFAB)	Research Foundation of Minas Gerais State (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); The Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation (FIOCRUZ, PAPES V); Malaria Network/Support Program for Centers of Excellence - Pronex (MS/DECIT, CNPq, FAPEMIG, FAPEMAT and FAPERJ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (TNS, LHC and CFAB)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Research Foundation of Minas Gerais State (FAPEMIG), The Brazilian National Research Council (CNPq), and Oswaldo Cruz Foundation (FIOCRUZ, PAPES V) and Malaria Network/Support Program for Centers of Excellence - Pronex (MS/DECIT, CNPq, FAPEMIG, FAPEMAT and FAPERJ). Scholarships from CNPq (TNS, LHC and CFAB) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Ampudia E, 1996, MOL BIOCHEM PARASIT, V78, P269, DOI 10.1016/S0166-6851(96)02611-4; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Babaeekho L, 2009, AM J TROP MED HYG, V80, P112, DOI 10.4269/ajtmh.2009.80.112; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bolton MJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-45; Cavasini CE, 2007, T ROY SOC TROP MED H, V101, P1042, DOI 10.1016/j.trstmh.2007.04.011; Ceravolo IP, 2008, SCAND J IMMUNOL, V67, P270, DOI 10.1111/j.1365-3083.2007.02059.x; Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; Cole-Tobian JL, 2007, AM J TROP MED HYG, V77, P955, DOI 10.4269/ajtmh.2007.77.955; Cole-Tobian JL, 2009, INFECT IMMUN, V77, P4009, DOI 10.1128/IAI.00158-09; Cole-Tobian JL, 2005, AM J TROP MED HYG, V73, P626, DOI 10.4269/ajtmh.2005.73.626; Cole-Tobian JL, 2002, J INFECT DIS, V186, P531, DOI 10.1086/341776; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Gosi P, 2007, AM J TROP MED HYG, V77, P247; Gosi P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-112; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hans D, 2005, MOL MICROBIOL, V55, P1423, DOI 10.1111/j.1365-2958.2005.04484.x; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Jia XL, 2002, J IMMUNOL, V169, P3200, DOI 10.4049/jimmunol.169.6.3200; Jia XL, 2000, MOL BIOCHEM PARASIT, V111, P253, DOI 10.1016/S0166-6851(00)00315-7; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; Kho Weon-Gyu, 2001, Korean Journal of Parasitology, V39, P143, DOI 10.3347/kjp.2001.39.2.143; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Krotoski W A, 1989, Prog Clin Parasitol, V1, P1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2002, MOL BIOL EVOL, V19, P1128, DOI 10.1093/oxfordjournals.molbev.a004171; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MONS B, 1988, EXP PARASITOL, V66, P183, DOI 10.1016/0014-4894(88)90089-6; PREMARATNE PH, 2011, INFECT GENET EV 0428; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Pritchard JK, 2000, GENETICS, V155, P945; Rezende AM, 2010, TROP MED INT HEALTH, V15, P718, DOI 10.1111/j.1365-3156.2010.02535.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Russell BM, 2003, ANTIMICROB AGENTS CH, V47, P170, DOI 10.1128/AAC.47.1.170-173.2003; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Saravia C, 2008, BIOCHEM BIOPH RES CO, V377, P1279, DOI 10.1016/j.bbrc.2008.10.153; Singh AP, 2005, MOL MICROBIOL, V55, P1925, DOI 10.1111/j.1365-2958.2005.04523.x; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Sousa TN, 2007, VOX SANG, V92, P373, DOI 10.1111/j.1423-0410.2007.00902.x; Sousa TN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-334; Sousa TN, 2006, MOL BIOCHEM PARASIT, V146, P251, DOI 10.1016/j.molbiopara.2005.11.006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; Udomsangpetch R, 2007, PARASITOL INT, V56, P65, DOI 10.1016/j.parint.2006.12.005; VanBuskirk KM, 2004, J INFECT DIS, V190, P1556, DOI 10.1086/424852; WELCH SG, 1977, T ROY SOC TROP MED H, V71, P295, DOI 10.1016/0035-9203(77)90102-X	63	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22944	10.1371/journal.pone.0022944	http://dx.doi.org/10.1371/journal.pone.0022944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829672	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511900017
J	Fiore-Donno, AM; Novozhilov, YK; Meyer, M; Schnittler, M				Fiore-Donno, Anna Maria; Novozhilov, Yuri K.; Meyer, Marianne; Schnittler, Martin			Genetic Structure of Two Protist Species (Myxogastria, Amoebozoa) Suggests Asexual Reproduction in Sexual Amoebae	PLOS ONE			English	Article							SUBUNIT RIBOSOMAL-RNA; PHYSARUM-POLYCEPHALUM; SLIME-MOLDS; DICTYOSTELIUM; REVEALS; SYSTEMS; DIVERSITY; EVOLUTION; HYPERAMOEBA; PHYLOGENY	Plasmodial slime molds (Myxogastria or Myxomycetes) are common and widespread unicellular organisms that are commonly assumed to have a sexual life cycle culminating with the formation of often macroscopic fruiting bodies that efficiently disseminate spores. However, laboratory studies based on mating compatibility revealed the coexistence of asexual as well as sexual strains. To test this hypothesis in natural populations, we investigated the genetic variability of two species of the genus Lamproderma. Detailed ecological releve's were carried out in 2007 and 2009 in several deep ravines in the Elbsandsteingebirge (Saxony, south-eastern Germany). Morphological characters of 93 specimens of Lamproderma were recorded and genetic analyses, based on the small subunit ribosomal gene, the internal transcribed spacer 1 and partial elongation factor 1 alpha sequences were carried out for 52 specimens. Genetic analyses showed the existence of two major clades, each composed of several discrete lineages. Most of these lineages were composed of several identical sequences (SSU, ITS 1 and EF-1 alpha) which is explained best by an asexual mode of reproduction. Detrended Correspondence Analysis of morphological characters revealed two morphospecies that corresponded to the two major clades, except for one genotype (Lc6), thus challenging the morphospecies concept. Genetic patterns were not related to the geographical distribution: specimens belonging to the same genotype were found in distinct ravines, suggesting effective long-distance dispersal via spores, except for the Lc6 genotype which was found only in one ravine. Implications for the morphological and biological species concept are discussed.	[Fiore-Donno, Anna Maria; Schnittler, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany; [Novozhilov, Yuri K.] Russian Acad Sci, VL Komarov Bot Inst, Lab Systemat & Geog Fungi, St Petersburg 196140, Russia; [Meyer, Marianne] Le Bayet, Rognaix, France	Ernst Moritz Arndt Universitat Greifswald; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences	Fiore-Donno, AM (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany.	afiore-donno6@infomaniak.ch	Novozhilov, Yuri/H-5161-2013; Schnittler, Martin/A-8916-2013	Novozhilov, Yuri/0000-0001-8875-2263; Fiore-Donno, Anna Maria/0000-0001-6265-1907	Ernst Moritz Arndt University of Greifswald; Federal goal-oriented state program "Scientific and scientific-teaching staff of innovative Russia'' [P1300]; RFBR [10-04-00536a]; Deutsche Forschungsgemeinschaft [SCHN1080-2/1]	Ernst Moritz Arndt University of Greifswald; Federal goal-oriented state program "Scientific and scientific-teaching staff of innovative Russia''; RFBR(Russian Foundation for Basic Research (RFBR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by a travel grant of the Ernst Moritz Arndt University of Greifswald, the Federal goal-oriented state program "Scientific and scientific-teaching staff of innovative Russia'' (project P1300) and grant RFBR 10-04-00536a to the second author. Publication was supported by a grant of the Deutsche Forschungsgemeinschaft to the first and last authors (SCHN1080-2/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; BETTERLEY DA, 1983, MYCOLOGIA, V75, P1044, DOI 10.2307/3792661; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Clark J, 1997, MYCOLOGIA, V89, P241, DOI 10.2307/3761077; CLARK J, 1993, MYCOLOGIA, V85, P764, DOI 10.2307/3760607; Clark J, 2010, MYCOSPHERE, V1, P337; COLLINS O R, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P101; COLLINS OR, 1975, MYCOLOGIA, V67, P98, DOI 10.2307/3758232; Dacks J, 1999, J MOL EVOL, V48, P779, DOI 10.1007/PL00013156; de Meeus T, 2007, CELL MOL LIFE SCI, V64, P1355, DOI 10.1007/s00018-007-6515-2; Dunthorn M, 2010, TRENDS MICROBIOL, V18, P183, DOI 10.1016/j.tim.2010.02.005; ElHage N, 2000, MYCOLOGIA, V92, P54, DOI 10.2307/3761450; Fiore-Donno AM, 2005, J EUKARYOT MICROBIOL, V52, P201, DOI 10.1111/j.1550-7408.2005.00032.x; Fiore-Donno AM, 2008, MOL PHYLOGENET EVOL, V46, P878, DOI 10.1016/j.ympev.2007.12.011; Fiore-Donno AM, 2010, J EUKARYOT MICROBIOL, V57, P189, DOI 10.1111/j.1550-7408.2009.00466.x; Fiore-Donno AM, 2010, PROTIST, V161, P55, DOI 10.1016/j.protis.2009.05.002; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Glockner G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-6; GREEN RF, 1995, J THEOR BIOL, V174, P87, DOI 10.1006/jtbi.1995.0081; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARKONEN M, 1978, Karstenia, V18, P20; Hood GM, 2009, POPTOOLS V 3 1 1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ING B, 1994, NEW PHYTOL, V126, P175, DOI 10.1111/j.1469-8137.1994.tb03937.x; ING B, 1983, J BIOGEOGR, V10, P299, DOI 10.2307/2844739; Ishida K, 2005, DEV GROWTH DIFFER, V47, P25; JOHANSEN T, 1988, CURR GENET, V14, P265, DOI 10.1007/BF00376747; Jolliffe I.T, 2002, PRINCIPAL COMPONENTS, V2nd, P487; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Lado C., 2001, CUADERNOS TRABAJO FL, V16, P1; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lundblad EW, 2004, MOL BIOL EVOL, V21, P1283, DOI 10.1093/molbev/msh126; Martin MP, 2003, MYCOLOGIA, V95, P474, DOI 10.2307/3761889; McCune B., 2006, PC ORD MULTIVARIATE; Nassonova E, 2010, PROTIST, V161, P102, DOI 10.1016/j.protis.2009.07.003; Neubert H, 1990, BEITR KENNTN PILZE M, V6, P49; Neubert H, 2000, STEMONITALES, P391; Olive LS, 1975, MYCETOZOANS; Otto SP, 2006, BIOCHEM SOC T, V34, P519, DOI 10.1042/BST0340519; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Poulain M, 2011, MYXOMYCETES SEVRIER; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Roger AJ, 2009, CURR BIOL, V19, pR165, DOI 10.1016/j.cub.2008.12.032; Schnittler M, 2008, MYCOL RES, V112, P697, DOI 10.1016/j.mycres.2008.01.012; Schnittler M, 2010, NOVA HEDWIGIA, V90, P277, DOI 10.1127/0029-5035/2010/0090-0277; Song J, 2005, PLOS COMPUT BIOL, V1, P579, DOI 10.1371/journal.pcbi.0010071; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stephenson SL, 2008, BIODIVERS CONSERV, V17, P285, DOI 10.1007/s10531-007-9252-9; THERRIEN CD, 1977, AM J BOT, V64, P286, DOI 10.2307/2441972; Tsuchiya M, 2003, J FORAMIN RES, V33, P285, DOI 10.2113/0330285; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Watkins RF, 2008, PROTIST, V159, P269, DOI 10.1016/j.protis.2007.12.001; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698	58	34	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22872	10.1371/journal.pone.0022872	http://dx.doi.org/10.1371/journal.pone.0022872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829662	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511200024
J	Huang, L; Pan, CQ; Li, BW; Tucker-Kellogg, L; Tidor, B; Chen, YZ; Low, BC				Huang, Lu; Pan, Catherine Qiurong; Li, Baowen; Tucker-Kellogg, Lisa; Tidor, Bruce; Chen, Yuzong; Low, Boon Chuan			Simulating EGFR-ERK Signaling Control by Scaffold Proteins KSR and MP1 Reveals Differential Ligand-Sensitivity Co-Regulated by Cbl-CIN85 and Endophilin	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MAP KINASE CASCADE; FACTOR-RECEPTOR; RHO-KINASE; PC12 CELLS; IN-VIVO; DOWN-REGULATION; ACTIVATION; CANCER; PATHWAY	ERK activation is enhanced by the scaffolding proteins KSR and MP1, localized near the cell membrane and late endosomes respectively, but little is known about their dynamic interplay. We develop here a mathematical model with ordinary differential equations to describe the dynamic activation of EGFR-ERK signaling under a conventional pathway without scaffolds, a KSR-scaffolded pathway, and an MP1-scaffolded pathway, and their impacts were examined under the influence of the endosomal regulators, Cbl-CIN85 and Endophilin A1. This new integrated model, validated against experimental results and computational constraints, shows that changes of ERK activation and EGFR endocytosis in response to EGF concentrations (i. e ligand sensitivity) depend on these scaffold proteins and regulators. The KSR-scaffolded and the conventional pathways act synergistically and are sensitive to EGF stimulation. When the KSR level is high, the sensitivity of ERK activation from this combined pathway remains low when Cbl-CIN85 level is low. But, such sensitivity can be increased with increasing levels of Endophilin if Cbl-CIN85 level becomes high. However, reduced KSR levels already present high sensitivity independent of Endophilin levels. In contrast, ERK activation by MP1 is additive to that of KSR but it shows little ligand-sensitivity under high levels of EGF. This can be partly reversed by increasing level of Endophilin while keeping CblCIN85 level low. Further analyses showed that high levels of KSR affect ligand-sensitivity of EGFR endocytosis whereas MP1 ensures the robustness of endosomal ERK activation. These simulations constitute a multi-dimensional exploration of how EGF-dependent EGFR endocytosis and ERK activation are dynamically affected by scaffolds KSR and MP1, co-regulated by Cbl-CIN85 and Endophilin A1. Together, these results provide a detailed and quantitative demonstration of how regulators and scaffolds can collaborate to fine-tune the ligand-dependent sensitivity of EGFR endocytosis and ERK activation which could underlie differences during normal physiology, disease states and drug responses.	[Huang, Lu; Tucker-Kellogg, Lisa; Tidor, Bruce; Chen, Yuzong; Low, Boon Chuan] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore; [Chen, Yuzong] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Tidor, Bruce] MIT, Dept Elect Engn & Comp Sci, Dept Biol Engn, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Tidor, Bruce] Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Pan, Catherine Qiurong; Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Li, Baowen] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore; [Huang, Lu; Pan, Catherine Qiurong; Tucker-Kellogg, Lisa; Low, Boon Chuan] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore; National University of Singapore	Huang, L (corresponding author), Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore.	phacyz@nus.edu.sg; dbslowbc@nus.edu.sg	Huang, Lu/J-8841-2019; Low, Boon Chuan/AAU-7685-2021; Li, Baowen/G-3003-2011; Tucker-Kellogg, Lisa/G-3376-2012; Tucker-Kellogg, Lisa/AAD-9265-2022; Low, Boon Chuan/H-8049-2012	Low, Boon Chuan/0000-0003-0756-096X; Li, Baowen/0000-0002-8728-520X; Tucker-Kellogg, Lisa/0000-0002-1301-7069; Low, Boon Chuan/0000-0003-0756-096X; Chen, Yu Zong/0000-0002-5473-8022; Huang, Lan/0000-0001-9594-4722; /0000-0002-3320-3969	National University of Singapore [R-148-000-081-112/101]; Singapore-MIT Alliance; Singapore National Research Foundation; Singapore National Research Foundation and the Ministry of Education, Singapore	National University of Singapore(National University of Singapore); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Singapore National Research Foundation(National Research Foundation, Singapore); Singapore National Research Foundation and the Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported by Academic Research Fund (R-148-000-081-112/101) from the National University of Singapore, the Computation and Systems Biology Program of Singapore-MIT Alliance, the Singapore-MIT Alliance for Research and Technology (through funding from the Singapore National Research Foundation), and also from the Mechanobiology Institute of Singapore (co-funded by the Singapore National Research Foundation and the Ministry of Education, Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Budzyn K, 2006, TRENDS PHARMACOL SCI, V27, P97, DOI 10.1016/j.tips.2005.12.002; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Costa M, 2003, J ENVIRON MONITOR, V5, P222, DOI 10.1039/b210260a; D'Alessio A, 2007, CELL SIGNAL, V19, P1193, DOI 10.1016/j.cellsig.2006.12.011; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Faried LS, 2006, ONCOL REP, V16, P57; Giurisato E, 2009, MOL CELL BIOL, V29, P1554, DOI 10.1128/MCB.01421-08; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kolesnick R, 2004, J CLIN INVEST, V114, P1233, DOI 10.1172/JCI200423441; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; KURACHI H, 1985, J ENDOCRINOL, V106, P197, DOI 10.1677/joe.0.1060197; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Lazzara MJ, 2010, CANCER RES, V70, P3843, DOI 10.1158/0008-5472.CAN-09-3421; Lerdrup M, 2006, J CELL SCI, V119, P85, DOI 10.1242/jcs.02707; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Liu G, 2005, BIOINFORMATICS, V21, P1194, DOI 10.1093/bioinformatics/bti118; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Lozano J, 2003, CANCER RES, V63, P4232; Marshall CJ, 1998, NATURE, V392, P553, DOI 10.1038/33293; Mayawala K, 2004, BIOPHYS J, V87, pL1, DOI 10.1529/biophysj.104.051888; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; OKAMOTO S, 1984, P NATL ACAD SCI-BIOL, V81, P6059, DOI 10.1073/pnas.81.19.6059; Pan CQ, 2010, J CELL SCI, V123, P903, DOI 10.1242/jcs.064162; Park ER, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-26; Peters SLM, 2006, TRENDS PHARMACOL SCI, V27, P492, DOI 10.1016/j.tips.2006.07.002; Price JT, 1996, EUR J CANCER, V32A, P1977, DOI 10.1016/0959-8049(96)00207-9; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SCOTT A, 1995, J BIOL CHEM, V270, P24540, DOI 10.1074/jbc.270.41.24540; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Singhal M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-199; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stoeger SM, 2009, CANCER CHEMOTH PHARM, V63, P807, DOI 10.1007/s00280-008-0794-7; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; TOMMOY M, 1981, AM J ANAT, V160, P267, DOI 10.1002/aja.1001600305; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Ung CY, 2008, FEBS LETT, V582, P2283, DOI 10.1016/j.febslet.2008.05.026; Vomastek T, 2004, P NATL ACAD SCI USA, V101, P6981, DOI 10.1073/pnas.0305894101; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WOJCIK J, 2001, BIOINFORMATICS S1, V17, P296; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52; Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776	83	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22933	10.1371/journal.pone.0022933	http://dx.doi.org/10.1371/journal.pone.0022933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829671	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200027
J	Medina, C; Camacho, EM; Flores, A; Mesa-Pereira, B; Santero, E				Medina, Carlos; Maria Camacho, Eva; Flores, Amando; Mesa-Pereira, Beatriz; Santero, Eduardo			Improved Expression Systems for Regulated Expression in Salmonella Infecting Eukaryotic Cells	PLOS ONE			English	Article							RESPONSIVE TRANSCRIPTION ANTITERMINATION; GENE-EXPRESSION; III SECRETION; IN-VIVO; PROTEIN; NITRATE; OVEREXPRESSION; INDUCTION; NASR; SALICYLATE	In this work we describe a series of improvements to the Salmonella-based salicylate-inducible cascade expression system comprised of a plasmid-borne expression module, where target gene expression is driven by the Pm promoter governed by the XylS2 regulator, and a genome-integrated regulatory module controlled by the nahR/P-sal system. We have constructed a set of high and low-copy number plasmids bearing modified versions of the expression module with a more versatile multiple cloning site and different combinations of the following elements: (i) the nasF transcriptional attenuator, which reduces basal expression levels, (ii) a strong ribosome binding site, and (iii) the Type III Secretion System (TTSS) signal peptide from the effector protein SspH2 to deliver proteins directly to the eukaryotic cytosol following bacterial infection of animal cells. We show that different expression module versions can be used to direct a broad range of protein production levels. Furthermore, we demonstrate that the efficient reduction of basal expression by the nasF attenuator allows the cloning of genes encoding highly cytotoxic proteins such as colicin E3 even in the absence of its immunity protein. Additionally, we show that the Salmonella TTSS is able to translocate most of the protein produced by this regulatory cascade to the cytoplasm of infected HeLa cells. Our results indicate that these vectors represent useful tools for the regulated overproduction of heterologous proteins in bacterial culture or in animal cells, for the cloning and expression of genes encoding toxic proteins and for pathogenesis studies.	[Medina, Carlos; Maria Camacho, Eva; Flores, Amando; Mesa-Pereira, Beatriz; Santero, Eduardo] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Medina, C (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.	cmedmor@upo.es	Santero, Eduardo/K-6510-2014; Camacho, Eva/K-9839-2014; Medina Morillas, Carlos/L-1773-2014; Mesa, Beatriz/O-9895-2019; Flores, Amando/K-9283-2017	Camacho, Eva/0000-0002-6465-7381; Medina Morillas, Carlos/0000-0003-0069-7330; Flores, Amando/0000-0002-1887-0659; Santero, Eduardo/0000-0002-6111-7160	Spanish Ministry of Science and Innovation [BIO2008-01805, CSD2007-00005]; Andalusian government [P07-CVI-2518]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian government	Work in the authors' laboratory was supported by the Spanish Ministry of Science and Innovation, grants BIO2008-01805 and CSD2007-00005, and by the Andalusian government, grant P07-CVI-2518 and a fellowship awarded to BMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony LC, 2004, J MICROBIOL METH, V58, P243, DOI 10.1016/j.mimet.2004.04.003; Aune TEV, 2010, MICROB BIOTECHNOL, V3, P38, DOI 10.1111/j.1751-7915.2009.00126.x; Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; CARLOMAGNO MS, 1985, J BACTERIOL, V163, P362, DOI 10.1128/JB.163.1.362-368.1985; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cebolla A, 2002, APPL ENVIRON MICROB, V68, P5034, DOI 10.1128/AEM.68.10.5034-5041.2002; Cebolla A, 2001, NUCLEIC ACIDS RES, V29, P759, DOI 10.1093/nar/29.3.759; Chai WH, 1999, J MOL BIOL, V292, P203, DOI 10.1006/jmbi.1999.3084; Chai WH, 1998, J MOL BIOL, V283, P339, DOI 10.1006/jmbi.1998.2105; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIAZ E, 1994, MOL MICROBIOL, V13, P855, DOI 10.1111/j.1365-2958.1994.tb00477.x; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; FRANTZ B, 1995, SCIENCE, V270, P2017, DOI 10.1126/science.270.5244.2017; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Kasinskas RW, 2007, CANCER RES, V67, P3201, DOI 10.1158/0008-5472.CAN-06-2618; Lin JT, 1996, J MOL BIOL, V256, P423, DOI 10.1006/jmbi.1996.0098; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miller JH, 1972, EXPT MOL GENETICS LA; Panthel K, 2005, INFECT IMMUN, V73, P334, DOI 10.1128/IAI.73.1.334-341.2005; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Royo JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni168; Royo JL, 2005, J BIOTECHNOL, V116, P113, DOI 10.1016/j.jbiotec.2004.10.006; Royo JL, 2007, NAT METHODS, V4, P937, DOI 10.1038/NMETH1107; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J., 2001, MOL CLONING LAB MANU; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Senatus PB, 2006, MOL CANCER THER, V5, P20, DOI 10.1158/1535-7163.MCT-05-0181; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; STRAGIER P, 1990, MOL MICROBIOL, V4, P1801, DOI 10.1111/j.1365-2958.1990.tb02028.x; Thone F, 2007, J MICROBIOL METH, V71, P220, DOI 10.1016/j.mimet.2007.08.016; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; WEISSMANN G, 1991, SCI AM, V264, P84, DOI 10.1038/scientificamerican0191-84; Wendland M, 2002, FEBS LETT, V521, P105, DOI 10.1016/S0014-5793(02)02834-X; Wu SQT, 1999, J BACTERIOL, V181, P7274, DOI 10.1128/JB.181.23.7274-7284.1999	39	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23055	10.1371/journal.pone.0023055	http://dx.doi.org/10.1371/journal.pone.0023055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829692	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200036
J	Stricker, S; Oberwahrenbrock, T; Zimmermann, H; Schroeter, J; Endres, M; Brandt, AU; Paul, F				Stricker, Sarah; Oberwahrenbrock, Timm; Zimmermann, Hanna; Schroeter, Jan; Endres, Matthias; Brandt, Alexander U.; Paul, Friedemann			Temporal Retinal Nerve Fiber Loss in Patients with Spinocerebellar Ataxia Type 1	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; DOMINANT CEREBELLAR ATAXIAS; MITOCHONDRIAL DYSFUNCTION; MULTIPLE-SCLEROSIS; CLINICAL-FEATURES; DISEASE; NEUROPATHIES; DEGENERATION; PATHOGENESIS; FAMILIES	Background: Autosomal dominant spinocerebellar ataxia type 1 is an adult onset progressive disorder with well characterized neurodegeneration in the cerebellum and brainstem. Beyond brain atrophy, few data exist concerning retinal and optic nerve involvement. Objective: To evaluate retinal changes in SCA1 patients compared to age and gender matched healthy controls. Methodology/Principal Findings: Nine patients with SCA1 were prospectively recruited from the ataxia clinic and were compared to nine age and gender matched healthy controls. Both cohorts received assessment of visually evoked potentials and eye examination by optical coherence tomography to determine retinal nerve fiber layer thickness and total macular volume. While no differences were found in visually evoked potentials, SCA1 patients showed a significant reduction of mean retinal nerve fiber layer thickness (RNFLT) compared to healthy controls (84613 mm vs. 9768 mm, p = 0.004). Temporal areas showed the most prominent RNFLT reduction with high statistical significances (temporal-inferior: p < 0.001, temporal: p < 0.001, temporal-superior: p = 0.005) whereas RNFLT in nasal areas was in the range of the control group. From six SCA1 patients an additional macular scan was obtained. The comparison to the corresponding healthy control showed a slight but not significant reduction in TMV (8.22+/-0.68 mm 3 vs. 8.61+/-0.41 mm 3, p = 0.15). Conclusion: In SCA1 patients, we found evidence for degeneration of retinal nerve fibers. The temporal focus of the observed retinal nerve fiber layer reduction suggests an involvement of the papillo-macular bundle which resembles pathology found in toxic or mitochondrial optic nerve disease such as Leber's hereditary optic neuropathy (LHON) or dominant optic atrophy (DOA).	[Stricker, Sarah; Endres, Matthias] Charite Univ Med Berlin, Neurol Klin, Berlin, Germany; [Oberwahrenbrock, Timm; Zimmermann, Hanna; Brandt, Alexander U.; Paul, Friedemann] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Oberwahrenbrock, Timm; Zimmermann, Hanna; Brandt, Alexander U.; Paul, Friedemann] Charite Univ Med Berlin, Expt & Clin Res Ctr, Berlin, Germany; [Oberwahrenbrock, Timm; Zimmermann, Hanna; Brandt, Alexander U.; Paul, Friedemann] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Schroeter, Jan] Charite Univ Med Berlin, Klin Augenheilkunde, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stricker, S (corresponding author), Charite Univ Med Berlin, Neurol Klin, Berlin, Germany.	sarah.stricker@charite.de	Paul, Friedemann/ABF-9415-2020	Zimmermann, Hanna/0000-0002-0276-8051; Endres, Matthias/0000-0001-6520-3720; paul, friedemann/0000-0002-6378-0070	Deutsche Forschungsgemeinschaft (DFG) [Exc. 257]; BMBF; EU; VolkswagenStiftung; Deutsche Forschungsgemeinschaft; Astra-Zeneca; Sanofi-Aventis; gfnmediber GmbH; ECTRIMS; BayerSchering; MerckSerono; Teva-SanofiAventis; Novartis	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Astra-Zeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); gfnmediber GmbH; ECTRIMS; BayerSchering(Bayer AG); MerckSerono(Merck & Company); Teva-SanofiAventis(Sanofi-Aventis); Novartis(Novartis)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG Exc. 257 to FP), (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Financial disclosure by SS TO HZ JS: none. Financial disclosure by ME: ME receives funding from the BMBF, EU, VolkswagenStiftung, and the Deutsche Forschungsgemeinschaft. ME has received grant support from Astra-Zeneca and Sanofi-Aventis, has participated in advisory board meetings of Boehringer Ingelheim, MSD, and Sanofi-Aventis, and has received honoraria from Novartis, Pfizer, Bayer, Astra-Zeneca, Boehringer Ingelheim, Sanofi-Aventis, Trommsdorff, Berlin-Chemie, GlaxoSmithKline, and Bristol-Myers-Squibbs. Financial disclosure by AUB: AUB received compensation from gfnmediber GmbH as an employee. gfnmediber was not involved in the planning and execution of this study. AUB received a travel grant from ECTRIMS. Financial disclosure by FP: FP has received research grants, travel grants and speaker honoraria from various pharmaceutical companies (BayerSchering, MerckSerono, Teva-SanofiAventis, Novartis). FP is supported by the German Research Foundation (DFG Exc 257).	Abe T, 1997, ARCH OPHTHALMOL-CHIC, V115, P231, DOI 10.1001/archopht.1997.01100150233013; Abe T, 2001, GRAEF ARCH CLIN EXP, V239, P722, DOI 10.1007/s004170100342; Abele M, 1997, BRAIN, V120, P2141, DOI 10.1093/brain/120.12.2141; Almarcegui C, 2010, NEUROPHYSIOL CLIN, V40, P129, DOI 10.1016/j.neucli.2009.12.001; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2; Fortuna F, 2009, BRAIN, V132, P116, DOI 10.1093/brain/awn269; GELFAND JM, 2010, J NEUROL; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Kang S, 2009, MOL CELLS, V27, P621, DOI 10.1007/s10059-009-0095-y; Kim SJ, 2003, BIOCHEM BIOPH RES CO, V307, P660, DOI 10.1016/S0006-291X(03)01241-5; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; Manrique RK, 2009, J NEURO-OPHTHALMOL, V29, P174, DOI 10.1097/WNO.0b013e3181b2828e; Mayer MA, 2010, BIOMED OPT EXPRESS, V1, P1358, DOI 10.1364/BOE.1.001358; McLaughlin ME, 2002, ARCH OPHTHALMOL-CHIC, V120, P655; Miller RC, 2009, J NEURO-OPHTHALMOL, V29, P180, DOI 10.1097/WNO.0b013e3181b1b3f8; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Perretti A, 1996, J NEUROL SCI, V142, P45, DOI 10.1016/0022-510X(96)00140-2; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; ROBITAILLE Y, 1995, ACTA NEUROPATHOL, V90, P572; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; van Velthoven MEJ, 2007, PROG RETIN EYE RES, V26, P57, DOI 10.1016/j.preteyeres.2006.10.002; Walia S, 2007, INVEST OPHTH VIS SCI, V48, P4748, DOI 10.1167/iovs.07-0404	28	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23024	10.1371/journal.pone.0023024	http://dx.doi.org/10.1371/journal.pone.0023024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829579	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000293286500069
J	Furuta, Y; Yahara, K; Hatakeyama, M; Kobayashi, I				Furuta, Yoshikazu; Yahara, Koji; Hatakeyama, Masanori; Kobayashi, Ichizo			Evolution of cagA Oncogene of Helicobacter pylori through Recombination	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HOMOLOGOUS RECOMBINATION; INSERTION SPECIFICITY; DIVERSITY; GENES; ORGANIZATION; KINASES; LOCALIZATION; DEPENDENCE; ACCURACY	Helicobacter pylori is a gastric pathogen that infects half the human population and causes gastritis, ulcers, and cancer. The cagA gene product is a major virulence factor associated with gastric cancer. It is injected into epithelial cells, undergoes phosphorylation by host cell kinases, and perturbs host signaling pathways. CagA is known for its geographical, structural, and functional diversity in the C-terminal half, where an EPIYA host-interacting motif is repeated. The Western version of CagA carries the EPIYA segment types A, B, and C, while the East Asian CagA carries types A, B, and D and shows higher virulence. Many structural variants such as duplications and deletions are reported. In this study, we gained insight into the relationships of CagA variants through various modes of recombination, by analyzing all known cagA variants at the DNA sequence level with the single nucleotide resolution. Processes that occurred were: (i) homologous recombination between DNA sequences for CagA multimerization (CM) sequence; (ii) recombination between DNA sequences for the EPIYA motif; and (iii) recombination between short similar DNA sequences. The left half of the EPIYA-D segment characteristic of East Asian CagA was derived from Western type EPIYA, with Amerind type EPIYA as the intermediate, through rearrangements of specific sequences within the gene. Adaptive amino acid changes were detected in the variable region as well as in the conserved region at sites to which no specific function has yet been assigned. Each showed a unique evolutionary distribution. These results clarify recombination-mediated routes of cagA evolution and provide a solid basis for a deeper understanding of its function in pathogenesis.	[Furuta, Yoshikazu; Kobayashi, Ichizo] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Minato Ku, Tokyo, Japan; [Furuta, Yoshikazu; Kobayashi, Ichizo] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Yahara, Koji] Kurume Univ, Grad Sch Med, Fukuoka, Japan; [Yahara, Koji] Fujitsu Kyushu Syst Ltd, Fukuoka, Japan; [Hatakeyama, Masanori] Univ Tokyo, Dept Microbiol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Kobayashi, Ichizo] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Minato Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; Kurume University; Fujitsu Ltd; University of Tokyo; University of Tokyo	Furuta, Y (corresponding author), Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Minato Ku, Tokyo, Japan.	ikobaya@ims.u-tokyo.ac.jp	Kobayashi, Ichizo/GVT-8377-2022; Furuta, Yoshikazu/AAB-2219-2020	Furuta, Yoshikazu/0000-0003-4710-1389; Kobayashi, Ichizo/0000-0002-3854-1879	Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT); Japan Society for the Promotion of Science (JSPS) [21370001]; Urakami Foundation; Grants-in-Aid for Scientific Research [22114002, 22114001, 22240085] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Urakami Foundation(Urakami Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants to I.K. from the global COE (Center of Excellence) project of "Genome Information Big Bang" from Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT), the 'Grants-in-Aid for Scientific Research' from the Japan Society for the Promotion of Science (JSPS) (21370001), and from Urakami Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aras RA, 2003, J INFECT DIS, V188, P486, DOI 10.1086/377098; Bui XT, 2009, J CLIN MICROBIOL, V47, P4021, DOI 10.1128/JCM.00504-09; Craig NL, 2002, MOBILE DNA 2; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrlich S. D., 1989, MOBILE DNA-UK, P799; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fischer Wolfgang, 2008, P115; Fujitani Y, 1999, GENETICS, V153, P1973; FUJITANI Y, 1995, GENETICS, V140, P797; Furuta Y, 2011, P NATL ACAD SCI USA, V108, P1501, DOI 10.1073/pnas.1012579108; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai M, 2011, BMC MICROBI IN PRESS; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; Kersulyte D, 1998, GENE, V223, P175, DOI 10.1016/S0378-1119(98)00164-4; Kersulyte D, 2004, J BACTERIOL, V186, P7521, DOI 10.1128/JB.186.22.7521-7528.2004; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Losich R., 2008, MOL BIOL GENE; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Nguyen LT, 2010, EUR J CLIN MICROBIOL, V29, P651, DOI 10.1007/s10096-010-0909-z; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Pond SLK, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P419; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; Satomi S, 2006, J GASTROENTEROL, V41, P668, DOI 10.1007/s00535-006-1838-6; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; SHEN P, 1986, GENETICS, V112, P441; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Morquecho A, 2010, INFECT GENET EVOL, V10, P764, DOI 10.1016/j.meegid.2010.04.005; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zeaiter Z, 2008, CELL MICROBIOL, V10, P781, DOI 10.1111/j.1462-5822.2007.01084.x	60	32	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23499	10.1371/journal.pone.0023499	http://dx.doi.org/10.1371/journal.pone.0023499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853141	Green Submitted, Green Published, gold			2022-12-27	WOS:000293953400049
J	Regner, M; Pavlinovic, L; Young, N; Mullbacher, A				Regner, Matthias; Pavlinovic, Lisa; Young, Nicolie; Muellbacher, Arno			In Vivo Elimination of MHC-I-Deficient Lymphocytes by Activated Natural Killer Cells Is Independent of Granzymes A and B	PLOS ONE			English	Article							TARGET-CELLS; MEDIATED CYTOTOXICITY; CYTOLYTIC LEUKOCYTES; DNA FRAGMENTATION; VIRAL-INFECTION; CUTTING EDGE; A-DEFICIENT; T-CELLS; PERFORIN; MICE	NK cells kill target cells mainly via exocytosis of granules containing perforin (perf) and granzymes (gzm). In vitro, gzm delivery into the target cell cytosol results in apoptosis, and induction of apoptosis is severely impaired in the absence of gzm A and B. However, their importance for in vivo cytotoxicity by cytotoxic T cells has been questioned. We used an in vivo NK cytotoxicity assay, in which splenocytes from wild-type and beta(2)microglobulin-deficient (MHC-I(neg)) mice are co-injected into recipients whose NK cells were activated by virus infection or synthetic Toll-like receptor ligands. Elimination of adoptively transferred MHC-I(neg) splenocytes was unimpaired in the absence of gzmA and gzmB, but dependent on perforin. This target cell rejection was NK cell dependent, since NK cell depletion abrogated it. Furthermore, target cell elimination in vivo was equally rapid in both wild-type and gzmAxB-deficient recipients, with the majority of specific target cells lost from lymphoid tissue within less than one to two hours after transfer. Thus, similar to T cell cytotoxicity, the contribution of gzmA and B to in vivo target cell elimination remains unresolved.	[Regner, Matthias; Pavlinovic, Lisa; Young, Nicolie; Muellbacher, Arno] Australian Natl Univ, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2601, Australia; [Regner, Matthias] Australian Natl Univ, Sch Med, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Regner, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2601, Australia.	Matthias.Regner@anu.edu.au			Australian National Health and Medical Research Council; government block	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); government block	This work was supported by the Australian National Health and Medical Research Council and by a government block grant to the John Curtin School of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharifi M, 2006, EUR J IMMUNOL, V36, P887, DOI 10.1002/eji.200535342; Alsharifi M, 2005, J IMMUNOL, V175, P4635, DOI 10.4049/jimmunol.175.7.4635; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Davis JE, 2001, EUR J IMMUNOL, V31, P39, DOI 10.1002/1521-4141(200101)31:1<39::AID-IMMU39>3.0.CO;2-1; EBNET K, 1995, EMBO J, V14, P4230, DOI 10.1002/j.1460-2075.1995.tb00097.x; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Grundy MA, 2007, CANCER IMMUNOL IMMUN, V56, P1153, DOI 10.1007/s00262-006-0264-1; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hirst CE, 2001, MOL HUM REPROD, V7, P1133, DOI 10.1093/molehr/7.12.1133; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; MULLBACHER A, 1988, IMMUNOL CELL BIOL, V66, P153, DOI 10.1038/icb.1988.19; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; MULLBACHER A, 1989, SCAND J IMMUNOL, V30, P21, DOI 10.1111/j.1365-3083.1989.tb01184.x; MULLBACHER A, 1978, IMMUNOGENETICS, V7, P551, DOI 10.1007/BF01844044; Oberg L, 2004, EUR J IMMUNOL, V34, P1646, DOI 10.1002/eji.200424913; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pardo J, 2002, EUR J IMMUNOL, V32, P1980, DOI 10.1002/1521-4141(200207)32:7<1980::AID-IMMU1980>3.0.CO;2-Z; Pardo J, 2002, EUR J IMMUNOL, V32, P2881, DOI 10.1002/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Riera L, 2000, EUR J IMMUNOL, V30, P1350, DOI 10.1002/(SICI)1521-4141(200005)30:5<1350::AID-IMMU1350>3.0.CO;2-J; Sedelies KA, 2008, CELL DEATH DIFFER, V15, P708, DOI 10.1038/sj.cdd.4402300; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; Smyth MJ, 2003, J IMMUNOL, V171, P515, DOI 10.4049/jimmunol.171.2.515; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; WONDERLICH J, 2006, INDUCTION MEASUREMEN	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23252	10.1371/journal.pone.0023252	http://dx.doi.org/10.1371/journal.pone.0023252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853094	gold, Green Submitted, Green Published			2022-12-27	WOS:000293953400034
J	Robinson, T; Campino, SG; Auburn, S; Assefa, SA; Polley, SD; Manske, M; MacInnis, B; Rockett, KA; Maslen, GL; Sanders, M; Quail, MA; Chiodini, PL; Kwiatkowski, DP; Clark, TG; Sutherland, CJ				Robinson, Timothy; Campino, Susana G.; Auburn, Sarah; Assefa, Samuel A.; Polley, Spencer D.; Manske, Magnus; MacInnis, Bronwyn; Rockett, Kirk A.; Maslen, Gareth L.; Sanders, Mandy; Quail, Michael A.; Chiodini, Peter L.; Kwiatkowski, Dominic P.; Clark, Taane G.; Sutherland, Colin J.			Drug-Resistant Genotypes and Multi-Clonality in Plasmodium falciparum Analysed by Direct Genome Sequencing from Peripheral Blood of Malaria Patients	PLOS ONE			English	Article							MEROZOITE SURFACE-ANTIGEN; POLYMERASE-CHAIN-REACTION; GENETIC DIVERSITY; STRUCTURAL VARIATION; CHILDREN; TRANSMISSION; COMPLEXITY; PCR; POLYMORPHISMS; PYRIMETHAMINE	Naturally acquired blood-stage infections of the malaria parasite Plasmodium falciparum typically harbour multiple haploid clones. The apparent number of clones observed in any single infection depends on the diversity of the polymorphic markers used for the analysis, and the relative abundance of rare clones, which frequently fail to be detected among PCR products derived from numerically dominant clones. However, minority clones are of clinical interest as they may harbour genes conferring drug resistance, leading to enhanced survival after treatment and the possibility of subsequent therapeutic failure. We deployed new generation sequencing to derive genome data for five non-propagated parasite isolates taken directly from 4 different patients treated for clinical malaria in a UK hospital. Analysis of depth of coverage and length of sequence intervals between paired reads identified both previously described and novel gene deletions and amplifications. Full-length sequence data was extracted for 6 loci considered to be under selection by antimalarial drugs, and both known and previously unknown amino acid substitutions were identified. Full mitochondrial genomes were extracted from the sequencing data for each isolate, and these are compared against a panel of polymorphic sites derived from published or unpublished but publicly available data. Finally, genome-wide analysis of clone multiplicity was performed, and the number of infecting parasite clones estimated for each isolate. Each patient harboured at least 3 clones of P. falciparum by this analysis, consistent with results obtained with conventional PCR analysis of polymorphic merozoite antigen loci. We conclude that genome sequencing of peripheral blood P. falciparum taken directly from malaria patients provides high quality data useful for drug resistance studies, genomic structural analyses and population genetics, and also robustly represents clonal multiplicity.	[Robinson, Timothy; MacInnis, Bronwyn; Rockett, Kirk A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Campino, Susana G.; Auburn, Sarah; Assefa, Samuel A.; Manske, Magnus; MacInnis, Bronwyn; Rockett, Kirk A.; Maslen, Gareth L.; Sanders, Mandy; Quail, Michael A.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, S Cambs, England; [Auburn, Sarah] Charles Darwin Univ, Global Hlth Div, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Polley, Spencer D.; Chiodini, Peter L.; Sutherland, Colin J.] Hosp Trop Dis, Dept Clin Parasitol, London NW1 0PE, England; [Chiodini, Peter L.; Clark, Taane G.; Sutherland, Colin J.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Chiodini, Peter L.; Clark, Taane G.; Sutherland, Colin J.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; Charles Darwin University; Menzies School of Health Research; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Robinson, T (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	colin.sutherland@lshtm.ac.uk	Quail, michael/ABE-6131-2020; Sutherland, Colin/AAN-3939-2020; Clark, Taane G./AAM-2570-2020; Polley, Spencer/F-7766-2013; Campino, Susana/AAM-2577-2020; Auburn, Sarah/N-2266-2013	Sutherland, Colin/0000-0003-1592-6407; Clark, Taane G./0000-0001-8985-9265; Campino, Susana/0000-0003-1403-6138; Robinson, Tim/0000-0003-0933-646X; Auburn, Sarah/0000-0002-4638-536X; Manske, Magnus/0000-0001-5916-0947; Kwiatkowski, Dominic/0000-0002-5023-0176; Maslen, Gareth/0000-0001-7318-3678	Foundation for Innovative New Diagnostics; UCL Hospitals Comprehensive Biomedical Research Centre for Infection; United Kingdom Health Protection Agency; Wellcome Trust [Wellcome 077012/Z/05/Z]; MRC Centre for Genomics and Global Health [MRC G0600718]; Medical Research Council [G0600718, G19/9] Funding Source: researchfish; MRC [G0600718, G19/9] Funding Source: UKRI	Foundation for Innovative New Diagnostics; UCL Hospitals Comprehensive Biomedical Research Centre for Infection; United Kingdom Health Protection Agency; Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Genomics and Global Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SDP is supported by the Foundation for Innovative New Diagnostics; PLC is supported by the UCL Hospitals Comprehensive Biomedical Research Centre for Infection; CJS is supported by the United Kingdom Health Protection Agency. Genome sequencing and the development of software for sequence analysis was funded by the Wellcome Trust core funding to the Sanger Institute (Wellcome 077012/Z/05/Z) and the MRC Centre for Genomics and Global Health (MRC G0600718). None of these funding agencies had any direct role in the design or conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahouidi AD, 2010, INFECT GENET EVOL, V10, P200, DOI 10.1016/j.meegid.2009.11.008; Ariey F, 2001, J INFECT DIS, V184, P237, DOI 10.1086/322012; Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; Basco LK, 2004, AM J TROP MED HYG, V70, P238, DOI 10.4269/ajtmh.2004.70.238; Beshir KB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-312; Biswas S, 2011, INT J PARASITOL; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Dahlstrom S, 2009, J INFECT DIS, V200, P1456, DOI 10.1086/606009; Dahlstrom S, 2009, ANTIMICROB AGENTS CH, V53, P2553, DOI 10.1128/AAC.00091-09; Druilhe P, 1998, J CLIN INVEST, V101, P2008, DOI 10.1172/JCI119890; Farnert A, 1997, AM J TROP MED HYG, V56, P538, DOI 10.4269/ajtmh.1997.56.538; Farnert A, 2002, AM J TROP MED HYG, V66, P487; Fluck C, 2007, INFECT GENET EVOL, V7, P44, DOI 10.1016/j.meegid.2006.03.006; Gadalla NB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-74; Gouagna LC, 2010, NAT GENET, V42, P328, DOI 10.1038/ng.554; Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015; Hill DR, 1996, T ROY SOC TROP MED H, V90, P680, DOI 10.1016/S0035-9203(96)90433-2; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Juliano JJ, 2007, EMERG INFECT DIS, V13, P873, DOI 10.3201/eid1306.061182; Juliano JJ, 2010, P NATL ACAD SCI USA, V107, P20138, DOI 10.1073/pnas.1007068107; Juliano JJ, 2010, TRENDS PARASITOL, V26, P119, DOI 10.1016/j.pt.2009.12.007; KEMP DJ, 1987, P NATL ACAD SCI USA, V84, P7672, DOI 10.1073/pnas.84.21.7672; Kilama W, 2009, LANCET, V374, P1480, DOI 10.1016/S0140-6736(09)61884-5; KIMURA E, 1990, GENE, V91, P57, DOI 10.1016/0378-1119(90)90162-K; Kiwanuka GN, 2009, J VECTOR DIS, V46, P1; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kun JFJ, 2002, AM J TROP MED HYG, V66, P653, DOI 10.4269/ajtmh.2002.66.653; Kun JFJ, 1998, T ROY SOC TROP MED H, V92, P110, DOI 10.1016/S0035-9203(98)90979-8; Manske HM, 2009, GENOME RES, V19, P2125, DOI 10.1101/gr.093443.109; Manske M, 2010, NEXT GENERA IN PRESS; Meyer CG, 2002, TROP MED INT HEALTH, V7, P395, DOI 10.1046/j.1365-3156.2002.00875.x; Nair S, 2011, PLOS GENET, V4; Nicastri Emanuele, 2008, Travel Med Infect Dis, V6, P205, DOI 10.1016/j.tmaid.2008.01.001; Nsobya SL, 2008, J INFECT DIS, V198, P1554, DOI 10.1086/592506; Ofosu-Okyere A, 2001, PARASITOLOGY, V123, P113, DOI 10.1017/S0031182001008162; Ranjit MR, 2004, TROP MED INT HEALTH, V9, P857, DOI 10.1111/j.1365-3156.2004.01286.x; SCHERF A, 1991, MOL BIOCHEM PARASIT, V44, P297, DOI 10.1016/0166-6851(91)90016-Y; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Sutherland CJ, 2002, AM J TROP MED HYG, V66, P700, DOI 10.4269/ajtmh.2002.66.700; Sutherland CJ, 2008, PLOS MED, V5, P1544, DOI 10.1371/journal.pmed.0050228; Sutherland CJ, 2009, ANTIMICROB AGENTS CH, V53, P3405, DOI 10.1128/AAC.00024-09; Takala SL, 2006, INFECT GENET EVOL, V6, P417, DOI 10.1016/j.meegid.2006.01.009; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wichmann O, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-17; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23204	10.1371/journal.pone.0023204	http://dx.doi.org/10.1371/journal.pone.0023204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853089	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000293953400032
J	Menon, MB; Kotlyarov, A; Gaestel, M				Menon, Manoj B.; Kotlyarov, Alexey; Gaestel, Matthias			SB202190-Induced Cell Type-Specific Vacuole Formation and Defective Autophagy Do Not Depend on p38 MAP Kinase Inhibition	PLOS ONE			English	Article							PROTEIN-KINASE; CANCER-CELL; IN-VIVO; MATURATION STEP; SB 203580; P38-ALPHA; STRESS; GROWTH; SENSITIVITY; METABOLISM	SB202190, a widely used inhibitor of p38 MAPK alpha and beta, was recently described to induce autophagic vacuoles and cell death in colon and ovarian cancer cells lines and, therefore, this effect was supposed to be specific for transformed cells and to open therapeutic options. Here, we demonstrate that SB202190 and the structurally related inhibitor SB203580 induce pro-autophagic gene expression and vacuole formation in various cancer and non-cancer cell lines of human, rat, mouse and hamster origin. This effect seems to induce defective autophagy leading to the accumulation of acidic vacuoles, p62 protein and lipid conjugated LC3. Using further p38 inhibitors we show that p38 MAPK inhibition is not sufficient for the autophagic response. In line with these results, expression of a SB202190-resistant mutant of p38 alpha, which significantly increases activity of the p38 pathway under inhibitory conditions, does not block SB202190-dependent vacuole formation, indicating that lack of p38 alpha activity is not necessary for this effect. Obviously, the induction of autophagic vacuole formation by SB203580 and SB202190 is due to off-target effects of these inhibitors on post-translational protein modifications, such as phosphorylation of the MAPKs ERK1/2 and JNK1/2, ribosomal protein S6, and PKB/Akt. Interestingly, the PI3K-inhibitor wortmannin induces transient vacuole formation indicating that the PI3K-PKB/Akt-mTOR pathway is essential for preventing autophagy and that cross-inhibition of this pathway by SB202190 could be the reason for the early part of the effect observed.	[Menon, Manoj B.; Kotlyarov, Alexey; Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany	Hannover Medical School	Menon, MB (corresponding author), Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany.	gaestel.matthias@mh-hannover.de	Menon, Manoj B./P-1543-2015; Gaestel, Matthias/A-6560-2013	Menon, Manoj B./0000-0001-5859-0347; Gaestel, Matthias/0000-0002-4944-4652	Deutsche Forschungsgemeinschaft; Hannover Medical School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hannover Medical School	This work was supported by Deutsche Forschungsgemeinschaft and the PhD-Program of the Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bawolak MT, 2010, CAN J ANAESTH, V57, P230, DOI 10.1007/s12630-009-9220-9; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P28766, DOI 10.1074/jbc.273.44.28766; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Comes F, 2007, CELL DEATH DIFFER, V14, P693, DOI 10.1038/sj.cdd.4402076; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gaestel M, 2007, CURR MED CHEM, V14, P2214, DOI 10.2174/092986707781696636; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hsu MY, 2002, HUMAN CELL CULTURE, P259; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kametaka S, 2007, MOL BIOL CELL, V18, P2991, DOI 10.1091/mbc.E06-12-1162; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Laufer SA, 2003, J MED CHEM, V46, P3230, DOI 10.1021/jm030766k; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; Matrone A, 2010, INT J GYNECOL CANCER, V20, P203, DOI 10.1111/IGC.0b013e3181c8ca12; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Menon MB, 2010, J BIOL CHEM, V285, P33242, DOI 10.1074/jbc.M110.132357; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Prick T, 2006, BIOCHEM J, V394, P153, DOI 10.1042/BJ20051243; RONKINA N, 2010, NUCL ACIDS RES; ROSS RA, 1983, J NATL CANCER I, V71, P741; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Simone C, 2007, AUTOPHAGY, V3, P468, DOI 10.4161/auto.4319; Singh AK, 2011, CELL MOL LIFE SCI, V68, P1041, DOI 10.1007/s00018-010-0503-7; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Son JK, 2010, CELL DEATH DIFFER, V17, P1288, DOI 10.1038/cdd.2010.9; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Szyniarowski P, 2011, AUTOPHAGY, V7, P892, DOI 10.4161/auto.7.8.15770; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yong HY, 2009, EXPERT OPIN INV DRUG, V18, P1893, DOI 10.1517/13543780903321490; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	53	43	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23054	10.1371/journal.pone.0023054	http://dx.doi.org/10.1371/journal.pone.0023054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853067	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200038
J	Nel, A; Louw, C; Hellstrom, E; Braunstein, SL; Treadwell, I; Marais, M; de Villiers, M; Hugo, J; Paschke, I; Andersen, C; van de Wijgert, J				Nel, Annalene; Louw, Cheryl; Hellstrom, Elizabeth; Braunstein, Sarah L.; Treadwell, Ina; Marais, Melanie; de Villiers, Martie; Hugo, Jannie; Paschke, Inge; Andersen, Chrisna; van de Wijgert, Janneke			HIV Prevalence and Incidence among Sexually Active Females in Two Districts of South Africa to Determine Microbicide Trial Feasibility	PLOS ONE			English	Article								Background: The suitability of populations of sexually active women in Madibeng (North-West Province) and Mbekweni (Western Cape), South Africa, for a Phase III vaginal microbicide trial was evaluated. Methods: Sexually active women 18-35 years not known to be HIV-positive or pregnant were tested cross-sectionally to determine HIV and pregnancy prevalence (798 in Madibeng and 800 in Mbekweni). Out of these, 299 non-pregnant, HIV-negative women were subsequently enrolled at each clinical research center in a 12-month cohort study with quarterly study visits. Results: HIV prevalence was 24% in Madibeng and 22% in Mbekweni. HIV incidence rates based on seroconversions over 12 months were 6.0/100 person-years (PY) (95% CI 3.0, 9.0) in Madibeng and 4.5/100 PY (95% CI 1.8, 7.1) in Mbekweni and those estimated by cross-sectional BED testing were 7.1/100 PY (95% CI 2.8, 11.3) in Madibeng and 5.8/100 PY (95% CI 2.0, 9.6) in Mbekweni. The 12-month pregnancy incidence rates were 4.8/100 PY (95% CI 2.2, 7.5) in Madibeng and 7.0/100 PY (95% CI 3.7, 10.3) in Mbekweni; rates decreased over time in both districts. Genital symptoms were reported very frequently, with an incidence of 46.8/100 PY (95% CI 38.5, 55.2) in Madibeng and 21.5/100 PY (95% CI 15.8, 27.3) in Mbekweni. Almost all (>99%) participants said that they would be willing to participate in a microbicide trial. Conclusion: These populations might be suitable for Phase III microbicide trials provided that HIV incidence rates over time remain sufficiently high to support endpoint-driven trials.	[Nel, Annalene] Int Partnership Microbicides, Silver Spring, MD USA; [Louw, Cheryl; de Villiers, Martie; Hugo, Jannie] Madibeng Ctr Res, Brits, South Africa; [Hellstrom, Elizabeth; Treadwell, Ina; Marais, Melanie; Paschke, Inge; Andersen, Chrisna] Be Part Yoluntu Ctr, Mbekweni, South Africa; [Hellstrom, Elizabeth; Treadwell, Ina; Marais, Melanie; Paschke, Inge; Andersen, Chrisna] Be Part Yoluntu Ctr, Paarl, South Africa; [Braunstein, Sarah L.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [van de Wijgert, Janneke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	New York City Department of Health & Mental Hygiene; University of Amsterdam; Academic Medical Center Amsterdam	Nel, A (corresponding author), Int Partnership Microbicides, Silver Spring, MD USA.	j.vandewijgert@amc-cpcd.org		van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	International Partnership for Microbicides	International Partnership for Microbicides	This study was funded by the International Partnership for Microbicides (a not-for-profit public-private partnership). The funders were involved in study design, data collection and preparation of the manuscript.	[Anonymous], 2011, US ASS REC INF EST H; Baldwin JI, 2000, ARCH SEX BEHAV, V29, P357, DOI 10.1023/A:1001918504344; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018402; Braunstein SL, 2009, AIDS REV, V11, P140; Elias CJ, 1996, AIDS, V10, pS43; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; National Department of Health, 2008, 1 LIN COMPR MAN CONT, P1; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Raymond EG, 2007, SEX TRANSM DIS, V34, P1035, DOI 10.1097/OLQ.0b013e3180e90586; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van de Wijgert J, 2006, STUD FAMILY PLANN, V37, P123, DOI 10.1111/j.1728-4465.2006.00091.x; WHO Department of Reproductive Health, 2010, MED EL CRIT CONTR US; FORMULA SPREADSHEET	15	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e21528	10.1371/journal.pone.0021528	http://dx.doi.org/10.1371/journal.pone.0021528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853020	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200002
J	Head, SI; Greenaway, B; Chan, S				Head, Stewart I.; Greenaway, Bronwen; Chan, Stephen			Incubating Isolated Mouse EDL Muscles with Creatine Improves Force Production and Twitch Kinetics in Fatigue Due to Reduction in Ionic Strength	PLOS ONE			English	Article							MAXIMUM SHORTENING VELOCITY; EXTENSOR DIGITORUM LONGUS; RAT SKELETAL-MUSCLE; CONTRACTILE PROPERTIES; CELLULAR MECHANISMS; ENERGY-METABOLISM; BODY-COMPOSITION; SINGLE FIBERS; KINASE; SUPPLEMENTATION	Background: Creatine supplementation can improve performance during high intensity exercise in humans and improve muscle strength in certain myopathies. In this present study, we investigated the direct effects of acute creatine incubation on isolated mouse fast-twitch EDL muscles, and examined how these effects change with fatigue. Methods and Results: The extensor digitorum longus muscle from mice aged 12-14 weeks was isolated and stimulated with field electrodes to measure force characteristics in 3 different states: (i) before fatigue; (ii) immediately after a fatigue protocol; and (iii) after recovery. These served as the control measurements for the muscle. The muscle was then incubated in a creatine solution and washed. The measurement of force characteristics in the 3 different states was then repeated. In un-fatigued muscle, creatine incubation increased the maximal tetanic force. In fatigued muscle, creatine treatment increased the force produced at all frequencies of stimulation. Incubation also increased the rate of twitch relaxation and twitch contraction in fatigued muscle. During repetitive fatiguing stimulation, creatine-treated muscles took 55.1 +/- 9.5% longer than control muscles to lose half of their original force. Measurement of weight changes showed that creatine incubation increased EDL muscle mass by 7%. Conclusion: Acute creatine application improves force production in isolated fast-twitch EDL muscle, and these improvements are particularly apparent when the muscle is fatigued. One likely mechanism for this improvement is an increase in Ca2+ sensitivity of contractile proteins as a result of ionic strength decreases following creatine incubation.	[Head, Stewart I.; Greenaway, Bronwen; Chan, Stephen] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Head, SI (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia.	S.Head@unsw.edu.au	Head, Stewart/O-7016-2019; Head, Stewart I/F-4435-2010	Head, Stewart/0000-0002-6891-7590; 	National Health and Medical Research Council of Australia (NHMRC) [512254]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council of Australia (NHMRC Project Grant #512254, http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen DG, 2001, J PHYSIOL-LONDON, V536, P657, DOI 10.1111/j.1469-7793.2001.t01-1-00657.x; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; APRIL E, 1968, NATURE, V220, P182, DOI 10.1038/220182a0; ASHLEY CC, 1977, J PHYSIOL-LONDON, V270, P627, DOI 10.1113/jphysiol.1977.sp011972; Balsom P. D., 1993, Scandinavian Journal of Medicine and Science in Sports, V3, P143; Bassit RA, 2010, EUR J APPL PHYSIOL, V108, P945, DOI 10.1007/s00421-009-1305-1; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Boehm EA, 1996, BBA-BIOENERGETICS, V1274, P119, DOI 10.1016/0005-2728(96)00018-7; Brosnan JT, 2007, ANNU REV NUTR, V27, P241, DOI 10.1146/annurev.nutr.27.061406.093621; CANNELL MB, 1986, J PHYSIOL-LONDON, V376, P203, DOI 10.1113/jphysiol.1986.sp016149; Casey A, 1996, AM J PHYSIOL-ENDOC M, V271, pE31, DOI 10.1152/ajpendo.1996.271.1.E31; Chan S, 2008, AM J PHYSIOL-CELL PH, V295, pC897, DOI 10.1152/ajpcell.00179.2008; Chan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012345; Dahlstedt AJ, 2000, FASEB J, V14, P982, DOI 10.1096/fasebj.14.7.982; Dahlstedt AJ, 2003, J PHYSIOL-LONDON, V547, P395, DOI 10.1113/jphysiol.2002.034793; EARNEST CP, 1995, ACTA PHYSIOL SCAND, V153, P207, DOI 10.1111/j.1748-1716.1995.tb09854.x; Eijnde BO, 2004, MUSCLE NERVE, V29, P428, DOI 10.1002/mus.10568; FINK RHA, 1986, J PHYSIOL-LONDON, V370, P317, DOI 10.1113/jphysiol.1986.sp015937; FITCH CD, 1966, J BIOL CHEM, V241, P3611; FRYER MW, 1995, J PHYSIOL-LONDON, V482, P123, DOI 10.1113/jphysiol.1995.sp020504; Gagnon M, 2002, CLIN EXP PHARMACOL P, V29, P885, DOI 10.1046/j.1440-1681.2002.03745.x; Gallo M, 2006, PFLUG ARCH EUR J PHY, V452, P744, DOI 10.1007/s00424-006-0079-0; GILLIS JM, 1985, BIOCHIM BIOPHYS ACTA, V811, P97, DOI 10.1016/0304-4173(85)90016-3; HEAD SI, 1990, J PHYSIOL-LONDON, V422, P351, DOI 10.1113/jphysiol.1990.sp017988; HOMSHER E, 1978, ANNU REV PHYSIOL, V40, P93, DOI 10.1146/annurev.ph.40.030178.000521; HOMSHER E, 1987, ANNU REV PHYSIOL, V49, P673, DOI 10.1146/annurev.ph.49.030187.003325; HULTMAN E, 1991, SCI PROG, V75, P361; JACOBUS WE, 1985, BIOCHEM BIOPH RES CO, V133, P1035, DOI 10.1016/0006-291X(85)91240-9; Jones AM, 2009, AM J PHYSIOL-REG I, V296, pR1078, DOI 10.1152/ajpregu.90896.2008; Kley RA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004760.pub2; Levine S, 1996, AM J PHYSIOL-CELL PH, V271, pC1480, DOI 10.1152/ajpcell.1996.271.5.C1480; Macdonald WA, 2001, J PHYSIOL-LONDON, V532, P499, DOI 10.1111/j.1469-7793.2001.0499f.x; McGuire M, 2001, EXP PHYSIOL, V86, P185, DOI 10.1113/eph8602131; Motulsky H, 2003, PRACTICAL GUIDE CURV; Murphy RM, 2004, AM J PHYSIOL-CELL PH, V287, pC1589, DOI 10.1152/ajpcell.00276.2004; Odoom JE, 1996, MOL CELL BIOCHEM, V158, P179; Pulido SM, 1998, FEBS LETT, V439, P357, DOI 10.1016/S0014-5793(98)01399-4; Robinson DM, 2002, CLIN EXP PHARMACOL P, V29, P1105, DOI 10.1046/j.1440-1681.2002.03782.x; Roman BB, 1996, AM J PHYSIOL-CELL PH, V270, pC1236, DOI 10.1152/ajpcell.1996.270.4.C1236; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Terjung RL, 2000, MED SCI SPORT EXER, V32, P706, DOI 10.1097/00005768-200003000-00024; van Leemputte M, 1999, J APPL PHYSIOL, V86, P840, DOI 10.1152/jappl.1999.86.3.840; van Loon LJC, 2003, CLIN SCI, V104, P153, DOI 10.1042/CS20020159; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VENTURACLAPIER R, 1995, J BIOL CHEM, V270, P19914, DOI 10.1074/jbc.270.34.19914; Volek JS, 1999, MED SCI SPORT EXER, V31, P1147, DOI 10.1097/00005768-199908000-00011; Wakatsuki T, 1995, JPN J PHYSIOL, V45, P979, DOI 10.2170/jjphysiol.45.979; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WESTERBLAD H, 1991, J PHYSIOL-LONDON, V434, P323, DOI 10.1113/jphysiol.1991.sp018472; WESTERBLAD H, 1995, J PHYSIOL-LONDON, V482, P383, DOI 10.1113/jphysiol.1995.sp020525; Westerblad H, 1998, J PHYSIOL-LONDON, V510, P269, DOI 10.1111/j.1469-7793.1998.269bz.x; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Willott CA, 1999, ACTA PHYSIOL SCAND, V166, P99; WYSS M, 1992, BIOCHIM BIOPHYS ACTA, V1102, P119, DOI 10.1016/0167-4838(92)90506-9; Ziegenfuss T.N., 1998, J EXERC PHYSL ONLINE, V1, P1	57	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22742	10.1371/journal.pone.0022742	http://dx.doi.org/10.1371/journal.pone.0022742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850234	Green Submitted, Green Published, gold			2022-12-27	WOS:000293563300019
J	Kronhardt, A; Rolando, M; Beitzinger, C; Stefani, C; Leuber, M; Flatau, G; Popoff, MR; Benz, R; Lemichez, E				Kronhardt, Angelika; Rolando, Monica; Beitzinger, Christoph; Stefani, Caroline; Leuber, Michael; Flatau, Gilles; Popoff, Michel R.; Benz, Roland; Lemichez, Emmanuel			Cross-Reactivity of Anthrax and C2 Toxin: Protective Antigen Promotes the Uptake of Botulinum C2I Toxin into Human Endothelial Cells	PLOS ONE			English	Article							LIPID BILAYER-MEMBRANES; CURRENT NOISE-ANALYSIS; MATRIX PROTEIN PORIN; CLOSTRIDIUM-BOTULINUM; LETHAL FACTOR; EDEMA FACTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ION-CHANNEL; PHENYLALANINE CLAMP	Binary toxins are among the most potent bacterial protein toxins performing a cooperative mode of translocation and exhibit fatal enzymatic activities in eukaryotic cells. Anthrax and C2 toxin are the most prominent examples for the AB(7/8) type of toxins. The B subunits bind both host cell receptors and the enzymatic A polypeptides to trigger their internalization and translocation into the host cell cytosol. C2 toxin is composed of an actin ADP-ribosyltransferase (C2I) and C2II binding subunits. Anthrax toxin is composed of adenylate cyclase (EF) and MAPKK protease (LF) enzymatic components associated to protective antigen (PA) binding subunit. The binding and translocation components anthrax protective antigen (PA(63)) and C2II of C2 toxin share a sequence homology of about 35%, suggesting that they might substitute for each other. Here we show by conducting in vitro measurements that PA(63) binds C2I and that C2II can bind both EF and LF. Anthrax edema factor (EF) and lethal factor (LF) have higher affinities to bind to channels formed by C2II than C2 toxin's C2I binds to anthrax protective antigen (PA(63)). Furthermore, we could demonstrate that PA in high concentration has the ability to transport the enzymatic moiety C2I into target cells, causing actin modification and cell rounding. In contrast, C2II does not show significant capacity to promote cell intoxication by EF and LF. Together, our data unveiled the remarkable flexibility of PA in promoting C2I heterologous polypeptide translocation into cells.	[Kronhardt, Angelika; Beitzinger, Christoph; Leuber, Michael; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany; [Rolando, Monica; Stefani, Caroline; Flatau, Gilles; Lemichez, Emmanuel] Fac Med Nice, INSERM, U895, F-06034 Nice, France; [Rolando, Monica; Lemichez, Emmanuel] Univ Nice Sophia Antipolis, Fac Med, Inst Federatif Rech 50, Nice, France; [Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Benz, Roland] Univ Bremen, Sch Sci & Engn, Bremen, Germany; [Lemichez, Emmanuel] Ctr Hosp Univ Nice, Lab Cent Bacteriol, Nice, France	University of Wurzburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Bremen; CHU Nice	Kronhardt, A (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany.	r.benz@jacobs-university.de; Emmanuel.Lemichez@unice.fr	Popoff, Michel/O-7719-2016; Lemichez, Emmanuel/G-3559-2013	Popoff, Michel/0000-0001-9305-8989; Lemichez, Emmanuel/0000-0001-9080-7761; Benz, Roland/0000-0002-9510-9265; stefani, caroline/0000-0003-3420-432X; Rolando, Monica/0000-0002-3710-0115	Deutsche Forschungsgemeinschaft [SFB 487, GRK 1141/1]; Association pour la Recherche sur le Cancer [ARC 3800]; L'Agence Nationale de la Recherche [Endotheltox R07113AS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); L'Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Deutsche Forschungsgemeinschaft (project A5 of the SFB 487 and area 2B of GRK 1141/1 to RB), the Association pour la Recherche sur le Cancer (grant ARC 3800 to EL and a fellowship to MR), and L'Agence Nationale de la Recherche (Endotheltox R07113AS to EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Aktories K, 2004, ANAEROBE, V10, P101, DOI 10.1016/j.anaerobe.2003.10.003; Ascenzi P, 2002, FEBS LETT, V531, P384, DOI 10.1016/S0014-5793(02)03609-8; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2002, N-S ARCH PHARMACOL, V366, P501, DOI 10.1007/s00210-002-0626-y; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Barth H, 2002, J BIOL CHEM, V277, P5074, DOI 10.1074/jbc.M109167200; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Boquet P, 2003, TRENDS CELL BIOL, V13, P238, DOI 10.1016/S0962-8924(03)00037-0; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; CONSIDINE RV, 1991, TOXICON, V29, P913, DOI 10.1016/0041-0101(91)90076-4; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; Doye A, 2006, METHOD ENZYMOL, V406, P447, DOI 10.1016/S0076-6879(06)06033-2; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; FINKELSTEIN A, 1994, TOXICOLOGY, V87, P29, DOI 10.1016/0300-483X(94)90153-8; Halverson KM, 2005, J BIOL CHEM, V280, P34056, DOI 10.1074/jbc.M507928200; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2005, P NATL ACAD SCI USA, V102, P16409, DOI 10.1073/pnas.0508259102; Leppla SH, 1999, J APPL MICROBIOL, V87, P284, DOI 10.1046/j.1365-2672.1999.00890.x; Leuber M, 2008, BBA-BIOMEMBRANES, V1778, P1436, DOI 10.1016/j.bbamem.2008.01.007; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Neumeyer T, 2006, BIOCHEMISTRY-US, V45, P3060, DOI 10.1021/bi0524316; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; Neumeyer T, 2006, J BIOL CHEM, V281, P32335, DOI 10.1074/jbc.M606552200; Nguyen TL, 2004, J BIOMOL STRUCT DYN, V22, P253, DOI 10.1080/07391102.2004.10531226; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rolando M, 2010, CELL MICROBIOL, V12, P891, DOI 10.1111/j.1462-5822.2010.01438.x; Rolando M, 2009, INFECT IMMUN, V77, P3596, DOI 10.1128/IAI.00186-09; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101	59	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23133	10.1371/journal.pone.0023133	http://dx.doi.org/10.1371/journal.pone.0023133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850257	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300042
J	Polacik, M; Reichard, M				Polacik, Matej; Reichard, Martin			Asymmetric Reproductive Isolation between Two Sympatric Annual Killifish with Extremely Short Lifespans	PLOS ONE			English	Article							AFRICAN ANNUAL KILLIFISH; NOTHOBRANCHIUS-FURZERI; SEXUAL COERCION; FISHES; VERTEBRATE; BARRIERS; BIOLOGY; SYSTEM	Background: Interspecific reproductive isolation is typically achieved by a combination of intrinsic and extrinsic barriers. Behavioural isolating barriers between sympatric, closely related species are often of primary importance and frequently aided by extrinsic factors causing spatial and temporal interspecific separation. Study systems with a severely limited role of extrinsic factors on reproductive isolation may provide valuable insights into how reproductive isolation between sympatric species is maintained. We used no-choice experimental set-up to study reproductive barriers between two closely related sympatric African killifish species, Nothobranchius furzeri and Nothobranchius orthonotus. These fish live in small temporary savannah pools and have complete spatial and temporal overlap in reproductive activities and share a similar ecology. Principal Findings: We found that the two species display largely incomplete and asymmetric reproductive isolation. Mating between N. furzeri males and N. orthonotus females was absent under standard experimental conditions and eggs were not viable when fish were forced to mate in a modified experimental setup. In contrast, male N. orthonotus indiscriminately mated with N. furzeri females, the eggs were viable, and offspring successfully hatched. Most spawnings, however, were achieved by male coercion and egg production and embryo survival were low. Behavioural asymmetry was likely facilitated by mating coercion from larger males of N. orthonotus and at relatively low cost to females. Interestingly, the direction of asymmetry was positively associated with asymmetry in post-mating reproductive barriers. Significance: We showed that, in fish species with a promiscuous mating system and multiple matings each day, selection for strong mate preferences was relaxed. This effect was likely due to the small proportion of resources allocated to each single mating and the high potential cost to females from mating refusal. We highlight and discuss the fact that males of rarer species may often coercively mate with females of a related, more abundant species.	[Polacik, Matej; Reichard, Martin] Acad Sci Czech Republ, Dept Fish Ecol, Inst Vertebrate Biol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Polacik, M (corresponding author), Acad Sci Czech Republ, Dept Fish Ecol, Inst Vertebrate Biol, Brno, Czech Republic.	polacik@ivb.cz	Polačik, Matej/A-8260-2010; Reichard, Martin/C-6563-2009	Polačik, Matej/0000-0003-1309-2146; Reichard, Martin/0000-0002-9306-0074	Czech Science Foundation [206/09/0815]	Czech Science Foundation(Grant Agency of the Czech Republic)	The work was funded by Czech Science Foundation grant No. 206/09/0815 (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntzen JW, 2009, EVOLUTION, V63, P1191, DOI 10.1111/j.1558-5646.2009.00611.x; Chamberlain NL, 2009, SCIENCE, V326, P847, DOI 10.1126/science.1179141; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cordingley JE, 2009, ANIM CONSERV, V12, P505, DOI 10.1111/j.1469-1795.2009.00294.x; Coyne J.A., 2004, SPECIATION; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Dorn A, 2011, MOL PHYLOGENET EVOL, V61, P739, DOI 10.1016/j.ympev.2011.06.010; EWULONU UK, 1985, COPEIA, P503; Genade T., 2005, LAB MANUAL CULTURING; Genner MJ, 2007, MOL ECOL, V16, P651, DOI 10.1111/j.1365-294X.2006.03173.x; HAAS R, 1976, COPEIA, P80; Hendry AP, 2005, MOL ECOL, V14, P901, DOI 10.1111/j.1365-294X.2005.02480.x; Hettyey A, 2009, ANIM BEHAV, V78, P1365, DOI 10.1016/j.anbehav.2009.09.006; Immler S, 2011, J EVOLUTION BIOL, V24, P111, DOI 10.1111/j.1420-9101.2010.02142.x; PETERSON C, 1996, J AM KILLIFISH ASS, V29, P93; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Polacik M, 2011, J FISH BIOL, V78, P796, DOI 10.1111/j.1095-8649.2010.02893.x; Polacik M, 2010, J FISH BIOL, V77, P754, DOI 10.1111/j.1095-8649.2010.02717.x; Qvarnstrom A, 2010, PHILOS T R SOC B, V365, P1841, DOI 10.1098/rstb.2009.0306; Reichard M, 2009, J FISH BIOL, V74, P198, DOI 10.1111/j.1095-8649.2008.02129.x; Reichard M, 2010, BIOL J LINN SOC, V100, P62, DOI 10.1111/j.1095-8312.2010.01406.x; Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16; Robertson JM, 2009, BIOL J LINN SOC, V98, P243, DOI 10.1111/j.1095-8312.2009.01291.x; Rosenthal GG, 1996, ANIM BEHAV, V51, P811, DOI 10.1006/anbe.1996.0085; Ross CL, 2008, BIOL J LINN SOC, V94, P777, DOI 10.1111/j.1095-8312.2008.01018.x; Shine R, 2004, CAN J ZOOL, V82, P1091, DOI 10.1139/Z04-086; Strecker U, 1999, J EVOLUTION BIOL, V12, P927, DOI 10.1046/j.1420-9101.1999.00096.x; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Valenzano DR, 2009, GENETICS, V183, P1385, DOI 10.1534/genetics.109.108670; Watters B.R., 2009, J AM KILLFISH ASSOC, V42, P37; Watters B.R., 2006, J AM KILLIFISH ASS, V39, P137; Wellenreuther M, 2007, MAR BIOL, V152, P619, DOI 10.1007/s00227-007-0713-1; Wildekamp RH., 2004, AWORLD KILLIES ATLAS; Wiwegweaw A, 2009, BIOL LETTERS, V5, P240, DOI 10.1098/rsbl.2008.0714; WOURMS JP, 1972, J EXP ZOOL, V182, P389, DOI 10.1002/jez.1401820310	36	31	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22684	10.1371/journal.pone.0022684	http://dx.doi.org/10.1371/journal.pone.0022684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850233	gold, Green Published, Green Submitted			2022-12-27	WOS:000293563300017
J	Hemelrijk, CK; Hildenbrandt, H				Hemelrijk, Charlotte K.; Hildenbrandt, Hanno			Some Causes of the Variable Shape of Flocks of Birds	PLOS ONE			English	Article							FISH SCHOOLS; STURNUS-VULGARIS; ANIMAL GROUPS; 3-DIMENSIONAL STRUCTURE; COLLECTIVE BEHAVIOR; STARLING FLOCKS; PATTERN; MODEL; INDIVIDUALS; SIMULATION	Flocks of birds are highly variable in shape in all contexts (while travelling, avoiding predation, wheeling above the roost). Particularly amazing in this respect are the aerial displays of huge flocks of starlings (Sturnus vulgaris) above the sleeping site at dawn. The causes of this variability are hardly known, however. Here we hypothesise that variability of shape increases when there are larger local differences in movement behaviour in the flock. We investigate this hypothesis with the help of a model of the self-organisation of travelling groups, called StarDisplay, since such a model has also increased our understanding of what causes the oblong shape of schools of fish. The flocking patterns in the model prove to resemble those of real birds, in particular of starlings and rock doves. As to shape, we measure the relative proportions of the flock in several ways, which either depend on the direction of movement or do not. We confirm that flock shape is usually more variable when local differences in movement in the flock are larger. This happens when a) flock size is larger, b) interacting partners are fewer, c) the flock turnings are stronger, and d) individuals roll into the turn. In contrast to our expectations, when variability of speed in the flock is higher, flock shape and the positions of members in the flock are more static. We explain this and indicate the adaptive value of low variability of speed and spatial restriction of interaction and develop testable hypotheses.	[Hemelrijk, Charlotte K.; Hildenbrandt, Hanno] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of Groningen	Hemelrijk, CK (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	c.k.hemelrijk@rug.nl	Hemelrijk, Charlotte K./E-4828-2013	Hemelrijk, Charlotte K./0000-0001-6160-077X	University of Groningen; STREP in the NEST [n12682]; NWO [051.07.006]	University of Groningen; STREP in the NEST; NWO(Netherlands Organization for Scientific Research (NWO))	The startup grant of the University of Groningen belonging to the Rosalind Franklin Fellowship of Hemelrijk, The 6th European framework under the STREP-project "Star-Flag" (n12682) in the NEST-programme of "Tackling Complexity in Science," The Cognitie Pilot project of NWO (051.07.006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajec IL, 2009, ANIM BEHAV, V78, P777, DOI 10.1016/j.anbehav.2009.07.007; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Barequet G, 2001, J ALGORITHMS, V38, P91, DOI 10.1006/jagm.2000.1127; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; Carere C, 2009, ANIM BEHAV, V77, P101, DOI 10.1016/j.anbehav.2008.08.034; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Davis M. J., 1980, ANIM BEHAV, V28, P668, DOI [10.1016/S0003-3472(80)80127-8, DOI 10.1016/S0003-3472(80)80127-8]; Feare C.J., 1984, STARLING; Gerlotto F, 2003, AQUAT LIVING RESOUR, V16, P113, DOI 10.1016/S0990-7440(03)00027-5; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Helbing D, 1998, NATURE, V396, P738, DOI 10.1038/25499; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Hemelrijk CK, 2010, ETHOLOGY, V116, P1099, DOI 10.1111/j.1439-0310.2010.01818.x; Hemelrijk CK, 2005, NEUROSCI BIOBEHAV R, V29, P125, DOI 10.1016/j.neubiorev.2004.07.003; Hemelrijk CK, 2005, BEHAV ECOL, V16, P178, DOI 10.1093/beheco/arh149; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; Huse G, 2002, J FISH BIOL, V60, P571, DOI 10.1006/jfbi.2002.1874; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Inada Y, 2002, J THEOR BIOL, V214, P371, DOI 10.1006/jtbi.2001.2449; Kunz H, 2003, ARTIF LIFE, V9, P237, DOI 10.1162/106454603322392451; Lee SH, 2006, J THEOR BIOL, V240, P250, DOI 10.1016/j.jtbi.2005.09.009; MAJOR PF, 1978, BEHAV ECOL SOCIOBIOL, V4, P111, DOI 10.1007/BF00354974; Mirabet V, 2008, BEHAV ECOL SOCIOBIOL, V63, P159, DOI 10.1007/s00265-008-0647-8; Norberg U., 1990, VERTEBRATE FLIGHT ME; PARTRIDGE BL, 1980, BEHAV ECOL SOCIOBIOL, V6, P277, DOI 10.1007/BF00292770; Pitcher T. J., 1983, PREDATORS PREY FISHE, P193; PITCHER TJ, 1980, FRESHWATER BIOL, V10, P539, DOI 10.1111/j.1365-2427.1980.tb01229.x; POMEROY H, 1992, AUK, V109, P256; POMEROY H, 1977, ANIM BEHAV, V25, P720, DOI 10.1016/0003-3472(77)90121-X; REUTER H, 1994, ECOL MODEL, V75, P147, DOI 10.1016/0304-3800(94)90014-0; REYNOLDS, 1987, COMPUTER GRAPHICS, V21, P25, DOI DOI 10.1145/37402.37406; Selous Edmund, 1931, THOUGHT TRANSFERENCE; Vabo R, 2008, ECOL MODEL, V214, P125, DOI 10.1016/j.ecolmodel.2008.01.026; van den Hout PJ, 2010, BEHAV ECOL, V21, P16, DOI 10.1093/beheco/arp146; Videler JJ., 2005, AVIAN FLIGHT; Ward S, 2004, J EXP BIOL, V207, P4291, DOI 10.1242/jeb.01281; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106; Zheng M, 2005, J THEOR BIOL, V235, P153, DOI 10.1016/j.jtbi.2004.12.025	43	84	85	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22479	10.1371/journal.pone.0022479	http://dx.doi.org/10.1371/journal.pone.0022479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829627	gold, Green Submitted, Green Published			2022-12-27	WOS:000293561200020
J	Reino, DC; Pisarenko, V; Palange, D; Doucet, D; Bonitz, RP; Lu, Q; Colorado, I; Sheth, SU; Chandler, B; Kannan, KB; Ramanathan, M; Xu, DZ; Deitch, EA; Feinman, R				Reino, Diego C.; Pisarenko, Vadim; Palange, David; Doucet, Danielle; Bonitz, Robert P.; Lu, Qi; Colorado, Iriana; Sheth, Sharvil U.; Chandler, Benjamin; Kannan, Kolenkode B.; Ramanathan, Madhuri; Xu, Da Zhong; Deitch, Edwin A.; Feinman, Rena			Trauma Hemorrhagic Shock-Induced Lung Injury Involves a Gut-Lymph-Induced TLR4 Pathway in Mice	PLOS ONE			English	Article							INDUCED NITRIC-OXIDE; ISCHEMIA-REPERFUSION INJURY; ORGAN DYSFUNCTION SYNDROME; TOLL-LIKE RECEPTOR-4; MESENTERIC LYMPH; SYSTEMIC INFLAMMATION; INTESTINAL PERMEABILITY; IMMUNE-RESPONSES; OXIDATIVE STRESS; TOLL-LIKE-RECEPTOR-4	Background: Injurious non-microbial factors released from the stressed gut during shocked states contribute to the development of acute lung injury (ALI) and multiple organ dysfunction syndrome (MODS). Since Toll-like receptors (TLR) act as sensors of tissue injury as well as microbial invasion and TLR4 signaling occurs in both sepsis and noninfectious models of ischemia/reperfusion (I/R) injury, we hypothesized that factors in the intestinal mesenteric lymph after trauma hemorrhagic shock (T/HS) mediate gut-induced lung injury via TLR4 activation. Methods/Principal Findings: The concept that factors in T/HS lymph exiting the gut recreates ALI is evidenced by our findings that the infusion of porcine lymph, collected from animals subjected to global T/HS injury, into naive wildtype (WT) mice induced lung injury. Using C3H/HeJ mice that harbor a TLR4 mutation, we found that TLR4 activation was necessary for the development of T/HS porcine lymph-induced lung injury as determined by Evan's blue dye (EBD) lung permeability and myeloperoxidase (MPO) levels as well as the induction of the injurious pulmonary iNOS response. TRIF and Myd88 deficiency fully and partially attenuated T/HS lymph-induced increases in lung permeability respectively. Additional studies in TLR2 deficient mice showed that TLR2 activation was not involved in the pathology of T/HS lymph-induced lung injury. Lastly, the lymph samples were devoid of bacteria, endotoxin and bacterial DNA and passage of lymph through an endotoxin removal column did not abrogate the ability of T/HS lymph to cause lung injury in naive mice. Conclusions/Significance: Our findings suggest that non-microbial factors in the intestinal mesenteric lymph after T/HS are capable of recreating T/HS-induced lung injury via TLR4 activation.	[Reino, Diego C.; Pisarenko, Vadim; Palange, David; Doucet, Danielle; Bonitz, Robert P.; Lu, Qi; Colorado, Iriana; Sheth, Sharvil U.; Chandler, Benjamin; Kannan, Kolenkode B.; Ramanathan, Madhuri; Xu, Da Zhong; Deitch, Edwin A.; Feinman, Rena] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Reino, DC (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA.	edeitch@umdnj.edu; feinmarr@umdnj.edu			NIH [R01-GM059841, 1P50GM069790, T32-GM069330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059841, P50GM069790, T32GM069330] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01-GM059841 (EAD), 1P50GM069790 (to EAD and RF) and T32-GM069330 (to DCR, VP, DD and SUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adams CA, 2001, SURGERY, V129, P351, DOI 10.1067/msy.2001.111698; Barsness KA, 2004, AM J PHYSIOL-REG I, V287, pR592, DOI 10.1152/ajpregu.00412.2003; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; BORDER JR, 1987, ANN SURG, V206, P427, DOI 10.1097/00000658-198710000-00004; Breslin J, 2008, SHOCK, V29, P197; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; DEITCH EA, 1992, ANN SURG, V216, P117, DOI 10.1097/00000658-199208000-00002; Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83; DEITCH EA, 1990, SURGERY, V107, P411; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Edwin A, 2006, J ORGAN DYSFUNCTION, V2, P70, DOI 10.1080/17471060600551772; Eswarappa SM, 2008, INNATE IMMUN-LONDON, V14, P13, DOI 10.1177/1753425907087349; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; Gonzalez RJ, 2000, SHOCK, V14, P404, DOI 10.1097/00024382-200014030-00028; Hierholzer C, 2004, AM J PHYSIOL-GASTR L, V286, pG225, DOI 10.1152/ajpgi.00447.2002; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ivatury RR, 1996, J AM COLL SURGEONS, V183, P145; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kaiser VL, 2005, SHOCK, V23, P417, DOI 10.1097/01.shk.0000160524.14235.6c; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Koury J, 2004, SHOCK, V22, P270, DOI 10.1097/01.shk.0000135256.67441.3f; Leaphart CL, 2007, SURGERY, V141, P563, DOI 10.1016/j.surg.2007.01.021; Levy RM, 2006, AM J PHYSIOL-REG I, V291, pR970, DOI 10.1152/ajpregu.00793.2005; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meng XZ, 2005, AM J PHYSIOL-REG I, V288, pR600, DOI 10.1152/ajpregu.00182.2004; Mollen KP, 2008, J LEUKOCYTE BIOL, V83, P80, DOI 10.1189/jlb.0407201; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Paterson HM, 2003, J IMMUNOL, V171, P1473, DOI 10.4049/jimmunol.171.3.1473; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Prince JM, 2006, J AM COLL SURGEONS, V202, P407, DOI 10.1016/j.jamcollsurg.2005.11.021; Rajnik M, 2002, SHOCK, V17, P322, DOI 10.1097/00024382-200204000-00015; Sambol JT, 2000, SHOCK, V14, P416, DOI 10.1097/00024382-200014030-00030; Senthil M, 2007, ANN SURG, V246, P822, DOI 10.1097/SLA.0b013e3180caa3af; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sethi G, 2004, MOL IMMUNOL, V40, P1315, DOI 10.1016/j.molimm.2004.01.001; Sutton TA, 2008, AM J PHYSIOL-RENAL, V295, pF1666, DOI 10.1152/ajprenal.90304.2008; Suzuki Y, 2000, CRIT CARE MED, V28, P3692, DOI 10.1097/00003246-200011000-00026; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834	49	76	91	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e14829	10.1371/journal.pone.0014829	http://dx.doi.org/10.1371/journal.pone.0014829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829592	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200001
J	Souza-Smith, FM; Katz, PS; Trask, AJ; Stewart, JA; Lord, KC; Varner, KJ; Vassallo, DV; Lucchesi, PA				Souza-Smith, Flavia M.; Katz, Paige S.; Trask, Aaron J.; Stewart, James A., Jr.; Lord, Kevin C.; Varner, Kurt J.; Vassallo, Dalton V.; Lucchesi, Pamela A.			Mesenteric Resistance Arteries in Type 2 Diabetic db/db Mice Undergo Outward Remodeling	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE ACTIVITY; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR-MATRIX; VASCULAR STRUCTURE; RATS; HYPERTENSION; EXPRESSION; STIFFNESS; MELLITUS; ROLES	Objective: Resistance vessel remodeling is controlled by myriad of hemodynamic and neurohormonal factors. This study characterized structural and molecular remodeling in mesenteric resistance arteries (MRAs) in diabetic (db/db) and control (Db/db) mice. Methods: Structural properties were assessed in isolated MRAs from 12 and 16 wk-old db/db and Db/db mice by pressure myography. Matrix regulatory proteins were measured by Western blot analysis. Mean arterial pressure and superior mesenteric blood flow were measured in 12 wk-old mice by telemetry and a Doppler flow nanoprobe, respectively. Results: Blood pressure was similar between groups. Lumen diameter and medial cross-sectional area were significantly increased in 16 wk-old db/db MRA compared to control, indicating outward hypertrophic remodeling. Moreover, wall stress and cross-sectional compliance were significantly larger in diabetic arteries. These remodeling indices were associated with increased expression of matrix regulatory proteins matrix metalloproteinase (MMP)-9, MMP-12, tissue inhibitors of matrix metalloproteinase (TIMP)-1, TIMP-2, and plasminogen activator inhibitor-1 (PAI-1) in db/db arteries. Finally, superior mesenteric artery blood flow was increased by 46% in 12 wk-old db/db mice, a finding that preceded mesenteric resistance artery remodeling. Conclusions: These data suggest that flow-induced hemodynamic changes may supersede the local neurohormonal and metabolic milieu to culminate in hypertrophic outward remodeling of type 2 DM mesenteric resistance arteries.	[Souza-Smith, Flavia M.; Varner, Kurt J.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Souza-Smith, Flavia M.; Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Katz, Paige S.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA USA; [Katz, Paige S.; Trask, Aaron J.; Stewart, James A., Jr.; Lucchesi, Pamela A.] Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Katz, Paige S.; Trask, Aaron J.; Stewart, James A., Jr.; Lucchesi, Pamela A.] Nationwide Childrens Hosp, Res Inst, Ctr Heart, Columbus, OH USA; [Katz, Paige S.; Trask, Aaron J.; Stewart, James A., Jr.; Lucchesi, Pamela A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Lord, Kevin C.] Univ Incarnate Word, Feik Sch Pharm, San Antonio, TX USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Universidade Federal do Espirito Santo; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Souza-Smith, FM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA.	pamela.lucchesi@nationwidechildrens.org	Lucchesi, Pamela A/E-3558-2011; Vassallo, Dalton/K-8289-2016	Vassallo, Dalton/0000-0002-4463-4174; Varner, Kurt/0000-0001-5460-8044	National Institutes of Health [COBRE P20RR18766, HL056046, T32HL098039]; Coordination for the Improvement of Higher Education Personnel; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098039, R29HL056046, R01HL056046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health COBRE P20RR18766 grant (LSUHSC), National Institutes of Health HL056046 grant (PAL), National Institutes of Health T32HL098039 grant (AJT), and Coordination for the Improvement of Higher Education Personnel (DVV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas SM, 2006, PHARMACOL THERAPEUT, V111, P771, DOI 10.1016/j.pharmthera.2005.12.003; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Brassard P, 2005, HYPERTENSION, V46, P598, DOI 10.1161/01.HYP.0000176744.15592.7d; Briones AM, 2003, J PHYSIOL-LONDON, V552, P185, DOI 10.1113/jphysiol.2003.046904; Briones AM, 2007, J GERONTOL A-BIOL, V62, P696, DOI 10.1093/gerona/62.7.696; Cooper ME, 2004, AM J HYPERTENS, V17, p16S, DOI 10.1016/j.amjhyper.2004.08.004; COOPER ME, 1994, DIABETES, V43, P1221, DOI 10.2337/diabetes.43.10.1221; COX JE, 1977, J COMP PHYSIOL PSYCH, V91, P347, DOI 10.1037/h0077322; Crijns FRL, 1999, AM J PHYSIOL-HEART C, V276, pH1672, DOI 10.1152/ajpheart.1999.276.5.H1672; Derosa G, 2007, DIABETES METAB, V33, P129, DOI 10.1016/j.diabet.2006.11.008; Dhalla NS, 1998, CARDIOVASC RES, V40, P239, DOI 10.1016/S0008-6363(98)00186-2; Ding H, 2005, AM J PHYSIOL-HEART C, V289, pH206, DOI 10.1152/ajpheart.00037.2005; Dunn WR, 1997, HYPERTENSION, V29, P1140, DOI 10.1161/01.HYP.29.5.1140; FRIEDMAN MI, 1994, PHYSIOL BEHAV, V56, P373, DOI 10.1016/0031-9384(94)90209-7; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; GLAGOV S, 1992, J HYPERTENS, V10, pS101; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Goldsmith EC, 2002, J CARD FAIL, V8, pS314, DOI 10.1054/jcaf.2002.129258; Han SY, 2006, NEPHROL DIAL TRANSPL, V21, P2406, DOI 10.1093/ndt/gfl238; HEAGERTY AM, 1993, HYPERTENSION, V21, P391, DOI 10.1161/01.HYP.21.4.391; Intengan HD, 1999, CIRCULATION, V100, P2267, DOI 10.1161/01.CIR.100.22.2267; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; LANGILLE BL, 1989, AM J PHYSIOL, V256, pH931, DOI 10.1152/ajpheart.1989.256.4.H931; Li Q, 2007, ACTA CARDIOL, V62, P485, DOI 10.2143/AC.62.5.2023412; McFarlane SI, 2003, AM J CARDIOL, V91, p30H, DOI 10.1016/S0002-9149(03)00432-6; Mulvany MJ, 1996, HYPERTENSION, V28, P505; Pourageaud F, 1997, AM J PHYSIOL-HEART C, V273, pH1699, DOI 10.1152/ajpheart.1997.273.4.H1699; QIU HY, 1995, J PHARMACOL TOXICOL, V33, P159, DOI 10.1016/1056-8719(94)00076-G; Rizzoni D, 2003, CIRCULATION, V108, P2230, DOI 10.1161/01.CIR.0000095031.51492.C5; Rizzoni D, 2001, J HYPERTENS, V19, P913, DOI 10.1097/00004872-200105000-00012; Rizzoni D, 2001, CIRCULATION, V103, P1238; SCHIFFRIN EL, 1992, HYPERTENSION, V19, P1; Schofield I, 2002, CIRCULATION, V106, P3037, DOI 10.1161/01.CIR.0000041432.80615.A5; Stewart JA, 2003, J MOL CELL CARDIOL, V35, P311, DOI 10.1016/S0022-2828(03)00013-0; Stockklauser-Farber K, 2000, BBA-MOL BASIS DIS, V1535, P10, DOI 10.1016/S0925-4439(00)00078-8; Thrailkill KM, 2007, DIABETES CARE, V30, P2321, DOI 10.2337/dc07-0162; Tulis DA, 1998, AM J PHYSIOL-HEART C, V274, pH874, DOI 10.1152/ajpheart.1998.274.3.H874; Tuttle JL, 2001, AM J PHYSIOL-HEART C, V281, pH1380, DOI 10.1152/ajpheart.2001.281.3.H1380; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; Unthank JL, 1996, CIRC RES, V79, P1015, DOI 10.1161/01.RES.79.5.1015; VANBORTEL LM, 1995, HYPERTENSION, V26, P531, DOI 10.1161/01.HYP.26.3.531; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wigg SJ, 2004, DIABETOLOGIA, V47, P1038, DOI 10.1007/s00125-004-1411-x; 2008, 2007 DIABETES CARE, V31, P596	45	36	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23337	10.1371/journal.pone.0023337	http://dx.doi.org/10.1371/journal.pone.0023337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829729	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200066
J	Kulkarni, B; Mohammed, I; Hopkinson, A; Dua, HS				Kulkarni, Bina; Mohammed, Imran; Hopkinson, Andrew; Dua, Harminder Singh			Validation of Endogenous Control Genes for Gene Expression Studies on Human Ocular Surface Epithelium	PLOS ONE			English	Article							REAL-TIME PCR; STEM-CELL NICHE; RT-PCR; HOUSEKEEPING GENES; CORNEAL EPITHELIUM; HUMAN LIMBAL; RNA; QUANTIFICATION; NORMALIZATION; SELECTION	Purpose: To evaluate a panel of ten known endogenous control genes (ECG) with quantitative reverse transcription PCR (qPCR), for identification of stably expressed endogenous control genes in the ocular surface (OS) epithelial regions including cornea, limbus, limbal epithelial crypt and conjunctiva to normalise the quantitative reverse transcription PCR data of genes of interest expressed in above-mentioned regions. Method: The lasermicrodissected (LMD) OS epithelial regions of cryosectioned corneoscleral buttons from the cadaver eyes were processed for RNA extraction and cDNA synthesis to detect genes of interest with qPCR. Gene expression of 10 known ECG-glyceraldehyde-3-phosphate dehydrogenase (GAPDH), beta actin (ACTB), peptidylprolyl isomerase (PPIA), TATA-box binding protein (TBP1), hypoxanthine guanine phosphoribosyl transferase (HPRT1), beta glucuronidase (GUSB), Eucaryotic 18S ribosomal RNA (18S), phosphoglycerate kinase (PGK1), beta-2-microglobulin (B2M), ribosomal protein, large, P0 (RPLP0)-was measured in the OS epithelial regions by qPCR method and the data collected was further analysed using geNorm software. Results: The expression stability of ECGs in the OS epithelial regions in increasing order as determined with geNorm software is as follows: ACTB < 18S < TBP < B2M < PGK1 < HPRT1 < GUSB < GAPDH < PPIA-RPLP0. In this study, geNorm analysis has shown the following ECGs pairs to be most stably expressed in individual OS epithelial regions: HPRT1-TBP in cornea, GUSB-PPIA in limbus, B2M-PPIA and RPLP0-TBP in LEC and conjunctiva respectively. However, across the entire ocular surface including all the regions mentioned above, PPIA-RPLP0 pair was shown to be most stable. Conclusion: This study has identified stably expressed ECGs on the OS epithelial regions for effective qPCR results in genes of interest. The results from this study are broadly applicable to quantitative reverse transcription PCR studies on human OS epithelium and provide evidence for the use of PPIA-RPLP0 ECGs pair in quantitative reverse transcription PCR across the OS epithelium.	[Kulkarni, Bina; Mohammed, Imran; Hopkinson, Andrew; Dua, Harminder Singh] Queens Med Ctr, Div Ophthalmol & Visual Sci, Nottingham NG7 2UH, England; [Mohammed, Imran] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Nottingham; University of Pennsylvania; Pennsylvania Medicine	Kulkarni, B (corresponding author), Queens Med Ctr, Div Ophthalmol & Visual Sci, Nottingham NG7 2UH, England.	Harminder.dua@nottingham.ac.uk	Hopkinson, Andrew/A-2287-2011; Mohammed, Imran/J-8271-2012	Mohammed, Imran/0000-0002-8412-0768	Royal Blind Asylum and School/Scottish National Institution for the War Blinded; Royal College of Surgeons of Edinburgh, Edinburgh, Scotland, UK	Royal Blind Asylum and School/Scottish National Institution for the War Blinded; Royal College of Surgeons of Edinburgh, Edinburgh, Scotland, UK	The study was funded by the Royal Blind Asylum and School/Scottish National Institution for the War Blinded, and the Royal College of Surgeons of Edinburgh, Edinburgh, Scotland, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000913; Ainscough SL, 2010, EXP EYS RES; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Ding ZH, 2008, MOL VIS, V14, P2031; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Erickson HS, 2009, NAT PROTOC, V4, P902, DOI 10.1038/nprot.2009.61; Etschmann B, 2006, VET PATHOL, V43, P934, DOI 10.1354/vp.43-6-934; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kulkarni BB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-526; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Li J, 2007, MOL VIS, V13, P813; Ma P, 2009, INVEST OPHTH VIS SCI, V50, P2702, DOI 10.1167/iovs.08-3074; Mohammed I, INVEST OPHTHALMOL VI, V51, P4677; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piehler AP, BMC IMMUNOL, V11, P21; Pinzani P., 2006, Molecular Aspects of Medicine, V27, P140; Qi H, 2008, BRIT J OPHTHALMOL, V92, P1269, DOI 10.1136/bjo.2007.132431; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Riau AK, 2009, MOL VIS, V15, P335; Robertson DM, 2008, EXP EYE RES, V86, P576, DOI 10.1016/j.exer.2007.12.007; Robinson TL, 2007, VET IMMUNOL IMMUNOP, V115, P160, DOI 10.1016/j.vetimm.2006.09.012; Sekiyama E, 2006, INVEST OPHTH VIS SCI, V47, P1352, DOI 10.1167/iovs.05-1305; Shanmuganathan VA, 2007, BRIT J OPHTHALMOL, V91, P514, DOI 10.1136/bjo.2006.102640; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walch A, 2001, HISTOCHEM CELL BIOL, V115, P269; Wang F, ANAL BIOCH, V399, P211; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yeung AM, 2009, EXP EYE RES, V88, P1161, DOI 10.1016/j.exer.2008.12.014; Yeung AMH, 2008, ARCH OPHTHALMOL-CHIC, V126, P665, DOI 10.1001/archopht.126.5.665; Zhang M, 2006, MOL VIS, V12, P937; Zhou MY, 2006, J BIOL CHEM, V281, P19600, DOI 10.1074/jbc.M600777200	40	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22301	10.1371/journal.pone.0022301	http://dx.doi.org/10.1371/journal.pone.0022301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857920	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000293558900013
J	Reyda, FB; Marques, FPL				Reyda, Florian B.; Marques, Fernando P. L.			Diversification and Species Boundaries of Rhinebothrium (Cestoda; Rhinebothriidea) in South American Freshwater Stingrays (Batoidea; Potamotrygonidae)	PLOS ONE			English	Article							OCELLATE RIVER STINGRAY; EVOLUTIONARY RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; PHYLOGENETIC ANALYSIS; AMENDED DESCRIPTIONS; MODEL SELECTION; TETRAPHYLLIDEA; EUCESTODA; CHONDRICHTHYES; DELIMITATION	Background: Neotropical freshwater stingrays (Batoidea: Potamotrygonidae) host a diverse parasite fauna, including cestodes. Both cestodes and their stingray hosts are marine-derived, but the taxonomy of this host/parasite system is poorly understood. Methodology: Morphological and molecular (Cytochrome oxidase I) data were used to investigate diversity in freshwater lineages of the cestode genus Rhinebothrium Linton, 1890. Results were based on a phylogenetic hypothesis for 74 COI sequences and morphological analysis of over 400 specimens. Cestodes studied were obtained from 888 individual potamotrygonids, representing 14 recognized and 18 potentially undescribed species from most river systems of South America. Results: Morphological species boundaries were based mainly on microthrix characters observed with scanning electron microscopy, and were supported by COI data. Four species were recognized, including two redescribed (Rhinebothrium copianullum and R. paratrygoni), and two newly described (R. brooksi n. sp. and R. fulbrighti n. sp.). Rhinebothrium paranaensis Menoret & Ivanov, 2009 is considered a junior synonym of R. paratrygoni because the morphological features of the two species overlap substantially. The diagnosis of Rhinebothrium Linton, 1890 is emended to accommodate the presence of marginal longitudinal septa observed in R. copianullum and R. brooksi n. sp. Patterns of host specificity and distribution ranged from use of few host species in few river basins, to use of as many as eight host species in multiple river basins. Significance: The level of intra-specific morphological variation observed in features such as total length and number of proglottids is unparalleled among other elasmobranch cestodes. This is attributed to the large representation of host and biogeographical samples. It is unclear whether the intra-specific morphological variation observed is unique to this freshwater system. Nonetheless, caution is urged when using morphological discontinuities to delimit elasmobranch cestode species because the amount of variation encountered is highly dependent on sample size and/or biogeographical representation.	[Reyda, Florian B.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Marques, Fernando P. L.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Lab Helmintol Evolut, Sao Paulo, Brazil; [Reyda, Florian B.] SUNY Coll Oneonta, Dept Biol, Oneonta, NY 13820 USA; [Reyda, Florian B.] SUNY Coll Oneonta, Biol Field Stn, Oneonta, NY 13820 USA	University of Connecticut; Universidade de Sao Paulo; State University of New York (SUNY) System; State University of New York (SUNY) System	Reyda, FB (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	reydafb@oneonta.edu	Marques, Fernando/J-3629-2012	Marques, Fernando/0000-0002-4281-8711	National Science Foundation (NSF) [9532943, 0118882, 0818696, 0818823, 0418932]; University of Connecticut; Harvard Museum of Comparative Zoology, United States of America; Fulbright Award; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo State Government, Brazil [2003/01816-2, 2005/01299-3, 2008/09436-8]; Direct For Biological Sciences [0818823] Funding Source: National Science Foundation; Division Of Environmental Biology [0818696] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Connecticut; Harvard Museum of Comparative Zoology, United States of America; Fulbright Award; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo State Government, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was partially supported with funds from the National Science Foundation (NSF) Partnerships for Enhancing Expertise in Taxonomy grants and an NSF Planetary Biodiversity Inventories collaborative grant (DEB Nos. 9532943, 0118882, 0818696, and 0818823, respectively). This work was supported with funds from the Judith Shaw Parasitology Fund (University of Connecticut), an Ernst Mayr Travel Grant in Animal Systematics (Harvard Museum of Comparative Zoology, United States of America), an NSF Doctoral Dissertation Improvement Grant (DEB No. 0418932) to J. Caira and FR, a Fulbright Award to FR, and funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo State Government, Brazil (No. 2003/01816-2, 2005/01299-3, and 2008/09436-8) to FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Blackburn TM, 1998, AM NAT, V151, P68, DOI 10.1086/286103; Boeger WA, 2003, ZOOL SCR, V32, P3, DOI 10.1046/j.1463-6409.2003.00109.x; Bristow G.A., 1981, ADV CLADISTICS, V1, P147; Brooks D.R., 1976, Journal Parasit, V62, P943, DOI 10.2307/3279188; BROOKS DR, 1992, J PARASITOL, V78, P393, DOI 10.2307/3283633; BROOKS DR, 1988, J PARASITOL, V74, P459, DOI 10.2307/3282056; BROOKS DR, 1992, J PARASITOL, V78, P588, DOI 10.2307/3283533; BROOKS DR, 1991, P BIOL SOC WASH, V104, P651; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Bueno VM, 2010, THESIS U SAO PAULO S; CAIRA J N, 1990, NOAA Technical Report NMFS, P71; Caira J. N., 2001, INTERRELATIONSHIPS P, P135; CAIRA JN, 1995, J HELMINTHOL SOC W, V62, P22; Caira JN, 2001, INT J PARASITOL, V31, P960, DOI 10.1016/S0020-7519(01)00206-5; Caira JN, 2011, PLANETARY BIODIVERSI; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Campbell RA, 1999, J PARASITOL, V85, P313, DOI 10.2307/3285640; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Charvet-Almeida P, 2001, AM EL SOC 17 ANN M P; Chervy L, 2009, FOLIA PARASIT, V56, P199, DOI 10.14411/fp.2009.025; Clayton DH, 2004, SYST BIOL, V53, P165, DOI 10.1080/10635150490265102; Clopton RE, 2004, COMP PARASITOL, V71, P130, DOI 10.1654/4151; Silva João Paulo C.B. da, 2011, Pap. Avulsos Zool. (São Paulo), V51, P139, DOI 10.1590/S0031-10492011000800001; da Silva JPCB, 2011, NEOTROP ICHTHYOL, V9, P209, DOI 10.1590/S1679-62252011000100021; de Carvalho M, 2001, AM EL SOC 17 ANN M P; De Carvalho MR, 2011, ZOOTAXA, P1; Carvalho Marcelo R. de, 2011, Pap. Avulsos Zool. (São Paulo), V51, P101, DOI 10.1590/S0031-10492011000700001; de Carvalho Marcelo R., 2011, Zootaxa, V2776, P13; de Carvalho MR, 2003, CHECKLIST FRESHWATER, P22; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K., 2005, BIOESSAYS, V26, P67; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Deynat P, 2006, CR BIOL, V329, P483, DOI 10.1016/j.crvi.2006.02.003; Domingues MV, 2010, J HELMINTHOL, DOI 101017/S0022149X10000684; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Euzet L., 1994, P149; Euzet L, 1980, MEMOIRE SOC ZOOLO 40, V3, P239; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fehlauer-Ale KH, 2009, THESIS U SAO PAULO B; FROST DR, 1994, CLADISTICS, V10, P259, DOI 10.1111/j.1096-0031.1994.tb00178.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Grabert H, 1983, NAT MUS, V113, P61; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hausdorf B, 2010, SYST BIOL, V59, P491, DOI 10.1093/sysbio/syq039; Healy CJ, 2006, J PARASITOL, V92, P364, DOI 10.1645/GE-560R.1; Healy CJ, 2006, THESIS U CONNECTICUT; Healy CJ, 2009, INT J PARASITOL, V39, P497, DOI 10.1016/j.ijpara.2008.09.002; Hoberg EP, 1997, J PARASITOL, V83, P1128, DOI 10.2307/3284374; Hoberg EP, 1999, SYST PARASITOL, V42, P1, DOI 10.1023/A:1006099009495; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Ivanov VA, 2005, J PARASITOL, V91, P390, DOI 10.1645/GE-354R1; Ivanov VA, 2004, SYST PARASITOL, V58, P159, DOI 10.1023/B:SYPA.0000032933.71645.1e; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima FCT, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P145; Lopez-Neyra C. R., 1958, Novedades Cientificas Museo de Historia Natural La Salle Ser Zool, VNo. 23, P1; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Luchetti NM, 2008, SYST PARASITOL, V70, P131, DOI 10.1007/s11230-008-9135-9; Lundberg John G., 1998, P13; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Marlier G., 1967, Amazoniana, V1, P91; Marques F. P. L., 2000, THESIS U TORONTO TOR; Marques FPL, 2003, J PARASITOL, V89, P994, DOI 10.1645/GE-3059; Marques FPL, 2003, ZOOL SCR, V32, P367, DOI 10.1046/j.1463-6409.2003.00111.x; Marques FPL, 2001, J PARASITOL, V87, P666, DOI 10.1645/0022-3395(2001)087[0666:ANGETI]2.0.CO;2; Marques FPL, 2011, COLLECTION DATABASE; Mayden R. L., 1997, V54, P381; MAYES MA, 1978, J PARASITOL, V64, P838, DOI 10.2307/3279513; McCormack JE, 2009, SYST BIOL, V58, P501, DOI 10.1093/sysbio/syp045; Menoret A, 2009, J PARASITOL, V95, P994, DOI 10.1645/GE-1850.1; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Peterson AT, 1999, CONSERV BIOL, V13, P427, DOI 10.1046/j.1523-1739.1999.013002427.x; Pleijel F, 2008, MOL PHYLOGENET EVOL, V48, P369, DOI 10.1016/j.ympev.2008.03.024; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulin R., 2007, EVOL ECOL, V2; Rego A.A., 1979, Revista Brasileira de Biologia, V39, P879; REGO A A, 1976, Revista Brasileira de Biologia, V36, P941; Reyda FB, 2007, THESIS U CONNECTICUT; Reyda FB, 2008, J PARASITOL, V94, P684, DOI 10.1645/GE-1230.1; Ripplinger J, 2008, SYST BIOL, V57, P76, DOI 10.1080/10635150801898920; ROBERTS T R, 1972, Bulletin of the Museum of Comparative Zoology, V143, P117; Rosa RS, 2008, NEOTROP ICHTHYOL, V6, P1, DOI 10.1590/S1679-62252008000100001; ROSA RS, 1985, THESIS COLL WILLIAM; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; RUHNKE TR, 1994, SYST PARASITOL, V28, P65, DOI 10.1007/BF00006910; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Shibuya Akemi, 2009, Pan-American Journal of Aquatic Sciences, V4, P466; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Sites JW, 1997, CONSERV BIOL, V11, P1289, DOI 10.1046/j.1523-1739.1997.96254.x; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vermeij GJ, 2002, J PALEONTOL, V76, P265, DOI 10.1666/0022-3360(2002)076<0265:NMFTMO>2.0.CO;2; Waeschenbach A, 2007, MOL PHYLOGENET EVOL, V45, P311, DOI 10.1016/j.ympev.2007.03.019; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wiens JJ, 1999, ANNU REV ECOL SYST, V30, P327, DOI 10.1146/annurev.ecolsys.30.1.327; Wilkinson MJ, 2010, AMAZONIA LANDSCAPE S, P62; Williams H. H., 1969, Nytt Magasin for Zoologi, V17, P1; WILLIAMS HH, 1964, PARASITOLOGY, V54, P737, DOI 10.1017/S0031182000082743; WOODLAND W. N. F., 1934, PROC ZOOL SOC LONDON, V1934, P33; Zwickl D. J, 2006, GENETIC ALGORITHM AP; Zwickl DJ, 2005, GARLI GENETIC ALGORI	116	25	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22604	10.1371/journal.pone.0022604	http://dx.doi.org/10.1371/journal.pone.0022604			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857936	Green Submitted, Green Published, gold			2022-12-27	WOS:000293558900020
J	Sakaguchi, M; Murata, H; Yamamoto, K; Ono, T; Sakaguchi, Y; Motoyama, A; Hibino, T; Kataoka, K; Huh, N				Sakaguchi, Masakiyo; Murata, Hitoshi; Yamamoto, Ken-ichi; Ono, Tomoyuki; Sakaguchi, Yoshihiko; Motoyama, Akira; Hibino, Toshihiko; Kataoka, Ken; Huh, Nam-ho			TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; HUMAN KERATINOCYTES; RECEPTOR; GROWTH; INFLAMMATION; ACTIVATION; DOMAIN; AMPHOTERIN; DISEASE; CELLS	The receptor for advanced glycation end products (RAGE) is thought to be involved in the pathogenesis of a broad range of inflammatory, degenerative and hyperproliferative diseases. It binds to diverse ligands and activates multiple intracellular signaling pathways. Despite these pivotal functions, molecular events just downstream of ligand-activated RAGE have been surprisingly unknown. Here we show that the cytoplasmic domain of RAGE is phosphorylated at Ser391 by PKCf upon binding of ligands. TIRAP and MyD88, which are known to be adaptor proteins for Toll-like receptor-2 and -4 (TLR2/4), bound to the phosphorylated RAGE and transduced a signal to downstream molecules. Blocking of the function of TIRAP and MyD88 largely abrogated intracellular signaling from ligand-activated RAGE. Our findings indicate that functional interaction between RAGE and TLRs coordinately regulates inflammation, immune response and other cellular functions.	[Sakaguchi, Masakiyo; Murata, Hitoshi; Yamamoto, Ken-ichi; Ono, Tomoyuki; Kataoka, Ken; Huh, Nam-ho] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Sakaguchi, Yoshihiko] Miyazaki Univ, Interdisciplinary Res Org, Kiyotake, Miyazaki, Japan; [Motoyama, Akira; Hibino, Toshihiko] Shiseido Res Ctr, Kanazawa Ku, Yokohama, Kanagawa, Japan	Okayama University; University of Miyazaki; Shiseido Company, Limited	Sakaguchi, M (corresponding author), Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan.	namu@md.okayama-u.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; KATAOKA, Ken/B-1607-2011; MURATA, Hitoshi/B-2327-2011		Ministry of Health, Labor and Welfare (Research for Intractable Diseases); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23790479] Funding Source: KAKEN	Ministry of Health, Labor and Welfare (Research for Intractable Diseases)(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Health, Labor and Welfare (Research for Intractable Diseases) (N. Huh), from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Young Scientists (A)) (M. Sakaguchi), and from Takeda Science Foundation (M. Sakaguchi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study. Akira Motoyama and Toshihiko Hibino are employees of the Shiseido Research Center who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Fages C, 2000, J CELL SCI, V113, P611; Fedorov YV, 2002, MOL CELL BIOL, V22, P1140, DOI 10.1128/MCB.22.4.1140-1149.2002; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2009, REV NEUROSCIENCE, V20, P95; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Sakaguchi M, 2008, MOL BIOL CELL, V19, P78, DOI 10.1091/mbc.E07-07-0682; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Zhou YJ, 2006, BIOCHEM BIOPH RES CO, V344, P658, DOI 10.1016/j.bbrc.2006.03.167	36	154	158	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23132	10.1371/journal.pone.0023132	http://dx.doi.org/10.1371/journal.pone.0023132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829704	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511200041
J	Janzen, DH; Hallwachs, W; Burns, JM; Hajibabaei, M; Bertrand, C; Hebert, PDN				Janzen, Daniel H.; Hallwachs, Winnie; Burns, John M.; Hajibabaei, Mehrdad; Bertrand, Claudia; Hebert, Paul D. N.			Reading the Complex Skipper Butterfly Fauna of One Tropical Place	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; DNA BARCODES; SWEEP SAMPLES; FOLIAGE INSECTS; HESPERIIDAE; GENUS; BIODIVERSITY; INTEGRATION; INVENTORY; GENITALIA	Background: An intense, 30-year, ongoing biodiversity inventory of Lepidoptera, together with their food plants and parasitoids, is centered on the rearing of wild-caught caterpillars in the 120,000 terrestrial hectares of dry, rain, and cloud forest of Area de Conservacion Guanacaste (ACG) in northwestern Costa Rica. Since 2003, DNA barcoding of all species has aided their identification and discovery. We summarize the process and results for a large set of the species of two speciose subfamilies of ACG skipper butterflies (Hesperiidae) and emphasize the effectiveness of barcoding these species (which are often difficult and time-consuming to identify). Methodology/Principal Findings: Adults are DNA barcoded by the Biodiversity Institute of Ontario, Guelph, Canada; and they are identified by correlating the resulting COI barcode information with more traditional information such as food plant, facies, genitalia, microlocation within ACG, caterpillar traits, etc. This process has found about 303 morphologically defined species of eudamine and pyrgine Hesperiidae breeding in ACG (about 25% of the ACG butterfly fauna) and another 44 units indicated by distinct barcodes (n = 9,094), which may be additional species and therefore may represent as much as a 13% increase. All but the members of one complex can be identified by their DNA barcodes. Conclusions/Significance: Addition of DNA barcoding to the methodology greatly improved the inventory, both through faster (hence cheaper) accurate identification of the species that are distinguishable without barcoding, as well as those that require it, and through the revelation of species "hidden" within what have long been viewed as single species. Barcoding increased the recognition of species-level specialization. It would be no more appropriate to ignore barcode data in a species inventory than it would be to ignore adult genitalia variation or caterpillar ecology.	[Janzen, Daniel H.; Hallwachs, Winnie] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Burns, John M.] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Hajibabaei, Mehrdad; Bertrand, Claudia; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Pennsylvania; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Guelph	Janzen, DH (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	djanzen@sas.upenn.edu	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	National Museum of Natural History Small Grants Program; U.S. National Science Foundation [BSR 9024770, DEB 9306296, 9400829, 9705072, 0072730, 0515699]; Wege Foundation; International Conservation Fund of Canada; Jessie B. Cox Charitable Trust; Blue Moon Fund; Guanacaste Dry Forest Conservation Fund; Area de Conservacion Guanacaste; University of Pennsylvania; Gordon and Betty Moore Foundation; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program	National Museum of Natural History Small Grants Program; U.S. National Science Foundation(National Science Foundation (NSF)); Wege Foundation; International Conservation Fund of Canada; Jessie B. Cox Charitable Trust; Blue Moon Fund; Guanacaste Dry Forest Conservation Fund; Area de Conservacion Guanacaste; University of Pennsylvania; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs)	This research was supported by the National Museum of Natural History Small Grants Program (J.M.B.); U.S. National Science Foundation grants BSR 9024770 and DEB 9306296, 9400829, 9705072, 0072730, and 0515699, and grants from the Wege Foundation, International Conservation Fund of Canada, Jessie B. Cox Charitable Trust, Blue Moon Fund, Guanacaste Dry Forest Conservation Fund, Area de Conservacion Guanacaste, and University of Pennsylvania (D.H.J.); and the Gordon and Betty Moore Foundation, the Natural Sciences and Engineering Research Council of Canada, and the Canada Research Chairs program (P.D.N.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Burns John M., 2005, Journal of the Lepidopterists' Society, V59, P19; Burns John M., 1996, Journal of the Lepidopterists' Society, V50, P173; Burns John M., 2001, Journal of the Lepidopterists' Society, V55, P15; Burns John M., 1999, Journal of the Lepidopterists' Society, V53, P77; Burns JM, 2010, J LEPID SOC, V64, P69; Burns JM, 2010, P ENTOMOL SOC WASH, V112, P32, DOI 10.4289/0013-8797-112.1.32; Burns JM, 2009, J LEPID SOC, V63, P141; CHACON IA, 2007, MARIPOSAS COSTA RICA; DEVRIES PJ, 1997, BUTTERFLIES COSTA RI, V2; DEVRIES PJ, 1987, BUTTERFLIES COSTA RI, V1, P327; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Greeney HF., 2003, J RES LEPIDOPTERA, V37, P27; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; JANZEN D H, 1976, Biotropica, V8, P193, DOI 10.2307/2989685; Janzen D. H., 2000, Biodiversity, V1, P7; JANZEN D H, 1976, Revista de Biologia Tropical, V24, P149; Janzen Daniel H., 1997, P251; Janzen Daniel H., 1993, P448; Janzen Daniel H., 2002, P559; Janzen DH, 2010, P NATL ACAD SCI USA, V107, P11659, DOI 10.1073/pnas.0912122107; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; JANZEN DH, 1973, ECOLOGY, V54, P687, DOI 10.2307/1935359; JANZEN DH, 1987, INSECT SCI APPL, V8, P489, DOI 10.1017/S1742758400022530; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; JANZEN DH, 1973, ECOLOGY, V54, P659, DOI 10.2307/1935358; Janzen DH, 2004, J APPL ECOL, V41, P181, DOI 10.1111/j.1365-2664.2004.00879.x; JANZEN DH, 1987, OIKOS, V48, P3, DOI 10.2307/3565679; JANZEN DH, 1975, T ROY ENT SOC LONDON, V127, P33; JANZEN DH, 1988, REHABILITATING DAMAG, P143; JANZEN DH, 1996, ASC NEWSLETTER, V24, P45; JANZEN DH, 1996, ASS SYSTEMATICS COLL, V24, P49; JANZEN DH, COSTA RICAN NATURAL, P816; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; Miller J. S., 1997, Tropical Lepidoptera, V8, P81; Miller JC, 2006, 100 CATERPILLARS; MILLER JC, 2007, 100 BUTTERFLIES MOTH; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pelham Jonathan P., 2008, Journal of Research on the Lepidoptera, V40; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Stoeckle MY, 2008, SCI AM, V299, P82; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Warren AD, 2009, SYST ENTOMOL, V34, P467, DOI 10.1111/j.1365-3113.2008.00463.x	51	39	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e19874	10.1371/journal.pone.0019874	http://dx.doi.org/10.1371/journal.pone.0019874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857895	Green Submitted, Green Published, gold			2022-12-27	WOS:000294125500002
J	Nelson, A; Chomitz, KM				Nelson, Andrew; Chomitz, Kenneth M.			Effectiveness of Strict vs. Multiple Use Protected Areas in Reducing Tropical Forest Fires: A Global Analysis Using Matching Methods	PLOS ONE			English	Article							LAND-USE; PARKS; DEFORESTATION; LOCATION; IMPACT; BIODIVERSITY; EMISSIONS; RESERVES; WORLDS; ROADS	Protected areas (PAs) cover a quarter of the tropical forest estate. Yet there is debate over the effectiveness of PAs in reducing deforestation, especially when local people have rights to use the forest. A key analytic problem is the likely placement of PAs on marginal lands with low pressure for deforestation, biasing comparisons between protected and unprotected areas. Using matching techniques to control for this bias, this paper analyzes the global tropical forest biome using forest fires as a high resolution proxy for deforestation; disaggregates impacts by remoteness, a proxy for deforestation pressure; and compares strictly protected vs. multiple use PAs vs indigenous areas. Fire activity was overlaid on a 1 km map of tropical forest extent in 2000; land use change was inferred for any point experiencing one or more fires. Sampled points in pre-2000 PAs were matched with randomly selected never-protected points in the same country. Matching criteria included distance to road network, distance to major cities, elevation and slope, and rainfall. In Latin America and Asia, strict PAs substantially reduced fire incidence, but multi-use PAs were even more effective. In Latin America, where there is data on indigenous areas, these areas reduce forest fire incidence by 16 percentage points, over two and a half times as much as naive (unmatched) comparison with unprotected areas would suggest. In Africa, more recently established strict PAs appear to be effective, but multi-use tropical forest protected areas yield few sample points, and their impacts are not robustly estimated. These results suggest that forest protection can contribute both to biodiversity conservation and CO2 mitigation goals, with particular relevance to the REDD agenda. Encouragingly, indigenous areas and multi-use protected areas can help to accomplish these goals, suggesting some compatibility between global environmental goals and support for local livelihoods.	[Nelson, Andrew] Int Rice Res Inst, Manila, Philippines; [Chomitz, Kenneth M.] World Bank, Independent Evaluat Grp, Washington, DC 20433 USA	CGIAR; International Rice Research Institute (IRRI); The World Bank	Nelson, A (corresponding author), Int Rice Res Inst, Manila, Philippines.	kchomitz@worldbank.org	Nelson, Andy/G-3649-2012	Nelson, Andy/0000-0002-7249-3778	Evaluation Department of the Norwegian Agency for Development Cooperation (Norad)	Evaluation Department of the Norwegian Agency for Development Cooperation (Norad)	This work was undertaken at the World Bank Group's Independent Evaluation Group and was supported in part by the Evaluation Department of the Norwegian Agency for Development Cooperation (Norad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; [Anonymous], 2009, SCIENCE, V323, P19; Applegate G, 2001, UNDERLYING CAUSES IM; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bonham CA, 2008, BIODIVERS CONSERV, V17, P1581, DOI 10.1007/s10531-008-9368-6; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Chomitz KM, 2002, CLIM POLICY, V2, P35, DOI 10.1016/S1469-3062(02)00011-6; Chomitz KM, 2007, AT LOGGERHEADS: AGRICULTURAL EXPANSION, POVERTY REDUCTION, AND ENVIRONMENT IN THE TROPICAL FORESTS, P1, DOI 10.1596/978-0-8213-6735-3; Chomitz KM, 1996, WORLD BANK ECON REV, V10, P487, DOI 10.1093/wber/10.3.487; Chomitz KM, 2003, AM J AGR ECON, V85, P1016, DOI 10.1111/1467-8276.00504; Chowdhury J. A., 2006, BETTER FOREST MANAGE; CIESIN, 2004, GLOB RUR URB MAPP PR; Coad L, 2008, STATE WORLDS PROTECT; Cropper M, 2001, LAND ECON, V77, P172, DOI 10.2307/3147088; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Dudley N, GUIDELINES APPL PROT; FAO, 2008, UN COLL PROGR RED EM; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Ferraro Paul J., 2006, PLOS BIOL       0411; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gaveau DLA, 2009, BIOL CONSERV, V142, P597, DOI 10.1016/j.biocon.2008.11.024; Gaveau DL, 2009, ENVIRON RES LETT, V4, P1; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Gorenflo LJ, 2011, ECOL STUD-ANAL SYNTH, V214, P197, DOI 10.1007/978-3-642-16707-2_11; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Hansen MC, 2003, EARTH INTERACT, V7; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; HIJMANS R, 2008, GLOBAL ADM AREAS VER; Ho DE, 2007, POLIT ANAL, pmp1013; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Joppa LN, 2010, P ROYAL SOC B; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; LEADERWILLIAMS N, 1990, SCI PROGRESS-UK, V74, P189; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Morgan SL, 2006, SOCIOL METHOD RES, V35, P3, DOI 10.1177/0049124106289164; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nelson A., 2006, CODATA SCI J, V5, P223, DOI [DOI 10.2481/dsj.5.223, DOI 10.2481/DSJ.5.223]; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Sanchez-Azofeifa GA, 2003, BIOL CONSERV, V109, P123, DOI 10.1016/S0006-3207(02)00145-3; SCHENKER N, 1985, J AM STAT ASSOC, V80, P360, DOI 10.2307/2287897; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Sekhon JS, 2007, J STAT SOFTWARE; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Southworth J, 2006, APPL GEOGR, V26, P87, DOI 10.1016/j.apgeog.2005.11.001; Southworth J, 2004, APPL GEOGR, V24, P303, DOI 10.1016/j.apgeog.2004.07.003; Stott P, 2000, PROG PHYS GEOG, V24, P355, DOI 10.1177/030913330002400303; Tang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019116; UNEP/IUCN, 2009, PROT AR EXTR 2009 WO; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308	65	260	265	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22722	10.1371/journal.pone.0022722	http://dx.doi.org/10.1371/journal.pone.0022722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810KZ	21857950	Green Published, gold			2022-12-27	WOS:000294125500012
J	Alves, JMP; Voegtly, L; Matveyev, AV; Lara, AM; da Silva, FM; Serrano, MG; Buck, GA; Teixeira, MMG; Camargo, EP				Alves, Joao M. P.; Voegtly, Logan; Matveyev, Andrey V.; Lara, Ana M.; da Silva, Flavia Maia; Serrano, Myrna G.; Buck, Gregory A.; Teixeira, Marta M. G.; Camargo, Erney P.			Identification and Phylogenetic Analysis of Heme Synthesis Genes in Trypanosomatids and Their Bacterial Endosymbionts	PLOS ONE			English	Article							BLASTOCRITHIDIA-CULICIS; EVOLUTION; GENOME; BIOSYNTHESIS; ONCOPELTI; INSIGHTS; PROTOZOA; GROWTH	It has been known for decades that some insect-infecting trypanosomatids can survive in culture without heme supplementation while others cannot, and that this capability is associated with the presence of a betaproteobacterial endosymbiont in the flagellate's cytoplasm. However, the specific mechanisms involved in this process remained obscure. In this work, we sequence and phylogenetically analyze the heme pathway genes from the symbionts and from their hosts, as well as from a number of heme synthesis-deficient Kinetoplastida. Our results show that the enzymes responsible for synthesis of heme are encoded on the symbiont genomes and produced in close cooperation with the flagellate host. Our evidence suggests that this synergistic relationship is the end result of a history of extensive gene loss and multiple lateral gene transfer events in different branches of the phylogeny of the Trypanosomatidae.	[Alves, Joao M. P.; Voegtly, Logan; Matveyev, Andrey V.; Lara, Ana M.; Serrano, Myrna G.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Alves, Joao M. P.; Voegtly, Logan; Matveyev, Andrey V.; Lara, Ana M.; Serrano, Myrna G.; Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [da Silva, Flavia Maia; Teixeira, Marta M. G.; Camargo, Erney P.] Univ Sao Paulo, Dept Parasitol, ICB, Sao Paulo, Brazil	Virginia Commonwealth University; Virginia Commonwealth University; Universidade de Sao Paulo	Alves, JMP (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	jmalves@vcu.edu	Teixeira, Marta M G/B-1115-2009; Camargo, Erney/A-6765-2009; Alves, Joao M.P./G-8927-2011	Camargo, Erney/0000-0003-0011-5871; Alves, Joao M.P./0000-0001-5914-2087	National Science Foundation [0830056]; National Council for Scientific and Technological Development (CNPq); Flavia Maia da Silva receives a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-CNPq)	National Science Foundation(National Science Foundation (NSF)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Flavia Maia da Silva receives a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-CNPq)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been funded by grants from the National Science Foundation's Assembling the Tree of Life program (Gregory A. Buck, award #0830056), and National Council for Scientific and Technological Development (CNPq) (Marta M. G. Teixeira and Erney P. Camargo). Flavia Maia da Silva receives a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-CNPq) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilov OE, 2007, EXP DERMATOL, V16, P651, DOI 10.1111/j.1600-0625.2007.00578.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], NUCLEIC ACIDS RES S1; BEALE SI, 1975, P NATL ACAD SCI USA, V72, P2719, DOI 10.1073/pnas.72.7.2719; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CHANG KP, 1975, J PROTOZOOL, V22, P271, DOI 10.1111/j.1550-7408.1975.tb05866.x; CHANG KP, 1974, SCIENCE, V183, P531, DOI 10.1126/science.183.4124.531; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; CHANG KP, 1975, S SOC EXP BIOL, V29, P409; de Souza W, 1999, FEMS MICROBIOL LETT, V173, P1, DOI 10.1111/j.1574-6968.1999.tb13477.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DU YB, 1994, P NATL ACAD SCI USA, V91, P8437, DOI 10.1073/pnas.91.18.8437; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kato K, 2010, P NATL ACAD SCI USA, V107, P16649, DOI 10.1073/pnas.1000771107; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LWOFF M, 1940, THESIS I PASTEUR PAR; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maslov DA, 2001, MEM I OSWALDO CRUZ, V96, P397, DOI 10.1590/S0074-02762001000300021; MOTTA MCM, 1991, CAN J ZOOL, V69, P571, DOI 10.1139/z91-086; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; MUNDIM MH, 1974, J PROTOZOOL, V21, P518, DOI 10.1111/j.1550-7408.1974.tb03691.x; NEWTON BA, 1956, NATURE, V177, P279, DOI 10.1038/177279b0; NEWTON BA, 1957, EXP CELL RES, V13, P563, DOI 10.1016/0014-4827(57)90086-1; NEWTON BA, 1957, J GEN MICROBIOL, V17, P708, DOI 10.1099/00221287-17-3-708; Novy FG, 1904, J INFECT DIS, V1, P1; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ozaki LS, 1984, GENES ANTIGENS PARAS, P165; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Roitman I., 1985, Parasitology Today, V1, P143, DOI 10.1016/0169-4758(85)90060-2; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; SHEMIN D, 1945, J BIOL CHEM, V159, P567; SILVA PMFE, 1991, J PROTOZOOL, V38, P489, DOI 10.1111/j.1550-7408.1991.tb04822.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; TEIXEIRA MMG, 2011, PHYLOGENETIC VALIDAT, DOI DOI 10.1016/J.PROTIS.2011.01.001; Tobey EN, 1906, J MED RES, V15, P117; UMAKI ACS, 2009, P 13 INT C PROT BUZ; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	42	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23518	10.1371/journal.pone.0023518	http://dx.doi.org/10.1371/journal.pone.0023518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853145	Green Published, gold			2022-12-27	WOS:000295454200093
J	Boekhorst, J; Boersema, PJ; Tops, BBJ; van Breukelen, B; Heck, AJR; Snel, B				Boekhorst, Jos; Boersema, Paul J.; Tops, Bastiaan B. J.; van Breukelen, Bas; Heck, Albert J. R.; Snel, Berend			Evaluating Experimental Bias and Completeness in Comparative Phosphoproteomics Analysis	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION; SITES	Unraveling the functional dynamics of phosphorylation networks is a crucial step in understanding the way in which biological networks form a living cell. Recently there has been an enormous increase in the number of measured phosphorylation events. Nevertheless, comparative and integrative analysis of phosphoproteomes is confounded by incomplete coverage and biases introduced by different experimental workflows. As a result, we cannot differentiate whether phosphosites indentified in only one or two samples are the result of condition or species specific phosphorylation, or reflect missing data. Here, we evaluate the impact of incomplete phosphoproteomics datasets on comparative analysis, and we present bioinformatics strategies to quantify the impact of different experimental workflows on measured phosphoproteomes. We show that plotting the saturation in observed phosphosites in replicates provides a reproducible picture of the extent of a particular phosphoproteome. Still, we are still far away from a complete picture of the total human phosphoproteome. The impact of different experimental techniques on the similarity between phosphoproteomes can be estimated by comparing datasets from different experimental pipelines to a common reference. Our results show that comparative analysis is most powerful when datasets have been generated using the same experimental workflow. We show this experimentally by measuring the tyrosine phosphoproteome from Caenorhabditis elegans and comparing it to the tyrosine phosphoproteome of HeLa cells, resulting in an overlap of about 4%. This overlap between very different organisms represents a three-fold increase when compared to dataset of older studies, wherein different workflows were used. The strategies we suggest enable an estimation of the impact of differences in experimental workflows on the overlap between datasets. This will allow us to perform comparative analyses not only on datasets specifically generated for this purpose, but also to extract insights through comparative analysis of the ever-increasing wealth of publically available phosphorylation data.	[Boekhorst, Jos; Snel, Berend] Univ Utrecht, Fac Sci, Dept Biol, Utrecht, Netherlands; [Boersema, Paul J.; Tops, Bastiaan B. J.; van Breukelen, Bas; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, Utrecht, Netherlands; [Boersema, Paul J.; Tops, Bastiaan B. J.; van Breukelen, Bas; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Snel, Berend] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Snel, Berend] Ctr Biosyst Genom, Wageningen, Netherlands; [Boersema, Paul J.] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Utrecht University; Utrecht University; Utrecht University; Centre for BioSystems Genomics; Max Planck Society	Boekhorst, J (corresponding author), NIZO Food Res, Ede, Netherlands.	Jos.Boekhorst@gmail.com	Snel, Berend/B-8886-2011; Heck, Albert/D-7098-2011; Tops, Bastiaan/L-4697-2015	Snel, Berend/0000-0002-5804-8547; Heck, Albert/0000-0002-2405-4404; Boekhorst, Jos/0000-0002-4807-7838; Tops, Bastiaan/0000-0002-1699-8210	Netherlands Proteomics Centre	Netherlands Proteomics Centre	The Netherlands Proteomics Centre, a program embedded in The Netherlands Genomics Initiative, partially funded this project (http://www.genomics.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Boekhorst J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r144; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; CHAO A, 1984, SCAND J STAT, V11, P265; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Grimsrud PA, 2010, ACS CHEM BIOL, V5, P105, DOI 10.1021/cb900277e; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lemeer S, 2009, CURR OPIN CHEM BIOL, V13, P414, DOI 10.1016/j.cbpa.2009.06.022; Moses AM, 2010, TRENDS GENET, V26, P462, DOI 10.1016/j.tig.2010.08.002; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pinkse MWH, 2008, J PROTEOME RES, V7, P687, DOI 10.1021/pr700605z; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23276	10.1371/journal.pone.0023276	http://dx.doi.org/10.1371/journal.pone.0023276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853102	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200062
J	Eikenaar, C; Whitham, M; Komdeur, J; van der Velde, M; Moore, IT				Eikenaar, Cas; Whitham, Megan; Komdeur, Jan; van der Velde, Marco; Moore, Ignacio T.			Testosterone, Plumage Colouration and Extra-Pair Paternity in Male North-American Barn Swallows	PLOS ONE			English	Article							TAIL STREAMER LENGTH; REPRODUCTIVE SUCCESS; MICROSATELLITE LOCI; CIRCULATING LEVELS; STEROID-HORMONES; SEXUAL SELECTION; MATING SYSTEMS; BEHAVIOR; POLYGYNY; BLACK	In most monogamous bird species, circulating testosterone concentration in males is elevated around the social female's fertile period. Variation in elevated testosterone concentrations among males may have a considerable impact on fitness. For example, testosterone implants enhance behaviours important for social and extra-pair mate choice. However, little is known about the relationship between natural male testosterone concentration and sexual selection. To investigate this relationship we measured testosterone concentration and sexual signals (ventral plumage colour and tail length), and determined within and extra-pair fertilization success in male North American barn swallows (Hirundo rustica erythrogaster). Dark rusty coloured males had higher testosterone concentrations than drab males. Extra-pair paternity was common (42% and 31% of young in 2009 and 2010, respectively), but neither within-nor extra-pair fertilization success was related to male testosterone concentration. Dark rusty males were less often cuckolded, but did not have higher extra-pair or total fertilization success than drab males. Tail length did not affect within-or extra-pair fertilization success. Our findings suggest that, in North American barn swallows, male testosterone concentration does not play a significant direct role in female mate choice and sexual selection. Possibly plumage colour co-varies with a male behavioural trait, such as aggressiveness, that reduces the chance of cuckoldry. This could also explain why dark males have higher testosterone concentrations than drab males.	[Eikenaar, Cas; Whitham, Megan; Moore, Ignacio T.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA; [van der Velde, Marco] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Haren, Netherlands	Virginia Polytechnic Institute & State University; University of Groningen	Eikenaar, C (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA.	eikenaar@vt.edu	Komdeur, Jan/X-1261-2019	Komdeur, Jan/0000-0002-9241-0124; Moore, Ignacio/0000-0001-8875-8913; Whitham, Megan/0000-0002-6685-8881	National Science Foundation [IOS 0545735]; Netherlands Organisation for Scientific Research [VICI 86503003]; Stichting Nicolaas Mulerius Fonds and Dobberke Stichting [DOBB2008-03]	National Science Foundation(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Stichting Nicolaas Mulerius Fonds and Dobberke Stichting	This research was supported by grants from the National Science Foundation (http://www.nsf.gov/) awarded to Ignacio Moore (IOS 0545735), from the Netherlands Organisation for Scientific Research (http://www.nwo.nl/) awarded to Jan Komdeur (VICI 86503003), and from Stichting Nicolaas Mulerius Fonds and Dobberke Stichting (DOBB2008-03) both allocated to Cas Eikenaar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo RV, 1996, P ROY SOC B-BIOL SCI, V263, P1697, DOI 10.1098/rspb.1996.0248; BALTHAZART J, 1976, J ZOOL, V180, P155, DOI 10.1111/j.1469-7998.1976.tb04670.x; BELETSKY LD, 1989, AUK, V106, P107, DOI 10.2307/4087763; Bensch S, 1997, MOL ECOL, V6, P91, DOI 10.1046/j.1365-294X.1997.00150.x; Birkhead TR, 1992, SPERM COMPETITION BI; BORGIA G, 1991, CONDOR, V93, P935, DOI 10.2307/3247728; De Ridder E, 2000, BEHAV ECOL SOCIOBIOL, V49, P24, DOI 10.1007/s002650000266; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Eikenaar C, 2011, BEHAV ECOL, V22, P601, DOI 10.1093/beheco/arr030; Enstrom DA, 1997, ANIM BEHAV, V54, P1135, DOI 10.1006/anbe.1997.0555; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foerster K, 2004, BEHAV ECOL SOCIOBIOL, V56, P482, DOI 10.1007/s00265-004-0809-2; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fusani L, 1997, ANIM BEHAV, V54, P1013, DOI 10.1006/anbe.1997.0518; Goymann W, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P465, DOI 10.1007/978-3-642-02624-9_16; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HANOTTE O, 1994, MOL ECOL, V3, P529, DOI 10.1111/j.1365-294X.1994.tb00133.x; HEGNER RE, 1986, HORM BEHAV, V20, P294, DOI 10.1016/0018-506X(86)90039-5; Hoskyn JL, 1988, THESIS YALE U NEW HA; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kleven O, 2006, BEHAV ECOL SOCIOBIOL, V59, P412, DOI 10.1007/s00265-005-0065-0; McGraw KJ, 2004, BEHAV ECOL, V15, P889, DOI 10.1093/beheco/arh109; MOLLER AP, 1987, ANIM BEHAV, V35, P247, DOI 10.1016/S0003-3472(87)80230-0; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Montgomerie Robert, 2006, P90; Moore IT, 2002, GEN COMP ENDOCR, V129, P13, DOI 10.1016/S0016-6480(02)00563-4; MOORE MC, 1984, BEHAVIOUR, V88, P215, DOI 10.1163/156853984X00326; Neuman CR, 2007, J AVIAN BIOL, V38, P28, DOI 10.1111/j.2007.0908-8857.03713.x; PRIMMER CR, 1995, MOL ECOL, V4, P493, DOI 10.1111/j.1365-294X.1995.tb00243.x; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Raouf SA, 1997, P ROY SOC B-BIOL SCI, V264, P1599, DOI 10.1098/rspb.1997.0223; Rasbash J., 2004, USERS GUIDE MLWIN VE; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Roberts ML, 2009, BEHAV ECOL, V20, P535, DOI 10.1093/beheco/arp028; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; SAINO N, 1995, ANIM BEHAV, V49, P465, DOI 10.1006/anbe.1995.0060; SAINO N, 1994, ANIM BEHAV, V48, P1325, DOI 10.1006/anbe.1994.1369; Savari L, 2009, ACTA ORNITHOL, V44, P59, DOI DOI 10.3161/000164509X464894; SHIELDS WM, 1987, ECOLOGY, V68, P1373, DOI 10.2307/1939221; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; SMITH HG, 1991, BEHAV ECOL SOCIOBIOL, V28, P195; van de Crommenacker J, 2004, P ROY SOC B-BIOL SCI, V271, P1023, DOI 10.1098/rspb.2004.2697; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WINGFIELD JC, 1984, AUK, V101, P665, DOI 10.2307/4086893; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1991, J ZOOL, V225, P43, DOI 10.1111/j.1469-7998.1991.tb03800.x	48	27	29	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23288	10.1371/journal.pone.0023288	http://dx.doi.org/10.1371/journal.pone.0023288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853105	gold, Green Published, Green Submitted			2022-12-27	WOS:000295454200065
J	Jacobs, U; De Castro, MS; Fuchs, FD; Ferreira, MBC				Jacobs, Ursula; De Castro, Mauro S.; Fuchs, Flavio D.; Ferreira, Maria Beatriz C.			The Influence of Cognition, Anxiety and Psychiatric Disorders over Treatment Adherence in Uncontrolled Hypertensive Patients	PLOS ONE			English	Article							STROKE RISK PROFILE; BLOOD-PRESSURE; MEDICATION ADHERENCE; VERSION; MEMORY; CARE	Background: Poor adherence is estimated to cause 125 thousand deaths per year and is linked to 10% of all hospital stays in the U. S. Up to one third of elderly hypertensive patients don't have adherence, which is responsible for high proportion of hospitalizations. Hypertension is also related to poor performance in tests that assess cognitive functions. On the other hand, poor cognitive performance is associated with low adherence to treatment. Objective: To assess the association between cognitive function, anxiety and psychiatric disorders with adherence to drug treatment in patients with hypertension. Methodology and Principal Findings: This a cohort studies with 56 adult patients with uncontrolled hypertension who participated of all meetings of a pharmaceutical intervention in a randomized clinical trial of pharmaceutical care. Cognitive function was measured by the Mini Mental State Examination (Mini-mental). The memory was measured by digit and word spans, tower and church shadow test, short story test and metamemory. Anxiety and psychiatric disorders were evaluated by the State Trace Anxiety Inventory and the Self-Report Questionnaire, respectively. The participants were classified as adherent or non-adherent to the drug treatment, according to the identification of plasma levels of hydrochlorothiazide. All non-adherent patients (n = 12) and 35 out 44 (79.5%) patients with adherence to treatment had at least one memory test with an altered score (P = 0.180). Participants with an unsatisfactory score in the Mini-mental had six-fold higher risk of non-adherence to treatment when compared to those with a normal score (RR = 5.8; CI 95%: 1.6-20.8; P = 0.007). The scores of anxiety and psychiatric disorders were not associated with adherence to the pharmacological treatment. Conclusion: Cognitive deficit impairs adherence to drug therapy and should be screened as part of a program of pharmaceutical care to improve adherence to treatment.	[Jacobs, Ursula] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Sch Med, Porto Alegre, RS, Brazil; [De Castro, Mauro S.] Univ Fed Rio Grande do Sul, Sch Pharm, Dept Drug Prod & Qual Control, Porto Alegre, RS, Brazil; [De Castro, Mauro S.] Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil; [Fuchs, Flavio D.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil; [Ferreira, Maria Beatriz C.] Univ Fed Rio Grande do Sul, Dept Pharmacol, Hlth Basic Sci Inst, Porto Alegre, RS, Brazil; [Ferreira, Maria Beatriz C.] Hosp Clin Porto Alegre, Postgrad Program Med Sci, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Jacobs, U (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Sch Med, Porto Alegre, RS, Brazil.	decastro.mauro@gmail.com	Fuchs, Flávio D/L-5078-2016; Ferreira, Maria Beatriz C/G-6561-2012; Iats, Inct/K-2300-2013	Ferreira, Maria Beatriz/0000-0002-6814-6773; fuchs, flavio/0000-0002-1191-0523	FIPE-Hospital de Clinicas de Porto Alegre; CNPq/Brazil	FIPE-Hospital de Clinicas de Porto Alegre; CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported in part by grants from FIPE-Hospital de Clinicas de Porto Alegre and CNPq/Brazil and had the cooperation of the Institute of Science and Technology for Pharmaceutical Innovation and the Institute of Science and Technology for Health Technology Assessment (IATS)I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 5 DIR BRAS HIP ART; BIAGGIO AMB, 1977, ARQ BRAS PSICOL APL, V29, P31; Campos LN, 2010, AIDS BEHAV, V14, P289, DOI 10.1007/s10461-008-9435-8; CASTRO MS, 2006, HYPERTENSION, V19, P528; CEITLIN LHF, 1992, JORNAL BRASILEIRO PS, V41, P317; Contardo C, 2009, ARCH CLIN NEUROPSYCH, V24, P547, DOI 10.1093/arclin/acp046; CURTIN M, 1990, CHRONIC ILLNESS IMPA, P2; ELIAS MF, 1993, AM J EPIDEMIOL, V138, P353, DOI 10.1093/oxfordjournals.aje.a116868; Elias MF, 2004, STROKE, V35, P404, DOI 10.1161/01.STR.0000103141.82869.77; FARMER ME, 1990, J CLIN EPIDEMIOL, V43, P475, DOI 10.1016/0895-4356(90)90136-D; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Maia ALG, 2006, ARQ NEURO-PSIQUIAT, V64, P485, DOI 10.1590/S0004-282X2006000300025; Hayes TL, 2009, J AGING HEALTH, V21, P567, DOI 10.1177/0898264309332836; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Izquierdo I., 2002, MEMORIA; Kuhl EA, 2009, AM J CARDIOL, V103, P1629, DOI 10.1016/j.amjcard.2009.02.014; Lee JK, 2006, JAMA-J AM MED ASSOC, V296, P2563, DOI 10.1001/jama.296.21.joc60162; Loayza MP, 2001, ARQ NEURO-PSIQUIAT, V59, P180, DOI 10.1590/S0004-282X2001000200005; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; Miura M, 2007, YAKUGAKU ZASSHI, V127, P1731, DOI 10.1248/yakushi.127.1731; Peterson AM, 2003, AM J HEALTH-SYST PH, V60, P657, DOI 10.1093/ajhp/60.7.657; ROSAT RM, 1990, BRAZ J MED BIOL RES, V23, P805; SANZ A, 1995, COMUNICACION INTERPE; Seshadri S, 2004, NEUROLOGY, V63, P1591, DOI 10.1212/01.WNL.0000142968.22691.70; WECHSLER D, 1981, ADULT INTELIGENCE SC; World Health Organisation, 2003, ADHERENCE LONG TERM; World Health Organization, WORLD HLTH REP 2002	27	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22925	10.1371/journal.pone.0022925	http://dx.doi.org/10.1371/journal.pone.0022925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	806AW	21857969	gold, Green Published, Green Submitted			2022-12-27	WOS:000293774300012
J	Zhang, HN; Yin, W; Zhao, J; Jin, L; Yang, YH; Wu, SW; Tabashnik, BE; Wu, YD				Zhang, Haonan; Yin, Wei; Zhao, Jing; Jin, Lin; Yang, Yihua; Wu, Shuwen; Tabashnik, Bruce E.; Wu, Yidong			Early Warning of Cotton Bollworm Resistance Associated with Intensive Planting of Bt Cotton in China	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; THURINGIENSIS TOXIN CRY1AC; BACILLUS-THURINGIENSIS; INSECTICIDAL PROTEIN; TOLERANCE RESPONSE; MULTIPLE CROPS; NORTHERN CHINA; NOCTUIDAE; POPULATIONS; FREQUENCY	Transgenic crops producing Bacillus thuringiensis (Bt) toxins kill some key insect pests, but evolution of resistance by pests can reduce their efficacy. The predominant strategy for delaying pest resistance to Bt crops requires refuges of non-Bt host plants to promote survival of susceptible pests. To delay pest resistance to transgenic cotton producing Bt toxin Cry1Ac, farmers in the United States and Australia planted refuges of non-Bt cotton, while farmers in China have relied on "natural" refuges of non-Bt host plants other than cotton. Here we report data from a 2010 survey showing field-evolved resistance to Cry1Ac of the major target pest, cotton bollworm (Helicoverpa armigera), in northern China. Laboratory bioassay results show that susceptibility to Cry1Ac was significantly lower in 13 field populations from northern China, where Bt cotton has been planted intensively, than in two populations from sites in northwestern China where exposure to Bt cotton has been limited. Susceptibility to Bt toxin Cry2Ab did not differ between northern and northwestern China, demonstrating that resistance to Cry1Ac did not cause cross-resistance to Cry2Ab, and implying that resistance to Cry1Ac in northern China is a specific adaptation caused by exposure to this toxin in Bt cotton. Despite the resistance detected in laboratory bioassays, control failures of Bt cotton have not been reported in China. This early warning may spur proactive countermeasures, including a switch to transgenic cotton producing two or more toxins distinct from Cry1A toxins.	[Zhang, Haonan; Yin, Wei; Zhao, Jing; Jin, Lin; Yang, Yihua; Wu, Shuwen; Wu, Yidong] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Peoples R China; [Zhang, Haonan; Yin, Wei; Zhao, Jing; Jin, Lin; Yang, Yihua; Wu, Shuwen; Wu, Yidong] Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Nanjing Agricultural University; Nanjing Agricultural University; University of Arizona	Zhang, HN (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Peoples R China.	wyd@njau.edu.cn	Jin, Lin/N-1361-2018; Wu, Yidong/E-9720-2012; ZHANG, HAONAN/N-6395-2018; Zhang, Haonan/J-2245-2019	Jin, Lin/0000-0002-5114-7139; Wu, Yidong/0000-0003-3456-3373; ZHANG, HAONAN/0000-0003-1196-2750; Zhang, Haonan/0000-0003-1196-2750	Ministry of Science and Technology of China [2007CB109204, 2008ZX08011-02, 2008ZX08012-04]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); U.S. Department of Agriculture-Agriculture and Food Research Initiative [2008-35302-0390]; Cotton Foundation; Cotton Inc.; National Cotton Council, Monsanto; Dow AgroSciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); U.S. Department of Agriculture-Agriculture and Food Research Initiative; Cotton Foundation; Cotton Inc.(Cotton R&D Corp); National Cotton Council, Monsanto; Dow AgroSciences	This work was supported by grants 2007CB109204, 2008ZX08011-02, and 2008ZX08012-04 from the Ministry of Science and Technology of China, a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and 2008-35302-0390 from the U.S. Department of Agriculture-Agriculture and Food Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; B. E. Tabashnik has received support for research that is not related to this publication from the following sources: Cotton Foundation, Cotton Inc., National Cotton Council, Monsanto, and Dow AgroSciences. He is also a coauthor of a patent application on engineering modified Bt toxins to counter pest resistance, which is related to research described by Soberon et al. (2007, Science 318: 1640-1642). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	An JJ, 2010, J ECON ENTOMOL, V103, P2169, DOI 10.1603/EC10105; Caprio MA., 2007, FIELD MANUAL TECHNIQ, P769; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Du WenXiao, 2010, Xinjiang Agricultural Sciences, V47, P902; Gao YL, 2009, ENVIRON ENTOMOL, V38, P1336, DOI 10.1603/022.038.0445; Gao YL, 2009, J ECON ENTOMOL, V102, P1217, DOI 10.1603/029.102.0347; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; LeOra Software, 2002, POL PLUS US GUID PRO; Li GP, 2004, ENTOMOL EXP APPL, V112, P135, DOI 10.1111/j.0013-8703.2004.00191.x; Li GP, 2007, ECOL ENTOMOL, V32, P366, DOI 10.1111/j.1365-2311.2007.00891.x; Li GP, 2010, ENVIRON ENTOMOL, V39, P1698, DOI 10.1603/EN10077; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mahon RJ, 2007, J ECON ENTOMOL, V100, P1844, DOI 10.1603/0022-0493(2007)100[1844:FOACRT]2.0.CO;2; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; National Research Council, 2010, IMP GEN ENG CROPS FA; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1987, J ECON ENTOMOL, V80, P1091, DOI 10.1093/jee/80.6.1091; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; Wan P, 2005, J ECON ENTOMOL, V98, P195, DOI 10.1603/0022-0493-98.1.195; Wu KM, 1999, J ECON ENTOMOL, V92, P273, DOI 10.1093/jee/92.2.273; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu KM, 2007, J INVERTEBR PATHOL, V95, P220, DOI 10.1016/j.jip.2007.03.012; Wu KM, 2006, J ECON ENTOMOL, V99, P893, DOI 10.1603/0022-0493-99.3.893; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YH, 2009, B ENTOMOL RES, V99, P175, DOI 10.1017/S0007485308006226; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07	38	195	216	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22874	10.1371/journal.pone.0022874	http://dx.doi.org/10.1371/journal.pone.0022874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857961	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300008
J	Aheng, C; Ly, N; Kelly, M; Ibrahim, S; Ricquier, D; Alves-Guerra, MC; Miroux, B				Aheng, Caroline; Ly, Nathalie; Kelly, Mairead; Ibrahim, Saleh; Ricquier, Daniel; Alves-Guerra, Marie-Clotilde; Miroux, Bruno			Deletion of UCP2 in iNOS Deficient Mice Reduces the Severity of the Disease during Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; UNCOUPLING PROTEIN UCP2; NITRIC-OXIDE; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS; GENE; MACROPHAGES; IMMUNITY; GLUCOSE; CELLS	Uncoupling protein 2 is a member of the mitochondrial anion carrier family that is widely expressed in neurons and the immune cells of humans. Deletion of Ucp2 gene in mice pre-activates the immune system leading to higher resistance toward infection and to an increased susceptibility to develop chronic inflammatory diseases as previously exemplified with the Experimental Autoimmune Encephalomyelitis (EAE), a mouse model for multiple sclerosis. Given that oxidative stress is enhanced in Ucp2-/- mice and that nitric oxide (NO) also plays a critical function in redox balance and in chronic inflammation, we generated mice deficient for both Ucp2 and iNos genes and submitted them to EAE. Mice lacking iNos gene exhibited the highest clinical score (3.4+/-0.5 p<0.05). Surprisingly, mice deficient for both genes developed milder disease with reduced immune cell infiltration, cytokines and ROS production as compared to iNos-/- mice.	[Aheng, Caroline; Ly, Nathalie; Ricquier, Daniel; Alves-Guerra, Marie-Clotilde] Fac Paris Descartes, CNRS, Inst Cochin, INSERM,U1016,UMR8104, Paris, France; [Kelly, Mairead] Univ Paris 05, INSERMU845, Paris, France; [Kelly, Mairead] Hop Necker Enfants Malad, Lab Biochim A, Paris, France; [Ibrahim, Saleh] Med Univ Lubeck, Dept Dermatol, Genet Grp, D-23538 Lubeck, Germany; [Ibrahim, Saleh] Univ Rostock, Dept Immunol, Rostock, Germany; [Miroux, Bruno] Univ Paris Diderot, CNRS, Inst Biol Phys Chim, Lab Biol Phys Chim Prot Membranaires,UMR 7099, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lubeck; University of Rostock; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Aheng, C (corresponding author), Fac Paris Descartes, CNRS, Inst Cochin, INSERM,U1016,UMR8104, Paris, France.	clotilde.alves-guerra@inserm.fr; Bruno.Miroux@ibpc.fr	Miroux, Bruno/E-9267-2017; Ibrahim, Saleh/AAO-9541-2020; Alves-Guerra, Marie-Clotilde/P-4356-2017	Alves-Guerra, Marie-Clotilde/0000-0002-7918-1216; Ibrahim, Saleh/0000-0001-7827-2290; Miroux, Bruno/0000-0002-3066-4700	Centre National de la Recherche Scientifique (CNRS); Federal Ministry of Education and Research (FKZ) [01ZZ0108]; l'Agence Nationale de la Recherche (ANR); Ministere de la Recherche et de l'enseignement superieur; Fondation pour la Recherche Medicale [FDT20090916769]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Federal Ministry of Education and Research (FKZ)(Federal Ministry of Education & Research (BMBF)); l'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de la Recherche et de l'enseignement superieur; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), by grants from The Federal Ministry of Education and Research (FKZ 01ZZ0108 to S. M. I.) and from l'Agence Nationale de la Recherche (ANR JCJC Ucp2 to BM). Caroline Aheng received a PhD fellowship from the Ministere de la Recherche et de l'enseignement superieur and from the Fondation pour la Recherche Medicale (FDT20090916769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; Couplan E, 2002, J BIOL CHEM, V277, P26268, DOI 10.1074/jbc.M202535200; Duhe RJ, 1998, P NATL ACAD SCI USA, V95, P126, DOI 10.1073/pnas.95.1.126; Dumollard R, 2009, SEMIN CELL DEV BIOL, V20, P346, DOI 10.1016/j.semcdb.2008.12.013; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Fenyk-Melody JE, 1998, J IMMUNOL, V160, P2940; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Jekabsone A, 2007, J NEUROCHEM, V103, P346, DOI 10.1111/j.1471-4159.2007.04756.x; Kean RB, 2000, J IMMUNOL, V165, P6511, DOI 10.4049/jimmunol.165.11.6511; Kizaki T, 2002, P NATL ACAD SCI USA, V99, P9392, DOI 10.1073/pnas.142206299; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; LIN RF, 1993, J EXP MED, V178, P643, DOI 10.1084/jem.178.2.643; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mozo J, 2006, BIOCHEM J, V393, P431, DOI 10.1042/BJ20050494; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nicotera P, 1997, TRENDS PHARMACOL SCI, V18, P189, DOI 10.1016/S0165-6147(97)90619-2; Nubel T, 2008, BBA-BIOENERGETICS, V1777, P48, DOI 10.1016/j.bbabio.2007.11.002; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Sahrbacher UC, 1998, EUR J IMMUNOL, V28, P1332, DOI 10.1002/(SICI)1521-4141(199804)28:04<1332::AID-IMMU1332>3.0.CO;2-G; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Vogler S, 2005, J MOL MED, V83, P806, DOI 10.1007/s00109-005-0661-5; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29	33	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22841	10.1371/journal.pone.0022841	http://dx.doi.org/10.1371/journal.pone.0022841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857957	Green Published, Green Submitted, gold			2022-12-27	WOS:000293773300009
J	Prot, JM; Briffaut, AS; Letourneur, F; Chafey, P; Merlier, F; Grandvalet, Y; Legallais, C; Leclerc, E				Prot, Jean Matthieu; Briffaut, Anne-Sophie; Letourneur, Franck; Chafey, Philippe; Merlier, Franck; Grandvalet, Yves; Legallais, Cecile; Leclerc, Eric			Integrated Proteomic and Transcriptomic Investigation of the Acetaminophen Toxicity in Liver Microfluidic Biochip	PLOS ONE			English	Article							INDUCED HEPATIC-NECROSIS; COVALENT BINDING; CELL-DEATH; DRUG; PARACETAMOL; HOMEOSTASIS; ACTIVATION; CLEARANCE	Microfluidic bioartificial organs allow the reproduction of in vivo-like properties such as cell culture in a 3D dynamical micro environment. In this work, we established a method and a protocol for performing a toxicogenomic analysis of HepG2/C3A cultivated in a microfluidic biochip. Transcriptomic and proteomic analyses have shown the induction of the NRF2 pathway and the related drug metabolism pathways when the HepG2/C3A cells were cultivated in the biochip. The induction of those pathways in the biochip enhanced the metabolism of the N-acetyl-p-aminophenol drug (acetaminophen-APAP) when compared to Petri cultures. Thus, we observed 50% growth inhibition of cell proliferation at 1 mM in the biochip, which appeared similar to human plasmatic toxic concentrations reported at 2 mM. The metabolic signature of APAP toxicity in the biochip showed similar biomarkers as those reported in vivo, such as the calcium homeostasis, lipid metabolism and reorganization of the cytoskeleton, at the transcriptome and proteome levels (which was not the case in Petri dishes). These results demonstrate a specific molecular signature for acetaminophen at transcriptomic and proteomic levels closed to situations found in vivo. Interestingly, a common component of the signature of the APAP molecule was identified in Petri and biochip cultures via the perturbations of the DNA replication and cell cycle. These findings provide an important insight into the use of microfluidic biochips as new tools in biomarker research in pharmaceutical drug studies and predictive toxicity investigations.	[Prot, Jean Matthieu; Legallais, Cecile; Leclerc, Eric] Univ Technol Compiegne, CNRS, UMR 6600, Lab Biomecan & Bioingn, F-60206 Compiegne, France; [Briffaut, Anne-Sophie; Grandvalet, Yves] Univ Technol Compiegne, CNRS, UMR 6599, F-60206 Compiegne, France; [Merlier, Franck] Univ Technol Compiegne, CNRS, UMR 6022, Lab Genie Enzymat & Cellulaire, F-60206 Compiegne, France; [Letourneur, Franck; Chafey, Philippe] Inst Cochin, INSERM, U1016, Paris, France	Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Technologie de Compiegne; Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Prot, JM (corresponding author), Univ Technol Compiegne, CNRS, UMR 6600, Lab Biomecan & Bioingn, F-60206 Compiegne, France.	eric.leclerc@utc.fr		Grandvalet, Yves/0000-0002-5645-5149; merlier, franck/0000-0002-8895-8357; Legallais, Cecile/0000-0002-8061-906X	foundation of the University of Technology in Compiegne "La Fondation UTC pour l'innovation"; ANR	foundation of the University of Technology in Compiegne "La Fondation UTC pour l'innovation"; ANR(French National Research Agency (ANR))	Part of the project was supported by the foundation of the University of Technology in Compiegne "La Fondation UTC pour l'innovation" and by the ANR PCV, mu HepaReTox. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DN, 1998, J ANAL TOXICOL, V22, P587, DOI 10.1093/jat/22.7.587; Baudoin R, 2007, BIOTECHNOL PROGR, V23, P1245, DOI 10.1021/bp0603513; Baudoin R, 2011, BIOCHEM ENG J, V53, P172, DOI 10.1016/j.bej.2010.10.007; Boulares HA, 1999, TOXICOL SCI, V48, P264, DOI 10.1093/toxsci/48.2.264; BRUSCHI SA, 1990, TOXICOL IN VITRO, V4, P743, DOI 10.1016/0887-2333(90)90043-S; Bruschi SA, 2005, METHOD PHARMACOL TOX, P197; Chao P, 2009, BIOCHEM PHARMACOL, V78, P625, DOI 10.1016/j.bcp.2009.05.013; Coen M, 2004, J PHARMACEUT BIOMED, V35, P93, DOI 10.1016/j.jpba.2003.12.019; Domansky K, 2005, P ANN INT IEEE EMBS, P7490, DOI 10.1109/IEMBS.2005.1616244; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Ferrer-Dufol A, 2009, TOXICOL LETT, V186, P2, DOI 10.1016/j.toxlet.2008.10.025; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jemnitz K, 2008, TOXICOL IN VITRO, V22, P961, DOI 10.1016/j.tiv.2008.02.001; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Li YJ, 2008, CLIN IMMUNOL, V128, P366, DOI 10.1016/j.clim.2008.05.005; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; MORRIS ME, 1984, J PHARM SCI, V73, P1038, DOI 10.1002/jps.2600730806; NAVARRO C, 1994, FASEB J, V8, pA1468; Novik E, 2010, BIOCHEM PHARMACOL, V79, P1036, DOI 10.1016/j.bcp.2009.11.010; Oberemm A, 2009, TOXICOL APPL PHARM, V241, P230, DOI 10.1016/j.taap.2009.08.020; Pierce RH, 2002, BIOCHEM PHARMACOL, V64, P413, DOI 10.1016/S0006-2952(02)01180-2; POTTER WZ, 1974, PHARMACOLOGY, V12, P129, DOI 10.1159/000136531; Prot JM, 2011, BIOTECHNOL BIOENG, V108, P1704, DOI 10.1002/bit.23104; RAY SD, 1993, FASEB J, V7, P453, DOI 10.1096/fasebj.7.5.8462787; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; Sigdel TK, 2008, PEDIATR TRANSPLANT, V12, P737, DOI 10.1111/j.1399-3046.2008.01018.x; Sung JH, 2010, BIOPROC BIOSYST ENG, V33, P5, DOI 10.1007/s00449-009-0369-y; SYLVIA C, 2003, J CELL BIOCHEM, V88, P695; TIRMENSTEIN MA, 1989, J BIOL CHEM, V264, P9814; VEENSTRA TD, 2006, DRUG DISCOV TODAY TE, V3, P433, DOI DOI 10.1016/J.DDTEC.2006.10.001; Viravaidya K, 2004, BIOTECHNOL PROGR, V20, P590, DOI 10.1021/bp034238d; WALKER RM, 1983, EXP MOL PATHOL, V39, P163, DOI 10.1016/0014-4800(83)90049-7; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501	34	38	40	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e21268	10.1371/journal.pone.0021268	http://dx.doi.org/10.1371/journal.pone.0021268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857903	gold, Green Submitted, Green Published			2022-12-27	WOS:000293773300002
J	Dexheimer, V; Mueller, S; Braatz, F; Richter, W				Dexheimer, Verena; Mueller, Sebastian; Braatz, Frank; Richter, Wiltrud			Reduced Reactivation from Dormancy but Maintained Lineage Choice of Human Mesenchymal Stem Cells with Donor Age	PLOS ONE			English	Article							HUMAN-BONE-MARROW; PROGENITOR CELLS; STROMAL CELLS; DIFFERENTIATION; SENESCENCE; EXPANSION; COLONIES; NUMBER	Mesenchymal stem cells (MSC) are promising for cell-based regeneration therapies but up to date it is still controversial whether their function is maintained throughout ageing. Aim of this study was to address whether frequency, activation in vitro, replicative function, and in vitro lineage choice of MSC is maintained throughout ageing to answer the question whether MSC-based regeneration strategies should be restricted to younger individuals. MSC from bone marrow aspirates of 28 donors (5-80 years) were characterized regarding colony-forming unit-fibroblast (CFU-F) numbers, single cell cloning efficiency (SSCE), osteogenic, adipogenic and chondrogenic differentiation capacity in vitro. Alkaline phosphatase (ALP) activity, mineralization, Oil Red O content, proteoglycan-and collagen type II deposition were quantified. While CFU-F frequency was maintained, SSCE and early proliferation rate decreased significantly with advanced donor age. MSC with higher proliferation rate before start of induction showed stronger osteogenic, adipogenic and chondrogenic differentiation. MSC with high osteogenic capacity underwent better chondrogenesis and showed a trend to better adipogenesis. Lineage choice was, however, unaltered with age. Conclusion: Ageing influenced activation from dormancy and replicative function of MSC in a way that it may be more demanding to mobilize MSC to fast cell growth at advanced age. Since fast proliferation came along with high multilineage capacity, the proliferation status of expanded MSC rather than donor age may provide an argument to restrict MSC-based therapies to certain individuals.	[Dexheimer, Verena; Richter, Wiltrud] Orthoped Univ Hosp Heidelberg, Res Ctr Expt Orthoped, Heidelberg, Germany; [Mueller, Sebastian; Braatz, Frank] Heidelberg Univ, Dept Orthoped Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Dexheimer, V (corresponding author), Orthoped Univ Hosp Heidelberg, Res Ctr Expt Orthoped, Heidelberg, Germany.	Wiltrud.Richter@med.uni-heidelberg.de	Richter, Wiltrud/V-3217-2017	Richter, Wiltrud/0000-0003-4694-2768	Baden Wurttemberg Stiftung; Network Ageing Research, Heidelberg, Germany	Baden Wurttemberg Stiftung; Network Ageing Research, Heidelberg, Germany	This study was in part funded by the Baden Wurttemberg Stiftung and supported by the Network Ageing Research, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613; Carrington JL, 2005, BIOCHEM BIOPH RES CO, V328, P700, DOI 10.1016/j.bbrc.2004.12.041; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Claes L, 2002, LANGENBECK ARCH SURG, V387, P146, DOI 10.1007/s00423-002-0306-x; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673; Fickert S, 2010, J BONE MINER METAB; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37; Jones E, 2010, ARTHRITIS RHEUM-US, V62, P1944, DOI 10.1002/art.27451; Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x; Lee CCI, 2010, EXP HEMATOL, V38, P46, DOI 10.1016/j.exphem.2009.11.001; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Mageed AS, 2007, TRANSPLANTATION, V83, P1019, DOI 10.1097/01.tp.0000259752.13304.0b; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402; Oreffo ROC, 1998, SCAND J RHEUMATOL, V27, P415; Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007-0300; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	38	73	74	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22980	10.1371/journal.pone.0022980	http://dx.doi.org/10.1371/journal.pone.0022980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850247	gold, Green Submitted, Green Published			2022-12-27	WOS:000293563300032
J	Dong, WH; Wang, TY; Wang, F; Zhang, JH				Dong, Wei-Hua; Wang, Tian-Yun; Wang, Fang; Zhang, Jun-He			Simple, Time-Saving Dye Staining of Proteins for Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis Using Coomassie Blue	PLOS ONE			English	Article							GLYCAN-BINDING PROFILE; SENSITIVITY; LECTIN; G-250	A fixation-free and fast protein-staining method for sodium dodecyl sulfate-polyacrylamide gel electrophoresis using Coomassie blue is described. The protocol comprises staining and quick washing steps, which can be completed in 0.5 h. It has a sensitivity of 10 ng, comparable with that of conventional Coomassie Brilliant Blue G staining with phosphoric acid in the staining solution. In addition, the dye stain does not contain any amount of acid and methanol, such as phosphoric acid. Considering the speed, simplicity, and low cost, the dye stain may be of more practical value than other dye-based protein stains in routine proteomic research.	[Dong, Wei-Hua; Wang, Tian-Yun; Wang, Fang; Zhang, Jun-He] Xinxiang Med Univ, Dept Biochem & Mol Biol, Xinxiang, Henan, Peoples R China	Xinxiang Medical University	Dong, WH (corresponding author), Xinxiang Med Univ, Dept Biochem & Mol Biol, Xinxiang, Henan, Peoples R China.	wtianyuncn@126.com	Zhang, Junhe/HII-7839-2022	Zhang, Junhe/0000-0003-3109-1569	National Natural Science Foundation [30970055/C010202]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (30970055/C010202), http://159.226.244.28/portal/Proj_List.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT J, 1971, ANAL BIOCHEM, V43, P173, DOI 10.1016/0003-2697(71)90122-9; Berggren KN, 2002, PROTEOMICS, V2, P486, DOI 10.1002/1615-9861(200205)2:5<486::AID-PROT486>3.0.CO;2-X; BERTOLINI MJ, 1976, ANAL BIOCHEM, V71, P6, DOI 10.1016/0003-2697(76)90003-8; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Choi JK, 2002, ARCH PHARM RES, V25, P704, DOI 10.1007/BF02976948; Choi JK, 1996, ANAL BIOCHEM, V236, P82, DOI 10.1006/abio.1996.0134; Divakar K, 2011, ANAL SCI, V27, P101, DOI 10.2116/analsci.27.101; DYBALLA N, 2009, J VIS EXP, V3; FAZEKAS SDS, 1963, BIOCHIM BIOPHYS ACTA, V71, P377; Kawsar SMA, 2008, COMP BIOCHEM PHYS B, V150, P349, DOI 10.1016/j.cbpb.2008.04.004; Kawsar SMA, 2009, COMP BIOCHEM PHYS B, V152, P382, DOI 10.1016/j.cbpb.2009.01.009; LAWRENCE AM, 2009, J VIS EXP, V14; Lin JF, 2008, ANAL BIOANAL CHEM, V390, P1765, DOI 10.1007/s00216-008-1910-6; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pink M, 2010, ELECTROPHORESIS, V31, P593, DOI 10.1002/elps.200900481; Shofuda K, 1998, LAB INVEST, V78, P915; Walker J. M., 2002, PROTEIN PROTOCOLS HD, V2nd, P61; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yasumitsu H, 2010, ELECTROPHORESIS, V31, P1913, DOI 10.1002/elps.200900524	21	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22394	10.1371/journal.pone.0022394	http://dx.doi.org/10.1371/journal.pone.0022394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850222	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300006
J	Burbelo, PD; Ching, KH; Esper, F; Iadarola, MJ; Delwart, E; Lipkin, WI; Kapoor, A				Burbelo, Peter D.; Ching, Kathryn H.; Esper, Frank; Iadarola, Michael J.; Delwart, Eric; Lipkin, W. Ian; Kapoor, Amit			Serological Studies Confirm the Novel Astrovirus HMOAstV-C as a Highly Prevalent Human Infectious Agent	PLOS ONE			English	Article							LUCIFERASE IMMUNOPRECIPITATION SYSTEMS; HUMAN STOOL; CHILDREN; DIARRHEA; GASTROENTERITIS; IDENTIFICATION; DIAGNOSIS; VIRUS; ASSAY; SEQUENCES	Molecular identification of a microbe is the first step in determining its prevalence of infection and pathogenic potential. Detection of specific adaptive immune responses can provide insights into whether a microbe is a human infectious agent and its epidemiology. Here we characterized human anti-IgG antibody responses by luciferase immunoprecipitation systems (LIPS) against two protein fragments derived from the capsid protein of the novel HMOAstV-C astrovirus. While antibodies to the N-terminal fragment were not informative, the C-terminal capsid fragment of HMOAstV-C showed a high frequency of immunoreactivity with serum from healthy blood donors. In contrast, a similar C-terminal capsid fragment from the related HMOAstV-A astrovirus failed to show immunoreactivity. Detailed analysis of adult serum from the United Sates using a standardized threshold demonstrated HMOAstV-C seropositivity in approximately 65% of the samples. Evaluation of serum samples from different pediatric age groups revealed that the prevalence of antibodies in 6-12 month, 1-2 year, 2-5 year and 5-10 year olds was 20%, 23%, 32% and 36%, respectively, indicating rising seroprevalence with age. Additionally, 50% (11/22) of the 0-6 month old children showed anti-HMOAstV-C antibody responses, likely reflecting maternal antibodies. Together these results document human humoral responses to HMOAstV-C and validate LIPS as a facile and effective approach for identifying humoral responses to novel infectious agents.	[Burbelo, Peter D.; Ching, Kathryn H.; Iadarola, Michael J.] Natl Inst Dent & Craniofacial Res, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, NIH, Bethesda, MD USA; [Esper, Frank] Case Western Reserve Univ Hosp, Med Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Delwart, Eric] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA; [Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lipkin, W. Ian; Kapoor, Amit] Columbia Univ, Ctr Infect & Immun, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Case Western Reserve University; Case Western Reserve University Hospital; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Columbia University	Burbelo, PD (corresponding author), Natl Inst Dent & Craniofacial Res, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, NIH, Bethesda, MD USA.	burbelop@nidcr.nih.gov	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Delwart, Eric/0000-0002-6296-4484	Division of Intramural Research, National Institute of Dental and Craniofacial Research; National Institute of Allergy and Infectious Diseases [K23 AI065829, AI090196, AI57158]; Department of Defense; Blood Systems Research Institute; NIH [R01220 HL083254]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, K23AI065829, R21AI090196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000724] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Blood Systems Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Division of Intramural Research, National Institute of Dental and Craniofacial Research. This study is supported in part by the National Institute of Allergy and Infectious Diseases K23 AI065829 (F.E.), AI090196 (A.K.) and AI57158 (Northeast Biodefense Center - A.K., W.I.L), and the Department of Defense (A.K., W.I.L.) and the Blood Systems Research Institute and NIH R01220 HL083254 (E.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Burbelo PD, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-22; Burbelo PD, 2011, MOL BIOSYST; Burbelo PD, 2008, J CLIN MICROBIOL, V46, P2298, DOI 10.1128/JCM.00490-08; Burbelo PD, 2007, BIOCHEM BIOPH RES CO, V352, P889, DOI 10.1016/j.bbrc.2006.11.140; Burbelo PD, 2011, MOL BIOSYST, V7, P1453, DOI 10.1039/c0mb00342e; Burbelo PD, 2010, EXPERT REV VACCINES, V9, P567, DOI [10.1586/erv.10.50, 10.1586/ERV.10.50]; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Burbelo PD, 2010, CLIN VACCINE IMMUNOL, V17, P904, DOI 10.1128/CVI.00476-09; Burbelo PD, 2009, CLIN VACCINE IMMUNOL, V16, P621, DOI 10.1128/CVI.00474-08; Clark B, 2004, CURR OPIN INFECT DIS, V17, P461, DOI 10.1097/00001432-200410000-00011; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Finkbeiner SR, 2009, EMERG INFECT DIS, V15, P441, DOI 10.3201/eid1503.081213; Fodha I, 2006, J MED VIROL, V78, P1198, DOI 10.1002/jmv.20681; Gabbay YB, 2007, VIRUS RES, V129, P166, DOI 10.1016/j.virusres.2007.07.006; Guix S, 2005, LETT APPL MICROBIOL, V41, P103, DOI 10.1111/j.1472-765X.2005.01759.x; Heininger U, 2006, VACCINE, V24, P3258, DOI 10.1016/j.vaccine.2006.01.026; Jin Y, 2009, J CLIN VIROL, V44, P238, DOI 10.1016/j.jcv.2008.12.010; Jonassen CM, 2003, VIRUS RES, V91, P195, DOI 10.1016/S0168-1702(02)00269-1; Jonassen CM, 2001, J GEN VIROL, V82, P1061, DOI 10.1099/0022-1317-82-5-1061; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Krishna NK, 2005, VIRAL IMMUNOL, V18, P17, DOI 10.1089/vim.2005.18.17; Leung J, 2005, J CLIN MICROBIOL, V43, P1213, DOI 10.1128/JCM.43.3.1213-1219.2005; Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000; Moser LA, 2005, VIRAL IMMUNOL, V18, P4, DOI 10.1089/vim.2005.18.4; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Ramanathan R, 2008, J INFECT DIS, V198, P444, DOI 10.1086/589718; Tayeb HT, 2008, J MED VIROL, V80, P1919, DOI 10.1002/jmv.21291	32	53	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22576	10.1371/journal.pone.0022576	http://dx.doi.org/10.1371/journal.pone.0022576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829634	Green Submitted, gold, Green Published			2022-12-27	WOS:000293561200023
J	Norden-Krichmar, TM; Allen, AE; Gaasterland, T; Hildebrand, M				Norden-Krichmar, Trina M.; Allen, Andrew E.; Gaasterland, Terry; Hildebrand, Mark			Characterization of the Small RNA Transcriptome of the Diatom, Thalassiosira pseudonana	PLOS ONE			English	Article							SEQUENCING TECHNOLOGIES; ENDOGENOUS SIRNAS; REGULATORY ROLES; GENE-EXPRESSION; MICRORNAS; GENOME; BIOGENESIS; EVOLUTION; REVEALS; DIVERSE	This study presents the first characterization of endogenous small RNAs in a diatom, Thalassiosira pseudonana. Small RNAs act as transcriptional and translational regulators, controlling specific target genes involved in various cellular functions. Diatoms are unicellular photosynthetic organisms that play major roles in environmental processes, such as food webs and global carbon fixation. Small RNA cDNA libraries were constructed for exponentially growing T. pseudonana, and then subjected to highly parallel pyrosequencing (454) and sequencing-by-ligation (Applied Biosystems SOLiD). From the computational analysis of approximately 300,000 sequences in the 454 library and over 17 million sequences in the SOLiD libraries, there exists evidence of a core set of small RNA genes including: novel microRNAs, repeat-associated short interfering RNAs, and endogenous short interfering RNAs. The diatom genome contains elements similar to plant small RNA systems, such as the RNAi machinery, a high percentage of short interfering RNAs originating from protein-coding and repetitive regions of the genome, and putative binding sites of the small RNAs occurring primarily in the coding section of the predicted targets. The characterization of the small RNA transcriptome of T. pseudonana establishes the possibility of a wide range of gene regulatory mechanisms in diatoms.	[Norden-Krichmar, Trina M.; Gaasterland, Terry; Hildebrand, Mark] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Norden-Krichmar, Trina M.; Allen, Andrew E.] J Craig Venter Inst, San Diego, CA USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; J. Craig Venter Institute	Norden-Krichmar, TM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	aallen@jcvi.org	Allen, Andrew E/C-4896-2012	Allen, Andrew E/0000-0001-5911-6081	National Science Foundation [NSF-OCE-0722374, NSF-OCE-0727997, NSF-MCB-1024913]; Air Force Office of Scientific Research [FA9550-08-1-0178]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the National Science Foundation [NSF-OCE-0722374, NSF-OCE-0727997, and NSF-MCB-1024913 to A.E.A.; NSF Graduate Research Fellowship to T.M.N.-K.]; and the Air Force Office of Scientific Research [FA9550-08-1-0178 to M.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; DARLEY WM, 1969, EXP CELL RES, V58, P334, DOI 10.1016/0014-4827(69)90514-X; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hildebrand M, 2000, J PHYCOL, V36, P702, DOI 10.1046/j.1529-8817.2000.99153.x; Hinas A, 2007, NUCLEIC ACIDS RES, V35, P6714, DOI 10.1093/nar/gkm707; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HSU D, 1994, J BACTERIOL, V176, P4761, DOI 10.1128/JB.176.15.4761-4765.1994; Hu Z, 2007, GEN ONT GO TERMS CLA; Hudson D, 1995, FASTA SOFTWARE; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Maheswari U, 2009, NUCLEIC ACIDS RES, V37, pD1001, DOI 10.1093/nar/gkn905; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maumus F, 2009, BMC EVOLUTI IN PRESS; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Norden-Krichmar TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-445; Ondov BD, 2008, BIOINFORMATICS, V24, P2776, DOI 10.1093/bioinformatics/btn512; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Tian G, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-64; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	75	25	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22870	10.1371/journal.pone.0022870	http://dx.doi.org/10.1371/journal.pone.0022870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857960	gold, Green Submitted, Green Published			2022-12-27	WOS:000293953500008
J	Lu, ZQ; Zhang, BJ; Qiu, W; Kang, Z; Shen, LP; Long, YM; Huang, JQ; Hu, XQ				Lu, Zhengqi; Zhang, Bingjun; Qiu, Wei; Kang, Zhuang; Shen, Liping; Long, Youming; Huang, Junqi; Hu, Xueqiang			Comparative Brain Stem Lesions on MRI of Acute Disseminated Encephalomyelitis, Neuromyelitis Optica, and Multiple Sclerosis	PLOS ONE			English	Article							INFLAMMATORY DEMYELINATION; DIAGNOSTIC-CRITERIA; CLINICALLY DEFINITE; PROGNOSTIC-FACTORS; CHILDREN; ADEM; MS; ABNORMALITIES; FEATURES; DISEASE	Background: Brain stem lesions are common in patients with acute disseminated encephalomyelitis (ADEM), neuromyelitis optica (NMO), and multiple sclerosis (MS). Objectives: To investigate comparative brain stem lesions on magnetic resonance imaging (MRI) among adult patients with ADEM, NMO, and MS. Methods: Sixty-five adult patients with ADEM (n = 17), NMO (n = 23), and MS (n = 25) who had brain stem lesions on MRI were enrolled. Morphological features of brain stem lesions among these diseases were assessed. Results: Patients with ADEM had a higher frequency of midbrain lesions than did patients with NMO (94.1% vs. 17.4%, P<0.001) and MS (94.1% vs. 40.0%, P<0.001); patients with NMO had a lower frequency of pons lesions than did patients with MS (34.8% vs. 84.0%, P<0.001) and ADEM (34.8% vs. 70.6%, P = 0.025); and patients with NMO had a higher frequency of medulla oblongata lesions than did patients with ADEM (91.3% vs. 35.3%, P<0.001) and MS (91.3% vs. 36.0%, P<0.001). On the axial section of the brain stem, the majority (82.4%) of patients with ADEM showed lesions on the ventral part; the brain stem lesions in patients with NMO were typically located in the dorsal part (91.3%); and lesions in patients with MS were found in both the ventral (44.0%) and dorsal (56.0%) parts. The lesions in patients with ADEM (100%) and NMO (91.3%) had poorly defined margins, while lesions of patients with MS (76.0%) had well defined margins. Brain stem lesions in patients with ADEM were usually bilateral and symmetrical (82.4%), while lesions in patients with NMO (87.0%) and MS (92.0%) were asymmetrical or unilateral. Conclusions: Brain stem lesions showed various morphological features among adult patients with ADEM, NMO, and MS. The different lesion locations may be helpful in distinguishing these diseases.	[Lu, Zhengqi; Zhang, Bingjun; Qiu, Wei; Shen, Liping; Long, Youming; Hu, Xueqiang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Kang, Zhuang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Junqi] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Junqi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lu, ZQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	Junqi_huang@yahoo.com.cn; huxueqiangzssy@yahoo.com.cn	wei, qiu/M-7363-2015		Sun Yat-sen University [5010]; Science and Technology program of Guangdong [2008B030301047]	Sun Yat-sen University; Science and Technology program of Guangdong	The study was supported by grants from Sun Yat-sen University Clinical Research 5010 program and Science and Technology program of Guangdong (2008B030301047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1994, PRINCIPLES NEUROLOGY, P517; Alper G, 2009, DEV MED CHILD NEUROL, V51, P480, DOI 10.1111/j.1469-8749.2008.03136.x; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Baudoin D, 1998, CLIN NEUROPATHOL, V17, P175; BRAININ M, 1987, NEURORADIOLOGY, V29, P530, DOI 10.1007/BF00350435; Brinar VV, 2010, EXPERT REV NEUROTHER, V10, P459, DOI 10.1586/ERN.10.9; Brinar VV, 2004, CLIN NEUROL NEUROSUR, V106, P197, DOI 10.1016/j.clineuro.2004.02.016; Callen DJA, 2009, NEUROLOGY, V72, P968, DOI 10.1212/01.wnl.0000338630.20412.45; Callen DJA, 2009, NEUROLOGY, V72, P961, DOI 10.1212/01.wnl.0000338629.01627.54; Chang KH, 2006, MULT SCLER J, V12, P501, DOI 10.1191/1352458506ms1297oa; Charil A, 2006, LANCET NEUROL, V5, P841, DOI 10.1016/S1474-4422(06)70572-5; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Dale RC, 2000, BRAIN, V123, P2407, DOI 10.1093/brain/123.12.2407; Dale RC, 2009, CURR OPIN NEUROL, V22, P233, DOI 10.1097/WCO.0b013e32832b4c47; de Seze J, 2007, ARCH NEUROL-CHICAGO, V64, P1426, DOI 10.1001/archneur.64.10.1426; Donmez FY, 2009, ACTA RADIOL, V50, P334, DOI 10.1080/02841850902736617; Fukazawa T, 2004, J NEUROL SCI, V225, P71, DOI 10.1016/j.jns.2004.07.003; Ketelslegers IA, 2010, NEUROLOGY, V74, P1412, DOI 10.1212/WNL.0b013e3181dc138b; Li R, 2011, J NEUROL, V258, P2206, DOI 10.1007/s00415-011-6093-y; Li Y, 2008, ACTA NEUROL SCAND, V118, P218, DOI 10.1111/j.1600-0404.2008.01012.x; Lu ZQ, 2010, J NEUROL SCI, V293, P92, DOI 10.1016/j.jns.2010.02.026; Menge T, 2005, ARCH NEUROL-CHICAGO, V62, P1673, DOI 10.1001/archneur.62.11.1673; Mikaeloff Y, 2004, BRAIN, V127, P1942, DOI 10.1093/brain/awh218; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER S, 1992, ACTA NEUROL SCAND, V86, P579, DOI 10.1111/j.1600-0404.1992.tb05490.x; QIU W, 2006, CHIN J CLIN REHABIL, V30, P105; Renard D, 2010, CLIN NEUROL NEUROSUR, V112, P286, DOI 10.1016/j.clineuro.2009.12.012; Schwarz S, 2001, NEUROLOGY, V56, P1313, DOI 10.1212/WNL.56.10.1313; Singh S, 2000, Australas Radiol, V44, P404, DOI 10.1046/j.1440-1673.2000.00845.x; Siritho S, 2007, CAN J NEUROL SCI, V34, P99, DOI 10.1017/S0317167100005874; Sonneville R, 2009, J INFECTION, V58, P321, DOI 10.1016/j.jinf.2009.02.011; Tanaka K, 2005, INTERNAL MED, V44, P560, DOI 10.2169/internalmedicine.44.560; Triulzi F, 1998, J NEUROL NEUROSUR PS, V64, pS6; Weng Wen-Chin, 2006, Acta Paediatrica Taiwanica, V47, P67; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; YU YL, 1989, BRAIN, V112, P1445, DOI 10.1093/brain/112.6.1445	39	38	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22766	10.1371/journal.pone.0022766	http://dx.doi.org/10.1371/journal.pone.0022766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853047	gold, Green Submitted, Green Published			2022-12-27	WOS:000295454200020
J	Magrini, E; Szabo, I; Doni, A; Cibella, J; Viola, A				Magrini, Elena; Szabo, Ildiko; Doni, Andrea; Cibella, Javier; Viola, Antonella			Serotonin-Mediated Tuning of Human Helper T Cell Responsiveness to the Chemokine CXCL12	PLOS ONE			English	Article							EXPERIMENTAL COLITIS; INTRACELLULAR PH; NA+/H+ EXCHANGE; RECEPTOR; LYMPHOCYTES; ACTIVATION; NETWORK; MOBILIZATION; NEUTROPHILS; CHEMOTAXIS	In addition to its role as neurotransmitter, serotonin (5-HT) is an important modulator of inflammation and immunity. Here, we report novel findings suggesting a 5-HT involvement in T cell migration. In particular, we show that 5-HT tunes the responsiveness of human T lymphocytes to the broadly expressed chemokine CXCL12 in transwell migration assays. By real-time PCR, western blot analysis and electrophysiological patch clamp experiments, we demonstrate that the type 3 5-HT receptor (5-HT3) is functionally expressed in human primary T cells. In addition, specific 5-HT3 receptor agonists selectively decrease T cell migration towards gradients of CXCL12 but not of inflammatory chemokines, such as CCL2 and CCL5. In transmigration experiments, 5-HT3 receptor stimulation reverts the inhibitory effect of endothelial-bound CXCL12 on T cell migration. Our data suggest that the reduced T cell responsiveness to CXCL12 induced by 5-HT may occur to facilitate T cell extravasation and migration into inflamed tissues.	[Magrini, Elena; Doni, Andrea; Cibella, Javier; Viola, Antonella] Humanitas Clin Inst IRCCS, Milan, Italy; [Szabo, Ildiko] Univ Padua, Dept Biol, Padua, Italy; [Viola, Antonella] Univ Milan, Dept Translat Med, Milan, Italy	University of Padua; University of Milan	Magrini, E (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, Milan, Italy.	elena.magrini@ifom-ieo-campus.it	Agatea, Lisa/L-8267-2016; Magrini, Elena/K-2635-2018; Szabo, Ildiko/AAW-5972-2021; Padova, Ildiko/K-5344-2016; Cibella, Javier/AAB-8800-2020; Viola, Antonella/A-4321-2015	Magrini, Elena/0000-0003-1507-2325; Szabo, Ildiko/0000-0002-3637-3947; Doni, Andrea/0000-0001-9203-5814; Viola, Antonella/0000-0002-0125-9271	Italian Association for Cancer Research (AIRC) [5118, 5629, RG 6278]; European Community [FP7/2007-2013, 201106]; EMBO YIP	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); EMBO YIP(European Molecular Biology Organization (EMBO))	The research leading to these results has received funding from the Italian Association for Cancer Research (AIRC) to I.S. (IG grant no 5118) and to A.V. (IG grant no5629 and RG 6278), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no201106 and EMBO YIP to A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes NM, 2008, SEMIN CANCER BIOL, V18, P218, DOI 10.1016/j.semcancer.2007.12.007; BIANCHI G, 1993, J IMMUNOL, V151, P5135; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cloez-Tayarani I, 2007, J LEUKOCYTE BIOL, V81, P599, DOI 10.1189/jlb.0906544; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DeVreese K, 1996, J VIROL, V70, P689, DOI 10.1128/JVI.70.2.689-696.1996; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; El-Nour H, 2007, EXP DERMATOL, V16, P644, DOI 10.1111/j.1600-0625.2007.00573.x; Faerber L, 2007, EUR J PHARMACOL, V560, P1, DOI 10.1016/j.ejphar.2007.01.028; Fiebich BL, 2004, SCAND J RHEUMATOL, V33, P9, DOI 10.1080/03009740410006952; Gordon J, 2003, TRENDS IMMUNOL, V24, P438, DOI 10.1016/S1471-4906(03)00176-5; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Khan NA, 1999, J NEUROIMMUNOL, V99, P53, DOI 10.1016/S0165-5728(99)00101-0; Khan WI, 2010, CLIN EXP IMMUNOL, V161, P19, DOI 10.1111/j.1365-2249.2010.04150.x; Lai ZF, 2000, J IMMUNOL, V165, P83, DOI 10.4049/jimmunol.165.1.83; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; Lonne-Rahm SB, 2008, J EUR ACAD DERMATOL, V22, P11, DOI 10.1111/j.1468-3083.2007.02202.x; Magro F, 2006, DIGEST DIS SCI, V51, P495, DOI 10.1007/s10620-006-3161-8; Menard G, 2007, CLIN EXP IMMUNOL, V150, P340, DOI 10.1111/j.1365-2249.2007.03492.x; Meredith EJ, 2005, IMMUNOLOGY, V115, P289, DOI 10.1111/j.1365-2567.2005.02166.x; Mikami S, 2008, J PHARMACOL EXP THER, V327, P383, DOI 10.1124/jpet.108.141085; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Scimone ML, 2004, J EXP MED, V199, P1113, DOI 10.1084/jem.20031645; SIMCHOWITZ L, 1986, J BIOL CHEM, V261, P6492; SIMCHOWITZ L, 1985, J BIOL CHEM, V260, P3248; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Thorslund K, 2007, DRUG NEWS PERSPECT, V20, P521, DOI 10.1358/dnp.2007.20.8.1157614; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Willemssen R, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004898, 10.1371/journal.pone.0006453]; Yao L, 2003, BLOOD, V102, P3900, DOI 10.1182/blood-2003-02-0641; Yin J, 2006, J NEUROIMMUNOL, V181, P68, DOI 10.1016/j.jneuroim.2006.08.004	42	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22482	10.1371/journal.pone.0022482	http://dx.doi.org/10.1371/journal.pone.0022482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853036	Green Published, gold			2022-12-27	WOS:000295454200013
J	Feng, BJ; Tavtigian, SV; Southey, MC; Goldgar, DE				Feng, Bing-Jian; Tavtigian, Sean V.; Southey, Melissa C.; Goldgar, David E.			Design Considerations for Massively Parallel Sequencing Studies of Complex Human Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; LINKAGE ANALYSIS; STRATEGIES; HETEROGENEITY	Massively Parallel Sequencing (MPS) allows sequencing of entire exomes and genomes to now be done at reasonable cost, and its utility for identifying genes responsible for rare Mendelian disorders has been demonstrated. However, for a complex disease, study designs need to accommodate substantial degrees of locus, allelic, and phenotypic heterogeneity, as well as complex relationships between genotype and phenotype. Such considerations include careful selection of samples for sequencing and a well-developed strategy for identifying the few "true" disease susceptibility genes from among the many irrelevant genes that will be found to harbor rare variants. To examine these issues we have performed simulation-based analyses in order to compare several strategies for MPS sequencing in complex disease. Factors examined include genetic architecture, sample size, number and relationship of individuals selected for sequencing, and a variety of filters based on variant type, multiple observations of genes and concordance of genetic variants within pedigrees. A two-stage design was assumed where genes from the MPS analysis of high-risk families are evaluated in a secondary screening phase of a larger set of probands with more modest family histories. Designs were evaluated using a cost function that assumes the cost of sequencing the whole exome is 400 times that of sequencing a single candidate gene. Results indicate that while requiring variants to be identified in multiple pedigrees and/or in multiple individuals in the same pedigree are effective strategies for reducing false positives, there is a danger of over-filtering so that most true susceptibility genes are missed. In most cases, sequencing more than two individuals per pedigree results in reduced power without any benefit in terms of reduced overall cost. Further, our results suggest that although no single strategy is optimal, simulations can provide important guidelines for study design.	[Feng, Bing-Jian; Goldgar, David E.] Univ Utah Sch Med, Dept Dermatol, Salt Lake City, UT 84112 USA; [Tavtigian, Sean V.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Tavtigian, Sean V.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Melbourne	Feng, BJ (corresponding author), Univ Utah Sch Med, Dept Dermatol, Salt Lake City, UT 84112 USA.	david.goldgar@hsc.utah.edu		Southey, Melissa/0000-0002-6313-9005	Canadian Institutes of Health Research [CRN-87521]; Cancer Council Victoria [ID 628774]; National Institutes of Health [R01CA11616, R01CA155767]; NATIONAL CANCER INSTITUTE [R01CA116167, R01CA155767] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Council Victoria(Cancer Council VictoriaCanadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	B.J.F. is supported by the Canadian Institutes of Health Research Team Grant in Familial Risks of Breast Cancer CRN-87521. M.C.S. is a National Health and Medical Research (NHMRC) fellow and a Victorian Breast Cancer Research Consortium (VBCRC) group leader and is supported by The Cancer Council Victoria through Grant ID 628774. D.E.G. is supported by grant R01CA116167 & R01CA155767 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu DJJ, 2010, AM J HUM GENET, V87, P790, DOI 10.1016/j.ajhg.2010.10.025; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204	22	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23221	10.1371/journal.pone.0023221	http://dx.doi.org/10.1371/journal.pone.0023221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850262	Green Published, gold			2022-12-27	WOS:000293563300047
J	Hombrink, P; Hadrup, SR; Bakker, A; Kester, MGD; Falkenburg, JHF; Borne, PAV; Schumacher, TNM; Heemskerk, MHM				Hombrink, Pleun; Hadrup, Sine R.; Bakker, Arne; Kester, Michel G. D.; Falkenburg, J. H. Frederik; Borne, Peter A. von Dem; Schumacher, Ton N. M.; Heemskerk, Mirjam H. M.			High-Throughput Identification of Potential Minor Histocompatibility Antigens by MHC Tetramer-Based Screening: Feasibility and Limitations	PLOS ONE			English	Article							T-CELL EPITOPES; HLA; IMMUNOTHERAPY; ASSOCIATION; PREDICTION; COMPLEXES; DATABASE; LIGANDS; BINDING	T-cell recognition of minor histocompatibility antigens (MiHA) plays an important role in the graft-versus-tumor (GVT) effect of allogeneic stem cell transplantation (allo-SCT). However, the number of MiHA identified to date remains limited, making clinical application of MiHA reactive T-cell infusion difficult. This study represents the first attempt of genome-wide prediction of MiHA, coupled to the isolation of T-cell populations that react with these antigens. In this unbiased high-throughput MiHA screen, both the possibilities and pitfalls of this approach were investigated. First, 973 polymorphic peptides expressed by hematopoietic stem cells were predicted and screened for HLA-A2 binding. Subsequently a set of 333 high affinity HLA-A2 ligands was identified and post transplantation samples from allo-SCT patients were screened for T-cell reactivity by a combination of pMHC-tetramer-based enrichment and multi-color flow cytometry. Using this approach, 71 peptide-reactive T-cell populations were generated. The isolation of a T-cell line specifically recognizing target cells expressing the MAP4K1(IMA) antigen demonstrates that identification of MiHA through this approach is in principle feasible. However, with the exception of the known MiHA HMHA1, none of the other T-cell populations that were generated demonstrated recognition of endogenously MiHA expressing target cells, even though recognition of peptide-loaded targets was often apparent. Collectively these results demonstrate the technical feasibility of high-throughput analysis of antigen-specific T-cell responses in small patient samples. However, the high-sensitivity of this approach requires the use of potential epitope sets that are not solely based on MHC binding, to prevent the frequent detection of T-cell responses that lack biological relevance.	[Hombrink, Pleun; Kester, Michel G. D.; Falkenburg, J. H. Frederik; Borne, Peter A. von Dem; Heemskerk, Mirjam H. M.] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Hadrup, Sine R.; Bakker, Arne; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	Hombrink, P (corresponding author), Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands.	p.hombrink@lumc.nl	Heemskerk, Mirjam H.M./ABI-2336-2020; Hadrup, Sine Reker/P-3388-2014; Schumacher, Ton/Y-2432-2019	Heemskerk, Mirjam H.M./0000-0001-6320-9133; Hadrup, Sine Reker/0000-0002-5937-4344; Schumacher, Ton/0000-0003-0517-8804; Bakker, Arne/0000-0003-1944-6515	Dutch Cancer Society [07-3825]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society grant no. 07-3825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amir AL, 2010, BLOOD, V115, P3146, DOI 10.1182/blood-2009-07-234906; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; DERIJKE RB, 2005, J CLIN INVEST, V115, P3506; Dierselhuis M, 2009, CURR OPIN ORGAN TRAN, V14, P419, DOI 10.1097/MOT.0b013e32832d399c; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eijsink C, 2006, J IMMUNOL METHODS, V315, P153, DOI 10.1016/j.jim.2006.07.020; Falkenburg JHF, 2003, EXP HEMATOL, V31, P743, DOI 10.1016/S0301-472X(03)00190-5; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Hadrup SR, 2010, CANCER IMMUNOL IMMUN, V59, P1425, DOI 10.1007/s00262-010-0824-2; Hadrup SR, 2009, METHODS MOL BIOL, V524, P383, DOI 10.1007/978-1-59745-450-6_28; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Kessler JH, 2007, LEUKEMIA, V21, P1859, DOI 10.1038/sj.leu.2404787; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Mullally A, 2007, BLOOD, V109, P1355, DOI 10.1182/blood-2006-06-030858; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; PARKER KC, 1994, J IMMUNOL, V152, P163; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; PORTER DL, 1994, NEW ENGL J MED, V330, P100, DOI 10.1056/NEJM199401133300204; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reddy P, 2003, BLOOD REV, V17, P187, DOI 10.1016/S0268-960X(03)00009-2; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Slager EH, 2006, BLOOD, V107, P4954, DOI 10.1182/blood-2005-09-3883; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Spierings E, 2005, J CLIN INVEST, V115, P3397, DOI 10.1172/JCI27094; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; van Bergen CAM, 2007, BLOOD, V109, P4089, DOI 10.1182/blood-2006-08-043935; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268	35	27	29	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22523	10.1371/journal.pone.0022523	http://dx.doi.org/10.1371/journal.pone.0022523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850230	gold, Green Submitted, Green Published			2022-12-27	WOS:000293563300014
J	Jeudy, S; Wardrop, KE; Alessi, A; Dominov, JA				Jeudy, Sheila; Wardrop, Katherine E.; Alessi, Amy; Dominov, Janice A.			Bcl-2 Inhibits the Innate Immune Response during Early Pathogenesis of Murine Congenital Muscular Dystrophy	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; SKELETAL-MUSCLE; INFLAMMATORY MYOPATHY; MEROSIN DEFICIENCY; GENE-EXPRESSION; LIMB-GIRDLE; ACTIVATION; DISEASE; ONSET	Laminin alpha 2 (LAMA2)-deficient congenital muscular dystrophy is a severe, early-onset disease caused by abnormal levels of laminin 211 in the basal lamina leading to muscle weakness, transient inflammation, muscle degeneration and impaired mobility. In a Lama2-deficient mouse model for this disease, animal survival is improved by muscle-specific expression of the apoptosis inhibitor Bcl-2, conferred by a MyoD-hBcl-2 transgene. Here we investigated early disease stages in this model to determine initial pathological events and effects of Bcl-2 on their progression. Using quantitative immunohistological and mRNA analyses we show that inflammation occurs very early in Lama2-deficient muscle, some aspects of which are reduced or delayed by the MyoD-hBcl-2 transgene. mRNAs for innate immune response regulators, including multiple Toll-like receptors (TLRs) and the inflammasome component NLRP3, are elevated in diseased muscle compared with age-matched controls expressing Lama2. MyoD-hBcl-2 inhibits induction of TLR4, TLR6, TLR7, TLR8 and TLR9 in Lama2-deficient muscle compared with non-transgenic controls, and leads to reduced infiltration of eosinophils, which are key death effector cells. This congenital disease model provides a new paradigm for investigating cell death mechanisms during early stages of pathogenesis, demonstrating that interactions exist between Bcl-2, a multifunctional regulator of cell survival, and the innate immune response.	[Jeudy, Sheila; Wardrop, Katherine E.; Alessi, Amy; Dominov, Janice A.] Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Jeudy, S (corresponding author), Boston Biomed Res Inst, Watertown, MA 02472 USA.	dominov@bbri.org		Dominov, Janice/0000-0002-5751-0955	NIH, NIAMS [R01AR051368, R21AR049306]; John W. Alden Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR049306, R01AR051368] Funding Source: NIH RePORTER	NIH, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); John W. Alden Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants to J.A.D. from the NIH, NIAMS (R01AR051368, R21AR049306) and from the John W. Alden Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd JH, 2006, INFECT IMMUN, V74, P6829, DOI 10.1128/IAI.00286-06; CARMIGNAC V, 2010, HUM MOL GENET; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Cheung PFY, 2008, INT IMMUNOL, V20, P353, DOI 10.1093/intimm/dxm146; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Evans NP, 2009, AM J PHYS MED REHAB, V88, P502, DOI 10.1097/PHM.0b013e3181a5a24f; Frost RA, 2006, AM J PHYSIOL-REG I, V290, pR773, DOI 10.1152/ajpregu.00490.2005; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guo Z, 2005, J IMMUNOL, V175, P7407, DOI 10.4049/jimmunol.175.11.7407; Han R, 2010, J CLIN INVEST, V120, P4366, DOI 10.1172/JCI42390; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Henriques-Pons A, 2009, CURR OPIN RHEUMATOL, V21, P581, DOI 10.1097/BOR.0b013e3283319265; Huang Qi-Quan, 2009, Curr Rheumatol Rep, V11, P357; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Mrak RE, 1998, J CHILD NEUROL, V13, P513, DOI 10.1177/088307389801301009; Musikacharoen T, 2001, J IMMUNOL, V166, P4516, DOI 10.4049/jimmunol.166.7.4516; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Pegoraro E, 1996, ANN NEUROL, V40, P782, DOI 10.1002/ana.410400515; Rawat R, 2010, AM J PATHOL, V176, P2891, DOI 10.2353/ajpath.2010.090058; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Rocha CT, 2010, CURR NEUROL NEUROSCI, V10, P267, DOI 10.1007/s11910-010-0119-1; RODRIGUEZ D, 2010, BIOCH BIOPHYS ACTA; SCHAEFER L, 2009, CURR OPIN PHARM; Schreiner B, 2005, FASEB J, V19, P118, DOI 10.1096/fj.05-4342fje; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Wardrop KE, 2011, J HISTOCHEM CYTOCHEM, V59, P167, DOI 10.1369/jhc.2010.956672	39	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22369	10.1371/journal.pone.0022369	http://dx.doi.org/10.1371/journal.pone.0022369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850221	gold, Green Published, Green Submitted			2022-12-27	WOS:000293563300005
J	Zou, F; Schafer, N; Palesch, D; Brucken, R; Beck, A; Sienczyk, M; Kalbacher, H; Sun, ZL; Boehm, BO; Burster, T				Zou, Fang; Schaefer, Nadja; Palesch, David; Bruecken, Ruth; Beck, Alexander; Sienczyk, Marcin; Kalbacher, Hubert; Sun, ZiLin; Boehm, Bernhard O.; Burster, Timo			Regulation of Cathepsin G Reduces the Activation of Proinsulin-Reactive T Cells from Type 1 Diabetes Patients	PLOS ONE			English	Article							LYSOSOMAL PROTEOLYSIS; INVARIANT CHAIN; DENDRITIC CELLS; VITAMIN-D; NOD MICE; INHIBITION; MELLITUS; PEPTIDE; INSULIN; INFLAMMATION	Autoantigenic peptides resulting from self-proteins such as proinsulin are important players in the development of type 1 diabetes mellitus (T1D). Self-proteins can be processed by cathepsins (Cats) within endocytic compartments and loaded to major histocompatibility complex (MHC) class II molecules for CD4(+) T cell inspection. However, the processing and presentation of proinsulin by antigen-presenting cells (APC) in humans is only partially understood. Here we demonstrate that the processing of proinsulin by B cell or myeloid dendritic cell (mDC1)-derived lysosomal cathepsins resulted in several proinsulin-derived intermediates. These intermediates were similar to those obtained using purified CatG and, to a lesser extent, CatD, S, and V in vitro. Some of these intermediates polarized T cell activation in peripheral blood mononuclear cells (PBMC) from T1D patients indicative for naturally processed T cell epitopes. Furthermore, CatG activity was found to be elevated in PBMC from T1D patients and abrogation of CatG activity resulted in functional inhibition of proinsulin-reactive T cells. Our data suggested the notion that CatG plays a critical role in proinsulin processing and is important in the activation process of diabetogenic T cells.	[Zou, Fang; Schaefer, Nadja; Palesch, David; Bruecken, Ruth; Boehm, Bernhard O.; Burster, Timo] Univ Med Ctr Ulm, Div Endocrinol & Diabet, Ctr Internal Med, Ulm, Germany; [Beck, Alexander] Panatecs, Tubingen, Germany; [Sienczyk, Marcin] Wroclaw Univ Technol, PL-50370 Wroclaw, Poland; [Kalbacher, Hubert] Univ Tubingen, Med & Nat Sci Res Ctr, Tubingen, Germany; [Sun, ZiLin] Southeast Univ, Inst Diabet, Zhongda Hosp, Sch Med, Nanjing, Peoples R China	Ulm University; Wroclaw University of Science & Technology; Eberhard Karls University of Tubingen; Southeast University - China	Zou, F (corresponding author), Univ Med Ctr Ulm, Div Endocrinol & Diabet, Ctr Internal Med, Ulm, Germany.	timo.burster@uni-ulm.de	李, 伟/J-5211-2016; Sienczyk, Marcin/I-3869-2012; Boehm, Bernhard Otto/F-8750-2015	Burster, Timo/0000-0002-9596-6558	Deutsche Forschungsgemeinschaft [SFB 518, GRK 1041-2]; Deutsche Diabetes-Stiftung (DDS) "Das zuckerkranke Kind" [226/06/10]; China Scholarship Council [2009609038]; State Committee for Scientific Research [N405 342633]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Diabetes-Stiftung (DDS) "Das zuckerkranke Kind"; China Scholarship Council(China Scholarship Council); State Committee for Scientific Research(Polish State Committee for Scientific Research)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 518), GRK 1041-2 to BOB, Deutsche Diabetes-Stiftung (DDS) "Das zuckerkranke Kind" 226/06/10 to TB, China Scholarship Council (No. 2009609038) to FZ, and State Committee for Scientific Research for financial support (grant N405 342633) MS. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AB was an employee of PANATecs GmbH when this study was conducted and played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Burster T, 2004, J IMMUNOL, V172, P5495, DOI 10.4049/jimmunol.172.9.5495; Burster T, 2010, DIABETES-METAB RES, V26, P227, DOI 10.1002/dmrr.1090; Burster T, 2010, MOL IMMUNOL, V47, P658, DOI 10.1016/j.molimm.2009.10.003; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; COLBERT JD, 2009, EUR J IMMUNOL; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; DELOVITCH TL, 1988, IMMUNOL REV, V106, P195, DOI 10.1111/j.1600-065X.1988.tb00780.x; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Durinovic-Bello I, 2002, J AUTOIMMUN, V18, P55, DOI 10.1006/jaut.2001.0566; Ettinger RA, 1998, J IMMUNOL, V160, P2365; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Hsing LC, 2010, J AUTOIMMUN, V34, P96, DOI 10.1016/j.jaut.2009.07.003; Jasinski J M, 2005, Clin Dev Immunol, V12, P181, DOI 10.1080/17402520500078204; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Lang Y, 1996, DIABETES, V45, P1711, DOI 10.2337/diabetes.45.12.1711; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Mathieu C, 2005, TRENDS ENDOCRIN MET, V16, P261, DOI 10.1016/j.tem.2005.06.004; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; Miyata J, 2007, RHEUMATOL INT, V27, P375, DOI 10.1007/s00296-006-0210-8; OLEKSYSZYN J, 1991, BIOCHEMISTRY-US, V30, P485, DOI 10.1021/bi00216a026; Palesch D, 2011, ACTA BIOCHIM POL, V58, P39; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pitocco D, 2006, DIABETIC MED, V23, P920, DOI 10.1111/j.1464-5491.2006.01921.x; Raymond WW, 2010, J IMMUNOL, V185, P5360, DOI 10.4049/jimmunol.1002292; REICH M, 2011, CELL IMMUNOL; Reich M, 2009, MOL IMMUNOL, V46, P2994, DOI 10.1016/j.molimm.2009.06.017; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Rudensky A, 2006, E SCHERING RES FDN W, V56, P81; Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149; Shimoda N, 2007, AM J PATHOL, V170, P930, DOI 10.2353/ajpath.2007.060486; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; Tausch L, 2009, J IMMUNOL, V183, P3433, DOI 10.4049/jimmunol.0803574; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; van Endert P, 2007, CURR OPIN IMMUNOL, V19, P63, DOI 10.1016/j.coi.2006.11.015; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Zaidi N, 2007, BIOCHEM BIOPH RES CO, V364, P243, DOI 10.1016/j.bbrc.2007.09.114; Zavasnik-Bergant T, 2006, TISSUE ANTIGENS, V67, P349, DOI 10.1111/j.1399-0039.2006.00585.x	39	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22815	10.1371/journal.pone.0022815	http://dx.doi.org/10.1371/journal.pone.0022815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850236	Green Submitted, gold, Green Published			2022-12-27	WOS:000293563300021
J	Alhyas, L; McKay, A; Balasanthiran, A; Majeed, A				Alhyas, Layla; McKay, Ailsa; Balasanthiran, Anjali; Majeed, Azeem			Quality of Type 2 Diabetes Management in the States of The Co-Operation Council for the Arab States of the Gulf: A Systematic Review	PLOS ONE			English	Review							OUTCOMES FRAMEWORK; FAMILY-PRACTICE; SAUDI-ARABIA; HEALTH-CARE; MELLITUS; PREVALENCE; COMPLICATIONS; IMPROVEMENT; CENTERS; PROGRAM	Type 2 diabetes mellitus is a growing, worldwide public health concern. Recent growth has been particularly dramatic in the states of The Co-operation Council for the Arab States of the Gulf (GCC), and these and other developing economies are at particular risk. We aimed to systematically review the quality of control of type 2 diabetes in the GCC, and the nature and efficacy of interventions. We identified 27 published studies for review. Studies were identified by systematic database searches. Medline and Embase were searched separately (via Dialog and Ovid, respectively; 1950 to July 2010 (Medline), and 1947 to July 2010 (Embase)) on 15/07/2009. The search was updated on 08/07/2010. Terms such as diabetes mellitus, non-insulin-dependent, hyperglycemia, hypertension, hyperlipidemia and Gulf States were used. Our search also included scanning reference lists, contacting experts and hand-searching key journals. Studies were judged against pre-determined inclusion/exclusion criteria, and where suitable for inclusion, data extraction/quality assessment was achieved using a specifically-designed tool. All studies wherein glycaemic-, blood pressure-and/or lipid-control were investigated (clinical and/or process outcomes) were eligible for inclusion. No limitations on publication type, publication status, study design or language of publication were imposed. We found the extent of control to be sub-optimal and relatively poor. Assessment of the efficacy of interventions was difficult due to lack of data, but suggestive that more widespread and controlled trial of secondary prevention strategies may have beneficial outcomes. We found no record of audited implementation of primary preventative strategies and anticipate that controlled trial of such strategies would also be useful.	[Alhyas, Layla; McKay, Ailsa; Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Balasanthiran, Anjali] Imperial Coll London, Dept Med, London, England	Imperial College London; Imperial College London	Alhyas, L (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, London, England.	l.alhyas08@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858	United Arab Emirates Ministry of Research and Higher Education, Abu Dhabi; NIHR; NIHR Biomedical Research Centre; Imperial Centre for Patient Safety and Service Quality	United Arab Emirates Ministry of Research and Higher Education, Abu Dhabi; NIHR(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality	This study was supported by a sponsor provided by the United Arab Emirates Ministry of Research and Higher Education, Abu Dhabi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Igor Wei who helped with the electronic search strategy. Imperial College London is grateful for support from the NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme, the NIHR Biomedical Research Centre scheme, and the Imperial Centre for Patient Safety and Service Quality.	Abou El-Enein N. Y., 2008, Eastern Mediterranean Health Journal, V14, P636; Afandi B, 2006, ANN NY ACAD SCI, V1084, P319, DOI 10.1196/annals.1372.017; Akbar DH, 2003, SAUDI MED J, V24, P1109; Akbar DH, 2003, ENDOCRINE, V21, P217, DOI 10.1385/ENDO:21:3:217; Akel M, 1999, INT J QUAL HEALTH C, V11, P517, DOI 10.1093/intqhc/11.6.517; Al kabi J., 2008, J SOC BIOMED DIAB RE, V5, P110; Al Khaja KAJ, 2005, DIABETES RES CLIN PR, V70, P174, DOI 10.1016/j.diabres.2005.03.029; Al Khaja KAJ, 2005, J EVAL CLIN PRACT, V11, P121, DOI 10.1111/j.1365-2753.2005.00511.x; Al-Adsani A, 2008, MED PRIN PRACT, V17, P14, DOI 10.1159/000109584; Al-Elq AH, 2009, SAUDI MED J, V30, P1551; Al-Ghamdi AA, 2004, SAUDI MED J, V25, P342; Al-Hussein FA, 2008, ANN SAUDI MED, V28, P267; Al-Shaikh AA, 2006, SAUDI MED J, V27, P424; Al-Shehri AM, 2008, SAUDI MED J, V29, P718; Al-Turki YA, 2002, SAUDI MED J, V23, P1332; AlShammari SA, 1996, INT J QUAL HEALTH C, V8, P383, DOI 10.1093/intqhc/8.4.383; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; ANDREWS D, 2002, E MEDITERRANEAN HLTH, V8, P4; [Anonymous], 2009, SYSTEMATIC REV CRDS; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; El-Shafie Kawther, 2010, Oman Med J, V25, P32, DOI 10.5001/omj.2010.8; El-Shazly M, 2000, PUBLIC HEALTH, V114, P276, DOI 10.1016/S0033-3506(00)00345-0; Eledrisi M, 2007, DIABETES RES CLIN PR, V78, P145, DOI 10.1016/j.diabres.2007.02.017; FAMUYIWA OO, 1992, ANN SAUDI MED, V12, P140, DOI 10.5144/0256-4947.1992.140; Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; GREENFIELD S, 2004, SELECTING INDICATORS; International Diabetes Federation, 2009, IDF DIAB ATL; Kharal M, 2010, SAUDI J KIDNEY DIS T, V21, P678; Khattab M. S., 2007, Eastern Mediterranean Health Journal, V13, P492; Khorsheed MM, 2005, SAUDI MED J, V26, P346; Khunti K, 2007, DIABETIC MED, V24, P1436, DOI 10.1111/j.1464-5491.2007.02276.x; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Millett C, 2007, J ROY SOC MED, V100, P275, DOI 10.1258/jrsm.100.6.275; Moharram MM, 2008, SAUDI MED J, V29, P98; QARI FA, 2005, PAK J MED SCI, V21, P408; REED RL, 2001, PHYSL BIOCH, V109, P272; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saadi H, 2007, DIABETES RES CLIN PR, V78, P369, DOI 10.1016/j.diabres.2007.04.008; SEQUEIRA P, 2002, J EVAL CLIN PRACT, V10, P107; *UAE NAT DIAB COMM, 2009, NAT DIAB GUID UN AR; Udezue E, 2005, ANN SAUDI MED, V25, P85, DOI 10.5144/0256-4947.2005.85; Wan Q, 2006, QUAL SAF HEALTH CARE, V15, P131, DOI 10.1136/qshc.2005.014845; *WHO, 2009, FACT SHEET 312 DIAB; *WHO HLTH CAR CHRO, 2002, INN CAR CHRON COND B; Youssef Adel A, 2006, J Egypt Public Health Assoc, V81, P301	46	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22186	10.1371/journal.pone.0022186	http://dx.doi.org/10.1371/journal.pone.0022186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829607	gold, Green Submitted, Green Published			2022-12-27	WOS:000293561200008
J	Barboni, B; Bernabo, N; Palestini, P; Botto, L; Pistilli, MG; Chiarini, M; Tettamanti, E; Battista, N; Maccarrone, M; Mattioli, M				Barboni, Barbara; Bernabo, Nicola; Palestini, Paola; Botto, Laura; Pistilli, Maria Gabriella; Chiarini, Marco; Tettamanti, Enzo; Battista, Natalia; Maccarrone, Mauro; Mattioli, Mauro			Type-1 Cannabinoid Receptors Reduce Membrane Fluidity of Capacitated Boar Sperm by Impairing Their Activation by Bicarbonate	PLOS ONE			English	Article							EXPOSURE INFLUENCES NEUROENDOCRINE; ACROSOME REACTION; ENDOCANNABINOID SYSTEM; PLASMA-MEMBRANES; REPRODUCTIVE FUNCTIONS; MONOCLONAL-ANTIBODY; CHOLESTEROL EFFLUX; HUMAN SPERMATOZOA; IN-VITRO; FERTILIZATION	Background: Mammalian spermatozoa acquire their full fertilizing ability (so called capacitation) within the female genital tract, where they are progressively exposed to inverse gradients of inhibiting and stimulating molecules. Methodology/Principal Findings: In the present research, the effect on this process of anandamide, an endocannabinoid that can either activate or inhibit cannabinoid receptors depending on its concentration, and bicarbonate, an oviductal activatory molecule, was assessed, in order to study the role exerted by the type 1 cannabinoid receptor (CB1R) in the process of lipid membrane remodeling crucial to complete capacitation. To this aim, boar sperm were incubated in vitro under capacitating conditions (stimulated by bicarbonate) in the presence or in the absence of methanandamide (Met-AEA), a non-hydrolysable analogue of anandamide. The CB1R involvement was studied by using the specific inhibitor (SR141716) or mimicking its activation by adding a permeable cAMP analogue (8Br-cAMP). By an immunocytochemistry approach it was shown that the Met-AEA inhibits the bicarbonate-dependent translocation of CB1R from the post-equatorial to equatorial region of sperm head. In addition it was found that Met-AEA is able to prevent the bicarbonate-induced increase in membrane disorder and the cholesterol extraction, both preliminary to capacitation, acting through a CB1R-cAMP mediated pathway, as indicated by MC540 and filipin staining, EPR spectroscopy and biochemical analysis on whole membranes (CB1R activity) and on membrane enriched fraction (C/P content and anisotropy). Conclusions/Significance: Altogether, these data demonstrate that the endocannabinoid system strongly inhibits the process of sperm capacitation, acting as membrane stabilizing agent, thus increasing the basic knowledge on capacitation-related signaling and potentially opening new perspectives in diagnostics and therapeutics of male infertility.	[Barboni, Barbara; Bernabo, Nicola; Pistilli, Maria Gabriella; Tettamanti, Enzo; Maccarrone, Mauro; Mattioli, Mauro] Univ Teramo, Dept Biomed Comparat Sci, Teramo, Italy; [Palestini, Paola; Botto, Laura] Univ Milano Bicocca, Dept Expt Med, Milan, Italy; [Chiarini, Marco; Battista, Natalia] Univ Teramo, Dept Food Sci, Teramo, Italy; [Maccarrone, Mauro] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy	University of Teramo; University of Milano-Bicocca; University of Teramo; IRCCS Santa Lucia	Barboni, B (corresponding author), Univ Teramo, Dept Biomed Comparat Sci, Teramo, Italy.	nbernabo@unite.it	Battista, Natalia/AAC-2529-2019; Palestini, PAOLA/AAD-9376-2019; Maccarrone, Mauro/K-5398-2012; Chiarini, Marco/B-9086-2008	Palestini, PAOLA/0000-0002-1045-8838; Maccarrone, Mauro/0000-0002-3990-2963; Chiarini, Marco/0000-0002-2298-5467; Bernabo, Nicola/0000-0001-5140-9656; Battista, Natalia/0000-0002-1936-6710				Abeydeera LR, 1997, THERIOGENOLOGY, V48, P537, DOI 10.1016/S0093-691X(97)00270-7; Abou-haila A, 2009, ARCH BIOCHEM BIOPHYS, V485, P72, DOI 10.1016/j.abb.2009.02.003; Barbonetti A, 2008, BIOL REPROD, V79, P649, DOI 10.1095/biolreprod.108.068254; Bari M, 2005, J NEUROSCI RES, V81, P275, DOI 10.1002/jnr.20546; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bernabo N, 2007, THERIOGENOLOGY, V67, P801, DOI 10.1016/j.theriogenology.2006.10.014; Bernabo N, 2010, MOL CELL ENDOCRINOL, V323, P224, DOI 10.1016/j.mce.2010.02.025; Bernabo N, 2010, THERIOGENOLOGY, V73, P1293, DOI 10.1016/j.theriogenology.2009.12.010; Boni R, 2007, THERIOGENOLOGY, V68, pS156, DOI 10.1016/j.theriogenology.2007.05.048; Botto L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-7; Botto L, 2010, J MEMBRANE BIOL, V238, P33, DOI 10.1007/s00232-010-9316-8; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; CARMENA MJ, 1991, REGUL PEPTIDES, V33, P287, DOI 10.1016/0167-0115(91)90231-5; CASTELLANICERESA L, 1993, MOL REPROD DEV, V36, P203, DOI 10.1002/mrd.1080360211; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; DALTERIO S, 1984, PHARMACOL BIOCHEM BE, V20, P115, DOI 10.1016/0091-3057(84)90111-4; DALTERIO S, 1984, PHARMACOL BIOCHEM BE, V20, P107, DOI 10.1016/0091-3057(84)90110-2; Fasano S, 2009, ANN NY ACAD SCI, V1163, P112, DOI 10.1111/j.1749-6632.2009.04437.x; Flesch FM, 2001, J CELL SCI, V114, P3543; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gadella BM, 2008, ANIM REPROD SCI, V107, P229, DOI 10.1016/j.anireprosci.2008.05.006; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; HARRIS RA, 1982, J PHARMACOL EXP THER, V223, P424; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; Laura B, 2008, J CELL BIOCHEM, V105, P503, DOI 10.1002/jcb.21850; Lewis SE, 2009, PHARMACOL RES, V60, P126, DOI 10.1016/j.phrs.2009.02.009; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Maccarrone M, 2009, PROG LIPID RES, V48, P344, DOI 10.1016/j.plipres.2009.07.001; MARQUANTLEGUIENNE B, 1986, J REPROD FERTIL, V77, P337, DOI 10.1530/jrf.0.0770337; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Nixon B, 2009, J REPROD IMMUNOL, V83, P8, DOI 10.1016/j.jri.2009.06.258; Ochsendorf FR, 2000, ANDROLOGIA, V32, P169, DOI 10.1046/j.1439-0272.2000.00360.x; OKABE M, 1986, J REPROD IMMUNOL, V9, P67, DOI 10.1016/0165-0378(86)90026-4; OKABE M, 1986, J PHARMACOBIO-DYNAM, V9, P55; Palestini P, 2002, AM J PHYSIOL-LUNG C, V282, pL1382, DOI 10.1152/ajplung.00447.2001; Rossato M, 2005, J CLIN ENDOCR METAB, V90, P984, DOI 10.1210/jc.2004-1287; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; SHALGI R, 1990, MOL REPROD DEV, V25, P286, DOI 10.1002/mrd.1080250311; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; Travis AJ, 2002, J CLIN INVEST, V110, P731, DOI [10.1172/JCI200216392, 10.1172/JCI0216392]; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; Volpe S, 2008, REPROD DOMEST ANIM, V43, P385, DOI 10.1111/j.1439-0531.2007.00918.x; Waterhouse KE, 2006, REPRODUCTION, V131, P887, DOI 10.1530/rep.1.01049; Wenger T, 1999, LIFE SCI, V65, P695, DOI 10.1016/S0024-3205(99)00292-1	52	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23038	10.1371/journal.pone.0023038	http://dx.doi.org/10.1371/journal.pone.0023038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829686	Green Submitted, Green Published, gold			2022-12-27	WOS:000293561200045
J	Chaudhury, S; Berrondo, M; Weitzner, BD; Muthu, P; Bergman, H; Gray, JJ				Chaudhury, Sidhartha; Berrondo, Monica; Weitzner, Brian D.; Muthu, Pravin; Bergman, Hannah; Gray, Jeffrey J.			Benchmarking and Analysis of Protein Docking Performance in Rosetta v3.2	PLOS ONE			English	Article							FERREDOXIN-NADP(+) REDUCTASE; BLIND PREDICTIONS	RosettaDock has been increasingly used in protein docking and design strategies in order to predict the structure of protein-protein interfaces. Here we test capabilities of RosettaDock 3.2, part of the newly developed Rosetta v3.2 modeling suite, against Docking Benchmark 3.0, and compare it with RosettaDock v2.3, the latest version of the previous Rosetta software package. The benchmark contains a diverse set of 116 docking targets including 22 antibody-antigen complexes, 33 enzyme-inhibitor complexes, and 60 'other' complexes. These targets were further classified by expected docking difficulty into 84 rigid-body targets, 17 medium targets, and 14 difficult targets. We carried out local docking perturbations for each target, using the unbound structures when available, in both RosettaDock v2.3 and v3.2. Overall the performances of RosettaDock v2.3 and v3.2 were similar. RosettaDock v3.2 achieved 56 docking funnels, compared to 49 in v2.3. A breakdown of docking performance by protein complex type shows that RosettaDock v3.2 achieved docking funnels for 63% of antibody-antigen targets, 62% of enzyme-inhibitor targets, and 35% of 'other' targets. In terms of docking difficulty, RosettaDock v3.2 achieved funnels for 58% of rigid-body targets, 30% of medium targets, and 14% of difficult targets. For targets that failed, we carry out additional analyses to identify the cause of failure, which showed that binding-induced backbone conformation changes account for a majority of failures. We also present a bootstrap statistical analysis that quantifies the reliability of the stochastic docking results. Finally, we demonstrate the additional functionality available in RosettaDock v3.2 by incorporating small-molecules and non-protein co-factors in docking of a smaller target set. This study marks the most extensive benchmarking of the RosettaDock module to date and establishes a baseline for future research in protein interface modeling and structure prediction.	[Chaudhury, Sidhartha] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Berrondo, Monica; Weitzner, Brian D.; Muthu, Pravin; Bergman, Hannah; Gray, Jeffrey J.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Chaudhury, S (corresponding author), Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA.	jgray@jhu.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Weitzner, Brian/0000-0002-1909-0961	National Institutes of Health [R01 GM078221]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM078221 (http://grants.nih.gov/grants/funding/r01.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; BAUGH EH, 2011, PLOS ONE IN PRESS; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berrondo M, 2010, J MOL BIOL, V398, P462, DOI 10.1016/j.jmb.2010.03.021; Bocik WE, 2011, J BIOL CHEM, V286, P3981, DOI 10.1074/jbc.M110.189050; Chaudhury S, 2008, J MOL BIOL, V381, P1068, DOI 10.1016/j.jmb.2008.05.042; Chaudhury S, 2007, PROTEINS, V69, P793, DOI 10.1002/prot.21731; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chaudhury S, 2009, STRUCTURE, V17, P1636, DOI 10.1016/j.str.2009.10.008; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Daily MD, 2005, PROTEINS, V60, P181, DOI 10.1002/prot.20555; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fleishman SJ, 2010, PROTEINS, V78, P3212, DOI 10.1002/prot.22784; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hermoso JA, 2002, J MOL BIOL, V319, P1133, DOI 10.1016/S0022-2836(02)00388-1; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Morales R, 2000, ACTA CRYSTALLOGR D, V56, P1408, DOI 10.1107/S0907444900010052; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sircar A, 2010, PROTEINS, V78, P3115, DOI 10.1002/prot.22765; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Sivasubramanian A, 2008, PROTEINS, V70, P218, DOI 10.1002/prot.21595; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747	35	196	197	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22477	10.1371/journal.pone.0022477	http://dx.doi.org/10.1371/journal.pone.0022477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829626	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511900007
J	Huang, YT; Lin, XH; Chirieac, LR; McGovern, R; Wain, JC; Heist, RS; Skaug, V; Zienolddiny, S; Haugen, A; Su, L; Christiani, DC				Huang, Yen-Tsung; Lin, Xihong; Chirieac, Lucian R.; McGovern, Ray; Wain, John C.; Heist, Rebecca S.; Skaug, Vidar; Zienolddiny, Shanbeh; Haugen, Aage; Su, Li; Christiani, David C.			Impact on Disease Development, Genomic Location and Biological Function of Copy Number Alterations in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							EXPRESSION PROFILES; GENETIC ALTERATIONS; CARCINOMA; CARCINOGENESIS; ADENOCARCINOMA; POLYMORPHISM; MUTATION; FREQUENT; EVENT; GAIN	Lung cancer, of which more than 80% is non-small cell, is the leading cause of cancer-related death in the United States. Copy number alterations (CNAs) in lung cancer have been shown to be positionally clustered in certain genomic regions. However, it remains unclear whether genes with copy number changes are functionally clustered. Using a dense single nucleotide polymorphism array, we performed genome-wide copy number analyses of a large collection of non-small cell lung tumors (n = 301). We proposed a formal statistical test for CNAs between different groups (e. g., non-involved lung vs. tumors, early vs. late stage tumors). We also customized the gene set enrichment analysis (GSEA) algorithm to investigate the overrepresentation of genes with CNAs in predefined biological pathways and gene sets (i.e., functional clustering). We found that CNAs events increase substantially from germline, early stage to late stage tumor. In addition to genomic position, CNAs tend to occur away from the gene locations, especially in germline, non-involved tissue and early stage tumors. Such tendency decreases from germline to early stage and then to late stage tumors, suggesting a relaxation of selection during tumor progression. Furthermore, genes with CNAs in non-small cell lung tumors were enriched in certain gene sets and biological pathways that play crucial roles in oncogenesis and cancer progression, demonstrating the functional aspect of CNAs in the context of biological pathways that were overlooked previously. We conclude that CNAs increase with disease progression and CNAs are both positionally and functionally clustered. The potential functional capabilities acquired via CNAs may be sufficient for normal cells to transform into malignant cells.	[Huang, Yen-Tsung; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Huang, Yen-Tsung; Lin, Xihong; McGovern, Ray] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Chirieac, Lucian R.] Massachusetts Gen Hosp, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02114 USA; [Wain, John C.; Heist, Rebecca S.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Wain, John C.] Massachusetts Gen Hosp, Thorac Surg Unit, Boston, MA 02114 USA; [Heist, Rebecca S.; Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Skaug, Vidar; Zienolddiny, Shanbeh; Haugen, Aage] Natl Inst Occupat Hlth, Dept Biol & Chem Working Environm, Oslo, Norway; [Christiani, David C.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Huang, YT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	dchris@hsph.harvard.edu	Huang, Yen-Tsung/AAQ-3919-2021; Zienolddiny, Shanbeh/O-7392-2015; Huang, Yen-Tsung/I-1003-2014; Pillay, Nischalan/F-9536-2012; Chirieac, Lucian R./AAD-2030-2019	Huang, Yen-Tsung/0000-0001-7657-0040; Zienolddiny, Shan/0000-0001-9747-9625	US National Institutes of Health [CA092824, CA074386, CA090578]; Norwegian Cancer Society; NATIONAL CANCER INSTITUTE [R01CA074386, P20CA090578, P50CA090578, R01CA092824] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by US National Institutes of Health (http://www.nih.gov/) grants no. CA092824 (D. C. C.), CA074386 (D. C. C.), CA090578 (D. C. C.); and Norwegian Cancer Society (http://www.kreftforeningen.no/english)(A.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Duesberg P, 2005, CELL ONCOL, V27, P293; Duesberg P, 2005, SCIENCE, V307, P41; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang JU, 2008, CANCER GENET CYTOGEN, V184, P31, DOI 10.1016/j.cancergencyto.2008.03.002; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kim TM, 2005, CLIN CANCER RES, V11, P8235, DOI 10.1158/1078-0432.CCR-05-1157; Mitsuuchi Y, 2002, AM J MED GENET, V115, P183, DOI 10.1002/ajmg.10692; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Panani AD, 2006, CANCER LETT, V239, P1, DOI 10.1016/j.canlet.2005.06.030; Sanchez-Cespedes M, 2003, LUNG CANCER, V40, P111, DOI 10.1016/S0169-5002(03)00033-3; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Smith MW, 2003, CANCER RES, V63, P859; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	28	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e22961	10.1371/journal.pone.0022961	http://dx.doi.org/10.1371/journal.pone.0022961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829676	Green Submitted, Green Published, gold			2022-12-27	WOS:000293511900019
J	Borge-Holthoefer, J; Moreno, Y; Arenas, A				Borge-Holthoefer, Javier; Moreno, Yamir; Arenas, Alex			Modeling Abnormal Priming in Alzheimer's Patients with a Free Association Network	PLOS ONE			English	Article							SEMANTIC MEMORY IMPAIRMENT; DISEASE; SIMULATION; FLUENCY; TIME	Alzheimer's Disease irremediably alters the proficiency of word search and retrieval processes even at its early stages. Such disruption can sometimes be paradoxical in specific language tasks, for example semantic priming. Here we focus in the striking side-effect of hyperpriming in Alzheimer's Disease patients, which has been well-established in the literature for a long time. Previous studies have evidenced that modern network theory can become a powerful complementary tool to gain insight in cognitive phenomena. Here, we first show that network modeling is an appropriate approach to account for semantic priming in normal subjects. Then we turn to priming in degraded cognition: hyperpriming can be readily understood in the scope of a progressive degradation of the semantic network structure. We compare our simulation results with previous empirical observations in diseased patients finding a qualitative agreement. The network approach presented here can be used to accommodate current theories about impaired cognition, and towards a better understanding of lexical organization in healthy and diseased patients.	[Borge-Holthoefer, Javier; Moreno, Yamir; Arenas, Alex] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Fis Teor, E-50009 Zaragoza, Spain; [Moreno, Yamir] Inst Sci Interchange, Complex Networks & Syst Lagrange Lab, Turin, Italy; [Arenas, Alex] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Zaragoza; Universitat Rovira i Virgili	Borge-Holthoefer, J (corresponding author), Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain.	borge.holthoefer@gmail.com	Borge-Holthoefer, Javier/J-9187-2013; Moreno, Yamir/A-1076-2009; Arenas, Alex/A-5216-2009	Borge-Holthoefer, Javier/0000-0001-9036-8463; Moreno, Yamir/0000-0002-0895-1893; Arenas, Alex/0000-0003-0937-0334	Government of Aragon (DGA); Generalitat de Catalunya [SGR2009 838]; Spanish MICINN [FIS2008-01240, FIS2009- 13364-C02-01, FIS2009-13730-02-02]; Office of Science, Computational and Technology Research, United States Department of Energy [DE-AC02-05CH11231]	Government of Aragon (DGA)(Gobierno de Aragon); Generalitat de Catalunya(Generalitat de Catalunya); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Office of Science, Computational and Technology Research, United States Department of Energy(United States Department of Energy (DOE))	Y.M. and J.B.-H. are supported by the Government of Aragon (DGA) through a grant to FENOL. A. A. acknowledges financial support from Generalitat de Catalunya through project SGR2009 838. Y.M., J. B.-H. and A. A. are supported by the Spanish MICINN through projects FIS2008-01240, FIS2009- 13364-C02-01 and FIS2009-13730-02-02. A. A. acknowledges partial support by the Director, Office of Science, Computational and Technology Research, United States Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borge-Holthoefer J, 2010, EUR PHYS J B, V74, P265, DOI 10.1140/epjb/e2010-00058-9; Borge-Holthoefer J, 2009, P 31 ANN C COGN SCI; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; Caramazza A, 2003, TRENDS COGN SCI, V7, P354, DOI 10.1016/S1364-6613(03)00159-1; CHERTKOW H, 1989, BRAIN LANG, V36, P420, DOI 10.1016/0093-934X(89)90078-3; Cohen R, 2000, PHYS REV LETT, V85; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; Cumming TB, 2006, BRAIN LANG, V98, P221, DOI 10.1016/j.bandl.2006.05.002; Giffard B, 2002, BRAIN, V125, P2044, DOI 10.1093/brain/awf209; Giffard B, 2001, BRAIN, V124, P1522, DOI 10.1093/brain/124.8.1522; Gomez S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38009; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Goni J, 2010, INT J BIFURCAT CHAOS, V20, P913, DOI 10.1142/S0218127410026204; Griffiths TL, 2007, PSYCHOL SCI, V18, P1069, DOI 10.1111/j.1467-9280.2007.02027.x; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Hills T, 2009, P 31 ANN C COGN SCI; Hills TT, 2010, J MEM LANG, V63, P259, DOI 10.1016/j.jml.2010.06.002; Hills TT, 2009, COGNITION, V112, P381, DOI 10.1016/j.cognition.2009.06.002; Hills TT, 2009, PSYCHOL SCI, V20, P729, DOI 10.1111/j.1467-9280.2009.02365.x; HODGES JR, 1992, NEUROPSYCHOLOGIA, V30, P301, DOI 10.1016/0028-3932(92)90104-T; Hutchison KA, 2003, PSYCHON B REV, V10, P785, DOI 10.3758/BF03196544; Hutchison KA, 2008, Q J EXP PSYCHOL, V61, P1036, DOI 10.1080/17470210701438111; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Laisney M, 2011, CORTEX, V47, P35, DOI 10.1016/j.cortex.2009.11.001; Leicht EA, 2006, PHYS REV E, V026120, P73; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Mahon B, 2011, TRENDS COGNITIVE SCI; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; NEBES RD, 1989, PSYCHOL BULL, V106, P377, DOI 10.1037/0033-2909.106.3.377; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; QUILLIAN MR, 1967, BEHAV SCI, V12, P410, DOI 10.1002/bs.3830120511; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rogers SL, 2008, NEUROPSYCHOLOGIA, V46, P12, DOI 10.1016/j.neuropsychologia.2007.08.010; Salton G, 1983, INTRO MODERN INFORM; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	45	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22651	10.1371/journal.pone.0022651	http://dx.doi.org/10.1371/journal.pone.0022651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	802LA	21829639	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200014
J	Karolina, DS; Armugam, A; Tavintharan, S; Wong, MTK; Lim, SC; Sum, CF; Jeyaseelan, K				Karolina, Dwi Setyowati; Armugam, Arunmozhiarasi; Tavintharan, Subramaniam; Wong, Michael T. K.; Lim, Su Chi; Sum, Chee Fang; Jeyaseelan, Kandiah			MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							STREPTOZOTOCIN-TREATED RAT; GENE-EXPRESSION; CIRCULATING MICRORNAS; ENDOTHELIAL-CELLS; TARGET TISSUES; BIOMARKERS; CANCER; PLASMA; MODEL; MIRNAS	Background: Dysregulation of microRNA (miRNA) expression in various tissues and body fluids has been demonstrated to be associated with several diseases, including Type 2 Diabetes mellitus (T2D). Here, we compare miRNA expression profiles in different tissues (pancreas, liver, adipose and skeletal muscle) as well as in blood samples from T2D rat model and highlight the potential of circulating miRNAs as biomarkers of T2D. In parallel, we have examined the expression profiles of miRNAs in blood samples from Impaired Fasting Glucose (IFG) and T2D male patients. Methodology/Principal Findings: Employing miRNA microarray and stem-loop real-time RT-PCR, we identify four novel miRNAs, miR-144, miR-146a, miR-150 and miR-182 in addition to four previously reported diabetes-related miRNAs, miR-192, miR-29a, miR-30d and miR-320a, as potential signature miRNAs that distinguished IFG and T2D. Of these microRNAs, miR-144 that promotes erythropoiesis has been found to be highly up-regulated. Increased circulating level of miR-144 has been found to correlate with down-regulation of its predicted target, insulin receptor substrate 1 (IRS1) at both mRNA and protein levels. We could also experimentally demonstrate that IRS1 is indeed the target of miR-144. Conclusion: We demonstrate that peripheral blood microRNAs can be developed as unique biomarkers that are reflective and predictive of metabolic health and disorder. We have also identified signature miRNAs which could possibly explain the pathogenesis of T2D and the significance of miR-144 in insulin signaling.	[Karolina, Dwi Setyowati; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Tavintharan, Subramaniam; Wong, Michael T. K.; Lim, Su Chi; Sum, Chee Fang] Khoo Teck Puat Hosp, Dept Med, Singapore, Singapore; [Jeyaseelan, Kandiah] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia	National University of Singapore; Monash University	Karolina, DS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Natl Univ Hlth Syst, Singapore 117595, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	National Medical Research Council [R-183-000-290-213]; National Research Foundation, Singapore [R184-002-165-281]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation, Singapore(National Research Foundation, Singapore)	This study was supported by research grants from the National Medical Research Council (R-183-000-290-213) and the National Research Foundation (R184-002-165-281), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; [Anonymous], 2009, GLO J PHARM, V3, P81; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS3, DOI 10.1331/JAPhA.2009.09077; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng JT, 2001, DIABETES, V50, P2815, DOI 10.2337/diabetes.50.12.2815; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Gavin JR, 1997, DIABETES CARE, V20, P1183; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P472, DOI 10.1093/abbs/gmp035; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Li YJ, 2008, BBA-GENE REGUL MECH, V1779, P702, DOI 10.1016/j.bbagrm.2008.07.003; Ling HY, 2009, CLIN EXP PHARM PHYSL; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Lv K, 2008, BIOCHEM BIOPH RES CO, V374, P101, DOI 10.1016/j.bbrc.2008.06.102; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nasrallah R, 2004, AM J PHYSIOL-RENAL, V287, pF673, DOI 10.1152/ajprenal.00025.2004; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; ROGGLI E, DIABETES, V59, P978; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Tavintharan S, 2009, CURR MOL MED, V9, P281, DOI 10.2174/156652409787847245; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vlassov VV, 2010, CURR MOL MED, V10, P142, DOI 10.2174/156652410790963295; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Wang HJ, 2007, ASIA PAC J CLIN NUTR, V16, P412; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Xia HQ, 2010, MOL BIOL REP; YAJNIK CS, 2004, ENDOCRINOLOGY, V142, P2833; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	67	315	338	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22839	10.1371/journal.pone.0022839	http://dx.doi.org/10.1371/journal.pone.0022839			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829658	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200021
J	Verma, K; Gu, JS; Werner, E				Verma, Kiran; Gu, Jingsheng; Werner, Erica			Tumor Endothelial Marker 8 Amplifies Canonical Wnt Signaling in Blood Vessels	PLOS ONE			English	Article							ANTHRAX LETHAL TOXIN; INTUSSUSCEPTIVE MICROVASCULAR GROWTH; CHORIOALLANTOIC MEMBRANE; PROTEIN LRP6; BETA-CATENIN; IN-VIVO; ANGIOGENESIS; PATHWAY; CELLS; INTERNALIZATION	Tumor Endothelial Marker 8/Anthrax Toxin Receptor 1 (TEM8/ANTXR1) expression is induced in the vascular compartment of multiple tumors and therefore, is a candidate molecule to target tumor therapies. This cell surface molecule mediates anthrax toxin internalization, however, its physiological function in blood vessels remains largely unknown. We identified the chicken chorioallantoic membrane (CAM) as a model system to study the endogenous function of TEM8 in blood vessels as we found that TEM8 expression was induced transiently between day 10 and 12 of embryonic development, when the vascular tree is undergoing final development and growth. We used the cell-binding component of anthrax toxin, Protective Antigen (PA), to engage endogenous TEM8 receptors and evaluate the effects of PA-TEM8 complexes on vascular development. PA applied at the time of highest TEM8 expression reduced vascular density and disrupted hierarchical branching as revealed by quantitative morphometric analysis of the vascular tree after 48h. PA-dependent reduced branching phenotype was partially mimicked by Wnt3a application and ameliorated by the Wnt antagonist, Dikkopf-1. These results implicate TEM8 expression in endothelial cells in regulating the canonical Wnt signaling pathway at this day of CAM development. Consistent with this model, PA increased beta catenin levels acutely in CAM blood vessels in vivo and in TEM8 transfected primary human endothelial cells in vitro. TEM8 expression in Hek293 cells, which neither express endogenous PA-binding receptors nor Wnt ligands, stabilized beta catenin levels and amplified beta catenin-dependent transcriptional activity induced by Wnt3a. This agonistic function is supported by findings in the CAM, where the increase in TEM8 expression from day 10 to day 12 and PA application correlated with Axin 2 induction, a universal reporter gene for canonical Wnt signaling. We postulate that the developmentally controlled expression of TEM8 modulates endothelial cell response to canonical Wnt signaling to regulate vessel patterning and density.	[Verma, Kiran; Gu, Jingsheng; Werner, Erica] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Werner, Erica] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University; Emory University	Verma, K (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	ewerner@emory.edu		Werner, Erica/0000-0002-8183-1601	Center to Reduce Cancer Health Disparities at the National Cancer Institute/National Institutes of Health [1K22CA12736]	Center to Reduce Cancer Health Disparities at the National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant number 1K22CA12736 from the Center to Reduce Cancer Health Disparities at the National Cancer Institute/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bell SE, 2001, J CELL SCI, V114, P2755; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bromberg-White JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006956; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; CADUFF JH, 1986, ANAT RECORD, V216, P154, DOI 10.1002/ar.1092160207; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Cui XZ, 2007, J INFECT DIS, V195, P572, DOI 10.1086/510856; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Dimitropoulou C, 1998, Angiogenesis, V2, P255, DOI 10.1023/A:1009210918738; Djonov V, 2001, MICROSC RES TECHNIQ, V52, P182, DOI 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.3.CO;2-D; Djonov VG, 2000, ANAT EMBRYOL, V202, P347, DOI 10.1007/s004290000126; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Fernando S, 2009, CANCER RES, V69, P5126, DOI [10.1158/0008-5476.CAN-09-0725, 10.1158/0008-5472.CAN-09-0725]; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Gu JS, 2010, EXP CELL RES, V316, P1946, DOI 10.1016/j.yexcr.2010.03.026; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Kurz H, 2008, HISTOCHEM CELL BIOL, V130, P1027, DOI 10.1007/s00418-008-0478-8; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MAHER MT, PLOS ONE, V5, pE184; Nanda A, 2004, CURR OPIN ONCOL, V16, P44, DOI 10.1097/00001622-200401000-00009; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Patan S, 1996, MICROVASC RES, V51, P260, DOI 10.1006/mvre.1996.0025; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Ribatti D, 2005, ONCOL REP, V14, P81; Ribatti D, 2001, ANAT RECORD, V264, P317, DOI 10.1002/ar.10021; Rmali KA, 2005, BIOCHEM BIOPH RES CO, V334, P231, DOI 10.1016/j.bbrc.2005.06.085; Rogers MS, 2007, CANCER RES, V67, P9980, DOI 10.1158/0008-5472.CAN-07-0829; Ryan PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001817; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; St Croix B, 2000, SCIENCE, V289, P1197; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Werner E, 2006, J BIOL CHEM, V281, P23227, DOI 10.1074/jbc.M603676200; WILTING J, 1993, CELL TISSUE RES, V274, P163, DOI 10.1007/BF00327997; WILTING J, 1992, ANAT EMBRYOL, V186, P251; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Young JJ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030027; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	53	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22334	10.1371/journal.pone.0022334	http://dx.doi.org/10.1371/journal.pone.0022334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829615	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200007
J	Zhou, T; Medo, M; Cimini, G; Zhang, ZK; Zhang, YC				Zhou, Tao; Medo, Matus; Cimini, Giulio; Zhang, Zi-Ke; Zhang, Yi-Cheng			Emergence of Scale-Free Leadership Structure in Social Recommender Systems	PLOS ONE			English	Article							FREE NETWORKS; DILEMMA	The study of the organization of social networks is important for the understanding of opinion formation, rumor spreading, and the emergence of trends and fashion. This paper reports empirical analysis of networks extracted from four leading sites with social functionality (Delicious, Flickr, Twitter and YouTube) and shows that they all display a scale-free leadership structure. To reproduce this feature, we propose an adaptive network model driven by social recommending. Artificial agent-based simulations of this model highlight a "good get richer" mechanism where users with broad interests and good judgments are likely to become popular leaders for the others. Simulations also indicate that the studied social recommendation mechanism can gradually improve the user experience by adapting to tastes of its users. Finally we outline implications for real online resource-sharing systems.	[Zhou, Tao; Zhang, Zi-Ke; Zhang, Yi-Cheng] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Zhou, Tao; Medo, Matus; Cimini, Giulio; Zhang, Zi-Ke; Zhang, Yi-Cheng] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Zhou, Tao] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China	University of Electronic Science & Technology of China; University of Fribourg; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, T (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China.	zhutou@ustc.edu	Cimini, Giulio/HGC-2758-2022; Cimini, Giulio/I-7413-2019; Medo, Matus/J-6660-2019; Zhou, Tao/D-5849-2012; zhou, tao/GQA-3572-2022; Zhang, Zi-Ke/G-6896-2011	Cimini, Giulio/0000-0001-5698-8597; Medo, Matus/0000-0001-8865-9085; 	Swiss National Science Foundation [200020-132253]; National Natural Science Foundation of China [90924011]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Swiss National Science Foundation (200020-132253) and the National Natural Science Foundation of China (90924011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anghel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.058701; Baiesi M, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.047103; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Billsus D., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P550; Bonhard P, 2006, BT TECHNOL J, V24, P84, DOI 10.1007/s10550-006-0080-3; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Caldarelli G., 2007, SCALE FREE NETWORKS; CHEN HQ, 2008, P 17 INT C WWW ACM P; Cimini G, 2011, EUR PHYS J B, V80, P201, DOI 10.1140/epjb/e2010-10716-5; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; EGGHE L, 1995, J AM SOC INFORM SCI, V46, P426, DOI 10.1002/(SICI)1097-4571(199507)46:6<426::AID-ASI3>3.0.CO;2-B; Garlaschelli D, 2007, NAT PHYS, V3, P813, DOI 10.1038/nphys729; Golbeck J, 2008, SCIENCE, V321, P1640, DOI 10.1126/science.1163357; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Hammond T., 2005, D LIB MAGAZINE, V11; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; HUANG J, 2010, P 2010 C ECAI 2010 1, P601; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Kim BJ, 2005, EUR PHYS J B, V43, P369, DOI 10.1140/epjb/e2005-00065-y; KUMAR R, 2006, P 12 ACM SIGKDD; KWAK G, 2010, P 19 WWW, P591; Lee SH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026118; Lee SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011233; Lo TS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.050101; LU L, PLOS ONE IN PRESS; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; Medo M, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38005; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Mislove A, 2007, P 7 ACM SIGCOMM C IN; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Perc M, 2010, J INFORMETR, V4, P475, DOI 10.1016/j.joi.2010.04.003; Perc M, 2010, J INFORMETR, V4, P358, DOI 10.1016/j.joi.2010.03.001; Perotti JI, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108701; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; PRICE DJD, 1965, SCIENCE, V149, P510; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Ren J, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/58007; Savarimuthu BTR, 2008, LECT NOTES ARTIF INT, V4870, P203; Schafer J. B., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P291; Sinha R, 2001, P 2 DELOS NETW EXC W; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Takacs G., 2007, ACM SIGKDD EXPLOR NE, V9, P80, DOI DOI 10.1145/1345448.134546; Valverde S, 2002, EUROPHYS LETT, V60, P512, DOI 10.1209/epl/i2002-00248-2; Vespignani, 2003, HDB GRAPH NETWORKS; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; Wei D, 2011, PHYSICA A, V390, P2117, DOI 10.1016/j.physa.2011.02.005; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhang ZK, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10005; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2006, PROG NAT SCI-MATER, V16, P452; Ziegler CN, 2004, LECT NOTES COMPUT SC, V3291, P840	59	43	44	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2011	6	7							e20648	10.1371/journal.pone.0020648	http://dx.doi.org/10.1371/journal.pone.0020648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799JJ	21857891	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000293282700003
J	Ansari, MA; Zubair, S; Mahmood, A; Gupta, P; Khan, AA; Gupta, UD; Arora, A; Owais, M				Ansari, Mairaj Ahmed; Zubair, Swaleha; Mahmood, Anjum; Gupta, Pushpa; Khan, Aijaz A.; Gupta, Umesh D.; Arora, Ashish; Owais, Mohammad			RD Antigen Based Nanovaccine Imparts Long Term Protection by Inducing Memory Response against Experimental Murine Tuberculosis	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUG-RESISTANCE; VACCINES; SUBUNIT; ARCHAEOSOMES; DELIVERY; PROTEIN; BCG	Background: The absence of certain genomic loci that are present in most of the virulent strains of Mycobacterium tuberculosis as well as lack of lasting memory responses are some of the major causes attributed to the non effectiveness of Bacille Calmette-Gue'rin (BCG) vaccine. Immunization schedules addressing these issues can offer better strategy for protection against tuberculosis. Methods: The immunological responses evoked upon administration of archaeosome based antigen delivery system comprising T cell antigen, Rv3619c (an ESAT-6 family protein), has been assessed against experimental murine tuberculosis in BALB/c mice. Results: Archaeosome based subunit vaccine has been found to elicit type-1 cytokines in the immunized mice. Besides effective T cell memory response, the Rv3619c based vaccine was able to reduce mycobacterial burden in the animals challenged with Mycobacterium tuberculosis infection. Conclusion: The data of the present study suggest that archaeosome encapsulated RD gene products offer substantial protection against M. tuberculosis infection.	[Ansari, Mairaj Ahmed; Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Womens Coll, Aligarh, Uttar Pradesh, India; [Mahmood, Anjum; Arora, Ashish] CDRI, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India; [Gupta, Pushpa; Gupta, Umesh D.] Natl JALMA Inst Leprosy & OMD, Agra, Uttar Pradesh, India; [Khan, Aijaz A.] JNMC, Dept Anat, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Aligarh Muslim University	Ansari, MA (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	owais_lakhnawi@yahoo.com		Mohammad, Owais/0000-0001-7377-7388; ANSARI, MAIRAJ/0000-0003-0040-4147	 [3/1/JRF/14/MPD/2006 (33644)]		A grant was received in the form of a fellowship and contingency of Mr. Mairaj Ahmed Ansari, 3/1/JRF/14/MPD/2006 (33644). Their website is www.icmr.nic.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Choquet CG, 1996, CAN J MICROBIOL, V42, P183, DOI 10.1139/m96-027; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Doherty TM, 2005, CLIN MICROBIOL REV, V18, P687, DOI 10.1128/CMR.18.4.687-702.2005; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Gareth JJ, 2010, INFECT IMMUN, V78, P1326; Grover A, 2006, PROTEIN EXPRES PURIF, V48, P274, DOI 10.1016/j.pep.2006.03.010; GUPTA RK, 1995, VACCINE DESIGN SUBUN; KIRBY C, 1984, BIO-TECHNOL, V2, P979, DOI 10.1038/nbt1184-979; Krishnan L, 2000, J IMMUNOL, V165, P5177, DOI 10.4049/jimmunol.165.9.5177; Krishnan L, 2000, INFECT IMMUN, V68, P54, DOI 10.1128/IAI.68.1.54-63.2000; KUMAR A, 1983, NATURE, V303, P632, DOI 10.1038/303632a0; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Mahmood A, 2011, FEBS J, V278, P341, DOI 10.1111/j.1742-4658.2010.07958.x; Mallick AI, 2007, VACCINE, V25, P7873, DOI 10.1016/j.vaccine.2007.09.008; Mathai JC, 2001, J BIOL CHEM, V276, P27266, DOI 10.1074/jbc.M103265200; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; Petroff SA, 1928, AM J PUBLIC HEALTH N, V18, P843, DOI 10.2105/AJPH.18.7.843-b; Sable SB, 2005, EUR RESPIR J, V25, P902, DOI 10.1183/09031936.05.00105404; Sambrook J., 2001, MOL CLONING LAB MANU; Simmons CP, 1999, J IMMUNOL, V163, P6502; Sjolander A, 1998, J LEUKOCYTE BIOL, V64, P713; Sprott G. D., 1996, Cells and Materials, V6, P143; Sprott GD, 1997, FEMS MICROBIOL LETT, V154, P17, DOI 10.1016/S0378-1097(97)00294-2; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; WHO, 2009, GLOB TUB CONTR EP ST, P6; World Health Organization, 2010, WHOHTMTB20103; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	35	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22889	10.1371/journal.pone.0022889	http://dx.doi.org/10.1371/journal.pone.0022889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853054	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400017
J	Keller, G; Cour, M; Hernu, R; Illinger, J; Robert, D; Argaud, L				Keller, Geoffray; Cour, Martin; Hernu, Romain; Illinger, Julien; Robert, Dominique; Argaud, Laurent			Management of Metformin-Associated Lactic Acidosis by Continuous Renal Replacement Therapy	PLOS ONE			English	Article							ACUTE PHYSIOLOGY; HEMODIALYSIS; HEMOFILTRATION; ABSENCE; SCORE	Background: Metformin-associated lactic acidosis (MALA) is a severe metabolic failure with high related mortality. Although its use is controversial, intermittent hemodialysis is reported to be the most frequently used treatment in conjunction with nonspecific supportive measures. Our aim was to report the evolution and outcome of cases managed by continuous renal replacement therapy (CRRT). Methodology and Principal Findings: Over a 3-year period, we retrospectively identified patients admitted to the intensive care unit for severe lactic acidosis caused by metformin. We included patients in our study who were treated with CRRT because of shock. We describe their clinical and biological features at admission and during renal support, as well as their evolution. We enrolled six patients with severe lactic acidosis; the mean pH and mean lactate was 6.92 +/- 0.20 and 14.4 +/- 5.1 mmol/l, respectively. Patients had high illness severity scores, including the Simplified Acute Physiology Score II (SAPS II) (average score 63 +/- 12 points). Early CRRT comprised either venovenous hemofiltration (n = 3) or hemodiafiltration (n = 3) with a mean effluent flow rate of 34 +/- 6 ml/kg/h. Metabolic acidosis control and metformin elimination was rapid and there was no rebound. Outcome was favorable in all cases. Conclusions and Significance: Standard use of CRRT efficiently treated MALA in association with symptomatic organ supportive therapies.	[Keller, Geoffray; Cour, Martin; Hernu, Romain; Illinger, Julien; Robert, Dominique; Argaud, Laurent] Groupement Hosp Edouard Herriot, Hosp Civils Lyon, Serv Reanimat Med, Lyon, France; [Keller, Geoffray; Cour, Martin; Robert, Dominique; Argaud, Laurent] Univ Lyon 1, Fac Med Lyon Est, F-69365 Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Keller, G (corresponding author), Groupement Hosp Edouard Herriot, Hosp Civils Lyon, Serv Reanimat Med, Lyon, France.	laurent.argaud@chu-lyon.fr	Cour, M/T-2525-2019	cour, martin/0000-0003-4909-9761				Arroyo AM, 2010, AM J THER, V17, P96, DOI 10.1097/MJT.0b013e318197eab6; Bruijstens LA, 2008, NETH J MED, V66, P185; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; FAGON JY, 1993, INTENS CARE MED, V19, P137, DOI 10.1007/BF01720528; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; Galea M, 2007, BRIT J ANAESTH, V98, P213, DOI 10.1093/bja/ael347; Guo PYF, 2006, SEMIN DIALYSIS, V19, P80, DOI 10.1111/j.1525-139X.2006.00123.x; JACKSON GG, 1962, ARCH INTERN MED, V110, P663, DOI 10.1001/archinte.1962.03620230109016; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kruse JA, 2001, J EMERG MED, V20, P267, DOI 10.1016/S0736-4679(00)00320-6; Lalau JD, 1999, DRUG SAFETY, V20, P377, DOI 10.2165/00002018-199920040-00006; Lalau JD, 2003, DIABETES OBES METAB, V5, P93, DOI 10.1046/j.1463-1326.2003.00241.x; LALAU JD, 1987, INTENS CARE MED, V13, P383; Lalau JD, 2000, DIABETES OBES METAB, V2, P131, DOI 10.1046/j.1463-1326.2000.00053.x; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leverve XM, 2005, CRIT CARE, V9, P622, DOI 10.1186/cc3935; Levraut J, 1997, CRIT CARE MED, V25, P58, DOI 10.1097/00003246-199701000-00013; Misbin RI, 1998, NEW ENGL J MED, V338, P265, DOI 10.1056/NEJM199801223380415; Pan LTT, 2009, ANAESTH INTENS CARE, V37, P830, DOI 10.1177/0310057X0903700520; Panzer U, 2004, NEPHROL DIAL TRANSPL, V19, P2157, DOI 10.1093/ndt/gfh337; Peters N, 2008, CRIT CARE, V12, DOI 10.1186/cc7137; Ronco C, 2008, INTENS CARE MED, V34, P2139, DOI 10.1007/s00134-008-1258-6; Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105; Seidowsky A, 2009, CRIT CARE MED, V37, P2191, DOI 10.1097/CCM.0b013e3181a02490; Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Uchino S, 2009, CRIT CARE MED, V37, P2576, DOI 10.1097/CCM.0b013e3181a38241; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	30	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23200	10.1371/journal.pone.0023200	http://dx.doi.org/10.1371/journal.pone.0023200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853087	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400031
J	van den Berg, M; Smit, F; Vos, T; van Baal, PHM				van den Berg, Matthijs; Smit, Filip; Vos, Theo; van Baal, Pieter H. M.			Cost-Effectiveness of Opportunistic Screening and Minimal Contact Psychotherapy to Prevent Depression in Primary Care Patients	PLOS ONE			English	Article							SUBTHRESHOLD DEPRESSION; DISORDERS; THERAPY; BURDEN	Background: Depression causes a large burden of disease worldwide. Effective prevention has the potential to reduce that burden considerably. This study aimed to investigate the cost-effectiveness of minimal contact psychotherapy, based on Lewinsohn's 'Coping with depression' course, targeted at opportunistically screened individuals with sub-threshold depression. Methods and Results: Using a Markov model, future health effects and costs of an intervention scenario and a current practice scenario were estimated. The time horizon was five years. Incremental cost-effectiveness ratios were expressed in euro per Disability Adjusted Life Year (DALY) averted. Probabilistic sensitivity analysis was employed to study the effect of uncertainty in the model parameters. From the health care perspective the incremental cost-effectiveness ratio was (sic) 1,400 per DALY, and from the societal perspective the intervention was cost-saving. Although the estimated incremental costs and effects were surrounded with large uncertainty, given a willingness to pay of (sic) 20,000 per DALY, the probability that the intervention is cost-effective was around 80%. Conclusion: This modelling study showed that opportunistic screening in primary care for sub-threshold depression in combination with minimal contact psychotherapy may be cost-effective in the prevention of major depression.	[van den Berg, Matthijs] Natl Inst Publ Hlth & Environm, Ctr Publ Hlth Forecasting, NL-3720 BA Bilthoven, Netherlands; [Smit, Filip] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Ctr Prevent & Early Intervent, Utrecht, Netherlands; [Smit, Filip] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Vos, Theo] Univ Queensland, Sch Populat Hlth, Ctr Burden Dis & Cost Effectiveness, Herston, Qld, Australia; [van Baal, Pieter H. M.] Erasmus Univ, Inst Med Technol Assessment, Inst Hlth Policy & Management, Rotterdam, Netherlands; [van Baal, Pieter H. M.] Natl Inst Publ Hlth & Environm, Expertise Ctr Methodol & Informat Serv, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Trimbos Institute; Vrije Universiteit Amsterdam; University of Queensland; Erasmus University Rotterdam; Netherlands National Institute for Public Health & the Environment	van den Berg, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Publ Hlth Forecasting, NL-3720 BA Bilthoven, Netherlands.	matthijs.van.den.berg@rivm.nl		van Baal, Pieter/0000-0001-9913-2393	Ministry of Health, Welfare and Sport of The Netherlands	Ministry of Health, Welfare and Sport of The Netherlands	This study was financially supported by the Ministry of Health, Welfare and Sport of The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Boshuizen HC, 2009, VALUE HEALTH, V12, P1210, DOI 10.1111/j.1524-4733.2009.00590.x; Bosmans JE, 2007, INT J TECHNOL ASSESS, V23, P480, DOI 10.1017/S0266462307070572; Buist-Bouwman MA, 2004, J AFFECT DISORDERS, V82, P363, DOI 10.1016/j.jad.2004.02.007; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P434, DOI 10.1111/j.1600-0447.2007.00998.x; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P229, DOI 10.1111/j.1600-0447.2006.00851.x; Cuijpers P, 2004, ACTA PSYCHIAT SCAND, V109, P325, DOI 10.1111/j.1600-0447.2004.00301.x; Cuijpers P, 2008, Tijdschr Psychiatr, V50, P519; Cuijpers P., 2006, GEZOND VERSTAND EVID; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Cuijpers P, 2009, CLIN PSYCHOL REV, V29, P449, DOI 10.1016/j.cpr.2009.04.005; *CVZ, 2005, RICHTL FARM EC OND E; de Hollander AEM, 2007, CARE HLTH 2006 DUTCH; Hakkaart-van Roijen L, 2006, BRIT J PSYCHIAT, V188, P323, DOI 10.1192/bjp.188.4.323; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Kruijshaar ME, 2005, B WORLD HEALTH ORGAN, V83, P443; Lynch FL, 2005, ARCH GEN PSYCHIAT, V62, P1241, DOI 10.1001/archpsyc.62.11.1241; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Poos MJJC, 2008, COST ILLNESS NETHERL; Smit F, 2006, BRIT J PSYCHIAT, V188, P330, DOI 10.1192/bjp.188.4.330; Smit F, 2006, J MENT HEALTH POLICY, V9, P193; Stant AD, 2008, ACTA PSYCHIAT SCAND, V117, P57, DOI 10.1111/j.1600-0447.2007.01122.x; Stinnett AA, 1997, MED DECIS MAKING, V17, P483, DOI 10.1177/0272989X9701700414; van den Berg M, 2008, Ned Tijdschr Geneeskd, V152, P1329; van der Werf SY, 2006, ARCH GEN PSYCHIAT, V63, P509, DOI 10.1001/archpsyc.63.5.509; Vos T, 2005, AUST NZ J PSYCHIAT, V39, P683, DOI 10.1080/j.1440-1614.2005.01652.x; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097; Willemse GRWM, 2004, BRIT J PSYCHIAT, V185, P416, DOI 10.1192/bjp.185.5.416; World Health Organization, 2008, GLOB BURD DIS 2004 U	29	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22884	10.1371/journal.pone.0022884	http://dx.doi.org/10.1371/journal.pone.0022884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	827UM	21853053	Green Published, gold, Green Submitted			2022-12-27	WOS:000295454200024
J	Watanabe, S				Watanabe, Shigeru			Empathy and Reversed Empathy of Stress in Mice	PLOS ONE			English	Article							CORTICOSTERONE; PAIN; MEMORY	Empathy is an emotional response to display of distress in others and reversed-empathy is an emotional response to non-distressed others in distressed subjects. Stress has memory enhancing effect on aversive experience. Here, I examine empathy and reversed empathy using the memory enhancing effects of stress in mice. Restrain stress enhanced aversive memory of a floor with electric shock, but restrain stress, with cage mates also restrained, reduced the enhancing effect. On the other hand, restrain stress with free-moving cage mates increased the memory enhancing effect, suggesting the stronger stress. This is the reversed-empathy. Level of corticosterone is the highest after the restrain with free-moving mates and lowest after the restrain with restrained mates.	Keio Univ, Dept Psychol, Tokyo, Japan	Keio University	Watanabe, S (corresponding author), Keio Univ, Dept Psychol, Tokyo, Japan.	swat@flet.keio.ac.jp			Japanese Government (JSPS)	Japanese Government (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Global COE Program (D-1) of Japanese Government (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Cabib S, 1996, BRAIN RES, V729, P110, DOI 10.1016/0006-8993(96)00418-0; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Darwin C., 1871, P423; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Hashimoto T, 2005, NEUROREPORT, V16, P1129, DOI 10.1097/00001756-200507130-00019; Kavaliers M, 2003, HORM BEHAV, V43, P99, DOI 10.1016/S0018-506X(02)00021-1; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Miracle AD, 2006, NEUROBIOL LEARN MEM, V85, P213, DOI 10.1016/j.nlm.2005.10.005; NABORS CJ, 1974, STEROIDS, V23, P363, DOI 10.1016/0039-128X(74)90088-9; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; WATANABE S, 1986, BEHAV PROCESS, V13, P269, DOI 10.1016/0376-6357(86)90089-6; Watanabe S, 2011, BEHAV PHARMACOL, V22, P203, DOI 10.1097/FBP.0b013e328345c815	15	24	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23357	10.1371/journal.pone.0023357	http://dx.doi.org/10.1371/journal.pone.0023357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853115	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200072
J	Combosch, DJ; Vollmer, SV				Combosch, David J.; Vollmer, Steven V.			Population Genetics of an Ecosystem-Defining Reef Coral Pocillopora damicornis in the Tropical Eastern Pacific	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SPATIAL AUTOCORRELATION ANALYSIS; LARVAL DISPERSAL; GENOTYPIC DIVERSITY; BROODING CORAL; EL-NINO; PLANT-POPULATIONS; PERIPHERAL-POPULATIONS; BALANOPHYLLIA-ELEGANS; CONSERVATION GENETICS	Background: Coral reefs in the Tropical Eastern Pacific (TEP) are amongst the most peripheral and geographically isolated in the world. This isolation has shaped the biology of TEP organisms and lead to the formation of numerous endemic species. For example, the coral Pocillopora damicornis is a minor reef-builder elsewhere in the Indo-West Pacific, but is the dominant reef-building coral in the TEP, where it forms large, mono-specific stands, covering many hectares of reef. Moreover, TEP P. damicornis reproduces by broadcast spawning, while it broods mostly parthenogenetic larvae throughout the rest of the Indo-West Pacific. Population genetic surveys for P. damicornis from across its Indo-Pacific range indicate that gene flow (i.e. larval dispersal) is generally limited over hundreds of kilometers or less. Little is known about the population genetic structure and the dispersal potential of P. damicornis in the TEP. Methodology: Using multilocus microsatellite data, we analyzed the population structure of TEP P. damicornis among and within nine reefs and test for significant genetic structure across three geographically and ecologically distinct regions in Panama. Principal Findings/Conclusions: We detected significant levels of population genetic structure (global R-ST = 0.162), indicating restricted gene flow (i.e. larvae dispersal), both among the three regions (R-RT = 0.081) as well as within regions (R-SR = 0.089). Limited gene flow across a distinct environmental cline, like the regional upwelling gradient in Panama, indicates a significant potential for differential adaptation and population differentiation. Individual reefs were characterized by unexpectedly high genet diversity (avg. 94%), relatively high inbreeding coefficients (global F-IS = 0.183), and localized spatial genetic structure among individuals (i.e. unique genets) over 10 m intervals. These findings suggest that gene flow is limited in TEP P. damicornis populations, particularly among regions, but even over meter scales within populations.	[Combosch, David J.; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University	Combosch, DJ (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	combosch.d@neu.edu		Combosch, David/0000-0001-7004-7435	German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Funding was provided to DJC by the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 1999, MAR BIOL, V134, P753, DOI 10.1007/s002270050592; [Anonymous], P 3 INT COR REEF S M; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Ayre DJ, 1997, MAR ECOL PROG SER, V159, P175, DOI 10.3354/meps159175; Ayre DJ, 2000, EVOLUTION, V54, P1590; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Beatty GE, 2008, DIVERS DISTRIB, V14, P546, DOI 10.1111/j.1472-4642.2008.00469.x; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; BEST BA, 1987, AM ZOOL, V127, pA103; Blanquer A, 2009, MAR ECOL PROG SER, V380, P95, DOI 10.3354/meps07931; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Calderon I, 2007, MOL ECOL, V16, P1799, DOI 10.1111/j.1365-294X.2007.03276.x; Carlon DB, 1999, TRENDS ECOL EVOL, V14, P491, DOI 10.1016/S0169-5347(99)01709-7; CARLON DB, 1993, J EXP MAR BIOL ECOL, V173, P247, DOI 10.1016/0022-0981(93)90056-T; CARPIZOITUARTE E, 2010, CIENC MAR, V37, P97; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Colborn J, 2001, EVOLUTION, V55, P807, DOI 10.1554/0014-3820(2001)055[0807:TEEOBA]2.0.CO;2; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Darwin C, 1859, ORIGINS SPECIES MEAN; David GK, 2010, MAR BIOL, V157, P1955, DOI 10.1007/s00227-010-1464-y; Duda TF, 2009, CORAL REEFS, V28, P651, DOI 10.1007/s00338-009-0485-9; Eakin CM, 1996, CORAL REEFS, V15, P120; ECKERT CG, 1993, AM J BOT, V80, P1175, DOI 10.2307/2445546; Ekman S., 1935, TIERGEOGRAPHIE MEERE; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; GERRODETTE T, 1981, ECOLOGY, V62, P611, DOI 10.2307/1937728; Gilmour JP, 2002, MAR ECOL PROG SER, V235, P81, DOI 10.3354/meps235081; GLYNN P, 1985, MARINE ECOLOGY PROGR, V26, P4; GLYNN P, 1977, P 3 INT COR REEF S, P251; GLYNN P, 2001, CORAL BLEACHING MARI, P36; GLYNN P, 1997, FIELD GUIDE PACIFIC, P145; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; Glynn P.W., 1988, P 6 INT COR REEF S, V1, P51; Glynn P. W., 1983, CORALS CORAL REEFS G; GLYNN PW, 1991, MAR BIOL, V109, P355, DOI 10.1007/BF01313501; Glynn PW, 1996, CORAL REEFS, V15, P71; GLYNN PW, 1992, AM ZOOL, V32, P707; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1976, ECOL MONOGR, V46, P431, DOI 10.2307/1942565; GLYNN PW, 1973, SCIENCE, V180, P504, DOI 10.1126/science.180.4085.504; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; GLYNN PW, 1977, J MAR RES, V35, P567; Glynn PW, 1997, REV BIOL TROP, V45, P1033; GLYNN PW, 1973, LIMNOL OCEANOGR, V18, P367, DOI 10.4319/lo.1973.18.3.0367; GLYNN PW, 1972, INT J EARTH SCI, V61, P483; GUO SW, 1992, AM J HUM GENET, V51, P1111; GUZMAN HM, 1993, REV BIOL TROP, V41, P535; GUZMAN HM, 1990, MAR ECOL PROG SER, V60, P299, DOI 10.3354/meps060299; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; HELLBERG ME, 1995, MAR BIOL, V123, P573, DOI 10.1007/BF00349236; Herlihy CR, 2002, NATURE, V416, P320, DOI 10.1038/416320a; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; HEYWOOD JS, 1991, ANNU REV ECOL SYST, V22, P335, DOI 10.1146/annurev.es.22.110191.002003; HIGHSMITH RC, 1980, J EXP MAR BIOL ECOL, V46, P177, DOI 10.1016/0022-0981(80)90030-1; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kinzie Robert A. Iii, 1993, Galaxea, V11, P93; Krupp D.A., 1983, Coral Reefs, V2, P159, DOI 10.1007/BF00336722; LaJeunesse TC, 2007, CORAL REEFS, V26, P265, DOI 10.1007/s00338-006-0189-3; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lessios HA, 2006, P ROY SOC B-BIOL SCI, V273, P2201, DOI 10.1098/rspb.2006.3543; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1999, EVOLUTION, V53, P806, DOI 10.1111/j.1558-5646.1999.tb05374.x; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Magalon H, 2004, MOL ECOL NOTES, V4, P206, DOI 10.1111/j.1471-8286.2004.00618.x; MAYR E, 1954, EVOLUTION PROCESS, P1; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; McFadden CS, 1996, MAR BIOL, V126, P215, DOI 10.1007/BF00347446; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Miller KJ, 1998, MAR ECOL PROG SER, V163, P225, DOI 10.3354/meps163225; NEIGEL J, 1983, EVOLUTION, P437; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Nishikawa A, 2008, PAC SCI, V62, P413, DOI 10.2984/1534-6188(2008)62[413:DAPOGF]2.0.CO;2; Noreen AME, 2009, P ROY SOC B-BIOL SCI, V276, P3927, DOI 10.1098/rspb.2009.1050; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; ORLOCI L, 1978, MULTIVARIANTE ANAL V, P135; Palumbi Stephen R., 1995, P369; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pemberton AJ, 2007, MAR BIOL, V153, P71, DOI 10.1007/s00227-007-0785-y; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RICHMOND RH, 1987, B MAR SCI, V41, P594; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Richmond RH, 1985, P 5 INT COR REEF S, V6, P101; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ruzzante DE, 1996, CAN J FISH AQUAT SCI, V53, P2695, DOI 10.1139/cjfas-53-12-2695; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sherman CDH, 2006, CORAL REEFS, V25, P7, DOI 10.1007/s00338-005-0053-x; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SOKAL RR, 1983, GENETICS, V105, P219; Soule M., 1973, Annual Rev Ecol Syst, V4, P165, DOI 10.1146/annurev.es.04.110173.001121; Souter Petra, 2009, BMC Ecology, V9, P19, DOI 10.1186/1472-6785-9-19; STARGER C, 2010, CORAL REEFS, P1; STARGER CJ, 2007, MOL ECOLOGY NOTES; Stoddart J.A., 1988, P111; STODDART JA, 1984, CORAL REEFS, V3, P149, DOI 10.1007/BF00301959; STODDART JA, 1983, MAR BIOL, V76, P279, DOI 10.1007/BF00393029; STODDART JA, 1988, AUST J MAR FRESH RES, V39, P109; TEMPLETON AR, 1980, GENETICS, V94, P1011; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; van Woesik R., 2009, P R SOC B, V277, P715, DOI DOI 10.1098/RSPB.2009.1524; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; WILLIS BL, 1990, OPHELIA, V32, P145, DOI 10.1080/00785236.1990.10422029; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yeoh SR, 2010, MAR BIOL, V157, P351, DOI 10.1007/s00227-009-1322-y; Yund PO, 2000, MAR BIOL, V137, P583, DOI 10.1007/s002270000378; Zhao R, 2009, AM J BOT, V96, P1138, DOI 10.3732/ajb.0800173	148	52	52	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e21200	10.1371/journal.pone.0021200	http://dx.doi.org/10.1371/journal.pone.0021200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857900	Green Published, Green Submitted, gold			2022-12-27	WOS:000293774300002
J	Sunday, JM; Crim, RN; Harley, CDG; Hart, MW				Sunday, Jennifer M.; Crim, Ryan N.; Harley, Christopher D. G.; Hart, Michael W.			Quantifying Rates of Evolutionary Adaptation in Response to Ocean Acidification	PLOS ONE			English	Article							LARVAL; SIZE; LIFE; CO2; GROWTH; SURVIVAL; IMPACTS; MUSSELS; CARBON	The global acidification of the earth's oceans is predicted to impact biodiversity via physiological effects impacting growth, survival, reproduction, and immunology, leading to changes in species abundances and global distributions. However, the degree to which these changes will play out critically depends on the evolutionary rate at which populations will respond to natural selection imposed by ocean acidification, which remains largely unquantified. Here we measure the potential for an evolutionary response to ocean acidification in larval development rate in two coastal invertebrates using a full-factorial breeding design. We show that the sea urchin species Strongylocentrotus franciscanus has vastly greater levels of phenotypic and genetic variation for larval size in future CO2 conditions compared to the mussel species Mytilus trossulus. Using these measures we demonstrate that S. franciscanus may have faster evolutionary responses within 50 years of the onset of predicted year-2100 CO2 conditions despite having lower population turnover rates. Our comparisons suggest that information on genetic variation, phenotypic variation, and key demographic parameters, may lend valuable insight into relative evolutionary potentials across a large number of species.	[Sunday, Jennifer M.; Hart, Michael W.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Crim, Ryan N.; Harley, Christopher D. G.] Simon Fraser Univ, Dept Zool, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Sunday, JM (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	sunday@sfu.ca	Harley, Christopher D. G./K-5593-2012; Sunday, Jennifer/ABE-7396-2020	Harley, Christopher D. G./0000-0003-4099-943X; 	Natural Sciences and Engineering Research Council of Canada [357084-07, 328205-10]; Canada Foundation for Innovation [CFI 12723]; Bamfield Marines Sciences Center; Pacific Northwest Shell Club	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Bamfield Marines Sciences Center; Pacific Northwest Shell Club	This work was financially supported by grants from the Natural Sciences and Engineering Research Council of Canada (357084-07 and 328205-10), the Canada Foundation for Innovation (CFI 12723), the Bamfield Marines Sciences Center (http://www.bms.bc.ca/), and the Pacific Northwest Shell Club (http://www.bily.com/pnwsc/web-content/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, BIOGEOSCI DISCUSS, DOI DOI 10.5194/BGD-6-3109-2009; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bergfeld Cord, 1999, Senckenbergiana Maritima, V29, P23; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; BOWDER LW, 1991, DEV BIOL; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; CLARKE A, 1991, AM ZOOL, V31, P81; Collins S, 2006, ECOL LETT, V9, P129, DOI 10.1111/j.1461-0248.2005.00854.x; COMSTOCK RE, 1948, BIOMETRICS, V4, P254, DOI 10.2307/3001412; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Falconer D. S., 1989, Introduction to quantitative genetics.; Featherstone M., 2008, FAO Fisheries Technical Paper, P383; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Findlay HS, 2010, ECOLOGY, V91, P2931, DOI 10.1890/09-1987.1; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gilmour A., 2006, ASREML USER GUIDE RE; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; HALE R, 2011, OIKOS IN PRESS; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hare JA, 1997, ECOLOGY, V78, P2415; HETTINGER A, 2010, EOS T AGU, V91; Borthagaray AI, 2007, ACTA OECOL, V31, P243, DOI 10.1016/j.actao.2006.10.008; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Lynch Michael, 1998; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; MCEDWARD LR, 1986, J EXP MAR BIOL ECOL, V96, P251, DOI 10.1016/0022-0981(86)90206-6; Meekan MG, 1996, MAR ECOL PROG SER, V137, P25, DOI 10.3354/meps137025; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Nakicenovic N., 2000, SPECIAL REPORT EMISS; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Orr JC, 2009, 2 S OC HIGH CO2 WORL; Parker LM, 2011, MAR BIOL, V158, P689, DOI 10.1007/s00227-010-1592-4; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; PISTEVOS JCA, 2011, OIKOS IN PRESS; PORTNER HO, 2010, STUDIES METABOLIC CH; Potvin C, 1996, OECOLOGIA, V108, P683, DOI 10.1007/BF00329043; Przeslawski R, 2009, J SHELLFISH RES, V28, P505, DOI 10.2983/035.028.0312; R Core Team, 2020, R LANG ENV STAT COMP; Rasband W.S., 1997, IMAGE J; Roff D.A., 1997, EVOLUTIONARY QUANTIT; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Shima JS, 2002, MAR ECOL PROG SER, V235, P303, DOI 10.3354/meps235303; SLOAN NA, 1987, FISH RES, V5, P55, DOI 10.1016/0165-7836(87)90015-4; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Strathmann MF, 1987, REPROD DEV MARINE IN; SUCHANEK TH, 1981, OECOLOGIA, V50, P143, DOI 10.1007/BF00348028; Ward JK, 1999, TREE PHYSIOL, V19, P211; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	58	203	208	2	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2011	6	8							e22881	10.1371/journal.pone.0022881	http://dx.doi.org/10.1371/journal.pone.0022881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AW	21857962	gold, Green Published, Green Submitted			2022-12-27	WOS:000293774300009
J	Kohman, RA; Rodriguez-Zas, SL; Southey, BR; Kelley, KW; Dantzer, R; Rhodes, JS				Kohman, Rachel A.; Rodriguez-Zas, Sandra L.; Southey, Bruce R.; Kelley, Keith W.; Dantzer, Robert; Rhodes, Justin S.			Voluntary Wheel Running Reverses Age-Induced Changes in Hippocampal Gene Expression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SPATIAL MEMORY; CALORIC RESTRICTION; PHYSICAL-ACTIVITY; EXERCISE; NEUROGENESIS; MICE; PROFILE; COMPLEMENT; PLASTICITY	Normal aging alters expression of numerous genes within the brain. Some of these transcription changes likely contribute to age-associated cognitive decline, reduced neural plasticity, and the higher incidence of neuropathology. Identifying factors that modulate brain aging is crucial for improving quality of life. One promising intervention to counteract negative effects of aging is aerobic exercise. Aged subjects that exercise show enhanced cognitive performance and increased hippocampal neurogenesis and synaptic plasticity. Currently, the mechanisms behind the anti-aging effects of exercise are not understood. The present study conducted a microarray on whole hippocampal samples from adult (3.5-month-old) and aged (18-month-old) male BALB/c mice that were individually housed with or without running wheels for 8 weeks. Results showed that aging altered genes related to chromatin remodeling, cell growth, immune activity, and synapse organization compared to adult mice. Exercise was found to modulate many of the genes altered by aging, but in the opposite direction. For example, wheel running increased expression of genes related to cell growth and attenuated expression of genes involved in immune function and chromatin remodeling. Collectively, findings show that even late-onset exercise may attenuate age-related changes in gene expression and identifies possible pathways through which exercise may exert its beneficial effects.	[Kohman, Rachel A.; Rhodes, Justin S.] Univ Illinois, Beckman Inst, Dept Psychol, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.; Southey, Bruce R.; Kelley, Keith W.; Dantzer, Robert] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Kelley, Keith W.; Dantzer, Robert] Univ Illinois, Integrated Immunol & Behav Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kohman, RA (corresponding author), Univ Illinois, Beckman Inst, Dept Psychol, Urbana, IL 61801 USA.	rakohman@illinois.edu		Southey, Bruce/0000-0002-8959-7709; Kohman, Rachel/0000-0002-9737-3668; Kelley, Keith W./0000-0002-6837-8793; Dantzer, Robert/0000-0001-9399-6107	National Institutes of Health [MH083807, DA027487]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027548, P30DA018310, R01DA027487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health, MH083807 and DA027487, to JSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2008, EXP NEUROL, V211, P141, DOI 10.1016/j.expneurol.2008.01.016; Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; BRANDEIS R, 1990, PHARMACOL BIOCHEM BE, V36, P89, DOI 10.1016/0091-3057(90)90131-Z; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Christie BR, 2008, NEUROMOL MED, V10, P47, DOI 10.1007/s12017-008-8033-2; Chung YH, 2004, BRAIN RES, V1021, P132, DOI 10.1016/j.brainres.2004.06.043; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; DCOSTA AP, 1993, ANN NY ACAD SCI, V692, P253; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; FESER J, 2011, FEBS LETT; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fontan-Lozano A, 2008, MOL NEUROBIOL, V38, P167, DOI 10.1007/s12035-008-8040-1; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Griffin EW, 2009, HIPPOCAMPUS, V19, P973, DOI 10.1002/hipo.20631; Haga S, 1996, NEUROSCI LETT, V216, P191, DOI 10.1016/S0304-3940(96)13040-8; HANES J, 1994, J MOL BIOL, V244, P665, DOI 10.1006/jmbi.1994.1763; Hu P, 2002, MOL CELL BIOL, V22, P8044, DOI 10.1128/MCB.22.22.8044-8055.2002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indra AK, 2005, DEV BIOL, V285, P28, DOI 10.1016/j.ydbio.2005.05.043; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Kelley KW, 2007, BRAIN BEHAV IMMUN, V21, P384, DOI 10.1016/j.bbi.2006.11.010; Kelley KW, 2004, BRAIN BEHAV IMMUN, V18, P95, DOI 10.1016/j.bbi.2003.10.003; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; Koteja P, 1999, ANIM BEHAV, V58, P1307, DOI 10.1006/anbe.1999.1270; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Liang KY, 2010, ANN NEUROL, V68, P311, DOI 10.1002/ana.22096; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Llorens-Martin M, 2008, NEUROMOL MED, V10, P99, DOI 10.1007/s12017-008-8026-1; Malykhin NV, 2008, NEUROREPORT, V19, P543, DOI 10.1097/WNR.0b013e3282f8b18c; Martin DM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001010; Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x; Min W, 2010, CARCINOGENESIS, V31, P2058, DOI 10.1093/carcin/bgq205; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Moyer JR, 2006, BEHAV NEUROSCI, V120, P612, DOI 10.1037/0735-7044.120.3.612; Murray CA, 1998, J BIOL CHEM, V273, P12161, DOI 10.1074/jbc.273.20.12161; Nakajima S, 2010, BEHAV BRAIN RES, V211, P178, DOI 10.1016/j.bbr.2010.03.028; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Rhodes JS, 2000, J THERM BIOL, V25, P391, DOI 10.1016/S0306-4565(99)00112-6; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Stranahan AM, 2008, NEUROMOL MED, V10, P118, DOI 10.1007/s12017-008-8027-0; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Terao A, 2002, J NEUROIMMUNOL, V132, P99, DOI 10.1016/S0165-5728(02)00317-X; Terry AV, 2011, PHYSIOL BEHAV, V102, P149, DOI 10.1016/j.physbeh.2010.11.005; Tong LQ, 2001, NEUROBIOL DIS, V8, P1046, DOI 10.1006/nbdi.2001.0427; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Verbitsky M, 2004, LEARN MEMORY, V11, P253, DOI 10.1101/lm.68204; von Bohlen und Halbach O, 2006, J NEUROSCI RES, V83, P525, DOI 10.1002/jnr.20759; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Woods JA, 2009, IMMUNOL ALLERGY CLIN, V29, P381, DOI 10.1016/j.iac.2009.02.011; Xu Q, 2010, NEUROLOGY, V75, P341, DOI 10.1212/WNL.0b013e3181ea1597; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zentner GE, 2010, HUM MOL GENET, V19, P3491, DOI 10.1093/hmg/ddq265	71	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e22654	10.1371/journal.pone.0022654	http://dx.doi.org/10.1371/journal.pone.0022654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806AM	21857943	Green Published, gold			2022-12-27	WOS:000293773300007
J	Morishita, Y; Watanabe, M; Nakazawa, E; Ishibashi, K; Kusano, E				Morishita, Yoshiyuki; Watanabe, Minami; Nakazawa, Eiko; Ishibashi, Kenichi; Kusano, Eiji			The Interaction of LFA-1 on Mononuclear Cells and ICAM-1 on Tubular Epithelial Cells Accelerates TGF-beta 1-Induced Renal Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; UP-REGULATION; T-CELLS; TUBULOINTERSTITIAL NEPHRITIS; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; INTEGRIN AVIDITY; GENE-EXPRESSION; DENDRITIC CELLS; CC CHEMOKINES	The epithelial-mesenchymal transition (EMT) of renal epithelial cells (RTECs) has pivotal roles in the development of renal fibrosis. Although the interaction of lymphocyte function-associated antigen 1 (LFA-1) on leukocytes and its ligand, intracellular adhesion molecule 1 (ICAM-1), plays essential roles in most inflammatory reactions, its pathogenetic role in the EMT of RTECs remains to be clarified. In the present study, we investigated the effect of the interaction of LFA-1 on peripheral blood mononuclear cells (PBMCs) and ICAM-1 on HK-2 cells after stimulation with TGF-beta(1) on the EMT of RTECs. ICAM-1 was highly expressed in HK-2 cells. After TGF-beta(1) stimulation, the chemokines CCL3 and CXCL12 increased on HK-2 cells. After co-culture of PBMCs and HK-2 cells pre-stimulated with TGF-beta(1) (0.1 ng/ml) (HK-2-TGF-beta(1) (0.1)), the expression of the active form of LFA-1 increased on PBMCs; however, total LFA-1 expression did not change. The expression of the active form of LFA-1 on PBMCs did not increase after co-culture with not CCL3 but CXCL12 knockdown HK-2-TGF-beta(1) (0.1). The expression of epithelial cell junction markers (E-cadherin and occludin) further decreased and that of mesenchymal markers (vimentin and fibronectin) further increased in HK-2-TGF-beta(1) (0.1) after co-culture with PBMCs for 24 hrs (HK-2-TGF-beta(1) (0.1)PBMCs). The phosphorylation of ERK 1/2 but not smad2 and smad3 increased in HK-2-TGF-beta(1) (0.1)-PBMCs. The snail and slug signaling did not increase HK-2-TGF-beta(1) (0.1)-PBMCs. Although the migration and invasion of HK-2 cells induced full EMT by a high dose (10.0 ng/ml) and long-term (72-96 hrs) TGF-beta(1) stimulation increased, that of HK-2-TGF-beta(1) (0.1)-PBMCs did not increase. These results suggested that HK-2 cells stimulated with TGF-beta(1) induced conformational activation of LFA-1 on PBMCs by increased CXCL12. Then, the direct interaction of LFA-1 on PBMCs and ICAM-1 on HK-2 cells activated ERK1/2 signaling to accelerate the part of EMT of HK-2 cells induced by TGF-beta(1).	[Morishita, Yoshiyuki; Watanabe, Minami; Nakazawa, Eiko; Kusano, Eiji] Jichi Med Univ, Dept Med, Div Nephrol, Shimotsuke, Tochigi, Japan; [Ishibashi, Kenichi] Meiji Pharmaceut Univ, Dept Med Physiol, Tokyo, Japan	Jichi Medical University; Meiji Pharmaceutical University	Morishita, Y (corresponding author), Jichi Med Univ, Dept Med, Div Nephrol, Shimotsuke, Tochigi, Japan.	ymori@jichi.ac.jp			Kidney Foundation, Japan [JFL 11-3]; Jichi Medical University	Kidney Foundation, Japan(Kidney Foundation, Japan); Jichi Medical University	This work was in part supported by grants from The Kidney Foundation, Japan (JFL 11-3), and Jichi Medical University Young Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma H, 1997, TRANSPLANTATION, V64, P190, DOI 10.1097/00007890-199707270-00002; BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; BUYON JP, 1988, J IMMUNOL, V140, P3156; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chan JR, 2001, J EXP MED, V193, P1149, DOI 10.1084/jem.193.10.1149; CHIRATHAWORN C, 1995, J IMMUNOL, V155, P5479; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Dwinell MB, 2004, AM J PHYSIOL-GASTR L, V286, pG844, DOI 10.1152/ajpgi.00112.2003; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Gardiner EE, 1999, J BIOL CHEM, V274, P11930, DOI 10.1074/jbc.274.17.11930; Gerritsma JSJ, 1998, KIDNEY INT, V53, P609, DOI 10.1046/j.1523-1755.1998.00799.x; Haberstroh U, 1998, J AM SOC NEPHROL, V9, P203; Hertig A, 2008, J AM SOC NEPHROL, V19, P1584, DOI 10.1681/ASN.2007101160; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Holland J, 1997, J BIOL CHEM, V272, P9108; HOOKE DH, 1987, KIDNEY INT, V31, P964, DOI 10.1038/ki.1987.93; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; KELLY KJ, 1994, P NATL ACAD SCI USA, V91, P812, DOI 10.1073/pnas.91.2.812; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Kopp JB, 1996, LAB INVEST, V74, P991; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Lin Y, 2009, NEOPLASIA, V11, P864, DOI 10.1593/neo.09542; Lloyd AR, 1996, J IMMUNOL, V156, P932; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Merck E, 2005, BLOOD, V105, P3623, DOI 10.1182/blood-2004-07-2809; MULLER GA, 1991, CLIN NEPHROL, V36, P203; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nishitani Y, 2005, KIDNEY INT, V68, P1078, DOI 10.1111/j.1523-1755.2005.00500.x; Ou ZL, 1999, J LAB CLIN MED, V133, P41, DOI 10.1053/lc.1999.v133.a94726; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Salahshor S, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-66; Schramek H, 2003, AM J PHYSIOL-CELL PH, V285, pC652, DOI 10.1152/ajpcell.00463.2002; Schramek H, 2002, NEWS PHYSIOL SCI, V17, P62, DOI 10.1152/nips.01365.2001; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; SHIMIZU Y, 1990, IMMUNOL REV, V114, P109, DOI 10.1111/j.1600-065X.1990.tb00563.x; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Soede RDM, 2001, J IMMUNOL, V166, P4293, DOI 10.4049/jimmunol.166.7.4293; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TANG WW, 1994, LAB INVEST, V70, P631; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; TOMINO Y, 1994, NEPHRON, V67, P302, DOI 10.1159/000187984; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	54	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23267	10.1371/journal.pone.0023267	http://dx.doi.org/10.1371/journal.pone.0023267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850266	gold, Green Published, Green Submitted			2022-12-27	WOS:000293563300051
J	Mullick, A; Tremblay, J; Leon, Z; Gros, P				Mullick, Alaka; Tremblay, Jessy; Leon, Zully; Gros, Philippe			A Novel Role for the Fifth Component of Complement (C5) in Cardiac Physiology	PLOS ONE			English	Article							CANDIDA-ALBICANS; NATRIURETIC PEPTIDE; MICE; A/J; DEFICIENCY; RESPONSES; C57BL/6J; FAILURE	We have previously demonstrated that C5-deficient A/J and recombinant congenic BcA17 mice suffer from cardiac dysfunction when infected with C. albicans blastospores intravenously. During these studies we had observed that, even in the control un-infected state, BcA17 hearts displayed alterations in gene expression that have been associated with pathological cardiac hypertrophy in comparison to parental C5-sufficient C57Bl/6J (B6) mice. Of note was an increase in the expression of Nppb, a member of the fetal gene program and a decrease in the expression of Rgs2, an inhibitor of the hypertrophic response. We now report that C5-deletion has also affected the expression of other elements of the fetal gene program. Moreover deleting the C5a receptor, C5aR, has essentially the same effect as deleting C5, indicating a key role for C5a-C5aR signaling in the phenotype. Having noted a pathological phenotype in the un-infected state, we investigated the role of C5 in the response to cardiac stress. In previous studies, comparison of the expression profiles of C. albicans-infected BcA17 and similarly infected B6 hearts had revealed a paucity of cardioprotective genes in the C5-deficient heart. To determine whether this was also directly linked to C5-deficiency, we tested the expression of 5 such genes in the C. albicans-infected C5aR(-/-) mice. We found again that deletion of C5aR recapitulated the alterations in stress response of BcA17. To determine whether our observations were relevant to other forms of cardiac injury, we tested the effect of C5-deficiency on the response to isoproterenol-induced hypertrophic stimulation. Consistent with our hypothesis, A/J, BcA17 and C5aR(-/-) mice responded with higher levels of Nppa expression than B6 and BALB/c mice. In conclusion, our results suggest that an absence of functional C5a renders the heart in a state of distress, conferring a predisposition to cardiac dysfunction in the face of additional injury.	[Mullick, Alaka; Tremblay, Jessy; Leon, Zully] Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Mullick, Alaka; Tremblay, Jessy] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada	National Research Council Canada; Universite de Montreal; McGill University	Mullick, A (corresponding author), Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada.	alaka.mullick@cnrc-nrc.gc.ca			Canadian Institute of Health Research (CIHR) [CTP-79843]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a team grant on fungal pathogenesis from the Canadian Institute of Health Research (CIHR) to AM and PG (CTP-79843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN RB, 1993, IMMUNOL CELL BIOL, V71, P221, DOI 10.1038/icb.1993.25; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Conroy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004953; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; EATON GJ, 1978, AM J PATHOL, V90, P173; Faulx MD, 2005, AM J PHYSIOL-HEART C, V289, pH30, DOI 10.1152/ajpheart.00636.2004; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Hoit BD, 2002, GENOMICS, V79, P679, DOI 10.1006/geno.2002.6754; Jacob A, 2010, FASEB J, V24, P1682, DOI 10.1096/fj.09-138834; Krusche CA, 2011, BASIC RES CARDIOL, V106, P617, DOI 10.1007/s00395-011-0175-y; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Li F, 2008, BIOCHEM BIOPH RES CO, V370, P317, DOI 10.1016/j.bbrc.2008.03.096; Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024; Markiewski MM, 2009, J IMMUNOL, V182, P5412, DOI 10.4049/jimmunol.0804179; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Mullick A, 2006, INFECT IMMUN, V74, P4439, DOI 10.1128/IAI.00159-06; NILSSON UR, 1967, J EXP MED, V125, P1, DOI 10.1084/jem.125.1.1; Nunn C, 2010, CELL SIGNAL, V22, P1231, DOI 10.1016/j.cellsig.2010.03.015; Odds FC, 2010, FUTURE MICROBIOL, V5, P67, DOI 10.2217/FMB.09.113; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Papp S, 2010, AM J PATHOL, V176, P1113, DOI 10.2353/ajpath.2010.090392; Parekh N, 2009, CURR OPIN CARDIOL, V24, P155, DOI 10.1097/HCO.0b013e328320d82a; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Richardson M, 2009, FRONT BIOSCI-LANDMRK, V14, P4363, DOI 10.2741/3533; Sawada T, 2010, J MOL CELL CARDIOL, V48, P1280, DOI 10.1016/j.yjmcc.2010.02.004; Scheuer J, 1999, AM J CARDIOL, V83, p70H; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tsang Sharon, 2010, Front Biosci (Schol Ed), V2, P547; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; YASUNAGA I, 1988, EXP ANIM TOKYO, V37, P121, DOI 10.1538/expanim1978.37.2_121; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zhang W, 2006, J BIOL CHEM, V281, P5811, DOI 10.1074/jbc.M507871200	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22919	10.1371/journal.pone.0022919	http://dx.doi.org/10.1371/journal.pone.0022919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829669	gold, Green Submitted, Green Published			2022-12-27	WOS:000293511200026
J	Lim, KH; Kim, KH; Choi, SI; Park, ES; Park, SH; Ryu, K; Park, YK; Kwon, SY; Yang, SI; Lee, HC; Sung, IK; Seong, BL				Lim, Keo-Heun; Kim, Kyun-Hwan; Choi, Seong Il; Park, Eun-Sook; Park, Seung Hwa; Ryu, Kisun; Park, Yong Kwang; Kwon, So Young; Yang, Sung-Il; Lee, Han Chu; Sung, In-Kyung; Seong, Baik L.			RPS3a Over-Expressed in HBV-Associated Hepatocellular Carcinoma Enhances the HBx-Induced NF-kappa B Signaling via Its Novel Chaperoning Function	PLOS ONE			English	Article							VIRUS-X-PROTEIN; HEPATITIS-B; GENE-EXPRESSION; RIBOSOMAL-PROTEINS; CELL-GROWTH; CANCER; TRANSLATION; SOLUBILITY; ACTIVATION; INDUCTION	Hepatitis B virus (HBV) infection is one of the major causes of hepatocellular carcinoma (HCC) development. Hepatitis B virus X protein (HBx) is known to play a key role in the development of hepatocellular carcinoma (HCC). Several cellular proteins have been reported to be over-expressed in HBV-associated HCC tissues, but their role in the HBV-mediated oncogenesis remains largely unknown. Here, we explored the effect of the over-expressed cellular protein, a ribosomal protein S3a (RPS3a), on the HBx-induced NF-kappa B signaling as a critical step for HCC development. The enhancement of HBx-induced NF-kappa B signaling by RPS3a was investigated by its ability to translocate NF-kappa B (p65) into the nucleus and the knock-down analysis of RPS3a. Notably, further study revealed that the enhancement of NF-kappa B by RPS3a is mediated by its novel chaperoning activity toward physiological HBx. The over-expression of RPS3a significantly increased the solubility of highly aggregation-prone HBx. This chaperoning function of RPS3a for HBx is closely correlated with the enhanced NF-kappa B activity by RPS3a. In addition, the mutational study of RPS3a showed that its N-terminal domain (1-50 amino acids) is important for the chaperoning function and interaction with HBx. The results suggest that RPS3a, via extra-ribosomal chaperoning function for HBx, contributes to virally induced oncogenesis by enhancing HBx-induced NF-kB signaling pathway.	[Lim, Keo-Heun; Ryu, Kisun; Seong, Baik L.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea; [Kim, Kyun-Hwan; Park, Eun-Sook; Park, Yong Kwang; Yang, Sung-Il] Konkuk Univ, Sch Med, IBST, Dept Pharmacol, Seoul, South Korea; [Kwon, So Young; Sung, In-Kyung] Konkuk Univ, Sch Med, IBST, Dept Internal Med, Seoul, South Korea; [Park, Seung Hwa] Konkuk Univ, Sch Med, IBST, Dept Anat, Seoul, South Korea; [Park, Seung Hwa] Konkuk Univ, Sch Med, IBST, Ctr Canc Res & Diagnost Med, Seoul, South Korea; [Kim, Kyun-Hwan; Yang, Sung-Il] Konkuk Univ, Res Inst Med Sci, Seoul, South Korea; [Lee, Han Chu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Choi, Seong Il; Seong, Baik L.] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea	Yonsei University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Konkuk University; University of Ulsan; Asan Medical Center; Yonsei University	Lim, KH (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea.	khkim10@kku.ac.kr; blseong@yonsei.ac.kr		Park, Eun-Sook/0000-0002-6652-9404; Kim, Kyun-Hwan/0000-0001-5266-072X	Ministry of Knowledge Economy/Korea Evaluation Institute of Industrial Technology (MKE/KEIT) [10031969]; Ministry of Education, Science and Technology (MEST), Republic of Korea [2010-0001932]; Ministry for Health, Welfare AMP; Family Affairs, Republic of Korea [A084826, A085105]	Ministry of Knowledge Economy/Korea Evaluation Institute of Industrial Technology (MKE/KEIT)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare AMP; Family Affairs, Republic of Korea	This work was supported by the R&D Program of Ministry of Knowledge Economy/Korea Evaluation Institute of Industrial Technology (MKE/KEIT) [10031969] and Ministry of Education, Science and Technology (MEST) [2010-0001932], Republic of Korea. This study was also supported in part by a grant from the Korea Healthcare Technology R&D Project [A084826 to K.H.K., A085105 to B.L.S.], Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Choi SI, 2009, RNA BIOL, V6, P21, DOI 10.4161/rna.6.1.7441; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; Henkler F, 2001, J GEN VIROL, V82, P871, DOI 10.1099/0022-1317-82-4-871; Iizuka N, 2002, CANCER RES, V62, P3939; JAMEEL S, 1990, J VIROL, V64, P3963, DOI 10.1128/JVI.64.8.3963-3966.1990; Kabir MA, 2008, FEMS YEAST RES, V8, P1236, DOI 10.1111/j.1567-1364.2008.00425.x; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kashuba E, 2005, EXP CELL RES, V303, P47, DOI 10.1016/j.yexcr.2004.08.025; KHO CJ, 1992, P NATL ACAD SCI USA, V89, P2200, DOI 10.1073/pnas.89.6.2200; Kho CJ, 1996, CELL GROWTH DIFFER, V7, P1157; Kim CW, 2007, PROTEIN SCI, V16, P635, DOI 10.1110/ps.062330907; Kim HK, 2010, BIOCHEM BIOPH RES CO, V391, P1177, DOI 10.1016/j.bbrc.2009.11.176; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Kim KH, 2003, EMBO J, V22, P2104, DOI 10.1093/emboj/cdg210; Kim MY, 2001, ONCOGENE, V20, P4568, DOI 10.1038/sj.onc.1204626; Kovacs D, 2009, FEBS LETT, V583, P88, DOI 10.1016/j.febslet.2008.11.049; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Liu D, 2009, BIOTECHNOL APPL BIOC, V54, P141, DOI 10.1042/BA20090116; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; LUTSCH G, 1990, EUR J CELL BIOL, V51, P140; Marczinovits I, 1997, J BIOTECHNOL, V56, P81, DOI 10.1016/S0168-1656(97)00080-1; Musholt TJ, 1997, J SURG RES, V69, P94, DOI 10.1006/jsre.1997.5038; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Naora H, 1996, BIOCHEM BIOPH RES CO, V224, P258, DOI 10.1006/bbrc.1996.1017; Naora H, 1998, J CELL BIOL, V141, P741, DOI 10.1083/jcb.141.3.741; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; Shuda M, 2000, ANTICANCER RES, V20, P2489; Slizhikova D. K., 2005, Bioorganicheskaya Khimiya, V31, P195; Song CZ, 2003, WORLD J GASTROENTERO, V9, P1521, DOI 10.3748/wjg.v9.i7.1521; Song DM, 2002, BIOCHEMISTRY-US, V41, P929, DOI 10.1021/bi015669c; STARKEY CR, 1995, INT J CANCER, V62, P325, DOI 10.1002/ijc.2910620316; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Tarantul VZ, 2000, AIDS RES HUM RETROV, V16, P173, DOI 10.1089/088922200309511; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Urban S, 1997, HEPATOLOGY, V26, P1045, DOI 10.1002/hep.510260437; Wang T, 2004, WORLD J GASTROENTERO, V10, P356; WANG WL, 1991, HEPATOLOGY, V14, P29, DOI 10.1002/hep.1840140106; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yun C, 2002, CANCER LETT, V184, P97, DOI 10.1016/S0304-3835(02)00187-8	47	36	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e22258	10.1371/journal.pone.0022258	http://dx.doi.org/10.1371/journal.pone.0022258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21857917	Green Submitted, Green Published, gold			2022-12-27	WOS:000294125500006
J	Pham, CD; Sims, HI; Archer, TK; Schnitzler, GR				Pham, Chuong D.; Sims, Hillel I.; Archer, Trevor K.; Schnitzler, Gavin R.			Multiple Distinct Stimuli Increase Measured Nucleosome Occupancy around Human Promoters	PLOS ONE			English	Article							TUMOR VIRUS PROMOTER; CHROMATIN REMODELING COMPLEXES; MEDIATES CRITICAL INTERACTIONS; SWI/SNF-RELATED COMPLEXES; LONG TERMINAL REPEAT; CELL-CYCLE CONTROL; C-MYC GENE; GLUCOCORTICOID-RECEPTOR; IN-VIVO; NUCLEAR RECEPTORS	Nucleosomes can block access to transcription factors. Thus the precise localization of nucleosomes relative to transcription start sites and other factor binding sites is expected to be a critical component of transcriptional regulation. Recently developed microarray approaches have allowed the rapid mapping of nucleosome positions over hundreds of kilobases (kb) of human genomic DNA, although these approaches have not yet been widely used to measure chromatin changes associated with changes in transcription. Here, we use custom tiling microarrays to reveal changes in nucleosome positions and abundance that occur when hormone-bound glucocorticoid receptor (GR) binds to sites near target gene promoters in human osteosarcoma cells. The most striking change is an increase in measured nucleosome occupancy at sites spanning similar to 1 kb upstream and downstream of transcription start sites, which occurs one hour after addition of hormone, but is lost at 4 hours. Unexpectedly, this increase was seen both on GR-regulated and GR-non-regulated genes. In addition, the human SWI/SNF chromatin remodeling factor (a GR co-activator) was found to be important for increased occupancy upon hormone treatment and also for low nucleosome occupancy without hormone. Most surprisingly, similar increases in nucleosome occupancy were also seen on both regulated and non-regulated promoters during differentiation of human myeloid leukemia cells and upon activation of human CD4+ T-cells. These results indicate that dramatic changes in chromatin structure over similar to 2 kb of human promoters may occur genomewide and in response to a variety of stimuli, and suggest novel models for transcriptional regulation.	[Pham, Chuong D.] AstraZeneca R&D Boston, Waltham, MA 02451 USA; [Sims, Hillel I.] Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; [Archer, Trevor K.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Schnitzler, Gavin R.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA	AstraZeneca; Brandeis University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tufts Medical Center	Pham, CD (corresponding author), AstraZeneca R&D Boston, Waltham, MA 02451 USA.	gschnitzler@tuftsmedicalcenter.org	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	American Cancer Society [RSG-04-188-01-GMC]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES071006] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant to GRS from the American Cancer Society (#RSG-04-188-01-GMC, www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P865, DOI 10.1093/nar/20.4.865; Burkhart BA, 2009, MOL CELL ENDOCRINOL, V298, P66, DOI 10.1016/j.mce.2008.10.011; Chen JG, 2006, MOL ENDOCRINOL, V20, P1, DOI 10.1210/me.2005-0192; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Fan HY, 2005, MOL CELL, V17, P805, DOI 10.1016/j.molcel.2005.02.024; Flavin M, 2004, MOL CELL BIOL, V24, P7891, DOI 10.1128/MCB.24.18.7891-7901.2004; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Fragoso G, 1998, MOL CELL BIOL, V18, P3633, DOI 10.1128/MCB.18.6.3633; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Fryer CJ, 2000, J BIOL CHEM, V275, P17771, DOI 10.1074/jbc.M908729199; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; GROSSO LE, 1985, CANCER RES, V45, P5035; Hebbar PB, 2003, CHROMOSOMA, V111, P495, DOI 10.1007/s00412-003-0232-x; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Hebbar PB, 2007, J BIOL CHEM, V282, P8284, DOI 10.1074/jbc.M610554200; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE HL, 1994, MOL CELL BIOL, V14, P32, DOI 10.1128/MCB.14.1.32; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu H, 2006, MOL CELL BIOL, V26, P2550, DOI 10.1128/MCB.26.7.2550-2559.2006; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Morand EF, 2007, CURR OPIN RHEUMATOL, V19, P302, DOI 10.1097/BOR.0b013e32805e87d0; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; MYMRYK JS, 1995, MOL ENDOCRINOL, V9, P1825, DOI 10.1210/me.9.12.1825; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Narlikar L, 2007, PLOS COMPUT BIOL, V3, P2199, DOI 10.1371/journal.pcbi.0030215; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Pham CD, 2010, NUCLEIC ACIDS RES, V38, P400, DOI 10.1093/nar/gkp1030; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Pullner A, 1996, J BIOL CHEM, V271, P31452, DOI 10.1074/jbc.271.49.31452; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Schnitzler GR, 2008, CELL BIOCHEM BIOPHYS, V51, P67, DOI 10.1007/s12013-008-9015-6; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Sims HI, 2008, NUCLEIC ACIDS RES, V36, P6118, DOI 10.1093/nar/gkn623; Sims HI, 2007, BIOCHEMISTRY-US, V46, P11377, DOI 10.1021/bi7008823; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Song IH, 2006, MOL CELL ENDOCRINOL, V246, P142, DOI 10.1016/j.mce.2005.11.012; Stafford JM, 2001, J BIOL CHEM, V276, P39885, DOI 10.1074/jbc.M105370200; Sugatani J, 2005, MOL PHARMACOL, V67, P845, DOI 10.1124/mol.104.007161; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Trotter KW, 2008, MOL CELL BIOL, V28, P1413, DOI 10.1128/MCB.01301-07; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Ulyanova NP, 2005, MOL CELL BIOL, V25, P11156, DOI 10.1128/MCB.25.24.11156-11170.2005; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	78	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23490	10.1371/journal.pone.0023490	http://dx.doi.org/10.1371/journal.pone.0023490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853138	Green Submitted, gold, Green Published			2022-12-27	WOS:000293953400047
J	Thomas, CJ; Briknarova, K; Hilmer, JK; Movahed, N; Bothner, B; Sumida, JP; Tall, GG; Sprang, SR				Thomas, Celestine J.; Briknarova, Klara; Hilmer, Jonathan K.; Movahed, Navid; Bothner, Brian; Sumida, John P.; Tall, Gregory G.; Sprang, Stephen R.			The Nucleotide Exchange Factor Ric-8A Is a Chaperone for the Conformationally Dynamic Nucleotide-Free State of G alpha i1	PLOS ONE			English	Article							PROTEIN ALPHA-SUBUNIT; HETEROTRIMERIC G-PROTEINS; SECONDARY STRUCTURE; HYDROGEN-EXCHANGE; ACTIVATION; MECHANISM; RECEPTOR; BINDING; GTP; STABILIZATION	Heterotrimeric G protein alpha subunits are activated upon exchange of GDP for GTP at the nucleotide binding site of G alpha, catalyzed by guanine nucleotide exchange factors (GEFs). In addition to transmembrane G protein-coupled receptors (GPCRs), which act on G protein heterotrimers, members of the family cytosolic proteins typified by mammalian Ric-8A are GEFs for Gi/q/12/13-class G alpha subunits. Ric-8A binds to G alpha.GDP, resulting in the release of GDP. The Ric-8A complex with nucleotide-free G alpha i1 is stable, but dissociates upon binding of GTP to G alpha i1. To gain insight into the mechanism of Ric-8A-catalyzed GDP release from G alpha i1, experiments were conducted to characterize the physical state of nucleotide-free G alpha i1 (hereafter referred to as G alpha i1[]) in solution, both as a monomeric species, and in the complex with Ric-8A. We found that Ric-8A-bound, nucleotide-free G alpha i1 is more accessible to trypsinolysis than G alpha i1.GDP, but less so than G alpha i1[] alone. The TROSY-HSQC spectrum of [N-15]G alpha i1[] bound to Ric-8A shows considerable loss of peak intensity relative to that of [N-15]G alpha i1.GDP. Hydrogen-deuterium exchange in G alpha i1[] bound to Ric-8A is 1.5-fold more extensive than in G alpha i1.GDP. Differential scanning calorimetry shows that both Ric-8A and G alpha i1.GDP undergo cooperative, irreversible unfolding transitions at 47 degrees and 52 degrees, respectively, while nucleotide-free G alpha i1 shows a broad, weak transition near 35 degrees. The unfolding transition for Ric-8A: G alpha i1[] is complex, with a broad transition that peaks at 50 degrees, suggesting that both Ric-8A and G alpha i1[] are stabilized within the complex, relative to their respective free states. The C-terminus of G alpha i1 is shown to be a critical binding element for Ric-8A, as is also the case for GPCRs, suggesting that the two types of GEF might promote nucleotide exchange by similar mechanisms, by acting as chaperones for the unstable and dynamic nucleotide-free state of G alpha.	[Thomas, Celestine J.; Briknarova, Klara; Sprang, Stephen R.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA; [Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Briknarova, Klara] Univ Montana, Dept Chem & Biochem, Missoula, MT 59812 USA; [Hilmer, Jonathan K.; Movahed, Navid; Bothner, Brian] Montana State Univ, Prote & Mass Spectrometry Facil, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Sumida, John P.] Univ Washington, Seattle, WA 98195 USA; [Tall, Gregory G.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Sch Med & Dent, Rochester, NY 14642 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana; Montana State University System; Montana State University Bozeman; University of Washington; University of Washington Seattle; University of Rochester	Thomas, CJ (corresponding author), Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA.	Stephen.sprang@umontana.edu		Hilmer, Jonathan/0000-0002-1494-6353	National Institutes of Health [DK46371, RR16455, RR020185, RR24237, GM088242]; The Murdock Charitable Trust; Washington State Life Science [2496490]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024237, P20RR020185, P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046371, R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Murdock Charitable Trust; Washington State Life Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants DK46371 (to S.R.S.), RR16455, RR020185 and RR24237 (to B.B.), GM088242 to (G.G.T.), and The Murdock Charitable Trust (B.B.). Funding for Bioanalytical Pharmacy Core at the University of Washington's Center for the Intracellular Delivery of Biologics is provided by the Washington State Life Science Discovery Fund (grant number 2496490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; Abdulaev NG, 2005, J BIOL CHEM, V280, P38071, DOI 10.1074/jbc.M505259200; Abdulaev NG, 2005, J BIOMOL NMR, V32, P31, DOI 10.1007/s10858-005-3340-5; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Anderson LL, 2005, PROTEIN PEPTIDE LETT, V12, P783, DOI 10.2174/0929866054864175; Anderson LL, 2005, J BIOL CHEM, V280, P31019, DOI 10.1074/jbc.M503690200; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COLEMAN DE, 1994, J MOL BIOL, V238, P630, DOI 10.1006/jmbi.1994.1320; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cooper Nutley Wadwood, 2000, DIFFERENTIAL SCANNIN; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; ENGLANDER SW, 1972, ANNU REV BIOCHEM, V41, P903, DOI 10.1146/annurev.bi.41.070172.004351; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; FERGUSON KM, 1991, METHOD ENZYMOL, V195, P188; Figueroa M, 2009, PROTEIN SCI, V18, P1139, DOI 10.1002/pro.124; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; GRIKO YV, 1994, J MOL BIOL, V235, P1318, DOI 10.1006/jmbi.1994.1085; HIGASHIJIMA T, 1991, METHOD ENZYMOL, V195, P321; Holdeman TC, 2001, J BIOMOL NMR, V21, P383, DOI 10.1023/A:1013334608913; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Lonhienne TG, 2009, J BIOL CHEM, V284, P22549, DOI 10.1074/jbc.M109.019935; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Privalov P L, 1986, Methods Enzymol, V131, P4; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Zelent B, 2001, BIOCHEMISTRY-US, V40, P9647, DOI 10.1021/bi010272u	51	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23197	10.1371/journal.pone.0023197	http://dx.doi.org/10.1371/journal.pone.0023197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853086	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400030
J	Bagher-Ebadian, H; Jafari-Khouzani, K; Mitsias, PD; Lu, M; Soltanian-Zadeh, H; Chopp, M; Ewing, JR				Bagher-Ebadian, Hassan; Jafari-Khouzani, Kourosh; Mitsias, Panayiotis D.; Lu, Mei; Soltanian-Zadeh, Hamid; Chopp, Michael; Ewing, James R.			Predicting Final Extent of Ischemic Infarction Using Artificial Neural Network Analysis of Multi-Parametric MRI in Patients with Stroke	PLOS ONE			English	Article							TISSUE VIABILITY; DIFFUSION; PERFUSION; ABCIXIMAB; ALGORITHMS; THERAPY; VOLUME	In hemispheric ischemic stroke, the final size of the ischemic lesion is the most important correlate of clinical functional outcome. Using a set of acute-phase MR images (Diffusion-weighted - DWI, T-1-weighted - T1WI, T-2-weighted-T2WI, and proton density weighted - PDWI) for inputs, and the chronic T2WI at 3 months as an outcome measure, an Artificial Neural Network (ANN) was trained to predict the 3-month outcome in the form of a voxel-by-voxel forecast of the chronic T2WI. The ANN was trained and tested using 12 subjects (with 83 slices and 140218 voxels) using a leave-one-out cross-validation method with calculation of the Area Under the Receiver Operator Characteristic Curve (AUROC) for training, testing and optimization of the ANN. After training and optimization, the ANN produced maps of predicted outcome that were well correlated (r = 0.80, p<0.0001) with the T2WI at 3 months for all 12 patients. This result implies that the trained ANN can provide an estimate of 3-month ischemic lesion on T2WI in a stable and accurate manner (AUROC = 0.89).	[Bagher-Ebadian, Hassan; Mitsias, Panayiotis D.; Chopp, Michael; Ewing, James R.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Bagher-Ebadian, Hassan; Chopp, Michael; Ewing, James R.] Oakland Univ, Dept Phys, Rochester, MI USA; [Jafari-Khouzani, Kourosh; Soltanian-Zadeh, Hamid] Henry Ford Hosp, Dept Diagnost Radiol, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Soltanian-Zadeh, Hamid] Univ Tehran, Sch Elect & Comp Engn, CIPCE, Tehran, Iran; [Ewing, James R.] Wayne State Univ, Dept Physiol, Detroit, MI USA; [Ewing, James R.] Wayne State Univ, Dept Neurol, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Tehran; Wayne State University; Wayne State University	Bagher-Ebadian, H (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	ebadian@neurnis.neuro.hfh.edu	Soltanian-Zadeh, Hamid/AAD-7027-2022; Soltanian-Zadeh, Hamid/K-2903-2016	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856	National Institutes of Health [1-R03-NS061170]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS061170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health grant 1-R03-NS061170. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2005, STROKE, V36, P880, DOI 10.1161/01.STR.0000157668.39374.56; Adams HP, 2000, STROKE, V31, P601; Albers GW, 1999, STROKE, V30, P2230, DOI 10.1161/01.STR.30.10.2230; Arenillas JF, 2002, STROKE, V33, P2197, DOI 10.1161/01.STR.0000027861.75884.DF; Bagher-Ebadian H, 2004, IEEE T NUCL SCI, V51, P184, DOI 10.1109/TNS.2003.823047; Bagher-Ebadian H, 2007, MAGN RESON MED, V58, P290, DOI 10.1002/mrm.21332; Baird AE, 1997, ANN NEUROL, V41, P581, DOI 10.1002/ana.410410506; Barber PA, 1998, NEUROLOGY, V51, P418, DOI 10.1212/WNL.51.2.418; BISHOP CM, 1997, NEURAL NETWORKS PATT; Buscema M, 2002, SUBST USE MISUSE, V37, P1093, DOI 10.1081/JA-120004171; Butcher KS, 2005, STROKE, V36, P1153, DOI 10.1161/01.STR.0000166181.86928.8b; Eckert B, 2005, STROKE, V36, P1160, DOI 10.1161/01.STR.0000165918.80812.1e; Elisseeff A, 2005, J MACH LEARN RES, V6, P55; Freeman J. A., 1991, NEURAL NETWORK ALGOR; Goutte C, 1997, NEURAL COMPUT, V9, P1245, DOI 10.1162/neco.1997.9.6.1245; Grandin CB, 2002, RADIOLOGY, V223, P361, DOI 10.1148/radiol.2232010673; Gurney K., 2018, INTRO NEURAL NETWORK; Hosseini-Ashrafi ME, 1999, PHYS MED BIOL, V44, P1513, DOI 10.1088/0031-9155/44/6/306; Jacobs MA, 2001, STROKE, V32, P950, DOI 10.1161/01.STR.32.4.950; Koga M, 2005, STROKE, V36, P2132, DOI 10.1161/01.STR.0000181066.23213.8f; Looney C.G., 1997, PATTERN RECOGN; Lu M, 2005, J MAGN RESON IMAGING, V21, P495, DOI 10.1002/jmri.20313; Luby M, 2008, NEURAL NETWORK MODEL; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; Menezes NM, 2007, STROKE, V38, P194, DOI 10.1161/01.STR.0000251792.76080.45; Mitsias PD, 2004, AM J NEURORADIOL, V25, P1499; Mitsias PD, 2002, STROKE, V33, P2839, DOI 10.1161/01.STR.0000043072.76353.7C; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Nguyen Viet Ha, 2008, Program and Proceedings of PPIC '08, Tokyo: Pan-Pacific Imaging Conference '08, P238; Nguyen VH, 2008, IMAGING SOC JAPAN, P238; Oppenheim C, 2001, STROKE, V32, P2486, DOI 10.1161/hs1101.098331; SAS Institute, 2008, SAS STAT US GUID; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Scholkopf B., 2002, LEARNING KERNELS; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1336, DOI 10.1038/sj.jcbfm.9600126; Soltanian-Zadeh H, 2007, CEREBROVASC DIS, V23, P91, DOI 10.1159/000097044; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Thijs VN, 2000, STROKE, V31, P2597, DOI 10.1161/01.STR.31.11.2597; WINDHAM JP, 1988, J COMPUT ASSIST TOMO, V12, P1, DOI 10.1097/00004728-198801000-00001; Wu O, 2007, J CEREBR BLOOD F MET, V27, P196, DOI 10.1038/sj.jcbfm.9600328	40	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e22626	10.1371/journal.pone.0022626	http://dx.doi.org/10.1371/journal.pone.0022626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853039	Green Published, gold			2022-12-27	WOS:000295454200015
J	Frere, CH; Prentis, PJ; Gilding, EK; Mudge, AM; Cruickshank, A; Godwin, ID				Frere, Celine H.; Prentis, Peter J.; Gilding, Edward K.; Mudge, Agnieszka M.; Cruickshank, Alan; Godwin, Ian D.			Lack of Low Frequency Variants Masks Patterns of Non-Neutral Evolution following Domestication	PLOS ONE			English	Article							SORGHUM-BICOLOR; SEED BANKS; SELECTION; BOTTLENECK; DIVERSITY; PROTEIN; TESTS	Detecting artificial selection in the genome of domesticated species can not only shed light on human history but can also be beneficial to future breeding strategies. Evidence for selection has been documented in domesticated species including maize and rice, but few studies have to date detected signals of artificial selection in the Sorghum bicolor genome. Based on evidence that domesticated S. bicolor and its wild relatives show significant differences in endosperm structure and quality, we sequenced three candidate seed storage protein (kafirin) loci and three candidate starch biosynthesis loci to test whether these genes show non-neutral evolution resulting from the domestication process. We found strong evidence of non-neutral selection at the starch synthase IIa gene, while both starch branching enzyme I and the beta kafirin gene showed weaker evidence of non-neutral selection. We argue that the power to detect consistent signals of non-neutral selection in our dataset is confounded by the absence of low frequency variants at four of the six candidate genes. A future challenge in the detection of positive selection associated with domestication in sorghum is to develop models that can accommodate for skewed frequency spectrums.	[Frere, Celine H.; Prentis, Peter J.; Gilding, Edward K.; Mudge, Agnieszka M.; Godwin, Ian D.] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Prentis, Peter J.] Queensland Univ Technol, Biogeosci Discipline, Brisbane, Qld 4001, Australia; [Cruickshank, Alan] Agri Sci Queensland, Dept Employment Econ Dev & Innovat, Warwick, Qld, Australia	University of Queensland; Queensland University of Technology (QUT); Queensland Department of Agriculture & Fisheries	Frere, CH (corresponding author), Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia.	c.frere@uq.edu.au	Frere, Celine Henria/B-4905-2013; Cruickshank, Alan W/C-9654-2011; Gilding, Edward/A-8630-2011; Prentis, Peter/C-8729-2011; Godwin, Ian D/A-7498-2008; Frere, Celine Henria/GYJ-3882-2022	Frere, Celine Henria/0000-0002-9671-2138; Cruickshank, Alan W/0000-0002-7982-1746; Gilding, Edward/0000-0003-1720-1282; Godwin, Ian D/0000-0002-4006-4426; Prentis, Peter/0000-0001-6587-8875	Pork CRC; Australian Research Council [DP0986043, LP0883808]	Pork CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council(Australian Research Council)	This study was funded by the Pork CRC and the Australian Research Council grant numbers DP0986043 and LP0883808. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Casa AM, 2006, CROP SCI, V46, pS27, DOI 10.2135/cropsci2006.0001tpg; CHANDRASHEKAR A, 1988, CEREAL CHEM, V65, P457; Dillon SL, 2007, PLANT SYST EVOL, V268, P29, DOI 10.1007/s00606-007-0571-9; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x; Fay JC, 2000, GENETICS, V155, P1405; Figueiredo LFD, 2008, GENETICS, V179, P997, DOI 10.1534/genetics.108.087312; Guo JA, 2010, ANN BOT-LONDON, V106, P505, DOI 10.1093/aob/mcq125; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; HAMBLIN MT, 2007, PL GEN; Heidari Mostafa, 2009, Asian Journal of Plant Sciences, V8, P240, DOI 10.3923/ajps.2009.240.244; HOUSE LR, 1985, INT CROPS RES I SEMI; HOWARTH CJ, 1994, J EXP BOT, V45, P1353, DOI 10.1093/jxb/45.10.1353; HUDSON RR, 1987, GENETICS, V116, P153; Jordan DR, 1998, EUPHYTICA, V102, P1, DOI 10.1023/A:1018311908636; JORDAN DR, CROP SCI IN PRESS; Laidlaw HKC, 2010, THEOR APPL GENET, V121, P1227, DOI 10.1007/s00122-010-1383-9; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Lindeboom N, 2004, STARCH-STARKE, V56, P89, DOI 10.1002/star.200300218; MARAMBE B, 1995, J AGRON CROP SCI, V174, P291, DOI 10.1111/j.1439-037X.1995.tb01115.x; McCouch S, 2004, PLOS BIOL, V2, P1507, DOI 10.1371/journal.pbio.0020347; Nei M., 1987, MOL EVOLUTIONARY GEN; Prada D, 2009, J EXP BOT, V60, P2541, DOI 10.1093/jxb/erp130; Przeworski M, 2002, GENETICS, V160, P1179; REDDY BVS, 2006, GENETIC RESOURCES CH, P309; Rosenow D.T., 2000, SORGHUM ORIGIN HIST; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Serna-Saldivar S., 1995, SORGHUM MILLETS CHEM, P69; Shapter F. M., 2008, Plant Genetic Resources Characterization and Utilization, V6, P85, DOI 10.1017/S1479262108986512; Sigmon B, 2010, MOL ECOL, V19, P1296, DOI 10.1111/j.1365-294X.2010.04562.x; TAJIMA F, 1989, GENETICS, V123; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tao YZ, 2000, THEOR APPL GENET, V100, P1225, DOI 10.1007/s001220051428; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; YI P, 2010, BMC EVOL BIOL; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231; Zhang GY, 1998, CEREAL CHEM, V75, P710, DOI 10.1094/CCHEM.1998.75.5.710	47	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23041	10.1371/journal.pone.0023041	http://dx.doi.org/10.1371/journal.pone.0023041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853065	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200036
J	Hoffman, JI; Nichols, HJ				Hoffman, Joseph I.; Nichols, Hazel J.			A Novel Approach for Mining Polymorphic Microsatellite Markers In Silico	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; NULL ALLELES; GENOTYPING ERRORS; SIMPLE SEQUENCES; CANINE SIZE; LOCI; HETEROZYGOSITY; DNA; IDENTIFICATION; TRANSCRIPTOME	An important emerging application of high-throughput 454 sequencing is the isolation of molecular markers such as microsatellites from genomic DNA. However, few studies have developed microsatellites from cDNA despite the added potential for targeting candidate genes. Moreover, to develop microsatellites usually requires the evaluation of numerous primer pairs for polymorphism in the focal species. This can be time-consuming and wasteful, particularly for taxa with low genetic diversity where the majority of primers often yield monomorphic polymerase chain reaction (PCR) products. Transcriptome assemblies provide a convenient solution, functional annotation of transcripts allowing markers to be targeted towards candidate genes, while high sequence coverage in principle permits the assessment of variability in silico. Consequently, we evaluated fifty primer pairs designed to amplify microsatellites, primarily residing within transcripts related to immunity and growth, identified from an Antarctic fur seal (Arctocephalus gazella) transcriptome assembly. In silico visualization was used to classify each microsatellite as being either polymorphic or monomorphic and to quantify the number of distinct length variants, each taken to represent a different allele. The majority of loci (n = 36, 76.0%) yielded interpretable PCR products, 23 of which were polymorphic in a sample of 24 fur seal individuals. Loci that appeared variable in silico were significantly more likely to yield polymorphic PCR products, even after controlling for microsatellite length measured in silico. We also found a significant positive relationship between inferred and observed allele number. This study not only demonstrates the feasibility of generating modest panels of microsatellites targeted towards specific classes of gene, but also suggests that in silico microsatellite variability may provide a useful proxy for PCR product polymorphism.	[Hoffman, Joseph I.] Univ Bielefeld, Dept Anim Behav, Bielefeld, North Rhine Wes, Germany; [Nichols, Hazel J.] Univ Cambridge, Dept Zool, Cambridge, Cambs, England	University of Bielefeld; University of Cambridge	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, Bielefeld, North Rhine Wes, Germany.	joseph.hoffman@uni-bielefeld.de	Nichols, Hazel/D-4737-2013; Hoffman, Joseph i/K-7725-2012	Hoffman, Joseph i/0000-0001-5895-8949	Biology Faculty, University of Bielefeld; Natural Environment Research Council	Biology Faculty, University of Bielefeld; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a FIF grant (Biology Faculty, University of Bielefeld) awarded to JIH. HJN is currently supported by the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Arnason U, 2007, MOL PHYLOGENET EVOL, V45, P863, DOI 10.1016/j.ympev.2007.06.019; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; CALLEN DF, 1993, AM J HUM GENET, V52, P922; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Crawley M. J, 2002, STAT COMPUTING INTRO; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Gemmell NJ, 1997, MAR MAMMAL SCI, V13, P512, DOI 10.1111/j.1748-7692.1997.tb00661.x; Grover A, 2007, MOL GENET GENOMICS, V277, P469, DOI 10.1007/s00438-006-0204-y; Habel JC, 2009, CONSERV GENET, V10, P1659, DOI 10.1007/s10592-008-9744-5; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hoffjan S, 2006, INT J IMMUNOGENET, V33, P401, DOI 10.1111/j.1744-313X.2006.00631.x; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Hoffman JI, 2004, EVOLUTION, V58, P2087; Hoffman JI, 2008, MOL ECOL RESOUR, V8, P459, DOI 10.1111/j.1471-8286.2007.01993.x; Hoffman JI, 2011, MOL ECOL RESOUR, V11, P703, DOI 10.1111/j.1755-0998.2011.02999.x; Hoffman JI, 2010, J HERED, V101, P539, DOI 10.1093/jhered/esq046; Hoffman JI, 2010, J HERED, V101, P527, DOI 10.1093/jhered/esq045; Hoffman JI, 2009, CONSERV GENET, V10, P989, DOI 10.1007/s10592-008-9669-z; Huang SW, 2003, GENETICA, V119, P201, DOI 10.1023/A:1026061216816; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Leclerc MC, 2004, P NATL ACAD SCI USA, V101, P14455, DOI 10.1073/pnas.0405186101; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Merkel A, 2008, BRIEF BIOINFORM, V9, P355, DOI 10.1093/bib/bbn028; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; MITTON JB, 1984, ANNU REV ECOL SYST, V15, P479; Obexer-Ruff G, 2003, GENET SEL EVOL, V35, pS113, DOI 10.1051/gse:2003020; PAETKAU D, 1995, MOL ECOL, V4, P519, DOI 10.1111/j.1365-294X.1995.tb00248.x; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Perry JC, 2011, J HERED, V102, P125, DOI 10.1093/jhered/esq099; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rozen S, 2000, BIOINFORMATICS METHO; Saarinen EV, 2010, J HERED, V101, P784, DOI 10.1093/jhered/esq080; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Santucci F, 2007, HEREDITY, V99, P340, DOI 10.1038/sj.hdy.6801006; Scaglione D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-454; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schultz Jennifer K., 2010, Diversity, V2, P863; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Team RDC, 2005, R LANG ENV STAT COMP; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wagner JL, 2003, J HERED, V94, P23, DOI 10.1093/jhered/esg002; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	64	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23283	10.1371/journal.pone.0023283	http://dx.doi.org/10.1371/journal.pone.0023283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853104	Green Published, Green Submitted, gold			2022-12-27	WOS:000295454200064
J	Safronetz, D; Haddock, E; Feldmann, F; Ebihara, H; Feldmann, H				Safronetz, David; Haddock, Elaine; Feldmann, Friederike; Ebihara, Hideki; Feldmann, Heinz			In Vitro and In Vivo Activity of Ribavirin against Andes Virus Infection	PLOS ONE			English	Article							HANTAVIRUS PULMONARY SYNDROME; TO-PERSON TRANSMISSION; SIN-NOMBRE-VIRUS; HANTAAN VIRUS; INTRAVENOUS RIBAVIRIN; CARDIOPULMONARY SYNDROME; ANTIVIRAL ACTIVITY; DOUBLE-BLIND; EXPERIENCE; HAMSTERS	In Pathogenic hantaviruses are a closely related group of rodent- borne viruses which are responsible for two distinct diseases in humans, hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome (HPS, otherwise known as hantavirus cardiopulmonary syndrome, HCPS). The antiviral effect of ribavirin against Old World hantaviruses, most notably Hantaan virus, is well documented; however, only a few studies have addressed its inhibitory effect on New World hantaviruses. In the present study, we demonstrate that ribavirin is highly active against Andes virus (ANDV), an important etiological agent of HPS, both in vitro and in vivo using a lethal hamster model of HPS. Treatment of ANDV infected Vero E6 cells with ribavirin resulted in dose-dependent reductions in viral RNA and protein as well as virus yields with a half maximal inhibitory concentration between 5 and 12.5 mu g.ml(-1). In hamsters, treatment with as little as 5 mg kg 21 day 21 was 100% effective at preventing lethal HPS disease when therapy was administered by intraperitoneal injection from day1 through day 10 post-infection. Significant reductions were observed in ANDV RNA and antigen positive cells in lung and liver tissues. Ribavirin remained completely protective when administered by intraperitoneal injections up to three days post-infection. In addition, we show that daily oral ribavirin therapy initiated 1 day post-infection and continuing for ten days is also protective against lethal ANDV disease, even at doses of 5 mg kg(-1) day(-1). Our results suggest ribavirin treatment is beneficial for postexposure prophylaxis against HPS-causing hantaviruses and should be considered in scenarios where exposure to the virus is probable. The similarities between the results obtained in this study and those from previous clinical evaluations of ribavirin against HPS, further validate the hamster model of lethal HPS and demonstrate its usefulness in screening antiviral agents against this disease.	[Safronetz, David; Haddock, Elaine; Ebihara, Hideki; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA; [Feldmann, Friederike] NIAID, Off Operat & Management, Div Intramural Res, NIH, Hamilton, MT USA; [Feldmann, Heinz] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Manitoba	Safronetz, D (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT 59840 USA.	feldmannh@niaid.nih.gov		Ebihara, Hideki/0000-0002-2576-9735	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Intramural Research Program of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges AA, 2008, MICROBES INFECT, V10, P1150, DOI 10.1016/j.micinf.2008.06.006; Bossi Philippe, 2004, Euro Surveill, V9, pE11, DOI 10.2807/esm.09.12.00504-en; Chapman LE, 1999, ANTIVIR THER, V4, P211; Chung DH, 2007, J VIROL, V81, P11722, DOI 10.1128/JVI.00874-07; Dietl CA, 2008, J THORAC CARDIOV SUR, V135, P579, DOI 10.1016/j.jtcvs.2007.11.020; Enria DA, 2001, CURR TOP MICROBIOL, V256, P117; FELDMANN H, 1993, VIRUS RES, V30, P351, DOI 10.1016/0168-1702(93)90101-R; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; HUGGINS JW, 1991, J INFECT DIS, V164, P1119, DOI 10.1093/infdis/164.6.1119; HUGGINS JW, 1986, J INFECT DIS, V153, P489, DOI 10.1093/infdis/153.3.489; Jonsson CB, 2008, ANTIVIR RES, V78, P162, DOI 10.1016/j.antiviral.2007.10.012; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; KIRSI JJ, 1983, ANTIMICROB AGENTS CH, V24, P353, DOI 10.1128/AAC.24.3.353; Martinez VP, 2005, EMERG INFECT DIS, V11, P1848, DOI 10.3201/eid1112.050501; Medina RA, 2007, J GEN VIROL, V88, P493, DOI 10.1099/vir.0.82459-0; Meissner JD, 2002, VIRUS RES, V89, P131, DOI 10.1016/S0168-1702(02)00129-6; Mertz GJ, 2004, CLIN INFECT DIS, V39, P1307, DOI 10.1086/425007; Murphy ME, 2001, J VET MED SCI, V63, P637, DOI 10.1292/jvms.63.637; Nichol S. T., 2005, VIRUS TAXONOMY, P695; Olschlager S, 2011, ANTIVIR RES, V91, P89, DOI 10.1016/j.antiviral.2011.05.006; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; Rusnak JM, 2009, ANTIVIR RES, V81, P68, DOI 10.1016/j.antiviral.2008.09.007; Rusnak JM, 2004, J OCCUP ENVIRON MED, V46, P801, DOI 10.1097/01.jom.0000135539.99691.4e; Safronetz D, 2009, J VIROL, V83, P7285, DOI 10.1128/JVI.00373-09; Schmaljohn C, 2009, VACCINE, V27, pD61, DOI 10.1016/j.vaccine.2009.07.096; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317; Sun YJ, 2007, ANTIMICROB AGENTS CH, V51, P84, DOI 10.1128/AAC.00790-06; Wahl-Jensen V, 2007, J VIROL, V81, P7449, DOI 10.1128/JVI.00238-07; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	31	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23560	10.1371/journal.pone.0023560	http://dx.doi.org/10.1371/journal.pone.0023560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853152	Green Submitted, Green Published, gold			2022-12-27	WOS:000295454200097
J	Forcato, C; Rodriguez, MLC; Pedreira, ME				Forcato, Cecilia; Rodriguez, Maria L. C.; Pedreira, Maria E.			Repeated Labilization-Reconsolidation Processes Strengthen Declarative Memory in Humans	PLOS ONE			English	Article							SLOW-WAVE SLEEP; PROTEIN-SYNTHESIS; FEAR MEMORIES; RETROGRADE-AMNESIA; EXTINCTION; CONSOLIDATION; REACTIVATION; RETRIEVAL; MECHANISMS; NEUROSCIENCE	The idea that memories are immutable after consolidation has been challenged. Several reports have shown that after the presentation of a specific reminder, reactivated old memories become labile and again susceptible to amnesic agents. Such vulnerability diminishes with the progress of time and implies a re-stabilization phase, usually referred to as reconsolidation. To date, the main findings describe the mechanisms associated with the labilization-reconsolidation process, but little is known about its functionality from a biological standpoint. Indeed, two functions have been proposed. One suggests that destabilization of the original memory after the reminder allows the integration of new information into the background of the original memory (memory updating), and the other suggests that the labilization-reconsolidation process strengthens the original memory (memory strengthening). We have previously reported the reconsolidation of human declarative memories, demonstrating memory updating in the framework of reconsolidation. Here we deal with the strengthening function attributed to the reconsolidation process. We triggered labilization-reconsolidation processes successively by repeated presentations of the proper reminder. Participants learned an association between five cue-syllables and their respective response-syllables. Twenty-four hours later, the paired-associate verbal memory was labilized by exposing the subjects to one, two or four reminders. The List-memory was evaluated on Day 3 showing that the memory was improved when at least a second reminder was presented in the time window of the first labilization-reconsolidation process prompted by the earlier reminder. However, the improvement effect was revealed on Day 3, only when at least two reminders were presented on Day2 and not as a consequence of only retrieval. Therefore, we propose central concepts for the reconsolidation process, emphasizing its biological role and the parametrical constrains for this function to be operative.	[Forcato, Cecilia; Rodriguez, Maria L. C.; Pedreira, Maria E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Neurobiol Memoria,IFIBYNE CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Forcato, C (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Lab Neurobiol Memoria,IFIBYNE CONICET, Buenos Aires, DF, Argentina.	mpedreira@fbmc.fcen.uba.ar		FORCATO, CECILIA/0000-0002-5954-4008	Agencia Nacional de Promocion Cientifica y Tecnologica [01-01161]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (Proyecto Investigacion Cientifica Tecnologica convocatoria 2006 No. 01-01161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2006, CELL MOL LIFE SCI, V63, P999, DOI 10.1007/s00018-006-6025-7; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alberini CM., 2007, DEBATES NEUROSCIENCE, V1, P17, DOI [10.1007/s11559-007-9000-z, DOI 10.1007/S11559-007-9000-Z]; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barlett F. C., 1932, REMEMBERING STUDY EX; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Bustos SG, 2006, NEUROSCIENCE, V139, P831, DOI 10.1016/j.neuroscience.2005.12.064; Coccoz V, 2011, NEUROSCIENCE, V185, P61, DOI 10.1016/j.neuroscience.2011.04.023; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y., 2002, MEMORY KEYWORDS CONC; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Forcato C, 2010, NEUROBIOL LEARN MEM, V93, P77, DOI 10.1016/j.nlm.2009.08.006; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Hardt O, 2010, ANNU REV PSYCHOL, V61, P141, DOI 10.1146/annurev.psych.093008.100455; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00168; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Merlo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003687; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; MULLER GE, 1900, Z PSYCHOL S, V1; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2010, ANN NY ACAD SCI, V1191, P27, DOI 10.1111/j.1749-6632.2010.05443.x; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rodriguez-Ortiz CJ, 2005, LEARN MEMORY, V12, P533, DOI 10.1101/lm.94505; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schacter D.L., 1982, EXPRESSION KNOWLEDGE, P33, DOI [10.1007/978-1-4684-7890-7_2, DOI 10.1007/978-1-4684-7890-7_2]; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Suzuki A, 2008, LEARN MEMORY, V15, P426, DOI 10.1101/lm.888808; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tronson NC, 2008, NEUROPSYCHOPHARMACOL, V33, P1570, DOI 10.1038/sj.npp.1301550; Tulving E., 1972, ORG MEMORY, P423	65	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23305	10.1371/journal.pone.0023305	http://dx.doi.org/10.1371/journal.pone.0023305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803EC	21850268	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300053
J	Mongrain, V; Carrier, J; Paquet, J; Belanger-Nelson, E; Dumont, M				Mongrain, Valerie; Carrier, Julie; Paquet, Jean; Belanger-Nelson, Erika; Dumont, Marie			Morning and Evening-Type Differences in Slow Waves during NREM Sleep Reveal Both Trait and State-Dependent Phenotypes	PLOS ONE			English	Article							CORTICAL SYNCHRONIZATION; EEG; HOMEOSTASIS; OSCILLATIONS; PRESSURE; NIGHT; ADOLESCENTS; MODULATION; DENSITY; RHYTHMS	Brain recovery after prolonged wakefulness is characterized by increased density, amplitude and slope of slow waves (SW, < 4 Hz) during non-rapid eye movement (NREM) sleep. These SW comprise a negative phase, during which cortical neurons are mostly silent, and a positive phase, in which most neurons fire intensively. Previous work showed, using EEG spectral analysis as an index of cortical synchrony, that Morning-types (M-types) present faster dynamics of sleep pressure than Evening-types (E-types). We thus hypothesized that single SW properties will also show larger changes in M-types than in E-types in response to increased sleep pressure. SW density (number per minute) and characteristics (amplitude, slope between negative and positive peaks, frequency and duration of negative and positive phases) were compared between chronotypes for a baseline sleep episode (BL) and for recovery sleep (REC) after two nights of sleep fragmentation. While SW density did not differ between chronotypes, M-types showed higher SW amplitude and steeper slope than E-types, especially during REC. SW properties were also averaged for 3 NREM sleep periods selected for their decreasing level of sleep pressure (first cycle of REC [REC1], first cycle of BL [BL1] and fourth cycle of BL [BL4]). Slope was significantly steeper in M-types than in E-types in REC1 and BL1. SW frequency was consistently higher and duration of positive and negative phases constantly shorter in M-types than in E-types. Our data reveal that specific properties of cortical synchrony during sleep differ between M-types and E-types, although chronotypes show a similar capacity to generate SW. These differences may involve 1) stable trait characteristics independent of sleep pressure (i.e., frequency and durations) likely linked to the length of silent and burst-firing phases of individual neurons, and 2) specific responses to increased sleep pressure (i.e., slope and amplitude) expected to depend on the synchrony between neurons.	[Mongrain, Valerie; Carrier, Julie; Paquet, Jean; Belanger-Nelson, Erika; Dumont, Marie] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Mongrain, Valerie; Dumont, Marie] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Carrier, Julie] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Carrier, Julie] Inst Univ Geriatrie Montreal, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Mongrain, V (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada.	valerie.mongrain@umontreal.ca	Mongrain, Valérie/A-3931-2012	Carrier, Julie/0000-0001-5311-2370	CIHR [MOP-68878, MOP-93733]; NSERC	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by CIHR grants to MD (MOP-68878) and JC (MOP-93733) (http://www.cihr-irsc.gc.ca/) and NSERC fellowships to VM (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 2000, ACTA NEUROBIOL EXP, V60, P229; Bersagliere A, 2010, J SLEEP RES, V19, P228, DOI 10.1111/j.1365-2869.2009.00775.x; Brunner DP, 1996, J SLEEP RES, V5, P155, DOI 10.1046/j.1365-2869.1996.00009.x; Cajochen C, 1999, Sleep Res Online, V2, P65; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Feinberg I, 2003, SLEEP, V26, P192, DOI 10.1093/sleep/26.2.192; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Huber R, 2000, J NEUROPHYSIOL, V84, P1888, DOI 10.1152/jn.2000.84.4.1888; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; Kurth S, 2010, SLEEP, V33, P475, DOI 10.1093/sleep/33.4.475; LANCEL M, 1991, PHYSIOL BEHAV, V49, P1195, DOI 10.1016/0031-9384(91)90351-N; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Misgeld U, 2007, PROG BRAIN RES, V160, P245, DOI 10.1016/S0079-6123(06)60014-9; Mongrain V, 2006, EUR J NEUROSCI, V23, P497, DOI 10.1111/j.1460-9568.2005.04561.x; Mongrain V, 2004, J BIOL RHYTHM, V19, P248, DOI 10.1177/0748730404264365; Mongrain V, 2007, SLEEP, V30, P773, DOI 10.1093/sleep/30.6.773; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Shaw PJ, 2003, J NEUROBIOL, V54, P179, DOI 10.1002/neu.10167; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Taillard J, 2003, J SLEEP RES, V12, P275, DOI 10.1046/j.0962-1105.2003.00369.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Winsky-Sommerer R, 2009, EUR J NEUROSCI, V29, P1779, DOI 10.1111/j.1460-9568.2009.06716.x	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22679	10.1371/journal.pone.0022679	http://dx.doi.org/10.1371/journal.pone.0022679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829643	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200026
J	Sathuluri, RR; Yoshikawa, H; Shimizu, E; Saito, M; Tamiya, E				Sathuluri, Ramachandra Rao; Yoshikawa, Hiroyuki; Shimizu, Eiichi; Saito, Masato; Tamiya, Eiichi			Gold Nanoparticle-Based Surface-Enhanced Raman Scattering for Noninvasive Molecular Probing of Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							SINGLE-MOLECULE; LIVE CELLS; SPECTROSCOPY; SERS; MITOCHONDRIA; DYNAMICS; FATE; PH	This study reports the use of gold nanoparticle-based surface-enhanced Raman scattering (SERS) for probing the differentiation of mouse embryonic stem (mES) cells, including undifferentiated single cells, embryoid bodies (EBs), and terminally differentiated cardiomyocytes. Gold nanoparticles (GNPs) were successfully delivered into all 3 mES cell differentiation stages without affecting cell viability or proliferation. Transmission electron microscopy (TEM) confirmed the localization of GNPs inside the following cell organelles: mitochondria, secondary lysosome, and endoplasmic reticulum. Using bright- and dark-field imaging, the bright scattering of GNPs and nanoaggregates in all 3 ES cell differentiation stages could be visualized. EB (an early differentiation stage) and terminally differentiated cardiomyocytes both showed SERS peaks specific to metabolic activity in the mitochondria and to protein translation (amide I, amide II, and amide III peaks). These peaks have been rarely identified in undifferentiated single ES cells. Spatiotemporal changes observed in the SERS spectra from terminally differentiated cardiomyocyte tissues revealed local and dynamic molecular interactions as well as transformations during ES cell differentiation.	[Sathuluri, Ramachandra Rao; Yoshikawa, Hiroyuki; Shimizu, Eiichi; Saito, Masato; Tamiya, Eiichi] Osaka Univ, Dept Appl Phys, Grad Sch Engn, Suita, Osaka 565, Japan; [Tamiya, Eiichi] Osaka Univ, Adv Photon Res Ctr, Grad Sch Engn, Suita, Osaka 565, Japan	Osaka University; Osaka University	Sathuluri, RR (corresponding author), Osaka Univ, Dept Appl Phys, Grad Sch Engn, Suita, Osaka 565, Japan.	sathuluri@ap.eng.osaka-u.ac.jp; tamiya@ap.eng.osaka-u.ac.jp	Tamiya, Eiichi/M-6111-2018	Tamiya, Eiichi/0000-0002-7646-4827				Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Bell SEJ, 2006, J AM CHEM SOC, V128, P15580, DOI 10.1021/ja066263w; Bizzarri AR, 2007, NANOMED-NANOTECHNOL, V3, P306, DOI 10.1016/j.nano.2007.09.005; Boheler KR, 2005, METH MOLEC MED, V108, P417; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Braun G, 2007, J AM CHEM SOC, V129, P6378, DOI 10.1021/ja070514z; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2009, NANOMED-NANOTECHNOL, V5, P118, DOI 10.1016/j.nano.2009.01.008; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chiu L, 2010, J RAMAN SPECTROSC, V41, P2, DOI 10.1002/jrs.2425; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Esumi K, 2004, LANGMUIR, V20, P2536, DOI 10.1021/la036299r; Esumi K, 2003, COLLOID SURFACE B, V32, P117, DOI 10.1016/S0927-7765(03)00151-6; Fujita K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3119242; Hossain MM, 2010, ANALYST, V135, P1624, DOI 10.1039/c0an00208a; Huh YS, 2009, MICROFLUID NANOFLUID, V6, P285, DOI 10.1007/s10404-008-0392-3; Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698; Karatas OF, 2009, COLLOID SURFACE B, V71, P315, DOI 10.1016/j.colsurfb.2009.02.020; Khan I, 2006, ANAL CHEM, V78, P224, DOI 10.1021/ac051158a; Kim JH, 2006, ANAL CHEM, V78, P6967, DOI 10.1021/ac0607663; Kneipp J, 2006, NANO LETT, V6, P2225, DOI 10.1021/nl061517x; Kneipp J, 2010, J PHYS CHEM C, V114, P7421, DOI 10.1021/jp910034z; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Kneipp K, 2002, APPL SPECTROSC, V56, P150, DOI 10.1366/0003702021954557; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Mandal D, 2009, J MATER SCI-MATER M, V20, P347, DOI 10.1007/s10856-008-3588-x; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720; Notingher I, 2007, SENSORS-BASEL, V7, P1343, DOI 10.3390/s7081343; Ochsenkuhn MA, 2009, ACS NANO, V3, P3613, DOI 10.1021/nn900681c; Oka M, 2002, MOL BIOL CELL, V13, P1274, DOI 10.1091/mbc.02-01-0600; Pallaoro A, 2010, SMALL, V6, P618, DOI 10.1002/smll.200901893; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Peticolas WL, 1996, J RAMAN SPECTROSC, V27, P571, DOI 10.1002/(SICI)1097-4555(199608)27:8<571::AID-JRS8>3.0.CO;2-5; Porter MD, 2008, CHEM SOC REV, V37, P1001, DOI 10.1039/b708461g; Qian XM, 2008, CHEM SOC REV, V37, P912, DOI 10.1039/b708839f; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schulze HG, 2010, ANAL CHEM, V82, P5020, DOI 10.1021/ac902697q; SEQUARIS JM, 1985, J COLLOID INTERF SCI, V105, P417, DOI 10.1016/0021-9797(85)90315-7; Sha MY, 2007, NANOMEDICINE-UK, V2, P725, DOI 10.2217/17435889.2.5.725; Shimizukawa R, 2005, GENESIS, V42, P47, DOI 10.1002/gene.20122; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Stewart S, 1999, SPECTROCHIM ACTA A, V55, P1641, DOI 10.1016/S1386-1425(98)00294-7; Sujith A, 2009, ANAL BIOANAL CHEM, V394, P1803, DOI 10.1007/s00216-009-2883-9; Sun L, 2007, NANO LETT, V7, P351, DOI 10.1021/nl062453t; Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708; Tkachenko AG, 2003, J AM CHEM SOC, V125, P4700, DOI 10.1021/ja0296935; Tran DN, 2007, FERTIL STERIL, V87, P965, DOI 10.1016/j.fertnstert.2006.07.1520; Willets KA, 2009, ANAL BIOANAL CHEM, V394, P85, DOI 10.1007/s00216-009-2682-3; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yakimovich NO, 2008, RUSS CHEM B+, V57, P520, DOI 10.1007/s11172-008-0080-1; Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002; Yamanaka S, 2008, CELL TISSUE RES, V331, P5, DOI 10.1007/s00441-007-0520-5; Yu KN, 2007, BIOCONJUGATE CHEM, V18, P1155, DOI 10.1021/bc070011i; Zhang XL, 2008, ANAL BIOANAL CHEM, V390, P833, DOI 10.1007/s00216-007-1564-9	63	62	63	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22802	10.1371/journal.pone.0022802	http://dx.doi.org/10.1371/journal.pone.0022802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829653	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200031
J	Pauwelyn, K; Roelandt, P; Notelaers, T; Sancho-Bru, P; Fevery, J; Verfaillie, CM				Pauwelyn, Karen; Roelandt, Philip; Notelaers, Tineke; Sancho-Bru, Pau; Fevery, Johan; Verfaillie, Catherine M.			Culture of Mouse Embryonic Stem Cells with Serum but without Exogenous Growth Factors Is Sufficient to Generate Functional Hepatocyte-Like Cells	PLOS ONE			English	Article							DEFINITIVE ENDODERM; LIVER DEVELOPMENT; IN-VITRO; PROGENITOR CELLS; TGF-BETA; DIFFERENTIATION; EXPRESSION; WNT; INTERFERENCE; MESENDODERM	Mouse embryonic stem cells (mESC) have been used to study lineage specification in vitro, including towards a hepatocyte-like fate, and such investigations guided lineage differentiation protocols for human (h)ESC. We recently described a four-step protocol to induce hepatocyte-like cells from hESC which also induced hepatocyte-like cell differentiation of mouse induced pluripotent stem cells. As ESC also spontaneously generate hepatocyte-like cells, we here tested whether the growth factors and serum used in this protocol are required to commit mESC and hESC to hepatocyte-like cells. Culture of mESC from two different mouse strains in the absence of serum and growth factors did not induce primitive streak/definitive endoderm genes but induced default differentiation to neuroectoderm on day 6. Although Activin-A and Wnt3 induced primitive streak/definitive endoderm transcripts most robustly in mESC, simple addition of serum also induced these transcripts. Expression of hepatoblast genes occurred earlier when growth factors were used for mESC differentiation. However, further maturation towards functional hepatocyte-like cells was similar in mESC progeny from cultures with serum, irrespective of the addition of growth factors, and irrespective of the mouse strain. This is in contrast to hESC, where growth factors are required for specification towards functional hepatocyte-like cells. Culture of mESC with serum but without growth factors did not induce preferential differentiation towards primitive endoderm or neuroectoderm. Thus, although induction of primitive streak/definitive endoderm specific genes and proteins is more robust when mESC are exposed to a combination of serum and exogenous growth factors, ultimate generation of hepatocyte-like cells from mESC occurs equally well in the presence or absence of exogenous growth factors. The latter is in contrast to what we observed for hESC. These results suggest that differences exist between lineage specific differentiation potential of mESC and hESC, requiring optimization of different protocols for ESC from either species.	[Pauwelyn, Karen; Roelandt, Philip; Notelaers, Tineke; Sancho-Bru, Pau; Verfaillie, Catherine M.] Katholieke Univ Leuven, Stem Cell Inst Leuven, Louvain, Belgium; [Pauwelyn, Karen; Roelandt, Philip; Fevery, Johan] Univ Hosp Leuven, Dept Hepatol, Louvain, Belgium; [Sancho-Bru, Pau] Hosp Clin Barcelona, Liver Unit, CIBERehd, IDIBAPS, Barcelona, Spain	KU Leuven; KU Leuven; University Hospital Leuven; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pauwelyn, K (corresponding author), Katholieke Univ Leuven, Stem Cell Inst Leuven, Louvain, Belgium.	Philip.roelandt@med.kuleuven.be	Sancho-Bru, Pau/D-4900-2014; Verfaillie, Catherine/H-5148-2013	Sancho-Bru, Pau/0000-0001-5569-9259; Verfaillie, Catherine/0000-0001-7564-4079	National Institutes of Health [RO1-DK58295, U19-DK61244]; Alpha 1 Foundation; FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders) [G.0667.07]; IWT-SBO (HepStem); K.U. Leuven SCIL Center of Excellence; K.U. Leuven OT [ETH-C0420-OT/09/053]; GOA [EME-C2161-GOA/11/012]; FWO [KAN 1.5163.09]; BAEF (Belgian American Education Foundation); VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology); IWT (Agentschap voor Innovatie door Wetenschap en Technologie); Agencia de Gestio d'Ajuts Universitaris i de Recerca; Beatriu de Pinos [2006 BP-A 10104]; Juan de la Cierva [JCI-2009-03849]; Ministerio de Ciencia e Innovacion; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061244, R01DK058295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha 1 Foundation; FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders)(FWO); IWT-SBO (HepStem)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); K.U. Leuven SCIL Center of Excellence; K.U. Leuven OT; GOA; FWO(FWO); BAEF (Belgian American Education Foundation); VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology); IWT (Agentschap voor Innovatie door Wetenschap en Technologie)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Beatriu de Pinos; Juan de la Cierva(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to C. Verfaillie from the National Institutes of Health (RO1-DK58295 and U19-DK61244), the Alpha 1 Foundation, FWO (Fonds Wetenschappelijk Onderzoek - Research Fundings Flanders, www.fwo.be) G.0667.07 Odysseus award, IWT-SBO grant (HepStem), a K.U. Leuven SCIL Center of Excellence/Program Financing Award, and a K.U. Leuven OT (ETH-C0420-OT/09/053) and GOA (EME-C2161-GOA/11/012) Award. K. Pauwelyn was funded by FWO, BAEF (Belgian American Education Foundation, www.baef.be), and VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology, www.vvge.be). P. Roelandt was funded by IWT (Agentschap voor Innovatie door Wetenschap en Technologie) and VVGE (Vlaamse Vereniging voor Gastro-Enterologie - Flemish Society Gastroenterology, www.vvge.be). P. Sancho-Bru was funded by FWO (KAN 1.5163.09) and Agencia de Gestio d'Ajuts Universitaris i de Recerca, Beatriu de Pinos (2006 BP-A 10104) and Postdoctoral contract Juan de la Cierva JCI-2009-03849, Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SL, 1996, DEVELOPMENT, V122, P243; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Dong XJ, 2009, WORLD J GASTROENTERO, V15, P5165, DOI 10.3748/wjg.15.5165; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Heo J, 2005, BIOCHEM BIOPH RES CO, V332, P1061, DOI 10.1016/j.bbrc.2005.04.173; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042; Niki T, 1996, HEPATOLOGY, V23, P1538, DOI 10.1053/jhep.1996.v23.pm0008675175; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Roelandt P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012101; Roelandt P, 2010, NAT PROTOC, V5, P1324, DOI 10.1038/nprot.2010.80; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; Saijoh Y, 1999, GENE DEV, V13, P259, DOI 10.1101/gad.13.3.259; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Sekhon SS, 2004, AM J PATHOL, V164, P2229, DOI 10.1016/S0002-9440(10)63779-0; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhou MM, 2010, J CELL BIOCHEM, V109, P606, DOI 10.1002/jcb.22442	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e23096	10.1371/journal.pone.0023096	http://dx.doi.org/10.1371/journal.pone.0023096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829697	Green Submitted, gold, Green Published			2022-12-27	WOS:000293511900025
J	Castillo, AF; Fan, JJ; Papadopoulos, V; Podesta, EJ				Fernanda Castillo, Ana; Fan, Jinjiang; Papadopoulos, Vassilios; Podesta, Ernesto J.			Hormone-Dependent Expression of a Steroidogenic Acute Regulatory Protein Natural Antisense Transcript in MA-10 Mouse Tumor Leydig Cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; NITRIC-OXIDE SYNTHASE; MYOSIN HEAVY-CHAIN; MITOCHONDRIAL CHOLESTEROL TRANSPORT; GENE-EXPRESSION; STAR GENE; MEDIATED INHIBITION; ARACHIDONIC-ACID; MAMMALIAN-CELLS; NONCODING RNAS	Cholesterol transport is essential for many physiological processes, including steroidogenesis. In steroidogenic cells hormone-induced cholesterol transport is controlled by a protein complex that includes steroidogenic acute regulatory protein (StAR). Star is expressed as 3.5-, 2.8-, and 1.6-kb transcripts that differ only in their 3'-untranslated regions. Because these transcripts share the same promoter, mRNA stability may be involved in their differential regulation and expression. Recently, the identification of natural antisense transcripts (NATs) has added another level of regulation to eukaryotic gene expression. Here we identified a new NAT that is complementary to the spliced Star mRNA sequence. Using 59 and 39 RACE, strand-specific RT-PCR, and ribonuclease protection assays, we demonstrated that Star NAT is expressed in MA-10 Leydig cells and steroidogenic murine tissues. Furthermore, we established that human chorionic gonadotropin stimulates Star NAT expression via cAMP. Our results show that sense-antisense Star RNAs may be coordinately regulated since they are co-expressed in MA-10 cells. Overexpression of Star NAT had a differential effect on the expression of the different Star sense transcripts following cAMP stimulation. Meanwhile, the levels of StAR protein and progesterone production were downregulated in the presence of Star NAT. Our data identify antisense transcription as an additional mechanism involved in the regulation of steroid biosynthesis.	[Fernanda Castillo, Ana; Podesta, Ernesto J.] Univ Buenos Aires, Sch Med, Dept Human Biochem, Inst Invest Mol Enfermedades Hormonales Neurodege, Buenos Aires, DF, Argentina; [Fan, Jinjiang; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ, Canada; [Fan, Jinjiang; Papadopoulos, Vassilios] McGill Univ, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ, Canada	University of Buenos Aires; McGill University; McGill University	Castillo, AF (corresponding author), Univ Buenos Aires, Sch Med, Dept Human Biochem, Inst Invest Mol Enfermedades Hormonales Neurodege, Buenos Aires, DF, Argentina.	ernestopodesta@yahoo.com.ar	Fan, Jinjiang/C-2010-2009; Papadopoulos, Vassilios/AAI-2613-2019	Fan, Jinjiang/0000-0003-3102-4833; Papadopoulos, Vassilios/0000-0002-1183-8568; Castillo, Ana Fernanda/0000-0002-1572-4728	University of Buenos Aires (UBA) [M059]; National Agency for Promotion of Science and Technology (ANPCyT) [PICT 2006-00819]; Bunge and Born Foundation; National Institutes of Health [R01 ES07747]; Canadian Institutes of Health Research [MOP102647]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la recherche en sante du Quebec; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	University of Buenos Aires (UBA)(University of Buenos Aires); National Agency for Promotion of Science and Technology (ANPCyT)(ANPCyT); Bunge and Born Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grant M059 from the University of Buenos Aires (UBA, http://www.uba.ar/homepage.php) and grant PICT 2006-00819 from the National Agency for Promotion of Science and Technology (ANPCyT, http://www.agencia.mincyt.gov.ar) to E.J.P.; a fellowship from Bunge and Born Foundation (http://www.fundacionbyb.org/) to A. F. C.; grant R01 ES07747 from the National Institutes of Health (http://www.nih.gov/) and MOP102647 from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) to V. P. V. P. was also supported by a Canada Research Chair in Biochemical Pharmacology. The Research Institute of McGill University Health Centre (MUHC) is supported in part by a Center grant from Le Fonds de la recherche en sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Ariyoshi N, 1998, J BIOL CHEM, V273, P7610, DOI 10.1074/jbc.273.13.7610; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Bartsch H, 2004, RNA, V10, P1215, DOI 10.1261/rna.5261204; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castillo AF, 2006, FEBS J, V273, P5011, DOI 10.1111/j.1742-4658.2006.05496.x; CELANO P, 1993, BIOTECHNIQUES, V15, P26; Chau YM, 2002, J CLIN ENDOCR METAB, V87, P2674, DOI 10.1210/jc.87.6.2674; Clark BJ, 1999, ENDOCRINOLOGY, V140, P4390, DOI 10.1210/en.140.10.4390; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; Dahary D, 2005, GENOME RES, V15, P364, DOI 10.1101/gr.3308405; Delihas N, 1997, NAT BIOTECHNOL, V15, P751, DOI 10.1038/nbt0897-751; Duan HC, 2007, J MOL ENDOCRINOL, V38, P159, DOI 10.1677/jme.1.02153; Duan H, 2009, MOL ENDOCRINOL, V23, P497, DOI 10.1210/me.2008-0296; EPSTEIN LF, 1991, MOL CELL ENDOCRINOL, V81, P113, DOI 10.1016/0303-7207(91)90210-J; Faghihi MA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r56; Ge XJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-27; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Haddad F, 2003, J BIOL CHEM, V278, P37132, DOI 10.1074/jbc.M305911200; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Haidan A, 2000, MOL CELL ENDOCRINOL, V165, P25, DOI 10.1016/S0303-7207(00)00267-7; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hiroi H, 2004, MOL CELL ENDOCRINOL, V215, P119, DOI 10.1016/j.mce.2003.11.014; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Ivell R, 2000, J MOL ENDOCRINOL, V24, P109, DOI 10.1677/jme.0.0240109; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Korneev SA, 1999, J NEUROSCI, V19, P7711; KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Kumar PA, 2010, J BIOL CHEM, V285, P31148, DOI 10.1074/jbc.M110.132332; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Luther HP, 2005, J CELL BIOCHEM, V94, P848, DOI 10.1002/jcb.20319; Luther HP, 2001, J CELL BIOCHEM, V80, P596, DOI 10.1002/1097-4644(20010315)80:4<596::AID-JCB1014>3.0.CO;2-Y; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Matsui K, 2008, HEPATOLOGY, V47, P686, DOI 10.1002/hep.22036; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Merzendorfer H, 1997, FEBS LETT, V411, P239, DOI 10.1016/S0014-5793(97)00699-6; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Oeder S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-200; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; Paz C, 2009, METHOD ENZYMOL, V457, P169, DOI 10.1016/S0076-6879(09)05010-1; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Podlowski S, 2002, J CELL BIOCHEM, V85, P198, DOI 10.1002/jcb.10116; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rosok O, 2004, NAT BIOTECHNOL, V22, P104, DOI 10.1038/nbt925; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Rusovici R, 2005, BIOL REPROD, V72, P862, DOI 10.1095/biolreprod.104.034298; Sambrook J., 2002, MOL CLONING LAB MANU; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shi MX, 2000, BRAIN RES BULL, V53, P317, DOI 10.1016/S0361-9230(00)00349-X; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; SIMPSON ER, 1983, CAN J BIOCHEM CELL B, V61, P692, DOI 10.1139/o83-088; Stein P, 2003, RNA, V9, P187, DOI 10.1261/rna.2860603; Stocco DM, 1996, BIOCHEM PHARMACOL, V51, P197, DOI 10.1016/0006-2952(95)02093-4; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; STOCCO DM, 1991, J BIOL CHEM, V266, P19731; Su WY, 2010, BIOCHEM BIOPH RES CO, V396, P177, DOI 10.1016/j.bbrc.2010.04.147; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Tommasi S, 1999, J BIOL CHEM, V274, P27829, DOI 10.1074/jbc.274.39.27829; Tsuchiya M, 2003, LIFE SCI, V73, P2855, DOI 10.1016/S0024-3205(03)00698-2; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; Volloch V, 1996, P NATL ACAD SCI USA, V93, P2476, DOI 10.1073/pnas.93.6.2476; Werner A, 2007, PHYSIOL GENOMICS, V28, P294, DOI 10.1152/physiolgenomics.00127.2006; Werner Andreas, 2005, RNA Biol, V2, P53, DOI 10.4161/rna.2.2.1852; Werner A, 2010, BIOCHEM SOC T, V38, P1144, DOI 10.1042/BST0381144; Werner A, 2009, CURR OPIN NEPHROL HY, V18, P343, DOI 10.1097/MNH.0b013e32832cb982; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Yamazaki T, 2006, BBA-PROTEINS PROTEOM, V1764, P1561, DOI 10.1016/j.bbapap.2006.08.016; Yeilding NM, 1998, J BIOL CHEM, V273, P15749, DOI 10.1074/jbc.273.25.15749; Zhang JX, 2006, BIOINFORMATICS, V22, P385, DOI 10.1093/bioinformatics/bti796; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473; Zhao D, 2005, J STEROID BIOCHEM, V96, P155, DOI 10.1016/j.jsbmb.2005.02.011	88	13	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e22822	10.1371/journal.pone.0022822	http://dx.doi.org/10.1371/journal.pone.0022822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829656	Green Published, gold, Green Submitted			2022-12-27	WOS:000293511200020
J	Welsch, T; Zschabitz, S; Becker, V; Giese, T; Bergmann, F; Hinz, U; Keleg, S; Heller, A; Sipos, B; Klingmuller, U; Buchler, MW; Werner, J; Giese, NA				Welsch, Thilo; Zschaebitz, Stefanie; Becker, Verena; Giese, Thomas; Bergmann, Frank; Hinz, Ulf; Keleg, Shereen; Heller, Anette; Sipos, Bence; Klingmueller, Ursula; Buechler, Markus W.; Werner, Jens; Giese, Nathalia A.			Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; HUMAN TUMOR-CELLS; QUALITY-OF-LIFE; CANCER-PATIENTS; TRANSFERRIN RECEPTOR; STIMULATING AGENTS; EPOETIN-BETA; ANEMIA; EXPRESSION; CARCINOMA	Background: Erythropoietin (Epo) administration has been reported to have tumor-promoting effects in anemic cancer patients. We investigated the prognostic impact of endogenous Epo in patients with pancreatic ductal adenocarcinoma (PDAC). Methodology: The clinico-pathological relevance of hemoglobin (Hb, n = 150), serum Epo (sEpo, n = 87) and tissue expression of Epo/Epo receptor (EpoR, n = 104) was analyzed in patients with PDAC. Epo/EpoR expression, signaling, growth, invasion and chemoresistance were studied in Epo-exposed PDAC cell lines. Results: Compared to donors, median preoperative Hb levels were reduced by 15% in both chronic pancreatitis (CP, p<0.05) and PDAC (p<0.001), reaching anemic grade in one third of patients. While inversely correlating to Hb (r = -0.46), 95% of sEPO values lay within the normal range. The individual levels of compensation were adequate in CP (observed to predicted ratio, O/P = 0.99) but not in PDAC (O/P = 0.85). Strikingly, lower sEPO values yielding inadequate Epo responses were prominent in non-metastatic M0-patients, whereas these parameters were restored in metastatic M1-group (8 vs. 13 mU/mL; O/P = 0.82 vs. 0.96; p<0.01)-although Hb levels and the prevalence of anemia were comparable. Higher sEpo values (upper quartile >= 16 mU/ml) were not significantly different in M0 (20%) and M1 (30%) groups, but were an independent prognostic factor for shorter survival (HR 2.20, 10 vs. 17 months, p<0.05). The pattern of Epo expression in pancreas and liver suggested ectopic release of Epo by capillaries/vasa vasorum and hepatocytes, regulated by but not emanating from tumor cells. Epo could initiate PI3K/Akt signaling via EpoR in PDAC cells but failed to alter their functions, probably due to co-expression of the soluble EpoR isoform, known to antagonize Epo. Conclusion/Significance: Higher sEPO levels counteract anemia but worsen outcome in PDAC patients. Further trials are required to clarify how overcoming a sEPO threshold $ 16 mU/ml by endogenous or exogenous means may predispose to or promote metastatic progression.	[Welsch, Thilo; Zschaebitz, Stefanie; Hinz, Ulf; Keleg, Shereen; Heller, Anette; Buechler, Markus W.; Werner, Jens; Giese, Nathalia A.] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Becker, Verena; Klingmueller, Ursula] Univ Heidelberg, Div Syst Biol Signal Transduct, German Canc Res Ctr & Bioquant, Heidelberg, Germany; [Giese, Thomas] Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany; [Bergmann, Frank] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Sipos, Bence] Univ Tubingen Hosp, Inst Pathol, Tubingen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Welsch, T (corresponding author), Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.	nathalia.giese@med.uni-heidelberg.de	Klingmüller, Ursula/G-8477-2013	Klingmüller, Ursula/0000-0001-9845-3099	Heidelberger Stiftung Chirurgie; Helmholtz Alliance on Systems Biology (SBCancer); Dietmar-Hopp-Stiftung; German Ministry of Education and Research (NGFNnetwork) [PKB-01GS08178, PKB-01GS08114]	Heidelberger Stiftung Chirurgie; Helmholtz Alliance on Systems Biology (SBCancer); Dietmar-Hopp-Stiftung; German Ministry of Education and Research (NGFNnetwork)(Federal Ministry of Education & Research (BMBF))	The work was supported by the grants from the Heidelberger Stiftung Chirurgie to TW, the Helmholtz Alliance on Systems Biology (SBCancer) to VB and UK, the Dietmar-Hopp-Stiftung to NAG and by the German Ministry of Education and Research (NGFNnetwork grants PKB-01GS08178 to BS and PKB-01GS08114 to NAG, who is responsible for the contents of publication). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2008, BRIT J CANCER, V99, P14, DOI 10.1038/sj.bjc.6604408; Aapro MS, 2008, ONCOLOGIST, V13, P33, DOI 10.1634/theoncologist.13-S3-33; Acs G, 2004, CANCER-AM CANCER SOC, V100, P2376, DOI 10.1002/cncr.20244; Acs G, 2001, CANCER RES, V61, P3561; Arcasoy MO, 2003, BIOCHEM BIOPH RES CO, V307, P999, DOI 10.1016/S0006-291X(03)01303-2; Arcasoy MO, 2008, CLIN CANCER RES, V14, P4685, DOI 10.1158/1078-0432.CCR-08-0264; BAROSI G, 1994, ANN HEMATOL, V68, P215, DOI 10.1007/BF01737420; Bartel M, 2008, J PATHOL, V215, P195, DOI 10.1002/path.2348; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; BEGUIN Y, 1993, BLOOD, V81, P1067; Cao Yiting, 2010, Genes Cancer, V1, P50; Crawford J, 2002, CANCER-AM CANCER SOC, V95, P888, DOI 10.1002/cncr.10763; Dernedde U, 2007, CLIN ONCOL-UK, V19, P223, DOI 10.1016/j.clon.2006.11.011; Dunlop EA, 2007, STEM CELLS, V25, P380, DOI 10.1634/stemcells.2006-0452; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Glimelius B, 1998, J CLIN ONCOL, V16, P434, DOI 10.1200/JCO.1998.16.2.434; Hardee ME, 2006, MOL CANCER THER, V5, P356, DOI 10.1158/1535-7163.MCT-05-0196; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Inthal A, 2008, CLIN CANCER RES, V14, P7196, DOI 10.1158/1078-0432.CCR-07-5051; Juneja V, 2008, CLIN CANCER RES, V14, P3242, DOI 10.1158/1078-0432.CCR-07-1872; Ketteler R, 2002, J BIOL CHEM, V277, P26547, DOI 10.1074/jbc.M202287200; Klingmuller U, 1997, EUR J BIOCHEM, V249, P637, DOI 10.1111/j.1432-1033.1997.t01-1-00637.x; Laugsch M, 2008, INT J CANCER, V122, P1005, DOI 10.1002/ijc.23201; LEITGEB C, 1994, CANCER-AM CANCER SOC, V73, P2535, DOI 10.1002/1097-0142(19940515)73:10<2535::AID-CNCR2820731014>3.0.CO;2-5; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; MILLER CB, 1990, NEW ENGL J MED, V322, P1689, DOI 10.1056/NEJM199006143222401; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Mirmohammadsadegh A, 2010, J INVEST DERMATOL, V130, P201, DOI 10.1038/jid.2009.162; NOWROUSIAN MR, 1997, RECOMBINANT HUMAN ER, P149; Opasich C, 2005, EUR HEART J, V26, P2232, DOI 10.1093/eurheartj/ehi388; Pajonk F, 2004, ONCOGENE, V23, P8987, DOI 10.1038/sj.onc.1208140; Papworth K, 2009, TUMOR BIOL, V30, P86, DOI 10.1159/000216844; Phillips TM, 2007, NEOPLASIA, V9, P1122, DOI 10.1593/neo.07694; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-7; Rades D, 2010, INT J RAD ONCOL BIOL; Ramadori P, 2010, LAB INVEST, V90, P1306, DOI 10.1038/labinvest.2010.85; Ribatti D, 2007, HISTOPATHOLOGY, V50, P591, DOI 10.1111/j.1365-2559.2007.02654.x; Ribatti D, 2007, J NEURO-ONCOL, V82, P327, DOI 10.1007/s11060-006-9289-8; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rizzo JD, 2010, J CLIN ONCOL, V28, P4996, DOI 10.1200/JCO.2010.29.2201; Roque ME, 2001, CLIN LAB HAEMATOL, V23, P291, DOI 10.1046/j.1365-2257.2001.00413.x; Samyn I, 2004, J CLIN ONCOL, V22, P2240, DOI 10.1200/JCO.2004.10.031; Sinclair AM, 2008, BRIT J CANCER, V98, P1059, DOI 10.1038/sj.bjc.6604220; Szenajch J, 2010, BBA-REV CANCER, V1806, P82, DOI 10.1016/j.bbcan.2010.04.002; Talar-Wojnarowska R, 2009, DIGEST DIS SCI, V54, P683, DOI 10.1007/s10620-008-0390-z; van der Meer P, 2004, J AM COLL CARDIOL, V44, P63, DOI 10.1016/j.jacc.2004.03.052; Welsch T, 2011, LANGENBECK ARCH SURG, V396, P353, DOI 10.1007/s00423-010-0629-y; Welsch T, 2009, CLIN EXP METASTAS, V26, P701, DOI 10.1007/s10585-009-9269-4; Westphal G, 2002, CLIN EXP MED, V2, P45, DOI 10.1007/s102380200006; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Yin D, 2007, INT J ONCOL, V31, P1193; Zeh H. J., 2005, Cancer Biomarkers, V1, P259	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e23151	10.1371/journal.pone.0023151	http://dx.doi.org/10.1371/journal.pone.0023151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829709	Green Published, Green Submitted, gold			2022-12-27	WOS:000293511200042
J	Wang, JL; Lin, YW; Chen, HM; Kong, X; Xiong, H; Shen, N; Hong, J; Fang, JY				Wang, Ji-Lin; Lin, Yan-Wei; Chen, Hui-Min; Kong, Xuan; Xiong, Hua; Shen, Nan; Hong, Jie; Fang, Jing-Yuan			Calcium Prevents Tumorigenesis in a Mouse Model of Colorectal Cancer	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; GENE-EXPRESSION PROFILES; NORMAL COLON MUCOSA; MATRIX METALLOPROTEINASES; TRANSCRIPTION FACTOR; DIETARY CALCIUM; TRANSGENIC MICE; POOLED ANALYSIS; CLINICAL-TRIAL; RISK	Background and Aim: Calcium has been proposed as a mediator of the chemoprevention of colorectal cancer (CRC), but the comprehensive mechanism underlying this preventive effect is not yet clear. Hence, we conducted this study to evaluate the possible roles and mechanisms of calcium-mediated prevention of CRC induced by 1,2-dimethylhydrazine (DMH) in mice. Methods: For gene expression analysis, 6 non-tumor colorectal tissues of mice from the DMH + Calcium group and 3 samples each from the DMH and control groups were hybridized on a 4644 K Agilent whole genome oligo microarray, and selected genes were validated by real-time polymerase chain reaction (PCR). Functional analysis of the microarray data was performed using KEGG and Gene Ontology (GO) analyses. Hub genes were identified using Pathway Studio software. Results: The tumor incidence rates in the DMH and DMH + Calcium groups were 90% and 40%, respectively. Microarray gene expression analysis showed that S100a9, Defa20, Mmp10, Mmp7, Ptgs2, and Ang2 were among the most downregulated genes, whereas Per3, Tef, Rnf152, and Prdx6 were significantly upregulated in the DMH + Calcium group compared with the DMH group. Functional analysis showed that the Wnt, cell cycle, and arachidonic acid pathways were significantly downregulated in the DMH + Calcium group, and that the GO terms related to cell differentiation, cell cycle, proliferation, cell death, adhesion, and cell migration were significantly affected. Forkhead box M1 (FoxM1) and nuclear factor kappa-B (NF-kappa B) were considered as potent hub genes. Conclusion: In the DMH-induced CRC mouse model, comprehensive mechanisms were involved with complex gene expression alterations encompassing many altered pathways and GO terms. However, how calcium regulates these events remains to be studied.	[Wang, Ji-Lin; Lin, Yan-Wei; Chen, Hui-Min; Kong, Xuan; Xiong, Hua; Hong, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol, Shanghai Inst Digest Dis,Renji Hosp, Shanghai 200030, Peoples R China; [Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Rheumatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, JL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Div Gastroenterol, Shanghai Inst Digest Dis,Renji Hosp, Shanghai 200030, Peoples R China.	jingyuanfang2007@126.com	Shen, Nan/AGK-6807-2022		Ministry of Public Health, China [200802094]; National Science Found of China [30830055]; National Natural Science Foundation of China [30900757]	Ministry of Public Health, China; National Science Found of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Ministry of Public Health, China (No. 200802094), a grant from the National Science Found of China (30830055) to Jing-Yuan Fang; and a grant from the National Natural Science Foundation of China (No: 30900757) to Hua Xiong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benito A, 2006, J BIOL CHEM, V281, P38351, DOI 10.1074/jbc.M607004200; Bonnet Agnes, 2009, BMC Proc, V3 Suppl 4, pS11, DOI 10.1186/1753-6561-3-S4-S11; Bousserouel S, 2010, INT J ONCOL, V36, P1485, DOI 10.3892/ijo_00000635; Carroll C, 2010, CLIN THER, V32, P789, DOI 10.1016/j.clinthera.2010.04.024; Chakrabarty S, 2003, CANCER RES, V63, P67; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chen-Goodspeed M, 2007, J BIOL RHYTHM, V22, P291, DOI 10.1177/0748730407303387; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Cooper K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI [10.3310/hta.14320, 10.3310/hta14320]; Corpet DE, 2005, EUR J CANCER, V41, P1911, DOI 10.1016/j.ejca.2005.06.006; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vogel S, 2008, J NUTR, V138, P2372, DOI 10.3945/jn.108.091157; Ding EL, 2008, INT J CANCER, V122, P1690, DOI 10.1002/ijc.23311; Fedirko V, 2009, CANCER EPIDEM BIOMAR, V18, P2933, DOI 10.1158/1055-9965.EPI-09-0239; Fedirko V, 2009, CANCER PREV RES, V2, P213, DOI 10.1158/1940-6207.CAPR-08-0157; Femia AP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-194; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gutierrez O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017169; Holterman DA, 2006, UROL ONCOL-SEMIN ORI, V24, P97, DOI 10.1016/j.urolonc.2005.07.010; Hubner RA, 2009, BRIT J CANCER, V100, P233, DOI 10.1038/sj.bjc.6604823; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koushik A, 2007, JNCI-J NATL CANCER I, V99, P1471, DOI 10.1093/jnci/djm155; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Liu H, 2008, CANCER SCI, V99, P2185, DOI 10.1111/j.1349-7006.2008.00922.x; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Lu R, 2008, EPIGENETICS-US, V3, P330, DOI 10.4161/epi.3.6.7125; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Molck AM, 2002, CANCER LETT, V186, P19, DOI 10.1016/S0304-3835(02)00285-9; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Muller CA, 2002, AM J PATHOL, V160, P1311, DOI 10.1016/S0002-9440(10)62558-8; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Notterman DA, 2001, CANCER RES, V61, P3124; Oshima T, 2011, ONCOL REP, V25, P1439, DOI 10.3892/or.2011.1207; Patrignani P, 2005, BRAIN RES REV, V48, P352, DOI 10.1016/j.brainresrev.2004.12.024; Peleg S, 2010, AM J PHYSIOL-GASTR L, V299, pG593, DOI 10.1152/ajpgi.00193.2010; PENCE BC, 1988, CARCINOGENESIS, V9, P187, DOI 10.1093/carcin/9.1.187; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; SANO H, 1995, CANCER RES, V55, P3785; Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3; SITRIN MD, 1991, CANCER RES, V51, P5608; Turner SL, 2009, BRIT J BIOMED SCI, V66, P117, DOI 10.1080/09674845.2009.11730257; Uddin S, 2011, AM J PATHOL, V178, P537, DOI 10.1016/j.ajpath.2010.10.020; VANDERMEER R, 1985, BIOCHEM J, V229, P265, DOI 10.1042/bj2290265; Vinas-Salas J, 1998, EUR J CANCER, V34, P1941, DOI 10.1016/S0959-8049(98)00197-X; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yang K, 2008, CANCER RES, V68, P7803, DOI 10.1158/0008-5472.CAN-08-1209; Yoo DR, 2009, CANCER LETT, V282, P48, DOI 10.1016/j.canlet.2009.02.051; Zhang SL, 2010, PROTEIN CELL, V1, P656, DOI 10.1007/s13238-010-0083-1	61	26	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e22566	10.1371/journal.pone.0022566	http://dx.doi.org/10.1371/journal.pone.0022566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21857934	Green Published, gold, Green Submitted			2022-12-27	WOS:000294121300006
J	Sales, KU; Hobson, JP; Wagenaar-Miller, R; Szabo, R; Rasmussen, AL; Bey, A; Shah, MF; Molinolo, AA; Bugge, TH				Sales, Katiuchia Uzzun; Hobson, John P.; Wagenaar-Miller, Rebecca; Szabo, Roman; Rasmussen, Amber L.; Bey, Alexandra; Shah, Maham F.; Molinolo, Alfredo A.; Bugge, Thomas H.			Expression and Genetic Loss of Function Analysis of the HAT/DESC Cluster Proteases TMPRSS11A and HAT	PLOS ONE			English	Article							TRYPSIN-LIKE PROTEASE; TRANSMEMBRANE SERINE PROTEASES; PROATRIAL NATRIURETIC PEPTIDE; AUTOSOMAL RECESSIVE DEAFNESS; SURFACE PROTEOLYTIC-ENZYMES; AIRWAY EPITHELIAL-CELLS; CONVERTING ENZYME; IRON-DEFICIENCY; MICE LACKING; HEARING-LOSS	Genome mining at the turn of the millennium uncovered a new family of type II transmembrane serine proteases (TTSPs) that comprises 17 members in humans and 19 in mice. TTSPs phylogenetically belong to one of four subfamilies: matriptase, hepsin/TMPRSS, corin and HAT/DESC. Whereas a wealth of information now has been gathered as to the physiological functions of members of the hepsin/TMPRSS, matriptase, and corin subfamilies of TTSPs, comparatively little is known about the functions of the HAT/DESC subfamily of proteases. Here we perform a combined expression and functional analysis of this TTSP subfamily. We show that the five human and seven murine HAT/DESC proteases are coordinately expressed, suggesting a level of functional redundancy. We also perform a comprehensive phenotypic analysis of mice deficient in two of the most widely expressed HAT/DESC proteases, TMPRSS11A and HAT, and show that the two proteases are dispensable for development, health, and long-term survival in the absence of external challenges or additional genetic deficits. Our comprehensive expression analysis and generation of TMPRSS11A- and HAT-deficient mutant mouse strains provide a valuable resource for the scientific community for further exploration of the HAT/DESC subfamily proteases in physiological and pathological processes.	[Sales, Katiuchia Uzzun; Hobson, John P.; Wagenaar-Miller, Rebecca; Szabo, Roman; Rasmussen, Amber L.; Bey, Alexandra; Shah, Maham F.; Molinolo, Alfredo A.; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Wagenaar-Miller, Rebecca] Natl Inst Dent & Craniofacial Res, Div Extramural Act, NIH, Bethesda, MD USA; [Bey, Alexandra] Duke Univ, Sch Med, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Duke University	Sales, KU (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	Wagenaar-Miller, Rebecca/0000-0002-5807-0111; sales, katiuchia/0000-0002-3768-5790	National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Dental and Craniofacial Research Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; ANTALIS TM, PROG MOL BIOL TRANSL, V99, P1; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Beaufort N, 2007, AM J PHYSIOL-LUNG C, V292, pL1263, DOI 10.1152/ajplung.00191.2006; Ben-Yosef T, 2001, J MED GENET, V38, P396, DOI 10.1136/jmg.38.6.396; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Diez-Roux G, PLOS BIOL, V9; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enshell-Seijffers D, 2008, DEVELOPMENT, V135, P217, DOI 10.1242/dev.011031; FASQUELLE L, J BIOL CHEM; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Guipponi M, 2008, HUM MUTAT, V29, P130, DOI 10.1002/humu.20617; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hansen IA, 2004, ENDOCRINOLOGY, V145, P1898, DOI 10.1210/en.2003-0930; HOBSON JP, 2004, J BIOL CHEM; Holzinger A, 2002, AM J HUM GENET, V70, P20, DOI 10.1086/338456; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Iwakiri K, 2004, J INVEST DERMATOL, V122, P937, DOI 10.1111/j.0022-202X.2004.22415.x; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Lang JC, 2001, BRIT J CANCER, V84, P237, DOI 10.1054/bjoc.2000.1586; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; Matsushima R, 2006, AM J PHYSIOL-LUNG C, V290, pL385, DOI 10.1152/ajplung.00098.2005; Meyer M., P NATL ACAD SCI US, V107, P15022; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Stallmach R, 2008, BIOCHEM J, V412, P81, DOI 10.1042/BJ20071432; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; SZABO R, 2011, ANN REV CEL IN PRESS; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615; Yoshinaga Sumiko, 1998, Journal of Medical Investigation, V45, P77; Zheng X Long, 2009, Front Biosci (Elite Ed), V1, P242	45	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23261	10.1371/journal.pone.0023261	http://dx.doi.org/10.1371/journal.pone.0023261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853097	Green Submitted, gold, Green Published			2022-12-27	WOS:000295454200058
J	Scholte, WF; Verduin, F; Kamperman, AM; Rutayisire, T; Zwinderman, AH; Stronks, K				Scholte, Willem F.; Verduin, Femke; Kamperman, Astrid M.; Rutayisire, Theoneste; Zwinderman, Aeilko H.; Stronks, Karien			The Effect on Mental Health of a Large Scale Psychosocial Intervention for Survivors of Mass Violence: A Quasi-Experimental Study in Rwanda	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMA; DEPRESSION; SYMPTOMS; OUTCOMES; WAR; PSYCHOTHERAPY; DISPLACEMENT; PREVALENCE; AFTERMATH	Background: War has serious and prolonged mental health consequences. It is argued that post-emergency mental health interventions should not only focus on psychological factors but also address the social environment. No controlled trials of such interventions exist. We studied the effect on mental health of a large scale psychosocial intervention primarily aimed at social bonding in post-genocide Rwanda. The programme is implemented at population level without diagnostic criteria for participation. It is open to any person older than 15 years, and enables participation of over 1500 individuals per year. We postulated that the mental health of programme participants would improve significantly relative to non-participants. Methods and Findings: We used a prospective quasi-experimental study design with measurement points pre and post intervention and at 8 months follow-up. 100 adults from both sexes in the experimental condition entered the study; follow-up measurements were taken from 81. We selected a control group of 100 respondents with similar age, sex and symptom score distribution from a random community sample in the same region; of these, 73 completed the study. Mental health was assessed by use of the Self Reporting Questionnaire (SRQ-20), a twenty item instrument to detect common mental disorders in primary health care settings. Mean SRQ-20 scores decreased by 2.3 points in the experimental group and 0.8 in the control group (p = 0.033). Women in the experimental group scoring above cut-off at baseline improved with 4.8 points to below cut-off (p<0.001). Men scoring above cut-off at baseline showed a similar trend which was statistically non-significant. No adverse events were observed. Conclusions: A large scale psychosocial intervention primarily aimed at social bonding caused a lasting improvement of mental health in survivors of mass violence in Rwanda. This approach may have a similar positive effect in other post-conflict settings.	[Scholte, Willem F.; Verduin, Femke; Kamperman, Astrid M.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Scholte, Willem F.; Verduin, Femke; Kamperman, Astrid M.] Equator Fdn, Diemen, Netherlands; [Kamperman, Astrid M.] Erasmus MC, Mental Hlth Care Res Ctr O3, Dept Psychiat, Rotterdam, Netherlands; [Rutayisire, Theoneste] Diocese Byumba, Episcopal Church Rwanda, Byumba, Rwanda; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Stronks, Karien] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Scholte, WF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.f.scholte@amc.uva.nl	Kamperman, Astrid/J-8046-2015; Scholte, Willem/AAJ-1088-2020; Scholte, Willem/R-1073-2018	Kamperman, Astrid/0000-0003-4455-6492; Stronks, Karien/0000-0002-0921-2232	Health Research Development Counsel, Department Prevention Programme (ZonMW) [ZonMW: 60-60105-98-117]; Cordaid; Prins Bernhard Cultuurfonds	Health Research Development Counsel, Department Prevention Programme (ZonMW)(Netherlands Organization for Health Research and Development); Cordaid(CGIAR); Prins Bernhard Cultuurfonds	This study was partly supported by a grant to FV from the Health Research Development Counsel, Department Prevention Programme (ZonMW), OOG-Geestkracht (ZonMW: 60-60105-98-117), partly by Cordaid and partly by Prins Bernhard Cultuurfonds through a grant to FV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager A, 2002, LANCET, V360, pS43, DOI 10.1016/S0140-6736(02)11817-4; Bass J, 2006, BRIT J PSYCHIAT, V188, P567, DOI 10.1192/bjp.188.6.567; Batniji R, 2006, SOC SCI MED, V62, P1853, DOI 10.1016/j.socscimed.2005.08.050; Beusenberg M, 1994, USERS GUIDE SELF REP; Bolton P, 2004, JAMA-J AM MED ASSOC, V292, P626, DOI 10.1001/jama.292.5.626; Bolton P, 2002, J NERV MENT DIS, V190, P631, DOI 10.1097/00005053-200209000-00009; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; de Jong JP, 2000, ACTA PSYCHIAT SCAND, V102, P171, DOI 10.1034/j.1600-0447.2000.102003171.x; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Dyregrov A, 2000, J TRAUMA STRESS, V13, P3, DOI 10.1023/A:1007759112499; Hagengimana A, 2003, PSYCHIAT RES, V117, P1, DOI 10.1016/S0165-1781(02)00301-3; HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993; Harpham T, 2003, HEALTH POLICY PLANN, V18, P344, DOI 10.1093/heapol/czg041; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Inter-Agency Standing Committee (IASC), 2007, IASC GUID MENT HLTH; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lewycka S, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-88; Miller KE, 2006, AM J ORTHOPSYCHIAT, V76, P409, DOI 10.1037/0002-9432.76.4.409; Miller KE, 2010, SOC SCI MED, V70, P7, DOI 10.1016/j.socscimed.2009.09.029; Mooren TTM, 2003, J CLIN PSYCHOL, V59, P57, DOI 10.1002/jclp.10118; Neugebauer R, 2009, INT J EPIDEMIOL, V38, P1033, DOI 10.1093/ije/dyn375; Neuner F, 2004, J CONSULT CLIN PSYCH, V72, P579, DOI 10.1037/0022-006X.72.4.579; Olff M, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.18597; ONYUT LP, 2009, BMC CONFLICT HLTH, V3, P6; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rath S, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-25; Richters A., 2005, INTERVENTION, V3, P203; Richters A., 2010, MED ANTROPOLOGIE, V22, P93; Richters A, 2008, INTERVENTION, V6, P100, DOI 10.1097/WTF.0b013e328307ed33; Schaal S, 2006, J TRAUMA STRESS, V19, P95, DOI 10.1002/jts.20104; Scholte WF, 2004, JAMA-J AM MED ASSOC, V292, P585, DOI 10.1001/jama.292.5.585; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Tol WA, 2009, INT J SOC PSYCHIATR, V55, P39, DOI 10.1177/0020764008091525; Verduin F, 2010, INTERVENTION, V8, P233, DOI 10.1097/WTF.0b013e3283417522; Weiss MG, 2003, J NERV MENT DIS, V191, P611, DOI 10.1097/01.nmd.0000087188.96516.a3	37	37	37	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2011	6	8							e21819	10.1371/journal.pone.0021819	http://dx.doi.org/10.1371/journal.pone.0021819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	806AM	21857908	Green Submitted, Green Published, gold			2022-12-27	WOS:000293773300003
J	Garcia-Lazaro, JA; Ahmed, B; Schnupp, JWH				Garcia-Lazaro, Jose A.; Ahmed, Bashir; Schnupp, Jan W. H.			Emergence of Tuning to Natural Stimulus Statistics along the Central Auditory Pathway	PLOS ONE			English	Article							MECHANISMS UNDERLYING SELECTIVITY; FREQUENCY-MODULATED SWEEPS; INFERIOR COLLICULUS; 1/F NOISE; PALLID BAT; CORTEX; MUSIC; COMMUNICATION; FLUCTUATIONS; RESPONSES	We have previously shown that neurons in primary auditory cortex (A1) of anaesthetized (ketamine/medetomidine) ferrets respond more strongly and reliably to dynamic stimuli whose statistics follow "natural" 1/f dynamics than to stimuli exhibiting pitch and amplitude modulations that are faster (1/f(0.5)) or slower (1/f(2)) than 1/f. To investigate where along the central auditory pathway this 1/f-modulation tuning arises, we have now characterized responses of neurons in the central nucleus of the inferior colliculus (ICC) and the ventral division of the mediate geniculate nucleus of the thalamus (MGV) to 1/f(gamma) distributed stimuli with gamma varying between 0.5 and 2.8. We found that, while the great majority of neurons recorded from the ICC showed a strong preference for the most rapidly varying (1/f(0.5) distributed) stimuli, responses from MGV neurons did not exhibit marked or systematic preferences for any particular gamma exponent. Only in A1 did a majority of neurons respond with higher firing rates to stimuli in which gamma takes values near 1. These results indicate that 1/f tuning emerges at forebrain levels of the ascending auditory pathway.	[Garcia-Lazaro, Jose A.; Ahmed, Bashir; Schnupp, Jan W. H.] Dept Physiol Anat & Genet, Oxford, England		Garcia-Lazaro, JA (corresponding author), Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford, England.	jan.schnupp@dpag.ox.ac.uk		schnupp, jan w h/0000-0002-2604-0057	BBSRC (Biotechnology and Biological Sciences Research Council) [BB/D009758/1]; EPSRC (Engineering and Physical Sciences Research Council) [EP/C010841/1]; Consejo Nacional de Ciencia y Tecnologia (National Council for Science and Technology, Mexico); Deafness Research UK; BBSRC [BB/D009758/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009758/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Consejo Nacional de Ciencia y Tecnologia (National Council for Science and Technology, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Deafness Research UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by BBSRC (Biotechnology and Biological Sciences Research Council) grant Nbr BB/D009758/1 and EPSRC (Engineering and Physical Sciences Research Council) grant Nbr EP/C010841/1 to JWHS, and studentships from Consejo Nacional de Ciencia y Tecnologia (National Council for Science and Technology, Mexico) and Deafness Research UK to JAGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 1997, ADV NEUR IN, V9, P27; Bizzarri AR, 1999, PHYSICA A, V267, P257, DOI 10.1016/S0378-4371(98)00651-7; Caspary DM, 2002, HEARING RES, V168, P163, DOI 10.1016/S0378-5955(02)00363-5; De Coensel B, 2003, ACTA ACUST UNITED AC, V89, P287; Escabi MA, 2003, J NEUROSCI, V23, P11489; Fuzessery ZM, 2006, J NEUROPHYSIOL, V96, P1320, DOI 10.1152/jn.00021.2006; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Gilden DL, 1997, PSYCHOL SCI, V8, P296, DOI 10.1111/j.1467-9280.1997.tb00441.x; Irvine D. R., 1986, PROGR SENSORY PHYSL; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MILLHAUSER GL, 1988, P NATL ACAD SCI USA, V85, P1503, DOI 10.1073/pnas.85.5.1503; Nozaki D, 1998, PHYS LETT A, V243, P281, DOI 10.1016/S0375-9601(98)00247-3; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Scalas E, 1998, EUROPHYS LETT, V43, P101, DOI 10.1209/epl/i1998-00308-1; Shi Y, 1996, FRACTALS, V4, P547, DOI 10.1142/S0218348X96000662; Szendro P, 2001, EUR BIOPHYS J BIOPHY, V30, P227, DOI 10.1007/s002490100143; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; YAMAMOTO Y, 1994, AM J PHYSIOL, V266, pR40, DOI 10.1152/ajpregu.1994.266.1.R40	26	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e22584	10.1371/journal.pone.0022584	http://dx.doi.org/10.1371/journal.pone.0022584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850231	Green Published, gold, Green Submitted			2022-12-27	WOS:000293563300015
J	Ivorra, A				Ivorra, Antoni			Remote Electrical Stimulation by Means of Implanted Rectifiers	PLOS ONE			English	Article							NERVE	Miniaturization of active implantable medical devices is currently compromised by the available means for electrically powering them. Most common energy supply techniques for implants - batteries and inductive couplers - comprise bulky parts which, in most cases, are significantly larger than the circuitry they feed. Here, for overcoming such miniaturization bottleneck in the case of implants for electrical stimulation, it is proposed to make those implants act as rectifiers of high frequency bursts supplied by remote electrodes. In this way, low frequency currents will be generated locally around the implant and these low frequency currents will perform stimulation of excitable tissues whereas the high frequency currents will cause only innocuous heating. The present study numerically demonstrates that low frequency currents capable of stimulation can be produced by a miniature device behaving as a diode when high frequency currents, neither capable of thermal damage nor of stimulation, flow through the tissue where the device is implanted. Moreover, experimental evidence is provided by an in vivo proof of concept model consisting of an anesthetized earthworm in which a commercial diode was implanted. With currently available microelectronic techniques, very thin stimulation capsules (diameter,500 mm) deliverable by injection are easily conceivable.	Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain	Pompeu Fabra University	Ivorra, A (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain.	antoni.ivorra@gmail.com	Ivorra, Antoni/A-3155-2008	Ivorra, Antoni/0000-0001-7718-8767	Spanish Ministry for Science and Innovation [RYC-2009-04271]; European Commission [256376]	Spanish Ministry for Science and Innovation(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This author's research is currently supported by a Ramon y Cajal fellowship from the Spanish Ministry for Science and Innovation (RYC-2009-04271) and a Marie Curie International Reintegration Grant (256376 - "TAMIVIVE'') from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bogie KM, 2000, ASSIST TECHNOL, V12, P50, DOI 10.1080/10400435.2000.10132009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRUMMER SB, 1983, ANN NY ACAD SCI, V405, P159, DOI 10.1111/j.1749-6632.1983.tb31628.x; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gan LS, 2010, IEEE T BIO-MED ENG, V57, P450, DOI 10.1109/TBME.2009.2031427; HEETDERKS WJ, 1988, IEEE T BIO-MED ENG, V35, P323, DOI 10.1109/10.1388; Imura R, 2004, 2004 SYMPOSIUM ON VLSI CIRCUITS, DIGEST OF TECHNICAL PAPERS, P120, DOI 10.1109/VLSIC.2004.1346529; Johnson M, 2007, PAIN, V130, P157, DOI 10.1016/j.pain.2007.02.007; Kane MJ, 2011, MED ENG PHYS, V33, P7, DOI 10.1016/j.medengphy.2010.08.010; Kladt Nikolay, 2010, J Undergrad Neurosci Educ, V9, pA20; LACOURSE JR, 1985, IEEE T BIO-MED ENG, V32, P82, DOI 10.1109/TBME.1985.325636; LOEB GE, 1991, MED BIOL ENG COMPUT, V29, pNS13, DOI 10.1007/BF02446097; Nilsson E, 2000, BIOELECTROCHEMISTRY, V51, P1, DOI 10.1016/S0302-4598(99)00073-2; Olivo J, 2011, IEEE SENS J, V11, P1573, DOI 10.1109/JSEN.2010.2085042; PIEKARSKI K, 1978, ACTA ORTHOP SCAND, V49, P113, DOI 10.3109/17453677809005736; Salter ACD, 2004, NEUROMODULATION, V7, P38, DOI 10.1111/j.1525-1403.2004.04005.x; SCHUDER JC, 1965, IEEE T BIO-MED ENG, VBM12, P154, DOI 10.1109/TBME.1965.4502372; Sheridan DM, 1996, J INVEST DERMATOL, V106, P642, DOI 10.1111/1523-1747.ep12345456; SLAGER CJ, 1993, IEEE T BIO-MED ENG, V40, P182, DOI 10.1109/10.212058; Tang C, 2009, PHYSIOL MEAS, V30, P1293, DOI 10.1088/0967-3334/30/12/001; VANDENBERG PM, 1983, IEEE T BIO-MED ENG, V30, P797, DOI 10.1109/TBME.1983.325081	22	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23456	10.1371/journal.pone.0023456	http://dx.doi.org/10.1371/journal.pone.0023456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850274	gold, Green Published, Green Submitted			2022-12-27	WOS:000293563300059
J	Li, HY; Yeh, PA; Chiu, HC; Tang, CY; Tu, BPH				Li, Huei-Ying; Yeh, Po-An; Chiu, Hsiu-Chiang; Tang, Chiou-Yang; Tu, Benjamin Pang-hsien			Hyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; BINDING PROTEIN; PHOSPHORYLATED TDP-43; CELLULAR TOXICITY; DROSOPHILA MODEL; TARDBP MUTATIONS; LEWY BODIES; FTLD-U	Several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) are characterized by inclusion bodies formed by TDP-43 (TDP). We established cell and transgenic Drosophila models expressing TDP carboxyl terminal fragment (ND251 and ND207), which developed aggregates recapitulating important features of TDP inclusions in ALS/FTLD-U, including hyperphosphorylation at previously reported serine(403,404,409,410) residues, polyubiquitination and colocalization with optineurin. These models were used to address the pathogenic role of hyperphosphorylation in ALS/FTLD-U. We demonstrated that hyperphosphorylation and ubiquitination occurred temporally later than aggregation in cells. Expression of CK2 alpha which phosphorylated TDP decreased the aggregation propensity of ND251 or ND207; this effect could be blocked by CK2 inhibitor DMAT. Mutation of serines(379,403,404,409,410) to alanines (S5A) to eliminate phosphorylation increased the aggregation propensity and number of aggregates of TDP, but mutation to aspartic acids (S5D) or glutamic acids (S5E) to simulate hyperphosphorylation had the opposite effect. Functionally, ND251 or ND207 aggregates decreased the number of neurites of Neuro2a cells induced by retinoic acid or number of cells by MTT assay. S5A mutation aggravated, but S5E mutation alleviated these cytotoxic effects of aggregates. Finally, ND251 or ND251S5A developed aggregates in neurons, and salivary gland of transgenic Drosophila, but ND251S5E did not. Taken together, our data indicate that hyperphosphorylation may represent a compensatory defense mechanism to stop or prevent pathogenic TDP from aggregation. Therefore, enhancement of phosphorylation may serve as an effective therapeutic strategy against ALS/FTLD-U.	[Li, Huei-Ying; Tu, Benjamin Pang-hsien] Acad Sinica, Inst Biomed Sci, Program Mol Med, Taiwan Int Grad Program, Taipei, Taiwan; [Li, Huei-Ying] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Sch Life Sci, Taipei 112, Taiwan; [Tang, Chiou-Yang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Li, HY (corresponding author), Acad Sinica, Inst Biomed Sci, Program Mol Med, Taiwan Int Grad Program, Taipei, Taiwan.	btu@ibms.sinica.edu.tw		Tu, Pang-hsien/0000-0003-2821-7335	National Science Council and Academia Sinica, Taipei, Taiwan [TMIIBMTP2009091]	National Science Council and Academia Sinica, Taipei, Taiwan	Grant from National Science Council and Academia Sinica, Taipei, Taiwan (TMIIBMTP2009091) http://web1.nsc.gov.tw/mp.aspx?mp=7 and http://www.sinica.edu.tw/main_e.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Braak H, 2010, ACTA NEUROPATHOL; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Ito K, 1997, DEVELOPMENT, V124, P761; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kametani F, 2009, BIOCH BIOPHYS RES CO; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2010, P NATL ACAD SCI US; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mackenzie IRA, 2007, ACTA NEUROPATHOL, V114, P49, DOI 10.1007/s00401-007-0223-8; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Mori F, 2008, ACTA NEUROPATHOL, V116, P193, DOI 10.1007/s00401-008-0396-9; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; OKAMOTO K, 1991, NEUROSCI LETT, V129, P233, DOI 10.1016/0304-3940(91)90469-A; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; WIGHTMAN G, 1992, NEUROSCI LETT, V139, P269, DOI 10.1016/0304-3940(92)90569-S; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, MOL NEURODEGENER, V5, P33; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	58	75	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23075	10.1371/journal.pone.0023075	http://dx.doi.org/10.1371/journal.pone.0023075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850253	Green Published, Green Submitted, gold			2022-12-27	WOS:000293563300038
J	Ballouard, JM; Brischoux, F; Bonnet, X				Ballouard, Jean-Marie; Brischoux, Francois; Bonnet, Xavier			Children Prioritize Virtual Exotic Biodiversity over Local Biodiversity	PLOS ONE			English	Article							CONSERVATION; EDUCATION; TELEVISION; ATTITUDES; INTERNET; IMPACT	Environmental education is essential to stem current dramatic biodiversity loss, and childhood is considered as the key period for developing awareness and positive attitudes toward nature. Children are strongly influenced by the media, notably the internet, about biodiversity and conservation issues. However, most media focus on a few iconic, appealing, and usually exotic species. In addition, virtual activities are replacing field experiences. This situation may curb children knowledge and concerns about local biodiversity. Focusing our analyses on local versus exotic species, we examined the level of knowledge and the level of diversity of the animals that French schoolchildren are willing to protect, and whether these perceptions are mainly guided by information available in the internet. For that, we collected and compared two complementary data sets: 1) a questionnaire was administered to schoolchildren to assess their knowledge and consideration to protect animals, 2) an internet content analysis (i.e. Google searching sessions using keywords) was performed to assess which animals are the most often represented. Our results suggest that the knowledge of children and their consideration to protect animal are mainly limited to internet contents, represented by a few exotic and charismatic species. The identification rate of local animals by schoolchildren was meager, suggesting a worrying disconnection from their local environment. Schoolchildren were more prone to protect "virtual'' (unseen, exotic) rather than local animal species. Our results reinforce the message that environmental education must also focus on outdoor activities to develop conservation consciousness and concerns about local biodiversity.	[Ballouard, Jean-Marie; Bonnet, Xavier] CNRS, Ctr Etud Biol Chize, UPR 1934, Villiers En Bois, France; [Ballouard, Jean-Marie] SOPTOM, Ctr Rech & Conservat Cheloniens, Le Village Des Tortues, Gonfaron, France; [Brischoux, Francois] Univ Florida, Dept Biol, Gainesville, FL USA	Centre National de la Recherche Scientifique (CNRS); State University System of Florida; University of Florida	Ballouard, JM (corresponding author), CNRS, Ctr Etud Biol Chize, UPR 1934, Villiers En Bois, France.	jmarie.ballouard@gmail.com		Bonnet, Xavier/0000-0001-6150-8199	Conseil General des Deux-Sevres; Region Poitou-Charentes; National Science Foundation [IOS-0926802]; Division Of Integrative Organismal Systems [0926802] Funding Source: National Science Foundation	Conseil General des Deux-Sevres(Region Nouvelle-Aquitaine); Region Poitou-Charentes(Region Nouvelle-Aquitaine); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a grant from the Conseil General des Deux-Sevres and the Region Poitou-Charentes. FB acknowledges funding by National Science Foundation grant IOS-0926802 to Harvey B. Lillywhite while working on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, J ENVIRON EDUC, DOI DOI 10.1080/00958964.1985.9942709; Archie M, 1993, PARTNERS ACTION ENV; Ballouard J-M, 2005, THESIS MUSEUM NATL H; Balmford A, 2002, SCIENCE, V295, P2367; Barker S, 2002, ENV ED, V71, P13; Barker S, 2002, ENV ED, V71, P9; Barney E.C., 2005, J ENVIRON EDUC, V36, P2, DOI [10.3200/JOEE.36.2.41-55, DOI 10.3200/JOEE.36.2.41-55]; BELL BF, 1981, J BIOL EDUC, V15, P213, DOI 10.1080/00219266.1981.9654381; Bjerke T, 1998, ANTHROZOOS, V11, P79, DOI 10.2752/089279398787000742; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Braschler B, 2009, BIOSCIENCE, V59, P103, DOI 10.1525/bio.2009.59.2.2; Brewer C, 2002, CONSERV BIOL, V16, P577, DOI 10.1046/j.1523-1739.2002.01633.x; CARO TM, 1994, CONSERV BIOL, V8, P846, DOI 10.1046/j.1523-1739.1994.08030846.x; Chawla L, 2006, BARN, V2, P57; CHIPENIUK R, 1995, ENVIRON BEHAV, V27, P490, DOI 10.1177/0013916595274003; Clark JA, 2002, SCIENCE, V297, P191; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Eagles P. F. J., 1999, J ENVIRON EDUC, V30, P33, DOI DOI 10.1080/00958969909601882; FEINSINGER P, 1987, TRENDS ECOL EVOL, V2, P51, DOI 10.1016/0169-5347(87)90100-5; Feldhamer G, 2002, J POP CULT, V36, P160, DOI 10.1111/1540-5931.00037; Feldman A, 2000, NETWORK SCI DECADE L, P179; Havick J, 2000, TECHNOL SOC, V22, P273, DOI 10.1016/S0160-791X(00)00008-7; Heerwagen JH, 2002, CHILDREN AND NATURE, P29; Hofferth SL, 2001, CHILDREN MILLENNIUM; Holbert RL, 2003, J BROADCAST ELECTRON, V47, P177, DOI 10.1207/s15506878jobem4702_2; Huston AC, 1999, DEV PSYCHOL, V35, P912, DOI 10.1037/0012-1649.35.4.912; Jacobson Susan K., 1998, P237, DOI 10.1002/9781444313499.ch12; Kaiser Family Foundation, 2006, ED HLTH, V24, P44; Kareiva P, 2008, P NATL ACAD SCI USA, V105, P2757, DOI 10.1073/pnas.0800474105; KELLERT SR, 1993, CONSERV BIOL, V7, P845, DOI 10.1046/j.1523-1739.1993.740845.x; Kellert SR, 2002, CHILDREN AND NATURE, P117; Lebo HJ, 2001, UCLA INTERNET REPORT; Levi D, 1999, ENVIRON BEHAV, V31, P203, DOI 10.1177/00139169921972065; Lindemann-Matthies P., 2002, J ENVIRON EDUC, V33, P22, DOI DOI 10.1080/00958960209600805; Lindemann-Matthies P, 2008, HUM ECOL, V36, P731, DOI 10.1007/s10745-008-9194-1; Lindemann-Matthies P, 2006, INT J SCI EDUC, V28, P895, DOI 10.1080/10670560500438396; Louv R., 2008, Last child in the woods: saving our children from nature-deficit disorder; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Mikami S, 1995, INT COMMUN GAZ, V54, P209, DOI DOI 10.1177/001654929505400302; Myers OE, 2002, CHILDREN AND NATURE, P153; Nie N., 2000, INTERNET SOC PRELIMI; Orr DW, 2002, CHILDREN AND NATURE, P279; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pergams ORW, 2006, J ENVIRON MANAGE, V80, P387, DOI 10.1016/j.jenvman.2006.02.001; Pyle RM, 2002, CHILDREN AND NATURE, P305; Randler C., 2008, EURASIA J MATH SCI T, V4, P223, DOI [DOI 10.12973/ejmste/75344, 10.12973/ejmste/75344, DOI 10.12973/EJMSTE/75344]; Rivas JA, 1999, CONSERV BIOL, V13, P453, DOI 10.1046/j.1523-1739.1999.013002453.x; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Trimble MJ, 2010, CONSERV BIOL, V24, P886, DOI 10.1111/j.1523-1739.2010.01453.x; Van Rompaey V., 2002, Information Communication & Society, V5, P189, DOI 10.1080/13691180210130770; Vining J., 2003, HUM ECOL REV, V10, P87, DOI DOI 10.2307/3802153; Wells J., 2006, 2007020 NCES US DEP; Wells N.M., 2006, J ENVIRON PSYCHOL, V16, P1, DOI DOI 10.1016/j.jenvp.2010.10.001; White R, 2004, YOUNG CHILDRENS RELA; Williams TM, 1986, IMPACT TELEVISION NA, P143; Wilson, 1996, STARTING EARLY ENV E; Wilson C, 2005, DISCUSSION PAPERS EC, V188, P188; Young J, 2001, ENVIRON EDUC RES, V7, P439; Zaradic PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007367	61	124	130	5	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23152	10.1371/journal.pone.0023152	http://dx.doi.org/10.1371/journal.pone.0023152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	803DK	21829710	gold, Green Published, Green Submitted			2022-12-27	WOS:000293561200051
J	Blagovic, K; Kim, LLY; Voldman, J				Blagovic, Katarina; Kim, Lily Y.; Voldman, Joel			Microfluidic Perfusion for Regulating Diffusible Signaling in Stem Cells	PLOS ONE			English	Article							ON-A-CHIP; SELF-RENEWAL; DIFFERENTIATION; GROWTH; FGF; EXPRESSION; MODEL; TRANSITION; INDUCTION; PLATFORM	Background: Autocrine & paracrine signaling are widespread both in vivo and in vitro, and are particularly important in embryonic stem cell (ESC) pluripotency and lineage commitment. Although autocrine signaling via fibroblast growth factor-4 (FGF4) is known to be required in mouse ESC (mESC) neuroectodermal specification, the question of whether FGF4 autocrine signaling is sufficient, or whether other soluble ligands are also involved in fate specification, is unknown. The spatially confined and closed-loop nature of diffusible signaling makes its experimental control challenging; current experimental approaches typically require prior knowledge of the factor/receptor in order to modulate the loop. A new approach explored in this work is to leverage transport phenomena at cellular resolution to downregulate overall diffusible signaling through the physical removal of cell-secreted ligands. Methodology/Principal Findings: We develop a multiplex microfluidic platform to continuously remove cell-secreted (autocrine\paracrine) factors to downregulate diffusible signaling. By comparing cell growth and differentiation in side-by-side chambers with or without added cell-secreted factors, we isolate the effects of diffusible signaling from artifacts such as shear, nutrient depletion, and microsystem effects, and find that cell-secreted growth factor(s) are required during neuroectodermal specification. Then we induce FGF4 signaling in minimal chemically defined medium (N2B27) and inhibit FGF signaling in fully supplemented differentiation medium with cell-secreted factors to determine that the non-FGF cell-secreted factors are required to promote growth of differentiating mESCs. Conclusions/Significance: Our results demonstrate for the first time that flow can downregulate autocrine\paracrine signaling and examine sufficiency of extracellular factors. We show that autocrine\paracrine signaling drives neuroectodermal commitment of mESCs through both FGF4-dependent and -independent pathways. Overall, by uncovering autocrine\paracrine processes previously hidden in conventional culture systems, our results establish microfluidic perfusion as a technique to study and manipulate diffusible signaling in cell systems.	[Blagovic, Katarina; Kim, Lily Y.; Voldman, Joel] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Voldman, Joel] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Blagovic, K (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	voldman@mit.edu			NIH [EB007278]; SNSF; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by NIH grant No. EB007278 and SNSF fellowship for prospective researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bansal R, 2003, J NEUROSCI RES, V74, P486, DOI 10.1002/jnr.10773; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; CATCHPOLE JP, 1966, IND ENG CHEM, V58, P46, DOI 10.1021/ie50675a012; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Domenech M, 2009, INTEGR BIOL-UK, V1, P267, DOI 10.1039/b823059e; Dowd CJ, 1999, J BIOL CHEM, V274, P5236, DOI 10.1074/jbc.274.8.5236; Ellison D, 2009, MOL BIOSYST, V5, P1004, DOI 10.1039/b905602e; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9; Gupta K, 2010, LAB CHIP, V10, P2019, DOI 10.1039/c004689b; Hall VJ, 2010, DEV DYNAM, V239, P2911, DOI 10.1002/dvdy.22424; Hirasawa R, 2009, GENE EXPR PATTERNS, V9, P27, DOI 10.1016/j.gep.2008.09.002; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Irimia D, 2006, LAB CHIP, V6, P345, DOI 10.1039/b515983k; Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Mehta K, 2006, BIOTECHNOL BIOENG, V94, P596, DOI 10.1002/bit.20857; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; OLWIN BB, 1989, J CELL BIOCHEM, V39, P443, DOI 10.1002/jcb.240390410; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; Skelley AM, 2008, LAB CHIP, V8, P1733, DOI 10.1039/b807037g; Squires TM, 2008, NAT BIOTECHNOL, V26, P417, DOI 10.1038/nbt1388; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tanford C., 1961, PHYS CHEM MACROMOLEC; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toh YC, 2010, INTEGR BIOL-UK, V2, P305, DOI 10.1039/c0ib00004c; Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Voorhoeve PM, 2003, TRENDS BIOTECHNOL, V21, P2, DOI 10.1016/S0167-7799(02)00002-1; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	51	68	70	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22892	10.1371/journal.pone.0022892	http://dx.doi.org/10.1371/journal.pone.0022892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829665	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200036
J	Dottorini, T; Sole, G; Nunziangeli, L; Baldracchini, F; Senin, N; Mazzoleni, G; Proietti, C; Balaci, L; Crisanti, A				Dottorini, Tania; Sole, Gabriella; Nunziangeli, Luisa; Baldracchini, Francesca; Senin, Nicola; Mazzoleni, Giorgio; Proietti, Carla; Balaci, Lenuta; Crisanti, Andrea			Serum IgE Reactivity Profiling in an Asthma Affected Cohort	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IGE; SENSITIZATION; AMPLIFICATION; ASSOCIATION; ENVIRONMENT; MICROARRAYS; CHILDHOOD; EXPOSURE; CHILDREN; ATOPY	Background: Epidemiological evidence indicates that atopic asthma correlates with high serum IgE levels though the contribution of allergen specific IgE to the pathogenesis and the severity of the disease is still unclear. Methods: We developed a microarray immunoassay containing 103 allergens to study the IgE reactivity profiles of 485 asthmatic and 342 non-asthmatic individuals belonging to families whose members have a documented history of asthma and atopy. We employed k-means clustering, to investigate whether a particular IgE reactivity profile correlated with asthma and other atopic conditions such as rhinitis, conjunctivitis and eczema. Results: Both case-control and parent-to-siblings analyses demonstrated that while the presence of specific IgE against individual allergens correlated poorly with pathological conditions, particular reactivity profiles were significantly associated with asthma (p<10E-09). An artificial neural network (ANN)-based algorithm, calibrated with the profile reactivity data, correctly classified as asthmatic or non-asthmatic 78% of the individual examined. Multivariate statistical analysis demonstrated that the familiar relationships of the study population did not affect the observed correlations. Conclusions: These findings indicate that asthma is a higher-order phenomenon related to patterns of IgE reactivity rather than to single antibody reactions. This notion sheds new light on the pathogenesis of the disease and can be readily employed to distinguish asthmatic and non-asthmatic individuals on the basis of their serum reactivity profile.	[Dottorini, Tania; Nunziangeli, Luisa; Proietti, Carla; Crisanti, Andrea] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Sole, Gabriella; Balaci, Lenuta] Natl Res Council Italy CNR, Inst Genet & Biomed Res IRGB, Cagliari, Italy; [Baldracchini, Francesca; Mazzoleni, Giorgio] Microtest Matrices LtD, London, England; [Senin, Nicola] Univ Perugia, Dept Ind Engn, I-06100 Perugia, Italy; [Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, London, England	University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Perugia; Imperial College London	Dottorini, T (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	a.crisanti@ic.ac.uk	Gung, Amber/D-9842-2011; Sole, Gabriella/I-4820-2013; Senin, Nicola/B-5292-2016	Sole, Gabriella/0000-0001-5292-5038; Dottorini, Tania/0000-0001-7733-906X; Senin, Nicola/0000-0002-9556-0363; Proietti, Carla/0000-0002-6290-0261; Crisanti, Andrea/0000-0002-2406-4426	Italian Ministery of Education (FIRB); European Union (FIGHTMAL)	Italian Ministery of Education (FIRB); European Union (FIGHTMAL)(European Commission)	Funding is provided by the Italian Ministery of Education (FIRB) and European Union (FIGHTMAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; Bacarese-Hamilton T, 2004, J APPL MICROBIOL, V96, P10, DOI 10.1046/j.1365-2672.2003.02111.x; Bacarese-Hamilton T, 2002, CLIN CHEM, V48, P1367; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bishop C.M., 1995, NEURAL NETWORKS PATT; Blaiss M, 2011, J ALLERGY CLIN IMMUN, V127, P64, DOI 10.1016/j.jaci.2010.11.034; Bolshakova N, 2005, BIOINFORMATICS, V21, P451, DOI 10.1093/bioinformatics/bti190; Burney P, 1997, J ALLERGY CLIN IMMUN, V99, P314, DOI 10.1016/S0091-6749(97)70048-4; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Halonen M, 1999, AM J RESP CRIT CARE, V160, P564, DOI 10.1164/ajrccm.160.2.9809038; Jansson SA, 2007, RESP MED, V101, P2263, DOI 10.1016/j.rmed.2007.06.029; Ker J, 2009, ANN ALLERG ASTHMA IM, V103, P282, DOI 10.1016/S1081-1206(10)60526-1; Mandhane PJ, 2009, J ALLERGY CLIN IMMUN, V124, P745, DOI 10.1016/j.jaci.2009.06.038; Menz G, 1998, ALLERGY, V53, P15, DOI 10.1111/j.1398-9995.1998.tb04934.x; Mullenix MC, 2001, CLIN CHEM, V47, P1926; [National Institutes of Health/ National Heart Lung and Blood Institute (NHLBI) World Health Organization (WHO) Global initiative for asthma (GINA)], 2009, GLOB IN ASTHM GINA G, P112; Nelson HS, 2011, J ALLERGY CLIN IMMUN, V127, P72, DOI 10.1016/j.jaci.2010.11.035; Palacin A, 2008, ANN ALLERG ASTHMA IM, V101, P200, DOI 10.1016/S1081-1206(10)60210-4; Platts-Mills TAE, 2001, AM J RESP CRIT CARE, V164, pS1, DOI 10.1164/ajrccm.164.supplement_1.2103024; Platts-Mills TAE, 2009, AM J RESP CRIT CARE, V180, P109, DOI 10.1164/rccm.200811-1756PR; PlattsMills TAE, 1997, NEW ENGL J MED, V336, P1382, DOI 10.1056/NEJM199705083361909; Prescott SL, 1998, J IMMUNOL, V160, P4730; SEARS MR, 1993, CLIN EXP ALLERGY, V23, P941, DOI 10.1111/j.1365-2222.1993.tb00279.x; SEATON A, 1994, THORAX, V49, P171, DOI 10.1136/thx.49.2.171; Simirenko L, 2004, MAPLETREE; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Tovey ER, 2008, J ALLERGY CLIN IMMUN, V122, P114, DOI 10.1016/j.jaci.2008.05.010; Venables KM, 1997, LANCET, V349, P1465, DOI 10.1016/S0140-6736(96)07219-4; Wickman M, 2004, ALLERGY, V59, P30, DOI 10.1111/j.1398-9995.2004.00572.x; Wickman M, 2005, ALLERGY, V60, P650, DOI 10.1111/j.1398-9995.2004.00764.x; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22319	10.1371/journal.pone.0022319	http://dx.doi.org/10.1371/journal.pone.0022319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829614	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200013
J	Gahete, MD; Cordoba-Chacon, J; Hergueta-Redondo, M; Martinez-Fuentes, AJ; Kineman, RD; Moreno-Bueno, G; Luque, RM; Castano, JP				Gahete, Manuel D.; Cordoba-Chacon, Jose; Hergueta-Redondo, Marta; Martinez-Fuentes, Antonio J.; Kineman, Rhonda D.; Moreno-Bueno, Gema; Luque, Raul M.; Castano, Justo P.			A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; PREPROGHRELIN ISOFORM; INTRON RETENTION; PROSTATE-CANCER; SPLICE VARIANTS; PROTEIN-KINASE; RECEPTOR; IDENTIFICATION; PEPTIDE; OBESTATIN	The human ghrelin gene, which encodes the ghrelin and obestatin peptides, contains 5 exons (Ex), with Ex1-Ex4 encoding a 117 amino-acid (aa) preproprotein that is known to be processed to yield a 28-aa (ghrelin) and/or a 23-aa (obestatin) mature peptides, which possess biological activities in multiple tissues. However, the ghrelin gene also encodes additional peptides through alternative splicing or post-translational modifications. Indeed, we previously identified a spliced mRNA ghrelin variant in mouse (In2-ghrelin-variant), which is regulated in a tissue-dependent manner by metabolic status and may thus be of biological relevance. Here, we have characterized a new human ghrelin variant that contains Ex0-1, intron (In) 1, and Ex2 and lacks Ex3-4. This human In1-ghrelin variant would encode a new prepropeptide that conserves the first 12aa of native-ghrelin (including the Ser3-potential octanoylation site) but has a different C-terminal tail. Expression of In1-variant was detected in 22 human tissues and its levels were positively correlated with those of ghrelin-O-acyltransferase (GOAT; p = 0.0001) but not with native-ghrelin expression, suggesting that In1-ghrelin could be a primary substrate for GOAT in human tissues. Interestingly, levels of In1-ghrelin variant expression in breast cancer samples were 8-times higher than those of normal mammary tissue, and showed a strong correlation in breast tumors with GOAT (p = 0.0001), ghrelin receptor-type 1b (GHSR1b; p = 0.049) and cyclin-D3 (a cell-cycle inducer/proliferation marker; p = 0.009), but not with native-ghrelin or GHSR1a expression. Interestingly, In1-ghrelin variant overexpression increased basal proliferation of MDA-MB-231 breast cancer cells. Taken together, our results provide evidence that In1-ghrelin is a novel element of the ghrelin family with a potential pathophysiological role in breast cancer.	[Gahete, Manuel D.; Cordoba-Chacon, Jose; Martinez-Fuentes, Antonio J.; Luque, Raul M.; Castano, Justo P.] Univ Cordoba, Hosp Univ Reina Sofia, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Gahete, Manuel D.; Cordoba-Chacon, Jose; Martinez-Fuentes, Antonio J.; Luque, Raul M.; Castano, Justo P.] CIBERobn Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Hergueta-Redondo, Marta; Moreno-Bueno, Gema] CSIC UAM, Dept Biochem, Inst Invest Biomed Alberto Sols, Inst Invest Sanitaria La Paz IdiPAZ, Madrid, Spain; [Hergueta-Redondo, Marta; Moreno-Bueno, Gema] Fdn MD Anderson Int, Madrid, Spain; [Kineman, Rhonda D.] Univ Illinois, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL USA; [Kineman, Rhonda D.] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL USA	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Gahete, MD (corresponding author), Univ Cordoba, Hosp Univ Reina Sofia, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain.	raul.luque@uco.es; justo@uco.es	Cordoba-Chacon, Jose/AAH-5753-2019; Castaño, Justo P/A-7124-2010; Gahete, Manuel D./C-4969-2009; Martinez-Fuentes, Antonio J/F-8198-2016; Kineman, Rhonda D/H-2221-2011; Raul, Luque Huertas/M-6948-2018; Moreno-Bueno, Gema/K-9354-2016	Cordoba-Chacon, Jose/0000-0001-8787-2706; Castaño, Justo P/0000-0002-3145-7287; Gahete, Manuel D./0000-0002-4578-2179; Kineman, Rhonda D/0000-0001-7322-1152; Moreno-Bueno, Gema/0000-0002-5030-6687; Luque, Raul M./0000-0002-7585-1913	Ministerio de Ciencia e Innovacion [FPU-AP20052473, SAF2007-63075, SAF2007-63075/FMM07, RYC-2007-00186/BFU2008-01136-BFI, BIO-0139/CTS-01705/BFU2007-60180-BFI]; Instituto de Salud Carlos III [FI06-00804]; National Institutes of Health [NIDDK30677]; Jesse Brown VA Medical Center [NIDDK30677]; Ramon y Cajal [RYC-2007-00186/BFU2008-01136-BFI]; Junta de Andalucia [BIO-0139/CTS-01705/BFU2007-60180-BFI]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jesse Brown VA Medical Center(US Department of Veterans Affairs); Ramon y Cajal(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work has been supported by FPU-AP20052473 (Ministerio de Ciencia e Innovacion to Manuel D. Gahete), FI06-00804 (Instituto de Salud Carlos III to Jose Cordoba-Chacon), SAF2007-63075 (Ministerio de Ciencia e Innovacion to Marta Hergueta-Redondo), NIDDK30677/VA-Merit-Award (National Institutes of Health and Jesse Brown VA Medical Center to Rhonda D. Kineman), SAF2007-63075/FMM07 (Ministerio de Ciencia e Innovacion to Gema Moreno-Bueno), RYC-2007-00186/BFU2008-01136-BFI (Ramon y Cajal and Ministerio de Ciencia e Innovacion to Raul M. Luque), and BIO-0139/CTS-01705/BFU2007-60180-BFI (Ministerio de Ciencia e Innovacion and Junta de Andalucia to Justo P. Castano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzon L, 2005, ONCOLOGY-BASEL, V68, P414, DOI 10.1159/000086983; Boyan BD, 2003, ENDOCRINOLOGY, V144, P1812, DOI 10.1210/en.2002-221018; Carraro G, 2004, INT J MOL MED, V13, P295; Cassoni P, 2001, J CLIN ENDOCR METAB, V86, P1738, DOI 10.1210/jc.86.4.1738; Cordoba-Chacon J, 2010, CELL MOL LIFE SCI, V67, P1147, DOI 10.1007/s00018-009-0240-y; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Eisen SF, 2002, MOL PHARMACOL, V62, P911, DOI 10.1124/mol.62.4.911; Gahete MD, 2010, J ALZHEIMERS DIS, V22, P819, DOI 10.3233/JAD-2010-100873; Gahete MD, 2010, MOL CELL ENDOCRINOL, V317, P154, DOI 10.1016/j.mce.2009.12.023; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Garg A, 2007, J CLIN ENDOCR METAB, V92, P3396, DOI 10.1210/jc.2007-0999; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Hosoda H, 2000, J BIOL CHEM, V275, P21995, DOI 10.1074/jbc.M002784200; Jeffery PL, 2005, ENDOCR-RELAT CANCER, V12, P839, DOI 10.1677/erc.1.00984; Jeffery PL, 2005, ENDOCRINOLOGY, V146, P432, DOI 10.1210/en.2003-1466; Jeffery PL, 2002, J ENDOCRINOL, V172, pR7, DOI 10.1677/joe.0.172R007; Jeffery PL, 2003, CYTOKINE GROWTH F R, V14, P113, DOI 10.1016/S1359-6101(02)00089-8; Karaoglu A, 2009, MOL CELL BIOCHEM, V323, P113, DOI 10.1007/s11010-008-9969-0; Kineman RD, 2007, J MOL ENDOCRINOL, V38, P511, DOI 10.1677/JME-06-0026; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lago F, 2005, VITAM HORM, V71, P405, DOI 10.1016/S0083-6729(05)71014-1; Lanfranco F, 2008, VITAM HORM, V77, P301, DOI 10.1016/S0083-6729(06)77013-3; Ledee DR, 2004, MOL VIS, V10, P663; Leontiou CA, 2007, PITUITARY, V10, P213, DOI 10.1007/s11102-007-0023-0; Leung PK, 2007, CELL SIGNAL, V19, P1011, DOI 10.1016/j.cellsig.2006.11.011; Martinez-Fuentes AJ, 2006, J CLIN ENDOCR METAB, V91, P2225, DOI 10.1210/jc.2006-0235; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Nikolopoulos D, 2010, SURG ONCOL, V19, pE2, DOI 10.1016/j.suronc.2009.02.011; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Sarrio D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-74; Seim I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-298; Seim I, 2010, CLIN EXP PHARMACOL P, V37, P125, DOI 10.1111/j.1440-1681.2009.05241.x; Seim Inge, 2009, BMC Res Notes, V2, P85, DOI 10.1186/1756-0500-2-85; Seim I, 2009, CYTOKINE GROWTH F R, V20, P297, DOI 10.1016/j.cytogfr.2009.07.006; Soares JB, 2008, PEPTIDES, V29, P1255, DOI 10.1016/j.peptides.2008.02.018; Taboada GF, 2007, EUR J ENDOCRINOL, V156, P65, DOI 10.1530/eje.1.02313; Takahashi K, 2006, CANCER RES, V66, P9408, DOI 10.1158/0008-5472.CAN-06-1349; Takahashi T, 2009, J BIOCHEM, V146, P675, DOI 10.1093/jb/mvp112; Tsolakis AV, 2009, EUR J ENDOCRINOL, V160, P941, DOI 10.1530/EJE-09-0001; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Volante M, 2009, J PATHOL, V218, P458, DOI 10.1002/path.2551; Wong SCC, 2001, J PATHOL, V194, P35, DOI 10.1002/path.838; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yeh AH, 2005, CLIN CANCER RES, V11, P8295, DOI 10.1158/1078-0432.CCR-05-0443; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200	48	61	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23302	10.1371/journal.pone.0023302	http://dx.doi.org/10.1371/journal.pone.0023302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829727	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200064
J	Gutman, R; Dayan, T; Levy, O; Schubert, I; Kronfeld-Schor, N				Gutman, Roee; Dayan, Tamar; Levy, Ofir; Schubert, Iris; Kronfeld-Schor, Noga			The Effect of the Lunar Cycle on Fecal Cortisol Metabolite Levels and Foraging Ecology of Nocturnally and Diurnally Active Spiny Mice	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; MICROHABITAT USE; DESERT RODENT; ACTIVITY PATTERNS; HETEROMYID RODENTS; ACOMYS-CAHIRINUS; CHRONIC STRESS; OCTODON-DEGUS; OWL PREDATION; VULPES-CANA	We studied stress hormones and foraging of nocturnal Acomys cahirinus and diurnal A. russatus in field populations as well as in two field enclosures populated by both species and two field enclosures with individuals of A. russatus alone. When alone, A. russatus individuals become also nocturnally active. We asked whether nocturnally active A. russatus will respond to moon phase and whether this response will be obtained also in diurnally active individuals. We studied giving-up densities (GUDs) in artificial foraging patches and fecal cortisol metabolite levels. Both species exhibited elevated fecal cortisol metabolite levels and foraged to higher GUDs in full moon nights; thus A. russatus retains physiological response and behavioral patterns that correlate with full moon conditions, as can be expected in nocturnal rodents, in spite of its diurnal activity. The endocrinological and behavioral response of this diurnal species to moon phase reflects its evolutionary heritage.	[Gutman, Roee; Dayan, Tamar; Levy, Ofir; Schubert, Iris; Kronfeld-Schor, Noga] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel	Tel Aviv University	Gutman, R (corresponding author), Tel Hai Coll, Dept Nutr Sci, Fac Sci & Technol, Upper Galilee, Israel.	DayanT@tauex.tau.ac.il	Callahan, Charles D/L-1641-2013; Levy, Ofir/H-6217-2013; Kronfeld-Schor, Noga/AAU-3792-2020	Levy, Ofir/0000-0003-0920-1207; Kronfeld-Schor, Noga/0000-0002-5224-3341; Gutman, Roee/0000-0002-3282-6558	National Geographic Society [6293-98]; ISF [04320021]	National Geographic Society(National Geographic Society); ISF(Israel Science Foundation)	This research was supported by a National Geographic Society grant (6293-98) to T. Dayan (http://www.nationalgeographic.com/) and an ISF grant (04320021) to T. Dayan and N. Kronfeld-Schor (http://www.isf.org.il/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky Z, 2004, CAN J ZOOL, V82, P464, DOI 10.1139/Z04-007; Abramsky Z, 2002, ECOLOGY, V83, P1330, DOI 10.2307/3071947; Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Angelier F, 2008, GEN COMP ENDOCR, V156, P134, DOI 10.1016/j.ygcen.2007.12.001; Ardayfio P, 2006, BEHAV NEUROSCI, V120, P1267, DOI 10.1037/0735-7044.120.6.1267; BLANCHARD RJ, 1995, ANTIPREDATOR BEHAV S; BOUSKILA A, 1995, ECOLOGY, V76, P165, DOI 10.2307/1940639; BOWERS MA, 1988, J MAMMAL, V69, P201, DOI 10.2307/1381778; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; Brown JS, 1999, EVOL ECOL RES, V1, P49; BROWN JS, 1989, ECOL MONOGR, V59, P1, DOI 10.2307/2937289; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; COCKREM JF, 2002, SIGHT PREDATOR CAN S; Cohen R, 2006, PHYSIOL BEHAV, V87, P563, DOI 10.1016/j.physbeh.2005.12.010; Cohen R, 2010, BRAIN BEHAV EVOLUT, V75, P9, DOI 10.1159/000282172; Cohen R, 2010, J BIOL RHYTHM, V25, P47, DOI 10.1177/0748730409351672; Conrad CD, 2004, NEUROBIOL LEARN MEM, V81, P185, DOI 10.1016/j.nlm.2004.01.002; Cowie R. J., 1979, POPULATION DYNAMICS, P183; Cowles MK, 1996, J AM STAT ASSOC, V91, P883, DOI 10.2307/2291683; CRAWFORD LL, 1983, Z TIERPSYCHOL, V63, P283; Crawley M. J, 2002, STAT COMPUTING INTRO; Curio E., 1976, ETHOLOGY PREDATION; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; Dallman MF, 2005, BRAIN BEHAV IMMUN, V19, P275, DOI 10.1016/j.bbi.2004.11.004; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; Ebensperger LA, 2001, ACTA THERIOL, V46, P115, DOI 10.1007/BF03192423; Eilam D, 1999, ANIM BEHAV, V58, P1085, DOI 10.1006/anbe.1999.1224; El Hage W, 2006, PHYSIOL BEHAV, V87, P45, DOI 10.1016/j.physbeh.2005.08.039; FENN MGP, 1995, J MAMMAL, V76, P130, DOI 10.2307/1382321; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; GEFFEN E, 1992, J MAMMAL, V73, P395, DOI 10.2307/1382074; Gutman R, 2006, AM J PHYSIOL-REG I, V290, pR881, DOI 10.1152/ajpregu.00156.2005; Gutman R, 2005, ECOLOGY, V86, P164, DOI 10.1890/03-0369; Hagenauer MH, 2008, BIOL RHYTHM RES, V39, P269, DOI 10.1080/09291010701683425; HALLE S, 1995, J MAMMAL, V76, P88, DOI 10.2307/1382318; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Hendrie CA, 1998, J ZOOL, V245, P439, DOI 10.1017/S0952836998008073; Hendrie CA, 1996, PHARMACOL BIOCHEM BE, V54, P13, DOI 10.1016/0091-3057(95)02176-0; HENDRIE CA, 1994, ETHOLOGY PSYCHOPHARM; JEDRZEJEWSKA B, 1990, ANN ZOOL FENN, V27, P321; Jones M, 2000, J CHEM ECOL, V26, P455, DOI 10.1023/A:1005417707588; Jones M, 2001, ECOLOGY, V82, P2164, DOI 10.1890/0012-9658(2001)082[2164:COTPSM]2.0.CO;2; KOTLER BP, 1994, OECOLOGIA, V100, P391, DOI 10.1007/BF00317860; Kotler BP, 1999, J MAMMAL, V80, P361, DOI 10.2307/1383285; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; Kotler BP, 2002, EVOL ECOL RES, V4, P495; KOTLER BP, 1992, BEHAV ECOL SOCIOBIOL, V30, P239, DOI 10.1007/BF00166708; Kramer KM, 2001, J MAMMAL, V82, P535, DOI 10.1644/1545-1542(2001)082<0535:EOLIOA>2.0.CO;2; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kronfeld-Schor N, 2001, J THERM BIOL, V26, P139, DOI 10.1016/S0306-4565(00)00034-6; Kronfeld-Schor N, 2001, AM NAT, V158, P451, DOI 10.1086/321991; Kronfeld-Schor N, 2001, J MAMMAL, V82, P1016, DOI 10.1644/1545-1542(2001)082<1016:RSAFMU>2.0.CO;2; Kronfeld-Schor N, 2008, BIOL RHYTHM RES, V39, P193, DOI 10.1080/09291010701683268; LAMERS WH, 1986, AM J PHYSIOL, V251, pE78, DOI 10.1152/ajpendo.1986.251.1.E78; Levy O, 2007, CHRONOBIOL INT, V24, P599, DOI 10.1080/07420520701534640; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LONGLAND WS, 1991, ECOLOGY, V72, P2261, DOI 10.2307/1941576; Mandelik Y, 2003, EVOL ECOL RES, V5, P501; Mandelik Y., 2000, Israel Journal of Zoology, V46, P167; MANDELIK Y, 1999, THESIS TEL AVIV U TE; MENDELSSOHN H, 1965, ISR J ZOOL, V14, P185; MENGERSEN K, 2000, SPATIAL EPIDEMIOLOGY, P393; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Mohawk JA, 2007, PHYSIOL BEHAV, V92, P800, DOI 10.1016/j.physbeh.2007.06.009; Monclus R, 2006, CHEMOECOLOGY, V16, P25, DOI 10.1007/s00049-005-0324-6; NELSON EH, 2004, PREDATORS REDUCE PRE; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1111/j.0014-3820.2002.tb01388.x; Plummer M, 2009, CODA OUTPUT ANAL DIA; PLUMMER M, 2008, JAGS JUST ANOTHER GI; PRICE MV, 1984, J MAMMAL, V65, P353, DOI 10.2307/1381183; Redlin U, 2004, J BIOL RHYTHM, V19, P58, DOI 10.1177/0748730403260371; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Roll U, 2006, EVOL ECOL, V20, P479, DOI 10.1007/s10682-006-0015-y; Rotics S, 2011, CHRONOBIOL INT, V28, P70, DOI 10.3109/07420528.2010.525674; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Shargal E, 1999, J ZOOL, V249, P187, DOI 10.1111/j.1469-7998.1999.tb00757.x; Shargal E, 2000, J MAMMAL, V81, P1046, DOI 10.1644/1545-1542(2000)081<1046:PBASRO>2.0.CO;2; SHKOLNIK A, 1971, International Journal of Biometeorology, V15, P115, DOI 10.1007/BF01803884; Sih A, 2000, TRENDS ECOL EVOL, V15, P3, DOI 10.1016/S0169-5347(99)01766-8; Skorzewska A, 2007, HORM BEHAV, V52, P317, DOI 10.1016/j.yhbeh.2007.05.007; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stoks R, 2003, EVOLUTION, V57, P574; Sundell J, 2006, MAMMAL REV, V36, P107, DOI 10.1111/j.1365-2907.2006.00083.x; Thaker M, 2009, HORM BEHAV, V56, P51, DOI 10.1016/j.yhbeh.2009.02.009; Thomas RM, 2006, EXP NEUROL, V201, P308, DOI 10.1016/j.expneurol.2006.04.010; Vivanco P, 2009, CHRONOBIOL INT, V26, P219, DOI 10.1080/07420520902768203; Volobouev V, 2007, BIOL J LINN SOC, V91, P203, DOI 10.1111/j.1095-8312.2007.00773.x; Weinert D, 2007, PHYSIOL BEHAV, V90, P325, DOI 10.1016/j.physbeh.2006.09.019; Weissenberg S, 1997, ISR J ZOOL, V43, P119	95	22	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23446	10.1371/journal.pone.0023446	http://dx.doi.org/10.1371/journal.pone.0023446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829733	Green Published, gold			2022-12-27	WOS:000293561200070
J	Hellen, EH; Volkov, E; Kurths, J; Dana, SK				Hellen, Edward H.; Volkov, Evgenii; Kurths, Jurgen; Dana, Syamal Kumar			An Electronic Analog of Synthetic Genetic Networks	PLOS ONE			English	Article							QUORUM; SYNCHRONIZATION	An electronic analog of a synthetic genetic network known as the repressilator is proposed. The repressilator is a synthetic biological clock consisting of a cyclic inhibitory network of three negative regulatory genes which produces oscillations in the expressed protein concentrations. Compared to previous circuit analogs of the repressilator, the circuit here takes into account more accurately the kinetics of gene expression, inhibition, and protein degradation. A good agreement between circuit measurements and numerical prediction is observed. The circuit allows for easy control of the kinetic parameters thereby aiding investigations of large varieties of potential dynamics.	[Hellen, Edward H.] Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA; [Volkov, Evgenii] PN Lebedev Phys Inst, Dept Theoret Phys, Moscow 117924, Russia; [Kurths, Jurgen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Dana, Syamal Kumar] Indian Inst Chem Biol, Council Sci & Ind Res, Kolkata, India	University of North Carolina; University of North Carolina Greensboro; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Potsdam Institut fur Klimafolgenforschung; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Hellen, EH (corresponding author), Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA.	ehhellen@uncg.edu	Hellen, Edward/AAN-7714-2021; Volkov, Evgeny I/K-9176-2015	Hellen, Edward/0000-0001-5060-7220; 	International Programs Center at the University of North Carolina Greensboro	International Programs Center at the University of North Carolina Greensboro	Travel funds to EHH were provided by the International Programs Center at the University of North Carolina Greensboro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Buldu JM, 2007, INT J BIFURCAT CHAOS, V17, P3507, DOI 10.1142/S0218127407019275; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Lucks JB, 2011, IEEE SPECTRUM, V48, P38, DOI 10.1109/MSPEC.2011.5719724; Mason J, 2004, CHAOS, V14, P707, DOI 10.1063/1.1786683; Potapov I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031901; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; Ullner E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031904; Wagemakers A, 2006, CHAOS, V16, DOI 10.1063/1.2173048; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	16	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23286	10.1371/journal.pone.0023286	http://dx.doi.org/10.1371/journal.pone.0023286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829723	Green Submitted, Green Published, gold			2022-12-27	WOS:000293561200061
J	Hooff, GP; van Huizen, NA; Meesters, RJW; Zijlstra, EE; Abdelraheem, M; Abdelraheem, W; Hamdouk, M; Lindemans, J; Luider, TM				Hooff, Gero P.; van Huizen, Nick A.; Meesters, Roland J. W.; Zijlstra, Eduard E.; Abdelraheem, Mohamed; Abdelraheem, Waleed; Hamdouk, Mohamed; Lindemans, Jan; Luider, Theo M.			Analytical Investigations of Toxic p-Phenylenediamine (PPD) Levels in Clinical Urine Samples with Special Focus on MALDI-MS/MS	PLOS ONE			English	Article							OXIDATIVE HAIR DYE; GENERAL-POPULATION; METABOLITES; ENZYMES; CANCER	Para-phenylenediamine (PPD) is a common chromophoric ingredient in oxidative hair-dyes. In some African countries like Sudan, Egypt and Morocco but also in India this chemical is used alone or in combination with colouring extracts like Henna for dyeing of the hair or the skin. Excessive dermal exposure to PPD mainly leads to the N-mono- and N,N'-diacetylated products (MAPPD, DAPPD) by N-acetyltransferase 1 and 2 (NAT1 and 2) catalyzed reactions. Metabolites and PPD are mainly excreted via renal clearance. Despite a low risk of intoxication when used in due form, there are numerous cases of acute intoxication in those countries every year. At the ENT Hospital - Khartoum (Sudan) alone more than 300 cases are reported every year (similar to 10% fatal), mostly caused by either an accidental or intended (suicidal) high systemic exposure to pure PPD. Intoxication leads to a severe clinical syndrome including laryngeal edema, rhabdomyolysis and subsequent renal failure, neurotoxicity and acute toxic hepatitis. To date, there is no defined clinical treatment or antidote available and treatment is largely supportive. Herein, we show the development of a quick on-site identification assay to facilitate differential diagnosis in the clinic and, more importantly, the implementation of an advanced analytical platform for future in-depth investigations of PPD intoxication and metabolism is described. The current work shows a sensitive (similar to 25 mu M) wet chemistry assay, a validated MALDI-MS/MS and HPLC-UV assay for the determination of PPD and its metabolites in human urine. We show the feasibility of the methods for measuring PPD over a range of 50-1000 mu M. The validation criteria included linearity, lower limit of quantification (LLOQ), accuracy and precision, recovery and stability. Finally, PPD concentrations were determined in clinical urine samples of cases of acute intoxication and the applied technique was expanded to identify MAPPD and DAPPD in the identical samples.	[Hooff, Gero P.; van Huizen, Nick A.; Meesters, Roland J. W.; Luider, Theo M.] Univ Med Ctr Rotterdam ErasmusMC, Dept Neurol, Lab Neurooncol & Clin & Canc Prote, Rotterdam, Netherlands; [Zijlstra, Eduard E.] Univ Med Ctr Rotterdam ErasmusMC, Dept Internal Med, Rotterdam, Netherlands; [Abdelraheem, Mohamed; Abdelraheem, Waleed; Hamdouk, Mohamed] Univ Khartoum, Soba Univ Hosp, Alsalam Med Ctr, Dept Pediat & Child Hlth, Khartoum, Sudan; [Lindemans, Jan] Univ Med Ctr Rotterdam ErasmusMC, Dept Clin Chem, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Khartoum; Erasmus University Rotterdam; Erasmus MC	Hooff, GP (corresponding author), Univ Med Ctr Rotterdam ErasmusMC, Dept Neurol, Lab Neurooncol & Clin & Canc Prote, Rotterdam, Netherlands.	g.hooff@erasmusmc.nl	Meesters, Roland/B-3259-2008	Meesters, Roland/0000-0002-8946-2329; van Huizen, Nick/0000-0002-5475-3433				Barker DF, 2008, DRUG METAB DISPOS, V36, P2445, DOI 10.1124/dmd.108.023564; BURGERS PC, 1983, CHEM PHYS LETT, V102, P1, DOI 10.1016/0009-2614(83)80645-9; Cervellin G, 2010, CLIN CHEM LAB MED, V48, P749, DOI 10.1515/CCLM.2010.151; Chrispal A, 2010, TROP DOCT, V40, P100, DOI 10.1258/td.2010.090367; Dressler WE, 2006, FOOD CHEM TOXICOL, V44, P371, DOI 10.1016/j.fct.2005.08.009; HAMDOUK MK, 2010, CLIN NEPHROTOXINS, P871; Hu T, 2009, TOXICOL LETT, V188, P119, DOI 10.1016/j.toxlet.2009.03.019; Kutting B, 2009, INT J HYG ENVIR HEAL, V212, P298, DOI 10.1016/j.ijheh.2008.07.004; Meesters RJW, 2010, ANAL BIOANAL CHEM, V398, P2943, DOI 10.1007/s00216-010-4192-8; Meyer A, 2009, J CHROMATOGR B, V877, P1627, DOI 10.1016/j.jchromb.2009.04.008; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; NEUBERGER J, 1989, BAILLIERE CLIN GASTR, V3, P447, DOI 10.1016/0950-3528(89)90010-9; Nohynek GJ, 2004, FOOD CHEM TOXICOL, V42, P1885, DOI 10.1016/j.fct.2004.07.009; Shalaby SA, 2010, TOXICOL IND HEALTH, V26, P81, DOI 10.1177/0748233709360200; Sim E, 2008, TOXICOLOGY, V254, P170, DOI 10.1016/j.tox.2008.08.022; Sleno L, 2005, RAPID COMMUN MASS SP, V19, P1928, DOI 10.1002/rcm.2006; Stambouli A, 2004, FORENSIC SCI INT, V146, pS87, DOI 10.1016/j.forsciint.2004.09.029; Stanley LA, 2005, TOXICOLOGY, V210, P147, DOI 10.1016/j.tox.2005.01.019; VERMA KK, 1979, TALANTA, V26, P257, DOI 10.1016/0039-9140(79)80061-2; Wang LH, 2003, ANAL BIOCHEM, V312, P201, DOI 10.1016/S0003-2697(02)00501-8; White JML, 2007, CLIN EXP ALLERGY, V37, P1848, DOI 10.1111/j.1365-2222.2007.02846.x	21	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22191	10.1371/journal.pone.0022191	http://dx.doi.org/10.1371/journal.pone.0022191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829608	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200009
J	Mossman, D; Scott, RJ				Mossman, David; Scott, Rodney J.			Long Term Transcriptional Reactivation of Epigenetically Silenced Genes in Colorectal Cancer Cells Requires DNA Hypomethylation and Histone Acetylation	PLOS ONE			English	Article							BREAST-CANCER; EARLY EVENT; PROMOTER DEMETHYLATION; ABERRANT METHYLATION; LUNG-CANCER; CHROMATIN; BINDING; IDENTIFICATION; PROGNOSIS; BIOMARKER	Epigenetic regulation of genes involves the coordination of DNA methylation and histone modifications to maintain transcriptional status. These two features are frequently disrupted in malignancy such that critical genes succumb to inactivation. 5-aza-2'-deoxycytidine (5-aza-dC) is an agent which inhibits DNA methyltransferase, and holds great potential as a treatment for cancer, yet the extent of its effectiveness varies greatly between tumour types. Previous evidence suggests expression status after 5-aza-dC exposure cannot be explained by the DNA methylation status alone. Aim: We sought to identify chromatin changes involved with short and long term gene reactivation following 5-aza-dC exposure. Two colorectal cancer cell lines, HCT116 and SW480, were treated with 5-aza-dC and then grown in drug-free media to allow DNA re-methylation. DNA methylation and chromatin modifications were assessed with bisulfite sequencing and Chromatin Immuno-Precipitation analysis. Results: Increased H3 acetylation, H3K4 tri-methylation and loss of H3K27 tri-methylation were associated with reactivation. Hypermethylated genes that did not show increased acetylation were transiently expressed with 5-aza-dC treatment before reverting to an inactive state. Three reactivated genes, CDO1, HSPC105 and MAGEA3, were still expressed 10 days post 5-aza-dC treatment and displayed localised hypomethylation at the transcriptional start site, and also an increased enrichment of histone H3 acetylation. Conclusions: These observations suggest that hypomethylation alone is insufficient to reactivate silenced genes and that increased Histone H3 acetylation in unison with localised hypomethylation allows long term reversion of these epigenetically silenced genes. This study suggests that combined DNA methyltransferase and histone deacetylase inhibitors may aid long term reactivation of silenced genes.	[Mossman, David; Scott, Rodney J.] Univ Newcastle, Discipline Med Genet, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia; [Mossman, David; Scott, Rodney J.] Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Scott, Rodney J.] John Hunter Hosp, Div Genet, Hunter Area Pathol Serv, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital	Mossman, D (corresponding author), Univ Newcastle, Discipline Med Genet, Sch Biomed Sci, Fac Hlth, Callaghan, NSW 2308, Australia.	rodney.scott@newcastle.edu.au	Scott, Rodney J/B-2827-2013	Scott, Rodney J/0000-0001-7724-3404	NBN Telethon; University of Newcastle; Hunter Medical Research Institute	NBN Telethon; University of Newcastle; Hunter Medical Research Institute	This study was supported by funds from the NBN Telethon, the University of Newcastle and the Hunter Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio Ana, 2002, Curr Opin Investig Drugs, V3, P627; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Deng GR, 2009, CLIN CANCER RES, V15, P1519, DOI 10.1158/1078-0432.CCR-08-1778; Dietrich D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-247; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Koga T, 2011, INT J CANCER, V128, P1009, DOI 10.1002/ijc.25447; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; KWON MJ, 2010, CARCINOGENESIS, V6, P6; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LIM HW, 2009, J REPROD DEVELOP, V9, P9; Litt MD, 1997, J BIOL CHEM, V272, P14921, DOI 10.1074/jbc.272.23.14921; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Marian A J, 2010, Methodist Debakey Cardiovasc J, V6, P13; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Menendez L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-10; Mitchell CM, 2008, MOL HUM REPROD, V14, P53, DOI 10.1093/molehr/gam086; Mittag F, 2006, CANCER LETT, V240, P69, DOI 10.1016/j.canlet.2005.08.034; Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366; NISHIOKA C, 2011, LEUK RES; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Owen-Hughes Thomas, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P403; Oyer JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004832; Qiu G, 2006, CLIN BIOCHEM, V39, P259, DOI 10.1016/j.clinbiochem.2006.01.014; Ramos EAS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-23; Shima K, 2011, INT J CANCER, V128, P1080, DOI 10.1002/ijc.25432; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Watt PM, 2000, GENE CHROMOSOME CANC, V29, P371, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y; Wiencke JK, 2008, ONCOGENE, V27, P2412, DOI 10.1038/sj.onc.1210895; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; You Y, 2010, MELANOMA RES, V20, P179, DOI 10.1097/CMR.0b013e32833413c0; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	38	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23127	10.1371/journal.pone.0023127	http://dx.doi.org/10.1371/journal.pone.0023127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829702	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200048
J	Vargas, N; Alvarez-Cubela, S; Giraldo, JA; Nieto, M; Fort, NM; Cechin, S; Garcia, E; Espino-Grosso, P; Fraker, CA; Ricordi, C; Inverardi, L; Pastori, RL; Dominguez-Bendala, J				Vargas, Nancy; Alvarez-Cubela, Silvia; Giraldo, Jaime A.; Nieto, Margarita; Fort, Nicholas M.; Cechin, Sirlene; Garcia, Enrique; Espino-Grosso, Pedro; Fraker, Christopher A.; Ricordi, Camillo; Inverardi, Luca; Pastori, Ricardo L.; Dominguez-Bendala, Juan			TAT-Mediated Transduction of MafA Protein In Utero Results in Enhanced Pancreatic Insulin Expression and Changes in Islet Morphology	PLOS ONE			English	Article							BETA-CELLS; TRANSCRIPTION FACTOR; THERAPEUTIC TARGET; GENE-TRANSCRIPTION; KEY REGULATOR; DNA-BINDING; DIFFERENTIATION; MATURATION; DELIVERY; DOMAIN	Alongside Pdx1 and Beta2/NeuroD, the transcription factor MafA has been shown to be instrumental in the maintenance of the beta cell phenotype. Indeed, a combination of MafA, Pdx1 and Ngn3 (an upstream regulator of Beta2/NeuroD) was recently reported to lead to the effective reprogramming of acinar cells into insulin-producing beta cells. These experiments set the stage for the development of new strategies to address the impairment of glycemic control in diabetic patients. However, the clinical applicability of reprogramming in this context is deemed to be poor due to the need to use viral vehicles for the delivery of the above factors. Here we describe a recombinant transducible version of the MafA protein (TAT-MafA) that penetrates across cell membranes with an efficiency of 100% and binds to the insulin promoter in vitro. When injected in utero into living mouse embryos, TAT-MafA significantly up-regulates target genes and induces enhanced insulin production as well as cytoarchitectural changes consistent with faster islet maturation. As the latest addition to our armamentarium of transducible proteins (which already includes Pdx1 and Ngn3), the purification and characterization of a functional TAT-MafA protein opens the door to prospective therapeutic uses that circumvent the use of viral delivery. To our knowledge, this is also the first report on the use of protein transduction in utero.	[Vargas, Nancy; Alvarez-Cubela, Silvia; Giraldo, Jaime A.; Nieto, Margarita; Fort, Nicholas M.; Cechin, Sirlene; Garcia, Enrique; Espino-Grosso, Pedro; Fraker, Christopher A.; Ricordi, Camillo; Inverardi, Luca; Pastori, Ricardo L.; Dominguez-Bendala, Juan] Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL 33152 USA; [Ricordi, Camillo; Dominguez-Bendala, Juan] Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL USA; [Inverardi, Luca; Pastori, Ricardo L.] Univ Miami, Dept Med, Div Endocrinol Diabet & Metab, Leonard M Miller Sch Med, Miami, FL USA; [Giraldo, Jaime A.; Fraker, Christopher A.] Univ Miami, Dept Biomed Engn, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami	Vargas, N (corresponding author), Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL 33152 USA.	rpastori@med.miami.edu; j.dominguezbendala@miami.edu	Dominguez-Bendala, Juan/AAE-8296-2019; RICORDI, CAMILLO/AAA-4740-2019; Fraker, Christopher/R-6404-2018	Ricordi, Camillo/0000-0001-8092-7153; Fraker, Christopher/0000-0002-2010-0573; Garcia, Enrique/0000-0002-4779-5766	Diabetes Research Institute Foundation (DRIF)	Diabetes Research Institute Foundation (DRIF)	This work was funded by the Diabetes Research Institute Foundation (DRIF). The DRIF funds work conducted at the Diabetes Research Institute with the goal of achieving a cure for type 1 diabetes in the fastest, safest and most efficient way possible. Funding is internal and as such is not associated with grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Baum C, 2006, HUM GENE THER, V17, P253, DOI 10.1089/hum.2006.17.253; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Carvalho CPF, 2010, DIABETOLOGIA, V53, P1428, DOI 10.1007/s00125-010-1726-8; Chiou SH, 2011, J CELL MOL MED; Collares-Buzato CB, 2004, J MOL HISTOL, V35, P811, DOI 10.1007/s10735-004-1746-0; Carvalho CPDF, 2006, ANN ANAT, V188, P221, DOI 10.1016/j.annat.2005.10.009; Deutsch G, 2001, DEVELOPMENT, V128, P871; Do Kwon Y, 2005, MOL THER, V12, P28, DOI 10.1016/y.ymthe.2005.03.01; Dominguez-Bendala J, 2005, DIABETES, V54, P720, DOI 10.2337/diabetes.54.3.720; Dominguez-Bendala J, 2006, CELL TRANSPLANT, V15, pS85; Embury J, 2001, DIABETES, V50, P1706, DOI 10.2337/diabetes.50.8.1706; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; GALLIGAN BR, 1989, TRANSFUSION, V29, P179, DOI 10.1046/j.1537-2995.1989.29289146839.x; Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kaneto H, 2007, DIABETES RES CLIN PR, V77, pS127, DOI 10.1016/j.diabres.2007.01.046; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Klein D, 2005, CELL TRANSPLANT, V14, P241, DOI 10.3727/000000005783983016; Klein D, 2004, BIOCHEM BIOPH RES CO, V323, P473, DOI 10.1016/j.bbrc.2004.08.116; Lajic Svetlana, 2008, V13, P82, DOI 10.1159/000134827; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Mendoza V, 2005, TRANSPL P, V37, P237, DOI 10.1016/j.transproceed.2004.12.270; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; Ogino H, 1998, SCIENCE, V280, P115, DOI 10.1126/science.280.5360.115; Pastori RL, 2004, TRANSPLANTATION, V77, P1627, DOI 10.1097/01.TP.0000119589.12467.20; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Rehman KK, 2003, J BIOL CHEM, V278, P9862, DOI 10.1074/jbc.M207700200; Ribeiro MM, 2003, BIOCHEM BIOPH RES CO, V305, P876, DOI 10.1016/S0006-291X(03)00856-8; Sambrook J., 2001, MOL CLONING LAB MANU; SHIEH SY, 1991, J BIOL CHEM, V266, P16708; Strasburger JF, 2010, NAT REV CARDIOL, V7, P277, DOI 10.1038/nrcardio.2010.32; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Yinon YM, 2010, ULTRASOUND OBSTET GY; Zaro JL, 2003, BIOCHEM BIOPH RES CO, V307, P241, DOI 10.1016/S0006-291X(03)01167-7; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e22364	10.1371/journal.pone.0022364	http://dx.doi.org/10.1371/journal.pone.0022364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21857924	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200014
J	Vazquez-Cedeira, M; Barcia-Sanjurjo, I; Sanz-Garcia, M; Barcia, R; Lazo, PA				Vazquez-Cedeira, Marta; Barcia-Sanjurjo, Iria; Sanz-Garcia, Marta; Barcia, Ramiro; Lazo, Pedro A.			Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2	PLOS ONE			English	Article							HUMAN VACCINIA-RELATED-KINASE-1 VRK1; VACCINIA-RELATED KINASE-1; PROTEIN-KINASE; BREAST-CANCER; ALZHEIMERS-DISEASE; CELL-DIVISION; GROWTH-FACTOR; BINDING-SITE; HUMAN GENOME; PHOSPHORYLATION	Human vaccinia-related kinases (VRK1 and VRK2) are atypical active Ser-Thr kinases implicated in control of cell cycle entry, apoptosis and autophagy, and affect signalling by mitogen activated protein kinases (MAPK). The specific structural differences in VRK catalytic sites make them suitable candidates for development of specific inhibitors. In this work we have determined the sensitivity of VRK1 and VRK2 to kinase inhibitors, currently used in biological assays or in preclinical studies, in order to discriminate between the two proteins as well as with respect to the vaccinia virus B1R kinase. Both VRK proteins and vaccinia B1R are poorly inhibited by inhibitors of different types targeting Src, MEK1, B-Raf, JNK, p38, CK1, ATM, CHK1/2 and DNA-PK, and most of them have no effect even at 100 mu M. Despite their low sensitivity, some of these inhibitors in the low micromolar range are able to discriminate between VRK1, VRK2 and B1R. VRK1 is more sensitive to staurosporine, RO-31-8220 and TDZD8. VRK2 is more sensitive to roscovitine, RO 31-8220, Cdk1 inhibitor, AZD7762, and IC261. Vaccinia virus B1R is more sensitive to staurosporine, KU55933, and RO 31-8220, but not to IC261. Thus, the three kinases present a different pattern of sensitivity to kinase inhibitors. This differential response to known inhibitors can provide a structural framework for VRK1 or VRK2 specific inhibitors with low or no cross-inhibition. The development of highly specific VRK1 inhibitors might be of potential clinical use in those cancers where these kinases identify a clinical subtype with a poorer prognosis, as is the case of VRK1 in breast cancer.	[Vazquez-Cedeira, Marta; Sanz-Garcia, Marta; Lazo, Pedro A.] Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain; [Barcia-Sanjurjo, Iria; Barcia, Ramiro] Univ Santiago de Compostela, Dept Bioquim & Biol Mol, Fac Vet, Lugo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidade de Santiago de Compostela	Vazquez-Cedeira, M (corresponding author), Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain.	pedro.lazo@csic.es	Lazo, Pedro A./M-6435-2014	Lazo, Pedro A./0000-0001-8997-3025	JAE/CSIC; Universidad de Santiago; Ministerio de Educacion, Ciencia e Innovacion [SAF2010-14935, CSD2007-0017]; Junta de Castilla y Leon [CSI14A08, GR15]; Fundacion Sandra Ibarra; Kutxa-Fundacion INBIOMED; Xunta de Galicia	JAE/CSIC; Universidad de Santiago; Ministerio de Educacion, Ciencia e Innovacion; Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Sandra Ibarra; Kutxa-Fundacion INBIOMED; Xunta de Galicia(Xunta de GaliciaEuropean Commission)	M.V.-C. and M.S.-G. have predoctoral fellowships from JAE/CSIC. I.B.-S. has a predoctoral fellowship from Zymofeed project of the Universidad de Santiago. This work was funded by grants from Ministerio de Educacion, Ciencia e Innovacion [SAF2010-14935 and CSD2007-0017], Junta de Castilla y Leon [CSI14A08 and GR15], Fundacion Sandra Ibarra, and Kutxa-Fundacion INBIOMED to P. A. L.; and from the Zymofeed project from Xunta de Galicia to R. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Andreani A, 2000, ANTI-CANCER DRUG DES, V15, P447; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BANHAM AH, 1992, VIROLOGY, V191, P803, DOI 10.1016/0042-6822(92)90256-O; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; CHEONG JK, 2011, ONCOGENE; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Eswaran J, 2010, BBA-PROTEINS PROTEOM, V1804, P429, DOI 10.1016/j.bbapap.2009.10.013; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fernandez IF, 2010, MOL CELL BIOL, V30, P4687, DOI 10.1128/MCB.01581-09; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KELLER HU, 1993, BIOCHEM BIOPH RES CO, V194, P1111, DOI 10.1006/bbrc.1993.1936; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kilpinen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015068; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; KOJIMA I, 1993, J BIOL CHEM, V268, P10003; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mahon TM, 1997, BIOCHEM J, V325, P39; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; Mitchell JB, 2010, CLIN CANCER RES, V16, P2076, DOI 10.1158/1078-0432.CCR-09-3277; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Nishijo K, 2009, CANCER RES, V69, P2902, DOI 10.1158/0008-5472.CAN-08-3723; REMPEL RE, 1992, J VIROL, V66, P4413, DOI 10.1128/JVI.66.7.4413-4426.1992; Santos CR, 2004, VIROLOGY, V328, P254, DOI 10.1016/j.virol.2004.08.013; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; Savage MJ, 2009, DRUG DEVELOP RES, V70, P125, DOI 10.1002/ddr.20287; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, LUNG CANCER, V58, P303, DOI 10.1016/j.lungcan.2007.06.023; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Yeo EJ, 1997, BBA-MOL CELL RES, V1356, P308, DOI 10.1016/S0167-4889(97)00006-2; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	63	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23235	10.1371/journal.pone.0023235	http://dx.doi.org/10.1371/journal.pone.0023235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829721	Green Submitted, gold, Green Published			2022-12-27	WOS:000293561200059
J	Wang, J; Svendsen, A; Kmiecik, J; Immervol, H; Skaftnesmo, KO; Planaguma, J; Reed, RK; Bjerkvig, R; Miletic, H; Enger, PO; Rygh, CB; Chekenya, M				Wang, Jian; Svendsen, Agnete; Kmiecik, Justyna; Immervol, Heike; Skaftnesmo, Kai Ove; Planaguma, Jesus; Reed, Rolf Kare; Bjerkvig, Rolf; Miletic, Hrvoje; Enger, Per Oyvind; Rygh, Cecilie Brekke; Chekenya, Martha			Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; ACUTE MYELOID-LEUKEMIA; GLIOBLASTOMA-MULTIFORME; NG2 PROTEOGLYCAN; BRAIN-TUMORS; MONOCLONAL-ANTIBODY; GENETIC ALTERATIONS; FACTOR RECEPTOR-2; HUMAN HOMOLOG; IN-VIVO	Aberrant expression of the progenitor marker Neuron-glia 2 (NG2/CSPG4) or melanoma proteoglycan on cancer cells and angiogenic vasculature is associated with an aggressive disease course in several malignancies including glioblastoma multiforme (GBM) and melanoma. Thus, we investigated the mechanism of NG2 mediated malignant progression and its potential as a therapeutic target in clinically relevant GBM and melanoma animal models. Xenografting NG2 overexpressing GBM cell lines resulted in increased growth rate, angiogenesis and vascular permeability compared to control, NG2 negative tumours. The effect of abrogating NG2 function was investigated after intracerebral delivery of lentivirally encoded shRNAs targeting NG2 in patient GBM xenografts as well as in established subcutaneous A375 melanoma tumours. NG2 knockdown reduced melanoma proliferation and increased apoptosis and necrosis. Targeting NG2 in two heterogeneous GBM xenografts significantly reduced tumour growth and oedema levels, angiogenesis and normalised vascular function. Vascular normalisation resulted in increased tumour invasion and decreased apoptosis and necrosis. We conclude that NG2 promotes tumour progression by multiple mechanisms and represents an amenable target for cancer molecular therapy.	[Wang, Jian; Svendsen, Agnete; Kmiecik, Justyna; Skaftnesmo, Kai Ove; Planaguma, Jesus; Bjerkvig, Rolf; Miletic, Hrvoje; Enger, Per Oyvind; Rygh, Cecilie Brekke; Chekenya, Martha] Univ Bergen, Dept Biomed, Translat Canc Res Grp, Bergen, Norway; [Immervol, Heike; Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Immervol, Heike] Univ Bergen, Gades Inst, Bergen, Norway; [Reed, Rolf Kare; Rygh, Cecilie Brekke] Haukeland Hosp, Heart & Circulatory Res Grp, N-5021 Bergen, Norway; [Bjerkvig, Rolf] Ctr Rech Publ Sante, Luxembourg, Luxembourg; [Enger, Per Oyvind] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Luxembourg Institute of Health; University of Bergen; Haukeland University Hospital	Wang, J (corresponding author), Univ Bergen, Dept Biomed, Translat Canc Res Grp, Bergen, Norway.	martha.chekenya@biomed.uib.no	Skaftnesmo, kai ove/AAF-6071-2021; Reed, Rolf K./B-9422-2017; Engelsen, Agnete Svendsen Tenfjord/AAB-6652-2020	Reed, Rolf K./0000-0002-2633-6595; Engelsen, Agnete Svendsen Tenfjord/0000-0003-0375-3406; Chekenya, PhD, Dr Philos, Dr. Martha/0000-0001-7241-3451	Norwegian Cancer Society [PK01-2008-0093]; Meltzer Fond; Norges Forskningsrads FRIFORSK; Bergen Medical Research Foundation; Helse-Vest [911382, 911383]; Norwegian Research Council	Norwegian Cancer Society(Norwegian Cancer Society); Meltzer Fond; Norges Forskningsrads FRIFORSK; Bergen Medical Research Foundation; Helse-Vest; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank The Norwegian Cancer Society (grant PK01-2008-0093), The Meltzer Fond, Norges Forskningsrads FRIFORSK, Bergen Medical Research Foundation and Helse-Vest (grants 911382 and 911383) that supported our work. The molecular imaging platform and MRI performed in Trondheim was supported by the National Program for Research in Functional Genomics (FUGE), funded by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behm FG, 1996, BLOOD, V87, P1134, DOI 10.1182/blood.V87.3.1134.bloodjournal8731134; Benassi MS, 2009, J ORTHOP RES, V27, P135, DOI 10.1002/jor.20694; Brekke C, 2006, NEUROIMAGE, V29, P965, DOI 10.1016/j.neuroimage.2005.08.026; Burg MA, 1998, J CELL PHYSIOL, V177, P299, DOI 10.1002/(SICI)1097-4652(199811)177:2<299::AID-JCP12>3.3.CO;2-0; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Chekenya M, 2002, NEUROPATH APPL NEURO, V28, P367, DOI 10.1046/j.1365-2990.2002.00412.x; Chekenya M, 2002, FASEB J, V16, P586, DOI 10.1096/fj.01-0632fje; Engebraaten O, 1999, J NEUROSURG, V90, P125, DOI 10.3171/jns.1999.90.1.0125; FESTING MFW, 1978, NATURE, V274, P365, DOI 10.1038/274365a0; Folkman J, 2003, CANCER BIOL THER, V2, pS127; Gerstner ER, 2010, NEURO-ONCOLOGY, V12, P466, DOI 10.1093/neuonc/nop051; Goretzki L, 2000, J BIOL CHEM, V275, P28625, DOI 10.1074/jbc.M002290200; Hjortland GO, 2004, J NEUROSURG, V100, P320, DOI 10.3171/jns.2004.100.2.0320; Hovinga KE, 2005, J NEURO-ONCOL, V74, P99, DOI 10.1007/s11060-004-4204-7; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kunkel P, 2001, CANCER RES, V61, P6624; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lai A, 2008, INT J RADIAT ONCOL, V71, P1372, DOI 10.1016/j.ijrobp.2007.11.068; Lamszus K, 2005, CLIN CANCER RES, V11, P4934, DOI 10.1158/1078-0432.CCR-04-2270; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Li Y, 2003, BRIT J OPHTHALMOL, V87, P629, DOI 10.1136/bjo.87.5.629; LUNDJOHANSEN M, 1990, CANCER RES, V50, P6039; Mahesparan R, 2003, ACTA NEUROPATHOL, V105, P49, DOI 10.1007/s00401-002-0610-0; Mauvieux L, 1999, BRIT J HAEMATOL, V107, P674; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Peroulis I, 2002, INT J CANCER, V97, P839, DOI 10.1002/ijc.10115; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471; Schoenegger K, 2009, EUR J NEUROL, V16, P874, DOI 10.1111/j.1468-1331.2009.02613.x; SCHRAPPE M, 1991, CANCER RES, V51, P4986; Shoshan Y, 1999, P NATL ACAD SCI USA, V96, P10361, DOI 10.1073/pnas.96.18.10361; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Smith JS, 2000, FRONT BIOSCI-LANDMRK, V5, pD213, DOI 10.2741/Smith; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SU MY, 1994, MAGN RESON MED, V32, P714, DOI 10.1002/mrm.1910320606; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	39	61	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2011	6	7							e23062	10.1371/journal.pone.0023062	http://dx.doi.org/10.1371/journal.pone.0023062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	799KV	21829586	Green Published, gold			2022-12-27	WOS:000293286500073
J	Juuti-Uusitalo, K; Klunder, LJ; Sjollema, KA; Mackovicova, K; Ohgaki, R; Hoekstra, D; Dekker, J; van Ijzendoorn, SCD				Juuti-Uusitalo, Kati; Klunder, Leon J.; Sjollema, Klaas A.; Mackovicova, Katarina; Ohgaki, Ryuichi; Hoekstra, Dick; Dekker, Jan; van Ijzendoorn, Sven C. D.			Differential Effects of TNF (TNFSF2) and IFN-gamma on Intestinal Epithelial Cell Morphogenesis and Barrier Function in Three-Dimensional Culture	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SPINDLE ORIENTATION; TIGHT JUNCTIONS; LUMEN FORMATION; APICAL SURFACE; MYOSIN-II; POLARITY; MECHANISMS; ALPHA; APOPTOSIS	Background: The cytokines TNF (TNFSF2) and IFN gamma are important mediators of inflammatory bowel diseases and contribute to enhanced intestinal epithelial permeability by stimulating apoptosis and/or disrupting tight junctions. Apoptosis and tight junctions are also important for epithelial tissue morphogenesis, but the effect of TNF and IFN gamma on the process of intestinal epithelial morphogenesis is unknown. Methods/Principal Findings: We have employed a three-dimensional cell culture system, reproducing in vivo-like multicellular organization of intestinal epithelial cells, to study the effect of TNF on intestinal epithelial morphogenesis and permeability. We show that human intestinal epithelial cells in three-dimensional culture assembled into luminal spheres consisting of a single layer of cells with structural, internal, and planar cell polarity. Exposure of preformed luminal spheres to TNF or IFN gamma enhanced paracellular permeability, but via distinctive mechanisms. Thus, while both TNF and IFN gamma, albeit in a distinguishable manner, induced the displacement of selected tight junction proteins, only TNF increased paracellular permeability via caspase-driven apoptosis and cell shedding. Infliximab and adalumimab inhibited these effects of TNF. Moreover, we demonstrate that TNF via its stimulatory effect on apoptosis fundamentally alters the process of intestinal epithelial morphogenesis, which contributes to the de novo generation of intestinal epithelial monolayers with increased permeability. Also IFN gamma contributes to the de novo formation of monolayers with increased permeability, but in a manner that does not involve apoptosis. Conclusions: Our study provides an optimized 3D model system for the integrated analysis of (real-time) intestinal epithelial paracellular permeability and morphogenesis, and reveals apoptosis as a pivotal mechanism underlying the enhanced permeability and altered morphogenesis in response to TNF, but not IFN gamma.	[Juuti-Uusitalo, Kati; Dekker, Jan; van Ijzendoorn, Sven C. D.] Top Inst Food & Nutr, Wageningen, Netherlands; [Juuti-Uusitalo, Kati; Klunder, Leon J.; Mackovicova, Katarina; Ohgaki, Ryuichi; Hoekstra, Dick; van Ijzendoorn, Sven C. D.] Univ Groningen, Dept Cell Biol, Sect Membrane Cell Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Sjollema, Klaas A.] Univ Groningen, Dept Cell Biol, Sect Mol Imaging & Electron Microscopy, Univ Med Ctr Groningen, Groningen, Netherlands; [Sjollema, Klaas A.] Univ Groningen, Univ Med Ctr Groningen, UMCG Microscopy & Imaging Ctr UMIC, Groningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; University of Groningen; University of Groningen	Juuti-Uusitalo, K (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	s.c.d.van.ijzendoorn@med.umcg.nl		Sjollema, Klaas/0000-0001-8840-2087; Ohgaki, Ryuichi/0000-0002-6894-7239; Juuti-Uusitalo, Kati/0000-0003-2275-5562	Top Institute Food and Nutrition; Grants-in-Aid for Scientific Research [23790334] Funding Source: KAKEN	Top Institute Food and Nutrition; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Top Institute Food and Nutrition (http://www.tifn.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Carpenter HA, 2000, AM J GASTROENTEROL, V95, P878; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; Haouzi D, 2005, J CELL SCI, V118, P2763, DOI 10.1242/jcs.02403; Ivanov AI, 2008, J CELL SCI, V121, P1803, DOI 10.1242/jcs.015842; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Melnick M, 2001, ANAT RECORD, V262, P318, DOI 10.1002/1097-0185(20010301)262:3<318::AID-AR1023>3.0.CO;2-3; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Sands BE, 2007, J CLIN PHARMACOL, V47, P930, DOI 10.1177/0091270007301623; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Toyli M, 2010, LAB INVEST, V90, P915, DOI 10.1038/labinvest.2010.63; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2008, EMBO REP, V9, P923, DOI 10.1038/embor.2008.135	35	29	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22967	10.1371/journal.pone.0022967	http://dx.doi.org/10.1371/journal.pone.0022967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853060	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400021
J	Leushacke, M; Sporle, R; Bernemann, C; Brouwer-Lehmitz, A; Fritzmann, J; Theis, M; Buchholz, F; Herrmann, BG; Morkel, M				Leushacke, Marc; Spoerle, Ralf; Bernemann, Christof; Brouwer-Lehmitz, Antje; Fritzmann, Johannes; Theis, Mirko; Buchholz, Frank; Herrmann, Bernhard G.; Morkel, Markus			An RNA Interference Phenotypic Screen Identifies a Role for FGF Signals in Colon Cancer Progression	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; GROWTH-FACTOR RECEPTOR; COLORECTAL-CANCER; BETA-CATENIN; STEM-CELLS; METASTASIS; EXPRESSION; MICE; ADHESION	In tumor cells, stepwise oncogenic deregulation of signaling cascades induces alterations of cellular morphology and promotes the acquisition of malignant traits. Here, we identified a set of 21 genes, including FGF9, as determinants of tumor cell morphology by an RNA interference phenotypic screen in SW480 colon cancer cells. Using a panel of small molecular inhibitors, we subsequently established phenotypic effects, downstream signaling cascades, and associated gene expression signatures of FGF receptor signals. We found that inhibition of FGF signals induces epithelial cell adhesion and loss of motility in colon cancer cells. These effects are mediated via the mitogen-activated protein kinase (MAPK) and Rho GTPase cascades. In agreement with these findings, inhibition of the MEK1/2 or JNK cascades, but not of the PI3K-AKT signaling axis also induced epithelial cell morphology. Finally, we found that expression of FGF9 was strong in a subset of advanced colon cancers, and overexpression negatively correlated with patients' survival. Our functional and expression analyses suggest that FGF receptor signals can contribute to colon cancer progression.	[Leushacke, Marc; Spoerle, Ralf; Bernemann, Christof; Brouwer-Lehmitz, Antje; Herrmann, Bernhard G.; Morkel, Markus] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Leushacke, Marc] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Fritzmann, Johannes] Max Delbruck Ctr Mol Med, Berlin, Germany; [Fritzmann, Johannes] Univ Heidelberg Hosp, Dept Surg, Heidelberg, Germany; [Theis, Mirko; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Theis, Mirko; Buchholz, Frank] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, D-8027 Dresden, Germany; [Herrmann, Bernhard G.] Charite Campus Benjamin Franklin, Inst Med Genet, Berlin, Germany; [Theis, Mirko; Buchholz, Frank] Tech Univ Dresden, Fac Med, D-8027 Dresden, Germany	Max Planck Society; Free University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ruprecht Karls University Heidelberg; Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden	Leushacke, M (corresponding author), Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany.	morkel@molgen.mpg.de	Buchholz, Frank/B-4700-2017	Buchholz, Frank/0000-0002-4577-3344; Morkel, Markus/0000-0002-2553-9999	German Bundesministerium fur Bildung und Forschung [NGFN2 01GR0405, PKT-01GS08111-5, PKM-01GS08105-8]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Parts of the work were funded by the German Bundesministerium fur Bildung und Forschung (grant NGFN2 01GR0405 to BGH, and grants PKT-01GS08111-5 and PKM-01GS08105-8 to BGH and MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bisson N, 2007, MOL BIOL CELL, V18, P1030, DOI 10.1091/mbc.E06-04-0294; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Buchholz F, 2006, NAT METHODS, V3, P696, DOI 10.1038/NMETH912; Camarero N, 2006, MOL CANCER RES, V4, P645, DOI 10.1158/1541-7786.MCR-05-0267; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christensen KL, 2008, ADV CANCER RES, V101, P93, DOI 10.1016/S0065-230X(08)00405-3; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254, DOI 10.1016/0016-5085(94)90017-5; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fu YL, 2010, EUR J CELL BIOL, V89, P428, DOI 10.1016/j.ejcb.2010.01.002; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Gulino A, 2009, EMBO MOL MED, V1, P300, DOI 10.1002/emmm.200900042; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Le NH, 2008, BRIT J CANCER, V98, P1886, DOI 10.1038/sj.bjc.6604401; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; Reynaud C, 2000, J BIOL CHEM, V275, P33962, DOI 10.1074/jbc.M000465200; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; Sonvilla G, 2010, BRIT J CANCER, V102, P1145, DOI 10.1038/sj.bjc.6605596; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Winder T, 2010, GASTROENTEROLOGY, V138, P2163, DOI 10.1053/j.gastro.2010.02.005; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392	56	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23381	10.1371/journal.pone.0023381	http://dx.doi.org/10.1371/journal.pone.0023381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853123	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000293953400042
J	Schussler, A; Kruger, M; Walker, C				Schuessler, Arthur; Krueger, Manuela; Walker, Christopher			Revealing Natural Relationships among Arbuscular Mycorrhizal Fungi: Culture Line BEG47 Represents Diversispora epigaea, Not Glomus versiforme	PLOS ONE			English	Article							SP-NOV; GLOMALES; PCR; GLOMEROMYCOTA; PHYLOGENY; PATTERNS; SPORE	Background: Understanding the mechanisms underlying biological phenomena, such as evolutionarily conservative trait inheritance, is predicated on knowledge of the natural relationships among organisms. However, despite their enormous ecological significance, many of the ubiquitous soil inhabiting and plant symbiotic arbuscular mycorrhizal fungi (AMF, phylum Glomeromycota) are incorrectly classified. Methodology/Principal Findings: Here, we focused on a frequently used model AMF registered as culture BEG47. This fungus is a descendent of the ex-type culture-lineage of Glomus epigaeum, which in 1983 was synonymised with Glomus versiforme. It has since then been used as 'G. versiforme BEG47'. We show by morphological comparisons, based on type material, collected 1860-61, of G. versiforme and on type material and living ex-type cultures of G. epigaeum, that these two AMF species cannot be conspecific, and by molecular phylogenetics that BEG47 is a member of the genus Diversispora. Conclusions: This study highlights that experimental works published during the last >25 years on an AMF named 'G. versiforme' or 'BEG47' refer to D. epigaea, a species that is actually evolutionarily separated by hundreds of millions of years from all members of the genera in the Glomerales and thus from most other commonly used AMF 'laboratory strains'. Detailed redescriptions substantiate the renaming of G. epigaeum (BEG47) as D. epigaea, positioning it systematically in the order Diversisporales, thus enabling an evolutionary understanding of genetical, physiological, and ecological traits, relative to those of other AMF. Diversispora epigaea is widely cultured as a laboratory strain of AMF, whereas G. versiforme appears not to have been cultured nor found in the field since its original description.	[Schuessler, Arthur; Krueger, Manuela] Univ Munich, Dept Biol, Bioctr, Martinsried, Germany; [Walker, Christopher] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Walker, Christopher] Univ Western Australia, Sch Earth & Environm, Nedlands, WA 6009, Australia	University of Munich; University of Western Australia	Schussler, A (corresponding author), Univ Munich, Dept Biol, Bioctr, Martinsried, Germany.	arthur.schuessler@lmu.de	Schüßler, Arthur/F-1681-2011; Krüger, Manuela/H-1603-2014	Krüger, Manuela/0000-0001-9223-3570; Walker, Christopher/0000-0003-0008-0664	DFG (German Research foundation) [Schu1203/8]	DFG (German Research foundation)(German Research Foundation (DFG))	Part of the work was funded by the DFG (German Research foundation) under grant number Schu1203/8 (was running until end 2007). There is no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERCH SM, 1983, CAN J BOT, V61, P2608, DOI 10.1139/b83-287; BONFANTEFASOLO P, 1984, PROTOPLASMA, V120, P51, DOI 10.1007/BF01287617; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; DANIELS BA, 1979, CAN J BOT, V57, P539, DOI 10.1139/b79-070; DANIELS BA, 1980, PHYTOPATHOLOGY, V70, P584, DOI 10.1094/Phyto-70-584; de la Providencia IE, 2005, NEW PHYTOL, V165, P261, DOI 10.1111/j.1469-8137.2004.01236.x; Gamper H, 2007, MYCORRHIZA, V17, P145, DOI 10.1007/s00572-006-0092-3; Gamper HA, 2009, NEW PHYTOL, V182, P495, DOI 10.1111/j.1469-8137.2008.02750.x; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; GERDEMANN JW, 1955, MYCOLOGIA, V47, P916, DOI 10.2307/3755515; Gomez SK, 2009, PEST MANAG SCI, V65, P504, DOI 10.1002/ps.1715; HARRISON MJ, 1995, NATURE, V378, P626, DOI 10.1038/378626a0; HAWKSWORTH DL, 1983, AINSWORTH BISBYS DIC; Karsten PA., 1884, HEDWIGIA, V23, P39; Kornerup A., 1978, METHUEN HDB COLOUR; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lanfranco L, 1999, FEMS MICROBIOL LETT, V170, P59, DOI 10.1111/j.1574-6968.1999.tb13355.x; Liu JY, 2007, PLANT J, V50, P529, DOI 10.1111/j.1365-313X.2007.03069.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Morton JB, 2001, MYCOLOGIA, V93, P181, DOI 10.2307/3761615; Naumann M, 2010, ISME J, V4, P862, DOI 10.1038/ismej.2010.21; Palenzuela J, 2010, MYCOLOGIA, V102, P624, DOI 10.3852/09-145; Pfeiffer CM, 1996, MYCOTAXON, V59, P373; Redecker D, 2000, MOL PHYLOGENET EVOL, V14, P276, DOI 10.1006/mpev.1999.0713; Redecker D, 2007, MYCOL PROG, V6, P35, DOI 10.1007/s11557-007-0524-2; Renker C, 2003, MYCORRHIZA, V13, P191, DOI 10.1007/s00572-002-0214-5; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2001, MYCOL RES, V105, P5, DOI 10.1017/S0953756200003725; Schussler A., 2010, GLOMEROMYCOTA SPECIE; Schwarzott D, 2001, MOL PHYLOGENET EVOL, V21, P190, DOI 10.1006/mpev.2001.1007; Sokolski S, 2010, BOTANY, V88, P829, DOI 10.1139/B10-050; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Thaxter R, 1922, P AM ACAD ARTS SCI, V57, P289; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Voets L, 2006, NEW PHYTOL, V172, P185, DOI 10.1111/j.1469-8137.2006.01873.x; WALKER C, 1983, MYCOTAXON, V18, P443; Walker C, 1998, ANN BOT-LONDON, V82, P601, DOI 10.1006/anbo.1998.0714; WALKER C, 1982, CAN J BOT, V60, P2518, DOI 10.1139/b82-305; Walker C., 2004, MYCOL RES, V108, P981, DOI [10.1017/S0953756204231173, DOI 10.1017/S0953756204231173]; Walker C, 2007, MYCOL RES, V111, P253, DOI DOI 10.1017/S0953756204231173; Walker C, 2007, MYCOL RES, V111, P137, DOI 10.1016/j.mycres.2006.11.008; Zhang Q, 2010, PLANT CELL, V22, P1483, DOI 10.1105/tpc.110.074955; [No title captured]	45	37	42	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23333	10.1371/journal.pone.0023333	http://dx.doi.org/10.1371/journal.pone.0023333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21853113	Green Published, Green Submitted, gold			2022-12-27	WOS:000293953400039
J	Berry, N; Ham, C; Mee, ET; Rose, NJ; Mattiuzzo, G; Jenkins, A; Page, M; Elsley, W; Robinson, M; Smith, D; Ferguson, D; Towers, G; Almond, N; Stebbings, R				Berry, Neil; Ham, Claire; Mee, Edward T.; Rose, Nicola J.; Mattiuzzo, Giada; Jenkins, Adrian; Page, Mark; Elsley, William; Robinson, Mark; Smith, Deborah; Ferguson, Deborah; Towers, Greg; Almond, Neil; Stebbings, Richard			Early Potent Protection against Heterologous SIVsmE660 Challenge Following Live Attenuated SIV Vaccination in Mauritian Cynomolgus Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTE; MUCOSAL INFECTION; IMMUNE-RESPONSES; RHESUS MACAQUES; CELL DEPLETION; SHIV VACCINE; LONG-TERM; REPLICATION; SUPERINFECTION	Background: Live attenuated simian immunodeficiency virus (SIV) vaccines represent the most effective means of vaccinating macaques against pathogenic SIV challenge. However, thus far, protection has been demonstrated to be more effective against homologous than heterologous strains. Immune correlates of vaccine-induced protection have also been difficult to identify, particularly those measurable in the peripheral circulation. Methodology/Principal Findings: Here we describe potent protection in 6 out of 8 Mauritian-derived cynomolgus macaques (MCM) against heterologous virus challenge with the pathogenic, uncloned SIVsmE660 viral stock following vaccination with live attenuated SIVmac251/C8. MCM provided a characterised host genetic background with limited Major Histocompatibility Complex (MHC) and TRIM5 alpha allelic diversity. Early protection, observed as soon as 3 weeks post-vaccination, was comparable to that of 20 weeks vaccination. Recrudescence of vaccine virus was most pronounced in breakthrough cases where simultaneous identification of vaccine and challenge viruses by virus-specific PCR was indicative of active co-infection. Persistence of the vaccine virus in a range of lymphoid tissues was typified by a consistent level of SIV RNA positive cells in protected vaccinates. However, no association between MHC class I/II haplotype or TRIM5 alpha polymorphism and study outcome was identified. Conclusion/Significance: This SIV vaccine study, conducted in MHC-characterised MCM, demonstrated potent protection against the pathogenic, heterologous SIVsmE660 challenge stock after only 3 weeks vaccination. This level of protection against this viral stock by intravenous challenge has not been hitherto observed. The mechanism(s) of protection by vaccination with live attenuated SIV must account for the heterologous and early protection data described in this study, including those which relate to the innate immune system.	[Berry, Neil; Ham, Claire; Mee, Edward T.; Rose, Nicola J.; Mattiuzzo, Giada; Jenkins, Adrian; Page, Mark; Elsley, William; Robinson, Mark; Smith, Deborah; Ferguson, Deborah; Almond, Neil] HPA, NIBSC, Div Retrovirol, Potters Bar, Herts, England; [Stebbings, Richard] NIBSC HPA, Div Biotherapeut, Potters Bar, Herts, England; [Towers, Greg] UCL, MRC Ctr Med Mol Virol, Div Infect & Immun, London, England	Health Protection Agency; National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; University of London; University College London	Berry, N (corresponding author), HPA, NIBSC, Div Retrovirol, Potters Bar, Herts, England.	neil.berry@nibsc.hpa.org.uk	Stebbings, Richard/E-2117-2013; Rose, Nicola/E-9366-2013; Towers, Greg J/H-8892-2012	Stebbings, Richard/0000-0001-9628-2708; Almond, Neil/0000-0001-6105-0616; Mee, Edward/0000-0003-3514-8067; Towers, Gregory/0000-0002-7707-0264; Rose, Nicola/0000-0003-1102-5062	UK Medical Research Council [G9025730, G9419998, G0600007, G0801172]; EU [037611]; National Institute for Health Research (NIHR) Centre for Research in Health Protection at the Health Protection Agency; UCL/UCLH NIHR Comprehensive Biomedical Research Centre; Wellcome Trust [090940]; MRC [G0601201, G0801172, G9721629, G0900950, G0600007, G9025730] Funding Source: UKRI; Medical Research Council [G0801172, G0601201, G0900950B, G0900950, G9025730, G0600007, G9721629B, G9721629] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); National Institute for Health Research (NIHR) Centre for Research in Health Protection at the Health Protection Agency(National Institute for Health Research (NIHR)); UCL/UCLH NIHR Comprehensive Biomedical Research Centre; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the UK Medical Research Council (G9025730, G9419998, G0600007 and G0801172), EUFP6 grant Europrise (037611), the National Institute for Health Research (NIHR) Centre for Research in Health Protection at the Health Protection Agency, and the UCL/UCLH NIHR Comprehensive Biomedical Research Centre. GT holds a Wellcome Trust senior fellowship (no 090940). This report is work commissioned by the National Institute for Health Research. The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Ahmed RKS, 1999, J GEN VIROL, V80, P1569, DOI 10.1099/0022-1317-80-7-1569; Alexander L, 2003, J VIROL, V77, P6823, DOI 10.1128/JVI.77.12.6823-6835.2003; Almond N, 1997, J GEN VIROL, V78, P1919, DOI 10.1099/0022-1317-78-8-1919; ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Berry N, 2008, J GEN VIROL, V89, P2240, DOI 10.1099/vir.0.2008/001693-0; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Canto-Nogues C, 2001, J GEN VIROL, V82, P2225, DOI 10.1099/0022-1317-82-9-2225; Clarke S, 2003, VIROLOGY, V306, P100, DOI 10.1016/S0042-6822(02)00043-0; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Cranage MP, 1997, VIROLOGY, V229, P143, DOI 10.1006/viro.1996.8419; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Das AT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-44; Florese RH, 2008, VACCINE, V26, P3312, DOI 10.1016/j.vaccine.2008.03.100; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Greene JM, 2010, J VIROL, V84, P3362, DOI 10.1128/JVI.02028-09; Greene JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002384; Gundlach BR, 2000, J VIROL, V74, P3537, DOI 10.1128/JVI.74.8.3537-3542.2000; Ham C, 2010, J CLIN MICROBIOL, V48, P2582, DOI 10.1128/JCM.00082-10; HIRSCH VM, 1994, VIRUS RES, V32, P183, DOI 10.1016/0168-1702(94)90041-8; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1997, J VIROL, V71, P7711, DOI 10.1128/JVI.71.10.7711-7718.1997; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Kumar A, 2008, VIROLOGY, V371, P238, DOI 10.1016/j.virol.2007.10.008; Li B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-8; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Mee ET, 2010, TISSUE ANTIGENS, V76, P223, DOI 10.1111/j.1399-0039.2010.01500.x; Mee ET, 2009, IMMUNOGENETICS, V61, P327, DOI 10.1007/s00251-009-0369-8; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Nilsson C, 1998, AIDS, V12, P2261, DOI 10.1097/00002030-199817000-00006; Norley S, 1996, VIROLOGY, V219, P195, DOI 10.1006/viro.1996.0237; O'Connor SL, 2007, IMMUNOGENETICS, V59, P449, DOI 10.1007/s00251-007-0209-7; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Pahar B, 2009, VIROLOGY, V387, P273, DOI 10.1016/j.virol.2009.02.014; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; RUD EW, 1994, J GEN VIROL, V75, P529, DOI 10.1099/0022-1317-75-3-529; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Sharpe SA, 1997, J GEN VIROL, V78, P1923, DOI 10.1099/0022-1317-78-8-1923; Sharpe SA, 2004, J GEN VIROL, V85, P2591, DOI 10.1099/vir.0.80050-0; Silvera P, 2001, J MED PRIMATOL, V30, P1, DOI 10.1111/j.1600-0684.2001.300101.x; StahlHennig C, 1996, J GEN VIROL, V77, P2969, DOI 10.1099/0022-1317-77-12-2969; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Stebbings R, 2004, VIROLOGY, V330, P249, DOI 10.1016/j.virol.2004.09.026; Stebbings R, 1998, AIDS RES HUM RETROV, V14, P1187, DOI 10.1089/aid.1998.14.1187; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Titti F, 1997, J GEN VIROL, V78, P2529, DOI 10.1099/0022-1317-78-10-2529; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Walther-Jallow L, 2001, J GEN VIROL, V82, P1601, DOI 10.1099/0022-1317-82-7-1601; WHATMORE AM, 1995, J VIROL, V69, P5117, DOI 10.1128/JVI.69.8.5117-5123.1995; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wodarz D, 2008, VIROLOGY, V378, P299, DOI 10.1016/j.virol.2008.05.017; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Yankee TM, 2009, VIROLOGY, V383, P103, DOI 10.1016/j.virol.2008.09.038; Yeh WW, 2009, J VIROL, V83, P2686, DOI 10.1128/JVI.02237-08	68	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23092	10.1371/journal.pone.0023092	http://dx.doi.org/10.1371/journal.pone.0023092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21853072	gold, Green Submitted, Green Published			2022-12-27	WOS:000295454200041
J	Dodla, MC; Young, A; Venable, A; Hasneen, K; Rao, RR; Machacek, DW; Stice, SL				Dodla, Mahesh C.; Young, Amber; Venable, Alison; Hasneen, Kowser; Rao, Raj R.; Machacek, David W.; Stice, Steven L.			Differing Lectin Binding Profiles among Human Embryonic Stem Cells and Derivatives Aid in the Isolation of Neural Progenitor Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; NERVOUS-SYSTEM; EXPRESSION; PLURIPOTENT; DIFFERENTIATION; PROLIFERATION; PROTEOGLYCANS; GALECTIN-1; MICROARRAY; PRECURSORS	Human embryonic stem cells (hESCs) and their differentiated progeny allow for investigation of important changes/events during normal embryonic development. Currently most of the research is focused on proteinacous changes occurring as a result of differentiation of stem cells and little is known about changes in cell surface glycosylation patterns. Identification of cell lineage specific glycans can help in understanding their role in maintenance, proliferation and differentiation. Furthermore, these glycans can serve as markers for isolation of homogenous populations of cells. Using a panel of eight biotinylated lectins, the glycan expression of hESCs, hESCs-derived human neural progenitors (hNP) cells, and hESCs-derived mesenchymal progenitor (hMP) cells was investigated. Our goal was to identify glycans that are unique for hNP cells and use the corresponding lectins for cell isolation. Flow cytometry and immunocytochemistry were used to determine expression and localization of glycans, respectively, in each cell type. These results show that the glycan expression changes upon differentiation of hESCs and is different for neural and mesenchymal lineage. For example, binding of PHA-L lectin is low in hESCs (14 +/- 4.4%) but significantly higher in differentiated hNP cells (99 +/- 0.4%) and hMP cells (90 +/- 3%). Three lectins: VVA, DBA and LTL have low binding in hESCs and hMP cells, but significantly higher binding in hNP cells. Finally, VVA lectin binding was used to isolate hNP cells from a mixed population of hESCs, hNP cells and hMP cells. This is the first report that compares glycan expression across these human stem cell lineages and identifies significant differences. Also, this is the first study that uses VVA lectin for isolation for human neural progenitor cells.	[Dodla, Mahesh C.; Young, Amber; Hasneen, Kowser; Stice, Steven L.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Venable, Alison] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Rao, Raj R.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA USA; [Machacek, David W.; Stice, Steven L.] ArunA Biomed Inc, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Virginia Commonwealth University	Dodla, MC (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.	sstice@uga.edu	Rao, Raj/AAW-4308-2021		Georgia Research Alliance endowment, Department of Defense; ArunA Biomedical Inc.	Georgia Research Alliance endowment, Department of Defense(United States Department of Defense); ArunA Biomedical Inc.	This work was supported by funding from Georgia Research Alliance endowment, Department of Defense grant to SLS, and ArunA Biomedical Inc. NP cells and some media were provided in part by ArunA Biomedical (NP cells: hNP1TM cells, AB2TM medium supplemented with ANSTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Dhara SK, 2008, DIFFERENTIATION, V76, P454, DOI 10.1111/j.1432-0436.2007.00256.x; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Hennig A., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P585; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Kabos P, 2004, BIOCHEM BIOPH RES CO, V318, P955, DOI 10.1016/j.bbrc.2004.04.114; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; LETOURNEAU PC, 1994, J NEUROSCI, V14, P915, DOI 10.1523/JNEUROSCI.14-03-00915.1994; Mandai M, 2010, CELL TRANSPLANT, V19, P9, DOI 10.3727/096368909X476599; Mujtaba T, 1999, DEV BIOL, V214, P113, DOI 10.1006/dbio.1999.9418; Muraglia A, 2000, J CELL SCI, V113, P1161; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rao Raj R., 2007, V407, P51, DOI 10.1007/978-1-59745-536-7_5; Sakaguchi M, 2007, CELL MOL LIFE SCI, V64, P1254, DOI 10.1007/s00018-007-6476-5; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shin S, 2005, STEM CELLS DEV, V14, P266, DOI 10.1089/scd.2005.14.266; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Toyoda M, 2011, GENES CELLS, V16, P1, DOI 10.1111/j.1365-2443.2010.01459.x; Varki A., 2009, ESSENTIALS GLYCOBIOL; Venable A, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-15; VENSTROM KA, 1993, FASEB J, V7, P996, DOI 10.1096/fasebj.7.11.8370483; Wearne KA, 2008, GLYCOCONJUGATE J, V25, P121, DOI 10.1007/s10719-007-9064-x; Wearne KA, 2006, GLYCOBIOLOGY, V16, P981, DOI 10.1093/glycob/cwl019; Yamagata M, 2005, J NEUROSCI, V25, P8457, DOI 10.1523/JNEUROSCI.1976-05.2005; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018	31	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23266	10.1371/journal.pone.0023266	http://dx.doi.org/10.1371/journal.pone.0023266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21850265	gold, Green Published, Green Submitted			2022-12-27	WOS:000293563300050
J	O'Bryan, JM; Potts, JA; Bonkovsky, HL; Mathew, A; Rothman, AL				O'Bryan, Joel M.; Potts, James A.; Bonkovsky, Herbert L.; Mathew, Anuja; Rothman, Alan L.		HALT-C Trial Grp	Extended Interferon-Alpha Therapy Accelerates Telomere Length Loss in Human Peripheral Blood T Lymphocytes	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; LONG-TERM TREATMENT; PEGYLATED INTERFERON; FIBROSIS STAGE; CELL; VIRUS; PROLIFERATION; NEUTROPENIA; RIBAVIRIN; SUBSETS	Background: Type I interferons have pleiotropic effects on host cells, including inhibiting telomerase in lymphocytes and antiviral activity. We tested the hypothesis that long-term interferon treatment would result in significant reduction in average telomere length in peripheral blood T lymphocytes. Methods/Principal Findings: Using a flow cytometry-based telomere length assay on peripheral blood mononuclear cell samples from the Hepatitis-C Antiviral Long-term Treatment against Cirrhosis ( HALT-C) study, we measured T cell telomere lengths at screening and at months 21 and 45 in 29 Hepatitis-C virus infected subjects. These subjects had failed to achieve a sustained virologic response following 24 weeks of pegylated-interferon-alpha plus ribavirin treatment and were subsequently randomized to either a no additional therapy group or a maintenance dose pegylated-IFN alpha group for an additional 3.5 years. Significant telomere loss in naive T cells occurred in the first 21 months in the interferon-alpha group. Telomere losses were similar in both groups during the final two years. Expansion of CD8(+)CD45RA(+)CD57(+) memory T cells and an inverse correlation of alanine aminotransferase levels with naive CD8(+) T cell telomere loss were observed in the control group but not in the interferon-alpha group. Telomere length at screening inversely correlated with Hepatitis-C viral load and body mass index. Conclusions/Significance: Sustained interferon-alpha treatment increased telomere loss in naive T cells, and inhibited the accumulation of T cell memory expansions. The durability of this effect and consequences for immune senescence need to be defined.	[O'Bryan, Joel M.; Potts, James A.; Mathew, Anuja; Rothman, Alan L.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA; [Bonkovsky, Herbert L.] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Rothman, Alan L.] Univ Rhode Isl, Inst Immunol & Informat, Providence, RI 02908 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Connecticut; Carolinas Medical Center; University of Rhode Island	O'Bryan, JM (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	Anuja.mathew@umassmed.edu	Bonkovsky, Herbert L./AAH-1892-2021; Mathew, Anuja/V-6711-2019	Bonkovsky, Herbert L./0000-0001-7387-3230; Mathew, Anuja/0000-0002-6752-009X; Rothman, Alan/0000-0002-4064-6848	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Center for Minority Health and Health Disparities; National Center for Research Resources, National Institutes of Health (NIH); Hoffmann-La Roche, Inc.; National Institutes of Health (NIH) [P01 AI049320, U19 AI057319, T32 AI007349]; University of Massachusetts Medical Center, Worcester, MA [N01-DK-9-2326]; University of Connecticut Health Center, Farmington, CT [M01RR-06192]; Saint Louis University School of Medicine, St Louis, MO [N01-DK-9-2324]; University of Texas Southwestern Medical Center, Dallas, TX (North and Central Texas Clinical and Translational Science Initiative) [N01-DK-9-2321, M01RR-00633, 1 UL1 RR024982-01]; University of Southern California, Los Angeles, CA [N01-DK-9-2325, M01RR-00043]; University of Michigan Medical Center, Ann Arbor, MI (Michigan Center for Clinical and Health Research) [N01-DK-9-2323, M01RR-00042, 1 UL1 RR024986]; University of Washington, Seattle, WA [N01-DK-9-2318]; New England Research Institutes, Watertown, MA [N01-DK-9-2328]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986, M01RR006192, M01RR000633, M01RR000043, UL1RR024982, M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007349, P01AI049320, U19AI057319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092323, N01DK092326, N01DK092324, N01DK092321, N01DK092325] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Hoffmann-La Roche, Inc.(Hoffmann-La Roche); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Medical Center, Worcester, MA; University of Connecticut Health Center, Farmington, CT; Saint Louis University School of Medicine, St Louis, MO; University of Texas Southwestern Medical Center, Dallas, TX (North and Central Texas Clinical and Translational Science Initiative); University of Southern California, Los Angeles, CA; University of Michigan Medical Center, Ann Arbor, MI (Michigan Center for Clinical and Health Research)(University of Michigan System); University of Washington, Seattle, WA(University of Washington); New England Research Institutes, Watertown, MA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The HALT-C study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases. Additional support was provided by the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, the National Center for Minority Health and Health Disparities and by General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health (NIH) (grant numbers are listed below). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Additional funding to conduct the HALT-C study was supplied by Hoffmann-La Roche, Inc., through a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health. This work was funded by the NIH under P01 AI049320, U19 AI057319 and T32 AI007349. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; University of Massachusetts Medical Center, Worcester, MA: (Contract N01-DK-9-2326) Gyongyi Szabo, MD, Barbara F. Banner, MD, Maureen Cormier, RN, Donna Giansiracusa, RN; University of Connecticut Health Center, Farmington, CT: (Grant M01RR-06192) Gloria Borders, RN, Michelle Kelley, RN, ANP; Saint Louis University School of Medicine, St Louis, MO: (Contract N01-DK-9-2324) Adrian M. Di Bisceglie, MD, Bruce Bacon, MD, Brent Neuschwander-Tetri, MD, Elizabeth M. Brunt, MD, Debra King, RN; University of Texas Southwestern Medical Center, Dallas, TX: (Contract N01-DK-9-2321, Grant M01RR-00633, Grant 1 UL1 RR024982-01, North and Central Texas Clinical and Translational Science Initiative) William M. Lee, MD, Thomas E. Rogers, MD, Peter F. Malet, MD, Janel Shelton, Nicole Crowder, LVN, Rivka Elbein, RN, BSN, Nancy Liston, MPH; University of Southern California, Los Angeles, CA: (Contract N01-DK-9-2325, Grant M01RR-00043) Karen L. Lindsay, MD, MMM, Sugantha Govindarajan, MD, Carol B. Jones, RN, Susan L. Milstein, RN; University of Michigan Medical Center, Ann Arbor, MI: (Contract N01-DK-9-2323, Grant M01RR-00042, Grant 1 UL1 RR024986, Michigan Center for Clinical and Health Research) Anna S. Lok, MD, Robert J. Fontana, MD, Joel K. Greenson, MD, Pamela A. Richtmyer, LPN, CCRC, R. Tess Bonham, BS; University of Washington, Seattle, WA: (Contract N01-DK-9-2318) Chihiro Morishima, MD, David R. Gretch, MD, PhD, Minjun Chung Apodaca, BS, ASCP, Rohit Shankar, BC, ASCP, Natalia Antonov, M. Ed.; New England Research Institutes, Watertown, MA: (Contract N01-DK-9-2328) Kristin K. Snow, MSc, ScD, Anne M. Stoddard, ScD, Linda Massey, Teresa M. Curto, MSW, MPH, Margaret C. Bell, MS, MPH, Deepa Naishadham, MA, MS	Antonini MG, 2008, INFECTION, V36, P250, DOI 10.1007/s15010-007-7132-6; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; De Boer RJ, 1998, J IMMUNOL, V160, P5832; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Delgado-Borrego A, 2010, CLIN GASTROENTEROL H, V8, P458, DOI 10.1016/j.cgh.2010.01.022; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Di Bisceglie AM, 2011, HEPATOLOGY, V53, P1100, DOI 10.1002/hep.24169; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Everhart JE, 2010, HEPATOLOGY, V51, P585, DOI 10.1002/hep.23315; Everhart JE, 2009, GASTROENTEROLOGY, V137, P549, DOI 10.1053/j.gastro.2009.05.007; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Gilley D, 2008, MECH AGEING DEV, V129, P27, DOI 10.1016/j.mad.2007.10.010; Hauschild A, 2008, CANCER-AM CANCER SOC, V112, P982, DOI 10.1002/cncr.23251; HIRSCH RL, 1986, J INTERFERON RES, V6, P171, DOI 10.1089/jir.1986.6.171; Hoare M, 2010, J HEPATOL, V53, P252, DOI 10.1016/j.jhep.2010.03.005; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huzen J, 2010, FRONT BIOSCI-LANDMRK, V15, P35, DOI 10.2741/3604; Jamal MM, 1999, HEPATOLOGY, V30, P1307, DOI 10.1002/hep.510300526; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Lam S, 2008, EXPERT OPIN DRUG MET, V4, P1111, DOI 10.1517/17425255.4.8.1111 ; Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145; Lee WM, 2004, CONTROL CLIN TRIALS, V25, P472, DOI 10.1016/j.cct.2004.08.003; Lin R, 1996, J VIRAL HEPATITIS, V3, P85, DOI 10.1111/j.1365-2893.1996.tb00086.x; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Manfras BJ, 2004, J CLIN IMMUNOL, V24, P258, DOI 10.1023/B:JOCI.0000025447.23473.ab; O'Callaghan NJ, 2009, REJUV RES, V12, P169, DOI 10.1089/rej.2008.0819; Reed JR, 2004, J EXP MED, V199, P1433, DOI 10.1084/jem.20040178; ROMEO R, 1995, BIOMED PHARMACOTHER, V49, P111, DOI 10.1016/0753-3322(96)82603-5; Rothman AL, 2005, HEPATOLOGY, V41, P617, DOI 10.1002/hep.20581; Soza A, 2002, HEPATOLOGY, V36, P1273, DOI 10.1053/jhep.2002.36502; Tillmann HL, 2005, SEMIN LIVER DIS, V25, P84, DOI 10.1055/s-2005-864784; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vandelli C, 1999, J MED VIROL, V58, P26, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;26::AID-JMV4&gt;3.0.CO;2-W; Weng NP, 2008, MECH AGEING DEV, V129, P60, DOI 10.1016/j.mad.2007.11.005; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Xu DW, 2000, BLOOD, V96, P4313, DOI 10.1182/blood.V96.13.4313.h8004313_4313_4318; Zannolli R, 2008, ACTA PAEDIATR, V97, P952, DOI 10.1111/j.1651-2227.2008.00783.x; Zee RYL, 2009, CLIN CHIM ACTA, V403, P139, DOI 10.1016/j.cca.2009.02.004	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e20922	10.1371/journal.pone.0020922	http://dx.doi.org/10.1371/journal.pone.0020922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829595	Green Published, Green Submitted, gold			2022-12-27	WOS:000293561200003
J	Ohka, F; Natsume, A; Motomura, K; Kishida, Y; Kondo, Y; Abe, T; Nakasu, Y; Namba, H; Wakai, K; Fukui, T; Momota, H; Iwami, K; Kinjo, S; Ito, M; Fujii, M; Wakabayashi, T				Ohka, Fumiharu; Natsume, Atsushi; Motomura, Kazuya; Kishida, Yugo; Kondo, Yutaka; Abe, Tatsuya; Nakasu, Yoko; Namba, Hiroki; Wakai, Kenji; Fukui, Takashi; Momota, Hiroyuki; Iwami, Kenichiro; Kinjo, Sayano; Ito, Maki; Fujii, Masazumi; Wakabayashi, Toshihiko			The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma	PLOS ONE			English	Article							CODON 132 MUTATION; IDH2 MUTATIONS; HUMAN GLIOBLASTOMA; COLORECTAL-CANCER; OLIGODENDROGLIAL TUMORS; DIFFUSE GLIOMAS; PHENOTYPE; HYPOMETHYLATION; BIOMARKER; HYPERMETHYLATION	Gliomas are the most frequently occurring primary brain tumor in the central nervous system of adults. Glioblastoma multiformes (GBMs, WHO grade 4) have a dismal prognosis despite the use of the alkylating agent, temozolomide (TMZ), and even low grade gliomas (LGGs, WHO grade 2) eventually transform to malignant secondary GBMs. Although GBM patients benefit from promoter hypermethylation of the O-6-methylguanine-DNA methyltransferase (MGMT) that is the main determinant of resistance to TMZ, recent studies suggested that MGMT promoter methylation is of prognostic as well as predictive significance for the efficacy of TMZ. Glioma-CpG island methylator phenotype (G-CIMP) in the global genome was shown to be a significant predictor of improved survival in patients with GBM. Collectively, we hypothesized that MGMT promoter methylation might reflect global DNA methylation. Additionally in LGGs, the significance of MGMT promoter methylation is still undetermined. In the current study, we aimed to determine the correlation between clinical, genetic, and epigenetic profiles including LINE-1 and different cancer-related genes and the clinical outcome in newly diagnosed 57 LGG and 54 GBM patients. Here, we demonstrated that (1) IDH1/2 mutation is closely correlated with MGMT promoter methylation and 1p/19q codeletion in LGGs, (2) LINE-1 methylation levels in primary and secondary GBMs are lower than those in LGGs and normal brain tissues, (3) LINE-1 methylation is proportional to MGMT promoter methylation in gliomas, and (4) higher LINE-1 methylation is a favorable prognostic factor in primary GBMs, even compared to MGMT promoter methylation. As a global DNA methylation marker, LINE-1 may be a promising marker in gliomas.	[Ohka, Fumiharu; Natsume, Atsushi; Motomura, Kazuya; Kishida, Yugo; Momota, Hiroyuki; Iwami, Kenichiro; Kinjo, Sayano; Ito, Maki; Fujii, Masazumi; Wakabayashi, Toshihiko] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan; [Kishida, Yugo; Kondo, Yutaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan; [Abe, Tatsuya] Oita Univ, Sch Med, Dept Neurosurg, Oita 87011, Japan; [Nakasu, Yoko] Shizuoka Canc Ctr, Dept Neurosurg, Shizuoka, Japan; [Namba, Hiroki] Hamamatsu Med Univ, Dept Neurosurg, Hamamatsu, Shizuoka, Japan; [Wakai, Kenji] Nagoya Univ, Sch Med, Dept Prevent Med, Nagoya, Aichi 466, Japan; [Fukui, Takashi] FALCO Biosyst, Kyoto, Japan	Nagoya University; Aichi Cancer Center; Oita University; Shizuoka Cancer Center; Hamamatsu University School of Medicine; Nagoya University	Ohka, F (corresponding author), Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi 466, Japan.	anatsume@med.nagoya-u.ac.jp	Ohka, Fumiharu/A-3420-2016; Wakai, Kenji/I-7248-2014; Natsume, Atsushi/I-7364-2014; Motomura, Kazuya/AAF-8776-2021; Wakabayashi, Toshihiko/I-3526-2012	Wakai, Kenji/0000-0001-7388-7157; Natsume, Atsushi/0000-0002-9113-0470; Motomura, Kazuya/0000-0002-4376-1104; Wakabayashi, Toshihiko/0000-0001-5254-2088; Ohka, Fumiharu/0000-0002-5569-5626	Ministry of Health, Labor, and Welfare, Japan	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from a Grant-in-Aid (B) for Scientific Research from the Ministry of Health, Labor, and Welfare, Japan (AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; DAY RS, 1980, NATURE, V288, P724, DOI 10.1038/288724a0; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; FULTS D, 1992, CANCER RES, V52, P674; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Jeuken J, 2006, J MOL DIAGN, V8, P433, DOI 10.2353/jmoldx.2006.060012; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawakami K, 2011, CANCER SCI, V102, P166, DOI 10.1111/j.1349-7006.2010.01776.x; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; Mollemann M, 2005, INT J CANCER, V113, P379, DOI 10.1002/ijc.20575; Motomura K, 2011, CANCER-AM CANCER SOC, V117, P1721, DOI 10.1002/cncr.25637; Natsume A, 2008, INT J CANCER, V122, P2542, DOI 10.1002/ijc.23407; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Rodriguez FJ, 2008, APPL IMMUNOHISTO M M, V16, P59; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; van den Bent MJ, 2009, J CLIN ONCOL, V27, P5881, DOI 10.1200/JCO.2009.24.1034; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	38	81	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2011	6	8							e23332	10.1371/journal.pone.0023332	http://dx.doi.org/10.1371/journal.pone.0023332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803DK	21829728	Green Published, gold, Green Submitted			2022-12-27	WOS:000293561200065
J	Gagliardo, A; Ioale, P; Filannino, C; Wikelski, M				Gagliardo, Anna; Ioale, Paolo; Filannino, Caterina; Wikelski, Martin			Homing Pigeons Only Navigate in Air with Intact Environmental Odours: A Test of the Olfactory Activation Hypothesis with GPS Data Loggers	PLOS ONE			English	Article							ORIENTATION; INFORMATION; HOME; ABILITIES; BEHAVIOR; MAP	A large body of evidence has shown that anosmic pigeons are impaired in their navigation. However, the role of odours in navigation is still subject to debate. While according to the olfactory navigation hypothesis homing pigeons possess a navigational map based on the distribution of environmental odours, the olfactory activation hypothesis proposes that odour perception is only needed to activate a navigational mechanism based on cues of another nature. Here we tested experimentally whether the perception of artificial odours is sufficient to allow pigeons to navigate, as expected from the olfactory activation hypothesis. We transported three groups of pigeons in air-tight containers to release sites 53 and 61 km from home in three different olfactory conditions. The Control group received natural environmental air; both the Pure Air and the Artificial Odour groups received pure air filtered through an active charcoal filter. Only the Artificial Odour group received additional puffs of artificial odours until release. We then released pigeons while recording their tracks with 1 Hz GPS data loggers. We also followed non-homing pigeons using an aerial data readout to a Cessna plane, allowing, for the first time, the tracking of non-homing homing pigeons. Within the first hour after release, the pigeons in both the Artificial Odour and the Pure Air group (receiving no environmental odours) showed impaired navigational performances at each release site. Our data provide evidence against an activation role of odours in navigation, and document that pigeons only navigate well when they perceive environmental odours.	[Gagliardo, Anna; Ioale, Paolo; Filannino, Caterina] Univ Pisa, Dept Biol, Pisa, Italy; [Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany	University of Pisa; Max Planck Society	Gagliardo, A (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	agagliardo@biologia.unipi.it			National Science Foundation, Innovation and Organizational Sciences [0744704]; Progetti di Ricerca di Interesse Nazionale [20083ML4XC]; Division Of Integrative Organismal Systems [0744704] Funding Source: National Science Foundation	National Science Foundation, Innovation and Organizational Sciences(National Science Foundation (NSF)); Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation, Innovation and Organizational Sciences, [0744704], http://nsf.gov/, and Progetti di Ricerca di Interesse Nazionale, [20083ML4XC], http://prin.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDACCINI NE, 1975, J COMP PHYSIOL, V99, P177, DOI 10.1007/BF00613834; Baldaccini NE, 1978, ANIMAL MIGRATION NAV, P65; Batschelet E, 1981, CIRCULAR STAT BIOL; BENVENUTI S, 1977, J COMP PHYSIOL, V120, P173, DOI 10.1007/BF00619313; BENVENUTI S, 1973, Monitore Zoologico Italiano, V7, P117; Gagliardo A, 2006, J EXP BIOL, V209, P2888, DOI 10.1242/jeb.02313; Gagliardo A, 2001, P ROY SOC B-BIOL SCI, V268, P197; Gagliardo A, 2008, J EXP BIOL, V211, P2046, DOI 10.1242/jeb.017608; Gagliardo A, 2011, J EXP BIOL, V214, P593, DOI 10.1242/jeb.049510; Gagliardo A, 2009, BEHAV ECOL SOCIOBIOL, V64, P289, DOI 10.1007/s00265-009-0847-x; Gagliardo A, 2009, J EXP BIOL, V212, P3119, DOI 10.1242/jeb.031864; Holland RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008264; IOALE P, 1990, BEHAV ECOL SOCIOBIOL, V26, P301; IOALE P, 1978, J COMP PHYSIOL, V128, P285, DOI 10.1007/BF00657603; Jorge PE, 2010, P R SOC B, V277, P45, DOI 10.1098/rspb.2009.1521; Jorge PE, 2009, CURR BIOL, V19, P650, DOI 10.1016/j.cub.2009.02.066; Odetti F, 2003, ANIM BEHAV, V66, P1093, DOI 10.1006/anbe.2003.2293; PAPI F, 1972, Monitore Zoologico Italiano, V6, P85; PAPI F, 1974, J COMP PHYSIOL, V94, P187, DOI 10.1007/BF00611866; PAPI F, 1971, Monitore Zoologico Italiano, V5, P265; Schmidt-Koenig K, 1978, ANIMAL MIGRATION NAV, P119; WALDVOGEL JA, 1978, J COMP PHYSIOL, V128, P297, DOI 10.1007/BF00657604; WALLRAFF HG, 1966, Z VERGL PHYSIOL, V52, P215, DOI 10.1007/BF02427711; WALLRAFF HG, 1988, COMP BIOCHEM PHYS A, V89, P621, DOI 10.1016/0300-9629(88)90844-4; WALLRAFF HG, 1970, Z VERGL PHYSIOL, V68, P182, DOI 10.1007/BF00297694; WALLRAFF HG, 1992, EXPERIENTIA, V48, P1153, DOI 10.1007/BF01948013; Wallraff HG., 2005, AVIAN NAVIGATION PIG; Wikelski M, 2010, MOVEBANK ARCH ANAL S; Wiltschko R, 1996, J EXP BIOL, V199, P113	29	43	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2011	6	8							e22385	10.1371/journal.pone.0022385	http://dx.doi.org/10.1371/journal.pone.0022385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803CQ	21857925	gold, Green Published, Green Submitted			2022-12-27	WOS:000293558900017
J	Skar, H; Gutenkunst, RN; Ramsay, KW; Alaeus, A; Albert, J; Leitner, T				Skar, Helena; Gutenkunst, Ryan N.; Ramsay, Karin Wilbe; Alaeus, Annette; Albert, Jan; Leitner, Thomas			Daily Sampling of an HIV-1 Patient with Slowly Progressing Disease Displays Persistence of Multiple env Subpopulations Consistent with Neutrality	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FREQUENCY-DEPENDENT SELECTION; EFFECTIVE POPULATION-SIZE; GENETIC DRIFT; MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; IN-VIVO; ANTIBODY NEUTRALIZATION; SEQUENCE DIVERSITY; EVOLUTIONARY RATE	The molecular evolution of HIV-1 is characterized by frequent substitutions, indels and recombination events. In addition, a HIV-1 population may adapt through frequency changes of its variants. To reveal such population dynamics we analyzed HIV-1 subpopulation frequencies in an untreated patient with stable, low plasma HIV-1 RNA levels and close to normal CD4+ T-cell levels. The patient was intensively sampled during a 32-day period as well as approximately 1.5 years before and after this period (days -664, 1, 2, 3, 11, 18, 25, 32 and 522). 77 sequences of HIV-1 env (approximately 3100 nucleotides) were obtained from plasma by limiting dilution with 7-11 sequences per time point, except day -664. Phylogenetic analysis using maximum likelihood methods showed that the sequences clustered in six distinct subpopulations. We devised a method that took into account the relatively coarse sampling of the population. Data from days 1 through 32 were consistent with constant within-patient subpopulation frequencies. However, over longer time periods, i.e. between days 1...32 and 522, there were significant changes in subpopulation frequencies, which were consistent with evolutionarily neutral fluctuations. We found no clear signal of natural selection within the subpopulations over the study period, but positive selection was evident on the long branches that connected the subpopulations, which corresponds to >3 years as the subpopulations already were established when we started the study. Thus, selective forces may have been involved when the subpopulations were established. Genetic drift within subpopulations caused by de novo substitutions could be resolved after approximately one month. Overall, we conclude that subpopulation frequencies within this patient changed significantly over a time period of 1.5 years, but that this does not imply directional or balancing selection. We show that the short-term evolution we study here is likely representative for many patients of slow and normal disease progression.	[Skar, Helena; Ramsay, Karin Wilbe; Albert, Jan] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden; [Skar, Helena; Ramsay, Karin Wilbe; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Skar, Helena; Leitner, Thomas] Los Alamos Natl Lab, Los Alamos, NM USA; [Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Alaeus, Annette] Karolinska Inst, Dept Med, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Arizona; Karolinska Institutet	Skar, H (corresponding author), Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden.	tkl@lanl.gov		Wilbe Ramsay, Karin/0000-0001-6161-9032	National Institutes of Health (NIH) [1R01AI087520-01A1]; Swedish Research Council; Swedish International Development Cooperation Agency [SWE-2006-018]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087520] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH) [grant 1R01AI087520-01A1], the Swedish Research Council, and the Swedish International Development Cooperation Agency [grant no. SWE-2006-018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196; ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Allain JP, 2000, J VIROL, V74, P2541, DOI 10.1128/JVI.74.6.2541-2549.2000; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; BERRY IM, 2009, EPIDEMICS IN PRESS; Berry IM, 2007, J VIROL, V81, P10625, DOI 10.1128/JVI.00985-07; Brown AJL, 1997, P NATL ACAD SCI USA, V94, P1862, DOI 10.1073/pnas.94.5.1862; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Chen RX, 2005, J VIROL, V79, P12045, DOI 10.1128/JVI.79.18.12045-12057.2005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edo-Matas D, 2010, VIROLOGY, V405, P492, DOI 10.1016/j.virol.2010.06.029; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; Fay JC, 2000, GENETICS, V155, P1405; Forster R, 2007, PHYSICA A, V381, P255, DOI 10.1016/j.physa.2007.03.017; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2001, P NATL ACAD SCI USA, V98, P6975, DOI 10.1073/pnas.131056998; FU YX, 1993, GENETICS, V133, P693; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; Gantt S, 2010, J VIROL, V84, P10812, DOI 10.1128/JVI.00543-10; Gao F, 2004, J VIROL, V78, P2426, DOI 10.1128/JVI.78.5.2426-2433.2004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrington PR, 2009, AIDS, V23, P907, DOI 10.1097/QAD.0b013e3283299129; Heath L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006949; Heeregrave EJ, 2009, VIROLOGY, V393, P24, DOI 10.1016/j.virol.2009.07.011; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ince WL, 2009, J VIROL, V83, P4068, DOI 10.1128/JVI.02486-08; Kemal KS, 2003, P NATL ACAD SCI USA, V100, P12972, DOI 10.1073/pnas.2134064100; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; Kouyos RD, 2006, TRENDS MICROBIOL, V14, P507, DOI 10.1016/j.tim.2006.10.001; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; KUIKEN C, 2010, HIV SEQUENCE COMPEND, P10; Lee HY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000240; Lee SK, 2002, J CLIN INVEST, V110, P1339, DOI 10.1172/JCI0216028; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Liitsola K, 2000, AIDS RES HUM RETROV, V16, P1047, DOI 10.1089/08892220050075309; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nielsen R, 1998, GENETICS, V148, P929; Nijhuis M, 1998, P NATL ACAD SCI USA, V95, P14441, DOI 10.1073/pnas.95.24.14441; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Poles MA, 2001, J INFECT DIS, V183, P143, DOI 10.1086/317640; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Reuter G, 2008, J CLIN VIROL, V42, P135, DOI 10.1016/j.jcv.2008.02.014; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Seo TK, 2002, GENETICS, V160, P1283; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shriner D, 2004, GENETICS, V166, P1155, DOI 10.1534/genetics.166.3.1155; Shriner D, 2006, EVOLUTION, V60, P1165, DOI 10.1554/05-473.1; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Trotter MV, 2008, GENETICS, V180, P1547, DOI 10.1534/genetics.108.088880; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; van Rij RP, 2000, J CLIN INVEST, V106, P1039, DOI 10.1172/JCI7953; Voronin Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000431; Wang WK, 2002, VIROLOGY, V303, P181, DOI 10.1006/viro.2002.1635; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Yuste E, 2002, J GEN VIROL, V83, P103, DOI 10.1099/0022-1317-83-1-103; Zhang LQ, 2002, J VIROL, V76, P9465, DOI 10.1128/JVI.76.18.9465-9473.2002	78	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2011	6	8							e21747	10.1371/journal.pone.0021747	http://dx.doi.org/10.1371/journal.pone.0021747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LF	21829600	gold, Green Submitted, Green Published			2022-12-27	WOS:000293511900003
J	Mindell, DP; Fisher, BL; Roopnarine, P; Eisen, J; Mace, GM; Page, RDM; Pyle, RL				Mindell, David P.; Fisher, Brian L.; Roopnarine, Peter; Eisen, Jonathan; Mace, Georgina M.; Page, Roderic D. M.; Pyle, Richard L.			Aggregating, Tagging and Integrating Biodiversity Research	PLOS ONE			English	Editorial Material							INFORMATICS		[Mindell, David P.; Fisher, Brian L.; Roopnarine, Peter] Calif Acad Sci, San Francisco, CA 94118 USA; [Eisen, Jonathan] Univ Calif Davis, Sect Evolut & Ecol, Dept Med Microbiol, Davis, CA 95616 USA; [Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England; [Page, Roderic D. M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Pyle, Richard L.] Bernice P Bishop Museum, Dept Nat Sci, Honolulu, HI USA	California Academy of Sciences; University of California System; University of California Davis; Imperial College London; University of Glasgow	Mindell, DP (corresponding author), Calif Acad Sci, San Francisco, CA 94118 USA.	dmindell@calacademy.org	Fisher, Brian L./S-9374-2019; Mace, Georgina M/I-3072-2016; Eisen, Jonathan A./H-2706-2019; Page, Roderic/A-1375-2009	Mace, Georgina M/0000-0001-8965-5211; Eisen, Jonathan A./0000-0002-0159-2197; Fisher, Brian/0000-0002-4653-3270; Page, Roderic/0000-0002-7101-9767; Roopnarine, Peter/0000-0002-9811-1176	Division Of Environmental Biology [0842395] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calix M., 2018, EUROPEAN RED LIST SA; Chavan VS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S2; Clark T, 2004, BRIEF BIOINFORM, V5, P59, DOI 10.1093/bib/5.1.59; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Johnson JA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-65; Miller Holly, 2009, BMC Res Notes, V2, P101, DOI 10.1186/1756-0500-2-101; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Sala OE, 2010, BIODIVERSITY CHANGE; Thomas C, 2009, SCIENCE, V324, P1632, DOI 10.1126/science.324_1632; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; *WORLD RES I, 2005, MILL EC ASS	15	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2011	6	8							e19491	10.1371/journal.pone.0019491	http://dx.doi.org/10.1371/journal.pone.0019491			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LA	21829594	Green Published, gold, Green Accepted			2022-12-27	WOS:000293511200001
J	Huang, WT; Chen, WC; Teng, HJ; Huang, WI; Huang, YW; Hsu, CW; Chuang, JH				Huang, Wan-Ting; Chen, Wan-Chin; Teng, Hwa-Jen; Huang, Wei-I; Huang, Yu-Wen; Hsu, Chien-Wen; Chuang, Jen-Hsiang			Adverse Events Following Pandemic A (H1N1) 2009 Monovalent Vaccines in Pregnant Women - Taiwan, November 2009-August 2010	PLOS ONE			English	Article							INFLUENZA VACCINATION; CAPTURE-RECAPTURE; SAFETY; SURVEILLANCE; SYSTEMS	Background: During the 2009 H1N1 pandemic, pregnant women were prioritized to receive the unadjuvanted or MF59 (R)-adjuvanted pandemic A (H1N1) 2009 monovalent vaccines ("2009 H1N1 vaccines") in Taiwan regardless of stage of pregnancy. Monitoring adverse events following 2009 H1N1 vaccination in pregnant women was a priority for the mass immunization campaign beginning November 2009. Methods/Findings: We characterized reports to the national passive surveillance from November 2009 through August 2010 involving adverse events following 2009 H1N1 vaccines among pregnant women. Reports from the passive surveillance were matched to a large-linked database on a unique identifier, date of vaccination, and date of diagnosis in a capture-recapture analysis to estimate the true number of spontaneous abortion after 2009 H1N1 vaccination. We verified 16 spontaneous abortions, 11 stillbirths, 4 neonatal deaths, 4 nonpregnancy-specific adverse events, and 2 inadvertent immunizations in recipients who were unaware of pregnancy at time of vaccination. The Chapman capture-recapture estimator of true number of spontaneous abortion after 2009 H1N1 vaccination was 329 (95% confidence interval [CI] 196-553). Of the 14,474 pregnant women who received the 2009 H1N1 vaccines, the estimated risk of spontaneous abortion was 2.3 (95% CI, 1.4-3.8) per 100 pregnancies, compared with a local background rate of 12.8 (95% CI, 12.8-12.9) per 100 pregnancies. Conclusions: The passive surveillance provided rapid initial assessment of adverse events after 2009 H1N1 vaccination among pregnant women. Its findings were reassuring for the safety of 2009 H1N1 vaccines in pregnancy.	[Huang, Wan-Ting; Chen, Wan-Chin; Teng, Hwa-Jen; Chuang, Jen-Hsiang] Taiwan Ctr Dis Control, Taipei, Taiwan; [Huang, Wei-I] Taiwan Drug Relief Fdn, Taipei, Taiwan; [Huang, Yu-Wen; Hsu, Chien-Wen] Taiwan Food & Drug Adm, Taipei, Taiwan; [Huang, Yu-Wen] Natl Taiwan Univ, Coll Bioresources & Agr, Inst Biotechnol, Taipei 10764, Taiwan	National Taiwan University	Huang, WT (corresponding author), Taiwan Ctr Dis Control, Taipei, Taiwan.	muagi@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010; Huang, Wan-Ting/E-3497-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; Huang, Wan-Ting/0000-0002-4344-9567; Weninger, Tim/0000-0003-3164-2615; , Heli/0000-0002-2765-6582; Chen, Wan-Chin/0000-0002-2278-6193	Taiwan Centers for Disease Control; Taiwan Food and Drug Administration	Taiwan Centers for Disease Control; Taiwan Food and Drug Administration	This work is funded by Taiwan Centers for Disease Control and Taiwan Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Carvajal A, 2011, VACCINE, V29, P519, DOI 10.1016/j.vaccine.2010.10.067; Chapman D. G., 1951, U CALIFORNIA PUBLICA, V1, P131; *DEP HLTH, PHARM TAIW, P11601; European Medicines Agency, CHMP REC PHARM PLAN; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; HARRIS JW, 1919, JAMA-J AM MED ASSOC, V72, P970; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Huang WT, 2010, LANCET, V375, P1164, DOI 10.1016/S0140-6736(10)60515-6; HUANG WT, 2011, EMER INFECT IN PRESS, P11601; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Lacroix I, 2011, VACCINE, V29, P1357, DOI 10.1016/j.vaccine.2010.12.011; Lim SH, 2010, VACCINE, V28, P7455, DOI 10.1016/j.vaccine.2010.08.087; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Moro PL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.050; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048; Reddy UM, 2009, OBSTET GYNECOL, V114, P901, DOI 10.1097/AOG.0b013e3181b8f6e4; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; SEBER GAF, 1970, BIOMETRICS, V26, P13, DOI 10.2307/2529040; SIMPSON JL, 1990, AM J MED GENET, V35, P165, DOI 10.1002/ajmg.1320350205; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Skowronski DM, 2009, VACCINE, V27, P4754, DOI 10.1016/j.vaccine.2009.03.079; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tsai T, 2010, VACCINE, V28, P1877, DOI 10.1016/j.vaccine.2009.11.077; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Verstraeten T, 2001, AM J EPIDEMIOL, V154, P1006, DOI 10.1093/aje/154.11.1006; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047	30	63	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23049	10.1371/journal.pone.0023049	http://dx.doi.org/10.1371/journal.pone.0023049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21887325	Green Published, gold			2022-12-27	WOS:000293563300035
J	Hofherr, SE; Adams, KE; Chen, CY; May, S; Weaver, EA; Barry, MA				Hofherr, Sean E.; Adams, Kristen E.; Chen, Christopher Y.; May, Shannon; Weaver, Eric A.; Barry, Michael A.			Real-Time Dynamic Imaging of Virus Distribution In Vivo	PLOS ONE			English	Article							GENE DELIVERY; ADENOVIRUS; TOXICITY; VECTORS; THERAPY	The distribution of viruses and gene therapy vectors is difficult to assess in a living organism. For instance, trafficking in murine models can usually only be assessed after sacrificing the animal for tissue sectioning or extraction. These assays are laborious requiring whole animal sectioning to ascertain tissue localization. They also obviate the ability to perform longitudinal or kinetic studies in one animal. To track viruses after systemic infection, we have labeled adenoviruses with a near-infrared (NIR) fluorophore and imaged these after intravenous injection in mice. Imaging was able to track and quantitate virus particles entering the jugular vein simultaneous with injection, appearing in the heart within 500 milliseconds, distributing in the bloodstream and throughout the animal within 7 seconds, and that the bulk of virus distribution was essentially complete within 3 minutes. These data provide the first in vivo real-time tracking of the rapid initial events of systemic virus infection.	[Hofherr, Sean E.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Chen, Christopher Y.; May, Shannon; Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Div Infect Dis, Translat Immunovirol & Biodef Program, Dept Internal Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Mayo Grad Sch, Dept Mol Med, Dept Immunol, Rochester, MN USA; [Adams, Kristen E.] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Health Science Center Houston	Hofherr, SE (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	mab@mayo.edu	Chen, Christopher/B-8141-2012	Chen, Christopher/0000-0003-2726-3989; Davies, Benjamin/0000-0003-3623-600X	Muscular Dystrophy Association; N.I.H. [R01-CA136945]; NATIONAL CANCER INSTITUTE [R01CA136945] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to M.A.B. from the Muscular Dystrophy Association and the N.I.H. (R01-CA136945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; Barry MA, 2009, CURR OPIN MOL THER, V11, P411; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; Dubensky TW, 2002, CANCER CELL, V1, P307, DOI 10.1016/S1535-6108(02)00062-4; Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Ottobrini L, 2008, EUR J NUCL MED MOL I, V35, P365, DOI 10.1007/s00259-007-0578-z; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Ray P, 2003, CANCER RES, V63, P1160; Reynolds PN, 2000, MOL THER, V2, P562, DOI 10.1006/mthe.2000.0205; Shashkova EV, 2008, CANCER RES, V68, P5896, DOI 10.1158/0008-5472.CAN-08-0488; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Weaver EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005059	13	202	206	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17076	10.1371/journal.pone.0017076	http://dx.doi.org/10.1371/journal.pone.0017076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347236	gold, Green Published, Green Submitted			2022-12-27	WOS:000287369200018
J	Wang, SY; Sudduth, EB; Wallenstein, MD; Wright, JP; Bernhardt, ES				Wang, Si-Yi; Sudduth, Elizabeth B.; Wallenstein, Matthew D.; Wright, Justin P.; Bernhardt, Emily S.			Watershed Urbanization Alters the Composition and Function of Stream Bacterial Communities	PLOS ONE			English	Article							GLOBAL NITROGEN-CYCLE; DENITRIFYING COMMUNITIES; MICROBIAL COMMUNITIES; CURRENT KNOWLEDGE; DENITRIFICATION; ECOLOGY; URBAN; SOIL; ENRICHMENT; DIVERSITY	Watershed urbanization leads to dramatic changes in draining streams, with urban streams receiving a high frequency of scouring flows, together with the nutrient, contaminant, and thermal pollution associated with urbanization. These changes are known to cause significant losses of sensitive insect and fish species from urban streams, yet little is known about how these changes affect the composition and function of stream microbial communities. Over the course of two years, we repeatedly sampled sediments from eight central North Carolina streams affected to varying degrees by watershed urbanization. For each stream and sampling date, we characterized both overall and denitrifying bacterial communities and measured denitrification potentials. Denitrification is an ecologically important process, mediated by denitrifying bacteria that use nitrate and organic carbon as substrates. Differences in overall and denitrifying bacterial community composition were strongly associated with the gradient in urbanization. Denitrification potentials, which varied widely, were not significantly associated with substrate supply. By incorporating information on the community composition of denitrifying bacteria together with substrate supply in a linear mixed-effects model, we explained 45% of the variation in denitrification potential (p-value<0.001). Our results suggest that (1) the composition of stream bacterial communities change in response to watershed urbanization and (2) such changes may have important consequences for critical ecosystem functions such as denitrification.	[Wang, Si-Yi; Sudduth, Elizabeth B.; Wright, Justin P.; Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Wallenstein, Matthew D.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA	Duke University; Colorado State University	Wang, SY (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	sw56@duke.edu	Bernhardt, Emily/B-4541-2010; Wallenstein, Matthew D/S-3512-2016; Wright, Justin/AAG-6461-2019; Wallenstein, Matthew/C-6441-2008; Bernhardt, Emily S/D-9940-2011	Wallenstein, Matthew D/0000-0002-6219-1442; Wright, Justin/0000-0002-9102-5347; Wallenstein, Matthew/0000-0002-6219-1442; Bernhardt, Emily S/0000-0003-3031-621X; Sudduth, Elizabeth/0000-0001-8274-8159; Sun, Dianjianyi/0000-0003-3651-6693; Lv, Jun/0000-0001-7916-3870; Liu, Miao/0000-0002-7975-6702	National Science Foundation [DEB 0546251]; NC Water Resources Institute; Sigma Xi; Wellesley College; Division Of Environmental Biology [1011376] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NC Water Resources Institute; Sigma Xi; Wellesley College; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from the National Science Foundation (DEB 0546251) (www.nsf.gov) and NC Water Resources Institute (water.usgs.gov/wrri/) to ESB and from Sigma Xi (www.sigmaxi.org) and Wellesley College (web.wellesley.edu) to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beaulieu JJ, 2011, P NATL ACAD SCI USA, V108, P214, DOI 10.1073/pnas.1011464108; Bernhardt ES, 2008, ANN NY ACAD SCI, V1134, P61, DOI 10.1196/annals.1439.014; Bernot MJ, 2003, APPL ENVIRON MICROB, V69, P5950, DOI 10.1128/AEM.69.10.5950-5956.2003; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Crawley M.J., 2007, R BOOK; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goslee SC, 2007, J STAT SOFTWARE, V22; Gotelli NJ, 2013, ECOSIMR 1 00; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017434; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lear G, 2009, ECOL INDIC, V9, P848, DOI 10.1016/j.ecolind.2008.10.001; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LORING DH, 1991, ICES J MAR SCI, V48, P101, DOI 10.1093/icesjms/48.1.101; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meyer JL, 2005, J N AM BENTHOL SOC, V24, P602, DOI 10.1899/04-021.1; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Perryman SE, 2008, AQUAT ECOL, V42, P95, DOI 10.1007/s10452-007-9085-3; Pinheiro J., 2011, NLME LINEAR NONLINEA; Roltsch WJ, 1999, INT J BIOMETEOROL, V42, P169, DOI 10.1007/s004840050101; Rosenberg D.M.., 1993, FRESHWATER BIOMONITO; Roy AH, 2009, J N AM BENTHOL SOC, V28, P908, DOI 10.1899/08-185.1; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Throback IN, 2007, FEMS MICROBIOL LETT, V270, P189, DOI 10.1111/j.1574-6968.2007.00632.x; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Urban D, 2002, ECOSCIENCE, V9, P200, DOI 10.1080/11956860.2002.11682706; USEPA-UNITED STATES ENVIRONMENTAL PROTECTION AGENCY, 1996, AC DIG SED SLUDG SOI; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Waldrop MP, 2006, MICROB ECOL, V52, P716, DOI 10.1007/s00248-006-9103-3; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang SG, 2010, PEDOBIOLOGIA, V54, P9, DOI 10.1016/j.pedobi.2010.08.002; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; Zak DR, 2006, TRENDS ECOL EVOL, V21, P288, DOI 10.1016/j.tree.2006.04.003; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	55	71	73	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2011	6	8							e22972	10.1371/journal.pone.0022972	http://dx.doi.org/10.1371/journal.pone.0022972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CT	21857975	gold, Green Submitted, Green Published			2022-12-27	WOS:000293953500011
